Citrus Sinensis ID: 012164
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 469 | 2.2.26 [Sep-21-2011] | |||||||
| P18160 | 2410 | Dual specificity protein | yes | no | 0.567 | 0.110 | 0.355 | 8e-38 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.535 | 0.390 | 0.353 | 5e-37 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.530 | 0.360 | 0.355 | 1e-35 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.507 | 0.610 | 0.359 | 1e-35 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.518 | 0.149 | 0.340 | 4e-35 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.509 | 0.144 | 0.323 | 9e-35 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.501 | 0.313 | 0.346 | 1e-34 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.520 | 0.266 | 0.334 | 3e-34 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.541 | 0.388 | 0.325 | 4e-34 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.492 | 0.139 | 0.342 | 5e-34 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 158 bits (400), Expect = 8e-38, Method: Composition-based stats.
Identities = 106/298 (35%), Positives = 158/298 (53%), Gaps = 32/298 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
EYEID +EL+F + I KG F +WR VA+K + + + F++E+ +
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164
Query: 204 LQKIRHPNVVQFLGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGAL---KPSTAVRFALD 258
L K+RHPNVVQFLGA T IVTE++ G LR FL L P ++ ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL--KVADFGVSKLLTV 316
IA+GMNYLH P PI+HRDL ++ + + + +N + ++ K++DFG+S+L
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM- 2282
Query: 317 KEDRPLTCQDTSC-RYVAPEVFKNEEYDTKVDVFSFALILQEMI------EGCPPFTMKH 369
E Q C Y+APEVFK + K DV+S+ ++L E++ + P M H
Sbjct: 2283 -EQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 370 DNEVPKAYAARQRP-PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426
AY + + P P +K KE++ +CW+ P RPTF+QII L+ + +
Sbjct: 2342 ----LAAYESYRPPIPLTTSSK-----WKEILTQCWDSNPDSRPTFKQIIVHLKEMED 2390
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (393), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 103/291 (35%), Positives = 157/291 (53%), Gaps = 40/291 (13%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+ID H++ V I KG + L WRG QVAVKKL I +++ ++ F E+ L++
Sbjct: 368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 424
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
+RHPNV+QFLG+ + I TEY+P+G L + L + L+ S ++ +D A+G+
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T
Sbjct: 485 YLHNSTPV-ILHRDLK-----------SHNLLVDENWKVKVADFGLSTI--EQQGATMTA 530
Query: 325 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE------GCPPFTMKHDNEVPKAYA 378
T C + +PEV +++ Y K DV+SF +IL E G PPF + +
Sbjct: 531 CGTPC-WTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQV-----IFAVGR 584
Query: 379 ARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427
RPP P K +L+ +C NE P+ RPT Q + RLESI++S
Sbjct: 585 EGMRPPVPQNGPPKYI-----QLLIDCLNENPSHRPTMEQCLERLESIDSS 630
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 151 bits (382), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 102/287 (35%), Positives = 152/287 (52%), Gaps = 38/287 (13%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+ID ++ V I KG F L WRG QVAVKKL I +++ ++ F E+ L++
Sbjct: 385 DIDTQQIKI--GVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 441
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
+RHPNV+QFLG+ S + I TEY+P+G L + L K + S R +D A+G+
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGII 501
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T
Sbjct: 502 YLHGSTPV-ILHRDLK-----------SHNLLVDENWKVKVADFGLSTI--EQQGATMTA 547
Query: 325 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE------GCPPFTMKHDNEVPKAYA 378
T C + +PEV +++ Y K DV+SF +IL E G PPF +
Sbjct: 548 CGTPC-WTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPF---------QVIF 597
Query: 379 ARQRPPFKAPAKLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESI 424
A R + P Y +L+++C NE P++RPT Q + LESI
Sbjct: 598 AVGREGMRPPTPKYGPPKYIQLLKDCLNENPSQRPTMEQCLEILESI 644
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 151 bits (381), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 96/267 (35%), Positives = 142/267 (53%), Gaps = 29/267 (10%)
Query: 172 FWRGI----QVAVKKLGEEVISDDDRVR---AFRDELALLQKIRHPNVVQFLGAVTQSSP 224
+RGI VAVK + ++ R + F+ E+ALL ++ HPN+VQF+ A +
Sbjct: 100 IYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 159
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
I+TEY+ +G+LR +L +K +L T +R ALDI+RGM YLH +IHRDL+
Sbjct: 160 YCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQG---VIHRDLK-- 214
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 342
N+L +D +KVADFG S L T + R + R++APE+ K + Y
Sbjct: 215 ---------SNNLLLNDEMRVKVADFGTSCLET--QCREAKGNMGTYRWMAPEMIKEKPY 263
Query: 343 DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIE 401
KVDV+SF ++L E+ PF + A A + +RPP A + L LI+
Sbjct: 264 TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQ---PALAHLIK 320
Query: 402 ECWNEKPAKRPTFRQIITRLESINNSI 428
CW+E P+KRP F I+ LE + +
Sbjct: 321 RCWSENPSKRPDFSNIVAVLEKYDECV 347
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 149 bits (376), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 96/282 (34%), Positives = 154/282 (54%), Gaps = 39/282 (13%)
Query: 162 EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
+I G++ + F W+G+ VAVKK ++ +S+ ++ FR E+A L +++H N+V F+GA
Sbjct: 1369 QIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSET-QLLEFRAEMAFLSELKHSNIVTFIGA 1427
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA------LDIARGMNYLHENKPV 272
+ + IVTEY+ G+LR LK P + FA A G++YLH + P+
Sbjct: 1428 CIKKPNICIVTEYMRMGNLRDVLKN-----PDIKITFANKLKLLYGAAMGIDYLHSSNPM 1482
Query: 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRY 331
I+HRD++P+ NIL D+ N+K+ADFG ++ +KED +T T C +
Sbjct: 1483 -IVHRDIKPA-----------NILVDEHFNVKIADFGFAR---IKEDNTTMTRCGTPC-W 1526
Query: 332 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--PFKAPA 389
APEV + E+Y K DVFSF +++ E++ G PF + +V RP P P
Sbjct: 1527 TAPEVIRGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDILEGGRPIIPSDCPH 1586
Query: 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 431
+ +LI++CW+ K KRPT +++ +L I +HK
Sbjct: 1587 E-----FAKLIKKCWHAKAHKRPTMTEVVQQLMLITEQFDHK 1623
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 148 bits (373), Expect = 9e-35, Method: Compositional matrix adjust.
Identities = 86/266 (32%), Positives = 151/266 (56%), Gaps = 27/266 (10%)
Query: 162 EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
+I G++ + + W+ + VA+KK ++ I D++ + R+E+A L+K+ HPN++ +GA
Sbjct: 1404 QIGLGSYGVVYRGKWKNVDVAIKKFIKQKI-DENHLLGIREEIAFLKKLHHPNIITMVGA 1462
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
+ + IVTEY+ KG+LR ++ L+ ++ ++IA+G++YLH P PIIHR
Sbjct: 1463 SLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHSFDP-PIIHR 1521
Query: 278 DLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 337
D++PS NIL D++ N+K+ADFG ++ +KE+ + + + + APE+
Sbjct: 1522 DIKPS-----------NILIDENWNVKIADFGFAR---IKEENAIMTRCGTPCWTAPEII 1567
Query: 338 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--PFKAPAKLYARG 395
+N+ YD KVDVFSF +++ E++ PF + ++ RP P P +
Sbjct: 1568 RNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDILEDVRPKIPQDCPEE----- 1622
Query: 396 LKELIEECWNEKPAKRPTFRQIITRL 421
+L+ +CW+ K KRPT +I L
Sbjct: 1623 FAKLMRKCWHAKSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (372), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 95/274 (34%), Positives = 143/274 (52%), Gaps = 39/274 (14%)
Query: 162 EITKGTFILAFWRGIQVAVKK---LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
E+ GT WRGI VA+KK L E+ D+D + E ++ ++RHPN+ QFLG
Sbjct: 504 EVFTGT-----WRGIIVAIKKAKLLNED---DEDFLNELAQEATIMSQLRHPNICQFLGT 555
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV------RFALDIARGMNYLHENKPV 272
++IV EY+P G L L PS ++ ALDIA+GMNYLH P+
Sbjct: 556 CNNPPEILIVMEYMPLGSLYRILH-----DPSISLDWPRMKSMALDIAKGMNYLHCCDPI 610
Query: 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR--PLTCQDTSCR 330
+IHRDL+ N+L D+ +K++DFG+S D+ +T T C
Sbjct: 611 -VIHRDLK-----------SHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPC- 657
Query: 331 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390
+ APEV +N+ Y K DVFSFA++L E++ P+ ++ + + P P
Sbjct: 658 WTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQ- 716
Query: 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+ LI ECW+E P +RP+F++I+ RLE++
Sbjct: 717 -VSAPFTRLITECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 146 bits (368), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 91/272 (33%), Positives = 147/272 (54%), Gaps = 28/272 (10%)
Query: 160 SVEITKGTFILAF---WRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214
S ++ +GTF + + WRG VA+K K+ E+V ++ + FR EL +L ++RHPN+V
Sbjct: 665 SSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDV--NNQVLEEFRKELTILSRLRHPNIVL 722
Query: 215 FLGAVTQSSPMMIVTEYLPKGDLR-AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
+ A T + +TEYLP G L A +K + + A+ IA+GMNYLH +
Sbjct: 723 LMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHLSG--- 779
Query: 274 IIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 333
+IHRD++ N+L D+ N+K+ DFG+SKL + + +T S +++
Sbjct: 780 VIHRDIK-----------SLNLLLDEHMNVKICDFGLSKLKS--KSTEMTKSIGSPIWMS 826
Query: 334 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLY 392
PE+ E+Y KVDV++F +IL E+ G P++ ++ A + RPP +
Sbjct: 827 PELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPI---PNAW 883
Query: 393 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
L LI+ CW++ P KRP+F +I+ L I
Sbjct: 884 PYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 146 bits (368), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 93/286 (32%), Positives = 155/286 (54%), Gaps = 32/286 (11%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
E+ +EID +E+ + ++ G F + RG +VA+KKL + V +++ + F+ E
Sbjct: 161 EIIRWEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVF-EENTMNEFKKE 219
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
++L+ K+R+P+++ F+GA T + IVTE +PKG + + L+ K + A+ IA
Sbjct: 220 VSLMAKLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIA 279
Query: 261 R----GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
R GM +LH + I+H DL+P+ N+L D + +KVADFG+SK +
Sbjct: 280 RDTVLGMTWLHASN---ILHLDLKPA-----------NLLVDQNWVVKVADFGLSKYMKP 325
Query: 317 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---V 373
L Q S Y+APE+ N+ YD KVDVFSF+++L E++ P+ + + V
Sbjct: 326 DSKDKLLGQAGSPLYMAPEMLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLV 385
Query: 374 PKAYAARQRP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 417
+ RP P P + LK+L+ CW+ P++RP+F +I
Sbjct: 386 EGVVNKKNRPIIPDYFPTR-----LKDLLARCWDHYPSRRPSFAEI 426
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 145 bits (367), Expect = 5e-34, Method: Compositional matrix adjust.
Identities = 90/263 (34%), Positives = 146/263 (55%), Gaps = 32/263 (12%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
G + W+ I VAVKK ++ I D+ ++ FR E+A L ++RHP+++ +GA + +
Sbjct: 1406 GIVNMGKWKNINVAVKKFVKQKI-DEKQMLEFRAEIAFLSQLRHPHIILMIGACLKRPNI 1464
Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL--DIARGMNYLHENKPVPIIHRDLEPSD 283
IVTE++ G LR +K KP ++ + A G+ YLH + P+ IIHRD++PS
Sbjct: 1465 CIVTEFMGNGSLRNVIKTT---KPEWKLKIKMLYQTALGIGYLHNSDPI-IIHRDIKPS- 1519
Query: 284 LYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 343
NIL DDS N+K+ADFG +++ +E+ +T T C + APE+ + E+Y
Sbjct: 1520 ----------NILVDDSMNVKIADFGFARI--KEENSVMTRCGTPC-WTAPEIIRGEKYT 1566
Query: 344 TKVDVFSFALILQEMIEGCPPFT----MKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 399
KVDVFSF +++ E++ PF+ MK ++ + AR + P P +L
Sbjct: 1567 EKVDVFSFGIVMWEVLTCKEPFSGCNFMKVSMDILE--GARPQIPSDCPID-----FTKL 1619
Query: 400 IEECWNEKPAKRPTFRQIITRLE 422
+++CW+ KP KRP+ +I L
Sbjct: 1620 MKQCWHAKPDKRPSMEDVIMGLN 1642
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 469 | ||||||
| 356555470 | 456 | PREDICTED: probable serine/threonine-pro | 0.936 | 0.962 | 0.774 | 0.0 | |
| 255562560 | 466 | protein kinase, putative [Ricinus commun | 0.938 | 0.944 | 0.777 | 0.0 | |
| 356549162 | 455 | PREDICTED: probable serine/threonine-pro | 0.933 | 0.962 | 0.770 | 0.0 | |
| 225443668 | 462 | PREDICTED: dual specificity protein kina | 0.942 | 0.956 | 0.757 | 0.0 | |
| 224076914 | 423 | predicted protein [Populus trichocarpa] | 0.901 | 1.0 | 0.772 | 0.0 | |
| 449459316 | 458 | PREDICTED: serine/threonine-protein kina | 0.923 | 0.945 | 0.762 | 0.0 | |
| 356499380 | 454 | PREDICTED: dual specificity protein kina | 0.927 | 0.958 | 0.716 | 0.0 | |
| 449433589 | 460 | PREDICTED: probable serine/threonine-pro | 0.929 | 0.947 | 0.735 | 0.0 | |
| 356553484 | 453 | PREDICTED: serine/threonine-protein kina | 0.933 | 0.966 | 0.702 | 0.0 | |
| 102139950 | 467 | protein kinase, putative [Musa balbisian | 0.927 | 0.931 | 0.689 | 1e-180 |
| >gi|356555470|ref|XP_003546054.1| PREDICTED: probable serine/threonine-protein kinase drkB-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/453 (77%), Positives = 395/453 (87%), Gaps = 14/453 (3%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
ME+K P R TL KQSSLAP+R KEAEL DGE + RLM+ A E DV+GI+E L
Sbjct: 1 MESKNPARFTLGKQSSLAPERHNKEAELQ---KDGEAVDQGVRLMYSAFEGDVDGIREAL 57
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+SG+ VN++DIDNRTALHVAAC+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58 ESGVSVNYKDIDNRTALHVAACEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGAKPLMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF A WRG +VAV
Sbjct: 118 VIKLLEKHGAKPLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCSALWRGTKVAV 177
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300
+KRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPS NILRDDS
Sbjct: 238 MKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPS-----------NILRDDS 286
Query: 301 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 360
G+LKVADFGVSKLL VKED+PLTCQDTSCRYVAPEVF+ EEYDTKVDVFSFALILQEMIE
Sbjct: 287 GHLKVADFGVSKLLAVKEDKPLTCQDTSCRYVAPEVFRQEEYDTKVDVFSFALILQEMIE 346
Query: 361 GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420
GCPPF+ K D+EVPK YAA++RPPF+APAK Y+ G++ELIEECWNE PAKRPTFRQIIT+
Sbjct: 347 GCPPFSAKQDDEVPKVYAAKERPPFQAPAKRYSHGIRELIEECWNENPAKRPTFRQIITK 406
Query: 421 LESINNSINHKRRWKIRTMKCFHNLEAMLKKDH 453
LESI N+I HKR WK+R +KCF NLEA+LK+DH
Sbjct: 407 LESIYNTIGHKRHWKVRPLKCFQNLEALLKRDH 439
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562560|ref|XP_002522286.1| protein kinase, putative [Ricinus communis] gi|223538539|gb|EEF40144.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1887), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/463 (77%), Positives = 396/463 (85%), Gaps = 23/463 (4%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-----------IKPEFRLMFLAN 49
ME K VR TL KQSSLAP+R R+E N ++ E+ I P RLM+ +
Sbjct: 1 MEGKSSVRFTLGKQSSLAPERSREEDVSNDQEEGSEDMSNDPEEELEDIHPGVRLMYSCH 60
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
E D++GI+ELLDSGIDVNFRDIDNRTALH+AACQG+T+VV+LLL GA+ DPKDRWGSTP
Sbjct: 61 EGDLDGIRELLDSGIDVNFRDIDNRTALHLAACQGYTDVVALLLNNGAETDPKDRWGSTP 120
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFI 169
L DAIYYKNH+VIKLLEK GAKPLMAPMHV HAREVPEYEI+PHELDFTNSVEITKGTF
Sbjct: 121 LADAIYYKNHDVIKLLEKRGAKPLMAPMHVNHAREVPEYEINPHELDFTNSVEITKGTFH 180
Query: 170 LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
LA WRGIQVAVKKLGE+VISD+D+VRAF DELALLQKIRHPNVVQFLGAVTQSSPMMIVT
Sbjct: 181 LASWRGIQVAVKKLGEDVISDEDKVRAFSDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 240
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
EYL KGDLRAFLK+KGAL+P TAVRF LDIARG+NYLHENKP PIIHRDLEPS
Sbjct: 241 EYLHKGDLRAFLKKKGALRPGTAVRFGLDIARGLNYLHENKP-PIIHRDLEPS------- 292
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 349
NILRDDSG+LKVADFGVSKLLTVKED+PLTCQDTSCRYVAPEVFK+EEYDTKVDVF
Sbjct: 293 ----NILRDDSGHLKVADFGVSKLLTVKEDKPLTCQDTSCRYVAPEVFKHEEYDTKVDVF 348
Query: 350 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 409
SFALILQEMIEGCPPF+ K D EVPK+YAA++RPPF+AP K Y GLK+LI+ECWNE PA
Sbjct: 349 SFALILQEMIEGCPPFSAKQDLEVPKSYAAKERPPFRAPTKHYPHGLKDLIQECWNENPA 408
Query: 410 KRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKD 452
KRPTFRQIIT+LESI NSI HKRRWK+R +KCF N EAMLKKD
Sbjct: 409 KRPTFRQIITKLESIYNSIGHKRRWKVRPLKCFQNFEAMLKKD 451
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549162|ref|XP_003542966.1| PREDICTED: probable serine/threonine-protein kinase drkA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1856), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/453 (77%), Positives = 393/453 (86%), Gaps = 15/453 (3%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
ME+K P R TL KQSSLAP+R KEAEL +DGE + RLM+ A E DV+GI E L
Sbjct: 1 MESKNPARFTLGKQSSLAPERHNKEAELQ---NDGEVVDQGVRLMYSAFEGDVDGICEAL 57
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ G+ VN++DIDNRTALHVA C+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58 EFGVSVNYKDIDNRTALHVAVCEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGAK LMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF +A WRG +VAV
Sbjct: 118 VIKLLEKHGAKLLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCIALWRGTEVAV 177
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300
LKRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPS NILRDDS
Sbjct: 238 LKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPS-----------NILRDDS 286
Query: 301 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 360
G+LKVADFGVSKLL VKED+PLTC DTSCRYVAPEVF+ +EYDTKVDVFSFALILQEMIE
Sbjct: 287 GHLKVADFGVSKLLAVKEDKPLTCHDTSCRYVAPEVFR-QEYDTKVDVFSFALILQEMIE 345
Query: 361 GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420
GCPPF+ K DNEVPK YAA++RPPF+APAK Y+ G++ELIEECWNE PAKRPTFRQIITR
Sbjct: 346 GCPPFSAKQDNEVPKVYAAKERPPFRAPAKHYSYGIRELIEECWNENPAKRPTFRQIITR 405
Query: 421 LESINNSINHKRRWKIRTMKCFHNLEAMLKKDH 453
LESI N+I+HKR WK+R +KCF NLEA+LK+DH
Sbjct: 406 LESIYNTISHKRHWKVRPLKCFQNLEALLKRDH 438
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225443668|ref|XP_002263226.1| PREDICTED: dual specificity protein kinase shkB [Vitis vinifera] gi|297740576|emb|CBI30758.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 710 bits (1833), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/457 (75%), Positives = 391/457 (85%), Gaps = 15/457 (3%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
+E+K VR TL KQSSLAP+R R EA G D E I P RLM+LANE D+EG++ELL
Sbjct: 3 VESKTAVRFTLGKQSSLAPERARDEALTEGEQGDVEGIDPRVRLMYLANEGDLEGLRELL 62
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
DSG+DVNFRDIDNRTALHVAACQGF++VV LL+ GA++D +DRWGSTPL DAI+YKNH+
Sbjct: 63 DSGMDVNFRDIDNRTALHVAACQGFSDVVEFLLKNGAEIDLEDRWGSTPLADAIHYKNHD 122
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGA+ LMAPMHV +AREVPEYEIDP ELDFTNSV+ITKGT+ +A WRGIQVAV
Sbjct: 123 VIKLLEKHGAQHLMAPMHVNNAREVPEYEIDPKELDFTNSVDITKGTYRIASWRGIQVAV 182
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
K+LG+EVI D+D+V+AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL AF
Sbjct: 183 KRLGDEVIIDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLHAF 242
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300
LKRKGALK +TAV+FALDIARGMNYLHE++P IIHRDLEPS NILRDDS
Sbjct: 243 LKRKGALKTATAVKFALDIARGMNYLHEHRPEAIIHRDLEPS-----------NILRDDS 291
Query: 301 GNLKVADFGVSKLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 356
G+LKVADFGVSKLL TVKED PL CQ+TSCRY+APEVFKNE YDTKVDVFSFALILQ
Sbjct: 292 GHLKVADFGVSKLLKVANTVKEDYPLICQETSCRYLAPEVFKNEAYDTKVDVFSFALILQ 351
Query: 357 EMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
EMIEGCPPF+ K +NEVPK YAA++RPPF+AP+KLY+ GLKELIEECWNE P KRPTF Q
Sbjct: 352 EMIEGCPPFSAKPENEVPKVYAAQERPPFRAPSKLYSHGLKELIEECWNENPTKRPTFGQ 411
Query: 417 IITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDH 453
I+TRL+ I N + KRRWK+R +KCF NLEAM KKDH
Sbjct: 412 ILTRLDRIYNHLGQKRRWKVRPLKCFQNLEAMWKKDH 448
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076914|ref|XP_002305047.1| predicted protein [Populus trichocarpa] gi|222848011|gb|EEE85558.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 703 bits (1814), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/439 (77%), Positives = 385/439 (87%), Gaps = 16/439 (3%)
Query: 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN 67
R TL KQSSLAP+R+R+E+++ D DG + P RLM+LANE ++EGIKEL++S +DVN
Sbjct: 1 RFTLGKQSSLAPERDREESDV---DMDG--VDPGVRLMYLANEGNLEGIKELVNSDVDVN 55
Query: 68 FRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
FRDID RTALH+A+CQG T+VV LLL+ GA++DPKDRWGSTPL DAI+YKNH+VIKLLEK
Sbjct: 56 FRDIDGRTALHIASCQGLTQVVDLLLDHGAEIDPKDRWGSTPLADAIFYKNHDVIKLLEK 115
Query: 128 HGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEV 187
GAKPLMAPMHVKHAREVPEYEI+P ELDFTNSVE+TKGTF +A WRGIQVAVKKLGEEV
Sbjct: 116 RGAKPLMAPMHVKHAREVPEYEINPDELDFTNSVELTKGTFCVALWRGIQVAVKKLGEEV 175
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
+SD+D+VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE+LPKGD AFLKRKGAL
Sbjct: 176 LSDEDKVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEFLPKGDFCAFLKRKGAL 235
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307
KP AVR ALDIARGMNYLHENKPVPIIHRDLEPS NILRDDSG+LKVAD
Sbjct: 236 KPIAAVRLALDIARGMNYLHENKPVPIIHRDLEPS-----------NILRDDSGHLKVAD 284
Query: 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 367
FG+SKLLTVKE++PL D S RYVAPEVFKNEEYDTKVD+FSFALILQEMIEGCPPF+
Sbjct: 285 FGISKLLTVKEEKPLISLDNSWRYVAPEVFKNEEYDTKVDIFSFALILQEMIEGCPPFSA 344
Query: 368 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427
K ++EVP AYAA++RPPF+AP K YA GLKELI+ECW+E PAKRPTFRQI+TRL++I NS
Sbjct: 345 KQEHEVPSAYAAKERPPFRAPTKSYAHGLKELIQECWHENPAKRPTFRQILTRLDAIQNS 404
Query: 428 INHKRRWKIRTMKCFHNLE 446
I HKRRWK+R +KCF NLE
Sbjct: 405 IGHKRRWKVRPLKCFQNLE 423
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449459316|ref|XP_004147392.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/447 (76%), Positives = 384/447 (85%), Gaps = 14/447 (3%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV 66
VR L KQSS+APDR+ +EAEL +DGEEI P RLM+LANE D+EGIKELLDSGIDV
Sbjct: 11 VRFLLGKQSSMAPDRQPEEAELA---EDGEEIDPGVRLMYLANEGDLEGIKELLDSGIDV 67
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
NF DIDNRTALH+AACQG E+V LLL RGA++DPKDRWGSTPL DAI+YKNHEVIKLLE
Sbjct: 68 NFHDIDNRTALHIAACQGCNEIVDLLLRRGAEIDPKDRWGSTPLADAIFYKNHEVIKLLE 127
Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEE 186
K GAK LMAPMHVKHAREVPEYEIDP E DFTNSV +TKGTF LA WRGIQVAVK+L E+
Sbjct: 128 KRGAKHLMAPMHVKHAREVPEYEIDPKEFDFTNSVNLTKGTFHLASWRGIQVAVKELPED 187
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
VIS++D+V AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL L +KG
Sbjct: 188 VISEEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCQLLHKKGP 247
Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306
LKP AV+FALDIARGMNYLHENKP PIIHRDLEPS NILRDD+GNLKVA
Sbjct: 248 LKPIVAVKFALDIARGMNYLHENKPAPIIHRDLEPS-----------NILRDDTGNLKVA 296
Query: 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 366
DFGVSKLLTVKED+PLTCQDT+CRYVAPEVFKN YDTKVDVFSFALILQEMIEG PPF+
Sbjct: 297 DFGVSKLLTVKEDKPLTCQDTACRYVAPEVFKNNGYDTKVDVFSFALILQEMIEGQPPFS 356
Query: 367 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426
K +N + K YAA RPPFKAPAK YA G+KELIE CW+E+P+KRPTFRQIITRLE+I++
Sbjct: 357 NKKENAICKGYAAGMRPPFKAPAKCYAHGIKELIEACWDERPSKRPTFRQIITRLETIHH 416
Query: 427 SINHKRRWKIRTMKCFHNLEAMLKKDH 453
S++H+RRWK+ T++CF + +A +++DH
Sbjct: 417 SLSHRRRWKLPTLRCFQDPDAKIRRDH 443
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499380|ref|XP_003518519.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/458 (71%), Positives = 372/458 (81%), Gaps = 23/458 (5%)
Query: 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDS 62
K+ R +L +QSSLAP+R G D E + P RLM+LANE D +GIKELLD+
Sbjct: 5 KLQPRFSLGRQSSLAPER-------GGCGGDASEALDPAVRLMYLANEGDSDGIKELLDA 57
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVNF DID RTALHVAACQG T+VV LLL RGADVDP+DRWGSTPL DA+YYKNH+V+
Sbjct: 58 GSDVNFTDIDGRTALHVAACQGRTDVVGLLLRRGADVDPQDRWGSTPLVDAMYYKNHDVV 117
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
KLLEKHGA+P MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRG QVAVK
Sbjct: 118 KLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGTQVAVKT 177
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
LGEE+ +DDD+V+AF DEL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDLRA+LK
Sbjct: 178 LGEELFTDDDKVKAFHDELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLRAYLK 237
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302
RKGALKP TAV+FALDIARGMNYLHE+KP IIHRDLEPS NILRDDSG+
Sbjct: 238 RKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPS-----------NILRDDSGH 286
Query: 303 LKVADFGVSKLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 358
LKVADFGVSKLL TVKED+P+T DTS RYVAPEV+KNEEYDTKVDVFSFALILQEM
Sbjct: 287 LKVADFGVSKLLKVAKTVKEDKPVTSLDTSWRYVAPEVYKNEEYDTKVDVFSFALILQEM 346
Query: 359 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
IEGCPPF K +NEVPKAY +RPPF+A KLYA GLK+LIEECW+EKP +RPTFRQII
Sbjct: 347 IEGCPPFYEKPENEVPKAYVENERPPFRASPKLYAYGLKQLIEECWDEKPYRRPTFRQII 406
Query: 419 TRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSP 456
RLE I + KRRWK+R CF NLE + + + ++P
Sbjct: 407 GRLEDIYYHLAQKRRWKVRAPGCFQNLEVIFRGNRTNP 444
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433589|ref|XP_004134580.1| PREDICTED: probable serine/threonine-protein kinase drkD-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 655 bits (1691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/450 (73%), Positives = 368/450 (81%), Gaps = 14/450 (3%)
Query: 6 PVRTTLLKQSSLAPDRERKEAELNGL---DDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
PV+ L KQSSLAPD + +L L E I RLM+LANE D+EGI E+LDS
Sbjct: 4 PVKFKLGKQSSLAPDGDVHLEDLEELVKQHQTEEGIDSRVRLMYLANEGDLEGINEVLDS 63
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G+DVNFRDIDNRTALH+AACQGF +VV+LLLERGA+VD KDRWGSTPL DAI+YKNH+VI
Sbjct: 64 GVDVNFRDIDNRTALHIAACQGFADVVALLLERGAEVDSKDRWGSTPLRDAIHYKNHDVI 123
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
KLLEKHGAKP +APM VK+AREVP+YEIDP ELDFTNSV ITKGTF A WRG +VAVK+
Sbjct: 124 KLLEKHGAKPPVAPMLVKNAREVPDYEIDPKELDFTNSVNITKGTFRRASWRGTEVAVKE 183
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
LGE++ +D+++VRAFRDELALLQKIRHPNVVQFLGAVTQS PMMIVTEYLPKGDL A L
Sbjct: 184 LGEDLFTDEEKVRAFRDELALLQKIRHPNVVQFLGAVTQSWPMMIVTEYLPKGDLGALLS 243
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302
RK +K + VR ALDIARGMNYLHENKP PIIHR+LEPS NILRDDSG+
Sbjct: 244 RKREIKTMSVVRLALDIARGMNYLHENKPAPIIHRNLEPS-----------NILRDDSGH 292
Query: 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 362
LKVADFGVSKLLTVKED+ TC +TS RY APEVFKNEEYDTKVDVFSFALILQEM+EGC
Sbjct: 293 LKVADFGVSKLLTVKEDKFSTCSETSRRYQAPEVFKNEEYDTKVDVFSFALILQEMLEGC 352
Query: 363 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
PF K D+EVPK YAA +RPPF A K YA GLKELIEECWNEKP KRPTFRQIIT+LE
Sbjct: 353 SPFPDKADSEVPKLYAAGERPPFGALIKRYANGLKELIEECWNEKPNKRPTFRQIITQLE 412
Query: 423 SINNSINHKRRWKIRTMKCFHNLEAMLKKD 452
I N HKRRWK+R +KCF N+EAMLKKD
Sbjct: 413 FIYNRFCHKRRWKVRPLKCFQNIEAMLKKD 442
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553484|ref|XP_003545086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 648 bits (1672), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/461 (70%), Positives = 371/461 (80%), Gaps = 23/461 (4%)
Query: 1 METK-VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKEL 59
METK + R +L +QSSLAP+R G D E + P RLM+LANE D +GIKEL
Sbjct: 1 METKKLHPRFSLGRQSSLAPERA-------GAGDSSEALDPAVRLMYLANEGDSDGIKEL 53
Query: 60 LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
LD+G +VNF DID RT+LHVAACQG T+VV LLL RGA VDP+DRWGSTPL DA+YYKNH
Sbjct: 54 LDAGSNVNFTDIDGRTSLHVAACQGRTDVVDLLLRRGAHVDPQDRWGSTPLVDAMYYKNH 113
Query: 120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVA 179
+V+KLLEKHGA+P MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRGIQVA
Sbjct: 114 QVVKLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGIQVA 173
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
VK LGEE+ +DDD+V+AF EL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDL A
Sbjct: 174 VKTLGEELFTDDDKVKAFHYELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLGA 233
Query: 240 FLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299
+LKRKGALKP TAV+FALDIARGMNYLHE+KP IIHRDLEPS NILRDD
Sbjct: 234 YLKRKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPS-----------NILRDD 282
Query: 300 SGNLKVADFGVSKLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 355
SG+LKVADFGVSKLL VKED+P+ DTS RYVAPEV++NEEYDT VDVFSFALIL
Sbjct: 283 SGHLKVADFGVSKLLKVAKMVKEDKPVASLDTSWRYVAPEVYRNEEYDTNVDVFSFALIL 342
Query: 356 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 415
QEMIEGCPPF K +NEVPKAY +RPPF+A KLYA GLK+LIEECW+EKP +RPTFR
Sbjct: 343 QEMIEGCPPFFAKPENEVPKAYVENERPPFRASPKLYAYGLKQLIEECWDEKPYRRPTFR 402
Query: 416 QIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSP 456
QII RLE I + KR WK+RT CF NLEA+ + + ++P
Sbjct: 403 QIIGRLEDIYYHLAQKRGWKVRTPGCFQNLEAIFRGNRTNP 443
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|102139950|gb|ABF70090.1| protein kinase, putative [Musa balbisiana] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1645), Expect = e-180, Method: Compositional matrix adjust.
Identities = 327/474 (68%), Positives = 368/474 (77%), Gaps = 39/474 (8%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAE-LNGLDDDG----EEIKPEFRLMFLANERDVEG 55
ME K R TL KQSSLAPDR+ E + L D DG EE+ RLM+LANE D+ G
Sbjct: 1 MEAKSTGRFTLGKQSSLAPDRDDGELQALRSGDLDGLQVPEEVDANIRLMYLANEGDLAG 60
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST------- 108
I+E L SG+DVNFRDID+RTALHVAACQGF +VV LLL+RGA VDP+DRWGST
Sbjct: 61 IEETLASGVDVNFRDIDDRTALHVAACQGFADVVQLLLDRGAQVDPEDRWGSTSNFITIA 120
Query: 109 ----PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEIT 164
PL DA++YKNHEVIKL EKHGAK + PM V++AREVPEYEIDP ELDFTNSV IT
Sbjct: 121 PAKQPLADAVHYKNHEVIKLFEKHGAKLRVTPMRVENAREVPEYEIDPSELDFTNSVNIT 180
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQFL 216
KGTFI+A WRGIQVAVKK ++V++D+D++ RAFRDELALLQ+IRHPNVVQFL
Sbjct: 181 KGTFIIAKWRGIQVAVKKFNDDVMADEDKLWDFFIFCRRAFRDELALLQQIRHPNVVQFL 240
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
GAVTQSSPMMIVTEYL KGDLRA+L RK L+PS+AV FALDIARGMNYLHE+KP IIH
Sbjct: 241 GAVTQSSPMMIVTEYLRKGDLRAYLNRKRTLRPSSAVLFALDIARGMNYLHEHKPEAIIH 300
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL----TVKEDRPLTCQDTSCRYV 332
RDLEPS NILRDDSG+LKVADFGVSKLL TVKE+RPLTC DT+CRYV
Sbjct: 301 RDLEPS-----------NILRDDSGHLKVADFGVSKLLKVAKTVKEERPLTCLDTACRYV 349
Query: 333 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 392
APEVF NEEYDTKVDVFSFALILQEMIEGCPPF+ K DNEVPKAY ++QRPPF+AP K Y
Sbjct: 350 APEVFLNEEYDTKVDVFSFALILQEMIEGCPPFSYKQDNEVPKAYVSKQRPPFRAPPKQY 409
Query: 393 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLE 446
A GLKELIE CW+E PA RPTFR+II RL I N I KRRWK+ + L+
Sbjct: 410 AHGLKELIEHCWSENPADRPTFREIIDRLSKIQNHIAQKRRWKVSLFNFYLGLQ 463
|
Source: Musa balbisiana Species: Musa balbisiana Genus: Musa Family: Musaceae Order: Zingiberales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 469 | ||||||
| TAIR|locus:2117129 | 459 | AT4G18950 [Arabidopsis thalian | 0.923 | 0.943 | 0.698 | 2.4e-163 | |
| TAIR|locus:2098999 | 471 | AT3G58760 [Arabidopsis thalian | 0.942 | 0.938 | 0.640 | 5.4e-150 | |
| TAIR|locus:2044034 | 479 | AT2G43850 [Arabidopsis thalian | 0.886 | 0.868 | 0.471 | 1.1e-96 | |
| TAIR|locus:2045258 | 476 | AT2G31800 [Arabidopsis thalian | 0.889 | 0.876 | 0.462 | 3e-94 | |
| TAIR|locus:2080517 | 477 | AT3G59830 [Arabidopsis thalian | 0.891 | 0.876 | 0.462 | 2.1e-91 | |
| TAIR|locus:2014849 | 438 | VIK "VH1-interacting kinase" [ | 0.810 | 0.867 | 0.444 | 1.6e-79 | |
| WB|WBGene00016030 | 850 | C24A1.3 [Caenorhabditis elegan | 0.545 | 0.301 | 0.35 | 2.6e-38 | |
| DICTYBASE|DDB_G0289791 | 642 | drkA "DRK subfamily protein ki | 0.545 | 0.398 | 0.360 | 1.5e-36 | |
| DICTYBASE|DDB_G0283385 | 2410 | splA "protein kinase, TKL grou | 0.579 | 0.112 | 0.363 | 3.9e-36 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.552 | 0.338 | 0.358 | 2.5e-35 |
| TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1590 (564.8 bits), Expect = 2.4e-163, P = 2.4e-163
Identities = 313/448 (69%), Positives = 363/448 (81%)
Query: 8 RTTLLKQSSLAPDR--ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
R T+ +QSS+AP++ E + +DGEEI RLM+LANE D+EGIKEL+DSGID
Sbjct: 9 RFTIGRQSSMAPEKIPEPSVHSEEEVFEDGEEIDGGVRLMYLANEGDIEGIKELIDSGID 68
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
N+RDID+RTALHVAACQG +VV LLL+R A+VDPKDRWGSTP DAI+YKN +VIK+L
Sbjct: 69 ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPKDRWGSTPFADAIFYKNIDVIKIL 128
Query: 126 EKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGE 185
E HGAK MAPMHVK AREVPEYEI+P ELDFT S EITKGT+ +A WRGIQVAVKKL +
Sbjct: 129 EIHGAKHPMAPMHVKTAREVPEYEINPSELDFTQSKEITKGTYCMAMWRGIQVAVKKLDD 188
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG 245
EV+SDDD+VR F DELALLQ++RHPN+VQFLGAVTQS+PMMIVTEYLP+GDLR LKRKG
Sbjct: 189 EVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRGDLRELLKRKG 248
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305
LKP+TAVR+ALDIARGM+YLHE K PIIHRDLEPS NILRDDSG+LKV
Sbjct: 249 QLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPS-----------NILRDDSGHLKV 297
Query: 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
ADFGVSKL+TVKED+P TCQD SCRY+APEVF +EEYDTK DVFSFALI+QEMIEG PF
Sbjct: 298 ADFGVSKLVTVKEDKPFTCQDISCRYIAPEVFTSEEYDTKADVFSFALIVQEMIEGRMPF 357
Query: 366 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425
K D+E +AYA + RP FKAP+K Y GLK LIEECW+EKPAKRPTFR+II RLESI
Sbjct: 358 AEKEDSEASEAYAGKHRPLFKAPSKNYPHGLKTLIEECWHEKPAKRPTFREIIKRLESIL 417
Query: 426 NSINHKRRWKIRTMKCFHNLEAMLKKDH 453
+ + HKR+W++R + CF N E KK H
Sbjct: 418 HHMGHKRQWRMRPLTCFQNFEH--KKKH 443
|
|
| TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1464 (520.4 bits), Expect = 5.4e-150, P = 5.4e-150
Identities = 298/465 (64%), Positives = 351/465 (75%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIK-------PEFRLMFLANERDV 53
++ K P R L +QSSLAP+ L +DD P RLM+LANE D+
Sbjct: 3 IKPKSPARFKLGRQSSLAPESRTPIDTLTEDEDDDLAAAATAGIGDPTIRLMYLANEGDI 62
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+GI ++LDSG +V++RDID RTALHVAACQG T+VV LLL RGA VD KDRWGSTPL DA
Sbjct: 63 DGINKMLDSGTNVDYRDIDARTALHVAACQGRTDVVELLLSRGAKVDTKDRWGSTPLADA 122
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW 173
+YYKNH+VIKLLEKHGAKP +APMHV +EVPEYEI P ELDF+NSV+I+KGTF A W
Sbjct: 123 VYYKNHDVIKLLEKHGAKPTIAPMHVLTDKEVPEYEIHPTELDFSNSVKISKGTFNKASW 182
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
RGI VAVK GEE+ +D+D+V AFRDELALLQKIRHPNVVQFLGAVTQS+PMMIVTEYLP
Sbjct: 183 RGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 242
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
KGDLR +L RKG L P+ AV+FAL+IARGMNYLHE+KP IIH DLEP
Sbjct: 243 KGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEHKPEAIIHCDLEPP----------- 291
Query: 294 NILRDDSGNLKVADFGVSKLL----TVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDV 348
NILRDDSG+LKVADFGVSKLL TVK+DRP+ TC D+S RY+APEV++NEEYDTKVDV
Sbjct: 292 NILRDDSGHLKVADFGVSKLLVVKKTVKKDRPVVTCLDSSWRYMAPEVYRNEEYDTKVDV 351
Query: 349 FSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 408
FSFALILQEMIEGC PF D EVPKAY +RPPF AP K Y GL+ELI++CW+++
Sbjct: 352 FSFALILQEMIEGCEPFHEIEDREVPKAYIEDERPPFNAPTKSYPFGLQELIQDCWDKEA 411
Query: 409 AKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDH 453
+KRPTFR II+ LE I++ I KR WK+ +C K+D+
Sbjct: 412 SKRPTFRVIISTLELISDRIARKRSWKVMLGRCLPRFRLFTKRDY 456
|
|
| TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
Identities = 209/443 (47%), Positives = 282/443 (63%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPE-----FRLMFLANERDVEGIKELLD 61
+R + +QSSL P R ++ + DD+ PE +L+F+A++ DV GI+ELLD
Sbjct: 42 MRFSFGRQSSLDPIRRSPDSSKS--DDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLD 99
Query: 62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
GIDVN D+D RTALH+AAC+G VV LL R A++D +DRWGST DA YY N +V
Sbjct: 100 EGIDVNSIDLDGRTALHIAACEGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDV 159
Query: 122 IKLLEKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQV 178
LL+ GAK P PM V + REVPEYE++P E+ S I+KG + +A W G +V
Sbjct: 160 YNLLKARGAKVPKTRKTPMTVSNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTRV 219
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
+VK L ++ SD +R+ AFR EL LL+K+RHPNV+QF+GAVTQ+ PMMIV EY PKGDL
Sbjct: 220 SVKILDKDSYSDPERINAFRHELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLS 279
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
+L++KG L PS A+RFALDIARGMNYLHE KP PIIH DL+P +NIL D
Sbjct: 280 VYLQKKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCDLKP-----------KNILLD 328
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFAL 353
G LK++ FG+ +L + +D+ D S Y+APEV+K+E +D +VD SF +
Sbjct: 329 RGGQLKISGFGMIRLSKISQDKAKVANHKAHIDLSNYYIAPEVYKDEIFDLRVDAHSFGV 388
Query: 354 ILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRP 412
IL E+ EG P F + EV + +RP FK ++ Y +KELIE+CW+ + RP
Sbjct: 389 ILYEITEGVPVFHPRPPEEVARMMCLEGKRPVFKTKSRSYPPDIKELIEKCWHPEAGIRP 448
Query: 413 TFRQIITRLESINNSINHKRRWK 435
TF +II RL+ I + + + WK
Sbjct: 449 TFSEIIIRLDKIVANCSKQGWWK 471
|
|
| TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
Identities = 203/439 (46%), Positives = 276/439 (62%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLD-DDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
+R + +QSSL P R + NG + + +L+F+A DVEG+++LLD GID
Sbjct: 42 MRFSFGRQSSLDPIRRSPDGS-NGPQLAVPDNLDATMQLLFVACRGDVEGVQDLLDEGID 100
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
VN D+D RTALH+AAC+G +VV LLL R A++D +DRWGST DA YY N +V +L
Sbjct: 101 VNSIDLDGRTALHIAACEGHVDVVKLLLTRKANIDARDRWGSTAAADAKYYGNMDVFNIL 160
Query: 126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
+ GAK P PM V + REVPEYE++P EL + I+KG + +A W G +V+VK
Sbjct: 161 KARGAKVPKTKRTPMVVANPREVPEYELNPQELQVRKADGISKGIYQVAKWNGTKVSVKI 220
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
L +++ D D + AF+ EL L +K+RHPNVVQF+GAVTQ+ PMMIV+EY PKGDL ++L+
Sbjct: 221 LDKDLYKDSDTINAFKHELTLFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQ 280
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302
+KG L P+ +RFALDIARGMNYLHE KP P+IH DL+P +NI+ D G+
Sbjct: 281 KKGRLSPAKVLRFALDIARGMNYLHECKPEPVIHCDLKP-----------KNIMLDSGGH 329
Query: 303 LKVADFGVSKLLTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357
LKVA FG+ + D+ D S +APEV+K+E +D VD +SF ++L E
Sbjct: 330 LKVAGFGLISFAKLSSDKSKILNHGAHIDPSNYCMAPEVYKDEIFDRSVDSYSFGVVLYE 389
Query: 358 MIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
MIEG PF K E K +RP FKA +K + ++ELIEECW+ + RPTF +
Sbjct: 390 MIEGVQPFHPKPPEEAVKLMCLEGRRPSFKAKSKSCPQEMRELIEECWDTETFVRPTFSE 449
Query: 417 IITRLESINNSINHKRRWK 435
II RL+ I + + WK
Sbjct: 450 IIVRLDKIFVHCSKQGWWK 468
|
|
| TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 2.1e-91, P = 2.1e-91
Identities = 203/439 (46%), Positives = 273/439 (62%)
Query: 7 VRTTLLKQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
+R + +QSSL P R E+ E + +L+F+A++ DV G++ELL+ GID
Sbjct: 42 MRFSFGRQSSLDPIRRSPESLSCEPHMSVPENLDSTMQLLFMASKGDVNGVEELLNEGID 101
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
VN D+D RTALH+A+C+G +VV +LL R A++D +DRWGST DA YY N EV LL
Sbjct: 102 VNSIDLDGRTALHIASCEGHYDVVKVLLSRRANIDARDRWGSTAAVDAKYYGNVEVYNLL 161
Query: 126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
+ GAK P PM V + +EVPEYE++P EL I+KGT+ +A W G +V+VK
Sbjct: 162 KARGAKAPKTRKTPMTVGNPKEVPEYELNPLELQVRKVDGISKGTYQVAKWNGTRVSVKI 221
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
++ SD +RV AF +EL LL K RHPN+VQF+GAVTQ+ PMMIV E PKGDL +L+
Sbjct: 222 FDKDSYSDPERVNAFTNELTLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQ 281
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302
+KG L PS A+RFALDIARGMNYLHE KP PIIH +L P +NIL D G
Sbjct: 282 KKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCELMP-----------KNILLDRGGQ 330
Query: 303 LKVADFGVSKLLTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357
LK++ FG+ KL + ED D S Y+APE++K+E +D + DV SF +IL E
Sbjct: 331 LKISGFGLIKLSKIGEDSAKVVNHEAQIDKSNYYIAPEIYKDEVFDKRADVHSFGVILYE 390
Query: 358 MIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
+ EG F K EV ++ +RP + +K Y LKELIEECW+ + + RP F +
Sbjct: 391 LTEGVSLFHPKPPEEVAESICIEGKRPTIRTKSKSYPPELKELIEECWHPEISVRPIFSE 450
Query: 417 IITRLESINNSINHKRRWK 435
II RL+ I + + + WK
Sbjct: 451 IIIRLDKIVTNCSKQGWWK 469
|
|
| TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
Identities = 183/412 (44%), Positives = 256/412 (62%)
Query: 44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+++ A++ D +++LL+ V+ RD D RT LHVA+ G+ +VV LLE GADV+ +
Sbjct: 41 ILWHAHQNDAAAVRKLLEEDPTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQ 100
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH--AREVP-------EYEIDPH 153
DRW +TPL DA + ++I+LL+ HG L + H + VP ++EI+P
Sbjct: 101 DRWKNTPLADAEGARKQKMIELLKSHGG--LSYGQNGSHFEPKPVPPPIPKKCDWEIEPA 158
Query: 154 ELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRV-RAFRDELALLQKIRH 209
ELDF+N+ I KG+F + A+WRG VAVK++ +SDD V + FR E+ LL K+RH
Sbjct: 159 ELDFSNAAMIGKGSFGEIVKAYWRGTPVAVKRILPS-LSDDRLVIQDFRHEVDLLVKLRH 217
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+VQFLGAVT+ P+M++TEYL GDL +LK KG L P+TAV FALDIARGM YLH N
Sbjct: 218 PNIVQFLGAVTERKPLMLITEYLRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLH-N 276
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP---LTCQD 326
+P IIHRDL+P ++ ++ + +LKV DFG+SKL+ V+ +T +
Sbjct: 277 EPNVIIHRDLKPRNVL---------LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 327
Query: 327 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386
S RY+APEVFK+ YD KVDVFSFA+IL EM+EG PPF E K + RP F+
Sbjct: 328 GSYRYMAPEVFKHRRYDKKVDVFSFAMILYEMLEGEPPFANHEPYEAAKHVSDGHRPTFR 387
Query: 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRT 438
+ K L+ELI +CW+ +RP+F I+ RLE I ++ W + T
Sbjct: 388 S--KGCTPDLRELIVKCWDADMNQRPSFLDILKRLEKIKETLPSDHHWGLFT 437
|
|
| WB|WBGene00016030 C24A1.3 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 355 (130.0 bits), Expect = 2.6e-38, Sum P(2) = 2.6e-38
Identities = 98/280 (35%), Positives = 144/280 (51%)
Query: 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
E++F S I G+F + +RG VAVK+ E+++L ++ HP
Sbjct: 515 EIEFQES--IGSGSFGKVYKGTYRGKLVAVKRYRAMAFGCKSETDMLCREVSILSRLAHP 572
Query: 211 NVVQFLG-AVTQSSPMMIVTEYLPKGDL--RAFLKRKG--ALKPSTAVRFALDIARGMNY 265
NVV F+G ++ S I+TE++ G L R +RK + P+ +R +LD+ARGM Y
Sbjct: 573 NVVAFVGTSLDDPSQFAIITEFVENGSLFRRENGERKNYRVMDPAFRLRISLDVARGMRY 632
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 325
LHE+ P+IHRDL N NIL G VADFG S+ + +ED LT Q
Sbjct: 633 LHESAAKPVIHRDL-----------NSHNILIHADGRSVVADFGESRFVCQREDENLTKQ 681
Query: 326 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRP 383
+ R++APEVF +YD KVDVFSFAL++ E+ PF+ +K + R RP
Sbjct: 682 PGNLRWMAPEVFSQSGKYDRKVDVFSFALVIWEIHTAELPFSHLKPAAAAAEMTYKRGRP 741
Query: 384 PF-KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
P + + LI + W+ + + RP F +I+ LE
Sbjct: 742 TLPNQPTAQFPAHILSLIPQAWHPESSSRPDFVEIVALLE 781
|
|
| DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 383 (139.9 bits), Expect = 1.5e-36, Sum P(2) = 1.5e-36
Identities = 103/286 (36%), Positives = 157/286 (54%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+ID H++ V I KG + L WRG QVAVKKL I+++ ++ F E+ L++
Sbjct: 368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENI-LKEFHREINLMK 424
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMN 264
+RHPNV+QFLG+ + I TEY+P+G L + L + L+ S ++ +D A+G+
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T
Sbjct: 485 YLHNSTPV-ILHRDLK-----------SHNLLVDENWKVKVADFGLSTI--EQQGATMTA 530
Query: 325 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP 383
T C + +PEV +++ Y K DV+SF +IL E P+ +V A RP
Sbjct: 531 CGTPC-WTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRP 589
Query: 384 PF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427
P P K Y +L+ +C NE P+ RPT Q + RLESI++S
Sbjct: 590 PVPQNGPPK-YI----QLLIDCLNENPSHRPTMEQCLERLESIDSS 630
|
|
| DICTYBASE|DDB_G0283385 splA "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 406 (148.0 bits), Expect = 3.9e-36, P = 3.9e-36
Identities = 106/292 (36%), Positives = 160/292 (54%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
EYEID +EL+F + I KG F +WR VA+K + + + F++E+ +
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164
Query: 204 LQKIRHPNVVQFLGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGAL---KPSTAVRFALD 258
L K+RHPNVVQFLGA T IVTE++ G LR FL L P ++ ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK--VADFGVSKLLTV 316
IA+GMNYLH P PI+HRDL ++ + + + +N + ++K ++DFG+S+L +
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRL-KM 2282
Query: 317 KEDRPLTCQDTSC-RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVP 374
++ +T Q C Y+APEVFK + K DV+S+ ++L E++ P MK
Sbjct: 2283 EQASQMT-QSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426
A RPP P ++ KE++ +CW+ P RPTF+QII L+ + +
Sbjct: 2342 LAAYESYRPPI--PLTTSSKW-KEILTQCWDSNPDSRPTFKQIIVHLKEMED 2390
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 390 (142.3 bits), Expect = 2.5e-35, P = 2.5e-35
Identities = 101/282 (35%), Positives = 159/282 (56%)
Query: 147 EYEIDPHELDFTNSV-EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+YEI +L + + + GT W G VAVK ++ S++ + +F+ E++L++
Sbjct: 479 DYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEI-ITSFKQEVSLMK 537
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMN 264
++RHPNV+ F+GAV + IVTE+LP+G L L+R K L + A DIARGMN
Sbjct: 538 RLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGMN 597
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YLH P PIIHRDL+ S+L V DRN +KVADFG+S+ +K + LT
Sbjct: 598 YLHHCSP-PIIHRDLKSSNLLV-----DRN------WTVKVADFGLSR---IKHETYLTT 642
Query: 325 QDTSC-RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQR 382
+++APEV +NE D K DV+SF ++L E++ P+ + +V A QR
Sbjct: 643 NGRGTPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQR 702
Query: 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+ P + + + L+E CW+ +P RP+F++++ +L +
Sbjct: 703 --LEVPKDVDPQWIA-LMESCWHSEPQCRPSFQELMDKLREL 741
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.IV.2537.1 | hypothetical protein (423 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 469 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-66 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-62 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-61 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-61 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-59 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-44 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-43 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-41 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-39 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-38 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-35 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-35 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-34 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-33 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-33 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-32 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-32 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-31 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-30 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-30 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-30 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-29 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-28 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-28 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-28 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-27 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-27 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-27 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-26 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-25 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-25 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-25 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-23 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 8e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-22 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 1e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-22 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-22 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-21 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-20 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 4e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-15 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 3e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-14 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 2e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-12 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 7e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 2e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-11 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 5e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 1e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-08 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 2e-08 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 3e-08 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 4e-08 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 4e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-08 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 2e-07 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-07 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 4e-07 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 4e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-07 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 5e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-07 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 3e-06 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 5e-06 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 6e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-06 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| pfam13606 | 30 | pfam13606, Ank_3, Ankyrin repeat | 4e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-05 | |
| smart00248 | 30 | smart00248, ANK, ankyrin repeats | 5e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-05 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 7e-05 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 8e-05 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 2e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 3e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 3e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 0.001 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 0.002 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 0.002 | |
| PHA02946 | 446 | PHA02946, PHA02946, ankyin-like protein; Provision | 0.002 | |
| TIGR00870 | 743 | TIGR00870, trp, transient-receptor-potential calci | 0.002 | |
| PHA02716 | 764 | PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provi | 0.003 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 | |
| PHA02736 | 154 | PHA02736, PHA02736, Viral ankyrin protein; Provisi | 0.003 | |
| PHA02798 | 489 | PHA02798, PHA02798, ankyrin-like protein; Provisio | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 211 bits (541), Expect = 9e-66
Identities = 84/277 (30%), Positives = 138/277 (49%), Gaps = 41/277 (14%)
Query: 162 EITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
++ +G F +G +VAVK L E + ++ F +E ++++K+ HPN+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLSHPNI 63
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKP 271
V+ LG TQ P+ IVTEY+P GDL FL++ G L ++ AL IA+GM YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN- 122
Query: 272 VPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-- 329
+HRDL A RN L ++ +K++DFG+S+ + + +
Sbjct: 123 --FVHRDL------AA-----RNCLVTENLVVKISDFGLSRDIYEDDY---YRKRGGGKL 166
Query: 330 --RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPKAYAARQR--PP 384
+++APE K+ ++ +K DV+SF ++L E+ P+ + EV + R P
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP 226
Query: 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
P +LY EL+ +CW P RPTF +++ L
Sbjct: 227 ENCPDELY-----ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 1e-62
Identities = 83/264 (31%), Positives = 130/264 (49%), Gaps = 47/264 (17%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+ ++VAVK L E+ + + ++ F E +++K+ HPNVV+ LG T+ P+ IV EY+
Sbjct: 26 KKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYM 83
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
GDL ++L K + L S + FAL IARGM YL IHRDL
Sbjct: 84 EGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAA---------- 130
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEEYDT 344
RN L ++ +K++DFG+S+ L + P+ R++APE K ++ +
Sbjct: 131 -RNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI-------RWMAPESLKEGKFTS 182
Query: 345 KVDVFSFALILQEMI-------EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 397
K DV+SF ++L E+ G + + Y R P P +LY
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY--LKNGY--RLPQPPNCPPELY----- 233
Query: 398 ELIEECWNEKPAKRPTFRQIITRL 421
+L+ +CW E P RPTF +++ L
Sbjct: 234 DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 1e-61
Identities = 87/278 (31%), Positives = 134/278 (48%), Gaps = 54/278 (19%)
Query: 166 GTFILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
G +G ++VAVK L E+ + + ++ F E +++K+ HPN+V+ LG
Sbjct: 13 GEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIVKLLGVC 70
Query: 220 TQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
T+ P+MIV EY+P GDL +L+ R L S + FAL IARGM YL IHR
Sbjct: 71 TEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHR 127
Query: 278 DLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE-------DRPLTCQDTSCR 330
DL RN L ++ +K++DFG+S+ L + P+ R
Sbjct: 128 DLAA-----------RNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI-------R 169
Query: 331 YVAPEVFKNEEYDTKVDVFSFALILQEMI-------EGCPPFTMKHDNEVPKAYAARQRP 383
++APE K ++ +K DV+SF ++L E+ G + + K Y R
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY--LKKGY--RLPK 225
Query: 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
P P +LY +L+ +CW E P RPTF +++ L
Sbjct: 226 PPNCPPELY-----KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 3e-61
Identities = 86/277 (31%), Positives = 136/277 (49%), Gaps = 40/277 (14%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ KG + +VAVK L E+ + ++ + F E +++K+ HPNVV+ LG T+
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE 67
Query: 222 SSPMMIVTEYLPKGDLRAFLKR---------KGALKPSTAVRFALDIARGMNYLHENKPV 272
P+ +V EY+ GDL +L++ K L + FA+ IA+GM YL K
Sbjct: 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-- 125
Query: 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--- 329
+HRDL A RN L + +K++DFG+S+ + + + T
Sbjct: 126 -FVHRDL------AA-----RNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLP 170
Query: 330 -RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF-- 385
R++APE K+ + +K DV+SF ++L E+ G P+ + EV + R P
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPE 230
Query: 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
P +LY EL+ CW P RPTF +++ RLE
Sbjct: 231 YCPDELY-----ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 6e-59
Identities = 92/270 (34%), Positives = 138/270 (51%), Gaps = 25/270 (9%)
Query: 157 FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
+ ++ G+F A + G VAVK L + A R E+ +L+++ HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKP 271
+V+ + A + +V EY GDL +L R G L A + AL I RG+ YLH N
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 272 VPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 331
IIHRDL+P NIL D++G +K+ADFG++K L K LT + Y
Sbjct: 119 --IIHRDLKPE-----------NILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWY 164
Query: 332 VAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390
+APEV Y KVDV+S +IL E++ G PPF+ ++ + + PP +
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEP 224
Query: 391 LYARG---LKELIEECWNEKPAKRPTFRQI 417
++ G K+LI++C N+ P+KRPT +I
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 3e-56
Identities = 79/266 (29%), Positives = 129/266 (48%), Gaps = 33/266 (12%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
++ +G+F LA + G VA+K + ++ I D E+ +L+K++HPN+V+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNIVRLY 63
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ +V EY GDL LK++G L A + I + YLH I+H
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVH 120
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVA 333
RDL+P NIL D+ G++K+ADFG+++ L E T Y+A
Sbjct: 121 RDLKPE-----------NILLDEDGHVKLADFGLARQLDPGEKL-----TTFVGTPEYMA 164
Query: 334 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKL 391
PEV + Y VD++S +IL E++ G PPF D+++ + + + +PPF P
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGKPPF--PGDDQLLELFKKIGKPKPPFPPPEWD 222
Query: 392 YARGLKELIEECWNEKPAKRPTFRQI 417
+ K+LI + + P KR T +
Sbjct: 223 ISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 4e-50
Identities = 79/267 (29%), Positives = 118/267 (44%), Gaps = 60/267 (22%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+ +G F LA + G +VA+K + + + E+ +L+K+ HPN+V+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V EY G L+ LK L +R L I G+ YLH N IIH
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115
Query: 277 RDLEPSDLYVAYWQNDRNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 335
RDL+P NIL D+G +K+ADFG+SKLLT + T T Y+APE
Sbjct: 116 RDLKPE-----------NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP-AYMAPE 163
Query: 336 VFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394
V + Y K D++S +IL E+ E
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYELPE---------------------------------- 189
Query: 395 GLKELIEECWNEKPAKRPTFRQIITRL 421
LK+LI + + P KRP+ ++I+ L
Sbjct: 190 -LKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 70/243 (28%), Positives = 113/243 (46%), Gaps = 27/243 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM--IVTEYLPKG 235
+AVK + E ++ + A E+ +L ++HPN+V++ G+ I EY+ G
Sbjct: 28 MAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
L + LK+ G L ++ I G+ YLH N I+HRD++ + NI
Sbjct: 87 SLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGA-----------NI 132
Query: 296 LRDDSGNLKVADFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 353
L D G +K+ADFG +K L + + + T ++APEV + EEY D++S
Sbjct: 133 LVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP-YWMAPEVIRGEEYGRAADIWSLGC 191
Query: 354 ILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKPAK 410
+ EM G PP++ N + Y + + P P L K+ + +C P K
Sbjct: 192 TVIEMATGKPPWSE-LGNPMAALYKIGSSGEPPEI--PEHLSE-EAKDFLRKCLRRDPKK 247
Query: 411 RPT 413
RPT
Sbjct: 248 RPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 6e-43
Identities = 95/290 (32%), Positives = 150/290 (51%), Gaps = 47/290 (16%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+ I+ EL + I KG F +L +RG +VAVK L ++ + +AF E +++
Sbjct: 1 WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVKCLKDDSTA----AQAFLAEASVM 54
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARG 262
+RHPN+VQ LG V Q +P+ IVTEY+ KG L +L+ +G + + + FALD+ G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
M YL E +HRDL RN+L + KV+DFG++K +
Sbjct: 115 MEYLEEKN---FVHRDLAA-----------RNVLVSEDLVAKVSDFGLAKEASQG----- 155
Query: 323 TCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----P 374
QD+ ++ APE + +++ TK DV+SF ++L E+ G P+ +V
Sbjct: 156 --QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE 213
Query: 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
K Y R P P ++Y +++++CW PAKRPTF+Q+ +L I
Sbjct: 214 KGY--RMEAPEGCPPEVY-----KVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 96/282 (34%), Positives = 148/282 (52%), Gaps = 37/282 (13%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP EL F E+ G F L WRG I VA+K + E +S+DD F +E ++
Sbjct: 1 IDPSELTFLK--ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
K+ HPN+VQ G T+ P+ IVTEY+ G L +L+ RKG L + D+ M
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YL N IHRDL RN L + +KV+DFG+++ V +D+ +
Sbjct: 115 YLESNG---FIHRDLAA-----------RNCLVGEDNVVKVSDFGLARY--VLDDQYTSS 158
Query: 325 QDTS--CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA-- 379
Q T ++ PEVF + +K DV+SF +++ E+ EG P+ ++EV ++ +A
Sbjct: 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY 218
Query: 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
R P AP ++Y ++ CW+EKP RP F++++++L
Sbjct: 219 RLYRPKLAPTEVY-----TIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 1e-39
Identities = 92/277 (33%), Positives = 140/277 (50%), Gaps = 33/277 (11%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
I+P EL F E+ G F L WR I+VA+K + E +S++D F +E ++
Sbjct: 1 INPSELTFMK--ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
K+ HP +VQ G TQ P+ IVTE++ G L +L+ R+G L + D+ GM
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YL N IHRDL RN L +G +KV+DFG+++ + E +
Sbjct: 115 YLERNS---FIHRDLAA-----------RNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160
Query: 325 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR- 382
++ PEVF +Y +K DV+SF +++ E+ EG PF K + EV + + R
Sbjct: 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL 220
Query: 383 -PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
P A +Y E++ CW+EKP RPTF +++
Sbjct: 221 YRPKLASMTVY-----EVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 8e-39
Identities = 78/270 (28%), Positives = 128/270 (47%), Gaps = 38/270 (14%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
F +I KG F A + G +VA+K + E +++ E+ +L+K +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHEN 269
N+V++ G+ + + IV E+ G L+ LK L S ++ +G+ YLH N
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 329
IIHRD++ + NIL G +K+ DFG+S L+ + R +T
Sbjct: 118 G---IIHRDIKAA-----------NILLTSDGEVKLIDFGLSAQLSDTKAR-----NTMV 158
Query: 330 ---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA--YAARQRPP 384
++APEV + YD K D++S + E+ EG PP+ + KA A PP
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPP 215
Query: 385 -FKAPAKLYARGLKELIEECWNEKPAKRPT 413
+ P K ++ K+ +++C + P KRPT
Sbjct: 216 GLRNPEK-WSDEFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 9e-38
Identities = 86/281 (30%), Positives = 142/281 (50%), Gaps = 35/281 (12%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGI-----QVAVKKLGEEVISDDDRVRAFRDELALL 204
I P EL EI G F L W G +VA+K + E +S++D F +E ++
Sbjct: 1 IHPSELTL--VQEIGSGQFGLV-WLGYWLEKRKVAIKTIREGAMSEED----FIEEAQVM 53
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
K+ HP +VQ G T+ SP+ +V E++ G L +L+ ++G T + LD+ GM
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 264 NYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLT 323
YL + +IHRDL RN L ++ +KV+DFG+++ + + T
Sbjct: 114 AYLESSN---VIHRDLAA-----------RNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
Query: 324 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR 382
++ +PEVF +Y +K DV+SF +++ E+ EG P+ + ++EV + A R
Sbjct: 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR 219
Query: 383 --PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
P A +Y EL++ CW E+P RP+F ++ +L
Sbjct: 220 LYKPRLASQSVY-----ELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 80/255 (31%), Positives = 130/255 (50%), Gaps = 34/255 (13%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+ G +VAVK I D +AF +E A++ K+ H N+V+ LG + + + IV E +
Sbjct: 27 YTGQKVAVK-----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80
Query: 233 PKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
KG+L FL+ +G S ++F+LD+A GM YL K ++HRDL
Sbjct: 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAA--------- 128
Query: 291 NDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 350
RNIL + G KV+DFG++++ + ++ APE K++++ +K DV+S
Sbjct: 129 --RNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182
Query: 351 FALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 407
+ ++L E+ G P+ EV + R PP PA +Y L+ CW +
Sbjct: 183 YGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV-----LMTSCWETE 237
Query: 408 PAKRPTFRQIITRLE 422
P KRP+F ++ +LE
Sbjct: 238 PKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 85/269 (31%), Positives = 125/269 (46%), Gaps = 34/269 (12%)
Query: 162 EITKGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
E+ GT W G +VAVK L +S AF E +++K+RH +VQ +
Sbjct: 21 EVWMGT-----WNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+ P+ IVTEY+ KG L FLK L+ V A IA GM YL IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRD 128
Query: 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 338
L RNIL ++ K+ADFG+++L+ E ++ APE
Sbjct: 129 LAA-----------RNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 339 NEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA--PAKLYARG 395
+ K DV+SF ++L E++ G P+ + EV + R P P +LY
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY--- 234
Query: 396 LKELIEECWNEKPAKRPTFRQIITRLESI 424
+L+ +CW++ P +RPTF + + LE
Sbjct: 235 --DLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 89/268 (33%), Positives = 131/268 (48%), Gaps = 30/268 (11%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L + I VA+K L + SD R F E +++ + HPN+++ G VT+
Sbjct: 19 EVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQR-LDFLTEASIMGQFDHPNIIRLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MI+TEY+ G L FL+ G V IA GM YL E V HRDL
Sbjct: 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV---HRDLA 133
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKN 339
RNIL + + KV+DFG+S+ L E T R+ APE
Sbjct: 134 A-----------RNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 340 EEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKA----YAARQRPPFKAPAKLYAR 394
++ + DV+SF +++ E M G P+ + +V KA Y R PP P+ LY
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY--RLPPPMDCPSALY-- 238
Query: 395 GLKELIEECWNEKPAKRPTFRQIITRLE 422
+L+ +CW + +RPTF QI++ L+
Sbjct: 239 ---QLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-35
Identities = 67/250 (26%), Positives = 119/250 (47%), Gaps = 23/250 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +K++ +S+ +R A E+ +L+K+ HPN++++ + + + IV EY
Sbjct: 25 GKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83
Query: 235 GDLRAFLKRKGALKPSTAVRFALD----IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
GDL +K++ LD + + YLH K I+HRD++P
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQ-------- 132
Query: 291 NDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 350
NI +G +K+ DFG+SK+L+ D T T Y++PE+ +N+ Y+ K D++S
Sbjct: 133 ---NIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY-YLSPELCQNKPYNYKSDIWS 188
Query: 351 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 410
+L E+ PF ++ E+ Q PP + Y+ L+ L+ + P +
Sbjct: 189 LGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQ---YSSELRNLVSSLLQKDPEE 245
Query: 411 RPTFRQIITR 420
RP+ QI+
Sbjct: 246 RPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 88/281 (31%), Positives = 140/281 (49%), Gaps = 33/281 (11%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP +L F E+ G F WRG VA+K + E +S+D+ F +E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
K+ H +VQ G T+ P+ IVTEY+ G L +L+ G +PS + D+ GM
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA 114
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YL + IHRDL RN L DD G +KV+DFG+S+ + E
Sbjct: 115 YLESKQ---FIHRDLAA-----------RNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160
Query: 325 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR- 382
R+ PEV ++ +K DV++F +++ E+ G P+ +++E + + R
Sbjct: 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL 220
Query: 383 -PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
P A K+YA ++ CW+EK +RPTF+Q+++ +E
Sbjct: 221 YRPHLASEKVYA-----IMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 35/264 (13%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K + E S +R F +E +++++ +VV+ LG V+ P ++V E +
Sbjct: 35 PETRVAIKTVNENA-SMRER-IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92
Query: 234 KGDLRAFLKRK-------GALKPSTAVRF---ALDIARGMNYLHENKPVPIIHRDLEPSD 283
KGDL+++L+ + L P T +F A +IA GM YL K +HRDL
Sbjct: 93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAA-- 147
Query: 284 LYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEY 342
RN + + +K+ DFG+++ + + R R++APE K+ +
Sbjct: 148 ---------RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 198
Query: 343 DTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKEL 399
TK DV+SF ++L EM P+ + EV K P P KL EL
Sbjct: 199 TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLL-----EL 253
Query: 400 IEECWNEKPAKRPTFRQIITRLES 423
+ CW P RPTF +I++ L+
Sbjct: 254 MRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 87/286 (30%), Positives = 144/286 (50%), Gaps = 41/286 (14%)
Query: 152 PHELDFTNSVEITKGTFILAF---WRG-IQVAVKKLGEEVISDDDRVRA--FRDELALLQ 205
P E +FT ++ G F + W+ ++VA+K ++ DD ++ F+ E+ L+
Sbjct: 4 PRE-EFTLERKLGSGYFGEVWEGLWKNRVRVAIK-----ILKSDDLLKQQDFQKEVQALK 57
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGM 263
++RH +++ + P+ I+TE + KG L AFL+ L ++ + A +A GM
Sbjct: 58 RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 264 NYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLT 323
YL E IHRDL RNIL + KVADFG+++L+ KED L+
Sbjct: 118 AYLEEQN---SIHRDLAA-----------RNILVGEDLVCKVADFGLARLI--KEDVYLS 161
Query: 324 CQDTSC--RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA- 379
D ++ APE + + TK DV+SF ++L EM G P+ +++EV A
Sbjct: 162 -SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220
Query: 380 -RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
R P K P ++Y +++ ECW +P RP+F+ + L++I
Sbjct: 221 YRMPCPAKCPQEIY-----KIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 87/275 (31%), Positives = 128/275 (46%), Gaps = 55/275 (20%)
Query: 176 IQVAVKKLGE--EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VA+K L E E + FR E L+ ++HPN+V LG T+ P ++ EYL
Sbjct: 36 TSVAIKTLKENAEPKVQQE----FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91
Query: 234 KGDLRAFLKR----------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
GDL FL R K +L S + A+ IA GM YL + +HR
Sbjct: 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHR 148
Query: 278 DLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRY 331
DL RN L + +K++DFG+S+ + V+ L R+
Sbjct: 149 DLAA-----------RNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-----PVRW 192
Query: 332 VAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAP 388
+ PE ++ T+ D++SF ++L E+ G P+ + EV + +RQ P P
Sbjct: 193 MPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCP 252
Query: 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423
A++YA L+ ECWNE PA+RP F+ I TRL S
Sbjct: 253 ARVYA-----LMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 79/266 (29%), Positives = 127/266 (47%), Gaps = 40/266 (15%)
Query: 171 AFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
W+ + VAVK L E+ + V F E A++++I+HPN+VQ LG T+ P I+
Sbjct: 25 GVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80
Query: 229 TEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYV 286
TE++ G+L +L+ + + + A I+ M YL + IHRDL
Sbjct: 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAA----- 132
Query: 287 AYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYD 343
RN L ++ +KVADFG+S+L+T T + ++ APE ++
Sbjct: 133 ------RNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 344 TKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKE 398
K DV++F ++L E+ G P+ ++V K Y R P P K+Y E
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--RMERPEGCPPKVY-----E 236
Query: 399 LIEECWNEKPAKRPTFRQIITRLESI 424
L+ CW P+ RP+F +I E++
Sbjct: 237 LMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 71/240 (29%), Positives = 112/240 (46%), Gaps = 25/240 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ I V E +L +I HP +V+ A + +V EY P G+L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
+ L ++G A +A +I + YLH II+RDL+P NIL D
Sbjct: 82 SHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPE-----------NILLD 127
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFALIL 355
G++K+ DFG++K L+ + R +T C Y+APEV + Y VD +S ++L
Sbjct: 128 ADGHIKLTDFGLAKELSSEGSRT----NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLL 183
Query: 356 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 415
EM+ G PPF + + + Y + P + P L + ++LI + P KR
Sbjct: 184 YEMLTGKPPF---YAEDRKEIYEKILKDPLRFPEFL-SPEARDLISGLLQKDPTKRLGSG 239
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 76/277 (27%), Positives = 129/277 (46%), Gaps = 27/277 (9%)
Query: 153 HELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
EL N + KG +++ + ++VAVK L +E I+ + F E +++ ++ HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
V+ +G V + P+M+V E P G L +LK++ + S A +A GM YL V
Sbjct: 59 VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCR 330
HRDL RN+L + K++DFG+S+ L D R T +
Sbjct: 118 ---HRDLAA-----------RNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK 163
Query: 331 YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKA 387
+ APE ++ +K DV+S+ + L E G P+ EV + +R P +
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEEC 223
Query: 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
P ++Y+ ++ CW +P RPTF ++ +
Sbjct: 224 PQEIYS-----IMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 61/281 (21%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIV 228
G QVAVK L E+ SD F E+ +L+ + H N+V++ G + + ++
Sbjct: 33 GEQVAVKSLNHSGEEQHRSD------FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86
Query: 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVA 287
EYLP G LR +L+R + + + F+ I +GM+YL + IHRDL
Sbjct: 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAA------ 137
Query: 288 YWQNDRNILRDDSGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNE 340
RNIL + +K++DFG++K+L VKE ++ + APE +
Sbjct: 138 -----RNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG-----ESPIFWYAPECLRTS 187
Query: 341 EYDTKVDVFSFALILQEMIEGC-----PP--FTMKHDNEVPKAYAAR--------QR--P 383
++ + DV+SF + L E+ PP F + R +R
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247
Query: 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
P P ++Y +L++ CW +P RP+F +I ++ +
Sbjct: 248 PPSCPDEVY-----DLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 86/274 (31%), Positives = 139/274 (50%), Gaps = 43/274 (15%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA- 218
I KG F +L +RG +VAVK I +D +AF E +++ ++RH N+VQ LG
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
V + + IVTEY+ KG L +L+ +G L ++F+LD+ M YL N +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVA 333
RDL RN+L + KV+DFG++K + + QDT ++ A
Sbjct: 126 RDLAA-----------RNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTA 167
Query: 334 PEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV-PKAYAA-RQRPPFKAPAK 390
PE + +++ TK DV+SF ++L E+ G P+ +V P+ + P P
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPV 227
Query: 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+Y +++++CW+ A RP+F Q+ +LE I
Sbjct: 228 VY-----DVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 77/262 (29%), Positives = 117/262 (44%), Gaps = 37/262 (14%)
Query: 173 WRGI-----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
W G+ VAVK L + D F E +++K+RHP ++Q T P+ I
Sbjct: 23 WEGLWNNTTPVAVKTLKPGTMDPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78
Query: 228 VTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285
VTE + G L +L+ ALK + A +A GM YL IHRDL
Sbjct: 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAA---- 131
Query: 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 345
RN+L ++ KVADFG+++++ ++ APE + K
Sbjct: 132 -------RNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 346 VDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELI 400
DV+SF ++L E++ G P+ + EV + Y R P P +LY +++
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY--RMPCPPGCPKELY-----DIM 237
Query: 401 EECWNEKPAKRPTFRQIITRLE 422
+CW E P RPTF + +LE
Sbjct: 238 LDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 77/259 (29%), Positives = 117/259 (45%), Gaps = 36/259 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+VAVK + D R F E +L++ HPN+V+ +G Q P+ IV E +P
Sbjct: 19 NTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76
Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G L FL++K L ++ +LD A GM YL E+K IHRDL R
Sbjct: 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ESKNC--IHRDLAA-----------R 122
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD----TSCRYVAPEVFKNEEYDTKVDVF 349
N L ++ LK++DFG+S+ +E T D ++ APE Y ++ DV+
Sbjct: 123 NCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 350 SFALILQEMIEG--CPPFTMKHD---NEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 404
S+ ++L E P M + + Y R P P ++Y L+ +CW
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTRERIESGY--RMPAPQLCPEEIY-----RLMLQCW 232
Query: 405 NEKPAKRPTFRQIITRLES 423
P RP+F +I L+
Sbjct: 233 AYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 34/256 (13%)
Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G ++AVK++ + S + + V A E+ LL+ ++H +VQ+ G + + I EY+
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
P G ++ LK GAL + ++ I G+ YLH N I+HRD++ +
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGA---------- 133
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTK 345
NILRD +GN+K+ DFG SK L + + T + +++PEV E Y K
Sbjct: 134 -NILRDSAGNVKLGDFGASKRL-----QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187
Query: 346 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 403
DV+S + EM+ PP+ + E A A Q + P+ + + + +
Sbjct: 188 ADVWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLRRT 243
Query: 404 WNEKPAKRPTFRQIIT 419
+ E KRP+ +++
Sbjct: 244 FVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 75/251 (29%), Positives = 115/251 (45%), Gaps = 23/251 (9%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G A+KK+ V D++ + EL L+ P VV+ GA + + IV EY+
Sbjct: 24 PTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
G L LK+ G + A I +G++YLH + IIHRD++PS
Sbjct: 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR--HIIHRDIKPS---------- 129
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 352
N+L + G +K+ADFG+SK+L D+ T T Y++PE + E Y D++S
Sbjct: 130 -NLLINSKGEVKIADFGISKVLENTLDQCNTFVGT-VTYMSPERIQGESYSYAADIWSLG 187
Query: 353 LILQEMIEGCPPFTMKHDNEVPK----AYAARQRPPFKAPAKLYARGLKELIEECWNEKP 408
L L E G PF P A PP PA+ ++ ++ I C + P
Sbjct: 188 LTLLECALGKFPFL---PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDP 244
Query: 409 AKRPTFRQIIT 419
KRP+ +++
Sbjct: 245 KKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 67/197 (34%), Positives = 102/197 (51%), Gaps = 27/197 (13%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
G VA+KK+ EE I A R E++LL++++HPN+V+ L + + +V E
Sbjct: 24 GEIVALKKIRLDNEEEGIP----STALR-EISLLKELKHPNIVKLLDVIHTERKLYLVFE 78
Query: 231 YLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
Y DL+ +L KR G L P+ + RG+ Y H ++ I+HRDL+P
Sbjct: 79 YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQ------- 127
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDV 348
NIL + G LK+ADFG+++ + R T + + Y APE+ ++ Y T VD+
Sbjct: 128 ----NILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHYSTAVDI 182
Query: 349 FSFALILQEMIEGCPPF 365
+S I EMI G P F
Sbjct: 183 WSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 33/272 (12%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ G L R I VA+K L + + + R F E +++ + HPN++ G VT+
Sbjct: 19 EVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MIVTEY+ G L AFL++ G V IA GM YL + + +HRDL
Sbjct: 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 133
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPE 335
RNIL + + KV+DFG+S++L ED P T R+ APE
Sbjct: 134 A-----------RNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTAPE 179
Query: 336 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 392
++ + DV+S+ +++ E++ G P+ + +V KA R P PA L+
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239
Query: 393 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+L+ +CW + +RP F QI++ L+ +
Sbjct: 240 -----QLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 68/244 (27%), Positives = 114/244 (46%), Gaps = 25/244 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K++ +S +R A +E+ +L + HPN++ + A + + IV EY P GDL
Sbjct: 29 ALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS 87
Query: 239 AFLKRKGALK---PSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
+ ++ + P + R + + RG+ LHE K I+HRDL+ + N
Sbjct: 88 KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSA-----------N 133
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
IL + +K+ D G+SK+L Q + Y+APEV+K Y K D++S +
Sbjct: 134 ILLVANDLVKIGDLGISKVLK---KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCL 190
Query: 355 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 414
L EM PPF + ++ + PP +Y++ L+ I KP RP
Sbjct: 191 LYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP---IYSQDLQNFIRSMLQVKPKLRPNC 247
Query: 415 RQII 418
+I+
Sbjct: 248 DKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 29/245 (11%)
Query: 179 AVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
AVK E I D+D ++ DE+ +L+ ++HPN+V++ G + I EY G
Sbjct: 29 AVK---EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
L L+ L + L + G+ YLH + I+HRD++P+ NI
Sbjct: 86 LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPA-----------NIF 131
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTK---VDVFS 350
D +G +K+ DFG + L + + Y+APEV + D++S
Sbjct: 132 LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWS 191
Query: 351 FALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKP 408
++ EM G P++ + DNE + A +PP +L G K+ ++ C P
Sbjct: 192 LGCVVLEMATGKRPWS-ELDNEFQIMFHVGAGHKPPIPDSLQLSPEG-KDFLDRCLESDP 249
Query: 409 AKRPT 413
KRPT
Sbjct: 250 KKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 72/270 (26%), Positives = 131/270 (48%), Gaps = 32/270 (11%)
Query: 156 DFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRH 209
++ I +G F ++G+ VA+K++ E I ++ +++ E+ LL+ ++H
Sbjct: 1 NYQLGDLIGRGAFG-VVYKGLNLETGDFVAIKQISLEKIKEEA-LKSIMQEIDLLKNLKH 58
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+V+++G++ S + I+ EY G LR +K+ G S + + +G+ YLHE
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 329
+IHRD++ + NIL G +K+ADFGV+ L + T
Sbjct: 119 G---VIHRDIKAA-----------NILTTKDGVVKLADFGVATKLNDVSKDDASVVGTP- 163
Query: 330 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYA--ARQRPPFK 386
++APEV + T D++S + E++ G PP+ +D N + + PP
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY---YDLNPMAALFRIVQDDHPPL- 219
Query: 387 APAKLYARGLKELIEECWNEKPAKRPTFRQ 416
P + LK+ + +C+ + P RPT +Q
Sbjct: 220 -PEGISPE-LKDFLMQCFQKDPNLRPTAKQ 247
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 66/267 (24%), Positives = 125/267 (46%), Gaps = 26/267 (9%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
++ +G ++ I VAVK + F E ++++ HP++V+ +G +T+
Sbjct: 21 DVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78
Query: 222 SSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ P+ IV E P G+LR++L K +L ++ + ++ ++ + YL + V HRD+
Sbjct: 79 N-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV---HRDIA 134
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 340
RN+L +K+ DFG+S+ L + + +++APE
Sbjct: 135 A-----------RNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 341 EYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLK 397
+ + DV+ F + + E ++ G PF +N+V +R P P LY+
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS---- 239
Query: 398 ELIEECWNEKPAKRPTFRQIITRLESI 424
L+ +CW P+KRP F ++ +L I
Sbjct: 240 -LMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 66/282 (23%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VAVK L ++ D + E+ +++ I +H N++ LG TQ P+ +V EY
Sbjct: 43 STVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100
Query: 235 GDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
G+LR FL+ + L V FA +ARGM +L K IHRD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRD 157
Query: 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TSCR--- 330
L RN+L + +K+ADFG++ R + D T+ R
Sbjct: 158 LAA-----------RNVLVTEDHVMKIADFGLA--------RDIHHIDYYRKTTNGRLPV 198
Query: 331 -YVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDNEVPKAYA-----ARQR 382
++APE + Y + DV+SF ++L E+ G P + V + + R
Sbjct: 199 KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEELFKLLKEGYRME 254
Query: 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
P +LY L+ +CW+E P++RPTF+Q++ L+ +
Sbjct: 255 KPQNCTQELYH-----LMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 88/272 (32%), Positives = 135/272 (49%), Gaps = 33/272 (12%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSS 223
GT I + + I AVK L I+D + V F E +++ HPNV+ LG ++ S
Sbjct: 14 GTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71
Query: 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEP 281
P+ +V Y+ GDLR F+ R P+ + F L +A+GM YL K +HRDL
Sbjct: 72 PL-VVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAA 126
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFK 338
RN + D+S +KVADFG+++ + KE T +++A E +
Sbjct: 127 -----------RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 339 NEEYDTKVDVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARG 395
+++ TK DV+SF ++L E M G PP+ D V R P P LY
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY--- 232
Query: 396 LKELIEECWNEKPAKRPTFRQIITRLESINNS 427
E++ CW+ KP RPTF ++++R+E I ++
Sbjct: 233 --EVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 53/281 (18%)
Query: 157 FTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
FT I KG+F + + I VA+K + E +D + + E+ L + R P
Sbjct: 3 FTLLECIGKGSFGEVY-KAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSP 59
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+ ++ G+ + S + I+ EY G LK G L + ++ G+ YLHE
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEG 118
Query: 271 PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 330
IHRD++ + NIL + G++K+ADFGVS LT T +
Sbjct: 119 K---IHRDIKAA-----------NILLSEEGDVKLADFGVSGQLT----------STMSK 154
Query: 331 ---------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT----MKHDNEVPKAY 377
++APEV K YD K D++S + E+ +G PP + M+ +PK
Sbjct: 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-- 212
Query: 378 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
P +++ K+ + C N+ P +RP+ ++++
Sbjct: 213 ----NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-29
Identities = 87/275 (31%), Positives = 133/275 (48%), Gaps = 41/275 (14%)
Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
N E+ KGT VAVK E+ + + +++ F E +L++ HPN+V+ +G
Sbjct: 7 NFGEVFKGTL----KDKTPVAVKTCKED-LPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 219 VTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
TQ P+ IV E +P GD +FL K+K LK V+FALD A GM YL IHR
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 278 DLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC----QDTSCRYVA 333
DL RN L ++ LK++DFG+S+ +ED + + ++ A
Sbjct: 118 DLAA-----------RNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTA 162
Query: 334 PEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDN---EVPKAYAARQRPPFKAP 388
PE Y ++ DV+S+ ++L E CP M + +V K Y R P K P
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--RMSCPQKCP 220
Query: 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423
+Y ++++ CW+ KP RP F ++ L +
Sbjct: 221 DDVY-----KVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-29
Identities = 69/236 (29%), Positives = 119/236 (50%), Gaps = 25/236 (10%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS 250
++ V A R E+ L+ ++ HP++++ LGA + S + E++ G + L + GA K +
Sbjct: 44 EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA 103
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN-LKVADFG 309
+ + + RG++YLHEN+ IIHRD++ + N+L D +G L++ADFG
Sbjct: 104 VIINYTEQLLRGLSYLHENQ---IIHRDVKGA-----------NLLIDSTGQRLRIADFG 149
Query: 310 VSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 366
+ L K Q + ++APEV + E+Y DV+S ++ EM PP+
Sbjct: 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
Query: 367 M-KHDNEVP---KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
KH N + K +A P P L + GL+++ C +P RP R+++
Sbjct: 210 AEKHSNHLALIFKIASATTAPSI--PEHL-SPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 67/250 (26%), Positives = 121/250 (48%), Gaps = 29/250 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+KK + +E+ +++ +HPN+V + + + +V EY+
Sbjct: 44 GKEVAIKK----MRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99
Query: 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G L + + + ++ +G+ YLH +IHRD++ SD
Sbjct: 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIK-SD---------- 145
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 353
NIL G++K+ADFG + LT ++ + + T ++APEV K ++Y KVD++S +
Sbjct: 146 NILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTP-YWMAPEVIKRKDYGPKVDIWSLGI 204
Query: 354 ILQEMIEGCPPFTMKHDNEVP-KA-YAARQR--PPFKAPAKLYARGLKELIEECWNEKPA 409
+ EM EG PP + E P +A + + PP K P K + K+ + +C + P
Sbjct: 205 MCIEMAEGEPP----YLREPPLRALFLITTKGIPPLKNPEKW-SPEFKDFLNKCLVKDPE 259
Query: 410 KRPTFRQIIT 419
KRP+ +++
Sbjct: 260 KRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 29/247 (11%)
Query: 179 AVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
AVK L ++ + + V+ E+ALL K++HPN+VQ+LG + + I E +P G
Sbjct: 29 AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
L LK+ G+ + I G+ YLH+ +HRD++ + NIL
Sbjct: 89 LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGA-----------NIL 134
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALIL 355
D +G +K+ADFG++K V E S ++APEV + Y D++S +
Sbjct: 135 VDTNGVVKLADFGMAK--QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTV 192
Query: 356 QEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
EM G PP+ E V K +++ PP P L K+ I +C P+ R
Sbjct: 193 LEMATGKPPW---SQLEGVAAVFKIGRSKELPPI--PDHLSDEA-KDFILKCLQRDPSLR 246
Query: 412 PTFRQII 418
PT +++
Sbjct: 247 PTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 29/250 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + + + ++V E +L + + P VV+ + + +V EYLP GDL
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
+ L+ G+L A + +I + YLH N IIHRDL+P NIL
Sbjct: 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPD-----------NILI 126
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFS 350
D +G+LK+ DFG+SK+ V+ L + + Y+APEV + + VD +S
Sbjct: 127 DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS 186
Query: 351 FALILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEK 407
IL E + G PPF H + + + + +LI +
Sbjct: 187 LGCILYEFLVGIPPF---HGETPEEIFQNILNGKIEWPEDVEVSDE--AIDLISKLLVPD 241
Query: 408 PAKRPTFRQI 417
P KR + I
Sbjct: 242 PEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 80/274 (29%), Positives = 115/274 (41%), Gaps = 56/274 (20%)
Query: 177 QVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VAVK L + D R F E+ +L ++ PN+ + LG T P+ ++ EY+ G
Sbjct: 48 LVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 236 DLRAFLKR-----------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDL 284
DL FL++ +L ST + A IA GM YL V HRDL
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLAT--- 158
Query: 285 YVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK-----EDRPLTCQDTSCRYVAPEVFKN 339
RN L + +K+ADFG+S+ L + R R++A E
Sbjct: 159 --------RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP----LPIRWMAWESVLL 206
Query: 340 EEYDTKVDVFSFALILQEMIEGC--PPFTMKHDNEV----------PKAYAARQRPPFKA 387
++ TK DV++F + L E++ C P+ D +V RPP
Sbjct: 207 GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPP-NC 265
Query: 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
P +Y EL+ ECW RPTFR+I L
Sbjct: 266 PKDIY-----ELMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 78/264 (29%), Positives = 111/264 (42%), Gaps = 50/264 (18%)
Query: 176 IQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
I VAVK L + +SD DD F E A++ + H N+++ G V P+M+VTE P
Sbjct: 24 IPVAVKCLKSDKLSDIMDD----FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78
Query: 234 KGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
G L L+ G ST +A+ IA GM YL + IHRDL
Sbjct: 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAA---------- 125
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDR---------PLTCQDTSCRYVAPEVFKNEEY 342
RNIL +K+ DFG+ + L ED P + APE + +
Sbjct: 126 -RNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA-------WCAPESLRTRTF 177
Query: 343 DTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYARGLK 397
DV+ F + L EM G P+ +++ K +RP P +Y
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA-CPQDIY----- 231
Query: 398 ELIEECWNEKPAKRPTFRQIITRL 421
++ +CW PA RPTF + L
Sbjct: 232 NVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 9e-28
Identities = 83/274 (30%), Positives = 131/274 (47%), Gaps = 35/274 (12%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L R I VA+K L + + + R F E +++ + HPN++ G VT+
Sbjct: 19 EVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MI+TE++ G L +FL++ G V IA GM YL E + +HRDL
Sbjct: 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLA 133
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-------RYVA 333
RNIL + + KV+DFG+S+ L ED TS R+ A
Sbjct: 134 A-----------RNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTA 179
Query: 334 PEVFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQR--PPFKAPAK 390
PE ++ + DV+S+ +++ E M G P+ + +V A R PP P
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239
Query: 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
L+ +L+ +CW + RP F QI++ L+ +
Sbjct: 240 LH-----QLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 77/274 (28%), Positives = 122/274 (44%), Gaps = 61/274 (22%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+QVAVK L E S+ D F E ++ K H N+V+ +G + P I+ E + G
Sbjct: 37 LQVAVKTL-PESCSEQDESD-FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGG 94
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
DL++FL+ R +PS+ + A D+A+G YL EN IHRD+
Sbjct: 95 DLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAA------- 144
Query: 289 WQNDRNILRDDSGN---LKVADFGVSK--------------LLTVKEDRPLTCQDTSCRY 331
RN L G K+ADFG+++ +L +K +
Sbjct: 145 ----RNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK-------------W 187
Query: 332 VAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAP 388
+ PE F + + +K DV+SF ++L E+ G P+ + + EV + R PP P
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCP 247
Query: 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
+Y ++ +CW P RP F I+ R++
Sbjct: 248 GPVY-----RIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 71/204 (34%), Positives = 106/204 (51%), Gaps = 29/204 (14%)
Query: 175 GIQVAVKK--LGEEVISDDDRVRAFRD----ELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
G +AVK+ L S DR R+ D E+ALL++++H N+VQ+LG+ + + I
Sbjct: 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
EY+P G + A L GA + + F I +G+NYLH IIHRD++ +
Sbjct: 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGA------ 135
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEE 341
NIL D+ G +K++DFG+SK L RP + Q S ++APEV K
Sbjct: 136 -----NILVDNKGGIKISDFGISKKLEANSLSTKTNGARP-SLQG-SVFWMAPEVVKQTS 188
Query: 342 YDTKVDVFSFALILQEMIEGCPPF 365
Y K D++S ++ EM+ G PF
Sbjct: 189 YTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 78/267 (29%), Positives = 128/267 (47%), Gaps = 42/267 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K L + I++ + F+ E +L+ ++ HPN+V LG VTQ P+ ++ EYL +GDL
Sbjct: 37 VAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 238 RAFL-----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
FL K +L + A+ IA GM YL + +H+DL
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLA 151
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKN 339
RNIL + ++K++D G+S+ + + R R++ PE
Sbjct: 152 A-----------RNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200
Query: 340 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK--APAKLYARGL 396
++ + D++SF ++L E+ G P+ + EV + RQ P P ++Y+
Sbjct: 201 GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYS--- 257
Query: 397 KELIEECWNEKPAKRPTFRQIITRLES 423
L+ ECW E P++RP F+ I TRL S
Sbjct: 258 --LMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 79/258 (30%), Positives = 123/258 (47%), Gaps = 34/258 (13%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
V VK L + D++ FR EL + +K+ H NVV+ LG ++ P ++ EY GDL
Sbjct: 38 VLVKALQK--TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 238 RAFL----KRKGALKP---STAVRFAL--DIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
+ FL + LKP ST + AL IA GM++L + +HRDL
Sbjct: 96 KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAA------- 145
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 348
RN L +KV+ +SK + E L R++APE + +++ TK DV
Sbjct: 146 ----RNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDV 201
Query: 349 FSFALILQEMI-EGCPPFTMKHDNEV---PKAYAARQRPPFKAPAKLYARGLKELIEECW 404
+SF +++ E+ +G PF D EV +A P P++LY +L+ CW
Sbjct: 202 WSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY-----KLMTRCW 256
Query: 405 NEKPAKRPTFRQIITRLE 422
P RP+F ++++ L
Sbjct: 257 AVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 81/256 (31%), Positives = 127/256 (49%), Gaps = 39/256 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K L + +S + AF E L+++++HP +V+ VTQ P+ I+TEY+ G
Sbjct: 32 KVAIKSLKQGSMSPE----AFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGS 86
Query: 237 LRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L FLK L + + A IA GM ++ IHRDL + N
Sbjct: 87 LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAA-----------N 132
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSF 351
IL ++ K+ADFG+++L+ ED T ++ + ++ APE + K DV+SF
Sbjct: 133 ILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 189
Query: 352 ALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNE 406
++L E++ G P+ + EV + Y R P P +LY EL+ CW E
Sbjct: 190 GILLTEIVTYGRIPYPGMTNPEVIQNLERGY--RMPRPDNCPEELY-----ELMRLCWKE 242
Query: 407 KPAKRPTFRQIITRLE 422
KP +RPTF + + LE
Sbjct: 243 KPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 80/272 (29%), Positives = 131/272 (48%), Gaps = 33/272 (12%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G + + + VA+K L + ++ R F E +++ + H N+++ G VT+
Sbjct: 20 EVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQD-FLSEASIMGQFSHHNIIRLEGVVTK 77
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
P MI+TEY+ G L +L+ G V IA GM YL + + +HRDL
Sbjct: 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLA 134
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPE 335
RNIL + + KV+DFG+S++L ED P TS R+ APE
Sbjct: 135 A-----------RNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPE 180
Query: 336 VFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLY 392
++ + DV+SF +++ E M G P+ ++EV KA R P P+ +Y
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240
Query: 393 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+L+ +CW + A+RP F I+ L+ +
Sbjct: 241 -----QLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 34/254 (13%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VAVK L +S V+AF +E L++ ++H +V+ VT+ P+ I+TEY+ KG
Sbjct: 32 KVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87
Query: 237 LRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L FLK G + + F+ IA GM Y+ IHRDL + N
Sbjct: 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAA-----------N 133
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSF 351
+L +S K+ADFG+++++ ED T ++ + ++ APE + K DV+SF
Sbjct: 134 VLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 190
Query: 352 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKP 408
++L E++ G P+ +++V A R P P +LY ++++ CW EK
Sbjct: 191 GILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELY-----DIMKTCWKEKA 245
Query: 409 AKRPTFRQIITRLE 422
+RPTF + + L+
Sbjct: 246 EERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 71/257 (27%), Positives = 127/257 (49%), Gaps = 27/257 (10%)
Query: 163 ITKGTFILAFWRGIQVAVKK-LGEEVI---SDDDRVRAFRDELALLQKIRH---PNVVQF 215
I +G + A +RG V + + ++I + DD V + E+ALL ++R PN+ ++
Sbjct: 9 IGRGAY-GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
G+ + + I+ EY G +R L + G + ++ + Y+H+ V +I
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK---VGVI 123
Query: 276 HRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 335
HRD++ + NIL ++GN+K+ DFGV+ LL + T T ++APE
Sbjct: 124 HRDIKAA-----------NILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP-YWMAPE 171
Query: 336 VFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394
V + YDTK D++S + + EM G PP++ D + +PP + Y++
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYS-DVDAFRAMMLIPKSKPP-RLEDNGYSK 229
Query: 395 GLKELIEECWNEKPAKR 411
L+E + C +E+P +R
Sbjct: 230 LLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 36/266 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 228
+VAVK L ++ S D + F E A +++ HPNV++ +G +S M++
Sbjct: 27 FQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 229 TEYLPKGDLRAFL--KRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
++ GDL FL R G L T VRF +DIA GM YL IHRDL
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAA- 141
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 341
RN + +++ + VADFG+S K+ + R +++A E +
Sbjct: 142 ----------RNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV 191
Query: 342 YDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLYARGLKE 398
Y T DV++F + + E M G P+ ++E+ R + P +Y E
Sbjct: 192 YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVY-----E 246
Query: 399 LIEECWNEKPAKRPTFRQIITRLESI 424
L+ +CW+ +P RP+F+ + +LE I
Sbjct: 247 LMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 59/297 (19%)
Query: 162 EITKGT-FILAFWRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
++ K T F L G VAVK L E + +R E LL+++ HP+V++ GA
Sbjct: 15 KVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVNHPHVIKLYGAC 72
Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPS------------------------TAVRF 255
+Q P++++ EY G LR+FL+ + PS + F
Sbjct: 73 SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315
A I+RGM YL E K ++HRDL RN+L + +K++DFG+S+ +
Sbjct: 133 AWQISRGMQYLAEMK---LVHRDLAA-----------RNVLVAEGRKMKISDFGLSRDVY 178
Query: 316 VKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-------GCPPFTM 367
++ + +++A E + Y T+ DV+SF ++L E++ G P +
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 368 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
N + Y R P ++Y L+ CW ++P KRPTF I LE +
Sbjct: 239 F--NLLKTGY--RMERPENCSEEMYN-----LMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 85/302 (28%), Positives = 141/302 (46%), Gaps = 42/302 (13%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALL 204
DP EL FT I KG+F F +GI VA+K + E +D + + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVF-KGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVL 56
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
+ P V ++ G+ + + + I+ EYL G L R G +I +G++
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLD 115
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YLH K IHRD++ + N+L + G++K+ADFGV+ LT + + T
Sbjct: 116 YLHSEKK---IHRDIKAA-----------NVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161
Query: 325 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384
T ++APEV + YD+K D++S + E+ +G PP + H V P
Sbjct: 162 VGTPF-WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFLIPK 215
Query: 385 FKAPAKL--YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRR 433
P +++ KE I+ C N+ P+ RPT ++++ + N+ I+ +R
Sbjct: 216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFKR 275
Query: 434 WK 435
WK
Sbjct: 276 WK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 85/298 (28%), Positives = 144/298 (48%), Gaps = 34/298 (11%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
DP EL FT +I KG+F F +GI +K+ I D +D + + E+ +L +
Sbjct: 1 DPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
P V ++ G+ + + + I+ EYL G L+ G L + +I +G++YL
Sbjct: 59 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYL 117
Query: 267 HENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 326
H K IHRD++ + N+L + G +K+ADFGV+ LT + + T
Sbjct: 118 HSEKK---IHRDIKAA-----------NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 163
Query: 327 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386
T ++APEV K YD+K D++S + E+ +G PP + H +V P +
Sbjct: 164 TPF-WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE 222
Query: 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRRWK 435
Y++ LKE +E C N++P+ RPT ++++ + + I+ +RWK
Sbjct: 223 GN---YSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELIDRYKRWK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 3e-26
Identities = 65/286 (22%), Positives = 118/286 (41%), Gaps = 36/286 (12%)
Query: 156 DFTNSVEITKGTFILAF--WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NV 212
+ ++ +G+F + VA+K L +++ S V F E+ +L + HP N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFALDIARGMNYLHEN 269
V+ + +V EY+ G L LK RKG L S A+ I + YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT-----VKEDRPLTC 324
IIHRD++P ++ +L D +K+ DFG++KLL +
Sbjct: 121 G---IIHRDIKPENI----------LLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
Query: 325 QDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA----- 376
+ Y+APEV + D++S + L E++ G PPF + ++
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227
Query: 377 ----YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ P + +L ++ +L+++ + P R + +
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 68/251 (27%), Positives = 118/251 (47%), Gaps = 27/251 (10%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L EE + + DE ++ + HP+VV+ LG + SS + ++T+ +P G
Sbjct: 37 IPVAIKVLREE--TSPKANKEILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L +++ K + + + + IA+GM+YL E + ++HRDL RN
Sbjct: 94 CLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAA-----------RN 139
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 353
+L ++K+ DFG++KLL V E +++A E + Y K DV+S+ +
Sbjct: 140 VLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGV 199
Query: 354 ILQE-MIEGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAK 410
+ E M G P+ E+P +R P +Y ++ +CW
Sbjct: 200 TVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM-----VLVKCWMIDAES 254
Query: 411 RPTFRQIITRL 421
RPTF+++I
Sbjct: 255 RPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 54/229 (23%), Positives = 104/229 (45%), Gaps = 25/229 (10%)
Query: 199 DELALLQKIRHPNVVQFLG--AVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTA 252
E+ +L++++HPN+V++ + + IV EY GDL +++ + ++
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 253 VRFALDIARGMNYLH---ENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309
R + + H + ++HRDL+P+ NI D + N+K+ DFG
Sbjct: 108 WRILTQLLLALYECHNRSDPGNT-VLHRDLKPA-----------NIFLDANNNVKLGDFG 155
Query: 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 369
++K+L T T Y++PE + YD K D++S ++ E+ PPFT ++
Sbjct: 156 LAKILGHDSSFAKTYVGTP-YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214
Query: 370 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
++ + Y+ L E+I+ N P KRP+ +++
Sbjct: 215 QLQLASKIKEGKFRRIPY---RYSSELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 85/298 (28%), Positives = 141/298 (47%), Gaps = 34/298 (11%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
DP EL FT I KG+F ++GI K++ I D +D + + E+ +L +
Sbjct: 1 DPEEL-FTKLERIGKGSF-GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
P + ++ G+ + + + I+ EYL G LK G L+ + +I +G++YL
Sbjct: 59 CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYL 117
Query: 267 HENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 326
H + IHRD++ + N+L + G++K+ADFGV+ LT + + T
Sbjct: 118 HSERK---IHRDIKAA-----------NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG 163
Query: 327 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386
T ++APEV K YD K D++S + E+ +G PP + H V P +
Sbjct: 164 TPF-WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLE 222
Query: 387 APAKLYARGLKELIEECWNEKPAKRPTFRQI-----ITRLES----INNSINHKRRWK 435
Y++ KE +E C N+ P RPT +++ ITR + I+ +RWK
Sbjct: 223 GQ---YSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWK 277
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 83/265 (31%), Positives = 126/265 (47%), Gaps = 46/265 (17%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A K+ +E S++D R F EL +L K+ HPN++ LGA + I EY P G+L
Sbjct: 32 AAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL 90
Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL++ L+ A ++FA D+A GM YL E + IHRDL
Sbjct: 91 LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAA 147
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 341
RN+L ++ K+ADFG+S+ V + T R++A E
Sbjct: 148 -----------RNVLVGENLASKIADFGLSRGEEVYVKK--TMGRLPVRWMAIESLNYSV 194
Query: 342 YDTKVDVFSFALILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGL 396
Y TK DV+SF ++L E++ G P M + ++P+ Y R P ++Y
Sbjct: 195 YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RMEKPRNCDDEVY---- 248
Query: 397 KELIEECWNEKPAKRPTFRQIITRL 421
EL+ +CW ++P +RP F QI +L
Sbjct: 249 -ELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-25
Identities = 88/268 (32%), Positives = 132/268 (49%), Gaps = 40/268 (14%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
G + W G +VAVK L +S + +F +E +++K+RH +VQ L AV P
Sbjct: 20 GEVWMGTWNGNTKVAVKTLKPGTMSPE----SFLEEAQIMKKLRHDKLVQ-LYAVVSEEP 74
Query: 225 MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ IVTEY+ KG L FLK ALK V A +A GM Y+ + IHRDL +
Sbjct: 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 131
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKN 339
NIL D K+ADFG+++L+ ED T + + ++ APE
Sbjct: 132 -----------NILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALY 177
Query: 340 EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYAR 394
+ K DV+SF ++L E++ +G P+ ++ E V + Y R P P L+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY--RMPCPQDCPISLH-- 233
Query: 395 GLKELIEECWNEKPAKRPTFRQIITRLE 422
EL+ +CW + P +RPTF + + LE
Sbjct: 234 ---ELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 83/268 (30%), Positives = 129/268 (48%), Gaps = 47/268 (17%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ A+K++ E DD R F EL +L K+ HPN++ LGA + + EY P
Sbjct: 35 MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92
Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
G+L FL++ L+ P+ A+ FA D+ARGM+YL + + IHRD
Sbjct: 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 149
Query: 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 338
L RNIL ++ K+ADFG+S+ V + T R++A E
Sbjct: 150 LAA-----------RNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLN 196
Query: 339 NEEYDTKVDVFSFALILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYA 393
Y T DV+S+ ++L E++ G P M + ++P+ Y R P ++Y
Sbjct: 197 YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY- 253
Query: 394 RGLKELIEECWNEKPAKRPTFRQIITRL 421
+L+ +CW EKP +RP+F QI+ L
Sbjct: 254 ----DLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 80/278 (28%), Positives = 130/278 (46%), Gaps = 61/278 (21%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---PMMIVTEYLPK 234
VAVKKL S + +R F E+ +L+ ++H N+V++ G V S+ + +V EYLP
Sbjct: 36 VAVKKLQH---STAEHLRDFEREIEILKSLQHDNIVKYKG-VCYSAGRRNLRLVMEYLPY 91
Query: 235 GDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G LR +L K + L + +A I +GM YL + +HRDL R
Sbjct: 92 GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLAT-----------R 137
Query: 294 NILRDDSGNLKVADFGVSKLL-------TVKE--DRPLTCQDTSCRYVAPEVFKNEEYDT 344
NIL + +K+ DFG++K+L V+E + P+ + APE ++
Sbjct: 138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-------WYAPESLTESKFSV 190
Query: 345 KVDVFSFALILQEMIEGC-----PP--FTMKHDNEVPKAYAA-----------RQRPPFK 386
DV+SF ++L E+ PP F N+ R P
Sbjct: 191 ASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPG 250
Query: 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
PA++YA +++ECWN P++RP+F ++ ++E+I
Sbjct: 251 CPAEIYA-----IMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 75/260 (28%), Positives = 122/260 (46%), Gaps = 37/260 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L + A EL ++ + H N+V LGA T P++++TEY
Sbjct: 66 MKVAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCY 123
Query: 235 GDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
GDL FL+RK L + F+ +A+GM +L IHRDL
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA----------- 169
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVF 349
RN+L +K+ DFG+++ + D + + +++APE N Y + DV+
Sbjct: 170 RNVLLTHGKIVKICDFGLAR--DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 227
Query: 350 SFALILQEMIE--GCP----PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 403
S+ ++L E+ P P K + + Y R P APA++Y ++++ C
Sbjct: 228 SYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY--RMAQPEHAPAEIY-----DIMKTC 280
Query: 404 WNEKPAKRPTFRQIITRLES 423
W+ P KRPTF+QI+ +
Sbjct: 281 WDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
G VA+KK+ + +A R E+ LQ +HP VV+ L S ++V EY+P
Sbjct: 24 TGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP 82
Query: 234 KGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
DL L+ + L + + + +G+ Y+H N I+HRDL+P+
Sbjct: 83 -SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPA---------- 128
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSF 351
N+L G LK+ADFG+++L + +E R + Q + Y APE+ + +YD VD+++
Sbjct: 129 -NLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAV 187
Query: 352 ALILQEMIEGCPPFTMKHDNE 372
I E++ G P F ++D E
Sbjct: 188 GCIFAELLNGSPLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-25
Identities = 83/265 (31%), Positives = 125/265 (47%), Gaps = 46/265 (17%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A K +E S DD R F EL +L K+ HPN++ LGA + + EY P G+L
Sbjct: 25 AAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 83
Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL++ L+ A + FA D+ARGM+YL + + IHRDL
Sbjct: 84 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAA 140
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 341
RNIL ++ K+ADFG+S+ V + T R++A E
Sbjct: 141 -----------RNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSV 187
Query: 342 YDTKVDVFSFALILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGL 396
Y T DV+S+ ++L E++ G P M + ++P+ Y R P ++Y
Sbjct: 188 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY---- 241
Query: 397 KELIEECWNEKPAKRPTFRQIITRL 421
+L+ +CW EKP +RP+F QI+ L
Sbjct: 242 -DLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 87/272 (31%), Positives = 133/272 (48%), Gaps = 45/272 (16%)
Query: 162 EITKGTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
E+ GT W G +VA+K L +S + AF E +++K+RH +VQ L AV
Sbjct: 21 EVWMGT-----WNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-LYAVV 70
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
P+ IVTEY+ KG L FLK + L+ V A IA GM Y+ + +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127
Query: 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPE 335
L + NIL ++ KVADFG+++L+ ED T + + ++ APE
Sbjct: 128 LRAA-----------NILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPE 173
Query: 336 VFKNEEYDTKVDVFSFALILQEM-IEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAK 390
+ K DV+SF ++L E+ +G P+ + E V + Y R P + P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCPPECPES 231
Query: 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
L+ +L+ +CW ++P +RPTF + LE
Sbjct: 232 LH-----DLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + ++ + VR +E +LQ++ HP +V + M +V + L GDLR
Sbjct: 29 AMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR 88
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L +K + +I + YLH IIHRD++P NIL D
Sbjct: 89 YHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPD-----------NILLD 134
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 358
+ G++ + DF ++ +T D T + Y+APEV + Y VD +S + E
Sbjct: 135 EQGHVHITDFNIATKVT--PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYEC 192
Query: 359 IEGCPPFTMKHDNEVPKAYAARQ 381
+ G P+ H + A+Q
Sbjct: 193 LRGKRPYR-GHSRTIRDQIRAKQ 214
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-24
Identities = 78/255 (30%), Positives = 119/255 (46%), Gaps = 34/255 (13%)
Query: 178 VAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK E + D ++A F E +L++ HPN+V+ +G TQ P+ IV E + GD
Sbjct: 23 VAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79
Query: 237 LRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
FL+ +G LK ++ + A GM YL E+K IHRDL RN
Sbjct: 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYL-ESKHC--IHRDLAA-----------RNC 125
Query: 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDTKVDVFSF 351
L + LK++DFG+S+ +ED + ++ APE Y ++ DV+SF
Sbjct: 126 LVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSF 182
Query: 352 ALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKP 408
++L E G P+ + + +A R P P +Y L+E CW P
Sbjct: 183 GILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVY-----RLMERCWEYDP 237
Query: 409 AKRPTFRQIITRLES 423
+RP+F + L+S
Sbjct: 238 GQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
EL + + + P +V++ GA SS + I EY G L + K+ +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 258 DIA----RGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313
IA +G++YLH K IIHRD++PS NIL G +K+ DFGVS
Sbjct: 109 KIAESVLKGLSYLHSRK---IIHRDIKPS-----------NILLTRKGQVKLCDFGVSGE 154
Query: 314 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373
L T TS Y+APE + + Y DV+S L L E+ + PF + + +
Sbjct: 155 LVNSLAGTFT--GTS-FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL 211
Query: 374 PK----AYAARQRPP-FKAPAKL---YARGLKELIEECWNEKPAKRPTFRQIIT 419
+Y P K ++ K+ I++C + P +RPT ++
Sbjct: 212 GPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 81/287 (28%), Positives = 135/287 (47%), Gaps = 47/287 (16%)
Query: 153 HELDFTNS---VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+E ++ + V + KGT+ + + +++A+K++ E D V+ +E+AL
Sbjct: 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALH 59
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKP--STAVRFALDIAR 261
++H N+VQ+LG+ +++ I E +P G L A L+ K G LK T + + I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 262 GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP 321
G+ YLH+N+ I+HRD++ ++ V + SG +K++DFG SK L P
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTY----------SGVVKISDFGTSKRLA--GINP 164
Query: 322 LTCQDT-SCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378
T T + +Y+APEV Y D++S + EM G PPF E+ + A
Sbjct: 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI-----ELGEPQA 219
Query: 379 A-------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
A + P P L A K I C+ P KR + ++
Sbjct: 220 AMFKVGMFKIHPEI--PESLSAEA-KNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 77/274 (28%), Positives = 119/274 (43%), Gaps = 53/274 (19%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L EE + D F+ E AL+ + HPN+V+ LG PM ++ EY+ GDL
Sbjct: 38 VAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95
Query: 238 RAFLKRKGALKPSTAVR----------------------FALDIARGMNYLHENKPVPII 275
FL+ + + A +A GM YL E K +
Sbjct: 96 NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FV 152
Query: 276 HRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAP 334
HRDL RN L ++ +K+ADFG+S+ + + + D R++ P
Sbjct: 153 HRDLA-----------TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP 201
Query: 335 EVFKNEEYDTKVDVFSFALILQEMIE-GCPP-FTMKHDNEVPKAYAARQ----RPPFKAP 388
E Y T+ DV+++ ++L E+ G P + M H+ + Y R P P
Sbjct: 202 ESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI---YYVRDGNVLSCPDNCP 258
Query: 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
+LY L+ CW++ P+ RP+F I L+
Sbjct: 259 LELYN-----LMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 49/270 (18%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VAVK L E + +D + F E LL +H N+V+F G T+ P ++V EY+ G
Sbjct: 36 ELVAVKTLKE--TASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93
Query: 236 DLRAFLKR--------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
DL FL+ G L S ++ A+ IA GM YL V HRDL
Sbjct: 94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLAT 150
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSK------LLTVKEDRPLTCQDTSCRYVAPE 335
RN L +K+ DFG+S+ V L R++ PE
Sbjct: 151 -----------RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML-----PIRWMPPE 194
Query: 336 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLY 392
++ T+ DV+SF ++L E+ G P+ + EV + + + P P+++Y
Sbjct: 195 SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVY 254
Query: 393 ARGLKELIEECWNEKPAKRPTFRQIITRLE 422
+++ CW P +R + I RL+
Sbjct: 255 -----DIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 72/259 (27%), Positives = 115/259 (44%), Gaps = 45/259 (17%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K++ E V R E+ + + HPNVV++ + + +V YL
Sbjct: 25 NNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82
Query: 234 KGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
G L +K G L + ++ +G+ YLH N IHRD++
Sbjct: 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAG-------- 131
Query: 291 NDRNILRDDSGNLKVADFGVSKLLTVKEDRPL----TCQDTSCRYVAPEVFKNEE-YDTK 345
NIL + G++K+ADFGVS L DR T T C ++APEV + YD K
Sbjct: 132 ---NILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC-WMAPEVMEQVHGYDFK 187
Query: 346 VDVFSFALILQEMIEGCPPF-----------TMKHDNEVPKAYAARQRPPFKAPAKLYAR 394
D++SF + E+ G P+ T+++D P + A K Y++
Sbjct: 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---PPSL------ETGADYKKYSK 238
Query: 395 GLKELIEECWNEKPAKRPT 413
+++I C + P+KRPT
Sbjct: 239 SFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 8e-24
Identities = 67/242 (27%), Positives = 112/242 (46%), Gaps = 26/242 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+K + V D + E+++L++ P +V++ G+ +++ + IV EY
Sbjct: 28 GQVVAIKVV--PVEEDLQEII---KEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82
Query: 235 GDLRAFLKRKGALKPSTAVRFAL---DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
G + +K K T A +G+ YLH NK IHRD++
Sbjct: 83 GSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAG--------- 128
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 351
NIL ++ G K+ADFGVS LT + T T ++APEV + Y+ K D++S
Sbjct: 129 --NILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYNNKADIWSL 185
Query: 352 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
+ EM EG PP++ H + P P K ++ + +++C + P +R
Sbjct: 186 GITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK-WSPEFNDFVKKCLVKDPEER 244
Query: 412 PT 413
P+
Sbjct: 245 PS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 9e-24
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
EL +L K P +V F GA + + I EY+ G L LK +G + + A+
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
+ +G+ YLHE IIHRD++PS NIL + G +K+ DFGVS L
Sbjct: 109 VLKGLTYLHEKH--KIIHRDVKPS-----------NILVNSRGQIKLCDFGVSGQLV--N 153
Query: 319 DRPLTCQDTSCR-YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEVP 374
T Y+APE + +Y K D++S L L E+ G PP D
Sbjct: 154 SLAKT--FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211
Query: 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 419
PP + P+ ++ ++ + C + P +RP++++++
Sbjct: 212 LLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 19/195 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK+ S+ A R E+ LL+++ HPN+++ L + +V E++ DL
Sbjct: 27 VAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDL 84
Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
+K + P + ++ + + +G+ + H + I+HRDL+P N+L
Sbjct: 85 YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPE-----------NLL 130
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALIL 355
+ G LK+ADFG+++ RP T + Y APE+ ++ Y T VD++S I
Sbjct: 131 INTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF 189
Query: 356 QEMIEGCPPFTMKHD 370
E++ P F K +
Sbjct: 190 AELLSRRPLFPGKSE 204
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 18/188 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L + I +V +E +LQ IRHP +V G+ S + +V EY+P G+L
Sbjct: 29 YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
+ L++ G A +A + + YLH I++RDL+P N+L
Sbjct: 89 FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKP-----------ENLLL 134
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357
D G +K+ DFG +K + + R T T Y+APE+ ++ Y VD ++ +++ E
Sbjct: 135 DSDGYIKITDFGFAKRV---KGRTYTLCGT-PEYLAPEIILSKGYGKAVDWWALGILIYE 190
Query: 358 MIEGCPPF 365
M+ G PPF
Sbjct: 191 MLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 27/236 (11%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
D V+A R E+ L+ + H N+VQ+LG T + I EY+P G + + L+ G +
Sbjct: 50 DMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311
F + G+ YLH I+HRDL+ N+L D G K++DFG+S
Sbjct: 110 VRFFTEQVLEGLAYLHSKG---ILHRDLKAD-----------NLLVDADGICKISDFGIS 155
Query: 312 KLLTVKEDRPLTCQDTSCR----YVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPF 365
K +D Q+ S + ++APEV + Y KVD++S ++ EM G P+
Sbjct: 156 KK---SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212
Query: 366 -TMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ + K R PP L L + + C+ P RPT R+++
Sbjct: 213 SDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVAL-DFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 70/266 (26%), Positives = 121/266 (45%), Gaps = 41/266 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K L ++ + F+ E + +++HPN+V LG VT+ P+ ++ Y DL
Sbjct: 38 VAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 238 RAFL----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL K L+P+ V IA GM +L + ++H+DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNE 340
RN+L D N+K++D G+ + + + L R+++PE
Sbjct: 153 -----------RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG 201
Query: 341 EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLK 397
++ D++S+ ++L E+ G P+ + +V + RQ P PA +Y
Sbjct: 202 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYT---- 257
Query: 398 ELIEECWNEKPAKRPTFRQIITRLES 423
L+ ECWNE P++RP F+ I +RL +
Sbjct: 258 -LMLECWNEFPSRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 38/266 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVT 229
++VAVK + ++ + + + F E A ++ HPNV++ +G ++S + M++
Sbjct: 28 LKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVIL 86
Query: 230 EYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSD 283
++ GDL +FL R G L T ++F +DIA GM YL IHRDL
Sbjct: 87 PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAA-- 141
Query: 284 LYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEE 341
RN + + + VADFG+SK + D R +++A E +
Sbjct: 142 ---------RNCMLREDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPVKWIAIESLADRV 191
Query: 342 YDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKE 398
Y +K DV++F + + E G P+ ++E+ + R + P +LY +
Sbjct: 192 YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELY-----D 246
Query: 399 LIEECWNEKPAKRPTFRQIITRLESI 424
L+ CW P RPTF ++ LE+I
Sbjct: 247 LMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 16/189 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E +D + A R E+ +L+++RH N+V A + + +V EY+ + L
Sbjct: 29 VAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
G L P + + + + Y H + IIHRD++P NIL
Sbjct: 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPE-----------NILV 133
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQ 356
+SG LK+ DFG ++ L + PLT + Y APE+ + Y VDV++ I+
Sbjct: 134 SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMA 193
Query: 357 EMIEGCPPF 365
E+++G P F
Sbjct: 194 ELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 6e-23
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 28/196 (14%)
Query: 178 VAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEY 231
VA+KK + ++++ + A R E+ LLQK+RHPN+V+ VT + +V EY
Sbjct: 27 VALKK----IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81
Query: 232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
+ DL L S + + G+ YLH N I+HRD++ S
Sbjct: 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGS-------- 129
Query: 291 NDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVF 349
NIL ++ G LK+ADFG+++ T + T + + Y PE+ Y +VD++
Sbjct: 130 ---NILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMW 186
Query: 350 SFALILQEMIEGCPPF 365
S IL E+ G P F
Sbjct: 187 SVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-23
Identities = 84/264 (31%), Positives = 125/264 (47%), Gaps = 32/264 (12%)
Query: 166 GTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
G + W G +VA+K L + + AF E +++K+RH +V L AV P
Sbjct: 20 GEVWMGTWNGTTKVAIKTLKPGTMMPE----AFLQEAQIMKKLRHDKLVP-LYAVVSEEP 74
Query: 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ IVTE++ KG L FLK LK V A IA GM Y+ + IHRDL +
Sbjct: 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAA 131
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKN 339
NIL D+ K+ADFG+++L+ ED T + + ++ APE
Sbjct: 132 -----------NILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALY 177
Query: 340 EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 398
+ K DV+SF ++L E++ +G P+ + EV + R P L E
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC---PESLHE 234
Query: 399 LIEECWNEKPAKRPTFRQIITRLE 422
L++ CW + P +RPTF I + LE
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-23
Identities = 48/104 (46%), Positives = 64/104 (61%), Gaps = 5/104 (4%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
N D+DG L A+ +E +K LL++G DVN +D D RT LH+AA G E+
Sbjct: 1 NARDEDGRTP-----LHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEI 55
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V LLLE+GADV+ +D+ G+TPL A N +V+KLL KHGA
Sbjct: 56 VKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADV 99
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 9e-23
Identities = 79/276 (28%), Positives = 131/276 (47%), Gaps = 32/276 (11%)
Query: 162 EITKGTF--ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
E+ +GT IL G I+VAVK L + D + F E L+ HPN+V+ LG
Sbjct: 10 EVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGV 67
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA-------VRFALDIARGMNYLHENKP 271
+ P I+ E + GDL ++L+ + + LD+A+G YL +
Sbjct: 68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH- 126
Query: 272 VPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSC 329
IHRDL + V+ D +K+ DFG+++ + K D R
Sbjct: 127 --FIHRDLAARNCLVSEKGYDA------DRVVKIGDFGLARDI-YKSDYYRKEGEGLLPV 177
Query: 330 RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA--RQRPPFK 386
R++APE + ++ T+ DV+SF +++ E++ G P+ ++ EV + A R + P
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237
Query: 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
P K+Y +L+ CW + P++RPTF +I L+
Sbjct: 238 CPDKIY-----QLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 70/264 (26%), Positives = 121/264 (45%), Gaps = 26/264 (9%)
Query: 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF +I KG+F + F A+K++ ++ +R A DE +L K+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
++++ + + IV EY GDL LK R L RF + I G+ +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 269 NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 328
K I+HRD++ +L++ D N+K+ D GV+KLL+ + T T
Sbjct: 120 KK---ILHRDIKSLNLFL-----------DAYDNVKIGDLGVAKLLSDNTNFANTIVGTP 165
Query: 329 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388
Y++PE+ +++ Y+ K DV++ ++L E G PF + + PP
Sbjct: 166 -YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM 224
Query: 389 AKLYARGLKELIEECWNEKPAKRP 412
Y++ L +LI++C + +RP
Sbjct: 225 ---YSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 42/272 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
+ + VAVK L ++ D + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 43 KPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
KG+LR +L+ + L V A +ARGM YL K IH
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPE 335
RDL RN+L + +K+ADFG+++ + + + T +++APE
Sbjct: 158 RDLAA-----------RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE 206
Query: 336 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 392
+ Y + DV+SF ++L E+ G P+ E+ K R P +LY
Sbjct: 207 ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELY 266
Query: 393 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
++ ECW+ P++RPTF+Q++ L+ +
Sbjct: 267 M-----IMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 69/283 (24%), Positives = 130/283 (45%), Gaps = 30/283 (10%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRH 209
+F +I KG F + + G VA+KK+ E++ R + E+ LL+++ H
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDH 61
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAV-RFALDIARGMNY 265
PNV+++L + +++ + IV E GDL +K ++ L P + ++ + + + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 325
+H + I+HRD++P+ N+ +G +K+ D G+ + + K +
Sbjct: 122 MHSKR---IMHRDIKPA-----------NVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 167
Query: 326 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRP 383
T Y++PE Y+ K D++S +L EM PF N + K P
Sbjct: 168 GTP-YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP 226
Query: 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426
P PA Y+ L++L+ C N P KRP ++ + ++
Sbjct: 227 PL--PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 1e-22
Identities = 42/89 (47%), Positives = 54/89 (60%), Gaps = 2/89 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A ++E +K LL+ G DVN D TALH+AA G E+V LLLE GADV+ KD
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLLLEHGADVNAKD 58
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ G+T L A N E++KLL +HGA
Sbjct: 59 KDGNTALHLAARNGNLEIVKLLLEHGADI 87
|
Length = 91 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-22
Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 35/254 (13%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VAVK + +S V AF E +++ ++H +V+ L AV P+ I+TE++ KG
Sbjct: 32 KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 86
Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L FLK +G+ +P + F+ IA GM ++ + IHRDL + N
Sbjct: 87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAA-----------N 132
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSF 351
IL S K+ADFG+++++ ED T ++ + ++ APE + K DV+SF
Sbjct: 133 ILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189
Query: 352 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKP 408
++L E++ G P+ + EV +A R P P +LY ++ CW +P
Sbjct: 190 GILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY-----NIMMRCWKNRP 244
Query: 409 AKRPTFRQIITRLE 422
+RPTF I + L+
Sbjct: 245 EERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-22
Identities = 77/278 (27%), Positives = 132/278 (47%), Gaps = 55/278 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYL 232
G QVAVK L E S + + + E+ +L+ + H N+V++ G T+ + + ++ E+L
Sbjct: 33 GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 233 PKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
P G L+ +L R K + +++A+ I +GM+YL + +HRDL
Sbjct: 91 PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAA---------- 137
Query: 292 DRNILRDDSGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 344
RN+L + +K+ DFG++K + TVK+D D+ + APE ++
Sbjct: 138 -RNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL-----DSPVFWYAPECLIQSKFYI 191
Query: 345 KVDVFSFALILQEMIEGC----PPFTM-------KHDN-------EVPKAYAARQRPPFK 386
DV+SF + L E++ C P T+ H V + RPP
Sbjct: 192 ASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPP-N 250
Query: 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
P ++Y +L+ +CW +P+KR TF+ +I E+I
Sbjct: 251 CPEEVY-----QLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 70/257 (27%), Positives = 112/257 (43%), Gaps = 32/257 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K++ + ++ + VR E +L + +V+ L A + + EY+P GD
Sbjct: 29 VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
R L G L A + ++ ++ LHE + IHRDL+P N L
Sbjct: 89 RTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPE-----------NFLI 134
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357
D SG++K+ DFG+SK + + + D Y+APEV + + YD VD +S +L E
Sbjct: 135 DASGHIKLTDFGLSKGIVTYANSVVGSPD----YMAPEVLRGKGYDFTVDYWSLGCMLYE 190
Query: 358 MIEGCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
+ G PPF+ NE QRP + P + +LI + N+
Sbjct: 191 FLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPS----- 245
Query: 414 FRQIITRLESINNSINH 430
R S+ + NH
Sbjct: 246 -----RRFGSLEDIKNH 257
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-22
Identities = 60/181 (33%), Positives = 91/181 (50%), Gaps = 28/181 (15%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALKPST 251
V A E+ LL+ ++H +VQ+ G + + + I EY+P G ++ LK GAL S
Sbjct: 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311
++ I GM+YLH N I+HRD++ + NILRD +GN+K+ DFG S
Sbjct: 108 TRKYTRQILEGMSYLHSNM---IVHRDIKGA-----------NILRDSAGNVKLGDFGAS 153
Query: 312 KLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 364
K L + + T R +++PEV E Y K DV+S + EM+ PP
Sbjct: 154 KRL-----QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
Query: 365 F 365
+
Sbjct: 209 W 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 61/231 (26%), Positives = 108/231 (46%), Gaps = 27/231 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL ++ + R P +V F GA + + + E++ G L K+ G + + A+ +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS-KLLTVKE 318
G+ YL+ I+HRD++PS NIL + G +K+ DFGVS +L+
Sbjct: 113 VEGLTYLYNVH--RIMHRDIKPS-----------NILVNSRGQIKLCDFGVSGELINSIA 159
Query: 319 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378
D T TS Y++PE + +Y K DV+S + + E+ G PF + ++ +
Sbjct: 160 D---TFVGTST-YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215
Query: 379 AR---------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420
Q PP + P+ + L++ ++ C + P +RPT +Q+
Sbjct: 216 MGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-22
Identities = 66/245 (26%), Positives = 123/245 (50%), Gaps = 23/245 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
V +K++ E ++ D+R+ A ++E +L+ + HPN++++ + +MIV EY P G L
Sbjct: 28 VIIKQIPVEQMTKDERLAA-QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86
Query: 238 RAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
+++++ L T + F + I ++++H I+HRDL+ +NI
Sbjct: 87 AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKT-----------QNI 132
Query: 296 LRDDSGN-LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
L D +K+ DFG+SK+L+ K + T T C Y++PE+ + + Y+ K D+++ +
Sbjct: 133 LLDKHKMVVKIGDFGISKILSSKS-KAYTVVGTPC-YISPELCEGKPYNQKSDIWALGCV 190
Query: 355 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 414
L E+ F + +P F + Y+ L++LI N P+KRP
Sbjct: 191 LYELASLKRAFEAAN---LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQL 247
Query: 415 RQIIT 419
QI+
Sbjct: 248 SQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 5e-22
Identities = 71/252 (28%), Positives = 112/252 (44%), Gaps = 45/252 (17%)
Query: 178 VAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K VI D + E+++L++ RHPN+V + G+ + + IV EY G
Sbjct: 31 VAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L+ + +G L + +G+ YLHE IHRD++ + N
Sbjct: 86 SLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGA-----------N 131
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSF 351
IL + G++K+ADFGVS LT + + T ++APEV E YD K D+++
Sbjct: 132 ILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP-YWMAPEVAAVERKGGYDGKCDIWAL 190
Query: 352 ALILQEMIEGCPP----------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 401
+ E+ E PP F + N P P K K ++ + I+
Sbjct: 191 GITAIELAELQPPMFDLHPMRALFLISKSNFPP--------PKLKDKEK-WSPVFHDFIK 241
Query: 402 ECWNEKPAKRPT 413
+C + P KRPT
Sbjct: 242 KCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 74/277 (26%), Positives = 128/277 (46%), Gaps = 42/277 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
+ + VAVK L + + D + E+ L++ I +H N++ LG TQ P+ ++ EY
Sbjct: 43 QTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100
Query: 233 PKGDLRAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIH 276
KG+LR FL+ + P V A +ARGM YL + IH
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIH 157
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPE 335
RDL RN+L + +K+ADFG+++ + + + + +++APE
Sbjct: 158 RDLAA-----------RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE 206
Query: 336 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLY 392
+ Y + DV+SF +++ E+ G P+ E+ K R P +LY
Sbjct: 207 ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELY 266
Query: 393 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429
L+ ECW+ P +RPTF+Q++ L+ + +++
Sbjct: 267 M-----LMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-22
Identities = 73/270 (27%), Positives = 126/270 (46%), Gaps = 42/270 (15%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ VAVK L ++ D + E+ +++ I +H N++ LGA TQ P+ ++ EY K
Sbjct: 48 VTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105
Query: 235 GDLRAFLKRKGALK----------PSTAVRF------ALDIARGMNYLHENKPVPIIHRD 278
G+LR +L+ + P + F +ARGM YL K IHRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRD 162
Query: 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVF 337
L RN+L ++ +K+ADFG+++ + + + T +++APE
Sbjct: 163 LAA-----------RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211
Query: 338 KNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYAR 394
+ Y + DV+SF +++ E+ G P+ E+ K R P +LY
Sbjct: 212 FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM- 270
Query: 395 GLKELIEECWNEKPAKRPTFRQIITRLESI 424
++ +CW+ P+ RPTF+Q++ L+ I
Sbjct: 271 ----MMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 18/177 (10%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
V A E+ LL+ +RH +VQ+ G + + + I EY+P G ++ LK GAL +
Sbjct: 48 VNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311
R+ I +G++YLH N I+HRD++ + NILRD +GN+K+ DFG S
Sbjct: 108 TRRYTRQILQGVSYLHSNM---IVHRDIKGA-----------NILRDSAGNVKLGDFGAS 153
Query: 312 KLLTV--KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 366
K + + + +++PEV E Y K DV+S A + EM+ PP+
Sbjct: 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 42/272 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
R +VAVK L + D + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 49 RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106
Query: 233 PKGDLRAFL--KRKGALK----PSTA----------VRFALDIARGMNYLHENKPVPIIH 276
KG+LR +L +R ++ P+ V A +ARGM YL K IH
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIH 163
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPE 335
RDL RN+L + +K+ADFG+++ + + + T +++APE
Sbjct: 164 RDLAA-----------RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 212
Query: 336 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 392
+ Y + DV+SF ++L E+ G P+ E+ K R P +LY
Sbjct: 213 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELY 272
Query: 393 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
++ +CW+ P++RPTF+Q++ L+ I
Sbjct: 273 M-----MMRDCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 74/247 (29%), Positives = 119/247 (48%), Gaps = 22/247 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-IVTEYLP 233
G Q +KKL S +R +A E LL +++HPN+V + + ++ IV +
Sbjct: 25 GKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 234 KGDLRAFLK-RKGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
GDL LK +KG L P + V + + IA + YLHE I+HRDL+
Sbjct: 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLK----------- 129
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 351
+N+ + +KV D G++++L + D T T Y++PE+F N+ Y+ K DV++
Sbjct: 130 TQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTP-YYMSPELFSNKPYNYKSDVWAL 188
Query: 352 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
+ EM F K N + + PP K Y+ L ELI +++P KR
Sbjct: 189 GCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM---PKDYSPELGELIATMLSKRPEKR 245
Query: 412 PTFRQII 418
P+ + I+
Sbjct: 246 PSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 65/195 (33%), Positives = 98/195 (50%), Gaps = 24/195 (12%)
Query: 175 GIQVAVKK--LGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
G VA+KK LGE + D + A R E+ LLQ+++HPN++ L S + +V E
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFT-ALR-EIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82
Query: 231 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
++ DL +K K L P+ + L RG+ YLH N I+HRDL+P+
Sbjct: 83 FME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPN------- 131
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDV 348
N+L G LK+ADFG+++ +R +T Q + Y APE+ F Y VD+
Sbjct: 132 ----NLLIASDGVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDM 186
Query: 349 FSFALILQEMIEGCP 363
+S I E++ P
Sbjct: 187 WSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 7e-21
Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 35/265 (13%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L R + VA+ L SD R R F E L + H N+V+ G +T+
Sbjct: 20 ELCRGCLKLPSKRELPVAIHTL-RAGCSDKQR-RGFLAEALTLGQFDHSNIVRLEGVITR 77
Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ MMIVTEY+ G L +FL++ +G L + +A GM YL E + +H+ L
Sbjct: 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLA 134
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPE 335
+L + K++ F ++ED+ T + APE
Sbjct: 135 A-----------HKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 336 VFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLY 392
+ + + DV+SF +++ E M G P+ +V KA R P P L+
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238
Query: 393 ARGLKELIEECWNEKPAKRPTFRQI 417
+L+ +CW ++ +RP F QI
Sbjct: 239 -----QLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 77/264 (29%), Positives = 119/264 (45%), Gaps = 34/264 (12%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-------SPMMIV 228
++VAVK + + I + F E +++ HPNV++ +G Q+ SP++I+
Sbjct: 27 LKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL 85
Query: 229 TEYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
++ GDL +FL R G L V+F DIA GM YL IHRDL
Sbjct: 86 P-FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAA- 140
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEE 341
RN + +++ N+ VADFG+SK + + R +++A E +
Sbjct: 141 ----------RNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV 190
Query: 342 YDTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 400
Y TK DV+SF + + E+ G P+ ++E+ RQ K P GL L+
Sbjct: 191 YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL--RQGNRLKQPPDCL-DGLYSLM 247
Query: 401 EECWNEKPAKRPTFRQIITRLESI 424
CW P RP+F + LE
Sbjct: 248 SSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 28/240 (11%)
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KG 245
I ++ + F E+ +L + +HPN+V A + + I+ E+ G L + + +G
Sbjct: 40 IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG 99
Query: 246 ALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303
+P R L+ +N+LH +K +IHRDL NIL G++
Sbjct: 100 LTEPQIRYVCRQMLE---ALNFLHSHK---VIHRDL-----------KAGNILLTLDGDV 142
Query: 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-----FKNEEYDTKVDVFSFALILQEM 358
K+ADFGVS + T T ++APEV FK+ YD K D++S + L E+
Sbjct: 143 KLADFGVSAKNKSTLQKRDTFIGTP-YWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
Query: 359 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ PP + V + P P+K ++ + ++ C + P RPT +++
Sbjct: 202 AQMEPPHHELNPMRVLLKILKSEPPTLDQPSK-WSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 71/262 (27%), Positives = 112/262 (42%), Gaps = 44/262 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP------MMIVTE 230
VA+K + +D ++E +L+K HPN+ F GA + +P + +V E
Sbjct: 34 VAIKIMD----IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89
Query: 231 YLPKG---DL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYV 286
G DL + K+ LK + RG+ YLHENK +IHRD++
Sbjct: 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQ---- 142
Query: 287 AYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE----- 341
NIL + +K+ DFGVS L R T T ++APEV +E
Sbjct: 143 -------NILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY-WMAPEVIACDEQPDAS 194
Query: 342 YDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLK 397
YD + DV+S + E+ +G PP H +P R PP + +++
Sbjct: 195 YDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP-----RNPPPTLKSPENWSKKFN 249
Query: 398 ELIEECWNEKPAKRPTFRQIIT 419
+ I EC + +RP +++
Sbjct: 250 DFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 175 GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTE 230
G ++AVK++ E V A E+ LL+ + H +VQ+ G + + I E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
++P G ++ LK GAL + ++ I G++YLH N I+HRD++ +
Sbjct: 87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGA-------- 135
Query: 291 NDRNILRDDSGNLKVADFGVSKLLTV--KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 348
NILRD GN+K+ DFG SK L + + +++PEV E Y K D+
Sbjct: 136 ---NILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADI 192
Query: 349 FSFALILQEMIEGCPPF 365
+S + EM+ PP+
Sbjct: 193 WSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L +HP + Q + V EY+ GDL
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
++R G A +A +I G+ +LHE II+RDL+ N+L
Sbjct: 84 MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLD-----------NVLL 129
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357
D G++K+ADFG+ K + T T Y+APE+ + Y VD ++ ++L E
Sbjct: 130 DSEGHIKIADFGMCKEGILGGVTTSTFCGTP-DYIAPEILSYQPYGPAVDWWALGVLLYE 188
Query: 358 MIEGCPPFTMKHDNEV 373
M+ G PF ++E+
Sbjct: 189 MLAGQSPFEGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 72/278 (25%), Positives = 118/278 (42%), Gaps = 53/278 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIVTEYL 232
G VAVK L E ++ E+ +L+ + H N+V++ G ++ + ++ EY+
Sbjct: 33 GEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
P G LR +L + L + + FA I GM YLH IHRDL
Sbjct: 91 PLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAA----------- 135
Query: 293 RNILRDDSGNLKVADFGVSKLLT-------VKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 345
RN+L D+ +K+ DFG++K + V+ED D+ + A E K ++
Sbjct: 136 RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED-----GDSPVFWYAVECLKENKFSYA 190
Query: 346 VDVFSFALILQEMIEGCPPF-------------TMKHDNEVP--KAYAARQRPPF--KAP 388
DV+SF + L E++ C V + R P P
Sbjct: 191 SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCP 250
Query: 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426
++Y L++ CW + RPTFR +I L+ +++
Sbjct: 251 QEVY-----ILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 66/263 (25%), Positives = 121/263 (46%), Gaps = 35/263 (13%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+ + VAVK L +V F E+ ++ ++++PN+++ LG P+ ++TEY+
Sbjct: 43 QPVLVAVKMLRADVTKTARN--DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100
Query: 234 KGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
GDL FL ++ ++ + + A+ IA GM YL + +HRDL
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLA- 156
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNE 340
RN L + +K+ADFG+S+ L + + + R++A E
Sbjct: 157 ----------TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG 206
Query: 341 EYDTKVDVFSFALILQEMIEGCP--PFTMKHDNEVPKA----YAARQRPPFKAPAKLYAR 394
++ T DV++F + L EM C P+++ D +V + + + R + + L
Sbjct: 207 KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPS 266
Query: 395 GLKELIEECWNEKPAKRPTFRQI 417
+ +L+ CW+ RPTF +I
Sbjct: 267 PVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-20
Identities = 39/82 (47%), Positives = 50/82 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A +E +K LL+ G DVN RD D T LH+AA G +VV LLL+ GADV+ +D
Sbjct: 44 LHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADVNARD 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLL 125
+ G TPL A + EV+KLL
Sbjct: 104 KDGRTPLHLAAKNGHLEVVKLL 125
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 51/167 (30%), Positives = 91/167 (54%), Gaps = 18/167 (10%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
+E +L+++ HP +++ + ++ EY+P G+L ++L+ G ST + +A +
Sbjct: 50 NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
I + YLH + I++RDL+P NIL D G++K+ DFG +K L
Sbjct: 110 IVCALEYLHSKE---IVYRDLKP-----------ENILLDKEGHIKLTDFGFAKKLR--- 152
Query: 319 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
DR T T Y+APEV +++ ++ VD ++ +++ EM+ G PPF
Sbjct: 153 DRTWTLCGTP-EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 58/249 (23%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
V K++ +S+ +R R +E+ +L ++HPN++ + + ++I EY G
Sbjct: 27 LVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85
Query: 237 L-RAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L +++KG L V + L I ++Y+H+ I+HRD++ N
Sbjct: 86 LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTL-----------N 131
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
I +G +K+ DFG+SK+L + T T Y++PE+ + +Y+ K D+++ +
Sbjct: 132 IFLTKAGLIKLGDFGISKILGSEYSMAETVVGTP-YYMSPELCQGVKYNFKSDIWALGCV 190
Query: 355 LQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 412
L E++ T N + P + Y+ L L+ + P KRP
Sbjct: 191 LYELL--TLKRTFDATNPLNLVVKIVQGNYTPVVSV---YSSELISLVHSLLQQDPEKRP 245
Query: 413 TFRQIITRL 421
T +++ +
Sbjct: 246 TADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-20
Identities = 51/177 (28%), Positives = 99/177 (55%), Gaps = 20/177 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFA 256
E++L+++++H N+V+ + + +M+V EY+ K DL+ ++ +GAL P+T F
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
+ +G+ + HEN+ ++HRDL+P +N+L + G LK+ADFG+++ +
Sbjct: 107 YQLLKGIAFCHENR---VLHRDLKP-----------QNLLINKRGELKLADFGLARAFGI 152
Query: 317 KEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372
+ + + + Y AP+V + Y T +D++S I+ EMI G P F ++ +
Sbjct: 153 PVNT-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 65/255 (25%), Positives = 122/255 (47%), Gaps = 35/255 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G Q +K++ +S +R + R E+A+L ++HPN+VQ+ + ++ + IV +Y
Sbjct: 25 GKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 235 GDLRAFL-KRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
GDL + ++G L P + + + I + ++H+ K I+HRD++
Sbjct: 84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQ---------- 130
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 352
NI G +K+ DFG++++L + TC T Y++PE+ +N Y+ K D+++
Sbjct: 131 -NIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP-YYLSPEICENRPYNNKSDIWALG 188
Query: 353 LILQEMIEGCPPFTMKH-------DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 405
+L EM T+KH N V K R + + Y+ L+ L+ + +
Sbjct: 189 CVLYEMC------TLKHAFEAGNMKNLVLKII----RGSYPPVSSHYSYDLRNLVSQLFK 238
Query: 406 EKPAKRPTFRQIITR 420
P RP+ I+ +
Sbjct: 239 RNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-19
Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 22/226 (9%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPS-TAVRF 255
R E LL K++HPN+V F + + IV EY GDL +K ++G L P T +++
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315
+ + G+ ++HE + ++HRD++ +NI +G +K+ DFG ++LLT
Sbjct: 106 FVQMCLGVQHIHEKR---VLHRDIK-----------SKNIFLTQNGKVKLGDFGSARLLT 151
Query: 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH-DNEVP 374
T T YV PE+++N Y+ K D++S IL E+ PF N +
Sbjct: 152 SPGAYACTYVGTP-YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
Query: 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420
K +P P+ Y+ L+ LI++ + P RP+ I++R
Sbjct: 211 KVCQGSYKP---LPSH-YSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 54/246 (21%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVR-- 254
E LL + H N++ L + P ++ Y+ G+L+ FL+ R G A+
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 255 ----FALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310
A+ IA GM+YLH+ +IH+D+ RN + D+ +K+ D +
Sbjct: 118 QLVHMAIQIACGMSYLHKRG---VIHKDIAA-----------RNCVIDEELQVKITDNAL 163
Query: 311 SK--------LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-- 360
S+ L E+RP+ +++A E N+EY + DV+SF ++L E++
Sbjct: 164 SRDLFPMDYHCLGDNENRPV-------KWMALESLVNKEYSSASDVWSFGVLLWELMTLG 216
Query: 361 GCP-----PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 415
P PF M + Y Q P P +L+A ++ CW P +RP+F
Sbjct: 217 QTPYVEIDPFEMAA--YLKDGYRLAQ--PINCPDELFA-----VMACCWALDPEERPSFS 267
Query: 416 QIITRL 421
Q++ L
Sbjct: 268 QLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+ A+K L + + + +V+ ++ L + HP +++ + V EY P
Sbjct: 26 NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G+L ++++ G+L +A +I + YLH IIHRDL+P
Sbjct: 86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPE----------- 131
Query: 294 NILRDDSGNLKVADFGVSKLL---------------TVKEDRPLTCQDTS----CRYVAP 334
NIL D ++K+ DFG +K+L + + S YV+P
Sbjct: 132 NILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP 191
Query: 335 EVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
E+ + D+++ I+ +M+ G PPF
Sbjct: 192 ELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 63/260 (24%), Positives = 105/260 (40%), Gaps = 23/260 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL-GAVTQSSPMMIVTEYLP 233
G +VA+K L + ++ + FR E AL ++ HPN+V L + V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
LR L GAL R L + + H I+HRDL+P ++ V+
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVS------ 113
Query: 294 NILRDDSGNLKVADFGVSKLLT-VKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVD 347
+ KV DFG+ LL V++ T T + Y APE + E D
Sbjct: 114 --QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 348 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP-PFKAPAKLYARGLKELIEECWNE 406
++++ LI E + G E+ + P P + L +++ + N+
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEI---LYQQLSPVDVSLPPWIAGHPLGQVLRKALNK 228
Query: 407 KPAKRP-TFRQIITRLESIN 425
P +R + + R ++
Sbjct: 229 DPRQRAASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 71/226 (31%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF + + KG+F +LA +G A+K L ++VI DD V E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK- 59
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P + Q + V EY+ GDL +++ G K AV +A +IA G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 268 ENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 327
II+RDL+ N++ D G++K+ADFG+ K T T
Sbjct: 119 SKG---IIYRDLKLD-----------NVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT 164
Query: 328 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373
Y+APE+ + Y VD ++F ++L EM+ G PPF + ++E+
Sbjct: 165 P-DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 60/193 (31%), Positives = 102/193 (52%), Gaps = 24/193 (12%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+KK+ E ++D+ V A R E++LL+++ HPN+V+ L V + + +V E+L
Sbjct: 27 VALKKIRLE--TEDEGVPSTAIR-EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL- 82
Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
DL+ ++ L P + + +G+ Y H ++ ++HRDL+P +
Sbjct: 83 DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKP-----------Q 128
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFA 352
N+L D G LK+ADFG+++ V R T + + Y APE+ + +Y T VD++S
Sbjct: 129 NLLIDREGALKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG 187
Query: 353 LILQEMIEGCPPF 365
I EM+ P F
Sbjct: 188 CIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 60/193 (31%), Positives = 95/193 (49%), Gaps = 21/193 (10%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPK 234
VA+KK+ + D + + R E+ LL +RHPN+V+ V + +V EY +
Sbjct: 34 IVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92
Query: 235 GDLRAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
DL + L + V+ L + RG+ YLHEN IIHRDL+ S
Sbjct: 93 -DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVS----------- 137
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFA 352
N+L D G LK+ADFG+++ + +P+T + + Y APE+ Y T +D+++
Sbjct: 138 NLLLTDKGCLKIADFGLARTYGLP-AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVG 196
Query: 353 LILQEMIEGCPPF 365
IL E++ P
Sbjct: 197 CILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 32/193 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAF--RDELALLQKIR---HPNVVQFLG-----AVTQSSPMMI 227
VA+KK+ V ++ + R E+ALL+++ HPN+V+ L + + +
Sbjct: 27 VALKKV--RVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83
Query: 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285
V E++ + DL +L + K L P T + RG+++LH ++ I+HRDL+P
Sbjct: 84 VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKP---- 135
Query: 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 345
+NIL G +K+ADFG++++ + + LT + Y APEV Y T
Sbjct: 136 -------QNILVTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAPEVLLQSSYATP 186
Query: 346 VDVFSFALILQEM 358
VD++S I E+
Sbjct: 187 VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 27/231 (11%)
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL-KPSTAV 253
A + E+ LL K++HPN+V F + ++ + IV EY GDL + R +G L +
Sbjct: 45 ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL-KVADFGVSK 312
+ + I+ G+ ++H+ K I+HRD++ +NI +G + K+ DFG+++
Sbjct: 105 SWFVQISLGLKHIHDRK---ILHRDIK-----------SQNIFLSKNGMVAKLGDFGIAR 150
Query: 313 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH--- 369
L + TC T Y++PE+ +N Y+ K D++S +L E+ C T+KH
Sbjct: 151 QLNDSMELAYTCVGTP-YYLSPEICQNRPYNNKTDIWSLGCVLYEL---C---TLKHPFE 203
Query: 370 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420
N + + + F + ++R L+ LI + + P RP+ I+ R
Sbjct: 204 GNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA-VTQSSPMMIVTEYL 232
G VA+KK+ + + R +R EL LL+ +RH N++ ++ + VTE L
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
DL L L+ F I RG+ Y+H ++HRDL+PS
Sbjct: 93 GT-DLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPS---------- 137
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSF 351
NIL +++ +LK+ DFG++++ +D +T ++ Y APE+ ++YD +VD++S
Sbjct: 138 -NILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192
Query: 352 ALILQEMIEGCPPFTMK-HDNE 372
I EM+EG P F K H N+
Sbjct: 193 GCIFAEMLEGKPLFPGKDHVNQ 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-19
Identities = 67/255 (26%), Positives = 118/255 (46%), Gaps = 34/255 (13%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK ++ +D+ A +DEL ++Q++ +P +V+ +G + ++ M+V E
Sbjct: 25 VAVK-----ILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG-ICEAESWMLVMELAE 78
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G L FL++ + ++ GM YL E +HRDL R
Sbjct: 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAA-----------R 124
Query: 294 NILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 351
N+L K++DFG+SK L E+ + T ++ APE ++ +K DV+SF
Sbjct: 125 NVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSF 184
Query: 352 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKP 408
+++ E G P+ NEV + + +R P + P ++Y +L++ CW
Sbjct: 185 GVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMY-----DLMKLCWTYGV 239
Query: 409 AKRPTFRQIITRLES 423
+RP F + RL +
Sbjct: 240 DERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 7e-19
Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 16/188 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + I + + E +L++ HP +V+ + ++ EY G+L
Sbjct: 22 ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L+ +G TA + + YLH II+RDL+P N+L D
Sbjct: 82 TILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPE-----------NLLLD 127
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 358
+G +K+ DFG +K L + + T T YVAPE+ N+ YD VD +S ++L E+
Sbjct: 128 SNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP-EYVAPEIILNKGYDFSVDYWSLGILLYEL 185
Query: 359 IEGCPPFT 366
+ G PPF
Sbjct: 186 LTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 38/206 (18%)
Query: 175 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIV 228
G +VA+KK+ V D D R R E+ LL+ +RH N++ L + SP IV
Sbjct: 25 GRKVAIKKI-SNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
TE + DL +K L F I RG+ YLH +IHRDL+PS
Sbjct: 83 TELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPS------ 132
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEVFKN- 339
NIL + + +LK+ DFG+++ + ED LT YV APE+ +
Sbjct: 133 -----NILVNSNCDLKICDFGLARGVDPDEDEKGFLT------EYVVTRWYRAPELLLSS 181
Query: 340 EEYDTKVDVFSFALILQEMIEGCPPF 365
Y +D++S I E++ P F
Sbjct: 182 SRYTKAIDIWSVGCIFAELLTRKPLF 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAF---RDELALLQKIRHPNVVQFL 216
KG+F +LA +G A+K L ++V+ +DD V R LAL + HP +
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFLTHLF 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ V EYL GDL ++ G + A +A +I G+ +LH+ II+
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIY 119
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVA 333
RDL+ N+L D G++K+ADFG+ K E + T C Y+A
Sbjct: 120 RDLKLD-----------NVLLDKDGHIKIADFGMCKENMNGEGK----ASTFCGTPDYIA 164
Query: 334 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373
PE+ K ++Y+ VD +SF ++L EM+ G PF + ++E+
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 41/267 (15%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VAVK L + + D+ + F E LL ++H ++V+F G + P+++V EY+ G
Sbjct: 36 ILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 236 DLRAFLKRKGA-------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
DL FL+ G L S + A IA GM YL +HRDL
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLA-- 147
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEE 341
RN L ++ +K+ DFG+S+ + + R R++ PE +
Sbjct: 148 ---------TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 198
Query: 342 YDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLK 397
+ T+ DV+S ++L E+ G P+ +NEV + QRP P ++Y
Sbjct: 199 FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR-TCPKEVY----- 252
Query: 398 ELIEECWNEKPAKRPTFRQIITRLESI 424
+L+ CW +P R ++I + L+++
Sbjct: 253 DLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 72/277 (25%), Positives = 127/277 (45%), Gaps = 34/277 (12%)
Query: 151 DPHELDFTNSVEI---TKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP N V+I + G +A + G QVAVKK+ + R +E+ +++
Sbjct: 16 DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMR 71
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+HPN+V+ + + +V E+L G L + + A L + + +++
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSF 130
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 325
LH +IHRD++ SD +IL G +K++DFG ++ + R +
Sbjct: 131 LHAQG---VIHRDIK-SD----------SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176
Query: 326 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR--- 382
T ++APEV Y T+VD++S +++ EM++G PP+ NE P R R
Sbjct: 177 GTP-YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF----NEPPLQAMKRIRDNL 231
Query: 383 -PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
P K K+ R L+ ++ PA+R T +++
Sbjct: 232 PPKLKNLHKVSPR-LRSFLDRMLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 174 RGIQVAVKKLG---EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
+G +AVK++ V++ + ++E+ LL+ ++H N+VQ+LG + + I E
Sbjct: 23 QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
++P G + + L R G L ++ I G+ YLH N ++HRD++ +
Sbjct: 83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGN-------- 131
Query: 291 NDRNILRDDSGNLKVADFGVSKLL-----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 345
N++ +G +K+ DFG ++ L L + ++APEV Y K
Sbjct: 132 ---NVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRK 188
Query: 346 VDVFSFALILQEMIEGCPPFT 366
D++S + EM G PP
Sbjct: 189 SDIWSIGCTVFEMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 56/222 (25%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + +++ R E +L P +V+ + + +V EY+P GDL
Sbjct: 30 AMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM 89
Query: 239 AFLKRKGALKPSTAVRF-------ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
L RK TA RF ALD + + IHRD++P
Sbjct: 90 NLLIRKDVFPEETA-RFYIAELVLALDSVHKLGF---------IHRDIKPD--------- 130
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT------------------------ 327
NIL D G++K+ADFG+ K + +DR D+
Sbjct: 131 --NILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188
Query: 328 ----SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ Y+APEV + Y + D +S +IL EM+ G PPF
Sbjct: 189 STVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ I + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 24 AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
L+R+ + A +A +IA + YLH II+RDL+P NIL
Sbjct: 84 FFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKP-----------ENILL 129
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357
D G++ + DFG+ K T T Y+APEV + + YD VD + +L E
Sbjct: 130 DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP-EYLAPEVLRKQPYDRTVDWWCLGAVLYE 188
Query: 358 MIEGCPPFTMKHDNEV 373
M+ G PPF + E+
Sbjct: 189 MLYGLPPFYSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 69/229 (30%), Positives = 110/229 (48%), Gaps = 31/229 (13%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF + + KG+F +LA +G A+K L ++V+ DD V E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK- 59
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P + Q + V EY+ GDL +++ G K AV +A +I+ G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 268 ENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 327
II+RDL+ N++ D G++K+ADFG+ K V T
Sbjct: 119 RRG---IIYRDLKLD-----------NVMLDSEGHIKIADFGMCKEHMVDG----VTTRT 160
Query: 328 SC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373
C Y+APE+ + Y VD +++ ++L EM+ G PPF + ++E+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 62/238 (26%), Positives = 107/238 (44%), Gaps = 22/238 (9%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
G A+K L + I +V+ E ++L ++ HP +V + + + + + E++
Sbjct: 42 TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G+L L++ G A + ++ YLH II+RDL+P
Sbjct: 102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKP-----------E 147
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 353
N+L D+ G++KV DFG +K + DR T T Y+APEV +++ + VD ++ +
Sbjct: 148 NLLLDNKGHVKVTDFGFAKKVP---DRTFTLCGTP-EYLAPEVIQSKGHGKAVDWWTMGV 203
Query: 354 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
+L E I G PPF D+ + Y K P R ++L++ KR
Sbjct: 204 LLYEFIAGYPPF---FDDTPFRIYEKILAGRLKFPNWFDGRA-RDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 66/260 (25%), Positives = 123/260 (47%), Gaps = 32/260 (12%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGA 218
E+ + T +L G+ VA+KK+ I D +A D E+ LL+++ HPNV+++ +
Sbjct: 17 EVYRATCLL---DGVPVALKKVQ---IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70
Query: 219 VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 274
+ + + IV E GDL + F K+K + T ++ + + + ++H + +
Sbjct: 71 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---V 127
Query: 275 IHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 334
+HRD++P+++++ +G +K+ D G+ + + K + T Y++P
Sbjct: 128 MHRDIKPANVFIT-----------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSP 175
Query: 335 EVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLY 392
E Y+ K D++S +L EM PF N + K PP P+ Y
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHY 233
Query: 393 ARGLKELIEECWNEKPAKRP 412
+ L++L+ C N P KRP
Sbjct: 234 SEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 82/306 (26%), Positives = 135/306 (44%), Gaps = 59/306 (19%)
Query: 144 EVPEYEID-PHEL---DFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
EV E+ P +L F +V KG R + VAVK L + ++ + F
Sbjct: 20 EVHLCEVVNPQDLPTLQFPFNVR--KG-------RPLLVAVKILRPD--ANKNARNDFLK 68
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------- 245
E+ +L +++ PN+++ LG P+ ++TEY+ GDL FL
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300
A+ S+ + AL IA GM YL + +HRDL RN L ++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA-----------TRNCLVGEN 174
Query: 301 GNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 359
+K+ADFG+S+ L + + + R++A E ++ T DV++F + L E++
Sbjct: 175 LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
Query: 360 EGC--PPFTMKHDNEVPKAYA------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
C P+ D +V + RQ F+ P +GL EL+ +CW+ +R
Sbjct: 235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP--CPQGLYELMLQCWSRDCRER 292
Query: 412 PTFRQI 417
P+F I
Sbjct: 293 PSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-18
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 23/223 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
E LL K+ HP +V+F + + I+TEY DL L + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315
+ + G++Y+H+ + I+HRDL+ ++++ +N L LK+ DFGVS+LL
Sbjct: 112 FIQLLLGVHYMHQRR---ILHRDLKAKNIFL------KNNL------LKIGDFGVSRLLM 156
Query: 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375
D T T Y++PE K++ YD+K D++S IL EM C + N +
Sbjct: 157 GSCDLATTFTGTP-YYMSPEALKHQGYDSKSDIWSLGCILYEMC--CLAHAFEGQNFLSV 213
Query: 376 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ P P Y+R L +++ N+ P+ RP+ +I+
Sbjct: 214 VLRIVEGPTPSLPET-YSRQLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 68/263 (25%), Positives = 126/263 (47%), Gaps = 41/263 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K + E S +R+ F +E +++++ +VV+ LG V+Q P +++ E + +GD
Sbjct: 38 RVAIKTVNEAA-SMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 95
Query: 237 LRAFLKRKGALKPSTA-------------VRFALDIARGMNYLHENKPVPIIHRDLEPSD 283
L+++L+ +L+P ++ A +IA GM YL+ NK +HRDL
Sbjct: 96 LKSYLR---SLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAA-- 147
Query: 284 LYVAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 342
RN + + +K+ DFG+++ + R R+++PE K+ +
Sbjct: 148 ---------RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 198
Query: 343 DTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKEL 399
T DV+SF ++L E+ P+ + +V + P P L+ EL
Sbjct: 199 TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLF-----EL 253
Query: 400 IEECWNEKPAKRPTFRQIITRLE 422
+ CW P RP+F +II+ ++
Sbjct: 254 MRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 62/247 (25%), Positives = 119/247 (48%), Gaps = 24/247 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ ++++ +HPN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G L + + + + + + +LH N+ +IHRD++ SD N
Sbjct: 101 GSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIK-SD----------N 145
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
IL G++K+ DFG +T ++ + T T ++APEV + Y KVD++S ++
Sbjct: 146 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIM 204
Query: 355 LQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 412
EM+EG PP+ ++N + Y A P + P KL A ++ + C KR
Sbjct: 205 AIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSA-IFRDFLNRCLEMDVEKRG 261
Query: 413 TFRQIIT 419
+ ++++
Sbjct: 262 SAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
AVK L ++ I + + + A R+ LL+ ++HP +V + + + V +Y+ G
Sbjct: 24 AVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
+L L+R+ A +A ++A + YLH + II+RDL+P NI
Sbjct: 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKP-----------ENI 127
Query: 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 355
L D G++ + DFG+ K E+ T T Y+APEV + E YD VD + +L
Sbjct: 128 LLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP-EYLAPEVLRKEPYDRTVDWWCLGAVL 186
Query: 356 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388
EM+ G PPF + +V + Y P + P
Sbjct: 187 YEMLYGLPPF---YSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 62/265 (23%), Positives = 111/265 (41%), Gaps = 43/265 (16%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+V VK+L + D F E+ +++ HPNV+Q LG +S P ++V E+ P
Sbjct: 21 SKARVVVKEL--RASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78
Query: 234 KGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
GDL+ +L+ + R A ++A G+ +LH+ IH DL
Sbjct: 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLAL------- 128
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLT--CQDTSCRYVAPEVFKNEEYDTKV 346
RN ++K+ D+G++ L ED +T C R++APE+ + D
Sbjct: 129 ----RNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLP 183
Query: 347 -------DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR------PPFKAPAKLY 392
+++S + + E+ P+ +E R++ P Y
Sbjct: 184 KDQTKKSNIWSLGVTMWELFTAADQPYP-DLSDEQVLKQVVREQDIKLPKPQLDLK---Y 239
Query: 393 ARGLKELIEECWNEKPAKRPTFRQI 417
+ E+++ CW + P RPT ++
Sbjct: 240 SDRWYEVMQFCWLD-PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 31/255 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+ +A+K++ E+ D+ + EL +L K P +V F GA + + EY+
Sbjct: 26 GVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83
Query: 235 GDLRAFLKRKGAL--KPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
G L A P +R + +G+ +L E IIHRD++P+
Sbjct: 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPT--------- 132
Query: 292 DRNILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNE------EYDT 344
N+L + +G +K+ DFGVS L+ + CQ Y+APE K+ Y
Sbjct: 133 --NVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS----YMAPERIKSGGPNQNPTYTV 186
Query: 345 KVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 403
+ DV+S L + EM G P+ + + N + A P P+ Y+ ++ + +C
Sbjct: 187 QSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG-YSDDAQDFVAKC 245
Query: 404 WNEKPAKRPTFRQII 418
N+ P +RPT+ Q++
Sbjct: 246 LNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 67/221 (30%), Positives = 115/221 (52%), Gaps = 30/221 (13%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIR 208
D+T +I +GT+ + + G VA+KK+ E S+++ V A R E++LL++++
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIR-EISLLKELQ 57
Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFAL-DIARGMNY 265
HPN+V + Q S + ++ E+L DL+ +L KG + V+ L I +G+ +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 325
H + ++HRDL+P +N+L D+ G +K+ADFG+++ + R T +
Sbjct: 117 CHSRR---VLHRDLKP-----------QNLLIDNKGVIKLADFGLARAFGIPV-RVYTHE 161
Query: 326 DTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ Y APEV + Y T VD++S I EM P F
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 215
I+KG F LA R G A+K L + + ++V + E A++ P V +
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ + +V EYL GD + +K G L A ++ ++ G+ LH+ II
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119
Query: 276 HRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 335
HRD++P N+L D +G+LK+ DFG+S+ + T Y+APE
Sbjct: 120 HRDIKPE-----------NLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-----YLAPE 163
Query: 336 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380
D D +S ++ E + G PPF E P A
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPF----HAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 65/250 (26%), Positives = 114/250 (45%), Gaps = 33/250 (13%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
I VA+K I D + F+ D + + + H +V+ LG +S + +VT+
Sbjct: 37 IPVAIK-----TIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLS 90
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
P G L + + + +L P + + + IA+GM YL E++ ++HR+L
Sbjct: 91 PLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAA---------- 137
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFS 350
RNIL +++ADFGV+ LL + + + T +++A E Y + DV+S
Sbjct: 138 -RNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWS 196
Query: 351 FALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEK 407
+ + + EM+ G P+ +EVP +R P +Y +K CW
Sbjct: 197 YGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVK-----CWMID 251
Query: 408 PAKRPTFRQI 417
RPTF+++
Sbjct: 252 ENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 65/257 (25%), Positives = 114/257 (44%), Gaps = 38/257 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +AVK++ V S + + R D ++ + P V F GA+ + + I E +
Sbjct: 26 GTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VMD 83
Query: 235 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
L F K+ KG P + + A+ I + + YLH V IHRD++PS
Sbjct: 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPS-------- 133
Query: 291 NDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVF----KNEEYDTK 345
N+L + +G +K+ DFG+S L D D C+ Y+APE + YD K
Sbjct: 134 ---NVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQKGYDVK 187
Query: 346 VDVFSFALILQEMIEGCPPFTMKHD-----NEVPKAYAARQRPPFKAPAKLYARGLKELI 400
DV+S + + E+ G P+ +V + P + PA+ ++ ++ +
Sbjct: 188 SDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE------PSPQLPAEKFSPEFQDFV 241
Query: 401 EECWNEKPAKRPTFRQI 417
+C + +RP + ++
Sbjct: 242 NKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 30/234 (12%)
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
AF + +L+ ++ H ++V+ G V ++V EY+ G L FL R+ S +
Sbjct: 47 AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKN-NVSLHWKL 104
Query: 256 --ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN---LKVADFGV 310
A +A ++YL + K ++H ++ ++ VA + G +K++D G+
Sbjct: 105 DVAKQLASALHYLEDKK---LVHGNVCGKNILVAR-------YGLNEGYVPFIKLSDPGI 154
Query: 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCP-PFTM 367
+ +E+R ++APE +N + D +SF L E+ P +
Sbjct: 155 PITVLSREERVERIP-----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209
Query: 368 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
+E + Y + R P A+L LI +CW P KRP+FR I+ L
Sbjct: 210 LSSSEKERFYQDQHRLPMPDCAELA-----NLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-17
Identities = 54/219 (24%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
E+ LL+++ HPNV+++L + + + + IV E GDL + F K+K + T ++
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315
+ + + ++H + ++HRD++P+++++ +G +K+ D G+ + +
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFIT-----------ATGVVKLGDLGLGRFFS 157
Query: 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375
K + T Y++PE Y+ K D++S +L EM PF N
Sbjct: 158 SKTTAAHSLVGTP-YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216
Query: 376 AYAARQ--RPPFKAPAKLYARGLKELIEECWNEKPAKRP 412
Q PP P + Y+ L+EL+ C P +RP
Sbjct: 217 CQKIEQCDYPPL--PTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-17
Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 30/244 (12%)
Query: 183 LGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYL---PKGDLR 238
G++ D + E+ ++ +++RHPN+V++ ++ + IV + + P G+
Sbjct: 41 FGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF 100
Query: 239 AFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
LK K + + + + YLH+ K I+HRDL P+ NI+
Sbjct: 101 NSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPN-----------NIML 147
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357
+ + + DFG++K + + LT + Y PE+ KNE Y K DV++F IL +
Sbjct: 148 GEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQ 205
Query: 358 MIEGCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
M PPF + + K A P P +Y+ + ++I C RP
Sbjct: 206 MCTLQPPF---YSTNMLSLATKIVEAVYEP---LPEGMYSEDVTDVITSCLTPDAEARPD 259
Query: 414 FRQI 417
Q+
Sbjct: 260 IIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 67/243 (27%), Positives = 112/243 (46%), Gaps = 28/243 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+G AVK L ++V+ DD V E +L +P + + V E+L
Sbjct: 19 KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
GDL ++ KG A +A +I G+ +LH II+RDL+
Sbjct: 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLD---------- 125
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 352
N++ D G++K+ADFG+ K ++R T T Y+APE+ + +Y VD +SF
Sbjct: 126 -NVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP-DYIAPEILQGLKYTFSVDWWSFG 183
Query: 353 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL----KELIEECWNEKP 408
++L EM+ G PF ++E+ + + R P Y R + K+++E+ + P
Sbjct: 184 VLLYEMLIGQSPFHGDDEDELFE--SIRVDTPH------YPRWITKESKDILEKLFERDP 235
Query: 409 AKR 411
+R
Sbjct: 236 TRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 24/242 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ + + +E +L+K+ +V A + +V + GDL+
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81
Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
+ G + A+ +A I G+ +LH+ + I++RDL+P N+L
Sbjct: 82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPE-----------NVL 127
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 356
DD GN++++D G++ + +K + + + + Y+APEV + E YD VD F+ L
Sbjct: 128 LDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLY 185
Query: 357 EMIEGCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
EMI G PF K + E K + P K ++ K+L E + P KR
Sbjct: 186 EMIAGRSPFRQRKEKVEKEELKRRTLEM--AVEYPDK-FSPEAKDLCEALLQKDPEKRLG 242
Query: 414 FR 415
R
Sbjct: 243 CR 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + HP +V S + V E++ GDL
Sbjct: 24 AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
++R+ L A ++ +I+ +N+LHE II+RDL+ N+L
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLD-----------NVLL 129
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G++K+ D+G+ K + RP T C Y+APE+ + E+Y VD ++ ++
Sbjct: 130 DAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185
Query: 355 LQEMIEGCPPFTMKHDNEVP 374
+ EM+ G PF + ++ P
Sbjct: 186 MFEMMAGRSPFDIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 22/197 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E++ DD+ + + E + Q +P +V +S + +V EY+ GDL
Sbjct: 24 AMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
++R+ L A +A +I +N+LHE II+RDL+ N+L
Sbjct: 84 MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLD-----------NVLL 129
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G++K+ D+G+ K + P T C Y+APE+ + EEY VD ++ ++
Sbjct: 130 DADGHIKLTDYGMCK----EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVL 185
Query: 355 LQEMIEGCPPFTMKHDN 371
+ EM+ G PF + DN
Sbjct: 186 MFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 22/200 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + Q HP +V S + V EY+ GDL
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD-----------NVLL 129
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G++K+ D+G+ K + RP T C Y+APE+ + E+Y VD ++ ++
Sbjct: 130 DSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185
Query: 355 LQEMIEGCPPFTMKHDNEVP 374
+ EM+ G PF + ++ P
Sbjct: 186 MFEMMAGRSPFDIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 163 ITKGTF---ILAFWRGIQV--AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFL 216
I KG+F +LA + + AVK L ++ I + E LL+ ++HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + + V +Y+ G+L L+R+ A +A +IA + YLH + I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVY 119
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVA 333
RDL+P NIL D G++ + DFG+ K + T C Y+A
Sbjct: 120 RDLKP-----------ENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLA 164
Query: 334 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373
PEV + YD VD + +L EM+ G PPF ++ E+
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 30/199 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S R +R EL LL+ + H NV+ L T +S + +V
Sbjct: 40 GRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLYVA 287
T L DL +K + L ++F + I RG+ Y+H IIHRDL+PS++ V
Sbjct: 99 TH-LMGADLNNIVKCQ-KLSDDH-IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAV- 151
Query: 288 YWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKV 346
++ LK+ DFG+++ D +T + Y APE+ N Y+ V
Sbjct: 152 ----------NEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQTV 197
Query: 347 DVFSFALILQEMIEGCPPF 365
D++S I+ E++ G F
Sbjct: 198 DIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 69/264 (26%), Positives = 122/264 (46%), Gaps = 41/264 (15%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+VAVK + E S +R+ F +E ++++ +VV+ LG V++ P ++V E + G
Sbjct: 37 TRVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94
Query: 236 DLRAFLK--------RKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285
DL+++L+ G P+ ++ A +IA GM YL+ K +HRDL
Sbjct: 95 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAA---- 147
Query: 286 VAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 344
RN + +K+ DFG+++ + R R++APE K+ + T
Sbjct: 148 -------RNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT 200
Query: 345 KVDVFSFALILQEMIE-GCPPFTMKHDNEVPK-----AYAARQRPPFKAPAKLYARGLKE 398
D++SF ++L E+ P+ + +V K Y + P P ++ +
Sbjct: 201 SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ---PDNCPERVT-----D 252
Query: 399 LIEECWNEKPAKRPTFRQIITRLE 422
L+ CW P RPTF +I+ L+
Sbjct: 253 LMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 67/265 (25%), Positives = 124/265 (46%), Gaps = 39/265 (14%)
Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
++G V +L + D D + E+ +L+K H N+ + GA + +P
Sbjct: 23 YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82
Query: 225 -MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ +V E+ G + +K + LK +I RG+++LH++K +IHRD++
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIK- 138
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFK 338
+N+L ++ +K+ DFGVS L DR + ++T + ++APEV
Sbjct: 139 ----------GQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIA 184
Query: 339 NEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 393
+E YD K D++S + EM EG PP H + + + P + +K ++
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPAPRLKSKKWS 242
Query: 394 RGLKELIEECWNEKPAKRPTFRQII 418
+ + IE C + ++RPT Q++
Sbjct: 243 KKFQSFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFL 216
KG+F +LA +G A+K L ++VI DD V E LAL K HP +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTALH 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ V EY+ GDL ++R + +A ++ + +LH + +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIY 119
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 336
RDL+ NIL D G+ K+ADFG+ K + T T Y+APE+
Sbjct: 120 RDLKLD-----------NILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP-DYIAPEI 167
Query: 337 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372
+ EY VD ++ +++ EM+ G PPF + DNE
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPF--EADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 58/244 (23%), Positives = 117/244 (47%), Gaps = 20/244 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ +++++++PN+V FL + + +V EYL
Sbjct: 44 GQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G L + + + + + + +LH N+ +IHRD++ SD N
Sbjct: 101 GSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIK-SD----------N 145
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
+L G++K+ DFG +T ++ + T T ++APEV + Y KVD++S ++
Sbjct: 146 VLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIM 204
Query: 355 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 414
EM+EG PP+ ++ A P + P KL + ++ + C KR +
Sbjct: 205 AIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL-SPIFRDFLNRCLEMDVEKRGSA 263
Query: 415 RQII 418
++++
Sbjct: 264 KELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 50/254 (19%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK+ G + + + ++ +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
RG+ YL E I+HRD++PS NIL + G +K+ DFGVS L D
Sbjct: 109 LRGLTYLREKH--KIMHRDVKPS-----------NILVNSRGEIKLCDFGVSGQLI---D 152
Query: 320 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMK-------- 368
+ Y++PE + Y + D++S L L EM G PP K
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212
Query: 369 ----------------HDNEVPKAYAARQ-------RPPFKAPAKLYARGLKELIEECWN 405
H + P+ A + PP K P+ ++ ++ +++C
Sbjct: 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLK 272
Query: 406 EKPAKRPTFRQIIT 419
+ P +R +++
Sbjct: 273 KNPKERADLKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 20/198 (10%)
Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
AVK L ++++ + + A R+ LL+ ++HP +V + + + V +++ G
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
+L L+R+ + A +A +IA + YLH + I++RDL+P NI
Sbjct: 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKP-----------ENI 127
Query: 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 355
L D G++ + DFG+ K + D T T Y+APEV + + YD VD + +L
Sbjct: 128 LLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP-EYLAPEVIRKQPYDNTVDWWCLGAVL 186
Query: 356 QEMIEGCPPFTMKHDNEV 373
EM+ G PPF + E+
Sbjct: 187 YEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 41/265 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L E S+ R + F+ E LL ++H ++V+F G T+ P+++V EY+ GDL
Sbjct: 38 VAVKALKE--ASESAR-QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL 94
Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
FL+ G L + A IA GM YL + +HRDL
Sbjct: 95 NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLA-- 149
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEE 341
RN L +K+ DFG+S+ + + R R++ PE +
Sbjct: 150 ---------TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 200
Query: 342 YDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKE 398
+ T+ D++SF ++L E+ G P+ + E + + P P ++YA
Sbjct: 201 FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYA----- 255
Query: 399 LIEECWNEKPAKRPTFRQIITRLES 423
+++ CW +P +R + I +RL++
Sbjct: 256 IMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 68/262 (25%), Positives = 120/262 (45%), Gaps = 34/262 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L E+ ++ + F E+ ++ +++ PN+++ L S P+ ++TEY+ GDL
Sbjct: 49 VAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 238 RAFLKRKGALKP-----------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYV 286
FL R + ST + A IA GM YL + +HRDL
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLA------ 157
Query: 287 AYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTK 345
RN L + +K+ADFG+S+ L + + + R+++ E ++ T
Sbjct: 158 -----TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 212
Query: 346 VDVFSFALILQEMIEGCP--PFTMKHDNEVPKA----YAARQRPPFKAPAKLYARGLKEL 399
DV++F + L E++ C P++ D +V + + + R + L L +L
Sbjct: 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKL 272
Query: 400 IEECWNEKPAKRPTFRQIITRL 421
+ CW +RP+F++I L
Sbjct: 273 MLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-16
Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 33/278 (11%)
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 211
EL N + KG + + + I VA+K K E D+ +R E ++ ++ +P
Sbjct: 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMR----EAEIMHQLDNPY 56
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENK 270
+V+ +G V ++ +M+V E G L FL +K + S V ++ GM YL
Sbjct: 57 IVRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 271 PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTS 328
+HRDL RN+L + K++DFG+SK L + + +
Sbjct: 116 ---FVHRDLAA-----------RNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP 161
Query: 329 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPF 385
++ APE ++ ++ DV+S+ + + E G P+ EV R P
Sbjct: 162 LKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPA 221
Query: 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423
+ P ++YA L+++CW K RP F ++ R+ +
Sbjct: 222 ECPPEMYA-----LMKDCWIYKWEDRPNFAKVEERMRT 254
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 51/194 (26%), Positives = 96/194 (49%), Gaps = 29/194 (14%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + DD+ V A R E+ LL++++H N+V+ + + +V EY +
Sbjct: 28 VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ- 83
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
DL+ + G + P F + +G+ + H + ++HRDL+P +N
Sbjct: 84 DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKP-----------QN 129
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTC---QDTSCRYVAPEV-FKNEEYDTKVDVFS 350
+L + +G LK+ADFG+++ + P+ C + + Y P+V F + Y T +D++S
Sbjct: 130 LLINKNGELKLADFGLARAFGI----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 185
Query: 351 FALILQEMIEGCPP 364
I E+ P
Sbjct: 186 AGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 19/198 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQ---KIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L + I D V + E + + RHP +V + V EY G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
DL + +P AV +A + G+ YLHENK I++RDL+ N+
Sbjct: 88 DLMMHIHTDVFSEPR-AVFYAACVVLGLQYLHENK---IVYRDLKLD-----------NL 132
Query: 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 355
L D G +K+ADFG+ K DR T T ++APEV Y VD + +++
Sbjct: 133 LLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLI 191
Query: 356 QEMIEGCPPFTMKHDNEV 373
EM+ G PF + EV
Sbjct: 192 YEMLVGESPFPGDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
G VA+KK+ D + A R E+ +L+K++HPNVV + + +
Sbjct: 33 GRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91
Query: 227 IVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285
+VT Y+ DL L+ L S + L + G+NYLHEN I+HRD++ +
Sbjct: 92 MVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAA--- 144
Query: 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP------LTCQDTSC---R-YVAPE 335
NIL D+ G LK+ADFG+++ P T + T+ R Y PE
Sbjct: 145 --------NILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE 196
Query: 336 VFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 370
+ E Y T VD++ + EM P K D
Sbjct: 197 LLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 52/168 (30%), Positives = 88/168 (52%), Gaps = 18/168 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V + + +V EYL DL+ +L G L V+ F
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
+ RG++Y H+ K I+HRDL+P +N+L ++ G LK+ADFG+++ +V
Sbjct: 112 LLRGLSYCHKRK---ILHRDLKP-----------QNLLINEKGELKLADFGLARAKSVPT 157
Query: 319 DRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ + + + Y P+V + EY T +D++ IL EM G P F
Sbjct: 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 166 GTFILAFWRGIQ---VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
G ILA ++ VA+K+ + I +V E +L I HP V G+
Sbjct: 44 GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
S + +V E++ G+ FL+R +A I YL + + I++RDL+P
Sbjct: 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKP- 159
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 342
N+L D G +K+ DFG +K++ + R T T Y+APE+ N +
Sbjct: 160 ----------ENLLLDKDGFIKMTDFGFAKVV---DTRTYTLCGTP-EYIAPEILLNVGH 205
Query: 343 DTKVDVFSFALILQEMIEGCPPF 365
D ++ + + E++ GCPPF
Sbjct: 206 GKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 35/269 (13%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGA 218
KG+F LA +G A+K L ++V+ DD V E +L HP +
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+ V EYL GDL ++ A +A +I G+ +LH I++RD
Sbjct: 65 FQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRD 121
Query: 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 338
L+ NIL D G++K+ADFG+ K + + + T T Y+APE+
Sbjct: 122 LKLD-----------NILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP-DYIAPEILL 169
Query: 339 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 398
++Y+T VD +SF ++L EM+ G PF + E+ + R P + R K+
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL--FQSIRMDNPCY--PRWLTREAKD 225
Query: 399 LIEECWNEKPAKR----------PTFRQI 417
++ + + +P +R P FR+I
Sbjct: 226 ILVKLFVREPERRLGVKGDIRQHPFFREI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 18/195 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + DRVR + E +L ++ HP +V+ A + ++ ++L GDL
Sbjct: 28 AMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 86
Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
L K + V+F L ++A +++LH + II+RDL+P NIL
Sbjct: 87 TRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKP-----------ENILL 131
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357
D+ G++K+ DFG+SK E + + T Y+APEV + D +SF +++ E
Sbjct: 132 DEEGHIKLTDFGLSKESIDHEKKAYSFCGT-VEYMAPEVVNRRGHTQSADWWSFGVLMFE 190
Query: 358 MIEGCPPFTMKHDNE 372
M+ G PF K E
Sbjct: 191 MLTGSLPFQGKDRKE 205
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 69/232 (29%), Positives = 112/232 (48%), Gaps = 37/232 (15%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + + KG+F +LA +G A+K L ++V+ DD V E +L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 211 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
+ L + Q+ + V EY+ GDL +++ G K AV +A +IA G+ +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL-----LTVKEDRPLTC 324
II+RDL+ N++ D G++K+ADFG+ K +T K
Sbjct: 121 G---IIYRDLKLD-----------NVMLDSEGHIKIADFGMCKENMWDGVTTK------- 159
Query: 325 QDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373
T C Y+APE+ + Y VD ++F ++L EM+ G PF + ++E+
Sbjct: 160 --TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E +L ++ P +V + + +V ++ G+L L+R+G S A + ++
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
+ LH+ +I+RDL+P NIL D G++ + DFG+ KL +D
Sbjct: 103 LCALENLHK---FNVIYRDLKP-----------ENILLDYQGHIALCDFGLCKLNMKDDD 148
Query: 320 RPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376
+ +T C Y+APE+ Y VD ++ ++L EM+ G PPF +D V +
Sbjct: 149 K----TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF---YDENVNEM 201
Query: 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
Y + P + P R K+L+ + P +R
Sbjct: 202 YRKILQEPLRFPDGF-DRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 71/265 (26%), Positives = 124/265 (46%), Gaps = 39/265 (14%)
Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
++G V +L + D +D + E+ +L+K H N+ + GA + SP
Sbjct: 33 YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92
Query: 225 -MMIVTEYLPKGDLRAFLKR-KG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ +V E+ G + +K KG ALK +I RG+ +LH +K +IHRD++
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIK- 148
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFK 338
+N+L ++ +K+ DFGVS L DR + ++T + ++APEV
Sbjct: 149 ----------GQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIA 194
Query: 339 NEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 393
+E YD + D++S + EM EG PP H + + + PP K +K ++
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPPPKLKSKKWS 252
Query: 394 RGLKELIEECWNEKPAKRPTFRQII 418
+ + IE C + RP+ Q++
Sbjct: 253 KKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
GDL+ + G + AV +A +I G+ LH+ + I++RDL+P
Sbjct: 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKP----------- 130
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 352
NIL DD G+++++D G++ + V E + + + + Y+APEV KNE Y D ++
Sbjct: 131 ENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALG 188
Query: 353 LILQEMIEGCPPFTMKHD-----------NEVPKAYAARQRPPFKAPAKL 391
+L EMI G PF + EV + Y+ + P ++ K+
Sbjct: 189 CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 28/237 (11%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKP 249
++ + + E+ +L HPN+V+ L A + + I+ E+ G + A L+ + L
Sbjct: 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE 102
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309
+NYLHENK IIHRDL+ NIL G++K+ADFG
Sbjct: 103 PQIRVVCKQTLEALNYLHENK---IIHRDLKAG-----------NILFTLDGDIKLADFG 148
Query: 310 VSKLLTVKEDRPLTCQDT---SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEG 361
VS K R + +D+ + ++APEV K+ YD K DV+S + L EM +
Sbjct: 149 VS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQI 204
Query: 362 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
PP + V A + P P++ ++ K+ +++C + R T Q++
Sbjct: 205 EPPHHELNPMRVLLKIAKSEPPTLAQPSR-WSSEFKDFLKKCLEKNVDARWTTTQLL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 32/283 (11%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELA 202
++ DP +L FT+ EI G+F + F R ++ VA+KK+ +++ + E+
Sbjct: 19 FKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQ+I+HPN +++ G + +V EY K L+ +G
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
+ YLH + +IHRD++ NIL + G +K+ADFG + + + P
Sbjct: 138 LAYLHSHN---MIHRDIKAG-----------NILLTEPGQVKLADFGSASIAS-----PA 178
Query: 323 TCQDTSCRYVAPEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYA 378
+ ++APEV +YD KVDV+S + E+ E PP F M N + Y
Sbjct: 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYH 235
Query: 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
Q + ++ + ++ C + P RPT +++ +
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-15
Identities = 30/60 (50%), Positives = 39/60 (65%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A ++E +K LL+ G DVN +D D TALH+AA G E+V LLLE GAD++ KD
Sbjct: 32 LHLAARNGNLEIVKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLEHGADINLKD 91
|
Length = 91 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 70/261 (26%), Positives = 115/261 (44%), Gaps = 44/261 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L + ++ + F+ E LL ++H ++V+F G P+++V EY+ GDL
Sbjct: 38 VAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94
Query: 238 RAFLK----------------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL+ KG L S + A IA GM YL +HRDL
Sbjct: 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLA- 150
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNE 340
RN L + +K+ DFG+S+ + + R R++ PE
Sbjct: 151 ----------TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR 200
Query: 341 EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGL 396
++ T+ DV+SF +IL E+ G P+ + EV + +RP P ++Y
Sbjct: 201 KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV-CPKEVY---- 255
Query: 397 KELIEECWNEKPAKRPTFRQI 417
+++ CW +P +R ++I
Sbjct: 256 -DIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 57/244 (23%), Positives = 116/244 (47%), Gaps = 20/244 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G L + + + + +++LH N+ +IHRD++ SD N
Sbjct: 101 GSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIK-SD----------N 145
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
IL G++K+ DFG +T ++ + T T ++APEV + Y KVD++S ++
Sbjct: 146 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIM 204
Query: 355 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 414
EM+EG PP+ ++ A P + P +L A ++ + C +R +
Sbjct: 205 AIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV-FRDFLNRCLEMDVDRRGSA 263
Query: 415 RQII 418
++++
Sbjct: 264 KELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 32/272 (11%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L F++ EI G+F + F R ++ VA+KK+ +++ + E+ LQ
Sbjct: 12 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 325
LH + +IHRD++ NIL + G +K+ DFG + ++ P
Sbjct: 131 LHSHN---MIHRDVKAG-----------NILLSEPGLVKLGDFGSASIMA-----PANXF 171
Query: 326 DTSCRYVAPEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQ 381
+ ++APEV +YD KVDV+S + E+ E PP F M N + Y Q
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQ 228
Query: 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
+ ++ + ++ C + P RPT
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 21/172 (12%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
+ E +L+ ++HP +V + A + ++ EYL G+L L+R+G TA +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
+I+ + +LH+ II+RDL+P NIL D G++K+ DFG+ K ++
Sbjct: 108 EISLALEHLHQQG---IIYRDLKP-----------ENILLDAQGHVKLTDFGLCK-ESIH 152
Query: 318 EDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 366
E T T C Y+APE+ + VD +S ++ +M+ G PPFT
Sbjct: 153 EG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 62/242 (25%), Positives = 109/242 (45%), Gaps = 35/242 (14%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFAL 257
E +L+K+ P +V A + + +V + GDL+ + G L+ + ++
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
I G+ +LH + I++RD++P N+L DD GN +++D G++ + +K
Sbjct: 103 QITCGILHLHS---MDIVYRDMKP-----------ENVLLDDQGNCRLSDLGLA--VELK 146
Query: 318 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377
+ + +T + + Y+APE+ K E Y VD F+ + EM+ G PF H +V K
Sbjct: 147 DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK-DHKEKVAKEE 205
Query: 378 AAR---------QRPPFKAPAKLYAR-GLKELIEE-----CWNEKPAKRPTFRQI-ITRL 421
R + F +K R L + E+ N+ P K F+ I RL
Sbjct: 206 LKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265
Query: 422 ES 423
E+
Sbjct: 266 EA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 73/262 (27%), Positives = 121/262 (46%), Gaps = 43/262 (16%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
QV VK+L + F +E + ++H N++Q LG T+ +P ++V E+ P GD
Sbjct: 24 QVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81
Query: 237 LRAFLK--RKGAL---KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
L+ +L+ RK L P+T R A +IA G+ +LH+N IH DL
Sbjct: 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLAL---------- 128
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKV--- 346
RN L +K+ D+G+S KED +T R++APE+ + V
Sbjct: 129 -RNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQ 186
Query: 347 ----DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ------RPPFKAPAKLYARG 395
+V+S + + E+ E G P+ D +V Y R+ +P K P +
Sbjct: 187 TKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVREQQLKLPKPRLKLP---LSDR 242
Query: 396 LKELIEECWNEKPAKRPTFRQI 417
E+++ CW +P +RP+ ++
Sbjct: 243 WYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 59/244 (24%), Positives = 116/244 (47%), Gaps = 20/244 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA++++ + + +E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 45 GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G L + + + + + +LH N+ +IHRD++ SD N
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIK-SD----------N 146
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
IL G++K+ DFG +T ++ + T T ++APEV + Y KVD++S ++
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 355 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 414
EMIEG PP+ ++ A P + P KL A ++ + C + KR +
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLDMDVEKRGSA 264
Query: 415 RQII 418
++++
Sbjct: 265 KELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 42/283 (14%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L FT+ EI G+F + F R ++ VA+KK+ +++ + E+ LQ
Sbjct: 12 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYL--PKGDLRAFLKRKGALKPSTAVRFA---LDIA 260
++RHPN +++ G + +V EY D+ K KP V A
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAICHGAL 125
Query: 261 RGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR 320
+G+ YLH ++ IHRD++ NIL + G +K+ADFG + L++
Sbjct: 126 QGLAYLHSHE---RIHRDIKAG-----------NILLTEPGTVKLADFGSASLVS----- 166
Query: 321 PLTCQDTSCRYVAPEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKA 376
P + ++APEV +YD KVDV+S + E+ E PP F M N +
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSAL 223
Query: 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 419
Y Q + ++ + ++ C + P RP+ +++
Sbjct: 224 YHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 63/239 (26%), Positives = 110/239 (46%), Gaps = 30/239 (12%)
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGAL 247
++ + + E+ +L HP +V+ LGA + I+ E+ P G + A + +G
Sbjct: 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT 108
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307
+P V + + YLH K IIHRDL+ N+L G++K+AD
Sbjct: 109 EPQIQV-ICRQMLEALQYLHSMK---IIHRDLKAG-----------NVLLTLDGDIKLAD 153
Query: 308 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMI 359
FGVS K + L +D+ + ++APEV K+ YD K D++S + L EM
Sbjct: 154 FGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 209
Query: 360 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ PP + V A + P P+K ++ ++ ++ ++ P RP+ Q++
Sbjct: 210 QIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-WSMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 77/294 (26%), Positives = 135/294 (45%), Gaps = 67/294 (22%)
Query: 164 TKGTFILAFWR--GIQVAVKKLGEEVISDDD--RVRAFRDELALLQKI-RHPNVVQFLGA 218
T G+ LA + G VA+KK+ ++ S ++ +R E+ L+K+ HPN+V+
Sbjct: 11 TFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR----EVKSLRKLNEHPNIVKLKEV 66
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIH 276
++ + V EY+ +G+L +K RKG + +R + I +G+ ++H++ H
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFH 122
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCR-YVAP 334
RDL+P N+L +K+ADFG+++ ++ P T D S R Y AP
Sbjct: 123 RDLKP-----------ENLLVSGPEVVKIADFGLAR--EIRSRPPYT--DYVSTRWYRAP 167
Query: 335 EVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV------------------PK 375
E+ ++ Y + VD+++ I+ E+ P F +E+ P+
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLF--PGSSEIDQLYKICSVLGTPTKQDWPE 225
Query: 376 AYA-ARQ---RPPFKAPAKLY------ARGLKELIEEC--WNEKPAKRPTFRQI 417
Y A + R P AP L+ + +LI++ W+ P KRPT Q
Sbjct: 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWD--PKKRPTASQA 277
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 51/188 (27%), Positives = 97/188 (51%), Gaps = 20/188 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+KK+ + ++ A R E++LL+++ HPN+V+ L + + + +V E+L +
Sbjct: 25 GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 83
Query: 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
DL+ F+ + + + +G+ + H ++ ++HRDL+P
Sbjct: 84 -DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKP----------- 128
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSF 351
+N+L + G +K+ADFG+++ V R T + + Y APE+ + Y T VD++S
Sbjct: 129 QNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 187
Query: 352 ALILQEMI 359
I EM+
Sbjct: 188 GCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 29/199 (14%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + V+ + V F +E +L P + Q A + +V EY P GDL
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
+ L R +F L ++ ++ +H+ + +HRD++P N+L
Sbjct: 90 SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPE-----------NVLI 135
Query: 298 DDSGNLKVADFGVSKLLT----VKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVD 347
D +G++K+ADFG + LT V P+ D Y+APEV Y + D
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPD----YIAPEVLTTMNGDGKGTYGVECD 191
Query: 348 VFSFALILQEMIEGCPPFT 366
+S +I EMI G PF
Sbjct: 192 WWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 36/240 (15%)
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
+D R E+ +L+ + HPNVV+ + + ++ E++ G L A +
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THIADEQ 168
Query: 250 STAVRFALDIAR----GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305
A D+AR G+ YLH I+HRD++PS N+L + + N+K+
Sbjct: 169 FLA-----DVARQILSGIAYLHRRH---IVHRDIKPS-----------NLLINSAKNVKI 209
Query: 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE----EYDTKV-DVFSFALILQEMIE 360
ADFGVS++L D P + Y++PE + YD D++S + + E
Sbjct: 210 ADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268
Query: 361 GCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
G PF + + A +PP +APA +R + I C +PAKR + Q++
Sbjct: 269 GRFPFGVGRQGDWASLMCAICMSQPP-EAPATA-SREFRHFISCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 18/193 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
GDL+ + G AV +A +I G+ LH + I++RDL+P
Sbjct: 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKP----------- 130
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 352
NIL DD G+++++D G++ + + E + + + Y+APEV KNE Y D +
Sbjct: 131 ENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLG 188
Query: 353 LILQEMIEGCPPF 365
++ EMIEG PF
Sbjct: 189 CLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 74/262 (28%), Positives = 111/262 (42%), Gaps = 41/262 (15%)
Query: 175 GIQVAVKKLGEEVISD-DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-----PMMI 227
G AVK L + ISD D+ + A E +LQ + HPNVV+F G ++ + +
Sbjct: 47 GSLAAVKIL--DPISDVDEEIEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101
Query: 228 VTEYLPKGD----LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSD 283
V E G ++ L L + G+ +LH N+ IIHRD++ +
Sbjct: 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGN- 157
Query: 284 LYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-- 341
NIL G +K+ DFGVS LT R T T ++APEV E+
Sbjct: 158 ----------NILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIACEQQY 206
Query: 342 ---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP--FKAPAKLYARGL 396
YD + DV+S + E+ +G PP H V + + PP P K + R
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPPLFDMH--PVKTLFKIPRNPPPTLLHPEK-WCRSF 263
Query: 397 KELIEECWNEKPAKRPTFRQII 418
I +C + RP+ ++
Sbjct: 264 NHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 79/279 (28%), Positives = 121/279 (43%), Gaps = 46/279 (16%)
Query: 163 ITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
I KGT+ +L G + AVK L + + D+ + A + L L HPNVV+F G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSD--HPNVVKFYG 82
Query: 218 A-----VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
V + +V E G + + FLKR ++ + G+ +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 269 NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 328
NK IHRD++ + NIL G +K+ DFGVS LT R T T
Sbjct: 143 NK---TIHRDVKGN-----------NILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 329 CRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFT----MKHDNEVPKAYAA 379
++APEV E+ YD + DV+S + E+ +G PP M+ ++P
Sbjct: 189 F-WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP----- 242
Query: 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
R PP +L++ + I +C + KRPT ++
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 65/260 (25%), Positives = 113/260 (43%), Gaps = 37/260 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEY-- 231
G +AVK++ D+ + +L ++ + P +V+F GA+ + I E
Sbjct: 29 GTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86
Query: 232 --LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
L K + K + + A+ + +NYL E + IIHRD++PS
Sbjct: 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPS------- 137
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE---VFKNEEYDTK 345
NIL D +GN+K+ DFG+S L D +D CR Y+APE + YD +
Sbjct: 138 ----NILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSARDGYDVR 190
Query: 346 VDVFSFALILQEMIEGCPPFTMKHDN------EVPKAYAARQRPPFKAPAKLYARGLKEL 399
DV+S + L E+ G P+ K ++ +V K + + ++
Sbjct: 191 SDVWSLGITLYEVATGKFPYP-KWNSVFDQLTQVVKGDPPILSN---SEEREFSPSFVNF 246
Query: 400 IEECWNEKPAKRPTFRQIIT 419
I C + +KRP +++++
Sbjct: 247 INLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 51/168 (30%), Positives = 87/168 (51%), Gaps = 18/168 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V V + +V EYL K DL+ ++ G + V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
I RG+ Y H K ++HRDL+P +N+L ++ G LK+ADFG+++ +V
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKP-----------QNLLINERGELKLADFGLARAKSVPT 158
Query: 319 DRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ + + + Y P+V + EY T++D++ I EM G P F
Sbjct: 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 62/261 (23%), Positives = 105/261 (40%), Gaps = 58/261 (22%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK+ G + + ++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
+G+ YL E I+HRD++PS NIL + G +K+ DFGVS L D
Sbjct: 113 IKGLTYLREKH--KIMHRDVKPS-----------NILVNSRGEIKLCDFGVSGQLI---D 156
Query: 320 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM-----------------IEGC 362
+ Y++PE + Y + D++S L L EM + GC
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGC 216
Query: 363 PPFTMKHDNEVP----------KAYAARQRPPF---------------KAPAKLYARGLK 397
P ++E +Y RPP K P+ ++ +
Sbjct: 217 PVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQ 276
Query: 398 ELIEECWNEKPAKRPTFRQII 418
+ + +C + PA+R +Q++
Sbjct: 277 DFVNKCLIKNPAERADLKQLM 297
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 48/168 (28%), Positives = 87/168 (51%), Gaps = 18/168 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V + + +V EYL K DL+ +L G V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
+ RG+NY H K ++HRDL+P +N+L ++ G LK+ADFG+++ ++
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKP-----------QNLLINERGELKLADFGLARAKSIPT 158
Query: 319 DRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ + + + Y P++ + +Y T++D++ I EM G P F
Sbjct: 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 62/246 (25%), Positives = 118/246 (47%), Gaps = 23/246 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K+L E ++ DE ++ + +P+V + LG + +S + ++T+ +P G
Sbjct: 37 IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L +++ K + + + + IA+GMNYL E + ++HRDL RN
Sbjct: 94 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAA-----------RN 139
Query: 295 ILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 353
+L ++K+ DFG++KLL E + +++A E + Y + DV+S+ +
Sbjct: 140 VLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 199
Query: 354 ILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 412
+ E M G P+ +E+ +R P + P + + ++ +CW RP
Sbjct: 200 TVWELMTFGSKPYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRP 256
Query: 413 TFRQII 418
FR++I
Sbjct: 257 KFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 21/242 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ + E +L K+ +V A + + +V + GDLR
Sbjct: 22 ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR 81
Query: 239 AFL----KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
+ + A + I G+ +LH+ + II+RDL+P N
Sbjct: 82 YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKP-----------EN 127
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
+L D+ GN++++D G++ L + + T ++APE+ + EEYD VD F+ +
Sbjct: 128 VLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP-GFMAPELLQGEEYDFSVDYFALGVT 186
Query: 355 LQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
L EMI PF + + K R P K ++ K E + P KR
Sbjct: 187 LYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK-FSPASKSFCEALLAKDPEKRLG 245
Query: 414 FR 415
FR
Sbjct: 246 FR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 16/167 (9%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E +LL+ ++H N+V + + +V EY+ + K G L P F +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
RG++Y+H+ I+HRDL+P +N+L D+G LK+ADFG+++ +V
Sbjct: 113 LRGLSYIHQRY---ILHRDLKP-----------QNLLISDTGELKLADFGLARAKSVPS- 157
Query: 320 RPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ + + Y P+V + EY T +D++ I EMI+G F
Sbjct: 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 49/192 (25%), Positives = 81/192 (42%), Gaps = 22/192 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI---VTEY 231
G +VA+KK+ R R EL +L+ +H N++ + V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
L + DL + L F + RG+ Y+H +IHRDL+PS
Sbjct: 89 LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPS--------- 136
Query: 292 DRNILRDDSGNLKVADFGVSKLL---TVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVD 347
N+L ++ L++ DFG+++ L + +T + Y APE+ EY T +D
Sbjct: 137 --NLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAID 194
Query: 348 VFSFALILQEMI 359
++S I EM+
Sbjct: 195 MWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 76/311 (24%), Positives = 131/311 (42%), Gaps = 36/311 (11%)
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELD-------FTNSVEITKGTFILAFWRG 175
+ EK+ A + P K ++PE E P + T V T RG
Sbjct: 32 EAFEKYCAD--LDPEAYKKCVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRG 89
Query: 176 IQVAVKKLGEEVISDDDRVRAF-RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
K + + V+ +D+R A+ R EL L H +V+ ++++ EY
Sbjct: 90 SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
GDL + LK + I ++ +H K ++HRDL+ +
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSA-------- 198
Query: 291 NDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 347
NI +G +K+ DFG SK + + L + C Y+APE+++ + Y K D
Sbjct: 199 ---NIFLMPTGIIKLGDFGFSKQYS--DSVSLDVASSFCGTPYYLAPELWERKRYSKKAD 253
Query: 348 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 407
++S +IL E++ PF E+ + + PF P + G+K L++ ++
Sbjct: 254 MWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPV---SSGMKALLDPLLSKN 310
Query: 408 PAKRPTFRQII 418
PA RPT +Q++
Sbjct: 311 PALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 60/252 (23%), Positives = 118/252 (46%), Gaps = 23/252 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L E ++ DE ++ + P V + LG + +S + +VT+ +P G
Sbjct: 37 IPVAIKVLRENTSPKANK--EILDEAYVMAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L +++ K + + + + IA+GM+YL E V ++HRDL RN
Sbjct: 94 CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAA-----------RN 139
Query: 295 ILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 353
+L ++K+ DFG+++LL + E + +++A E + + + DV+S+ +
Sbjct: 140 VLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGV 199
Query: 354 ILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 412
+ E++ G P+ E+P +R P + P + + ++ +CW RP
Sbjct: 200 TVWELMTFGAKPYDGIPAREIPDLLEKGERLP-QPP--ICTIDVYMIMVKCWMIDSECRP 256
Query: 413 TFRQIITRLESI 424
FR+++ +
Sbjct: 257 RFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L R HP + Q + V E++ GDL
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
+++ + A +A +I + +LH+ II+RDL+ N+L
Sbjct: 84 MFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLD-----------NVLL 129
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G+ K+ADFG+ K + T C Y+APE+ + Y VD ++ ++
Sbjct: 130 DHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVL 185
Query: 355 LQEMIEGCPPFTMKHDNEVPKA 376
L EM+ G PF ++++++ +A
Sbjct: 186 LYEMLCGHAPFEAENEDDLFEA 207
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 25/193 (12%)
Query: 178 VAVKKLGEEVISDDDRVR--AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+KK E DD V+ A R E+ +L+++RH N+V + + + +V E++
Sbjct: 29 VAIKKFLES--EDDKMVKKIAMR-EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
L K L S ++ I RG+ + H + IIHRD++P NI
Sbjct: 86 VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKP-----------ENI 131
Query: 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCR-YVAPE-VFKNEEYDTKVDVFSFA 352
L SG +K+ DFG ++ L + D + R Y APE + + +Y VD+++
Sbjct: 132 LVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVG 188
Query: 353 LILQEMIEGCPPF 365
++ EM+ G P F
Sbjct: 189 CLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 79/316 (25%), Positives = 128/316 (40%), Gaps = 83/316 (26%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L + + D A EL +L + +H N+V LGA T P++++TEY
Sbjct: 69 LRVAVKML--KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126
Query: 235 GDLRAFLKRKGA--LKPSTAVRFALD-------IARGMNYLH--------------ENKP 271
GDL FL++K L A+ + I Y+ E +P
Sbjct: 127 GDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP 186
Query: 272 VPIIH------------RDLEPSDLY------------VAYWQNDRNILRD--------- 298
V D P DL + + + I RD
Sbjct: 187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT 246
Query: 299 DSGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 352
D K+ DFG+++ + VK + L +++APE + Y + DV+S+
Sbjct: 247 DGRVAKICDFGLARDIMNDSNYVVKGNARL-----PVKWMAPESIFDCVYTVQSDVWSYG 301
Query: 353 LILQEMIE-GCPPF-----TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 406
++L E+ G P+ K V + Y RP F AP ++Y+ +++ CWN
Sbjct: 302 ILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDF-APPEIYS-----IMKMCWNL 354
Query: 407 KPAKRPTFRQIITRLE 422
+P +RPTF QI ++
Sbjct: 355 EPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 28/225 (12%)
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR 254
+ EL +L K P ++ F GA + + I TE++ G L + + R
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGR 99
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314
A+ + +G+ YL K I+HRD++PS N+L + G +K+ DFGVS L
Sbjct: 100 IAVAVVKGLTYLWSLK---ILHRDVKPS-----------NMLVNTRGQVKLCDFGVSTQL 145
Query: 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-- 372
+ + Y+APE E+Y DV+S + E+ G P+ N+
Sbjct: 146 VNSIAKTYVGTNA---YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202
Query: 373 -VPKAY---AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
+P + PP P ++ I +C ++P +RP
Sbjct: 203 LMPLQLLQCIVDEDPP-VLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 57/192 (29%), Positives = 96/192 (50%), Gaps = 21/192 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKG 235
VA+KKL E + + + R E+ +L K++HPN+V V S+ + +V EY+ +
Sbjct: 33 VALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-EH 90
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
DL++ ++ K S L + G+ +LH+N I+HRDL+ S N
Sbjct: 91 DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTS-----------N 136
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFAL 353
+L ++ G LK+ DFG+++ +P T + Y APE+ EY T +D++S
Sbjct: 137 LLLNNRGILKICDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGC 195
Query: 354 ILQEMIEGCPPF 365
I E++ P F
Sbjct: 196 IFAELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 28/173 (16%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E +LL+ ++H N+V + + V EY+ DL ++ + G L P F
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
+ RG+ Y+H I+HRDL+P +L ++Y G LK+ADFG+++
Sbjct: 112 LLRGLAYIHGQH---ILHRDLKPQNLLISYL-----------GELKLADFGLAR------ 151
Query: 319 DRPLTCQDTSCR-----YVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ + Q S Y P+V +Y + +D++ I EM++G P F
Sbjct: 152 AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 28/201 (13%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+KK+ ++ + ++++ E +L +P VV + + +V EY+ GD
Sbjct: 30 AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
LK GAL A + + + YLH I+HRDL+P N+L
Sbjct: 90 TLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPD-----------NLLIT 135
Query: 299 DSGNLKVADFGVSKL----LTV--------KEDRPLTCQDT--SCRYVAPEVFKNEEYDT 344
G++K+ DFG+SK+ LT K+ R + + Y+APEV + Y
Sbjct: 136 SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK 195
Query: 345 KVDVFSFALILQEMIEGCPPF 365
VD ++ +IL E + GC PF
Sbjct: 196 PVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 78/305 (25%), Positives = 128/305 (41%), Gaps = 75/305 (24%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-PMMIVTEYLPKG 235
VAVK L E + + + A EL +L I H NVV LGA T+ P+M++ EY G
Sbjct: 40 VAVKMLKEGATASEYK--ALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFG 97
Query: 236 DLRAFLK--------------RKGALKPST--AVRFALDIARG---MNYLHENKPVPIIH 276
+L +L+ RK +K R + + E+K + +
Sbjct: 98 NLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157
Query: 277 RDLEPSDLY---------VAY----------------WQND---RNILRDDSGNLKVADF 308
D E +LY ++Y D RNIL ++ +K+ DF
Sbjct: 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDF 217
Query: 309 GVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 360
G+++ + D PL +++APE ++ Y T+ DV+SF ++L E+
Sbjct: 218 GLARDIYKDPDYVRKGDARLPL-------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
Query: 361 -GCPPFT-MKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
G P+ ++ D E + R R P A ++Y+ L +CW+ P RPTF +
Sbjct: 271 LGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML-----DCWHNNPEDRPTFSE 325
Query: 417 IITRL 421
++ L
Sbjct: 326 LVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 32/275 (11%)
Query: 148 YEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAFRDELA 202
Y+ DP E+ F EI G+F ++ VAVKK+ +++ + E+
Sbjct: 15 YKDDPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQ+++HPN +++ G + +V EY K L+ +G
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
+ YLH + +IHRD++ NIL + G +K+ADFG + + P
Sbjct: 134 LAYLHSHN---MIHRDIKAG-----------NILLTEPGQVKLADFGSASKSS-----PA 174
Query: 323 TCQDTSCRYVAPEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYA 378
+ ++APEV +YD KVDV+S + E+ E PP F M N + Y
Sbjct: 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYH 231
Query: 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
Q + + + ++ C + P +RP
Sbjct: 232 IAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 28/230 (12%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE 268
P +V+ G S + I E L L LKR +G + + + I + ++YL E
Sbjct: 74 PYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 269 NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 328
V IHRD++PS NIL D SGN+K+ DFG+S L + + T
Sbjct: 133 KHGV--IHRDVKPS-----------NILLDASGNVKLCDFGISGRLV--DSKAKTRSAGC 177
Query: 329 CRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRP 383
Y+APE N +YD + DV+S + L E+ G P+ K + EV ++ P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-LTKILQEEP 236
Query: 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI-----ITRLESINNSI 428
P P + ++ ++ C + KRP +R++ I R E+ +
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 31 LDDDGEEIKPE---FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHV---AACQG 84
+D+ +I E + + A+ VE ++ LL +G DVNFR +T LH+ + +
Sbjct: 2 EEDESVDIIMEAALYDYLLNASNVTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEK 61
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE-VIKLLEKHGA 130
++V LLLE GADV+ +R G TPL +Y VIKLL K GA
Sbjct: 62 VKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGA 108
|
Length = 471 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 165 KGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
KGTF IL + G A+K L +EVI D V E +LQ RHP + A
Sbjct: 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 64
Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
+ V EY G+L L R+ A + +I + YLH +++RD+
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 121
Query: 280 EPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 339
+ N++ D G++K+ DFG+ K T T Y+APEV ++
Sbjct: 122 KL-----------ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-EYLAPEVLED 169
Query: 340 EEYDTKVDVFSFALILQEMIEGCPPF 365
+Y VD + +++ EM+ G PF
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 57/264 (21%), Positives = 111/264 (42%), Gaps = 48/264 (18%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++V+ E +L + HP + + + + +V +Y P G+L
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 239 AFL-KRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
L ++ G RF A ++ + YLH I++RDL+P NIL
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPE-----------NIL 135
Query: 297 RDDSGNLKVADFGVSKLLTVK--------------------EDRPLTCQDT----SC--- 329
+SG++ ++DF +SK V+ + + + S
Sbjct: 136 LHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGT 195
Query: 330 -RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388
Y+APEV + + + VD ++ ++L EM+ G PF + +E ++ + P
Sbjct: 196 EEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET---FSNILKKEVTFP 252
Query: 389 AKL-YARGLKELIEECWNEKPAKR 411
+ ++LI + + P+KR
Sbjct: 253 GSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
E +LL+ ++H N+V + + +V EYL DL+ ++ G L F
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
+ RG+ Y H+ + ++HRDL+P +N+L + G LK+ADFG+++ +V
Sbjct: 112 LLRGLAYCHQRR---VLHRDLKP-----------QNLLISERGELKLADFGLARAKSVPS 157
Query: 319 DRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ + + + Y P+V + EY T +D++ I EM G P F
Sbjct: 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 31/188 (16%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL ++ +I+H N++ + + + +V + + DL+ + RK L S L I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV--------- 310
G+N LH+ +HRDL P+ NI + G K+ADFG+
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPA-----------NIFINSKGICKIADFGLARRYGYPPY 174
Query: 311 ----SKLLTVKEDRPLTCQDTSCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
SK T++ +T + + Y APE + E+Y VD++S I E++ G P F
Sbjct: 175 SDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
Query: 366 TMKHDNEV 373
+NE+
Sbjct: 235 P--GENEI 240
|
Length = 335 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 51/174 (29%), Positives = 84/174 (48%), Gaps = 24/174 (13%)
Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
L+ HPNVV+ T S + + +V E++ + DL +L + + + T
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 116
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
+ RG+++LH ++ ++HRDL+P +NIL SG +K+ADFG++++ +
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKP-----------QNILVTSSGQIKLADFGLARIYSF 162
Query: 317 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 370
+ LT + Y APEV Y T VD++S I EM P F D
Sbjct: 163 QM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 64/234 (27%), Positives = 98/234 (41%), Gaps = 38/234 (16%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK + + ++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
RG+ YL E I+HRD++PS NIL + G +K+ DFGVS L D
Sbjct: 113 LRGLAYLREKH--QIMHRDVKPS-----------NILVNSRGEIKLCDFGVSGQLI---D 156
Query: 320 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEV--- 373
+ Y++PE + Y + D++S L L E+ G PP K +
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR 216
Query: 374 ---------PKAYAARQRPPFKAPAKLY------ARGLKELIEECWNEKPAKRP 412
P + + R RPP + P + A + EL++ NE P K P
Sbjct: 217 PVVDGEEGEPHSISPRPRPPGR-PVSGHGMDSRPAMAIFELLDYIVNEPPPKLP 269
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 14/187 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L R+ A + +I ++YLH K V ++RDL+ N++ D
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKL-----------ENLMLD 130
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 358
G++K+ DFG+ K +K+ + + Y+APEV ++ +Y VD + +++ EM
Sbjct: 131 KDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 189
Query: 359 IEGCPPF 365
+ G PF
Sbjct: 190 MCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 40/206 (19%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRH-PNVVQFLGA--VTQSSP---MMIVT 229
VA+KK E D++ + A R E++LLQ + +V+ L V + + + +V
Sbjct: 29 VALKKTRLE--MDEEGIPPTALR-EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85
Query: 230 EYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDL 284
EYL DL+ F+ G L T F + +G+ + H++ ++HRDL+P
Sbjct: 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKP--- 138
Query: 285 YVAYWQNDRNILRDDSGN-LKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVF-KN 339
+N+L D LK+AD G+ + ++ P+ T + + Y APEV +
Sbjct: 139 --------QNLLVDKQKGLLKIADLGLGRAFSI----PVKSYTHEIVTLWYRAPEVLLGS 186
Query: 340 EEYDTKVDVFSFALILQEMIEGCPPF 365
Y T VD++S I EM P F
Sbjct: 187 THYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 25/221 (11%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ +R P +V A + + ++ +Y+ G+L L ++ S +
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK-LLT 315
+I +++LH+ II+RD++ NIL D G++ + DFG+SK L
Sbjct: 112 AEIVLALDHLHQLG---IIYRDIKL-----------ENILLDSEGHVVLTDFGLSKEFLA 157
Query: 316 VKEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373
+E+R + T Y+APEV + +D VD +S ++ E++ G PFT+ +
Sbjct: 158 EEEERAYSFCGT-IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216
Query: 374 PKAYAAR---QRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
+ R +PPF P + A ++ I++ + P KR
Sbjct: 217 QSEISRRILKSKPPF--PKTMSAEA-RDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 18/193 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A K+L ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
GDL+ + G + A+ +A +I G+ LH ++RDL+P
Sbjct: 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKP----------- 130
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 352
NIL DD G+++++D G++ + + E + + + Y+APEV N+ Y D +
Sbjct: 131 ENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLG 188
Query: 353 LILQEMIEGCPPF 365
++ EMIEG PF
Sbjct: 189 CLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 23/245 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L E + F DE ++ + HP++V+ LG V S + +VT+ +P G
Sbjct: 37 IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 93
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L ++ + K + + + + IA+GM YL E + ++HRDL RN
Sbjct: 94 CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAA-----------RN 139
Query: 295 ILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 353
+L ++K+ DFG+++LL E + +++A E ++ + DV+S+ +
Sbjct: 140 VLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGV 199
Query: 354 ILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 412
+ E++ G P+ E+P +R P + P + + ++ +CW RP
Sbjct: 200 TIWELMTFGGKPYDGIPTREIPDLLEKGERLP-QPP--ICTIDVYMVMVKCWMIDADSRP 256
Query: 413 TFRQI 417
F+++
Sbjct: 257 KFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 34/208 (16%)
Query: 174 RGIQVAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVTQSS-----P 224
G++VA+KK IS + R R E+ +L++ +H N++ L + S
Sbjct: 29 TGVKVAIKK-----ISPFEHQTFCQRTLR-EIKILRRFKHENIIGILDIIRPPSFESFND 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDL 284
+ IV E + DL +K + L F I RG+ Y+H ++HRDL+PS
Sbjct: 83 VYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPS-- 135
Query: 285 YVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKN-EE 341
N+L + + +LK+ DFG++++ + D LT + Y APE+ N +
Sbjct: 136 ---------NLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG 186
Query: 342 YDTKVDVFSFALILQEMIEGCPPFTMKH 369
Y +D++S IL EM+ P F K
Sbjct: 187 YTKAIDIWSVGCILAEMLSNRPLFPGKD 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 64/247 (25%), Positives = 114/247 (46%), Gaps = 26/247 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G QVAVKK+ + R +E+ +++ H NVV + + +V E+L
Sbjct: 47 GKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G L + + A L + R ++YLH +IHRD++ SD +
Sbjct: 104 GALTDIVTHTRMNEEQIAT-VCLSVLRALSYLHNQG---VIHRDIK-SD----------S 148
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
IL G +K++DFG ++ + + + T ++APEV Y T+VD++S ++
Sbjct: 149 ILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTP-YWMAPEVISRLPYGTEVDIWSLGIM 207
Query: 355 LQEMIEGCPPFTMKHDNEVPKAYAARQR---PPFKAPAKLYARGLKELIEECWNEKPAKR 411
+ EMI+G PP+ NE P R R PP + + L+ ++ +P++R
Sbjct: 208 VIEMIDGEPPYF----NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR 263
Query: 412 PTFRQII 418
T ++++
Sbjct: 264 ATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 16/195 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L R+ A + +I + YLH +++RDL+ N++ D
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKL-----------ENLMLD 129
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 358
G++K+ DFG+ K T T Y+APEV ++ +Y VD + +++ EM
Sbjct: 130 KDGHIKITDFGLCKEGISDGATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 359 IEGCPPFTMKHDNEV 373
+ G PF + D+E
Sbjct: 189 MCGRLPFYNQ-DHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 15/191 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A+K L +EVI D V E +L+ RHP + + + V EY+
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G+L L R+ + +I ++YLH K I++RDL+ N
Sbjct: 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKL-----------EN 125
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
++ D G++K+ DFG+ K + + + + Y+APEV ++ +Y VD + ++
Sbjct: 126 LMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 184
Query: 355 LQEMIEGCPPF 365
+ EM+ G PF
Sbjct: 185 MYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 50/214 (23%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+KK+ + + + A R E+ +L+++ H N+V IVT+ K
Sbjct: 32 GELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNL---------KEIVTD---K 78
Query: 235 GDLRAFLKRKGA--------------LKPSTAVRFALD--------IARGMNYLHENKPV 272
D F K KGA L S V F+ D + G+NY H+
Sbjct: 79 QDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN-- 136
Query: 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 332
+HRD++ S NIL ++ G +K+ADFG+++L +E RP T + + Y
Sbjct: 137 -FLHRDIKCS-----------NILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 333 APEVFKNEE-YDTKVDVFSFALILQEMIEGCPPF 365
PE+ EE Y +DV+S IL E+ P F
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 27/176 (15%)
Query: 200 ELALLQKIR---HPNVVQFLGAVT-----QSSPMMIVTEYLPKGDLRAFLKRKGA--LKP 249
E+ALL+++ HPN+V+ + + + + +V E++ + DLR +L + L
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA 107
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309
T RG+++LH N I+HRDL+P NIL G +K+ADFG
Sbjct: 108 ETIKDLMRQFLRGLDFLHANC---IVHRDLKP-----------ENILVTSGGQVKLADFG 153
Query: 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
++++ + + LT + Y APEV Y T VD++S I EM P F
Sbjct: 154 LARIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 55/216 (25%), Positives = 84/216 (38%), Gaps = 68/216 (31%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
VRA RD LA + +P VV+ + + + ++ EYLP GD+ L +K
Sbjct: 48 VRAERDILA---EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET- 103
Query: 254 RF-------ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306
RF A+D + Y IHRD++P N+L D G++K++
Sbjct: 104 RFYIAETILAIDSIHKLGY---------IHRDIKPD-----------NLLLDAKGHIKLS 143
Query: 307 DFGVSKLL----------TVKEDRPLTCQDTSCR-------------------------- 330
DFG+ L + P D +
Sbjct: 144 DFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTP 203
Query: 331 -YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
Y+APEVF Y+ + D +S +I+ EM+ G PPF
Sbjct: 204 DYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 52/184 (28%), Positives = 89/184 (48%), Gaps = 28/184 (15%)
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305
AL + F+ +A+GM++L IHRDL RNIL K+
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAA-----------RNILLTHGRITKI 255
Query: 306 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 361
DFG+++ ++ D + + +++APE N Y + DV+S+ ++L E+ G
Sbjct: 256 CDFGLAR--DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 313
Query: 362 CPPFT-MKHDNEVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
P+ M D++ K R P AP+++Y ++++ CW+ P KRPTF+QI+
Sbjct: 314 SSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY-----DIMKSCWDADPLKRPTFKQIV 368
Query: 419 TRLE 422
+E
Sbjct: 369 QLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 65/239 (27%), Positives = 104/239 (43%), Gaps = 34/239 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY--- 231
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T + ++
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98
Query: 232 LP--KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
+P DL +K + L + +G+ Y+H IIHRDL+P +L V
Sbjct: 99 MPFMGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAV--- 151
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDV 348
++ LK+ DFG+++ + D +T + Y APEV N Y VD+
Sbjct: 152 --------NEDCELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDI 199
Query: 349 FSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPFKAPAKL-------YARGLKEL 399
+S I+ EM+ G P F H +++ + P + KL Y + L
Sbjct: 200 WSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF 258
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 19/191 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L ++ I V E +L + P +V + S + +VT+Y+ G
Sbjct: 22 AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
+L L+++G A + ++ + +LH+ I++RDL+P NI
Sbjct: 82 ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKP-----------ENI 127
Query: 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALI 354
L D +G++ + DFG+SK T T+ Y+APEV +E+ Y VD +S ++
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKTTNTFCGTT-EYLAPEVLLDEKGYTKHVDFWSLGVL 186
Query: 355 LQEMIEGCPPF 365
+ EM G PF
Sbjct: 187 VFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 28/196 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
G +VA+KK+ + R FR EL +L +H NV L A+ P +
Sbjct: 25 GKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNV---LSALDILQPPHIDPFEEIY 80
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYV 286
+VTE L + DL + L F I RG+ YLH I+HRD++P
Sbjct: 81 VVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPG---- 132
Query: 287 AYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTK 345
N+L + + LK+ DFG++++ E + +T + + Y APE+ + Y +
Sbjct: 133 -------NLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSA 185
Query: 346 VDVFSFALILQEMIEG 361
VD++S I E++
Sbjct: 186 VDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 21/226 (9%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
+ E+ +++ +H N+V + G+ + + I E+ G L+ G L S +
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR 113
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
+ +G+ YLH +HRD++ + NIL D+G++K+ADFGVS +T
Sbjct: 114 ETLQGLYYLHSKGK---MHRDIKGA-----------NILLTDNGHVKLADFGVSAQITAT 159
Query: 318 EDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV- 373
+ + T ++APEV E Y+ D+++ + E+ E PP H
Sbjct: 160 IAKRKSFIGTP-YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
Query: 374 -PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ Q P K K ++ ++ + P KRPT +++
Sbjct: 219 FLMTKSNFQPPKLKDKMK-WSNSFHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 25/194 (12%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+A+KK+ E +D+ V A R E++LL++++H N+V+ V + +V EYL
Sbjct: 30 IALKKIRLE--QEDEGVPSTAIR-EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL- 85
Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
DL+ + A P + I RG+ Y H ++ ++HRDL+P +
Sbjct: 86 DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKP-----------Q 131
Query: 294 NILRDDSGN-LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSF 351
N+L D N LK+ADFG+++ + R T + + Y APE+ + Y T VD++S
Sbjct: 132 NLLIDRRTNALKLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSV 190
Query: 352 ALILQEMIEGCPPF 365
I EM+ P F
Sbjct: 191 GCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 37/82 (45%), Positives = 45/82 (54%)
Query: 47 LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
LA D G + LL G D N RD D RT LH+A G +VV +LLE GAD D+ G
Sbjct: 89 LAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDG 148
Query: 107 STPLGDAIYYKNHEVIKLLEKH 128
TPL A EV++LL +H
Sbjct: 149 KTPLELAEENGFREVVQLLSRH 170
|
Length = 664 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 28/194 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
G++VAVKKL S R +R EL LL+ ++H NV+ L T + + + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
+L DL +K + V+F + I RG+ Y+H IIHRDL+PS+L V
Sbjct: 101 THLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAV-- 153
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVD 347
++ LK+ DFG+++ D +T + Y APE+ N Y+ VD
Sbjct: 154 ---------NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVD 200
Query: 348 VFSFALILQEMIEG 361
++S I+ E++ G
Sbjct: 201 IWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 38/179 (21%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314
++ +A+GM +L K IHRDL RNIL ++ +K+ DFG+++ +
Sbjct: 184 YSFQVAKGMEFLASRK---CIHRDLAA-----------RNILLSENNVVKICDFGLARDI 229
Query: 315 TVKEDR--------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 365
D PL +++APE + Y + DV+SF ++L E+ G P+
Sbjct: 230 YKDPDYVRKGDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
Query: 366 T-MKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
+K D E + R R P ++Y L +CW+ +P++RPTF +++ L
Sbjct: 283 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-----DCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 62/264 (23%), Positives = 113/264 (42%), Gaps = 23/264 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
GDL+ + G A+ +A ++ G+ L + I++RDL+P
Sbjct: 85 GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKP----------- 130
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 352
NIL DD G+++++D G++ + + E + + + Y+APEV NE+Y D +
Sbjct: 131 ENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLG 188
Query: 353 LILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKR 411
++ EMI+G PF K V + R+ + + ++ ++ K + + P +R
Sbjct: 189 CLIYEMIQGQSPFR-KRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
Query: 412 PTFRQ---IITRLESINNSINHKR 432
R + I +IN KR
Sbjct: 248 LGCRGNGAAGVKQHPIFKNINFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 15/188 (7%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK + +++ + R EL +L+ ++ N+V+ A + + +V EY+ K L
Sbjct: 29 VAIKKFKDSEENEEVKETTLR-ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
+ + P + + + +++ H+N I+HRD++P +L +++ ND
Sbjct: 88 ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISH--NDV---- 138
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357
LK+ DFG ++ L+ + T + Y +PE+ Y VD++S IL E
Sbjct: 139 -----LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGE 193
Query: 358 MIEGCPPF 365
+ +G P F
Sbjct: 194 LSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 22/163 (13%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFL-KRKGALKPSTAVRFA 256
E LLQ + HP+V++ + + +V LP DL +L KR L A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
I G+ YLH + IIHRD++ NI +D + + D G ++ V
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKT-----------ENIFINDVDQVCIGDLGAAQF-PV 208
Query: 317 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 359
L T APEV ++Y++K D++S ++L EM+
Sbjct: 209 VAPAFLGLAGT-VETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 53/213 (24%), Positives = 106/213 (49%), Gaps = 35/213 (16%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF--------------LGAVTQS 222
+VAVKK+ V++D V+ E+ +++++ H N+V+ +G++T+
Sbjct: 32 RVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ + IV EY+ + DL L+ +G L A F + RG+ Y+H ++HRDL+P+
Sbjct: 89 NSVYIVQEYM-ETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE-VFKN 339
++++ N +++ LK+ DFG+++++ L+ + Y +P +
Sbjct: 144 NVFI----NTEDLV------LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP 193
Query: 340 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372
Y +D+++ I EM+ G P F H+ E
Sbjct: 194 NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 41/205 (20%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM---IVTEYLP 233
VA+KK+ + + D R FR E+ LQ++ HPN+V+ L V ++ +V EY+
Sbjct: 35 VALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYM- 91
Query: 234 KGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
+ DL A + R L+ R+ + + + + Y+H +IHRDL+PS
Sbjct: 92 ETDLHAVI-RANILED-VHKRYIMYQLLKALKYIHSGN---VIHRDLKPS---------- 136
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRP----LTCQDTSCRYVA------PEV-FKNEE 341
NIL + +K+ADFG+++ L+ E+ P LT YVA PE+ +
Sbjct: 137 -NILLNSDCRVKLADFGLARSLSELEENPENPVLT------DYVATRWYRAPEILLGSTR 189
Query: 342 YDTKVDVFSFALILQEMIEGCPPFT 366
Y VD++S IL EM+ G P F
Sbjct: 190 YTKGVDMWSVGCILGEMLLGKPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 33/77 (42%), Positives = 48/77 (62%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+ IK +LD GIDVN +D + +T LH A +G E + +L E GADV+ +D G P+ A
Sbjct: 105 DMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIA 164
Query: 114 IYYKNHEVIKLLEKHGA 130
I + ++IKLL + GA
Sbjct: 165 IKHNFFDIIKLLLEKGA 181
|
Length = 434 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 34/204 (16%)
Query: 232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
+++ L G+ L + F +ARGM +L V HRDL
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV---HRDLAA-------- 265
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKV 346
RN+L +K+ DFG+++ + D + ++ +++APE + Y T
Sbjct: 266 ---RNVLLAQGKIVKICDFGLAR--DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS 320
Query: 347 DVFSFALILQEMIE--GCPPFTMKHD----NEVPKAYAARQRPPFKAPAKLYARGLKELI 400
DV+S+ ++L E+ G P M D N++ Y R P A ++Y +++
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY--RMAKPDHATQEVY-----DIM 373
Query: 401 EECWNEKPAKRPTFRQIITRLESI 424
+CWN +P KRP+F + +ES+
Sbjct: 374 VKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 30/275 (10%)
Query: 151 DPHELDFTNSVEITKG-TFILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP L N ++I +G T I+ R G QVAVK + + R +E+ +++
Sbjct: 18 DPRSL-LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 73
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+H NVV+ + + ++ E+L G L + + L + + + Y
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCY 132
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 325
LH +IHRD++ SD +IL G +K++DFG + +D P
Sbjct: 133 LHSQG---VIHRDIK-SD----------SILLTLDGRVKLSDFGFCA--QISKDVPKRKS 176
Query: 326 DTSCRY-VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384
Y +APEV Y T+VD++S +++ EM++G PP+ D+ V R PP
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRLRDSPP 234
Query: 385 FKAP-AKLYARGLKELIEECWNEKPAKRPTFRQII 418
K A + L++ +E +P +R T ++++
Sbjct: 235 PKLKNAHKISPVLRDFLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 23/195 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-----QSSPMMIVTEY 231
+VA+KK+ + D R R E+ LL+ + H NV+ + + + IV E
Sbjct: 32 KVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE- 89
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
L DL ++ L F + RG+ Y+H ++HRDL+PS
Sbjct: 90 LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPS--------- 137
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFS 350
N+L + + +LK+ DFG+++ + K D +T + Y APE+ N EY T +DV+S
Sbjct: 138 --NLLLNANCDLKICDFGLARTTSEKGDF-MTEYVVTRWYRAPELLLNCSEYTTAIDVWS 194
Query: 351 FALILQEMIEGCPPF 365
I E++ P F
Sbjct: 195 VGCIFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
G+D + ++ + + L + + D+E IK L + G DVN D + +H+A F +++
Sbjct: 114 GIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDII 173
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA------KPLMAPMH--VKH 141
LLLE+GA + KD G +PL +A Y ++ IKLL HG K P+H + H
Sbjct: 174 KLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAIIH 233
Query: 142 AREVPEYEIDPHELDFTN 159
R E I+ ++ +
Sbjct: 234 NRSAIELLINNASINDQD 251
|
Length = 434 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 20/134 (14%)
Query: 193 RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 252
+V+A RD LAL + P +V ++ ++ + +V EYL GD+++ L G A
Sbjct: 50 QVQAERDALAL---SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA 106
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312
V++ ++A ++YLH + IIHRDL+P N+L + G++K+ DFG+SK
Sbjct: 107 VKYISEVALALDYLHRHG---IIHRDLKPD-----------NMLISNEGHIKLTDFGLSK 152
Query: 313 LLTVKEDRPLTCQD 326
V +R L D
Sbjct: 153 ---VTLNRELNMMD 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 19/234 (8%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
D + E+ ++++ +H N+V + G+ + I EY G L+ G L
Sbjct: 48 DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311
+ +G+ YLH +HRD++ + NIL D+G++K+ADFGV+
Sbjct: 108 IAYVCRETLQGLAYLHSKGK---MHRDIKGA-----------NILLTDNGDVKLADFGVA 153
Query: 312 KLLTVKEDRPLTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMK 368
+T + + T ++APEV KN Y+ D+++ + E+ E PP
Sbjct: 154 AKITATIAKRKSFIGTP-YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212
Query: 369 HDNEVPKAYAARQRPPFKAPAKL-YARGLKELIEECWNEKPAKRPTFRQIITRL 421
H + P K K ++ ++ + P KRPT +++T L
Sbjct: 213 HPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 53/220 (24%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ IR P +V A + + ++ +Y+ G+L L ++ K ++
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
+I + +LH+ + II+RD++ NIL D +G++ + DFG+SK
Sbjct: 112 GEIVLALEHLHK---LGIIYRDIKL-----------ENILLDSNGHVVLTDFGLSKEFHE 157
Query: 317 KEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374
E + Y+AP++ + + +D VD +S +++ E++ G PFT+ +
Sbjct: 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
Query: 375 KAYAAR---QRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
+ R PP+ P ++ A K++I+ + P KR
Sbjct: 218 AEISRRILKSEPPY--PQEMSALA-KDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 23/190 (12%)
Query: 178 VAVKKLGEEVISDDD---RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+KK E S+DD + A R E+ +L++++HPN+V + + + +V EY
Sbjct: 29 VAIKKFVE---SEDDPVIKKIALR-EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L K + + + +N+ H++ IHRD++P N
Sbjct: 85 TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKP-----------EN 130
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFAL 353
IL G +K+ DFG +++LT D T Y APE+ + +Y VDV++
Sbjct: 131 ILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-YRAPELLVGDTQYGPPVDVWAIGC 189
Query: 354 ILQEMIEGCP 363
+ E++ G P
Sbjct: 190 VFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 30/172 (17%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314
++ +ARGM +L K IHRDL RNIL ++ +K+ DFG+++
Sbjct: 179 YSFQVARGMEFLASRK---CIHRDLAA-----------RNILLSENNVVKICDFGLAR-- 222
Query: 315 TVKEDRPLTCQDTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MK 368
+ +D P + S R ++APE ++ Y T+ DV+SF ++L E+ G P+ ++
Sbjct: 223 DIYKD-PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281
Query: 369 HDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ E + R R P A ++Y ++ CW P +RPTF ++
Sbjct: 282 INEEFCQRLKDGTRMRAPENATPEIY-----RIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 37/221 (16%)
Query: 218 AVTQSSPMMI-VTEYLP----KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
A +SS +YLP + + AL V F+ +A GM +L V
Sbjct: 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261
Query: 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 329
HRDL RN+L + +K+ DFG+++ + D + ++
Sbjct: 262 ---HRDLAA-----------RNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLPL 305
Query: 330 RYVAPEVFKNEEYDTKVDVFSFALILQEM--IEGCP----PFTMKHDNEVPKAYAARQRP 383
+++APE N Y T DV+SF ++L E+ + G P P + N + + Y R
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY--RMAK 363
Query: 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
P A ++Y E++++CW EK RP F Q++ + +
Sbjct: 364 PAHASDEIY-----EIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----MMIVT 229
G +VA+KK+ + D R R E+ LL+ +RHP++V+ + S + +V
Sbjct: 25 GEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
E L + DL +K L P F + R + Y+H + HRDL+P
Sbjct: 84 E-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKP-------- 131
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-------- 341
+NIL + LK+ DFG++++ D P T YVA ++ E
Sbjct: 132 ---KNILANADCKLKICDFGLARVAF--NDTPTAIFWTD--YVATRWYRAPELCGSFFSK 184
Query: 342 YDTKVDVFSFALILQEMIEGCPPFTMK 368
Y +D++S I E++ G P F K
Sbjct: 185 YTPAIDIWSIGCIFAEVLTGKPLFPGK 211
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 60/290 (20%), Positives = 121/290 (41%), Gaps = 44/290 (15%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGI----QVAVKKLGEEVISDDDRVRAFRDELALLQ 205
I+ ++D SV I + + ++GI +V ++ + + +E+ L+
Sbjct: 15 IESDDIDKYTSVLIKEND-QNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLR 73
Query: 206 KIRHPNVVQFLG---AVTQSSP-MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
+I N+++ G + P + ++ EY +G LR L ++ L T + A+D +
Sbjct: 74 RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCK 133
Query: 262 GMNYLHE--NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
G+ L++ NKP +++L V ++ LK+ G+ K+L+
Sbjct: 134 GLYNLYKYTNKP----YKNLTSVSFLV-----------TENYKLKIICHGLEKILSS--- 175
Query: 320 RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPF-----TMKHDNE 372
P Y + ++ + EY K D++S ++L E+ G PF +D
Sbjct: 176 -PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234
Query: 373 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
+ K + + P P +K ++E C + KRP ++I+ L
Sbjct: 235 INKNNS--LKLPLDCP-----LEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 26/191 (13%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY----- 231
+VAVKKL S R +R EL LL+ ++H NV+ L T ++ + E
Sbjct: 42 KVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
L DL +K + L + RG+ Y+H IIHRDL+PS++ V
Sbjct: 101 LMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAV----- 151
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFS 350
++ L++ DFG+++ + D +T + Y APE+ N Y+ VD++S
Sbjct: 152 ------NEDCELRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201
Query: 351 FALILQEMIEG 361
I+ E+++G
Sbjct: 202 VGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 34/197 (17%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
GI VAVKKL + RA+R EL LL+ + H N++ L T P + E+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKSLEEF--- 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSDL 284
D+ ++ A + LD R G+ +LH IIHRDL+PS
Sbjct: 99 QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS-- 152
Query: 285 YVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 344
NI+ LK+ DFG+++ T + +T + Y APEV Y
Sbjct: 153 ---------NIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKE 201
Query: 345 KVDVFSFALILQEMIEG 361
VD++S I+ E+++G
Sbjct: 202 NVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 31/195 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 228
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T + +V
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLYVA 287
Y+ + DL+ K G V++ + + G+ Y+H IIHRDL+P +L V
Sbjct: 99 MPYM-QTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAV- 150
Query: 288 YWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKV 346
++ LK+ DFG+++ D +T + Y APEV N Y+ V
Sbjct: 151 ----------NEDCELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILNWMHYNQTV 196
Query: 347 DVFSFALILQEMIEG 361
D++S I+ EM+ G
Sbjct: 197 DIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV----RFALDIARG 262
++HPN++Q LG ++ P ++V EY GDL+++L ++ + ++ + R A +IA G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
+ ++H++ +H DL RN +KV D+G+ KED +
Sbjct: 112 VTHMHKHN---FLHSDLAL-----------RNCFLTSDLTVKVGDYGIG-PSRYKEDY-I 155
Query: 323 TCQDTSC---RYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 371
+D C R++APE+ E +V++ + L E+ E P++ D
Sbjct: 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215
Query: 372 EV-PKAYAARQRPPFKAPAKL-YARGLKELIEECWNEKPAKRPTFRQI 417
EV +Q FK +L Y+ E+++ CW P KR T ++
Sbjct: 216 EVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 60/253 (23%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VAVKK+ + R +E+ +++ +H NVV+ + + +V E+L
Sbjct: 45 GKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G L + + A L + + ++ LH +IHRD++ SD +
Sbjct: 102 GALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHAQG---VIHRDIK-SD----------S 146
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
IL G +K++DFG ++ + R + T ++APE+ Y +VD++S ++
Sbjct: 147 ILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP-YWMAPELISRLPYGPEVDIWSLGIM 205
Query: 355 LQEMIEGCPPF---------TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 405
+ EM++G PP+ M DN PK + P LK ++
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPS----------LKGFLDRLLV 255
Query: 406 EKPAKRPTFRQII 418
PA+R T +++
Sbjct: 256 RDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 45/210 (21%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229
VA+KK+ +++++ RA R EL LL+ R H N+ M IV
Sbjct: 27 EETVAIKKITNVFSKKILAK----RALR-ELKLLRHFRGHKNITCLYD-------MDIVF 74
Query: 230 ----------EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
E L + DL ++ L + F I G+ Y+H ++HRDL
Sbjct: 75 PGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDL 131
Query: 280 EPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV 336
+P N+L + LK+ DFG+++ + + +T + Y APE+
Sbjct: 132 KPG-----------NLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 337 -FKNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ Y +DV+S IL E++ P F
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 35/181 (19%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
F +E ++ P VVQ A + +V EY+P GDL + K A +
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311
V ALD M + IHRD++P N+L D SG+LK+ADFG
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPD-----------NMLLDKSGHLKLADFGTC 189
Query: 312 KLLTVKEDRPLTCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPP 364
+ + ++ + C DT+ Y++PEV K++ Y + D +S + L EM+ G P
Sbjct: 190 --MKMNKEGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
Query: 365 F 365
F
Sbjct: 247 F 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 59/199 (29%), Positives = 83/199 (41%), Gaps = 36/199 (18%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 232
G VA+KKL + RA+R EL L++ + H N++ L T Q S YL
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPS 282
+ A L ++ LD R G+ +LH IIHRDL+PS
Sbjct: 99 VMELMDANL--------CQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 147
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 342
NI+ LK+ DFG+++ T +T + Y APEV Y
Sbjct: 148 -----------NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGY 194
Query: 343 DTKVDVFSFALILQEMIEG 361
VD++S I+ EMI G
Sbjct: 195 KENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 45/202 (22%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM---------IV 228
VA+KK+ E + + A R E+ +LQ ++H NVV L + ++ +V
Sbjct: 40 VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN-LIEICRTKATPYNRYKGSFYLV 97
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIAR-------GMNYLHENKPVPIIHRDLE 280
E+ DL L K V+F L +I + G+ Y+H NK I+HRD++
Sbjct: 98 FEFCEH-DLAGLLSNK-------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMK 146
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVF 337
+ NIL G LK+ADFG+++ ++ ++ + Y PE+
Sbjct: 147 AA-----------NILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL 195
Query: 338 KNE-EYDTKVDVFSFALILQEM 358
E +Y +D++ I+ EM
Sbjct: 196 LGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 27/177 (15%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF- 255
F +E ++ P VVQ A + +V EY+P GDL + P +F
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFY 147
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315
++ ++ +H + +IHRD++P N+L D G+LK+ADFG +
Sbjct: 148 TAEVVLALDAIHS---MGLIHRDVKPD-----------NMLLDKHGHLKLADFGTC--MK 191
Query: 316 VKEDRPLTCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 365
+ E + C DT+ Y++PEV K++ Y + D +S + L EM+ G PF
Sbjct: 192 MDETGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE-VVSLLLERGADVDPK 102
+ ++E+ + ++ LL++G DVN + T LH+ T V+ LL++ GADV+ K
Sbjct: 54 YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAK 113
Query: 103 DRWGSTPL-----GDAIYYKNHEVIKLLEKHGAKP------LMAPMHV 139
D+ G TPL G I K VI+LL + GA M P+ V
Sbjct: 114 DKVGRTPLHVYLSGFNINPK---VIRLLLRKGADVNALDLYGMTPLAV 158
|
Length = 471 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 35/168 (20%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMN 264
+VQ A + +V EY+P GDL + K A + V ALD M
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
+ IHRD++P N+L D SG+LK+ADFG + + + + C
Sbjct: 163 F---------IHRDVKPD-----------NMLLDKSGHLKLADFGTC--MKMDANGMVRC 200
Query: 325 QDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 365
DT+ Y++PEV K++ Y + D +S + L EM+ G PF
Sbjct: 201 -DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 60/239 (25%), Positives = 109/239 (45%), Gaps = 27/239 (11%)
Query: 200 ELALLQKIRHPNVVQ----FLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPST 251
E+ ++++++H N+V+ FL Q + I+ E+ GDL + K G ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQK--LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119
Query: 252 AVRFALDIARGMNYLHENKPVP----IIHRDLEPSDLYVAYWQNDRNILRDDSGNL---- 303
V + + Y H K P ++HRDL+P +++++ + + NL
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 304 --KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMI 359
K+ DFG+SK + + E +C T Y +PE+ +E YD K D+++ I+ E+
Sbjct: 180 IAKIGDFGLSKNIGI-ESMAHSCVGTP-YYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 360 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
G PF N + + +R P P K ++ L LI+ N +RP+ Q +
Sbjct: 238 SGKTPF--HKANNFSQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 57/254 (22%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ +V +Y GDLR +K + + A + + ++++H +IHRD++
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIK 170
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFK 338
+ NIL +G +K+ DFG SK+ TV +D T T YVAPE+++
Sbjct: 171 SA-----------NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP-YYVAPEIWR 218
Query: 339 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRP-------------- 383
+ Y K D+FS ++L E++ PF ++ EV K A R P
Sbjct: 219 RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVT 278
Query: 384 ------PFKAPA----------KLYARGLKELIEECWNEKPAKRPTFRQIITR-LESINN 426
P + P+ KL+ GL E+++ +P R I+R ++
Sbjct: 279 ALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQ----TQPGFSGPLRDTISRQIQQTKQ 334
Query: 427 SINHKRRWKIRTMK 440
+ +RR +R M+
Sbjct: 335 LLQVERRRIVRQME 348
|
Length = 496 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 48/221 (21%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + + ++V R E +L + VV+ + + ++ E+LP GD+
Sbjct: 30 AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L +K L + + ++ +H+ + IHRD++P N+L D
Sbjct: 90 TLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPD-----------NLLLD 135
Query: 299 DSGNLKVADFGV--------------------------------SKLLTVKEDRPLTCQD 326
G++K++DFG+ K T K++R
Sbjct: 136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYS 195
Query: 327 T--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
T + Y+APEVF Y+ D +S +I+ EM+ G PPF
Sbjct: 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 51/220 (23%), Positives = 105/220 (47%), Gaps = 24/220 (10%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ +R P +V A + + ++ +Y+ G++ L ++ ++
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK-LLT 315
+I + +LH+ + I++RD++ NIL D G++ + DFG+SK L+
Sbjct: 112 GEIILALEHLHK---LGIVYRDIKL-----------ENILLDSEGHVVLTDFGLSKEFLS 157
Query: 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVP 374
+++R + T Y+APE+ + + K VD +S +++ E++ G PFT++ +
Sbjct: 158 EEKERTYSFCGTI-EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ 216
Query: 375 KAYAAR---QRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
+ R PPF + A+ +L+ + + P KR
Sbjct: 217 SEVSRRILKCDPPFPSFIGPEAQ---DLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 31/181 (17%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKGDLRAFLK-----RKGALKPSTA 252
E+ALL++++H NVV + + + + + +Y + DL +K ++ ++ PS
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL----RDDSGNLKVADF 308
I G++YLH N ++HRDL+P+ NIL + G +K+ D
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPA-----------NILVMGEGPERGVVKIGDL 156
Query: 309 GVSKLLTVKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPP 364
G+++L +PL D + Y APE+ + TK +D+++ I E++ P
Sbjct: 157 GLARLF-NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215
Query: 365 F 365
F
Sbjct: 216 F 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 48/231 (20%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + + ++V R E +L + VV+ + + ++ E+LP GD+
Sbjct: 30 AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L +K L + + ++ +H+ + IHRD++P N+L D
Sbjct: 90 TLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPD-----------NLLLD 135
Query: 299 DSGNLKVADFGV--------------------------------SKLLTVKEDRPLTCQD 326
G++K++DFG+ K T K +R
Sbjct: 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFS 195
Query: 327 T--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375
T + Y+APEVF Y+ D +S +I+ EM+ G PPF + E K
Sbjct: 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYK 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 55.2 bits (132), Expect = 1e-08
Identities = 32/77 (41%), Positives = 42/77 (54%), Gaps = 3/77 (3%)
Query: 56 IKELLDSGI--DVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
K LL++G DVN D D T LH AA G ++V LLLE GAD + ++ +G T L
Sbjct: 127 AKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDP 186
Query: 113 AIYYKNHEVIKLLEKHG 129
A E++KLL G
Sbjct: 187 AAKNGRIELVKLLLDKG 203
|
Length = 235 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 59/214 (27%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
V+A RD LA + + VV+ + + V +Y+P GD+ + L R G + A
Sbjct: 48 VKAERDILA---EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV--- 310
+ ++ + +H+ + IHRD++P NIL D G++K+ DFG+
Sbjct: 105 FYIAELTCAIESVHK---MGFIHRDIKPD-----------NILIDRDGHIKLTDFGLCTG 150
Query: 311 -----------------------SKLLTVKEDRPLTC-------QDTSCR---------Y 331
S+ + + L Q C Y
Sbjct: 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNY 210
Query: 332 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
+APEV Y D +S +IL EM+ G PPF
Sbjct: 211 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 18/132 (13%)
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
GDL L + G + +A +I G+ ++H N+ V ++RDL+P+ N
Sbjct: 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-NRFV--VYRDLKPA-----------N 127
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFAL 353
IL D+ G+++++D G++ + K +P T Y+APEV K YD+ D FS
Sbjct: 128 ILLDEHGHVRISDLGLACDFSKK--KPHASVGTH-GYMAPEVLQKGVAYDSSADWFSLGC 184
Query: 354 ILQEMIEGCPPF 365
+L +++ G PF
Sbjct: 185 MLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 13/134 (9%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + +D + LL G +VN D N + LH A +V +LLE GA D +D
Sbjct: 172 LHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARD 231
Query: 104 RWGSTPLGDAI-YYKNHEVIKLLEKHG----AKPL---MAPMHVKHARE-----VPEYEI 150
+ G+TPL ++ Y K+++++KLL +HG AK + +H E + EY
Sbjct: 232 KCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSSIKSERKLKLLLEYGA 291
Query: 151 DPHELDFTNSVEIT 164
D + L+ ++
Sbjct: 292 DINSLNSYKLTPLS 305
|
Length = 477 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 18/95 (18%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAA--CQGFTEVVSLLLERGADVDPKDR--------- 104
++ LLD+G +VN ++ D LH+ + +++ LL+++G D++ K+R
Sbjct: 124 VEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRVNYLLSYGV 183
Query: 105 -------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+G TPL A+Y N E +K L GA P
Sbjct: 184 PINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANP 218
|
Length = 422 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
R L+L+ P +V A + + + + GDL L + G +A
Sbjct: 45 RIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT 104
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
+I G+ ++H +++RDL+P+ NIL D+ G+++++D G++ + K
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPA-----------NILLDEHGHVRISDLGLACDFSKK 150
Query: 318 EDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 365
+P T Y+APEV K YD+ D FS +L +++ G PF
Sbjct: 151 --KPHASVGTH-GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 2/96 (2%)
Query: 32 DDDGEEIKP--EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
D+ GE P L+ +A+ + ++ELL + +D + D RT LH+AA +G+ + V
Sbjct: 515 DNGGEHDDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCV 574
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+LL+ +V +D G+T L +AI K+H++ ++L
Sbjct: 575 LVLLKHACNVHIRDANGNTALWNAISAKHHKIFRIL 610
|
Length = 823 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 21/165 (12%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFLKRKGALKPSTAVRFAL 257
E +L+ I HP+++Q G T + ++ LP K DL +L K + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL-LTV 316
+ R + YLHEN+ IIHRD++ NI + G++ + DFG + + +
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKA-----------ENIFINHPGDVCLGDFGAACFPVDI 235
Query: 317 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 361
++ T APE+ + Y VD++S ++L EM
Sbjct: 236 NANKYYGWAGTIATN-APELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-08
Identities = 19/33 (57%), Positives = 23/33 (69%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104
D T LH+AA G EVV LLLE GADV+ +D+
Sbjct: 1 DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-08
Identities = 25/50 (50%), Positives = 30/50 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
L A +++ +K LL G DVN RD D RT LH+AA G EVV LLL
Sbjct: 77 LHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 27/75 (36%), Positives = 40/75 (53%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G+ +N +D+ T LH A E V LL+ GA+ + +++G TPL AI
Sbjct: 175 VNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAIL 234
Query: 116 YKNHEVIKLLEKHGA 130
N E+ KLL +G
Sbjct: 235 NNNKEIFKLLLNNGP 249
|
Length = 422 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 59/237 (24%), Positives = 110/237 (46%), Gaps = 22/237 (9%)
Query: 189 SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL 247
S D AF + +L+ ++ H ++ G + S ++V E++ G L L++ KG +
Sbjct: 55 SHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV 114
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN-LKVA 306
+ + A +A ++YL E+K ++H ++ ++ +A R L + + +K++
Sbjct: 115 PVAWKITVAQQLASALSYL-EDKN--LVHGNVCAKNILLA-----RLGLAEGTSPFIKLS 166
Query: 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEM-IEGCPP 364
D GVS +E+R ++APE T D +SF L E+ +G P
Sbjct: 167 DPGVSFTALSREERV-----ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221
Query: 365 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
+ +E + Y + R P P+ + L LI +C +P +RP+FR I+ L
Sbjct: 222 LKERTPSEKERFYEKKHRLP--EPS---CKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 56/225 (24%), Positives = 86/225 (38%), Gaps = 57/225 (25%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
E+ +L+ I H ++ + A S + M++ +Y K DL ++ R G L A+
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYVDRSGPLPLEQAITIQRR 193
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
+ + YLH IIHRD++ NI D+ N + DFG + L
Sbjct: 194 LLEALAYLHGRG---IIHRDVKT-----------ENIFLDEPENAVLGDFGAACKLDAHP 239
Query: 319 DRPL------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM-IEGCPPFTMK--- 368
D P T + S PE+ + Y K D++S L+L EM ++ F +
Sbjct: 240 DTPQCYGWSGTLETNS-----PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
Query: 369 --------------HDNEVP-----------KAYAARQRPPFKAP 388
H E P K YA RPP+ P
Sbjct: 295 SSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIP 339
|
Length = 392 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 34/195 (17%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VA+KKL + RA+R EL L++ + H N++ L T P + E+ D
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QD 103
Query: 237 LRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSDLYV 286
+ ++ A ++ LD R G+ +LH IIHRDL+PS
Sbjct: 104 VYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS---- 155
Query: 287 AYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 346
NI+ LK+ DFG+++ T +T + Y APEV Y V
Sbjct: 156 -------NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 347 DVFSFALILQEMIEG 361
D++S I+ EMI+G
Sbjct: 207 DIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 42/201 (20%), Positives = 86/201 (42%), Gaps = 29/201 (14%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVKK+ + + ++ + E+ ++++HPN++ ++ + S + +V+ + G
Sbjct: 28 VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86
Query: 238 RAFLKR--KGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
LK L P A+ F L D+ ++Y+H IHR ++ S +
Sbjct: 87 EDLLKTHFPEGL-PELAIAFILKDVLNALDYIHSKG---FIHRSVKAS-----------H 131
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY-------VAPEVFKN--EEYDTK 345
IL G + ++ S + +K + + ++PEV + + Y+ K
Sbjct: 132 ILLSGDGKVVLSGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEK 190
Query: 346 VDVFSFALILQEMIEGCPPFT 366
D++S + E+ G PF
Sbjct: 191 SDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 31/83 (37%), Positives = 46/83 (55%), Gaps = 7/83 (8%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFT-----EVVSLLLERGADVDPKDRWGSTPL 110
+K LLD+G D+N +N T LH + + E+V LLLE GA+V+ D G TPL
Sbjct: 51 VKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPL 110
Query: 111 GDAIYYK--NHEVIKLLEKHGAK 131
AI K ++ +++ L +GA
Sbjct: 111 LYAISKKSNSYSIVEYLLDNGAN 133
|
Length = 422 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 54/192 (28%), Positives = 83/192 (43%), Gaps = 34/192 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KKL + RA+R EL L++ + H N++ L T P + E+ D+
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKSLEEF---QDV 97
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSDLYVA 287
++ A ++ LD R G+ +LH IIHRDL+PS
Sbjct: 98 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS----- 148
Query: 288 YWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 347
NI+ LK+ DFG+++ T +T + Y APEV Y VD
Sbjct: 149 ------NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200
Query: 348 VFSFALILQEMI 359
++S I+ EM+
Sbjct: 201 IWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-07
Identities = 26/53 (49%), Positives = 32/53 (60%)
Query: 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
RTALH AA G E+V LLE+G D++ D G+T L A N EV+KLL
Sbjct: 1 GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLL 53
|
Length = 54 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 3e-07
Identities = 23/50 (46%), Positives = 30/50 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
L A +E +K LL+ G+D+N D D TALH+AA G EV+ LLL
Sbjct: 5 LHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 51/187 (27%), Positives = 91/187 (48%), Gaps = 27/187 (14%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
E+ALL++++HPNV+ S + ++ +Y + DL +K A K P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106
Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308
+ V+ L I G++YLH N ++HRDL+P+++ V +R G +K+AD
Sbjct: 107 RSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPER-------GRVKIADM 156
Query: 309 GVSKLLTVKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPP 364
G ++L +PL D + Y APE+ + TK +D+++ I E++ P
Sbjct: 157 GFARLFN-SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215
Query: 365 FTMKHDN 371
F + ++
Sbjct: 216 FHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-07
Identities = 20/47 (42%), Positives = 28/47 (59%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
ID+N D + T LH+AA G E+V LL+ G D++ +D G T L
Sbjct: 7 IDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53
|
Length = 56 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 44/128 (34%), Positives = 61/128 (47%), Gaps = 4/128 (3%)
Query: 8 RTTLLKQSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLA-NERDVEGIKELLDSGI 64
+ T L +S AP R +L G D + + IK E L +A N D E I+ L+ G
Sbjct: 273 KNTPLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGA 332
Query: 65 DVNFRDIDNRTALHVAAC-QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
DVN D T LH A+ ++V LLE GA+V+ +D TP+ A N +I
Sbjct: 333 DVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIIN 392
Query: 124 LLEKHGAK 131
L +GA
Sbjct: 393 TLLDYGAD 400
|
Length = 682 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 51/218 (23%), Positives = 86/218 (39%), Gaps = 63/218 (28%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
V+A RD LA + P VV + + + ++ E+LP GDL L +
Sbjct: 48 VKAERDVLA---ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS-- 311
+ + + +H+ + IHRD++P NIL D G++K++DFG+S
Sbjct: 105 FYMAECVLAIEAVHK---LGFIHRDIKPD-----------NILIDRGGHIKLSDFGLSTG 150
Query: 312 -----------KLLTVKEDRP----------------LTCQDT----------------- 327
KLL K ++ ++ +D
Sbjct: 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVG 210
Query: 328 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ Y+APE+F + Y + D +S I+ E + G PPF
Sbjct: 211 TPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 50.2 bits (119), Expect = 5e-07
Identities = 39/97 (40%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-----CQGFTEVVSLLLERGAD 98
L A++ D + +K LL SG DVN +D D T LH+AA +G EV LLLE GAD
Sbjct: 77 LHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGAD 136
Query: 99 VDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+D + G+TPL A + ++++LL + GA P
Sbjct: 137 LDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADP 173
|
Length = 235 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 60/233 (25%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + + ++V + E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
+ L R A + ++ + +H+ + IHRD++P NIL D
Sbjct: 90 SLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPD-----------NILID 135
Query: 299 DSGNLKVADFGV-------------SKLLTVKED--RPLTCQD--TSCR----------- 330
G++K+ DFG+ K +++D P D ++CR
Sbjct: 136 LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQR 195
Query: 331 ------------------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
Y+APEV + Y D +S +IL EM+ G PPF
Sbjct: 196 ATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 60/233 (25%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++V + E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
+ L R G A + ++ + +H+ + IHRD++P NIL D
Sbjct: 90 SLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPD-----------NILID 135
Query: 299 DSGNLKVADFGV---------SKLLT----VKEDR---------PLTC------------ 324
G++K+ DFG+ SK V++D P C
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERR 195
Query: 325 ---QDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
Q C Y+APEV Y D +S +IL EM+ G PPF
Sbjct: 196 AARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 60/250 (24%), Positives = 115/250 (46%), Gaps = 31/250 (12%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I+V +K L S D AF + ++++++ H ++V G + ++V E++ G
Sbjct: 33 IKVILKVLDP---SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89
Query: 236 DLRAFLKRKGALKPSTAVRF--ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
L F+ RK + +T +F A +A ++YL + ++H ++ ++ +A R
Sbjct: 90 PLDLFMHRKSDVL-TTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLA-----R 140
Query: 294 NILRDDSGN-LKVADFGVSKLLTVKEDRPLTCQDTSCR--YVAPEVFKNEE-YDTKVDVF 349
+ + G +K++D G+ +TV L+ Q+ R ++APE ++ + D +
Sbjct: 141 EGIDGECGPFIKLSDPGIP--ITV-----LSRQECVERIPWIAPECVEDSKNLSIAADKW 193
Query: 350 SFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 408
SF L E+ G P K E + Y + P+ + L +L+ C N P
Sbjct: 194 SFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCML--VTPS---CKELADLMTHCMNYDP 248
Query: 409 AKRPTFRQII 418
+RP FR I+
Sbjct: 249 NQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 23/57 (40%), Positives = 32/57 (56%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
L A D+ +KELL G++V+ D TAL VA + ++V LL+ GADVD
Sbjct: 626 LCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVD 682
|
Length = 823 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 27/187 (14%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
E+ALL++++HPNV+ + + ++ +Y + DL +K A K P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106
Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308
V+ L I G++YLH N ++HRDL+P+++ V +R G +K+AD
Sbjct: 107 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPER-------GRVKIADM 156
Query: 309 GVSKLLTVKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPP 364
G ++L +PL D + Y APE+ + TK +D+++ I E++ P
Sbjct: 157 GFARLFN-SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215
Query: 365 FTMKHDN 371
F + ++
Sbjct: 216 FHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 44/187 (23%), Positives = 83/187 (44%), Gaps = 25/187 (13%)
Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
+PN ++ +VT +++ +Y+ GDL LK++G L + + + +N LH+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 269 NKPVPIIHRD--LEPSDLYVAYWQNDRNILRDDS-GNLKVADFGVSKLLTVKEDRPLTCQ 325
+ IIH D LE N+L D + + + D+G+ K++ +C
Sbjct: 128 HN---IIHNDIKLE-------------NVLYDRAKDRIYLCDYGLCKIIGTP-----SCY 166
Query: 326 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPP 384
D + Y +PE K YD D ++ ++ E++ G PF D E+ ++ RQ+
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK 226
Query: 385 FKAPAKL 391
+
Sbjct: 227 LPFIKNV 233
|
Length = 267 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 47.9 bits (113), Expect = 3e-06
Identities = 34/98 (34%), Positives = 45/98 (45%), Gaps = 5/98 (5%)
Query: 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
+ + L + + L + RD+D R LH AA +G ++V LLL GADV
Sbjct: 40 NLYLELALLPAASLSELLLKLIVDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGADV 99
Query: 100 DPKDRWGSTPLGDAIYYKN-----HEVIKLLEKHGAKP 132
+ KD G TPL A N EV KLL + GA
Sbjct: 100 NAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADL 137
|
Length = 235 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 23/82 (28%), Positives = 42/82 (51%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ ++ +K L+ G D + + D + LH+A G + + LL++ A +D +D G TPL
Sbjct: 113 KKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPL 172
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
A+ + + K+L GA
Sbjct: 173 IIAMAKGDIAICKMLLDSGANI 194
|
Length = 413 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 38/204 (18%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV-----QFLGAVTQSSP---MMIV 228
+VA+KK V+ D + EL +++ + H N++ + ++ + +V
Sbjct: 93 KVAIKK----VLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 229 TEYLPKGDLRAFLK---RKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSDL 284
E++P+ + ++K R P V+ ++ + R + Y+H I HRDL+P +L
Sbjct: 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNL 201
Query: 285 YVAYWQNDRNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEV-FKNEEY 342
++ ++ LK+ DFG +K LL + C S Y APE+ Y
Sbjct: 202 ----------LIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFYRAPELMLGATNY 248
Query: 343 DTKVDVFSFALILQEMIEGCPPFT 366
T +D++S I+ EMI G P F+
Sbjct: 249 TTHIDLWSLGCIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
FR+E +L + + A + + +V +Y GDL L + P RF
Sbjct: 48 FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107
Query: 257 L-DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315
L ++ ++ +H+ + +HRD++P NIL D +G++++ADFG L
Sbjct: 108 LAEMVIAIDSVHQ---LHYVHRDIKPD-----------NILMDMNGHIRLADFG--SCLK 151
Query: 316 VKEDRPLTCQDT----SCRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFT 366
+ ED T Q + + Y++PE+ + E Y + D +S + + EM+ G PF
Sbjct: 152 LMEDG--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
Query: 367 MKHDNEV-PKAYAARQRPPFKAPAKLYARGLKELI 400
+ E K ++R F A + K+LI
Sbjct: 210 AESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLI 244
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 1/80 (1%)
Query: 52 DVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ E K LL G D+N +D TALH A + LLL GA+V+ D+ ++PL
Sbjct: 146 EAEITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPL 205
Query: 111 GDAIYYKNHEVIKLLEKHGA 130
A+ + N ++ +L ++GA
Sbjct: 206 HHAVKHYNKPIVHILLENGA 225
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 40/104 (38%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANER---DVEGIKE-LLDSGIDVNFRDIDNRTALHV 79
KEA ++G D ++I M L ER D I E LL+ G DVN +DI T +H
Sbjct: 126 KEA-ISGNDIHYDKINESIEYMKLIKERIQQDELLIAEMLLEGGADVNAKDIYCITPIHY 184
Query: 80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
AA +G ++V+LLL GADV+ + L A+ KN + IK
Sbjct: 185 AAERGNAKMVNLLLSYGADVNIIALDDLSVLECAVDSKNIDTIK 228
|
Length = 682 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 64/273 (23%), Positives = 119/273 (43%), Gaps = 36/273 (13%)
Query: 165 KGTFILAFWRGIQVAVKKLGE----EVI------SDDDRVRAFRDELALLQKIRHPNVVQ 214
+GTF F +GI+ V GE EV+ S + +F + +++ ++ H ++V
Sbjct: 5 QGTFTKIF-KGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVL 63
Query: 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-AVRFALDIARGMNYLHENKPVP 273
G ++V EY+ G L +LK+ L + + A +A +++L +
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--- 120
Query: 274 IIHRDLEPSDLYVAYWQNDRNILRDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSCR 330
+ H ++ ++ + ++ + +GN +K++D G+S +TV L
Sbjct: 121 LTHGNVCAKNVLLIREEDRK------TGNPPFIKLSDPGIS--ITVLPKEILL---ERIP 169
Query: 331 YVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVPKAYAARQRPPFKAP 388
+V PE +N + D +SF L E+ G P + + + Y R + P
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH----QLP 225
Query: 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
A + L LI +C + +P RP+FR II L
Sbjct: 226 APKWTE-LANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 23/79 (29%), Positives = 37/79 (46%), Gaps = 2/79 (2%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTE--VVSLLLERGADVDPKDRWGSTPLGDA 113
++EL+ +G D D+ T LH A + +V LL G ++ ++R+G TPL A
Sbjct: 205 VRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYA 264
Query: 114 IYYKNHEVIKLLEKHGAKP 132
+ N + L GA
Sbjct: 265 AVFNNPRACRRLIALGADI 283
|
Length = 471 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 29/203 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G V V+ E +++ ++A ++E+ L RHPN++ T S + +++ ++
Sbjct: 25 GTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 235 GDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
G + LK S A+ RG+NYLH+N IHR+++ S + +
Sbjct: 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILI------ 134
Query: 293 RNILRDDSGNLKVADFGVSKL--LTVKEDRPLTCQD-----TSCR-YVAPEVFKNE--EY 342
SG+ V+ G+S L L + D TS +++PE+ + + Y
Sbjct: 135 -------SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY 187
Query: 343 DTKVDVFSFALILQEMIEGCPPF 365
+ K D++S + E+ G PF
Sbjct: 188 NVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 41/150 (27%), Positives = 65/150 (43%), Gaps = 28/150 (18%)
Query: 150 IDPHELDFTNSVEITKGTFIL-------AFWR--------------GIQVAVKKLGEEVI 188
+DP +L + ++ E+ + +L AF R ++VAVK L
Sbjct: 21 VDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR 80
Query: 189 SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
S + + A EL ++ + H N+V LGA T+ P+ I+TEY GDL +L R
Sbjct: 81 SSEKQ--ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR---- 134
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHR 277
T +++ LD R L P+ R
Sbjct: 135 NKHTFLQYYLDKNRDDGSLISGGSTPLSQR 164
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 4e-05
Identities = 16/29 (55%), Positives = 20/29 (68%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVD 100
D T LH+AA G E+V LLLE GAD++
Sbjct: 1 DGNTPLHLAARNGNLELVKLLLEHGADIN 29
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 29/202 (14%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--MMIVTEYLPK 234
A+K + ++ ++V R E+ L+++ HPN+++ + + + +V E L
Sbjct: 27 YAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE-LMD 83
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
+L +K RK L + + + ++++H N I HRD++P
Sbjct: 84 MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKP-----------E 129
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE-VFKNEEYDTKVDVFSF 351
NIL D LK+ADFG + + P T + S R Y APE + + Y K+D+++
Sbjct: 130 NILIKD-DILKLADFGSCR--GIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAV 185
Query: 352 ALILQEMIEGCPPFTMKHDNEV 373
+ E++ P F NE+
Sbjct: 186 GCVFFEILSLFPLFPGT--NEL 205
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|197603 smart00248, ANK, ankyrin repeats | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 5e-05
Identities = 17/29 (58%), Positives = 22/29 (75%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVD 100
D RT LH+AA G EVV LLL++GAD++
Sbjct: 1 DGRTPLHLAAENGNLEVVKLLLDKGADIN 29
|
Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 28/151 (18%)
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSD 283
+ +V +Y GDL L + P RF + ++ ++ +H+ V HRD++P
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV---HRDIKPD- 131
Query: 284 LYVAYWQNDRNILRDDSGNLKVADFG----VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 339
N+L D +G++++ADFG +++ TV+ + D Y++PE+ +
Sbjct: 132 ----------NVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD----YISPEILQA 177
Query: 340 EE-----YDTKVDVFSFALILQEMIEGCPPF 365
E Y + D +S + + EM+ G PF
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 28/149 (18%)
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSDLY 285
+V +Y GDL L + P RF L ++ ++ +H+ + +HRD++P
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPD--- 131
Query: 286 VAYWQNDRNILRDDSGNLKVADFGVS-KLL---TVKEDRPLTCQDTSCRYVAPEVFKNEE 341
N+L D +G++++ADFG +LL TV+ + + D Y++PE+ + E
Sbjct: 132 --------NVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD----YISPEILQAME 179
Query: 342 -----YDTKVDVFSFALILQEMIEGCPPF 365
Y + D +S + + EM+ G PF
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 20/61 (32%), Positives = 29/61 (47%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
LL +GI +N R+ +T LH AA L+ GAD++ G+TPL + N
Sbjct: 243 LLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTPLSLMVRNNN 302
Query: 119 H 119
Sbjct: 303 G 303
|
Length = 471 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 9/97 (9%)
Query: 44 LMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ--GFTEVVSLLLERG 96
L +L+N E +K LL+ G +VN D + T L A + +V LL+ G
Sbjct: 72 LHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNG 131
Query: 97 ADVDPKDRWGSTPLGDAIYYKNH--EVIKLLEKHGAK 131
A+V+ K+ G L + +++KLL G
Sbjct: 132 ANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVD 168
|
Length = 422 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 32/85 (37%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA---DVDPKDRWGS 107
RD E IK L+ G + + D + LH A +G + V LL+ G DV KD G
Sbjct: 46 RDSEAIKLLMKHGAIPDVKYPDIESELHDAVEEGDVKAVEELLDLGKFADDVFYKD--GM 103
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
TPL A K +++KLL GA P
Sbjct: 104 TPLHLATILKKLDIMKLLIARGADP 128
|
Length = 413 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 3/68 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK L + A EL +L + H N+V LGA T P +++TEY GD
Sbjct: 68 VAVKMLKPSAHLTERE--ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGD 125
Query: 237 LRAFLKRK 244
L FL+RK
Sbjct: 126 LLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 50 ERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
E DV+ ++ELLD G DV ++D T LH+A +++ LL+ RGAD D +
Sbjct: 78 EGDVKAVEELLDLGKFADDVFYKD--GMTPLHLATILKKLDIMKLLIARGADPDIPNTDK 135
Query: 107 STPLGDAIYYKNHEVIKLLEKHGA 130
+PL A+ + + I+LL H A
Sbjct: 136 FSPLHLAVMMGDIKGIELLIDHKA 159
|
Length = 413 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 11/106 (10%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR-WG 106
N R+VE K +L + N + ID + E+ LLL GAD++ KDR G
Sbjct: 110 NNRNVEIFKIILTNRYK-NIQTIDLVYIDKKSKDDIIEAEITKLLLSYGADINMKDRHKG 168
Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKPLM------APMH--VKHARE 144
+T L A K+ + +LL +GA + +P+H VKH +
Sbjct: 169 NTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNK 214
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 28/73 (38%), Positives = 37/73 (50%), Gaps = 1/73 (1%)
Query: 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-CQGFTEVVSLLLERGA 97
K + L+ D+E L D+G VN D T LH A+ + +V LLERGA
Sbjct: 239 KNDLSLLKAIRNEDLETSLLLYDAGFSVNSIDDCKNTPLHHASQAPSLSRLVPKLLERGA 298
Query: 98 DVDPKDRWGSTPL 110
DV+ K+ G TPL
Sbjct: 299 DVNAKNIKGETPL 311
|
Length = 682 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 50/196 (25%), Positives = 88/196 (44%), Gaps = 39/196 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+Q VK+ I+D + + + E+A + K++HPN+V+ +G ++ EY+
Sbjct: 715 GMQFVVKE-----INDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
+L L+ L + A+ IA+ + +LH ++ +L P
Sbjct: 768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP-----------EK 813
Query: 295 ILRD--DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR----YVAPEVFKNEEYDTKVDV 348
I+ D D +L+++ G L C DT C YVAPE + ++ K D+
Sbjct: 814 IIIDGKDEPHLRLSLPG------------LLCTDTKCFISSAYVAPETRETKDITEKSDI 861
Query: 349 FSFALILQEMIEGCPP 364
+ F LIL E++ G P
Sbjct: 862 YGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 3/69 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L S + + A EL ++ + H N+V LGA T+S P+ I+TEY
Sbjct: 68 MKVAVKMLKPTARSSEKQ--ALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFY 125
Query: 235 GDLRAFLKR 243
GDL +L +
Sbjct: 126 GDLVNYLHK 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 35/153 (22%), Positives = 60/153 (39%), Gaps = 20/153 (13%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+V + + +V ++ G L + + + + R+A ++ ++ LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 329
I+ RDL P+ NIL DD G++++ F E +
Sbjct: 105 G---IVCRDLNPN-----------NILLDDRGHIQLTYFS-----RWSEVEDSCDGEAVE 145
Query: 330 R-YVAPEVFKNEEYDTKVDVFSFALILQEMIEG 361
Y APEV E D +S IL E++ G
Sbjct: 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 7/79 (8%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAA---CQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
+K L+D G +VN ++ D T LH A C+ +V+ +LL+ GADV+ + PL
Sbjct: 425 VKTLIDRGANVNSKNKDLSTPLHYACKKNCK--LDVIEMLLDNGADVNAINIQNQYPLLI 482
Query: 113 AIYYKNHEVIKLLEKHGAK 131
A+ Y H ++ +L +GA+
Sbjct: 483 ALEY--HGIVNILLHYGAE 499
|
Length = 682 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 4/79 (5%)
Query: 52 DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
D + +K LL+ G+DVN + I TALH + + LLLE GAD++ + + TPL
Sbjct: 247 DYDILKLLLEHGVDVNAKSYILGLTALHSSIKS--ERKLKLLLEYGADINSLNSYKLTPL 304
Query: 111 GDAIY-YKNHEVIKLLEKH 128
A+ Y + ++L +
Sbjct: 305 SSAVKQYLCINIGRILISN 323
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
+R+ + + LL+ G +VN RD ++T +H AA + +++ LL+ GAD++ + T
Sbjct: 352 DRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTA 411
Query: 110 LGDAIYYKN-HEVIKLLEKHGA------KPLMAPMH 138
L A+ N + +K L GA K L P+H
Sbjct: 412 LHFALCGTNPYMSVKTLIDRGANVNSKNKDLSTPLH 447
|
Length = 682 |
| >gnl|CDD|165256 PHA02946, PHA02946, ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 34/89 (38%), Positives = 46/89 (51%), Gaps = 13/89 (14%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
+ER VE ELL G N D D LH+A+ +V++LL GAD + D+ T
Sbjct: 51 DERFVE---ELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKT 107
Query: 109 PLGDAIYY---KNHEVIK---LLEKHGAK 131
PL YY + EVI+ LL ++GAK
Sbjct: 108 PL----YYLSGTDDEVIERINLLVQYGAK 132
|
Length = 446 |
| >gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 26/83 (31%), Positives = 38/83 (45%), Gaps = 19/83 (22%)
Query: 68 FRDIDNRTALHVAA-CQGFTEVVSLLLERGADVDPK---DRWGSTPLGDAIYY------- 116
I TALH+AA Q + E+V LLLERGA V + D + + D+ Y+
Sbjct: 126 TPGI---TALHLAAHRQNY-EIVKLLLERGASVPARACGDFFVKSQGVDSFYHGESPLNA 181
Query: 117 ----KNHEVIKLLEKHGAKPLMA 135
+ ++ LL + A L A
Sbjct: 182 AACLGSPSIVALLSEDPADILTA 204
|
The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743 |
| >gnl|CDD|165089 PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 24/95 (25%), Positives = 43/95 (45%), Gaps = 4/95 (4%)
Query: 20 DRERKEAELNGLDDDGEEIKPEFRLMF--LANERDVEGIKELLDSGIDVNFRDIDNRTAL 77
+ E + LD + + P + LA D+ + L G+ ++++D RT L
Sbjct: 262 NPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCL 321
Query: 78 HVAACQGF--TEVVSLLLERGADVDPKDRWGSTPL 110
H + T+++ LL E G D++ D G+T L
Sbjct: 322 HQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVL 356
|
Length = 764 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 18/90 (20%), Positives = 34/90 (37%), Gaps = 10/90 (11%)
Query: 332 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-------AARQRPP 384
+APEV + + Y K D++S + L E ++ P+ + E+ A
Sbjct: 71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN--EERELSAILEILLNGMPADDPRD 128
Query: 385 FKAPAK-LYARGLKELIEECWNEKPAKRPT 413
AR ++ + C + P +R
Sbjct: 129 RSNLEGVSAARSFEDFMRLCASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165103 PHA02736, PHA02736, Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 19/58 (32%), Positives = 34/58 (58%), Gaps = 4/58 (6%)
Query: 72 DNRTALHVAACQGFT---EVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLL 125
+ +H+ + E + LL+E GAD++ K+R +G+TPL A+Y +N+E+ L
Sbjct: 54 HGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWL 111
|
Length = 154 |
| >gnl|CDD|222931 PHA02798, PHA02798, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 23/84 (27%), Positives = 44/84 (52%), Gaps = 8/84 (9%)
Query: 56 IKELLDSGIDVNFRDIDNRTAL-----HVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+K ++ G +VN D + T L ++ + ++V +L+E GAD++ K+ G TPL
Sbjct: 54 VKLFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPL 113
Query: 111 GDAI---YYKNHEVIKLLEKHGAK 131
+ Y N E++ + ++GA
Sbjct: 114 YCLLSNGYINNLEILLFMIENGAD 137
|
Length = 489 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 469 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.87 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.78 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.76 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.76 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.76 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.74 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.74 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.73 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.72 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.71 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.71 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.7 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.7 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.7 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.7 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.7 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.7 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.7 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.69 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.69 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.69 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.68 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.68 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.68 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.67 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.66 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.66 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.66 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.66 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.66 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.65 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.63 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.62 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.61 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.6 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.59 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.59 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.59 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.58 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.58 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.57 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.56 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.56 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.56 | |
| KOG0505 | 527 | consensus Myosin phosphatase, regulatory subunit [ | 99.56 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.56 | |
| PF13857 | 56 | Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A | 99.55 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.55 | |
| PF13637 | 54 | Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A | 99.55 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.55 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.54 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.54 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.53 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.49 | |
| cd00204 | 126 | ANK ankyrin repeats; ankyrin repeats mediate prote | 99.49 | |
| PTZ00322 | 664 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatas | 99.49 | |
| PHA02792 | 631 | ankyrin-like protein; Provisional | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=395.51 Aligned_cols=257 Identities=27% Similarity=0.462 Sum_probs=229.7
Q ss_pred CCccccCCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEE
Q 012164 145 VPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (469)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 219 (469)
.|..=.++....|...+.||+|+|+.+|. +|+.||+|++.+..+......+++.+|+++.++|+|||||+++++|
T Consensus 8 ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 8 IPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred CCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence 33333344556799999999999998874 7899999999988888888889999999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 220 ~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
++.+++|+|+|+|..++|..++++.+.+++.++..++.||+.||.|||+++ |+|||||.. |+++++
T Consensus 88 EDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLG-----------NlfL~~ 153 (592)
T KOG0575|consen 88 EDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLG-----------NLFLNE 153 (592)
T ss_pred ecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchh-----------heeecC
Confidence 999999999999999999999999999999999999999999999999999 999999999 888899
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
+.+|||+|||||....... ....+.+|||.|.|||++....++..+||||+||+||-|+.|++||...+..+....++.
T Consensus 154 ~~~VKIgDFGLAt~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~ 232 (592)
T KOG0575|consen 154 NMNVKIGDFGLATQLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL 232 (592)
T ss_pred cCcEEecccceeeeecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh
Confidence 9999999999998876432 344557899999999999999999999999999999999999999998887777777755
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....- |..++.++++||.++|+.||.+|||+++++.|
T Consensus 233 ~~Y~~----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 233 NEYSM----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cCccc----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 44221 34678899999999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=387.93 Aligned_cols=273 Identities=42% Similarity=0.731 Sum_probs=230.8
Q ss_pred CCCccccCCCCcccccceeeecCeEEEEE---Eecee-ehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEE
Q 012164 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (469)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~ig~G~~~~~~---~~g~~-vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 219 (469)
..+.+++++.++.+. +.||+|+||.|| |.|+. ||||.+......... .+.|.+|+.+|++++|||||+++|++
T Consensus 32 ~~~~~~i~~~~l~~~--~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIE--EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred cccceecChHHhhhh--hhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 345666666665544 459999999886 67888 999999876554444 78899999999999999999999999
Q ss_pred EeCC-ceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 220 TQSS-PMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 220 ~~~~-~~~lv~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
.+.. .+++||||+++|+|.+++.. +..+++..++.++.||++||+|||+.++ ||||||||+ |+|
T Consensus 109 ~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~-----------NiL 175 (362)
T KOG0192|consen 109 TSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSD-----------NIL 175 (362)
T ss_pred cCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChh-----------hEE
Confidence 8887 79999999999999999987 5679999999999999999999999985 999999999 888
Q ss_pred eCCCC-CeEEeecCCccccccCCCCCcccCCCCCcccCCcccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH
Q 012164 297 RDDSG-NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373 (469)
Q Consensus 297 ~~~~~-~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~ 373 (469)
++.++ ++||+|||+++...... .......||+.|||||++. +..|+.|+||||||+++|||+||+.||.+....++
T Consensus 176 v~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~ 254 (362)
T KOG0192|consen 176 VDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV 254 (362)
T ss_pred EcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 89997 99999999998765432 2333468999999999999 56999999999999999999999999999887666
Q ss_pred HHHHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccchhh
Q 012164 374 PKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKI 436 (469)
Q Consensus 374 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~~ 436 (469)
...+.... +++. +..+++.+..||.+||..||+.||++.+++..|+.+.+.......+..
T Consensus 255 ~~~v~~~~~Rp~~---p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~~ 315 (362)
T KOG0192|consen 255 ASAVVVGGLRPPI---PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPEDS 315 (362)
T ss_pred HHHHHhcCCCCCC---CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcccc
Confidence 66555444 5444 233788999999999999999999999999999999988765444443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=379.97 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=216.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHH----HHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
.|...+.||+|+||.|.. +|+.||||.+++....... ......+|+++|++|+|||||+++++|...+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 467788999999998863 7999999999876554322 2234579999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
+||||++||+|.+.+-.++.+.+..-..+++|++.|+.|||+.| |+||||||+|||+... .++..+||+
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~--------~e~~llKIt 321 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSND--------AEDCLLKIT 321 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccC--------CcceEEEec
Confidence 99999999999999999999999999999999999999999999 9999999994444310 133789999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCC---CchhHHHHHHHHHHHHhCCCCCCCCCCCc-HHHHHhhcCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQR 382 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDi~SlGvil~el~tg~~p~~~~~~~~-~~~~~~~~~~ 382 (469)
|||+|+..+ +.....+.+||+.|.|||++.+..++ .+.|+||+||++|-+++|.+||.+..... ..+++..+..
T Consensus 322 DFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 322 DFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred ccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 999999876 34445668999999999999876433 47899999999999999999999887776 7788866666
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+..+..++++..+||++||..||++|||++|+|+|
T Consensus 400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 66667788899999999999999999999999999988
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-50 Score=371.98 Aligned_cols=244 Identities=28% Similarity=0.480 Sum_probs=211.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc-eEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 229 (469)
+++....||+|..|.|+. +++.+|+|.+... .+....+++.+|+++++..+|||||++||+|..+.. +.|+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 456677999999999874 7899999999543 456677889999999999999999999999999985 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|||++|||+++++..+++++...-.++.++++||.|||+ ++ ||||||||+ |+|++..|.||||||
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPs-----------NlLvNskGeVKicDF 223 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPS-----------NLLVNSKGEVKICDF 223 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHH-----------HeeeccCCCEEeccc
Confidence 999999999999998999999999999999999999996 76 999999999 888899999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--CCc---HHHHHhhcCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH--DNE---VPKAYAARQRP 383 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~--~~~---~~~~~~~~~~~ 383 (469)
|.+...... ......||..|||||.+.+..|+.++||||||++++|+.+|+.||.... ... ....+.....+
T Consensus 224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP 300 (364)
T KOG0581|consen 224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP 300 (364)
T ss_pred cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC
Confidence 999876533 4456889999999999999999999999999999999999999998641 222 23333333233
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+ +...++++++.|+..||++||.+|||++++++|
T Consensus 301 ~l--P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RL--PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CC--CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 32 222599999999999999999999999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=382.06 Aligned_cols=259 Identities=34% Similarity=0.592 Sum_probs=228.7
Q ss_pred CccccCCCCcccccceeeecCeEEEEE---Eece-eehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 012164 146 PEYEIDPHELDFTNSVEITKGTFILAF---WRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (469)
Q Consensus 146 ~~~~~~~~~~~~~~~~~ig~G~~~~~~---~~g~-~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 221 (469)
..|+++..++. ..+.||+|-||.|+ |+|. .||+|.++...... +.|.+|+++|++|+|++||+++++|..
T Consensus 199 d~wei~r~~l~--l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 199 DPWEIPREELK--LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred CCeeecHHHHH--HHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 34566655544 46799999999875 6676 99999998653332 568899999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 222 SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 222 ~~~~~lv~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
++.++||||||..|+|.++|+. .+.+...+.+.++.|||+||+||++++ +|||||.+. |||++.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAAR-----------NiLV~~ 338 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAAR-----------NILVDE 338 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhh-----------heeecc
Confidence 8899999999999999999986 455999999999999999999999999 999999999 888899
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~ 378 (469)
+..+||+|||||+..............-++.|.|||.+..+.++.|||||||||+||||+| |+.||.+++..++...+.
T Consensus 339 ~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le 418 (468)
T KOG0197|consen 339 DLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE 418 (468)
T ss_pred CceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh
Confidence 9999999999999666555555555566889999999999999999999999999999998 999999999999999998
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.+.+.+. |..+|+++.++|..||..+|++|||++.+...|+++...
T Consensus 419 ~GyRlp~---P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 419 RGYRLPR---PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ccCcCCC---CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 8888876 567899999999999999999999999999999988765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=354.70 Aligned_cols=253 Identities=27% Similarity=0.477 Sum_probs=215.6
Q ss_pred ccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEe-EEEeCC-ceEEE
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSS-PMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~~-~~~lv 228 (469)
+|++.++||+|.||.|| ++|..||.|.+.-.. .+....+.+..|+.+|++|+||||+++++ .|.++. -++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 68899999999999887 489999999998544 46667788999999999999999999998 454444 48999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP-VPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~-~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
||||++|+|.++++. +..+++..+|+++.|++.||..+|+.-+ ..|+||||||. ||+++.+|.|
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPa-----------NIFl~~~gvv 167 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPA-----------NIFLTANGVV 167 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcch-----------heEEcCCCce
Confidence 999999999999973 4459999999999999999999999321 13899999999 8888899999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
||+|||+++++.... .......|||.||+||.+.+.+|+.||||||+||++|||+.-+.||.+.+-.+....+.....+
T Consensus 168 KLGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP 246 (375)
T ss_pred eeccchhHhHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC
Confidence 999999999887543 3445688999999999999999999999999999999999999999998766777777555444
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
+. +...++.++..||..|+..||+.||+...+++.+.+
T Consensus 247 ~~--p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 PL--PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CC--cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 44 237899999999999999999999997666655544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=364.00 Aligned_cols=253 Identities=30% Similarity=0.532 Sum_probs=214.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|...++||+|+|++||. ++..||||.+.+... ..+.++.+..|+.+|+.++|||||.+++++..++.+|+|||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 677778899999999985 679999999987754 45667888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||+||+|.+|+.+++.+++.++..++.||+.||++||+++ ||||||||+|||++..... +....+||+|||+
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~-----~~~~~LKIADFGf 161 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARN-----DTSPVLKIADFGF 161 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCC-----CCCceEEecccch
Confidence 9999999999999999999999999999999999999999 9999999996666532111 0115799999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+.... .......+|++.|||||++..+.|+.|+|+||+|+++|+|++|+.||...+..+....+.... ...+..+.
T Consensus 162 AR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~-~~~~~~~~ 238 (429)
T KOG0595|consen 162 ARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN-EIVPVLPA 238 (429)
T ss_pred hhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc-cccCchhh
Confidence 998763 334456789999999999999999999999999999999999999999988888877664433 22223344
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+..+.+|+...+..+|..|.++.+...+
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 556677788889999999999888776654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=360.63 Aligned_cols=247 Identities=29% Similarity=0.480 Sum_probs=222.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.|+. +++.+|+|++++..+.....++....|..+|..++||+||+++..|.+.+.+|+|+|
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence 788899999999999874 789999999999888877788999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+.||.|...|++.+.+++..+..++..|+.||.|||++| ||||||||+ |||+|.+|+++|+||||
T Consensus 106 ~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPE-----------NILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 106 YLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPE-----------NILLDEQGHIKLTDFGL 171 (357)
T ss_pred ccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHH-----------HeeecCCCcEEEecccc
Confidence 9999999999999999999999999999999999999999 999999999 99999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
++..-. ........+||+.|||||++.+.+|+..+|.||||+++|||++|.+||...+...+.+.+.....+. ++.
T Consensus 172 ~k~~~~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~---~p~ 247 (357)
T KOG0598|consen 172 CKEDLK-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL---PPG 247 (357)
T ss_pred chhccc-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC---CCc
Confidence 985432 2334455899999999999999999999999999999999999999999988878777775554222 345
Q ss_pred hhHHHHHHHHHHHcccCCCCCC----CHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRP----TFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rp----s~~~ll~~ 420 (469)
.++.+.++|++++|..||++|. ++.++..|
T Consensus 248 ~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 248 YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 5788999999999999999995 67776665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=341.88 Aligned_cols=372 Identities=29% Similarity=0.453 Sum_probs=293.6
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcc
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t 108 (469)
.+-|.|.-|..|.+||||||+.|+..+++.|+..|+.+|..+....||||+||.+||.++|+.|++..+|+|..+..|.|
T Consensus 23 tehdln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgnt 102 (448)
T KOG0195|consen 23 TEHDLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNT 102 (448)
T ss_pred cccccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCC
Confidence 44566777778999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhcCCCCCC------cc-----------------cccccCCCCccccC--------------
Q 012164 109 PLGDAIYYKNHEVIKLLEKHGAKPLMA------PM-----------------HVKHAREVPEYEID-------------- 151 (469)
Q Consensus 109 pl~~A~~~~~~~~~~~L~~~~~~~~~~------~~-----------------~~~~~~~~~~~~~~-------------- 151 (469)
||||||.+|...+++-|+..|+....- +. +..++..+|.-+..
T Consensus 103 plhyacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatls 182 (448)
T KOG0195|consen 103 PLHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLS 182 (448)
T ss_pred chhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccccc
Confidence 999999999999999999998765321 11 11111222211111
Q ss_pred ------CCCccc-ccceeeecCeEEEEEEeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 152 ------PHELDF-TNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 152 ------~~~~~~-~~~~~ig~G~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
...+++ +...+--+|..+.+.|.|..++.|++....... ..-+.|..|.-.++.+.||||+.+++.|.+..+
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred cccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 111111 112222356677788899999999987654432 223678999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEec-CCCCCcccccccccCcceeeCCCC
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHR-DLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~-Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
+.++..||+.|||+.++++... .+-.++.+++.++++|+.|||+..+ ++-| -|.+. .+++|++.
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~-----------hvmidedl 328 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSK-----------HVMIDEDL 328 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccc-----------eEEecchh
Confidence 9999999999999999987543 7788999999999999999999873 4432 34444 88899888
Q ss_pred CeEEe--ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCC---CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 302 NLKVA--DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 302 ~vkl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
+++|+ |--++.. .....-.+.||+||.+...+-+ .++|+|||++++||+.|...||.+.++.+.--.
T Consensus 329 tarismad~kfsfq--------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk 400 (448)
T KOG0195|consen 329 TARISMADTKFSFQ--------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK 400 (448)
T ss_pred hhheecccceeeee--------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh
Confidence 77764 3333321 1123346789999999876544 479999999999999999999999999887766
Q ss_pred HhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 377 YAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 377 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
+...+ +... ++..+..+..|++-|++.||.+||.++.++-.|+++.
T Consensus 401 ialeglrv~i---ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 IALEGLRVHI---PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhccccccC---CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 65555 3332 4567888999999999999999999999999888763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.09 Aligned_cols=255 Identities=27% Similarity=0.496 Sum_probs=207.8
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC--ceE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 226 (469)
..++...+.||+|+||.|+. +|...|||.+..... ...+.+.+|+.+|++++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 34677888999999999985 378999998875521 22677999999999999999999999855444 689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC-CCCeE
Q 012164 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD-SGNLK 304 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~-~~~vk 304 (469)
+.|||+++|+|.+++.+.+ .+++..+..+.+||++||.|||++| ||||||||+ |||++. ++.+|
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~-----------NiLl~~~~~~~K 158 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPA-----------NILLDPSNGDVK 158 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccc-----------eEEEeCCCCeEE
Confidence 9999999999999999877 7999999999999999999999999 999999999 888888 79999
Q ss_pred EeecCCcccccc--CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC-CCCcHHHHHhhc
Q 012164 305 VADFGVSKLLTV--KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAAR 380 (469)
Q Consensus 305 l~Dfgla~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~-~~~~~~~~~~~~ 380 (469)
|+|||+++.... ..........||+.|||||++.++ ....++|||||||++.||+||+.||... ...+....+...
T Consensus 159 laDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~ 238 (313)
T KOG0198|consen 159 LADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE 238 (313)
T ss_pred eccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc
Confidence 999999987653 112223456799999999999963 3335999999999999999999999874 222222222222
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
. ..+..+..++.+.++|+.+|+..||++||||+++++|.-.....
T Consensus 239 ~--~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 239 D--SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred C--CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 2 22244667899999999999999999999999999996555444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=354.31 Aligned_cols=248 Identities=28% Similarity=0.501 Sum_probs=221.1
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 228 (469)
.+|..++.||.|+|..|+. +++.||||++.+..+..+..+.-...|-++|.+| .||.|+++|-.|.++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 4788899999999998874 6899999999988776666667788999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
+||+++|+|.++|++.|.+.+..+..++.||+.||+|||++| ||||||||+ |||+|++|++||+||
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPE-----------NILLd~dmhikITDF 218 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPE-----------NILLDKDGHIKITDF 218 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChh-----------heeEcCCCcEEEeec
Confidence 999999999999999999999999999999999999999999 999999999 999999999999999
Q ss_pred CCccccccCCCC------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 309 GVSKLLTVKEDR------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 309 gla~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
|.|+.+...... ....++||..|.+||++.....+..+|||+||||+|+|+.|.+||.+.+..-+.+.
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk 298 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK 298 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence 999987543211 11347899999999999999999999999999999999999999999888777777
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+...... + ++++++.+++||+++|..||.+|+|..+|-+|
T Consensus 299 I~~l~y~-f---p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 IQALDYE-F---PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHhccc-C---CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 7544322 1 45678899999999999999999999999888
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=358.31 Aligned_cols=245 Identities=23% Similarity=0.458 Sum_probs=219.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..++||+|+-|.||. +++.||||++....... .+.+.+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 577788999999998874 68899999998664332 3568899999999999999999999998999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||+||+|.+++... .+++.++..+++++++||+|||.++ |+|||||.+ |||++.+|.+||+|||+
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSD-----------nILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSD-----------NILLTMDGSVKLTDFGF 415 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccc-----------eeEeccCCcEEEeeeee
Confidence 99999999998854 4999999999999999999999999 999999999 99999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
+..+..... ......||+.|||||+.....|.+|.||||||++++||+.|.+||-+.++-.....+...+.+.+.. +.
T Consensus 416 caqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~-~~ 493 (550)
T KOG0578|consen 416 CAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN-PE 493 (550)
T ss_pred eeccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC-cc
Confidence 987765433 3455789999999999999999999999999999999999999999888877888888888877754 46
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+++.+++|+.+||+.|+++|+++.|||+|
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 789999999999999999999999999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=370.74 Aligned_cols=252 Identities=31% Similarity=0.544 Sum_probs=220.6
Q ss_pred cccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 157 FTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
....++||+|.||.|+. ..+.||||.++... +....++|++|++++..|+|||||+++|+|.+++.++
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44467999999999974 35789999998663 4456789999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccC
Q 012164 227 IVTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~ 292 (469)
+|+|||..|+|.+||... ++|+..+.+.|+.|||.||+||-++. +|||||...
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATR---------- 632 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATR---------- 632 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhh----------
Confidence 999999999999999742 12788999999999999999999998 999999999
Q ss_pred cceeeCCCCCeEEeecCCccccccCCCCCcc-cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012164 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 370 (469)
Q Consensus 293 ~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~ 370 (469)
|+|++++..|||+|||+++.+...+..... ...-+++|||||.+..+++|++||||||||+|||+++ |+.||.+.++
T Consensus 633 -NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 633 -NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred -hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence 888899999999999999977655444332 3445789999999999999999999999999999998 9999999999
Q ss_pred CcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 371 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+++.+.+..+.-.+ -++++|.++.+||..||+.+|++||+++||-..|++....
T Consensus 712 ~EVIe~i~~g~lL~---~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 712 QEVIECIRAGQLLS---CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHHHcCCccc---CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 99998886655432 3578999999999999999999999999999999887554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=340.27 Aligned_cols=246 Identities=26% Similarity=0.457 Sum_probs=222.1
Q ss_pred ccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.|. ..|+.||||.++++.+.++..+-.+++|+++|+.|+||||+++|++|++.+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 68888999999999886 3789999999999999888888899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|..+|.|++|+.+.+.|++.++..+++||..|+.|+|.++ ++|||||.+ |||+|.++++||+|||+
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLE-----------NILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLE-----------NILLDQNNNIKIADFGL 199 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchh-----------heeecCCCCeeeeccch
Confidence 9999999999999999999999999999999999999999 999999999 99999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+..+. .....+.++|++.|.+||++.+.+|. +..|-|||||++|-|+.|..||++.+...+..++..+...+.
T Consensus 200 SNly~--~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---- 273 (668)
T KOG0611|consen 200 SNLYA--DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---- 273 (668)
T ss_pred hhhhc--cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC----
Confidence 98765 34556778999999999999998886 789999999999999999999999887777777755442221
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
.-|.+..-||++||..||++|-|..++..|..
T Consensus 274 -~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 274 -ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 12456888999999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=357.94 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=214.9
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|+.++.||+|+-|.|.. +|+.+|||.+.+...........+.+|+-+|+.+.||||+++|+++.++.++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 45567899999998863 8999999999877544555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
+++|-|.+++-++|++++.++.++++||+.|+.|+|..+ |+||||||+ |+|+|..+.+||+|||+|
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpE-----------NlLLd~~~nIKIADFGMA 159 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPE-----------NLLLDVKNNIKIADFGMA 159 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCch-----------hhhhhcccCEeeecccee
Confidence 999999999999999999999999999999999999999 999999999 888898889999999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 312 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 312 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
.... +.......+|++.|+|||++.|.+|. .++||||.|||+|.|+||++||.+.+-..+...+..+. +.. +.
T Consensus 160 sLe~--~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~---f~M-Ps 233 (786)
T KOG0588|consen 160 SLEV--PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV---FEM-PS 233 (786)
T ss_pred eccc--CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc---ccC-CC
Confidence 7633 34556778999999999999999887 69999999999999999999999665555544443332 222 36
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.++.++++||.+|+..||++|.|..+|++|
T Consensus 234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 234 NISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 789999999999999999999999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=323.49 Aligned_cols=234 Identities=27% Similarity=0.500 Sum_probs=213.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.|-+ +|..+|+|++.+..+......+...+|..+|+.+.||+++++++.+.+...+++|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 788889999999998753 789999999998887777788889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|++||.|..++++.+++++..+..++.||+.||+|||+.+ |++|||||+ |||+|.+|.+||+|||+
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPE-----------NiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPE-----------NLLLDQNGHIKITDFGF 190 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChH-----------HeeeccCCcEEEEeccc
Confidence 9999999999999999999999999999999999999999 999999999 99999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+.... ..-+.+|||.|+|||++...+|..++|.|||||++|||+.|.+||...+...+.+.+.... ..+ |.
T Consensus 191 AK~v~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~-v~f---P~ 262 (355)
T KOG0616|consen 191 AKRVSG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK-VKF---PS 262 (355)
T ss_pred eEEecC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-ccC---Cc
Confidence 987542 2345789999999999999999999999999999999999999999988877777775544 222 45
Q ss_pred hhHHHHHHHHHHHcccCCCCC
Q 012164 391 LYARGLKELIEECWNEKPAKR 411 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~R 411 (469)
.+++++++|+..+|+.|-.+|
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhh
Confidence 678899999999999999999
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=329.73 Aligned_cols=248 Identities=22% Similarity=0.400 Sum_probs=204.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+....+|+|+||+|+. +|+.||||++.... .++...+-..+|+++|++++|||+|.++++|.....+++|+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 466777899999999985 79999999987542 344555667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+. ++.+-+.+. ..++...+..++.|++.|+.|+|+++ +|||||||+ |||++.+|.+||||||
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPE-----------NILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPE-----------NILITQNGVVKLCDFG 146 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChh-----------heEEecCCcEEeccch
Confidence 9977 444445543 44999999999999999999999999 999999999 8899999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-C------
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-Q------ 381 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~------ 381 (469)
+|+.... +....+.+..|.+|+|||.+.+ .+|....||||+||++.||++|.+.|.+.++-+....+... +
T Consensus 147 FAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh 225 (396)
T KOG0593|consen 147 FARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH 225 (396)
T ss_pred hhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence 9998764 3344456778999999999988 59999999999999999999999999988775543322110 0
Q ss_pred -------------CCCCCC-------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 -------------RPPFKA-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 -------------~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.|... ..+..+.-+.+|++.||..||++|++.++++.|
T Consensus 226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 011111 113456679999999999999999999999977
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=337.14 Aligned_cols=255 Identities=29% Similarity=0.484 Sum_probs=214.2
Q ss_pred ccCCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 012164 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (469)
Q Consensus 149 ~~~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 223 (469)
+....-..|+..++||.|.-+.|+. .+..||||++..+...+. ...+.+|+..|+.++||||++++..|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 3444455788889999998887764 679999999998876433 788999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
.+|+||.||.+||+.++++.. ..+.+..+..|++++++||.|||++| .||||||+. |||++.+|
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAg-----------nILi~~dG 163 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAG-----------NILIDSDG 163 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccc-----------cEEEcCCC
Confidence 999999999999999999863 33899999999999999999999999 999999999 99999999
Q ss_pred CeEEeecCCccccccCCCCCc---ccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 302 NLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
.|||+|||.+..+.....+.. ....|+++|||||++.. ..|+.|+||||||++..||.+|..||....+..+...
T Consensus 164 ~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~ 243 (516)
T KOG0582|consen 164 TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL 243 (516)
T ss_pred cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence 999999998765543332211 45689999999999654 3899999999999999999999999998877666554
Q ss_pred HhhcCCCCC-------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 377 YAARQRPPF-------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 377 ~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... +.++. ......++..++.+|..||.+||++|||+++++++
T Consensus 244 tLq-n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 244 TLQ-NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred Hhc-CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 433 33331 11234677889999999999999999999999976
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=354.10 Aligned_cols=291 Identities=27% Similarity=0.502 Sum_probs=244.6
Q ss_pred HHHHHHHHhhcCCCCCCcccccccCCCCccccCCCCcccccceeeecCeEEEEEE------ec---eeehhhhcccccCC
Q 012164 119 HEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW------RG---IQVAVKKLGEEVIS 189 (469)
Q Consensus 119 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~~~~~~------~g---~~vaiK~~~~~~~~ 189 (469)
.+++.+.......+.-.......|...+.|++.+..+.+. +.||+|.||.|+. ++ ..||+|....+...
T Consensus 123 ~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~ 200 (474)
T KOG0194|consen 123 SELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL 200 (474)
T ss_pred HHHHHHHHhcccceeccceeecccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccc
Confidence 3455555555555444455567778888999999988877 7999999998874 12 23899998865556
Q ss_pred CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHh
Q 012164 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHE 268 (469)
Q Consensus 190 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~ 268 (469)
..+.+..+.+|+++|++++||||+++||++....++++|||+|.||+|.++|++.+. ++..+...++.++++||+|||+
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence 678889999999999999999999999999999999999999999999999998774 9999999999999999999999
Q ss_pred CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhH
Q 012164 269 NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 348 (469)
Q Consensus 269 ~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi 348 (469)
++ +|||||..+ |+|++.++.+||+|||+++..... ........-+..|+|||.+..+.|+.++||
T Consensus 281 k~---~IHRDIAAR-----------NcL~~~~~~vKISDFGLs~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV 345 (474)
T KOG0194|consen 281 KN---CIHRDIAAR-----------NCLYSKKGVVKISDFGLSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDV 345 (474)
T ss_pred CC---CcchhHhHH-----------HheecCCCeEEeCccccccCCcce-eeccccccCcceecChhhhccCccccccch
Confidence 99 999999999 888888888999999999865411 111112245789999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhh-cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 349 FSFALILQEMIE-GCPPFTMKHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 349 ~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
|||||++||+++ |..||.+....++...+.. ..+.+.+ ...|.++..++.+||..||+.||++.++.+.|+.+..
T Consensus 346 ~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 346 WSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred hheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 999999999998 8999999999888888844 4455443 3567889999999999999999999999999999987
Q ss_pred hhh
Q 012164 427 SIN 429 (469)
Q Consensus 427 ~~~ 429 (469)
...
T Consensus 423 ~~~ 425 (474)
T KOG0194|consen 423 KKE 425 (474)
T ss_pred ccc
Confidence 754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=348.33 Aligned_cols=248 Identities=29% Similarity=0.496 Sum_probs=217.9
Q ss_pred CCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
....|+..+.||+|.||.||. +++.||+|++..+. ..+.++.+.+|+.++.+++++||.++|+.+..+..+|+
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 345678889999999999985 67899999998764 45667889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
+||||.||++.+.++..+.+.+..+.-++++++.||.|||..+ .+|||||+. |||+..+|.|||+|
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaa-----------nil~s~~g~vkl~D 154 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAA-----------NILLSESGDVKLAD 154 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eeccccccc-----------ceeEeccCcEEEEe
Confidence 9999999999999998777789999999999999999999999 999999999 88888889999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||.+.......... ....||+.|||||++.+..|+.|+||||||++.+||.+|.+||....+......+-....|.+
T Consensus 155 fgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L-- 231 (467)
T KOG0201|consen 155 FGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRL-- 231 (467)
T ss_pred cceeeeeechhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcc--
Confidence 99998877654444 668899999999999998999999999999999999999999998877544444423223332
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+++.+++|+..||++||+.||+|.+|++|
T Consensus 232 -~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 -DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 33789999999999999999999999999988
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=349.04 Aligned_cols=248 Identities=29% Similarity=0.469 Sum_probs=211.7
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCH--HHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCce
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 225 (469)
.-.|...+.||+|+||.|+. +|..||+|.+........ ...+.+.+|+.++++++ ||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34788899999999999874 689999997765432211 23456778999999998 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC-CCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS-GNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~-~~vk 304 (469)
++|||||.||+|.+++.+.+++.+..+..+++|++.|++|||++| |+||||||+ |+|++.+ +.+|
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~E-----------Nilld~~~~~~K 161 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPE-----------NILLDGNEGNLK 161 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHH-----------HEEecCCCCCEE
Confidence 999999999999999999999999999999999999999999999 999999999 8888988 9999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCCCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 382 (469)
|+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||.+.+...+...+... .
T Consensus 162 l~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-~ 239 (370)
T KOG0583|consen 162 LSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-E 239 (370)
T ss_pred EeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-C
Confidence 99999998764 2344556788999999999999977 86 6899999999999999999999986555555554322 2
Q ss_pred CCCCCChhhh-HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
-.+ +..+ +++++.|+.+||..||.+|+|+.+++.+
T Consensus 240 ~~~---p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 240 FKI---PSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ccC---CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 222 2334 8899999999999999999999999955
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=344.35 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=219.1
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|...+.||+|+||.|++ +|..+|+|++++........+...+.|..+|....+|+||++|..|.+.+++||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 3788899999999999985 79999999999888777888899999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||++||++..+|.+.+.|++..+..++.+++.|++.||+.| +|||||||+ |+|||..|++||+|||
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPd-----------NlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPD-----------NLLIDAKGHIKLSDFG 286 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChh-----------heeecCCCCEeecccc
Confidence 99999999999999999999999999999999999999999 999999999 9999999999999999
Q ss_pred Ccccccc--------------------CC-CCC-----c--------------------ccCCCCCcccCCcccCCCCCC
Q 012164 310 VSKLLTV--------------------KE-DRP-----L--------------------TCQDTSCRYVAPEVFKNEEYD 343 (469)
Q Consensus 310 la~~~~~--------------------~~-~~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~ 343 (469)
|+.-+.. .. ... . -...|||.|+|||++.+.+|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 9853211 00 000 0 134699999999999999999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 012164 344 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 420 (469)
Q Consensus 344 ~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 420 (469)
..+|.||||||||||+.|-+||...++.+....+......-..+.....++++.+||.+||. ||++|.. ++||-+|
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 99999999999999999999999999988888776655332223334567899999999999 9999964 7777766
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=316.32 Aligned_cols=248 Identities=27% Similarity=0.448 Sum_probs=205.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|...+.+|+|.||.||. +|+.||||+++.....+.-. ....+|+..|+.++|+||+.++++|...+.+.+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 577788999999999985 78999999998765433222 346779999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+ .+|..+++.+ ..+++..+..++.++++||+|||++. |+||||||. |+|++.+|.+||+|||
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPn-----------NLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPN-----------NLLISSDGQLKIADFG 146 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCcc-----------ceEEcCCCcEEeeccc
Confidence 995 6999999864 45999999999999999999999999 999999999 8899999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH-hhcCCCCC--
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-AARQRPPF-- 385 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~-- 385 (469)
+|+.+..... .......|.+|+|||.+.|. .|+...|+||.|||+.||+.|.+.|.+.++-+....+ ...+.|..
T Consensus 147 LAr~f~~p~~-~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 147 LARFFGSPNR-IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred chhccCCCCc-ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence 9998875432 23334678999999998775 8999999999999999999999999888775544333 12222110
Q ss_pred ---------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 386 ---------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 386 ---------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.......+.++.+|+..||..||.+|+|++|++++
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00123456778999999999999999999999988
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=343.08 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=210.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 228 (469)
.|+..++||+|+||.||. +|+.||+|++..+.... .......+|+.+|++|.||||+++.+...+. ..+|+|
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 688889999999999985 78999999998765433 3345567899999999999999999998876 689999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
+|||+. +|.-++...+ .+++.++..++.||+.||+|||.+| |+|||||.+ |||+|.+|.+||+|
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~S-----------NiLidn~G~LKiaD 261 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGS-----------NILIDNNGVLKIAD 261 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeecccccc-----------ceEEcCCCCEEecc
Confidence 999965 9999998754 5999999999999999999999999 999999999 99999999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-cCCC--
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRP-- 383 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~-- 383 (469)
||||+++........+....|.+|+|||.+.|. .|+.+.|+||.||||.||++|++.|++.+..+....|.. -+.+
T Consensus 262 FGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e 341 (560)
T KOG0600|consen 262 FGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE 341 (560)
T ss_pred ccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence 999998877666667778889999999999886 899999999999999999999999998876554433321 1111
Q ss_pred --------CC-------CC-------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 --------PF-------KA-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 --------~~-------~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+. .. ....++....+|+..+|..||.+|.||.+++..
T Consensus 342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 10 00 123567788999999999999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=342.85 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=204.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCC-ceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS-PMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv 228 (469)
+|+..++||.|+||.|+. +|..||||+++.......+ -.=.+|+.-|++++ ||||+++.+++.+.+ .+++|
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 788999999999999985 6889999999876554222 22357999999998 999999999998887 89999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||| .++|+++++.+. .++++.+..|+.||++||+|+|.+| +.|||+||+ |||+.....+||+|
T Consensus 89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPE-----------NiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPE-----------NILISGNDVIKIAD 153 (538)
T ss_pred HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChh-----------heEecccceeEecc
Confidence 9999 679999998754 4999999999999999999999999 999999999 77888888999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH-hhcCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-AARQRPPF 385 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~ 385 (469)
||+|+...+. .+.+.+..|.+|+|||++.. +.|+.+.|+|++|||++|+++-++.|.+.+..+....+ ...+.+..
T Consensus 154 FGLARev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 154 FGLAREVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK 231 (538)
T ss_pred cccccccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence 9999976543 34466788999999999754 58899999999999999999999999887664432222 11121111
Q ss_pred -------------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 386 -------------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 386 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+..+.++.++|.+|++.||.+||||++++++
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 01123477899999999999999999999999988
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=343.77 Aligned_cols=268 Identities=33% Similarity=0.522 Sum_probs=212.2
Q ss_pred CCccccCCCCcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 012164 145 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (469)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 220 (469)
++..++..++.+|...+.||+|+||.||. +|..||||++....... ..+|.+|+.++.+++|||+++++|||.
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 44556667777899999999999999984 45899999877543321 345999999999999999999999999
Q ss_pred eCCc-eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 221 QSSP-MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 221 ~~~~-~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
+.+. .+||+|||++|+|.+++.... .++|..+.+|+.++|+||+|||+..+.+||||||||+ |||+
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss-----------NILL 210 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS-----------NILL 210 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH-----------HeeE
Confidence 9884 999999999999999998654 7999999999999999999999988778999999999 9999
Q ss_pred CCCCCeEEeecCCccccccCCCCCcccC-CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--CCc-H
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH--DNE-V 373 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~--~~~-~ 373 (469)
|++..+||+|||+|+..+.. ....... .||.+|+|||++..+..+.|+|||||||++.|++||+.|..... ... .
T Consensus 211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 99999999999999765431 1111112 79999999999998999999999999999999999998887543 111 1
Q ss_pred HH---HHhhcC------CCCCC--CChh-hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 374 PK---AYAARQ------RPPFK--APAK-LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 374 ~~---~~~~~~------~~~~~--~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.. .....+ .+.+. .... ..-..+..+..+|++.+|.+||++.++++.|+.+...
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 11 111111 11111 1110 1223477788899999999999999999988665443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=332.64 Aligned_cols=256 Identities=20% Similarity=0.321 Sum_probs=213.0
Q ss_pred cCCCCcccccceeeecCeEEEEE---EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe----C
Q 012164 150 IDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S 222 (469)
Q Consensus 150 ~~~~~~~~~~~~~ig~G~~~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~ 222 (469)
++..+++......||+|+++.++ ++|+.||||.+...........+.+.+|+.++++++||||+++++++.+ .
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 44445555555689999998775 5899999999986654444556788899999999999999999999876 3
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
...++||||+++|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+ ||+++.++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~-----------nill~~~~ 160 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSV-----------SFLVTENY 160 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChh-----------hEEECCCC
Confidence 46899999999999999999888899999999999999999999985 6 889999999 88889999
Q ss_pred CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 302 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..++...+..
T Consensus 161 ~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~ 236 (283)
T PHA02988 161 KLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN 236 (283)
T ss_pred cEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 99999999997644221 22457889999999976 6889999999999999999999999997766565555433
Q ss_pred cC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 380 RQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 380 ~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
.. +++. +..+++.+.+|+.+||+.||++|||++++++.|+.++.
T Consensus 237 ~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 237 KNNSLKL---PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCCCCC---CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 33 2222 23568899999999999999999999999999998764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=315.10 Aligned_cols=275 Identities=22% Similarity=0.347 Sum_probs=230.5
Q ss_pred cccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
..|+..+.||+|.|..|+ -+|+.+|+|.+...++... ..+++.+|+.+-+.|+||||+++.+.+.+....|+|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 367788899999998775 3899999999987766544 4578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+|+|++|-.-+-.+-..++..+..+.+||++||.|+|.++ |||||+||.|+++.+.+ ...-+||+|||
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~--------~~A~vKL~~FG 158 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKA--------KGAAVKLADFG 158 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeecc--------CCCceeecccc
Confidence 99999999766655555788889999999999999999999 99999999966665322 23469999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+|.... .....-...|||.|||||++...+|+..+|||+-||++|-|+.|++||.+.+...+.+.+......-..+.+
T Consensus 159 vAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w 236 (355)
T KOG0033|consen 159 LAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW 236 (355)
T ss_pred eEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc
Confidence 998876 334445578999999999999999999999999999999999999999998888888888665543334457
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccchhhhhhhcch
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFH 443 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~~~~~~~~~ 443 (469)
.+++++.++|+++||..||.+|.|+.|+|+|=.-..++-..++.....+.++++
T Consensus 237 ~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lr 290 (355)
T KOG0033|consen 237 DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLK 290 (355)
T ss_pred CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHH
Confidence 789999999999999999999999999999866655555555555555555543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.19 Aligned_cols=252 Identities=35% Similarity=0.544 Sum_probs=210.4
Q ss_pred ccccCCCCcccccceeeecCeEEEEE---EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 223 (469)
.|||...++ ...+-||.|+.|.|+ +.++.||||+++.- -..+++.|++|+||||+.|.|+|....
T Consensus 118 ~WeiPFe~I--sELeWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEI--SELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHh--hhhhhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 455554432 345678999998876 46899999987522 234789999999999999999999888
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
-+|||||||..|.|..+|+....+++.....|..+||.||.|||.+. |||||||.- ||||+.+..|
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSP-----------NiLIs~~d~V 251 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSP-----------NILISYDDVV 251 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCC-----------ceEeeccceE
Confidence 89999999999999999999889999999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
||+|||-++..... ...-.++||..|||||++.+.+++.|+||||||||||||+||..||.+.+...+..-+-.. ..
T Consensus 252 KIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN-sL 328 (904)
T KOG4721|consen 252 KISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN-SL 328 (904)
T ss_pred EeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC-cc
Confidence 99999999876533 2234578999999999999999999999999999999999999999876654443322111 11
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
. .+.+..+|+.++-||+.||+..|.+||++.+++.||+-....+
T Consensus 329 ~-LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 329 H-LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred c-ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 1 1235678999999999999999999999999999997664443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=343.53 Aligned_cols=244 Identities=27% Similarity=0.505 Sum_probs=214.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|-+.+.||+|+||.||. +.+.||+|.+.+... .+.....+.+|+++++.++||||+.+++.|+...++|+|.|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 566778999999999985 568899999886653 45567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||.| +|..++...+.++++.+..++.|++.||.|||+++ |+|||+||. |||++..|.+|++|||+
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPq-----------niLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQ-----------NILLEKGGTLKLCDFGL 146 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcc-----------eeeecCCCceeechhhh
Confidence 9955 99999999999999999999999999999999999 999999999 99999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+.+... ....+...|||.|||||...+++|+..+|+|||||++||+++|++||...+-.+....+...... ++.
T Consensus 147 Ar~m~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~----~p~ 221 (808)
T KOG0597|consen 147 ARAMSTN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK----PPS 221 (808)
T ss_pred hhhcccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC----Ccc
Confidence 9987643 34456678999999999999999999999999999999999999999865554444444333222 234
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+..+.+|++.+|.+||..|.|..+++.|
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 788899999999999999999999999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.71 Aligned_cols=254 Identities=28% Similarity=0.469 Sum_probs=203.8
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC-C
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~ 223 (469)
+|++.+.||+|+||.||.. +..||+|.+.... .......+.+|+.+++.+ +||||+++++++... .
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 5777889999999998742 3579999987432 234456789999999999 899999999988764 4
Q ss_pred ceEEEEeccCCCCHHHHHHhc-----------------------------------------------------------
Q 012164 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~----------------------------------------------------------- 244 (469)
.++++|||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999999752
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCC-
Q 012164 245 ---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR- 320 (469)
Q Consensus 245 ---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~- 320 (469)
..+++..+..++.||+.||+|||+.+ |+||||||+ ||+++.++.+||+|||+++........
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~-----------Nil~~~~~~~kl~DfG~a~~~~~~~~~~ 231 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAAR-----------NILLSENNVVKICDFGLARDIYKDPDYV 231 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccc-----------eEEEcCCCcEEEeecccccccccCcchh
Confidence 23677888999999999999999998 999999999 888888999999999999765322211
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHH
Q 012164 321 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 399 (469)
Q Consensus 321 ~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 399 (469)
......++..|+|||++.+..++.++|||||||++|||++ |..||......+........+... ..+..+++.+.+|
T Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 309 (338)
T cd05102 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--RAPENATPEIYRI 309 (338)
T ss_pred cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--CCCCCCCHHHHHH
Confidence 1122345678999999998899999999999999999997 999998765443322222222111 1234677889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 400 IEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 400 i~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+.+||+.||++|||+.++++.|+.+...
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=329.45 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=203.5
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|+..+.||+|+||.||. +|+.||+|.+.............+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 56778999999999874 5789999988755433333345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~-----------Nill~~~~~~kl~Dfg 147 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPE-----------NILLDDRGHIRISDLG 147 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHH-----------HEEECCCCCEEEeeCC
Confidence 9999999888643 35899999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+...........+
T Consensus 148 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05631 148 LAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYS 225 (285)
T ss_pred CcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCC
Confidence 997654221 223356899999999999999999999999999999999999999876554333322222212222234
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
..++.++.+|+.+||+.||++||+ ++++++|
T Consensus 226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 457889999999999999999997 8888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.62 Aligned_cols=246 Identities=26% Similarity=0.484 Sum_probs=216.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc-eEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 229 (469)
.|...+.+|+|+||.+++ .+..+++|.+.......+.. +...+|+.++++++||||+.+.+.|.+++. ++|||
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 577888999999998753 67899999998776655443 467889999999999999999999998887 99999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
+||+||+|.+.+++.+ .++++.+..++.|++.|+.|||+++ |+|||||+. ||+++.++.|||+|
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~-----------Nifltk~~~VkLgD 149 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCA-----------NIFLTKDKKVKLGD 149 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhh-----------hhhccccCceeecc
Confidence 9999999999998644 4999999999999999999999888 999999999 88888999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||+|+...... .......||+.||+||++.+.+|..|+|||||||++|||++-+++|...+-......+.... ..+
T Consensus 150 fGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---~~P 225 (426)
T KOG0589|consen 150 FGLAKILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---YSP 225 (426)
T ss_pred hhhhhhcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc---CCC
Confidence 99999876543 23455789999999999999999999999999999999999999999877766666665444 333
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..++.+++.+|..|+..+|..||++.+|+.+
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 467889999999999999999999999999987
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=321.31 Aligned_cols=249 Identities=29% Similarity=0.424 Sum_probs=204.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe-----CCce
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-----SSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 225 (469)
.|...+.||+|+||.|.. +|..||||++.... .+.-..++..+|+.+++.++|+||+.+++++.. -+.+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 344467899999998753 78999999997442 344555777889999999999999999999865 2568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
|+|+|+| +.+|.++++.+..++...+..++.||++||.|+|+.+ |+||||||+ |++++.++.+||
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPs-----------Nll~n~~c~lKI 166 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPS-----------NLLLNADCDLKI 166 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchh-----------heeeccCCCEEe
Confidence 9999999 6799999999888999999999999999999999999 999999999 888889999999
Q ss_pred eecCCccccccC-CCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh----
Q 012164 306 ADFGVSKLLTVK-EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---- 379 (469)
Q Consensus 306 ~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~---- 379 (469)
+|||+|+..... .....+.+..|.+|+|||++.+ ..|+...||||+|||+.||++|++.|.+.+.-+....+..
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 999999876532 1223356778999999999765 5899999999999999999999999988765432222211
Q ss_pred --------------------cC---CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 --------------------RQ---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 --------------------~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. +.++....++.++...+|+.+||..||.+|+|++|++.|
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 111122234677899999999999999999999999998
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=337.92 Aligned_cols=241 Identities=25% Similarity=0.399 Sum_probs=204.3
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~g 235 (469)
+.||+|+||.||. +|+.||+|.+.............+.+|+.++++++||||+++++++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999884 57899999987654444455567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccc
Q 012164 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315 (469)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~ 315 (469)
+|.+++...+.+++..+..++.||+.||+|||+.+ |+||||||+ ||+++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~-----------NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLE-----------NLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHH-----------HEEECCCCCEEEeeCCCCcccc
Confidence 99999998888999999999999999999999999 999999999 8888889999999999987532
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHH
Q 012164 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 395 (469)
Q Consensus 316 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (469)
.. ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ...+ +..++++
T Consensus 147 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~---p~~~~~~ 221 (323)
T cd05571 147 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRF---PRTLSPE 221 (323)
T ss_pred cC-CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCHH
Confidence 22 12223356899999999999989999999999999999999999999876554444444222 2222 3457889
Q ss_pred HHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 396 LKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 396 l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+.+||.+||+.||++|| ++.++++|
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=332.99 Aligned_cols=243 Identities=24% Similarity=0.409 Sum_probs=206.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+...........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 577888999999999874 578999999875433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++|+|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+ ||+++.++.+||+|||+
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-----------NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPE-----------NILLDKEGHIKLTDFGF 147 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHH-----------HeEECCCCCEEEEecCc
Confidence 9999999999998888999999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
++..... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ...+ +.
T Consensus 148 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~---~~ 219 (291)
T cd05612 148 AKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-KLEF---PR 219 (291)
T ss_pred chhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CcCC---Cc
Confidence 9765322 12346899999999999988999999999999999999999999877665555554332 2222 33
Q ss_pred hhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
.+++.+++||.+||+.||.+||+ ++++++|
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 45788999999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=306.64 Aligned_cols=246 Identities=26% Similarity=0.440 Sum_probs=218.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|.+++.||+|.||.||. ++-.||+|++.++.+.......++.+|+++.+.|+||||+++|++|.+...+|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 678889999999999985 567899999987766555666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|..+|+|...|. ..+++++.....++.|++.||.|+|..+ ||||||||+ |+|++..+.+|++||
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpe-----------nlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPE-----------NLLLGSAGELKIADF 168 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHH-----------HhccCCCCCeeccCC
Confidence 999999999998 5667999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|.+...+ .......+||..|.+||...+..++...|+|++|++.||++.|.+||......+....+..-... +
T Consensus 169 GwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-~--- 241 (281)
T KOG0580|consen 169 GWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-F--- 241 (281)
T ss_pred CceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-C---
Confidence 9997644 33345578999999999999999999999999999999999999999988877777666443321 1
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
+..++.+.+++|.+|+..+|.+|.+..++++|-.
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 3678899999999999999999999999998843
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=362.32 Aligned_cols=255 Identities=33% Similarity=0.565 Sum_probs=222.2
Q ss_pred ccccceeeecCeEEEEEE------ec----eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW------RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~------~g----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
..+....||+|.||.||. .| ..||||.+.+ ..+.....+|.+|..+|+.+.||||++++|++.+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 344567899999999984 22 4588888874 35677788999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 226 MIVTEYLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
+|++|||++|+|..||++. ..++...++.++.|||+|++||++++ +|||||..+ |+|++
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaR-----------NCLL~ 836 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAAR-----------NCLLD 836 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhh-----------heeec
Confidence 9999999999999999864 24899999999999999999999998 999999999 99999
Q ss_pred CCCCeEEeecCCccccccCCCCCcccC-CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHH
Q 012164 299 DSGNLKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKA 376 (469)
Q Consensus 299 ~~~~vkl~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~ 376 (469)
....|||+|||+|+.+........... .-+..|||||.+..+.++.|+|||||||++||++| |..||.+.++.++...
T Consensus 837 ~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~ 916 (1025)
T KOG1095|consen 837 ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD 916 (1025)
T ss_pred ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH
Confidence 999999999999995544433332222 34678999999999999999999999999999998 9999999999999887
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
+..+++.+. +..+|..+.++|..||+.+|++||++..|++.+..+.+...
T Consensus 917 ~~~ggRL~~---P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 917 VLEGGRLDP---PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHhCCccCC---CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 777776554 56788999999999999999999999999999999977743
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.33 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=220.6
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 228 (469)
.+|...+.||+|.||.|.. +++.+|||++++..+...+.++..+.|..++.... ||+++.++.+|...+++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 3788899999999999875 67899999999998888888999999999999885 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|||+.||++..+. ..+.+++..+..++..++.||.|||+++ ||+||||.+ |||+|.+|.+||+||
T Consensus 448 mey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLd-----------NiLLD~eGh~kiADF 512 (694)
T KOG0694|consen 448 MEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLD-----------NLLLDTEGHVKIADF 512 (694)
T ss_pred EEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchh-----------heEEcccCcEEeccc
Confidence 9999999954333 3467999999999999999999999999 999999999 999999999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|+++...... ....+.+||+.|||||++.+..|+...|.|||||+||||+.|..||.+.+.+++...+.......
T Consensus 513 GlcKe~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y---- 587 (694)
T KOG0694|consen 513 GLCKEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY---- 587 (694)
T ss_pred ccccccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC----
Confidence 9998755333 34566899999999999999999999999999999999999999999999999999886654322
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCH-----HHHHHH--HHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTF-----RQIITR--LESIN 425 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~--L~~~~ 425 (469)
|..++.+..++++++|.+||++|..+ .+|.+| ++.|.
T Consensus 588 P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 588 PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 45678899999999999999999754 666665 44443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.61 Aligned_cols=263 Identities=29% Similarity=0.534 Sum_probs=219.1
Q ss_pred CccccCCCCcccccceeeecCeEEEEEEe--ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 012164 146 PEYEIDPHELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (469)
Q Consensus 146 ~~~~~~~~~~~~~~~~~ig~G~~~~~~~~--g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 223 (469)
.+|+|...++ .....||+|.||.||.. .-.||||++..+... .+..+.|++|+.++++-+|.||+-|.|+|....
T Consensus 385 ~~WeIp~~ev--~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEV--LLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHh--hccceeccccccceeecccccceEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3566665543 45679999999999853 247999999987654 457899999999999999999999999998776
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC
Q 012164 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~ 302 (469)
. .||+.+|+|-+|+.+++-. -++...+.+.|++||++||.|||.++ |||||||.. ||++..++.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSn-----------NIFl~~~~k 526 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSN-----------NIFLHEDLK 526 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhcccc-----------ceEEccCCc
Confidence 5 9999999999999999753 34899999999999999999999999 999999999 888888999
Q ss_pred eEEeecCCccccccC-CCCCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh
Q 012164 303 LKVADFGVSKLLTVK-EDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 303 vkl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 378 (469)
|||+||||+.....- .........|...|||||++..+ +|+..+||||||+++|||++|..||.....+++...+
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV- 605 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV- 605 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-
Confidence 999999998654332 22233445688899999999643 8899999999999999999999999965555544333
Q ss_pred hcC--CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 379 ARQ--RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 379 ~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
..+ .+.......++++++++|+..||..++++||.+.+|+..|+.+..+
T Consensus 606 GrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 606 GRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 333 4555556678899999999999999999999999999999998886
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=337.43 Aligned_cols=243 Identities=25% Similarity=0.418 Sum_probs=207.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+...........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 688889999999999874 578999999875543334455678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++|+|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~-----------NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPE-----------NLLLDNKGHVKVTDFGF 164 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHH-----------HEEECCCCCEEEeeccC
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
++..... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. +..++ +.
T Consensus 165 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-~~~~~---p~ 236 (329)
T PTZ00263 165 AKKVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-GRLKF---PN 236 (329)
T ss_pred ceEcCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-CCcCC---CC
Confidence 9765422 1234689999999999998899999999999999999999999987655444444432 22222 23
Q ss_pred hhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
.++..+++||.+||+.||++||+ +++++.|
T Consensus 237 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 46788999999999999999997 7888877
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=313.81 Aligned_cols=248 Identities=28% Similarity=0.415 Sum_probs=203.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 228 (469)
+|+..+.|++|+||.||. +++.||+|+++.+.-...-- -...+|+.+|.+.+|||||.+-++.+.. +.+|+|
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP-ItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP-ITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc-chhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 688899999999999985 67899999998654222211 2346799999999999999998887644 679999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
||||+. +|..++.+.+ ++...++.-+..|+++|++|||.+. |+||||||+ |+|++..|.+||+|
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~S-----------NLLm~~~G~lKiaD 220 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTS-----------NLLLSHKGILKIAD 220 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchh-----------heeeccCCcEEecc
Confidence 999965 9999998765 6999999999999999999999999 999999999 88888999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh-hcCCCC-
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPP- 384 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~-~~~~~~- 384 (469)
||+|+.++.. ....+....|.+|+|||.+.+. .|+++.|+||+|||+.||+++++.|.+.+.......+. ..+.+.
T Consensus 221 FGLAR~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 221 FGLAREYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred cchhhhhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence 9999988754 3445567789999999999875 79999999999999999999999999887655444432 222110
Q ss_pred -----CCC---------------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 -----FKA---------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 -----~~~---------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.. ....+++.-.+|++.+|.+||.+|.|+++.|+|
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000 001145778899999999999999999999988
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=336.28 Aligned_cols=247 Identities=29% Similarity=0.453 Sum_probs=209.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||+|++.............+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 578889999999999874 478999999876544334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~-----------Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPE-----------NFLIDASGHIKLTDFGL 147 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHH-----------HEEECCCCCEEEEeCcC
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC----CCCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK 386 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~~ 386 (469)
+..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... .+...
T Consensus 148 a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 223 (333)
T cd05600 148 SKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD 223 (333)
T ss_pred Cccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Confidence 976432 2234568999999999999899999999999999999999999998776655544443221 11111
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+...+++++.+||.+||..+|++||++.++++|
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1123568899999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=332.18 Aligned_cols=241 Identities=24% Similarity=0.387 Sum_probs=204.0
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~g 235 (469)
+.||+|+||.||. +|..||+|.+.............+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999874 57899999987654444455667888999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccc
Q 012164 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315 (469)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~ 315 (469)
+|..++...+.+++..+..++.||+.||.|||+++ |+||||||+ ||+++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLE-----------NLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHH-----------HEEEcCCCCEEecccHHhcccc
Confidence 99999988888999999999999999999999999 999999999 8888889999999999987532
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHH
Q 012164 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 395 (469)
Q Consensus 316 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (469)
.. ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... .. .+..++++
T Consensus 147 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~---~p~~~~~~ 221 (323)
T cd05595 147 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IR---FPRTLSPE 221 (323)
T ss_pred CC-CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CC---CCCCCCHH
Confidence 21 112233568999999999999899999999999999999999999998766555444443222 11 23457889
Q ss_pred HHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 396 LKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 396 l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+.+||.+||+.||++|| ++.++++|
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 99999999999999998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=331.36 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=222.9
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 227 (469)
...|+..+.||+|.||.|+. +|+.+|+|.+.+...........+.+|+.+|++++ ||||+.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 34688889999999999874 68999999998876655555678999999999998 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||+|.||.|.+.+... .+++..+..++.|++.|+.|||+.| |+||||||+|+|+.... +.++.+|++|
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~-------~~~~~ik~~D 182 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKD-------EGSGRIKLID 182 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeecccc-------CCCCcEEEee
Confidence 99999999999999876 4999999999999999999999999 99999999977775221 1236899999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||+|..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+.......+......-...
T Consensus 183 FGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~ 260 (382)
T KOG0032|consen 183 FGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSE 260 (382)
T ss_pred CCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCC
Confidence 999998764 344566789999999999998999999999999999999999999999988888777776555444445
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
.+..++..+++||..|+..||.+|+|+.++++|-
T Consensus 261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred CccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 6778899999999999999999999999999983
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=336.11 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=207.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 577889999999999874 678999999886544344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++|+|.+++.+. +.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~-----------NIll~~~~~~kL~Dfg 147 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPE-----------NVLIDRTGHIKLADFG 147 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchH-----------heEECCCCCEEeccCC
Confidence 99999999999876 67999999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
++...............||+.|+|||++. +..++.++|||||||++|+|++|+.||...........+......
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 227 (330)
T cd05601 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227 (330)
T ss_pred CCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc
Confidence 99865433222223346899999999986 456788999999999999999999999876655544444332221
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+....+++.+.+|+..||. ||.+|||+.++++|
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1111223578899999999998 99999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=326.26 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=204.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC-----------CHHHHHHHHHHHHHHhcCCCCceeeEEeEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----------DDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 219 (469)
+|+..++||+|.||.|.+ +++.||||++.+.... .....++..+|+.+|++++|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 688999999999999864 6899999998764321 112235788999999999999999999999
Q ss_pred EeC--CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 220 TQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 220 ~~~--~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
.+. +.+|||+|||..|.+...=.....+.+.++++++++++.||+|||.+| ||||||||+ |+|+
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs-----------NLLl 243 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS-----------NLLL 243 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh-----------heEE
Confidence 764 689999999998877543332333899999999999999999999999 999999999 8899
Q ss_pred CCCCCeEEeecCCccccccCCCC----CcccCCCCCcccCCcccCCC---C-CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDR----PLTCQDTSCRYVAPEVFKNE---E-YDTKVDVFSFALILQEMIEGCPPFTMKH 369 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~---~-~~~~sDi~SlGvil~el~tg~~p~~~~~ 369 (469)
+.+|+|||+|||.+......... ......||+.|+|||.+.++ . .+.+.||||+||+||.|+.|+.||-+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 99999999999999876433211 12346799999999998773 2 3468999999999999999999998877
Q ss_pred CCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 370 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
..+....++.. ...++. .+...+.+++||.+||.+||++|.+..++..|....
T Consensus 324 ~~~l~~KIvn~-pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 324 ELELFDKIVND-PLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HHHHHHHHhcC-cccCCC-cccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 66666666443 222221 234678899999999999999999999999886544
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=318.30 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=207.2
Q ss_pred ccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|++.+.||+|+||.||. .+..||+|.+.... .......+.+|+.++++++||||+++++++......++
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 577888999999999863 25689999987542 33445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
||||+++|+|.+++... +.+++..++.++.|++.||+|||+.+ ++||||||+ ||+++.++.++++
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~-----------nili~~~~~~~l~ 149 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAH-----------KVLVNSDLVCKIS 149 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHh-----------hEEEcCCCcEEEC
Confidence 99999999999999864 46899999999999999999999998 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
|||.+...............++..|+|||.+.+..++.++|||||||++|++++ |+.||...+..+....+......+
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~- 228 (266)
T cd05064 150 GFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP- 228 (266)
T ss_pred CCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-
Confidence 999876532221111112334678999999998899999999999999999775 999998776665555553332322
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
.+..++..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 229 --~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 --APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 2456788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=337.88 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=205.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..+.||+|+||.||. +++.||+|.+.............+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 467788999999999975 578999999976554445556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++.+.+.+++..+..++.||+.||+|||+.+ |+||||||+ |||++.++.+||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~-----------Nili~~~~~~kL~DFGl 147 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPD-----------NILIDLDGHIKLTDFGL 147 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHH-----------HEEECCCCCEEEeeCcC
Confidence 9999999999998888999999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCC----------------------------------------------CCcccCCCCCcccCCcccCCCCCCC
Q 012164 311 SKLLTVKED----------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDT 344 (469)
Q Consensus 311 a~~~~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 344 (469)
++....... .......||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 754311000 0012246899999999999889999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHc--ccCCCCCCCHHHHHHH
Q 012164 345 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW--NEKPAKRPTFRQIITR 420 (469)
Q Consensus 345 ~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dp~~Rps~~~ll~~ 420 (469)
++|||||||++|||++|+.||...+..+....+.........+....+++++.+||.+|+ ..+|..||++++++.|
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999999999999999876655544444322211111223357889999999854 5566669999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=335.59 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=204.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|++.............+..|+.++++++||||+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 577889999999999874 578999999876543334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++.+.+.+++..+..++.|++.||+|||+++ |+||||||+ |||++.++.+||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~-----------NILi~~~~~vkL~DFGl 147 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPD-----------NLLLDSKGHVKLSDFGL 147 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHH-----------HeEECCCCCEEEeeccC
Confidence 9999999999998888999999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCC----------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHH
Q 012164 311 SKLLTVKED----------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 356 (469)
Q Consensus 311 a~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~ 356 (469)
++....... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 875432110 0012346899999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCCCcHHHHHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCC---CCCCHHHHHHH
Q 012164 357 EMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPA---KRPTFRQIITR 420 (469)
Q Consensus 357 el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~---~Rps~~~ll~~ 420 (469)
+|++|+.||.+.+..+....+.... ...++ ....++++++++|.+|+. +|. .||+++++++|
T Consensus 228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKKVMNWKETLIFP-PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCcCcccCC-CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 9999999998776655555554322 22221 122467889999998764 444 45899999988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.06 Aligned_cols=239 Identities=25% Similarity=0.382 Sum_probs=200.8
Q ss_pred eecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 163 ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
||+|+||.||. +++.||+|.+.............+..|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999874 4778999998765444445567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccC
Q 012164 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317 (469)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~ 317 (469)
.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~-----------Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPE-----------NILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHH-----------HeEECCCCcEEEEECcccccCccC
Confidence 999988888999999999999999999999999 999999999 888889999999999999753322
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHH
Q 012164 318 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 397 (469)
Q Consensus 318 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 397 (469)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ... .+..+++.+.
T Consensus 147 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~ 221 (312)
T cd05585 147 D-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLR---FPDGFDRDAK 221 (312)
T ss_pred C-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCC---CCCcCCHHHH
Confidence 1 1223356899999999999989999999999999999999999999876554444443222 222 2345788999
Q ss_pred HHHHHHcccCCCCCCC---HHHHHHH
Q 012164 398 ELIEECWNEKPAKRPT---FRQIITR 420 (469)
Q Consensus 398 ~li~~cl~~dp~~Rps---~~~ll~~ 420 (469)
+||.+||..||++||+ +.+++.|
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 9999999999999974 6777766
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=331.78 Aligned_cols=241 Identities=25% Similarity=0.397 Sum_probs=204.0
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~g 235 (469)
+.||+|+||.||. +|+.||+|.+.............+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999874 57899999987654444555677889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccc
Q 012164 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315 (469)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~ 315 (469)
+|.+++...+.+++..+..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~-----------NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLE-----------NLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHH-----------HeEECCCCcEEEecCcCCccCC
Confidence 99999988888999999999999999999999999 999999999 8888899999999999987532
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHH
Q 012164 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 395 (469)
Q Consensus 316 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (469)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. .... .+..++++
T Consensus 147 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~---~p~~~~~~ 221 (328)
T cd05593 147 TD-AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EDIK---FPRTLSAD 221 (328)
T ss_pred Cc-ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-CCcc---CCCCCCHH
Confidence 21 1122335689999999999988999999999999999999999999987655444443322 2222 23457889
Q ss_pred HHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 396 LKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 396 l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+.+||.+||..||++|| ++.++++|
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999997 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=332.74 Aligned_cols=244 Identities=24% Similarity=0.392 Sum_probs=206.9
Q ss_pred cccccceeeecCeEEEEEEe------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~~------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
.+|+..+.||+|+||.||.. +..||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 36888899999999998741 257999988755443444556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|||+++|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ |||++.++.+||+||
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~-----------NILl~~~~~ikL~DF 175 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPE-----------NLLLDKDGFIKMTDF 175 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHH-----------HEEECCCCCEEEecC
Confidence 999999999999998888999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ...+
T Consensus 176 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~--- 247 (340)
T PTZ00426 176 GFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG-IIYF--- 247 (340)
T ss_pred CCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCC---
Confidence 999765321 22356899999999999888999999999999999999999999876554444444322 2221
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+..+++.+.++|++||+.||++|+ +++++++|
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 345678899999999999999995 89999877
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=337.14 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=206.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||||++.............+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 578889999999999874 578999999875543334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++...+.+++..+..++.|++.||+|||+.+ |+||||||+ |||++.++.+||+|||+
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~-----------NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPD-----------NLLLDAKGHIKLSDFGL 147 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHH-----------HeEECCCCCEEEeeccc
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCC-------------------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHH
Q 012164 311 SKLLTVKEDR-------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 353 (469)
Q Consensus 311 a~~~~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGv 353 (469)
++........ ......||+.|+|||++.+..++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 8754321100 001235899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 012164 354 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 420 (469)
Q Consensus 354 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 420 (469)
++|+|++|+.||...+..+....+..............+++++.+||.+|+. +|.+|++ +.++++|
T Consensus 228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999999999998776555444443322111111223567899999999996 9999998 9999887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=336.84 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=209.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||||++.............+..|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 577889999999999874 478999999876543333455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~-----------NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPD-----------NILIDADGHIKLADFGL 147 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH-----------HeEECCCCCEEeecCCC
Confidence 9999999999998888999999999999999999999998 999999999 88888999999999999
Q ss_pred ccccccCC----------------------------CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCC
Q 012164 311 SKLLTVKE----------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 362 (469)
Q Consensus 311 a~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~ 362 (469)
+....... ........||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 97654332 01123356899999999999999999999999999999999999
Q ss_pred CCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC-HHHHHHH
Q 012164 363 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT-FRQIITR 420 (469)
Q Consensus 363 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~ll~~ 420 (469)
.||......+....+.........+....+++.+.+||.+||. ||.+||+ ++++++|
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9998776555444443321111111122368899999999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=325.98 Aligned_cols=247 Identities=26% Similarity=0.448 Sum_probs=204.1
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.|+. +|..||+|.+.... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 34788899999999999874 57889999887542 344557799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|||+++++|.+++...+.+++..+..++.|++.||.|||+.+ .|+||||||+ ||+++.++.+||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~-----------Nil~~~~~~~kl~Df 148 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPS-----------NILVNSRGEIKLCDF 148 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChh-----------hEEEcCCCcEEEccC
Confidence 999999999999998888999999999999999999999853 2999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh----------
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---------- 378 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~---------- 378 (469)
|++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......++...+.
T Consensus 149 g~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (331)
T cd06649 149 GVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGE 225 (331)
T ss_pred ccccccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCC
Confidence 998765322 2233568999999999999899999999999999999999999997544332211110
Q ss_pred ------------------------------------hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ------------------------------------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ------------------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+. .....+++++++||.+||+.||++|||++++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000010 1122467889999999999999999999999988
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=330.48 Aligned_cols=248 Identities=22% Similarity=0.388 Sum_probs=202.2
Q ss_pred ccccceeeecCeEEEEEE--------eceeehhhhcccccC-CCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 225 (469)
+|++.+.||+|+||.||. +|..||+|.+..... ......+.+..|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467889999999999874 468899998865322 12233456788999999995 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++||||+++|+|.+++.+++.+++..+..++.||+.||.|||+.+ |+||||||+ |||++.++.+||
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~-----------Nili~~~~~~kl 146 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLE-----------NILLDSEGHVVL 146 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHH-----------HeEECCCCCEEE
Confidence 999999999999999988888999999999999999999999999 999999999 888888999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh---hcC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---ARQ 381 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~---~~~ 381 (469)
+|||+++..............||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+. ...
T Consensus 147 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 226 (332)
T cd05614 147 TDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC 226 (332)
T ss_pred eeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC
Confidence 99999976543322223345689999999999865 47889999999999999999999997543322222121 122
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
.++ .+..+++.+.+++.+||+.||++|| +++++++|
T Consensus 227 ~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPP---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 222 2345788999999999999999999 78899877
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=323.03 Aligned_cols=250 Identities=21% Similarity=0.352 Sum_probs=200.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 577889999999998874 578899999875432 22334668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|++++.+..+......+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||+
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~-----------Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPE-----------NLLISHNDVLKLCDFGF 146 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEEcCCCcEEEeeccC
Confidence 9988777666555567999999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-C--------
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-Q-------- 381 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~-------- 381 (469)
+...............+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... +
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 147 ARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred cccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 9876433322333456889999999999888999999999999999999999999875443221111100 0
Q ss_pred ------------CCCCCC-------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 ------------RPPFKA-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ------------~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+.... ....++.++.+||.+||+.||++|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 012357789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=322.18 Aligned_cols=244 Identities=24% Similarity=0.461 Sum_probs=209.9
Q ss_pred cccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|...+.||+|-|++|. ++|..||||++.+.+..+ -....+.+|+++|+.++|||||++|++......+|+|+|+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 5566789999999875 589999999998876643 3446678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
-++|+|.+|+-++. .+.+..+.++++||+.|+.|+|+.+ +|||||||+||.+. ..-|.|||.|||+
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFF----------EKlGlVKLTDFGF 165 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFF----------EKLGLVKLTDFGF 165 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEe----------eecCceEeeeccc
Confidence 99999999996643 4999999999999999999999998 99999999965543 5678999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+..+.. .......+|+..|-|||++.+..|+ ++.||||||||+|-|++|++||+..++.+..-.+..-.. ..+
T Consensus 166 SNkf~P--G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY----tvP 239 (864)
T KOG4717|consen 166 SNKFQP--GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY----TVP 239 (864)
T ss_pred cccCCC--cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc----cCc
Confidence 976553 3455668899999999999999888 589999999999999999999998888776665532221 135
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..++.+.++||..||..||.+|-+.++|..+
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 7889999999999999999999999998754
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=333.98 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=205.9
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|..||+|.+.............+.+|+.+++.++||||+++++++.+....++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 3788889999999999874 57899999987543333344456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|||++|+|.+++.+. .+++..+..++.||+.||+|||+.+ |+||||||+ |||++.++.+||+|||
T Consensus 123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~-----------NILl~~~~~~kL~DfG 187 (370)
T cd05596 123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPD-----------NMLLDKSGHLKLADFG 187 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH-----------HEEEcCCCCEEEEecc
Confidence 999999999998754 5889999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
++...............||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+........
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 267 (370)
T cd05596 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT 267 (370)
T ss_pred ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC
Confidence 9976543322222345689999999998653 478899999999999999999999987665544444433221111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAK--RPTFRQIITR 420 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 420 (469)
.+....++.++.+||.+||+.+|++ |||++++++|
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1122357889999999999999998 9999999988
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=336.56 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=204.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||.+...........+.+.+|++++++++||||+++++++.+...+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 577889999999999984 678999998865433334556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++|+|.+++...+.+++..+..++.|++.||+|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~-----------NIll~~~~~~kl~DfGl 147 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPD-----------NILIDRGGHIKLSDFGL 147 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH-----------HEEECCCCCEEEeeccc
Confidence 9999999999988888999999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCC-------------C---------------------------------CcccCCCCCcccCCcccCCCCCCC
Q 012164 311 SKLLTVKED-------------R---------------------------------PLTCQDTSCRYVAPEVFKNEEYDT 344 (469)
Q Consensus 311 a~~~~~~~~-------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ 344 (469)
++.+..... . ......||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 863321000 0 001245899999999999989999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCC---CCHHHHHHH
Q 012164 345 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKR---PTFRQIITR 420 (469)
Q Consensus 345 ~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~ll~~ 420 (469)
++|||||||++|||++|+.||......+....+.... ...+ +....++.++.+||.+||. +|.+| +++.+++.|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCC-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999999999999998766544444443322 1121 1223567889999999997 67765 599999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=335.74 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=204.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..+.||+|+||.||. +++.||+|.+.............+.+|+.++++++||||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477889999999999875 578899999876543344556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++.+.+.+++..+..++.||+.||+|||+.+ |+||||||+ |||++.++.+||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~-----------NILl~~~g~~kL~DFGl 147 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPD-----------NILIDRDGHIKLTDFGL 147 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEECCCCCEEEeECCC
Confidence 9999999999988888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCC----------------------------------------------CCCcccCCCCCcccCCcccCCCCCCC
Q 012164 311 SKLLTVKE----------------------------------------------DRPLTCQDTSCRYVAPEVFKNEEYDT 344 (469)
Q Consensus 311 a~~~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 344 (469)
+....... ........||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 75321000 00011245899999999999989999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 012164 345 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 420 (469)
Q Consensus 345 ~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 420 (469)
++|||||||++|||++|+.||...+..+....+.........+....+++++.++|.+|+ .+|.+|++ +.+++.|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999999999999999876655444444332222111223457888999998876 59999997 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=304.38 Aligned_cols=249 Identities=25% Similarity=0.418 Sum_probs=212.7
Q ss_pred ccccceeeecCeEEEEE-----Eeceeehhhhccccc-----CCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCc
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV-----ISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 224 (469)
.|...+.||+|+-..+. .+|..+|+|++..-. .......+.-..|+.+|+++. ||+|+++.++++++..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 45667789999886553 478899999875321 112333456678999999995 9999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
+++|+|.|+.|.|.|++.+.-.+++++...|++|+++|++|||.++ ||||||||+ |||++++.++|
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpE-----------NILlddn~~i~ 163 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPE-----------NILLDDNMNIK 163 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChh-----------heeeccccceE
Confidence 9999999999999999998888999999999999999999999999 999999999 99999999999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 378 (469)
|+|||+|+.+.. .......+|||+|+|||.+.+ ..|+...|+|+.|||||-|+.|++||-.....-+...+.
T Consensus 164 isDFGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im 241 (411)
T KOG0599|consen 164 ISDFGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM 241 (411)
T ss_pred EeccceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence 999999988764 345566899999999999864 378889999999999999999999997655555556665
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+...-..+.+.+++.+.++||.+||+.||++|.|++|+|.|
T Consensus 242 eGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 242 EGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 555555556678899999999999999999999999999988
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=336.61 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=204.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||+|.+.............+.+|++++++++||||+++++.+.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 578889999999999874 578999999875433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++.+.+.+++..+..++.||+.||+|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~-----------Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPD-----------NILIDRDGHIKLTDFGL 147 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHH-----------HEEECCCCCEEEEeCCC
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCC------------------------------------------CCCcccCCCCCcccCCcccCCCCCCCchhH
Q 012164 311 SKLLTVKE------------------------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 348 (469)
Q Consensus 311 a~~~~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi 348 (469)
|..+.... ........||+.|+|||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 75321000 000112468999999999999899999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCC---CHHHHHHH
Q 012164 349 FSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP---TFRQIITR 420 (469)
Q Consensus 349 ~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~ll~~ 420 (469)
|||||++|+|++|+.||......+....+..............+++++.++|.+|+ .+|.+|+ ++.++++|
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999999999999877655444443322211111122357788999999977 5999999 99999988
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=330.18 Aligned_cols=241 Identities=25% Similarity=0.403 Sum_probs=203.1
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~g 235 (469)
+.||+|+||.||. +|..||+|.+.............+..|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999974 67899999988655444455567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
+|.+++...+.+++..+..++.||+.||.|||+ .+ |+||||||+ ||+++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~-----------NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLE-----------NLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCC-----------eEEECCCCCEEEecCCCCeec
Confidence 999999888889999999999999999999997 67 999999999 888889999999999998753
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ...+ +..+++
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~~~ 221 (325)
T cd05594 147 IKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRF---PRTLSP 221 (325)
T ss_pred CCC-CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCC---CCCCCH
Confidence 222 11223356899999999999889999999999999999999999999876654444443222 2222 345788
Q ss_pred HHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 395 GLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
++.+|+.+||+.||++|+ ++.++++|
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 999999999999999996 99999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=319.88 Aligned_cols=251 Identities=28% Similarity=0.477 Sum_probs=201.0
Q ss_pred ccccceeeecCeEEEEEE---------------------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceee
Q 012164 156 DFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---------------------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 214 (469)
+|+..+.||+|+||.||. ++..||+|.+.... .......+.+|+.++++++||||++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 577788999999999874 23469999887542 3455677999999999999999999
Q ss_pred EEeEEEeCCceEEEEeccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012164 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------------ALKPSTAVRFALDIARGMNYLHENKPVPII 275 (469)
Q Consensus 215 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 275 (469)
+++++.+.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986531 3577888999999999999999999 99
Q ss_pred ecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHH
Q 012164 276 HRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354 (469)
Q Consensus 276 H~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvi 354 (469)
||||||+ ||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||++
T Consensus 161 H~dlkp~-----------Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 229 (304)
T cd05096 161 HRDLATR-----------NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT 229 (304)
T ss_pred ccCcchh-----------heEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHH
Confidence 9999999 888888999999999999765332211 1122345778999999988899999999999999
Q ss_pred HHHHHh--CCCCCCCCCCCcHHHHHhh----cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 355 LQEMIE--GCPPFTMKHDNEVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 355 l~el~t--g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
+|+|++ +..||...+..+....... .........+..+++.+.+|+.+||+.||++|||+.++.+.|+
T Consensus 230 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 230 LWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 999986 6678887665544333211 1111111123456788999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=316.29 Aligned_cols=249 Identities=33% Similarity=0.556 Sum_probs=207.8
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|+..+.||+|+||.||.. ...||+|.+.... .......+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 5777889999999988741 2569999887442 345557789999999999999999999999988899
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccc
Q 012164 226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~ 289 (469)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~------- 153 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAAR------- 153 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccc-------
Confidence 9999999999999999764 34788899999999999999999999 999999999
Q ss_pred ccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 012164 290 QNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 367 (469)
Q Consensus 290 ~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~ 367 (469)
||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 154 ----Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 154 ----NCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred ----eEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 88888899999999999976533221 11223446788999999988899999999999999999998 9999988
Q ss_pred CCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 368 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
....+....+......+ .+..+++++.+|+.+||+.||.+||++.+++++|++
T Consensus 230 ~~~~~~~~~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 230 FSNQEVIEMIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCHHHHHHHHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 77666555554333222 245688999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=296.30 Aligned_cols=256 Identities=23% Similarity=0.408 Sum_probs=204.1
Q ss_pred CCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC----
Q 012164 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---- 223 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 223 (469)
.+.+|++.+.+|.|||..|+. ++..+|+|++.-. ..+..+..++|++..++++||||++++++...+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 345899999999999998875 6789999998644 3466678899999999999999999998875443
Q ss_pred -ceEEEEeccCCCCHHHHHHh---cC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 224 -PMMIVTEYLPKGDLRAFLKR---KG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 224 -~~~lv~E~~~~gsL~~~l~~---~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
..|+++.|...|||.+.+.. .+ .+++.+.+.|+.++++||++||+..+ |++||||||. |||++
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~-----------NILls 163 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPA-----------NILLS 163 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcc-----------eeEec
Confidence 48999999999999999975 23 59999999999999999999999985 7999999999 88888
Q ss_pred CCCCeEEeecCCccccccCCCCCc--------ccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 012164 299 DSGNLKVADFGVSKLLTVKEDRPL--------TCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTM 367 (469)
Q Consensus 299 ~~~~vkl~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~---~~~~~sDi~SlGvil~el~tg~~p~~~ 367 (469)
+++.++|.|||.+....-.-.... .....|..|+|||.+... ..+.++|||||||++|.|+.|.-||..
T Consensus 164 ~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 164 DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 899999999999876543211111 122468899999998643 567899999999999999999999964
Q ss_pred CCC--CcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 368 KHD--NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 368 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
... ..+...+... ...++. ...+++.+.+||++||+.||.+||++.+++.+++.+.
T Consensus 244 ~~~~GgSlaLAv~n~-q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 244 IYQQGGSLALAVQNA-QISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HhhcCCeEEEeeecc-ccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 322 1111122111 112221 2238999999999999999999999999999988764
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=318.76 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=203.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..+.||+|+||.||. +++.||+|.+.............+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 367788999999999874 578999999875443333334567789999999999999999999999899999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.++|+||
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~-----------Nil~~~~~~~~l~Df 146 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPE-----------NILLDDYGHIRISDL 146 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHH-----------HEEECCCCCEEEeeC
Confidence 99999999988653 35899999999999999999999999 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|++....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.+.........+...........
T Consensus 147 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd05605 147 GLAVEIPEGE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY 224 (285)
T ss_pred CCceecCCCC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc
Confidence 9997654221 11234678999999999988899999999999999999999999987655433332222111111122
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+..++..+.+|+.+||..||++|| +++++++|
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 345788999999999999999999 88888776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=326.05 Aligned_cols=241 Identities=24% Similarity=0.423 Sum_probs=200.9
Q ss_pred eeeecCeEEEEEE--------eceeehhhhcccccC-CCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 161 ~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+.||+|+||.||. +++.||+|.+..... ........+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999874 467899999875322 1223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||++
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~-----------Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPE-----------NILLDAQGHVKLTDFGLC 147 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HeEECCCCCEEEeeCcCC
Confidence 999999999998888999999999999999999999999 999999999 888889999999999998
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhh
Q 012164 312 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 391 (469)
Q Consensus 312 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (469)
+...... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+... .... +..
T Consensus 148 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-~~~~---~~~ 222 (323)
T cd05584 148 KESIHEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-KLNL---PPY 222 (323)
T ss_pred eecccCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC---CCC
Confidence 7533221 2223356899999999999888999999999999999999999999876554444444222 2222 345
Q ss_pred hHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 392 YARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 392 ~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+++.+.+||.+||+.||++|| ++.++++|
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 678899999999999999999 89999886
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=325.14 Aligned_cols=241 Identities=29% Similarity=0.478 Sum_probs=198.4
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. +++.||+|.+...........+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999874 4678999998765433334445566677777654 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||+++..
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~-----------Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLD-----------NVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHH-----------HeEECCCCCEEEccCcCCeEC
Confidence 999999988888999999999999999999999999 999999999 888889999999999999754
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ..+.. +..++.
T Consensus 147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~---~~~~~~ 221 (316)
T cd05592 147 MNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DRPHF---PRWISK 221 (316)
T ss_pred CCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCH
Confidence 3222 222345689999999999998999999999999999999999999987766555444432 22222 345778
Q ss_pred HHHHHHHHHcccCCCCCCCHH-HHHHH
Q 012164 395 GLKELIEECWNEKPAKRPTFR-QIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~~-~ll~~ 420 (469)
++.+|+.+||..||++||++. ++++|
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 899999999999999999875 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=317.02 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=197.1
Q ss_pred eecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 163 ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
||+|+||.||. +|+.||+|.+...........+.+..|+.+++.++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999874 5789999998765443334446678899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 238 RAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 238 ~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
.+++.. +..+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.++|+|||++..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-----------Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPE-----------NVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEECCCCCEEEeeCcccee
Confidence 988743 345899999999999999999999999 999999999 88888899999999999976
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhH
Q 012164 314 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 393 (469)
Q Consensus 314 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (469)
...... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......................+..++
T Consensus 147 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (280)
T cd05608 147 LKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFS 225 (280)
T ss_pred cCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCC
Confidence 543221 2233568899999999999999999999999999999999999997654332222221111111112234578
Q ss_pred HHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 394 RGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 394 ~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
..+.+++.+||+.||++|| +++++++|
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 8999999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.35 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=206.8
Q ss_pred CCCcccccceeeecCeEEEEEE-----e-ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 152 PHELDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~~~~-----~-g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+....|...+.||+|+||.||. + +..||+|.+... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 3444688999999999998874 2 567888876433 344456778899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 226 MIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
|+||||+++|+|.+++.. ...+++.++..++.|++.||.|||+.+ |+||||||+ ||+++.++
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~-----------NIll~~~~ 206 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSA-----------NIFLMPTG 206 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHH-----------hEEECCCC
Confidence 999999999999988754 345889999999999999999999998 999999999 88888999
Q ss_pred CeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc
Q 012164 302 NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 380 (469)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+...
T Consensus 207 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~ 286 (478)
T PTZ00267 207 IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286 (478)
T ss_pred cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 999999999986543221 1223456899999999999989999999999999999999999999876655555544433
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+. +..++.++.+||.+||..||++||++.+++.+
T Consensus 287 ~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 287 KYDPF---PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCC---CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 33322 34577899999999999999999999999865
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=328.84 Aligned_cols=251 Identities=28% Similarity=0.468 Sum_probs=202.1
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCc
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 224 (469)
+|+..+.||+|+||.||. ++..||||++..... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 577889999999999863 245899999874432 23446788999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-----------------------------------------------------------
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------------- 245 (469)
.++|||||++|+|.+++.+..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986421
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 246 ----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
.+++..+..++.||+.||.|||+.+ ++||||||+ ||+++.++.+||+|||
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~-----------Nill~~~~~~kl~DfG 259 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAAR-----------NILLTHGRITKICDFG 259 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchh-----------hEEEECCCcEEEecCc
Confidence 3677889999999999999999998 999999999 8888888999999999
Q ss_pred CccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 310 VSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 310 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
+++......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...............+....
T Consensus 260 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-- 337 (375)
T cd05104 260 LARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-- 337 (375)
T ss_pred cceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--
Confidence 997654322111 112334667999999999899999999999999999998 8999987654433333323222111
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
.+...+.++.+|+.+||+.||++|||++++++.|+..
T Consensus 338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1234577899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.40 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=200.5
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHH---hcCCCCceeeEEeEEEeCCceEEE
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL---QKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
|++.+.||+|+||.||. +|+.||||.+...........+.+..|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56678999999999874 5789999998765433344456677776665 566799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|||+++++|..++.. +.+++..+..++.||+.||.|||+.+ ++||||||+ ||+++.++.+||+||
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~-----------Nill~~~~~~kL~Df 145 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLD-----------NLLLDTEGFVKIADF 145 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHH-----------HeEECCCCcEEeCcc
Confidence 999999999988864 46999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|+++...... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.... .. .
T Consensus 146 g~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~---~ 220 (324)
T cd05589 146 GLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VR---Y 220 (324)
T ss_pred cCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC---C
Confidence 9987533221 22234568999999999999899999999999999999999999998766555554443322 11 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+..+++.+.++|.+||+.||.+|| ++.+++++
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 345788899999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.57 Aligned_cols=241 Identities=25% Similarity=0.406 Sum_probs=200.8
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. +++.||+|.+...........+.+..|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999874 5788999998765433334456677888888877 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+ ||+++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~-----------NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLD-----------NVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHH-----------HeEECCCCcEEEeeCCCCeec
Confidence 999999988888999999999999999999999999 999999999 888889999999999998753
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+.... .. .+..++.
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~---~~~~~~~ 221 (320)
T cd05590 147 IFN-GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VV---YPTWLSQ 221 (320)
T ss_pred CcC-CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CC---CCCCCCH
Confidence 222 122233568999999999998899999999999999999999999998776655555553322 22 2345778
Q ss_pred HHHHHHHHHcccCCCCCCCH------HHHHHH
Q 012164 395 GLKELIEECWNEKPAKRPTF------RQIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~------~~ll~~ 420 (469)
++.+|+.+||+.||++||++ ++++.|
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 99999999999999999998 666655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=327.66 Aligned_cols=252 Identities=28% Similarity=0.466 Sum_probs=203.4
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCc
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 224 (469)
+|+..+.||+|+||.||. ++..||+|++.... ..+....+.+|+.+++.+ +||||+++++++.....
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 678889999999998873 12479999987543 234456788999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc------------------------------------------------------------
Q 012164 225 MMIVTEYLPKGDLRAFLKRK------------------------------------------------------------ 244 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~------------------------------------------------------------ 244 (469)
.++|||||++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 245 ----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 245 ----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
..+++..+..++.||+.||.|||+.+ ++||||||+ ||+++.++.+||+|||+++..
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~-----------Nil~~~~~~~kL~DfGla~~~ 262 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAAR-----------NVLLTDGRVAKICDFGLARDI 262 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchh-----------eEEEeCCCeEEEeeceeeeec
Confidence 13677889999999999999999998 999999999 888888999999999999765
Q ss_pred ccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhh
Q 012164 315 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 392 (469)
Q Consensus 315 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (469)
...... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.................... .+..+
T Consensus 263 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 340 (374)
T cd05106 263 MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFA 340 (374)
T ss_pred cCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCC
Confidence 432111 1112234667999999988899999999999999999997 9999987654443333322221111 12345
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 393 ARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 393 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=325.04 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=198.3
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. +++.||+|.+.............+..|..+++.+ +||||+++++++.+...+++|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999874 5789999999866544455567788999999998 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||+++..
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~-----------Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLD-----------NVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHH-----------HeEECCCCCEEECcCcccccc
Confidence 999999988888999999999999999999999999 999999999 888888999999999998743
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--------cHHHHHhhcCCCCCC
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--------EVPKAYAARQRPPFK 386 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~ 386 (469)
... ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...... .............
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 223 (329)
T cd05588 147 IRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-- 223 (329)
T ss_pred ccC-CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--
Confidence 211 12223456899999999999989999999999999999999999999632211 1111111222222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCC------HHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPT------FRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps------~~~ll~~ 420 (469)
.+..++..+.++|.+||+.||.+||+ +.++++|
T Consensus 224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 23456788999999999999999997 6677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.31 Aligned_cols=241 Identities=27% Similarity=0.455 Sum_probs=197.9
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. +|..||+|.+.............+..|..++... +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 3689999999874 5788999998764332223345667788887754 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|.+++...+.+++..+..++.|++.||+|||+++ |+||||||+ ||+++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~-----------Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLD-----------NVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHH-----------HeEECCCCCEEeCccCCCeec
Confidence 999999988888999999999999999999999999 999999999 888889999999999998743
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... .+.. +..++.
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~---~~~~~~ 221 (316)
T cd05620 147 VFG-DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHY---PRWITK 221 (316)
T ss_pred ccC-CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCC---CCCCCH
Confidence 211 12223456899999999999989999999999999999999999999876655554444322 2222 334678
Q ss_pred HHHHHHHHHcccCCCCCCCHH-HHHHH
Q 012164 395 GLKELIEECWNEKPAKRPTFR-QIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~~-~ll~~ 420 (469)
++++||.+||..||++||++. ++++|
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 899999999999999999984 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=330.28 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=204.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +++.||+|.+.+...........+.+|+.+++.++||||+++++++.+...+++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4788889999999999874 57889999986543333344566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|||++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+ |||++.++.+||+|||
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~-----------NILl~~~~~~kL~DFG 187 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPD-----------NMLLDKHGHLKLADFG 187 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHH-----------HEEECCCCCEEEEecc
Confidence 999999999999754 5899999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC-CC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PP 384 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~ 384 (469)
++...............||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+..... ..
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 267 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN 267 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC
Confidence 9986543322222345689999999998754 377899999999999999999999987665444444433221 22
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAK--RPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 420 (469)
. +....++..+++++..|+..++.+ |+++.++++|
T Consensus 268 ~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 F-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 2 122356888999999999865544 8999999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.38 Aligned_cols=240 Identities=25% Similarity=0.388 Sum_probs=201.9
Q ss_pred eeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCCC
Q 012164 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (469)
Q Consensus 162 ~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~g 235 (469)
.||+|+||.||. +|+.||+|.+...........+.+..|.++++.+ +||||+++++++.+.+..|+||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 689999999874 4678999998765444445556778899998876 7999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccc
Q 012164 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315 (469)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~ 315 (469)
+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+ ||+++.++.+||+|||++....
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~-----------Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLD-----------NILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH-----------HeEECCCCCEEEeecccceecc
Confidence 99999988888999999999999999999999999 999999999 8888899999999999987533
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHH
Q 012164 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 395 (469)
Q Consensus 316 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (469)
... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... .. .+..++.+
T Consensus 148 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~---~p~~~~~~ 222 (321)
T cd05591 148 LNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VL---YPVWLSKE 222 (321)
T ss_pred cCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC---CCCCCCHH
Confidence 221 22233568999999999998899999999999999999999999998776655555543322 11 12346788
Q ss_pred HHHHHHHHcccCCCCCC-------CHHHHHHH
Q 012164 396 LKELIEECWNEKPAKRP-------TFRQIITR 420 (469)
Q Consensus 396 l~~li~~cl~~dp~~Rp-------s~~~ll~~ 420 (469)
+.+++.+||+.||++|| ++.++++|
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 99999999999999999 88888877
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=324.98 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=196.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-----Cce
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 225 (469)
+|+..+.||+|+||.||. +|..||||.+..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 477889999999998874 578999998864322 223345688999999999999999999988643 247
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
|+||||| +++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~-----------NIll~~~~~~kL 144 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPK-----------NILANADCKLKI 144 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HeEECCCCcEEE
Confidence 9999999 5799999988888999999999999999999999999 999999999 888889999999
Q ss_pred eecCCccccccCCC--CCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh---
Q 012164 306 ADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA--- 378 (469)
Q Consensus 306 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~--- 378 (469)
+|||+++....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~ 224 (338)
T cd07859 145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224 (338)
T ss_pred ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 99999975432211 11233568999999999876 578899999999999999999999997654322111110
Q ss_pred ------------------------hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ------------------------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....+.....+.+++.+.+++.+||+.||++|||++++++|
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000011111112456788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=323.19 Aligned_cols=246 Identities=28% Similarity=0.440 Sum_probs=203.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCC-CceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.||. +++.||+|.+...........+.+..|..++..+.| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 467788999999999875 467899999876544344455678889999999975 56888999999889999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++|+|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ |||++.++.+||+|||
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~-----------Nill~~~~~~kL~Dfg 146 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLD-----------NVMLDAEGHIKIADFG 146 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHH-----------HeEEcCCCCEEEeecC
Confidence 99999999999988888999999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++...... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ...+ +
T Consensus 147 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~~---~ 221 (324)
T cd05587 147 MCKENIFG-GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-NVSY---P 221 (324)
T ss_pred cceecCCC-CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCC---C
Confidence 98643221 11223356899999999999989999999999999999999999999876655555444322 2222 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCH-----HHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTF-----RQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~ 420 (469)
..+++++.+++.+||..||.+|++. .++++|
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 4578889999999999999999986 666655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=309.28 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=215.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..+.||+|..|.||+ ++..+|+|++.++.....+...+...|.+||+.+.||.++.+|..|+.++..|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 577788999999999986 458999999998877777778888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+||+|..+++++ +.+++..+..++.+++.||+|||-.| ||+|||||+ |||+-++|+|-|+||
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPE-----------NILvredGHIMLsDF 223 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPE-----------NILVREDGHIMLSDF 223 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcc-----------eeEEecCCcEEeeec
Confidence 99999999999865 35999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCC---------------------------------C----------------------CCcccCCCCCcccC
Q 012164 309 GVSKLLTVKE---------------------------------D----------------------RPLTCQDTSCRYVA 333 (469)
Q Consensus 309 gla~~~~~~~---------------------------------~----------------------~~~~~~~gt~~y~a 333 (469)
.|+....... . .....++||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 9976432100 0 00123468899999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 012164 334 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413 (469)
Q Consensus 334 PE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 413 (469)
||++.|...+.++|.|+|||++|||+.|+.||.+.+..+....+... ...++.. +.++..+++||+++|.+||++|..
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-~l~Fp~~-~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-PLKFPEE-PEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-CCcCCCC-CcchhHHHHHHHHHhccChhhhhc
Confidence 99999999999999999999999999999999999998887777443 3333222 367889999999999999999998
Q ss_pred ----HHHHHHH
Q 012164 414 ----FRQIITR 420 (469)
Q Consensus 414 ----~~~ll~~ 420 (469)
+.||-+|
T Consensus 382 ~~rGA~eIK~H 392 (459)
T KOG0610|consen 382 SKRGAAEIKRH 392 (459)
T ss_pred cccchHHhhcC
Confidence 8888776
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=323.73 Aligned_cols=241 Identities=27% Similarity=0.414 Sum_probs=196.4
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHH-HHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. +|+.||+|.+.............+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3689999999874 57899999987543333333344555555 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+ ||+++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~-----------NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPE-----------NILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHH-----------HeEECCCCcEEEeccCCCccc
Confidence 999999998888999999999999999999999999 999999999 888889999999999998753
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ... .+..+++
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~---~~~~~~~ 221 (323)
T cd05575 147 IEH-SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-PLR---LKPNISV 221 (323)
T ss_pred ccC-CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCC---CCCCCCH
Confidence 221 12223356899999999999989999999999999999999999999876655544444322 111 1235688
Q ss_pred HHHHHHHHHcccCCCCCCCHH----HHHHH
Q 012164 395 GLKELIEECWNEKPAKRPTFR----QIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~~----~ll~~ 420 (469)
.+.++|.+||+.||.+||++. +++++
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 999999999999999999984 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.07 Aligned_cols=245 Identities=32% Similarity=0.578 Sum_probs=202.2
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. .+..+|+|.+..... ....+.+|++++++++||||+++++++.+....+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 466678999999998874 345899998764422 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
+++|+|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||+
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~-----------ni~i~~~~~~kl~d~g~ 146 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAAR-----------NCLVSSTGVVKVSDFGM 146 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcc-----------eEEEcCCCeEEECCCCC
Confidence 999999999975 346899999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++..............++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.....+.. +
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~ 223 (256)
T cd05114 147 TRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---P 223 (256)
T ss_pred ccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---C
Confidence 87654322222222345668999999988889999999999999999999 9999987766555555544333222 2
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
...+..+.+++.+||..||++|||++++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 34567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=310.11 Aligned_cols=247 Identities=30% Similarity=0.532 Sum_probs=205.4
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..++||+|+||.||. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 677888999999998874 45679999876432 2346789999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+ ||+++.++.++|+|||
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~-----------nili~~~~~~~l~dfg 148 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAA-----------NVLVSESLMCKIADFG 148 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchh-----------hEEecCCCcEEECCCc
Confidence 9999999999753 45888999999999999999999998 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++...............++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+......+ .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~ 225 (261)
T cd05072 149 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP---R 225 (261)
T ss_pred cceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence 998654322222222345678999999988889999999999999999998 999998766555555443332222 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
...++.++.+++.+||..+|++||+++++++.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 24577889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=327.78 Aligned_cols=242 Identities=23% Similarity=0.307 Sum_probs=195.1
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|++.+.||+|+||.||. +++.||+|.... ..+.+|++++++++||||+++++++......++|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 4799999999999999875 578999996432 34678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|++ +++|..++.....+++..++.++.||+.||.|||+++ |+||||||+ ||+++.++.+||+|||
T Consensus 163 e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~-----------NIll~~~~~vkL~DFG 227 (391)
T PHA03212 163 PRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAE-----------NIFINHPGDVCLGDFG 227 (391)
T ss_pred ecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChH-----------hEEEcCCCCEEEEeCC
Confidence 999 5799999988778999999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--------cHHHHHhhcC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--------EVPKAYAARQ 381 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~--------~~~~~~~~~~ 381 (469)
+++..............||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .+...+...+
T Consensus 228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g 307 (391)
T PHA03212 228 AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG 307 (391)
T ss_pred cccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhc
Confidence 99754322222233457899999999999989999999999999999999999887532210 0100000000
Q ss_pred --------------------------CCCC-CCC---hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 --------------------------RPPF-KAP---AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 --------------------------~~~~-~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+. ... ...++.++.+||.+||+.||++|||++++++|
T Consensus 308 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred CChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 000 11346789999999999999999999999976
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=336.53 Aligned_cols=264 Identities=22% Similarity=0.375 Sum_probs=212.1
Q ss_pred CCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeE-EEe--
Q 012164 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGA-VTQ-- 221 (469)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~-~~~-- 221 (469)
.-...++++.+.|.+|||+.||. .|..||+|++-.. ++...+.+.+|+++|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 34455788899999999999986 3489999998643 6778899999999999997 9999999993 221
Q ss_pred -C---CceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 222 -S---SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 222 -~---~~~~lv~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
. -.++|+||||.||+|-|++.+ ...|++.++++|+.|+++|+.+||... .||||||||-+ |+
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiE-----------Nv 177 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIE-----------NV 177 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-Cccchhhhhhh-----------he
Confidence 1 247899999999999999985 345999999999999999999999987 47999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCCCCc--------ccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHHHHhCCCC
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKEDRPL--------TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPP 364 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~sDi~SlGvil~el~tg~~p 364 (469)
|++.+|..||||||.|........... .....|+.|+|||.+ .+.+.++|+|||+|||+||-|+..+.|
T Consensus 178 Lls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~P 257 (738)
T KOG1989|consen 178 LLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTP 257 (738)
T ss_pred EEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCC
Confidence 889999999999999864332211110 123469999999986 567899999999999999999999999
Q ss_pred CCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccchh
Q 012164 365 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWK 435 (469)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~ 435 (469)
|....... |..... .+ ++.+.++..+++||..||+.||++||++-+++.++-.+.......+...
T Consensus 258 Fe~sg~la----Ilng~Y-~~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 258 FEESGKLA----ILNGNY-SF-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred cCcCccee----EEeccc-cC-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 98653322 222221 11 1235789999999999999999999999999999999988865544333
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=323.33 Aligned_cols=241 Identities=27% Similarity=0.438 Sum_probs=201.5
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. ++..||+|.+.............+..|..+++.+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999874 4678999998765443444556778899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~-----------Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLD-----------NVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHH-----------HeEECCCCcEEecccCCCeec
Confidence 999999998888999999999999999999999999 999999999 888889999999999998653
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... .. .+..++.
T Consensus 147 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~~---~~~~~~~ 221 (318)
T cd05570 147 ILG-GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VR---YPRWLSK 221 (318)
T ss_pred CcC-CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CC---CCCcCCH
Confidence 221 112233458899999999999999999999999999999999999998766554444443222 21 2345778
Q ss_pred HHHHHHHHHcccCCCCCCCH-----HHHHHH
Q 012164 395 GLKELIEECWNEKPAKRPTF-----RQIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~-----~~ll~~ 420 (469)
.+.+||.+||..||++||++ .+++++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999999999 888766
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=322.78 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=204.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.||. +++.||+|.+.............+..|..++..+ +||+|+++++++.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 467788999999999874 4678999998765443344455677788888877 5899999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++|+|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ |||++.++.+||+|||
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~-----------Nill~~~~~~kL~DfG 146 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLD-----------NVMLDSEGHIKIADFG 146 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHH-----------HeEECCCCcEEEccCC
Confidence 99999999999988888999999999999999999999999 999999999 8888999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... .. .+
T Consensus 147 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~---~p 221 (323)
T cd05616 147 MCKENMWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VA---YP 221 (323)
T ss_pred CceecCCC-CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC---CC
Confidence 98754322 122234568999999999999999999999999999999999999998776655555543322 22 13
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCH-----HHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTF-----RQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~ 420 (469)
..+++++.+++.+||+.||++|++. .+++.|
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 4578899999999999999999984 666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=328.09 Aligned_cols=245 Identities=26% Similarity=0.472 Sum_probs=215.7
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
+..|+..++||.|+||.||+ +.+.||||++.-..-++.+..+.+..|+..|+++.|||++.+-|+|..+...|+|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34577788999999999986 6789999999866556666678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||| -||-.|++.- ++++.+-++..|+.+.+.||.|||+++ .||||||.. |||+++.|.|||+|
T Consensus 105 MEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAG-----------NILLse~g~VKLaD 169 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAG-----------NILLSEPGLVKLAD 169 (948)
T ss_pred HHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhcccc-----------ceEecCCCeeeecc
Confidence 9999 6799999975 356899999999999999999999999 999999999 99999999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
||.|..... ...+.|||.|||||++. .+.|+-++||||||+++.||...++|+.+++.......+.....|.
T Consensus 170 FGSAsi~~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt 244 (948)
T KOG0577|consen 170 FGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT 244 (948)
T ss_pred ccchhhcCc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC
Confidence 999876442 34578999999999985 4589999999999999999999999999998877777776555555
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+. ...++..+++|+..||++-|.+|||..+++.|
T Consensus 245 Lq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 245 LQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 53 56799999999999999999999999999877
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=308.44 Aligned_cols=252 Identities=24% Similarity=0.462 Sum_probs=207.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|..||||.+......+......+.+|+.+++.++||||+++++++...+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 577888999999998863 678999998765444455666778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 231 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+ ||+++.++.++|+
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~-----------nil~~~~~~~~l~ 148 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPA-----------NVFITATGVVKLG 148 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHH-----------HEEEcCCCCEEEC
Confidence 9999999998853 334888999999999999999999998 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--cHHHHHhhcCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPP 384 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~ 384 (469)
|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... .....+.....++
T Consensus 149 d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08228 149 DLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227 (267)
T ss_pred ccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC
Confidence 9999876543221 112345788999999998888899999999999999999999999754332 2222222222222
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
. ....++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 228 ~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 L--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 2 2345778899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=316.50 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=197.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.||. ++..||+|.+..... ......+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 588889999999999874 578999998864422 1223457789999999999999999999998889999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|++ ++|.+++...+ .++...+..++.||+.||+|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~-----------Nil~~~~~~~kl~DfG 148 (288)
T cd07871 84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQ-----------NLLINEKGELKLADFG 148 (288)
T ss_pred CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH-----------HEEECCCCCEEECcCc
Confidence 996 59999987654 4788999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CC----
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP---- 383 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~---- 383 (469)
+++...... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... .+
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 149 LARAKSVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred ceeeccCCC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 997643221 12233457889999999865 468899999999999999999999998765444332221110 00
Q ss_pred ----------------CC-----CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 ----------------PF-----KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ----------------~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. ......+++++.+||.+||..||.+|||++++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00112356789999999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=337.66 Aligned_cols=255 Identities=31% Similarity=0.530 Sum_probs=224.1
Q ss_pred cccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+.+.||.|.||.|+. ....||||.++.- ..+.....|..|+.||-+++||||+++.|+.......+||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45667899999999874 3468999999854 3566678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
.|||++|+|+.||.++ +.++..++..+++.|+.||+||.+.+ +|||||.+. |||++.+-.+|++|
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAAR-----------NILVNsnLvCKVsD 774 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAAR-----------NILVNSNLVCKVSD 774 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhh-----------heeeccceEEEecc
Confidence 9999999999999864 56999999999999999999999999 999999999 88888889999999
Q ss_pred cCCccccccCCCCCcccC--CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
||+++..........+.. .-+++|.|||.+...+++.+|||||+||+|||.++ |..||-+++++++...+..+.+.|
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP 854 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP 854 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC
Confidence 999997754432222222 23678999999999999999999999999999876 999999999999999997777765
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
. +..+|..|.+|+..||++|-.+||.+.+|+..|+++.++.+.
T Consensus 855 p---PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 855 P---PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred C---CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 4 567899999999999999999999999999999999888654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=319.83 Aligned_cols=245 Identities=27% Similarity=0.486 Sum_probs=201.9
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|..+|+|.+.... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4788889999999999875 57789999876542 3345567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+.+++|.+++...+.+++..+..++.|++.||.|||+. + ++|+||||+ ||+++.++.+||+||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~-----------Nili~~~~~~kL~Df 148 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPS-----------NILVNSRGEIKLCDF 148 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChh-----------hEEEcCCCCEEEeeC
Confidence 9999999999999888899999999999999999999975 5 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh----------
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---------- 378 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~---------- 378 (469)
|++...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 149 g~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (333)
T cd06650 149 GVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225 (333)
T ss_pred Ccchhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence 998754322 1223468899999999998889999999999999999999999997544332211110
Q ss_pred ----------------------------------hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ----------------------------------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ----------------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+.. ....++.++++|+.+||+.||++|||+.+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000 112356789999999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=308.98 Aligned_cols=248 Identities=29% Similarity=0.514 Sum_probs=204.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.++. .+..||+|.+... ......+.+|++++++++||||+++++++......+++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 466778999999998764 4788999987643 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+||
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~-----------nil~~~~~~~kl~df 148 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAAR-----------NCLVGENHLVKVADF 148 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcc-----------eEEEcCCCcEEeCCC
Confidence 99999999999753 34889999999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
|++................+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--- 225 (263)
T cd05052 149 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME--- 225 (263)
T ss_pred ccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---
Confidence 9997654322221122234567999999988899999999999999999998 999998765544444443222222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
.+..++.++.+++.+||..||++|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2356788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=322.78 Aligned_cols=249 Identities=27% Similarity=0.505 Sum_probs=217.7
Q ss_pred ccceeeecCeEEEEEE-------e--ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 158 TNSVEITKGTFILAFW-------R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 158 ~~~~~ig~G~~~~~~~-------~--g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
+..+.||.|-||-||. . ...||||.-+.+ .+.+..+.|..|..+|+.+.||||++++|+|.+ ...|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 3466899999998873 2 246999988765 345567899999999999999999999999976 578999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
||.++-|.|..|++.++ .++......++.||+.||.|||+.+ +|||||... |||+.....|||+|
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaR-----------NiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAAR-----------NILVSSPQCVKLAD 534 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhh-----------heeecCcceeeecc
Confidence 99999999999998765 4999999999999999999999998 999999999 77888888999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
||+++.+........+...-++.|||||.+.-..++.+||||-|||++||++. |..||.+..+.++.-.+..+.+.|.
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~- 613 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC- 613 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC-
Confidence 99999887655444444556788999999999999999999999999999876 9999999888887777777777776
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
++++|+.+..|+.+||++||.+||++.++...|..+..
T Consensus 614 --P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 614 --PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 56789999999999999999999999999999988866
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=323.02 Aligned_cols=236 Identities=26% Similarity=0.392 Sum_probs=192.4
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHH-HHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. +|+.||+|.+.............+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999874 57889999987543323333344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
++|...+...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~-----------NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPE-----------NILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHH-----------HeEECCCCCEEEccCCCCccC
Confidence 999999988788999999999999999999999998 999999999 888889999999999998753
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.. ..... +...+.
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~~~~~---~~~~~~ 221 (321)
T cd05603 147 VEP-EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-KPLQL---PGGKTV 221 (321)
T ss_pred CCC-CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCH
Confidence 221 1222345689999999999988999999999999999999999999987654444444322 22222 235677
Q ss_pred HHHHHHHHHcccCCCCCCCHH
Q 012164 395 GLKELIEECWNEKPAKRPTFR 415 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~~ 415 (469)
.+.+++.+||+.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=322.76 Aligned_cols=242 Identities=24% Similarity=0.400 Sum_probs=196.9
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. +++.||+|.+.............+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3689999999874 5788999999866544455566788899998877 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|..++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~-----------Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD-----------NVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHH-----------HEEECCCCCEEEeeCCccccc
Confidence 999999988888999999999999999999999999 999999999 888889999999999998753
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-----cH---HHHHhhcCCCCCC
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-----EV---PKAYAARQRPPFK 386 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-----~~---~~~~~~~~~~~~~ 386 (469)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .. ...........
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-- 223 (329)
T cd05618 147 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-- 223 (329)
T ss_pred cCC-CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC--
Confidence 221 11223356899999999999999999999999999999999999999532111 11 11111222222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCH------HHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTF------RQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~ 420 (469)
.+..++..+.+||.+||+.||++||++ .++++|
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 234567889999999999999999984 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=325.05 Aligned_cols=244 Identities=24% Similarity=0.385 Sum_probs=195.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||||.+.... .......+.+|+++++.++|+||+++++++...+.+++|||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 577788999999999874 47899999986432 33445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+. ....+..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~-----------NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPS-----------NLLINSAKNVKIADFGV 214 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHH-----------HEEEcCCCCEEEccccc
Confidence 9999998653 23567788899999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
++...... .......|+..|+|||.+.. ...+.++|||||||++|+|++|+.||......+.............
T Consensus 215 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 293 (353)
T PLN00034 215 SRILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP 293 (353)
T ss_pred ceeccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC
Confidence 98654321 12233568999999998743 2344689999999999999999999985444443332221111111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+..++.++.+||.+||+.||++|||+.++++|
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22234678899999999999999999999999987
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=310.06 Aligned_cols=244 Identities=27% Similarity=0.439 Sum_probs=211.0
Q ss_pred ccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
-|.+..+||+|+||.|+ .+|+.+|||.+..+ ..++++..|+.+|++..+|+||++||.+.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 36778899999999876 48999999988754 446889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||.-|+..+++. +++++++.++..+++..+.||+|||... -||||||.. |||++.+|.+||+|||
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAG-----------NILLNT~G~AKLADFG 174 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAG-----------NILLNTDGIAKLADFG 174 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccc-----------cEEEcccchhhhhhcc
Confidence 999999999997 4667999999999999999999999987 899999999 8888999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
.|-.....- .......||+.|||||++..-.|+.++||||||++..||..|++||.+..+....-.+ -...++....+
T Consensus 175 VAGQLTDTM-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-PT~PPPTF~KP 252 (502)
T KOG0574|consen 175 VAGQLTDTM-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-PTKPPPTFKKP 252 (502)
T ss_pred ccchhhhhH-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-cCCCCCCCCCh
Confidence 997654321 1224578999999999999999999999999999999999999999876553332222 23344444567
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.++.++.+|+++||.++|++|-|+-++++|
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 7899999999999999999999999999988
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=327.27 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=203.9
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|++.+.||+|+||.||. +++.||+|.+.............+.+|+.+++.++||||+++++++.+....++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4788899999999999874 57889999986543333344466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|||++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~-----------NIll~~~~~ikL~DfG 187 (371)
T cd05622 123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPD-----------NMLLDKSGHLKLADFG 187 (371)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHH-----------HEEECCCCCEEEEeCC
Confidence 999999999999754 5889999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
+++..............||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+........
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 267 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 267 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence 9986543322222345689999999998754 378899999999999999999999987665444444433322111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCC--CCCHHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAK--RPTFRQIITRL 421 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~L 421 (469)
.+....++..++++|..||..++.+ ||++.++++|.
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1223467889999999999844433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=320.69 Aligned_cols=241 Identities=27% Similarity=0.449 Sum_probs=197.7
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. +++.||+|.+.............+..|..+++.. +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3689999999874 4678999998765332233345566788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|.+++.....+++.++..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~-----------Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLD-----------NILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHH-----------HEEECCCCCEEEccCCcceEC
Confidence 999999988778999999999999999999999999 999999999 888888999999999998753
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... .+.. +..++.
T Consensus 147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~~---~~~~~~ 221 (316)
T cd05619 147 MLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-NPCY---PRWLTR 221 (316)
T ss_pred CCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCC---CccCCH
Confidence 2211 1223356899999999999889999999999999999999999999876655544444322 2221 234678
Q ss_pred HHHHHHHHHcccCCCCCCCHH-HHHHH
Q 012164 395 GLKELIEECWNEKPAKRPTFR-QIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~~-~ll~~ 420 (469)
++.+|+.+||..||++||++. ++++|
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 899999999999999999997 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=310.89 Aligned_cols=252 Identities=28% Similarity=0.505 Sum_probs=209.0
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|.+.+.||+|+||.+|.. +..+|+|.+... .......+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 5778889999999988742 356899987643 234456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccC
Q 012164 226 MIVTEYLPKGDLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~ 292 (469)
+++|||+++++|.+++...+ .+++..+..++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~---------- 149 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR---------- 149 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcc----------
Confidence 99999999999999997543 3899999999999999999999999 999999999
Q ss_pred cceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012164 293 RNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 370 (469)
Q Consensus 293 ~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~ 370 (469)
||+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 150 -Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 150 -NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred -eEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 88888999999999999976532211 11122335678999999998889999999999999999998 9999987665
Q ss_pred CcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 371 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.+....+........ +..++.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 229 ~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 229 NEVIECITQGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 555555543332222 345678899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=328.54 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=204.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.|+. +|+.||+|.+.............+..|+.++..++||||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 577788999999999874 578999999875443344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++.+.+.+++..+..++.|++.||+|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~-----------NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPD-----------NLLLDAKGHVKLSDFGL 147 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHH-----------HEEECCCCCEEEeeccC
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCC----------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHH
Q 012164 311 SKLLTVKED----------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 356 (469)
Q Consensus 311 a~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~ 356 (469)
+........ .......||+.|+|||++.+..++.++|||||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 875421100 0011346899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCcHHHHHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 012164 357 EMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 420 (469)
Q Consensus 357 el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 420 (469)
+|++|+.||...+..+....+.... ...++ ....+++++++||.+|+ .||.+|++ +.++++|
T Consensus 228 el~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 228 EMLIGYPPFCSETPQETYRKVMNWKETLVFP-PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred ecccCCCCCCCCCHHHHHHHHHcCCCceecC-CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9999999998776655555443322 11111 12236788999999987 49999985 6777777
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=313.94 Aligned_cols=244 Identities=36% Similarity=0.681 Sum_probs=197.9
Q ss_pred cceeeecCeEEEEEE---e------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 159 NSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 159 ~~~~ig~G~~~~~~~---~------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
..+.||.|.||.|+. . +..|+||.+... ...+..+.+.+|++.+++++||||++++|++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 457899999998764 3 678999999643 34455788999999999999999999999999888899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 230 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||++|+|.+++... ..+++..+..++.||+.||.|||+++ ++|++|+++ ||+++.++.+||+|
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~-----------nill~~~~~~Kl~~ 146 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPS-----------NILLDSNGQVKLSD 146 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGG-----------GEEEETTTEEEEES
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc---ccccccccc-----------cccccccccccccc
Confidence 999999999999986 56999999999999999999999998 999999999 88888999999999
Q ss_pred cCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 308 FGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 308 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
||++........ ...........|+|||.+.+..++.++||||||+++|||++ |+.||.+....++...+....+.+
T Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~- 225 (259)
T PF07714_consen 147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP- 225 (259)
T ss_dssp TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce-
Confidence 999987522111 11122346778999999988889999999999999999999 789998876666555554443433
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
.+..++..+.++|..||+.||++|||+.++++.|
T Consensus 226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2456788899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=306.51 Aligned_cols=250 Identities=32% Similarity=0.524 Sum_probs=207.6
Q ss_pred ccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|+..+.||+|+||.||.. ...||+|.+.... .......+..|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 5778889999999998741 3579999886442 34455678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
+|||+++++|.+++... +.+++..+..++.|++.||.|||+++ |+|+||||+ ||+++.++.++|+
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~-----------nili~~~~~~~l~ 148 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAAR-----------NILVNSNLVCKVS 148 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcc-----------eEEEcCCCCEEEC
Confidence 99999999999999764 46899999999999999999999998 999999999 8888899999999
Q ss_pred ecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 307 DFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 307 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......+
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 228 (266)
T cd05033 149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP 228 (266)
T ss_pred ccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999876421111 1122334678999999998899999999999999999998 999998766555555443332222
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
. +..+++.+.+++.+||+.+|++||++++++++|+.+
T Consensus 229 ~---~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 P---PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2 345788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=306.23 Aligned_cols=247 Identities=29% Similarity=0.496 Sum_probs=204.5
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 577788999999998874 457899999875432 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|||
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~~~~~l~dfg 148 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAAR-----------NVLVGENNICKVADFG 148 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcc-----------eEEEcCCCCEEECCcc
Confidence 99999999997644 5899999999999999999999998 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
+++...............+..|+|||.+.+..++.++||||||+++++|++ |+.||.+.........+......+ .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~ 225 (261)
T cd05068 149 LARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP---C 225 (261)
T ss_pred eEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence 998765222111111223457999999998899999999999999999999 999998766555444443332222 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
+..++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 34567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.37 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=203.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.|+. +++.||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 577889999999999874 578999999875433334445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~-----------Nill~~~~~~kl~Dfg 147 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPD-----------NVLLDKNGHIRLADFG 147 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHH-----------HEEECCCCCEEEEECC
Confidence 9999999999976 456999999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP 383 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~ 383 (469)
++...............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.... ..
T Consensus 148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 227 (331)
T cd05597 148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF 227 (331)
T ss_pred ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 987654332222223468999999999863 357789999999999999999999998765544444443222 22
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAK--RPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 420 (469)
........++..++++|.+|+..++++ ||++.++++|
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 232333457889999999988664444 7899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=306.56 Aligned_cols=246 Identities=30% Similarity=0.543 Sum_probs=201.6
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.+|. .+..||+|.+..... ....+.+|+.++++++||||+++++++.+....+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 567788999999998874 234699998864432 135688999999999999999999999988899999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||+
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~-----------nili~~~~~~kl~d~g~ 146 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAAR-----------NCLVDDQGCVKVSDFGL 146 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcc-----------eEEEcCCCCEEECCCcc
Confidence 9999999999764 35899999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++..............++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....+... +
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 223 (256)
T cd05113 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---P 223 (256)
T ss_pred ceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---C
Confidence 87654322111122335678999999988889999999999999999998 9999987665555444433333222 2
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
...+..+.+++.+||+.||++||++.+++..|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 345788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.30 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=203.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.|+. +++.||+|.+.............+.+|..+++.++|+||+++++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 578889999999998874 567899998875433333445668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++|+|.+++.+ .+.+++..+..++.|++.||+|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~-----------Nill~~~~~~kl~DfG 147 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPD-----------NVLLDMNGHIRLADFG 147 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchH-----------HEEEcCCCCEEEEecc
Confidence 9999999999987 457899999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP 383 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~ 383 (469)
++...............|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.... +.
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~ 227 (331)
T cd05624 148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 227 (331)
T ss_pred ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc
Confidence 997654332222233568999999999875 467889999999999999999999998765544444443322 23
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAK--RPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 420 (469)
+++.....+++++.+++.+|+..++++ |++++++++|
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 333333456889999999999876654 4689988877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=309.15 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=202.1
Q ss_pred cccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
.+|+..+.||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3678889999999998873 24679999876432 23344668899999999999999999999998899
Q ss_pred eEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcc
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~n 294 (469)
.++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+ |
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~-----------N 149 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAAR-----------N 149 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchh-----------e
Confidence 999999999999999997532 2567788999999999999999998 999999999 8
Q ss_pred eeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012164 295 ILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE 372 (469)
Q Consensus 295 il~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~ 372 (469)
|+++.++.++|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 150 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~ 229 (277)
T cd05062 150 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229 (277)
T ss_pred EEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 88888999999999998754322111 1112345678999999998889999999999999999999 789998766555
Q ss_pred HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 373 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
....+......+. +...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 230 ~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 5444433332222 3456788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=305.06 Aligned_cols=244 Identities=26% Similarity=0.437 Sum_probs=202.1
Q ss_pred eeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 162 ~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+||+|+||.||. ++..+|+|.+.... .+....+.+.+|+.+++.+.||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999998874 46889999886443 23445577899999999999999999999885 4567899999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
++|.+++...+.+++..+..++.|++.||+|||+.+ ++||||||. ||+++.++.+||+|||++...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~-----------nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAAR-----------NVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecccchh-----------hEEEcCCCeEEECCCcccccc
Confidence 999999988778999999999999999999999999 999999999 888888999999999999765
Q ss_pred ccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhh
Q 012164 315 TVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 391 (469)
Q Consensus 315 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (469)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......++...+.....++. +..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~ 222 (257)
T cd05116 146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC---PQR 222 (257)
T ss_pred CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCC
Confidence 4332211 112234578999999988888999999999999999998 9999987666555555544333332 345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 392 YARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 392 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
+++++.+||.+||+.||++||++.+|...|+.+
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=310.30 Aligned_cols=242 Identities=25% Similarity=0.388 Sum_probs=193.1
Q ss_pred eecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 163 ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
||+|+||.||. +|+.||+|.+.............+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999874 5789999988654332222334566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccc
Q 012164 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315 (469)
Q Consensus 238 ~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~ 315 (469)
.+++...+ .+++..+..++.|++.||+|||+.+ ++||||||+ ||+++.++.++|+|||++....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~-----------Nili~~~~~~~l~Dfg~~~~~~ 146 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPE-----------NVLLDDQGNCRLSDLGLAVELK 146 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChH-----------hEEEcCCCCEEEeeceeeeecC
Confidence 99886543 4888899999999999999999999 999999999 8888889999999999987654
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CCCCCCChhhhHH
Q 012164 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 394 (469)
Q Consensus 316 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 394 (469)
... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ..........+++
T Consensus 147 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (277)
T cd05607 147 DGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTE 224 (277)
T ss_pred CCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCH
Confidence 321 2233468889999999998889999999999999999999999997643322211111111 1111122345788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 395 GLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
++.+|+.+||+.||++||++.++++.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhh
Confidence 99999999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=309.54 Aligned_cols=248 Identities=29% Similarity=0.496 Sum_probs=205.6
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|...+.||+|+||.||.. +..||+|.+.... ..+..+.+.+|+++++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 5777889999999988742 3679999886542 333557899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc
Q 012164 226 MIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~ 291 (469)
+++|||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~--------- 151 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATR--------- 151 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccc---------
Confidence 99999999999999997643 3788899999999999999999999 999999999
Q ss_pred CcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 012164 292 DRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKH 369 (469)
Q Consensus 292 ~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~ 369 (469)
||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 152 --nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 152 --NCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred --eEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 88888899999999999975432221 11122345678999999999999999999999999999998 999998766
Q ss_pred CCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 370 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
..+....+....... .+..++..+.+++.+||..||++||++.++++.|+
T Consensus 230 ~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 230 NEEVIECITQGRLLQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 655555543222222 23457889999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=305.10 Aligned_cols=248 Identities=28% Similarity=0.453 Sum_probs=200.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCc-eeeEEeEEEeCC------
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSS------ 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~------ 223 (469)
.|...++||+|+||.||. +|+.||+|++..+... +-.-....+|+.+++.++|+| |+.+++++...+
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 467778899999999984 7899999999865331 111134678999999999999 999999998877
Q ss_pred ceEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
.+++|+||+ .-+|.+++...+ .++...+..+++||++||+|||+++ |+||||||+ |+|+++
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQ-----------NlLi~~ 155 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQ-----------NLLISS 155 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcc-----------eEEECC
Confidence 789999999 569999998754 4788899999999999999999999 999999999 888899
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 378 (469)
+|.+||+|||+|+.+... ....+...+|.+|+|||++.+. .|++..||||+|||++||++++..|.+.+..+....+.
T Consensus 156 ~G~lKlaDFGlAra~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If 234 (323)
T KOG0594|consen 156 SGVLKLADFGLARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIF 234 (323)
T ss_pred CCcEeeeccchHHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 999999999999865422 2334556789999999999887 89999999999999999999999999877644433331
Q ss_pred -hcCCCC----------------CCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 -ARQRPP----------------FKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 -~~~~~~----------------~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+.+. +.. ..+..+++..+++.+||+.+|.+|.|++.++.|
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 112110 000 011223578999999999999999999999998
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=311.15 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=200.9
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|+..+.||+|+||.||. +++.||+|.+.............+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 56678899999999875 5789999988765444444445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+.+++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.++|+|||
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~-----------Nil~~~~~~~~l~Dfg 147 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPE-----------NILLDDHGHIRISDLG 147 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHH-----------HEEECCCCCEEEeecc
Confidence 99999999986533 4899999999999999999999998 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......................+
T Consensus 148 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05630 148 LAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS 225 (285)
T ss_pred ceeecCCCc--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcC
Confidence 987643221 112346889999999999989999999999999999999999999865433221111111000011123
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
..+++++.+|+.+||+.||++||| ++++++|
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 457788999999999999999999 8888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=309.36 Aligned_cols=252 Identities=28% Similarity=0.492 Sum_probs=207.8
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|...+.||+|+||.+|.. +..+++|.+... .....+.+.+|++++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 4667789999999988742 346888887643 234446788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccc
Q 012164 226 MIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~ 289 (469)
++||||+++++|.+++..++ .+++..++.++.||+.||+|||+++ ++||||||+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~------- 152 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATR------- 152 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcc-------
Confidence 99999999999999997542 3788999999999999999999999 999999999
Q ss_pred ccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 012164 290 QNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 367 (469)
Q Consensus 290 ~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~ 367 (469)
||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..
T Consensus 153 ----Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 153 ----NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred ----eEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 88888899999999999976543221 11223446788999999998899999999999999999998 9999987
Q ss_pred CCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 368 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
....+....+....... .+..++..+.+++.+||+.||++|||++++++.|+++...
T Consensus 229 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 229 LSNTEVIECITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCHHHHHHHHhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 66655554443332222 2344678899999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=304.92 Aligned_cols=249 Identities=27% Similarity=0.472 Sum_probs=204.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC--CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
+|+..+.||+|+||.+|. +++.||+|.+...... .....+.+.+|++++++++||||+++++++.+....+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 477788999999998874 5789999988644321 122346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
+||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+||
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~-----------nilv~~~~~~~l~df 148 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGA-----------NILRDSAGNVKLGDF 148 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEEcCCCCEEEeec
Confidence 999999999999998888999999999999999999999999 999999999 888888999999999
Q ss_pred CCccccccCCCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 309 GVSKLLTVKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 309 gla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|+++.......... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||................. ..
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~ 226 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NP 226 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC--CC
Confidence 99876543211111 234577899999999998899999999999999999999999986544333332222211 11
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+..++..+.++|.+||..+|++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 2344678899999999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=332.26 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=206.9
Q ss_pred CCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC----
Q 012164 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---- 223 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 223 (469)
...+|++.+.||+|+||.||. +|+.||||.+..... +......+.+|+.++..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345899999999999999874 578999999876543 3445567889999999999999999988775432
Q ss_pred ----ceEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 224 ----PMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 224 ----~~~lv~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+ ||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~-----------NI 174 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSA-----------NI 174 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH-----------HE
Confidence 368999999999999999753 35899999999999999999999998 999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~ 374 (469)
+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++.
T Consensus 175 Ll~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~ 254 (496)
T PTZ00283 175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254 (496)
T ss_pred EEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 888899999999999976543211 1223456899999999999989999999999999999999999999876655544
Q ss_pred HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+......+ .+..+++++.+++.+||+.||.+||++.+++.+
T Consensus 255 ~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HKTLAGRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 4443333332 245678899999999999999999999999876
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=308.54 Aligned_cols=249 Identities=30% Similarity=0.525 Sum_probs=203.7
Q ss_pred ccccceeeecCeEEEEEE---------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
+|+..+.||+|+||.||. .+..||+|.+... ........+.+|+.+++.++||||+++++++......|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 466778999999998874 3468999988743 23444567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccc
Q 012164 227 IVTEYLPKGDLRAFLKRK-----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~ 289 (469)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~------- 153 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAAR------- 153 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccc-------
Confidence 999999999999998532 23778889999999999999999999 999999999
Q ss_pred ccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 012164 290 QNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 367 (469)
Q Consensus 290 ~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~ 367 (469)
||+++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 154 ----nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 154 ----NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred ----eEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 88888899999999999976532221 11222345678999999988889999999999999999998 9999987
Q ss_pred CCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 368 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
.....+...+......+ .+..+++.+.+++.+||+.||++||++.+++++|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 230 FSNQEVIEMVRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 65544444443333222 234678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=309.29 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=205.2
Q ss_pred CCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC----
Q 012164 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---- 223 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 223 (469)
.++.|+..+.+|.|+||.||. ++..||||++-.+.- --.+|+++|+.+.|||||++.-+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 345788899999999999985 578999998764421 1246999999999999999988886432
Q ss_pred -ceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 224 -PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 224 -~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
.+.+|||||+ .+|.++++. +.+++...+.-+..||++||.|||+.+ |+||||||+ |+|+|
T Consensus 95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPq-----------NlLvD 159 (364)
T KOG0658|consen 95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQ-----------NLLVD 159 (364)
T ss_pred hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChh-----------eEEEc
Confidence 3568999996 599999984 567999999999999999999999999 999999999 77777
Q ss_pred CC-CCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 299 DS-GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 299 ~~-~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
.+ |.+||||||.|+..... .+...+..|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+.......
T Consensus 160 ~~tg~LKicDFGSAK~L~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~e 237 (364)
T KOG0658|consen 160 PDTGVLKICDFGSAKVLVKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVE 237 (364)
T ss_pred CCCCeEEeccCCcceeeccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHH
Confidence 65 89999999999987643 334557788999999999875 899999999999999999999999998776554333
Q ss_pred Hh-hcCCC------------------CCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHhhhh
Q 012164 377 YA-ARQRP------------------PFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINNSIN 429 (469)
Q Consensus 377 ~~-~~~~~------------------~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~~~~ 429 (469)
+. ..+.+ .+.. .....++++.+|+.++|..+|.+|.++.+++.| ++.+... +
T Consensus 238 Iik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~-~ 316 (364)
T KOG0658|consen 238 IIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP-N 316 (364)
T ss_pred HHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc-C
Confidence 31 11111 1100 234567899999999999999999999999977 5555444 4
Q ss_pred cccchhh
Q 012164 430 HKRRWKI 436 (469)
Q Consensus 430 ~~~~~~~ 436 (469)
.+..+..
T Consensus 317 ~~l~~g~ 323 (364)
T KOG0658|consen 317 TKLPNGR 323 (364)
T ss_pred ccCcCCC
Confidence 4444444
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.48 Aligned_cols=245 Identities=27% Similarity=0.420 Sum_probs=202.2
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEe
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E 230 (469)
|+..+.||+|+||.||. +|+.||+|.+...........+.+..|..+++.+. |++|+++++++.+.+.+++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 56678999999999974 57899999987654333444566788999998886 6788899999999899999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++|+|.+++...+.+++.++..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||+
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~-----------Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLD-----------NVMLDSEGHIKIADFGM 147 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH-----------HeEECCCCCEEEecccc
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... .. .+.
T Consensus 148 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~---~p~ 222 (323)
T cd05615 148 CKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VS---YPK 222 (323)
T ss_pred ccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC---CCc
Confidence 87543221 12233568999999999999899999999999999999999999998776555555443322 22 134
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCH-----HHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTF-----RQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~ 420 (469)
.++.++.+++.+||+.||.+|++. .++++|
T Consensus 223 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 223 SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 567889999999999999999984 455554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=312.08 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=193.4
Q ss_pred ccccceeeecCeEEEEEE------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC---CCCceeeEEeEEEe-----
Q 012164 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ----- 221 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~----- 221 (469)
+|+..+.||+|+||.||. +|..||+|.+....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 578889999999999874 35789999886543222 1223455677777665 69999999998852
Q ss_pred CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 222 ~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
...+++||||++ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~-----------Nil~~~ 145 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQ-----------NILVTS 145 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHH-----------HEEEcC
Confidence 356899999995 6999999753 34899999999999999999999999 999999999 888888
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
++.+||+|||+++..... .......+++.|+|||.+.+..++.++|||||||++|+|++|++||.+....+....+..
T Consensus 146 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 146 SGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred CCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 999999999999765432 222345689999999999888899999999999999999999999987665444333321
Q ss_pred cCCCCC-----------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 RQRPPF-----------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ~~~~~~-----------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+. ......+++.+.+|+.+||+.||++|||+.++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 110000 00012456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=318.49 Aligned_cols=242 Identities=24% Similarity=0.407 Sum_probs=198.3
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.|+. +++.||+|.+...........+.+..|..++.++ +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999874 5688999999876554455567788999999888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|.+++...+.+++..+..++.||+.||+|||+.+ ++||||||+ ||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~-----------Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLD-----------NVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH-----------HEEEeCCCCEEEeccccceec
Confidence 999999988888999999999999999999999999 999999999 888889999999999998753
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc------HHHHHhhcCCCCCCCC
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE------VPKAYAARQRPPFKAP 388 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 388 (469)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ............ .
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~ 222 (327)
T cd05617 147 LGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR---I 222 (327)
T ss_pred cCC-CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC---C
Confidence 221 122234568999999999999899999999999999999999999996432211 111221222222 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCH------HHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTF------RQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~ 420 (469)
+..++..+.+++.+||+.||++|+++ .++++|
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 34567889999999999999999984 566665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.57 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=203.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.|+. +++.||+|.+.+...........+.+|+.++..++|++|+++++++.+...+++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 577889999999998874 467899999865333333444568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++|+|.+++.+ .+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~-----------Nili~~~~~~kL~DfG 147 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPD-----------NILMDMNGHIRLADFG 147 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHH-----------HEEECCCCCEEEeecc
Confidence 9999999999986 456899999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP 383 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~ 383 (469)
++...............||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+.... +.
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~ 227 (332)
T cd05623 148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 227 (332)
T ss_pred hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc
Confidence 98765433222223356899999999986 3467889999999999999999999998766555554443322 22
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAK--RPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 420 (469)
+.+.....+++++.+|+.+|+..++++ |+++.++++|
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 333334467889999999999765554 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=322.64 Aligned_cols=236 Identities=25% Similarity=0.372 Sum_probs=196.3
Q ss_pred eeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 161 ~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
+.||+|+||.||. +|+.||+|++...... ......+..|++++++++||||+++++++.+.+..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999998873 5789999998754322 223355778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcc
Q 012164 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312 (469)
Q Consensus 233 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~ 312 (469)
++|+|.+++.+...+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||+++
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-----------Nil~~~~~~~kL~Dfg~~~ 146 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPE-----------NILLDEEGHIKLTDFGLSK 146 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHH-----------HeEECCCCcEEEeeccCCc
Confidence 99999999988888999999999999999999999999 999999999 8888889999999999987
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhh
Q 012164 313 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 392 (469)
Q Consensus 313 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (469)
...... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......+....+... ... .+..+
T Consensus 147 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~-~~~---~p~~~ 221 (318)
T cd05582 147 ESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA-KLG---MPQFL 221 (318)
T ss_pred ccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-CCC---CCCCC
Confidence 643321 2223356899999999999888999999999999999999999999876554444444222 111 23456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHH
Q 012164 393 ARGLKELIEECWNEKPAKRPTFRQ 416 (469)
Q Consensus 393 ~~~l~~li~~cl~~dp~~Rps~~~ 416 (469)
++.+.+||.+||+.||++||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 788999999999999999999444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=309.79 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=201.8
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|+..+.||+|+||.||. +|+.||+|.+.............+.+|++++++++|+||+++++++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999875 5789999998765443334445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.++|+|||
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~-----------Nili~~~~~~kl~Dfg 147 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPE-----------NILLDDYGHIRISDLG 147 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHH-----------HEEECCCCCEEEecCC
Confidence 9999999988653 35999999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++...... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+............
T Consensus 148 ~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05632 148 LAVKIPEG--ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS 225 (285)
T ss_pred cceecCCC--CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccC
Confidence 98754322 1122346899999999999889999999999999999999999999876544333333221111111223
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
..++..+.+|+..||+.||++||+ +.+++.+
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 457788999999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=304.11 Aligned_cols=245 Identities=31% Similarity=0.562 Sum_probs=201.4
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. ++..+|+|.+...... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 577788999999998874 3457999987643321 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
+++++|.+++..+ +.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~-----------ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAAR-----------NCLVGEDNVVKVSDFGL 146 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHh-----------hEEECCCCcEEECCccc
Confidence 9999999999764 46899999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++..............++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+......+. +
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 223 (256)
T cd05059 147 ARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---P 223 (256)
T ss_pred ceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC---C
Confidence 87654222111112233457999999998899999999999999999998 8999987666555555433323222 2
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
..++..+.+++.+||..+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 34788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=310.92 Aligned_cols=265 Identities=28% Similarity=0.513 Sum_probs=212.3
Q ss_pred CCccccCCCCcccccceeeecCeEEEEEEe------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCc
Q 012164 145 VPEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN 211 (469)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~ig~G~~~~~~~~------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 211 (469)
.|.|++.. .+|.+.+.||+|+||.||.. +..+|+|.+.... .......+..|+++++.+ +|||
T Consensus 10 ~~~~~~~~--~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 10 DPRWEVPR--DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred CCcceeeh--HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCC
Confidence 34444432 36888999999999998742 2469999887542 234456788899999999 7999
Q ss_pred eeeEEeEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012164 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPII 275 (469)
Q Consensus 212 i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 275 (469)
|+++++++...+..++||||+++|+|.+++...+ .+++.++..++.|++.||+|||+.+ ++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~ 162 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CI 162 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999999997532 3788999999999999999999998 99
Q ss_pred ecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHH
Q 012164 276 HRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354 (469)
Q Consensus 276 H~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvi 354 (469)
||||||+ ||+++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++|||||||+
T Consensus 163 H~dlkp~-----------Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~ 231 (307)
T cd05098 163 HRDLAAR-----------NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 231 (307)
T ss_pred cccccHH-----------heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHH
Confidence 9999999 8888889999999999987654221111 111224568999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 355 LQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 355 l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
+|+|++ |..||......+....+......+ .+..++.++.+|+.+||..+|++|||+.++++.|+.+......
T Consensus 232 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 232 LWEIFTLGGSPYPGVPVEELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred HHHHHcCCCCCCCcCCHHHHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 999998 899997655444444443332222 2345678999999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=313.39 Aligned_cols=248 Identities=25% Similarity=0.454 Sum_probs=193.9
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|++.+.||+|+||.||. +|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3688889999999999874 578999999874422 122245678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+ .++|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+ ||+++.++.+||+||
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~-----------Nill~~~~~~kl~Df 147 (303)
T cd07869 83 EYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQ-----------NLLISDTGELKLADF 147 (303)
T ss_pred ECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEECCCCCEEECCC
Confidence 999 46888887654 56899999999999999999999999 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH-HHHH-hhcCCCC-
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAY-AARQRPP- 384 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~-~~~~-~~~~~~~- 384 (469)
|++...... ........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... ...+ ...+.+.
T Consensus 148 g~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
T cd07869 148 GLARAKSVP-SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNE 226 (303)
T ss_pred CcceeccCC-CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCCh
Confidence 998754322 122233567899999999865 4678899999999999999999999986543211 1111 0000000
Q ss_pred -----------CC-------C--------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 -----------FK-------A--------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 -----------~~-------~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. . ....+++.+.+|+.+||+.||++|||+.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 0 001234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=305.25 Aligned_cols=253 Identities=25% Similarity=0.487 Sum_probs=207.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|..||||.+......+......+.+|+.+++.++||||+++++++...+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 567788999999998864 678999998875444445556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 231 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~-----------nili~~~~~~~l~ 148 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPA-----------NVFITATGVVKLG 148 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEEcCCCCEEEC
Confidence 9999999999864 345899999999999999999999999 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--cHHHHHhhcCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPP 384 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~ 384 (469)
|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... +....+.....++
T Consensus 149 dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08229 149 DLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227 (267)
T ss_pred cchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC
Confidence 9999876543221 122345788999999998888999999999999999999999999754332 1222221111222
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
. ....+++.+.+++.+||..||++|||+.++++.++++.
T Consensus 228 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 L--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 23457889999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=313.71 Aligned_cols=255 Identities=24% Similarity=0.485 Sum_probs=206.9
Q ss_pred CcccccceeeecCeEEEEEE-----ece----eehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
..+|+..+.||+|+||.||. +|. .||+|.+... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34688899999999999874 233 4899988643 2344557788999999999999999999999764 5
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.++++||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+.+ |+||||||+ ||+++.++.+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~-----------Nill~~~~~~ 148 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAAR-----------NVLVKTPQHV 148 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchh-----------heEecCCCcE
Confidence 689999999999999998743 5889999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 304 KVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....++...+....
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC
Confidence 999999998764322211 112234668999999999899999999999999999997 999998765544444333332
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
..+. +..++..+.+++.+||..||++||++.+++..|..+....
T Consensus 229 ~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 RLPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 3222 2346778999999999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.28 Aligned_cols=253 Identities=26% Similarity=0.454 Sum_probs=204.0
Q ss_pred cccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCC
Q 012164 155 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 223 (469)
.+|++.+.||+|+||.||.. +..||||++.... .....+.+.+|+++++++. ||||+++++++.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 36778899999999998742 2369999986542 3344567899999999996 999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc-----------------------------------------------------------
Q 012164 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~----------------------------------------------------------- 244 (469)
..++|||||++|+|.+++..+
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999988642
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccc
Q 012164 245 -------------------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVA 287 (469)
Q Consensus 245 -------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~ 287 (469)
..+++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~----- 266 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR----- 266 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH-----
Confidence 13677788899999999999999998 999999999
Q ss_pred ccccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 012164 288 YWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 365 (469)
Q Consensus 288 ~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~ 365 (469)
||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 267 ------Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~ 340 (400)
T cd05105 267 ------NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340 (400)
T ss_pred ------hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 888888999999999999765432211 1122346778999999998889999999999999999997 99999
Q ss_pred CCCCCCcHH-HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 366 TMKHDNEVP-KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 366 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
......... ..+....+.+ .+..++..+.+++.+||+.||++|||+.++.+.|+++..
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 341 PGMIVDSTFYNKIKSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred cccchhHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 865443332 2222222222 234578899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=301.95 Aligned_cols=243 Identities=30% Similarity=0.536 Sum_probs=198.9
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~g 235 (469)
+.||+|+||.||. +|+.||+|.+.... ..+....+.+|++++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3689999998874 57889999876432 3455577899999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 236 DLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 236 sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
+|.+++...+ .+++..++.++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||++...
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~-----------nil~~~~~~~kl~dfg~~~~~ 144 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAAR-----------NCLVTEKNVLKISDFGMSREE 144 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchh-----------eEEEcCCCcEEECccccCccc
Confidence 9999997644 5899999999999999999999998 999999999 888888999999999998754
Q ss_pred ccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhh
Q 012164 315 TVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 392 (469)
Q Consensus 315 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (469)
....... ......+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+......+. +..+
T Consensus 145 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 221 (252)
T cd05084 145 EDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC---PELC 221 (252)
T ss_pred ccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---cccC
Confidence 3211111 011123457999999998889999999999999999997 9999976655444444433323222 3456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 393 ARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 393 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
+..+.+|+.+||+.||++|||++++++.|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.93 Aligned_cols=253 Identities=29% Similarity=0.524 Sum_probs=205.9
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|+..+.||+|+||.||.. ...+++|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 3667789999999988752 2468888876442 234456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 012164 226 MIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 281 (469)
++++||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence 9999999999999998642 23778899999999999999999998 99999999
Q ss_pred CcccccccccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh
Q 012164 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 360 (469)
Q Consensus 282 ~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t 360 (469)
+ ||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++++|++
T Consensus 156 ~-----------nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t 224 (290)
T cd05045 156 R-----------NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224 (290)
T ss_pred h-----------eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence 9 888888999999999999754322211 1122345678999999988889999999999999999998
Q ss_pred -CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 361 -GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 361 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
|+.||.+....++..........+ .+..++.++.+++.+||+.||++||++.++++.|+++..+
T Consensus 225 ~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 225 LGGNPYPGIAPERLFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred cCCCCCCCCCHHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 999998766555544443322222 2345678999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=305.10 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=198.6
Q ss_pred cccceeeecCeEEEEEE---------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--Cce
Q 012164 157 FTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 225 (469)
|+..+.||+|+||.|+. ++..||+|.+.... .......+.+|+++++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 47788999999998853 46789999987542 223446788999999999999999999988654 358
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
+++|||+++++|.+++... .+++..+..++.|++.||.|||+++ ++|+||||+ ||+++.++.++|
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~-----------Nili~~~~~~~l 148 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAAR-----------NVLLDNDRLVKI 148 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChh-----------eEEEcCCCcEEE
Confidence 9999999999999999764 5999999999999999999999999 999999999 888888999999
Q ss_pred eecCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH--H-------
Q 012164 306 ADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV--P------- 374 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~--~------- 374 (469)
+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05080 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM 228 (283)
T ss_pred eecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc
Confidence 999999865432211 11223456679999999888899999999999999999999999865432110 0
Q ss_pred ---HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 375 ---KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 375 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
..............+..++..+.+++..||+.||++|||++++++.|+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000000000011123456789999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=306.29 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=201.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 688899999999998874 56889999886432 2233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||+
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~-----------nill~~~~~~~l~dfg~ 152 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGA-----------NILLTDNGDVKLADFGV 152 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHH-----------HEEECCCCCEEECcCcc
Confidence 9999999999988788999999999999999999999998 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CCCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK 386 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~ 386 (469)
+....... .......++..|+|||.+. ...++.++|+|||||++|+|++|+.||......+....+.... .++..
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 153 AAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred ceeecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence 97654221 1122345788999999884 3457789999999999999999999997554332222211111 11111
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
.....++..+.+||.+||..||++|||+++++++|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 12235678999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.94 Aligned_cols=243 Identities=25% Similarity=0.445 Sum_probs=199.4
Q ss_pred eeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 162 ~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
.||+|+||.|+. .+..||+|.+.... .....+.+.+|+.++++++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 489999998873 24569999887542 3444567999999999999999999999885 4578999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 235 gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+ ||+++.++.+||+|||++..
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~-----------nil~~~~~~~kl~dfg~~~~ 144 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAAR-----------NVLLVNQHYAKISDFGLSKA 144 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchh-----------eEEEcCCCcEEeccCCcccc
Confidence 999999975 456899999999999999999999998 999999999 88888899999999999976
Q ss_pred cccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 314 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 314 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
........ .....++..|+|||.+.+..++.++||||||+++|++++ |..||......++...+.....++. +.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 221 (257)
T cd05115 145 LGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PA 221 (257)
T ss_pred ccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CC
Confidence 54322211 111233568999999988889999999999999999996 9999987766555554433333332 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
.+++++.++|.+||..||++||++.++.+.|+.+
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 5678999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=313.57 Aligned_cols=253 Identities=28% Similarity=0.488 Sum_probs=203.3
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC-C
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~ 223 (469)
+|++.+.||+|+||.||.. ++.||+|++.... .....+.+..|+.+++++ +||||+++++++... .
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 6788899999999999742 3679999887442 234456788899999999 799999999988654 5
Q ss_pred ceEEEEeccCCCCHHHHHHhc-----------------------------------------------------------
Q 012164 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~----------------------------------------------------------- 244 (469)
.+++++||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCC-CC
Q 012164 245 --GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RP 321 (469)
Q Consensus 245 --~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~ 321 (469)
..+++..+..++.||+.||+|||+.+ |+||||||+ ||+++.++.++|+|||++........ ..
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~-----------Nill~~~~~vkL~DfG~a~~~~~~~~~~~ 231 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAAR-----------NILLSENNVVKICDFGLARDIYKDPDYVR 231 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcc-----------eEEEeCCCcEEEeccccchhcccCcchhh
Confidence 25788999999999999999999998 999999999 88888899999999999986533221 11
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHH
Q 012164 322 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 400 (469)
Q Consensus 322 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 400 (469)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+............ ..+..+++++.+++
T Consensus 232 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~ 309 (337)
T cd05054 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--RAPEYATPEIYSIM 309 (337)
T ss_pred ccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--CCCccCCHHHHHHH
Confidence 222345678999999999999999999999999999997 999998654444332222222111 11345678899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 401 EECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 401 ~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
.+||+.+|++||++.+++++|+.+..
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=301.65 Aligned_cols=245 Identities=28% Similarity=0.508 Sum_probs=201.6
Q ss_pred eeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 161 ~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
+.||+|+||.|+. .+..||+|.+...... ...+.+.+|+.+++.+.||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 3689999998863 1268999998765432 34567889999999999999999999876 45689999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcc
Q 012164 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312 (469)
Q Consensus 233 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~ 312 (469)
++++|.+++...+.+++..+..++.|++.||.|||..+ ++|+||||+ ||+++.++.+||+|||+++
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~-----------nili~~~~~~kl~df~~~~ 143 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAAR-----------NVLLVNRHQAKISDFGMSR 143 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccc-----------eEEEcCCCcEEeccccccc
Confidence 99999999998778999999999999999999999998 999999999 8888889999999999998
Q ss_pred ccccCCCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 313 LLTVKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 313 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
.......... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+......+ .+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 220 (257)
T cd05060 144 ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---RP 220 (257)
T ss_pred eeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---CC
Confidence 6543322111 11123467999999998899999999999999999998 999998766555544443332222 23
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
..++..+.++|.+||..||++||++.++++.|+.+.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 457789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=319.15 Aligned_cols=238 Identities=26% Similarity=0.398 Sum_probs=193.4
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHH-HHHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. +++.||+|.+.............+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3689999999874 4678999998754332222233444444 457888999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~-----------Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPE-----------NILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHH-----------HeEECCCCCEEEccCCCCccc
Confidence 999999988888999999999999999999999999 999999999 888888999999999998753
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ... ....+++
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~---~~~~~~~ 221 (325)
T cd05602 147 IEH-NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQ---LKPNITN 221 (325)
T ss_pred ccC-CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcC---CCCCCCH
Confidence 322 12223456899999999999989999999999999999999999999876655544444222 111 1345788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHH
Q 012164 395 GLKELIEECWNEKPAKRPTFRQI 417 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~~~l 417 (469)
.+.+++.+||+.||.+||++.+.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCC
Confidence 99999999999999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=304.76 Aligned_cols=249 Identities=30% Similarity=0.522 Sum_probs=208.8
Q ss_pred cccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.+|+..+.||.|+||.||. .+..+|+|.+.... ......+..|+.+++.++||||+++++++.+....++|||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3688889999999998874 46889999987542 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+||
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~-----------nilv~~~~~~kl~d~ 148 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAAR-----------NILVGEDLVCKVADF 148 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcc-----------eEEEcCCceEEEccc
Confidence 99999999999753 35899999999999999999999999 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
|++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+....+.+.
T Consensus 149 g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 225 (261)
T cd05148 149 GLARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC-- 225 (261)
T ss_pred cchhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC--
Confidence 999765432211 123345678999999988889999999999999999998 8999987776666555543333322
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
+..+++.+.+++.+||+.||++|||++++++.|+.+
T Consensus 226 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 -PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 345678899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=308.37 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=204.4
Q ss_pred cccccceeeecCeEEEEEE---------------------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCcee
Q 012164 155 LDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~---------------------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 213 (469)
.+|+..+.||+|+||.|+. .+..||+|.+.... .....+.+.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3677889999999998874 22468999887543 235567889999999999999999
Q ss_pred eEEeEEEeCCceEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012164 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (469)
Q Consensus 214 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 282 (469)
++++++..+...++++||+.+++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 99999999899999999999999999998755 6899999999999999999999998 999999999
Q ss_pred cccccccccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-
Q 012164 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 360 (469)
Q Consensus 283 Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t- 360 (469)
||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 160 -----------Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 160 -----------NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred -----------ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence 88888889999999999876432221 11223345778999999988889999999999999999998
Q ss_pred -CCCCCCCCCCCcHHHHHhhc----CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 361 -GCPPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 361 -g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
|..||...+..+........ ........+..++.++.+++.+||+.||++|||+.++++.|+
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 229 CREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 78888766554443333221 111111223456789999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=322.15 Aligned_cols=246 Identities=25% Similarity=0.417 Sum_probs=210.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
-|.+...||.|+||.||. ++-..|-|++.. .+.+.++.|..|+++|..+.||+|+++++.|...+.+|+++|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 356677899999999985 344566777643 356778999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||.||..+.++-+-+ .|++.++..+++|++.||.|||+.+ |||||||+. |||++-+|.++|+|||
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAG-----------NiL~TldGdirLADFG 175 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAG-----------NILLTLDGDIRLADFG 175 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhcccc-----------ceEEEecCcEeeeccc
Confidence 999999999987754 4999999999999999999999999 999999999 8888999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
.+...... ......+.|||.|||||+..+ .+|+.++||||||+++.||..+.+|....++..+...+... .||
T Consensus 176 VSAKn~~t-~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-ePP 253 (1187)
T KOG0579|consen 176 VSAKNKST-RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPP 253 (1187)
T ss_pred ccccchhH-HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-CCC
Confidence 88653322 233456889999999998754 48999999999999999999999999887776665555433 444
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+..|+..+.+|+.+||.+||..||++.+|++|
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 455678899999999999999999999999999988
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=321.70 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=199.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC-----ce
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 225 (469)
+|+..+.||+|+||.||. +|+.||+|.+.... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 367788999999999874 57899999886432 23334567889999999999999999999998766 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++|+||+. ++|.+++...+.+++..+..++.||+.||.|||+.+ ++||||||+ ||+++.++.+||
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~-----------Nili~~~~~~kL 144 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPG-----------NLLVNSNCVLKI 144 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH-----------HEEECCCCCEEe
Confidence 99999995 689999988788999999999999999999999999 999999999 888889999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-----
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA----- 379 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~----- 379 (469)
+|||+++..............+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+..
T Consensus 145 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~ 224 (372)
T cd07853 145 CDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224 (372)
T ss_pred ccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999976543322223334678899999998774 578899999999999999999999987654332222211
Q ss_pred ------------------cC-CCCC----CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 ------------------RQ-RPPF----KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ------------------~~-~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. .++. .......++++.+||.+||+.||++|||+.+++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 0100 00112346789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.97 Aligned_cols=257 Identities=28% Similarity=0.523 Sum_probs=209.3
Q ss_pred cccccceeeecCeEEEEEEe------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEe
Q 012164 155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~~------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 221 (469)
.+|.+.+.||+|+||.||.. +..||+|.+.... .......+..|+.+++++ +||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 36778899999999988742 3468999887442 234456788999999999 59999999999998
Q ss_pred CCceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccc
Q 012164 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285 (469)
Q Consensus 222 ~~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil 285 (469)
.+..+++|||+++|+|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~--- 163 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAAR--- 163 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccce---
Confidence 88999999999999999999753 24788899999999999999999998 999999999
Q ss_pred ccccccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 012164 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 363 (469)
Q Consensus 286 ~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~ 363 (469)
||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 164 --------Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~ 235 (314)
T cd05099 164 --------NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235 (314)
T ss_pred --------eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCC
Confidence 888888999999999999765432211 1112234567999999988889999999999999999999 899
Q ss_pred CCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 364 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 364 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
||......+....+....... .+..++.++.+++.+||+.||++|||+.++++.|+.+......
T Consensus 236 p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 236 PYPGIPVEELFKLLREGHRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred CCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 998766555555443332222 2345678899999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=301.03 Aligned_cols=246 Identities=27% Similarity=0.462 Sum_probs=205.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.+|. +|..|++|.+...... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 366778999999998874 5788999988754433 4455778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~-----------nili~~~~~~~l~df 145 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSL-----------NLFLDAYDNVKIGDL 145 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcc-----------eEEEeCCCCEEEccc
Confidence 99999999999764 46899999999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|+++....... ......+++.|+|||++.+..++.++|+||||+++++|++|+.||...+.......+.....++.
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 221 (256)
T cd08529 146 GVAKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV--- 221 (256)
T ss_pred ccceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 99886543321 12334578899999999998899999999999999999999999987664444444433333332
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..++..+.+++.+||+.+|++||++.+++.+
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 33678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=307.44 Aligned_cols=249 Identities=27% Similarity=0.494 Sum_probs=205.0
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|...++||+|+||.||.. +..||+|.+.... .....+.+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4667789999999988752 4689999987542 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccc
Q 012164 226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~ 289 (469)
++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~------- 153 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATR------- 153 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh-------
Confidence 9999999999999998531 24788889999999999999999999 999999999
Q ss_pred ccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 012164 290 QNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 367 (469)
Q Consensus 290 ~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~ 367 (469)
||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+
T Consensus 154 ----Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 154 ----NVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred ----heEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 88888889999999999876533221 11122345778999999988889999999999999999998 8899987
Q ss_pred CCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 368 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
....++...+......+ .+..++..+.+|+.+||+.+|++||+++++++.|+.
T Consensus 230 ~~~~~~~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 230 YSNQDVIEMIRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 66655555554433332 235678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=302.04 Aligned_cols=248 Identities=31% Similarity=0.513 Sum_probs=203.1
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. ++..||+|.+..... ....+.+|+++++.++||||+++++.+. ....++||||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 578889999999998864 235799999875432 1246888999999999999999999875 4567999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|||
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~-----------Nill~~~~~~~L~dfg 147 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAA-----------NILVGENLVCKVADFG 147 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcc-----------cEEEcCCCcEEeccCC
Confidence 9999999999763 34889999999999999999999998 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
.+...............++..|+|||...+..++.++||||||+++|+|++ |..||......+....+......+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--- 224 (262)
T cd05071 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--- 224 (262)
T ss_pred ceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC---
Confidence 997654332222223346678999999988889999999999999999999 8999987665555444433222222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
...++..+.+|+.+||+.||++||++.++++.|+.+.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 3457788999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.90 Aligned_cols=246 Identities=31% Similarity=0.530 Sum_probs=203.3
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. +++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..+++|||
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 577788999999998874 568899998875432 2356889999999999999999999874 4578999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+.+++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||||+ ||+++.++.++|+|||
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~-----------ni~i~~~~~~~l~dfg 147 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAA-----------NILVSETLCCKIADFG 147 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHH-----------hEEEcCCCCEEEccCc
Confidence 9999999998753 35889999999999999999999998 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++...............++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+......+ .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 224 (260)
T cd05067 148 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP---R 224 (260)
T ss_pred ceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---C
Confidence 997654222222223345678999999998889999999999999999998 999998776655555443332222 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
+..++.++.+++.+||+.+|++|||+++++..|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 34567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=300.28 Aligned_cols=244 Identities=34% Similarity=0.614 Sum_probs=205.1
Q ss_pred ccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
+|+..+.||+|+||.||. .|+.||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hccceeeeecCCCceEEEEEecCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 567788999999998874 68899999987542 14577899999999999999999999999888999999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 233 ~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||.
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~-----------Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAAR-----------NVLVSEDLVAKVSDFGL 148 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccc-----------eEEEeCCCCEEEccccc
Confidence 9999999998765 6899999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++....... ....+..|+|||.+.+..++.++||||||+++++|++ |+.||......+....+....... .+
T Consensus 149 ~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 221 (256)
T cd05039 149 AKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME---AP 221 (256)
T ss_pred ccccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC---Cc
Confidence 976532211 2334567999999988889999999999999999997 999998765544444433322222 23
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
..+++.+.++|.+||..+|++|||++++++.|+.+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 45678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=307.53 Aligned_cols=255 Identities=28% Similarity=0.519 Sum_probs=209.4
Q ss_pred CcccccceeeecCeEEEEEEe------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEE
Q 012164 154 ELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~~------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 220 (469)
..+|++.+.||+|+||.||.. +..||+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 447788899999999988732 3479999886442 234457789999999999 7999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcc
Q 012164 221 QSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDL 284 (469)
Q Consensus 221 ~~~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Ni 284 (469)
.....+++|||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~-- 166 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR-- 166 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc--
Confidence 999999999999999999999753 23677889999999999999999999 999999999
Q ss_pred cccccccCcceeeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CC
Q 012164 285 YVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GC 362 (469)
Q Consensus 285 l~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~ 362 (469)
||+++.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 167 ---------Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 237 (304)
T cd05101 167 ---------NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237 (304)
T ss_pred ---------eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 8888889999999999998664322211 122335678999999988889999999999999999998 88
Q ss_pred CCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 363 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 363 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.||...+..++...+........ +..++..+.+|+.+||..+|++|||+.++++.|+.+...
T Consensus 238 ~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 238 SPYPGIPVEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCcccCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 89987665555555533332222 345778999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=318.30 Aligned_cols=236 Identities=26% Similarity=0.405 Sum_probs=194.2
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHH-HHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||+|+||.||. +|+.||+|++.............+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999874 57899999987554333334455555655 46778999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|..++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~-----------NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPE-----------NILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHH-----------HeEECCCCCEEEeecCCcccC
Confidence 999999988888999999999999999999999999 999999999 888889999999999998753
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... .... .+..+.
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-~~~~---~~~~~~ 221 (325)
T cd05604 147 IAQ-SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-PLVL---RPGASL 221 (325)
T ss_pred CCC-CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-CccC---CCCCCH
Confidence 222 12223456899999999999989999999999999999999999999876655554444322 2111 234678
Q ss_pred HHHHHHHHHcccCCCCCCCHH
Q 012164 395 GLKELIEECWNEKPAKRPTFR 415 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~~ 415 (469)
.+.+++.+||+.||.+||++.
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCC
Confidence 899999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=304.93 Aligned_cols=247 Identities=28% Similarity=0.500 Sum_probs=202.6
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
++...++||+|+||.||. ++..+|+|.+... .......+.+|+++++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 566778999999999874 2457888887643 344557899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccc
Q 012164 226 MIVTEYLPKGDLRAFLKRKG---------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~---------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~ 290 (469)
+++|||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||||+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~-------- 151 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATR-------- 151 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHh--------
Confidence 99999999999999997643 3788999999999999999999999 999999999
Q ss_pred cCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 012164 291 NDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMK 368 (469)
Q Consensus 291 ~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~ 368 (469)
||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...
T Consensus 152 ---nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 152 ---NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred ---hEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 88888899999999999875432211 11122334678999999998899999999999999999998 99999776
Q ss_pred CCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 369 HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
...+....+....... .+..+++.+.+|+.+||..||.+||++.++++.|+
T Consensus 229 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 229 SNTEAIECITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CHHHHHHHHHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 5555444443332222 23457788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.26 Aligned_cols=248 Identities=28% Similarity=0.478 Sum_probs=200.4
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|+..+.||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++.+....
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 577888999999998763 34678999876432 334446788899999999999999999999988899
Q ss_pred EEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 226 MIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
++||||+++++|.+++.+.+ .+++..+..++.||+.||+|||+.+ ++|+||||+ ||+++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~-----------nil~~ 150 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAAR-----------NCLLT 150 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecccchh-----------eEEEe
Confidence 99999999999999997643 4888999999999999999999999 999999999 66665
Q ss_pred CCC---CeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcH
Q 012164 299 DSG---NLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 373 (469)
Q Consensus 299 ~~~---~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~ 373 (469)
.++ .+||+|||+++......... ......+..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+.
T Consensus 151 ~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~ 230 (277)
T cd05036 151 CKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230 (277)
T ss_pred ccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 443 69999999998653221111 112233567999999988899999999999999999997 9999987766555
Q ss_pred HHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 374 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
...+........ +..++..+.+++.+||+.||++|||+.+++++|+
T Consensus 231 ~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 MEFVTGGGRLDP---PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 544433323222 3456788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=299.26 Aligned_cols=253 Identities=26% Similarity=0.502 Sum_probs=207.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.++. +|+.||+|.+......+......+.+|++++++++|+||+++++++...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 577888999999998874 588999998875444445556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 231 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|+++++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~-----------nil~~~~~~~~l~ 148 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPA-----------NVFITATGVVKLG 148 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChh-----------hEEECCCCcEEEe
Confidence 9999999999864 234889999999999999999999999 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--cHHHHHhhcCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPP 384 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~ 384 (469)
|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .....+.....++
T Consensus 149 d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08224 149 DLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP 227 (267)
T ss_pred ccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC
Confidence 9999876543221 122345788899999998888999999999999999999999999654322 1112222222222
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
. +...++..+.++|.+||..+|++|||+.++++.|+.+.
T Consensus 228 ~--~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 L--PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C--ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 2 22367788999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=301.48 Aligned_cols=246 Identities=33% Similarity=0.539 Sum_probs=202.5
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|++.+.||+|+||.||. .+..||+|.+...... .+.+.+|+.++++++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 577888999999998873 4567999988754332 246889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|||
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~-----------Nili~~~~~~~l~dfg 147 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSA-----------NILVGDGLVCKIADFG 147 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccc-----------eEEEeCCceEEeCCce
Confidence 9999999999753 34899999999999999999999998 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+......+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 224 (260)
T cd05070 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC--- 224 (260)
T ss_pred eeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 997654332222222345668999999988889999999999999999999 9999987766555555543323322
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
+...+..+.+|+.+||..||++|||+.++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 34567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.01 Aligned_cols=251 Identities=30% Similarity=0.547 Sum_probs=205.8
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCc
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 224 (469)
+|+..+.||+|+||.|+.. ...+|+|.+.... .......+.+|+++++++ +||||+++++++...+.
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 5777889999999988742 2578999887542 233446788999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccc
Q 012164 225 MMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~ 288 (469)
.+++|||+.+|+|.+++... +.+++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~------ 161 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAAR------ 161 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---cccccccee------
Confidence 99999999999999999642 35888999999999999999999998 999999999
Q ss_pred cccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 012164 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 366 (469)
Q Consensus 289 ~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~ 366 (469)
||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 162 -----Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 162 -----NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred -----eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 888888999999999999865432211 1122234667999999988889999999999999999997 999998
Q ss_pred CCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 367 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
.....+....+....... .+..++..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 237 GIPVEELFKLLKEGYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 766555555443333222 23356778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=308.93 Aligned_cols=251 Identities=32% Similarity=0.546 Sum_probs=202.4
Q ss_pred ccccceeeecCeEEEEEE-----ece--eehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~--~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 227 (469)
+|+..+.||+|+||.||. +|. .+|+|.+... ........+.+|+.++.++ +||||+++++++...+..++
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 567778999999998875 233 4577766532 2344557788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc
Q 012164 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~ 291 (469)
||||+++++|.+++.+.+ .+++..+..++.|++.||+|||+.+ ++||||||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~--------- 153 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR--------- 153 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchh---------
Confidence 999999999999997542 4788899999999999999999999 999999999
Q ss_pred CcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012164 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 370 (469)
Q Consensus 292 ~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~ 370 (469)
||+++.++.+||+|||++...... ........+..|+|||.+.+..++.++|||||||++|+|+| |..||...+.
T Consensus 154 --Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 229 (303)
T cd05088 154 --NILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229 (303)
T ss_pred --eEEecCCCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence 888888999999999998643211 11111234567999999988888999999999999999998 9999987665
Q ss_pred CcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 371 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.+............ .+..+++.+.+|+.+||+.+|++||++.+++..|+.+...
T Consensus 230 ~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 230 AELYEKLPQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHHHHHhcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 55444332221221 1234678899999999999999999999999999988666
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=303.91 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=204.5
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|++.+.||+|+||.||. .+..||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 677788999999998873 23679999986442 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 226 MIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+ ||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~-----------ni 150 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAAR-----------NC 150 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChh-----------eE
Confidence 99999999999999997532 3677889999999999999999998 999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcH
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 373 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~ 373 (469)
+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|++++ |..||...+..+.
T Consensus 151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 230 (277)
T cd05032 151 MVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230 (277)
T ss_pred EEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH
Confidence 888999999999999876543221 11223346778999999988889999999999999999998 9999987766665
Q ss_pred HHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 374 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
...+........ +..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 231 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 LKFVIDGGHLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 555543333322 3446889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=309.23 Aligned_cols=262 Identities=29% Similarity=0.537 Sum_probs=211.0
Q ss_pred CccccCCCCcccccceeeecCeEEEEEEe------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCce
Q 012164 146 PEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV 212 (469)
Q Consensus 146 ~~~~~~~~~~~~~~~~~ig~G~~~~~~~~------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 212 (469)
|.|++.. .+|++.+.||+|+||.||.- +..||+|.+... ......+.+.+|+++++++ +||||
T Consensus 5 ~~~~~~~--~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 5 PKWELSR--TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred cccccCH--hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence 4555543 36888999999999988732 236899987643 2334557889999999999 79999
Q ss_pred eeEEeEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 012164 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (469)
Q Consensus 213 ~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 276 (469)
+++++++...+..++++||+++|+|.+++.+.. .+++.++..++.|++.||.|||+++ ++|
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH 157 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 999999999899999999999999999997532 3677888999999999999999999 999
Q ss_pred cCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHH
Q 012164 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 355 (469)
Q Consensus 277 ~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil 355 (469)
|||||+ ||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++
T Consensus 158 ~dlkp~-----------Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 226 (334)
T cd05100 158 RDLAAR-----------NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 226 (334)
T ss_pred cccccc-----------eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHH
Confidence 999999 8888889999999999997654322111 1222345679999999998999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 356 QEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 356 ~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
|+|++ |..||...+..+....+......+. +..++..+.+|+.+||+.+|++|||+.+++++|+.+...-
T Consensus 227 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 227 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 99998 8999987665555544433323222 3356778999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=335.19 Aligned_cols=257 Identities=20% Similarity=0.301 Sum_probs=206.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||+|++...........+.+.+|++++++++||||+++++++.+.+..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 678889999999999875 478999999986554445556779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 231 YLPKGDLRAFLKRK-----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
|++|++|.+++... ..++...+..++.||+.||+|||+.+ |+||||||+ ||+++.
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPe-----------NILLd~ 148 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPD-----------NILLGL 148 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchh-----------eEEEcC
Confidence 99999999998641 22456678899999999999999999 999999999 888889
Q ss_pred CCCeEEeecCCccccccCCC-----------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCC
Q 012164 300 SGNLKVADFGVSKLLTVKED-----------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 362 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~ 362 (469)
++.++|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|+|+||+
T Consensus 149 dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 149 FGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred CCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCC
Confidence 99999999999986521110 0011245899999999999999999999999999999999999
Q ss_pred CCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHHHhh
Q 012164 363 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP-TFRQIITRLESINNS 427 (469)
Q Consensus 363 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~L~~~~~~ 427 (469)
.||.............. ..+....+...+++.+.+++.+||..||++|| +++++++.|+.....
T Consensus 229 ~PF~~~~~~ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 229 FPYRRKKGRKISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCCCcchhhhhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 99987544333222111 11111122346788899999999999999995 667777888877654
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=300.89 Aligned_cols=250 Identities=27% Similarity=0.467 Sum_probs=203.2
Q ss_pred cccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc----
Q 012164 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 224 (469)
|+..+.||+|+||.|+. .+..||+|.+..+.. .......+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 45677899999998874 136799999875433 33445678999999999999999999998865543
Q ss_pred --eEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 225 --MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 225 --~~lv~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
.++++||+++++|..++... ..+++..+..++.|++.||.|||+.+ ++||||||+ ||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~-----------Nil 145 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAAR-----------NCM 145 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchh-----------eEE
Confidence 79999999999999998532 25889999999999999999999998 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHH
Q 012164 297 RDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 374 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~ 374 (469)
+++++.+||+|||+++......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||.+....+..
T Consensus 146 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~ 225 (273)
T cd05035 146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY 225 (273)
T ss_pred ECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 8889999999999998654322111 112234678999999988889999999999999999999 99999876665555
Q ss_pred HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
..+....... .+..++..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 226 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 226 DYLRHGNRLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHcCCCCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 5554333322 2346788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=296.69 Aligned_cols=242 Identities=31% Similarity=0.538 Sum_probs=198.6
Q ss_pred eeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 162 EITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 162 ~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
.||+|+||.||. ++..||+|.+.... .......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 689999998874 46789999887542 334445788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccccc
Q 012164 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316 (469)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~ 316 (469)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~-----------nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAAR-----------NCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChh-----------eEEEcCCCeEEECCCccceeccc
Confidence 9998754 45889999999999999999999999 999999999 88888899999999999875432
Q ss_pred CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHH
Q 012164 317 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 395 (469)
Q Consensus 317 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (469)
..........++..|+|||++.+..++.++||||||+++|++++ |..||...........+....+.. .+..++..
T Consensus 146 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 222 (250)
T cd05085 146 GIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMS---CPQKCPDD 222 (250)
T ss_pred cccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHH
Confidence 22111122234667999999988889999999999999999998 999998765544444443222222 13356789
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 396 LKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 396 l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
+.+|+.+||+.+|++||++.++++.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.27 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=212.9
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
.+..+++||+|.||.+.. .+..||+|+++... .......|..|+++|.+++||||+.++|+|..++.+++|+||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 355688999999998753 45899999998663 345568899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+.|+|.+++.++. .+......+|+.||+.||+||.+.+ +|||||.+. |+|++.++++||+|||
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~r-----------NcLv~~e~~iKiadfg 682 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATR-----------NCLVDGEFTIKIADFG 682 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhcccccc-----------ceeecCcccEEecCcc
Confidence 99999999998763 3456777889999999999999999 999999999 9999999999999999
Q ss_pred CccccccCCCCCc-ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCCcHHHHHh----hcCC
Q 012164 310 VSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDNEVPKAYA----ARQR 382 (469)
Q Consensus 310 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t--g~~p~~~~~~~~~~~~~~----~~~~ 382 (469)
+++.....+.... ....-+++|||||.+..++++++||+|+||+++||+++ ...||...+++++.+..- ..+.
T Consensus 683 msR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR 762 (807)
T ss_pred cccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc
Confidence 9986654443332 23446789999999999999999999999999999864 789999888877655432 2223
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
......+..+|..+.++|.+||..|-++||+++++-.+|.+.
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 333334567889999999999999999999999999888764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=302.36 Aligned_cols=247 Identities=24% Similarity=0.402 Sum_probs=201.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.+|. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++++|
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 678888999999998874 57899999886442 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++.++..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|||+
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~-----------nili~~~~~~~l~dfg~ 152 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGA-----------NILLTDNGHVKLADFGV 152 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEECCCCCEEECccee
Confidence 9999999999998888999999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CCCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK 386 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~ 386 (469)
+...... ........|+..|+|||.+. ...++.++|+|||||++|+|++|..||................ .++..
T Consensus 153 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06645 153 SAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL 231 (267)
T ss_pred eeEccCc-ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcc
Confidence 8765422 11223356889999999974 4468889999999999999999999997654433322221221 11111
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....++..+.++|.+||+.||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1122467789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=299.86 Aligned_cols=247 Identities=30% Similarity=0.504 Sum_probs=202.5
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCC------HHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
|+....||+|+||.++. +++.||+|.+....... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56778999999998874 56889999876543222 12335688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++++||+++++|.+++.+.+.+++..+..++.|++.||+|||+.+ ++|+||+|+ ||+++.++.++|
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~-----------nil~~~~~~~~l 147 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGA-----------NILVDNKGGIKI 147 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHH-----------HEEEcCCCCEEe
Confidence 999999999999999998888999999999999999999999998 999999999 888889999999
Q ss_pred eecCCccccccCCCC-----CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc
Q 012164 306 ADFGVSKLLTVKEDR-----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 380 (469)
+|||+++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+...
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN 227 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc
Confidence 999998766421110 111234788999999999888999999999999999999999999865443332222222
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+. .+..++..+.++|.+||+.||++||++.+++++
T Consensus 228 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 ASPE---IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCCc---CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 2222 234578899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.16 Aligned_cols=251 Identities=27% Similarity=0.468 Sum_probs=201.3
Q ss_pred ccccceeeecCeEEEEEEe-------------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEE
Q 012164 156 DFTNSVEITKGTFILAFWR-------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~-------------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 216 (469)
+|++.+.||+|+||.||.- ...||+|.+.... .......+.+|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 6778889999999998741 2358999987542 345556799999999999999999999
Q ss_pred eEEEeCCceEEEEeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcc
Q 012164 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDL 284 (469)
Q Consensus 217 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Ni 284 (469)
+++......++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~-- 158 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATR-- 158 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChh--
Confidence 99999999999999999999999996532 3678889999999999999999999 999999999
Q ss_pred cccccccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--C
Q 012164 285 YVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--G 361 (469)
Q Consensus 285 l~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t--g 361 (469)
||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++++|++ |
T Consensus 159 ---------Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~ 229 (295)
T cd05097 159 ---------NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229 (295)
T ss_pred ---------hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCC
Confidence 888888899999999999764322211 1122345678999999988889999999999999999988 6
Q ss_pred CCCCCCCCCCcHHHHHhh----cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 362 CPPFTMKHDNEVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 362 ~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
..||...+..+....... .........+..+++.+.+|+.+||+.||++|||++++++.|+
T Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 230 EQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 778876655444332211 1122222233456789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.33 Aligned_cols=246 Identities=25% Similarity=0.380 Sum_probs=193.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 223 (469)
.+|+..+.||+|+||.|+. +|..||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 3788899999999999874 578999999875432 3344466788999999999999999999986443
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++||||++ ++|.+.+.. .++...+..++.|++.||.|||+++ |+||||||+ ||+++.++.+
T Consensus 100 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~-----------NIl~~~~~~~ 162 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS-----------NIVVKSDCTL 162 (359)
T ss_pred eeEEEEeCCC-cCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH-----------HEEECCCCCE
Confidence 4799999995 577777653 4888999999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh----
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---- 379 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~---- 379 (469)
||+|||+++.... ........+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 163 kl~Dfg~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 240 (359)
T cd07876 163 KILDFGLARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240 (359)
T ss_pred EEecCCCcccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999999975432 1222345678999999999999999999999999999999999999986543221111000
Q ss_pred -----------------cCCCCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 -----------------RQRPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 -----------------~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+... ......++.+++||.+||..||++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 0011235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=299.30 Aligned_cols=243 Identities=30% Similarity=0.559 Sum_probs=200.1
Q ss_pred ccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEE-eCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.+|. .|..||+|.+... ...+.+.+|+.++++++|+|++++++++. .....++++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 577788999999998764 6788999987643 22356889999999999999999999764 44678999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+++++|.+++.+.+ .+++..+..++.|++.||+|||+.+ ++||||||+ ||+++.++.+||+|||
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~-----------nil~~~~~~~kl~dfg 147 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAAR-----------NVLVSEDNVAKVSDFG 147 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeccccchh-----------eEEEcCCCcEEecCCc
Confidence 99999999998644 3788999999999999999999998 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++....... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.....+. .
T Consensus 148 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 220 (256)
T cd05082 148 LTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---A 220 (256)
T ss_pred cceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---C
Confidence 987543221 22334668999999988889999999999999999997 999998665444444443222222 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
+..+++.+.+++.+||+.||++|||+.++++.|+.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 345788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=298.92 Aligned_cols=246 Identities=33% Similarity=0.524 Sum_probs=200.7
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|.+...||+|+||.+|. .+..+|+|.+..... ..+.+.+|++++++++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 477778999999998874 235799998764322 2356888999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+.+++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|||
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~-----------Nill~~~~~~~l~dfg 147 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAA-----------NILVGDNLVCKIADFG 147 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcc-----------eEEEcCCCeEEECCCc
Confidence 99999999997642 4788999999999999999999998 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+......+ .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~ 224 (260)
T cd05069 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP---C 224 (260)
T ss_pred cceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence 997654332222222345678999999988889999999999999999999 999998766555544443332222 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 34577899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=300.66 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=199.8
Q ss_pred ccceeeecCeEEEEEE-----ec--eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------Cc
Q 012164 158 TNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (469)
Q Consensus 158 ~~~~~ig~G~~~~~~~-----~g--~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~ 224 (469)
.+.+.||+|+||.||. ++ ..||+|.+.... ......+.+..|+.+++.++||||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999874 22 268999887543 2345567889999999999999999999987432 24
Q ss_pred eEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 225 MMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
.+++|||+.+|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+ ||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~-----------Nil~~ 146 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAAR-----------NCMLN 146 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchh-----------heEEc
Confidence 6899999999999998842 124789999999999999999999998 999999999 88888
Q ss_pred CCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHH
Q 012164 299 DSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKA 376 (469)
Q Consensus 299 ~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~ 376 (469)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....
T Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 226 (272)
T cd05075 147 ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226 (272)
T ss_pred CCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 8999999999999865432211 1122345678999999999899999999999999999999 8999987665555554
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
+......+. +..++..+.++|.+||+.||++|||+.++++.|+.+
T Consensus 227 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGNRLKQ---PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 443333222 345778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=305.11 Aligned_cols=252 Identities=32% Similarity=0.531 Sum_probs=203.9
Q ss_pred ccccceeeecCeEEEEEE-----ec--eeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g--~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 227 (469)
+|++.+.||+|+||.|+. +| ..+++|.+... ......+.+.+|+.+++++ +||||+++++++.+....++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 577788999999998874 22 24688877632 2334456788999999999 69999999999999899999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc
Q 012164 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~ 291 (469)
++||+++++|.+++.+.+ .+++..+..++.|++.||+|||+.+ ++||||||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~--------- 148 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAAR--------- 148 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcc---------
Confidence 999999999999997532 4788899999999999999999998 999999999
Q ss_pred CcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012164 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 370 (469)
Q Consensus 292 ~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~ 370 (469)
||+++.++.+||+|||++...... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 149 --Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 149 --NVLVGENLASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred --eEEECCCCeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 888888999999999998642211 11111223557999999988889999999999999999997 9999987665
Q ss_pred CcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 371 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.+....+......+ .+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+..
T Consensus 225 ~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 225 AELYEKLPQGYRME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 55544443322222 23457889999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=318.36 Aligned_cols=240 Identities=25% Similarity=0.413 Sum_probs=194.8
Q ss_pred eecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC---CCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 163 ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
||+|+||.||. +|+.||+|.+................|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999874 5789999998754333333444556677777665 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+|.+++...+.+++..+..++.||+.||+|||+.+ |+||||||+ ||+++.++.+||+|||++...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~-----------Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPE-----------NILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHH-----------HeEECCCCCEEEecCCcCcCC
Confidence 999999998888999999999999999999999999 999999999 888888999999999998753
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 393 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (469)
... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.... ..+ +...++
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~--~~~~~~ 222 (330)
T cd05586 147 LTD-NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK-VRF--PKNVLS 222 (330)
T ss_pred CCC-CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC-CCC--CCccCC
Confidence 322 1222345689999999998764 57899999999999999999999998766555444443222 111 223467
Q ss_pred HHHHHHHHHHcccCCCCCC----CHHHHHHH
Q 012164 394 RGLKELIEECWNEKPAKRP----TFRQIITR 420 (469)
Q Consensus 394 ~~l~~li~~cl~~dp~~Rp----s~~~ll~~ 420 (469)
+++.+|+.+||+.||++|| ++.++++|
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 8899999999999999998 67777765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=300.36 Aligned_cols=250 Identities=24% Similarity=0.466 Sum_probs=204.5
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCC---CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
+|+..+.||+|+||.||. +|+.+|+|.+...... .......+.+|++++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999998875 5788999987644221 223346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
+||+++++|.+++.+.+.+++..+..++.|++.||+|||+.+ ++|+||+|+ ||+++.++.++|+||
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~-----------nil~~~~~~~~l~df 146 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGN-----------NVMLMPNGIIKLIDF 146 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHH-----------hEEECCCCeEEeccc
Confidence 999999999999988788999999999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCC-----CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 309 GVSKLLTVKE-----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 309 gla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
|++....... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ..
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~ 225 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-RG 225 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-cC
Confidence 9987643211 11122345788999999999888999999999999999999999999865443332222221 11
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....+..++.++.++|.+||..+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2222345678899999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=297.60 Aligned_cols=247 Identities=22% Similarity=0.398 Sum_probs=207.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.++. ++..+++|.+...... ......+.+|++++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 477889999999997653 5789999988755432 3445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.+||+||
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~-----------ni~~~~~~~~kl~d~ 145 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTL-----------NIFLTKAGLIKLGDF 145 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChH-----------hEEEeCCCCEEECcC
Confidence 99999999999865 45899999999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+......+ .
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~ 221 (256)
T cd08221 146 GISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---V 221 (256)
T ss_pred cceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence 99976543321 2233457889999999988888999999999999999999999998766555555554333322 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
...++.++.+++.+||..+|.+||+++++++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 356788999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=300.89 Aligned_cols=252 Identities=24% Similarity=0.470 Sum_probs=203.7
Q ss_pred ccccceeeecCeEEEEEE-----ece----eehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
+|+..+.||+|+||.||. +|+ .|++|.+... ........+..|+..++++.||||+++++++.. ...+
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 567778999999998874 233 4788877532 223444678889999999999999999998754 5578
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
+++||+.+|+|.+++... +.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~-----------nili~~~~~~kl 150 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAAR-----------NILLKSDSIVQI 150 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcc-----------eEEEcCCCcEEE
Confidence 999999999999999764 46899999999999999999999998 999999999 888888999999
Q ss_pred eecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCC
Q 012164 306 ADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 306 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.........+.....+
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd05111 151 ADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL 230 (279)
T ss_pred cCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC
Confidence 99999976543221 11223456778999999988899999999999999999998 99999876655544444333333
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+. +..++..+.+++.+||..||++|||+.++++.|..+.+.
T Consensus 231 ~~---~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 231 AQ---PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 22 234567889999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=299.58 Aligned_cols=250 Identities=31% Similarity=0.531 Sum_probs=205.5
Q ss_pred ccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|+..+.||+|+||.||.. +..+|+|.+.... .......+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5677889999999988741 2369999886542 23445678999999999999999999999999899999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
||||+++++|.+++... +.+++.++..++.|++.||.|||+.+ ++||||||+ ||+++.++.++|+
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~-----------nili~~~~~~~l~ 148 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAAR-----------NILVNSNLVCKVS 148 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeehhhchh-----------cEEECCCCeEEeC
Confidence 99999999999999865 45899999999999999999999999 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCC
Q 012164 307 DFGVSKLLTVKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
|||++........... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+....+.
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd05066 149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL 228 (267)
T ss_pred CCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC
Confidence 9999986643322111 11223567999999998889999999999999999886 99999876655555555433222
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
+. +..+++.+.+++.+||+.+|++||++.++++.|+.+
T Consensus 229 ~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PA---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 22 345678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=299.24 Aligned_cols=245 Identities=27% Similarity=0.456 Sum_probs=203.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.++. ++..||+|.+.... .....+.+..|+.+++.++||||+++++.+.+.+.++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 467788999999998763 67899999886432 23445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++++||
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~-----------nili~~~~~~~l~df 144 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSK-----------NIFLTQNGKVKLGDF 144 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcc-----------eEEECCCCcEEEccc
Confidence 99999999988653 34889999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|++....... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+......+.
T Consensus 145 g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 220 (255)
T cd08219 145 GSARLLTSPG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL--- 220 (255)
T ss_pred Ccceeecccc-cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---
Confidence 9987654321 122235678899999999988899999999999999999999999986554444444433333222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..++..+.+||.+||+.||++|||+.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 34577889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=306.12 Aligned_cols=246 Identities=27% Similarity=0.479 Sum_probs=200.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.|+. +|..+|+|.+.... .......+.+|++++++++||||+++++++.+++.+++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 578889999999998874 57889999886442 34455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+ .+ ++|+||||+ ||+++.++.+||+|||
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~-----------nil~~~~~~~~l~dfg 145 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPS-----------NILVNSRGEIKLCDFG 145 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChH-----------HEEEecCCcEEEccCC
Confidence 99999999999988889999999999999999999998 46 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC--------
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------- 381 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------- 381 (469)
++...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+....
T Consensus 146 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (308)
T cd06615 146 VSGQLIDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222 (308)
T ss_pred Cccccccc---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCC
Confidence 98654322 1233567889999999988889999999999999999999999996544322221111000
Q ss_pred --------------------------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 --------------------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 --------------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+...+...++.++.+|+.+||..||++|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000001112367789999999999999999999999988
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=303.81 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=204.1
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCc
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 224 (469)
+|...+.||+|+||.|+. .+..||+|++.... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 678888999999998863 23479999887542 234456789999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~ 302 (469)
.+++|||+.+++|.+++.... .+++.++..++.|++.||.|||+.+ ++|+||||+ ||+++.++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~-----------Nil~~~~~~ 179 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR-----------NVLLTHGKI 179 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccc-----------eEEEcCCCe
Confidence 999999999999999997643 3899999999999999999999998 999999999 888888899
Q ss_pred eEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhc
Q 012164 303 LKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 380 (469)
++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+........
T Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~ 259 (302)
T cd05055 180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259 (302)
T ss_pred EEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc
Confidence 999999999765432211 1122345678999999998889999999999999999998 99999876554433333222
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
.... ..+...++.+.+|+.+||..+|++|||+.++++.|++.
T Consensus 260 ~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GYRM--AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCcC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 2211 12334678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=298.80 Aligned_cols=252 Identities=26% Similarity=0.494 Sum_probs=206.1
Q ss_pred ccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|+..+.||+|+||.+|.. ...||+|...... .....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 5677889999999988741 2368889876442 24556789999999999999999999998875 45789
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~-----------nili~~~~~~~l~ 149 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAAR-----------NVLVSSPDCVKLG 149 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChh-----------eEEEecCCCeEEc
Confidence 999999999999998644 4899999999999999999999998 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
|||+++..............++..|+|||.+.+..++.++||||||+++++|++ |..||......+....+......+.
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (270)
T cd05056 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM 229 (270)
T ss_pred cCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 999997654332211222334568999999988889999999999999999986 9999987766555544433333322
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+..++..+.+++.+|+..+|++|||+.++++.|+.+.+.
T Consensus 230 ---~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 230 ---PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 345778999999999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=310.99 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=198.6
Q ss_pred CcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 228 (469)
...|++.++||+||-..||. +.+.||+|++.... .+...+..|.+|+..|.+|+ |.+|+++|+|-..++.+|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34789999999999988874 44788998887554 35677789999999999996 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||- ..+|..+|++... .+.-.+..+..|++.|+.++|++| |||.||||.|+|+. .|.+||+|
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV------------kG~LKLID 502 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV------------KGRLKLID 502 (677)
T ss_pred eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE------------eeeEEeee
Confidence 9987 6799999998665 444588889999999999999999 99999999977775 78999999
Q ss_pred cCCccccccCCC-CCcccCCCCCcccCCcccCCC-----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH-H
Q 012164 308 FGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-P 374 (469)
Q Consensus 308 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~-~ 374 (469)
||+|..+..... ......+||+.|||||.+... +++++|||||||||+|+|+.|++||..-..... .
T Consensus 503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl 582 (677)
T KOG0596|consen 503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKL 582 (677)
T ss_pred echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHH
Confidence 999988765432 223456899999999998532 367899999999999999999999974332111 1
Q ss_pred HHHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 375 KAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 375 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+.... ..+++..++.. ++.++++.||..||++|||..+||+|
T Consensus 583 ~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1121111 22333333332 39999999999999999999999987
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=300.95 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=207.4
Q ss_pred CcccccceeeecCeEEEEEE----e-----ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe-CC
Q 012164 154 ELDFTNSVEITKGTFILAFW----R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS 223 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----~-----g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 223 (469)
..+|+..+.||+|+||.|+. . +..|++|.+... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34677889999999998863 2 578999987643 345556778999999999999999999998766 46
Q ss_pred ceEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 224 PMMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
..++++||+.+++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+ ||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~-----------ni 148 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAAR-----------NC 148 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHh-----------hE
Confidence 789999999999999999753 34889999999999999999999998 999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcH
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 373 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~ 373 (469)
+++.++.+||+|||+++.+...... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||......++
T Consensus 149 l~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 228 (280)
T cd05043 149 VIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228 (280)
T ss_pred EEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence 8888899999999999765322211 1122345678999999988889999999999999999998 9999987655454
Q ss_pred HHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 374 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
...+........ ...+++++.+++.+||..||++|||+.++++.|+++.+.
T Consensus 229 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 229 AAYLKDGYRLAQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHHHcCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 444433222222 234678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=301.99 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=203.2
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|++.+.||+|+||.||.. +..||+|.+.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 6788899999999998841 3479999876442 233345678899999999999999999999988999
Q ss_pred EEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 226 MIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
++||||+++|+|.+++...+ .++...+..++.|++.||.|||+++ ++||||||+ ||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~-----------ni 150 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAAR-----------NC 150 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChh-----------eE
Confidence 99999999999999997532 2456778899999999999999999 999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcH
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 373 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~ 373 (469)
+++.++.++|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.
T Consensus 151 li~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~ 230 (288)
T cd05061 151 MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230 (288)
T ss_pred EEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 88889999999999987543322111 112234678999999998889999999999999999998 7999987665555
Q ss_pred HHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 374 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
...+........ +...++.+.+++.+||+.||++|||+.++++.|++...
T Consensus 231 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 231 LKFVMDGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 444433333222 23457889999999999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=300.98 Aligned_cols=253 Identities=23% Similarity=0.482 Sum_probs=205.9
Q ss_pred cccccceeeecCeEEEEEE-----ece----eehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
.+|+..+.||+|+||.||. +|. .||+|.+... ........+.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 3677888999999999874 333 4899988644 234455678899999999999999999999875 457
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++++||+++|+|.+++..+ +.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+|
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~-----------Nil~~~~~~~k 149 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAAR-----------NVLVKSPNHVK 149 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc-----------eEEEcCCCcEE
Confidence 8999999999999999764 56899999999999999999999999 999999999 88888889999
Q ss_pred EeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCC
Q 012164 305 VADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 382 (469)
|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.....
T Consensus 150 L~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~ 229 (279)
T cd05109 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER 229 (279)
T ss_pred ECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc
Confidence 99999998654322111 112234678999999998899999999999999999998 9999987655555444433333
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.+. +..++..+.+++.+||..||++||++.++++.|+.+...
T Consensus 230 ~~~---~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 LPQ---PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 322 345678899999999999999999999999999887665
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=297.61 Aligned_cols=247 Identities=29% Similarity=0.513 Sum_probs=202.8
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. .+..+|+|.+... ....+.+.+|+++++.++|+||+++++++.+ ...+++|||
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 677888999999999874 3467999987643 2334678899999999999999999999887 778999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~-----------ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAA-----------NILVSASLVCKIADFG 147 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcc-----------eEEEcCCCcEEECCCc
Confidence 9999999999763 34788899999999999999999998 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++...............++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+.......+......+ .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~ 224 (260)
T cd05073 148 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---R 224 (260)
T ss_pred ceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC---C
Confidence 997654322222222345677999999988889999999999999999998 999998766555554443332222 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
....+.++.+++.+||+.+|++||+++++++.|+.+
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 345678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.66 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=191.6
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------- 222 (469)
.+|+..+.||+|+||.||. +++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4688999999999999874 57899999875431 2245799999999999999999887432
Q ss_pred -CceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 223 -SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 223 -~~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
..+++||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+ |||+
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~-----------NILl 203 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQ-----------NLLI 203 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHH-----------HEEE
Confidence 24679999995 588777753 456899999999999999999999999 999999999 7777
Q ss_pred CCCC-CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHH
Q 012164 298 DDSG-NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375 (469)
Q Consensus 298 ~~~~-~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~ 375 (469)
+.++ .+||+|||+|+...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+...
T Consensus 204 ~~~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 281 (440)
T PTZ00036 204 DPNTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281 (440)
T ss_pred cCCCCceeeeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 7554 79999999998654322 22335678999999998764 68999999999999999999999998765544332
Q ss_pred HHhh-cCCC------------------CCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHH
Q 012164 376 AYAA-RQRP------------------PFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESIN 425 (469)
Q Consensus 376 ~~~~-~~~~------------------~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~ 425 (469)
.+.. .+.+ ... ..+...++++.+||.+||..||.+|||+.++++| ++.+.
T Consensus 282 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 282 RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 2211 1110 000 0112356789999999999999999999999977 44443
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=298.35 Aligned_cols=243 Identities=33% Similarity=0.606 Sum_probs=204.7
Q ss_pred eeeecCeEEEEEE-----e---ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 161 VEITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~---g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
+.||+|+||.++. . +..|++|.+..... ....+.+.+|+++++.++|+||+++++++......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 3689999998864 2 77899999876533 224678899999999999999999999999989999999999
Q ss_pred CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 233 PKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 233 ~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||||+ ||+++.++.+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~-----------nili~~~~~~ 144 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAAR-----------NCLVGEDLVV 144 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcc-----------eEEECCCCcE
Confidence 999999999875 67999999999999999999999998 999999999 8888889999
Q ss_pred EEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 304 KVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
||+|||.+........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....
T Consensus 145 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 224 (262)
T cd00192 145 KISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY 224 (262)
T ss_pred EEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987654321 11233456788999999988889999999999999999999 699998876655555554432
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
... .+..++.++.+++.+||..||++|||+.+++++|+
T Consensus 225 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLP---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC---CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 322 23456889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=297.91 Aligned_cols=250 Identities=30% Similarity=0.531 Sum_probs=205.2
Q ss_pred ccccceeeecCeEEEEEE-----ec---eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|+..+.||+|+||.+|. ++ ..+|+|.+.... .....+.+..|++++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 567788999999998873 22 369999886442 23445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
||||+++++|.+++..+ +.+++.++..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~-----------Nili~~~~~~kl~ 149 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAAR-----------NILVNSNLECKVS 149 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchh-----------hEEEcCCCcEEEC
Confidence 99999999999999764 56899999999999999999999998 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCC
Q 012164 307 DFGVSKLLTVKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
|||++........... .....+..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~ 229 (268)
T cd05063 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL 229 (268)
T ss_pred CCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC
Confidence 9999876543221111 11223457999999988889999999999999999997 99999876655555555433322
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
+. ...++..+.+++.+||..+|++||++.++++.|+++
T Consensus 230 ~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PA---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22 235678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=303.24 Aligned_cols=250 Identities=30% Similarity=0.489 Sum_probs=204.1
Q ss_pred cccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
.+|+..+.||+|+||.++. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3677888999999998874 35789999887442 34455678999999999999999999999999889
Q ss_pred eEEEEeccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~----------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 282 (469)
.++++||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999997432 3678889999999999999999998 999999999
Q ss_pred cccccccccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-
Q 012164 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 360 (469)
Q Consensus 283 Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t- 360 (469)
||+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|+|++
T Consensus 160 -----------nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~ 228 (288)
T cd05050 160 -----------NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 228 (288)
T ss_pred -----------heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhC
Confidence 88888899999999999875432211 11122334667999999988899999999999999999997
Q ss_pred CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 361 GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 361 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
|..||.+....+....+......+ .+..++.++.+|+.+||+.||++|||+.|+++.|++
T Consensus 229 ~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 229 GMQPYYGMAHEEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 889998766555555443332222 234567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=298.94 Aligned_cols=247 Identities=32% Similarity=0.523 Sum_probs=203.9
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|++.+.||+|+||.||. ++..||+|.+..... ....+.+|+.++++++||||+++++++......+++|||
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 677788999999998874 346799998875432 235688999999999999999999999988899999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+++++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|+||||+ ||+++.++.+||+|||
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~-----------nili~~~~~~~l~d~g 148 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAAR-----------NILVGENLVCKIADFG 148 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchh-----------eEEEcCCCCEEECccc
Confidence 99999999997643 5899999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++................+..|+|||.+.+..++.++|+||||+++++|++ |+.||.+.........+......+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~--- 225 (261)
T cd05034 149 LARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR--- 225 (261)
T ss_pred cceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 987654321111122234568999999998889999999999999999998 9999987665554444433322222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
+...+..+.+++.+||..+|++||+++++++.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 23457889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=304.99 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=202.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.+|. +++.||+|.+.............+.+|+++++.++||||+++++.+...+..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 577788999999998873 467899998876543334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||+
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~-----------NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPD-----------NLLITSMGHIKLTDFGL 147 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchH-----------HEEECCCCCEEEeeCCC
Confidence 9999999999988888999999999999999999999998 999999999 88888899999999999
Q ss_pred ccccccCCC--------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 311 SKLLTVKED--------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 311 a~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
++....... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~ 227 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 864211000 000123467889999999888899999999999999999999999987665555544
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...... ........++..+.+||.+||+.||++||+..++.+.
T Consensus 228 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~l 270 (305)
T cd05609 228 VISDDI-EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEV 270 (305)
T ss_pred HHhccc-CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHH
Confidence 433322 1222223578889999999999999999996444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=317.43 Aligned_cols=244 Identities=27% Similarity=0.360 Sum_probs=197.2
Q ss_pred ccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CC-----ceeeEEeEEEeCCc
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HP-----NVVQFLGAVTQSSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~~ 224 (469)
+|.+.+.||+|+||.|. .+++.||||+++.. .....+-..|+.+|..++ |. |+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 68889999999999875 37899999999855 455667788999999997 43 99999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~ 302 (469)
+|||+|.+ ..+|+++++.+. .++...+..++.||+.||.+||+.+ |||+||||+|||+..+ ....
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~---------~r~~ 329 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDP---------KRSR 329 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccC---------CcCc
Confidence 99999999 679999999765 3889999999999999999999999 9999999996666422 1237
Q ss_pred eEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-cC
Q 012164 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQ 381 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~~ 381 (469)
|||+|||+|.+..... -.+..+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+....+.. .+
T Consensus 330 vKVIDFGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG 405 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG 405 (586)
T ss_pred eeEEecccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence 9999999998755332 246678899999999999999999999999999999999999987766433222110 00
Q ss_pred CC----------------------------------------------------C-CCC----C-hhhhHHHHHHHHHHH
Q 012164 382 RP----------------------------------------------------P-FKA----P-AKLYARGLKELIEEC 403 (469)
Q Consensus 382 ~~----------------------------------------------------~-~~~----~-~~~~~~~l~~li~~c 403 (469)
.+ + ... . ...-...+.+|+.+|
T Consensus 406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 00 0 000 0 012235689999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 012164 404 WNEKPAKRPTFRQIITR 420 (469)
Q Consensus 404 l~~dp~~Rps~~~ll~~ 420 (469)
|..||.+|+|+.++++|
T Consensus 486 L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNH 502 (586)
T ss_pred hccCchhcCCHHHHhcC
Confidence 99999999999999998
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.16 Aligned_cols=250 Identities=26% Similarity=0.518 Sum_probs=199.7
Q ss_pred ccccceeeecCeEEEEEE---------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--Cc
Q 012164 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 224 (469)
-|++.+.||+|+||.||. ++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 467888999999999863 46789999986442 344456799999999999999999999998775 56
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.++||||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++||||||+ ||+++.++.+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~-----------Nil~~~~~~~ 148 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAAR-----------NVLVESEHQV 148 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchh-----------eEEEcCCCCE
Confidence 899999999999999997653 5899999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----------C
Q 012164 304 KVADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD----------N 371 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~----------~ 371 (469)
+|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++++.|+..... .
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05079 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG 228 (284)
T ss_pred EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc
Confidence 99999999765432211 11234567789999999888899999999999999999998776532111 0
Q ss_pred c--H---HHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 372 E--V---PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 372 ~--~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
+ . .......... ..+..++..+.+|+.+||+.||++|||++++++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 229 QMTVTRLVRVLEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccHHHHHHHHHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 0 0111111111 12345788999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=303.72 Aligned_cols=243 Identities=28% Similarity=0.476 Sum_probs=205.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.+|. +++.||+|.+.............+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 577889999999998863 578999999876544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.+||+|||+
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~-----------nili~~~~~~kl~dfg~ 147 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPE-----------NLLLDSDGYIKITDFGF 147 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHH-----------HEEECCCCCEEEeeCCC
Confidence 9999999999998888999999999999999999999998 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
+...... .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...........+. ....+. +.
T Consensus 148 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~---~~ 219 (290)
T cd05580 148 AKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGKVRF---PS 219 (290)
T ss_pred ccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCccC---Cc
Confidence 9765432 223457889999999988888899999999999999999999998665433333332 222222 33
Q ss_pred hhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
.++..+.+++.+||..||.+|| +++++++|
T Consensus 220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 4678999999999999999999 78888776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=307.17 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=196.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. ++..||+|.+..... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 588889999999999874 567899998875432 1222456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|++ ++|.+++...+ .++...+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 85 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~-----------Nill~~~~~~kl~Dfg 149 (309)
T cd07872 85 YLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQ-----------NLLINERGELKLADFG 149 (309)
T ss_pred CCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEECCCCCEEECccc
Confidence 996 58888887544 4889999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-------
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------- 381 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~------- 381 (469)
+++...... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07872 150 LARAKSVPT-KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228 (309)
T ss_pred cceecCCCc-cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 987543221 11223457889999999865 467899999999999999999999998765543322221100
Q ss_pred --------------CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 --------------RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 --------------~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+... .....+++++.+||.+||+.||.+|||+.++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000 0112467789999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=317.58 Aligned_cols=242 Identities=30% Similarity=0.520 Sum_probs=200.7
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~g 235 (469)
..||+|+||+||. +...+|||.+.... ....+-+.+|+..-++++|.|||+++|.+.+++.+-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 3799999999995 45689999887542 344567899999999999999999999999999999999999999
Q ss_pred CHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcc
Q 012164 236 DLRAFLKR-KGAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312 (469)
Q Consensus 236 sL~~~l~~-~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~ 312 (469)
||.+++.. .|++ .+.+.-.+.+||++||.|||++. |||||||-+|||+ | +-.|.+||+|||-++
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLv-------N---TySGvlKISDFGTsK 724 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLV-------N---TYSGVLKISDFGTSK 724 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEE-------e---eccceEEecccccch
Confidence 99999975 5677 77888889999999999999998 9999999995555 2 357999999999998
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 313 LLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 313 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
....- ......+.||..|||||++..+ .|..++|||||||++.||.||++||......+..... .+-...-++.+.
T Consensus 725 RLAgi-nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-VGmyKvHP~iPe 802 (1226)
T KOG4279|consen 725 RLAGI-NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-VGMYKVHPPIPE 802 (1226)
T ss_pred hhccC-CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-hcceecCCCCcH
Confidence 76532 2233457899999999999876 7889999999999999999999999876554433222 222222233467
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.++.+.+.||.+|+.+||..||++++++..
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 889999999999999999999999999865
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.34 Aligned_cols=253 Identities=28% Similarity=0.494 Sum_probs=201.6
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC-C
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~ 223 (469)
+|+..+.||+|+||.||. +++.||||.+.... .......+.+|+.++.++ +||||+++++++... .
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 688889999999999873 35789999987543 234456788999999999 689999999988654 5
Q ss_pred ceEEEEeccCCCCHHHHHHhc-----------------------------------------------------------
Q 012164 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~----------------------------------------------------------- 244 (469)
..+++||||++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccccc
Q 012164 245 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316 (469)
Q Consensus 245 --------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~ 316 (469)
..+++..+..++.|++.||+|||+.+ |+||||||+ ||+++.++.+||+|||++.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~-----------Nil~~~~~~~kl~dfg~~~~~~~ 231 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAAR-----------NILLSENNVVKICDFGLARDIYK 231 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccC-----------eEEEcCCCcEEEEeccccccccc
Confidence 13577788899999999999999999 999999999 88888899999999999976432
Q ss_pred CCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHH-HHHhhcCCCCCCCChhhhH
Q 012164 317 KED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP-KAYAARQRPPFKAPAKLYA 393 (469)
Q Consensus 317 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 393 (469)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..+......+. +...+
T Consensus 232 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 308 (343)
T cd05103 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTT 308 (343)
T ss_pred CcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC---CCCCC
Confidence 211 11122335677999999988889999999999999999997 99999865443322 22222222222 23356
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 394 RGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 394 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+++.+++..||+.||++|||+.+++++|+.+.+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 7899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.71 Aligned_cols=251 Identities=27% Similarity=0.475 Sum_probs=200.9
Q ss_pred ccccceeeecCeEEEEEEe---------------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceee
Q 012164 156 DFTNSVEITKGTFILAFWR---------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~---------------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 214 (469)
+|+..+.||+|+||.||.. +..||+|.+.... .......+.+|+++++.++||||++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 5788899999999998752 3468999887542 3445578899999999999999999
Q ss_pred EEeEEEeCCceEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 012164 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSD 283 (469)
Q Consensus 215 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 283 (469)
+++++...+..+++|||+++++|.+++.... .+++.++..++.|++.||+|||+.+ ++|+||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~- 159 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR- 159 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh-
Confidence 9999999999999999999999999997532 3667789999999999999999999 999999999
Q ss_pred ccccccccCcceeeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--
Q 012164 284 LYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-- 360 (469)
Q Consensus 284 il~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-- 360 (469)
||+++.++.++|+|||+++......... .....++..|+|||...++.++.++|||||||++|||++
T Consensus 160 ----------Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 160 ----------NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred ----------eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 8888889999999999997653322111 122334678999999888889999999999999999998
Q ss_pred CCCCCCCCCCCcHHHHHh----hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 361 GCPPFTMKHDNEVPKAYA----ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 361 g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
|..||...+..+...... ........+.+..+++.+.+|+.+||+.||++||++.++++.|+
T Consensus 230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 230 KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 788997665544332221 11111111223456788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.73 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=202.7
Q ss_pred ccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCc
Q 012164 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 224 (469)
+|...+.||+|+||.||.. +..||+|++.... .....+.+.+|+.++.++. ||||+++++++...+.
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 4566789999999998742 3579999997542 2333457889999999997 9999999999999899
Q ss_pred eEEEEeccCCCCHHHHHHhcC-----------------------------------------------------------
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------------- 245 (469)
.++|||||.+|+|.+++.+.+
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996432
Q ss_pred ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccc
Q 012164 246 ---------------------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYV 286 (469)
Q Consensus 246 ---------------------------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~ 286 (469)
.+++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~---- 268 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR---- 268 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc----
Confidence 2456678889999999999999998 999999999
Q ss_pred cccccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 012164 287 AYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 364 (469)
Q Consensus 287 ~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p 364 (469)
||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 269 -------NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P 341 (401)
T cd05107 269 -------NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341 (401)
T ss_pred -------eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence 88888889999999999976432211 11122346788999999998889999999999999999998 8999
Q ss_pred CCCCCCCcHHHHHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 365 FTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 365 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
|......+........+ +++ .+..++.++.+|+.+||..+|.+||++++|+..|+.+.
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 342 YPELPMNEQFYNAIKRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCchHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 98765544433332222 222 23456789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=295.73 Aligned_cols=247 Identities=31% Similarity=0.553 Sum_probs=196.1
Q ss_pred eeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEE-eCCceEEEEec
Q 012164 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY 231 (469)
Q Consensus 161 ~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~E~ 231 (469)
+.||+|+||.||. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++. .+...++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 3689999998873 2357999987532 23445577889999999999999999999775 34568999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
+.+++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||+
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~-----------nili~~~~~~kl~dfg~ 144 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAAR-----------NCMLDESFTVKVADFGL 144 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcc-----------eEEEcCCCcEEECCccc
Confidence 9999999999764 34677888899999999999999998 999999999 88888899999999999
Q ss_pred ccccccCCC---CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 311 SKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 311 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
++....... .......++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..+..........+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 223 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ- 223 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC-
Confidence 875432111 11122345678999999988889999999999999999999 5677776554444444433222222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
+..+++.+.+++.+||..+|++||++.++++.|+++..
T Consensus 224 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 --PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 34467889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=295.66 Aligned_cols=247 Identities=29% Similarity=0.468 Sum_probs=203.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.++. ++..+++|.+.... ....+.+.+|+.++++++||||+++++++.+...++++||
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 677888999999998874 46789999987542 2345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.+||+|||
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~-----------ni~i~~~~~~~l~d~g 146 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGA-----------NILLTEDGDVKLADFG 146 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChh-----------hEEECCCCCEEECccc
Confidence 99999999999876 67999999999999999999999998 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPF 385 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~ 385 (469)
++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||................ .++.
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd06613 147 VSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK 225 (262)
T ss_pred cchhhhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc
Confidence 9876543211 12234578889999999776 78899999999999999999999998655433333332221 2222
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
......++.++.+|+.+||..||.+|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 22344578889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.02 Aligned_cols=250 Identities=30% Similarity=0.536 Sum_probs=203.7
Q ss_pred ccccceeeecCeEEEEEE-----ec---eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
.|+..+.||+|+||.+|. +| ..||+|.+.... .......+..|+.+++.++||||+++++++.+....++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 466788999999998874 12 359999987542 34556789999999999999999999999999899999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
||||+++++|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~-----------nili~~~~~~kl~ 148 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAAR-----------NILVNSNLVCKVS 148 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChh-----------eEEEcCCCcEEEC
Confidence 99999999999999764 45899999999999999999999998 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCc--ccCC--CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 307 DFGVSKLLTVKEDRPL--TCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
|||++........... .... .+..|+|||.+.+..++.++||||||+++|||++ |..||...........+....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~ 228 (269)
T cd05065 149 DFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY 228 (269)
T ss_pred CCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999876543221111 1111 2457999999998899999999999999999886 999998766555544443222
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
..+. +..++..+.+++.+||..+|++||++.+++..|+.+
T Consensus 229 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 RLPP---PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2222 345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.36 Aligned_cols=250 Identities=24% Similarity=0.435 Sum_probs=204.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+|+.++. +++.|++|.+...... ....+.+..|+.+++.++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 477788999999998764 5788999998765432 4566889999999999999999999999998899999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.+||+|||+
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~-----------nil~~~~~~~kl~d~g~ 145 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPA-----------NIFLDHNGVIKLGDFGC 145 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEECCCCCEEEccccc
Confidence 9999999999988777899999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCc---ccCCCCCcccCCcccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 311 SKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 311 a~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
+........... ....++..|+|||++.+.. ++.++||||||++++++++|+.||..................+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06626 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP 225 (264)
T ss_pred ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC
Confidence 877543322111 1245788999999998765 7889999999999999999999997654322222111222222
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+....+++.+.+++.+||+.||++|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 222233457889999999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=298.16 Aligned_cols=254 Identities=26% Similarity=0.479 Sum_probs=199.1
Q ss_pred CcccccceeeecCeEEEEEE---------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe--C
Q 012164 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--S 222 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 222 (469)
+.+|+..+.||+|+||.||. ++..||+|.+... .....+.+.+|++++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 44678889999999999874 4678999998643 34455778999999999999999999998754 3
Q ss_pred CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
..+++|+||+++++|.+++.+. +.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~-----------nili~~~~ 145 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATR-----------NILVESEN 145 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHh-----------hEEECCCC
Confidence 4689999999999999999764 45899999999999999999999999 999999999 88888899
Q ss_pred CeEEeecCCccccccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH------
Q 012164 302 NLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV------ 373 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~------ 373 (469)
.+||+|||++.......... .....++..|+|||.+.+..++.++||||||++++||++|..|+........
T Consensus 146 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd05081 146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND 225 (284)
T ss_pred eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc
Confidence 99999999998654322211 1122344569999999888899999999999999999998877643321100
Q ss_pred ------HHHHh-hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 374 ------PKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 374 ------~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
..... .............++..+.+|+.+||..+|++|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 226 KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000 0000111112345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=294.64 Aligned_cols=246 Identities=27% Similarity=0.402 Sum_probs=217.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|...+.||+|+||.|.+ +|+.+|+|+++++.+..++.+..-..|-++|+..+||++..+-..|...+++|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 566678999999998854 789999999999999888988999999999999999999999889999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|..||.|.-.+.+...+++.....+...|+.||.|||+++ ||.||||.+ |.++|.+|++||+|||+
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLE-----------NLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLE-----------NLLLDKDGHIKITDFGL 314 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhh-----------hheeccCCceEeeeccc
Confidence 9999999999998888999999999999999999999999 999999999 99999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
++..-.. .......+|||.|+|||++....|....|.|.+||+||||++|++||.+.+...+...+..... .+ +.
T Consensus 315 CKE~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~-kF---Pr 389 (516)
T KOG0690|consen 315 CKEEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL-KF---PR 389 (516)
T ss_pred chhcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-cC---Cc
Confidence 9864322 2334568999999999999999999999999999999999999999999888887777644331 12 45
Q ss_pred hhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
.++++.+.|+..+|.+||.+|. +++|+..|
T Consensus 390 ~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 390 TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 6788999999999999999995 46666655
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.56 Aligned_cols=245 Identities=28% Similarity=0.416 Sum_probs=200.0
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|++.+.||+|+||.+|. ++..+++|.+... .....+.+.+|+++++.++||||+++++++...+..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 56778899999998874 4678899987543 344567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
+++++|..++.+ ...+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||+
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~-----------nili~~~~~~kl~dfg~ 149 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAG-----------NILFTLDGDIKLADFGV 149 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcc-----------cEEEccCCCEEEccccc
Confidence 999999998865 456899999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
+....... .......++..|+|||++. +..++.++|||||||++|+|++|+.||...+..+....+.....+ .
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~ 227 (282)
T cd06643 150 SAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-T 227 (282)
T ss_pred cccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC-C
Confidence 87643221 1223345788999999984 346778999999999999999999999876544443333222222 2
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+..++.++.+||.+||+.||++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22344578899999999999999999999998876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=315.23 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=196.7
Q ss_pred cccccceeeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 155 LDFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
.+|.+.+.||+|+||.||. .+..||+|.+... ....+|++++++++||||+++++++......++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3689999999999999874 2467899987643 234679999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
+||++ +++|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+ |||++.++.++|+|
T Consensus 164 v~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~-----------Nill~~~~~~~l~D 228 (392)
T PHA03207 164 VMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTE-----------NIFLDEPENAVLGD 228 (392)
T ss_pred Eehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHH-----------HEEEcCCCCEEEcc
Confidence 99999 5799999977778999999999999999999999999 999999999 88888999999999
Q ss_pred cCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH----HHHhh---
Q 012164 308 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP----KAYAA--- 379 (469)
Q Consensus 308 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~----~~~~~--- 379 (469)
||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....... ..+..
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 9999765433221 122356899999999999989999999999999999999999999765432211 00000
Q ss_pred ----------------------cCCCCCCCC----hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 ----------------------RQRPPFKAP----AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ----------------------~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+++...+ ...++.++.+||.+||..||++|||+.+++.|
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001111110 12346788999999999999999999999988
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=301.53 Aligned_cols=247 Identities=22% Similarity=0.435 Sum_probs=203.3
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.+|. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+......++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 34788889999999998874 578999998875432 2346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|||+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+||
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~-----------Nill~~~~~~kl~df 160 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSD-----------NILLGMDGSVKLTDF 160 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEEcCCCCEEECcc
Confidence 999999999999875 45899999999999999999999999 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|++........ ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.................+.. ..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~ 238 (296)
T cd06654 161 GFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QN 238 (296)
T ss_pred ccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCC-CC
Confidence 99876432221 12234678899999999988889999999999999999999999976554332222222222222 22
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..++..+.+++.+||..||++|||+.+++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 34677889999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=310.10 Aligned_cols=251 Identities=30% Similarity=0.520 Sum_probs=220.6
Q ss_pred ccccceeeecCeEEEEE---E--eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~---~--~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+++...+||-|.||.|| | ..-.||||.++.+ ...+++|..|+.+|+.++|||+|+++|+|..+..+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 45667899999999876 4 3468999999855 3456889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||..|+|.+||.+. ..++.-.+++++.||..||+||..++ +|||||... |+|+.++..||++||
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAAR-----------NCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAAR-----------NCLVGENHIVKVADF 409 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhh-----------hccccccceEEeecc
Confidence 99999999999864 34888889999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++++............-++.|.|||.+....++.|+|||+|||+|||+.| |-.||.+.+-.++......+.++..
T Consensus 410 GLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~-- 487 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG-- 487 (1157)
T ss_pred chhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC--
Confidence 9999987665555555556788999999998899999999999999999988 9999998877777777766666665
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
++.+|+.+.+||..||+.+|.+||++.|+-+.|+.++.+
T Consensus 488 -PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 488 -PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred -CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 567899999999999999999999999999999988654
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=294.26 Aligned_cols=245 Identities=31% Similarity=0.595 Sum_probs=201.3
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.+|. ++..+|+|.+...... ...+.+|++++++++||||+++++++......++++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 566778999999998874 3678999988754332 24688899999999999999999999988999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
+++++|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|||+
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~-----------ni~i~~~~~~~l~d~g~ 146 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAAR-----------NCLVGENQVVKVSDFGM 146 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccc-----------eEEEcCCCeEEECCCcc
Confidence 9999999999764 45899999999999999999999998 999999999 88888889999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+...............++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+....+... +
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 223 (256)
T cd05112 147 TRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---P 223 (256)
T ss_pred eeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---C
Confidence 87654322211222334678999999998889999999999999999998 9999987655555444433222221 2
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 34578899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.74 Aligned_cols=255 Identities=25% Similarity=0.508 Sum_probs=204.7
Q ss_pred cccCCCCcccccceeeecCeEEEEEE-----eceeehhhhccc-ccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 012164 148 YEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (469)
Q Consensus 148 ~~~~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 221 (469)
.+.++...-.+....||+|+|.+||. +|..||=-.++. +...+....++|..|+.+|+.|+||||+++|+++.+
T Consensus 33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 34444444444566899999999985 577777433332 233456667899999999999999999999999987
Q ss_pred CCc--eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 222 SSP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 222 ~~~--~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
... +.+|+|.+..|+|..|+++.+++....++.|++||++||.|||++.| ||||||||.+||||. ..
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFin----------G~ 181 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVN----------GN 181 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEc----------CC
Confidence 755 78999999999999999999999999999999999999999999986 799999999955552 24
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-CcHHHHHh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYA 378 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~-~~~~~~~~ 378 (469)
.|.|||+|+|||...... ......|||.|||||.+. ..|+...||||||++|+||+|+..||..-.. .++...+.
T Consensus 182 ~G~VKIGDLGLAtl~r~s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~ 257 (632)
T KOG0584|consen 182 LGEVKIGDLGLATLLRKS---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT 257 (632)
T ss_pred cCceeecchhHHHHhhcc---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH
Confidence 589999999999875432 223378999999999998 5899999999999999999999999986544 44555554
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..|.-. .+--.+++++||.+||.. .++|||+.|||++
T Consensus 258 SGiKP~sl--~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 258 SGIKPAAL--SKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cCCCHHHh--hccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 44333211 112257899999999999 9999999999976
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=293.81 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=201.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-CceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 229 (469)
+|+..+.||+|+||.++. +++.||+|.+..... .....+.+.+|++++++++|||++++++.+... ..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 477889999999998873 467899999875433 234456788999999999999999999987644 4579999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 230 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
||+++++|.+++... ..+++.++..++.|++.||.+||+.+ ++|+||||+ ||+++.++.++|+|
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~-----------nil~~~~~~~~l~d 145 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQ-----------NVFLTRTNIIKVGD 145 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCch-----------hEEEecCCcEEEec
Confidence 999999999999763 35899999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++....... .......+++.|+|||++.+..++.++|+||||+++++|++|+.||...+.......+.....++
T Consensus 146 f~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--- 221 (257)
T cd08223 146 LGIARVLENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--- 221 (257)
T ss_pred ccceEEecccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---
Confidence 99997654322 22233457889999999999889999999999999999999999998655433333332222222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..+++.+.+++.+||+.||++|||+.+++.+
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 234678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=302.22 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=190.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC---CCCceeeEEeEEEeC-----
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQS----- 222 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~----- 222 (469)
+|+..+.||+|+||.||. +|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 477889999999999874 57889999887543221 1123455677777665 699999999988642
Q ss_pred CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
...+++|||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.+
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~-----------Nili~~~ 144 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPE-----------NILVTSG 144 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEECCC
Confidence 45799999996 5899988763 34899999999999999999999999 999999999 8888889
Q ss_pred CCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc
Q 012164 301 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 380 (469)
+.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++|++||...........+...
T Consensus 145 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (288)
T cd07863 145 GQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 222 (288)
T ss_pred CCEEECccCccccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence 99999999999765422 1223346788999999999889999999999999999999999999765443322222110
Q ss_pred -CC-----------------C-----CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 -QR-----------------P-----PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 -~~-----------------~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+. . +.....+.++..+.+|+.+||+.||++|||+.+++.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0 0000112467789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=312.66 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=194.5
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------C
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 223 (469)
.+|+..+.||+|+||.|+. .++.||||.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4788999999999998863 578899999875432 233446678899999999999999999987543 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++||||++ ++|.+.+.. .++...+..++.|++.||.|||+++ |+||||||+ ||+++.++.+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~ 165 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS-----------NIVVKSDCTL 165 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHH-----------HEEECCCCcE
Confidence 5799999995 588887754 4888999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC--
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-- 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-- 381 (469)
||+|||+++..... .......++..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 166 kL~DfG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 166 KILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred EEEeCCCccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999999764322 22234568999999999999999999999999999999999999998655433222221100
Q ss_pred -------------------CCCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 -------------------RPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 -------------------~~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
++... ......+..+++||.+||..||++|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 0011134578999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=302.79 Aligned_cols=248 Identities=28% Similarity=0.547 Sum_probs=199.2
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|+..+.||+|+||.|+. +++.||+|.+...... ........+|+.++++++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 56788999999999985 5678999999865332 22223345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
+++++|.+++...+.+++..+..++.|+++||.+||+.+ ++|+||||+ ||+++.++.++|+|||.+
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~-----------NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPE-----------NILLDENGEVKLIDFGSS 145 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGG-----------GEEESTTSEEEESSGTTT
T ss_pred ccccccccccccccccccccccccccccccccccccccc---ccccccccc-----------cccccccccccccccccc
Confidence 988899999997788999999999999999999999999 999999999 888899999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC---CC
Q 012164 312 KLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF---KA 387 (469)
Q Consensus 312 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~ 387 (469)
.... ..........++..|+|||++. +..++.++||||||+++++|++|..||...........+........ ..
T Consensus 146 ~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T PF00069_consen 146 VKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ 224 (260)
T ss_dssp EEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT
T ss_pred cccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc
Confidence 7542 1222334466888999999998 77889999999999999999999999987622222222211111000 00
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....++.+.++|.+||+.||++|||+++++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011124789999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=295.09 Aligned_cols=246 Identities=24% Similarity=0.464 Sum_probs=205.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.++. +|+.||+|.+...... ......+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 477889999999998775 6789999988754332 3344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+||
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~-----------nil~~~~~~~~l~d~ 145 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQ-----------NIFLTKDGTIKLGDF 145 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH-----------HEEEcCCCCEEEeec
Confidence 999999999997643 4789999999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|++........ ......+++.|+|||++.+..++.++|+||||+++++|++|+.||......+....+.....++.
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--- 221 (256)
T cd08218 146 GIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV--- 221 (256)
T ss_pred cceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---
Confidence 99976543211 11234578889999999988899999999999999999999999986655555444433333322
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..++.++.++|.+||+.+|++||++++++.+
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 34578889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=300.55 Aligned_cols=250 Identities=22% Similarity=0.439 Sum_probs=206.2
Q ss_pred CCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
.....+|+..+.||.|+||.+|. +|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++......
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 33445788999999999998873 678999998864422 2346688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++|+||+++++|.+++... .+++.++..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~-----------Nili~~~~~~kl 156 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSD-----------NVLLGMDGSVKL 156 (296)
T ss_pred EEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEECCCCCEEE
Confidence 9999999999999998754 5899999999999999999999999 999999999 888888999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.....+.
T Consensus 157 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~- 234 (296)
T cd06655 157 TDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE- 234 (296)
T ss_pred ccCccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-
Confidence 99999876543221 1223457889999999998889999999999999999999999998765433333332222222
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+..+++.+.+||.+||..||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 22345678899999999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=321.54 Aligned_cols=256 Identities=19% Similarity=0.217 Sum_probs=188.4
Q ss_pred CCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC------CCceeeEEeEEEe
Q 012164 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGAVTQ 221 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~ 221 (469)
...+|++.+.||+|+||.||. +++.||||++.... .....+..|+.+++.++ |++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 345799999999999999975 47889999986321 22234556777766664 4568899998876
Q ss_pred C-CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCc-----c
Q 012164 222 S-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDR-----N 294 (469)
Q Consensus 222 ~-~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~-----n 294 (469)
. ..+|+|||++ +++|.+++.+.+.+++..+..++.||+.||.|||+ .+ ||||||||+|||+....... .
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 5 5789999999 78999999888889999999999999999999998 47 99999999966664211000 0
Q ss_pred eeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH
Q 012164 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374 (469)
Q Consensus 295 il~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~ 374 (469)
.+-...+.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred ccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 000122359999999886432 1223457899999999999999999999999999999999999999876543332
Q ss_pred HHHhhc-CCCC-----------------------CCCCh--------------hhhHHHHHHHHHHHcccCCCCCCCHHH
Q 012164 375 KAYAAR-QRPP-----------------------FKAPA--------------KLYARGLKELIEECWNEKPAKRPTFRQ 416 (469)
Q Consensus 375 ~~~~~~-~~~~-----------------------~~~~~--------------~~~~~~l~~li~~cl~~dp~~Rps~~~ 416 (469)
..+... +..+ ....+ ...++.+.+||.+||..||++|||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 222110 0000 00000 012356789999999999999999999
Q ss_pred HHHH
Q 012164 417 IITR 420 (469)
Q Consensus 417 ll~~ 420 (469)
+++|
T Consensus 435 ~L~H 438 (467)
T PTZ00284 435 MTTH 438 (467)
T ss_pred HhcC
Confidence 9987
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=295.96 Aligned_cols=243 Identities=33% Similarity=0.559 Sum_probs=196.2
Q ss_pred eeecCeEEEEEE-----ec--eeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccC
Q 012164 162 EITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 162 ~ig~G~~~~~~~-----~g--~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
.||+|+||.|+. +| ..+++|.+... ......+.+.+|+++++++ +||||+++++++...+..+++|||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 589999998874 22 25688887633 2344556788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 234 KGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 234 ~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
+++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+ ||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~-----------nili 145 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR-----------NILV 145 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecccccc-----------eEEE
Confidence 999999997532 3788899999999999999999998 999999999 8888
Q ss_pred CCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHH
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKA 376 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~ 376 (469)
+.++.+||+|||++...... ........+..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus 146 ~~~~~~kl~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 223 (270)
T cd05047 146 GENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223 (270)
T ss_pred cCCCeEEECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH
Confidence 89999999999998632211 11111234567999999988889999999999999999997 9999987655544444
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
+......+. +...+.++.+++.+||..||.+|||+.++++.|+.+.
T Consensus 224 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 LPQGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HhCCCCCCC---CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 433222222 2346778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=293.78 Aligned_cols=240 Identities=32% Similarity=0.604 Sum_probs=199.7
Q ss_pred ccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
+|+..+.||+|+||.++. ++..||+|.+.... ..+.+.+|+.++++++||||+++++++... ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 577889999999998875 67889999886431 235788999999999999999999998754 579999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 233 ~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||+
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~-----------nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAAR-----------NILVSEDGVAKVSDFGL 146 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcc-----------eEEEcCCCcEEECCCcc
Confidence 9999999997643 4789999999999999999999998 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+...... ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+....+....++. .+
T Consensus 147 ~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 219 (254)
T cd05083 147 ARVGSMG----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PP 219 (254)
T ss_pred ceecccc----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC---CC
Confidence 8754321 112234567999999988899999999999999999997 999998776555554443332222 23
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
..++..+.+++.+||+.+|++||++++++..|+
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=311.05 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=193.8
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------C
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 223 (469)
.+|+..+.||+|+||.|+. .++.||+|.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 3788899999999999874 578999999875432 334456778899999999999999999988643 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++||||++ ++|.+.+.. .++...+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 96 ~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~-----------Nill~~~~~~ 158 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS-----------NIVVKSDCTL 158 (355)
T ss_pred eeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChH-----------HEEECCCCCE
Confidence 4799999995 578777754 4889999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh----
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---- 379 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~---- 379 (469)
||+|||+++..... .......+|..|+|||++.+..++.++|||||||++|+|++|+.||.+....+.......
T Consensus 159 kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 159 KILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred EEeeCcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999764322 222345689999999999998999999999999999999999999976543221111000
Q ss_pred -----------------cCCCCC-----------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 -----------------RQRPPF-----------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 -----------------~~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+.. .......+..+++||.+||..||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 00112235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=304.50 Aligned_cols=246 Identities=17% Similarity=0.364 Sum_probs=190.8
Q ss_pred ceeeecC--eEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 160 SVEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 160 ~~~ig~G--~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
.+.||+| +|+.|+. +|+.||+|.+..... .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 4679999 5566653 678999999875533 2344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 233 PKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 233 ~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
++|+|.+++..+ +.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.++++||+.
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~-----------Nil~~~~~~~~l~~~~~ 147 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKAS-----------HILISVDGKVYLSGLRS 147 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChh-----------hEEEecCCcEEEcccch
Confidence 999999999753 45899999999999999999999999 999999999 88888899999999986
Q ss_pred ccccccCCCC------CcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC
Q 012164 311 SKLLTVKEDR------PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 311 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+......... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 227 (327)
T cd08227 148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 227 (327)
T ss_pred hhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCc
Confidence 5433211110 0112345678999999976 4688999999999999999999999976543332211111100
Q ss_pred C------------------------------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 P------------------------------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~------------------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+ ........+++.+.+|+.+||+.||++|||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 0000112356789999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=295.62 Aligned_cols=249 Identities=29% Similarity=0.496 Sum_probs=203.8
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|+....||+|+||.||. ....|++|.+.... .....+.+.+|++++++++||||+++++++.+....
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 577888999999999874 23578999876432 233557789999999999999999999999988899
Q ss_pred EEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 226 MIVTEYLPKGDLRAFLKRKG---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+ ||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~-----------Nil 149 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAAR-----------NCL 149 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccc-----------eEE
Confidence 99999999999999998655 6899999999999999999999999 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHH
Q 012164 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 375 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~ 375 (469)
++.++.++++|||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 150 i~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~ 229 (275)
T cd05046 150 VSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN 229 (275)
T ss_pred EeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH
Confidence 8889999999999987543222222233345678999999988888999999999999999998 889997665554444
Q ss_pred HHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 376 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
...... .... ....++..+.+++.+||+.||++|||+.++++.|.
T Consensus 230 ~~~~~~-~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGK-LELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCC-cCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 443222 1111 23357789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=296.37 Aligned_cols=240 Identities=25% Similarity=0.445 Sum_probs=195.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +++.||+|.+.... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 466778999999998874 57899999886542 34455678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|..+ ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|||+
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-----------Nill~~~~~~~l~dfg~ 141 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPS-----------NMLVNTRGQVKLCDFGV 141 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHH-----------HEEECCCCCEEEeeCCc
Confidence 9999999765 34788899999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-------HHHHHhhcCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-------VPKAYAARQRP 383 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-------~~~~~~~~~~~ 383 (469)
+...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+ ....+.....+
T Consensus 142 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (279)
T cd06619 142 STQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218 (279)
T ss_pred ceecccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC
Confidence 9764322 2223468889999999998889999999999999999999999997533221 11111111111
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
. .....+++++.+|+.+||+.||++||++++++++
T Consensus 219 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 V--LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C--CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1 1233467889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=298.11 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=200.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|++.+.||+|+||.+|. ++..|++|.+... +....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 578889999999999874 4789999998643 34556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++++|..++.+ ...+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.++|+|||
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~-----------Nili~~~~~~kl~dfg 155 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAG-----------NVLLTLDGDIKLADFG 155 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcc-----------eEEEcCCCCEEEccCc
Confidence 9999999988765 456899999999999999999999998 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
++...... ........++..|+|||++. ...++.++|||||||++|+|++|..||...+.......+..... +
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~ 233 (292)
T cd06644 156 VSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-P 233 (292)
T ss_pred cceecccc-ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC-c
Confidence 98653322 11122345788999999985 33567899999999999999999999976554333333322222 2
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+..++.++.++|.+||..||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 222344577889999999999999999999999876
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=294.35 Aligned_cols=249 Identities=29% Similarity=0.505 Sum_probs=205.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.+|. ++..+|+|.+...... ...+.+.+|+++++.++|+||+++++.+...+..++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 577889999999998863 5678999988754332 255778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
++++++|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~-----------ni~~~~~~~~~l~d 145 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAG-----------NILLGEDGSVKIAD 145 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------hEEEcCCCCEEEcc
Confidence 99999999999763 45899999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 308 FGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 308 fgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
||++......... ......++..|+|||.+... .++.++|+||||+++++|++|+.||...+.............+
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP 225 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC
Confidence 9998765533222 11234578899999998776 7889999999999999999999999876655444443333222
Q ss_pred CCCCCh--hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPA--KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...... ..+++.+.+++.+||..||++|||+.+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 222222 3678899999999999999999999999876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=295.38 Aligned_cols=253 Identities=26% Similarity=0.513 Sum_probs=207.9
Q ss_pred cccccceeeecCeEEEEEEe-----c----eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 155 LDFTNSVEITKGTFILAFWR-----G----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~~-----g----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
.+|+..+.||+|+||.+|.. | ..||+|.+.... .......+.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 36777889999999988752 2 258999876543 24455778899999999999999999999987 788
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++++||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||||+ ||+++.++.+|
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~-----------nil~~~~~~~k 149 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAAR-----------NVLVKTPQHVK 149 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcc-----------eEEEcCCCeEE
Confidence 9999999999999999874 45899999999999999999999998 999999999 88888899999
Q ss_pred EeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCC
Q 012164 305 VADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 382 (469)
|+|||+++......... .....++..|+|||.+....++.++|+||||+++|++++ |+.||......++...+.....
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 229 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER 229 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Confidence 99999998654322111 112223567999999988889999999999999999998 9999988766666555543332
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.+. +..++..+.+++.+||..||.+||++.++++.|+++.+.
T Consensus 230 ~~~---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 LPQ---PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 222 234667899999999999999999999999999998665
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.67 Aligned_cols=246 Identities=26% Similarity=0.470 Sum_probs=199.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.++. +|..||+|.+.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 577788999999998864 57899999886432 33445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 231 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|+++++|..++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+ ||+++.++.+||+
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~-----------nil~~~~~~~~l~ 145 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPT-----------NVLVNGNGQVKLC 145 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHH-----------HEEECCCCCEEEe
Confidence 99999999998763 368999999999999999999997 46 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 380 (469)
|||++...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+...
T Consensus 146 dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 222 (286)
T cd06622 146 DFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI 222 (286)
T ss_pred ecCCcccccCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH
Confidence 99998764322 12234577889999998654 3478999999999999999999999765544433332221
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
........+..+++++.+||.+||..+|++||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111122234588999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=293.69 Aligned_cols=249 Identities=27% Similarity=0.481 Sum_probs=199.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccC--CCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--Cce
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 225 (469)
.+|+..+.||+|+||.+|. +|..||+|.+..... ........+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3678889999999998874 578899998764432 1233456788999999999999999999988753 567
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++++||+++++|.+++...+.+++.....++.|++.||.|||+.+ ++|+||+|+ ||+++.++.+||
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~-----------nil~~~~~~~~l 147 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGA-----------NILRDSAGNVKL 147 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHH-----------HEEECCCCCEEE
Confidence 899999999999999988778999999999999999999999998 999999999 888888999999
Q ss_pred eecCCccccccCC--CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 306 ADFGVSKLLTVKE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 306 ~Dfgla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
+|||++....... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||.................
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~- 226 (266)
T cd06651 148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT- 226 (266)
T ss_pred ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-
Confidence 9999987543211 1111234578899999999988899999999999999999999999986544333222222111
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+..+++.+.+++ +||..+|++||++++++.|
T Consensus 227 -~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 -NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1122345678889999 6888999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=294.82 Aligned_cols=251 Identities=26% Similarity=0.518 Sum_probs=202.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC---CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|+..+.||+|+||.+|. ++..||+|.+...... .....+.+..|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 367778999999998874 6788999988643321 12345778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC-CeEEe
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG-NLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~-~vkl~ 306 (469)
|+||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++ .++|+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~-----------nil~~~~~~~~~l~ 146 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGA-----------NLLIDSTGQRLRIA 146 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEEcCCCCEEEEc
Confidence 9999999999999998888999999999999999999999999 999999999 77776665 59999
Q ss_pred ecCCccccccCCCC---CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CC
Q 012164 307 DFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR 382 (469)
Q Consensus 307 Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~ 382 (469)
|||++......... ......++..|+|||.+.+..++.++|+||||+++++|++|..||...........+... ..
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 226 (268)
T cd06630 147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226 (268)
T ss_pred ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc
Confidence 99998766533111 112345788999999998888999999999999999999999999755433322222111 11
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
......+..+++++.+++.+||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11122345678899999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=297.57 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=205.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+|+.+|. ++..||+|.+...........+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 477889999999998764 478999999986655454566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++.....+++..+..++.|+++||.|||+.+ ++|+||+|+ ||+++.++.++|+|||+
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~-----------nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPD-----------NILLDEQGHVHITDFNI 146 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH-----------HeEEcCCCCEEEeeccc
Confidence 9999999999988778999999999999999999999998 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......... ........+.
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 223 (258)
T cd05578 147 ATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QETADVLYPA 223 (258)
T ss_pred ccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH-hccccccCcc
Confidence 87654322 22334578889999999888889999999999999999999999987664322221111 1112222344
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCH--HHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTF--RQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~--~~ll~~ 420 (469)
.++..+.++|.+||..||.+||++ ++++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 578899999999999999999999 666543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=293.26 Aligned_cols=243 Identities=30% Similarity=0.516 Sum_probs=199.9
Q ss_pred eeeecCeEEEEEE------ec--eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 161 VEITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 161 ~~ig~G~~~~~~~------~g--~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
+.||+|+||.||. ++ ..||+|.+...... ...+.+.+|+.++++++||||+++++.+.. ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 3689999998873 12 36999998866432 556789999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 233 ~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
++++|.+++.+.. .+++..++.++.|++.||+|||+.+ ++|+||||+ ||+++.++.+||+|||+
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~-----------nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAAR-----------NILLASDDKVKIGDFGL 143 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcc-----------cEEEecCCEEEeccccc
Confidence 9999999998754 5899999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 311 SKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 311 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+...... ..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~ 221 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER--LE 221 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc--CC
Confidence 9876432211 1122346778999999998899999999999999999998 99999876655554444322211 11
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
.+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 23356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=296.14 Aligned_cols=245 Identities=28% Similarity=0.483 Sum_probs=204.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.+|. +|+.||+|.+.... .......+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 567778999999998874 57899999987542 23344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||+
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~-----------ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAA-----------NILLSEEGDVKLADFGV 144 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH-----------HEEECCCCCEEEccccc
Confidence 99999999999865 7899999999999999999999998 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.....+... ..
T Consensus 145 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 221 (274)
T cd06609 145 SGQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GN 221 (274)
T ss_pred ceeecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--cc
Confidence 98765332 1222345788899999999888999999999999999999999999765544433333222222221 12
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.++.++.+++.+||..||++|||+++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 278899999999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=293.21 Aligned_cols=245 Identities=26% Similarity=0.467 Sum_probs=202.9
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||.|+||.++. ++..|++|.+... ...+.+.+|++++++++||||+++++++.+....++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 4678888999999998764 3688999988643 12578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+||
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~-----------ni~~~~~~~~~l~df 143 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAG-----------NILLNEEGQAKLADF 143 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcc-----------eEEECCCCcEEEccc
Confidence 99999999999975 445899999999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|++........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||............... ..+....
T Consensus 144 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 221 (256)
T cd06612 144 GVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-PPPTLSD 221 (256)
T ss_pred ccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC-CCCCCCc
Confidence 99986543321 222345788999999999888999999999999999999999999876544333222221 1222223
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..++..+.++|.+||+.||++|||+++++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 44577899999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.19 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=209.4
Q ss_pred ccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+.-+.||+|+||.|+ .+|+.+|.|.+.+..+..+.......+|..++++++.++||.+-.+|++.+.+|+|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 57778899999998765 4899999999987766555555677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
.|+||+|.-+|.+.+ .+++..+..++.+|+.||++||+.+ ||.|||||+ |||+|+.|+|+|+|+
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPe-----------NILLDd~GhvRISDL 331 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPE-----------NILLDDHGHVRISDL 331 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChh-----------heeeccCCCeEeecc
Confidence 999999999998766 6999999999999999999999999 999999999 999999999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|||..++.. .+....+||.+|||||++.++.|+...|.|||||++|||+.|+.||.......-.+.+...........
T Consensus 332 GLAvei~~g--~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey 409 (591)
T KOG0986|consen 332 GLAVEIPEG--KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEY 409 (591)
T ss_pred ceEEecCCC--CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhc
Confidence 999987643 344556899999999999999999999999999999999999999975433222222211111111223
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
+..+++++++|....|.+||.+|.. +.++.+|
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 4678999999999999999999964 4466555
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=290.51 Aligned_cols=243 Identities=30% Similarity=0.534 Sum_probs=199.1
Q ss_pred eeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCC
Q 012164 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (469)
Q Consensus 161 ~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gs 236 (469)
+.||+|+||.++. .++.||+|.+..... ......+.+|++++++++||||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 3689999988763 378999998875532 2455678999999999999999999999999999999999999999
Q ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccc
Q 012164 237 LRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315 (469)
Q Consensus 237 L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~ 315 (469)
|.+++... ..++...+..++.+++.||.|||+++ ++||||||+ ||+++.++.+||+|||++....
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~-----------nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAAR-----------NCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcc-----------eEEEcCCCcEEEeecccccccc
Confidence 99999753 45889999999999999999999999 999999999 8888889999999999997644
Q ss_pred cCCCCCc-ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhH
Q 012164 316 VKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 393 (469)
Q Consensus 316 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (469)
....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+......+ .+..++
T Consensus 145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 221 (251)
T cd05041 145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP---APQLCP 221 (251)
T ss_pred CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC---CCccCC
Confidence 2111111 11223567999999988889999999999999999999 899998766554444443322222 234567
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 394 RGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 394 ~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
..+.+++.+||..+|++|||+.++++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 89999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=291.78 Aligned_cols=245 Identities=34% Similarity=0.608 Sum_probs=202.8
Q ss_pred ccceeeecCeEEEEEE---e------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 158 TNSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 158 ~~~~~ig~G~~~~~~~---~------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
++.+.||.|+||.++. . +..||+|.+.... .......+..|+.+++.++||||+++++++.+.+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 4567899999998763 2 3789999986542 233557889999999999999999999999998999999
Q ss_pred EeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 229 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~-----------nil~~~~~~~~l~ 145 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAAR-----------NCLVGENLVVKIS 145 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccc-----------eEEEccCCeEEEc
Confidence 999999999999986544 899999999999999999999998 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
|||++...............+++.|+|||.+.+..++.++||||||+++++|++ |+.||...+.......+........
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (258)
T smart00219 146 DFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK 225 (258)
T ss_pred ccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 999997665432222112336788999999988889999999999999999998 8999987655555555443333322
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
+..++..+.+++.+||..||++|||+.++++.|
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 344788999999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=295.09 Aligned_cols=240 Identities=24% Similarity=0.417 Sum_probs=185.7
Q ss_pred eeecCeEEEEEEec-----------------------------eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCce
Q 012164 162 EITKGTFILAFWRG-----------------------------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212 (469)
Q Consensus 162 ~ig~G~~~~~~~~g-----------------------------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 212 (469)
.||+|+||.||... ..|++|.+.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 58999999887421 358888876432 2334568889999999999999
Q ss_pred eeEEeEEEeCCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc
Q 012164 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291 (469)
Q Consensus 213 ~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~ 291 (469)
+++++++.+....++||||+++|+|..++.+ .+.+++..+..++.|++.||+|||+.+ |+||||||+||++....
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~- 154 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG- 154 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC-
Confidence 9999999999999999999999999999975 456899999999999999999999998 99999999955553110
Q ss_pred CcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHH-hCCCCCCCCC
Q 012164 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI-EGCPPFTMKH 369 (469)
Q Consensus 292 ~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~-tg~~p~~~~~ 369 (469)
..-+....+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....
T Consensus 155 ---~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 ---LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred ---cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 00012335899999988643211 12346778999998865 46889999999999999985 6999998766
Q ss_pred CCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 370 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
..+...........+ ...++.+.++|.+||+.+|++|||+.+++++|
T Consensus 227 ~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 227 PSEKERFYEKKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hHHHHHHHHhccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 544433332211111 22346799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=302.10 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=204.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.+|. +++.||+|.+...........+.+..|+++++.++||||+++++.+.+....++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 577888999999998874 478999999986654444456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+||
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-----------Nili~~~~~~~l~df 147 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPE-----------NILLHESGHIMLSDF 147 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChH-----------HeEEcCCCCEEEeec
Confidence 99999999999754 45899999999999999999999999 999999999 888888999999999
Q ss_pred CCccccccCCCC----------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh
Q 012164 309 GVSKLLTVKEDR----------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 360 (469)
Q Consensus 309 gla~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t 360 (469)
|++......... ......|+..|+|||++.+..++.++||||||+++|+|++
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence 998754322110 0112357888999999998889999999999999999999
Q ss_pred CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC----HHHHHHH
Q 012164 361 GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT----FRQIITR 420 (469)
Q Consensus 361 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~ll~~ 420 (469)
|+.||...+.......+... ..... .....++.+.+++.+||..||++||| +++++++
T Consensus 228 g~~pf~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 228 GTTPFKGSNRDETFSNILKK-EVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCCCchHHHHHHHhcC-CccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 99999876654444333221 22221 12236889999999999999999999 8888776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.93 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=203.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||.|+||.++. ++..||+|.+... .....+.+..|++++++++||||+++++.+......++|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 588888999999998864 4788999988643 34556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|||
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~-----------nili~~~~~~~l~d~g 148 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAG-----------NILLTLDGDVKLADFG 148 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChh-----------hEEECCCCCEEEccCc
Confidence 99999999999764 46999999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
++....... .......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...........+.....+
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 226 (280)
T cd06611 149 VSAKNKSTL-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP- 226 (280)
T ss_pred cchhhcccc-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC-
Confidence 986543221 1222345788999999975 335678999999999999999999999876554444333222222
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+..++.++.++|.+||..||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 222344678899999999999999999999999887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=293.43 Aligned_cols=244 Identities=27% Similarity=0.419 Sum_probs=189.3
Q ss_pred eeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 162 ~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
.||+|+||.||. ++..+|+|.+.... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 689999998874 23568999886543 223345688899999999999999999999988899999999999
Q ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 235 gsL~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+|.+++.... ..++..+..++.|++.||+|||+.+ ++|+||||+ ||+++.++.+||+|||
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~-----------nil~~~~~~~kL~dfg 145 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALR-----------NCLLTADLTVKIGDYG 145 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcc-----------eEEEcCCCcEEECCcc
Confidence 99999997532 3566778889999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCC-CCcccCCCCCcccCCcccCCC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhc
Q 012164 310 VSKLLTVKED-RPLTCQDTSCRYVAPEVFKNE-------EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 310 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 380 (469)
+++....... .......++..|+|||++.+. .++.++||||||+++|+|++ |+.||......+........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05087 146 LSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225 (269)
T ss_pred ccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc
Confidence 9875432211 111234467889999998642 35789999999999999996 99999876554443322222
Q ss_pred CCCCC--CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 381 QRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 381 ~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
..... +......++.+.+++..|| .+|++|||+++|+..|.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 21111 1122345678999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=293.51 Aligned_cols=242 Identities=29% Similarity=0.527 Sum_probs=194.5
Q ss_pred eeecCeEEEEEEe-----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 162 EITKGTFILAFWR-----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 162 ~ig~G~~~~~~~~-----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.||+|+||.||.. +..+|+|.+.... .......+.+|+.+++.++||||+++++++......+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999988741 2579999886442 22345678899999999999999999999998899999999
Q ss_pred ccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC--
Q 012164 231 YLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG-- 301 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~-- 301 (469)
|+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+ ||+++.++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~-----------nil~~~~~~~ 145 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAAR-----------NCLVSEKGYD 145 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChh-----------eEEEecCCCC
Confidence 99999999999742 23788999999999999999999998 999999999 66666555
Q ss_pred ---CeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHH
Q 012164 302 ---NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKA 376 (469)
Q Consensus 302 ---~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~ 376 (469)
.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....
T Consensus 146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~ 225 (269)
T cd05044 146 ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225 (269)
T ss_pred CCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH
Confidence 899999999875532211 11122345678999999998899999999999999999998 9999986655444443
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
+....... .+..++..+.++|.+||..+|++||+++++++.|+
T Consensus 226 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 VTAGGRLQ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HhcCCccC---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 32222222 23457889999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.75 Aligned_cols=259 Identities=20% Similarity=0.349 Sum_probs=199.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 228 (469)
+|++.+.||+|+||.||. ++..||+|.+..... .......+..|+.++++++||||++++++|... ..+|+|
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 788999999999999985 567899998875543 334457789999999999999999999988654 568999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCcccccccccC------cc
Q 012164 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP----VPIIHRDLEPSDLYVAYWQND------RN 294 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~ivH~Dlkp~Nil~~~~~~~------~n 294 (469)
|||+++++|.+++.. .+.+++..++.|+.||+.||.|||+.++ .+||||||||+|||+...... ..
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 999999999999975 3569999999999999999999998431 239999999998877531100 00
Q ss_pred eeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012164 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372 (469)
Q Consensus 295 il~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~ 372 (469)
...+..+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred cccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 11234567999999999765422 12234568999999999864 357899999999999999999999997654432
Q ss_pred HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 373 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
........ .+.+ +...++.++.+||..||..+|.+||++.+++.+
T Consensus 251 qli~~lk~-~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 251 QLISELKR-GPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHhc-CCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 22222111 1211 223467889999999999999999999999965
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=294.96 Aligned_cols=244 Identities=29% Similarity=0.504 Sum_probs=203.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..+.||.|+||.+|. ++..||+|.+.... .......+.+|+.+++.+.||||+++++++.+....++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 567778999999998874 46889999886442 23445788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++.. +.+++..+..++.|++.||+|||+.+ ++|+||+|+ ||+++.++.++|+|||+
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~-----------Nil~~~~~~~~l~dfg~ 147 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAA-----------NVLLSEQGDVKLADFGV 147 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChh-----------hEEEcCCCCEEEccccc
Confidence 9999999999875 46899999999999999999999998 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
+....... .......++..|+|||++.+..++.++|+||||+++|+|++|..||...........+.....+ ....
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~ 223 (277)
T cd06640 148 AGQLTDTQ-IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP---TLTG 223 (277)
T ss_pred ceeccCCc-cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC---CCch
Confidence 97654322 1222345788899999998888999999999999999999999999876554443333222222 2244
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.++..+.+++.+||..+|++||++.+++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 678899999999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=290.80 Aligned_cols=245 Identities=26% Similarity=0.460 Sum_probs=202.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.+|. +++.+|+|.+...... ......+.+|++++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 477788999999998874 6788999998765433 3445788999999999999999999999998899999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC-CCeEEee
Q 012164 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS-GNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~-~~vkl~D 307 (469)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+ ||+++.+ +.+||+|
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~-----------nil~~~~~~~~~l~d 145 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQ-----------NILLDKHKMVVKIGD 145 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEEcCCCCEEEEcc
Confidence 99999999999764 34899999999999999999999998 999999999 6666644 4689999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+......+
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--- 220 (256)
T cd08220 146 FGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP--- 220 (256)
T ss_pred CCCceecCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---
Confidence 99998654322 2223457889999999998888999999999999999999999998766554444443332222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..++..+.+++.+||..||++|||+.+++++
T Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 234578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=296.63 Aligned_cols=242 Identities=26% Similarity=0.406 Sum_probs=195.8
Q ss_pred eecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 163 ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
||+|+||.||. +|+.||+|.+.............+..|++++++++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999998874 5789999988754433333445677899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccc
Q 012164 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315 (469)
Q Consensus 238 ~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~ 315 (469)
.+++.+.+ .+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||++....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~-----------Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPE-----------NVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH-----------HEEECCCCCEEEccCcchhhhc
Confidence 99998755 6899999999999999999999999 999999999 8888889999999999987654
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHH
Q 012164 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 395 (469)
Q Consensus 316 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (469)
. ........++..|+|||.+.+..++.++||||||+++++|++|+.||...........+...........+..+++.
T Consensus 147 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (277)
T cd05577 147 G--GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPE 224 (277)
T ss_pred c--CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHH
Confidence 2 12223345778999999998888999999999999999999999999765542222222222111111223456889
Q ss_pred HHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 396 LKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 396 l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+.++|.+||+.||++|| ++.+++.|
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 99999999999999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=298.96 Aligned_cols=245 Identities=24% Similarity=0.444 Sum_probs=201.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.+|. +|..||+|.+.... .......+.+|+++++.++||||+++++++.....+++|||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 677888999999999874 47889999876432 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++++|.+++...+.+++..+..++.+++.||.|||+ .+ ++|+||+|+ ||+++.++.++|+|||
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~-----------nil~~~~~~~~l~d~g 149 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPS-----------NILVNSRGQIKLCDFG 149 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHH-----------HEEECCCCcEEEccCC
Confidence 99999999999888889999999999999999999997 46 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--------cH---HHHHh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--------EV---PKAYA 378 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~--------~~---~~~~~ 378 (469)
++...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...... .+ ...+.
T Consensus 150 l~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd06620 150 VSGELINS---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226 (284)
T ss_pred cccchhhh---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence 98654321 112346788999999998888999999999999999999999999865442 11 11111
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
....+. .....++..+.+|+.+||..||++|||+++++++.
T Consensus 227 ~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 QEPPPR--LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hccCCC--CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111111 11233678899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=291.73 Aligned_cols=247 Identities=27% Similarity=0.462 Sum_probs=204.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccC--CCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
+|+..+.||+|+||.+|. ++..|++|.+..... ...+..+.+.+|+.+++.++||||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 366778899999998874 578999998864321 2234557789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
+||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.+||+||
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~-----------ni~~~~~~~~kl~d~ 146 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGA-----------NILVDTNGVVKLADF 146 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEECCCCCEEEccC
Confidence 999999999999988878999999999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
|++....... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.............. ......
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~ 222 (258)
T cd06632 147 GMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKELPP 222 (258)
T ss_pred ccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccCCC
Confidence 9987654322 223456788999999987766 88999999999999999999999976553333322222 112222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..+++.+.+++.+||..+|++||++.+++.+
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 345678899999999999999999999999865
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=293.56 Aligned_cols=251 Identities=28% Similarity=0.484 Sum_probs=200.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC-------CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 223 (469)
+|...+.||.|+||.||. +|+.||+|.+...... .....+.+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 567788999999999874 5789999987532111 1122356888999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++|+||+++++|.+++.+.+.++...+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~-----------nil~~~~~~~ 147 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKAD-----------NLLVDADGIC 147 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChh-----------hEEEcCCCeE
Confidence 99999999999999999988888999999999999999999999998 999999999 8888889999
Q ss_pred EEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc
Q 012164 304 KVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 380 (469)
+|+|||+++....... .......++..|+|||.+.+.. ++.++|+||||+++|++++|..||......+........
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc
Confidence 9999999876432211 1122345788999999987654 788999999999999999999999754433222222111
Q ss_pred C-CCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 Q-RPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ~-~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
. ..... .....++..+.+++.+||..||++|||++++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 11111 1223567899999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=292.86 Aligned_cols=243 Identities=26% Similarity=0.439 Sum_probs=190.3
Q ss_pred eeecCeEEEEEEe-------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 162 EITKGTFILAFWR-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 162 ~ig~G~~~~~~~~-------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+||+|+||.||.. ...+|+|.+... ........+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 6899999988742 246788876543 2344456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 235 gsL~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+|.+++.... ..++..+..++.||+.||+|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~-----------Nill~~~~~~kl~dfg 145 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALR-----------NCQLTADLSVKIGDYG 145 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHh-----------heEecCCCcEEEeccc
Confidence 99999997643 2467788899999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCC-CCcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhc
Q 012164 310 VSKLLTVKED-RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 310 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 380 (469)
++........ .......++..|+|||++.. ..++.++|||||||++|+|++ |..||......+........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05042 146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225 (269)
T ss_pred cccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc
Confidence 9865332211 11122345678999998642 356789999999999999998 88999876554444443333
Q ss_pred CCCC--CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 381 QRPP--FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 381 ~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
.... .+.....+++.+.+++..|| .||++|||++++++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 3222 22223467788999999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=310.58 Aligned_cols=245 Identities=27% Similarity=0.507 Sum_probs=211.2
Q ss_pred ccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+++..++||+|.||.|.. +...||||.+....... ....|.+|+.+|.+|+|||++++||+..+ ....+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 566788999999998863 23689999998765432 56789999999999999999999999987 67899
Q ss_pred EEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
|+|+++.|||.+.|.. ...|....+..++.||+.||.||.+++ +|||||... |+|+-....|||
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAAR-----------NlllasprtVKI 253 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAAR-----------NLLLASPRTVKI 253 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhh-----------hheecccceeee
Confidence 9999999999999986 345889999999999999999999998 999999999 777777889999
Q ss_pred eecCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCC
Q 012164 306 ADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+||||.+..+..+.. +......++.|+|||.+....++.+||||+|||++|||+| |..||.+.....+...+..+.+
T Consensus 254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er 333 (1039)
T KOG0199|consen 254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER 333 (1039)
T ss_pred ecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc
Confidence 999999987654432 2233345778999999999999999999999999999998 9999999999888888875555
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+. ++.+++++.+++..||..+|.+|||+..|...
T Consensus 334 LpR---Pk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 334 LPR---PKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCC---CCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 443 56789999999999999999999999999844
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=307.64 Aligned_cols=248 Identities=27% Similarity=0.475 Sum_probs=216.5
Q ss_pred CCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
.....|.+...||+|.|+.|.. +|..||||.+.+.... ....+.+.+|+++|+.++||||++++.+......+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3444678889999999998864 7899999998876543 444466889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
+||||+.+|.+.+++.++++..+.++..++.|+..|++|||+++ |||||||++ |+|++.+..+||+
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~e-----------NilL~~~mnikIa 197 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAE-----------NILLDENMNIKIA 197 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchh-----------hcccccccceeee
Confidence 99999999999999999999999999999999999999999999 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP 384 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~ 384 (469)
|||++.++.. .......+|++.|.|||++.+..|+ +.+|+||+|+++|-|+.|.+||.+.+-.+......... +.+
T Consensus 198 DfgfS~~~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp 275 (596)
T KOG0586|consen 198 DFGFSTFFDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP 275 (596)
T ss_pred ccccceeecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc
Confidence 9999988763 3455678999999999999998765 79999999999999999999999888777666554433 333
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
+ -++.+..++|+++|.++|.+|++.+++..+-
T Consensus 276 ~-----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 276 F-----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred c-----eeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 3 3567789999999999999999999998873
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=297.11 Aligned_cols=244 Identities=29% Similarity=0.502 Sum_probs=201.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..+.||+|+||.+|. ++..||+|.+.... .....+.+.+|+.++++++||||+++++++......++|+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 466778899999998874 46789999886442 23445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++.. +.+++..+..++.|+++||.|||+.+ ++|+||+|+ ||+++.++.++|+|||+
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~-----------ni~i~~~~~~~l~dfg~ 147 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAA-----------NVLLSEQGDVKLADFGV 147 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChh-----------eEEEeCCCCEEEccccc
Confidence 9999999998864 46899999999999999999999998 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
+....... .......++..|+|||++.+..++.++|+||||+++|+|++|+.||...........+.....+. ...
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~ 223 (277)
T cd06642 148 AGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT---LEG 223 (277)
T ss_pred cccccCcc-hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC---CCc
Confidence 87654321 11222457888999999998889999999999999999999999997655544433332222221 233
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.++..+.+++.+||..+|++||++.+++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 567889999999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=290.83 Aligned_cols=241 Identities=22% Similarity=0.380 Sum_probs=184.8
Q ss_pred eeecCeEEEEEEe-----------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 162 EITKGTFILAFWR-----------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 162 ~ig~G~~~~~~~~-----------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
.||+|+||.||.. ...|++|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 6899999988743 125888887643 23444678889999999999999999999998888
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.+++|||+++++|..++... +.+++..+..++.||+.||.|||+.+ ++||||||+|||+.... .-......+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~----~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREG----IDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCC----ccCCCCcee
Confidence 99999999999999998754 56899999999999999999999998 99999999955553110 000111238
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCCCcHHHHHhhcC
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDi~SlGvil~el~-tg~~p~~~~~~~~~~~~~~~~~ 381 (469)
+++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|+.||......+..... ...
T Consensus 152 ~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~ 225 (262)
T cd05077 152 KLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQ 225 (262)
T ss_pred EeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcC
Confidence 99999998654321 2245678899999886 457889999999999999997 589998765443332222 111
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
.. . ....++++.+||.+||+.||++||++.+|+.+|+
T Consensus 226 ~~-~---~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 226 CM-L---VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cc-C---CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11 1 1123567999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=291.90 Aligned_cols=239 Identities=26% Similarity=0.422 Sum_probs=198.4
Q ss_pred eecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 163 ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
||.|+||.+|. +++.||+|.+...........+.+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68899988763 3789999998765544445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccC
Q 012164 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317 (469)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~ 317 (469)
.+++.+...++...+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~-----------nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPE-----------NLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHH-----------HEEEcCCCCEEEeeCCcccccCcc
Confidence 999988777999999999999999999999998 999999999 888888999999999999865432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--cHHHHHhh-cCCCCCCCChhhhHH
Q 012164 318 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAA-RQRPPFKAPAKLYAR 394 (469)
Q Consensus 318 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~ 394 (469)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+.. ..... .+...++
T Consensus 147 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 221 (262)
T cd05572 147 Q--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDK 221 (262)
T ss_pred c--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC---CCcccCH
Confidence 2 122345788999999998888999999999999999999999999876532 22222221 11211 2233478
Q ss_pred HHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 395 GLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
++.++|.+||..||++||+ ++++++|
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 9999999999999999999 8888775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.88 Aligned_cols=248 Identities=26% Similarity=0.446 Sum_probs=199.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhccccc--CCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 226 (469)
+|+..+.||+|+||.+|. +|..||+|.+.... .......+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 577788999999998874 57899999875332 12234457889999999999999999999998764 4578
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
++|||+++++|.+++.+.+.+++.....++.|++.||+|||+.+ ++|+||||+ ||+++.++.++|+
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~-----------nil~~~~~~~~l~ 148 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGA-----------NILRDSVGNVKLG 148 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH-----------HEEecCCCCEEEC
Confidence 99999999999999988778899999999999999999999999 999999999 8888889999999
Q ss_pred ecCCccccccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 307 DFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 307 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.............. .+.
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~ 226 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPT 226 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc--CCC
Confidence 9999875432111 111234578899999999888899999999999999999999999976543332222211 111
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+..++..+.+++.+|+. +|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 222345677889999999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=299.87 Aligned_cols=247 Identities=23% Similarity=0.420 Sum_probs=195.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.||. ++..||+|.+..... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 688889999999999874 478899998864432 1222456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|++ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~-----------Nil~~~~~~~kl~dfg 149 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQ-----------NLLINERGELKLADFG 149 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHH-----------HEEECCCCcEEECcCc
Confidence 996 6999988754 45889999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-------
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------- 381 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~------- 381 (469)
++....... .......+++.|+|||.+.+. .++.++||||||+++|+|++|++||...+..+....+....
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 150 LARAKSIPT-KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred chhccCCCC-CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 987543221 112234568899999998654 57889999999999999999999998665433222111100
Q ss_pred --------------CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 --------------RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 --------------~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+... .....+++.+.+||.+||+.||.+|||++++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0113467789999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=298.72 Aligned_cols=247 Identities=21% Similarity=0.428 Sum_probs=203.6
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.+|. +|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 45788899999999998874 578999998864432 2336688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+||
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~-----------Nili~~~~~~~l~Df 159 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSD-----------NILLGMDGSVKLTDF 159 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEECCCCCEEECcC
Confidence 999999999999875 45889999999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|++....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...............+.+. ...
T Consensus 160 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~ 237 (297)
T cd06656 160 GFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQN 237 (297)
T ss_pred ccceEccCCc-cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCC-CCC
Confidence 9987644322 11223467889999999998889999999999999999999999997654433222222222222 223
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..++..+.+|+.+||..||++||++.+++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 45677889999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=296.50 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=194.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.||. +|..||+|.+..... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 467788999999998875 578899998865432 22233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|++ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~-----------nil~~~~~~~~l~d 144 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQ-----------NLLIDNKGVIKLAD 144 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHH-----------HEEEcCCCcEEECc
Confidence 996 6898888642 45899999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-cC----
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQ---- 381 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~~---- 381 (469)
||++....... .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.............. .+
T Consensus 145 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
T cd07861 145 FGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE 223 (285)
T ss_pred ccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99987543221 112223567889999988654 578899999999999999999999976543221111100 00
Q ss_pred --------------------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 --------------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 --------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..........+++++.++|.+||..||++|||+.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000001123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=296.52 Aligned_cols=249 Identities=23% Similarity=0.393 Sum_probs=198.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+....||+|+||.+|. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 477788999999998874 578999998864422 12223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|..++.....+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|||+
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~-----------nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPE-----------NILITKQGQIKLCDFGF 146 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChh-----------hEEEcCCCcEEECcccc
Confidence 9999888888877667999999999999999999999998 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc---------
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------- 380 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~--------- 380 (469)
+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+...
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 147 ARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred ceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 986543321 2223457788999999876 45788999999999999999999999876543322221110
Q ss_pred ------------CCCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 ------------QRPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ------------~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+... .....++..+.+|+.+||..||++|||+.+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000 0012457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=280.07 Aligned_cols=246 Identities=26% Similarity=0.481 Sum_probs=204.3
Q ss_pred ccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+++....||.|+.|.|. .+|...|||.+... .+.+..+++...+.++..-+ +|+||+.+|+|..+...++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 34556789999998775 36799999999855 45677788888888876665 899999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|.| ...+..++++ .+++|+..+-++...++.||.||.+++ .|+|||+||+ |||+|..|.+||+||
T Consensus 171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPS-----------NILlDe~GniKlCDF 236 (391)
T KOG0983|consen 171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPS-----------NILLDERGNIKLCDF 236 (391)
T ss_pred HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCcc-----------ceEEccCCCEEeecc
Confidence 999 5678888875 456888888889999999999998876 4999999999 999999999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-CcHHHHHhhcCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPP 384 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~-~~~~~~~~~~~~~~ 384 (469)
|++-++.. ....+..+|-+.|||||.+. ...|+.++||||||++++||.||+.||.+.+. .+..-.+.. ..+|
T Consensus 237 GIsGrlvd--SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP 313 (391)
T KOG0983|consen 237 GISGRLVD--SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPP 313 (391)
T ss_pred cccceeec--ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCC
Confidence 99976542 34445567888999999985 34788999999999999999999999997544 344444434 4445
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.......+++.+++|+..||.+|+.+||.+.+|++|
T Consensus 314 ~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 545555699999999999999999999999999988
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=298.01 Aligned_cols=255 Identities=23% Similarity=0.482 Sum_probs=204.8
Q ss_pred cccccceeeecCeEEEEEE-----ece----eehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
.+|+..+.||+|+||.+|. +|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3567788999999998875 233 57888876442 233445688999999999999999999998754 46
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++++||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+|
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~-----------Nill~~~~~~k 149 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAAR-----------NVLVKSPNHVK 149 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccc-----------eeeecCCCceE
Confidence 79999999999999998654 5889999999999999999999998 999999999 88888889999
Q ss_pred EeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCC
Q 012164 305 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 382 (469)
|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus 150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~ 229 (303)
T cd05110 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 229 (303)
T ss_pred EccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC
Confidence 9999999865432211 1122345678999999998899999999999999999997 9999987654444444433333
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
.+. +..++..+.+++.+||..+|++||+++++++.|+.+.+...
T Consensus 230 ~~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 230 LPQ---PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 222 23467789999999999999999999999999999876644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=290.07 Aligned_cols=246 Identities=24% Similarity=0.442 Sum_probs=203.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe--CCceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 228 (469)
+|+..+.||.|+||.+|. +|..||+|.+..... .....+.+..|+++++.++||||+++++++.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 467778999999998873 568899998875433 34455778899999999999999999998764 3457999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLH-----ENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
|||+++++|.+++.. ...+++..++.++.|++.||.||| +.+ ++|+||+|+ ||+++.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~-----------nili~~ 145 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPA-----------NIFLDA 145 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHH-----------HEEEec
Confidence 999999999999975 356899999999999999999999 777 999999999 888888
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
++.+||+|||++........ ......++..|+|||.+.+..++.++|+||||+++++|++|+.||......+....+..
T Consensus 146 ~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 224 (265)
T cd08217 146 NNNVKLGDFGLAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE 224 (265)
T ss_pred CCCEEEecccccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc
Confidence 99999999999987653322 12234678899999999988899999999999999999999999987664444444433
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+ ..+..++..+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKFR---RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 2222 2345678899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=299.98 Aligned_cols=241 Identities=23% Similarity=0.388 Sum_probs=181.1
Q ss_pred ceeeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe--CCceEEEEe
Q 012164 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (469)
Q Consensus 160 ~~~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~E 230 (469)
.++||+|+||.||. +++.||+|.+..... ...+.+|+.++++++||||+++++++.. ....+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 35899999999874 346799998865422 1346789999999999999999999864 356899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee----
Q 012164 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR---- 297 (469)
Q Consensus 231 ~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~---- 297 (469)
|+ +++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+ |||+
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~-----------Nil~~~~~ 145 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPA-----------NILVMGEG 145 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHH-----------HEEEecCC
Confidence 99 56998888632 24889999999999999999999999 999999999 5555
Q ss_pred CCCCCeEEeecCCccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc--
Q 012164 298 DDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-- 372 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-- 372 (469)
+..+.+||+|||+++....... .......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.......
T Consensus 146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~ 225 (317)
T cd07868 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 225 (317)
T ss_pred CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccc
Confidence 3567899999999986543211 122345689999999998774 58899999999999999999999996543210
Q ss_pred -------HHHHH-hhcCCCC------------------------CC---------CChhhhHHHHHHHHHHHcccCCCCC
Q 012164 373 -------VPKAY-AARQRPP------------------------FK---------APAKLYARGLKELIEECWNEKPAKR 411 (469)
Q Consensus 373 -------~~~~~-~~~~~~~------------------------~~---------~~~~~~~~~l~~li~~cl~~dp~~R 411 (469)
....+ ...+.+. .. ......+..+.+||.+||+.||++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 305 (317)
T cd07868 226 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 305 (317)
T ss_pred cccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccC
Confidence 00000 0000000 00 0000123568899999999999999
Q ss_pred CCHHHHHHH
Q 012164 412 PTFRQIITR 420 (469)
Q Consensus 412 ps~~~ll~~ 420 (469)
||++++++|
T Consensus 306 ~t~~e~l~h 314 (317)
T cd07868 306 ITSEQAMQD 314 (317)
T ss_pred CCHHHHhcC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=293.02 Aligned_cols=250 Identities=26% Similarity=0.491 Sum_probs=200.9
Q ss_pred ccccceeeecCeEEEEEE---------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe--CCc
Q 012164 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 224 (469)
.|+..+.||+|+||.+|. ++..||+|.+..... ......+.+|+++++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 566778999999998874 257899999875532 2345789999999999999999999999877 557
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.+++|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+ ||+++.++.+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~-----------nil~~~~~~~ 148 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAAR-----------NILVESEDLV 148 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------hEEEcCCCCE
Confidence 899999999999999998654 5899999999999999999999998 999999999 8888889999
Q ss_pred EEeecCCccccccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH--------
Q 012164 304 KVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-------- 373 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~-------- 373 (469)
+|+|||++.......... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+........
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 228 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG 228 (284)
T ss_pred EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc
Confidence 999999998765222111 1123445679999999888899999999999999999999999865432221
Q ss_pred ---H----HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 374 ---P----KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 374 ---~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
. ..+...... ..+..++.++.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 229 QMIVTRLLELLKEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccHHHHHHHHHcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 111111111 12345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=288.42 Aligned_cols=244 Identities=29% Similarity=0.507 Sum_probs=193.0
Q ss_pred ccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 158 ~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
.....||+|+||.||. ++..||+|.+... .....+.+.+|+.++++++|+||+++++++...+..++++||+
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 3446899999999874 4567999987644 2344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC-CCCeEEeec
Q 012164 233 PKGDLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD-SGNLKVADF 308 (469)
Q Consensus 233 ~~gsL~~~l~~~-~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~-~~~vkl~Df 308 (469)
++++|.+++... +.+ +...+..++.|++.||.|||+.+ ++||||||+ ||+++. ++.++|+||
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~-----------nil~~~~~~~~~l~df 153 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGD-----------NVLVNTYSGVVKISDF 153 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHH-----------HEEEcCCCCeEEEecc
Confidence 999999999764 445 78888899999999999999998 999999999 777765 678999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|++....... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............ ........
T Consensus 154 g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~ 231 (268)
T cd06624 154 GTSKRLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHP 231 (268)
T ss_pred hhheecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCC
Confidence 9987653221 122234578899999998664 3788999999999999999999999754332221111 11111111
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+..+++++.+|+.+||..+|++|||+.+++.|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 2234577889999999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=288.54 Aligned_cols=248 Identities=28% Similarity=0.461 Sum_probs=204.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.++. +|+.|++|.+..... ......+.+|+..+++++||||+++++++......++++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 467778999999998764 488999999875532 2455789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++++|.+++.....+++..+..++.|+++||.|||+ .+ ++|+||+|+ ||+++.++.++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~-----------ni~~~~~~~~~l~df~ 145 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPS-----------NLLINSKGEVKIADFG 145 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHH-----------HEEECCCCCEEEccCc
Confidence 99999999999987889999999999999999999999 98 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........................
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (264)
T cd06623 146 ISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP 224 (264)
T ss_pred cceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCC
Confidence 98765432221 12345788999999999888999999999999999999999999876432222222111111112223
Q ss_pred hh-hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KL-YARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~-~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. ++..+.++|.+||..+|++||++.+++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 34 78899999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=305.96 Aligned_cols=244 Identities=25% Similarity=0.364 Sum_probs=192.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------Cc
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~ 224 (469)
+|+..+.||+|+||.||. ++..||+|.+..... .......+.+|+.++++++||||+++++++... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 688889999999999874 567899999875422 223345677899999999999999999987543 34
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
.++++|++ +++|.+++.. +.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+|
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~-----------Nil~~~~~~~k 158 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPS-----------NVAVNEDCELR 158 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh-----------hEEECCCCCEE
Confidence 78999998 7899988764 46999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CC
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR 382 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~ 382 (469)
|+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+... +.
T Consensus 159 l~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 159 ILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred EcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999764321 233568899999999877 46889999999999999999999999765432222211110 00
Q ss_pred ---------------------CCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 ---------------------PPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ---------------------~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+... ......++.+.+||.+||..||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0011345668899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=292.97 Aligned_cols=246 Identities=26% Similarity=0.435 Sum_probs=195.3
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC-----
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----- 222 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~----- 222 (469)
+-.|+..+.||+|+||.||. +++.||+|.+.... .....+..|+.+++++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 34577788999999998874 46789999886432 2235678899999999 699999999998753
Q ss_pred -CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 223 -SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 223 -~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
...+++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~-----------nili~~ 146 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQ-----------NVLLTE 146 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHH-----------HEEECC
Confidence 3589999999999999999863 35889999999999999999999998 999999999 888888
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~ 374 (469)
++.++|+|||++....... .......|+..|+|||++. +..++.++|||||||++|+|++|..||.........
T Consensus 147 ~~~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~ 225 (272)
T cd06637 147 NAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225 (272)
T ss_pred CCCEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 9999999999997643221 1223356888999999986 336788999999999999999999999755433222
Q ss_pred HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...... .........++..+.+|+.+||..||.+|||+.+++.+
T Consensus 226 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 226 FLIPRN--PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHHhcC--CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 222111 11112234567899999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=293.36 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=197.0
Q ss_pred CCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEE-----
Q 012164 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT----- 220 (469)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~----- 220 (469)
....+|++.+.||+|+||.+|. +|+.+|+|.+.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 3455788899999999998874 57889999875421 1235678899999999 6999999999874
Q ss_pred eCCceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 221 QSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 221 ~~~~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
.....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+ ||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~-----------nil 156 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGN-----------NIL 156 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHH-----------hEE
Confidence 33568999999999999998753 345888999999999999999999998 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 012164 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 371 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~ 371 (469)
++.++.+||+|||+++...... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 157 LTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred ECCCCCEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 8889999999999987654321 12233468899999999853 35788999999999999999999999865543
Q ss_pred cHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 372 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
......... ..+....+..++..+.+||.+||+.||++|||+.+++++.
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 RALFKIPRN-PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHHhhcccc-CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 322222111 1111122344677899999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=289.52 Aligned_cols=241 Identities=26% Similarity=0.376 Sum_probs=192.5
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHH-hcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+.||.|+||.+|. +|+.||+|.+.............+..|..++ ...+|||++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999998874 5789999998654332223333445555544 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||++...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~-----------nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPE-----------NLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HeEECCCCcEEEeecccceec
Confidence 999999998888999999999999999999999998 999999999 888888999999999998754
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 315 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 315 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..............+++
T Consensus 148 ~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd05611 148 LE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSP 222 (260)
T ss_pred cc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCH
Confidence 32 1224577889999999888889999999999999999999999987665554444432222111122335788
Q ss_pred HHHHHHHHHcccCCCCCCCHH---HHHHH
Q 012164 395 GLKELIEECWNEKPAKRPTFR---QIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~~---~ll~~ 420 (469)
.+.+++.+||+.||++||++. +++.|
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 999999999999999999765 55444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.38 Aligned_cols=243 Identities=20% Similarity=0.262 Sum_probs=191.0
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|.+.+.||+|+||.||. .++.||||.... ..+.+|++++++++||||+++++++...+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 44788999999999999985 467899995321 2356799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
||++ .++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+ |||++.++.+||+|
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~-----------NILl~~~~~vkL~D 303 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTE-----------NVLVNGPEDICLGD 303 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHH-----------HEEECCCCCEEEcc
Confidence 9999 57999888764 46999999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--------CcHHHHHh
Q 012164 308 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--------NEVPKAYA 378 (469)
Q Consensus 308 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~--------~~~~~~~~ 378 (469)
||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..|+..... .++...+.
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 9999765432211 11234689999999999998999999999999999999998765432211 11111111
Q ss_pred hcCC--CCC------------------------C-CCh---hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ARQR--PPF------------------------K-APA---KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~~~--~~~------------------------~-~~~---~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.... ..+ . ..+ ..++..+.+||.+||+.||.+|||+.|+|+|
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1110 000 0 000 1234578999999999999999999999987
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=291.91 Aligned_cols=241 Identities=22% Similarity=0.345 Sum_probs=190.1
Q ss_pred eeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhc---CCCCceeeEEeEEEeCCceEEEEeccC
Q 012164 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK---IRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 162 ~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
.||+|+||.||. +|+.||+|.+.............+.+|..+++. ..||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 379999999884 578999998876543333322334445444443 469999999999998889999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 234 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
+++|.+++..++.+++..+..++.|++.||+|||+.+ ++|+||||+ ||+++.++.++|+|||++..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~-----------Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPA-----------NILLDEHGHVRISDLGLACD 146 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHH-----------HEEECCCCCEEEccCCccee
Confidence 9999999988888999999999999999999999999 999999999 88888899999999999875
Q ss_pred cccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhh
Q 012164 314 LTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 392 (469)
Q Consensus 314 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (469)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||................... ...+..+
T Consensus 147 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 222 (279)
T cd05633 147 FSKK---KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN-VELPDSF 222 (279)
T ss_pred cccc---CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCC-cCCcccc
Confidence 4322 1123468899999999864 568899999999999999999999997654333222111111111 1123457
Q ss_pred HHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 393 ARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 393 ~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+.++.++|.+||..||++|| |++++++|
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 88999999999999999999 69998887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=292.28 Aligned_cols=245 Identities=24% Similarity=0.434 Sum_probs=201.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|...+.||.|++|.++. +++.+++|.+... .....+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 345567999999998874 4678999987533 23344668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++.. +.++...+..++.|++.||+|||+.+ ++||||+|+ ||+++.++.++|+|||.
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~~~~~l~d~g~ 161 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSD-----------SILLTSDGRVKLSDFGF 161 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChh-----------hEEEcCCCcEEEccccc
Confidence 9999999999987 56899999999999999999999999 999999999 88888999999999998
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+... .++......
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (285)
T cd06648 162 CAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLH 239 (285)
T ss_pred chhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccc
Confidence 865443211 112345788999999998888999999999999999999999999876554444433322 222222223
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.++..+.+++.+||..+|++|||+.+++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 467899999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.76 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=216.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|.+.+.||+|+||.|.. +++.||+|++++..+........|..|..+|..-..+.|++++-+|.++.++|+|||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence 788899999999997643 689999999998655555566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||+||+|-.++.+.+++|+..+..++..|+-||.-||+.| +|||||||+ |||+|..|++||+|||.
T Consensus 156 Y~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPD-----------NvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPD-----------NVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcc-----------eeEecccCcEeeccchh
Confidence 9999999999999889999999999999999999999999 999999999 99999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP 384 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~ 384 (469)
+-.+...+.......+|||.|.|||++.. +.|++.+|.||+||++|||+.|..||...+-.+....|.... ...
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS 301 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence 98777665555667789999999999852 478899999999999999999999998776666666665443 333
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~ll~~ 420 (469)
++ ....+|+++++||.+.+. +|+.|.. +.++..|
T Consensus 302 FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 302 FP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 33 234589999999998885 5899988 8888776
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.63 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=209.3
Q ss_pred CCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
...+.+++....||.|.||.||- +|..-|+|-+...... ......+.+|..++..++|||+|++||+=...+..
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34455788889999999999984 7899999988654332 34446688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
+|.||||++|+|.+++...+-.++.....+-.|++.|+.|||++| ||||||||+ ||+++.+|.+|+
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~a-----------NI~Ld~~g~iK~ 1375 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPA-----------NILLDFNGLIKY 1375 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCcc-----------ceeeecCCcEEe
Confidence 999999999999999987666777777778899999999999999 999999999 889999999999
Q ss_pred eecCCccccccCCCCC---cccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHH-HHh
Q 012164 306 ADFGVSKLLTVKEDRP---LTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK-AYA 378 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~-~~~ 378 (469)
+|||.|..+....... .....||+.|||||++.+. +...+.||||||||+.||+||+.||...+.+-..- .+.
T Consensus 1376 ~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~ 1455 (1509)
T KOG4645|consen 1376 GDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA 1455 (1509)
T ss_pred ecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh
Confidence 9999998776442121 2456799999999999764 45578999999999999999999999876543332 233
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..|+. |..++++-++||..||..||++|.++.+|+++
T Consensus 1456 ~gh~Pq~---P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGHKPQI---PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ccCCCCC---chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 3334443 44589999999999999999999999988877
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=294.64 Aligned_cols=245 Identities=26% Similarity=0.461 Sum_probs=200.5
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
..|+..+.||+|+||.+|. +|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 3588888999999998874 57899999886544444555577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+. |+|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+||
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~-----------nIl~~~~~~~kL~df 159 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAG-----------NILLTEPGTVKLADF 159 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcc-----------cEEECCCCCEEEeec
Confidence 9995 688787764 456899999999999999999999998 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
|++...... ....++..|+|||.+. ...++.++||||||+++|+|++|+.||...........+.....+.
T Consensus 160 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~- 233 (307)
T cd06607 160 GSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT- 233 (307)
T ss_pred CcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC-
Confidence 998754322 2345778899999874 3468889999999999999999999997655433322222222222
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
.....++..+.++|.+||..||++||++.+++.+.
T Consensus 234 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 234 -LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 22345778899999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=297.60 Aligned_cols=244 Identities=23% Similarity=0.419 Sum_probs=199.5
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|.....||+|+||.++. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 33455799999998863 578899999864322 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||++
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~-----------Nill~~~~~~kL~dfg~~ 164 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSD-----------SILLTLDGRVKLSDFGFC 164 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HeEEccCCcEEEeechhH
Confidence 999999998765 46899999999999999999999999 999999999 888889999999999998
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhh
Q 012164 312 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 391 (469)
Q Consensus 312 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (469)
....... .......++..|+|||++.+..++.++||||||+++++|++|+.||......+....+.. ...+.......
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 242 (297)
T cd06659 165 AQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKLKNAHK 242 (297)
T ss_pred hhccccc-ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCCCccccCC
Confidence 7544321 112235578899999999988899999999999999999999999986554443333322 22222223345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 392 YARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 392 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
++..+.++|.+||+.+|++||++++++++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 67889999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=289.31 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=199.4
Q ss_pred cccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC-----
Q 012164 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----- 223 (469)
|+..+.||+|+||.||. +++.||||.+..+.. .....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 45567899999998863 368899999875543 3445577889999999999999999999886532
Q ss_pred -ceEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 224 -PMMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 224 -~~~lv~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
..++++||+.+|+|.+++... ..++...+..++.|++.||+|||+.+ ++||||||+ ||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~-----------nil 145 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAAR-----------NCM 145 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeecccchh-----------hEE
Confidence 247889999999999887532 14788999999999999999999998 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHH
Q 012164 297 RDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 374 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~ 374 (469)
++.++.+||+|||+++........ ......++..|++||.+.+..++.++||||||+++|+|++ |+.||......+..
T Consensus 146 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~ 225 (273)
T cd05074 146 LNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225 (273)
T ss_pred EcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH
Confidence 888999999999999865432211 1122345678999999988889999999999999999999 89999876554444
Q ss_pred HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
..+........ ....++.+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 226 NYLIKGNRLKQ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 44433322222 234667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=291.07 Aligned_cols=244 Identities=29% Similarity=0.529 Sum_probs=199.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.++. +++.||+|.+.... .......+.+|++++++++||||+++++.+......++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 466677899999998864 47889999887543 23455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+ ||+++.++.++|+||
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~-----------ni~~~~~~~~~l~d~ 145 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPS-----------NILVNSRGQIKLCDF 145 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHH-----------HEEECCCCCEEEeec
Confidence 99999999999876 679999999999999999999999 88 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--CcHHHHH---hhcCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAY---AARQRP 383 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~--~~~~~~~---~~~~~~ 383 (469)
|.+........ ....++..|+|||.+.+..++.++||||||+++++|++|..||..... ....... .....+
T Consensus 146 g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (265)
T cd06605 146 GVSGQLVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222 (265)
T ss_pred ccchhhHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC
Confidence 99876532211 115678899999999988999999999999999999999999975421 1121211 111111
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. +...++.++.++|.+||..||++|||+.+++.+
T Consensus 223 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RL--PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CC--ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11 122378899999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.84 Aligned_cols=240 Identities=23% Similarity=0.326 Sum_probs=187.3
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|++.+.||+|+||.||. ++..||+|..... ....|+.++++++||||+++++++......++|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4689999999999999875 4568999975432 2345899999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|++ .++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+||
T Consensus 137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~-----------Nill~~~~~~kl~Df 201 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTE-----------NIFINDVDQVCIGDL 201 (357)
T ss_pred Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEECCCCCEEEecC
Confidence 999 5688888865 456999999999999999999999999 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCCC----------cHHHHH
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDN----------EVPKAY 377 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p-~~~~~~~----------~~~~~~ 377 (469)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||+++..| |...... .+...+
T Consensus 202 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~ 279 (357)
T PHA03209 202 GAAQFPVVA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279 (357)
T ss_pred ccccccccC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence 999753221 122235689999999999998999999999999999999985444 4432211 001111
Q ss_pred hhcCC--CCCC-----------------------C----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AARQR--PPFK-----------------------A----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~~~--~~~~-----------------------~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+. ..+. . ....++.++.+||.+||+.||++|||+.++++|
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 10010 0000 0 011345677889999999999999999999987
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=297.00 Aligned_cols=244 Identities=23% Similarity=0.431 Sum_probs=198.7
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|.....||+|+||.++. ++..||||.+... .....+.+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 33346799999998873 5788999987543 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
+++++|.+++.. +.+++..+..++.||+.||.|||+.+ ++||||||+ ||+++.++.++|+|||++
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~-----------Nill~~~~~~kL~dfg~~ 165 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSD-----------SILLTSDGRIKLSDFGFC 165 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHH-----------HEEEcCCCCEEEccCcch
Confidence 999999998864 46899999999999999999999998 999999999 888888999999999998
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhh
Q 012164 312 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 391 (469)
Q Consensus 312 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (469)
....... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+... .++.......
T Consensus 166 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 243 (292)
T cd06658 166 AQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-LPPRVKDSHK 243 (292)
T ss_pred hhccccc-ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCccccccc
Confidence 7543221 1122345788999999998888999999999999999999999999866544433333221 1222122335
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 392 YARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 392 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
++..+.+++.+||..||.+|||+.+++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 67789999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=286.19 Aligned_cols=232 Identities=27% Similarity=0.491 Sum_probs=185.6
Q ss_pred eeeecCeEEEEEE-----ec----------eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 161 VEITKGTFILAFW-----RG----------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g----------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+.||+|+||.||. ++ ..|++|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 3689999998863 12 247788765432 115778899999999999999999999987 778
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC---
Q 012164 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG--- 301 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~--- 301 (469)
++||||+++++|.+++...+ .++...+..++.||+.||.|||+.+ ++||||||+ ||+++.++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~-----------Nill~~~~~~~ 141 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGK-----------NILVARYGLNE 141 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccc-----------eEEEecCcccc
Confidence 99999999999999998765 6899999999999999999999998 999999999 66666565
Q ss_pred ----CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHH
Q 012164 302 ----NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 374 (469)
Q Consensus 302 ----~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~ 374 (469)
.+||+|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+..
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~ 216 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216 (259)
T ss_pred CCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH
Confidence 799999999876442 1223456789999999876 78899999999999999999 68888776544433
Q ss_pred HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
..+......+.. ....+.+++.+||..+|++|||+.++++.|
T Consensus 217 ~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 217 RFYQDQHRLPMP-----DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHhcCCCCCCC-----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 333222221111 126899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=296.20 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=197.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.+|. +++.||+|.+...... ....+.+.+|+++++.++||||+++++++......++|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 477788999999998864 4788999987654332 2334568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.++......+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||+
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~-----------ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPE-----------NILVSQSGVVKLCDFGF 146 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHH-----------HEEECCCCcEEEEeeee
Confidence 9999999888876667999999999999999999999998 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh----------
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---------- 379 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~---------- 379 (469)
+....... .......++..|+|||++.+ ..++.++||||||+++|+|++|++||......+....+..
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 147 ARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred eeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence 87654322 22233457889999999875 3577899999999999999999999975443221111100
Q ss_pred -----------cCCCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 -----------RQRPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 -----------~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+... ...+.++..+.+|+.+||..||++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000 0123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.74 Aligned_cols=242 Identities=21% Similarity=0.363 Sum_probs=184.9
Q ss_pred eeecCeEEEEEEe------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 162 EITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 162 ~ig~G~~~~~~~~------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.||+|+||.||.. ...||+|.+... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 6899999988742 234888987543 2344467888999999999999999999999988999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+++|+|.+++..++ .+++..+..++.||+.||.|||+.+ ++||||||+||++..... ......+.++++||
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~---~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREED---RKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccc---cccCCCceEEeccc
Confidence 9999999999998654 4899999999999999999999999 999999999555532110 00112234799999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|++..... .....++..|+|||.+.+. .++.++||||||+++|+|++| ..||............ ......
T Consensus 153 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~- 224 (258)
T cd05078 153 GISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQL- 224 (258)
T ss_pred ccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH--HccccC-
Confidence 99865432 1224577889999999874 578899999999999999998 5666554433222222 112222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
+...+.++.+|+.+||+.||++|||++++++.|+
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 --PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 2234567999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=292.94 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=199.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.++. +++.||+|.+..... .......+.+|++++++++|+||+++++++...+..++++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 577888999999998865 478899998875432 23344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|++++.+..+..+...+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.+||+|||+
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~-----------ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPE-----------NILVSESGVLKLCDFGF 146 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HeEECCCCCEEEEeeec
Confidence 9988777766666667999999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-c--------
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-R-------- 380 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~-------- 380 (469)
+...............++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....... .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 147 ARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred ccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 877654332233345678889999999887 888999999999999999999999976543221111100 0
Q ss_pred ------------CCCCCCC-------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 ------------QRPPFKA-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ------------~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..++... .+..++.++.+||.+||..+|++|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 112347889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=288.80 Aligned_cols=243 Identities=30% Similarity=0.529 Sum_probs=201.7
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|+..+.||.|+||.||. ++..||+|.+.... .......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 56778999999999874 46789999876432 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
+++++|.+++.. +.+++..+..++.|++.|+.|||+.+ ++|+||+|+ ||+++.++.++|+|||++
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~-----------Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAA-----------NVLLSEHGEVKLADFGVA 148 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHH-----------hEEECCCCCEEEeecccc
Confidence 999999999874 46899999999999999999999998 999999999 888888999999999998
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhh
Q 012164 312 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 391 (469)
Q Consensus 312 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (469)
....... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.....+. ....
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 224 (277)
T cd06641 149 GQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGN 224 (277)
T ss_pred eecccch-hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcc
Confidence 7654321 11223457888999999988888999999999999999999999998655444444332222222 2345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 392 YARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 392 ~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
++.++.+++.+||..+|++||++.+++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 67889999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=291.54 Aligned_cols=249 Identities=27% Similarity=0.440 Sum_probs=198.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.++. +|..||+|.+...... ......+.+|+.++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 467788999999998874 5789999998755332 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+ +++|.+++.. ...+++.++..++.||+.||.|||+.+ ++|+||||+ ||+++.++.++|+|||
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~-----------ni~~~~~~~~~l~dfg 144 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPA-----------NLLISADGVLKIADFG 144 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHH-----------HEEEcCCCcEEEeeee
Confidence 99 9999999875 355899999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CCC----
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP---- 383 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~---- 383 (469)
++...............++..|+|||.+.+. .++.++||||||+++++|++|++||............... ..+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07832 145 LARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEET 224 (286)
T ss_pred ecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHH
Confidence 9986654332223345678899999998654 4688999999999999999998888765443322221110 000
Q ss_pred ---------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 ---------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ---------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+........+..+.++|.+||..||++|||+++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000112456889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=289.51 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=198.1
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCC----
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS---- 223 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~---- 223 (469)
..+|+..+.||+|+||.++. +++.+++|.+.... ...+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 34788889999999998764 46789999876442 2346788999999999 6999999999997654
Q ss_pred --ceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 224 --PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 224 --~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
..++||||+++++|.+++.. +..+++..+..++.|++.||.|||+.+ ++|+||+|+ ||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~-----------ni~~ 146 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQ-----------NILL 146 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHH-----------HEEE
Confidence 48999999999999999865 346899999999999999999999999 999999999 8888
Q ss_pred CCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~ 372 (469)
+.++.++|+|||++....... .......++..|+|||++.. ..++.++||||||+++++|++|+.||.......
T Consensus 147 ~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 225 (275)
T cd06608 147 TKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225 (275)
T ss_pred ccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH
Confidence 889999999999987654321 12233557889999998754 246789999999999999999999997654433
Q ss_pred HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 373 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+.....+.. ..+..+++++.+||.+||..||++|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 226 ALFKIPRNPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHHHhhccCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 3333322222222 2233477899999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=290.28 Aligned_cols=245 Identities=27% Similarity=0.505 Sum_probs=199.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC---CCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~l 227 (469)
.|+..+.||.|+||.+|. +|..||+|.+.... .......+.+|+.++++++ |||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 366778899999998874 57899999886542 2344567888999999996 9999999999999899999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
+|||+++++|.+++.. +.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~-----------ni~i~~~~~~~l~d 144 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAA-----------NILVTNTGNVKLCD 144 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHH-----------HEEEcCCCCEEEcc
Confidence 9999999999999875 47899999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
||++....... .......++..|+|||.+.++ .++.++|+||||+++|+|++|+.||...........+.....+..
T Consensus 145 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~- 222 (277)
T cd06917 145 FGVAALLNQNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRL- 222 (277)
T ss_pred CCceeecCCCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCC-
Confidence 99997665332 222334688899999998654 568899999999999999999999986544333222211111111
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....++.++.+++.+||+.||++||++.+++.+
T Consensus 223 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 -EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 122377899999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=290.43 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=198.7
Q ss_pred cCCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC-
Q 012164 150 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS- 222 (469)
Q Consensus 150 ~~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~- 222 (469)
+.....+|+..+.||+|+||.+|. +|+.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 334456789999999999998874 57889999886431 2235677899999999 799999999998754
Q ss_pred ----CceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcc
Q 012164 223 ----SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294 (469)
Q Consensus 223 ----~~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~n 294 (469)
...++|+||+++++|.++++. ...+++..++.++.|++.||+|||+.+ ++|+||||+ |
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~-----------n 158 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGN-----------N 158 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH-----------H
Confidence 358999999999999998863 346899999999999999999999998 999999999 8
Q ss_pred eeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 012164 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKH 369 (469)
Q Consensus 295 il~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDi~SlGvil~el~tg~~p~~~~~ 369 (469)
|+++.++.+||+|||++........ ......++..|+|||.+... .++.++|||||||++|+|++|+.||....
T Consensus 159 ili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 159 ILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred EEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 8888899999999999876543221 11234578899999997643 36789999999999999999999998665
Q ss_pred CCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 370 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.......+.....+.. ..+..++..+.+||.+||+.||++||++.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 238 PVKTLFKIPRNPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHHHHhcCCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 4333333322222222 2233466789999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=286.75 Aligned_cols=243 Identities=25% Similarity=0.399 Sum_probs=186.1
Q ss_pred eeecCeEEEEEEe----ce---eehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 162 EITKGTFILAFWR----GI---QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 162 ~ig~G~~~~~~~~----g~---~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
+||+|+||.||.. +. .+++|.+.... .......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 6899999998742 22 34556554332 234457889999999999999999999999998999999999999
Q ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 235 GDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 235 gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+|.+++.+. ..++...+..++.||+.||+|||+.+ ++||||||+ ||+++.++.++|+|||+
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~-----------nil~~~~~~~~l~Dfg~ 145 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALR-----------NCFLTSDLTVKVGDYGI 145 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccc-----------eEEEcCCccEEeccccc
Confidence 9999999753 23566778899999999999999998 999999999 88888899999999999
Q ss_pred ccccccCC-CCCcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 311 SKLLTVKE-DRPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 311 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
+....... ........++..|+|||++.+ ..++.++||||||+++|+|++ |..||......+....+....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 225 (268)
T cd05086 146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ 225 (268)
T ss_pred ccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc
Confidence 86422111 111123457889999999753 245789999999999999997 678887655544444332222
Q ss_pred CCC--CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 382 RPP--FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 382 ~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
... .+.....+++.+.+++..|| .+|++||+++++++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 226 QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 211 11122346788999999999 6899999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=282.90 Aligned_cols=245 Identities=29% Similarity=0.517 Sum_probs=203.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|++|.+|. ++..+++|++..... .....+.+|+++++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 366778999999998864 478899999875432 345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++++|.+++... ..+++..+..++.|++.||.+||+.+ ++|+||+|+ ||+++.++.++|+|||
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~-----------ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAA-----------NILLTSDGEVKLIDFG 143 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHH-----------HEEEccCCeEEEeecc
Confidence 99999999999876 57999999999999999999999998 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
.+........ .....++..|+|||.+.+..++.++|+||||+++++|++|+.||...+..+..........+.. ...
T Consensus 144 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 220 (253)
T cd05122 144 LSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL-RNP 220 (253)
T ss_pred cccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc-Ccc
Confidence 9877654321 2335678899999999888889999999999999999999999987654443333322222222 122
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..++..+.++|.+||..||++|||+.+++.+
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2347889999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=294.62 Aligned_cols=248 Identities=22% Similarity=0.420 Sum_probs=192.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.+|. +|..||+|.+..... .......+.+|+.++++++||||+++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 367788999999998874 578999998865432 12223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|++ ++|.+++.. .+.+++..+..++.||++||.|||+.+ ++|+||||+ ||+++.++.+||+|||
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~-----------nil~~~~~~~~l~dfg 144 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQ-----------NLLINKNGELKLADFG 144 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHH-----------HEEEcCCCcEEECccc
Confidence 995 688888765 566999999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-cHHHHHhhc-------
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAAR------- 380 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~------- 380 (469)
+++...... .......++..|+|||.+.+. .++.++|||||||++|+|++|..||...... +....+...
T Consensus 145 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07839 145 LARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 223 (284)
T ss_pred hhhccCCCC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChH
Confidence 997643221 112234568899999998764 4688999999999999999998886433322 111111000
Q ss_pred ---------C---CCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 ---------Q---RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ---------~---~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
. .+... .....+++++.+||.+||+.||.+|||+++++.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 00000 0112467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=288.59 Aligned_cols=246 Identities=27% Similarity=0.451 Sum_probs=196.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 228 (469)
+|...+.||.|++|.++. +++.||+|.+.... .......+.+|++++++++||||+++++++.+. ..+++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 467788999999998863 57889999887542 234457788999999999999999999998654 468999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
|||+++++|.+++.. ...++...+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~-----------nil~~~~~~~~ 145 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPS-----------NILLTRKGQVK 145 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEEecCCeEE
Confidence 999999999998753 345889999999999999999999999 999999999 88888899999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-----CcHHHHHhh
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-----NEVPKAYAA 379 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~-----~~~~~~~~~ 379 (469)
|+|||++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .+....+..
T Consensus 146 l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd06621 146 LCDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222 (287)
T ss_pred Eeeccccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc
Confidence 99999986543221 1234567889999999988999999999999999999999999986532 112222211
Q ss_pred cCCCCCCCC---hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 RQRPPFKAP---AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+..... ...+++.+.+|+.+||..||++|||+.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 223 MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 111111111 12467889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=293.17 Aligned_cols=249 Identities=29% Similarity=0.460 Sum_probs=197.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC--CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
+|+..+.||+|+||.+|. +|+.||+|.+...... .......+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 366778899999998874 4789999998755332 122335677899999999999999999999998999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||+ +++|.+++.... .+++..+..++.||++||.|||+++ ++|+||+|+ ||+++.++.++|+|
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~-----------nill~~~~~~~l~d 145 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPN-----------NLLIASDGVLKLAD 145 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChh-----------hEEEcCCCCEEEcc
Confidence 9999 899999998766 7999999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CC--
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP-- 383 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~-- 383 (469)
||++....... .......++..|+|||.+.+ ..++.++|||||||++++|++|.+||......+....+.... .+
T Consensus 146 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (298)
T cd07841 146 FGLARSFGSPN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224 (298)
T ss_pred ceeeeeccCCC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence 99997654322 12223346778999998855 467889999999999999999988887655433222211100 00
Q ss_pred ---------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 ---------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ---------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+........+..+.++|.+||..||++|||+++++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000112346789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=292.06 Aligned_cols=246 Identities=22% Similarity=0.439 Sum_probs=201.9
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|...+.||.|+||.+|. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 4788889999999998874 46789999875432 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~-----------Nili~~~~~~kL~dfg 160 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSD-----------NILLGMDGSVKLTDFG 160 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHH-----------HEEEcCCCCEEEccCc
Confidence 999999999999754 4889999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++........ ......+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+.......+.....+. ...+
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~ 238 (293)
T cd06647 161 FCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQNP 238 (293)
T ss_pred ceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCC-CCCc
Confidence 8875543222 2223457888999999988888999999999999999999999998655433222222222222 2234
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..++..+.++|.+||..+|++||++++++.|
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4567889999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=291.11 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=198.2
Q ss_pred ccccceeeecCeEEEEEE--------eceeehhhhcccccCC-CHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 225 (469)
+|+..+.||.|+||.+|. +|..||+|.+...... .....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999998873 5788999998753221 123346678899999999 599999999999988899
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++|+||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||+|+ ||+++.++.+||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~-----------nil~~~~~~~kl 146 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLE-----------NILLDSNGHVVL 146 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH-----------HeEECCCCCEEE
Confidence 999999999999999988888999999999999999999999998 999999999 888888999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh---c
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---R 380 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~---~ 380 (469)
+|||++...............++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+.. .
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 226 (290)
T cd05613 147 TDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK 226 (290)
T ss_pred eeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc
Confidence 99999976543322222334578899999998753 567899999999999999999999975433222222211 1
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
..++. +..+++.+.+++.+||+.||++|| ++.+++.+
T Consensus 227 ~~~~~---~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 227 SEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred cCCCC---CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 22222 345778899999999999999997 77777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=286.32 Aligned_cols=249 Identities=23% Similarity=0.452 Sum_probs=200.9
Q ss_pred ccccceeeecCeEEEEEE------eceeehhhhcccccC-------CCHHHHHHHHHHHHHHhc-CCCCceeeEEeEEEe
Q 012164 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI-------SDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ 221 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~------~g~~vaiK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~ 221 (469)
+|+..+.||+|+||.++. .+..+|+|.+..... ........+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 367788999999998864 357899998753221 223445667788888765 789999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCccee
Q 012164 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 222 ~~~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
.+..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+ ||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~-----------nil 146 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPN-----------NIM 146 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHH-----------HEE
Confidence 9999999999999999998843 3458999999999999999999996 56 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........
T Consensus 147 ~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~ 224 (269)
T cd08528 147 LGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK 224 (269)
T ss_pred ECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH
Confidence 8899999999999997654332 22345678899999999988899999999999999999999999976554444433
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
+......+. ....+++.+.++|.+||+.||++||++.++..+++
T Consensus 225 ~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 IVEAVYEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HhhccCCcC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 333222221 22356789999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=290.11 Aligned_cols=246 Identities=26% Similarity=0.438 Sum_probs=195.7
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEe------
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ------ 221 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------ 221 (469)
.-.|+..+.||.|+||.+|. +++.||+|.+... ......+..|+.+++++ +||||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 34678888999999998874 5788999987543 23346688899999999 69999999999853
Q ss_pred CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 222 ~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
....+++|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~-----------nili~~ 156 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQ-----------NVLLTE 156 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEECC
Confidence 35689999999999999999753 34888889999999999999999999 999999999 888888
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~ 374 (469)
++.++|+|||++....... .......++..|+|||.+. +..++.++|+|||||++|+|++|+.||.........
T Consensus 157 ~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred CCCEEEeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 9999999999987543221 1223355788999999986 346788999999999999999999999765432222
Q ss_pred HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+ ....+.......++.++.+||.+||..||.+|||+.+++++
T Consensus 236 ~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 FLI--PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhH--hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 222 11122222344678899999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=300.37 Aligned_cols=244 Identities=24% Similarity=0.376 Sum_probs=212.7
Q ss_pred ceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 160 ~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
.+.||.|-||+|| .+|+.||||++.+..+..... .++++|+.+|+.+.||.||.+-..|+..+.+|+|||-+ .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 4679999999998 479999999999887765444 78999999999999999999999999999999999999 5
Q ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcc
Q 012164 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312 (469)
Q Consensus 235 gsL~~~l~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~ 312 (469)
|++.+++- +.+++++.....++.||+.||.|||-++ |+|+||||+|||+... +.-..+||+|||+|+
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~--------~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASA--------SPFPQVKLCDFGFAR 715 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccC--------CCCCceeecccccee
Confidence 67766663 4688999999999999999999999999 9999999996666421 344689999999999
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhh
Q 012164 313 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 392 (469)
Q Consensus 313 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (469)
.++.. .......||+.|+|||++.+..|+..-|+||.|||+|--++|..||.. ++++..++.....+..+.++..+
T Consensus 716 iIgEk--sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~ei 791 (888)
T KOG4236|consen 716 IIGEK--SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEI 791 (888)
T ss_pred ecchh--hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhc
Confidence 98743 344567899999999999999999999999999999999999999973 45677777777776667788899
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 393 ARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 393 ~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.+..+||..+|+..=.+|-|.+..+.|
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 9999999999999999999999998877
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=282.63 Aligned_cols=246 Identities=27% Similarity=0.523 Sum_probs=206.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|++|.+|. +++.|++|.+...... ......+.+|++++++++|||++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 467788999999998875 5688999998765432 3456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||+
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~-----------ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAA-----------NILTTKDGVVKLADFGV 145 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHH-----------HEEECCCCCEEEecccc
Confidence 9999999999988888999999999999999999999998 999999999 78888889999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
+......... .....++..|+|||.+.+..++.++||||||+++++|++|+.||.................+ ..+.
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 221 (254)
T cd06627 146 ATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPE 221 (254)
T ss_pred ceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCC
Confidence 9876543221 23345788999999998888889999999999999999999999865543333333222222 2345
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+++.+.+++.+||..+|++|||+.+++.+
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 678899999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=276.95 Aligned_cols=245 Identities=25% Similarity=0.368 Sum_probs=200.4
Q ss_pred ccccc-eeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC----Cc
Q 012164 156 DFTNS-VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----SP 224 (469)
Q Consensus 156 ~~~~~-~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~----~~ 224 (469)
+|++. ..||-|--|.|. .+|+.+|+|++... ++.++|++.--.. .|||||.++++|.+. .-
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 44442 467888877653 48999999998643 4577888876666 499999999998653 44
Q ss_pred eEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~ 302 (469)
+.+|||.|+||.|...++.++. +++.++..|.+||+.|+.|||+.+ |.||||||+|+|+... ..+..
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t--------~~na~ 202 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTT--------SPNAP 202 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecC--------CCCcc
Confidence 7899999999999999988765 999999999999999999999999 9999999997776522 24567
Q ss_pred eEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----HHHHHh
Q 012164 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYA 378 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~----~~~~~~ 378 (469)
+||+|||+|+.... .......+-|+.|.|||++....|+...|+||+||++|-|++|-+||....... +...+.
T Consensus 203 lKLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~ 280 (400)
T KOG0604|consen 203 LKLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR 280 (400)
T ss_pred eEecccccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh
Confidence 99999999986442 334455677999999999999999999999999999999999999998766544 345554
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
.....-..+.+..+++..+++|+.+|..+|++|.|+.++++|=
T Consensus 281 ~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 281 TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 5444444456788999999999999999999999999999883
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=291.56 Aligned_cols=249 Identities=26% Similarity=0.469 Sum_probs=203.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..+.||+|+||.++. +|..||+|.+........+....+.+|+++++.++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377788999999998864 578899999875544444555778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+. |+|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||
T Consensus 106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~-----------Nil~~~~~~~kl~dfg 170 (317)
T cd06635 106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAG-----------NILLTEPGQVKLADFG 170 (317)
T ss_pred CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcc-----------cEEECCCCCEEEecCC
Confidence 996 588887754 456899999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
++..... .....++..|+|||.+. +..++.++|||||||++|+|++|+.||...........+.....+..
T Consensus 171 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 244 (317)
T cd06635 171 SASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL- 244 (317)
T ss_pred CccccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC-
Confidence 9865432 12345788999999974 45688899999999999999999999987654444444433333222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
....+++.+.+|+.+||+.+|.+||++.++++++..+..
T Consensus 245 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 245 -QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 234577889999999999999999999999998655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=293.14 Aligned_cols=241 Identities=24% Similarity=0.407 Sum_probs=180.2
Q ss_pred ceeeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe--CCceEEEEe
Q 012164 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (469)
Q Consensus 160 ~~~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~E 230 (469)
...||+|+||.||. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ....++|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 35899999999874 236799998864422 1357789999999999999999999854 457899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee----
Q 012164 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR---- 297 (469)
Q Consensus 231 ~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~---- 297 (469)
|++ ++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+ ||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~-----------Nil~~~~~ 145 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPA-----------NILVMGEG 145 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHH-----------HEEEccCC
Confidence 995 6888887521 24788899999999999999999999 999999999 5555
Q ss_pred CCCCCeEEeecCCccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH-
Q 012164 298 DDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV- 373 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~- 373 (469)
+.++.+||+|||+++....... .......+|+.|+|||++.+. .++.++|||||||++|+|+||++||........
T Consensus 146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~ 225 (317)
T cd07867 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 225 (317)
T ss_pred CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccc
Confidence 4567899999999986543221 122334678999999998764 578999999999999999999999975432110
Q ss_pred ---------HHHHhhcC------------CCCC---------------------CCChhhhHHHHHHHHHHHcccCCCCC
Q 012164 374 ---------PKAYAARQ------------RPPF---------------------KAPAKLYARGLKELIEECWNEKPAKR 411 (469)
Q Consensus 374 ---------~~~~~~~~------------~~~~---------------------~~~~~~~~~~l~~li~~cl~~dp~~R 411 (469)
.......+ .+.. .......+..+.+|+.+||..||.+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 305 (317)
T cd07867 226 SNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKR 305 (317)
T ss_pred cccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccc
Confidence 00000000 0000 00001224568899999999999999
Q ss_pred CCHHHHHHH
Q 012164 412 PTFRQIITR 420 (469)
Q Consensus 412 ps~~~ll~~ 420 (469)
||+.|+++|
T Consensus 306 ~t~~e~l~h 314 (317)
T cd07867 306 ITSEQALQD 314 (317)
T ss_pred cCHHHHhcC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=288.67 Aligned_cols=248 Identities=25% Similarity=0.478 Sum_probs=205.2
Q ss_pred CCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
....|+....||.|+||.+|. ++..|++|.+..... ....+.+|+++++.++|+||+++++++......++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 344677888999999998764 478899999864421 44678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
++||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~-----------ni~i~~~~~~~l~ 158 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSD-----------NILLSKDGSVKLA 158 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChh-----------hEEEcCCCCEEEC
Confidence 999999999999999876 7999999999999999999999998 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+..
T Consensus 159 d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 236 (286)
T cd06614 159 DFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL- 236 (286)
T ss_pred ccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-
Confidence 9999865443211 11233467889999999888899999999999999999999999986655443333333322222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....++..+.++|.+||+.+|.+|||+.+++.+
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 2234478899999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=310.99 Aligned_cols=251 Identities=16% Similarity=0.226 Sum_probs=185.2
Q ss_pred cccccceeeecCeEEEEEEe------ceeehhh--------------hcccccCCCHHHHHHHHHHHHHHhcCCCCceee
Q 012164 155 LDFTNSVEITKGTFILAFWR------GIQVAVK--------------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~~------g~~vaiK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 214 (469)
.+|++.+.||+|+||.||.- +..++.| .+.+...........+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 37999999999999998841 1122222 111111122334566889999999999999999
Q ss_pred EEeEEEeCCceEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccc
Q 012164 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289 (469)
Q Consensus 215 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~ 289 (469)
+++++...+..++++|++ +++|.+++... .......+..++.||+.||.|||+++ |+||||||+
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~------- 296 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLE------- 296 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-------
Confidence 999999999999999999 56888877542 12345677889999999999999999 999999999
Q ss_pred ccCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCC
Q 012164 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP-PFTMK 368 (469)
Q Consensus 290 ~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~-p~~~~ 368 (469)
|||++.++.+||+|||+++.+............|+..|+|||++.+..++.++|||||||++|||++|.. ||...
T Consensus 297 ----NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 297 ----NIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred ----HEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 8888889999999999998765332222334568999999999999999999999999999999999875 44433
Q ss_pred CCCc---HHHHHhhcC--CCCCCC-------------------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHH
Q 012164 369 HDNE---VPKAYAARQ--RPPFKA-------------------------PAKLYARGLKELIEECWNEKPAKRPTFRQII 418 (469)
Q Consensus 369 ~~~~---~~~~~~~~~--~~~~~~-------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll 418 (469)
.... +...+.... ...++. ....++..+.++|.+||+.||++|||+.|++
T Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 373 GGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred CCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 2221 111111000 000000 0012456678889999999999999999999
Q ss_pred HH
Q 012164 419 TR 420 (469)
Q Consensus 419 ~~ 420 (469)
.|
T Consensus 453 ~h 454 (501)
T PHA03210 453 AL 454 (501)
T ss_pred hC
Confidence 86
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=283.77 Aligned_cols=248 Identities=28% Similarity=0.485 Sum_probs=200.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccC--CCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 226 (469)
+|+..+.||+|+||.+|. +|..||+|.+..... ........+.+|++++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 678889999999998874 578899998753211 1234456789999999999999999999998764 4588
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
+++||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~-----------ni~i~~~~~~~l~ 148 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGA-----------NILRDSAGNVKLG 148 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH-----------HEEEcCCCCEEEC
Confidence 99999999999999988778999999999999999999999999 999999999 8888889999999
Q ss_pred ecCCccccccCC--CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 307 DFGVSKLLTVKE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 307 Dfgla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
|||+++...... ........++..|+|||.+.+..++.++|+|||||++++|++|+.||.............. .+.
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~ 226 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPT 226 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCC
Confidence 999997653211 1111234578899999999988889999999999999999999999986544333332222 222
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+..+++.+.+++.+||. +|..||++.+++.|
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 222355678899999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=280.69 Aligned_cols=249 Identities=28% Similarity=0.508 Sum_probs=205.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 228 (469)
+|+..+.||+|++|.+|. ++..|++|.+...... ....+.+.+|+.++++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 366778999999998874 4788999998755322 35567899999999999999999999999988 889999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
+||+++++|.+++.+...+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+||
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~-----------ni~i~~~~~~~l~d~ 145 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGA-----------NILVDSDGVVKLADF 145 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHH-----------HEEEcCCCCEEEccc
Confidence 999999999999998778999999999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 309 GVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 309 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
|.+......... ......++..|+|||.+.+..++.++||||||+++++|++|..||..... ................
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~ 224 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-PMAALYKIGSSGEPPE 224 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHhccccCCCcC
Confidence 999876543221 12335678899999999888899999999999999999999999986652 1111111111112222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+...+..+.++|.+|+..||++||++.+++++
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 344568899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=287.32 Aligned_cols=244 Identities=25% Similarity=0.480 Sum_probs=191.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHH-HhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.||. +|..||+|.+...... .. ...+..|+.+ ++.++||||+++++++......+++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 577888999999999875 5889999988754322 22 2345556654 66678999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 230 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
||++ ++|.+++.. ...+++..+..++.|++.||+|||++ + ++||||||+ ||+++.++.+|
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~-----------nil~~~~~~~k 144 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPS-----------NVLINRNGQVK 144 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHH-----------HEEECCCCCEE
Confidence 9995 789888764 23589999999999999999999997 7 999999999 88888899999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-cHHHHHhh
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAA 379 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~ 379 (469)
|+|||++...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... +.......
T Consensus 145 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (283)
T cd06617 145 LCDFGISGYLVDS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222 (283)
T ss_pred Eeecccccccccc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh
Confidence 9999998765422 11122457888999998865 35688999999999999999999999753321 22222222
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+.. +...++.++.++|.+||..+|++||++++++++
T Consensus 223 ~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 223 EPSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred cCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 212222 234578899999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=291.04 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=198.3
Q ss_pred ccccceeeecCeEEEEEE--------eceeehhhhcccccCC-CHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 225 (469)
+|+..+.||+|+||.+|. ++..||+|.+...... .......+.+|+.+++++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366788999999998874 4578999988643221 123345678899999999 599999999999988999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++||||+.+++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~-----------nil~~~~~~~~l 146 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLE-----------NILLDSEGHVVL 146 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH-----------HeEECCCCCEEE
Confidence 999999999999999987777999999999999999999999998 999999999 888888999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
+|||++...............++..|+|||.+.+.. .+.++||||||+++|+|++|..||...........+......
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd05583 147 TDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK 226 (288)
T ss_pred EECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc
Confidence 999998765433222222345788999999987754 778999999999999999999999644322211111111101
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
.....+..++..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 227 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1112234567889999999999999999998766655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=287.33 Aligned_cols=241 Identities=30% Similarity=0.454 Sum_probs=198.1
Q ss_pred eecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 163 ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
||.|+||.+|. +|+.|++|.+...........+.+.+|++++++++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 58899988764 4889999998765444445567889999999999999999999999988999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccC
Q 012164 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317 (469)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~ 317 (469)
.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~-----------nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPD-----------NILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHH-----------HeEEcCCCCEEEEecccchhcccC
Confidence 999998778999999999999999999999998 999999999 888889999999999998754322
Q ss_pred CC-------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 318 ED-------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 318 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
.. .......++..|+|||.+.+..++.++||||||+++++|++|..||......+....+.... ..... ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~ 224 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-IEWPE-DV 224 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-cCCCc-cc
Confidence 11 01223457788999999988888999999999999999999999998776555544443322 22111 11
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCH---HHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTF---RQIIT 419 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~---~~ll~ 419 (469)
.++..+.+++.+||+.+|++|||+ .++++
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 247899999999999999999999 55554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=284.43 Aligned_cols=244 Identities=28% Similarity=0.485 Sum_probs=204.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||.|+|+.++. +|+.+|+|.+..... .......+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 467788999999998764 578899999875433 23445677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 231 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+ ||+++.++.+||+
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~-----------ni~~~~~~~~kl~ 145 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSA-----------NILLVANDLVKIG 145 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcc-----------eEEEecCCcEEEe
Confidence 9999999999876 345889999999999999999999999 999999999 7777888999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|||++...... ......++..|+|||.+.+..++.++|+||||+++++|++|+.||...+..+....+.....++
T Consensus 146 d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 220 (256)
T cd08530 146 DLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP-- 220 (256)
T ss_pred eccchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--
Confidence 99999765433 2223457889999999999889999999999999999999999998766555444443333332
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..++.++.+++.+||..+|++||++.+++++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 -IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 234678899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=285.18 Aligned_cols=246 Identities=24% Similarity=0.450 Sum_probs=200.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.+|. +|..||+|.+...... ....+.+.+|+.+++.++||||+++++.+......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 467788999999998874 5788999988654322 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC-CeEEee
Q 012164 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG-NLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~-~vkl~D 307 (469)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++ .+||+|
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~-----------nil~~~~~~~~~l~d 145 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQ-----------NIFLSKNGMVAKLGD 145 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHH-----------HEEEcCCCCeEEecc
Confidence 999999999997643 4789999999999999999999998 999999999 77777775 469999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||.+....... .......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+...........+
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 221 (257)
T cd08225 146 FGIARQLNDSM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP--- 221 (257)
T ss_pred cccchhccCCc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---
Confidence 99987654322 12223457889999999988889999999999999999999999997655444433332222222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....++..+.+++.+||..+|++|||+.+++++
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 234567889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=289.65 Aligned_cols=247 Identities=25% Similarity=0.453 Sum_probs=205.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|...+.||+|+||.+|. +|..||+|++.............+..|.+++++++ ||||+++++++...+..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 577788999999998874 67899999987654444455577889999999998 999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~-----------ni~i~~~~~~~l~df~ 147 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPE-----------NILLDKDMHIKITDFG 147 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHH-----------HeEECCCCCEEecCCc
Confidence 99999999999998888999999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCC-------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q 012164 310 VSKLLTVKED-------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 370 (469)
Q Consensus 310 la~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~ 370 (469)
++........ .......++..|+|||...+..++.++|+||||++++++++|+.||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 9876543221 111233567889999999888889999999999999999999999987664
Q ss_pred CcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCH----HHHHHH
Q 012164 371 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF----RQIITR 420 (469)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~~ll~~ 420 (469)
......+.. .... .+..+++.+.+|+.+||+.||++|||+ .++++|
T Consensus 228 ~~~~~~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YLTFQKILK-LEYS---FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHHh-cCCC---CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 333333321 1111 234567889999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=289.07 Aligned_cols=244 Identities=28% Similarity=0.464 Sum_probs=192.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+....||+|+||.||. +|+.||+|.+..... ......+.+|+.++.++. ||||+++++++......+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 455667899999999874 578999998875432 244567889999999996 999999999999888999999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 230 E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
||+. ++|.++.. ..+.+++..+..++.|++.||+|||+. + ++||||||+ ||+++.++.+
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~-----------Nil~~~~~~~ 147 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPS-----------NILLDRNGNI 147 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHH-----------HEEEccCCcE
Confidence 9994 57666542 235699999999999999999999975 7 999999999 8888889999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA- 379 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~- 379 (469)
+|+|||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.... .....+..
T Consensus 148 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~ 223 (288)
T cd06616 148 KLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQV 223 (288)
T ss_pred EEeecchhHHhccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhh
Confidence 999999997543221 11223578899999998775 68899999999999999999999997654 12222211
Q ss_pred --cCCCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 --RQRPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 --~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+... ..+..++..+.+||.+||+.||++|||+++++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 224 VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 1123578899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=285.60 Aligned_cols=239 Identities=22% Similarity=0.352 Sum_probs=189.0
Q ss_pred eeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHH---HHHhcCCCCceeeEEeEEEeCCceEEEEeccC
Q 012164 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL---ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 162 ~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
.||+|+||.||. +|+.||+|.+.............+..|. ..++...||+|+++++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 379999999873 5789999988765433222222233343 34455679999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 234 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
+++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||++..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~-----------nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPA-----------NILLDEHGHVRISDLGLACD 146 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHH-----------HEEECCCCCEEEccCcCccc
Confidence 9999999988888999999999999999999999998 999999999 88888899999999999875
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH--hhcCCCCCCCChh
Q 012164 314 LTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAK 390 (469)
Q Consensus 314 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~ 390 (469)
.... ......|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||............ ....... .+.
T Consensus 147 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 220 (278)
T cd05606 147 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE---LPD 220 (278)
T ss_pred cCcc---CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC---CCC
Confidence 4322 11234688999999998754 6889999999999999999999999865332221111 1111222 233
Q ss_pred hhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
.+++.+.+++.+||..||.+|| ++.+++++
T Consensus 221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 4688999999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=281.36 Aligned_cols=246 Identities=26% Similarity=0.479 Sum_probs=205.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.++. ++..|++|.+..... .......+.+|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 467788999999998763 478999999875433 23455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 231 YLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 231 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~-----------nil~~~~~~~~l~ 145 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQ-----------NIFLTSNGLVKLG 145 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChH-----------HeEEcCCCcEEEC
Confidence 99999999999864 66999999999999999999999998 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|||++....... .......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||......+...........+
T Consensus 146 d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 222 (258)
T cd08215 146 DFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-- 222 (258)
T ss_pred CccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC--
Confidence 999997654332 12233457888999999988889999999999999999999999998766544444443332222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..++..+.+++.+||..+|++|||+.+++++
T Consensus 223 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 -IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 234678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=283.60 Aligned_cols=230 Identities=23% Similarity=0.406 Sum_probs=184.6
Q ss_pred eecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCCCC
Q 012164 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (469)
Q Consensus 163 ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~gs 236 (469)
||.|+||.|+. ++..+|+|.+....... .|+.....+ +||||+++++.+...+..++||||+++++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 59999998864 56789999886543211 122222223 69999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC-CeEEeecCCccccc
Q 012164 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG-NLKVADFGVSKLLT 315 (469)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~-~vkl~Dfgla~~~~ 315 (469)
|.+++.++..+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++ .++|+|||++....
T Consensus 96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~-----------nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLE-----------NVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHH-----------HEEEeCCCCeEEEecCccceecC
Confidence 9999988778999999999999999999999999 999999999 77777787 99999999987643
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH-HHHhhcCCCCCCCChhhhHH
Q 012164 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 316 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 394 (469)
.. ....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ......... .....+.+++
T Consensus 162 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (267)
T PHA03390 162 TP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-KLPFIKNVSK 235 (267)
T ss_pred CC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-cCCcccccCH
Confidence 22 2245788999999999889999999999999999999999999865444321 111111111 1122346889
Q ss_pred HHHHHHHHHcccCCCCCCC-HHHHHHH
Q 012164 395 GLKELIEECWNEKPAKRPT-FRQIITR 420 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps-~~~ll~~ 420 (469)
.+.+||.+||+.||.+||+ ++++++|
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhcC
Confidence 9999999999999999996 6998865
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=288.91 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=195.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 228 (469)
+|+..+.||.|+||.||. +++.+|+|.+...... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 677888999999998874 5788999998754322 22234567899999999999999999998877 889999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
+||+. ++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+ ||+++.++.++|+|
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~-----------nili~~~~~~~l~d 149 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTS-----------NLLLNNRGILKICD 149 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHH-----------HEEECCCCcEEEee
Confidence 99996 59999987644 4899999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC----
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---- 382 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---- 382 (469)
||++....... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.....
T Consensus 150 ~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (293)
T cd07843 150 FGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE 228 (293)
T ss_pred cCceeeccCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence 99998655332 222334567889999998764 468899999999999999999999986654332222111000
Q ss_pred -------------------CC---CCC-Chhh-hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 -------------------PP---FKA-PAKL-YARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 -------------------~~---~~~-~~~~-~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. ... .+.. +++.+.++|.+||+.||++|||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000 0111 47789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=288.01 Aligned_cols=248 Identities=24% Similarity=0.443 Sum_probs=194.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.+|. +|..||||.+..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 367788999999998874 578999998865432 22233568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+. ++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+ ||+++.++.+||+||
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~-----------nill~~~~~~~l~df 144 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQ-----------NLLINTEGAIKLADF 144 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEECCCCCEEEeec
Confidence 995 689998865 345899999999999999999999998 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-cCCCC--
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP-- 384 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~~-- 384 (469)
|++....... .......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+.......+.. .+.+.
T Consensus 145 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07860 145 GLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223 (284)
T ss_pred cchhhcccCc-cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9987654221 112223467889999988664 458899999999999999999999976543222111111 00000
Q ss_pred ----------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 ----------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ----------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.......+++++.++|.+||+.||++|||+.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 224 VWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000112356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=296.19 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=194.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------C
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 223 (469)
.+|+..+.||+|+||.|+. +|+.||+|.+..... .......+.+|+.++++++||||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 3688899999999998864 678999998865432 233445677899999999999999999988643 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++||||+ .++|.+.+... ++...+..++.|++.||+|||+.+ ++||||||+ ||+++.++.+
T Consensus 95 ~~~lv~e~~-~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~-----------Nil~~~~~~~ 157 (353)
T cd07850 95 DVYLVMELM-DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS-----------NIVVKSDCTL 157 (353)
T ss_pred cEEEEEecc-CCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHH-----------HEEECCCCCE
Confidence 579999999 46999888754 889999999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh----
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---- 379 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~---- 379 (469)
||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 158 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 235 (353)
T cd07850 158 KILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235 (353)
T ss_pred EEccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999997654321 12334578899999999998999999999999999999999999975543211111100
Q ss_pred -----------------cCCCCC------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 -----------------RQRPPF------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 -----------------~~~~~~------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..++.. .......++.++++|.+||..||++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00012346778999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=275.52 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=200.4
Q ss_pred ceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEeccC
Q 012164 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 160 ~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
.+.||+|+|+.|. .+|..+|||++.+. ......+..+|++++.+.+ |+||++++++|+++..+|+|||-|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 4578999998764 58999999999765 3344567888999999996 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 234 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
||+|...+.++..+.+.++.++.++|+.||.|||.+| |.||||||+|||.... +.-.-|||+||.+..-
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~p--------n~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESP--------NKVSPVKICDFDLGSG 228 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCC--------CCcCceeeeccccccc
Confidence 9999999999999999999999999999999999999 9999999996665421 1223589999998754
Q ss_pred cccCCC------CCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----------
Q 012164 314 LTVKED------RPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---------- 372 (469)
Q Consensus 314 ~~~~~~------~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~---------- 372 (469)
+..... .......|+..|||||+.. ...|+.+.|.||||||+|-|++|.+||.+.-...
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 332211 1124467888999999863 2378899999999999999999999998765532
Q ss_pred -----HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 373 -----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 373 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+...+..+...-....+..++.+.+++|..++..|+.+|.++.++++|
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 223333333333334577889999999999999999999999999985
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=290.05 Aligned_cols=248 Identities=29% Similarity=0.445 Sum_probs=194.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 228 (469)
+|+..+.||+|+||.++. +|+.||+|.+....... .....+.+|+.++++++|+||+++++++... +..++|
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 688889999999998874 57899999886543221 1123456799999999999999999998755 468999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||++ ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|
T Consensus 87 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~-----------nil~~~~~~~kL~d 151 (309)
T cd07845 87 MEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVS-----------NLLLTDKGCLKIAD 151 (309)
T ss_pred EecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEECCCCCEEECc
Confidence 99995 589888875 356899999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC---
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--- 383 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 383 (469)
||++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+......
T Consensus 152 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 152 FGLARTYGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred cceeeecCCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99997654322 12222345778999999865 46788999999999999999999999876654443333221100
Q ss_pred --------------------CCCC---ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 --------------------PFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 --------------------~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+... .....++.+.+||.+||..||++|||+++++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 011247788999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=294.50 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=217.2
Q ss_pred ccccceeeecCeEEEEE---Eecee--ehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAF---WRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~---~~g~~--vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+++....||-|+||.|. .+++. +|+|.+++..+.+....+.+..|-++|...+.|+||++|-.|.++.++|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 45566789999999864 35555 89999999888888888899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
-|-||.|+..+..++.+...++..++..+++|++|||++| ||+|||||+ |.+++.+|-+||.|||+
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPE-----------NllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPE-----------NLLLDNRGYLKLVDFGF 566 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChh-----------heeeccCCceEEeehhh
Confidence 9999999999999999999999999999999999999999 999999999 99999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+.+.... ..-.++||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.++......+..+...- ..|.
T Consensus 567 AKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--~~Pr 642 (732)
T KOG0614|consen 567 AKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--EFPR 642 (732)
T ss_pred HHHhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--hccc
Confidence 99887543 3445889999999999999999999999999999999999999999988877777765443221 1246
Q ss_pred hhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
.++....+||+++...+|.+|.. ..++.+|
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 78888999999999999999976 4555544
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=284.68 Aligned_cols=247 Identities=25% Similarity=0.482 Sum_probs=195.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|++|.+|. +|..||+|.+..... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 477888999999998874 578899998875432 2223567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|++ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~-----------ni~~~~~~~~~l~d 143 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQ-----------NLLINKRGELKLAD 143 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHH-----------HEEECCCCcEEEee
Confidence 996 5899988754 35899999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC-C--
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-P-- 383 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~-- 383 (469)
||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+..... +
T Consensus 144 ~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd07836 144 FGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE 222 (284)
T ss_pred cchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 999975433211 11223467889999988654 568899999999999999999999987665443322211100 0
Q ss_pred --------------CCC--------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 --------------PFK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 --------------~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... ...+.+++.+.+++.+||+.||.+||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 223 STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 0012346789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=285.31 Aligned_cols=248 Identities=29% Similarity=0.419 Sum_probs=195.8
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceEEEE
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 229 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 229 (469)
|++.+.||.|+||.+|. +|+.+|+|.+.... ........+.+|++++++++|||++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 45678999999998875 46899999998653 2233346688899999999999999999999887 7899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||++ ++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+ ||+++.++.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~-----------nil~~~~~~~~l~d~ 144 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGS-----------NILINNDGVLKLADF 144 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHH-----------HeEEcCCCCEEEccc
Confidence 9996 5999998765 56999999999999999999999998 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CCC--
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP-- 384 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~-- 384 (469)
|++...............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.... .+.
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07840 145 GLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDE 224 (287)
T ss_pred cceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchh
Confidence 9998665433222233456788999998765 367889999999999999999999998655433222221100 000
Q ss_pred -----------------CC------CChhh-hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 -----------------FK------APAKL-YARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 -----------------~~------~~~~~-~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. ..... +++.+.+++.+||..||++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00011 27789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=288.65 Aligned_cols=249 Identities=18% Similarity=0.340 Sum_probs=194.4
Q ss_pred cccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccC
Q 012164 157 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
+.+.+.+|.|+++.++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 44555667777765543 689999999876532 34556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 234 KGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 234 ~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
+++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+ ||+++.++.+||+|||.+
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~-----------Nili~~~~~~kl~d~~~~ 148 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKAS-----------HILLSGDGKVVLSGLRYS 148 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcc-----------eEEEecCCceEEecCccc
Confidence 99999999863 35889999999999999999999999 999999999 888888999999999988
Q ss_pred cccccCCCC------CcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 312 KLLTVKEDR------PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 312 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
......... ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.................+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (314)
T cd08216 149 VSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP 228 (314)
T ss_pred eeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCc
Confidence 654322110 1122346778999999876 35788999999999999999999999865433221111110000
Q ss_pred ------------------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 ------------------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
........++.++.+|+.+||..||++|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0001123456789999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.19 Aligned_cols=259 Identities=30% Similarity=0.525 Sum_probs=215.0
Q ss_pred ccccCCCCcccccceeeecCeEEEEEEe------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCcee
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVV 213 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~~------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~ 213 (469)
.||+....+.+ .+.+|.|.||.|+.. ...||||+++.... ....+.+..|+++|+.+. ||||+
T Consensus 290 ~~e~~~~~l~~--~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKL--GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhccc--cceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchh
Confidence 67777666644 449999999987531 46799999986543 366788999999999995 99999
Q ss_pred eEEeEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012164 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (469)
Q Consensus 214 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 277 (469)
.++|++...+.+++|+||+..|+|.+++..+. .++....+.++.||+.|++||++.. +|||
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 99999999999999999999999999998755 3888999999999999999999998 9999
Q ss_pred CCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCCcccCC--CCCcccCCcccCCCCCCCchhHHHHHHHH
Q 012164 278 DLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALIL 355 (469)
Q Consensus 278 Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDi~SlGvil 355 (469)
||... |||+..+..+||+|||+|+.............. -+..|||||.+....|+.+||||||||++
T Consensus 443 DLAaR-----------NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 443 DLAAR-----------NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILL 511 (609)
T ss_pred hhhhh-----------hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHH
Confidence 99999 888888999999999999865543333222222 35569999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCC-CCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 356 QEMIE-GCPPFTMKH-DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 356 ~el~t-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
||++| |..||.+.. ..++...+..+.+... +..+++++.++++.||+.+|++||++.++.+.|+....
T Consensus 512 ~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 99998 999999855 4445444444445544 45678899999999999999999999999999999644
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=286.49 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=190.3
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|..||+|.+...... .....+.+|+.+++.++|+||+++++++......++|+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4688889999999998874 4789999998654321 12235678999999999999999999999988999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+. ++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+||
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~-----------Nil~~~~~~~~l~Df 147 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQ-----------NLLISYLGELKLADF 147 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChH-----------HEEEcCCCcEEEecc
Confidence 9995 677777654 355888899999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-HHHHHhh-cCC---
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAA-RQR--- 382 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-~~~~~~~-~~~--- 382 (469)
|+++...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ....... .+.
T Consensus 148 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07870 148 GLARAKSIPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE 226 (291)
T ss_pred ccccccCCCC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCCh
Confidence 9987543221 112233468899999998764 57889999999999999999999997554311 0000000 000
Q ss_pred -------------CC---------CCCC--hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 -------------PP---------FKAP--AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 -------------~~---------~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+. .... .-..+..+.+++.+|+..||++|||+++++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 0000 00124678999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.59 Aligned_cols=242 Identities=22% Similarity=0.407 Sum_probs=197.6
Q ss_pred cceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccC
Q 012164 159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 159 ~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
....||+|+||.+|. +|..||+|.+... .......+.+|+.+++.++||||+++++.+...+..+++|||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 345799999998864 5789999987533 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 234 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
+++|.+++.. +.+++..+..++.|++.||+|||+.+ ++|+||+|+ ||+++.++.++|+|||++..
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~-----------Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSD-----------SILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEECCCCCEEEccccccee
Confidence 9999998764 46899999999999999999999998 999999999 88888899999999999875
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhH
Q 012164 314 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 393 (469)
Q Consensus 314 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (469)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+........ .....++
T Consensus 166 ~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 243 (292)
T cd06657 166 VSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL-KNLHKVS 243 (292)
T ss_pred ccccc-ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc-CCcccCC
Confidence 54321 112234578899999999888889999999999999999999999986554443333322222222 1223567
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 394 RGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 394 ~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+.+++.+||..||.+||++.+++.+
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 889999999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=286.41 Aligned_cols=242 Identities=26% Similarity=0.464 Sum_probs=197.5
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|...+.||+|+||.+|. +|..|++|.+.............+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 45566799999998875 5788999998755444445556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
+. ++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.+||+|||+
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~-----------nili~~~~~~kL~dfg~ 167 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAG-----------NILLTEPGQVKLADFGS 167 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChh-----------hEEECCCCCEEEeecCC
Confidence 95 688888765 446899999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
+..... .....++..|+|||.+. ...++.++||||||+++|+|++|..||...........+.....+..
T Consensus 168 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 240 (313)
T cd06633 168 ASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL-- 240 (313)
T ss_pred CcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--
Confidence 864321 12345788999999984 35688899999999999999999999987654444333322222222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....++..+.+|+.+||+.+|.+||++.+++.+
T Consensus 241 ~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 233467789999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=285.81 Aligned_cols=239 Identities=29% Similarity=0.430 Sum_probs=211.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|.....||+|+||.|.+ +.+.+|||+++++.+...+.++--+.|-++|.... -|.+++++.+|..-+.+|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 566778999999999865 45789999999887766666677778889988774 789999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+.||+|-..+++-+++.+..+..++..|+-||-+||++| ||.||||.+ ||++|.+|++||+|||
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLD-----------NvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLD-----------NVMLDSEGHIKIADFG 495 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeecccc-----------ceEeccCCceEeeecc
Confidence 99999999999999999999999999999999999999999 999999999 9999999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+++.-- .........+||+.|+|||++...+|+..+|.||+||++|||+.|++||.+.+.+++...+....-. .+
T Consensus 496 mcKEni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs----yP 570 (683)
T KOG0696|consen 496 MCKENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS----YP 570 (683)
T ss_pred cccccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc----Cc
Confidence 997532 2334456688999999999999999999999999999999999999999999998988888655422 24
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCC
Q 012164 390 KLYARGLKELIEECWNEKPAKRPT 413 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps 413 (469)
+.++.+..++++..|.+.|.+|..
T Consensus 571 KslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 571 KSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ccccHHHHHHHHHHhhcCCccccC
Confidence 678899999999999999999953
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=284.43 Aligned_cols=252 Identities=15% Similarity=0.149 Sum_probs=185.0
Q ss_pred cccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHH--------HHHHHHHHHHHhcCCCCceeeEEeE
Q 012164 155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDR--------VRAFRDELALLQKIRHPNVVQFLGA 218 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~ 218 (469)
.+|++.+.||+|+||.||.. +..+|+|............ ......+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 47889999999999999852 3455666533221110000 0112234455667789999999998
Q ss_pred EEeCC----ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcc
Q 012164 219 VTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294 (469)
Q Consensus 219 ~~~~~----~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~n 294 (469)
+.... ..++++|++ ..++.+.+......++..+..++.|++.||.|||+.+ ++||||||+ |
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~-----------N 156 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPE-----------N 156 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------H
Confidence 76543 347888888 5688888876655788889999999999999999998 999999999 8
Q ss_pred eeeCCCCCeEEeecCCccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 012164 295 ILRDDSGNLKVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 368 (469)
Q Consensus 295 il~~~~~~vkl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~ 368 (469)
||++.++.++|+|||+|+....... .......||+.|+|||++.+..++.++|||||||++++|++|+.||...
T Consensus 157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 8888899999999999976532211 1112246899999999999999999999999999999999999999876
Q ss_pred CCCc-HHHHHhh---cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 369 HDNE-VPKAYAA---RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 369 ~~~~-~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
.... ....... .............++.+.+++..|+..+|++||++.++++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 4322 1111100 000000111234578899999999999999999999999876
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=285.81 Aligned_cols=247 Identities=25% Similarity=0.437 Sum_probs=190.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||.|+||.||. +++.||+|.+...... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 678889999999998874 5788999998654321 112346689999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~-----------nil~~~~~~~kl~dfg 148 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQ-----------NLLISERGELKLADFG 148 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHH-----------HEEEcCCCCEEECccc
Confidence 996 5999988764 45899999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-cHHHHH-hhcCCC---
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAY-AARQRP--- 383 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-~~~~~~-~~~~~~--- 383 (469)
+++...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... +....+ ...+.+
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 149 LARAKSVPS-KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred cccccCCCC-ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 986543211 11122345788999999875 46788999999999999999999999755421 111100 000000
Q ss_pred ----------------------CCCCChhhhH--HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 ----------------------PFKAPAKLYA--RGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ----------------------~~~~~~~~~~--~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+........+ ..+.+++.+||+.||++|||+++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000001223 678899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=285.40 Aligned_cols=247 Identities=27% Similarity=0.462 Sum_probs=194.2
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|+..+.||.|++|.+|. +|..||+|++..+... ......+.+|+.+++.++|||++++++++.+....++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 45678999999998874 5889999988754322 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+ +++|.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+ ||+++.++.++|+|||
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~-----------nil~~~~~~~~l~df~ 144 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQ-----------NLLIDREGALKLADFG 144 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHH-----------HEEEcCCCcEEEeecc
Confidence 9 469999998765 6899999999999999999999998 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc--------
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------- 380 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-------- 380 (469)
++....... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+...
T Consensus 145 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07835 145 LARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223 (283)
T ss_pred cccccCCCc-cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 997543221 111223457889999988664 5788999999999999999999999765432211111000
Q ss_pred -----------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 -----------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 -----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...........++..+.++|.+||+.||++|||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0001111123566789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=294.18 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=198.6
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-----Cc
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 224 (469)
.+|+..+.||+|+||.+|. +|..||||.+..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3688889999999998874 578999998875422 223345677899999999999999999988644 34
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
.++++||+ +++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+|
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~-----------Nil~~~~~~~k 148 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPS-----------NLLLNANCDLK 148 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH-----------HEEEcCCCCEE
Confidence 89999999 5799999988888999999999999999999999998 999999999 88888899999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh----
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---- 379 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~---- 379 (469)
|+|||+++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 149 L~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 149 ICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred ECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999998654322 22233457889999998865 4688999999999999999999999976532111111100
Q ss_pred --------------------cC---CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHH
Q 012164 380 --------------------RQ---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESI 424 (469)
Q Consensus 380 --------------------~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~ 424 (469)
.. ........+.+++.+.++|.+||+.||++|||++++++| ++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 001111123567889999999999999999999999998 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=275.28 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=191.9
Q ss_pred ccccceeeecCeEEEEEEe---------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe-CCce
Q 012164 156 DFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~---------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 225 (469)
.|+....||+|+||.||.. ...+|||++.-++-.+.-. ....+|+.+++.++||||+.+..+|.+ +..+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 6788889999999999862 3479999998663222221 346789999999999999999999987 6789
Q ss_pred EEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 226 MIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
++++||.+. +|+.+++-+ ..++...+..|+.||+.|+.|||++- |+||||||. |||+..+
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPa-----------NIlvmgd 168 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPA-----------NILVMGD 168 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcc-----------eEEEecc
Confidence 999999965 999999632 34899999999999999999999998 999999999 6666655
Q ss_pred ----CCeEEeecCCccccccCC--CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--
Q 012164 301 ----GNLKVADFGVSKLLTVKE--DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-- 371 (469)
Q Consensus 301 ----~~vkl~Dfgla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-- 371 (469)
|+|||+|||+++.+...- -........|++|+|||.+.|. .|+.+.|||++|||+.||+|-.+.|.+....
T Consensus 169 gperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~ 248 (438)
T KOG0666|consen 169 GPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK 248 (438)
T ss_pred CCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcc
Confidence 899999999999775321 1122445679999999999886 7899999999999999999998888643221
Q ss_pred -----c---HHHHHhhcCCCCCCC-----------------------C---------hhhhHHHHHHHHHHHcccCCCCC
Q 012164 372 -----E---VPKAYAARQRPPFKA-----------------------P---------AKLYARGLKELIEECWNEKPAKR 411 (469)
Q Consensus 372 -----~---~~~~~~~~~~~~~~~-----------------------~---------~~~~~~~l~~li~~cl~~dp~~R 411 (469)
. +...+...+.+.... . ...-++...+|+.+||+.||.+|
T Consensus 249 ~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 249 TKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred cCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhh
Confidence 0 111111122211100 0 01123447889999999999999
Q ss_pred CCHHHHHHH
Q 012164 412 PTFRQIITR 420 (469)
Q Consensus 412 ps~~~ll~~ 420 (469)
.|+++++++
T Consensus 329 Ita~qAleh 337 (438)
T KOG0666|consen 329 ITAEQALEH 337 (438)
T ss_pred ccHHHHhcc
Confidence 999999988
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=283.59 Aligned_cols=244 Identities=22% Similarity=0.336 Sum_probs=188.9
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeC--CceEEE
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMIV 228 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv 228 (469)
|+..+.||+|+||.+|. ++..||+|.+..... +... .....|+.+++++. ||||+++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 45678899999998874 578899998875432 2222 23446888999885 99999999999887 889999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
+||++ ++|.+.+.. .+.+++..+..++.|++.||+|||+.+ ++|+||+|+ ||+++. +.+||+|
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~-----------ni~l~~-~~~kl~d 142 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPE-----------NILIKD-DILKLAD 142 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHH-----------HEEEcC-CCeEEEe
Confidence 99996 588888875 356899999999999999999999999 999999999 777777 9999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc------
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR------ 380 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~------ 380 (469)
||++....... ......++..|+|||.+.. ..++.++|||||||++|+|++|..||...+..+........
T Consensus 143 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
T cd07831 143 FGSCRGIYSKP--PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220 (282)
T ss_pred cccccccccCC--CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH
Confidence 99997654322 1223457889999997644 45788999999999999999999999865543322211110
Q ss_pred ---------CCCCCC----------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 ---------QRPPFK----------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ---------~~~~~~----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...... .....++..+.++|.+||++||++||++++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 0012467899999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=287.31 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=200.4
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
..|+..+.||+|+||.+|. ++..||+|.+.............+.+|+++++.++|||++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3577788999999998873 56789999886543334455567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+||
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~-----------nil~~~~~~~kl~df 159 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAG-----------NILLSEPGLVKLGDF 159 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH-----------hEEECCCCcEEECCc
Confidence 9995 688887754 445899999999999999999999998 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
|++...... ....++..|+|||.+. ...++.++|||||||++|+|++|+.||......+....+.....+..
T Consensus 160 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06634 160 GSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234 (308)
T ss_pred ccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc
Confidence 998764322 2245788999999974 34678899999999999999999999976654444443333322222
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
....++..+.+||.+||..+|++||++.+++.+..-
T Consensus 235 --~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 235 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred --CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 234577889999999999999999999999988443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.08 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=191.8
Q ss_pred ccccceeeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceE
Q 012164 156 DFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 226 (469)
+|+..+.||+|+||.++. .+..||+|.+...........+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 367788999999998874 4689999998864322223335678899999999999999999999888 7899
Q ss_pred EEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC--
Q 012164 227 IVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD-- 299 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~-- 299 (469)
+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~-----------Nil~~~~~ 145 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPA-----------NILVMGEG 145 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHH-----------HEEEcCCC
Confidence 9999995 5787777532 25889999999999999999999999 999999999 777777
Q ss_pred --CCCeEEeecCCccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc--
Q 012164 300 --SGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-- 372 (469)
Q Consensus 300 --~~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-- 372 (469)
++.+||+|||++........ .......++..|+|||.+.+. .++.++||||||+++++|++|+.||.......
T Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~ 225 (316)
T cd07842 146 PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK 225 (316)
T ss_pred CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence 89999999999986543222 112334578899999988664 57889999999999999999999997654432
Q ss_pred --------HHHHHh------------------------hcCCCCCC--CCh------hhhHHHHHHHHHHHcccCCCCCC
Q 012164 373 --------VPKAYA------------------------ARQRPPFK--APA------KLYARGLKELIEECWNEKPAKRP 412 (469)
Q Consensus 373 --------~~~~~~------------------------~~~~~~~~--~~~------~~~~~~l~~li~~cl~~dp~~Rp 412 (469)
+...+. ........ ... ...+..+.+++.+||+.||++||
T Consensus 226 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 305 (316)
T cd07842 226 SNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI 305 (316)
T ss_pred cchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc
Confidence 000000 00000110 000 13456799999999999999999
Q ss_pred CHHHHHHH
Q 012164 413 TFRQIITR 420 (469)
Q Consensus 413 s~~~ll~~ 420 (469)
|+.++++|
T Consensus 306 s~~eil~~ 313 (316)
T cd07842 306 TAEEALEH 313 (316)
T ss_pred CHHHHhcC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=294.20 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=196.8
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe----CCce
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~ 225 (469)
.+|+..+.||.|+||.+|. +|..||+|.+..... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4678888999999998863 588999999875432 22334667789999999999999999998753 3468
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++|+||+ +++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||
T Consensus 84 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~-----------Nil~~~~~~~kl 148 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPS-----------NLLVNEDCELRI 148 (334)
T ss_pred EEEEehh-hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEEcCCCcEEe
Confidence 9999999 5699999987777999999999999999999999998 999999999 888889999999
Q ss_pred eecCCccccccCCCC---CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-c
Q 012164 306 ADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-R 380 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~ 380 (469)
+|||++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.. .
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 228 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHh
Confidence 999999765432211 1123467889999999865 4688999999999999999999999976543222111100 0
Q ss_pred C------------------------CCCCC--CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 Q------------------------RPPFK--APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ~------------------------~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+ ..+.. ...+..+..+.++|.+||+.||++|||+++++.+
T Consensus 229 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 229 GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 00000 0113457889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=288.85 Aligned_cols=245 Identities=22% Similarity=0.429 Sum_probs=189.4
Q ss_pred eeeecC--eEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccC
Q 012164 161 VEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 161 ~~ig~G--~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
..||+| +|+.||. +|+.||+|.+..... .....+.+.+|+.+++.++||||++++++|......++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456766 7777753 679999999875433 33455789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 234 KGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 234 ~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
+++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++||||||+ ||+++.++.++++||+.+
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~-----------Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKAS-----------HILISGDGLVSLSGLSHL 148 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEEeCCCcEEEechHHH
Confidence 999999998643 4888999999999999999999998 999999999 888888999999999865
Q ss_pred cccccCCCCC------cccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-C
Q 012164 312 KLLTVKEDRP------LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R 382 (469)
Q Consensus 312 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~--~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~ 382 (469)
.......... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||......+......... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd08226 149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY 228 (328)
T ss_pred hhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCC
Confidence 4322111100 0112345679999999764 57889999999999999999999997654333221111100 0
Q ss_pred CC-----------------------------------------C-CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PP-----------------------------------------F-KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~-----------------------------------------~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+ . ......+++.+.+|+.+||..||++|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 0 01123467789999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=286.03 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=190.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC-------
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------- 223 (469)
+|+..+.||+|+||.||. +|+.||||.+....... .....+.+|++++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 688899999999998874 57899999886443211 12234567999999999999999999986543
Q ss_pred -ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 224 -PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 224 -~~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
..++||||+. ++|.+++.... .+++.++..++.|++.||.|||+++ ++|+||||+ ||+++.++
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~-----------nil~~~~~ 156 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAA-----------NILITKDG 156 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH-----------HEEECCCC
Confidence 3599999995 68988887543 6899999999999999999999998 999999999 88888899
Q ss_pred CeEEeecCCccccccCCCC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH
Q 012164 302 NLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~ 377 (469)
.+||+|||++......... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999765432211 11223467889999988664 4688999999999999999999999765543222211
Q ss_pred hhc-CCC-----------------CCCC----------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AAR-QRP-----------------PFKA----------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~-~~~-----------------~~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... +.. .... .....+..+.+||.+||..||.+|||++++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 110 000 0000 001124567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=292.16 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=194.1
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-----Cc
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 224 (469)
.+|++.+.||+|+||.||. +|+.||+|.+... ........+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3688899999999998874 5789999988642 2233446678899999999999999999987644 35
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
.++++||+. ++|.+++.. +.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+|
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~-----------Nill~~~~~~k 146 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPS-----------NLLLNTNCDLK 146 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH-----------HEEECCCCCEE
Confidence 799999995 689888864 46999999999999999999999999 999999999 88888899999
Q ss_pred EeecCCccccccCCCC--CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh--
Q 012164 305 VADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-- 379 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-- 379 (469)
|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~ 226 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL 226 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 9999999765432211 1123467889999998754 4688999999999999999999999975432211111100
Q ss_pred ---------------------cC----CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHH
Q 012164 380 ---------------------RQ----RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESI 424 (469)
Q Consensus 380 ---------------------~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~ 424 (469)
.. ..+.....+.+++.+.+++.+||+.||++|||+.++++| |+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 000000112356789999999999999999999999998 5444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=284.02 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=191.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|++|.+|. +|+.||+|.+..... .......+.+|++++++++||||+++++++.+....++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 577888999999998864 578899998865432 22333567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC-CCCeEEee
Q 012164 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD-SGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~-~~~vkl~D 307 (469)
|++ ++|.+++..... +++..+..++.||+.||+|||+++ ++|+||+|+ ||+++. ++.+||+|
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~-----------nill~~~~~~~kl~d 146 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQ-----------NLLIDRRTNALKLAD 146 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcc-----------eEEEECCCCEEEEcc
Confidence 995 688888865443 577888899999999999999998 999999999 777764 45799999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-cCCC--
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRP-- 383 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~-- 383 (469)
||++...... ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+.. .+.+
T Consensus 147 fg~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (294)
T PLN00009 147 FGLARAFGIP-VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNE 225 (294)
T ss_pred cccccccCCC-ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9999764322 1112234567899999988664 578899999999999999999999986544322221111 0000
Q ss_pred -----------------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 -----------------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 -----------------~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... .....+++.+.+++.+||+.||++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0112457789999999999999999999999975
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=284.39 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=191.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCc-----
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP----- 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~----- 224 (469)
+|+..+.||+|+||.+|. +|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 577888999999998874 578999998765432 1222356788999999995 6999999999877655
Q ss_pred eEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 225 MMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
.+++|||++ ++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+ ||+++.
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~-----------nil~~~ 145 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQ-----------NLLVDK 145 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChH-----------HEEEec
Confidence 899999996 4898888642 34799999999999999999999999 999999999 777777
Q ss_pred -CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH
Q 012164 300 -SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377 (469)
Q Consensus 300 -~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~ 377 (469)
++.+||+|||++....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+
T Consensus 146 ~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 224 (295)
T cd07837 146 QKGLLKIADLGLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224 (295)
T ss_pred CCCeEEEeecccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 7899999999987543221 11122346788999998865 45789999999999999999999999865443322211
Q ss_pred hhc-CCC------------------CC-----CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AAR-QRP------------------PF-----KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~-~~~------------------~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... ..+ .. ....+.+++.+.+||.+||..||.+||++++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 110 000 00 00113467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=278.10 Aligned_cols=239 Identities=29% Similarity=0.458 Sum_probs=199.3
Q ss_pred eecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 163 ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
||.|+||.++. +++.||+|.+.............+..|+.++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999988764 4789999998766555555667889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccC
Q 012164 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317 (469)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~ 317 (469)
.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~-----------ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPE-----------NILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcc-----------eEEEcCCCcEEEeecCcceecccC
Confidence 999998878999999999999999999999998 999999999 888888999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHH
Q 012164 318 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 397 (469)
Q Consensus 318 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 397 (469)
. .......++..|+|||.+.+...+.++|+||||+++|+|++|..||......+....+.. ...+ .+...+..+.
T Consensus 147 ~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~ 221 (250)
T cd05123 147 G-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLR---FPEFLSPEAR 221 (250)
T ss_pred C-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCC---CCCCCCHHHH
Confidence 1 122335578899999999888888999999999999999999999976654333333322 2222 2344578899
Q ss_pred HHHHHHcccCCCCCCCH---HHHHHH
Q 012164 398 ELIEECWNEKPAKRPTF---RQIITR 420 (469)
Q Consensus 398 ~li~~cl~~dp~~Rps~---~~ll~~ 420 (469)
+++.+||..||++||++ +++++|
T Consensus 222 ~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred HHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 99999999999999999 565543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=283.58 Aligned_cols=245 Identities=28% Similarity=0.482 Sum_probs=192.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.++. +|+.||||.+..... ......+..|+.++.+.. ||||+++++++.+....+++|
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 677889999999998864 388999999875422 233455666777666665 999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
||+ +++|.+++.. .+.+++..+..++.|++.||.|||+ .+ ++||||+|+ ||+++.++.+||+|
T Consensus 94 e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~-----------nill~~~~~~kL~d 158 (296)
T cd06618 94 ELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPS-----------NILLDASGNVKLCD 158 (296)
T ss_pred ecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHH-----------HEEEcCCCCEEECc
Confidence 999 5688888765 4568999999999999999999997 47 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCC-cHHHHHhhcCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQR 382 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDi~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~ 382 (469)
||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... +..........
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (296)
T cd06618 159 FGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236 (296)
T ss_pred cccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC
Confidence 999876543221 12234678899999987543 788999999999999999999999754322 22222222222
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.. .....++.++.+|+.+||..||++||++.+++.+
T Consensus 237 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222 1223467889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=290.62 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=203.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC-----ce
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 225 (469)
+|++.+.||.|+||.++. +|..||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 467788999999998864 47899999887542 22344567889999999999999999999987765 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
+++|||+. ++|.+++.+...+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~-----------nili~~~~~~~L 144 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPS-----------NILVNSNCDLKI 144 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEEcCCCCEEE
Confidence 99999996 689999988778999999999999999999999999 999999999 888888999999
Q ss_pred eecCCccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-
Q 012164 306 ADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ- 381 (469)
Q Consensus 306 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~- 381 (469)
+|||++........ .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+....
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 224 (330)
T cd07834 145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224 (330)
T ss_pred cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcC
Confidence 99999987554321 122334578899999999887 88999999999999999999999998765443322221111
Q ss_pred CCC--------------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHh
Q 012164 382 RPP--------------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINN 426 (469)
Q Consensus 382 ~~~--------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~ 426 (469)
.++ .......++..+.++|.+||+.||++|||+.+++.+ |+.+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000 000112357789999999999999999999999987 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=279.97 Aligned_cols=246 Identities=27% Similarity=0.435 Sum_probs=193.0
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC---CCCceeeEEeEEEeCCc----
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSP---- 224 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~---- 224 (469)
|++.+.||+|+||.+|. ++..||+|.+...... ......+.+|+.+++++ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 46678999999998864 4789999998754322 22234566788777666 59999999999988776
Q ss_pred -eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 225 -MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 225 -~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
.+++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~-----------nili~~~~ 144 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQ-----------NILVTSDG 144 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChh-----------hEEEccCC
Confidence 999999995 58999887643 4899999999999999999999998 999999999 88888899
Q ss_pred CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC
Q 012164 302 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 381 (469)
.+||+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|++||......+....+....
T Consensus 145 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07838 145 QVKIADFGLARIYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222 (287)
T ss_pred CEEEeccCcceeccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence 99999999987654321 1123346888999999998889999999999999999999999998765544333221100
Q ss_pred -----------------------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 -----------------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 -----------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..........+++.+.++|.+||+.||++||++.+++.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000001112456788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=284.41 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=193.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC-------
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------- 223 (469)
+|+..+.||+|+||.||. +|+.||+|.+...... ......+.+|+.++++++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 677888999999998874 5788999998654221 122345778999999999999999999987654
Q ss_pred ---ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 224 ---PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 224 ---~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
.+++|+||+++ +|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~-----------nili~~ 151 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCS-----------NILLNN 151 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEECC
Confidence 78999999965 787777654 45899999999999999999999999 999999999 888889
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 378 (469)
++.+||+|||++...............++..|+|||.+.+. .++.++|||||||++++|++|++||......+....+.
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 152 KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred CCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999999976543322222223457789999988653 56889999999999999999999998654433222221
Q ss_pred hc--CCCC-----C-------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 AR--QRPP-----F-------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~--~~~~-----~-------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. ...+ . ......++..+.+++..||..||++|||+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 0000 0 00122457889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=275.46 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=197.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+++...+||.|.||.|.. +|+..|||+++.... ...++++..|.++..+- +.||||++||++..++..|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 455677899999999863 799999999986543 45567788888875554 6999999999999999999999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 230 E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
|+| ..||+.+-+ ++.++++..+-.|....+.||.||-+.- .|||||+||+ |||++..|.||
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPS-----------NILldr~G~vK 208 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPS-----------NILLDRHGDVK 208 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChh-----------heEEecCCCEe
Confidence 999 578877664 3456899888889999999999998754 4999999999 99999999999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 382 (469)
|+|||.+-.... +...+.-+|-..|||||.+.. ..|+.+|||||||++|+|+.||..||...+..--.......+.
T Consensus 209 LCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gd 286 (361)
T KOG1006|consen 209 LCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGD 286 (361)
T ss_pred eecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCC
Confidence 999999865432 233344567778999999864 3689999999999999999999999987654221222223344
Q ss_pred CCCCCCh---hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPA---KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
++..... -+++..+..+|..|+.+|-+.||.+++|+++
T Consensus 287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 4333222 2478899999999999999999999999875
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=288.69 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=195.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC--CceE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMM 226 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 226 (469)
.+|+..+.||+|+||.+|. +|..||+|++..... .......+..|+.+++++ +||||+++++++... ...+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3688889999999998864 578899998864322 223345677899999999 999999999998654 3589
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
+||||++ ++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~-----------nill~~~~~~kl~ 149 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPS-----------NILLNSDCRVKLA 149 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEEcCCCcEEEe
Confidence 9999995 6999998765 7888999999999999999999998 999999999 8888899999999
Q ss_pred ecCCccccccCCCC----CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-
Q 012164 307 DFGVSKLLTVKEDR----PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR- 380 (469)
Q Consensus 307 Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~- 380 (469)
|||++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+...
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999765433211 2223457889999998765 46788999999999999999999999765433221111110
Q ss_pred --------------------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 --------------------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 --------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+.....+.++.++.++|.+||+.||++|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0111111123367889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=307.98 Aligned_cols=244 Identities=30% Similarity=0.478 Sum_probs=187.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe---------
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------- 221 (469)
+|.+...||+||||.|+. +|+.||||++.... +......+.+|+.++.+|+|||||++|..+.+
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 577888999999999874 89999999998664 45556788999999999999999999832200
Q ss_pred --------------------------------------------------------------------------------
Q 012164 222 -------------------------------------------------------------------------------- 221 (469)
Q Consensus 222 -------------------------------------------------------------------------------- 221 (469)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CceEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 012164 222 ----------------------S--------SPMMIVTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHENK 270 (469)
Q Consensus 222 ----------------------~--------~~~~lv~E~~~~gsL~~~l~~~~~l-~~~~~~~i~~qi~~~L~~LH~~~ 270 (469)
+ ..+||-||||+...|.+++.++... .....++++++|++||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 1268899999998888888876543 57889999999999999999999
Q ss_pred CCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccc-----------------cCCCCCcccCCCCCcccC
Q 012164 271 PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT-----------------VKEDRPLTCQDTSCRYVA 333 (469)
Q Consensus 271 ~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~a 333 (469)
+|||||||. ||++++++.|||+|||+|.... .......+...||.-|+|
T Consensus 718 ---iIHRDLKP~-----------NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 718 ---IIHRDLKPR-----------NIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred ---eeeccCCcc-----------eeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 999999999 8888899999999999998721 001112355679999999
Q ss_pred CcccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC---hhhhHHHHHHHHHHHcccC
Q 012164 334 PEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP---AKLYARGLKELIEECWNEK 407 (469)
Q Consensus 334 PE~~~~~~---~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~d 407 (469)
||++.+.. |+.|+|+||||||++||+ .||.. ..+-...+...+...++.+ ...--+.-..+|.+|++.|
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~T--sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGT--SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHh---ccCCc--hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCC
Confidence 99998764 999999999999999998 45642 2222222222222222212 1122234578999999999
Q ss_pred CCCCCCHHHHHHH
Q 012164 408 PAKRPTFRQIITR 420 (469)
Q Consensus 408 p~~Rps~~~ll~~ 420 (469)
|.+||||.|||+.
T Consensus 859 P~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 859 PSKRPTATELLNS 871 (1351)
T ss_pred CccCCCHHHHhhc
Confidence 9999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=251.02 Aligned_cols=248 Identities=23% Similarity=0.434 Sum_probs=199.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|...++||+|+||.|+. +++.||+|.++.+.-. +..-....+|+-+++.++|.||++++++..++..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 466778999999999985 5789999998765321 1222456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|| ..+|..+... ++.++...+..++.|+++||.++|+++ ++|||+||+ |.|++.+|.+|++|||
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpq-----------nllin~ngelkladfg 146 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQ-----------NLLINRNGELKLADFG 146 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcc-----------eEEeccCCcEEecccc
Confidence 99 5699999876 678999999999999999999999999 999999999 8899999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHh-hcCCCC--
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA-ARQRPP-- 384 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~-~~~~~~-- 384 (469)
+++.++... .-......|.+|++|.++.+. -|++..|+||.||++.|+.. |++.|.+.+..+....+. ..+.+.
T Consensus 147 larafgipv-rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 147 LARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED 225 (292)
T ss_pred hhhhcCCce-EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc
Confidence 998765321 122334578999999999886 68899999999999999985 999998876655444432 111110
Q ss_pred -------------CCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 -------------FKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 -------------~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
++. ..+..+..-++++++++.-+|..|.++++++++
T Consensus 226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 000 012334457889999999999999999998876
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=279.43 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=197.2
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|+..+.||.|++|.+|. +|+.+++|.+...... ......+..|+.++++++||||+++++++......++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 45677899999998874 5788999988755332 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
++ ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.++|+|||.
T Consensus 80 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~-----------nili~~~~~~~l~df~~ 144 (283)
T cd05118 80 MD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPE-----------NLLINTEGVLKLADFGL 144 (283)
T ss_pred cC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHH-----------HEEECCCCcEEEeeeee
Confidence 96 588888876 357899999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-C------
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R------ 382 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~------ 382 (469)
+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.... .
T Consensus 145 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd05118 145 ARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW 223 (283)
T ss_pred eEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhc
Confidence 87665332 122234577889999998876 78899999999999999999999997655433222211100 0
Q ss_pred -------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 -------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 -------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.......+.++..+.+||.+||+.||.+||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00001123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.76 Aligned_cols=144 Identities=29% Similarity=0.516 Sum_probs=130.4
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|++.+.||+|+||.||. +++.||||++.............+..|+.+++.++||||+++++++.....+|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 3688889999999999874 47899999997655555566678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+.+++|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+ |||++.++.+||+|||
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~-----------NILl~~~g~vkL~DFG 149 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPD-----------NMLISNEGHIKLTDFG 149 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHH-----------HEEEcCCCCEEEEeCC
Confidence 99999999999988788999999999999999999999998 999999999 8888888999999999
Q ss_pred Ccc
Q 012164 310 VSK 312 (469)
Q Consensus 310 la~ 312 (469)
+++
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=276.10 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=199.3
Q ss_pred CcccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-C-C----ceeeEEeEEEeC
Q 012164 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H-P----NVVQFLGAVTQS 222 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----~i~~~~~~~~~~ 222 (469)
.-+|.+...+|+|+||.|. .++..||||+++.- ....+..+-|+++++++. + | -++++.++|.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 4478999999999999875 25789999998732 344566778999999994 2 2 477888889999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc------Ccc
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN------DRN 294 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~------~~n 294 (469)
++.|||+|.+ |-|+.+++++++ +++...+..++.|+++++.+||+.+ ++|.||||+|||+..... ..+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999 779999999865 4889999999999999999999999 999999999999986541 122
Q ss_pred ---eeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 012164 295 ---ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 371 (469)
Q Consensus 295 ---il~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~ 371 (469)
+-...+..|+|+|||.|.+..... .....|..|+|||++.+-+++.++||||+||||+|++||...|+...+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 223346679999999998754332 3456789999999999999999999999999999999999999876655
Q ss_pred cHH---HHHh-----------------hcCCCCCCC---------------C-------hhhhHHHHHHHHHHHcccCCC
Q 012164 372 EVP---KAYA-----------------ARQRPPFKA---------------P-------AKLYARGLKELIEECWNEKPA 409 (469)
Q Consensus 372 ~~~---~~~~-----------------~~~~~~~~~---------------~-------~~~~~~~l~~li~~cl~~dp~ 409 (469)
|-. +.+. ..++..++. + .......|.+|+++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 421 1110 000111000 0 011124599999999999999
Q ss_pred CCCCHHHHHHH
Q 012164 410 KRPTFRQIITR 420 (469)
Q Consensus 410 ~Rps~~~ll~~ 420 (469)
+|+|+.|+++|
T Consensus 396 ~RiTl~EAL~H 406 (415)
T KOG0671|consen 396 RRITLREALSH 406 (415)
T ss_pred ccccHHHHhcC
Confidence 99999999987
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.29 Aligned_cols=255 Identities=24% Similarity=0.474 Sum_probs=219.5
Q ss_pred CcccccceeeecCeEEEEEEe---------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 154 ELDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~~---------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
+......+.||+|+||.||.. ..+||||++.... ..+.-.++..|+.+|.++.|||++++++++....
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 345666789999999999852 3579999887543 3444577999999999999999999999998665
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
+.||++|++.|+|.++++.+ +.+.....+.|..||++||.|||.++ +|||||... |+|+.....+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaR-----------NVLVksP~hv 837 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAAR-----------NVLVKSPNHV 837 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhh-----------heeecCCCeE
Confidence 78999999999999999864 45899999999999999999999998 999999999 8888888999
Q ss_pred EEeecCCccccccCCCCCc-ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 304 KVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
||.|||+++.......... ......+.|||-|.+....|+.++|||||||++||++| |..||.+....++...+....
T Consensus 838 kitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge 917 (1177)
T KOG1025|consen 838 KITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE 917 (1177)
T ss_pred EEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc
Confidence 9999999998765433222 23345778999999999999999999999999999998 999999999999999987777
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
+.+. ++.++.++..++.+||..|+..||+++++...+.+..+..
T Consensus 918 RLsq---PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 918 RLSQ---PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred cCCC---CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 7544 5678899999999999999999999999999998887663
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=283.92 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=192.9
Q ss_pred cceeeecCeEEEEEE-----eceeehhhhcccccCCCHH-----------HHHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 012164 159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD-----------RVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (469)
Q Consensus 159 ~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 222 (469)
..+.||.|+||.+|. +|+.||+|.+......... ....+.+|++++++++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 356799999999874 5788999988644221100 012467899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~ 302 (469)
+..+++|||+. ++|.+++.....+++.....++.|++.||.|||+.+ ++|+||+|+ ||+++.++.
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~-----------nill~~~~~ 157 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPA-----------NIFINSKGI 157 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHH-----------HeEECCCCC
Confidence 99999999995 699999988778999999999999999999999999 999999999 888888999
Q ss_pred eEEeecCCccccccCC-------------CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 012164 303 LKVADFGVSKLLTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMK 368 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~ 368 (469)
++|+|||++....... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987654110 1111223467789999998764 4688999999999999999999999876
Q ss_pred CCCcHHHHHhhc-CCCCC-----------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 369 HDNEVPKAYAAR-QRPPF-----------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 369 ~~~~~~~~~~~~-~~~~~-----------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..+....+... +.+.. .......+..+.++|.+||+.||++|||+++++.+
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 554333222110 00000 00012346789999999999999999999999976
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=296.23 Aligned_cols=245 Identities=27% Similarity=0.441 Sum_probs=204.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEe-----CCc
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ-----SSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-----~~~ 224 (469)
.|.+.+.||+|.||.||. +|+..|+|++.... +..+++..|.++++... |||++.+|++|.. ++.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 566778999999998874 67888999876543 23356888999999985 9999999999853 367
Q ss_pred eEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC
Q 012164 225 MMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~ 302 (469)
+|||||||.+||.-|+++. ..++.+..+..|++.++.||.+||.+. ++|||||-. |||++.++.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~-----------NiLLT~e~~ 161 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQ-----------NVLLTENAE 161 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCc-----------eEEEeccCc
Confidence 9999999999999999986 345899999999999999999999998 999999999 999999999
Q ss_pred eEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH
Q 012164 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~ 377 (469)
|||+|||.+....... .......||+.|||||++.+. .|+.++|+||||++..||-.|.+|+.++.+....-.+
T Consensus 162 VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I 240 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 240 (953)
T ss_pred EEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence 9999999998776543 333557899999999999654 5677999999999999999999999877653332222
Q ss_pred hhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....++....++.+++++.+||..||.+|.++||+..++++|
T Consensus 241 -pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 -PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 233444445578999999999999999999999999999987
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=283.33 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=192.0
Q ss_pred ccccceeeecCeEEEEEE-----e--ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC----C
Q 012164 156 DFTNSVEITKGTFILAFW-----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----S 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~--g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~----~ 223 (469)
+|+..+.||+|+||.+|. . +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 367788999999998864 3 6689999886432 2223346678899999999 599999999875432 4
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++++||+ +++|.+++.....+++..+..++.||+.||+|||+.+ ++||||||+ ||+++.++.+
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~-----------Nili~~~~~~ 144 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPG-----------NLLVNADCEL 144 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH-----------HeEEcCCCCE
Confidence 578999999 5799999988778999999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCCC---CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 304 KVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
||+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~ 224 (332)
T cd07857 145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224 (332)
T ss_pred EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH
Confidence 99999999765432211 1123467889999998765 4688999999999999999999999976543221111100
Q ss_pred ------------------------cC---CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 ------------------------RQ---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ------------------------~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. ...+.......+..+.+|+.+||+.||++|||+++++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 011111112346789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=278.01 Aligned_cols=247 Identities=28% Similarity=0.479 Sum_probs=195.9
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|+..+.||+|+||.+|. +++.||+|.+..... .....+.+..|+.+++.++||||+++++++.+....++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 45567899999998874 588999999876531 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
++ ++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|||+
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~-----------ni~~~~~~~~~l~d~g~ 144 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQ-----------NILINRDGVLKLADFGL 144 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChh-----------eEEEcCCCCEEEecCCc
Confidence 96 6999999876 57999999999999999999999998 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc---------
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------- 380 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~--------- 380 (469)
+........ ......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+...
T Consensus 145 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07829 145 ARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW 223 (282)
T ss_pred ccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHH
Confidence 976543221 22233457789999998776 7889999999999999999999999765533222111100
Q ss_pred -----------CCCCC-----CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 -----------QRPPF-----KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 -----------~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+.. ....+..+..+.++|.+||..||++||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 01112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=274.43 Aligned_cols=246 Identities=26% Similarity=0.426 Sum_probs=191.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC--CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
+|...+.||+|+||.+|. .+..+++|.+...... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 467788999999999874 2334555554422111 122234566799999999999999999999988899999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
+||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++ ++.++
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~-----------nili~-~~~~~ 145 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAK-----------NIFLK-NNLLK 145 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChh-----------heEee-cCCEe
Confidence 999999999998864 345899999999999999999999998 999999999 66665 35699
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
|+|||++....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.................
T Consensus 146 l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-- 222 (260)
T cd08222 146 IGDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT-- 222 (260)
T ss_pred ecccCceeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC--
Confidence 99999987654321 122234578899999999888889999999999999999999999975443333333222212
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+..++.++.++|.+||..||++||++.+++++
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 -PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 22245678899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=281.47 Aligned_cols=246 Identities=28% Similarity=0.427 Sum_probs=193.1
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe-CCceEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMI 227 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l 227 (469)
..+|+..+.||.|+||.++. +|..||+|.+..... .....+.+..|+++++.++||||+++++++.. ....++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 45788999999999998874 678899998765432 22334667889999999999999999999865 457899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
++||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+ ||+++.++.++|+|
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~-----------Nili~~~~~~~l~d 151 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPS-----------NILINENCDLKICD 151 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH-----------HEeECCCCCEEeCc
Confidence 99999 6799988874 45888889999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh--------
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-------- 378 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~-------- 378 (469)
||++..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.
T Consensus 152 fg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 152 FGLARIQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred cccccccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999875432 1123456788999998766 568899999999999999999999997654311110000
Q ss_pred ----------------hcC---CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ----------------ARQ---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ----------------~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... ..+.......++..+.++|.+||+.+|++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 001101112457889999999999999999999999887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=284.13 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=193.3
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 223 (469)
.+|+..+.||+|+||.|+. +|..||+|.+.... ........+.+|+.++++++||||+++++++....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 3688899999999998864 57899999886442 23334456889999999999999999999987553
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~-----------Nill~~~~~~ 157 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPG-----------NLAVNEDCEL 157 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEEcCCCCE
Confidence 358999999 7899988874 46999999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ- 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~- 381 (469)
+|+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+....
T Consensus 158 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 158 KILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred EEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999998764321 223456889999999876 357889999999999999999999997654322211111100
Q ss_pred C--------------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 R--------------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~--------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
. ..+......+++.+.++|.+|++.||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00001113456789999999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=274.20 Aligned_cols=245 Identities=24% Similarity=0.405 Sum_probs=191.4
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEe
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E 230 (469)
|+..+.||+|+||.+|. +++.|+||.+...... .......+|+..+++++ ||||+++++++...+..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 45678899999998873 4678999988654321 12233456999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+ +|+|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|+ ||+++.++.++|+||
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~-----------ni~i~~~~~~~l~d~ 143 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPE-----------NLLVSGPEVVKIADF 143 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChh-----------hEEEcCCCCEEEeec
Confidence 99 789999998754 6899999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CCC---
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP--- 383 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~--- 383 (469)
|++....... ......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...........+... +.+
T Consensus 144 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd07830 144 GLAREIRSRP--PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221 (283)
T ss_pred ccceeccCCC--CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChh
Confidence 9997654321 2233457888999998754 46788999999999999999999999765443222111100 000
Q ss_pred ----------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 ----------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.........+..+.++|.+||..||++|||+++++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000011225789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=282.60 Aligned_cols=245 Identities=27% Similarity=0.380 Sum_probs=191.8
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------C
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 223 (469)
.+|+..+.||+|+||.++. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 4788899999999998763 578999998875322 223345678899999999999999999988543 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..+++++++ +++|.+++... .+++..+..++.|+++||.|||+.+ ++||||||+ ||+++.++.+
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~-----------NIll~~~~~~ 159 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS-----------NLAVNEDCEL 159 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChH-----------HEEEcCCCCE
Confidence 478888888 78999888653 5899999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ- 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~- 381 (469)
||+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 160 kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999875432 1223457889999999866 467889999999999999999999997654322211111100
Q ss_pred ------------------------CC--CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 ------------------------RP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ------------------------~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+ .+.......++.+.++|.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0000011346789999999999999999999999988
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=279.92 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=190.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 223 (469)
.+|+..+.||.|+||.+|. +++.||+|.+......+. ....+.+|+++++.++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4788899999999998874 578899998864432221 1234678999999999999999999875433
Q ss_pred --ceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 224 --PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 224 --~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
.+++|+||+. ++|...+.. ...+++..+..++.|+++||.|||+.+ ++|+||||+ ||+++.+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~-----------nil~~~~ 151 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAA-----------NILIDNQ 151 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEECCC
Confidence 4699999995 577777764 346999999999999999999999999 999999999 8888899
Q ss_pred CCeEEeecCCccccccCCCCC----------cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 012164 301 GNLKVADFGVSKLLTVKEDRP----------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKH 369 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~ 369 (469)
+.++|+|||++.......... .....+++.|+|||.+.+. .++.++||||||+++|+|++|++||.+.+
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999997654322111 1123457789999987654 57889999999999999999999998655
Q ss_pred CCcHHHHHhhcC-CC---------------------CCCC----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 370 DNEVPKAYAARQ-RP---------------------PFKA----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 370 ~~~~~~~~~~~~-~~---------------------~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.......+.... .+ .... ....+++.+.++|.+||+.||++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 433222221110 00 0000 011234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=285.71 Aligned_cols=245 Identities=27% Similarity=0.382 Sum_probs=194.6
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc-----
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----- 224 (469)
.+|+....||+|+||.+|. ++..||+|.+..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 4688899999999998874 478999998865422 23334567789999999999999999988766554
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 -~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~-----------Nill~~~~~~ 157 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPS-----------NIAVNEDCEL 157 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HeEECCCCCE
Confidence 89999999 6799999875 46999999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.....
T Consensus 158 kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 233 (343)
T cd07851 158 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233 (343)
T ss_pred EEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence 99999999764322 233457888999999865 3678899999999999999999999976554332222211100
Q ss_pred ---------------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 ---------------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ---------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.+......+++.+.+||.+||+.||++|||+.+++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000112357889999999999999999999999877
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=284.03 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=193.4
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 223 (469)
.+|...+.||+|+||.++. +|+.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 3688889999999998863 578999998875432 2223356788999999999999999999986542
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++|+||+. .+|.+++. ..+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~-----------NIll~~~~~~ 156 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPG-----------NLAVNEDCEL 156 (342)
T ss_pred eEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEECCCCCE
Confidence 4699999995 58877653 35899999999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ- 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~- 381 (469)
||+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 157 kL~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 157 KILDFGLARHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred EEeeCCCCcCCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999875432 1123456788999999876 468889999999999999999999998654322221111100
Q ss_pred --------------------------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHh
Q 012164 382 --------------------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINN 426 (469)
Q Consensus 382 --------------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~~~~~ 426 (469)
........+..++.+.+||.+||+.||++||++.+++.| ++.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000112356779999999999999999999999977 665544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=287.94 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=198.0
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------Cce
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SPM 225 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~ 225 (469)
+...+.||+|+||.||. +|+.||||.+.... .....+...+|++++++++|||||+++++=++. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34456899999999874 79999999998654 334457788999999999999999999876543 346
Q ss_pred EEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC-
Q 012164 226 MIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG- 301 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~- 301 (469)
.++||||.+|||...+.+ ...|++.+.+.++.+++.||.|||+++ |+||||||.||++. +..+|
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~---------~Gedgq 160 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQ---------IGEDGQ 160 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEe---------ecCCCc
Confidence 899999999999999975 345999999999999999999999999 99999999977774 23333
Q ss_pred -CeEEeecCCccccccCCCCCcccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----CcHHH
Q 012164 302 -NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPK 375 (469)
Q Consensus 302 -~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~----~~~~~ 375 (469)
.-||+|||.|+..... ......+||..|++||.+. ...|+..+|.|||||++|+..||..||..... .++..
T Consensus 161 ~IyKLtDfG~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 161 SIYKLTDFGAARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred eEEeeecccccccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 3699999999987643 3556788999999999998 47899999999999999999999999953322 22333
Q ss_pred HHhhcCCC------------------CCCCC---hhhhHHHHHHHHHHHcccCCCCCC--CHHHHHHHHHHHHhh
Q 012164 376 AYAARQRP------------------PFKAP---AKLYARGLKELIEECWNEKPAKRP--TFRQIITRLESINNS 427 (469)
Q Consensus 376 ~~~~~~~~------------------~~~~~---~~~~~~~l~~li~~cl~~dp~~Rp--s~~~ll~~L~~~~~~ 427 (469)
.+..+... .++.+ ...+-..+-..+..+|..+|.+|- ...+....+..|++.
T Consensus 239 ~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 239 HIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred hhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 32221111 01110 112223466688899999999998 888888888887655
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=285.87 Aligned_cols=235 Identities=27% Similarity=0.432 Sum_probs=194.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|.....+|.|+|+.+.+ +++..++|.+.+.. ....+|+.++... +||||+++.+.+.+....|+||
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 566677899999987754 68899999987652 2234577676666 6999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee-CCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR-DDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~-~~~~~vkl~Df 308 (469)
|.+.|+-|.+-+....... ..+..|+++|+.|+.|||++| +|||||||+ |||+ +..+.++|+||
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~-----------NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPG-----------NILLDGSAGHLRLTYF 460 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChh-----------heeecCCCCcEEEEEe
Confidence 9999988877777655444 788889999999999999999 999999999 7777 58899999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-cHHHHHhhcCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKA 387 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~ 387 (469)
|.++..... ....+-|..|.|||++....|++++|+||||++||+|++|+.||...... ++...+ +.+++
T Consensus 461 G~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~-- 531 (612)
T KOG0603|consen 461 GFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKF-- 531 (612)
T ss_pred chhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCcc--
Confidence 999865433 22345688999999999999999999999999999999999999877665 332222 22222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
...++..+++|+..||+.||.+||++++++.|=.
T Consensus 532 -s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 532 -SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred -ccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 2678999999999999999999999999998833
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=263.36 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=193.0
Q ss_pred ccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--------
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-------- 222 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-------- 222 (469)
.|....+||+|.||.|+ .+|+.||+|++..+.....- -....+|+.++..+.|+|++.++++|...
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGf-pitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCC-cHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 56677899999999765 36788999976532211111 13356799999999999999999988532
Q ss_pred CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
..+++||.+|+. +|.-++... .+++..++.++..++..||.|+|... |+|||+||+ |+|++.+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaa-----------NvLIt~dg 161 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAA-----------NVLITKDG 161 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHh-----------hEEEcCCc
Confidence 348999999964 999999765 56999999999999999999999998 999999999 99999999
Q ss_pred CeEEeecCCccccccCCCCC---cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH
Q 012164 302 NLKVADFGVSKLLTVKEDRP---LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~ 377 (469)
.+||+|||+++.+....... .+....|.+|++||.+.|. .|+++.|||..|||+.||+||.+.+++.+.......+
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 99999999997665433222 2334569999999998875 8899999999999999999999999887665543333
Q ss_pred hhc---CCC------------------CCCCC----------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AAR---QRP------------------PFKAP----------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~---~~~------------------~~~~~----------~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... ..+ |+... +-.-+++..+|+..+|..||.+|++++++++|
T Consensus 242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 110 000 00000 00113478899999999999999999999887
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=283.68 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=189.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------- 222 (469)
.+|+..+.||.|+||.||. +|..||+|.+..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 5788999999999999874 578999998865432 3346688899999999999999999876543
Q ss_pred -------CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 223 -------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 223 -------~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
...++|+||++ ++|.+++.. +.+++..+..++.||+.||.|||+.+ ++||||||+ ||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~-----------Ni 145 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA-----------NV 145 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH-----------HE
Confidence 34789999995 699988864 46899999999999999999999999 999999999 77
Q ss_pred eeC-CCCCeEEeecCCccccccCCC--CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 012164 296 LRD-DSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 371 (469)
Q Consensus 296 l~~-~~~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~ 371 (469)
+++ .++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......
T Consensus 146 li~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 225 (342)
T cd07854 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225 (342)
T ss_pred EEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 776 456789999999876432211 11122356888999998754 46788999999999999999999999765432
Q ss_pred cHHHHHhh-----------------------cCCCCCCC---ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 372 EVPKAYAA-----------------------RQRPPFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 372 ~~~~~~~~-----------------------~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+....... ........ ....++.++.+||.+||..||.+|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 226 EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 22211110 00000000 012456789999999999999999999999977
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=265.68 Aligned_cols=215 Identities=19% Similarity=0.251 Sum_probs=173.4
Q ss_pred CeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCHHHH
Q 012164 166 GTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240 (469)
Q Consensus 166 G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL~~~ 240 (469)
|.|+.|+. +|+.||+|.+.... .+..|...+....||||+++++++.+....+++|||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 66776653 68899999986542 233455555556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCC
Q 012164 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR 320 (469)
Q Consensus 241 l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~ 320 (469)
+.+...+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.++++|||.+.......
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~-----------Nil~~~~~~~~l~df~~~~~~~~~~-- 139 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPN-----------NILLDDRGHIQLTYFSRWSEVEDSC-- 139 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH-----------HEEEcCCCCEEEecccchhcccccc--
Confidence 988778999999999999999999999998 999999999 8888899999999999876543221
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHH
Q 012164 321 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 400 (469)
Q Consensus 321 ~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 400 (469)
....++..|+|||.+.+..++.++|+||+|+++|+|++|+.|+...... +...... ..+..+++.+.++|
T Consensus 140 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~li 209 (237)
T cd05576 140 --DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTL---NIPEWVSEEARSLL 209 (237)
T ss_pred --ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccccccc---CCcccCCHHHHHHH
Confidence 1234566799999998888899999999999999999999887643211 1000111 12345678899999
Q ss_pred HHHcccCCCCCCCH
Q 012164 401 EECWNEKPAKRPTF 414 (469)
Q Consensus 401 ~~cl~~dp~~Rps~ 414 (469)
.+||+.||++||++
T Consensus 210 ~~~l~~dp~~R~~~ 223 (237)
T cd05576 210 QQLLQFNPTERLGA 223 (237)
T ss_pred HHHccCCHHHhcCC
Confidence 99999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=271.60 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=199.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCH----HHHHHHHHHHHHHhcCCCCceeeEEeEEE-eCCce
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD----DRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 225 (469)
+|-....||+|+|..||. ..+.||+|+-...+.... ...+...+|..+-+.|.||.||++|++|. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 566778999999987753 568899997654432222 22345678999999999999999999995 45779
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
|.|+|||+|.+|+-+|+.+.-++++++..|+.||+.||.||.+.. .||||-||||.|||+. | -+..|.+||
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv------~--GtacGeIKI 614 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLV------N--GTACGEIKI 614 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEe------c--CcccceeEe
Confidence 999999999999999999999999999999999999999999987 4799999999966654 1 134578999
Q ss_pred eecCCccccccCCCC------CcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-HH
Q 012164 306 ADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VP 374 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-~~ 374 (469)
.|||+++.+...... .....+||.+|++||.+.-+ ..+.|+||||+|||+|..+.|+.||....... +.
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL 694 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL 694 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence 999999987643222 12446799999999987533 56789999999999999999999998654333 22
Q ss_pred HHH-hhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 375 KAY-AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 375 ~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..- ....+.-..++.+.++.+.+.||++||++--++|.+..+|..+
T Consensus 695 qeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 695 QENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 111 1111111122345678899999999999999999998887654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=276.55 Aligned_cols=242 Identities=23% Similarity=0.337 Sum_probs=201.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
-|...+.||-|+||.|.+ +...+|+|.+.+..+..+..+...+.|..||..-..+.||++|-.|.+++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 366788999999998764 456899999988776667777888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|++||++-.+|-+.+.+++..+..++..+.+|+++.|..| +|||||||+ |||||.+|++||.||||
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPD-----------NILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPD-----------NILIDRDGHIKLTDFGL 775 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCcc-----------ceEEccCCceeeeeccc
Confidence 9999999999999999999999999999999999999999 999999999 99999999999999999
Q ss_pred ccccccCC--------------CCC---------------------------cccCCCCCcccCCcccCCCCCCCchhHH
Q 012164 311 SKLLTVKE--------------DRP---------------------------LTCQDTSCRYVAPEVFKNEEYDTKVDVF 349 (469)
Q Consensus 311 a~~~~~~~--------------~~~---------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDi~ 349 (469)
+.-+.... ... .....||+.|+|||++....|+-.+|.|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 86331100 000 0134689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCC
Q 012164 350 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 412 (469)
Q Consensus 350 SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 412 (469)
|.|||||||+.|++||-..+..+....++.....--.....+++++..++|.+++ .+++.|.
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 9999999999999999888777765555444322222235677888888886654 3466774
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=310.89 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=188.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.+.....||+|+||.||. +|..||+|.+..... ....|++.+++++||||+++++++.+....++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 355667899999999874 578999998864321 12346889999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++|+|.++++. +++..+..++.|+++||+|||.....+|+||||||+ ||+++.++..++. ||.
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~-----------Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPE-----------KIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHH-----------hEEECCCCceEEE-ecc
Confidence 9999999999963 889999999999999999999543234999999999 7777878877775 665
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--cHHHHHhh---cC----
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAA---RQ---- 381 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~--~~~~~~~~---~~---- 381 (469)
+..... .....+++.|+|||++.+..++.++|||||||++|||+||+.||...... .+...... ..
T Consensus 829 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 829 PGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred cccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence 543211 11235788999999999989999999999999999999999999543221 11111100 00
Q ss_pred --CCCC---CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 382 --RPPF---KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 382 --~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.+.. .........++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 0110 011123345688899999999999999999999999988664
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=259.02 Aligned_cols=239 Identities=24% Similarity=0.415 Sum_probs=200.1
Q ss_pred ccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|.....||+|+|+.|. .+.+.+|+|+++++.+.+.+.+.-.+.|-.+..+- +||++|-+..+|..+..+++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 67788899999998764 47789999999998887777767677888888887 4999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||++||+|--.++++.++|++.+..+...|+-||.|||++| ||.||||.+ |+|+|..|.+||.|+|
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkld-----------nvlldaeghikltdyg 396 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLD-----------NVLLDAEGHIKLTDYG 396 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeecccc-----------ceEEccCCceeecccc
Confidence 99999999999998888999999999999999999999999 999999999 9999999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--C-CCCc-----HHHHHhhcC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM--K-HDNE-----VPKAYAARQ 381 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~--~-~~~~-----~~~~~~~~~ 381 (469)
+++..- .........+||+.|.|||++.+..|....|.|+|||+|+||+.|+.||.- + ++++ ..+.+. ..
T Consensus 397 mcke~l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-ek 474 (593)
T KOG0695|consen 397 MCKEGL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-EK 474 (593)
T ss_pred hhhcCC-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-hh
Confidence 998533 233445668999999999999999999999999999999999999999952 1 1111 122222 22
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 413 (469)
+... +..++-....+++.-|++||.+|..
T Consensus 475 qiri---prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 475 QIRI---PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cccc---cceeehhhHHHHHHhhcCCcHHhcC
Confidence 1111 3345556778999999999999954
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=261.84 Aligned_cols=255 Identities=31% Similarity=0.508 Sum_probs=199.4
Q ss_pred cccccceeeecCeEEEEE---EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcC--CCCceeeEEeEEEeCC----ce
Q 012164 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~~----~~ 225 (469)
.+.+..+.||+|.||.|+ |.|..||||++... ++ +.+.+|.++++.. +|+||+.|++.-..+. .+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr-----dE-~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR-----DE-RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEeccc-----ch-hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 367778899999999775 78999999998643 11 4567788887765 8999999998865443 58
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-----NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
|||++|.+.|||.|||.+ ..++....++++..++.||++||. .|...|.|||||+. |||+..+
T Consensus 285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK-----------NILVKkn 352 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK-----------NILVKKN 352 (513)
T ss_pred EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc-----------cEEEccC
Confidence 999999999999999997 569999999999999999999995 44456999999999 8888999
Q ss_pred CCeEEeecCCccccccCC---CCCcccCCCCCcccCCcccCCCC----CC--CchhHHHHHHHHHHHHhC----------
Q 012164 301 GNLKVADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEE----YD--TKVDVFSFALILQEMIEG---------- 361 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~--~~sDi~SlGvil~el~tg---------- 361 (469)
+.+-|+|+|||....... ........||.+|||||++.... +. ..+||||||.|+||+..+
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999999998765442 22335678999999999997641 11 369999999999998753
Q ss_pred CCCCCCCCC-----CcHHHHHh-hcCCCCCCCChhhhH--HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 362 CPPFTMKHD-----NEVPKAYA-ARQRPPFKAPAKLYA--RGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 362 ~~p~~~~~~-----~~~~~~~~-~~~~~~~~~~~~~~~--~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
++||.+.-+ +++...+- .+.+|..+..+...+ ..+.++|+.||..||.-|.|+=.+-+.|.++.++
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 578865422 22333322 233555544444332 4578899999999999999999999999888764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=258.84 Aligned_cols=254 Identities=29% Similarity=0.446 Sum_probs=198.4
Q ss_pred ccccceeeecCeEEEEE---EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcC--CCCceeeEEeEEEeCC----ceE
Q 012164 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PMM 226 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~~----~~~ 226 (469)
..+....||+|.||.|+ +.++.||||++.. ...+.|.+|-++++.. +|+||++|+++-.... .++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34556789999999987 4789999999863 4457899999998876 6999999998865443 689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC------CCeEecCCCCCcccccccccCcceeeCCC
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKP------VPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~------~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
||+||.+.|+|.++|+.+ .+++....+++..+++||+|||+..+ .+|+|||||+. |||+..+
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSk-----------NVLvK~D 352 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSK-----------NVLVKND 352 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccccccc-----------ceEEccC
Confidence 999999999999999975 58999999999999999999998543 47999999999 8888889
Q ss_pred CCeEEeecCCccccccCC-CCCcccCCCCCcccCCcccCCC-CCC-----CchhHHHHHHHHHHHHhCCCCCC-CC----
Q 012164 301 GNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNE-EYD-----TKVDVFSFALILQEMIEGCPPFT-MK---- 368 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~sDi~SlGvil~el~tg~~p~~-~~---- 368 (469)
+++-|+|||+|..+.... .......+||.+|||||++.+. .+. .+.||||+|.|+|||++++..+. +.
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 999999999998765432 2333446899999999999775 222 37999999999999998754432 11
Q ss_pred ------------CCCcHHHHHh-hcCCCCCCCChhh--hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 369 ------------HDNEVPKAYA-ARQRPPFKAPAKL--YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 369 ------------~~~~~~~~~~-~~~~~~~~~~~~~--~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+-+++..... .+.+|.++..+.. ...-+++.+..||..||+-|.|+.=+-+.+..+...
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 1112223332 3345555443332 245689999999999999999999888888777665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=251.13 Aligned_cols=229 Identities=34% Similarity=0.558 Sum_probs=187.7
Q ss_pred eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHH
Q 012164 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253 (469)
Q Consensus 174 ~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~ 253 (469)
+|+.+|+|.+........ .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.....++...+.
T Consensus 13 ~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~ 90 (244)
T smart00220 13 TGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEAR 90 (244)
T ss_pred CCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHH
Confidence 468999999875533221 578899999999999999999999999989999999999988999999876668999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccC
Q 012164 254 RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 333 (469)
Q Consensus 254 ~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 333 (469)
.++.+++.++.+||+.+ ++|+||+|+ ||+++.++.++|+|||.+....... ......++..|+|
T Consensus 91 ~~~~~l~~~l~~lh~~~---i~h~~i~~~-----------ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 91 FYARQILSALEYLHSNG---IIHRDLKPE-----------NILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred HHHHHHHHHHHHHHHcC---eecCCcCHH-----------HeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 99999999999999998 999999999 8888888999999999998765332 2234557889999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 012164 334 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413 (469)
Q Consensus 334 PE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 413 (469)
||.+.+..++.++||||||+++++|++|..||......+...................++.++.+++.+||..+|++||+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 99998888899999999999999999999999763333322222222222222112227788999999999999999999
Q ss_pred HHHHHHH
Q 012164 414 FRQIITR 420 (469)
Q Consensus 414 ~~~ll~~ 420 (469)
+.+++++
T Consensus 235 ~~~~~~~ 241 (244)
T smart00220 235 AEEALQH 241 (244)
T ss_pred HHHHhhC
Confidence 9999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=234.31 Aligned_cols=207 Identities=25% Similarity=0.426 Sum_probs=167.6
Q ss_pred ccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+.....||+|+||.+. .+|+..|+|.+.... +.....++.+|+.+..+- .+|++|.+||.+......|+.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 44556789999999763 589999999998543 344557788899987666 6999999999999999999999
Q ss_pred eccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 230 EYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 230 E~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
|.| ..||+.+-+ ..+..++..+=+|+..+..||.|||++- .+||||+||+ |||++.+|+||+
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPs-----------NiLIn~~GqVKi 190 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPS-----------NILINYDGQVKI 190 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcc-----------eEEEccCCcEEE
Confidence 999 569877654 4567999999999999999999999975 4999999999 999999999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCCcHHHHHhhc
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAAR 380 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDi~SlGvil~el~tg~~p~~~~-~~~~~~~~~~~~ 380 (469)
||||.+-....+ ...+...|-..|||||.+.. ..|+.+|||||||+++.||.+++.||... ++.+...++...
T Consensus 191 CDFGIsG~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 191 CDFGISGYLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cccccceeehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 999998665422 22233456678999999854 37899999999999999999999999864 334444555443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=248.83 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=211.7
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-Cc
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 224 (469)
+++....+-+|+||.+|. +.+.|-+|.++.. -++-.+..+..|.-.+..++|||+.++.+++.+. ..
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 355566788999998874 2467889988754 2455667888999999999999999999988654 56
Q ss_pred eEEEEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 225 MMIVTEYLPKGDLRAFLKR--------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
.++++.++..|+|+.++.. ...++..+...++.|++.|++|||.++ +||.||... |++
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaR-----------NCv 428 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAAR-----------NCV 428 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhh-----------cce
Confidence 7899999999999999972 123677788899999999999999999 999999999 999
Q ss_pred eCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHH
Q 012164 297 RDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 374 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~ 374 (469)
+|+.-+|||+|=.+++..-.....- ......+..||+||.+.+..|+.++|+|||||++|||+| |+.||...++.|+.
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 9999999999999998654332211 122345778999999999999999999999999999998 99999999888887
Q ss_pred HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
..++.+.+... +-++|+++..++.-||+.+|++||+++++...|......+
T Consensus 509 ~ylkdGyRlaQ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 509 HYLKDGYRLAQ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred HHHhccceecC---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 77665555443 5678999999999999999999999999999998876654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-33 Score=279.48 Aligned_cols=245 Identities=25% Similarity=0.389 Sum_probs=184.4
Q ss_pred cccceeeecCeEEEE----EEeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILA----FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~----~~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|.-.+.+|.|+-|.+ .+.|+.||||++-.+. .....+|+..++.-. ||||+++|+.-.+...+||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 344556778777654 3578999999986442 245678999999885 99999999888888899999999
Q ss_pred cCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 232 LPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
| .++|.+++...+. ......+.++.|++.||++||+.+ ||||||||+|||+.-.+. +...+++|+|
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~------~~~~ra~iSD 654 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSA------DGTLRAKISD 654 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCC------CcceeEEecc
Confidence 9 6899999987421 122456788999999999999998 999999999555541110 1234789999
Q ss_pred cCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 308 FGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 308 fgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
||+++........ ......||.+|+|||++.....+.++|||||||++|+.++ |.+||.+....+. .+......
T Consensus 655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~- 731 (903)
T KOG1027|consen 655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYT- 731 (903)
T ss_pred cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccc-
Confidence 9999987654432 2355679999999999999888889999999999999988 5999986544332 22222211
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+......-..+..+||.+|+++||..||++.+++.|
T Consensus 732 L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111111111278999999999999999999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-33 Score=248.12 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=196.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC-----ce
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 225 (469)
+.+-.+.||.|+||+|+. +|+.||+|++..- +++--..+.+-+|+.++..++|.||+..+++..-.. .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 344457899999998873 7999999988642 223333466778999999999999999988875432 46
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
|+++|.| ..+|..++-....++...++-++.||++||.|||+.+ |+||||||. |.|++.+..+||
T Consensus 133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPG-----------NLLVNSNCvLKI 197 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPG-----------NLLVNSNCILKI 197 (449)
T ss_pred HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCc-----------cEEeccCceEEe
Confidence 8899999 6799999988888999999999999999999999999 999999999 888888999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-cCCC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRP 383 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~ 383 (469)
+|||+++..........+....|..|+|||++.|. .|+.+.||||.|||+.|++..+..|+..++-+..+.+.. .+.+
T Consensus 198 CDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 198 CDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP 277 (449)
T ss_pred cccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence 99999987655444444445568899999999875 789999999999999999999999987766544333311 0111
Q ss_pred ------------------------CCCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 384 ------------------------PFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 384 ------------------------~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
.+.. .+..-.-+...++..++..||++|.+..+.+.++
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1100 0112234567788899999999999999998874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=244.97 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=192.4
Q ss_pred CcccccceeeecCeEEEEE----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------C
Q 012164 154 ELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 223 (469)
..+|.....+|.|.-..+- ..+++||+|++..+...... .+...+|..++..+.|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n~~~-akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQNQTH-AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCceEEecchhhccCceehhhhcCccccCcc-chhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 3467777788888873332 47899999998876433222 34566799999999999999999999543 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..|+|||+| ..+|..++.- .++=.++..++.|+++|++|||+.+ |+||||||+ ||++..++.+
T Consensus 95 e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPs-----------nivv~~~~~l 157 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPS-----------NIVVNSDCTL 157 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcc-----------cceecchhhe
Confidence 579999999 5799998873 3677889999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH-hhcCC
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-AARQR 382 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~ 382 (469)
||.|||+|+.... ....+.+..+..|+|||++.+..+.+.+||||+||++.||++|+..|.+.+.-.....+ ...+.
T Consensus 158 Ki~dfg~ar~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt 235 (369)
T KOG0665|consen 158 KILDFGLARTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT 235 (369)
T ss_pred eeccchhhcccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence 9999999986442 24556788899999999999999999999999999999999999999765442211000 00000
Q ss_pred C--------------------------------C--CC---CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 P--------------------------------P--FK---APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~--------------------------------~--~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+ . +. ...+.-+..+++++.+||..||++|.|++++|.|
T Consensus 236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0 00 0011123458999999999999999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=259.83 Aligned_cols=243 Identities=24% Similarity=0.370 Sum_probs=195.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCC------CceeeEEeEEEeCCc
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH------PNVVQFLGAVTQSSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~~~ 224 (469)
+|.+.-..|+|.|+.|.. .|..||||++.....+ .+.=+.|+++|++|.. -|+++++..|...++
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 677888889999998753 5789999999865433 2344679999999952 389999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC-
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS- 300 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~- 300 (469)
+|||+|.+ .-+|.++|+..|. |....+..++.|++.||..|-..| |+|.||||+ |||+++.
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPD-----------NiLVNE~k 573 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPD-----------NILVNESK 573 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCcc-----------ceEeccCc
Confidence 99999999 5799999997654 889999999999999999999998 999999999 5555544
Q ss_pred CCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc
Q 012164 301 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 380 (469)
..+||||||.|-+.... ..+++..+..|+|||++.|-+|+...|+||+||+||||+||+..|.+.++.++...+...
T Consensus 574 ~iLKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 574 NILKLCDFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred ceeeeccCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 46899999999776533 334455677899999999999999999999999999999999999998887765443211
Q ss_pred -C-CC-----------------------------------------C-------------CCCChhhhHHHHHHHHHHHc
Q 012164 381 -Q-RP-----------------------------------------P-------------FKAPAKLYARGLKELIEECW 404 (469)
Q Consensus 381 -~-~~-----------------------------------------~-------------~~~~~~~~~~~l~~li~~cl 404 (469)
+ .+ | ++......-..|.+|+..||
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 1 11 0 00011223356999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 012164 405 NEKPAKRPTFRQIITR 420 (469)
Q Consensus 405 ~~dp~~Rps~~~ll~~ 420 (469)
..||++|.|..++|+|
T Consensus 731 ~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 731 ILDPEKRITVNQALKH 746 (752)
T ss_pred ccChhhcCCHHHHhcC
Confidence 9999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=261.86 Aligned_cols=252 Identities=18% Similarity=0.212 Sum_probs=176.6
Q ss_pred CcccccceeeecCeEEEEEE---------------------eceeehhhhcccccCCCHH-----------HHHHHHHHH
Q 012164 154 ELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDD-----------RVRAFRDEL 201 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~---------------------~g~~vaiK~~~~~~~~~~~-----------~~~~~~~E~ 201 (469)
..+|.+.++||+|+||.||. .++.||||++......... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 44788899999999999984 2467999998643211000 012233467
Q ss_pred HHHhcCCCCce-----eeEEeEEEe--------CCceEEEEeccCCCCHHHHHHhcC-----------------------
Q 012164 202 ALLQKIRHPNV-----VQFLGAVTQ--------SSPMMIVTEYLPKGDLRAFLKRKG----------------------- 245 (469)
Q Consensus 202 ~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~----------------------- 245 (469)
.++.+++|.++ ++++++|.. .+..++||||+++++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766544 567777643 356899999999999999986421
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCCccc
Q 012164 246 -ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324 (469)
Q Consensus 246 -~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~ 324 (469)
.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||++.............
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~-----------NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 369 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPE-----------NLLVTVDGQVKIIDFGAAVDMCTGINFNPLY 369 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchH-----------hEEECCCCcEEEEeCcCccccccCCccCccc
Confidence 2355678889999999999999998 999999999 8888889999999999997654322222222
Q ss_pred CCCCCcccCCcccCCCC--------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCCCCc--------H
Q 012164 325 QDTSCRYVAPEVFKNEE--------------------Y--DTKVDVFSFALILQEMIEGCP-PFTMKHDNE--------V 373 (469)
Q Consensus 325 ~~gt~~y~aPE~~~~~~--------------------~--~~~sDi~SlGvil~el~tg~~-p~~~~~~~~--------~ 373 (469)
..+++.|+|||.+.... + ..+.||||+||++++|++|.. ||....... .
T Consensus 370 g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~ 449 (507)
T PLN03224 370 GMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND 449 (507)
T ss_pred cCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch
Confidence 33578999999875432 1 124799999999999999875 775321110 1
Q ss_pred HHHH--hhcCCCCCCCChhhhHHHHHHHHHHHcccCC---CCCCCHHHHHHH
Q 012164 374 PKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKP---AKRPTFRQIITR 420 (469)
Q Consensus 374 ~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~~ll~~ 420 (469)
...+ .......+. .....++...+|+.+||..+| .+|+|++++++|
T Consensus 450 ~~~~r~~~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 450 LNRWRMYKGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHHHHhhcccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1111 111122222 234567889999999999876 689999999987
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=272.22 Aligned_cols=245 Identities=19% Similarity=0.233 Sum_probs=161.6
Q ss_pred CcccccceeeecCeEEEEEE-----e----ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeE------
Q 012164 154 ELDFTNSVEITKGTFILAFW-----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA------ 218 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~----g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~------ 218 (469)
..+|+..+.||+|+||.||. + +..||+|++..... .+....| .++...+.++..++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 34788899999999999985 3 68899998754321 1111111 1112222222222211
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012164 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGA--------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278 (469)
Q Consensus 219 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 278 (469)
.......++|+||+.+++|.+++..... .....+..++.||+.||.|||+.+ |+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCc
Confidence 2345678999999999999999875321 112345679999999999999998 99999
Q ss_pred CCCCcccccccccCcceeeCC-CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-----------------
Q 012164 279 LEPSDLYVAYWQNDRNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE----------------- 340 (469)
Q Consensus 279 lkp~Nil~~~~~~~~nil~~~-~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------- 340 (469)
|||+ |||++. ++.+||+|||+|+..............+++.|+|||.+...
T Consensus 281 LKP~-----------NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp 349 (566)
T PLN03225 281 VKPQ-----------NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSP 349 (566)
T ss_pred CCHH-----------HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccc
Confidence 9999 777775 57899999999986543333333456788999999965322
Q ss_pred -----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC----------CCCCCCC-------hhhhHHHHHH
Q 012164 341 -----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----------RPPFKAP-------AKLYARGLKE 398 (469)
Q Consensus 341 -----~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~-------~~~~~~~l~~ 398 (469)
.++.++|||||||++|||+++..|+..... .....+.... ....... ....+....+
T Consensus 350 ~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d 428 (566)
T PLN03225 350 VLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE 428 (566)
T ss_pred hhccccCCCCcccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence 233467999999999999997766542100 0000010000 0000000 0011234558
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 012164 399 LIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 399 li~~cl~~dp~~Rps~~~ll~~ 420 (469)
||.+||+.||++|||++++++|
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHccCCcccCCCHHHHhCC
Confidence 9999999999999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-31 Score=263.27 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=209.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|.....+|.|+||-||. +++..|+|+++.+.- +...-+.+|+-+++..+||||+.+++.+.....+|+.||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 455667899999999874 688999999986643 344667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||.+|+|.+.-.--+.+++.++...++..++||+|||+.+ -+|||||-. ||++++.|.+|++|||.
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGa-----------nilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGA-----------NILLTDEGDVKLADFGV 158 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---ccccccccc-----------ceeecccCceeecccCc
Confidence 9999999998888888999999999999999999999999 899999999 99999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CCCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK 386 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~ 386 (469)
+-.+...- .....+.||+.|||||+. ..+.|...+|||++|+...|+-.-++|.-+..+......+...+ .++..
T Consensus 159 saqitati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 159 SAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL 237 (829)
T ss_pred hhhhhhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc
Confidence 87765432 233457899999999986 35588899999999999999988888876555544444443333 44444
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....+++.+.+|++.++.++|++||+++.+++|
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 5566889999999999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=222.73 Aligned_cols=240 Identities=19% Similarity=0.390 Sum_probs=186.3
Q ss_pred ccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeC--CceEE
Q 012164 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~l 227 (469)
+|++.+++|+|.|..|+ .+.+.++||++++- ..+.+.+|+.+|+.|. ||||++++++..+. ....+
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 78899999999997665 46788999998743 3467999999999997 99999999998765 45789
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC-CCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS-GNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~-~~vkl~ 306 (469)
|+||+++.+...+-. .++...+..++.+++.||.|+|+.| |.|||+||. |+++|.. ..++|+
T Consensus 113 iFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPh-----------NvmIdh~~rkLrlI 175 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPH-----------NVMIDHELRKLRLI 175 (338)
T ss_pred HhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcc-----------eeeechhhceeeee
Confidence 999999887776643 4888899999999999999999999 999999999 7777644 569999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCCcHHHHHh------
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYA------ 378 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~-~~~~~~~~~~------ 378 (469)
|+|+|.++...... .....+..|--||.+.. ..|+..-|+|||||++..|+..+.||-.. ++.+....+.
T Consensus 176 DWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~ 253 (338)
T KOG0668|consen 176 DWGLAEFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD 253 (338)
T ss_pred ecchHhhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence 99999887644322 22345667888999865 47888999999999999999988887543 3322211110
Q ss_pred ------hcCCCCCC---------------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ------ARQRPPFK---------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ------~~~~~~~~---------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
......+. .....+++++.+|+.++|..|-++|||++|++.|
T Consensus 254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00000000 0112345889999999999999999999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=236.74 Aligned_cols=128 Identities=27% Similarity=0.364 Sum_probs=108.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-----C---CceeeEEeEEEe
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----H---PNVVQFLGAVTQ 221 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~i~~~~~~~~~ 221 (469)
-+|-+.++||.|-|.+|++ +.+.||+|+.+.. ....+....|+.+|++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 3788999999999998874 5789999998643 445577788999999994 2 389999999964
Q ss_pred C----CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccc
Q 012164 222 S----SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289 (469)
Q Consensus 222 ~----~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~ 289 (469)
. .++|+|+|++ |.+|..+|... ..++...+.+|++||+.||.|||... +|||.||||+|||+...
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 3 5799999999 88999999863 44999999999999999999999975 59999999999999844
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=218.97 Aligned_cols=207 Identities=38% Similarity=0.660 Sum_probs=176.8
Q ss_pred eecCeEEEEEE---e--ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 163 ITKGTFILAFW---R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 163 ig~G~~~~~~~---~--g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
||.|.+|.++. . |+.+++|.+....... ..+.+.+|+..++.++|++|+++++++......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 57888887664 3 7899999987553211 346789999999999999999999999988899999999988999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC-CCCeEEeecCCccccc
Q 012164 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD-SGNLKVADFGVSKLLT 315 (469)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~-~~~vkl~Dfgla~~~~ 315 (469)
.+++... ..++...+..++.+++.++.+||+.+ ++|+||+|. ||+++. ++.++|+|||.+....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~-----------ni~~~~~~~~~~l~d~~~~~~~~ 144 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPE-----------NILLDSDNGKVKLADFGLSKLLT 144 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHh-----------hEEEeCCCCcEEEecCCceEEcc
Confidence 9999875 46899999999999999999999998 999999999 777777 7899999999997654
Q ss_pred cCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHH
Q 012164 316 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 394 (469)
Q Consensus 316 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (469)
.... ......+...|++||.+... .++.++|+|++|+++++| .
T Consensus 145 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~ 188 (215)
T cd00180 145 SDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------P 188 (215)
T ss_pred CCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------H
Confidence 3321 12234567789999999887 788899999999999998 5
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 395 GLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 395 ~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
.+.+++..|+..||++||++.++++++
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 689999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=245.65 Aligned_cols=195 Identities=24% Similarity=0.399 Sum_probs=170.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHH-----HHHHHHHHHhcCC---CCceeeEEeEEEeC
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVR-----AFRDELALLQKIR---HPNVVQFLGAVTQS 222 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~---h~~i~~~~~~~~~~ 222 (469)
+|+..+.+|.|+||.|.. +...|+||++.++++....+++ .+-.|+++|..++ |+||+|++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 688899999999998853 5678999999988765443332 3457999999997 99999999999999
Q ss_pred CceEEEEecc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 223 SPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 223 ~~~~lv~E~~-~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
+++||+||.. ++.+|.+++..+..+++.++..|++|++-|+++||+.+ |||||||-+ |+.++.+|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikde-----------nvivd~~g 707 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDE-----------NVIVDSNG 707 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccc-----------cEEEecCC
Confidence 9999999975 35589999999999999999999999999999999999 999999999 99999999
Q ss_pred CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCC
Q 012164 302 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTM 367 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDi~SlGvil~el~tg~~p~~~ 367 (469)
.+||+|||.|..... .+.....||..|.|||++.|.+|- ..-|||+||+++|-++....||.+
T Consensus 708 ~~klidfgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eEEEeeccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999976543 344557899999999999998775 579999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=214.87 Aligned_cols=264 Identities=16% Similarity=0.235 Sum_probs=215.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|...++||.|+||-.|. +|..||||+-+...- ..++..|..+++.|+ ...|+.+..++.+...-.+||
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 688999999999997764 799999998764422 246888999999997 568888888888888899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
+.+ |.||.+++.- ...++.++++-++-|++.-++|+|.++ +|||||||+|+|++. -.....+.++||
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGl--------grh~~kl~LIDF 158 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGL--------GRHCNKLYLIDF 158 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeecc--------ccccceEEEEec
Confidence 999 8999999873 455999999999999999999999999 999999999777752 123456899999
Q ss_pred CCccccccCCCCC------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-
Q 012164 309 GVSKLLTVKEDRP------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ- 381 (469)
Q Consensus 309 gla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~- 381 (469)
|+|+.+....... .....||.+|.+-..+.+...+.+.|+-|+|.++.++..|.+||++.......+.+..-.
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 9998765432221 234579999999999999889999999999999999999999999887665444432211
Q ss_pred ---CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccchhh
Q 012164 382 ---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKI 436 (469)
Q Consensus 382 ---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~~ 436 (469)
..+.......+|.++...+..|-..--++-|++..+.+.+..++..+++.+.+-.
T Consensus 239 kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iy 296 (341)
T KOG1163|consen 239 KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIY 296 (341)
T ss_pred hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEe
Confidence 2222234567899999999999999999999999999999999999998765443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=223.04 Aligned_cols=247 Identities=17% Similarity=0.345 Sum_probs=184.6
Q ss_pred CCccccCCCCc--ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEE
Q 012164 145 VPEYEIDPHEL--DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFL 216 (469)
Q Consensus 145 ~~~~~~~~~~~--~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~ 216 (469)
+++.|+...++ .|.+.+.+|.|-||...+ +.+.+++|.+..+. -.+..|.+|..---.|+ |.||+.-|
T Consensus 12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY 87 (378)
T KOG1345|consen 12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTY 87 (378)
T ss_pred cccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHH
Confidence 44555544433 788999999999997653 56899999988653 34577888988777775 99999887
Q ss_pred eE-EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 217 GA-VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 217 ~~-~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
++ |...+.+++++||++.|+|.+-+...| +.+.....++.|++.|+.|+|+++ +||||||.+|||+.
T Consensus 88 ~vaFqt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif-------- 155 (378)
T KOG1345|consen 88 EVAFQTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIF-------- 155 (378)
T ss_pred HHHhhcCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEe--------
Confidence 75 566788899999999999998887644 778888999999999999999999 99999999966553
Q ss_pred eeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC---C--CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN---E--EYDTKVDVFSFALILQEMIEGCPPFTMKHD 370 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDi~SlGvil~el~tg~~p~~~~~~ 370 (469)
-....+|||+|||+++..+.... ....+..|.+||.... + ...+.+|+|.||++++.++||++||+....
T Consensus 156 -~~df~rvKlcDFG~t~k~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 156 -DADFYRVKLCDFGLTRKVGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred -cCCccEEEeeecccccccCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 12345899999999976543211 1223556899997642 2 456789999999999999999999984332
Q ss_pred CcH-H---HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCC
Q 012164 371 NEV-P---KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 412 (469)
Q Consensus 371 ~~~-~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 412 (469)
..- . ..+..+..+..+.....+++.+..+.++-|..+|++|-
T Consensus 231 ~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 231 MDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred cCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccc
Confidence 221 1 12222223333333456778899999999999999993
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=216.96 Aligned_cols=205 Identities=32% Similarity=0.554 Sum_probs=170.4
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
|...+.||.|+++.++. +++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 44567899999988764 3688999998765322 2457889999999999999999999999988899999999
Q ss_pred cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
+++++|.+++..... +++..+..++.+++.++.+||+.+ ++|+|++|. |++++.++.++|+|||.
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~-----------ni~v~~~~~~~l~d~g~ 144 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPE-----------NILLGMDGLVKLADFGL 144 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEEcCCCCEEEeeCce
Confidence 998899999988766 899999999999999999999998 999999999 88888889999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCCC-cHHHHH
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDN-EVPKAY 377 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDi~SlGvil~el~tg~~p~~~-~~~~-~~~~~~ 377 (469)
+...............++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .... ++.+.+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 145 ARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred eeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 987654321122334567789999998 666788899999999999999999999976 3433 334444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=215.28 Aligned_cols=270 Identities=14% Similarity=0.245 Sum_probs=219.6
Q ss_pred CCcccccceeeecCeEEEEE-----EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceE
Q 012164 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 226 (469)
....|+++++||+|.||..+ ++++.||||.-... ....++..|...++.|. .++|...|-+..+..+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 34589999999999999865 47899999976543 22357888999999995 799999998888888889
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
||+|++ |.||.|+..=. .+++.+++..++.|++.-++|+|+++ +|.|||||+|+|++.... .....+.+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~------k~~n~Ihi 170 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGT------KDANVIHI 170 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCC------CCCceEEE
Confidence 999999 89999999754 45999999999999999999999999 999999999776664321 12335899
Q ss_pred eecCCccccccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 306 ADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
+|||+|+.+...... ......||.+||+-..+.+...+.+.|+-|||-++.+++.|.+||++.........+..
T Consensus 171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK 250 (449)
T KOG1165|consen 171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK 250 (449)
T ss_pred EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence 999999987543322 22445699999999999999999999999999999999999999999888777666654
Q ss_pred cC----CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh----cccchhhh
Q 012164 380 RQ----RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN----HKRRWKIR 437 (469)
Q Consensus 380 ~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~----~~~~~~~~ 437 (469)
-+ ..+......++|.++...+...-..+-.+-|+++-+...+.+++.-.. ..+.|...
T Consensus 251 IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~l 316 (449)
T KOG1165|consen 251 IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGL 316 (449)
T ss_pred hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 43 223334456789999999999999999999999999999888876643 34555543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=207.13 Aligned_cols=165 Identities=18% Similarity=0.289 Sum_probs=130.3
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 235 gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
|+|.+++..+ +.+++.+++.++.|++.||.|||+.+ ||+ ||+++.++.+|+ ||++..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~-----------Nil~~~~~~~~~--fG~~~~ 58 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSG-----------NILLTWDGLLKL--DGSVAF 58 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------Ccc-----------cEeEcCccceee--ccceEe
Confidence 6899999874 45999999999999999999999874 999 888888999999 999876
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-HHHHHhhcCCCC---CCCCh
Q 012164 314 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPP---FKAPA 389 (469)
Q Consensus 314 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~---~~~~~ 389 (469)
..... ..|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....... .....
T Consensus 59 ~~~~~------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (176)
T smart00750 59 KTPEQ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNL 132 (176)
T ss_pred ecccc------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccH
Confidence 54321 257899999999999999999999999999999999999997654322 222221111111 11123
Q ss_pred hhhHH--HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 390 KLYAR--GLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 390 ~~~~~--~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
..++. .+.+++.+||..||.+||++.++++++..+..+
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 34454 699999999999999999999999998777544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=261.30 Aligned_cols=206 Identities=16% Similarity=0.211 Sum_probs=144.0
Q ss_pred cCCC-CceeeEEeEE-------EeCCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 012164 206 KIRH-PNVVQFLGAV-------TQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (469)
Q Consensus 206 ~l~h-~~i~~~~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 276 (469)
.++| +||++++++| .....+++++|++ +++|.+++.. ...+++.++..++.||++||.|||+++ |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4455 5777888877 2334677889988 6799999975 345999999999999999999999999 999
Q ss_pred cCCCCCcccccccccC--------cceeeCCCCCeEEeecCCccccccCCC---------------CCcccCCCCCcccC
Q 012164 277 RDLEPSDLYVAYWQND--------RNILRDDSGNLKVADFGVSKLLTVKED---------------RPLTCQDTSCRYVA 333 (469)
Q Consensus 277 ~Dlkp~Nil~~~~~~~--------~nil~~~~~~vkl~Dfgla~~~~~~~~---------------~~~~~~~gt~~y~a 333 (469)
|||||+|||+.....- ...--+.++.+|++|||+++....... .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999996666411000 000003456688888888764321000 00011357889999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 012164 334 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413 (469)
Q Consensus 334 PE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 413 (469)
||++.+..++.++|||||||++|||++|..|+.... .....+.....++. .....+....++.+||++||.+||+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQ---ILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChh---hhhcCHHHHHHHHHhCCCChhhCcC
Confidence 999999999999999999999999999988875321 11111211111111 1111334678899999999999999
Q ss_pred HHHHHHH
Q 012164 414 FRQIITR 420 (469)
Q Consensus 414 ~~~ll~~ 420 (469)
+.++++|
T Consensus 259 ~~eil~h 265 (793)
T PLN00181 259 MSELLQS 265 (793)
T ss_pred hHHHhhc
Confidence 9999876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=223.91 Aligned_cols=245 Identities=20% Similarity=0.345 Sum_probs=187.3
Q ss_pred cccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCce
Q 012164 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 225 (469)
..|...++||.|+|+.|+. ..+.||+|.+..-.. . ..+.+|+++|..+. +.||+++.+++..++..
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--P---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--c---hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3677888999999998863 567899998874422 2 45889999999996 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++|+||++..+..++... ++..++..+++.++.||.++|.+| ||||||||+|+|+. ...+.-.|
T Consensus 111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n----------~~t~rg~L 174 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYN----------RRTQRGVL 174 (418)
T ss_pred EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccc----------cccCCceE
Confidence 999999999999988764 678899999999999999999999 99999999966663 24567789
Q ss_pred eecCCcccccc--------C-------C----------------------------CCCcccCCCCCcccCCcccCC-CC
Q 012164 306 ADFGVSKLLTV--------K-------E----------------------------DRPLTCQDTSCRYVAPEVFKN-EE 341 (469)
Q Consensus 306 ~Dfgla~~~~~--------~-------~----------------------------~~~~~~~~gt~~y~aPE~~~~-~~ 341 (469)
.|||+|..... . . .......+||++|+|||++.. +.
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 99999872100 0 0 000023468999999999865 46
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-H-------------HHHHhhcCC-------------------------
Q 012164 342 YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-V-------------PKAYAARQR------------------------- 382 (469)
Q Consensus 342 ~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-~-------------~~~~~~~~~------------------------- 382 (469)
.++++||||.|||+..+++++.||-...++- . ...-...++
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~ 334 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE 334 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence 7889999999999999999999985443321 0 000000001
Q ss_pred ------C---CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 ------P---PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ------~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
. ........++..+.+|+.+|+..||.+|.|++++|+|
T Consensus 335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 0000112345578999999999999999999999988
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=210.74 Aligned_cols=260 Identities=20% Similarity=0.296 Sum_probs=197.6
Q ss_pred ccccceeeecCeEEEEEEe------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC----CCceeeEEeEE-EeCCc
Q 012164 156 DFTNSVEITKGTFILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAV-TQSSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~ 224 (469)
+|++.+.||+|+||.||.. ...+|+|.......... ..+..|+.++..+. .+++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7899999999999998852 24688888765422111 15778899988886 26899999999 47778
Q ss_pred eEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC
Q 012164 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~ 302 (469)
.|+||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.| ++||||||+|++++.... .....
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~------~~~~~ 165 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSR------SEVRT 165 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCC------cccce
Confidence 89999999 88999998654 46999999999999999999999999 999999999555542110 01146
Q ss_pred eEEeecCCccccc--cCCC---C---C-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH
Q 012164 303 LKVADFGVSKLLT--VKED---R---P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373 (469)
Q Consensus 303 vkl~Dfgla~~~~--~~~~---~---~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~ 373 (469)
+.|.|||+++... .... . . .....||..|+++..+.+...+++.|+||+++++.+|+.|..||........
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 8999999998322 1111 1 1 1234599999999999999999999999999999999999999987665433
Q ss_pred HHHHhhcCCCCCCC-ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 374 PKAYAARQRPPFKA-PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 374 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
...+.......... .....+..+.++...+-..+...+|.+..+...|+......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 33332222111111 22345678888998888899999999999999988887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=224.74 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=185.6
Q ss_pred cceeeecCeEEEEEE-----eceeehhhhccc---ccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 159 NSVEITKGTFILAFW-----RGIQVAVKKLGE---EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 159 ~~~~ig~G~~~~~~~-----~g~~vaiK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
....+|.|.||.++. ....++.|.... ......+....+..|+.+-..++|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 456789999984433 223344443331 111122222236778888899999999887777766655555699
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++ +|..++...+.+...++..++.|++.|++|+|+.| +.|||+|++ |+++...|.+||+|||.
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~e-----------nll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLE-----------NLLVTENGILKIIDFGA 466 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccc-----------cEEEecCCceEEeecCc
Confidence 9998 99999998888999999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCCC---CCcccCCCCCcccCCcccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCCCcHH---HHHhhcC--
Q 012164 311 SKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVP---KAYAARQ-- 381 (469)
Q Consensus 311 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDi~SlGvil~el~tg~~p~~~~~~~~~~---~~~~~~~-- 381 (469)
+..+..... .......|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......+.. .....+.
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~ 546 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNI 546 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccc
Confidence 865443222 2334567899999999999999986 699999999999999999999755443321 1110111
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..........++..-+.+|.+||+.||.+|.|+++|++.
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 111122345667889999999999999999999999865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-22 Score=192.81 Aligned_cols=250 Identities=26% Similarity=0.451 Sum_probs=197.3
Q ss_pred cccceeeecCeEEEEEEec--eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCC-ceeeEEeEEEeCCceEEEEeccC
Q 012164 157 FTNSVEITKGTFILAFWRG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~~g--~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
|.....||.|+|+.++... ..+++|.+.............+.+|+.+++.+.|+ +++++++.+......+++++++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 5667789999998776532 56889988866554434567899999999999988 79999999977777899999999
Q ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC-CeEEeecC
Q 012164 234 KGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG-NLKVADFG 309 (469)
Q Consensus 234 ~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~-~vkl~Dfg 309 (469)
++++.+++.... .++......++.|++.++.|+|+.+ ++|||+||+ |++++..+ .++++|||
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~-----------nil~~~~~~~~~l~dfg 147 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPE-----------NILLDRDGRVVKLIDFG 147 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH-----------HeeecCCCCeEEEeccC
Confidence 999998887664 6999999999999999999999999 999999999 88888887 79999999
Q ss_pred CccccccCCCC-----CcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----CcHHHHH
Q 012164 310 VSKLLTVKEDR-----PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAY 377 (469)
Q Consensus 310 la~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~SlGvil~el~tg~~p~~~~~~----~~~~~~~ 377 (469)
.+......... ......++..|+|||.+.+ ..++...|+||+|++++++++|..||..... ......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 227 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence 99755433221 2355678999999999987 5788899999999999999999999876653 2233333
Q ss_pred hhcCCC-CCCCChhh----hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AARQRP-PFKAPAKL----YARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~~~~-~~~~~~~~----~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....+ ........ ....+.+++..|+..+|..|.+..+....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 222222 11111111 12578999999999999999999988876
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=197.67 Aligned_cols=179 Identities=20% Similarity=0.226 Sum_probs=131.5
Q ss_pred CccccCCCCcccccceeeecCeEEEEEE------eceeehhhhcccccC--CCHHHHHHHHHHHHHHhcCCCCceee-EE
Q 012164 146 PEYEIDPHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQ-FL 216 (469)
Q Consensus 146 ~~~~~~~~~~~~~~~~~ig~G~~~~~~~------~g~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~-~~ 216 (469)
|...+.+...+|+..+.||+|+||.||. +++.||||++..... ........+.+|++++++++|+|+++ ++
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 3344455566899999999999999874 366789998653311 12334567999999999999999985 54
Q ss_pred eEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCcccccccccCcce
Q 012164 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSDLYVAYWQNDRNI 295 (469)
Q Consensus 217 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~Nil~~~~~~~~ni 295 (469)
+. +..++|||||+|++|... .. .. ...++.|+++||.|||+.+ |+|||| ||+ ||
T Consensus 89 ~~----~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~-----------NI 143 (365)
T PRK09188 89 AT----GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQ-----------NW 143 (365)
T ss_pred Ec----CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcc-----------eE
Confidence 32 457999999999999632 11 11 1467899999999999999 999999 999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCCCC-------cccCCCCCcccCCcccCCC------CCCCchhHH
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKEDRP-------LTCQDTSCRYVAPEVFKNE------EYDTKVDVF 349 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~sDi~ 349 (469)
|++.++.+||+|||+|+......... .....+++.|+|||.+.-. ..+..+|-|
T Consensus 144 Lv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 144 LMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 88888999999999998664332111 1234577889999998643 233446665
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=169.86 Aligned_cols=136 Identities=30% Similarity=0.243 Sum_probs=113.2
Q ss_pred cccccccccccCCCcccccccc-ccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHC-CCCCCCcCCCCCcHHHHHHHc
Q 012164 6 PVRTTLLKQSSLAPDRERKEAE-LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~-g~~in~~d~~g~t~Lh~A~~~ 83 (469)
-.|||+|-+.|.++.--..=.- --++.+|.+|-.|+||||+||..|+.++|+.|+.. |+|+|..+..|.|+|||||..
T Consensus 37 D~Rt~LHwa~S~g~~eiv~fLlsq~nv~~ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK 116 (226)
T KOG4412|consen 37 DGRTPLHWACSFGHVEIVYFLLSQPNVKPDDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGK 116 (226)
T ss_pred cCCceeeeeeecCchhHHHHHHhcCCCCCCCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcC
Confidence 5789999999998854211110 12334555577789999999999999999999988 999999999999999999999
Q ss_pred CCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCcccccc
Q 012164 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (469)
Q Consensus 84 g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 141 (469)
|..+|+++|+++|+.|+.+|..|.||||-|+.-|+.+++++|+..++.+..+......
T Consensus 117 ~r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~T 174 (226)
T KOG4412|consen 117 GRLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFT 174 (226)
T ss_pred ChhhHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCcccccCcc
Confidence 9999999999999999999999999999999999999999999999877666544433
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-22 Score=166.23 Aligned_cols=133 Identities=27% Similarity=0.317 Sum_probs=119.7
Q ss_pred cccccccccccccCCCccccccc-cccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHH
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~ 82 (469)
+...=||+|-+.|.|+.--.+.. +-.|+|+|..+..|.|+|||||..|..+++++|+++|+.|+.+|..|.||||.||.
T Consensus 69 DdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAa 148 (226)
T KOG4412|consen 69 DDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAA 148 (226)
T ss_pred cccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHh
Confidence 45677899999999866543333 23489999999999999999999999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 83 ~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
.|+++++++|+..|+.+|.+|..|+||||.|...|+.+++..|+.+|++.....
T Consensus 149 vGklkvie~Li~~~a~~n~qDk~G~TpL~~al~e~~~d~a~lLV~~gAd~~~ed 202 (226)
T KOG4412|consen 149 VGKLKVIEYLISQGAPLNTQDKYGFTPLHHALAEGHPDVAVLLVRAGADTDRED 202 (226)
T ss_pred ccchhhHHHHHhcCCCCCcccccCccHHHHHHhccCchHHHHHHHhccceeecc
Confidence 999999999999999999999999999999988899999999999998875554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-22 Score=199.84 Aligned_cols=222 Identities=22% Similarity=0.326 Sum_probs=184.1
Q ss_pred eecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEeccC
Q 012164 163 ITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 163 ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
+|.|.||.|+. .|.-+|+|.+.+......... ....|..++...+ ||+++++...+..+..+++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 68899987753 467899998876544333333 5667888999997 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 234 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
+|.|...+.....+.......+...++-+++++|+.+ ++|||+|++ ||+++.+|.+++.|||+++.
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~e-----------nilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLE-----------NVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhccccc-----------ceeecccCccccCCchhhhH
Confidence 9999988887777888888899999999999999999 999999999 99999999999999999986
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhH
Q 012164 314 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 393 (469)
Q Consensus 314 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (469)
.-.... .+||..|||||++. .....+|.||||+++++|+||..||.. ++...+.... .. .+...+
T Consensus 147 ~v~~~~-----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~---~p~~l~ 211 (612)
T KOG0603|consen 147 AVKEKI-----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LE---MPRELS 211 (612)
T ss_pred hHhhhh-----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cC---Cchhhh
Confidence 543221 27899999999998 467789999999999999999999986 3333332222 11 245678
Q ss_pred HHHHHHHHHHcccCCCCCCCH
Q 012164 394 RGLKELIEECWNEKPAKRPTF 414 (469)
Q Consensus 394 ~~l~~li~~cl~~dp~~Rps~ 414 (469)
..+++++..++..+|.+|.-.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 889999999999999999755
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=188.00 Aligned_cols=211 Identities=29% Similarity=0.507 Sum_probs=165.2
Q ss_pred HhcCCCCceeeEEeEEEeCCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012164 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (469)
Q Consensus 204 l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 282 (469)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.|.+.. ...+++.....++++|+.||.|||..- . ..|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeeccc
Confidence 4678899999999999999999999999999999999987 445889999999999999999999875 1 289999999
Q ss_pred cccccccccCcceeeCCCCCeEEeecCCccccccC-CCCCcccCCCCCcccCCcccCCC---C----CCCchhHHHHHHH
Q 012164 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK-EDRPLTCQDTSCRYVAPEVFKNE---E----YDTKVDVFSFALI 354 (469)
Q Consensus 283 Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~sDi~SlGvi 354 (469)
|++++....+||+|||+....... .........-...|.|||.+.+. . .+.+.||||||++
T Consensus 79 -----------nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii 147 (484)
T KOG1023|consen 79 -----------NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGII 147 (484)
T ss_pred -----------cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHH
Confidence 999999999999999998765321 11111112234569999998764 1 3567999999999
Q ss_pred HHHHHhCCCCCCCCCCC----cHHHHHhhcCCCCCCCC---hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 355 LQEMIEGCPPFTMKHDN----EVPKAYAARQRPPFKAP---AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 355 l~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
++|+++...||...... ++...+...+..++.+. ....++++..++..||..+|.+||+++.+...++.+...
T Consensus 148 ~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 148 MYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred HHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99999999999864332 33344333233322221 114556899999999999999999999999998888664
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-21 Score=175.07 Aligned_cols=169 Identities=10% Similarity=0.175 Sum_probs=130.6
Q ss_pred cccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHH------HHHHHHHHhcCCCCceeeEEeEEEeC---
Q 012164 155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRA------FRDELALLQKIRHPNVVQFLGAVTQS--- 222 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~~i~~~~~~~~~~--- 222 (469)
-+|+..+.+|.|+||.|+. ++..+|||.+.......+...+. +.+|+..+.++.||+|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 3788899999999998875 45689999998766555444444 67999999999999999998886543
Q ss_pred -----CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 223 -----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 223 -----~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
...+++|||++|.+|.++.. ++. ....+++.+|..+|+.| ++|||+||+ |+++
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~-----------Nili 168 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKG-----------NFIV 168 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChH-----------HEEE
Confidence 35789999999999988742 232 34569999999999999 999999999 8888
Q ss_pred CCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHH
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 359 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~ 359 (469)
+.+| ++|+|||........... ..+.....+..++|+||||+++..+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8888 999999987654211100 01333445667999999999988754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=204.74 Aligned_cols=258 Identities=20% Similarity=0.252 Sum_probs=174.9
Q ss_pred ccccceeeecCeEEEEE---Eeceeehhhhccccc-CCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~---~~g~~vaiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
++...+.+|++.|-.+. -..-.|+||++.+.. .-+-....+-..|++ ...+++||++++.-....+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 45567789999996543 233348889886543 111122222233444 5566899999988777777888999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
+. -+|+|.+..++-+..-+.+.|+.|++.||..+|..| |+|+|||.+ |||++.=+-+.|+||..-
T Consensus 103 vk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsE-----------NILiTSWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSE-----------NILITSWNWLYLTDFASF 167 (1431)
T ss_pred Hh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccc-----------eEEEeeechhhhhccccc
Confidence 94 599999998888899999999999999999999999 999999999 555555556889999755
Q ss_pred cccccCCCCCc------ccCCCCCcccCCcccCCC----------C-CCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcH
Q 012164 312 KLLTVKEDRPL------TCQDTSCRYVAPEVFKNE----------E-YDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 373 (469)
Q Consensus 312 ~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~----------~-~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~ 373 (469)
+..-..+..+. .+...-..|+|||.+... . .+++-||||+||++.||++ |++||.-. .
T Consensus 168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----Q 243 (1431)
T KOG1240|consen 168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----Q 243 (1431)
T ss_pred CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----H
Confidence 43211111111 112233479999987542 2 5678999999999999987 89998511 0
Q ss_pred HHHHhhcCCCCCCC-ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH-----HHHHHhhhhcccc
Q 012164 374 PKAYAARQRPPFKA-PAKLYARGLKELIEECWNEKPAKRPTFRQIITR-----LESINNSINHKRR 433 (469)
Q Consensus 374 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~-----L~~~~~~~~~~~~ 433 (469)
.-.+...+.-.... ...--+..++++|..|++.||++|.++++.|+. +-.++.++-.++.
T Consensus 244 L~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~ 309 (1431)
T KOG1240|consen 244 LLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYL 309 (1431)
T ss_pred HHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHHHHHH
Confidence 11111111000000 001113468999999999999999999999987 3444555444333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.9e-20 Score=171.71 Aligned_cols=199 Identities=20% Similarity=0.290 Sum_probs=145.3
Q ss_pred CCCceeeEEeEEEe---------------------------CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 012164 208 RHPNVVQFLGAVTQ---------------------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260 (469)
Q Consensus 208 ~h~~i~~~~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~ 260 (469)
.||||+++.++|.+ ...+|+||... ..+|..++..+. .+.-...-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999999887732 23489999988 569999998654 45566677889999
Q ss_pred HHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC--CeEEeecCCccccccCC-----CCCcccCCCCCcccC
Q 012164 261 RGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG--NLKVADFGVSKLLTVKE-----DRPLTCQDTSCRYVA 333 (469)
Q Consensus 261 ~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~--~vkl~Dfgla~~~~~~~-----~~~~~~~~gt~~y~a 333 (469)
+|+.|||.+| |.|||+|++|||+.. ++++ .+.|+|||.+-.-.... ........|...-||
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~El---------ddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLEL---------DDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEe---------cCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 9999999999 999999999776642 3333 57899999874322111 011122357778999
Q ss_pred CcccCCCC-----CC-CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccC
Q 012164 334 PEVFKNEE-----YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 407 (469)
Q Consensus 334 PE~~~~~~-----~~-~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 407 (469)
||+....+ .+ .|+|.|+.|.+.||+++...||..... +.......+...+++.+..+++.+++++...|+.|
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRD 497 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heechhhhhhhhCCCCcccCChHHHHHHHHHhcCC
Confidence 99986431 12 489999999999999999999986322 21111122233444556788999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 012164 408 PAKRPTFRQIITRLE 422 (469)
Q Consensus 408 p~~Rps~~~ll~~L~ 422 (469)
|++|++++-....|.
T Consensus 498 pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 498 PSKRVSPNIAANVLN 512 (598)
T ss_pred ccccCCccHHHhHHH
Confidence 999999887666553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-20 Score=176.41 Aligned_cols=231 Identities=19% Similarity=0.310 Sum_probs=149.8
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCC----------CceeeEEeE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH----------PNVVQFLGA 218 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~~i~~~~~~ 218 (469)
...+.....||.|+|+.|+. +|+.+|+|.+...........+.+++|.-....+.+ -.++..++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 34566788999999998874 689999998775543444556778877766655432 233333333
Q ss_pred EE---------eC---C-----ceEEEEeccCCCCHHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012164 219 VT---------QS---S-----PMMIVTEYLPKGDLRAFLKR---KGA----LKPSTAVRFALDIARGMNYLHENKPVPI 274 (469)
Q Consensus 219 ~~---------~~---~-----~~~lv~E~~~~gsL~~~l~~---~~~----l~~~~~~~i~~qi~~~L~~LH~~~~~~i 274 (469)
.. .. . +.+++|+-+ .++|.+++.. ... +.......+..|+++.+++||..| +
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---L 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence 32 11 1 347788888 6799888752 211 223344556689999999999999 9
Q ss_pred EecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC--------CCCCCch
Q 012164 275 IHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--------EEYDTKV 346 (469)
Q Consensus 275 vH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~s 346 (469)
+|+||+|+ |++++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.
T Consensus 167 VHgdi~~~-----------nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~ 231 (288)
T PF14531_consen 167 VHGDIKPE-----------NFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFAT 231 (288)
T ss_dssp EEST-SGG-----------GEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHH
T ss_pred Eeccccee-----------eEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeecc
Confidence 99999999 88889999999999987765432211 1233467899997643 2577899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCC
Q 012164 347 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411 (469)
Q Consensus 347 Di~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 411 (469)
|.|+||+++|.|.+|+.||........... .+. .+.++|+.++.||..+|+.||.+|
T Consensus 232 DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------~f~-~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 232 DAWQLGITLYSLWCGRLPFGLSSPEADPEW-------DFS-RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------GGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred CHHHHHHHHHHHHHccCCCCCCCccccccc-------cch-hcCCcCHHHHHHHHHHccCCcccC
Confidence 999999999999999999986543322211 111 123788999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.8e-20 Score=164.08 Aligned_cols=137 Identities=20% Similarity=0.230 Sum_probs=104.2
Q ss_pred eeeecCeEEEEEE----eceeehhhhcccccCCCHHH-----------------------HHHHHHHHHHHhcCCCCcee
Q 012164 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDR-----------------------VRAFRDELALLQKIRHPNVV 213 (469)
Q Consensus 161 ~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~~i~ 213 (469)
..||+|+||.||. +|+.||||++.......... ......|+++++++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4799999999875 58999999987543211110 12234599999999887775
Q ss_pred eEEeEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCcccccccccC
Q 012164 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL-HENKPVPIIHRDLEPSDLYVAYWQND 292 (469)
Q Consensus 214 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dlkp~Nil~~~~~~~ 292 (469)
....+.. ...++||||++++++.......+.++...+..++.|++.+|.++ |+.+ |+||||||+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~---------- 147 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY---------- 147 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH----------
Confidence 4433322 22389999998887766544456789999999999999999999 6888 999999999
Q ss_pred cceeeCCCCCeEEeecCCcccc
Q 012164 293 RNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 293 ~nil~~~~~~vkl~Dfgla~~~ 314 (469)
||+++ ++.++|+|||+|...
T Consensus 148 -NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 148 -NLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred -HEEEE-CCcEEEEEccccccC
Confidence 66776 478999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=158.06 Aligned_cols=185 Identities=14% Similarity=0.058 Sum_probs=132.0
Q ss_pred cceeeecCeEEEEEEe---ceeehhhhcccccCCCH-HHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEeccC
Q 012164 159 NSVEITKGTFILAFWR---GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 159 ~~~~ig~G~~~~~~~~---g~~vaiK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
+...|++|+||.|++. +..++.+.+........ -....+.+|+++|++++ |++|++++++ +..+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 3467999999999874 55666665543321111 11125789999999995 5889999886 34699999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCcccccccccCcceeeCCCCCeEEeecCCcc
Q 012164 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312 (469)
Q Consensus 234 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~ 312 (469)
|.+|.+.... ....++.|++++|.++|+.| |+|||| ||+ ||+++.++.++|+|||+|.
T Consensus 82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~-----------NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEA-----------NWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcc-----------eEEEcCCCCEEEEECCCce
Confidence 9998764421 12357889999999999999 999999 799 8888889999999999998
Q ss_pred ccccCCCC----C--------cccCCCCCcccCCcccCCC-CCC-CchhHHHHHHHHHHHHhCCCCCCCC
Q 012164 313 LLTVKEDR----P--------LTCQDTSCRYVAPEVFKNE-EYD-TKVDVFSFALILQEMIEGCPPFTMK 368 (469)
Q Consensus 313 ~~~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDi~SlGvil~el~tg~~p~~~~ 368 (469)
........ . ......++.|++|+...-- ..+ ...+.++.|+-+|.++|++.|.-+.
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 54432210 0 0011245567777653221 233 5788999999999999999887543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=188.10 Aligned_cols=210 Identities=28% Similarity=0.417 Sum_probs=158.3
Q ss_pred cccCCCCcccccceeeecCeEEEEEEe-----ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 012164 148 YEIDPHELDFTNSVEITKGTFILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (469)
Q Consensus 148 ~~~~~~~~~~~~~~~ig~G~~~~~~~~-----g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 222 (469)
+...+.+.+|...+.|..|+||.||.. .+++|+| +++.... +++ ++.....|.+|
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFAGNPFVV--------- 135 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---cccccCCccee---------
Confidence 355678889999999999999998863 5788884 4332210 111 33333455444
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~ 302 (469)
|+=...++.-+.++... +.+++|||+.+ |+|||+||+ |.+++.-|+
T Consensus 136 ------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpd-----------nllIT~mGh 181 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPD-----------NLLITSMGH 181 (1205)
T ss_pred ------------chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCC-----------cceeeeccc
Confidence 44455566555565443 77899999999 999999999 888889999
Q ss_pred eEEeecCCccccccCCC--------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 012164 303 LKVADFGVSKLLTVKED--------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 368 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~ 368 (469)
+|+.|||+++....... ..-...+||+.|+|||++....|...+|.|++|+|+|+++-|+.||.+.
T Consensus 182 iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 182 IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 99999999985421110 0113357999999999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCC
Q 012164 369 HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 412 (469)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 412 (469)
+++++...+....... ......++++++++|.++|+.+|..|-
T Consensus 262 tpeelfg~visd~i~w-pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 262 TPEELFGQVISDDIEW-PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CHHHHHhhhhhhhccc-cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 9988877775544222 222445788999999999999999994
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-19 Score=187.05 Aligned_cols=257 Identities=19% Similarity=0.246 Sum_probs=188.3
Q ss_pred CccccCCCCcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC---CCceeeEEeE
Q 012164 146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGA 218 (469)
Q Consensus 146 ~~~~~~~~~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~ 218 (469)
+..++......|.+.++||+|+||.||+ +|+.||+|+-.+.....-.-. .+++.+|+ -+.|..+..+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHH
Confidence 3344444555788999999999999996 689999998776543221111 23344444 2345555555
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 219 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
..-.+.-++|+||.+.|+|.+++...+.+++..++.+..|++..++.||..+ |||+||||+|+++. |-..+
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~------~~~~~ 833 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLR------REICA 833 (974)
T ss_pred HccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEee------cccCC
Confidence 5556677899999999999999998888999999999999999999999999 99999999999888 44444
Q ss_pred CC--CCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHH
Q 012164 299 DS--GNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375 (469)
Q Consensus 299 ~~--~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~ 375 (469)
+. .-++|+|||.+..+...... .....++|-.+-.+|...|.+++...|.|.|+.+++-|+.|+.-=
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q---------- 903 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME---------- 903 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------
Confidence 33 45899999999876654433 335567788899999999999999999999999999999986431
Q ss_pred HHhhcCCCCCCC-ChhhhH-HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 376 AYAARQRPPFKA-PAKLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 376 ~~~~~~~~~~~~-~~~~~~-~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
...+....... .++.+. .-..+|...+|+.|-..=|...+|...|+.....-
T Consensus 904 -~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 904 -VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred -hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 11111100000 112222 22456778888866666688999999888886663
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-19 Score=178.33 Aligned_cols=134 Identities=26% Similarity=0.285 Sum_probs=119.8
Q ss_pred ccccccccCCCcccccccccc-CCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcC-CCCCcHHHHHHHcCCH
Q 012164 9 TTLLKQSSLAPDRERKEAELN-GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFT 86 (469)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~-~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d-~~g~t~Lh~A~~~g~~ 86 (469)
.-+.++...|.+...+.+--. |.+++..|.+|.|+|||||.+++++++++||++|||||..+ .-|.||||+||++|+.
T Consensus 46 ~~~v~A~q~G~l~~v~~lve~~g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~ 125 (600)
T KOG0509|consen 46 DDIVKATQYGELETVKELVESEGESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHI 125 (600)
T ss_pred hhhhhHhhcchHHHHHHHHhhcCcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcH
Confidence 445667777888776666655 99999999999999999999999999999999999999998 6699999999999999
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCccccccc
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (469)
.+|++|+++|||++.+|.+|.||+|+|+.+++.-++-+++.+++++.+.+....++
T Consensus 126 ~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTp 181 (600)
T KOG0509|consen 126 SVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTP 181 (600)
T ss_pred HHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCH
Confidence 99999999999999999999999999999999999999999999887766544333
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=157.65 Aligned_cols=139 Identities=14% Similarity=0.235 Sum_probs=101.0
Q ss_pred ccccceeeecCeEEEEEEeceee---hhhhcccccCCCHHHHHHHHHHHHHHhcC-----CCCceeeEEeEEEeCC---c
Q 012164 156 DFTNSVEITKGTFILAFWRGIQV---AVKKLGEEVISDDDRVRAFRDELALLQKI-----RHPNVVQFLGAVTQSS---P 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~~g~~v---aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~---~ 224 (469)
++.....||+|+|+.||. .... +||++.... ....+.+.+|+.+++.+ .||||++++|++.++. .
T Consensus 3 ~L~~~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 3 RLSEQSPLGTGRHRKCYA-HPEDAQRCIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred ecCCcceecCCCceEEEE-CCCCcCeEEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 345567899999999986 3333 455554322 22346789999999999 5799999999998874 3
Q ss_pred -eEEEEec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 225 -MMIVTEY--LPKGDLRAFLKRKGALKPSTAVRFALDIARGM-NYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 225 -~~lv~E~--~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
+.+|+|| +.+++|.+++++. .+++. ..++.|++.++ +|||+++ |+||||||+||+++... +.+
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~-------~~~ 145 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRIS-------ESE 145 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccC-------CCC
Confidence 3378999 5479999999763 45555 35678888777 9999999 99999999944443100 123
Q ss_pred CCeEEeecCCc
Q 012164 301 GNLKVADFGVS 311 (469)
Q Consensus 301 ~~vkl~Dfgla 311 (469)
+.++|+||+.+
T Consensus 146 ~~~~LiDg~G~ 156 (210)
T PRK10345 146 VIPVVCDNIGE 156 (210)
T ss_pred CcEEEEECCCC
Confidence 47999995444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=156.67 Aligned_cols=139 Identities=19% Similarity=0.163 Sum_probs=106.5
Q ss_pred ceeeecCeEEEEEE----eceeehhhhcccccCCCH-----------------------HHHHHHHHHHHHHhcCCCCce
Q 012164 160 SVEITKGTFILAFW----RGIQVAVKKLGEEVISDD-----------------------DRVRAFRDELALLQKIRHPNV 212 (469)
Q Consensus 160 ~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~~i 212 (469)
...||+|+||.||. +|+.||||.+........ .....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999874 589999999876521100 001234679999999999987
Q ss_pred eeEEeEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCccccccccc
Q 012164 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQN 291 (469)
Q Consensus 213 ~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~ 291 (469)
.....+... ..++||||++|+++.........++......++.|++.++.++|+ .| |+||||||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~--------- 147 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEY--------- 147 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChh---------
Confidence 554444333 248999999887654443334568888999999999999999999 88 999999999
Q ss_pred CcceeeCCCCCeEEeecCCccccc
Q 012164 292 DRNILRDDSGNLKVADFGVSKLLT 315 (469)
Q Consensus 292 ~~nil~~~~~~vkl~Dfgla~~~~ 315 (469)
||+++ ++.++|+|||++....
T Consensus 148 --NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 148 --NILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred --hEEEE-CCCEEEEEcccceecC
Confidence 77777 7899999999997644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-19 Score=155.99 Aligned_cols=127 Identities=19% Similarity=0.130 Sum_probs=106.4
Q ss_pred ccccccccCCCcccc----ccccccCCCCCCCCCCCChHHHHHHHcCCHHH---HHHHHHCCCCCCCcC-CCCCcHHHHH
Q 012164 9 TTLLKQSSLAPDRER----KEAELNGLDDDGEEIKPEFRLMFLANERDVEG---IKELLDSGIDVNFRD-IDNRTALHVA 80 (469)
Q Consensus 9 ~~~~~~~~~~~~~~~----~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~---v~~Ll~~g~~in~~d-~~g~t~Lh~A 80 (469)
++++.+...+.+-.. +...-+|.+.+..+.+|+||||+||..|+.+. +++|++.|+++|.+| ..|+||||+|
T Consensus 22 ~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A 101 (166)
T PHA02743 22 NTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIA 101 (166)
T ss_pred cHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHH
Confidence 445555555554211 12334677788888899999999999988654 899999999999998 5899999999
Q ss_pred HHcCCHHHHHHHHH-CCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 81 ACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 81 ~~~g~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
+..|+.+++++|++ .|++++.+|..|.||||+|+..++.+++++|+.+++++...
T Consensus 102 ~~~g~~~iv~~Ll~~~gad~~~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~ 157 (166)
T PHA02743 102 ASTKNYELAEWLCRQLGVNLGAINYQHETAYHIAYKMRDRRMMEILRANGAVCDDP 157 (166)
T ss_pred HHhCCHHHHHHHHhccCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCc
Confidence 99999999999995 79999999999999999999999999999999999887443
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=165.11 Aligned_cols=96 Identities=27% Similarity=0.291 Sum_probs=62.6
Q ss_pred CCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccccc
Q 012164 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (469)
Q Consensus 35 ~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~ 114 (469)
..|.+|.||||+||..|+.+++++|++.|+++|.+| |+||||+|+..|+.+++++|++.|++++.+|..|+||||+|+
T Consensus 25 ~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa 102 (284)
T PHA02791 25 KADVHGHSALYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAV 102 (284)
T ss_pred CCCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 345556666666666666666666666666666543 466666666666666666666666666666666666666666
Q ss_pred ccchHHHHHHHHhhcCCC
Q 012164 115 YYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 115 ~~~~~~~~~~L~~~~~~~ 132 (469)
..|+.+++++|+.+|+++
T Consensus 103 ~~g~~eivk~Ll~~gadi 120 (284)
T PHA02791 103 DSGNMQTVKLFVKKNWRL 120 (284)
T ss_pred HcCCHHHHHHHHHCCCCc
Confidence 666666666666666655
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=164.46 Aligned_cols=126 Identities=21% Similarity=0.099 Sum_probs=92.4
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
+.-.+||++.+...+.....+-.--+|++.+.. +|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+||..
T Consensus 27 D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~--d~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~~ 104 (284)
T PHA02791 27 DVHGHSALYYAIADNNVRLVCTLLNAGALKNLL--ENEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVDS 104 (284)
T ss_pred CCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCC--CCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHc
Confidence 344677777777777665444444455555544 367888888888888888888888888888888888888888888
Q ss_pred CCHHHHHHHHHCCCCCCCCcCCCc-cccccccccchHHHHHHHHhhcCC
Q 012164 84 GFTEVVSLLLERGADVDPKDRWGS-TPLGDAIYYKNHEVIKLLEKHGAK 131 (469)
Q Consensus 84 g~~~~v~~Ll~~g~~~~~~~~~g~-tpl~~A~~~~~~~~~~~L~~~~~~ 131 (469)
|+.+++++|+++|++++.++..|+ ||||+|+..|+.+++++|+.+++.
T Consensus 105 g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~~ 153 (284)
T PHA02791 105 GNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPS 153 (284)
T ss_pred CCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCCc
Confidence 888888888888888877777774 778888888888888877776543
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=153.78 Aligned_cols=128 Identities=16% Similarity=0.174 Sum_probs=108.5
Q ss_pred cccccccccccccCCCccccccc------cccCCCCCCCCCCCChHHHHHHHcCC----HHHHHHHHHCCCCCCCcCC-C
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEA------ELNGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDI-D 72 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~d~~~~~~~g~t~l~~Aa~~~~----~~~v~~Ll~~g~~in~~d~-~ 72 (469)
....+|+++.++..+.....+.. ...|++.+.++..|.||||+||..|+ .+++++|++.|+++|.+|. .
T Consensus 18 ~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~ 97 (169)
T PHA02741 18 NSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLE 97 (169)
T ss_pred ccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCC
Confidence 34567888888888887644332 13467788888899999999999998 5889999999999999985 8
Q ss_pred CCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCcCCCccccccccccchHHHHHHHHhhcCC
Q 012164 73 NRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (469)
Q Consensus 73 g~t~Lh~A~~~g~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~ 131 (469)
|+||||+|+..++.+++++|+. .|++++.+|..|.||||+|...++.++++.|.+.++.
T Consensus 98 g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tpL~~A~~~~~~~iv~~L~~~~~~ 157 (169)
T PHA02741 98 GDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSPFELAIDNEDVAMMQILREIVAT 157 (169)
T ss_pred CCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCHHHHHHHCCCHHHHHHHHHHHHH
Confidence 9999999999999999999997 5999999999999999999999999999999987654
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.4e-19 Score=153.42 Aligned_cols=129 Identities=19% Similarity=0.145 Sum_probs=107.3
Q ss_pred cccccccccccccCCCccc---cccccc--cCCCCCCCCCCCChHHHHHHHcCCH---HHHHHHHHCCCCCCCcC-CCCC
Q 012164 4 KVPVRTTLLKQSSLAPDRE---RKEAEL--NGLDDDGEEIKPEFRLMFLANERDV---EGIKELLDSGIDVNFRD-IDNR 74 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~---~~~~~~--~~~d~~~~~~~g~t~l~~Aa~~~~~---~~v~~Ll~~g~~in~~d-~~g~ 74 (469)
+.-..|||+.+...+.... ..+... ++...+..+.+|.||||+||..|+. +++++|++.|+++|.+| ..|+
T Consensus 14 d~~g~tpLh~A~~~g~~~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~ 93 (154)
T PHA02736 14 DIEGENILHYLCRNGGVTDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGN 93 (154)
T ss_pred CCCCCCHHHHHHHhCCHHHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCC
Confidence 3346789998888886321 112111 1222345678899999999999987 46889999999999998 5999
Q ss_pred cHHHHHHHcCCHHHHHHHHH-CCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCC
Q 012164 75 TALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 75 t~Lh~A~~~g~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
||||+|+..|+.+++++|+. .|++++.+|..|.||||+|+..|+.+++++|+..|++.
T Consensus 94 T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tpL~~A~~~~~~~i~~~Ll~~ga~~ 152 (154)
T PHA02736 94 TPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTPYYVACERHDAKMMNILRAKGAQC 152 (154)
T ss_pred cHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence 99999999999999999998 49999999999999999999999999999999999875
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-18 Score=153.93 Aligned_cols=107 Identities=22% Similarity=0.251 Sum_probs=61.4
Q ss_pred cCCCCCCCC-CCCChHHHHHHHc---CCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHH--cCCHHHHHHHHHCCCCCCCC
Q 012164 29 NGLDDDGEE-IKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAAC--QGFTEVVSLLLERGADVDPK 102 (469)
Q Consensus 29 ~~~d~~~~~-~~g~t~l~~Aa~~---~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~--~g~~~~v~~Ll~~g~~~~~~ 102 (469)
+|+|++..+ ..|.||||+|+.. ++.+++++|+++|+++|.+|..|.||||+|+. .++.+++++|++.|++++.+
T Consensus 75 ~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~ 154 (209)
T PHA02859 75 NGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNK 154 (209)
T ss_pred CCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccc
Confidence 455555554 2456666665542 34566666666666666666666666666554 24566666666666666666
Q ss_pred cCCCcccccc-ccccchHHHHHHHHhhcCCCCCC
Q 012164 103 DRWGSTPLGD-AIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 103 ~~~g~tpl~~-A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
|..|.||||. |+..++.+++++|+++|+++...
T Consensus 155 d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~ 188 (209)
T PHA02859 155 DFDNNNILYSYILFHSDKKIFDFLTSLGIDINET 188 (209)
T ss_pred cCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCC
Confidence 6666666663 34455566666666666555433
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=130.75 Aligned_cols=87 Identities=44% Similarity=0.583 Sum_probs=81.8
Q ss_pred HHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHH
Q 012164 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123 (469)
Q Consensus 44 l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~ 123 (469)
||+||..|+.+++++|++.|.+++. |.||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.++++
T Consensus 1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~ 76 (89)
T PF12796_consen 1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK 76 (89)
T ss_dssp HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence 7999999999999999999999987 999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCC
Q 012164 124 LLEKHGAKPLM 134 (469)
Q Consensus 124 ~L~~~~~~~~~ 134 (469)
+|+++|+++..
T Consensus 77 ~Ll~~g~~~~~ 87 (89)
T PF12796_consen 77 LLLEHGADVNI 87 (89)
T ss_dssp HHHHTTT-TTS
T ss_pred HHHHcCCCCCC
Confidence 99999988753
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-17 Score=169.05 Aligned_cols=99 Identities=24% Similarity=0.241 Sum_probs=79.7
Q ss_pred CCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccc
Q 012164 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (469)
Q Consensus 36 ~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~ 115 (469)
.+.+|.||||+||..|+.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 98 ~~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~ 177 (413)
T PHA02875 98 FYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMA 177 (413)
T ss_pred ccCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence 34567888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cchHHHHHHHHhhcCCCCC
Q 012164 116 YKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 116 ~~~~~~~~~L~~~~~~~~~ 134 (469)
.|+.+++++|++.|+++..
T Consensus 178 ~g~~eiv~~Ll~~ga~~n~ 196 (413)
T PHA02875 178 KGDIAICKMLLDSGANIDY 196 (413)
T ss_pred cCCHHHHHHHHhCCCCCCc
Confidence 8888888888888877643
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.8e-17 Score=138.30 Aligned_cols=95 Identities=35% Similarity=0.421 Sum_probs=73.4
Q ss_pred ChHHHHHHHcCCHHHHHHHHHCCCC-CCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchH
Q 012164 41 EFRLMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119 (469)
Q Consensus 41 ~t~l~~Aa~~~~~~~v~~Ll~~g~~-in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~ 119 (469)
...+.+|+..+.+..|+.||+..++ +|.+|.+|.||||.|+++|+.+||+.|+..||+.+.+...||||||-||.+++.
T Consensus 64 ~rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~ 143 (228)
T KOG0512|consen 64 IRLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNF 143 (228)
T ss_pred HHHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccch
Confidence 4456778888888888878776654 777888888888888888888888888878888888888888888888888888
Q ss_pred HHHHHHHhhcCCCCCC
Q 012164 120 EVIKLLEKHGAKPLMA 135 (469)
Q Consensus 120 ~~~~~L~~~~~~~~~~ 135 (469)
+++..|+++|+++...
T Consensus 144 ~va~~LLqhgaDVnA~ 159 (228)
T KOG0512|consen 144 EVAGRLLQHGADVNAQ 159 (228)
T ss_pred hHHHHHHhccCccccc
Confidence 8888888888776543
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-17 Score=168.32 Aligned_cols=128 Identities=24% Similarity=0.235 Sum_probs=115.9
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
..||++.+...+...-.+-.--.|+|++..+.+|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus 102 g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~ 181 (413)
T PHA02875 102 GMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDI 181 (413)
T ss_pred CCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCH
Confidence 56777777777666555555557899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHCCCCCCCCcCCCc-cccccccccchHHHHHHHHhhcCCCCC
Q 012164 87 EVVSLLLERGADVDPKDRWGS-TPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~-tpl~~A~~~~~~~~~~~L~~~~~~~~~ 134 (469)
+++++|+++|++++..+..|. ||+|+|+..|+.+++++|+++|+++..
T Consensus 182 eiv~~Ll~~ga~~n~~~~~~~~t~l~~A~~~~~~~iv~~Ll~~gad~n~ 230 (413)
T PHA02875 182 AICKMLLDSGANIDYFGKNGCVAALCYAIENNKIDIVRLFIKRGADCNI 230 (413)
T ss_pred HHHHHHHhCCCCCCcCCCCCCchHHHHHHHcCCHHHHHHHHHCCcCcch
Confidence 999999999999999998885 789999999999999999999998753
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.2e-17 Score=168.41 Aligned_cols=107 Identities=31% Similarity=0.438 Sum_probs=101.2
Q ss_pred cCCCCCCCCCC-CChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCc
Q 012164 29 NGLDDDGEEIK-PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (469)
Q Consensus 29 ~~~d~~~~~~~-g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~ 107 (469)
+|+|++..+.. |.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|++.|++++.+|..|.
T Consensus 156 ~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~ 235 (477)
T PHA02878 156 YGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGN 235 (477)
T ss_pred cCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCC
Confidence 68888888888 99999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc-chHHHHHHHHhhcCCCCCC
Q 012164 108 TPLGDAIYY-KNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 108 tpl~~A~~~-~~~~~~~~L~~~~~~~~~~ 135 (469)
||||+|+.. ++.+++++|+++|+++...
T Consensus 236 TpLh~A~~~~~~~~iv~~Ll~~gadvn~~ 264 (477)
T PHA02878 236 TPLHISVGYCKDYDILKLLLEHGVDVNAK 264 (477)
T ss_pred CHHHHHHHhcCCHHHHHHHHHcCCCCCcc
Confidence 999999975 6899999999999987543
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-17 Score=150.71 Aligned_cols=125 Identities=23% Similarity=0.196 Sum_probs=101.4
Q ss_pred ccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcC--CHHHHHHHHHCCCCCCCcC-CCCCcHHHHHHHc--
Q 012164 9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQ-- 83 (469)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~--~~~~v~~Ll~~g~~in~~d-~~g~t~Lh~A~~~-- 83 (469)
+|++.+.+.+.....+..- . ..+..+..|.||||+|+..+ +.+++++|+++|+++|.++ ..|+||||+|+..
T Consensus 23 ~pL~~A~~~~~~~~vk~Li-~--~~n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~ 99 (209)
T PHA02859 23 NPLFYYVEKDDIEGVKKWI-K--FVNDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNK 99 (209)
T ss_pred cHHHHHHHhCcHHHHHHHH-H--hhhccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCc
Confidence 4555555555544333221 1 24556778999999999855 8999999999999999997 5899999999864
Q ss_pred -CCHHHHHHHHHCCCCCCCCcCCCccccccccc--cchHHHHHHHHhhcCCCCCCc
Q 012164 84 -GFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 84 -g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~--~~~~~~~~~L~~~~~~~~~~~ 136 (469)
++.+++++|+++|++++.+|..|.||||+|+. .++.+++++|++.|+++....
T Consensus 100 ~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d 155 (209)
T PHA02859 100 NVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKD 155 (209)
T ss_pred cccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccccc
Confidence 47999999999999999999999999999875 468999999999999875543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.6e-18 Score=166.47 Aligned_cols=170 Identities=27% Similarity=0.406 Sum_probs=125.5
Q ss_pred ceEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
.++|.|++|+..+|.+++..+. ..+......++.|++.|++| ++ .+|+|+||. ||+...+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~-----------nif~~~d 392 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPS-----------NIFFSDD 392 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhcccc-----------ccccccc
Confidence 5889999999999999997543 36788899999999999999 66 999999999 6666677
Q ss_pred CCeEEeecCCccccccCC-----CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHH
Q 012164 301 GNLKVADFGVSKLLTVKE-----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 374 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~ 374 (469)
..+||.|||+........ ....+...||.+||+||.+.+..|+.++||||||++++|++. =..++.... ..
T Consensus 393 ~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~ 469 (516)
T KOG1033|consen 393 DQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---TL 469 (516)
T ss_pred hhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hh
Confidence 899999999987655433 122355679999999999999999999999999999999986 222222110 01
Q ss_pred HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHH
Q 012164 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416 (469)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 416 (469)
..+..+..++. ...++| .-..|+.+++.+.|.+||++.+
T Consensus 470 ~d~r~g~ip~~--~~~d~p-~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 470 TDIRDGIIPPE--FLQDYP-EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhcCCCChH--HhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence 11111112211 112233 3457999999999999995444
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.6e-17 Score=144.52 Aligned_cols=103 Identities=20% Similarity=0.188 Sum_probs=92.4
Q ss_pred CCCCCCCCChHHHHHHHcCCHHHHHHHHH------CCCCCCCcCCCCCcHHHHHHHcCC----HHHHHHHHHCCCCCCCC
Q 012164 33 DDGEEIKPEFRLMFLANERDVEGIKELLD------SGIDVNFRDIDNRTALHVAACQGF----TEVVSLLLERGADVDPK 102 (469)
Q Consensus 33 ~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~------~g~~in~~d~~g~t~Lh~A~~~g~----~~~v~~Ll~~g~~~~~~ 102 (469)
.+.++..|.||||+||..|+.++++.|+. .|+++|.+|..|+||||+|+..|+ .+++++|++.|++++.+
T Consensus 14 ~~~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~ 93 (169)
T PHA02741 14 IAEKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQ 93 (169)
T ss_pred hhccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCC
Confidence 45667789999999999999999999864 378999999999999999999999 58999999999999999
Q ss_pred cC-CCccccccccccchHHHHHHHHh-hcCCCCCC
Q 012164 103 DR-WGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMA 135 (469)
Q Consensus 103 ~~-~g~tpl~~A~~~~~~~~~~~L~~-~~~~~~~~ 135 (469)
+. .|+||||+|+..++.+++++|+. .++++...
T Consensus 94 ~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~ 128 (169)
T PHA02741 94 EMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFC 128 (169)
T ss_pred CcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcC
Confidence 85 99999999999999999999997 47776544
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.8e-17 Score=179.70 Aligned_cols=131 Identities=26% Similarity=0.256 Sum_probs=112.8
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHH----
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC---- 82 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~---- 82 (469)
+.++++.++..|.....+..--.|+|+|..|..|+||||+||..|+.++++.|+++|+|+|.+|.+|+||||+|+.
T Consensus 525 ~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~ 604 (823)
T PLN03192 525 MASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHH 604 (823)
T ss_pred chhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCH
Confidence 4456666666676666666666899999999999999999999999999999999999999999999999886555
Q ss_pred ---------------------------cCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 83 ---------------------------QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 83 ---------------------------~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
.|+.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|+++...
T Consensus 605 ~iv~~L~~~~~~~~~~~~~~~L~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~ 684 (823)
T PLN03192 605 KIFRILYHFASISDPHAAGDLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKA 684 (823)
T ss_pred HHHHHHHhcCcccCcccCchHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCC
Confidence 45556667788899999999999999999999999999999999999988655
Q ss_pred cc
Q 012164 136 PM 137 (469)
Q Consensus 136 ~~ 137 (469)
..
T Consensus 685 ~~ 686 (823)
T PLN03192 685 NT 686 (823)
T ss_pred CC
Confidence 43
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-17 Score=163.24 Aligned_cols=108 Identities=32% Similarity=0.415 Sum_probs=98.3
Q ss_pred cCCCCCCCC-CCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCc
Q 012164 29 NGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (469)
Q Consensus 29 ~~~d~~~~~-~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~ 107 (469)
.|+|+|... ..|-|||||||++|++.+|+.|+++|||++.+|.+|.||||.||+.|+.-+|.+|+.+|+|++.+|..|+
T Consensus 100 ~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~gr 179 (600)
T KOG0509|consen 100 HGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGR 179 (600)
T ss_pred cCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCC
Confidence 556666555 5678999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 108 tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
|||++|+..|....+..|+..++.+....
T Consensus 180 TpLmwAaykg~~~~v~~LL~f~a~~~~~d 208 (600)
T KOG0509|consen 180 TPLMWAAYKGFALFVRRLLKFGASLLLTD 208 (600)
T ss_pred CHHHHHHHhcccHHHHHHHHhcccccccc
Confidence 99999999998887889999998887665
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.3e-17 Score=141.88 Aligned_cols=104 Identities=27% Similarity=0.288 Sum_probs=99.0
Q ss_pred CCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccc
Q 012164 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (469)
Q Consensus 33 ~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~ 112 (469)
+|.-|..|.|||+|||.+|++.+|++|++.|||+....+.-.|+|.+|+..|..+||++|+.++.|+|..|.+|-|||-|
T Consensus 153 VN~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLly 232 (296)
T KOG0502|consen 153 VNACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLY 232 (296)
T ss_pred ccCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeee
Confidence 57778889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHhhcCCCCCCc
Q 012164 113 AIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 113 A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
|++.|+.++++.|+..|+++....
T Consensus 233 Avrgnhvkcve~Ll~sGAd~t~e~ 256 (296)
T KOG0502|consen 233 AVRGNHVKCVESLLNSGADVTQED 256 (296)
T ss_pred eecCChHHHHHHHHhcCCCccccc
Confidence 999999999999999999975543
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.4e-17 Score=168.21 Aligned_cols=130 Identities=23% Similarity=0.205 Sum_probs=116.0
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc-CC
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GF 85 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~-g~ 85 (469)
..||++.+...+.....+-.--+|+|++..+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+.. ++
T Consensus 168 g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~ 247 (477)
T PHA02878 168 GNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKD 247 (477)
T ss_pred CCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCC
Confidence 78889888888776655555567889999999999999999999999999999999999999999999999999975 79
Q ss_pred HHHHHHHHHCCCCCCCCcC-CCccccccccccchHHHHHHHHhhcCCCCCCccc
Q 012164 86 TEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (469)
Q Consensus 86 ~~~v~~Ll~~g~~~~~~~~-~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~ 138 (469)
.+++++|+++|++++.++. .|.||||+| .++.+++++|+++|+++......
T Consensus 248 ~~iv~~Ll~~gadvn~~~~~~g~TpLh~A--~~~~~~v~~Ll~~gadin~~d~~ 299 (477)
T PHA02878 248 YDILKLLLEHGVDVNAKSYILGLTALHSS--IKSERKLKLLLEYGADINSLNSY 299 (477)
T ss_pred HHHHHHHHHcCCCCCccCCCCCCCHHHHH--ccCHHHHHHHHHCCCCCCCcCCC
Confidence 9999999999999999986 899999999 46778999999999998665443
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-17 Score=164.62 Aligned_cols=106 Identities=33% Similarity=0.501 Sum_probs=101.4
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcc
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t 108 (469)
.|+|.+..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++..|..|.|
T Consensus 113 ~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~t 192 (434)
T PHA02874 113 CGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGES 192 (434)
T ss_pred CcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence 56788889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhcCCCCC
Q 012164 109 PLGDAIYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 109 pl~~A~~~~~~~~~~~L~~~~~~~~~ 134 (469)
|||+|+..|+.+++++|++.|+++..
T Consensus 193 pL~~A~~~g~~~iv~~Ll~~g~~i~~ 218 (434)
T PHA02874 193 PLHNAAEYGDYACIKLLIDHGNHIMN 218 (434)
T ss_pred HHHHHHHcCCHHHHHHHHhCCCCCcC
Confidence 99999999999999999999987543
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.9e-17 Score=155.09 Aligned_cols=99 Identities=22% Similarity=0.241 Sum_probs=73.4
Q ss_pred ccCCCCCCC----CCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 012164 28 LNGLDDDGE----EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPK 102 (469)
Q Consensus 28 ~~~~d~~~~----~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~ 102 (469)
-+|+|++.. +..|.||||+||..|+.+++++|+++|||+|.++ ..|.||||+|+..|+.+++++|+++|++++.+
T Consensus 54 ~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklLL~~GAdin~k 133 (300)
T PHA02884 54 KLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEILLSYGADINIQ 133 (300)
T ss_pred HCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence 355555554 3467788888888888888888888888888753 56788888888888888888888888888888
Q ss_pred cCCCccccccccccchHHHHHHHH
Q 012164 103 DRWGSTPLGDAIYYKNHEVIKLLE 126 (469)
Q Consensus 103 ~~~g~tpl~~A~~~~~~~~~~~L~ 126 (469)
|..|.||||+|+..++.+++..+.
T Consensus 134 d~~G~TpL~~A~~~~~~~~~~~~~ 157 (300)
T PHA02884 134 TNDMVTPIELALMICNNFLAFMIC 157 (300)
T ss_pred CCCCCCHHHHHHHhCChhHHHHhc
Confidence 888888888887777666664443
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-17 Score=158.89 Aligned_cols=125 Identities=26% Similarity=0.295 Sum_probs=108.9
Q ss_pred ccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHH
Q 012164 9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88 (469)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~ 88 (469)
.|+--++.-|++--.+-.--.|+++|..+.-.-|||--||..|+.++|++|+++|+|++..|..|.|.||+||+.||.+|
T Consensus 86 ppLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I 165 (615)
T KOG0508|consen 86 PPLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDI 165 (615)
T ss_pred chhhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHH
Confidence 34445555566655566666778888888777899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCC
Q 012164 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (469)
Q Consensus 89 v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~ 133 (469)
+++|++.|||+|.++..|+|+||.|+..|+.+++++|+.+|+.+.
T Consensus 166 ~qyLle~gADvn~ks~kGNTALH~caEsG~vdivq~Ll~~ga~i~ 210 (615)
T KOG0508|consen 166 AQYLLEQGADVNAKSYKGNTALHDCAESGSVDIVQLLLKHGAKID 210 (615)
T ss_pred HHHHHHhCCCcchhcccCchHHHhhhhcccHHHHHHHHhCCceee
Confidence 999999999999999999999999999999999999999887653
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.9e-17 Score=161.19 Aligned_cols=97 Identities=26% Similarity=0.208 Sum_probs=85.5
Q ss_pred CCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccc
Q 012164 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (469)
Q Consensus 38 ~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~ 117 (469)
..|.|++|.|+..++.+++++|+++|||+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|
T Consensus 186 ~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g 265 (437)
T PHA02795 186 IIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRG 265 (437)
T ss_pred hhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcC
Confidence 45778888888888999999999999999999999999999999999999999999999999999999999999999887
Q ss_pred --------hHHHHHHHHhhcCCCCC
Q 012164 118 --------NHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 118 --------~~~~~~~L~~~~~~~~~ 134 (469)
+.+++++|+++++++..
T Consensus 266 ~~~~~~~~~~eIvelLL~~gadI~~ 290 (437)
T PHA02795 266 SVIARRETHLKILEILLREPLSIDC 290 (437)
T ss_pred CcccccccHHHHHHHHHhCCCCCCc
Confidence 46899999988876643
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.5e-17 Score=142.76 Aligned_cols=108 Identities=20% Similarity=0.189 Sum_probs=95.5
Q ss_pred ccCCCCCCCCCCCChHHHHHHHcCCH----HHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHH---HHHHHHCCCCCC
Q 012164 28 LNGLDDDGEEIKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV---VSLLLERGADVD 100 (469)
Q Consensus 28 ~~~~d~~~~~~~g~t~l~~Aa~~~~~----~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~---v~~Ll~~g~~~~ 100 (469)
=|++|++..+.++.++||.||+.|+. +++++|++.|+++|.+|..|+||||+||..|+.+. +++|+++|++++
T Consensus 8 ~~~~~~~~~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin 87 (166)
T PHA02743 8 GNNLGAVEIDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADIN 87 (166)
T ss_pred ccchHHhhhccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCC
Confidence 46777777778888899999999998 66677889999999999999999999999998664 899999999999
Q ss_pred CCc-CCCccccccccccchHHHHHHHHh-hcCCCCCC
Q 012164 101 PKD-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMA 135 (469)
Q Consensus 101 ~~~-~~g~tpl~~A~~~~~~~~~~~L~~-~~~~~~~~ 135 (469)
.+| ..|.||||+|+..++.+++++|+. .++++...
T Consensus 88 ~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~ 124 (166)
T PHA02743 88 ARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAI 124 (166)
T ss_pred CCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCc
Confidence 998 589999999999999999999995 78876544
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1e-16 Score=133.80 Aligned_cols=95 Identities=27% Similarity=0.235 Sum_probs=87.6
Q ss_pred CCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccc
Q 012164 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (469)
Q Consensus 32 d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~ 111 (469)
-+|.+|.+|.||||-||.+|+.++|+.|+..|||.+++...||||||-||..++.+++.+|+++|+|+|....-..||||
T Consensus 89 ~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~ltpLh 168 (228)
T KOG0512|consen 89 HVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGLLTPLH 168 (228)
T ss_pred cccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccccccchhhH
Confidence 37888999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchHH-HHHHHH
Q 012164 112 DAIYYKNHE-VIKLLE 126 (469)
Q Consensus 112 ~A~~~~~~~-~~~~L~ 126 (469)
+|+...+.. .+.+|+
T Consensus 169 laa~~rn~r~t~~~Ll 184 (228)
T KOG0512|consen 169 LAAGNRNSRDTLELLL 184 (228)
T ss_pred HhhcccchHHHHHHHh
Confidence 999877654 445554
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=163.11 Aligned_cols=113 Identities=25% Similarity=0.223 Sum_probs=95.0
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
.-.+||++.+...+.....+-.--+|+|++.++..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 122 ~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~tpL~~A~~~g 201 (434)
T PHA02874 122 AELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESPLHNAAEYG 201 (434)
T ss_pred CCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcC
Confidence 34678888887777665555555578888999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccc
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~ 117 (469)
+.+++++|++.|++++.++..|.||||+|+..+
T Consensus 202 ~~~iv~~Ll~~g~~i~~~~~~g~TpL~~A~~~~ 234 (434)
T PHA02874 202 DYACIKLLIDHGNHIMNKCKNGFTPLHNAIIHN 234 (434)
T ss_pred CHHHHHHHHhCCCCCcCCCCCCCCHHHHHHHCC
Confidence 999999999999887766666666666655544
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=161.20 Aligned_cols=108 Identities=21% Similarity=0.250 Sum_probs=97.2
Q ss_pred ccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC--CHHHHHHHHHCCCCCCC-CcC
Q 012164 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDP-KDR 104 (469)
Q Consensus 28 ~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g--~~~~v~~Ll~~g~~~~~-~~~ 104 (469)
-+|+|++..+.+|.||||+||..|+.++|++|+++|||+|.+|..|+||||+|+..+ ..+++++|+++|++++. .|.
T Consensus 60 ~~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~ 139 (446)
T PHA02946 60 HRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDE 139 (446)
T ss_pred HCcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCC
Confidence 378888999999999999999999999999999999999999999999999999876 48899999999999995 689
Q ss_pred CCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 105 ~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
.|.|||| |+..++.+++++|+..|+++....
T Consensus 140 ~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d 170 (446)
T PHA02946 140 EGCGPLL-ACTDPSERVFKKIMSIGFEARIVD 170 (446)
T ss_pred CCCcHHH-HHHCCChHHHHHHHhccccccccC
Confidence 9999997 666788999999999998875544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.1e-18 Score=177.51 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=195.6
Q ss_pred CcccccceeeecCeEEEEEE------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceE
Q 012164 154 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 226 (469)
...|...+.||+|+|+.+.. ....+|.|.+.... ........+..|..+-+.+. |+|++.+++...+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 44566777899999987642 33566777665443 23444456677888888887 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCcccccccccCcceeeCCCC-C
Q 012164 227 IVTEYLPKGDLRAFL-KRKG-ALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG-N 302 (469)
Q Consensus 227 lv~E~~~~gsL~~~l-~~~~-~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~-~ 302 (469)
++++|..++++.+.+ .... ..+...+..++.|+..++.|+| ..+ +.|+|+||+ |.+++..+ .
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~-----------n~~l~~s~~~ 163 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPS-----------NSLLDESGSA 163 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCc-----------cchhccCCCc
Confidence 999999999999988 5544 5778888999999999999999 888 999999999 88888888 9
Q ss_pred eEEeecCCcccccc--CCCCCcccCCC-CCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHH-HH
Q 012164 303 LKVADFGVSKLLTV--KEDRPLTCQDT-SCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK-AY 377 (469)
Q Consensus 303 vkl~Dfgla~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~-~~ 377 (469)
++++|||+|..+.. ..........| ++.|+|||...+. ...+..|+||.|+++..+++|..||.......... .+
T Consensus 164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~ 243 (601)
T KOG0590|consen 164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW 243 (601)
T ss_pred ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence 99999999987665 22333344567 9999999999884 44578999999999999999999997654433221 11
Q ss_pred hhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..........++...+....+++.+++..+|..|.+.+++-..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 244 KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 1111111233456777889999999999999999999987654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.2e-16 Score=142.42 Aligned_cols=134 Identities=23% Similarity=0.363 Sum_probs=109.4
Q ss_pred eeeecCeEEEEEE---eceeehhhhcccccCCCHH-----HHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 161 VEITKGTFILAFW---RGIQVAVKKLGEEVISDDD-----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 161 ~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
+.||+|++|.||. .|..|++|........... ....+.+|+.++..+.|++|+....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 4689999998874 5789999976543322211 2245788999999999999887777777777889999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcc
Q 012164 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312 (469)
Q Consensus 233 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~ 312 (469)
+|++|.+++.... . ....++.+++.+|.++|+.+ ++|+|++|. ||+++ ++.++|+|||.+.
T Consensus 82 ~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~-----------Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 82 EGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTS-----------NMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred CCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcc-----------cEEEE-CCCEEEEECCccc
Confidence 9999999987543 2 78899999999999999999 999999999 77777 7889999999875
Q ss_pred c
Q 012164 313 L 313 (469)
Q Consensus 313 ~ 313 (469)
.
T Consensus 143 ~ 143 (211)
T PRK14879 143 F 143 (211)
T ss_pred C
Confidence 4
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-16 Score=162.26 Aligned_cols=111 Identities=29% Similarity=0.328 Sum_probs=101.8
Q ss_pred ccccCCCCCCCCCCCChHHHHHHHcC---CHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC-CHHHHHHHHHCCCCCCC
Q 012164 26 AELNGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDP 101 (469)
Q Consensus 26 ~~~~~~d~~~~~~~g~t~l~~Aa~~~---~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g-~~~~v~~Ll~~g~~~~~ 101 (469)
.--+|+|++..+..|.||||+|+..+ +.+++++|++.|+|+|.+|..|+||||+|+..| +.+++++|+++|++++.
T Consensus 33 Ll~~ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~ 112 (471)
T PHA03095 33 LLAAGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNA 112 (471)
T ss_pred HHHcCCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCC
Confidence 33478888899999999999999998 999999999999999999999999999999999 59999999999999999
Q ss_pred CcCCCcccccccc--ccchHHHHHHHHhhcCCCCCCc
Q 012164 102 KDRWGSTPLGDAI--YYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 102 ~~~~g~tpl~~A~--~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
+|..|.||||+|+ ..++.+++++|++.|+++....
T Consensus 113 ~~~~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d 149 (471)
T PHA03095 113 KDKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALD 149 (471)
T ss_pred CCCCCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccC
Confidence 9999999999999 5668899999999999876543
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-16 Score=163.91 Aligned_cols=108 Identities=25% Similarity=0.294 Sum_probs=100.0
Q ss_pred ccCCCCCCCCCCCChHHHHHHHc-----CCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC---CHHHHHHHHHCCCCC
Q 012164 28 LNGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADV 99 (469)
Q Consensus 28 ~~~~d~~~~~~~g~t~l~~Aa~~-----~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g---~~~~v~~Ll~~g~~~ 99 (469)
-+|+|+|..+..|.||||.|+.+ +..+++++|+++|||+|.+|..|+||||+|+.+| +.+++++|+++|+|+
T Consensus 59 ~~Gadvn~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadv 138 (489)
T PHA02798 59 NLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADT 138 (489)
T ss_pred HCCCCCCCCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCc
Confidence 47889999999999999999865 6799999999999999999999999999999986 789999999999999
Q ss_pred CCCcCCCccccccccccch---HHHHHHHHhhcCCCCCC
Q 012164 100 DPKDRWGSTPLGDAIYYKN---HEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 100 ~~~~~~g~tpl~~A~~~~~---~~~~~~L~~~~~~~~~~ 135 (469)
+.+|..|.||||+|+..++ .+++++|++.|+++...
T Consensus 139 n~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~ 177 (489)
T PHA02798 139 TLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH 177 (489)
T ss_pred cccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence 9999999999999999887 89999999999987543
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.6e-16 Score=164.43 Aligned_cols=131 Identities=27% Similarity=0.282 Sum_probs=90.7
Q ss_pred ccccccccccc--cCCCccccccccccCCCCCCCCCCCChHHHHHHHcC--CHHHHHHHHHCCCCCCCcCCCCCcHHHHH
Q 012164 5 VPVRTTLLKQS--SLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRDIDNRTALHVA 80 (469)
Q Consensus 5 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~--~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A 80 (469)
....||++.+. ..+.....+-.--+|+|.+..+..|.||||+|+..| +.+++++|+++|+++|.+|..|.||||+|
T Consensus 104 ~~g~tpL~~A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A 183 (480)
T PHA03100 104 NNGITPLLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIA 183 (480)
T ss_pred CCCCchhhHHHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHH
Confidence 34566677666 555555555555566677777777777777777777 77777777777777777777777777777
Q ss_pred HHcCCHHHHHHHHHCCCCCCCCcCCC------ccccccccccch--HHHHHHHHhhcCCCCCC
Q 012164 81 ACQGFTEVVSLLLERGADVDPKDRWG------STPLGDAIYYKN--HEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 81 ~~~g~~~~v~~Ll~~g~~~~~~~~~g------~tpl~~A~~~~~--~~~~~~L~~~~~~~~~~ 135 (469)
+..|+.+++++|+++|++++..+..| .||||+|+..++ .+++++|++.|+++...
T Consensus 184 ~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din~~ 246 (480)
T PHA03100 184 VEKGNIDVIKFLLDNGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPINIK 246 (480)
T ss_pred HHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCCCC
Confidence 77777777777777777777666666 667777777666 67777777776665443
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-16 Score=162.49 Aligned_cols=132 Identities=27% Similarity=0.225 Sum_probs=122.4
Q ss_pred ccccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHH-CC-CCCCCcCCCCCcHHHHH
Q 012164 3 TKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SG-IDVNFRDIDNRTALHVA 80 (469)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~-~g-~~in~~d~~g~t~Lh~A 80 (469)
.++-.=||+|.+++.|........--.|+|.+.++.++.||||.||..|+.++|+.||+ .| ..+|..|-.|.||||.|
T Consensus 269 ~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHla 348 (929)
T KOG0510|consen 269 EDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLA 348 (929)
T ss_pred ccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhh
Confidence 36677899999999999999988888999999999999999999999999999999999 44 56889999999999999
Q ss_pred HHcCCHHHHHHHHHCCCCCC---CCcCCCccccccccccchHHHHHHHHhhcCCCCC
Q 012164 81 ACQGFTEVVSLLLERGADVD---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 81 ~~~g~~~~v~~Ll~~g~~~~---~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~ 134 (469)
+..||.++++.|++.||+.. ..|..|.||||.|+.+|+..++++|+.+|+++..
T Consensus 349 a~~gH~~v~qlLl~~GA~~~~~~e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~ 405 (929)
T KOG0510|consen 349 AKSGHDRVVQLLLNKGALFLNMSEADSDGNTALHLAAKYGNTSAVQKLISHGADIGV 405 (929)
T ss_pred hhcCHHHHHHHHHhcChhhhcccccccCCchhhhHHHHhccHHHHHHHHHcCCceee
Confidence 99999999999999999887 5599999999999999999999999999999854
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-16 Score=165.81 Aligned_cols=108 Identities=21% Similarity=0.208 Sum_probs=87.9
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCC--HHHHHHHHHCCCCCCCcCCCCCcHHHHH--------------------------
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERD--VEGIKELLDSGIDVNFRDIDNRTALHVA-------------------------- 80 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~--~~~v~~Ll~~g~~in~~d~~g~t~Lh~A-------------------------- 80 (469)
+|+|++..+..|.||||+||..|+ .++|++|+++|||+|.+|..|+||||+|
T Consensus 201 ~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~ 280 (764)
T PHA02716 201 NGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKN 280 (764)
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhcccccccc
Confidence 678888888888888988888885 4888888888888888888888888865
Q ss_pred -----------HHcCCHHHHHHHHHCCCCCCCCcCCCccccccccc--cchHHHHHHHHhhcCCCCCCc
Q 012164 81 -----------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 81 -----------~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~--~~~~~~~~~L~~~~~~~~~~~ 136 (469)
|..|+.+++++|+++|++++.+|..|+||||+|+. .++.+++++|++.|+++....
T Consensus 281 ~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD 349 (764)
T PHA02716 281 IPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPD 349 (764)
T ss_pred chhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCC
Confidence 34577888888888888888888888899887653 457788888888888775443
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-16 Score=162.70 Aligned_cols=104 Identities=23% Similarity=0.270 Sum_probs=75.5
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCCH--HHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCC
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERDV--EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~~--~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g 106 (469)
.|+|++.++..|+||||+||..|+. .+++.|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+|++.+|..|
T Consensus 211 ~g~~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~g 290 (471)
T PHA03095 211 AGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDG 290 (471)
T ss_pred cCCCCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCC
Confidence 5666667777777777777777663 46667777777777777777777777777777777777777777777777777
Q ss_pred ccccccccccchHHHHHHHHhhcCCC
Q 012164 107 STPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 107 ~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
.||||+|+..|+.++++.|+..++++
T Consensus 291 ~tpl~~A~~~~~~~~v~~LL~~~~~~ 316 (471)
T PHA03095 291 NTPLSLMVRNNNGRAVRAALAKNPSA 316 (471)
T ss_pred CCHHHHHHHhCCHHHHHHHHHhCCCH
Confidence 77777777777777777777766554
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.4e-17 Score=172.53 Aligned_cols=125 Identities=32% Similarity=0.296 Sum_probs=114.1
Q ss_pred cccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHH
Q 012164 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~ 87 (469)
-++++-....+.....+..-.+|++.+-++..|.||||.||..|++++|++|+++|||+|.+|+.|+||||.||..|+.+
T Consensus 508 l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~ 587 (1143)
T KOG4177|consen 508 LTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHND 587 (1143)
T ss_pred cchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHH
Confidence 34455555555555566677789999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCC
Q 012164 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 88 ~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
|+.+|+++||++|..|.+|.|||++|...|+.++++.+...++++
T Consensus 588 i~~LLlk~GA~vna~d~~g~TpL~iA~~lg~~~~~k~l~~~~~~~ 632 (1143)
T KOG4177|consen 588 IAELLLKHGASVNAADLDGFTPLHIAVRLGYLSVVKLLKVVTATP 632 (1143)
T ss_pred HHHHHHHcCCCCCcccccCcchhHHHHHhcccchhhHHHhccCcc
Confidence 999999999999999999999999999999999999999999884
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.6e-16 Score=140.41 Aligned_cols=130 Identities=25% Similarity=0.365 Sum_probs=102.8
Q ss_pred eeecCeEEEEE---EeceeehhhhcccccCCC-----HHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccC
Q 012164 162 EITKGTFILAF---WRGIQVAVKKLGEEVISD-----DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 162 ~ig~G~~~~~~---~~g~~vaiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
.||+|+||.|| ++|..|++|......... ......+.+|+++++.++|+++....-++......+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999887 477899999865432211 1123567889999999998876655555556667799999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 234 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
|++|.+++..... .++.+++.+|.+||+.+ ++|+|++|. |++++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~-----------Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTS-----------NIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcc-----------eEEEE-CCcEEEEECCCCcC
Confidence 9999998865321 78999999999999999 999999999 77777 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.5e-16 Score=165.71 Aligned_cols=134 Identities=23% Similarity=0.203 Sum_probs=111.2
Q ss_pred cccccccccccccCCCcc--ccccccccCCCCCCCCCCCChHHHHH----------------------------------
Q 012164 4 KVPVRTTLLKQSSLAPDR--ERKEAELNGLDDDGEEIKPEFRLMFL---------------------------------- 47 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~~~~~~g~t~l~~A---------------------------------- 47 (469)
+.-..||++.+...+... -.+-.--+|+|++.++..|.||||+|
T Consensus 209 D~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~ 288 (764)
T PHA02716 209 NNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIPMILHSY 288 (764)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccccccccchhhhHHH
Confidence 345678888887777531 23333446888888999999999975
Q ss_pred ---HHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHH--cCCHHHHHHHHHCCCCCCCCcCCCccccccccc-------
Q 012164 48 ---ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC--QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY------- 115 (469)
Q Consensus 48 ---a~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~--~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~------- 115 (469)
|..|+.+++++|+++|+++|.+|.+|+||||+|+. .++.+++++|+++|++++.+|..|+||||+|+.
T Consensus 289 i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~~G~TPLH~A~~~lav~~~ 368 (764)
T PHA02716 289 ITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVLHTYLSMLSVVNI 368 (764)
T ss_pred HHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCCCCCCHHHHHHHhhhhhcc
Confidence 45688999999999999999999999999999874 468999999999999999999999999998764
Q ss_pred -------cchHHHHHHHHhhcCCCCCCcc
Q 012164 116 -------YKNHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 116 -------~~~~~~~~~L~~~~~~~~~~~~ 137 (469)
.++.+++++|+++|+++.....
T Consensus 369 ld~~~~~~~~~eVVklLL~~GADIn~kn~ 397 (764)
T PHA02716 369 LDPETDNDIRLDVIQCLISLGADITAVNC 397 (764)
T ss_pred ccccccccChHHHHHHHHHCCCCCCCcCC
Confidence 3688999999999999865543
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.9e-16 Score=147.06 Aligned_cols=101 Identities=19% Similarity=0.074 Sum_probs=89.2
Q ss_pred CCCCCh-HHHHHHHcCCHHHHHHHHHCCCCCCCcC----CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC-cCCCcccc
Q 012164 37 EIKPEF-RLMFLANERDVEGIKELLDSGIDVNFRD----IDNRTALHVAACQGFTEVVSLLLERGADVDPK-DRWGSTPL 110 (469)
Q Consensus 37 ~~~g~t-~l~~Aa~~~~~~~v~~Ll~~g~~in~~d----~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~-~~~g~tpl 110 (469)
|.+|.| +||.|+..|+.+++++|+++|||+|.++ ..|.||||+|+..|+.+++++|+++|||++.+ +..|.|||
T Consensus 29 d~~~~~~lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpL 108 (300)
T PHA02884 29 NKICIANILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPL 108 (300)
T ss_pred CcCCCCHHHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHH
Confidence 344444 4567778899999999999999999984 58999999999999999999999999999986 46899999
Q ss_pred ccccccchHHHHHHHHhhcCCCCCCcc
Q 012164 111 GDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 111 ~~A~~~~~~~~~~~L~~~~~~~~~~~~ 137 (469)
|+|+..++.+++++|+..|+++.....
T Consensus 109 h~Aa~~~~~eivklLL~~GAdin~kd~ 135 (300)
T PHA02884 109 YISVLHGCLKCLEILLSYGADINIQTN 135 (300)
T ss_pred HHHHHcCCHHHHHHHHHCCCCCCCCCC
Confidence 999999999999999999999866543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.3e-16 Score=143.85 Aligned_cols=141 Identities=20% Similarity=0.137 Sum_probs=106.5
Q ss_pred ccccceeeecCeEEEEEE------eceeehhhhcccccCCC-------------------H--HHHHHHHHHHHHHhcCC
Q 012164 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISD-------------------D--DRVRAFRDELALLQKIR 208 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~------~g~~vaiK~~~~~~~~~-------------------~--~~~~~~~~E~~~l~~l~ 208 (469)
.|++.+.||+|+||.||. +|+.||+|.+....... . .....+..|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467778999999998753 57899999887542110 0 01134678999999997
Q ss_pred CC--ceeeEEeEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccc
Q 012164 209 HP--NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYV 286 (469)
Q Consensus 209 h~--~i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~ 286 (469)
+. .++++++. ...++||||+++.+|.........+...+...++.|++.++.+||+.+ +++||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~---- 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY---- 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh----
Confidence 53 34455543 234899999998888776544455666777899999999999999987 4999999999
Q ss_pred cccccCcceeeCCCCCeEEeecCCcccc
Q 012164 287 AYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 287 ~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
||+++ ++.++|+|||.+...
T Consensus 179 -------NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 -------NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred -------hEEEE-CCCEEEEEChhhhcc
Confidence 77777 788999999998653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-15 Score=157.89 Aligned_cols=134 Identities=24% Similarity=0.239 Sum_probs=107.4
Q ss_pred cccceeeecCeEEEEEE---eceeehhhhcccccCC-----CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 157 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
|...+.||+|+||.||. .+..+++|+....... .....+.+.+|+++++.++|++++..+.++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 45578999999999986 4555666543322111 112235688999999999999999887777777778999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|||+++++|.+++. ....++.|++++|.+||+.+ ++||||||+ ||++ .++.++|+||
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~-----------NILl-~~~~~~liDF 471 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTS-----------NFIV-RDDRLYLIDF 471 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChH-----------HEEE-ECCcEEEEeC
Confidence 99999999999886 34678999999999999999 999999999 7777 4778999999
Q ss_pred CCccc
Q 012164 309 GVSKL 313 (469)
Q Consensus 309 gla~~ 313 (469)
|+++.
T Consensus 472 Gla~~ 476 (535)
T PRK09605 472 GLGKY 476 (535)
T ss_pred ccccc
Confidence 99865
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.3e-16 Score=167.14 Aligned_cols=132 Identities=27% Similarity=0.269 Sum_probs=102.7
Q ss_pred cccccccccccCCCcc-ccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 6 PVRTTLLKQSSLAPDR-ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~-~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
-.+||++.++..+... ...-.-..|+|++.++..|.||||+||..|+.+++++|++.|++++..+..|.||||+|+..+
T Consensus 340 ~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~ 419 (682)
T PHA02876 340 LYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGT 419 (682)
T ss_pred CCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcC
Confidence 3455665555443222 122233467778888888899999999999999999999999999998888999999998766
Q ss_pred C-HHHHHHHHHCCCCCCCCcCCCccccccccccc-hHHHHHHHHhhcCCCCCCcc
Q 012164 85 F-TEVVSLLLERGADVDPKDRWGSTPLGDAIYYK-NHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 85 ~-~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~-~~~~~~~L~~~~~~~~~~~~ 137 (469)
+ ..++++|+++|+++|.+|..|+||||+|+..+ +.+++++|++.|+++.....
T Consensus 420 ~~~~~vk~Ll~~gadin~~d~~G~TpLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~ 474 (682)
T PHA02876 420 NPYMSVKTLIDRGANVNSKNKDLSTPLHYACKKNCKLDVIEMLLDNGADVNAINI 474 (682)
T ss_pred CHHHHHHHHHhCCCCCCcCCCCCChHHHHHHHhCCcHHHHHHHHHCCCCCCCCCC
Confidence 5 56788999999999999999999999998866 67899999999988765543
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=8e-16 Score=159.23 Aligned_cols=129 Identities=23% Similarity=0.157 Sum_probs=110.2
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHH-----HHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMF-----LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~-----Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~ 81 (469)
..||++.+...+.....+-.--+|+|++..+..|.||||+ |+..|+.++++.|++.|+++|..|..|.||||+|+
T Consensus 35 ~~t~L~~A~~~~~~~ivk~Ll~~g~~~~~~~~~~~t~L~~~~~~~a~~~~~~~iv~~Ll~~ga~i~~~d~~g~tpL~~A~ 114 (480)
T PHA03100 35 PVLPLYLAKEARNIDVVKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAI 114 (480)
T ss_pred cchhhhhhhccCCHHHHHHHHHcCCCCCCccccCcCHHHHHHHHHHHhhchHHHHHHHHHCCCCCCCCCCCCCchhhHHH
Confidence 4578888888777766666666788888888888899999 99999999999999999999888888999999999
Q ss_pred --HcCCHHHHHHHHHCCCCCCCCcCCCccccccccccc--hHHHHHHHHhhcCCCCCC
Q 012164 82 --CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK--NHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 82 --~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~--~~~~~~~L~~~~~~~~~~ 135 (469)
..|+.+++++|+++|++++..+..|.||||+|+..+ +.+++++|+++|+++...
T Consensus 115 ~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~ 172 (480)
T PHA03100 115 SKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAK 172 (480)
T ss_pred hcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccc
Confidence 889999999999999999999999999999999888 889999999888876543
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-15 Score=154.65 Aligned_cols=133 Identities=18% Similarity=0.208 Sum_probs=112.4
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCC--HHHHHHHHHCCCCCCC-cCCCCCcHHHHH
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERD--VEGIKELLDSGIDVNF-RDIDNRTALHVA 80 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~--~~~v~~Ll~~g~~in~-~d~~g~t~Lh~A 80 (469)
+.-.+||++.+...+...-.+-.--+|+|++.+|.+|.||||+|+..++ .+++++|+++|+++|. .|..|.|||| |
T Consensus 69 d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~-a 147 (446)
T PHA02946 69 DDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL-A 147 (446)
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH-H
Confidence 4457889998888887655555555788899999999999999988664 8999999999999996 6899999997 7
Q ss_pred HHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccc--hHHHHHHHHhhcCCCCCCcc
Q 012164 81 ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK--NHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 81 ~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~--~~~~~~~L~~~~~~~~~~~~ 137 (469)
|..|+.+++++|++.|++++.+|..|+||||+|+..+ +.+++++|++.|+++.....
T Consensus 148 a~~~~~~vv~~Ll~~gad~~~~d~~G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~ 206 (446)
T PHA02946 148 CTDPSERVFKKIMSIGFEARIVDKFGKNHIHRHLMSDNPKASTISWMMKLGISPSKPDH 206 (446)
T ss_pred HHCCChHHHHHHHhccccccccCCCCCCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCC
Confidence 7789999999999999999999999999999987754 46889999999998865543
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-15 Score=141.65 Aligned_cols=90 Identities=37% Similarity=0.441 Sum_probs=75.1
Q ss_pred CCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHC-CCCCCCCcCCCccccccccccc
Q 012164 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYK 117 (469)
Q Consensus 39 ~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~-g~~~~~~~~~g~tpl~~A~~~~ 117 (469)
.|+|+|++|+.+|.+++|+.||..|||||.+|.+|.|+|++||.+||.||+++|+.. ++|+...|.+|.|+|.+|...|
T Consensus 339 ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTAl~IAleag 418 (452)
T KOG0514|consen 339 HGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTALSIALEAG 418 (452)
T ss_pred hcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchhhhhHHhcC
Confidence 588888888888888888888888888888888888888888888888888888874 7888888888888888888888
Q ss_pred hHHHHHHHHhh
Q 012164 118 NHEVIKLLEKH 128 (469)
Q Consensus 118 ~~~~~~~L~~~ 128 (469)
+.|+.-+|..+
T Consensus 419 h~eIa~mlYa~ 429 (452)
T KOG0514|consen 419 HREIAVMLYAH 429 (452)
T ss_pred chHHHHHHHHH
Confidence 88887666544
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-15 Score=150.44 Aligned_cols=133 Identities=17% Similarity=0.017 Sum_probs=110.7
Q ss_pred cccccccccccccc--CCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCC-cC-----CCCC
Q 012164 3 TKVPVRTTLLKQSS--LAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF-RD-----IDNR 74 (469)
Q Consensus 3 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~-~d-----~~g~ 74 (469)
+.+..+|+++...+ .+..--.+=.-.+|+|++.. ++.||||+|+.+|+.+++++|+++|++++. .+ ..|.
T Consensus 112 ~~~~~~~~L~~~~~n~~n~~eiV~~LI~~GADIn~~--~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~ 189 (437)
T PHA02795 112 NCNSVQDLLLYYLSNAYVEIDIVDFMVDHGAVIYKI--ECLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQY 189 (437)
T ss_pred ccccccHHHHHHHHhcCCCHHHHHHHHHCCCCCCCC--CCCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhcc
Confidence 44556777777666 55555555556677777764 458999999999999999999999985433 22 3588
Q ss_pred cHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCcc
Q 012164 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 75 t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~ 137 (469)
|++|.|+..++.+++++|+++|||+|.+|..|.||||+|+..|+.+++++|+++|+++.....
T Consensus 190 t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~ 252 (437)
T PHA02795 190 TRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMS 252 (437)
T ss_pred chhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCC
Confidence 999999999999999999999999999999999999999999999999999999999865543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-15 Score=136.56 Aligned_cols=135 Identities=21% Similarity=0.111 Sum_probs=102.6
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCH-------------------HHHHHHHHHHHHHhcCCCC--
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD-------------------DRVRAFRDELALLQKIRHP-- 210 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~-- 210 (469)
.|...+.||+|+||.||. +|+.||||++........ ........|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 356677899999998873 588999998654321000 0112367789999999877
Q ss_pred ceeeEEeEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccc
Q 012164 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290 (469)
Q Consensus 211 ~i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~ 290 (469)
.+++.++. ...+++|||++|++|.++... .....++.+++.++.++|+.+ ++|+||||+
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~-------- 154 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF-------- 154 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc--------
Confidence 44555442 455899999999998775431 345678899999999999998 999999999
Q ss_pred cCcceeeCCCCCeEEeecCCcccc
Q 012164 291 NDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 291 ~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
||+++.++.++|+|||++...
T Consensus 155 ---Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 155 ---NILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred ---cEEEcCCCcEEEEECCccccC
Confidence 888888999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.5e-15 Score=113.52 Aligned_cols=90 Identities=29% Similarity=0.509 Sum_probs=76.8
Q ss_pred HHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHH
Q 012164 43 RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122 (469)
Q Consensus 43 ~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~ 122 (469)
-+.|+..+|.++-|+..+..|.|+|..- .|+|||||||.+|..++++||+..||+|+.+|+.|.|||-.|++.|+.+++
T Consensus 5 ~~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cV 83 (117)
T KOG4214|consen 5 SVAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCV 83 (117)
T ss_pred hHhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHH
Confidence 3778888888888888888888887654 788889999888888888888888888888888888888888888888888
Q ss_pred HHHHhhcCCCC
Q 012164 123 KLLEKHGAKPL 133 (469)
Q Consensus 123 ~~L~~~~~~~~ 133 (469)
++|++.|++-.
T Consensus 84 klLL~~GAdrt 94 (117)
T KOG4214|consen 84 KLLLQNGADRT 94 (117)
T ss_pred HHHHHcCcccc
Confidence 88888888753
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.8e-15 Score=142.51 Aligned_cols=136 Identities=29% Similarity=0.277 Sum_probs=113.5
Q ss_pred ccccccccccCCCcc------ccccccc---cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHH
Q 012164 7 VRTTLLKQSSLAPDR------ERKEAEL---NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTAL 77 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~------~~~~~~~---~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~L 77 (469)
.+||+.-+..-|+.. +.-++++ ....-|+.+.+|-+||..|+..|++++|+.|+++||++|.......|||
T Consensus 42 g~tPL~iaaRnGH~~vVeyLle~~~a~~e~~GsV~FDge~IegappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPL 121 (615)
T KOG0508|consen 42 GGTPLLIAARNGHADVVEYLLEHCRASPEQGGSVRFDGETIEGAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPL 121 (615)
T ss_pred CCCceeeehhcCcHHHHHHHHHHhcCCccCCceEEeCCcccCCCchhhHHhccCcHHHHHHHHHhcCccccccccCCccH
Confidence 345555555555532 2223333 2233467888999999999999999999999999999999988899999
Q ss_pred HHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCccccccc
Q 012164 78 HVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (469)
Q Consensus 78 h~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (469)
--||.-|+.++|++|+++|+|++..|+.|.|-|++||..|+.+++++|++.|+++.......+.+
T Consensus 122 raACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTA 186 (615)
T KOG0508|consen 122 RAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTA 186 (615)
T ss_pred HHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchH
Confidence 99999999999999999999999999999999999999999999999999999998776554444
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.2e-15 Score=154.99 Aligned_cols=105 Identities=21% Similarity=0.266 Sum_probs=75.6
Q ss_pred cCCCCCCCCCCCChHHHHHHHc---CCHHHHHHHHHCCCCC-CCcCCCCCcHHHHHHHc--CCHHHHHHHHHCCCCCCC-
Q 012164 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDV-NFRDIDNRTALHVAACQ--GFTEVVSLLLERGADVDP- 101 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~---~~~~~v~~Ll~~g~~i-n~~d~~g~t~Lh~A~~~--g~~~~v~~Ll~~g~~~~~- 101 (469)
+|+|+|.++..|.||||.|+.. |+.+++++|+++|||+ +.+|..|+||||+|+.. ++.+++++|+++|+|++.
T Consensus 97 ~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~ 176 (494)
T PHA02989 97 FGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEK 176 (494)
T ss_pred CCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccc
Confidence 5666666677777778766654 5677888888888887 67777788888877643 577778888877877777
Q ss_pred CcCCCcccccccccc----chHHHHHHHHhhcCCCC
Q 012164 102 KDRWGSTPLGDAIYY----KNHEVIKLLEKHGAKPL 133 (469)
Q Consensus 102 ~~~~g~tpl~~A~~~----~~~~~~~~L~~~~~~~~ 133 (469)
.+..|.||||+|+.. ++.+++++|++.|+++.
T Consensus 177 ~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn 212 (494)
T PHA02989 177 TSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIE 212 (494)
T ss_pred ccccCCChHHHHHhcccccccHHHHHHHHhCCCCcc
Confidence 567777777776554 36777777777777654
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.4e-15 Score=160.94 Aligned_cols=131 Identities=30% Similarity=0.264 Sum_probs=113.9
Q ss_pred ccccccccccccCCCcc-ccccccccCCCCCCCCCCCChHHHHHHHcC-CHHHHHHHHHCCCCCCCcCCCCCcHHHHHHH
Q 012164 5 VPVRTTLLKQSSLAPDR-ERKEAELNGLDDDGEEIKPEFRLMFLANER-DVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~-~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~ 82 (469)
.-..||++.+...+.+. ..+-..-.|+|++..+.+|.||||+|+..| ..++++.|+..|+++|.+|..|+||||+|+.
T Consensus 271 ~~g~TpLh~Aa~~~~~~~iv~lLl~~gadin~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~ 350 (682)
T PHA02876 271 DCKNTPLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQAST 350 (682)
T ss_pred CCCCCHHHHHHhCCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHH
Confidence 45678888888877653 233334467888888899999999999999 5999999999999999999999999999998
Q ss_pred c-CCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 83 Q-GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 83 ~-g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
. ++.+++++|++.|++++.+|..|.||||+|+..|+.+++++|++.|+++...
T Consensus 351 ~~~~~~iv~lLl~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~ 404 (682)
T PHA02876 351 LDRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEAL 404 (682)
T ss_pred hCCcHHHHHHHHHcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccc
Confidence 5 5789999999999999999999999999999999999999999999887543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=135.46 Aligned_cols=138 Identities=20% Similarity=0.211 Sum_probs=104.5
Q ss_pred cccceeeecCeEEEEEEeceeehhhhcccccC----------CCHHHHHHHHHHHHHHhcCCCCce--eeEEeEEEeCCc
Q 012164 157 FTNSVEITKGTFILAFWRGIQVAVKKLGEEVI----------SDDDRVRAFRDELALLQKIRHPNV--VQFLGAVTQSSP 224 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~~g~~vaiK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~ 224 (469)
+...+..|+|+++.++..+..++||.+..... .+......+.+|++++.++.|++| ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 33445778888888888888999987753211 112234567889999999998775 677776543322
Q ss_pred ----eEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 225 ----MMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 225 ----~~lv~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
.++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+.| |+|+||||. |||++.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~-----------NILv~~ 177 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAG---VYHADLNAH-----------NILLDP 177 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCch-----------hEEEcC
Confidence 3599999987 699998865 345543 3678999999999999 999999999 888888
Q ss_pred CCCeEEeecCCccc
Q 012164 300 SGNLKVADFGVSKL 313 (469)
Q Consensus 300 ~~~vkl~Dfgla~~ 313 (469)
++.++|+|||.+..
T Consensus 178 ~~~v~LIDfg~~~~ 191 (239)
T PRK01723 178 DGKFWLIDFDRGEL 191 (239)
T ss_pred CCCEEEEECCCccc
Confidence 88999999998865
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.5e-15 Score=153.49 Aligned_cols=107 Identities=18% Similarity=0.158 Sum_probs=91.9
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCC----HHHHHHHHHCCC--CCCCcCCCCCcHHHH---HHHcC---------CHHHHH
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGI--DVNFRDIDNRTALHV---AACQG---------FTEVVS 90 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~----~~~v~~Ll~~g~--~in~~d~~g~t~Lh~---A~~~g---------~~~~v~ 90 (469)
+|+|+|.. ..|.||||+||..++ .+++++|+++|+ ++|.+|.+|+||||. |+..+ ..++++
T Consensus 368 ~GAdIN~k-~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~~ivk 446 (672)
T PHA02730 368 NGATMDKT-TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILIDVFD 446 (672)
T ss_pred CCCCCCcC-CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHHHHHH
Confidence 67777765 689999999998875 899999999997 699999999999994 33332 235799
Q ss_pred HHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 91 ~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
+|+++|||+|.+|..|.||||+|+..++.+++++|+.+|+++....
T Consensus 447 ~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d 492 (672)
T PHA02730 447 ILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTS 492 (672)
T ss_pred HHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999999999999999999999999875544
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.5e-15 Score=116.97 Aligned_cols=64 Identities=42% Similarity=0.587 Sum_probs=59.8
Q ss_pred CChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCc
Q 012164 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (469)
Q Consensus 40 g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~ 103 (469)
|+||||+||..|+.+++++|++.|+++|.+|..|+||||+|+.+|+.+++++|+++|++++.+|
T Consensus 26 ~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 26 GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLLLEHGADVNIRN 89 (89)
T ss_dssp SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHHHHTTT-TTSS-
T ss_pred CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 8899999999999999999999999999999999999999999999999999999999999875
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.5e-15 Score=154.81 Aligned_cols=107 Identities=21% Similarity=0.181 Sum_probs=90.0
Q ss_pred ccCCCCCCCCCCCChHHHHHHHc---CCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC--------------------
Q 012164 28 LNGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-------------------- 84 (469)
Q Consensus 28 ~~~~d~~~~~~~g~t~l~~Aa~~---~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g-------------------- 84 (469)
.++.+++..|.+|+||||+||.. |+.++|++|++.|++++.+|..|+||||+|+..|
T Consensus 20 ~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n 99 (661)
T PHA02917 20 RDRDPNDTRNQFKNNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSN 99 (661)
T ss_pred hccCcccccCCCCCcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCC
Confidence 36666777788888889987555 7789999999999999888888999998777644
Q ss_pred ---------------CHHHHHHHHHCCCCCCCCcCCCccccccc--cccchHHHHHHHHhhcCCCCC
Q 012164 85 ---------------FTEVVSLLLERGADVDPKDRWGSTPLGDA--IYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 85 ---------------~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A--~~~~~~~~~~~L~~~~~~~~~ 134 (469)
+.++|++|+++|+|+|.+|..|.||||.| +..|+.+++++|+++|+++..
T Consensus 100 ~~~~~~~~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~ 166 (661)
T PHA02917 100 INDFNIFSYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLY 166 (661)
T ss_pred CCCcchHHHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccc
Confidence 56788999999999999999999999954 467899999999999998853
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=9.4e-15 Score=151.27 Aligned_cols=108 Identities=24% Similarity=0.319 Sum_probs=97.8
Q ss_pred ccCCCCCCCCCCCChHHHHHHHcC---CHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCC---HHHHHHHHHCCCCCCC
Q 012164 28 LNGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVDP 101 (469)
Q Consensus 28 ~~~~d~~~~~~~g~t~l~~Aa~~~---~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~---~~~v~~Ll~~g~~~~~ 101 (469)
-+|+|+|..+.+|.||||+|+.++ +.+++++|+++|||+|.+|..|.||||+|+..|+ .+++++|+++|+|++.
T Consensus 97 ~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~ 176 (489)
T PHA02798 97 ENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINT 176 (489)
T ss_pred HCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCccc
Confidence 378899999999999999999986 7899999999999999999999999999999998 9999999999999998
Q ss_pred Cc-CCCcccccccccc----chHHHHHHHHhhcCCCCCC
Q 012164 102 KD-RWGSTPLGDAIYY----KNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 102 ~~-~~g~tpl~~A~~~----~~~~~~~~L~~~~~~~~~~ 135 (469)
.+ ..|.||||.+... ++.+++++|+++|+++...
T Consensus 177 ~~~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~~~ 215 (489)
T PHA02798 177 HNNKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIINKE 215 (489)
T ss_pred ccCcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCcccC
Confidence 85 5789999988654 4789999999999987553
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.5e-15 Score=140.89 Aligned_cols=122 Identities=30% Similarity=0.227 Sum_probs=94.5
Q ss_pred ccccccccccCCCccc-cccccccCCCCCCCCCCCChHHHHHHHc-----CCHHHHHHHHHCCCCCCCcC-CCCCcHHHH
Q 012164 7 VRTTLLKQSSLAPDRE-RKEAELNGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRD-IDNRTALHV 79 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~-~~~~~~~~~d~~~~~~~g~t~l~~Aa~~-----~~~~~v~~Ll~~g~~in~~d-~~g~t~Lh~ 79 (469)
+-|+||++.|++-..- ..-.|....|+|..+.-|.||+++||.. .+.++|+.|.+.| |||++- .-|+|+|++
T Consensus 268 GNTALHYsVSHaNF~VV~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mg-nVNaKAsQ~gQTALML 346 (452)
T KOG0514|consen 268 GNTALHYAVSHANFDVVSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMG-DVNAKASQHGQTALML 346 (452)
T ss_pred CCeeeeeeecccchHHHHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhcc-Ccchhhhhhcchhhhh
Confidence 3456666666654432 2334445566777777777777776642 3466777777766 788775 568999999
Q ss_pred HHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhc
Q 012164 80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (469)
Q Consensus 80 A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~ 129 (469)
|+.+|+.++|+.|+..|||+|.+|.+|.|+|+.|+.+|+.|++++|+...
T Consensus 347 AVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p 396 (452)
T KOG0514|consen 347 AVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVP 396 (452)
T ss_pred hhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccC
Confidence 99999999999999999999999999999999999999999999998653
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.2e-14 Score=150.80 Aligned_cols=105 Identities=23% Similarity=0.283 Sum_probs=93.4
Q ss_pred cCCCCCCCCCCCChHHHHHHH------cCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc---CCHHHHHHHHHCCCCC
Q 012164 29 NGLDDDGEEIKPEFRLMFLAN------ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ---GFTEVVSLLLERGADV 99 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~------~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~---g~~~~v~~Ll~~g~~~ 99 (469)
+|+|+|.++ .+.||||.|+. .+..+++++|+++|||+|.+|..|+||||.|+.. |+.+++++|+++|||+
T Consensus 59 ~GAdvn~~~-~~~tpL~~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadi 137 (494)
T PHA02989 59 NGADVNYKG-YIETPLCAVLRNREITSNKIKKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINV 137 (494)
T ss_pred cCCCccCCC-CCCCcHHHHHhccCcchhhHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCc
Confidence 677777665 57999999875 5789999999999999999999999999998765 6899999999999999
Q ss_pred -CCCcCCCccccccccc--cchHHHHHHHHhhcCCCCC
Q 012164 100 -DPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 100 -~~~~~~g~tpl~~A~~--~~~~~~~~~L~~~~~~~~~ 134 (469)
+.+|..|.||||+|+. .++.+++++|+++|+++..
T Consensus 138 n~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~ 175 (494)
T PHA02989 138 NDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE 175 (494)
T ss_pred ccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence 8999999999999865 4688999999999999865
|
|
| >KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.5e-15 Score=144.69 Aligned_cols=70 Identities=27% Similarity=0.401 Sum_probs=47.3
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCC
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~ 98 (469)
.|.+++..+.+|.|+||-||...+.+||++|+++|++||..|..||||||-|+..|+..++++|+++|++
T Consensus 62 ~ga~~~~~n~DglTalhq~~id~~~e~v~~l~e~ga~Vn~~d~e~wtPlhaaascg~~~i~~~li~~gA~ 131 (527)
T KOG0505|consen 62 RGASPNLCNVDGLTALHQACIDDNLEMVKFLVENGANVNAQDNEGWTPLHAAASCGYLNIVEYLIQHGAN 131 (527)
T ss_pred cCCCccccCCccchhHHHHHhcccHHHHHHHHHhcCCccccccccCCcchhhcccccHHHHHHHHHhhhh
Confidence 3455566666666777777777777777777777777777777777777776666666666666666655
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.2e-14 Score=153.75 Aligned_cols=105 Identities=30% Similarity=0.253 Sum_probs=94.6
Q ss_pred cCCCCCCCCCCCChHHHHHHHcC-----------------------CHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCC
Q 012164 29 NGLDDDGEEIKPEFRLMFLANER-----------------------DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~-----------------------~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~ 85 (469)
+|++.+..+.+|.||||.||+.+ ..++++.|+++|||+|.+|..|+||||+|+..++
T Consensus 385 ~ga~~~~~~~~G~TpL~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~~ 464 (661)
T PHA02917 385 EGGDAVNHLDDGEIPIGHLCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYNK 464 (661)
T ss_pred cCCCccccCCCCCChhHHHHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcCC
Confidence 56776666668999999988533 3678899999999999999999999999999999
Q ss_pred HHHHHHHHHCCCCCCCCcCCCccccccccc-cchHHHHHHHHhhcCCCC
Q 012164 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIY-YKNHEVIKLLEKHGAKPL 133 (469)
Q Consensus 86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~-~~~~~~~~~L~~~~~~~~ 133 (469)
.+++++|+++|+|++.+|..|.||||+|+. .++.+++++|+.+++++.
T Consensus 465 ~~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~ 513 (661)
T PHA02917 465 QSLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLD 513 (661)
T ss_pred HHHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChh
Confidence 999999999999999999999999999996 678999999999998764
|
|
| >PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-15 Score=106.34 Aligned_cols=55 Identities=53% Similarity=0.668 Sum_probs=29.1
Q ss_pred HHHCC-CCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccc
Q 012164 59 LLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (469)
Q Consensus 59 Ll~~g-~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A 113 (469)
||++| +++|.+|..|.||||+||..|+.+++++|++.|+|++.+|..|+||+|+|
T Consensus 1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 56777 78888888888888888888888888888888888888888888888876
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.6e-15 Score=148.31 Aligned_cols=101 Identities=29% Similarity=0.333 Sum_probs=94.9
Q ss_pred CCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHH-CC-CCCCCCcCCCcccc
Q 012164 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RG-ADVDPKDRWGSTPL 110 (469)
Q Consensus 33 ~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~-~g-~~~~~~~~~g~tpl 110 (469)
++..|.+|.||||+||+.|+.+.++.|+..||+||.++.++.||||.||++|+..+|+-|++ .| ..+|..|-.|.|||
T Consensus 266 v~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpL 345 (929)
T KOG0510|consen 266 VNDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPL 345 (929)
T ss_pred hhcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCch
Confidence 45678899999999999999999999999999999999999999999999999999999998 43 56789999999999
Q ss_pred ccccccchHHHHHHHHhhcCCCC
Q 012164 111 GDAIYYKNHEVIKLLEKHGAKPL 133 (469)
Q Consensus 111 ~~A~~~~~~~~~~~L~~~~~~~~ 133 (469)
|+|+..|+..+++.|++.|+...
T Consensus 346 Hlaa~~gH~~v~qlLl~~GA~~~ 368 (929)
T KOG0510|consen 346 HLAAKSGHDRVVQLLLNKGALFL 368 (929)
T ss_pred hhhhhcCHHHHHHHHHhcChhhh
Confidence 99999999999999999999876
|
|
| >PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-14 Score=102.38 Aligned_cols=54 Identities=39% Similarity=0.524 Sum_probs=46.1
Q ss_pred CChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHH
Q 012164 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93 (469)
Q Consensus 40 g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll 93 (469)
|+||||+||..|+.+++++|++.|+|+|.+|.+|+||||+||..|+.+++++|+
T Consensus 1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll 54 (54)
T PF13637_consen 1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL 54 (54)
T ss_dssp SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence 789999999999999999999999999999999999999999999999999986
|
... |
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.3e-15 Score=129.96 Aligned_cols=102 Identities=25% Similarity=0.337 Sum_probs=82.4
Q ss_pred CCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCC--C-----CCCcCCCCCcHHHHHHHcCCHH---HHHHHHHCCCCCCC
Q 012164 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGI--D-----VNFRDIDNRTALHVAACQGFTE---VVSLLLERGADVDP 101 (469)
Q Consensus 32 d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~--~-----in~~d~~g~t~Lh~A~~~g~~~---~v~~Ll~~g~~~~~ 101 (469)
..+..+.+|.||||+||..|+. ++.++..++ + ++.+|.+|+||||+||..|+.+ ++++|++.|++++.
T Consensus 9 ~~~~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~ 86 (154)
T PHA02736 9 FASEPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADING 86 (154)
T ss_pred HHHhcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccc
Confidence 3455677899999999999984 333333322 2 3457899999999999999874 68999999999999
Q ss_pred Cc-CCCccccccccccchHHHHHHHHhh-cCCCCCC
Q 012164 102 KD-RWGSTPLGDAIYYKNHEVIKLLEKH-GAKPLMA 135 (469)
Q Consensus 102 ~~-~~g~tpl~~A~~~~~~~~~~~L~~~-~~~~~~~ 135 (469)
++ ..|+||||+|+..++.+++++|+.+ ++++...
T Consensus 87 ~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~ 122 (154)
T PHA02736 87 KERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEIL 122 (154)
T ss_pred cCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccc
Confidence 98 4999999999999999999999974 7776443
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-14 Score=149.89 Aligned_cols=102 Identities=16% Similarity=0.174 Sum_probs=89.8
Q ss_pred CCC-CCCCCCChHHHHHHHcC---CHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC--CHHHHHHHHHCCC--CCCCCc
Q 012164 32 DDD-GEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGA--DVDPKD 103 (469)
Q Consensus 32 d~~-~~~~~g~t~l~~Aa~~~---~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g--~~~~v~~Ll~~g~--~~~~~~ 103 (469)
+.+ .+|.+|+||||+|+.+| +.++|++||++|||+|.+|..|+||||+|+..| +.|+|++|++.|+ +++..+
T Consensus 32 ~in~~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~~ 111 (672)
T PHA02730 32 NLSKHIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELTS 111 (672)
T ss_pred chhhhcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCccccc
Confidence 445 77788999999999997 599999999999999999999999999999977 7999999999955 558888
Q ss_pred CCCccccccccc--cchHHHHHHHHh-hcCCCC
Q 012164 104 RWGSTPLGDAIY--YKNHEVIKLLEK-HGAKPL 133 (469)
Q Consensus 104 ~~g~tpl~~A~~--~~~~~~~~~L~~-~~~~~~ 133 (469)
..+.+||+.++. .++.+++++|+. .+.++.
T Consensus 112 ~~~d~~l~~y~~s~n~~~~~vk~Li~~~~~~~~ 144 (672)
T PHA02730 112 NINDFDLYSYMSSDNIDLRLLKYLIVDKRIRPS 144 (672)
T ss_pred ccCCchHHHHHHhcCCcHHHHHHHHHhcCCChh
Confidence 889999998888 889999999996 445543
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.1e-15 Score=110.65 Aligned_cols=84 Identities=23% Similarity=0.273 Sum_probs=74.9
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcc
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t 108 (469)
.|.|+|.. ..|+|||||||-.|+.+++++|+..||+|+.+|+.|.|||.-|+..||.++|++|++.|||-......|.+
T Consensus 24 ~g~nVn~~-~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~~GAdrt~~~PdG~~ 102 (117)
T KOG4214|consen 24 EGLNVNEI-YGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQNGADRTIHAPDGTA 102 (117)
T ss_pred ccccHHHH-hCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHHcCcccceeCCCchh
Confidence 34444443 37999999999999999999999999999999999999999999999999999999999999998888888
Q ss_pred ccccc
Q 012164 109 PLGDA 113 (469)
Q Consensus 109 pl~~A 113 (469)
.+..+
T Consensus 103 ~~eat 107 (117)
T KOG4214|consen 103 LIEAT 107 (117)
T ss_pred HHhhc
Confidence 76543
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.6e-14 Score=155.24 Aligned_cols=134 Identities=32% Similarity=0.350 Sum_probs=108.1
Q ss_pred cccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHH
Q 012164 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~ 87 (469)
.||++-++..|+.....-..-.++..+-....|.|++|.|+..+...+++.++++|++++.++.+|.||||.||.+|+.+
T Consensus 475 ~T~Lhlaaq~Gh~~~~~llle~~~~~~~~~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~ 554 (1143)
T KOG4177|consen 475 FTPLHLAAQEGHTEVVQLLLEGGANDNLDAKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVD 554 (1143)
T ss_pred CcchhhhhccCCchHHHHhhhcCCccCccchhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCch
Confidence 34555555555555444444444445555556777777777777777788888888999999999999999999999999
Q ss_pred HHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCcccccc
Q 012164 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (469)
Q Consensus 88 ~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 141 (469)
+|++|+++|||++.+++.|+||||.|+..|+.+++.+|+++|+.+.........
T Consensus 555 ~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~T 608 (1143)
T KOG4177|consen 555 LVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADLDGFT 608 (1143)
T ss_pred HHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccccCcc
Confidence 999999999999999999999999999999999999999999998776654333
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.8e-15 Score=128.06 Aligned_cols=131 Identities=21% Similarity=0.123 Sum_probs=116.9
Q ss_pred ccccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHH
Q 012164 3 TKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82 (469)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~ 82 (469)
++-++-||++-++..|++.-..=.--+|+|++.....-+++|..|++.|..++|+.|+..+.|||.-|-+|-|||-||++
T Consensus 156 ~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyAvr 235 (296)
T KOG0502|consen 156 CDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYAVR 235 (296)
T ss_pred ccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeeeec
Confidence 35567789999999999887766667889999998999999999999999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCC
Q 012164 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 83 ~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~ 134 (469)
.||.++++.|++.|||++..+..|.+++.+|+.-|+. +++..++..+....
T Consensus 236 gnhvkcve~Ll~sGAd~t~e~dsGy~~mdlAValGyr-~Vqqvie~h~lkl~ 286 (296)
T KOG0502|consen 236 GNHVKCVESLLNSGADVTQEDDSGYWIMDLAVALGYR-IVQQVIEKHALKLC 286 (296)
T ss_pred CChHHHHHHHHhcCCCcccccccCCcHHHHHHHhhhH-HHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999999987 66666555554433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.8e-14 Score=125.81 Aligned_cols=134 Identities=23% Similarity=0.222 Sum_probs=93.2
Q ss_pred ceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHH---------------------HHHHHHHHhcCCCC--ce
Q 012164 160 SVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRA---------------------FRDELALLQKIRHP--NV 212 (469)
Q Consensus 160 ~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--~i 212 (469)
.+.||+|+||.||. +|+.||||++............. ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999998875 58999999877543221111111 13566666666543 34
Q ss_pred eeEEeEEEeCCceEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccc
Q 012164 213 VQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQ 290 (469)
Q Consensus 213 ~~~~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~ 290 (469)
.+++++ ...+++|||++++++.. .+.... . ...+..++.+++.++.++|. .+ ++|+||||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~-------- 144 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEY-------- 144 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChh--------
Confidence 555543 24589999998844321 111111 1 16678899999999999999 88 999999999
Q ss_pred cCcceeeCCCCCeEEeecCCcccc
Q 012164 291 NDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 291 ~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
||+++ ++.++|+|||.+...
T Consensus 145 ---Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 145 ---NILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred ---hEEEE-CCcEEEEECcccccc
Confidence 77777 889999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.7e-14 Score=127.76 Aligned_cols=125 Identities=22% Similarity=0.263 Sum_probs=105.1
Q ss_pred ccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHH
Q 012164 9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88 (469)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~ 88 (469)
+|++-+..-|+..-....-.-|+-+|..+....||||.||.+|+.++|+.|++..+|+|+.+..|.|||||||..|...+
T Consensus 36 splhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacfwgydqi 115 (448)
T KOG0195|consen 36 SPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQI 115 (448)
T ss_pred chhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHH
Confidence 56666666666555555555677777777778899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCC
Q 012164 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (469)
Q Consensus 89 v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~ 133 (469)
.+-|+..||-++..++.|.|||.-|.-.-...+.+.-.++|..+.
T Consensus 116 aedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~n 160 (448)
T KOG0195|consen 116 AEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPN 160 (448)
T ss_pred HHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998876555556666666666553
|
|
| >cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-13 Score=113.42 Aligned_cols=97 Identities=45% Similarity=0.606 Sum_probs=90.2
Q ss_pred CCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccc
Q 012164 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (469)
Q Consensus 36 ~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~ 115 (469)
.+.+|.||||+|+..|+.+++++|++.|++++.+|..|.||||+|+..++.+++++|++.|++++..+..|.||+|+|+.
T Consensus 3 ~~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~ 82 (126)
T cd00204 3 RDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAAR 82 (126)
T ss_pred cCcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHH
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHhhcCCC
Q 012164 116 YKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 116 ~~~~~~~~~L~~~~~~~ 132 (469)
.++.+++++|+..+.+.
T Consensus 83 ~~~~~~~~~L~~~~~~~ 99 (126)
T cd00204 83 NGNLDVVKLLLKHGADV 99 (126)
T ss_pred cCcHHHHHHHHHcCCCC
Confidence 99999999999887443
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. |
| >PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=147.38 Aligned_cols=87 Identities=44% Similarity=0.555 Sum_probs=84.8
Q ss_pred hHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHH
Q 012164 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (469)
Q Consensus 42 t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~ 121 (469)
+.|+.||..|+.++++.|++.|+|+|.+|.+|+||||+||.+|+.+++++|+++|+|++.+|..|.||||+|+..|+.++
T Consensus 84 ~~L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~i 163 (664)
T PTZ00322 84 VELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREV 163 (664)
T ss_pred HHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHH
Confidence 45889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhh
Q 012164 122 IKLLEKH 128 (469)
Q Consensus 122 ~~~L~~~ 128 (469)
+++|+.+
T Consensus 164 v~~Ll~~ 170 (664)
T PTZ00322 164 VQLLSRH 170 (664)
T ss_pred HHHHHhC
Confidence 9999998
|
|
| >PHA02792 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.5e-14 Score=142.65 Aligned_cols=104 Identities=17% Similarity=0.136 Sum_probs=78.2
Q ss_pred cCCCCCCCCCC--CChHHHHHHHcCCH---HHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCc
Q 012164 29 NGLDDDGEEIK--PEFRLMFLANERDV---EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (469)
Q Consensus 29 ~~~d~~~~~~~--g~t~l~~Aa~~~~~---~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~ 103 (469)
+|+|++.++.+ |.||||+|+..+.. +++++|+++|||+|.+|..|+||||+|+..++.+++++|+++|++++.+|
T Consensus 361 ~GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n~eivelLLs~GADIN~kD 440 (631)
T PHA02792 361 NGNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHSVSLVEWLIDNGADINITT 440 (631)
T ss_pred cCCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCcC
Confidence 55565555554 35888887776654 35778888888888888888888888888888888888888888888888
Q ss_pred CCCccccccccc---c-------chHHHHHHHHhhcCCC
Q 012164 104 RWGSTPLGDAIY---Y-------KNHEVIKLLEKHGAKP 132 (469)
Q Consensus 104 ~~g~tpl~~A~~---~-------~~~~~~~~L~~~~~~~ 132 (469)
..|.|||++|+. . ...++++.++.+++++
T Consensus 441 ~~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i 479 (631)
T PHA02792 441 KYGSTCIGICVILAHACIPEIAELYIKILEIILSKLPTI 479 (631)
T ss_pred CCCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCCh
Confidence 888888888865 1 2245677777776554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.4e-14 Score=128.84 Aligned_cols=201 Identities=23% Similarity=0.340 Sum_probs=138.4
Q ss_pred HHHHhcCCCCceeeEEeEEEeC-----CceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 012164 201 LALLQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP 271 (469)
Q Consensus 201 ~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 271 (469)
+..+-++-|.||++++.++.+. ....++.|||..|+|.++|++ ...+......+|+.||+.||.|||+-.|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 3455566799999999888554 347889999999999999985 3358889999999999999999999875
Q ss_pred CCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCC---CCCcccCCCCCcccCCcccCCCCCCCchhH
Q 012164 272 VPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 348 (469)
Q Consensus 272 ~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi 348 (469)
+++|+++..+ .|++..+|.+|+.--.-...-.... ........+.++|.+||.=.-...+.++||
T Consensus 198 -piihgnlTc~-----------tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dI 265 (458)
T KOG1266|consen 198 -PIIHGNLTCD-----------TIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDI 265 (458)
T ss_pred -ccccCCcchh-----------heeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhh
Confidence 6999999999 6777778888875221111101000 001112235678999998655566779999
Q ss_pred HHHHHHHHHHHhCCCCCCC-CCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 349 FSFALILQEMIEGCPPFTM-KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 349 ~SlGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
|+||....+|.-+..--.+ .+..+....+.... ..+ -..--+.++.+|++..|..||++.+++-|
T Consensus 266 y~fgmcAlemailEiq~tnseS~~~~ee~ia~~i-~~l------en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 266 YKFGMCALEMAILEIQSTNSESKVEVEENIANVI-IGL------ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred hhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-eec------cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 9999999999876543222 12111111111100 000 01123568899999999999999999876
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 469 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-34 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-34 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-30 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-30 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-30 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-29 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-29 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-29 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-29 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-27 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-27 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-27 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-27 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-27 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-27 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-27 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-27 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-27 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-27 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-27 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-26 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-26 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-26 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-26 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-26 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-26 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-26 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-26 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-25 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-25 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-25 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-25 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-25 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-25 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-25 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-25 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-25 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-24 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-24 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-24 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-24 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-24 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-24 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-24 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-24 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-24 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-23 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-23 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-23 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-23 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-23 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-23 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-23 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-23 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-23 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-23 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-23 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-23 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-23 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-22 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-22 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-22 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-22 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-22 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-22 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-22 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-22 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-22 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-22 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-22 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-22 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-22 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-22 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-21 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-21 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-21 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-21 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-21 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-21 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-21 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-21 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-21 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-21 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-21 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-21 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-21 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-20 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-20 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-20 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-20 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-20 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-20 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-20 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-20 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-19 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-19 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-19 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-19 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-19 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-19 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-19 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-19 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-19 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-19 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-19 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-18 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-18 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-18 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-18 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-18 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-18 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-18 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-18 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-18 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-18 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-17 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-16 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-15 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-15 | ||
| 4hqd_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 7e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-13 | ||
| 4gpm_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 4gmr_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 1n0r_A | 126 | 4ank: A Designed Ankyrin Repeat Protein With Four I | 3e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-13 | ||
| 1n0q_A | 93 | 3ank: A Designed Ankyrin Repeat Protein With Three | 4e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 4dui_A | 169 | Darpin D1 Binding To Tubulin Beta Chain (not In Com | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-12 | ||
| 4hb5_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 4atz_D | 154 | Ad5 Knob In Complex With A Designed Ankyrin Repeat | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-12 | ||
| 4drx_E | 169 | Gtp-Tubulin In Complex With A Darpin Length = 169 | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-12 | ||
| 2y0b_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4_ | 7e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-12 | ||
| 2l6b_A | 115 | Nrc Consensus Ankyrin Repeat Protein Solution Struc | 8e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-11 | ||
| 1mj0_A | 166 | Sank E3_5: An Artificial Ankyrin Repeat Protein Len | 1e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-11 | ||
| 2xeh_A | 157 | Structural Determinants For Improved Thermal Stabil | 3e-11 | ||
| 2xzd_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4 | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-11 | ||
| 2xee_A | 157 | Structural Determinants For Improved Thermal Stabil | 4e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-11 | ||
| 2qyj_A | 166 | Crystal Structure Of A Designed Full Consensus Anky | 7e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-11 | ||
| 3zu7_B | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-11 | ||
| 3q9u_C | 158 | In Silico And In Vitro Co-Evolution Of A High Affin | 8e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-11 | ||
| 2bkg_A | 166 | Crystal Structure Of E3_19 An Designed Ankyrin Repe | 9e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-11 | ||
| 1svx_A | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-10 | ||
| 4f6r_D | 169 | Tubulin:stathmin-Like Domain Complex Length = 169 | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 2xzt_G | 136 | Caspase-3 In Complex With Darpin-3.4_i78s Length = | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 2v4h_C | 136 | Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13 | 2e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-10 | ||
| 3utm_A | 351 | Crystal Structure Of A Mouse Tankyrase-Axin Complex | 5e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 2p2c_P | 169 | Inhibition Of Caspase-2 By A Designed Ankyrin Repea | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3zuv_B | 136 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 3twr_A | 165 | Crystal Structure Of Arc4 From Human Tankyrase 2 In | 4e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 3noc_D | 169 | Designed Ankyrin Repeat Protein (Darpin) Binders To | 5e-09 | ||
| 2v5q_C | 167 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-09 | ||
| 3twu_A | 167 | Crystal Structure Of Arc4 From Human Tankyrase 2 In | 5e-09 | ||
| 3twq_A | 175 | Crystal Structure Of Arc4 From Human Tankyrase 2 (A | 5e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 2j8s_D | 169 | Drug Export Pathway Of Multidrug Exporter Acrb Reve | 7e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-09 | ||
| 3nog_D | 169 | Designed Ankyrin Repeat Protein (Darpin) Binders To | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 2y1l_E | 169 | Caspase-8 In Complex With Darpin-8.4 Length = 169 | 1e-08 | ||
| 3hg0_D | 136 | Crystal Structure Of A Darpin In Complex With Orf49 | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2xen_A | 91 | Structural Determinants For Improved Thermal Stabil | 2e-08 | ||
| 2bkk_B | 169 | Crystal Structure Of Aminoglycoside Phosphotransfer | 2e-08 | ||
| 4grg_A | 135 | Crystal Structure Of Ige Complexed With E2_79, An A | 2e-08 | ||
| 1k1b_A | 241 | Crystal Structure Of The Ankyrin Repeat Domain Of B | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 2jab_A | 136 | A Designed Ankyrin Repeat Protein Evolved To Picomo | 5e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UTM|A Chain A, Crystal Structure Of A Mouse Tankyrase-Axin Complex Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P2C|P Chain P, Inhibition Of Caspase-2 By A Designed Ankyrin Repeat Protein (Darpin) Length = 169 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ZUV|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 136 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3TWR|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human 3bp2 Length = 165 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NOC|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169 | Back alignment and structure |
|
| >pdb|2V5Q|C Chain C, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 167 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TWU|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human Mcl1 Length = 167 | Back alignment and structure |
|
| >pdb|3TWQ|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 (Apo Form) Length = 175 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2J8S|D Chain D, Drug Export Pathway Of Multidrug Exporter Acrb Revealed By Darpin Inhibitors Length = 169 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NOG|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y1L|E Chain E, Caspase-8 In Complex With Darpin-8.4 Length = 169 | Back alignment and structure |
|
| >pdb|3HG0|D Chain D, Crystal Structure Of A Darpin In Complex With Orf49 From Lactococcal Phage Tp901-1 Length = 136 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XEN|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module Length = 91 | Back alignment and structure |
|
| >pdb|2BKK|B Chain B, Crystal Structure Of Aminoglycoside Phosphotransferase Aph (3')-Iiia In Complex With The Inhibitor Ar_3a Length = 169 | Back alignment and structure |
|
| >pdb|4GRG|A Chain A, Crystal Structure Of Ige Complexed With E2_79, An Anti-Ige Inhibitor Length = 135 | Back alignment and structure |
|
| >pdb|1K1B|A Chain A, Crystal Structure Of The Ankyrin Repeat Domain Of Bcl-3: A Unique Member Of The Ikappab Protein Family Length = 241 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2JAB|A Chain A, A Designed Ankyrin Repeat Protein Evolved To Picomolar Affinity To Her2 Length = 136 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 2e-90
Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 36/291 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ ID E++ + +G F A WR VA+K++ + +AF EL
Sbjct: 2 LHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQI-----ESESERKAFIVELRQ 54
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIA 260
L ++ HPN+V+ GA P+ +V EY G L L + + A+ + L +
Sbjct: 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 261 RGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN-LKVADFGVSKLLTVKED 319
+G+ YLH +P +IHRDL+P N+L G LK+ DFG + +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPP-----------NLLLVAGGTVLKICDFGTACDIQTH-- 159
Query: 320 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379
+T S ++APEVF+ Y K DVFS+ +IL E+I PF +A
Sbjct: 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV 217
Query: 380 RQ--RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428
RPP K + ++ L+ CW++ P++RP+ +I+ + +
Sbjct: 218 HNGTRPPL---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 4e-90
Identities = 99/307 (32%), Positives = 153/307 (49%), Gaps = 30/307 (9%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
P ++ + A + + +I +L+ +I G+F A W G VAVK L E+
Sbjct: 14 DIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQ 71
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
+ RV F E+A+++++RHPN+V F+GAVTQ + IVTEYL +G L L + GA
Sbjct: 72 DFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 247 ---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303
L + A D+A+GMNYLH P PI+HR+L+ N+L D +
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSP-----------NLLVDKKYTV 178
Query: 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 363
KV DFG+S+L + ++APEV ++E + K DV+SF +IL E+
Sbjct: 179 KVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 364 PFTMKHDNEVPKAYAAR-QRP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420
P+ + +V A + +R P + + +IE CW +P KRP+F I+
Sbjct: 238 PWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ-----VAAIIEGCWTNEPWKRPSFATIMDL 292
Query: 421 LESINNS 427
L + S
Sbjct: 293 LRPLIKS 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 2e-87
Identities = 84/283 (29%), Positives = 127/283 (44%), Gaps = 21/283 (7%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISD-DDRVRAFRDELALL 204
EID EL I G F AFW G +VAVK + D + R E L
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
++HPN++ G + + +V E+ G L L K + P V +A+ IARGMN
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YLH+ VPIIHRDL+ S++ + + LK+ DFG+++
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILIL---QKVENGDLSNKILKITDFGLAR---EWHRTTKMS 173
Query: 325 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP 383
+ ++APEV + + DV+S+ ++L E++ G PF V A +
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 384 --PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
P P +L+E+CWN P RP+F I+ +L +I
Sbjct: 234 PIPSTCPEPFA-----KLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 8e-83
Identities = 79/293 (26%), Positives = 134/293 (45%), Gaps = 33/293 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFW--RGIQVAVKKLGEEVISDD----DRVRAF 197
+ +E+++ +I KG F VA+K L + ++ + F
Sbjct: 13 LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFA 256
+ E+ ++ + HPN+V+ G + P +V E++P GDL L + +K S +R
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
LDIA G+ Y+ P PI+HRDL ++++ + + KVADFG+S+
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPV------CAKVADFGLSQQ--- 178
Query: 317 KEDRPLTCQDTSCRYVAPEVF--KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374
++ + +++APE + E Y K D +SFA+IL ++ G PF ++
Sbjct: 179 -SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 375 KAYAARQ---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
R+ RP P R L+ +IE CW+ P KRP F I+ L +
Sbjct: 238 FINMIREEGLRPTI--PEDCPPR-LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 5e-81
Identities = 68/295 (23%), Positives = 128/295 (43%), Gaps = 38/295 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
E++I +L+ I KG F W G +VA++ + E ++D+++AF+ E+
Sbjct: 27 EWDIPFEQLEIGE--LIGKGRFGQVYHGRWHG-EVAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
++ RH NVV F+GA + I+T L + + K L + + A +I +G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV----KE 318
M YLH I+H+DL+ +N+ D+ G + + DFG+ + V +
Sbjct: 143 MGYLHAK---GILHKDLKS-----------KNVFYDN-GKVVITDFGLFSISGVLQAGRR 187
Query: 319 DRPLTCQDTSCRYVAPEVFKNEE---------YDTKVDVFSFALILQEMIEGCPPFTMKH 369
+ L Q+ ++APE+ + + DVF+ I E+ PF +
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247
Query: 370 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+ +P + + +++ CW + +RPTF +++ LE +
Sbjct: 248 AEAIIWQMGTGMKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 8e-81
Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 35/291 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
ID +L+F ++ + W+G + VK L S + R F +E
Sbjct: 4 HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60
Query: 204 LQKIRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFALDI 259
L+ HPNV+ LGA + ++T ++P G L L + S AV+FALD+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
ARGM +LH +P I L R+++ D+ +++ V
Sbjct: 121 ARGMAFLHTLEP-LIPRHALNS-----------RSVMIDEDMTARISMADVKFSFQSPGR 168
Query: 320 RPLTCQDTSCRYVAPEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376
+ +VAPE + + DT D++SFA++L E++ PF + E+
Sbjct: 169 M------YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK 222
Query: 377 YAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426
A RP P + + + +L++ C NE PAKRP F I+ LE + +
Sbjct: 223 VALEGLRPTI--PPGI-SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 4e-78
Identities = 86/310 (27%), Positives = 136/310 (43%), Gaps = 51/310 (16%)
Query: 145 VPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRD 199
+P P +L + KG F I R G + +K+L D++ R F
Sbjct: 2 MPHRIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLK 56
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALD 258
E+ +++ + HPNV++F+G + + + +TEY+ G LR +K S V FA D
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
IA GM YLH IIHRDL N N L ++ N+ VADFG+++L+ ++
Sbjct: 117 IASGMAYLHSMN---IIHRDL-----------NSHNCLVRENKNVVVADFGLARLMVDEK 162
Query: 319 DRPLTCQDT-------------SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI------ 359
+P + + ++APE+ YD KVDVFSF ++L E+I
Sbjct: 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
Query: 360 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 419
P TM V + P P + + C + P KRP+F ++
Sbjct: 223 PDYLPRTMDFGLNVRGFL--DRYCPPNCPPSFF-----PITVRCCDLDPEKRPSFVKLEH 275
Query: 420 RLESINNSIN 429
LE++ +
Sbjct: 276 WLETLRMHLA 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 5e-77
Identities = 73/288 (25%), Positives = 136/288 (47%), Gaps = 29/288 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++EI ++ I G+F W G VAVK L +++AF++E+ +
Sbjct: 18 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGV 73
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L+K RH N++ F+G T + IVT++ L L + + + A ARG
Sbjct: 74 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
M+YLH IIHRDL+ NI + +K+ DFG++ +
Sbjct: 133 MDYLHAKS---IIHRDLKS-----------NNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 323 TCQDT-SCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAY 377
Q + S ++APEV + ++ Y + DV++F ++L E++ G P++ + + +++ +
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
Query: 378 AARQRPPFKAPAKLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESI 424
P + + + +K L+ EC +K +RP+F +I+ +E +
Sbjct: 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-74
Identities = 69/324 (21%), Positives = 124/324 (38%), Gaps = 57/324 (17%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++ +I KG + + WRG +VAVK + ++ E+
Sbjct: 31 VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVF----FTTEEASWFRETEIYQ 84
Query: 204 LQKIRHPNVVQFLGAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
+RH N++ F+ A + + + ++T+Y G L +LK L + ++ A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143
Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314
G+ +LH I HRDL+ +NIL +G +AD G++
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKS-----------KNILVKKNGTCCIADLGLAVKF 192
Query: 315 TVKEDRPLTCQDTSC---RYVAPEV------FKNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ +T RY+ PEV + + D++SF LIL E+ C
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 366 TMKHDNEVPKAYAA----------------RQRP--PFKAPAKLYARGLKELIEECWNEK 407
+ + ++P + RP P + + R + +L+ ECW
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312
Query: 408 PAKRPTFRQIITRLESINNSINHK 431
PA R T ++ L ++ S + K
Sbjct: 313 PASRLTALRVKKTLAKMSESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 4e-70
Identities = 70/302 (23%), Positives = 117/302 (38%), Gaps = 55/302 (18%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
+ KG + W+G VAVK R EL +RH N++ F+ +
Sbjct: 16 VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRET----ELYNTVMLRHENILGFIASD 71
Query: 220 TQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV--- 272
S + ++T Y G L +L+ L + +R L IA G+ +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 273 --PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 329
I HRDL+ +NIL +G +AD G++ + + ++ +
Sbjct: 131 KPAIAHRDLKS-----------KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 330 --RYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGCPPFTMKHD------NEVPK 375
RY+APEV + +VD+++F L+L E+ + D + VP
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 376 AYAA----------RQRPPFKAPAKLYA--RGLKELIEECWNEKPAKRPTFRQIITRLES 423
+ +QRP L +L++ECW + P+ R T +I L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 424 IN 425
I+
Sbjct: 300 ID 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 3e-69
Identities = 68/324 (20%), Positives = 116/324 (35%), Gaps = 57/324 (17%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ I KG F WRG +VAVK R E+
Sbjct: 36 VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA----EIYQ 89
Query: 204 LQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
+RH N++ F+ A + + + +V++Y G L +L R + ++ AL
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST 148
Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314
A G+ +LH I HRDL+ +NIL +G +AD G++
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKS-----------KNILVKKNGTCCIADLGLAVRH 197
Query: 315 TVKEDRPLTCQDTSC---RYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGC--- 362
D + RY+APEV + E + D+++ L+ E+ C
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257
Query: 363 ---PPFTMKHDNEVPKAYAA----------RQRPPFKAPAKL--YARGLKELIEECWNEK 407
+ + + + VP + + RP + R + +++ ECW
Sbjct: 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317
Query: 408 PAKRPTFRQIITRLESINNSINHK 431
A R T +I L ++ K
Sbjct: 318 GAARLTALRIKKTLSQLSQQEGIK 341
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 6e-65
Identities = 68/323 (21%), Positives = 116/323 (35%), Gaps = 57/323 (17%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
L +G F A VAVK + D + E+
Sbjct: 17 ENLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVY 70
Query: 203 LLQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
L ++H N++QF+GA + + + ++T + KG L FLK + + A
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129
Query: 259 IARGMNYLHENKPV-------PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311
+ARG+ YLHE+ P I HRD++ N+L ++ +ADFG++
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSK-----------NVLLKNNLTACIADFGLA 178
Query: 312 KLLTVKEDRPLTCQDT-SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPF 365
+ T + RY+APEV + ++D+++ L+L E+ C
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 366 TMKHDNEVPKAYAA-----------------RQRPPFKA--PAKLYARGLKELIEECWNE 406
D + ++RP + L E IEECW+
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 407 KPAKRPTFRQIITRLESINNSIN 429
R + + R+ + N
Sbjct: 299 DAEARLSAGCVGERITQMQRLTN 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-62
Identities = 80/339 (23%), Positives = 120/339 (35%), Gaps = 72/339 (21%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
E +D L I +G + VAVK S +R + F +E
Sbjct: 4 AASEPSLDLDNLKLLEL--IGRGRYGAVYKGSLDERPVAVKVF-----SFANR-QNFINE 55
Query: 201 LA--LLQKIRHPNVVQFLGA-----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
+ + H N+ +F+ ++V EY P G L +L ++
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114
Query: 254 RFALDIARGMNYLHENKPV------PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307
R A + RG+ YLH P I HRDL RN+L + G ++D
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS-----------RNVLVKNDGTCVISD 163
Query: 308 FGVSKLLTVKEDRPLTCQDTSC-------RYVAPEVFKN-------EEYDTKVDVFSFAL 353
FG+S LT +D + RY+APEV + E +VD+++ L
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 354 ILQEMIEGC---------PPFTMKHDNEVPKAYAA----------RQRPPFK---APAKL 391
I E+ C P + M EV +QRP F L
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283
Query: 392 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430
R LKE IE+CW++ R T + R+ +
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-59
Identities = 79/320 (24%), Positives = 145/320 (45%), Gaps = 35/320 (10%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
+ + + + A P + ++E++ ++ + ++ G +
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--KLGGGQYGEVYEG 239
Query: 172 FWRG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
W+ + VAVK L E+ + ++ F E A++++I+HPN+VQ LG T+ P I+T
Sbjct: 240 VWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295
Query: 230 EYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVA 287
E++ G+L +L+ + + + A I+ M YL + IHR+L A
Sbjct: 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNL------AA 346
Query: 288 YWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 347
RN L ++ +KVADFG+S+L+T ++ APE ++ K D
Sbjct: 347 -----RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 348 VFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECW 404
V++F ++L E+ G P+ ++V + R P P K+Y EL+ CW
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY-----ELMRACW 456
Query: 405 NEKPAKRPTFRQIITRLESI 424
P+ RP+F +I E++
Sbjct: 457 QWNPSDRPSFAEIHQAFETM 476
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 8e-59
Identities = 86/313 (27%), Positives = 131/313 (41%), Gaps = 41/313 (13%)
Query: 127 KHGAKPLMAPMHVKHAREVP--EYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVA 179
+PL V R VP ++ ++ +L +I +G F R VA
Sbjct: 86 LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVA 143
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
VK E + D F E +L++ HPN+V+ +G TQ P+ IV E + GD
Sbjct: 144 VKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201
Query: 240 FLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
FL+ L+ T ++ D A GM YL IHRDL A RN L
Sbjct: 202 FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDL------AA-----RNCLVT 247
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALI 354
+ LK++DFG+S+ D ++ APE Y ++ DV+SF ++
Sbjct: 248 EKNVLKISDFGMSREE---ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGIL 304
Query: 355 LQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKR 411
L E G P+ + + + R P P ++ L+E+CW +P +R
Sbjct: 305 LWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF-----RLMEQCWAYEPGQR 359
Query: 412 PTFRQIITRLESI 424
P+F I L+SI
Sbjct: 360 PSFSTIYQELQSI 372
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-58
Identities = 84/297 (28%), Positives = 140/297 (47%), Gaps = 45/297 (15%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
+ ++ EL I KG F +L +RG +VAVK + + + F E +
Sbjct: 14 SGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-----FLAEAS 66
Query: 203 LLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
++ ++RH N+VQ LG + + + IVTEY+ KG L +L+ + L ++F+LD+
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
M YL N +HRDL A RN+L + KV+DFG++K + +D
Sbjct: 127 CEAMEYLEGNN---FVHRDL------AA-----RNVLVSEDNVAKVSDFGLTKEASSTQD 172
Query: 320 R---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK 375
P+ ++ APE + +++ TK DV+SF ++L E+ G P+ +V
Sbjct: 173 TGKLPV-------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225
Query: 376 AYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430
+ P P +Y E+++ CW+ A RP+F Q+ +LE I H
Sbjct: 226 RVEKGYKMDAPDGCPPAVY-----EVMKNCWHLDAAMRPSFLQLREQLEHIKTHELH 277
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-58
Identities = 87/289 (30%), Positives = 147/289 (50%), Gaps = 39/289 (13%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
++ IDP EL F EI G F L +W +VA+K + E +S++D F +E
Sbjct: 2 KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 55
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
++ K+ HP +VQ G + +P+ +VTE++ G L +L+ ++G T + LD+
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 262 GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP 321
GM YL E +IHRDL A RN L ++ +KV+DFG+++ + D
Sbjct: 116 GMAYLEEAC---VIHRDL------AA-----RNCLVGENQVIKVSDFGMTRFV---LDDQ 158
Query: 322 LTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAY 377
T + ++ +PEVF Y +K DV+SF +++ E+ EG P+ + ++EV +
Sbjct: 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
Query: 378 AARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+ R P A +Y +++ CW E+P RP F +++ +L I
Sbjct: 219 STGFRLYKPRLASTHVY-----QIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-58
Identities = 78/289 (26%), Positives = 138/289 (47%), Gaps = 35/289 (12%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVAVKKLGEEVISDDDRVRAFRDE 200
++E++ ++ + ++ G + W+ + VAVK L E+ + ++ F E
Sbjct: 6 DKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKE 59
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALD 258
A++++I+HPN+VQ LG T+ P I+TE++ G+L +L+ + + + A
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
I+ M YL + IHRDL A RN L ++ +KVADFG+S+L+T
Sbjct: 120 ISSAMEYLEKKN---FIHRDL------AA-----RNCLVGENHLVKVADFGLSRLMTGDT 165
Query: 319 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAY 377
++ APE ++ K DV++F ++L E+ G P+ ++V +
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 378 AARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
R P P K+Y EL+ CW P+ RP+F +I E++
Sbjct: 226 EKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-57
Identities = 85/332 (25%), Positives = 143/332 (43%), Gaps = 42/332 (12%)
Query: 114 IYYKNH--EVIKLLEKHGAKPLMAPMHVKHAREVPEY-------EIDPHELDFTNSV--- 161
+++ +H + L G P H E P EI+ + +
Sbjct: 1 MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60
Query: 162 ---EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
E+ G + R + VA+K L + + R F E +++ + HPN+++ G
Sbjct: 61 DSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
VT+ MIVTEY+ G L FL+ G V + GM YL + +HR
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHR 175
Query: 278 DLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPE 335
DL A RN+L D + KV+DFG+S++L D T R+ APE
Sbjct: 176 DL------AA-----RNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 336 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 392
+ + DV+SF +++ E++ G P+ + +V + R P P L+
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH 284
Query: 393 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+L+ +CW++ A+RP F QI++ L+++
Sbjct: 285 -----QLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-57
Identities = 85/287 (29%), Positives = 142/287 (49%), Gaps = 39/287 (13%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALL 204
E+ E+ E+ G F L W+G VAVK + E +S+D+ F E +
Sbjct: 4 ELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTM 57
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
K+ HP +V+F G ++ P+ IVTEY+ G L +L+ L+PS + D+ GM
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 264 NYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLT 323
+L ++ IHRDL A RN L D +KV+DFG+++ + D
Sbjct: 118 AFLESHQ---FIHRDL------AA-----RNCLVDRDLCVKVSDFGMTRYV---LDDQYV 160
Query: 324 CQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA 379
+ ++ APEVF +Y +K DV++F +++ E+ G P+ + ++EV +
Sbjct: 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
Query: 380 RQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
R P A +Y +++ CW+E P KRPTF+Q+++ +E +
Sbjct: 221 GHRLYRPHLASDTIY-----QIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 9e-57
Identities = 81/289 (28%), Positives = 138/289 (47%), Gaps = 39/289 (13%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
+EIDP +L F E+ G F WRG VA+K + E +S+D+ F +E
Sbjct: 18 SWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAK 71
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
++ + H +VQ G T+ P+ I+TEY+ G L +L+ + + + D+
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 262 GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP 321
M YL + +HRDL A RN L +D G +KV+DFG+S+ + D
Sbjct: 132 AMEYLESKQ---FLHRDL------AA-----RNCLVNDQGVVKVSDFGLSRYV---LDDE 174
Query: 322 LTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAY 377
T S R+ PEV ++ +K D+++F +++ E+ G P+ ++E +
Sbjct: 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
Query: 378 AARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
A R P A K+Y ++ CW+EK +RPTF+ +++ + +
Sbjct: 235 AQGLRLYRPHLASEKVY-----TIMYSCWHEKADERPTFKILLSNILDV 278
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-56
Identities = 89/313 (28%), Positives = 147/313 (46%), Gaps = 45/313 (14%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
K + + + + ++ EL I KG F +L +RG +VAVK
Sbjct: 170 PKVMEGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK----- 222
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLKRKG 245
I +D +AF E +++ ++RH N+VQ LG + + + IVTEY+ KG L +L+ +G
Sbjct: 223 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282
Query: 246 --ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303
L ++F+LD+ M YL N +HRDL A RN+L +
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDL------AA-----RNVLVSEDNVA 328
Query: 304 KVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 359
KV+DFG++K + +D P+ ++ APE + +++ TK DV+SF ++L E+
Sbjct: 329 KVSDFGLTKEASSTQDTGKLPV-------KWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
Query: 360 EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 417
G P+ +V + P P +Y ++++ CW+ A RPTF Q+
Sbjct: 382 FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY-----DVMKNCWHLDAATRPTFLQL 436
Query: 418 ITRLESINNSINH 430
+LE I H
Sbjct: 437 REQLEHIRTHELH 449
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-55
Identities = 72/306 (23%), Positives = 124/306 (40%), Gaps = 48/306 (15%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRD 199
E +D L + E+ G F +++ VAVK L E +D
Sbjct: 10 EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLA 67
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E ++Q++ +P +V+ +G M+V E G L +L++ +K + +
Sbjct: 68 EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
+ GM YL E+ +HRDL A RN+L K++DFG+SK L E+
Sbjct: 127 SMGMKYLEESN---FVHRDL------AA-----RNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 320 R---------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKH 369
P+ ++ APE ++ +K DV+SF +++ E G P+
Sbjct: 173 YYKAQTHGKWPV-------KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
Query: 370 DNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427
+EV +R P P ++Y +L+ CW RP F + RL +
Sbjct: 226 GSEVTAMLEKGERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRLRNYYYD 280
Query: 428 INHKRR 433
+ ++
Sbjct: 281 VVNEGH 286
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-55
Identities = 88/319 (27%), Positives = 135/319 (42%), Gaps = 37/319 (11%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
YY H L +EI L ++ +G F +
Sbjct: 148 YYSKHA--DGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMG 203
Query: 172 FWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
W G +VA+K L +S + F E +++K+RH +VQ V++ P+ IVTE
Sbjct: 204 TWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTE 258
Query: 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
Y+ KG L FLK + L+ V A IA GM Y+ +HRDL A
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL------RA- 308
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 348
NIL ++ KVADFG+++L+ E ++ APE + K DV
Sbjct: 309 ----ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 349 FSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWN 405
+SF ++L E+ +G P+ + EV R P + P L+ +L+ +CW
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-----DLMCQCWR 419
Query: 406 EKPAKRPTFRQIITRLESI 424
++P +RPTF + LE
Sbjct: 420 KEPEERPTFEYLQAFLEDY 438
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-55
Identities = 80/293 (27%), Positives = 132/293 (45%), Gaps = 38/293 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
EI P + I G F + + VA+K L ++ R F
Sbjct: 38 TTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQR-VDF 93
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
E ++ + H N+++ G +++ PMMI+TEY+ G L FL+ + G V
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
IA GM YL +HRDL A RNIL + + KV+DFG+S++L
Sbjct: 154 RGIAAGMKYLANMN---YVHRDL------AA-----RNILVNSNLVCKVSDFGLSRVLED 199
Query: 317 KEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV 373
+ T R+ APE ++ + DV+SF +++ E++ G P+ ++EV
Sbjct: 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259
Query: 374 PKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
KA R P P+ +Y +L+ +CW ++ A+RP F I++ L+ +
Sbjct: 260 MKAINDGFRLPTPMDCPSAIY-----QLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-55
Identities = 73/315 (23%), Positives = 136/315 (43%), Gaps = 56/315 (17%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
+ + L F ++ KG F + + VAVKKL S ++ +R F
Sbjct: 4 PTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDF 58
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
E+ +L+ ++H N+V++ G + + ++ EYLP G LR +L++ K + ++
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314
+ I +GM YL + IHRDL RNIL ++ +K+ DFG++K+L
Sbjct: 119 YTSQICKGMEYLGTKR---YIHRDL------AT-----RNILVENENRVKIGDFGLTKVL 164
Query: 315 TVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI------------- 359
++ + ++ + APE ++ DV+SF ++L E+
Sbjct: 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224
Query: 360 ---EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTF 414
G + + R P P ++Y ++ ECWN +RP+F
Sbjct: 225 MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY-----MIMTECWNNNVNQRPSF 279
Query: 415 RQIITRLESINNSIN 429
R + R++ I +++
Sbjct: 280 RDLALRVDQIRDNMA 294
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-55
Identities = 85/288 (29%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 149 EIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
E+D + V E+ G L + I VA+K L + + R F E +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEAS 98
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIAR 261
++ + HPN+++ G VT+S P+MIVTEY+ G L +FL K V IA
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP 321
GM YL + +HRDL A RNIL + + KV+DFG+ ++L +
Sbjct: 159 GMKYLSDMG---YVHRDL------AA-----RNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 322 LTCQDTSC--RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYA 378
T + R+ +PE ++ + DV+S+ ++L E++ G P+ + +V KA
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
Query: 379 ARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
R PP PA LY +L+ +CW + RP F QI++ L+ +
Sbjct: 265 EGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-55
Identities = 76/347 (21%), Positives = 143/347 (41%), Gaps = 58/347 (16%)
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---IL 170
++ +H + A R+ + + L F ++ KG F +
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSAFEDRD--PTQFEERHLKFLQ--QLGKGNFGSVEM 59
Query: 171 AFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223
+ VAVKKL S ++ +R F E+ +L+ ++H N+V++ G +
Sbjct: 60 CRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116
Query: 224 -PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ ++ EYLP G LR +L++ K + +++ I +GM YL + IHRDL
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDL-- 171
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN 339
RNIL ++ +K+ DFG++K+L ++ + ++ + APE
Sbjct: 172 ----AT-----RNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 340 EEYDTKVDVFSFALILQEMI----------------EGCPPFTMKHDNEVPKAYAARQR- 382
++ DV+SF ++L E+ G + + R
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 282
Query: 383 -PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428
P P ++Y ++ ECWN +RP+FR + R++ I + +
Sbjct: 283 PRPDGCPDEIY-----MIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 7e-55
Identities = 75/296 (25%), Positives = 121/296 (40%), Gaps = 37/296 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVRAFR 198
I +L ++ G+F W + VAVK L +V+S + + F
Sbjct: 12 TCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL 257
E+ + + H N+++ G V PM +VTE P G L L+ +G T R+A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
+A GM YL + IHRDL A RN+L +K+ DFG+ + L
Sbjct: 129 QVAEGMGYLESKR---FIHRDL------AA-----RNLLLATRDLVKIGDFGLMRALPQN 174
Query: 318 EDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVP 374
+D + + + APE K + D + F + L EM G P+ + +++
Sbjct: 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 234
Query: 375 KA-YAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427
+R P P +Y ++ +CW KP RPTF + L +
Sbjct: 235 HKIDKEGERLPRPEDCPQDIY-----NVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-54
Identities = 84/287 (29%), Positives = 131/287 (45%), Gaps = 35/287 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
+EI L ++ +G F + W G +VA+K L +S + F E
Sbjct: 261 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 314
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIA 260
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 261 RGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR 320
GM Y+ +HRDL A NIL ++ KVADFG+++L+ E
Sbjct: 374 SGMAYVERMN---YVHRDL------RA-----ANILVGENLVCKVADFGLARLIEDNEYT 419
Query: 321 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA 379
++ APE + K DV+SF ++L E+ +G P+ + EV
Sbjct: 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
Query: 380 RQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
R P + P L+ +L+ +CW ++P +RPTF + LE
Sbjct: 480 GYRMPCPPECPESLH-----DLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-54
Identities = 87/291 (29%), Positives = 137/291 (47%), Gaps = 41/291 (14%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDEL 201
E+E+ L + G F + ++ G +VAVK L + +S D F E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
L+++++H +V+ VTQ P+ I+TEY+ G L FLK L + + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
A GM ++ E IHRDL A NIL D+ + K+ADFG+++L+ ED
Sbjct: 119 AEGMAFIEERN---YIHRDL------RA-----ANILVSDTLSCKIADFGLARLI---ED 161
Query: 320 RPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK 375
T ++ + ++ APE + K DV+SF ++L E++ G P+ + EV +
Sbjct: 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221
Query: 376 AYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
R P P +LY +L+ CW E+P RPTF + + LE
Sbjct: 222 NLERGYRMVRPDNCPEELY-----QLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-54
Identities = 65/273 (23%), Positives = 124/273 (45%), Gaps = 42/273 (15%)
Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
KG +I + I VA+K+L E + + DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ ++T+ +P G L ++ + K + + + + IA+GMNYL + + ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDL--- 143
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAP 334
A RN+L ++K+ DFG++KLL +E P+ +++A
Sbjct: 144 ---AA-----RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-------KWMAL 188
Query: 335 EVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKL 391
E + Y + DV+S+ + + E++ G P+ +E+ +R P +
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
Query: 392 YARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
Y ++ +CW RP FR++I +
Sbjct: 249 Y-----MIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 8e-54
Identities = 69/304 (22%), Positives = 123/304 (40%), Gaps = 50/304 (16%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 2 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 58
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E ++ ++ +P +V+ +G + +M+V E G L FL ++ + S
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
++ GM YL E +HRDL A RN+L + K++DFG+SK L
Sbjct: 118 QVSMGMKYLEEKN---FVHRDL------AA-----RNVLLVNRHYAKISDFGLSKALGAD 163
Query: 318 EDR---------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTM 367
+ PL ++ APE ++ ++ DV+S+ + + E + G P+
Sbjct: 164 DSYYTARSAGKWPL-------KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216
Query: 368 KHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425
EV +R P + P +LY L+ +CW K RP F + R+ +
Sbjct: 217 MKGPEVMAFIEQGKRMECPPECPPELY-----ALMSDCWIYKWEDRPDFLTVEQRMRACY 271
Query: 426 NSIN 429
S+
Sbjct: 272 YSLA 275
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-53
Identities = 69/294 (23%), Positives = 135/294 (45%), Gaps = 38/294 (12%)
Query: 144 EVPEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAF 197
+YEI ++ + ++ +G ++ + VA+K + D F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKF 63
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL+ RK +L ++ + +A
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
++ + YL + +HRD+ A RN+L + +K+ DFG+S+ +
Sbjct: 123 YQLSTALAYLESKR---FVHRDI------AA-----RNVLVSSNDCVKLGDFGLSRYM-- 166
Query: 317 KEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNE 372
ED +++APE + + DV+ F + + E++ G PF +N+
Sbjct: 167 -EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225
Query: 373 VPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
V +R P P LY L+ +CW P++RP F ++ +L +I
Sbjct: 226 VIGRIENGERLPMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 74/292 (25%), Positives = 128/292 (43%), Gaps = 38/292 (13%)
Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
P+Y I ++ + E+ +G + I VAVK ++ D F
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMS 62
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
E +++ + HP++V+ +G + + P I+ E P G+L +L+R K +LK T V ++L
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
I + M YL +HRD+ RNIL +K+ DFG+S+ + E
Sbjct: 122 ICKAMAYLESIN---CVHRDI------AV-----RNILVASPECVKLGDFGLSRYI---E 164
Query: 319 DRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVP 374
D + ++++PE + T DV+ FA+ + E++ G PF + +V
Sbjct: 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224
Query: 375 KAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
R P P LY L+ CW+ P+ RP F +++ L +
Sbjct: 225 GVLEKGDRLPKPDLCPPVLY-----TLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-53
Identities = 72/313 (23%), Positives = 137/313 (43%), Gaps = 56/313 (17%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRV 194
EV + L ++ +G F L + G QVAVK L E S + +
Sbjct: 12 EVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHI 67
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKR-KGALKPST 251
+ E+ +L+ + H N+V++ G T+ + + ++ E+LP G L+ +L + K +
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311
+++A+ I +GM+YL + +HRDL A RN+L + +K+ DFG++
Sbjct: 128 QLKYAVQICKGMDYLGSRQ---YVHRDL------AA-----RNVLVESEHQVKIGDFGLT 173
Query: 312 KLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI---------- 359
K + ++ +D+ + APE ++ DV+SF + L E++
Sbjct: 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233
Query: 360 ------EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKR 411
G M + +R P P ++Y +L+ +CW +P+ R
Sbjct: 234 ALFLKMIGPTHGQMTV-TRLVNTLKEGKRLPCPPNCPDEVY-----QLMRKCWEFQPSNR 287
Query: 412 PTFRQIITRLESI 424
+F+ +I E++
Sbjct: 288 TSFQNLIEGFEAL 300
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-53
Identities = 80/309 (25%), Positives = 141/309 (45%), Gaps = 41/309 (13%)
Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGE 185
++ ++ + + V I P L + I +G F I AVK L
Sbjct: 4 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFL-KR 243
I+D V F E +++ HPNV+ LG +S ++V Y+ GDLR F+
Sbjct: 64 --ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303
+ F L +A+GM YL K +HRDL A RN + D+ +
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDL------AA-----RNCMLDEKFTV 167
Query: 304 KVADFGVSKLLTVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEM 358
KVADFG+++ + + + + + +++A E + +++ TK DV+SF ++L E+
Sbjct: 168 KVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 225
Query: 359 IE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 415
+ G PP+ + ++ +R P P LY E++ +CW+ K RP+F
Sbjct: 226 MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKCWHPKAEMRPSFS 280
Query: 416 QIITRLESI 424
++++R+ +I
Sbjct: 281 ELVSRISAI 289
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 7e-53
Identities = 78/310 (25%), Positives = 134/310 (43%), Gaps = 57/310 (18%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
+ L + + ++ KG F L + VAVK+L S D+ R F
Sbjct: 17 PTIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDF 71
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVR 254
+ E+ +L+ + +V++ G + +V EYLP G LR FL + + L S +
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314
++ I +GM YL + +HRDL A RNIL + ++K+ADFG++KLL
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDL------AA-----RNILVESEAHVKIADFGLAKLL 177
Query: 315 TVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI------------- 359
+ +D + + APE + + + DV+SF ++L E+
Sbjct: 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 237
Query: 360 ---EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTF 414
GC + + + QR P PA+++ EL++ CW P RP+F
Sbjct: 238 LRMMGCERDVPAL-SRLLELLEEGQRLPAPPACPAEVH-----ELMKLCWAPSPQDRPSF 291
Query: 415 RQIITRLESI 424
+ +L+ +
Sbjct: 292 SALGPQLDML 301
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 80/327 (24%), Positives = 144/327 (44%), Gaps = 41/327 (12%)
Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAF 172
E + + ++ ++ + + V I P L + I +G F
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGT 109
Query: 173 WRG-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMM 226
I AVK L I+D V F E +++ HPNV+ LG +S +
Sbjct: 110 LLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167
Query: 227 IVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285
+V Y+ GDLR F+ + F L +A+GM +L K +HRDL
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDL------ 218
Query: 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-----RYVAPEVFKNE 340
A RN + D+ +KVADFG+++ + + + + + +++A E + +
Sbjct: 219 AA-----RNCMLDEKFTVKVADFGLARD--MYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 341 EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLK 397
++ TK DV+SF ++L E++ G PP+ + ++ +R P P LY
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY----- 326
Query: 398 ELIEECWNEKPAKRPTFRQIITRLESI 424
E++ +CW+ K RP+F ++++R+ +I
Sbjct: 327 EVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 84/299 (28%), Positives = 138/299 (46%), Gaps = 41/299 (13%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
EV + I + + I KG F + IQ A+K L I++ +V
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVE 67
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLK-RKGALKPSTAV 253
AF E L++ + HPNV+ +G + + ++ Y+ GDL F++ + +
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313
F L +ARGM YL E K +HRDL A RN + D+S +KVADFG+++
Sbjct: 128 SFGLQVARGMEYLAEQK---FVHRDL------AA-----RNCMLDESFTVKVADFGLARD 173
Query: 314 LTVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 367
+ + + Q ++ A E + + TK DV+SF ++L E++ G PP+
Sbjct: 174 --ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231
Query: 368 KHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
++ A +R P P LY +++++CW PA RPTFR ++ +E I
Sbjct: 232 IDPFDLTHFLAQGRRLPQPEYCPDSLY-----QVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-52
Identities = 77/324 (23%), Positives = 132/324 (40%), Gaps = 51/324 (15%)
Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQV 178
H + L+ + ++ + ID + L + +G F + + ++V
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTEYLP 233
AVK + + S + F E A ++ HPNV++ LG + S M++ ++
Sbjct: 66 AVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 234 KGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVA 287
GDL +L + T ++F +DIA GM YL +HRDL A
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDL------AA 175
Query: 288 YWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKNEEYD 343
RN + D + VADFG+SK + Q +++A E + Y
Sbjct: 176 -----RNCMLRDDMTVCVADFGLSKKI---YSGDYYRQGRIAKMPVKWIAIESLADRVYT 227
Query: 344 TKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELI 400
+K DV++F + + E+ G P+ ++E+ R P +LY E++
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELY-----EIM 282
Query: 401 EECWNEKPAKRPTFRQIITRLESI 424
CW P RPTF + +LE +
Sbjct: 283 YSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 38/290 (13%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
EL + G F W I V +K + ++ S +A D
Sbjct: 9 IFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTD 64
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALD 258
+ + + H ++V+ LG S + +VT+YLP G L ++ +GAL P + + +
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
IA+GM YL E+ ++HR+L A RN+L ++VADFGV+ LL +
Sbjct: 124 IAKGMYYLEEHG---MVHRNL------AA-----RNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 319 D-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKA 376
+ T +++A E +Y + DV+S+ + + E++ G P+ EVP
Sbjct: 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 229
Query: 377 YAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+R P +Y ++ +CW RPTF+++ +
Sbjct: 230 LEKGERLAQPQICTIDVY-----MVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-52
Identities = 81/314 (25%), Positives = 132/314 (42%), Gaps = 42/314 (13%)
Query: 127 KHGAKPLM-------APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG- 175
K G L + E +EI L ++ G F +A +
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKH 212
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+VAVK + +S + F E +++ ++H +V+ VT+ P+ I+TE++ KG
Sbjct: 213 TKVAVKTMKPGSMSVEA----FLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKG 267
Query: 236 DLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
L FLK + F+ IA GM ++ + IHRDL A
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDL------RA-----A 313
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 353
NIL S K+ADFG+++++ E ++ APE + K DV+SF +
Sbjct: 314 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 373
Query: 354 ILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAK 410
+L E++ G P+ + EV +A R P P +LY ++ CW +P +
Sbjct: 374 LLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY-----NIMMRCWKNRPEE 428
Query: 411 RPTFRQIITRLESI 424
RPTF I + L+
Sbjct: 429 RPTFEYIQSVLDDF 442
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-52
Identities = 73/307 (23%), Positives = 130/307 (42%), Gaps = 56/307 (18%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
L ++ +G F L + VAVK L + + ++
Sbjct: 27 VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQ 82
Query: 200 ELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
E+ +L+ + H +++++ G + + + +V EY+P G LR +L + ++ + + FA
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQ 141
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
I GM YLH IHRDL A RN+L D+ +K+ DFG++K +
Sbjct: 142 QICEGMAYLHAQH---YIHRDL------AA-----RNVLLDNDRLVKIGDFGLAKAVPEG 187
Query: 318 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI---------------- 359
+ R D+ + APE K ++ DV+SF + L E++
Sbjct: 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
Query: 360 EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 417
G M + + +R P K PA++Y L++ CW + + RPTF +
Sbjct: 248 IGIAQGQMTV-LRLTELLERGERLPRPDKCPAEVY-----HLMKNCWETEASFRPTFENL 301
Query: 418 ITRLESI 424
I L+++
Sbjct: 302 IPILKTV 308
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 7e-52
Identities = 69/321 (21%), Positives = 124/321 (38%), Gaps = 59/321 (18%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRG---------IQVAVKKLGEEVISDDDRVR 195
++I +L F + +GTF R +V +K L + + +
Sbjct: 3 HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK---AHRNYSE 57
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
+F + +++ K+ H ++V G ++V E++ G L +LK+ K + +
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL--------RDDSGNLKVA 306
A +A M++L EN +IH ++ A +NIL + +K++
Sbjct: 118 VAKQLAAAMHFLEENT---LIHGNV------CA-----KNILLIREEDRKTGNPPFIKLS 163
Query: 307 DFGVSKLLTVKE--DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI-EGC 362
D G+S + K+ + +V PE +N + + D +SF L E+ G
Sbjct: 164 DPGISITVLPKDILQERI-------PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216
Query: 363 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
P + + Y R + P A+L LI C + +P RP+FR II L
Sbjct: 217 KPLSALDSQRKLQFYEDRHQLPAPKAAELA-----NLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 423 SINNSINHKRRWKIRTMKCFH 443
S+ R H
Sbjct: 272 SLFTPDLVPRG---SHHHHHH 289
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-51
Identities = 88/320 (27%), Positives = 134/320 (41%), Gaps = 71/320 (22%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A G+ VAVK L +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL +L + H N+V LGA T P +++TEY GDL FL+RK
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 245 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
AL + F+ +A+GM +L IHRDL RNIL
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA-----------RNIL 177
Query: 297 RDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDV 348
K+ DFG+++ + VK + P+ +++APE N Y + DV
Sbjct: 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPV-------KWMAPESIFNCVYTFESDV 230
Query: 349 FSFALILQEMIE--GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECW 404
+S+ + L E+ P M D++ K R P APA++Y ++++ CW
Sbjct: 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY-----DIMKTCW 285
Query: 405 NEKPAKRPTFRQIITRLESI 424
+ P KRPTF+QI+ +E
Sbjct: 286 DADPLKRPTFKQIVQLIEKQ 305
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-51
Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 62/313 (19%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
++ + I + + KG F A + ++VAVK L ++I+ D
Sbjct: 14 KLEDVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI-E 70
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLKR------ 243
F E A +++ HP+V + +G +S M++ ++ GDL AFL
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303
L T VRF +DIA GM YL IHRDL A RN + + +
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDL------AA-----RNCMLAEDMTV 176
Query: 304 KVADFGVSKLLTVKEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALI 354
VADFG+S R + D +++A E + Y DV++F +
Sbjct: 177 CVADFGLS--------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228
Query: 355 LQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKR 411
+ E++ G P+ + E+ R P + ++Y +L+ +CW+ P +R
Sbjct: 229 MWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVY-----DLMYQCWSADPKQR 283
Query: 412 PTFRQIITRLESI 424
P+F + LE+I
Sbjct: 284 PSFTCLRMELENI 296
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-51
Identities = 88/350 (25%), Positives = 137/350 (39%), Gaps = 83/350 (23%)
Query: 124 LLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---- 176
LL++ P+ M + ++ E + +++ +I +G F A G+
Sbjct: 18 LLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYE 75
Query: 177 ---QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK L EE S D + F+ E AL+ + +PN+V+ LG PM ++ EY+
Sbjct: 76 PFTMVAVKMLKEEA-SADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133
Query: 234 KGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHEN 269
GDL FL+ L + + A +A GM YL E
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 329
K +HRDL RN L ++ +K+ADFG+S R + D
Sbjct: 194 K---FVHRDL------AT-----RNCLVGENMVVKIADFGLS--------RNIYSADY-- 229
Query: 330 RYV------------APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKA 376
Y PE Y T+ DV+++ ++L E+ G P+ EV
Sbjct: 230 -YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 288
Query: 377 YAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
P P +LY L+ CW++ PA RP+F I L+ +
Sbjct: 289 VRDGNILACPENCPLELY-----NLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-51
Identities = 74/314 (23%), Positives = 136/314 (43%), Gaps = 69/314 (21%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
E+E+ ++ + E+ +G+F +G+ +VA+K + E S +R
Sbjct: 18 DEWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRER-I 73
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------G 245
F +E +++++ +VV+ LG V+Q P +++ E + +GDL+++L+
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305
S ++ A +IA GM YL+ NK +HRDL RN + + +K+
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDL-----------AARNCMVAEDFTVKI 179
Query: 306 ADFGVSKLLTVKEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFAL 353
DFG++ R + D Y +PE K+ + T DV+SF +
Sbjct: 180 GDFGMT--------RDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228
Query: 354 ILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAK 410
+L E+ P+ + +V + P P L+ EL+ CW P
Sbjct: 229 VLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKM 283
Query: 411 RPTFRQIITRLESI 424
RP+F +II+ ++
Sbjct: 284 RPSFLEIISSIKEE 297
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-51
Identities = 85/313 (27%), Positives = 133/313 (42%), Gaps = 63/313 (20%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
EI + F E+ + F G VA+K L ++ R FR
Sbjct: 5 EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLR-EEFR 60
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--------------- 243
E L +++HPNVV LG VT+ P+ ++ Y GDL FL
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 244 -KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302
K AL+P V IA GM YL + ++H+DL RN+L D N
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDL------AT-----RNVLVYDKLN 166
Query: 303 LKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 356
+K++D G+ + + + + L R++APE ++ D++S+ ++L
Sbjct: 167 VKISDLGLFREVYAADYYKLLGNSLL-----PIRWMAPEAIMYGKFSIDSDIWSYGVVLW 221
Query: 357 EMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
E+ G P+ + +V + RQ P PA +Y L+ ECWNE P++RP
Sbjct: 222 EVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVY-----ALMIECWNEFPSRRPR 276
Query: 414 FRQIITRLESINN 426
F+ I +RL + N
Sbjct: 277 FKDIHSRLRAWGN 289
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 9e-51
Identities = 80/325 (24%), Positives = 132/325 (40%), Gaps = 70/325 (21%)
Query: 141 HAREVPEY-------EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKL 183
H E P+Y I ++ E+ +G F LA + VAVK L
Sbjct: 22 HIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79
Query: 184 GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
E S+ R + F+ E LL ++H ++V+F G T+ P+++V EY+ GDL FL+
Sbjct: 80 KEA--SESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRS 136
Query: 244 ---------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
G L + A +A GM YL +HRDL
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDL--------- 184
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEY 342
RN L +K+ DFG+S+ + V L R++ PE ++
Sbjct: 185 --ATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-----PIRWMPPESILYRKF 237
Query: 343 DTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKEL 399
T+ DV+SF ++L E+ G P+ + E + P P ++Y +
Sbjct: 238 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVY-----AI 292
Query: 400 IEECWNEKPAKRPTFRQIITRLESI 424
+ CW +P +R + + + RL+++
Sbjct: 293 MRGCWQREPQQRHSIKDVHARLQAL 317
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-50
Identities = 64/270 (23%), Positives = 122/270 (45%), Gaps = 36/270 (13%)
Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
KG +I + I VA+K+L E + + DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ ++T+ +P G L ++ + K + + + + IA+GMNYL + + ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDL--- 143
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVF 337
A RN+L ++K+ DFG++KLL +E +++A E
Sbjct: 144 ---AA-----RNVLVKTPQHVKITDFGLAKLLGAEEK----EYHAEGGKVPIKWMALESI 191
Query: 338 KNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYAR 394
+ Y + DV+S+ + + E++ G P+ +E+ +R P +Y
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY-- 249
Query: 395 GLKELIEECWNEKPAKRPTFRQIITRLESI 424
++ +CW RP FR++I +
Sbjct: 250 ---MIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-50
Identities = 90/323 (27%), Positives = 145/323 (44%), Gaps = 66/323 (20%)
Query: 138 HVKHAREVPEY----EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEE 186
H H + P+ +D +++ F + I +G F + A + + A+K++ E
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 187 VISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK- 244
S DD R F EL +L K+ HPN++ LGA + + EY P G+L FL++
Sbjct: 64 A-SKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121
Query: 245 ---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
L + FA D+ARGM+YL + + IHRDL A
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDL------AA-- 170
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDR-----PLTCQDTSCRYVAPEVFKNEEYDT 344
RNIL ++ K+ADFG+S+ V + P+ R++A E Y T
Sbjct: 171 ---RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-------RWMAIESLNYSVYTT 220
Query: 345 KVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIE 401
DV+S+ ++L E++ G P+ E+ + R P ++Y +L+
Sbjct: 221 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVY-----DLMR 275
Query: 402 ECWNEKPAKRPTFRQIITRLESI 424
+CW EKP +RP+F QI+ L +
Sbjct: 276 QCWREKPYERPSFAQILVSLNRM 298
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 83/325 (25%), Positives = 135/325 (41%), Gaps = 77/325 (23%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
P++E L + +G F + A + VAVK L E + +R
Sbjct: 16 PKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELR 71
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------- 244
E +L+++ HP+V++ GA +Q P++++ EY G LR FL+
Sbjct: 72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
AL + FA I++GM YL E K ++HRDL A
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL------AA---- 178
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD----TSC-----RYVAPEVFKNEEY 342
RNIL + +K++DFG+S R + +D S +++A E + Y
Sbjct: 179 -RNILVAEGRKMKISDFGLS--------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229
Query: 343 DTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKEL 399
T+ DV+SF ++L E++ G P+ + R P ++Y L
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY-----RL 284
Query: 400 IEECWNEKPAKRPTFRQIITRLESI 424
+ +CW ++P KRP F I LE +
Sbjct: 285 MLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-50
Identities = 78/317 (24%), Positives = 125/317 (39%), Gaps = 76/317 (23%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
I ++ E+ +G F LA + VAVK L + + R + F+
Sbjct: 11 HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR-KDFQ 65
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---------------- 242
E LL ++H ++V+F G P+++V EY+ GDL FL+
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302
KG L S + A IA GM YL +HRDL RN L +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQH---FVHRDL-----------ATRNCLVGANLL 171
Query: 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFS 350
+K+ DFG+S R + D Y PE ++ T+ DV+S
Sbjct: 172 VKIGDFGMS--------RDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 220
Query: 351 FALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEK 407
F +IL E+ G P+ + EV + + P P ++Y +++ CW +
Sbjct: 221 FGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY-----DVMLGCWQRE 275
Query: 408 PAKRPTFRQIITRLESI 424
P +R ++I L ++
Sbjct: 276 PQQRLNIKEIYKILHAL 292
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 4e-50
Identities = 78/314 (24%), Positives = 133/314 (42%), Gaps = 63/314 (20%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A G+ +VAVK L + D
Sbjct: 39 EKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKE 94
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
A EL ++ + +H N+V LGA T P++++TEY GDL FL+RK
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300
+ F+ +A+GM +L IHRD+ RN+L +
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAA-----------RNVLLTNG 200
Query: 301 GNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354
K+ DFG+++ + VK + L +++APE + Y + DV+S+ ++
Sbjct: 201 HVAKIGDFGLARDIMNDSNYIVKGNARLP-----VKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 355 LQEMIE--GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAK 410
L E+ P + +++ K + P AP +Y +++ CW +P
Sbjct: 256 LWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIY-----SIMQACWALEPTH 310
Query: 411 RPTFRQIITRLESI 424
RPTF+QI + L+
Sbjct: 311 RPTFQQICSFLQEQ 324
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-50
Identities = 84/334 (25%), Positives = 148/334 (44%), Gaps = 70/334 (20%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------QV 178
P++A + E P++E +L + +G F ++A GI V
Sbjct: 13 DPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTV 70
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ ++ D E+ +++ I +H N++ LGA TQ P+ ++ EY KG+L
Sbjct: 71 AVKMLKDDA-TEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 238 RAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
R +L+ + + V +ARGM YL K IHRDL
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL-- 183
Query: 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVA 333
A RN+L ++ +K+ADFG+++ + + P+ +++A
Sbjct: 184 ----AA-----RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWMA 227
Query: 334 PEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAK 390
PE + Y + DV+SF +++ E+ G P+ E+ K R P +
Sbjct: 228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNE 287
Query: 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
LY ++ +CW+ P++RPTF+Q++ L+ I
Sbjct: 288 LY-----MMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-50
Identities = 88/350 (25%), Positives = 152/350 (43%), Gaps = 70/350 (20%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
++ + I E + ++A + E P +E+ L + +G F +LA
Sbjct: 31 HHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGAFGQVVLA 88
Query: 172 FWRGI---------QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221
G+ +VAVK L + ++ D E+ +++ I +H N++ LGA TQ
Sbjct: 89 EAIGLDKDKPNRVTKVAVKMLKSDA-TEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQ 146
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNY 265
P+ ++ EY KG+LR +L+ + L V A +ARGM Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL------TVKED 319
L K IHRDL A RN+L + +K+ADFG+++ + +
Sbjct: 207 LASKK---CIHRDL------AA-----RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 320 R--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKA 376
P+ +++APE + Y + DV+SF ++L E+ G P+ E+ K
Sbjct: 253 GRLPV-------KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 377 YAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
R P +LY ++ +CW+ P++RPTF+Q++ L+ I
Sbjct: 306 LKEGHRMDKPSNCTNELY-----MMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-50
Identities = 82/309 (26%), Positives = 126/309 (40%), Gaps = 61/309 (19%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
E+ + + G F G+ QVAVK L E S+ D
Sbjct: 24 LKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-LD 79
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALKP 249
F E ++ K H N+V+ +G QS P I+ E + GDL++FL+ +L
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN---LKVA 306
+ A DIA G YL EN IHRD+ RN L G K+
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDI-----------AARNCLLTCPGPGRVAKIG 185
Query: 307 DFGVSKLL-----TVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 358
DFG+++ + K P+ +++ PE F + +K D +SF ++L E+
Sbjct: 186 DFGMARDIYRASYYRKGGCAMLPV-------KWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 359 I-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 415
G P+ K + EV + + R PP P +Y ++ +CW +P RP F
Sbjct: 239 FSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRPNFA 293
Query: 416 QIITRLESI 424
I+ R+E
Sbjct: 294 IILERIEYC 302
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-49
Identities = 83/335 (24%), Positives = 148/335 (44%), Gaps = 70/335 (20%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------Q 177
P++A + E P++E +L + +G F ++A GI
Sbjct: 58 DTPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVT 115
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK L ++ + + + E+ +++ I +H N++ LGA TQ P+ ++ EY KG+
Sbjct: 116 VAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173
Query: 237 LRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
LR +L+ + + V +ARGM YL K IHRDL
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL- 229
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYV 332
A RN+L ++ +K+ADFG+++ + + P+ +++
Sbjct: 230 -----AA-----RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWM 272
Query: 333 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPA 389
APE + Y + DV+SF +++ E+ G P+ E+ K R P
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTN 332
Query: 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+LY ++ +CW+ P++RPTF+Q++ L+ I
Sbjct: 333 ELY-----MMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-49
Identities = 79/326 (24%), Positives = 127/326 (38%), Gaps = 78/326 (23%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E L+F + G F + A GI QVAVK L E+ +D
Sbjct: 38 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 93
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL ++ ++ H N+V LGA T S P+ ++ EY GDL +L+ K
Sbjct: 94 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
L + FA +A+GM +L +HRDL
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA---------- 200
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TSC----RYVAPEVFKNEEY 342
RN+L +K+ DFG++ R + + +++APE Y
Sbjct: 201 -RNVLVTHGKVVKICDFGLA--------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251
Query: 343 DTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKE 398
K DV+S+ ++L E+ G P+ + D K + PF A ++Y
Sbjct: 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY-----I 306
Query: 399 LIEECWNEKPAKRPTFRQIITRLESI 424
+++ CW KRP+F + + L
Sbjct: 307 IMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-49
Identities = 69/296 (23%), Positives = 135/296 (45%), Gaps = 46/296 (15%)
Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
+YEI ++ + ++ +G ++ + VA+K + D F
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQ 440
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL RK +L ++ + +A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL---- 314
++ + YL + +HRD+ A RN+L + +K+ DFG+S+ +
Sbjct: 500 LSTALAYLESKR---FVHRDI------AA-----RNVLVSSNDCVKLGDFGLSRYMEDST 545
Query: 315 ---TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHD 370
K P+ +++APE + + DV+ F + + E++ G PF +
Sbjct: 546 YYKASKGKLPI-------KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598
Query: 371 NEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
N+V +R P P LY L+ +CW P++RP F ++ +L +I
Sbjct: 599 NDVIGRIENGERLPMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 7e-49
Identities = 81/311 (26%), Positives = 123/311 (39%), Gaps = 63/311 (20%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
E+ + + G F G+ QVAVK L E S+ D
Sbjct: 64 DLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-L 119
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALK 248
F E ++ K H N+V+ +G QS P I+ E + GDL++FL+ +L
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 249 PSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN---LKV 305
+ A DIA G YL EN IHRD+ RN L G K+
Sbjct: 180 MLDLLHVARDIACGCQYLEENH---FIHRDI-----------AARNCLLTCPGPGRVAKI 225
Query: 306 ADFGVSKLLTVKEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQ 356
DFG++ R + +++ PE F + +K D +SF ++L
Sbjct: 226 GDFGMA--------RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 277
Query: 357 EMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
E+ G P+ K + EV + + R PP P +Y ++ +CW +P RP
Sbjct: 278 EIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRPN 332
Query: 414 FRQIITRLESI 424
F I+ R+E
Sbjct: 333 FAIILERIEYC 343
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 85/318 (26%), Positives = 138/318 (43%), Gaps = 70/318 (22%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
++E L + +G F I A GI VAVK L E + RA
Sbjct: 21 KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 76
Query: 197 FRDELALLQKI-RHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKR----------- 243
EL +L I H NVV LGA T+ P+M++ E+ G+L +L+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 244 -----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
K L + ++ +A+GM +L K IHRDL A RNIL
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL------AA-----RNILLS 182
Query: 299 DSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 350
+ +K+ DFG+++ + K D PL +++APE + Y + DV+S
Sbjct: 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVYTIQSDVWS 235
Query: 351 FALILQEMIE-GCPPF-TMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNE 406
F ++L E+ G P+ +K D E + R P ++Y + + +CW+
Sbjct: 236 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-----QTMLDCWHG 290
Query: 407 KPAKRPTFRQIITRLESI 424
+P++RPTF +++ L ++
Sbjct: 291 EPSQRPTFSELVEHLGNL 308
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-48
Identities = 68/278 (24%), Positives = 129/278 (46%), Gaps = 28/278 (10%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ +EI +G+F ++VA +L + ++ +R + F++E +
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEM 78
Query: 204 LQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
L+ ++HPN+V+F + V +++VTE + G L+ +LKR +K + I
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD-DSGNLKVADFGVSKLLTVKE 318
+G+ +LH P PIIHRDL+ D NI +G++K+ D G++ L
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLK-CD----------NIFITGPTGSVKIGDLGLATLKRASF 186
Query: 319 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378
+ T ++APE+++ E+YD VDV++F + + EM P++ +
Sbjct: 187 AK--AVIGTPE-FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
Query: 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
P + K+ +KE+IE C + +R + +
Sbjct: 243 TSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 67/299 (22%), Positives = 122/299 (40%), Gaps = 36/299 (12%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 328 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 384
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E ++ ++ +P +V+ +G + +M+V E G L FL ++ + S
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
++ GM YL E +HR+L A RN+L + K++DFG+SK L
Sbjct: 444 QVSMGMKYLEEKN---FVHRNL------AA-----RNVLLVNRHYAKISDFGLSKALGAD 489
Query: 318 EDRPLTCQDTS--CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVP 374
+ ++ APE ++ ++ DV+S+ + + E + G P+ EV
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549
Query: 375 KAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 431
+R P + P +LY L+ +CW K RP F + R+ + S+ K
Sbjct: 550 AFIEQGKRMECPPECPPELY-----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-46
Identities = 60/299 (20%), Positives = 128/299 (42%), Gaps = 24/299 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G Q +K++ +S +R + R E+A+L ++HPN+VQ+ + ++ + IV +Y
Sbjct: 49 GRQYVIKEINISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 235 GDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
GDL + + + + + I + ++H+ K I+HRD++
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQ---------- 154
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 352
NI G +++ DFG++++L + C T Y++PE+ +N+ Y+ K D+++
Sbjct: 155 -NIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY-YLSPEICENKPYNNKSDIWALG 212
Query: 353 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 412
+L E+ F + + PP Y+ L+ L+ + + P RP
Sbjct: 213 CVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV--SLH-YSYDLRSLVSQLFKRNPRDRP 269
Query: 413 TFRQIITR---LESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSSRSKSSCSTSS 468
+ I+ + + I ++ + + +K F + S ++ S +
Sbjct: 270 SVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQ 328
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-45
Identities = 61/265 (23%), Positives = 113/265 (42%), Gaps = 24/265 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +G F A G+ VA+KK+ + D E+ LL+++ HPNV+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPV 272
+ + + + IV E GDL +K + T ++ + + + ++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 332
++HRD++P+ N+ +G +K+ D G+ + + K + T Y+
Sbjct: 157 -VMHRDIKPA-----------NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YM 203
Query: 333 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 392
+PE Y+ K D++S +L EM PF N Q P+ Y
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 393 ARGLKELIEECWNEKPAKRPTFRQI 417
+ L++L+ C N P KRP +
Sbjct: 264 SEELRQLVNMCINPDPEKRPDVTYV 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 53/268 (19%), Positives = 90/268 (33%), Gaps = 29/268 (10%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
F + G++ + G AVK+ DR R + + + +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHEN 269
V+ A + + + TE L+ + GA L + + D + +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 329
++H D++P+ NI G K+ DFG+ L +
Sbjct: 177 G---LVHLDVKPA-----------NIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGD-P 220
Query: 330 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389
RY+APE+ Y T DVFS L + E+ + P F A
Sbjct: 221 RYMAPELL-QGSYGTAADVFSLGLTILEVACNMELP--HGGEGWQQLRQGYLPPEFTAG- 276
Query: 390 KLYARGLKELIEECWNEKPAKRPTFRQI 417
+ L+ ++ P R T +
Sbjct: 277 --LSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 59/252 (23%), Positives = 111/252 (44%), Gaps = 24/252 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYL 232
G + K+L +++ ++ E+ LL++++HPN+V++ + ++ + IV EY
Sbjct: 31 GKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 233 PKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVP--IIHRDLEPSDLYV 286
GDL + + + + L +R + + H ++HRDL+P+
Sbjct: 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA---- 145
Query: 287 AYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 346
N+ D N+K+ DFG++++L T T Y++PE Y+ K
Sbjct: 146 -------NVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY-YMSPEQMNRMSYNEKS 197
Query: 347 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 406
D++S +L E+ PPFT E+ + P + Y+ L E+I N
Sbjct: 198 DIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--PYR-YSDELNEIITRMLNL 254
Query: 407 KPAKRPTFRQII 418
K RP+ +I+
Sbjct: 255 KDYHRPSVEEIL 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-43
Identities = 71/314 (22%), Positives = 127/314 (40%), Gaps = 61/314 (19%)
Query: 147 EYEIDPHEL-DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
+ +D DF I G F A R G +K++ + +A R E
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAER-E 54
Query: 201 LALLQKIRHPNVVQFLGA----------------VTQSSPMMIVTEYLPKGDLRAFLKRK 244
+ L K+ H N+V + G +++ + I E+ KG L +++++
Sbjct: 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 245 GA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302
L A+ I +G++Y+H K +I+RDL+PS NI D+
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPS-----------NIFLVDTKQ 160
Query: 303 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 359
+K+ DFG+ L R S RY++PE +++Y +VD+++ LIL E++
Sbjct: 161 VKIGDFGLVTSLKNDGKR-----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
Query: 360 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 419
C E K + + ++ + K L+++ ++KP RP +I+
Sbjct: 216 HVCDTA-----FETSKFFTDLRDGIIS---DIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267
Query: 420 RLESINNSINHKRR 433
L S R
Sbjct: 268 TLTVWKKSPEKNER 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 57/280 (20%), Positives = 107/280 (38%), Gaps = 32/280 (11%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
+F +I G F R G A+K+ + + D A R+ A +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYL 266
+VV++ A + M+I EY G L + K + L + RG+ Y+
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 267 HENKPVPIIHRDLEPS--------DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
H ++H D++PS A + D + + K+ D G ++
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--- 185
Query: 319 DRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377
P + R++A EV + N + K D+F+ AL + P ++ ++ +
Sbjct: 186 -SPQVEEGD-SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP--RNGDQW---H 238
Query: 378 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 417
RQ + P ++ EL++ + P +RP+ +
Sbjct: 239 EIRQGRLPRIPQV-LSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-42
Identities = 67/299 (22%), Positives = 110/299 (36%), Gaps = 59/299 (19%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + +G F + A A+KK+ +++ E+ LL + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILS-EVMLLASLNHQ 62
Query: 211 NVVQFLGA-------------VTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFA 256
VV++ A V + S + I EY G L + + + R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
I ++Y+H IIHRDL+P NI D+S N+K+ DFG++K +
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPM-----------NIFIDESRNVKIGDFGLAKNVHR 168
Query: 317 KEDRPLTCQD----------TSC---RYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGC 362
D ++ YVA EV Y+ K+D++S +I EMI
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--Y 226
Query: 363 PPFTMKHDNEVPKAYAARQRPPFKAPAKL---YARGLKELIEECWNEKPAKRPTFRQII 418
P T + + + P + K++I + P KRP R ++
Sbjct: 227 PFSTGMERVNI---LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-41
Identities = 56/270 (20%), Positives = 99/270 (36%), Gaps = 47/270 (17%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA------------VTQS 222
A+K++ + R + R E+ L K+ HP +V++ A +
Sbjct: 30 DCNYAIKRIRLPN-RELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDL 279
+ I + K +L+ ++ + ++ S + L IA + +LH ++HRDL
Sbjct: 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDL 144
Query: 280 EPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS----------- 328
+PS NI +KV DFG+ + E+
Sbjct: 145 KPS-----------NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193
Query: 329 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388
Y++PE Y KVD+FS LIL E++ P T E + + F
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFST---QMERVRTLTDVRNLKFPPL 248
Query: 389 AKLYARGLKELIEECWNEKPAKRPTFRQII 418
++++ + P +RP II
Sbjct: 249 FTQKYPCEYVMVQDMLSPSPMERPEAINII 278
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 66/286 (23%), Positives = 121/286 (42%), Gaps = 31/286 (10%)
Query: 142 AREVPEYEIDPHEL-DFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVR 195
A+E+PE +DP + + KG F I A K + + ++ +
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
E+++ + + H +VV F G + + +V E + L KR+ AL A +
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315
I G YLH N+ +IHRDL+ N+ ++ +K+ DFG++ +
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLG-----------NLFLNEDLEVKIGDFGLATKVE 166
Query: 316 VKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372
+R + C Y+APEV + + +VDV+S I+ ++ G PPF +
Sbjct: 167 YDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSC 219
Query: 373 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ + Y ++ + P + LI++ P RPT +++
Sbjct: 220 LKETYLRIKKNEYSIPKHI-NPVAASLIQKMLQTDPTARPTINELL 264
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 60/247 (24%), Positives = 110/247 (44%), Gaps = 27/247 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+A+K L + + R E+ + +RHPN+++ G ++ + ++ EY P
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G + L++ + ++A ++Y H + +IHRD++P N
Sbjct: 94 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPE-----------N 139
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSF 351
+L +G LK+ADFG S P + + C Y+ PE+ + +D KVD++S
Sbjct: 140 LLLGSAGELKIADFGWSVHA------PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193
Query: 352 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
++ E + G PPF N + Y R F P + G ++LI P++R
Sbjct: 194 GVLCYEFLVGKPPF---EANTYQETYKRISRVEFTFPDFV-TEGARDLISRLLKHNPSQR 249
Query: 412 PTFRQII 418
P R+++
Sbjct: 250 PMLREVL 256
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-41
Identities = 52/272 (19%), Positives = 102/272 (37%), Gaps = 37/272 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----IVTE 230
G A+K++ + + + E + + HPN+++ + + ++
Sbjct: 54 GHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYV 286
+ +G L ++R L + L I RG+ +H HRDL+P+
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPT---- 163
Query: 287 AYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC--------QDTSCRYVAPEVFK 338
NIL D G + D G + + Q + Y APE+F
Sbjct: 164 -------NILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216
Query: 339 NEEY---DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 395
+ + D + DV+S +L M+ G P+ M A A + + + ++
Sbjct: 217 VQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR-HSSA 275
Query: 396 LKELIEECWNEKPAKRPTFRQIITRLESINNS 427
L +L+ P +RP ++++LE++
Sbjct: 276 LWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-40
Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 37/280 (13%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
+YE T+ + +G+F + G Q AVKK+ EV + E
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------E 100
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
L + P +V GAV + + I E L G L +K+ G L A+ +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 261 RGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL-KVADFGVSKLLTVKED 319
G+ YLH + I+H D++ N+L G+ + DFG + L
Sbjct: 161 EGLEYLHTRR---ILHGDVKAD-----------NVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 320 RPLTCQDTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375
++APEV + D KVD++S ++ M+ GC P+T P
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT--QYFRGPL 264
Query: 376 AY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
A+ P + P A + I+E ++P R +
Sbjct: 265 CLKIASEPPPIREIPPSC-APLTAQAIQEGLRKEPVHRAS 303
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 56/247 (22%), Positives = 106/247 (42%), Gaps = 25/247 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
A K + + ++ + E+++ + + H +VV F G + + +V E +
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
L KR+ AL A + I G YLH N+ +IHRDL+ N
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLG-----------N 171
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSF 351
+ ++ +K+ DFG++ + +R + C Y+APEV + + +VDV+S
Sbjct: 172 LFLNEDLEVKIGDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227
Query: 352 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
I+ ++ G PPF + + + Y ++ + P + LI++ P R
Sbjct: 228 GCIMYTLLVGKPPF---ETSCLKETYLRIKKNEYSIPKHI-NPVAASLIQKMLQTDPTAR 283
Query: 412 PTFRQII 418
PT +++
Sbjct: 284 PTINELL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 55/260 (21%), Positives = 113/260 (43%), Gaps = 38/260 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 33 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 90
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+
Sbjct: 91 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPA---------- 137
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN---------- 339
N L D G LK+ DFG++ + + D +D+ Y+ PE K+
Sbjct: 138 -NFLIVD-GMLKLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193
Query: 340 -EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLK 397
+ K DV+S IL M G PF + N++ K +A + P + L+
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQ 251
Query: 398 ELIEECWNEKPAKRPTFRQI 417
++++ C P +R + ++
Sbjct: 252 DVLKCCLKRDPKQRISIPEL 271
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 60/246 (24%), Positives = 108/246 (43%), Gaps = 27/246 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+A+K L + + + R E+ + +RHPN+++ + ++ E+ P+
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G+L L++ G + F ++A ++Y HE K +IHRD++P N
Sbjct: 99 GELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPE-----------N 144
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSF 351
+L G LK+ADFG S P + T C Y+ PE+ + + +D KVD++
Sbjct: 145 LLMGYKGELKIADFGWSVH------APSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCA 198
Query: 352 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
++ E + G PPF + + K P L + G K+LI + P +R
Sbjct: 199 GVLCYEFLVGMPPF---DSPSHTETHRRIVNVDLKFPPFL-SDGSKDLISKLLRYHPPQR 254
Query: 412 PTFRQI 417
+ +
Sbjct: 255 LPLKGV 260
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 55/260 (21%), Positives = 113/260 (43%), Gaps = 38/260 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 52 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 109
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+
Sbjct: 110 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPA---------- 156
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN---------- 339
N L D G LK+ DFG++ + + D +D+ Y+ PE K+
Sbjct: 157 -NFLIVD-GMLKLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212
Query: 340 -EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLK 397
+ K DV+S IL M G PF + N++ K +A + P + L+
Sbjct: 213 KSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQ 270
Query: 398 ELIEECWNEKPAKRPTFRQI 417
++++ C P +R + ++
Sbjct: 271 DVLKCCLKRDPKQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 55/260 (21%), Positives = 113/260 (43%), Gaps = 38/260 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 80 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+
Sbjct: 138 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPA---------- 184
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN---------- 339
N L D G LK+ DFG++ + + D +D+ Y+ PE K+
Sbjct: 185 -NFLIVD-GMLKLIDFGIANQM--QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240
Query: 340 -EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLK 397
+ K DV+S IL M G PF + N++ K +A + P + L+
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQ 298
Query: 398 ELIEECWNEKPAKRPTFRQI 417
++++ C P +R + ++
Sbjct: 299 DVLKCCLKRDPKQRISIPEL 318
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 74/266 (27%), Positives = 118/266 (44%), Gaps = 38/266 (14%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ KGT+ +++A+K E+ D + +E+AL + ++H N+VQ+L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIK----EIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAV--RFALDIARGMNYLHENKPVP 273
G+ +++ + I E +P G L A L+ K G LK + + I G+ YLH+N+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 274 IIHRDLEPSDLYVAYWQNDRNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 332
I+HRD++ N+L + SG LK++DFG SK L T T Y+
Sbjct: 143 IVHRDIKGD-----------NVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ-YM 190
Query: 333 APEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP---KAYAARQRPPFKA 387
APE+ Y D++S + EM G PPF + K + P
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY-ELGEPQAAMFKVGMFKVHPEI-- 247
Query: 388 PAKLYARGLKELIEECWNEKPAKRPT 413
P + A K I +C+ P KR
Sbjct: 248 PESMSAEA-KAFILKCFEPDPDKRAC 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 64/248 (25%), Positives = 113/248 (45%), Gaps = 28/248 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K + + ++ + FR E+ +++ + HPN+V+ + + ++ EY
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G++ +L G +K A I + Y H+ + I+HRDL+ N
Sbjct: 99 GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKA-----------EN 144
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFS 350
+L D N+K+ADFG S L D C Y APE+F+ ++YD +VDV+S
Sbjct: 145 LLLDADMNIKIADFGFSNE--FTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWS 199
Query: 351 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 410
+IL ++ G PF + + R ++ P + + + L++ P K
Sbjct: 200 LGVILYTLVSGSLPF---DGQNLKELRERVLRGKYRIPFYM-STDCENLLKRFLVLNPIK 255
Query: 411 RPTFRQII 418
R T QI+
Sbjct: 256 RGTLEQIM 263
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-38
Identities = 59/248 (23%), Positives = 115/248 (46%), Gaps = 26/248 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++VA+K + ++ + V+ ++E+ + +++HP++++ S+ + +V E
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G++ +LK R + A F I GM YLH + I+HRDL S
Sbjct: 96 GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLS----------- 141
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFS 350
N+L + N+K+ADFG++ L + ++ T C Y++PE+ + + DV+S
Sbjct: 142 NLLLTRNMNIKIADFGLATQLKMPHEK----HYTLCGTPNYISPEIATRSAHGLESDVWS 197
Query: 351 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 410
+ ++ G PPF + V ++ P+ L + K+LI + PA
Sbjct: 198 LGCMFYTLLIGRPPF---DTDTVKNTLNKVVLADYEMPSFL-SIEAKDLIHQLLRRNPAD 253
Query: 411 RPTFRQII 418
R + ++
Sbjct: 254 RLSLSSVL 261
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 65/309 (21%), Positives = 119/309 (38%), Gaps = 51/309 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--------M 225
G + A+K+L + +++++ RA E+ ++K+ HPN+VQF A +
Sbjct: 53 GREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 226 MIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSD 283
+++TE + K +G L T ++ R + ++H KP PIIHRDL+
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVE- 167
Query: 284 LYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----------TSCRYV 332
N+L + G +K+ DFG + ++ D + Q T+ Y
Sbjct: 168 ----------NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYR 217
Query: 333 APEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389
PE+ N K D+++ IL + PF D + + P
Sbjct: 218 TPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF---EDGAKLRIVNGKYSIPPHDT- 273
Query: 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAML 449
LI P +R + +++ +L+ I + N + I + LE
Sbjct: 274 --QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL-----LEQNG 326
Query: 450 KKDHSSPSS 458
++ S
Sbjct: 327 GYGSATLSR 335
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-36
Identities = 54/314 (17%), Positives = 94/314 (29%), Gaps = 78/314 (24%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
G A+K V E +L+K+ H N+V+ +++ + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
P G L L+ L S + D+ GMN+L EN I+HR+++P
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPG------- 141
Query: 290 QNDRNILR----DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK---- 338
NI+R D K+ DFG ++ L +D + Y+ P++++
Sbjct: 142 ----NIMRVIGEDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVL 192
Query: 339 ----NEEYDTKVDVFSFALILQEMIEGCPPF----------------TMKHDNEVPKAYA 378
++Y VD++S + G PF +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 379 ARQRPPFKAPAKLYARG---------LKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429
+ P + L ++ K F Q
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF----------FA 302
Query: 430 HKRRWKIRTMKCFH 443
I H
Sbjct: 303 ET--SDILHRGNSH 314
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-36
Identities = 71/297 (23%), Positives = 115/297 (38%), Gaps = 43/297 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL------GAVTQSSPMMIV 228
G QVA+K+ + +S +R R E+ +++K+ HPNVV + + ++
Sbjct: 39 GEQVAIKQC-RQELSPKNRERWCL-EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 229 TEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285
EY GDLR +L + LK DI+ + YLHEN+ IIHRDL+P
Sbjct: 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPE--- 150
Query: 286 VAYWQNDRNILRDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN 339
NI+ K+ D G +K L + T +Y+APE+ +
Sbjct: 151 --------NIVLQPGPQRLIHKIIDLGYAKEL--DQGELCT---EFVGTLQYLAPELLEQ 197
Query: 340 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 399
++Y VD +SF + E I G PF N P + + R +Y +
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRPF---LPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 400 IEECWNEKPAKRPTFRQI-ITRLESINNSINHKRRWK---IRTMKCFHNLEAMLKKD 452
P + R + ++R + CF L+++L
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 71/249 (28%), Positives = 116/249 (46%), Gaps = 29/249 (11%)
Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
G +VAVK L +++ S D + R E+ L+ RHP++++ ++ + +V EY+
Sbjct: 36 GHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G+L ++ + G ++ A R I ++Y H + ++HRDL+P
Sbjct: 95 GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKP-----------E 140
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVF 349
N+L D N K+ADFG+S ++ + L TSC Y APEV Y +VD++
Sbjct: 141 NVLLDAHMNAKIADFGLSNMM--SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIW 195
Query: 350 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 409
S +IL ++ G PF D VP + + F P L R + L+ P
Sbjct: 196 SCGVILYALLCGTLPF---DDEHVPTLFKKIRGGVFYIPEYL-NRSVATLLMHMLQVDPL 251
Query: 410 KRPTFRQII 418
KR T + I
Sbjct: 252 KRATIKDIR 260
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 53/297 (17%), Positives = 93/297 (31%), Gaps = 66/297 (22%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
G A+K V E +L+K+ H N+V+ +++ + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
P G L L+ L S + D+ GMN+L EN I+HR+++P
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPG------- 141
Query: 290 QNDRNILR----DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK---- 338
NI+R D K+ DFG ++ L +D + Y+ P++++
Sbjct: 142 ----NIMRVIGEDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVL 192
Query: 339 ----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----------------VPKAYA 378
++Y VD++S + G PF
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 379 ARQRPPFKAPAKL---------YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426
+ P + L ++ K F Q I +
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 88/324 (27%), Positives = 142/324 (43%), Gaps = 47/324 (14%)
Query: 134 MAPMHVKHA-REVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV 187
MA V+ + + DP EL FT +I KG+F F VA+K + E
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE- 58
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
+D + + E+ +L + P V ++ G+ + + + I+ EYL G L+
Sbjct: 59 -EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 248 KPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305
+ A R L +G++YLH K IHRD++ + N+L + G +K+
Sbjct: 118 ETQIATILREIL---KGLDYLHSEK---KIHRDIKAA-----------NVLLSEHGEVKL 160
Query: 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
ADFGV+ LT + + T T ++APEV K YD+K D++S + E+ G PP
Sbjct: 161 ADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219
Query: 366 TMKHDNEVPKAYAARQRPPFKAPAKL---YARGLKELIEECWNEKPAKRPT--------- 413
+ H P P L Y++ LKE +E C N++P+ RPT
Sbjct: 220 SELH------PMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273
Query: 414 FRQIITRLESINNSINHKRRWKIR 437
+ + + I+ +RWK
Sbjct: 274 ILRNAKKTSYLTELIDRYKRWKAE 297
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-35
Identities = 49/253 (19%), Positives = 90/253 (35%), Gaps = 33/253 (13%)
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
+ + +S + A ++ + N V L + + I + K +L+
Sbjct: 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150
Query: 240 FLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
++ R+ +L+ + + IA + +LH ++HRDL+PS NI
Sbjct: 151 WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPS-----------NIF 196
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-----------YVAPEVFKNEEYDTK 345
+KV DFG+ + E+ Y++PE Y K
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 346 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 405
VD+FS LIL E++ T E + + F ++++ +
Sbjct: 257 VDIFSLGLILFELL--YSFST---QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLS 311
Query: 406 EKPAKRPTFRQII 418
P +RP II
Sbjct: 312 PSPTERPEATDII 324
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-34
Identities = 66/298 (22%), Positives = 127/298 (42%), Gaps = 34/298 (11%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP + +T +I +G + G +VA++++ + + +E+ +++
Sbjct: 17 DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+ ++PN+V +L + + +V EYL G L + + A + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 325
LH N+ +IHRD++ NIL G++K+ DFG +T ++ + T
Sbjct: 132 LHSNQ---VIHRDIKSD-----------NILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 326 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385
T ++APEV + Y KVD++S ++ EMIEG PP+ ++ A P
Sbjct: 178 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 386 KAPAKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWK 435
+ P K + ++ + C KR + F +I L S+ I +
Sbjct: 237 QNPEK-LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 62/251 (24%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK + + + + ++ + E+ + + + H NVV+F G + + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G+L ++ + A RF + G+ YLH I HRD++P
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKP-----------E 134
Query: 294 NILRDDSGNLKVADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDV 348
N+L D+ NLK++DFG++ + +R L + C YVAPE+ K E+ VDV
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 349 FSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY-ARGLKELIEECWNEK 407
+S ++L M+ G P+ D+ + Y+ + L+ + E
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN 249
Query: 408 PAKRPTFRQII 418
P+ R T I
Sbjct: 250 PSARITIPDIK 260
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 69/248 (27%), Positives = 118/248 (47%), Gaps = 28/248 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+VA+K + +++ D E++ L+ +RHP++++ +T + +++V EY
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G+L ++ K + RF I + Y H +K I+HRDL+P N
Sbjct: 93 GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPE-----------N 138
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFS 350
+L DD+ N+K+ADFG+S ++ + L TSC Y APEV + Y +VDV+S
Sbjct: 139 LLLDDNLNVKIADFGLSNIM--TDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWS 193
Query: 351 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 410
++L M+ G PF D +P + + P L + G + LI P +
Sbjct: 194 CGIVLYVMLVGRLPF---DDEFIPNLFKKVNSCVYVMPDFL-SPGAQSLIRRMIVADPMQ 249
Query: 411 RPTFRQII 418
R T ++I
Sbjct: 250 RITIQEIR 257
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 59/301 (19%), Positives = 107/301 (35%), Gaps = 69/301 (22%)
Query: 165 KGTF---ILAFWRGIQVAVKKL--------------GEEVISDDDRVRAFRDELALLQKI 207
+G F IL A+KK + IS + F++EL ++ I
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR------ 261
++ + G +T + I+ EY+ + F + L + + + +
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 262 --GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
+Y+H K I HRD++PS NIL D +G +K++DFG S+ + D
Sbjct: 161 LNSFSYIHNEKN--ICHRDVKPS-----------NILMDKNGRVKLSDFGESEYM---VD 204
Query: 320 RPLTCQDTSC---RYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374
+ + S ++ PE F NE KVD++S + L M PF +
Sbjct: 205 KKIK---GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF--SLKISLV 259
Query: 375 KAYAARQRPPFKAPAKLYAR------------------GLKELIEECWNEKPAKRPTFRQ 416
+ + + + P + ++ + PA+R T
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319
Query: 417 I 417
Sbjct: 320 A 320
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 55/254 (21%), Positives = 99/254 (38%), Gaps = 39/254 (15%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+V VK K+ E+ +D ++ E+A+L ++ H N+++ L +V
Sbjct: 49 NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108
Query: 230 E-YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
E + DL AF+ R L A + + YL IIHRD++
Sbjct: 109 EKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDE------ 159
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-T 344
NI+ + +K+ DFG + ++ + T C Y APEV Y
Sbjct: 160 -----NIVIAEDFTIKLIDFGSAAY--LERGKLF---YTFCGTIEYCAPEVLMGNPYRGP 209
Query: 345 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 404
+++++S + L ++ PF E+ + A PP+ L L+
Sbjct: 210 ELEMWSLGVTLYTLVFEENPF-----CELEETVEAAIHPPYLVSK-----ELMSLVSGLL 259
Query: 405 NEKPAKRPTFRQII 418
P +R T +++
Sbjct: 260 QPVPERRTTLEKLV 273
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 65/298 (21%), Positives = 119/298 (39%), Gaps = 34/298 (11%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP L + V+I +G+ + G QVAVK + + R +E+ +++
Sbjct: 42 DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 97
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+H NVV+ + + ++ E+L G L + + L + + + Y
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAY 156
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 325
LH +IHRD++ +IL G +K++DFG ++ + +
Sbjct: 157 LHAQG---VIHRDIKSD-----------SILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202
Query: 326 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385
T ++APEV Y T+VD++S +++ EM++G PP+ + K P
Sbjct: 203 GTPY-WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL 261
Query: 386 KAPAKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWK 435
K K + L++ +E P +R T F E + I R+
Sbjct: 262 KNSHK-VSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQT 318
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-33
Identities = 82/293 (27%), Positives = 128/293 (43%), Gaps = 37/293 (12%)
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
PM K + I + L T + GTF + G +VAVK L + I
Sbjct: 1 GPMAEKQKHDGRVK-IGHYILGDT----LGVGTFGKVKVGKHELTGHKVAVKILNRQKIR 55
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
D V R E+ L+ RHP++++ ++ S + +V EY+ G+L ++ + G L
Sbjct: 56 SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE 115
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309
+ R I G++Y H + ++HRDL+P N+L D N K+ADFG
Sbjct: 116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPE-----------NVLLDAHMNAKIADFG 161
Query: 310 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPF 365
+S ++ + L TSC Y APEV Y +VD++S +IL ++ G PF
Sbjct: 162 LSNMM--SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216
Query: 366 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
D+ VP + F P L + L++ P KR T + I
Sbjct: 217 ---DDDHVPTLFKKICDGIFYTPQYL-NPSVISLLKHMLQVDPMKRATIKDIR 265
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 61/256 (23%), Positives = 103/256 (40%), Gaps = 43/256 (16%)
Query: 175 GIQVAVKKLGEEVISD----DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIV 228
+ VA+K + ++ ISD + R E+ LL+K+ V++ L + +++
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126
Query: 229 TEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVA 287
E P DL F+ +GAL+ A F + + + H ++HRD++
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDE----- 178
Query: 288 YWQNDRNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD 343
NIL D + G LK+ DFG LL D Y PE + Y
Sbjct: 179 ------NILIDLNRGELKLIDFGSGALLK---DTVY---TDFDGTRVYSPPEWIRYHRYH 226
Query: 344 -TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 402
V+S ++L +M+ G PF +E + + + + + LI
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPF---EHDE--EIIRGQVFFRQRVSS-----ECQHLIRW 276
Query: 403 CWNEKPAKRPTFRQII 418
C +P+ RPTF +I
Sbjct: 277 CLALRPSDRPTFEEIQ 292
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-33
Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 57/282 (20%)
Query: 175 GIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVKKL V + + F E+ ++ K +H N+V+ LG + + +V Y+P
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113
Query: 234 KGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
G L L P + A A G+N+LHEN IHRD++ +
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSA-------- 162
Query: 291 NDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR------YVAPEVFKNEEYDT 344
NIL D++ K++DFG+++ + R Y+AP E
Sbjct: 163 ---NILLDEAFTAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAP------EALR 208
Query: 345 -----KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-------- 391
K D++SF ++L E+I G P + ++ +
Sbjct: 209 GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK---EEIEDEEKTIEDYIDKKM 265
Query: 392 ---YARGLKELIE---ECWNEKPAKRPTFRQIITRLESINNS 427
+ ++ + +C +EK KRP +++ L+ + S
Sbjct: 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 200 ELALLQKIRHPNVVQF---LGAVTQSSPMMIVTEYLPKGDLRAF-LKRKGALKPSTAVRF 255
E+A+L+K+ HPNVV+ L + + +V E + +G + + L A +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKPLSEDQARFY 142
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315
D+ +G+ YLH K IIHRD++PS N+L + G++K+ADFGVS
Sbjct: 143 FQDLIKGIEYLHYQK---IIHRDIKPS-----------NLLVGEDGHIKIADFGVSNEFK 188
Query: 316 VKEDRPLTCQDTSC---RYVAPEVFKNE--EYD-TKVDVFSFALILQEMIEGCPPFTMKH 369
D L+ + ++APE + +DV++ + L + G PF
Sbjct: 189 -GSDALLS---NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF---M 241
Query: 370 DNEVPKAYAARQRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQI 417
D + ++ + + P + A LK+LI ++ P R +I
Sbjct: 242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 25/242 (10%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K + ++ ++ F E+ ++ H N+V + + +V EY+
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
L +++ G L TA+ F I G+ + H+ + I+HRD++P NIL
Sbjct: 98 LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQ-----------NIL 143
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFAL 353
D + LK+ DFG++K L+ + LT + + +Y +PE K E D D++S +
Sbjct: 144 IDSNKTLKIFDFGIAKALS---ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGI 200
Query: 354 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECWNEKPAK 410
+L EM+ G PPF + V A Q + L +I + A
Sbjct: 201 VLYEMLVGEPPFN--GETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKAN 258
Query: 411 RP 412
R
Sbjct: 259 RY 260
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 63/253 (24%), Positives = 107/253 (42%), Gaps = 33/253 (13%)
Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK + + + + ++ + E+ + + + H NVV+F G + + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G+L ++ + A RF + G+ YLH I HRD++P
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKP-----------E 134
Query: 294 NILRDDSGNLKVADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDV 348
N+L D+ NLK++DFG++ + +R L + C YVAPE+ K E+ VDV
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 349 FSFALILQEMIEGCPPFTMKHDNEVP---KAYAARQRPPFKAPAKLYARGLKELIEECWN 405
+S ++L M+ G P+ D+ P+K L+ +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK----IDSAPLALLHKILV 247
Query: 406 EKPAKRPTFRQII 418
E P+ R T I
Sbjct: 248 ENPSARITIPDIK 260
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 67/258 (25%), Positives = 101/258 (39%), Gaps = 45/258 (17%)
Query: 175 GIQVAVKKLG----EEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAVTQSSPMM 226
+QVA+K + D V E+ALL K+ HP V++ L M
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114
Query: 227 IVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285
+V E LP DL ++ KG L + F + + + H ++HRD++
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDE--- 168
Query: 286 VAYWQNDRNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 341
NIL D G K+ DFG LL D P Y PE +
Sbjct: 169 --------NILIDLRRGCAKLIDFGSGALL---HDEPY---TDFDGTRVYSPPEWISRHQ 214
Query: 342 YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 400
Y V+S ++L +M+ G PF + D E+ +A PA + + LI
Sbjct: 215 YHALPATVWSLGILLYDMVCGDIPF--ERDQEILEA-------ELHFPAHV-SPDCCALI 264
Query: 401 EECWNEKPAKRPTFRQII 418
C KP+ RP+ +I+
Sbjct: 265 RRCLAPKPSSRPSLEEIL 282
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 49/208 (23%), Positives = 79/208 (37%), Gaps = 27/208 (12%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VA+K + E + SD + E +++ P+VV + + + D
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
L A L+R+G L P AV I ++ H HRD++P NIL
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPE-----------NIL 166
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFAL 353
+ DFG++ T D LT + Y+APE F + D+++
Sbjct: 167 VSADDFAYLVDFGIASATT---DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTC 223
Query: 354 ILQEMIEGCPPFT-------MKHDNEVP 374
+L E + G PP+ H N+
Sbjct: 224 VLYECLTGSPPYQGDQLSVMGAHINQAI 251
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 66/283 (23%), Positives = 110/283 (38%), Gaps = 42/283 (14%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
D+ I G + + +VA+K++ E + E+ + + HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHP 73
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA-LDIA-------RG 262
N+V + + + +V + L G + +K A + IA G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
+ YLH+N IHRD++ NIL + G++++ADFGVS L D
Sbjct: 134 LEYLHKNG---QIHRDVKAG-----------NILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 323 TCQD-----TSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376
T C ++APEV + YD K D++SF + E+ G P+ +V
Sbjct: 180 NKVRKTFVGTPC-WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 377 YAARQRPPFKAPA------KLYARGLKELIEECWNEKPAKRPT 413
P + K Y + +++I C + P KRPT
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 81/352 (23%), Positives = 134/352 (38%), Gaps = 88/352 (25%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
++E L + +G F I A GI VAVK L E + RA
Sbjct: 16 KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 71
Query: 197 FRDELALLQKI-RHPNVVQFLGAVTQSS-PMMIVTEYLPKGDLRAFLKRK---------- 244
EL +L I H NVV LGA T+ P+M++ E+ G+L +L+ K
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
Query: 245 ------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S+A ++ + E P + L
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 281 PSDLYVAYWQ---------------ND---RNILRDDSGNLKVADFGVSKLL------TV 316
L +Q D RNIL + +K+ DFG+++ +
Sbjct: 192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251
Query: 317 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVP 374
K D L +++APE + Y + DV+SF ++L E+ G P+ +K D E
Sbjct: 252 KGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 375 KAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+ R R P ++Y + + +CW+ +P++RPTF +++ L ++
Sbjct: 307 RRLKEGTRMRAPDYTTPEMY-----QTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 74/290 (25%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+ +A K + E I R + R EL +L + P +V F GA + I E++
Sbjct: 58 GLVMARKLIHLE-IKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G L LK+ G + + ++ + +G+ YL E I+HRD++PS N
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPS-----------N 162
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVD 347
IL + G +K+ DFGVS L D+ Y++PE + Y + D
Sbjct: 163 ILVNSRGEIKLCDFGVSGQLI----------DSMANSFVGTRSYMSPERLQGTHYSVQSD 212
Query: 348 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---------------------------- 379
++S L L EM G P E+ +
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272
Query: 380 -------------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
+ PP K P+ +++ ++ + +C + PA+R +Q
Sbjct: 273 PPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 45/334 (13%), Positives = 106/334 (31%), Gaps = 36/334 (10%)
Query: 138 HVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEV 187
+ + E+++ + + + +G F A + +K
Sbjct: 50 KLPAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA- 246
+ + L+ ++F A + ++V E G L +
Sbjct: 108 PWEFYIGT---QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164
Query: 247 ----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302
+ + FA+ + + +H+ + IIH D++P + + +++ D S
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 303 LKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 361
L + D G S + + + T + + + E+ N+ ++ ++D F A + M+ G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 362 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421
E + F+ L E N ++ +
Sbjct: 282 TYMKVKNEGGEC------KPEGLFRRLPHLDM--WNEFFHVMLNIPDCHHLPSLDLLRQK 333
Query: 422 ESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSS 455
+ KIR ++ + L +L + S
Sbjct: 334 --LKKVFQQHYTNKIRALR--NRLIVLLLECKRS 363
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-31
Identities = 68/301 (22%), Positives = 129/301 (42%), Gaps = 36/301 (11%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
P E+ F ++ +G++ + G VA+K + + ++ E++++Q
Sbjct: 26 QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQ 79
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
+ P+VV++ G+ +++ + IV EY G + ++ R L +G+
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YLH + IHRD++ NIL + G+ K+ADFGV+ LT + T
Sbjct: 140 YLHFMR---KIHRDIKAG-----------NILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185
Query: 325 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384
T ++APEV + Y+ D++S + EM EG PP+ H P
Sbjct: 186 IGTPF-WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT 244
Query: 385 FKAPAKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWKI 436
F+ P ++ + +++C + P +R T F + + + + IN K+
Sbjct: 245 FRKPEL-WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKL 303
Query: 437 R 437
+
Sbjct: 304 K 304
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 57/283 (20%), Positives = 115/283 (40%), Gaps = 35/283 (12%)
Query: 148 YEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
E+ +L+ E+ +G + + G +AVK++ V + ++ R D
Sbjct: 2 MEVKADDLEPIM--ELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDI 58
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFALDI 259
++ + P V F GA+ + + I E + + + + + + A+ I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
+ + +LH +IHRD++PS N+L + G +K+ DFG+S L
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPS-----------NVLINALGQVKMCDFGISGYLVDDVA 165
Query: 320 RPLTCQDTSCR-YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPF-TMKHDNEV 373
+ D C+ Y+APE E Y K D++S + + E+ P+ + +
Sbjct: 166 K---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222
Query: 374 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
+ P + PA ++ + +C + +RPT+ +
Sbjct: 223 --LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 74/299 (24%), Positives = 114/299 (38%), Gaps = 51/299 (17%)
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
P+ + + Y+ +I G F L + VAVK +
Sbjct: 9 GPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERGAA- 58
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
D+ V+ R E+ + +RHPN+V+F + + + I+ EY G+L + G
Sbjct: 59 IDENVQ--R-EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE 115
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS--GNLKVAD 307
A F + G++Y H + I HRDL+ N L D S LK+ D
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQ---ICHRDLKL-----------ENTLLDGSPAPRLKICD 161
Query: 308 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCP 363
FG SK ++ Y+APEV +EYD DV+S + L M+ G
Sbjct: 162 FGYSKSS--VLHSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAY 216
Query: 364 PFTMKHDNEVPKAYAAR----QRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQI 417
PF D E P+ Y + P + + LI + PA R + +I
Sbjct: 217 PF---EDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 60/281 (21%), Positives = 117/281 (41%), Gaps = 30/281 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
Y+ + ++L+ E+ GT + G +AVK++ + ++ R D
Sbjct: 19 RYQAEINDLENLG--EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLD 75
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
+L+ P +VQ G ++ + I E + + + +G + + + I +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 262 GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP 321
+ YL E +IHRD++PS NIL D+ G +K+ DFG+S L + +
Sbjct: 136 ALYYLKEKH--GVIHRDVKPS-----------NILLDERGQIKLCDFGISGRLVDDKAK- 181
Query: 322 LTCQDTSCR-YVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375
+ C Y+APE + YD + DV+S + L E+ G P+ +
Sbjct: 182 --DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239
Query: 376 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
++ PP ++ + +++C + KRP + +
Sbjct: 240 TKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 60/260 (23%), Positives = 105/260 (40%), Gaps = 39/260 (15%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+VA++ K + D E+ +L+K+ HP +++ + IV
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
E + G+L + LK +T + + + YLHEN IIHRDL+P
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPE------- 268
Query: 290 QNDRNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-- 341
N+L +++ +K+ DFG SK+ + E + T C Y+APEV +
Sbjct: 269 ----NVLLSSQEEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTA 319
Query: 342 -YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLK 397
Y+ VD +S +IL + G PPF+ + +++A
Sbjct: 320 GYNRAVDCWSLGVILFICLSGYPPFS--EHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 377
Query: 398 ELIEECWNEKPAKRPTFRQI 417
+L+++ P R T +
Sbjct: 378 DLVKKLLVVDPKARFTTEEA 397
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 57/255 (22%), Positives = 101/255 (39%), Gaps = 33/255 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTE 230
+ AVK L ++ + + E+ LL+++RH NV+Q + + + V E
Sbjct: 30 LCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88
Query: 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
Y G + A + + G+ YLH I+H+D++P
Sbjct: 89 YCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPG------- 138
Query: 290 QNDRNILRDDSGNLKVADFGVSKLL-TVKEDRPLTCQDTSC---RYVAPEVFKNEE-YD- 343
N+L G LK++ GV++ L D TS + PE+ + +
Sbjct: 139 ----NLLLTTGGTLKISALGVAEALHPFAADDTC---RTSQGSPAFQPPEIANGLDTFSG 191
Query: 344 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 403
KVD++S + L + G PF + + K + + + P L +L++
Sbjct: 192 FKVDIWSAGVTLYNITTGLYPF---EGDNIYKLFENIGKGSYAIPGDC-GPPLSDLLKGM 247
Query: 404 WNEKPAKRPTFRQII 418
+PAKR + RQI
Sbjct: 248 LEYEPAKRFSIRQIR 262
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 61/277 (22%), Positives = 107/277 (38%), Gaps = 53/277 (19%)
Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G +VA+K+ + + + F E+ L RHP++V +G + + M+++ +Y+
Sbjct: 63 GAKVALKRR-----TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 233 PKGDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
G+L+ L + + ARG++YLH IIHRD++
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSI------ 168
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNE 340
NIL D++ K+ DFG+SK T + T S Y+ PE F
Sbjct: 169 -----NILLDENFVPKITDFGISKKGTELD-------QTHLSTVVKGTLGYIDPEYFIKG 216
Query: 341 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKA------PAK 390
K DV+SF ++L E++ E A + + K
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276
Query: 391 LYARGLK---ELIEECWNEKPAKRPTFRQIITRLESI 424
+ L+ + +C RP+ ++ +LE
Sbjct: 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 63/269 (23%), Positives = 101/269 (37%), Gaps = 42/269 (15%)
Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
GT + + VAVK++ E S DR E+ LL++ HPNV+++
Sbjct: 38 GTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQ 91
Query: 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
I E L+ ++++K A + G+ +LH I+HRDL+P
Sbjct: 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKP- 146
Query: 283 DLYVAYWQNDRNILRDDSGN-----LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAP 334
NIL ++DFG+ K L + + ++AP
Sbjct: 147 ----------HNILISMPNAHGKIKAMISDFGLCKKLA-VGRHSFSRRSGVPGTEGWIAP 195
Query: 335 EVFK---NEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA--P 388
E+ E VD+FS + +I EG PF + +A P
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF---GKSLQRQANILLGACSLDCLHP 252
Query: 389 AKLYARGLKELIEECWNEKPAKRPTFRQI 417
K +ELIE+ P KRP+ + +
Sbjct: 253 EKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 62/251 (24%), Positives = 106/251 (42%), Gaps = 38/251 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL--GAVTQSSPMM--IVTEYL 232
VAVK L ++ D FR E + HP +V G + + IV EY+
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292
LR + +G + P A+ D + +N+ H+N IIHRD++P+
Sbjct: 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA---------- 145
Query: 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVF 349
NI+ + +KV DFG+++ + +T + +Y++PE + + D + DV+
Sbjct: 146 -NIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203
Query: 350 SFALILQEMIEGCPPFT--------MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 401
S +L E++ G PPFT +H E P P A + + L ++
Sbjct: 204 SLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP--------IPPSARHEGLSADLDAVVL 255
Query: 402 ECWNEKPAKRP 412
+ + P R
Sbjct: 256 KALAKNPENRY 266
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 62/247 (25%), Positives = 112/247 (45%), Gaps = 22/247 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G + AVK + + + + E+ LL+++ HPN+++ +V E
Sbjct: 51 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G+L + + A R + G+ Y+H+NK I+HRDL+P N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKP-----------EN 156
Query: 295 IL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 351
+L + N+++ DFG+S + + + + + Y+APEV YD K DV+S
Sbjct: 157 LLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWST 213
Query: 352 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAK 410
+IL ++ GCPPF ++ ++ K + + F+ P K + K+LI + P+
Sbjct: 214 GVILYILLSGCPPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 272
Query: 411 RPTFRQI 417
R + R
Sbjct: 273 RISARDA 279
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 34/205 (16%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+VA+K K + D E+ +L+K+ HP +++ + IV
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
E + G+L + LK +T + + + YLHEN IIHRDL+P
Sbjct: 94 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKP-------- 142
Query: 290 QNDRNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-- 341
N+L +++ +K+ DFG SK+ + E + T C Y+APEV +
Sbjct: 143 ---ENVLLSSQEEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTA 194
Query: 342 -YDTKVDVFSFALILQEMIEGCPPF 365
Y+ VD +S +IL + G PPF
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPF 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 58/256 (22%), Positives = 105/256 (41%), Gaps = 40/256 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++ A K + + +S D + E + +K++HPN+V+ ++ + S +V + +
Sbjct: 31 GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G+L + + + A I + Y H N I+HR+L+P N
Sbjct: 90 GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPE-----------N 135
Query: 295 IL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDV 348
+L + +K+ADFG++ V + Y++PEV K + Y VD+
Sbjct: 136 LLLASKAKGAAVKLADFGLAIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDI 190
Query: 349 FSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIE 401
++ +IL ++ G PPF + + + A P + A K LI+
Sbjct: 191 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-------KSLID 243
Query: 402 ECWNEKPAKRPTFRQI 417
P KR T Q
Sbjct: 244 SMLTVNPKKRITADQA 259
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 59/247 (23%), Positives = 117/247 (47%), Gaps = 23/247 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++ A+K + + +S + +E+A+L+ + HPN+++ +V E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G+L + + A + G+ YLH++ I+HRDL+P N
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPE-----------N 166
Query: 295 IL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 351
+L ++ +K+ DFG+S + + + + + + Y+APEV + ++YD K DV+S
Sbjct: 167 LLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSI 223
Query: 352 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAK 410
+IL ++ G PPF + D E+ + + + F +P K + G K+LI++ +
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRK-VEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQR 282
Query: 411 RPTFRQI 417
R + +Q
Sbjct: 283 RISAQQA 289
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 66/313 (21%), Positives = 125/313 (39%), Gaps = 51/313 (16%)
Query: 149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++DP+E+ + E+ G F + G A K + ++ + + E+ +
Sbjct: 14 DLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEI 69
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARG 262
L HP +V+ LGA + I+ E+ P G + A + ++ +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
+N+LH + IIHRDL+ N+L G++++ADFGVS +
Sbjct: 130 LNFLHSKR---IIHRDLKAG-----------NVLMTLEGDIRLADFGVSAKNLKTLQKRD 175
Query: 323 TCQDTSCRYV------APEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 371
+ ++ APEV K+ YD K D++S + L EM + PP +
Sbjct: 176 S-------FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
Query: 372 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLES 423
V A P P+K ++ ++ ++ ++ P RP+ F IT ++
Sbjct: 229 RVLLKIAKSDPPTLLTPSK-WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287
Query: 424 INNSINHKRRWKI 436
+ + + +
Sbjct: 288 LRELVAEAKAEVM 300
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 63/274 (22%), Positives = 115/274 (41%), Gaps = 48/274 (17%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G F L R G A+K + + D + +E+A+L+KI+H N+V
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
++ +V + + G+L + +G A + + YLHEN I+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 277 RDLEPSDLYVAYWQNDRNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---R 330
RDL+P N+L +++ + + DFG+SK+ ++ ++ T+C
Sbjct: 130 RDLKP-----------ENLLYLTPEENSKIMITDFGLSKME---QNGIMS---TACGTPG 172
Query: 331 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK 386
YVAPEV + Y VD +S +I ++ G PPF + ++++ + P +
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD 232
Query: 387 ---APAKLYARGLKELIEECWNEKPAKRPTFRQI 417
A K+ I + P +R T +
Sbjct: 233 DISESA-------KDFICHLLEKDPNERYTCEKA 259
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 39/278 (14%)
Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
GT + ++G VAVK++ D E+ LL + HPNV+++ + T
Sbjct: 29 GTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82
Query: 224 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ I E +L+ ++ K K + IA G+ +LH K IIH
Sbjct: 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIH 138
Query: 277 RDLEPSDLYVAY--WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RY 331
RDL+P ++ V+ ++ + ++DFG+ K L + T + +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 332 VAPEVFKNEE-------YDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRP 383
APE+ + +D+FS + ++ +G PF D ++ R
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF---GDKYSRESNIIRGIF 255
Query: 384 PFKAPAKLYARGL----KELIEECWNEKPAKRPTFRQI 417
L+ R L +LI + + P KRPT ++
Sbjct: 256 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 57/250 (22%), Positives = 103/250 (41%), Gaps = 31/250 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
I+ A KK+ + + D DR + E+ +++ + HPN+++ ++ + +V E
Sbjct: 34 RIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G+L + K + S A R D+ + Y H+ + HRDL+P N
Sbjct: 91 GELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPE-----------N 136
Query: 295 IL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDV 348
L LK+ DFG++ K + + T YV+P+V + Y + D
Sbjct: 137 FLFLTDSPDSPLKLIDFGLAAR--FKPGKMMR---TKVGTPYYVSPQVLEG-LYGPECDE 190
Query: 349 FSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEK 407
+S +++ ++ G PPF+ D+EV F + + LI +
Sbjct: 191 WSAGVMMYVLLCGYPPFSAPTDSEVMLK-IREGTFTFPEKDWLNVSPQAESLIRRLLTKS 249
Query: 408 PAKRPTFRQI 417
P +R T Q
Sbjct: 250 PKQRITSLQA 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 37/287 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
++ +L EI +G + ++ G +AVK++ V + ++ + D
Sbjct: 16 HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLD 72
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-----AVRFA 256
+++ P +VQF GA+ + I E + F K ++ +
Sbjct: 73 VVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
L + +N+L EN IIHRD++PS NIL D SGN+K+ DFG+S L
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPS-----------NILLDRSGNIKLCDFGISGQLV- 177
Query: 317 KEDRPLTCQDTSCR-YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDN 371
D +D CR Y+APE YD + DV+S + L E+ G P+ +
Sbjct: 178 --DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
Query: 372 EVPKAYAARQRPP--FKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
+ PP + + ++ + C + +KRP +++
Sbjct: 236 FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 57/253 (22%), Positives = 106/253 (41%), Gaps = 33/253 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++ +K + ++ + E+ +L+ + HPN+++ M IV E
Sbjct: 47 GLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
G+L + R AL + + Y H ++H+DL+P
Sbjct: 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPE-------- 153
Query: 291 NDRNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 344
NIL +K+ DFG+++L K D T + Y+APEVFK +
Sbjct: 154 ---NILFQDTSPHSPIKIIDFGLAEL--FKSDEHST---NAAGTALYMAPEVFK-RDVTF 204
Query: 345 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 404
K D++S +++ ++ GC PFT EV + A + P + + +L+++
Sbjct: 205 KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK-ATYKEPNYAVECRPLTPQAVDLLKQML 263
Query: 405 NEKPAKRPTFRQI 417
+ P +RP+ Q+
Sbjct: 264 TKDPERRPSAAQV 276
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 54/346 (15%), Positives = 104/346 (30%), Gaps = 79/346 (22%)
Query: 134 MAPMHVKHAREVPEYEI----DPHELDFTNSVEITKGTFILAF-WRGIQ------VAVKK 182
MA H H + + + I KG L V V++
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRR 59
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
+ E S++ V + EL + + HPN+V + + + +VT ++ G + +
Sbjct: 60 INLEACSNEM-VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 243 --RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300
+ + + ++Y+H +HR ++ S +IL
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKAS-----------HILISVD 164
Query: 301 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEVFK--NEEYDTKVDVFSFA 352
G + ++ + + R D V +PEV + + YD K D++S
Sbjct: 165 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 224
Query: 353 LILQEMIEGCPPF---------TMKHDNEVPK---------------------------- 375
+ E+ G PF K + VP
Sbjct: 225 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDS 284
Query: 376 -----AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
+ P + ++ +E+C P RP+
Sbjct: 285 LTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 65/247 (26%), Positives = 115/247 (46%), Gaps = 23/247 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ AVK + + + D E+ LL+K+ HPN+++ + SS IV E
Sbjct: 47 QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G+L + ++ A R + G+ Y+H++ I+HRDL+P N
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPE-----------N 151
Query: 295 IL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 351
IL ++ ++K+ DFG+S +++ + + + Y+APEV + YD K DV+S
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSA 208
Query: 352 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAK 410
+IL ++ G PPF K++ ++ K + F P + + K+LI + P+
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKR-VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 411 RPTFRQI 417
R T Q
Sbjct: 268 RITATQC 274
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 69/297 (23%), Positives = 115/297 (38%), Gaps = 67/297 (22%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VAVK+L EE + F+ E+ ++ H N+++ G + ++V Y+
Sbjct: 54 GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 235 GDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
G + + L+ + +P R AL ARG+ YLH++ IIHRD++ +
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA-------- 163
Query: 291 NDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEY 342
NIL D+ V DFG++KL+ K DT + ++APE +
Sbjct: 164 ---NILLDEEFEAVVGDFGLAKLMDYK--------DTHVTTAVRGTIGHIAPEYLSTGKS 212
Query: 343 DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARG-LKE 398
K DVF + ++L E+I G F + + L L+
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK---------GLLKEKKLEA 263
Query: 399 LI----------EE----------CWNEKPAKRPTFRQIITRLESINNSINHKRRWK 435
L+ EE C P +RP +++ LE + W+
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG-DGLAERWEEWQ 319
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 54/239 (22%), Positives = 107/239 (44%), Gaps = 26/239 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + ++ + + VR EL ++Q + HP +V + M +V + L GDLR
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L++ K T F ++ ++YL + IIHRD++P NIL D
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPD-----------NILLD 149
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSFA 352
+ G++ + DF ++ + + + +T T Y+APE+F + + Y VD +S
Sbjct: 150 EHGHVHITDFNIAAM--LPRETQIT---TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG 204
Query: 353 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
+ E++ G P+ ++ + + P+ ++ + L+++ P +R
Sbjct: 205 VTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW-SQEMVSLLKKLLEPNPDQR 262
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 82/383 (21%), Positives = 145/383 (37%), Gaps = 73/383 (19%)
Query: 132 PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKK 182
P MA M + F+++ ++ + G F + G++ A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
+ + +S D + E + +K++HPN+V+ ++ + S +V + + G+L +
Sbjct: 62 INTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL---RDD 299
+ + A I + Y H N I+HR+L+P N+L +
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKP-----------ENLLLASKAK 166
Query: 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQ 356
+K+ADFG++ V + Y++PEV K + Y VD+++ +IL
Sbjct: 167 GAAVKLADFGLAIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 221
Query: 357 EMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPA 409
++ G PPF + + + A P + A K LI+ P
Sbjct: 222 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-------KSLIDSMLTVNPK 274
Query: 410 KRPTFRQI-----ITRLESINNSI------------NHKRRWK---IRTMKCFHNLE--- 446
KR T Q I E + ++I N +R+ K + TM NL
Sbjct: 275 KRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNLG 334
Query: 447 -AMLKKDHSSPSSRSKSSCSTSS 468
+L K P S K S +S
Sbjct: 335 RNLLNKKEQGPPSTIKESSESSQ 357
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-28
Identities = 48/196 (24%), Positives = 83/196 (42%), Gaps = 31/196 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E + A R E+ +L++++HPN+V L + + +V EY +
Sbjct: 31 VAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV 88
Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
L R P V+ + +N+ H++ IHRD++P NIL
Sbjct: 89 LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPE-----------NIL 134
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVF 349
+K+ DFG ++LLT V +PE+ + +Y VDV+
Sbjct: 135 ITKHSVIKLCDFGFARLLTG-PSDYYDD------EVATRWYRSPELLVGDTQYGPPVDVW 187
Query: 350 SFALILQEMIEGCPPF 365
+ + E++ G P +
Sbjct: 188 AIGCVFAELLSGVPLW 203
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 66/257 (25%), Positives = 112/257 (43%), Gaps = 43/257 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ AVK + + + D E+ LL+K+ HPN+++ + SS IV E
Sbjct: 47 QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G+L + ++ A R + G+ Y+H++ I+HRDL+P N
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPE-----------N 151
Query: 295 IL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDV 348
IL ++ ++K+ DFG+S +++ + Y+APEV + YD K DV
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTC--FQQNTKMK---DRIGTAYYIAPEVLR-GTYDEKCDV 205
Query: 349 FSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP--------AKLYARGLKELI 400
+S +IL ++ G PPF K++ ++ K + F P A K+LI
Sbjct: 206 WSAGVILYILLSGTPPFYGKNEYDILKR-VETGKYAFDLPQWRTISDDA-------KDLI 257
Query: 401 EECWNEKPAKRPTFRQI 417
+ P+ R T Q
Sbjct: 258 RKMLTFHPSLRITATQC 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 52/237 (21%), Positives = 106/237 (44%), Gaps = 25/237 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + I +++V E ++ ++ HP V+ + Y G+L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
++++ G+ + RF +I + YLH IIHRDL+P NIL
Sbjct: 119 KYIRKIGSFDETCT-RFYTAEIVSALEYLHGKG---IIHRDLKPE-----------NILL 163
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
++ ++++ DFG +K+L+ + + + +YV+PE+ + D+++ I
Sbjct: 164 NEDMHIQITDFGTAKVLSPESKQARAN--SFVGTAQYVSPELLTEKSACKSSDLWALGCI 221
Query: 355 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
+ +++ G PPF + NE + + + P K + + ++L+E+ KR
Sbjct: 222 IYQLVAGLPPF--RAGNEY-LIFQKIIKLEYDFPEKFFPKA-RDLVEKLLVLDATKR 274
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 28/282 (9%), Positives = 53/282 (18%), Gaps = 57/282 (20%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT----- 229
A+K + + + ++ + + P V
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 230 --------------------EYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARG 262
DL +G + R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
L ++H P N+ G L + D K
Sbjct: 207 AANLQSKG---LVHGHFTPD-----------NLFIMPDGRLMLGDVSAL----WKVGTRG 248
Query: 323 TCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380
Y E + ++ + L + + PF +
Sbjct: 249 PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 381 QRPPFKAPAKLYAR-----GLKELIEECWNEKPAKRPTFRQI 417
R P + +K LI N +R +
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 58/192 (30%), Positives = 104/192 (54%), Gaps = 23/192 (11%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + ++D+ + A R E++LL+++ HPN+V + + + +V E++ K
Sbjct: 48 VALKRIRLD--AEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
DL+ L K L+ S + + RG+ + H+++ I+HRDL+P N
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQ-----------N 149
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFAL 353
+L + G LK+ADFG+++ + R T + + Y AP+V +++Y T VD++S
Sbjct: 150 LLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGC 208
Query: 354 ILQEMIEGCPPF 365
I EMI G P F
Sbjct: 209 IFAEMITGKPLF 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 56/192 (29%), Positives = 103/192 (53%), Gaps = 23/192 (11%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+KK+ E +D+ + R E+++L++++H N+V+ + +++V E+L +
Sbjct: 29 FALKKIRLE--KEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
DL+ L +G L+ TA F L + G+ Y H+ + ++HRDL+P N
Sbjct: 85 DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQ-----------N 130
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFAL 353
+L + G LK+ADFG+++ + R T + + Y AP+V +++Y T +D++S
Sbjct: 131 LLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189
Query: 354 ILQEMIEGCPPF 365
I EM+ G P F
Sbjct: 190 IFAEMVNGTPLF 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 34/253 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++ AVK I D + + LL+ +HPN++ + +VTE +
Sbjct: 47 NMEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
G+L + R+ A I + + YLH ++HRDL+PS N
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPS-----------N 146
Query: 295 IL----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 347
IL + ++++ DFG +K L E+ L T C +VAPEV + + YD D
Sbjct: 147 ILYVDESGNPESIRICDFGFAKQLR-AENGLLM---TPCYTANFVAPEVLERQGYDAACD 202
Query: 348 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECW 404
++S ++L M+ G PF D+ + A F + K+L+ +
Sbjct: 203 IWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKML 262
Query: 405 NEKPAKRPTFRQI 417
+ P +R T +
Sbjct: 263 HVDPHQRLTAALV 275
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 62/257 (24%), Positives = 114/257 (44%), Gaps = 32/257 (12%)
Query: 175 GIQVAVK----------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
+ A+K + ++ + + +E++LL+ + HPN+++
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDL 284
+VTE+ G+L + + A I G+ YLH++ I+HRD++P
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKP--- 174
Query: 285 YVAYWQNDRNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 341
NIL ++ N+K+ DFG+S +D L + + Y+APEV K ++
Sbjct: 175 --------ENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRLGTAYYIAPEVLK-KK 223
Query: 342 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELI 400
Y+ K DV+S +I+ ++ G PPF ++D ++ K + + F K + KELI
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK-VEKGKYYFDFNDWKNISDEAKELI 282
Query: 401 EECWNEKPAKRPTFRQI 417
+ KR T +
Sbjct: 283 KLMLTYDYNKRCTAEEA 299
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 56/290 (19%), Positives = 110/290 (37%), Gaps = 46/290 (15%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G++ A K + E+++L+++ H NV+ + ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
E + G+L FL +K +L A F I G+NYLH K I H DL+P
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPE------- 144
Query: 290 QNDRNIL----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 345
NI+ ++K+ DFG++ + ++ + +VAPE+ E +
Sbjct: 145 ----NIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 346 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKE 398
D++S +I ++ G PF E + F A K+
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA-------KD 251
Query: 399 LIEECWNEKPAKRPTFRQI-----ITRLESINNSINHKRRWKIRTMKCFH 443
I + ++ KR T ++ IT +++ + + + + +
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQY 301
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 61/193 (31%), Positives = 96/193 (49%), Gaps = 22/193 (11%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+KK+ D A R E+ LLQ++ HPN++ L A S + +V +++
Sbjct: 38 VAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
DL +K L PS + L +G+ YLH++ I+HRDL+P+
Sbjct: 97 -DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPN----------- 141
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFA 352
N+L D++G LK+ADFG++K +R T Q + Y APE+ F Y VD+++
Sbjct: 142 NLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG 200
Query: 353 LILQEMIEGCPPF 365
IL E++ P
Sbjct: 201 CILAELLLRVPFL 213
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVR-AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227
+ AVK G + +R A E+ +L+K+ HPN++Q ++ +
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVA 287
V + + KG+L +L K L + + + LH+ I+HRDL+P
Sbjct: 102 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPE----- 153
Query: 288 YWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE--- 341
NIL DD N+K+ DFG S + L C Y+APE+ +
Sbjct: 154 ------NILLDDDMNIKLTDFGFSCQ--LDPGEKLR---EVCGTPSYLAPEIIECSMNDN 202
Query: 342 ---YDTKVDVFSFALILQEMIEGCPPF 365
Y +VD++S +I+ ++ G PPF
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPF 229
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 57/261 (21%), Positives = 99/261 (37%), Gaps = 47/261 (18%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G + A K +L E+ +L++IRHPN++ + ++++
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVS--REEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
E + G+L FL K +L A +F I G++YLH + I H DL+P
Sbjct: 88 ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPE------- 137
Query: 290 QNDRNIL----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEY 342
NI+ + +K+ DFG++ + + +VAPE+ E
Sbjct: 138 ----NIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFK---NIFGTPEFVAPEIVNYEPL 188
Query: 343 DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARG 395
+ D++S +I ++ G PF + E +A F A
Sbjct: 189 GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA------ 242
Query: 396 LKELIEECWNEKPAKRPTFRQ 416
K+ I + P +R T Q
Sbjct: 243 -KDFIRRLLVKDPKRRMTIAQ 262
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 19/190 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E + A R E+ LL+++RH N+V L + +V E++ +
Sbjct: 53 VAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI 110
Query: 238 RAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
L+ L ++ I G+ + H + IIHRD++P NIL
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPE-----------NIL 156
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALIL 355
SG +K+ DFG ++ L + + Y APE+ + +Y VDV++ ++
Sbjct: 157 VSQSGVVKLCDFGFARTLAAP-GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV 215
Query: 356 QEMIEGCPPF 365
EM G P F
Sbjct: 216 TEMFMGEPLF 225
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228
G + AVK ++ A R E +L+++ HP+++ + + SS M +V
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
+ + KG+L +L K AL + +++LH N I+HRDL+P
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPE------ 229
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---- 341
NIL DD+ ++++DFG S ++ L C Y+APE+ K
Sbjct: 230 -----NILLDDNMQIRLSDFGFSCH--LEPGEKLR---ELCGTPGYLAPEILKCSMDETH 279
Query: 342 --YDTKVDVFSFALILQEMIEGCPPF 365
Y +VD+++ +IL ++ G PPF
Sbjct: 280 PGYGKEVDLWACGVILFTLLAGSPPF 305
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 71/308 (23%), Positives = 116/308 (37%), Gaps = 48/308 (15%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L F++ EI G+F + VA+KK+ +++ + E+ LQ
Sbjct: 51 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED---RPL 322
LH + +IHRD++ NIL + G +K+ DFG + ++ P
Sbjct: 170 LHSHN---MIHRDVKAG-----------NILLSEPGLVKLGDFGSASIMAPANSFVGTPY 215
Query: 323 TCQDTSCRYVAPEV---FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KA-Y 377
++APEV +YD KVDV+S + E+ E PP N A Y
Sbjct: 216 --------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMSALY 263
Query: 378 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLESINNSIN 429
Q + ++ + ++ C + P RPT F I + I
Sbjct: 264 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 323
Query: 430 HKRRWKIR 437
+
Sbjct: 324 RTKDAVRE 331
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 64/299 (21%), Positives = 111/299 (37%), Gaps = 43/299 (14%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G+Q A K + E+++L++I+HPNV+ + ++++
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVS--REDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
E + G+L FL K +L A F I G+ YLH + I H DL+P
Sbjct: 94 ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPE------- 143
Query: 290 QNDRNIL----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 345
NI+ +K+ DFG++ + + +VAPE+ E +
Sbjct: 144 ----NIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYEPLGLE 197
Query: 346 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKE 398
D++S +I ++ G PF E +A F A A K+
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA-------KD 250
Query: 399 LIEECWNEKPAKRPTFRQIITR--LESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSS 455
I + P KR T + + ++ + R+ M+ F A K ++ S
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGS 309
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 57/268 (21%), Positives = 101/268 (37%), Gaps = 60/268 (22%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
AVK +IS + E+ L+ HPN+V+ +V E L
Sbjct: 36 NQAFAVK-----IISKRMEANTQK-EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G+L +K+K + A + ++++H+ ++HRDL+P
Sbjct: 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPE----------- 135
Query: 294 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVD 347
N+L +D+ +K+ DFG ++L +++PL T C Y APE+ YD D
Sbjct: 136 NLLFTDENDNLEIKIIDFGFARLKPP-DNQPLK---TPCFTLHYAAPELLNQNGYDESCD 191
Query: 348 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL----------- 396
++S +IL M+ G PF + + + ++ +
Sbjct: 192 LWSLGVILYTMLSGQVPF-----------QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240
Query: 397 -------KELIEECWNEKPAKRPTFRQI 417
K+LI+ P KR +
Sbjct: 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 49/192 (25%), Positives = 93/192 (48%), Gaps = 23/192 (11%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + DD+ V A R E+ LL++++H N+V+ + + +V E+ +
Sbjct: 30 VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
DL+ + G L P F + +G+ + H ++HRDL+P N
Sbjct: 86 DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQ-----------N 131
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFAL 353
+L + +G LK+A+FG+++ + R + + + Y P+V F + Y T +D++S
Sbjct: 132 LLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190
Query: 354 ILQEMIEGCPPF 365
I E+ P
Sbjct: 191 IFAELANAGRPL 202
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 56/296 (18%), Positives = 97/296 (32%), Gaps = 71/296 (23%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
A+K K+ + D +R++ E+ L++K+ HPN+ + + +V
Sbjct: 51 RAIRAIKIMNKNKIRQINPKDVERIK---TEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107
Query: 230 EYLPKGDLRAFLKRKGALKPST-------------------------------------- 251
E G L L
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167
Query: 252 --AVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL--RDDSGNLKVAD 307
I ++YLH I HRD++P N L + S +K+ D
Sbjct: 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPE-----------NFLFSTNKSFEIKLVD 213
Query: 308 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGC 362
FG+SK + T +VAPEV NE Y K D +S ++L ++ G
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 363 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 417
PF +D + ++ F+ P + + ++L+ N +R +
Sbjct: 274 VPFPGVNDADTISQ-VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 26/193 (13%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+K++ EE A R E++LL+ ++H N+V + + +V EYL K
Sbjct: 30 VALKEIRLEHEEGAP----CTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
DL+ +L G + F + RG+ Y H K ++HRDL+P
Sbjct: 85 -DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQ----------- 129
Query: 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFA 352
N+L ++ G LK+ADFG+++ ++ + + + Y P++ + +Y T++D++
Sbjct: 130 NLLINERGELKLADFGLARAKSI-PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 188
Query: 353 LILQEMIEGCPPF 365
I EM G P F
Sbjct: 189 CIFYEMATGRPLF 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 66/332 (19%), Positives = 124/332 (37%), Gaps = 62/332 (18%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G++ A K + E+++L+++ HPN++ + ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVC--REEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
E + G+L FL +K +L A F I G+NYLH K I H DL+P
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKP-------- 143
Query: 290 QNDRNIL----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 345
NI+ ++K+ DFG++ +++ + +VAPE+ E +
Sbjct: 144 ---ENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 346 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKE 398
D++S +I ++ G PF E A F A K+
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA-------KD 251
Query: 399 LIEECWNEKPAKRPTFRQI-----ITRLESINNSINH--------------KRRWK--IR 437
I + ++ KR T ++ IT +++ + +RRWK
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFS 311
Query: 438 TMKCFHNLEAMLKKDHSSPSSRSKSSCSTSSI 469
+ ++L L K +S +C + +
Sbjct: 312 IVSLCNHLTRSLMKKVHLRTSEDLRNCESDTE 343
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 142 AREVPEYEIDPHELDFTNSV-----EITKGTF---ILAFWR--GIQVAVKKLGEEVISDD 191
A VP+Y ID D + E+ +G + A+K V+
Sbjct: 35 ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK-----VLKKT 89
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
+ R E+ +L ++ HPN+++ + + +V E + G+L + KG
Sbjct: 90 VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL---RDDSGNLKVADF 308
A I + YLHEN I+HRDL+P N+L LK+ADF
Sbjct: 150 AADAVKQILEAVAYLHENG---IVHRDLKP-----------ENLLYATPAPDAPLKIADF 195
Query: 309 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365
G+SK+ V+ + T C Y APE+ + Y +VD++S +I ++ G PF
Sbjct: 196 GLSKI--VEHQVLMK---TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 56/241 (23%), Positives = 95/241 (39%), Gaps = 27/241 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL- 237
A KKL ++ + + E +L K+ +V A + + +V + GD+
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 238 ---RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294
+ + A+ + I G+ +LH+ II+RDL+P N
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKP-----------EN 319
Query: 295 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSF 351
+L DD GN++++D G++ L + + ++APE+ EEYD VD F+
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQTKT----KGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 352 ALILQEMIEGCPPFTM-KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 410
+ L EMI PF E + P K + K+ E + P K
Sbjct: 376 GVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF-SPASKDFCEALLQKDPEK 434
Query: 411 R 411
R
Sbjct: 435 R 435
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ E +++ V A R E++LL++++H N+++ + + + ++ EY
Sbjct: 62 VAIKRIRLE--HEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
DL+ ++ + + F + G+N+ H + +HRDL+P N+
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQ-----------NL 163
Query: 296 L-----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVF 349
L ++ LK+ DFG+++ + R T + + Y PE+ + Y T VD++
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIW 222
Query: 350 SFALILQEMIEGCPPF 365
S A I EM+ P F
Sbjct: 223 SIACIWAEMLMKTPLF 238
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 73/285 (25%), Positives = 124/285 (43%), Gaps = 47/285 (16%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP + F + GT+ + G A+K + +V D++ + E+ +L+
Sbjct: 21 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEE--EIKQEINMLK 75
Query: 206 KI-RHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFA 256
K H N+ + GA + +P + +V E+ G + +K + LK
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
+I RG+++LH++K +IHRD++ N+L ++ +K+ DFGVS L
Sbjct: 136 REILRGLSHLHQHK---VIHRDIKGQ-----------NVLLTENAEVKLVDFGVSAQLDR 181
Query: 317 KEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDN 371
R T T ++APEV +E YD K D++S + EM EG PP H
Sbjct: 182 TVGRRNTFIGTPY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-- 238
Query: 372 EVP-KAYA--ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 413
P +A R P K +++ + IE C + ++RP
Sbjct: 239 --PMRALFLIPRNPAPRLKSKK-WSKKFQSFIESCLVKNHSQRPA 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 53/275 (19%), Positives = 111/275 (40%), Gaps = 46/275 (16%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ KG F G + A + + +S D + E + + ++HPN+V+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLH 76
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
++++ ++ + + G+L + + + A I + + H+ ++H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVH 133
Query: 277 RDLEPSDLYVAYWQNDRNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---R 330
R+L+P N+L + +K+ADFG++ + E +
Sbjct: 134 RNLKP-----------ENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWF---GFAGTPG 178
Query: 331 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP-- 388
Y++PEV + + Y VD+++ +IL ++ G PPF + + + + F +P
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ-IKAGAYDFPSPEW 237
Query: 389 ------AKLYARGLKELIEECWNEKPAKRPTFRQI 417
A K+LI + P+KR T +
Sbjct: 238 DTVTPEA-------KDLINKMLTINPSKRITAAEA 265
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 49/206 (23%), Positives = 86/206 (41%), Gaps = 36/206 (17%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G Q AVK K + ++ E ++ ++HP++V+ L + + +V
Sbjct: 49 GQQFAVKIVDVAKFTSSPGLSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 230 EYLPKGDLRAFLKRKGALKPS----TAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285
E++ DL + ++ A + I + Y H+N IIHRD++P
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPH--- 159
Query: 286 VAYWQNDRNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKN 339
+L +++S +K+ FGV+ L + ++APEV K
Sbjct: 160 --------CVLLASKENSAPVKLGGFGVAIQLG-ESGLVAG---GRVGTPHFMAPEVVKR 207
Query: 340 EEYDTKVDVFSFALILQEMIEGCPPF 365
E Y VDV+ +IL ++ GC PF
Sbjct: 208 EPYGKPVDVWGCGVILFILLSGCLPF 233
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 51/291 (17%), Positives = 104/291 (35%), Gaps = 46/291 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
K + + + E+++L RH N++ + ++++ E++
Sbjct: 30 KKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
D+ F L V + + + +LH + I H D+ P
Sbjct: 86 LDI--FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPE--------- 131
Query: 292 DRNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 349
NI+ S +K+ +FG ++ L K T+ Y APEV +++ T D++
Sbjct: 132 --NIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMW 187
Query: 350 SFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFK---APAKLYARGLKELIEE 402
S ++ ++ G PF + + + + A FK A + ++
Sbjct: 188 SLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA-------MDFVDR 240
Query: 403 CWNEKPAKRPTFRQIITRLES--INNSINHKRRWKIRTMKCFHNLEAMLKK 451
++ R T + L+ + I IRT+K ++KK
Sbjct: 241 LLVKERKSRMTASEA---LQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 31/198 (15%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+K++ EE A R E++L+++++H N+V+ + + + +V E++
Sbjct: 33 VALKEVKLDSEEGTP----STAIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87
Query: 235 GDLRAFLK------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
DL+ ++ L+ + F + +G+ + HENK I+HRDL+P
Sbjct: 88 -DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQ------ 137
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVD 347
N+L + G LK+ DFG+++ + + + + Y AP+V + Y T +D
Sbjct: 138 -----NLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPDVLMGSRTYSTSID 191
Query: 348 VFSFALILQEMIEGCPPF 365
++S IL EMI G P F
Sbjct: 192 IWSCGCILAEMITGKPLF 209
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 73/315 (23%), Positives = 117/315 (37%), Gaps = 67/315 (21%)
Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITK-----GTF---ILAFWR--GIQVAVKKLGE 185
H EV +P + T+ +++K G + F R G + A+K L
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-- 62
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFL 241
D +A ++ Q P++V L ++I+ E + G+L + +
Sbjct: 63 -----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117
Query: 242 KRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL--- 296
+ +G + A DI + +LH + I HRD++P N+L
Sbjct: 118 QERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPE-----------NLLYTS 163
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFAL 353
++ LK+ DFG +K L T C YVAPEV E+YD D++S +
Sbjct: 164 KEKDAVLKLTDFGFAKET---TQNALQ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 354 ILQEMIEGCPPFTMKHDNEVPKAYAARQR---PPFKAP--------AKLYARGLKELIEE 402
I+ ++ G PPF + R R F P A K+LI
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA-------KQLIRL 270
Query: 403 CWNEKPAKRPTFRQI 417
P +R T Q
Sbjct: 271 LLKTDPTERLTITQF 285
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 52/240 (21%), Positives = 97/240 (40%), Gaps = 28/240 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L ++ I +E L+L+ P +V A + + + + G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
DL L + G + +A +I G+ ++H +++RDL+P NI
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKP-----------ANI 323
Query: 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF-KNEEYDTKVDVFSF 351
L D+ G+++++D G++ + +P S Y+APEV K YD+ D FS
Sbjct: 324 LLDEHGHVRISDLGLACD--FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 352 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
+L +++ G PF + + + P + L+ L+E +R
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF-SPELRSLLEGLLQRDVNRR 436
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 55/258 (21%), Positives = 99/258 (38%), Gaps = 43/258 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
G + A K L + D R E+A+L+ + P V+ +S ++++ EY
Sbjct: 54 GQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112
Query: 234 KGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
G++ + + + +R I G+ YLH+N I+H DL+P
Sbjct: 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKP---------- 159
Query: 292 DRNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTK 345
+NIL G++K+ DFG+S+ + L Y+APE+ + T
Sbjct: 160 -QNILLSSIYPLGDIKIVDFGMSRKI--GHACELR---EIMGTPEYLAPEILNYDPITTA 213
Query: 346 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKE 398
D+++ +I ++ PF + + E + F A +
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA-------TD 266
Query: 399 LIEECWNEKPAKRPTFRQ 416
I+ + P KRPT
Sbjct: 267 FIQSLLVKNPEKRPTAEI 284
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 44/246 (17%), Positives = 82/246 (33%), Gaps = 50/246 (20%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVTEY 231
V +K L D + E L ++ HP++VQ V + IV EY
Sbjct: 108 PVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
+ L+ L + A+ + L+I ++YLH +++ DL+P
Sbjct: 166 VGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPE--------- 211
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKV 346
NI+ + LK+ D G + + + APE+ +
Sbjct: 212 --NIMLTEEQ-LKLIDLGAVSRIN----------SFGYLYGTPGFQAPEIVRTGP-TVAT 257
Query: 347 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 406
D+++ L + P ++ + +P P K L+ +
Sbjct: 258 DIYTVGRTLAALTLDLPTRNGRYVDGLP-----EDDPVLKTYDSYGR-----LLRRAIDP 307
Query: 407 KPAKRP 412
P +R
Sbjct: 308 DPRQRF 313
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 26/239 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ I +E +L+K+ VV A + +V + GDL+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
+ G + AV +A +I G+ LH + I++RDL+P NIL
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKP-----------ENIL 318
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFAL 353
DD G+++++D G++ V E + + Y+APEV KNE Y D ++
Sbjct: 319 LDDHGHIRISDLGLAV--HVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGC 373
Query: 354 ILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
+L EMI G PF K + + + P + + + + L + + PA+R
Sbjct: 374 LLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF-SPQARSLCSQLLCKDPAER 431
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 39/204 (19%), Positives = 85/204 (41%), Gaps = 26/204 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G K + D V+ +E++++ ++ HP ++ A M+++ E+L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
G+L F + + + + G+ ++HE+ I+H D++P
Sbjct: 133 GEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKP---------- 177
Query: 292 DRNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 349
NI+ + ++K+ DFG++ L D + + + APE+ E D++
Sbjct: 178 -ENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 350 SFALILQEMIEGCPPFTMKHDNEV 373
+ ++ ++ G PF + D E
Sbjct: 235 AIGVLGYVLLSGLSPFAGEDDLET 258
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++ +E +LQ + P +V+ + +S + +V EY+ G++
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
+ L+R G A +A I YLH +I+RDL+P N+L D
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE-----------NLLID 175
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 355
G ++V DFG +K + T T C +APE+ ++ Y+ VD ++ +++
Sbjct: 176 QQGYIQVTDFGFAK-----RVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 356 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
EM G PPF ++ + Y + P+ + LK+L+ KR
Sbjct: 229 YEMAAGYPPF---FADQPIQIYEKIVSGKVRFPSHF-SSDLKDLLRNLLQVDLTKR 280
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 21/198 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + A + V EY G+L
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L R+ A + +I + YLH +++RD++ N++ D
Sbjct: 94 FHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLE-----------NLMLD 139
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 355
G++K+ DFG+ K T C Y+APEV ++ +Y VD + +++
Sbjct: 140 KDGHIKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 356 QEMIEGCPPFTMKHDNEV 373
EM+ G PF + +
Sbjct: 196 YEMMCGRLPFYNQDHERL 213
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 97.5 bits (244), Expect = 4e-24
Identities = 21/87 (24%), Positives = 37/87 (42%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ LA + ++ + ++ +N D + T L AA G VV LL+ GAD
Sbjct: 7 VHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLG 66
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + L A +++K+L G
Sbjct: 67 KGRESALSLACSKGYTDIVKMLLDCGV 93
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 94.4 bits (236), Expect = 6e-23
Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ L E L ++ + +K LLD G+DVN D + T L A
Sbjct: 60 ADPQLLGKGRE--SA---LSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNH 114
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ V +LLE GAD + G + A+ V +++E H K
Sbjct: 115 VKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLK 160
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 93.2 bits (233), Expect = 1e-22
Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 5/107 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+E +N D++G P LM+ A + ++ LL +G D +AL +A +
Sbjct: 25 QENVINHTDEEGF--TP---LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSK 79
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+T++V +LL+ G DV+ D G TPL A++ + + +K+L + GA
Sbjct: 80 GYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGA 126
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 76.3 bits (189), Expect = 1e-16
Identities = 17/61 (27%), Positives = 30/61 (49%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
N ++H A QG ++ +E+ ++ D G TPL A + V++ L ++GA
Sbjct: 2 ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61
Query: 132 P 132
P
Sbjct: 62 P 62
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 67.4 bits (166), Expect = 2e-13
Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 5/79 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D +G P L++ + V+ +K LL+SG D ++ +A G+
Sbjct: 93 VDVNEYDWNGG--TP---LLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAVALGY 147
Query: 86 TEVVSLLLERGADVDPKDR 104
V ++ + +
Sbjct: 148 RSVQQVIESHLLKLLQNIK 166
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 67/257 (26%), Positives = 106/257 (41%), Gaps = 52/257 (20%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGI----------QVAV 180
PL P V + E+ +TN I G+F G+ +VA+
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSF------GVVFQAKLVESDEVAI 69
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPK 234
KK + D R R EL +++ ++HPNVV + +V EY+P+
Sbjct: 70 KK-----VLQDKR-FKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290
+ R + K K + + + R + Y+H I HRD++P
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQ-------- 170
Query: 291 NDRNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDV 348
N+L D SG LK+ DFG +K+L P S Y APE+ F Y T +D+
Sbjct: 171 ---NLLLDPPSGVLKLIDFGSAKILI--AGEPNVSYICSRYYRAPELIFGATNYTTNIDI 225
Query: 349 FSFALILQEMIEGCPPF 365
+S ++ E+++G P F
Sbjct: 226 WSTGCVMAELMQGQPLF 242
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 58/323 (17%), Positives = 107/323 (33%), Gaps = 56/323 (17%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A K + SD + VR E+ + +RHP +V A + M+++ E++
Sbjct: 182 GNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
G+L F + AV + + +G+ ++HEN +H DL+P
Sbjct: 239 GEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKP---------- 283
Query: 292 DRNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 349
NI+ S LK+ DFG++ L + + + + APEV + + D++
Sbjct: 284 -ENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340
Query: 350 SFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFK---APAKLYARGLKELIEE 402
S ++ ++ G PF ++D+E V F K+ I +
Sbjct: 341 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG-------KDFIRK 393
Query: 403 CWNEKPAKRPTFRQ----------------IITRLESINNSINHKRRWKIRTMKCFHNLE 446
P R T Q + + + L
Sbjct: 394 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLG 453
Query: 447 AMLKKDHSSPSSRSKSSCSTSSI 469
+ + S +
Sbjct: 454 RISNYSSLRKHRPQEYSIRDAFW 476
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 24/236 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L R+ A + +I ++YLH K +++RDL+ N++ D
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLE-----------NLMLD 283
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 355
G++K+ DFG+ K T C Y+APEV ++ +Y VD + +++
Sbjct: 284 KDGHIKITDFGLCKEGIKDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 339
Query: 356 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
EM+ G PF + ++ + + P L K L+ + P +R
Sbjct: 340 YEMMCGRLPFYNQDHEKL---FELILMEEIRFPRTL-GPEAKSLLSGLLKKDPKQR 391
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 96.3 bits (241), Expect = 5e-24
Identities = 29/89 (32%), Positives = 45/89 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + D+ ++ LL +G D N +D T LH A G +VV LLL+ A V+
Sbjct: 14 LHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTG 73
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+PL DA + +++KLL +GA
Sbjct: 74 YQNDSPLHDAAKNGHVDIVKLLLSYGASR 102
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 96.0 bits (240), Expect = 7e-24
Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ N D G P L N ++ ++ LL VN N + LH AA G
Sbjct: 34 SDPNVKDHAGW--TP---LHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGH 88
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++V LLL GA + + +G P+ ++ L EK+ +
Sbjct: 89 VDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNES 133
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 2e-20
Identities = 25/68 (36%), Positives = 39/68 (57%), Gaps = 1/68 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
GID + T LH+A+ +G V LL+ G+D + KD G TPL +A + + +V+
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59
Query: 123 KLLEKHGA 130
+LL +H A
Sbjct: 60 ELLLQHKA 67
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 49.7 bits (120), Expect = 1e-07
Identities = 13/73 (17%), Positives = 24/73 (32%), Gaps = 5/73 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N + P L A V+ +K LL G N +I + +
Sbjct: 67 ALVNTTGYQND--SP---LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESM 121
Query: 86 TEVVSLLLERGAD 98
++ L + +
Sbjct: 122 KSLLLLPEKNESS 134
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 38.9 bits (92), Expect = 6e-04
Identities = 9/37 (24%), Positives = 16/37 (43%), Gaps = 1/37 (2%)
Query: 96 GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G D + G T L A + ++ L ++G+ P
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDP 36
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 34/251 (13%), Positives = 70/251 (27%), Gaps = 55/251 (21%)
Query: 172 FWRGI------QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
FW+ + QVA+ + + + DD ++ L +I P V + L V +
Sbjct: 47 FWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106
Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285
++V E++ G L+ + P A+R +A + H + PS
Sbjct: 107 LVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPS--- 158
Query: 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 345
+ G++ +A + + +
Sbjct: 159 --------RVRVSIDGDVVLAYPA---------------------TMPDA-------NPQ 182
Query: 346 VDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKLYA---RGLKELIE 401
D+ L ++ P + + A P PA + + +
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP-IEPADIDRDIPFQISAVAA 241
Query: 402 ECWNEKPAKRP 412
R
Sbjct: 242 RSVQGDGGIRS 252
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 95.5 bits (239), Expect = 5e-24
Identities = 30/89 (33%), Positives = 45/89 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
M+ D++ +K+ + G DVN R LH AA G E++ LL +GAD++ D
Sbjct: 11 FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPD 70
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ TPL A+Y + +KLL GA
Sbjct: 71 KHHITPLLSAVYEGHVSCVKLLLSKGADK 99
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 78.2 bits (194), Expect = 9e-18
Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 5/100 (5%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K ++N + G KP L + A+ +E ++ LL G D+N D + T L A +
Sbjct: 29 KGEDVNRTLEGGR--KP---LHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
G V LLL +GAD K G T +++
Sbjct: 84 GHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALLQ 123
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 72.0 bits (178), Expect = 1e-15
Identities = 14/59 (23%), Positives = 21/59 (35%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
A G + V + +G DV+ G PL A E+++ L GA
Sbjct: 6 MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGA 64
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 60/290 (20%), Positives = 117/290 (40%), Gaps = 37/290 (12%)
Query: 95 RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVP---EYEID 151
R + K+ W + L + + K+ L A P + A++ Y +
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
E + G F G+++A K + + D + V+ +E++++ +
Sbjct: 93 KTE-------ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQ 142
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNY 265
+ H N++Q A + +++V EY+ G+L + L + F I G+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRH 202
Query: 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNIL--RDDSGNLKVADFGVSKLLTVKEDRPLT 323
+H+ I+H DL+P NIL D+ +K+ DFG+++ K L
Sbjct: 203 MHQMY---ILHLDLKP-----------ENILCVNRDAKQIKIIDFGLARRY--KPREKLK 246
Query: 324 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373
+ ++APEV + D++S +I ++ G PF +D E
Sbjct: 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 9e-24
Identities = 25/89 (28%), Positives = 39/89 (43%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ A ++ L+ G VN D+ + LH A G V +LL+ GA V+
Sbjct: 63 MHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVT 122
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
TPL +A + + + LL +HGA
Sbjct: 123 ADWHTPLFNACVSGSWDCVNLLLQHGASV 151
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 2e-20
Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 7/105 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ P L + +K+LL+SG DVN + + LH
Sbjct: 181 GNIDHKISHLG--TP---LYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVRTAS 234
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E+ LL++ GAD K+ G P+ ++ LE+ GA
Sbjct: 235 EELACLLMDFGADTQAKNAEGKRPVELVP-PESPLAQLFLEREGA 278
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 5e-20
Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ L+ G +++ + T L++A V LLE GADV+ + + +PL +
Sbjct: 173 VNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVR 231
Query: 116 YKNHEVIKLLEKHGAKP 132
+ E+ LL GA
Sbjct: 232 TASEELACLLMDFGADT 248
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 4e-19
Identities = 28/107 (26%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+N + D P L + +K LL G VN D T L A G
Sbjct: 83 WAVNIITADHV--SP---LHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGS 137
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V+LLL+ GA V P+ ++P+ +A + E + L +G
Sbjct: 138 WDCVNLLLQHGASVQPESD-LASPIHEAARRGHVECVNSLIAYGGNI 183
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 82.5 bits (205), Expect = 7e-18
Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++NG+ D P L + + LL G V + D + +H AA +G
Sbjct: 116 AQVNGVTADWH--TP---LFNACVSGSWDCVNLLLQHGASVQ-PESDLASPIHEAARRGH 169
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E V+ L+ G ++D K TPL A + +K L + GA
Sbjct: 170 VECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADV 216
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 1e-17
Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
RD GI+ LL + + + + + + +H AA G + L+ +G V+ +
Sbjct: 38 GPRDFPGIR-LLSNPLMGD--AVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVS 94
Query: 109 PLGDAIYYKNHEVIKLLEKHGAKP 132
PL +A + +K+L KHGA+
Sbjct: 95 PLHEACLGGHLSCVKILLKHGAQV 118
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 3e-09
Identities = 12/80 (15%), Positives = 22/80 (27%), Gaps = 12/80 (15%)
Query: 56 IKELLDSGIDVNFRD-----IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
L+ G + D +D G LL D +P+
Sbjct: 11 SSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPGI-----RLLSNPLMGDAVS--DWSPM 63
Query: 111 GDAIYYKNHEVIKLLEKHGA 130
+A + + ++ L G
Sbjct: 64 HEAAIHGHQLSLRNLISQGW 83
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 53.6 bits (130), Expect = 4e-08
Identities = 7/45 (15%), Positives = 17/45 (37%), Gaps = 1/45 (2%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
L+D G D ++ + + + + + + L GA +
Sbjct: 238 ACLLMDFGADTQAKNAEGKRPVELVPPESPLAQL-FLEREGASLP 281
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 55/276 (19%), Positives = 99/276 (35%), Gaps = 53/276 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
+ AVK + ++ RV E+ +L + + H NV++ + + +V E +
Sbjct: 38 SQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293
G + + + ++ A D+A +++LH I HRDL+P
Sbjct: 95 GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPE----------- 140
Query: 294 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQD---TSC---RYVAPEVFK-----N 339
NIL + +K+ DF + + + D T C Y+APEV +
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 340 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL--- 396
YD + D++S +IL ++ G PPF R L+
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPF---VGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 397 ---------------KELIEECWNEKPAKRPTFRQI 417
K+LI + +R + Q+
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G VA+KK + D R R EL +++K+ H N+V+ S +V
Sbjct: 79 GELVAIKK-----VLQDKR-FKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 229 TEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDL 284
+Y+P+ + R + + K L + + R + Y+H I HRD++P
Sbjct: 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQ-- 185
Query: 285 YVAYWQNDRNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEY 342
N+L D D+ LK+ DFG +K L P S Y APE+ F +Y
Sbjct: 186 ---------NLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDY 234
Query: 343 DTKVDVFSFALILQEMIEGCPPF 365
+ +DV+S +L E++ G P F
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIF 257
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 3e-23
Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 4/105 (3%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N +++G P L + ++ LL G D R + T +AA G
Sbjct: 29 ANVNFQEEEGGWT-P---LHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGS 84
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+++ L L +GADV+ D +G T +A Y + +K L K GA
Sbjct: 85 VKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGA 129
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 7e-22
Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPK 102
L+ DV+ +++LL+ G +VNF++ + T LH A ++V LLL GAD +
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G+TP A + +++KL GA
Sbjct: 69 KKNGATPFLLAAIAGSVKLLKLFLSKGA 96
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 4e-21
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 10/112 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE----LLDSGIDVNFRDIDNRTALHVAA 81
A++N D+ G L+ D ++ LLD G DVN R +T L +A
Sbjct: 173 ADVNACDNMGR--NA---LIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227
Query: 82 CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +V LLE+ +++ D G T L A+ K ++ +LL K GA
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 84.4 bits (210), Expect = 2e-18
Identities = 34/116 (29%), Positives = 51/116 (43%), Gaps = 16/116 (13%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ +G P + A V+ +K L G DVN D TA AA G
Sbjct: 63 ADPVLRKKNGA--TP---FLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGK 117
Query: 86 TEVVSLLLERGADVDPKD----------RWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
+ + L +RGA+V+ + + G+T L DA + EV+K LL++ GA
Sbjct: 118 VKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGA 173
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 37/120 (30%), Positives = 49/120 (40%), Gaps = 20/120 (16%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN----------RT 75
A++N D G M A V+ +K L G +VN R T
Sbjct: 96 ADVNECDFYGF--TA---FMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGAT 150
Query: 76 ALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLLEKHGA 130
AL AA +G EV+ +LL E GADV+ D G L A+ + + LL HGA
Sbjct: 151 ALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGA 210
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 1e-15
Identities = 19/62 (30%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKH 128
+++ L A ++V LLE GA+V+ ++ G TPL +A+ ++++LL +H
Sbjct: 2 AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 5e-13
Identities = 22/79 (27%), Positives = 40/79 (50%), Gaps = 6/79 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A++N + G+ P L+ ++ + ++ LL+ I++N D D +TAL +A
Sbjct: 210 ADVNVRGERGK--TP---LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264
Query: 85 FTEVVSLLLERGADVDPKD 103
++ LL +RGA D D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 3e-23
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++V+ DD V E L + P + Q + V EY+ GDL
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
+++ G K AV +A +IA G+ +L II+RDL+ N++
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLD-----------NVML 475
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G++K+ADFG+ K T C Y+APE+ + Y VD ++F ++
Sbjct: 476 DSEGHIKIADFGMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 531
Query: 355 LQEMIEGCPPFTMKHDNEV 373
L EM+ G PF + ++E+
Sbjct: 532 LYEMLAGQAPFEGEDEDEL 550
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 4e-23
Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A+ + ++ L+ A + E + LL ++ + D T LH+AA
Sbjct: 15 AKAVLTGEYKKDE-----LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYN 69
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+V LLL+ GADV KD+ G PL +A Y ++EV +LL KHGA
Sbjct: 70 RVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGA 115
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 35/89 (39%), Positives = 42/89 (47%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V ++ LL G DV+ +D LH A G EV LLL+ GA V+ D
Sbjct: 62 LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMD 121
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
W TPL +A EV LL HGA P
Sbjct: 122 LWQFTPLHEAASKNRVEVCSLLLSHGADP 150
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 25/77 (32%), Positives = 41/77 (53%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G +VN ++ D T LHVAA + +V+ +L + GA ++ D G T L A
Sbjct: 230 AELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAAL 289
Query: 116 YKNHEVIKLLEKHGAKP 132
+ + +LL +G+ P
Sbjct: 290 AGHLQTCRLLLSYGSDP 306
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 9e-21
Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 6/110 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+++ D G P L + E + LL G VN D+ T LH AA +
Sbjct: 82 ADVHAKDKGGL--VP---LHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNR 136
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
EV SLLL GAD + G + + A + E + K + L A
Sbjct: 137 VEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHS-LLQA 185
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 1e-20
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVD 100
L+ A E D+ +K+ L I + + TALH A +V LLL +GA+V+
Sbjct: 182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVN 241
Query: 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
K++ TPL A +++V+++L KHGAK
Sbjct: 242 EKNKDFMTPLHVAAERAHNDVMEVLHKHGAKM 273
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 7e-19
Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+L D + L AA G ++++LL + D STPL A
Sbjct: 7 ALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAA 66
Query: 115 YYKNHEVIKLLEKHGA 130
Y +++LL +HGA
Sbjct: 67 GYNRVRIVQLLLQHGA 82
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 5/77 (6%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
++ L G +N D +TALH AA G + LLL G+D G T
Sbjct: 263 MEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMG-- 320
Query: 116 YKNHEVIKLLEKHGAKP 132
+E ++ +
Sbjct: 321 ---NEAVQQILSESTPM 334
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 26/131 (19%), Positives = 43/131 (32%), Gaps = 29/131 (22%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA----- 80
A +N +D P L A++ VE LL G D + ++A+ +A
Sbjct: 115 ACVNAMDLWQF--TP---LHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPEL 169
Query: 81 ----------------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA---IYYKNHEV 121
A + V L + + T L A ++ K +V
Sbjct: 170 RERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQV 229
Query: 122 IKLLEKHGAKP 132
+LL + GA
Sbjct: 230 AELLLRKGANV 240
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 62.1 bits (152), Expect = 1e-10
Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 10/83 (12%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N LD G+ L A ++ + LL G D + + TA +
Sbjct: 271 AKMNALDSLGQTA-----LHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN---- 321
Query: 86 TEVVSLLLERGADVDPKDRWGST 108
E V +L + D
Sbjct: 322 -EAVQQILSESTPMRTSDVDYRL 343
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 9/60 (15%), Positives = 17/60 (28%), Gaps = 14/60 (23%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGA 130
++AL L + A + L +A N +++ LL
Sbjct: 3 FGKSALD-------------LADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNV 49
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 28/236 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +E++ +V DE +L + HP +++ G + + ++ +Y+ G+L
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
+ L++ A +A ++ + YLH II+RDL+P NIL D
Sbjct: 95 SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPE-----------NILLD 140
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 355
+G++K+ DFG +K +T T C Y+APEV + Y+ +D +SF +++
Sbjct: 141 KNGHIKITDFGFAK-----YVPDVT--YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 193
Query: 356 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
EM+ G PF +D+ K Y + P +K+L+ ++R
Sbjct: 194 YEMLAGYTPF---YDSNTMKTYEKILNAELRFPPFF-NEDVKDLLSRLITRDLSQR 245
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 94.8 bits (237), Expect = 4e-23
Identities = 27/107 (25%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ + L + E L + + + LL+ +D+N D + T L A
Sbjct: 60 ADPHILAKERE--SA---LSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNH 114
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V LL RGAD+ + G TP+ A+ +V +++E H K
Sbjct: 115 VKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKL 161
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 4e-22
Identities = 27/87 (31%), Positives = 50/87 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L++ + ++E ++ LL+ G D + + +AL +A+ G+T++V LLLER D++ D
Sbjct: 40 LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A+ + + ++ L GA
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARGA 126
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 1e-21
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+ LA + +++ +KE L G + VN D T L A+ G E V LLE GAD
Sbjct: 6 IHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHIL 65
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ + L A +++ LL +
Sbjct: 66 AKERESALSLASTGGYTDIVGLLLERDVDI 95
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 77.1 bits (191), Expect = 9e-17
Identities = 15/84 (17%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D +G P L++ V+ ++ LL G D+ T + +A G+
Sbjct: 93 VDINIYDWNGG--TP---LLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLAVALGY 147
Query: 86 TEVVSLLLERGADVDPKDRWGSTP 109
+V ++ + + + P
Sbjct: 148 RKVQQVIENHILKLFQSNLVPADP 171
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 4e-14
Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 1/61 (1%)
Query: 73 NRTALHVAACQGFTEVVSLLLERGAD-VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ ++H A QG + + L +G + V+ D G TPL A + E ++ L + GA
Sbjct: 2 DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61
Query: 132 P 132
P
Sbjct: 62 P 62
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 92.8 bits (232), Expect = 4e-23
Identities = 38/87 (43%), Positives = 51/87 (58%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E +K+LL G DVN R D T LH+AA G E+V LLL +GADV+ +
Sbjct: 13 LHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARS 72
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G+TP A +HE++KLL+ GA
Sbjct: 73 KDGNTPEHLAKKNGHHEIVKLLDAKGA 99
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 79.0 bits (196), Expect = 4e-18
Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 2/68 (2%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G D T LH AA G E V LL +GADV+ + + G+TPL A + E++
Sbjct: 1 GHMWG--SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIV 58
Query: 123 KLLEKHGA 130
KLL GA
Sbjct: 59 KLLLAKGA 66
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 74.3 bits (184), Expect = 2e-16
Identities = 30/85 (35%), Positives = 38/85 (44%), Gaps = 5/85 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N DG P L A E +K LL G DVN R D T H+A G
Sbjct: 33 ADVNARSKDGN--TP---LHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGH 87
Query: 86 TEVVSLLLERGADVDPKDRWGSTPL 110
E+V LL +GADV+ + S
Sbjct: 88 HEIVKLLDAKGADVNARSWGSSHHH 112
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 22/199 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++V+ DD V E +L + P + Q + V EY+ GDL
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
+++ G K AV +A +IA G+ +L II+RDL+ N++
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLD-----------NVML 154
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G++K+ADFG+ K T C Y+APE+ + Y VD ++F ++
Sbjct: 155 DSEGHIKIADFGMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 210
Query: 355 LQEMIEGCPPFTMKHDNEV 373
L EM+ G PF + ++E+
Sbjct: 211 LYEMLAGQAPFEGEDEDEL 229
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 99.9 bits (250), Expect = 6e-23
Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
G + G P L + + +K LL G N ++ T LH+AA G
Sbjct: 5 ISGGGGGESGL--TP---LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGH 59
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
TEV LL+ A V+ K + TPL A + ++KLL ++ A P
Sbjct: 60 TEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANP 106
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 2e-22
Identities = 32/107 (29%), Positives = 45/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
N G P L A E E + LL + N + T LH+ A +G
Sbjct: 236 GSANAESVQGV--TP---LHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGH 290
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V +L++ G VD R G TPL A +Y N +++K L +H A
Sbjct: 291 VPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADV 337
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 2e-22
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K+A N + G P L +A E V L+ G+ V+ T LHVA+
Sbjct: 267 KQANGNLGNKSGL--TP---LHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHY 321
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G ++V LL+ ADV+ K + G +PL A + +++ LL K+GA P
Sbjct: 322 GNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASP 370
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 2e-22
Identities = 36/107 (33%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N G P L A E VE + LL+ T LHVAA G
Sbjct: 104 ANPNLATTAGH--TP---LHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGK 158
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V LLLER A + + G TPL A+++ N +++KLL G P
Sbjct: 159 VRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSP 205
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 3e-22
Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
++A N +G P L + +++ +K LL G + + T LH+AA Q
Sbjct: 168 RDAHPNAAGKNGL--TP---LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQ 222
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
EV LL+ G + + G TPL A + E++ LL A
Sbjct: 223 NQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANG 271
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 6e-22
Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 5/110 (4%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
+ +A++N D + P L A +K LL++ + N T LH+AA
Sbjct: 68 QNKAKVNAKAKDDQT--P---LHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAR 122
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+G E V LLE+ A + G TPL A Y V +LL + A P
Sbjct: 123 EGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHP 172
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 6e-22
Identities = 31/109 (28%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
KEA + G P L A V + LL+ N + T LHVA
Sbjct: 135 KEASQACMTKKGF--TP---LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHH 189
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
++V LLL RG G TPL A EV + L ++G
Sbjct: 190 NNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSA 238
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 9e-22
Identities = 34/109 (31%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ A N + E P L A E K LL + VN + D++T LH AA
Sbjct: 36 RGASPNVSNVKVE--TP---LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 90
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G T +V LLLE A+ + G TPL A + E + L + A
Sbjct: 91 GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQ 139
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (240), Expect = 1e-21
Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ G P L ++ +++ +K LL DVN + + LH AA QG
Sbjct: 302 VMVDATTRMGY--TP---LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGH 356
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
T++V+LLL+ GA + G+TPL A V +L+ +
Sbjct: 357 TDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDE 402
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 6e-21
Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ +G P L A + VE + LL G N + T LH+AA +G
Sbjct: 203 GSPHSPAWNGY--TP---LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGH 257
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E+V+LLL + A+ + ++ G TPL + V +L KHG
Sbjct: 258 AEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMV 304
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 24/70 (34%), Positives = 32/70 (45%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
GI T LHVA+ G +V LL+RGA + + TPL A + EV
Sbjct: 4 GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVA 63
Query: 123 KLLEKHGAKP 132
K L ++ AK
Sbjct: 64 KYLLQNKAKV 73
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 11/38 (28%), Positives = 16/38 (42%)
Query: 95 RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G G TPL A + + ++K L + GA P
Sbjct: 3 PGISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASP 40
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 7e-23
Identities = 28/113 (24%), Positives = 54/113 (47%), Gaps = 6/113 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +DD G+ L + A +V+ LL +G + + ++ T L +AA +G
Sbjct: 116 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 170
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
E +LL+ A+ D D P A +H++++LL+++ +H
Sbjct: 171 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRS-PQLH 222
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 91.3 bits (228), Expect = 2e-21
Identities = 27/87 (31%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A +++L++S DVN D ++ALH AA + +LL+ GA+ D ++
Sbjct: 96 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 155
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A ++E K+L H A
Sbjct: 156 NREETPLFLAAREGSYETAKVLLDHFA 182
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 1e-19
Identities = 25/90 (27%), Positives = 37/90 (41%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
L A + K LL++ D N +D RT LH A V +L+ A D+D +
Sbjct: 29 LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 88
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G+TPL A +++ L A
Sbjct: 89 MHDGTTPLILAARLAVEGMLEDLINSHADV 118
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 2e-19
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
I + + G + N D TALH+AA ++ LLE AD + +D G TPL A+
Sbjct: 7 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66
Query: 115 YYKNHEVIKLLEKHGAK 131
V ++L ++ A
Sbjct: 67 SADAQGVFQILIRNRAT 83
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 84.0 bits (209), Expect = 1e-18
Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A+ N D+ G P L + + L+ + D++ R D T L +AA
Sbjct: 49 ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 103
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++ L+ ADV+ D G + L A N + +L K+GA
Sbjct: 104 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 149
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 50.9 bits (123), Expect = 2e-07
Identities = 14/48 (29%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 84 GFTEVVSLLLERGADV-DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
V+S + +GA + + DR G T L A Y + K L + A
Sbjct: 2 DAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASA 49
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 22/199 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L ++V+ DD V E +L HP + + V EYL GDL
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
++ S A +A +I G+ +LH I++RDL+ NIL
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLD-----------NILL 151
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G++K+ADFG+ K + + + +T C Y+APE+ ++Y+ VD +SF ++
Sbjct: 152 DKDGHIKIADFGMCKENMLGDAKT----NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVL 207
Query: 355 LQEMIEGCPPFTMKHDNEV 373
L EM+ G PF + + E+
Sbjct: 208 LYEMLIGQSPFHGQDEEEL 226
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 8e-23
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 17/141 (12%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ DDG + + D E + LL+ G D+N+ ++D TALH A
Sbjct: 32 KKTKVKFDDGAV------FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDN 85
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLMA 135
++V L+E GA+++ D G PL A ++ + L GA PL
Sbjct: 86 VDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDI 145
Query: 136 PMHVKHAREVPEYEIDPHELD 156
E+ + E++ +D
Sbjct: 146 AEEEAM-EELLQNEVNRQGVD 165
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 9e-21
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 56 IKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
++ L+S I+ TALHVAA +G+TEV+ LL++ DV+ KD G TPL A
Sbjct: 181 ARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAA 240
Query: 115 YYKNHEVIKLLEKHGAKP 132
++ E ++L ++
Sbjct: 241 HWGKEEACRILVENLCDM 258
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 4e-20
Identities = 22/76 (28%), Positives = 35/76 (46%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K L+ + DVN +D D T LH AA G E +L+E D++ ++ G T A
Sbjct: 215 LKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADE 274
Query: 116 YKNHEVIKLLEKHGAK 131
+ +L +K
Sbjct: 275 DILGYLEELQKKQNLL 290
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 2e-16
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 1/77 (1%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
++ + + D+ A G TE V LLERGAD++ + G T L A
Sbjct: 22 TDLEPPVVKRKKTKVKF-DDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQA 80
Query: 114 IYYKNHEVIKLLEKHGA 130
N +++K L ++GA
Sbjct: 81 CIDDNVDMVKFLVENGA 97
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 4e-13
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 11/105 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + ++ +G+ P L E E ++ ++ +D A
Sbjct: 130 AHVGAVNSEGD--TP---LDIAEEEAMEELLQNEVNRQ------GVDIEAARKEEERIML 178
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ L + + G T L A EV+KLL +
Sbjct: 179 RDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARY 223
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 7e-12
Identities = 10/67 (14%), Positives = 20/67 (29%), Gaps = 1/67 (1%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ D + + G + + + K G+ L A + E + L
Sbjct: 1 MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFL-AACSSGDTEEVLRL 59
Query: 126 EKHGAKP 132
+ GA
Sbjct: 60 LERGADI 66
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 2e-07
Identities = 16/78 (20%), Positives = 29/78 (37%), Gaps = 5/78 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D DG P L A+ E + L+++ D+ + +TA VA
Sbjct: 223 YDVNIKDYDGWT--P---LHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDIL 277
Query: 86 TEVVSLLLERGADVDPKD 103
+ L ++ K
Sbjct: 278 GYLEELQKKQNLLHSEKR 295
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + ++ HP +V S + V EY+ GDL
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L
Sbjct: 98 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD-----------NVLL 143
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G++K+ D+G+ K D T T C Y+APE+ + E+Y VD ++ ++
Sbjct: 144 DSEGHIKLTDYGMCKEGLRPGDT--T--STFCGTPNYIAPEILRGEDYGFSVDWWALGVL 199
Query: 355 LQEMIEGCPPFTMKHDNEVPKA 376
+ EM+ G PF + ++ P
Sbjct: 200 MFEMMAGRSPFDIVGSSDNPDQ 221
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 28/199 (14%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + + V FR+E +L + Q A + + +V EY GDL
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
L + G P+ RF +I ++ +H +HRD++P NIL
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPD-----------NILL 195
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-------YDTKVD 347
D G++++ADFG L + Y++PE+ + Y + D
Sbjct: 196 DRCGHIRLADFGSCLKLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECD 252
Query: 348 VFSFALILQEMIEGCPPFT 366
++ + EM G PF
Sbjct: 253 WWALGVFAYEMFYGQTPFY 271
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 32/282 (11%), Positives = 72/282 (25%), Gaps = 60/282 (21%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----------------------HPNV 212
G V + ++ ++E+ L+ +R P
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 213 VQFLGAVTQSSPMMIVTEYLPK-----------GDLRAFLKRKGALKPSTAVRFALDIAR 261
+ + M +++ + L + +L ++ L + R
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 262 GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP 321
+ LH ++H L P +I+ D G + + F P
Sbjct: 223 LLASLHHYG---LVHTYLRPV-----------DIVLDQRGGVFLTGFEHLVRDGASAVSP 268
Query: 322 LTCQDTSCRYVAPEVFKNEEYDTK-----VDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376
+ A + ++ D ++ L + + P D+
Sbjct: 269 IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN---TDDAALGG 325
Query: 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
R P + ++ L+E R Q +
Sbjct: 326 SEWIFRSCKNIP-----QPVRALLEGFLRYPKEDRLLPLQAM 362
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 90.9 bits (227), Expect = 1e-22
Identities = 40/74 (54%), Positives = 50/74 (67%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 19 KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78
Query: 117 KNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 79 GHLEVVKLLLEAGA 92
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 75.5 bits (187), Expect = 4e-17
Identities = 32/59 (54%), Positives = 39/59 (66%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ RT LH+AA G EVV LLLE GADV+ KD+ G TPL A + EV+KLL + GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 53.9 bits (131), Expect = 2e-09
Identities = 32/74 (43%), Positives = 42/74 (56%), Gaps = 5/74 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
A++N D +G P L A +E +K LL++G DVN +D + RT LH+AA
Sbjct: 24 AGADVNAKDKNGR--TP---LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78
Query: 84 GFTEVVSLLLERGA 97
G EVV LLLE GA
Sbjct: 79 GHLEVVKLLLEAGA 92
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 1e-22
Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +DD G+ L + A +V+ LL +G + + ++ T L +AA +G
Sbjct: 148 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 202
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E +LL+ A+ D D P A +H++++LL+
Sbjct: 203 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHH 247
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-21
Identities = 27/87 (31%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A +++L++S DVN D ++ALH AA + +LL+ GA+ D ++
Sbjct: 128 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 187
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A ++E K+L H A
Sbjct: 188 NREETPLFLAAREGSYETAKVLLDHFA 214
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 87.5 bits (218), Expect = 1e-19
Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A+ N D+ G P L + + L+ + D++ R D T L +AA
Sbjct: 81 ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 135
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++ L+ ADV+ D G + L A N + +L K+GA
Sbjct: 136 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 181
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
L A + K LL++ D N +D RT LH A V +L+ A D+D +
Sbjct: 61 LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 120
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+TPL A +++ L A
Sbjct: 121 MHDGTTPLILAARLAVEGMLEDLINSHA 148
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 3e-18
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
I + + G + N D TALH+AA ++ LLE AD + +D G TPL A+
Sbjct: 39 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 98
Query: 115 YYKNHEVIKLLEKHGAK 131
V ++L ++ A
Sbjct: 99 SADAQGVFQILIRNRAT 115
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 1e-14
Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 14/83 (16%)
Query: 64 IDVNFRDIDNRTALHVAACQGFT-------------EVVSLLLERGADV-DPKDRWGSTP 109
+DVN R D T L +A+C G V+S + +GA + + DR G T
Sbjct: 1 MDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETA 60
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A Y + K L + A
Sbjct: 61 LHLAARYSRSDAAKRLLEASADA 83
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 56.3 bits (137), Expect = 4e-09
Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + ++ E P L A E E K LLD + + D +R +A +
Sbjct: 181 ANKDMQNNREE--TP---LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMH 235
Query: 86 TEVVSLLLERGADVDPK 102
++V LL
Sbjct: 236 HDIVRLLDLEHHHHHHH 252
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 2/108 (1%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
RK P L+ A ++E +++ + D + + + TALH A C
Sbjct: 6 RKAGSPRKARRARLN--PLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAIC 63
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+V L+ GA+V+ D G TPL A + + L +HGA
Sbjct: 64 GANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGA 111
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-18
Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 8/109 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + +++G L + + L+ +G +VN D T LH AA
Sbjct: 45 NDPSQPNEEGI--TA---LHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCND 99
Query: 86 TEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKN--HEVIKLLEKHGAK 131
T + L++ GA + G+T Y+ + L
Sbjct: 100 TVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQS 148
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 10/67 (14%), Positives = 18/67 (26%), Gaps = 1/67 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
L D + + AL + F + +S V +D T A
Sbjct: 139 ATYLADVEQSMGLMNSGAVYALWDYS-AEFGDELSFREGESVTVLRRDGPEETDWWWAAL 197
Query: 116 YKNHEVI 122
+ +
Sbjct: 198 HGQEGYV 204
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 11/88 (12%), Positives = 21/88 (23%), Gaps = 7/88 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
E + ++ ++ + + + + V RD T AA
Sbjct: 145 VEQSMGLMNSGAVY------ALWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALH 198
Query: 84 GFTEVV-SLLLERGADVDPKDRWGSTPL 110
G V V P+
Sbjct: 199 GQEGYVPRNYFGLFPRVKPQRSKVKHHH 226
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 9/47 (19%), Positives = 14/47 (29%), Gaps = 3/47 (6%)
Query: 89 VSLLLERGADVDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +L + R L DA EV++ K P
Sbjct: 1 MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDP 47
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 32/288 (11%), Positives = 73/288 (25%), Gaps = 71/288 (24%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-------------------------H 209
G V + ++ ++E+ L+ +R
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 210 PNVVQFLGAVTQSSPMMIVTEY-LPKGD-------LRAFLKRKGALKPSTAVRFALDIAR 261
+++ + Y + + L + +L ++ L + R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 262 GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP 321
+ LH ++H L P +I+ D G + + F V++
Sbjct: 218 LLASLHHYG---LVHTYLRPV-----------DIVLDQRGGVFLTGFEHL----VRDGAR 259
Query: 322 LTCQDTSCRYVAPEVFKNEE-----------YDTKVDVFSFALILQEMIEGCPPFTMKHD 370
+ S + PE+ D ++ L++ + P
Sbjct: 260 VVS-SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI---TK 315
Query: 371 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ R P ++ L+E R Q +
Sbjct: 316 DAALGGSEWIFRSCKNIPQ-----PVRALLEGFLRYPKEDRLLPLQAM 358
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A++ + +E+++DD+ + + E + ++ HP +V S + V EY+ GDL
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD-----------NVLL 186
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G++K+ D+G+ K D T T C Y+APE+ + E+Y VD ++ ++
Sbjct: 187 DSEGHIKLTDYGMCKEGLRPGDT--T--STFCGTPNYIAPEILRGEDYGFSVDWWALGVL 242
Query: 355 LQEMIEGCPPFTMKHDNEVPKA 376
+ EM+ G PF + ++ P
Sbjct: 243 MFEMMAGRSPFDIVGSSDNPDQ 264
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 92.4 bits (231), Expect = 2e-22
Identities = 32/87 (36%), Positives = 48/87 (55%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + LL +G+ + R +RT LH+AA +G +V +LL+ GADV+ KD
Sbjct: 38 LHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKD 97
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
T L A + + EV++LL K+GA
Sbjct: 98 MLKMTALHWATEHNHQEVVELLIKYGA 124
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 87.4 bits (218), Expect = 1e-20
Identities = 28/83 (33%), Positives = 44/83 (53%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A+E ++ LL G DVN +D+ TALH A EVV LL++ GADV +
Sbjct: 71 LHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQS 130
Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
++ T +I N ++ ++L+
Sbjct: 131 KFCKTAFDISIDNGNEDLAEILQ 153
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 2e-20
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 1/87 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G D + LH+AA G +LL G D +
Sbjct: 6 LLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDART 64
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ TPL A + ++++L KHGA
Sbjct: 65 KVDRTPLHMAASEGHANIVEVLLKHGA 91
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 70.9 bits (175), Expect = 7e-15
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 1/59 (1%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D L AA G + V +L+ GA D G++PL A Y + ++L + G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGV 58
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 92.9 bits (232), Expect = 2e-22
Identities = 20/85 (23%), Positives = 33/85 (38%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+++LL D+N + LH A G +V L+ GA V +++G P+ A
Sbjct: 88 VQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKA 147
Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVK 140
+ + EK G P
Sbjct: 148 PLRELLRERAEKMGQNLNRIPYKDT 172
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 2e-21
Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 5/111 (4%)
Query: 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
+ E +LN DD G P L + E ++ L+ G +N + + T LH+AA
Sbjct: 26 DNTENDLNQGDDHGF--SP---LHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAA 80
Query: 82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G ++V LL+ AD++ + G+ PL A ++ +V + L +GA
Sbjct: 81 SHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALV 131
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 8e-14
Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ + +G V L L+ D++ D G +PL A V+++L
Sbjct: 2 SPEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMR 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 19/120 (15%), Positives = 36/120 (30%), Gaps = 18/120 (15%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANE------RDVEGIKELLDSGIDVNFRDIDNRTALHV 79
A++ +G L E K L+ G D+ + +
Sbjct: 66 ADIKSRTKEGT--TL---FFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFK 120
Query: 80 AACQGFTEVVS-------LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
F + + + G + KD+WG T L + +K++E + K
Sbjct: 121 NIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKY 180
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-16
Identities = 16/96 (16%), Positives = 34/96 (35%), Gaps = 9/96 (9%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN---RTALHVAACQGFTEVVSLLLERGADVD 100
+ A E EL + G + + + L + ++ L+ +GAD+
Sbjct: 10 VSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIK 69
Query: 101 PKDRWGSTPLGDAIYYKNH------EVIKLLEKHGA 130
+ + G+T + E+ K+ + GA
Sbjct: 70 SRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGA 105
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-12
Identities = 10/85 (11%), Positives = 25/85 (29%), Gaps = 12/85 (14%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE-------LLDSGIDVNFRDIDNRTALH 78
A++ L + + V+ + SG+ + +D TAL
Sbjct: 105 ADITALYKPYK--IV---VFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALE 159
Query: 79 VAACQGFTEVVSLLLERGADVDPKD 103
+ ++ + + K+
Sbjct: 160 FVKRCQKPIALKMMEDYIKKYNLKE 184
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 12/63 (19%), Positives = 20/63 (31%), Gaps = 3/63 (4%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
+ + AA G E L E+G + K L + +++ L
Sbjct: 4 MSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLIN 63
Query: 128 HGA 130
GA
Sbjct: 64 KGA 66
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)
Query: 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
+ +DG+ L + + LL ++ ++ +TALH+AA G
Sbjct: 2 FGYVTEDGD--TA---LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V L GA V +R G T L A + H +L +
Sbjct: 57 EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQG 84
+L + DG P L +D E ++ L D+G D+N + RT LH+A
Sbjct: 149 LQLEAENYDGH--TP---LHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQ 203
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V+ LLL+ GAD + G TPLG A+ N + +LL HGA
Sbjct: 204 AASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPE 251
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 30/115 (26%), Positives = 47/115 (40%), Gaps = 1/115 (0%)
Query: 19 PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALH 78
R+ + L D + + + E D + + + D T LH
Sbjct: 104 HPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLH 163
Query: 79 VAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
VA E+V LL + GAD++ + G TPL A+ + V++LL K GA P
Sbjct: 164 VAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADP 218
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 2e-18
Identities = 14/74 (18%), Positives = 26/74 (35%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
++ LL +G D R RT L A + + LL GA +P +
Sbjct: 208 LELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSGS 267
Query: 116 YKNHEVIKLLEKHG 129
+ + +++
Sbjct: 268 DSDSDNRDEGDEYD 281
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 14/101 (13%), Positives = 24/101 (23%), Gaps = 14/101 (13%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + +++L +G V + TALH+A +LL+
Sbjct: 49 LHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDA 108
Query: 104 RWGSTPLGDAIYYKN--------------HEVIKLLEKHGA 130
+E E
Sbjct: 109 SDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRL 149
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 31/201 (15%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MM 226
VA+K + + R E+ALL+++ HPNVV+ + S +
Sbjct: 37 VALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95
Query: 227 IVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDL 284
+V E++ + DLR +L + L T RG+++LH N I+HRDL+P
Sbjct: 96 LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPE-- 149
Query: 285 YVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 344
NIL G +K+ADFG++++ + LT + Y APEV Y T
Sbjct: 150 ---------NILVTSGGTVKLADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYAT 198
Query: 345 KVDVFSFALILQEMIEGCPPF 365
VD++S I EM P F
Sbjct: 199 PVDMWSVGCIFAEMFRRKPLF 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 65/267 (24%), Positives = 100/267 (37%), Gaps = 58/267 (21%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
+ A+K ++ D + R E+ L + + P++V+ + ++IV
Sbjct: 87 QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138
Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVA 287
E L G+L R + A A I + YLH I HRD++P
Sbjct: 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE----- 190
Query: 288 YWQNDRNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 341
N+L + + LK+ DFG +K LT T C YVAPEV E+
Sbjct: 191 ------NLLYTSKRPNAILKLTDFGFAKE--TTSHNSLT---TPCYTPYYVAPEVLGPEK 239
Query: 342 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---PPFKAP--------AK 390
YD D++S +I+ ++ G PPF H + R R F P
Sbjct: 240 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV- 298
Query: 391 LYARGLKELIEECWNEKPAKRPTFRQI 417
K LI +P +R T +
Sbjct: 299 ------KMLIRNLLKTEPTQRMTITEF 319
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 91.3 bits (228), Expect = 3e-22
Identities = 21/76 (27%), Positives = 34/76 (44%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ LL G + N D T +H AA +GF + + +L GA +D D WG P+ A
Sbjct: 60 AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAE 119
Query: 115 YYKNHEVIKLLEKHGA 130
+ ++ + L
Sbjct: 120 EQGHRDIARYLHAATG 135
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 9e-22
Identities = 27/106 (25%), Positives = 45/106 (42%), Gaps = 7/106 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ L + L A VE +++LL++G D N + R + V G
Sbjct: 3 PGIHMLGGSSD--AG---LATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM-MGS 56
Query: 86 TEVVSLLLERGADVDPKDRWGST-PLGDAIYYKNHEVIKLLEKHGA 130
+V LLL GA+ + D T P+ DA + + +L + GA
Sbjct: 57 AQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGA 102
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 2e-20
Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EV 121
++ + L AA +G E V LLE GAD + +R+G P+ + +V
Sbjct: 2 SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM--GSAQV 59
Query: 122 IKLLEKHGAKP 132
+LL HGA+P
Sbjct: 60 AELLLLHGAEP 70
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 60.5 bits (148), Expect = 2e-11
Identities = 16/73 (21%), Positives = 28/73 (38%), Gaps = 4/73 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
AE N D +P + A E ++ + L +G ++ D R + +A QG
Sbjct: 68 AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGH 123
Query: 86 TEVVSLLLERGAD 98
++ L D
Sbjct: 124 RDIARYLHAATGD 136
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 3e-22
Identities = 26/77 (33%), Positives = 39/77 (50%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
E + LL G + + +D +H AA GF + + LLE ADV+ +D G+ PL A
Sbjct: 51 EIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLA 110
Query: 114 IYYKNHEVIKLLEKHGA 130
+ V++ L KH A
Sbjct: 111 AKEGHLRVVEFLVKHTA 127
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 87.8 bits (219), Expect = 1e-20
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 1/87 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A D+E + LL + ++VN ++ RTAL V G E+ LL RGA+ D KD
Sbjct: 9 LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKD 67
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
R G + DA + ++ L + A
Sbjct: 68 RTGFAVIHDAARAGFLDTLQTLLEFQA 94
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 87.8 bits (219), Expect = 1e-20
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + D G + A ++ ++ LL+ DVN D + LH+AA +G
Sbjct: 61 ANPDLKDRTGF--AV---IHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGH 115
Query: 86 TEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
VV L++ A +V ++ G T A Y +EV+ L++ +GA
Sbjct: 116 LRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGA 161
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 71.3 bits (176), Expect = 7e-15
Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
L AA +G E ++ LL+ +V+ ++ +G T L N E+ + L GA
Sbjct: 4 PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGAN 62
Query: 132 P 132
P
Sbjct: 63 P 63
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 94.4 bits (236), Expect = 3e-22
Identities = 30/88 (34%), Positives = 43/88 (48%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V+ L+ +G +++ D RT L AA E V L++ GA VDPKD
Sbjct: 15 LHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKD 74
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
GST L A ++EV++ L +G
Sbjct: 75 AEGSTCLHLAAKKGHYEVVQYLLSNGQM 102
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 1e-20
Identities = 21/75 (28%), Positives = 34/75 (45%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL + D++ +I + LH+AA + + V L L R +DV K++ G TPL A
Sbjct: 160 AEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASL 219
Query: 116 YKNHEVIKLLEKHGA 130
+ K
Sbjct: 220 NSQVWSALQMSKALQ 234
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 1e-20
Identities = 21/75 (28%), Positives = 34/75 (45%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K LL G D+N RD + LH AA G ++ +LL D+ + G +PL A
Sbjct: 127 VKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAAR 186
Query: 116 YKNHEVIKLLEKHGA 130
++ + L +
Sbjct: 187 ENRYDCVVLFLSRDS 201
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 88.6 bits (221), Expect = 3e-20
Identities = 20/67 (29%), Positives = 34/67 (50%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
++ + R+ LH AA G ++ +L++ GA++D TPL +A + E +K
Sbjct: 2 MNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVK 61
Query: 124 LLEKHGA 130
L K GA
Sbjct: 62 YLIKAGA 68
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 88.6 bits (221), Expect = 3e-20
Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A ++ D +G L A + E ++ LL +G +DVN +D T + A
Sbjct: 68 ALVDPKDAEGS--TC---LHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYK 122
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
++V LLL +G+D++ +D + L A + ++ ++L
Sbjct: 123 HVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDL 170
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 54.3 bits (132), Expect = 1e-08
Identities = 13/75 (17%), Positives = 27/75 (36%), Gaps = 5/75 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ +L+ ++ G+ P L A E + + L DV ++ + T L A+
Sbjct: 166 AKCDLHAVNIHGD--SP---LHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLN 220
Query: 84 GFTEVVSLLLERGAD 98
+ + D
Sbjct: 221 SQVWSALQMSKALQD 235
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-22
Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQG 84
+++ +D++G L+F+A + ++ L ++G D++ RD+ TALH+AA
Sbjct: 68 RDVDAVDENGR--TA---LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYV 122
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EVV L+E GAD++ +D G T L A + G +
Sbjct: 123 RPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 169
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
A + D + + +LL DV+ D + RTAL A G + V LL E GAD+D +D
Sbjct: 49 WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 107
Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
R G T L A Y EV++ L + GA
Sbjct: 108 MRGGLTALHMAAGYVRPEVVEALVELGADI 137
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 3/87 (3%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E ++ L++ G D+ D TAL +A T ++ G + +
Sbjct: 115 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 174
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + ++ EV +++EK G
Sbjct: 175 ---VINVLEGQVFEYAEVDEIVEKRGK 198
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 9/69 (13%), Positives = 17/69 (24%), Gaps = 4/69 (5%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
I + + + G + ADV + TP A + + +
Sbjct: 6 IIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQALS 62
Query: 124 LLEKHGAKP 132
L
Sbjct: 63 QL-LEDRDV 70
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 12/106 (11%), Positives = 27/106 (25%), Gaps = 16/106 (15%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++ D+ G L + G + + + +
Sbjct: 135 ADIEVEDERGL--TA---LELAREILKTTPKGNPMQFGRRIGLEKV---INVLEGQVFEY 186
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EV ++ +RG G + + + H A+
Sbjct: 187 AEVDEIVEKRGK--------GKDVEYLVRWKDGGDCEWVKGVHVAE 224
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 4/48 (8%), Positives = 14/48 (29%), Gaps = 2/48 (4%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
++ + + ++ + + + A+ KD L
Sbjct: 189 VDEIVEKRGKGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD--YEDGL 234
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 3e-22
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L A DV+ ++ LL + + + +TAL V G T + LL++GA + +
Sbjct: 6 LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQ 64
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D G++P+ DA + +K+L +HGA
Sbjct: 65 DTSGTSPVHDAARTGFLDTLKVLVEHGA 92
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 1e-21
Identities = 23/73 (31%), Positives = 36/73 (49%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
ELL G N +D + +H AA GF + + +L+E GADV+ D G+ P+ A+
Sbjct: 51 ALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQ 110
Query: 116 YKNHEVIKLLEKH 128
+ V+ L
Sbjct: 111 EGHTAVVSFLAAE 123
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 4e-20
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N D G P + A ++ +K L++ G DVN D +H+A +G
Sbjct: 59 ASPNVQDTSGT--SP---VHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGH 113
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
T VVS L +D+ +D G TPL A+ +++ +L+ H
Sbjct: 114 TAVVSFLAA-ESDLHRRDARGLTPLELALQRGAQDLVDILQGH 155
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 64.0 bits (157), Expect = 2e-12
Identities = 17/60 (28%), Positives = 24/60 (40%), Gaps = 4/60 (6%)
Query: 75 TALHVAACQGFTEVV-SLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGAKP 132
L AA +G + V LL D +R+G T L ++ + L K GA P
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMF--GSTAIALELLKQGASP 61
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 22/199 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L HP + Q + V E++ GDL
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
+++ + A +A +I + +LH+ II+RDL+ N+L
Sbjct: 112 MFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLD-----------NVLL 157
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G+ K+ADFG+ K T T C Y+APE+ + Y VD ++ ++
Sbjct: 158 DHEGHCKLADFGMCKEGICNGVT--T--ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVL 213
Query: 355 LQEMIEGCPPFTMKHDNEV 373
L EM+ G PF ++++++
Sbjct: 214 LYEMLCGHAPFEAENEDDL 232
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 4e-22
Identities = 35/89 (39%), Positives = 46/89 (51%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L F A V ++ LL G DV+ +D LH A G EV LL++ GA V+ D
Sbjct: 46 LHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVAD 105
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
W TPL +A +E+ KLL +HGA P
Sbjct: 106 LWKFTPLHEAAAKGKYEICKLLLQHGADP 134
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 85.5 bits (213), Expect = 6e-20
Identities = 28/72 (38%), Positives = 39/72 (54%), Gaps = 1/72 (1%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
L+ G VN D+ T LH AA +G E+ LLL+ GAD K+R G+TPL D + +
Sbjct: 94 LVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL-DLVKDGD 152
Query: 119 HEVIKLLEKHGA 130
++ LL A
Sbjct: 153 TDIQDLLRGDAA 164
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 84.7 bits (211), Expect = 1e-19
Identities = 35/88 (39%), Positives = 47/88 (53%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ A DVE +K+L ++ + T LH AA VV LL+ GADV K
Sbjct: 12 LLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAK 71
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D+ G PL +A Y ++EV +LL KHGA
Sbjct: 72 DKGGLVPLHNACSYGHYEVAELLVKHGA 99
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 4e-14
Identities = 20/69 (28%), Positives = 26/69 (37%), Gaps = 4/69 (5%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEV 121
G N + L AA G E V L + + STPL A Y V
Sbjct: 1 GAMGN---SEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSV 57
Query: 122 IKLLEKHGA 130
++ L +HGA
Sbjct: 58 VEYLLQHGA 66
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 47.0 bits (113), Expect = 1e-06
Identities = 20/72 (27%), Positives = 27/72 (37%), Gaps = 6/72 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N D P L A + E K LL G D ++ D T L + G
Sbjct: 99 AVVNVADLWKF--TP---LHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVK-DGD 152
Query: 86 TEVVSLLLERGA 97
T++ LL A
Sbjct: 153 TDIQDLLRGDAA 164
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 92.5 bits (231), Expect = 5e-22
Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ AN+RD + +KE+L V+ D + T L++A E+ L++RGAD++ +
Sbjct: 9 LLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQ 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ +P A E++ + KH
Sbjct: 69 NSISDSPYLYAGAQGRTEILAYMLKHAT 96
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 82.1 bits (204), Expect = 3e-18
Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 44 LMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAAC-----QGFTEVVSLLLERGA 97
L+ A + ++ +K LL+ G D++F++ TAL A Q + ++V LL+E GA
Sbjct: 110 LIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGA 169
Query: 98 DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
D KD G T + A E+ K+L ++
Sbjct: 170 DQSIKDNSGRTAMDYANQKGYTEISKILAQY 200
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 4e-17
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 7/82 (8%)
Query: 56 IKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPLGDA 113
+ +L D+N + AL AA +G + V LLLE G D+D ++ +G T L +A
Sbjct: 88 LAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEA 147
Query: 114 IYY----KNH-EVIKLLEKHGA 130
+ + + +++KLL ++GA
Sbjct: 148 VGLREGNQLYQDIVKLLMENGA 169
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 77.1 bits (191), Expect = 1e-16
Identities = 17/62 (27%), Positives = 28/62 (45%)
Query: 69 RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ + L A + +V +L + VD D G+TPL A++ + E+ K L
Sbjct: 2 KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 5e-22
Identities = 33/87 (37%), Positives = 51/87 (58%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DVN D T LH+AA G E+V +LL+ GADV+ D
Sbjct: 18 LLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVD 77
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A + + E++++L K+GA
Sbjct: 78 HAGMTPLRLAALFGHLEIVEVLLKNGA 104
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 90.9 bits (227), Expect = 9e-22
Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N D G P L A +E ++ LL +G DVN D T L +AA G
Sbjct: 38 ADVNAEDASGW--TP---LHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGH 92
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E+V +LL+ GADV+ D G TPL A + + E++++L K+GA
Sbjct: 93 LEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGA 137
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 89.7 bits (224), Expect = 3e-21
Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 5/103 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +D G P L A +E ++ LL +G DVN D++ T LH+AA G
Sbjct: 71 ADVNAVDHAGM--TP---LRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGH 125
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
E+V +LL+ GADV+ +D++G T +I N ++ ++L+K
Sbjct: 126 LEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKL 168
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 74.7 bits (185), Expect = 5e-16
Identities = 22/61 (36%), Positives = 34/61 (55%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
D L AA G + V +L+ GADV+ +D G TPL A + + E++++L K+G
Sbjct: 11 GSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNG 70
Query: 130 A 130
A
Sbjct: 71 A 71
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 5e-22
Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
A + D + + +LL DV+ D + RTAL A G + V LL E GAD+D +D
Sbjct: 48 WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 106
Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
R G T L A Y EV++ L + GA
Sbjct: 107 MRGGLTALHMAAGYVRPEVVEALVELGADI 136
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 2e-21
Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 26 AELNGLDDDGEEIKPEFR--LMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAAC 82
+++ +D++G R L+F+A + ++ L ++G D++ RD+ TALH+AA
Sbjct: 67 RDVDAVDENG-------RTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EVV L+E GAD++ +D G T L A + G +
Sbjct: 120 YVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 168
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 7e-12
Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 17/85 (20%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E ++ L++ G D+ D TAL +A T ++ G + +
Sbjct: 114 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 173
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKH 128
VI +LE
Sbjct: 174 -----------------VINVLEGQ 181
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 6e-11
Identities = 9/69 (13%), Positives = 18/69 (26%), Gaps = 4/69 (5%)
Query: 62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+ I + + + G + ADV + TP A + +
Sbjct: 3 NKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQA 59
Query: 122 IKLLEKHGA 130
+ L
Sbjct: 60 LSQL-LEDR 67
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 7e-22
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 22/198 (11%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + DRVR + E +L ++ HP +V+ A + ++ ++L GDL
Sbjct: 56 AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L ++ + ++A +++LH II+RDL+P NIL D
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPE-----------NILLD 160
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 355
+ G++K+ DFG+SK E + + C Y+APEV + D +SF +++
Sbjct: 161 EEGHIKLTDFGLSKESIDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLM 216
Query: 356 QEMIEGCPPFTMKHDNEV 373
EM+ G PF K E
Sbjct: 217 FEMLTGTLPFQGKDRKET 234
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 90.1 bits (225), Expect = 8e-22
Identities = 32/87 (36%), Positives = 50/87 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DVN +D T L++A G E+V +LL+ GADV+ D
Sbjct: 18 LLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVD 77
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A + + E+ ++L KHGA
Sbjct: 78 AIGFTPLHLAAFIGHLEIAEVLLKHGA 104
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 3e-20
Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N D+ G P L +E ++ LL +G DVN D T LH+AA G
Sbjct: 38 ADVNAKDEYGL--TP---LYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGH 92
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
E+ +LL+ GADV+ +D++G T +I N ++ ++L+K
Sbjct: 93 LEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQKL 135
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 72.4 bits (179), Expect = 2e-15
Identities = 23/59 (38%), Positives = 35/59 (59%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D L AA G + V +L+ GADV+ KD +G TPL A + + E++++L K+GA
Sbjct: 13 DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGA 71
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 92.9 bits (232), Expect = 9e-22
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
++ E +EL+++G DV D +N T LH AA ++V + +GA VD
Sbjct: 13 IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 72
Query: 104 R-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
STPL A + ++ L K+GA P
Sbjct: 73 GDLNSTPLHWATRQGHLSMVVQLMKYGADP 102
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 8e-21
Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 49 NERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
+ D + LL + VN D TALH A G T V+SLLLE GA+VD ++ G
Sbjct: 154 HSVDP--TRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGE 211
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAK 131
+ L A KN +I L++
Sbjct: 212 SALDLAKQRKNVWMINHLQEARQA 235
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 1e-19
Identities = 28/134 (20%), Positives = 49/134 (36%), Gaps = 16/134 (11%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQG 84
++ D + L + A ++ +K + G V+ D N T LH A QG
Sbjct: 33 YDVRQPDKENV--TL---LHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQG 87
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLM 134
+V L++ GAD D G + + A + + ++ L G PLM
Sbjct: 88 HLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLM 147
Query: 135 APMHVKHAREVPEY 148
+ H+ +
Sbjct: 148 WAAYRTHSVDPTRL 161
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 1e-19
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ +L+ G D + D + + +H+AA G T +V+ L+ +G DVD D+ G TPL A Y
Sbjct: 92 VVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAY 151
Query: 116 YKNH-EVIKLLEKHGA 130
+ + +LL
Sbjct: 152 RTHSVDPTRLLLTFNV 167
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 85.2 bits (212), Expect = 5e-19
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 7/107 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ + +D +G + A + L+ G DV+ D + T L AA +
Sbjct: 100 ADPSLIDGEGC--SC---IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTH 154
Query: 86 T-EVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + LLL V+ D++ +T L A+ N VI LL + GA
Sbjct: 155 SVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 201
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 79.4 bits (197), Expect = 5e-17
Identities = 16/65 (24%), Positives = 24/65 (36%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ D + + A G E L+E G DV D+ T L A +++K
Sbjct: 2 MTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYY 61
Query: 126 EKHGA 130
GA
Sbjct: 62 ISKGA 66
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 58.2 bits (142), Expect = 8e-10
Identities = 12/60 (20%), Positives = 27/60 (45%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + I LL++G +V+ ++I +AL +A + +++ L E +
Sbjct: 181 LHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKGYDN 240
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 89.3 bits (223), Expect = 1e-21
Identities = 40/75 (53%), Positives = 51/75 (68%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 18 VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAAR 77
Query: 116 YKNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 78 NGHLEVVKLLLEAGA 92
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 89.3 bits (223), Expect = 1e-21
Identities = 40/74 (54%), Positives = 50/74 (67%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 52 KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 111
Query: 117 KNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 112 GHLEVVKLLLEAGA 125
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 75.8 bits (188), Expect = 8e-17
Identities = 32/59 (54%), Positives = 39/59 (66%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ RT LH+AA G EVV LLLE GADV+ KD+ G TPL A + EV+KLL + GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 54.7 bits (133), Expect = 2e-09
Identities = 24/42 (57%), Positives = 30/42 (71%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA 97
+K LL++G DVN +D + RT LH+AA G EVV LLLE GA
Sbjct: 84 VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 32/200 (16%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MMI 227
VA+K++ + + ++ + R E+A+L+ + HPNVV+ T S + +
Sbjct: 40 VALKRVRVQ--TGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 228 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285
V E++ + DL +L + + T + RG+++LH ++ ++HRDL+P
Sbjct: 97 VFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQ--- 149
Query: 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 345
NIL SG +K+ADFG++++ + LT + Y APEV Y T
Sbjct: 150 --------NILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATP 199
Query: 346 VDVFSFALILQEMIEGCPPF 365
VD++S I EM P F
Sbjct: 200 VDLWSVGCIFAEMFRRKPLF 219
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 92.9 bits (232), Expect = 1e-21
Identities = 21/105 (20%), Positives = 36/105 (34%), Gaps = 19/105 (18%)
Query: 47 LANERDVEG-------------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87
+A D +G + G +++ + +T LH+A
Sbjct: 1 MATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPS 60
Query: 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
VV LL+ GA DR G T A +++ ++ L A
Sbjct: 61 VVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPG 105
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 6e-21
Identities = 22/87 (25%), Positives = 39/87 (44%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ + ++ LL G +VN + +ALH A+ +G +V L+ GAD K+
Sbjct: 154 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 213
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A + ++++ A
Sbjct: 214 CHNDTPLMVARSRRVIDILRGKATRPA 240
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 6e-20
Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 1/78 (1%)
Query: 56 IKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
++ LL+ G D++ DI + R+ L A +V LLL+ GA+V+ + GS+ L A
Sbjct: 132 VQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSAS 191
Query: 115 YYKNHEVIKLLEKHGAKP 132
+++ L + GA
Sbjct: 192 GRGLLPLVRTLVRSGADS 209
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 85.2 bits (212), Expect = 5e-19
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 9/109 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
EL+ ++ + P L ++ L+ +G D +TA H+A
Sbjct: 37 RELDIYNNLRQ--TP---LHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRS 91
Query: 86 TEVVSLLLERGA----DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ LL+ A D++ ++ G T L A+ + E ++LL + GA
Sbjct: 92 PTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGA 140
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 85.2 bits (212), Expect = 5e-19
Identities = 39/110 (35%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG----IDVNFRDIDNRTALHVAA 81
A LD G+ R ++ LLDS +D+ R+ D TALHVA
Sbjct: 70 ASPMALDRHGQ--TA---AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAV 124
Query: 82 CQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGA 130
E V LLLERGAD+D D G +PL A+ + +++LL +HGA
Sbjct: 125 NTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGA 174
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 1e-21
Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 2/87 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + +V + LL++G N + N LH AA T++V +LL G D D
Sbjct: 35 SYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFD 92
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+T L A+ N + +KL K
Sbjct: 93 DKGNTALYYAVDSGNMQTVKLFVKKNW 119
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 3/85 (3%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
N + +K L S D D+ +A + A +V LL GA + +
Sbjct: 7 INTWKSKQLKSFL-SSKDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NE 63
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
PL A ++ +++K+L G
Sbjct: 64 FPLHQAATLEDTKIVKILLFSGLDD 88
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 7e-20
Identities = 20/88 (22%), Positives = 35/88 (39%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A D + +K LL SG+D + D TAL+ A G + V L +++ +
Sbjct: 66 LHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYG 125
Query: 104 RWG-STPLGDAIYYKNHEVIKLLEKHGA 130
+ G T A+ + ++
Sbjct: 126 KTGWKTSFYHAVMLNDVSIVSYFLSEIP 153
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 8e-18
Identities = 18/106 (16%), Positives = 35/106 (33%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
L G + DV + L F + +H+ G
Sbjct: 119 WRLMFYGKTGWKT-S---FYHAVMLNDVSIVSYFLSEI-PSTFDLAILLSCIHITIKNGH 173
Query: 86 TEVVSLLLERGADVDPKDRWGSTP-LGDAIYYKNHEVIKLLEKHGA 130
+++ LLL+ + + P + AI K+ E+++ L K+
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDI 219
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 2e-16
Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 8/81 (9%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111
V+ + LLD N + + +A E++ L + ++ +
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIY-------SANL 226
Query: 112 DAIYYKNHEVIKLLEKHGAKP 132
+ + + E+ K++ + +
Sbjct: 227 ENVLLDDAEIAKMIIEKHVEY 247
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 8e-11
Identities = 11/97 (11%), Positives = 29/97 (29%), Gaps = 13/97 (13%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
N + + + +D+E ++ L I++ +A
Sbjct: 185 TSTNTNNSLLFIPD----IKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDD 233
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
E+ +++E+ + + K E+I
Sbjct: 234 AEIAKMIIEKHVEYKSDSYTKDLDI--VKNNKLDEII 268
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-21
Identities = 22/76 (28%), Positives = 35/76 (46%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ LL G + N D T +H AA +GF + + +L GA +D +D WG P+ A
Sbjct: 60 AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAE 119
Query: 115 YYKNHEVIKLLEKHGA 130
+ +V + L
Sbjct: 120 ELGHRDVARYLRAAAG 135
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 4e-20
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A VE ++ LL++G + N + R + V G V LLL GA+ + D
Sbjct: 16 LATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCAD 74
Query: 104 RWGST-PLGDAIYYKNHEVIKLLEKHGAKP 132
T P+ DA + + +L + GA+
Sbjct: 75 PATLTRPVHDAAREGFLDTLVVLHRAGARL 104
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 76.7 bits (190), Expect = 6e-17
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 5/74 (6%)
Query: 60 LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
++ + + L AA +G E V LLE GA+ + + +G P+ +
Sbjct: 1 MEPAAGSS--MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMM--GS 56
Query: 120 -EVIKLLEKHGAKP 132
V +LL HGA+P
Sbjct: 57 ARVAELLLLHGAEP 70
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 8e-14
Identities = 18/96 (18%), Positives = 31/96 (32%), Gaps = 9/96 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
AE N D +P + A E ++ + L +G ++ RD R + +A G
Sbjct: 68 AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGH 123
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+V L GS ++
Sbjct: 124 RDVARYLRAAAGGTR-----GSNHARIDAAEGPSDI 154
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 28/87 (32%), Positives = 46/87 (52%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ + E + + ++ ++ D + + + TALH A C G TE+V L++ G +V+ D
Sbjct: 41 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A N +V K L + GA
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGA 127
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 8/110 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + +D+G I L E +K L+ G++VN D D T LH AA
Sbjct: 61 DDPSLPNDEG--ITA---LHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNN 115
Query: 86 TEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+V L+E GA V D + + + + + L K
Sbjct: 116 VQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 165
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 16/77 (20%), Positives = 33/77 (42%), Gaps = 1/77 (1%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+ E + G+ V F L ++ +G ++V ++ D + G T L +A
Sbjct: 19 KTGSERIAHGMRVKFNP-LPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNA 77
Query: 114 IYYKNHEVIKLLEKHGA 130
+ + E++K L + G
Sbjct: 78 VCAGHTEIVKFLVQFGV 94
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 8/63 (12%), Positives = 19/63 (30%), Gaps = 1/63 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
+I + +L + S + G V L D+ ++++ +
Sbjct: 2 EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60
Query: 130 AKP 132
P
Sbjct: 61 DDP 63
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 25/124 (20%), Positives = 44/124 (35%), Gaps = 13/124 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN---FRDIDNRTALHVAAC 82
+N D DG P L A+ +V+ K L++SG V + D+
Sbjct: 94 VNVNAADSDGW--TP---LHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEME 148
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142
+G+T+ L + ++ L Y+ +L K G M +H +
Sbjct: 149 EGYTQCSQFLYGVQEKMGIMNKGVIYAL---WDYEPQNDDELPMKEGDC--MTIIHREDE 203
Query: 143 REVP 146
E+
Sbjct: 204 DEIE 207
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 26/197 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
VA+KKL + RA+R EL L++ + H N++ L T + IV
Sbjct: 50 ERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
E + +L ++ + L + G+ +LH IIHRDL+PS
Sbjct: 109 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS------ 156
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 348
NI+ LK+ DFG+++ T +T + Y APEV Y VD+
Sbjct: 157 -----NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 349 FSFALILQEMIEGCPPF 365
+S I+ EMI+G F
Sbjct: 210 WSVGCIMGEMIKGGVLF 226
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 26/108 (24%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SGIDVNFRDIDNRTALHVAACQG 84
+NGLD G L + + + ++ L I++N ++ TALH AA +G
Sbjct: 97 VGVNGLDKAGS--TA---LYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKG 151
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ ++V LLL +GA D ++ A ++K + A
Sbjct: 152 YADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVR 199
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-18
Identities = 18/108 (16%), Positives = 39/108 (36%), Gaps = 11/108 (10%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+E ++ + D + ++ + L V + LH AA +
Sbjct: 34 EEGDIIYITDMSDT-----NWWKGTSK-----GRTGLIPSNYVAEQAESIDNPLHEAAKR 83
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
G + L+ V+ D+ GST L A + + ++++ L +
Sbjct: 84 GNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNI 131
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 11/89 (12%), Positives = 24/89 (26%), Gaps = 5/89 (5%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + EL D+ + + T +G T ++ V +
Sbjct: 16 VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLI-----PSNYVAEQA 70
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
PL +A N ++ +
Sbjct: 71 ESIDNPLHEAAKRGNLSWLRECLDNRVGV 99
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-14
Identities = 9/58 (15%), Positives = 20/58 (34%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
++ LL G + R+I+ + A +A ++ A + D+
Sbjct: 156 VQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDS 213
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 7/66 (10%), Positives = 12/66 (18%), Gaps = 5/66 (7%)
Query: 74 RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL-----EKH 128
+ + A L D+ T +I +
Sbjct: 13 QVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLIPSNYVAEQAES 72
Query: 129 GAKPLM 134
PL
Sbjct: 73 IDNPLH 78
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 44/197 (22%), Positives = 79/197 (40%), Gaps = 26/197 (13%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + FR+E +L + A + + +V +Y GDL
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
L + P RF ++ ++ +H+ +HRD++P NIL
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPD-----------NILM 208
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-----YDTKVDVF 349
D +G++++ADFG L + Y++PE+ + E Y + D +
Sbjct: 209 DMNGHIRLADFGSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWW 265
Query: 350 SFALILQEMIEGCPPFT 366
S + + EM+ G PF
Sbjct: 266 SLGVCMYEMLYGETPFY 282
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-21
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP- 101
L+ A E DV+ + +LL G +V+ R TALH+AA E +L+E ++
Sbjct: 7 LLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFE 66
Query: 102 ----KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G T L A+ +N +++ L GA
Sbjct: 67 PMTSELYEGQTALHIAVINQNVNLVRALLARGA 99
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 28/105 (26%), Positives = 40/105 (38%), Gaps = 17/105 (16%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-------------RTALHVAACQGFTEVVS 90
L ++V ++ LL G V+ R + L AAC G E+V
Sbjct: 79 LHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVR 138
Query: 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEV----IKLLEKHGAK 131
LL+E GAD+ +D G+T L I N LL +
Sbjct: 139 LLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGG 183
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 23/123 (18%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVA 80
E++ GE L A ++E L+++ ++ + +TALH+A
Sbjct: 28 CEVHQRGAMGETA-----LHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIA 82
Query: 81 ACQGFTEVVSLLLERGADVDPKDR-------------WGSTPLGDAIYYKNHEVIKLLEK 127
+V LL RGA V + +G PL A + E+++LL +
Sbjct: 83 VINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIE 142
Query: 128 HGA 130
HGA
Sbjct: 143 HGA 145
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 22/97 (22%), Positives = 33/97 (34%), Gaps = 10/97 (10%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS----LLLERGADV 99
L F A E ++ L++ G D+ +D T LH+ Q LLL
Sbjct: 125 LSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184
Query: 100 DPK------DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
K + G TP A N + + L +
Sbjct: 185 HLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRK 221
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 1/67 (1%)
Query: 75 TALHVAACQGFTEVVS-LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
+ L +AA + + +S LL G +V + G T L A Y N E +L + + +
Sbjct: 5 SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELV 64
Query: 134 MAPMHVK 140
PM +
Sbjct: 65 FEPMTSE 71
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 64/237 (27%), Positives = 102/237 (43%), Gaps = 26/237 (10%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ I + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
L+R+ A +A +IA + YLH I++RDL+P NIL
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPE-----------NILL 172
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
D G++ + DFG+ K T T C Y+APEV + YD VD + +
Sbjct: 173 DSQGHIVLTDFGLCKENIEHNST--T--STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAV 228
Query: 355 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 411
L EM+ G PPF ++ E+ Y P + + + L+E + KR
Sbjct: 229 LYEMLYGLPPFYSRNTAEM---YDNILNKPLQLKPNI-TNSARHLLEGLLQKDRTKR 281
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L ++ + + E +L++++HP +V + A + ++ EYL G+L
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297
L+R+G TA + +I+ + +LH+ II+RDL+P NI+
Sbjct: 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPE-----------NIML 154
Query: 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALI 354
+ G++K+ DFG+ K T C Y+APE+ ++ VD +S +
Sbjct: 155 NHQGHVKLTDFGLCKESIHDGTV----THTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210
Query: 355 LQEMIEGCPPFTMKHDNEV 373
+ +M+ G PPFT ++ +
Sbjct: 211 MYDMLTGAPPFTGENRKKT 229
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 4e-21
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 46 FLANERDVEG---------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS 90
FL N RD I +L+++ + +DI+ TAL A +
Sbjct: 26 FLRNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAE 85
Query: 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
LL +G++V+ KD G TPL +I + E+ L +HGA
Sbjct: 86 KLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGA 125
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 89.0 bits (222), Expect = 7e-21
Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L++ + ++LL G +VN +D +T L + G++E+ LLE GA+V+ ++
Sbjct: 72 LIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRN 131
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A Y E++K L + GA
Sbjct: 132 LEGETPLIVASKYGRSEIVKKLLELGA 158
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 87.4 bits (218), Expect = 3e-20
Identities = 30/87 (34%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
LM+ E LL+ G +VN R+++ T L VA+ G +E+V LLE GAD+ +D
Sbjct: 105 LMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARD 164
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G T A + EVIK+ +
Sbjct: 165 LTGLTAEASARIFGRQEVIKIFTEVRR 191
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 51.6 bits (125), Expect = 7e-08
Identities = 9/64 (14%), Positives = 19/64 (29%), Gaps = 6/64 (9%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+ D + + + + + L +D + TPL A I L
Sbjct: 2 SHMDKNGEIVEKIKDEKSINQNLDFLRNY------RDSYNRTPLMVACMLGMENAIDKLV 55
Query: 127 KHGA 130
++
Sbjct: 56 ENFD 59
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 36/205 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKG 235
A+K++ IS A R E+ALL++++HPNV+ + + + +Y
Sbjct: 51 YALKQIEGTGISMS----ACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104
Query: 236 DLRAFLK---------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYV 286
DL +K + L I G++YLH N ++HRDL+P+++ V
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILV 161
Query: 287 AYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-----YVAPEV-FKNE 340
+R G +K+AD G ++L +PL D Y APE+
Sbjct: 162 MGEGPER-------GRVKIADMGFARLFNS-PLKPLA--DLDPVVVTFWYRAPELLLGAR 211
Query: 341 EYDTKVDVFSFALILQEMIEGCPPF 365
Y +D+++ I E++ P F
Sbjct: 212 HYTKAIDIWAIGCIFAELLTSEPIF 236
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 68/242 (28%), Positives = 99/242 (40%), Gaps = 42/242 (17%)
Query: 145 VPEYEIDPHELD-FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
E E+D F +GTF L + G+ VA+KK+ D R
Sbjct: 12 AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNR 65
Query: 199 D--ELALLQKIRHPNVVQFLGAVTQSSP-------MMIVTEYLPKGDL----RAFLKRKG 245
+ + L + HPN+VQ + +V EY+P L R + +R+
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV 124
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD-DSGNLK 304
A P F + R + LH V + HRD++P N+L + G LK
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPH-----------NVLVNEADGTLK 172
Query: 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 363
+ DFG +K L+ P S Y APE+ F N+ Y T VD++S I EM+ G P
Sbjct: 173 LCDFGSAKKLS--PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
Query: 364 PF 365
F
Sbjct: 231 IF 232
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 29/201 (14%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MMIVT 229
VA+KK+ E + + A R E+ +LQ ++H NVV + + + +V
Sbjct: 45 VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103
Query: 230 EYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
++ DL L S R + G+ Y+H NK I+HRD++ +
Sbjct: 104 DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAA------ 153
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTV---KEDRPLTCQDTSCRYVAPEV-FKNEEYDT 344
N+L G LK+ADFG+++ ++ + T + + Y PE+ +Y
Sbjct: 154 -----NVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 208
Query: 345 KVDVFSFALILQEMIEGCPPF 365
+D++ I+ EM P
Sbjct: 209 PIDLWGAGCIMAEMWTRSPIM 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 25/194 (12%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + F +E ++ P VVQ A + +V EY+P GDL
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298
L + A + ++ ++ +H IHRD++P N+L D
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPD-----------NMLLD 202
Query: 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNE----EYDTKVDVFSF 351
SG+LK+ADFG + + DT+ Y++PEV K++ Y + D +S
Sbjct: 203 KSGHLKLADFGTCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259
Query: 352 ALILQEMIEGCPPF 365
+ L EM+ G PF
Sbjct: 260 GVFLYEMLVGDTPF 273
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 41/204 (20%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T +S + +V
Sbjct: 49 GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
++ DL+ + K + +G+ Y+H ++HRDL+P
Sbjct: 108 MPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPG------ 155
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEE 341
N+ ++ LK+ DFG+++ D +T YV APEV
Sbjct: 156 -----NLAVNEDCELKILDFGLAR----HADAEMT------GYVVTRWYRAPEVILSWMH 200
Query: 342 YDTKVDVFSFALILQEMIEGCPPF 365
Y+ VD++S I+ EM+ G F
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-20
Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 1/91 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
L + + ++ L+ G DVN ++ N RTALH+A ++VSLLL+ GADV+
Sbjct: 121 LHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRV 180
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
G +P + + + L + + L
Sbjct: 181 TYQGYSPYQLTWGRPSTRIQQQLGQLTLENL 211
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-20
Identities = 21/87 (24%), Positives = 38/87 (43%)
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
+E I+++ +NF++ +T LH+A E+ LL G D + +D G+TP
Sbjct: 22 ALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTP 81
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136
L A + +L + P +
Sbjct: 82 LHLACEQGCLASVGVLTQSCTTPHLHS 108
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 12/114 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHV 79
+ D G P L + + + L S + + + T LH+
Sbjct: 69 CDPELRDFRGN--TP---LHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHL 123
Query: 80 AACQGFTEVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
A+ G+ +V LL+ GADV+ ++ G T L A+ +N +++ LL K GA
Sbjct: 124 ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADV 177
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 1e-12
Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 70 DIDNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
D + LH+A EV+ + A ++ ++ TPL A+ E+ + L
Sbjct: 5 TEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEAL 64
Query: 126 EKHGAKP 132
G P
Sbjct: 65 LGAGCDP 71
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 9/66 (13%), Positives = 17/66 (25%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G DVN + + + T + L + +
Sbjct: 167 VSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESEDEESYDTE 226
Query: 116 YKNHEV 121
+ E
Sbjct: 227 SEFTEF 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 46/214 (21%)
Query: 174 RGIQVAVKKLGEEVISDDDRV---------RAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
GI VA+K++ V R R E+ LL HPN++
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLRDIFVHFEE 103
Query: 225 MM-----IVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+VTE + DL + ++ + P F I G++ LHE ++HRD
Sbjct: 104 PAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159
Query: 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------ 332
L P NIL D+ ++ + DF +++ D T YV
Sbjct: 160 LHPG-----------NILLADNNDITICDFNLAR--EDTADANKT------HYVTHRWYR 200
Query: 333 APEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 365
APE+ + + + VD++S ++ EM F
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 1/78 (1%)
Query: 55 GIKELLD-SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
G + D ++ D +N +HVAA +G T+ V L+E G ++R+G T L A
Sbjct: 1 GPGSMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLA 60
Query: 114 IYYKNHEVIKLLEKHGAK 131
+ + K L G
Sbjct: 61 CKFGCVDTAKYLASVGEV 78
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 20/111 (18%), Positives = 41/111 (36%), Gaps = 5/111 (4%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ A + + ++ L+++G+ ++ TALH+A G + L G
Sbjct: 24 IHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWH 83
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV---KHAREVPEYEID 151
G P+ A+ +++ L + + P + REV E
Sbjct: 84 --GQKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSH 132
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 24/125 (19%), Positives = 47/125 (37%), Gaps = 10/125 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-----GIDVNFRDIDNRTALHVA 80
A D E P LM R+ E + ++D+ + +++ + + LH A
Sbjct: 164 ASPTAKDKADE--TP---LMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWA 218
Query: 81 ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
+ +V +E G DV+ +D + PL ++ + K L + L+
Sbjct: 219 ILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYH 278
Query: 141 HAREV 145
+ V
Sbjct: 279 NGTTV 283
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 14/86 (16%), Positives = 23/86 (26%)
Query: 47 LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
L +G V + + AA EV+ LL E+ +V G
Sbjct: 264 LQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTG 323
Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V ++ A
Sbjct: 324 AGGAVKRKKKAAPAVKRMKLAPSAPV 349
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 5/82 (6%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-----GADVDPKDRWGSTPL 110
IK L+ G +D + T L A E + L+++ +D ++ G++ L
Sbjct: 156 IKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHL 215
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
AI +V + G
Sbjct: 216 HWAILINWEDVAMRFVEMGIDV 237
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 7/75 (9%)
Query: 63 GIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
I + + +TALH G + E++ +L++ GA KD+ TPL A+ ++N E
Sbjct: 128 EIGSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNRE 187
Query: 121 VIKLL-----EKHGA 130
+ L+ K
Sbjct: 188 ALDLMMDTVPSKSSL 202
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 13/100 (13%), Positives = 29/100 (29%), Gaps = 2/100 (2%)
Query: 11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
LL+++ + NG + + + A+ E ++ L + +V
Sbjct: 263 LLQKT--DVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSL 320
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ V + L A V + R +
Sbjct: 321 NTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSS 360
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 7e-09
Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 14/91 (15%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + + L++ + + + EV K
Sbjct: 88 IHLAVMANKTDLVVALVEGAKE------RGQMPESLLNECDEREVN------EIGSHVKH 135
Query: 104 RWGSTPLGDAIYY-KNH-EVIKLLEKHGAKP 132
G T L + + E+IK+L + GA P
Sbjct: 136 CKGQTALHWCVGLGPEYLEMIKILVQLGASP 166
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 6/43 (13%), Positives = 13/43 (30%)
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
S+ + D + A + ++ L + G P
Sbjct: 4 SMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSP 46
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 3e-20
Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 4/93 (4%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV--- 99
L E + ++ELL S + +D D R LH + E+ S LL + +V
Sbjct: 6 LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 65
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D D G TP A N EV+K L KP
Sbjct: 66 DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKP 98
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 2e-19
Identities = 23/76 (30%), Positives = 35/76 (46%), Gaps = 3/76 (3%)
Query: 58 ELL---DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ L D+N T LH+A + + EV L+E GA V KD++ PL A
Sbjct: 89 KSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAA 148
Query: 115 YYKNHEVIKLLEKHGA 130
+ ++I+LL G
Sbjct: 149 SVGSLKLIELLCGLGK 164
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 2e-19
Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 7/109 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+LN + + G L ++ E + L+++G V +D N+ LH AA G
Sbjct: 98 PDLNKITNQGV--TC---LHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGS 152
Query: 86 TEVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLL-EKHGAKP 132
+++ LL G + V+ +D+ G TPL A+ + + LL EK+GA+
Sbjct: 153 LKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEY 201
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 82.9 bits (206), Expect = 2e-18
Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 10/110 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI---DNRTALHVAAC 82
+ L D DG P L + + + E LL +VN D T H+A
Sbjct: 27 SLLLQKDQDGR--IP---LHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACS 81
Query: 83 QGFTEVVSLLLER--GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G EVV L +R D++ G T L A+ K EV + L ++GA
Sbjct: 82 VGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGA 131
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 5e-15
Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 10/105 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQG 84
A + D + P L A+ ++ I+ L G VN++D T L A +G
Sbjct: 131 ASVRIKDKFNQ--IP---LHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEG 185
Query: 85 FTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ LL+E+ GA+ D D G+ N +V K +
Sbjct: 186 HGDAAVLLVEKYGAEYDLVDNKGAKAE---DVALNEQVKKFFLNN 227
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 70.9 bits (175), Expect = 3e-14
Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 1/59 (1%)
Query: 73 NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ LH A + F +V LL + + + KD+ G PL ++ ++ HE+ L
Sbjct: 2 SNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKME 60
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-20
Identities = 28/75 (37%), Positives = 37/75 (49%), Gaps = 3/75 (4%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
L+ G + D L AA G + V +L+ GADV KD+ GSTPL A
Sbjct: 10 SSGLVPRGSHMG---SDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAAR 66
Query: 116 YKNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 67 NGHLEVVKLLLEAGA 81
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-19
Identities = 30/83 (36%), Positives = 48/83 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DV +D + T LH+AA G EVV LLLE GADV +D
Sbjct: 28 LLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQD 87
Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
++G T +I N ++ ++L+
Sbjct: 88 KFGKTAFDISIDNGNEDLAEILQ 110
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 8e-10
Identities = 9/51 (17%), Positives = 19/51 (37%), Gaps = 3/51 (5%)
Query: 80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ S L+ RG+ + L +A + +++L +GA
Sbjct: 1 GSSHHHHHHSSGLVPRGSHMGSD---LGKKLLEAARAGQDDEVRILMANGA 48
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 5e-20
Identities = 44/183 (24%), Positives = 67/183 (36%), Gaps = 11/183 (6%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+ LA ++ +KE + + D D+RTALH A G TE+V LL+ G V+ K
Sbjct: 10 ICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 69
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL------MAPMHV---KHAREVPEYEIDPH 153
D G +PL A E++K L GA P+H K+ E+ ++
Sbjct: 70 DDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLE-G 128
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
+ A +G V L S + + L L
Sbjct: 129 GANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEA 188
Query: 214 QFL 216
+FL
Sbjct: 189 KFL 191
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 11/60 (18%), Positives = 23/60 (38%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ N ++A E+ +L + D+ T L A + E+++ L + G
Sbjct: 5 VSNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGV 64
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N ++ +G L + A++ E LL+ G + + +D + TA+H AA +G
Sbjct: 97 AHVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGN 151
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
++V +LL A + +D G+TPL A + E K L GA
Sbjct: 152 LKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGAS 197
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 7/107 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + D + A + +++ + LL N +D + T LH+A +
Sbjct: 130 ANPDAKDHYDATA-----MHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEER 184
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E L+ +GA + +++ TPL A +I G +
Sbjct: 185 VEEAKFLVTQGASIYIENKEEKTPLQVA--KGGLGLILKRLAEGEEA 229
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 7/75 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N D +G L +E VE K L+ G + + + +T L VA G
Sbjct: 163 ASTNIQDTEGNTP-----LHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK--GG 215
Query: 86 TEVVSLLLERGADVD 100
++ L G +
Sbjct: 216 LGLILKRLAEGEEAS 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 6e-20
Identities = 53/203 (26%), Positives = 82/203 (40%), Gaps = 38/203 (18%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
VA+KKL + RA+R EL L++ + H N++ L T + +V
Sbjct: 87 DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
E + +L ++ + L + G+ +LH IIHRDL+PS
Sbjct: 146 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS------ 193
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEVFKNEEY 342
NI+ LK+ DFG+++ T +T YV APEV Y
Sbjct: 194 -----NIVVKSDCTLKILDFGLAR--TAGTSFMMT------PYVVTRYYRAPEVILGMGY 240
Query: 343 DTKVDVFSFALILQEMIEGCPPF 365
VD++S I+ EM+ F
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILF 263
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 23/110 (20%), Positives = 53/110 (48%), Gaps = 4/110 (3%)
Query: 26 AELNGLDDDGEEIKPEFR---LMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAA 81
A+++ ++ + L + A ++ +K L+ + G + + +D D +T + +AA
Sbjct: 262 AKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAA 321
Query: 82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+G EVV L+++GA V+ D T A +H ++ + ++ +
Sbjct: 322 QEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPE 371
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 18/72 (25%), Positives = 33/72 (45%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
KE + +G DVN D D T L +A +V+ L++ GAD ++ + L A
Sbjct: 147 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 206
Query: 114 IYYKNHEVIKLL 125
++ ++ +
Sbjct: 207 AANRDFGMMVYM 218
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 11/124 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +D D P LM R + L+ +G D + R+ALH AA
Sbjct: 157 ADVNAMDCDEN--TP---LMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRD 211
Query: 86 TEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKNHEVI---KLLEKHGAKPLMAPMHV 139
++ +L D++ DR G T L + + + + KLL + GAK
Sbjct: 212 FGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAAR 271
Query: 140 KHAR 143
K +
Sbjct: 272 KDSE 275
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 9/87 (10%)
Query: 53 VEGIKELLDSGIDVNFR--------DIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKD 103
V K L++ G V++ RTALH AA +V L+ E+G++ D +D
Sbjct: 251 VASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQD 310
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TP+ A EV+ L + GA
Sbjct: 311 EDGKTPIMLAAQEGRIEVVMYLIQQGA 337
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 9/83 (10%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL--------ERGADVDPKDRWGS 107
+ + +++ NRT LH A E L+ GADV+ D +
Sbjct: 109 TEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDEN 167
Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
TPL A+ + ++ L K GA
Sbjct: 168 TPLMLAVLARRRRLVAYLMKAGA 190
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 14/111 (12%), Positives = 29/111 (26%), Gaps = 7/111 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ + N L + + + + ++ LH A
Sbjct: 50 IKRQRNELQHYSL-----YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEA-A 103
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
G + + ++ R T L + E + L H AK +
Sbjct: 104 GSYAITEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECI 153
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 9/116 (7%), Positives = 26/116 (22%), Gaps = 5/116 (4%)
Query: 19 PDRERKEAELNGL----DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR 74
+R RK +N + EE + +++ + N +
Sbjct: 3 GNRTRKRRMINASVWMPPMENEEKNRKNHQSITSSQHSLLEASYDGYIKRQRNELQHYSL 62
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G + + L ++ + + + +
Sbjct: 63 YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEAAG-SYAITEPITRESV 117
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 16/75 (21%), Positives = 30/75 (40%), Gaps = 5/75 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + D+DG+ P +M A E +E + L+ G V D + TA +A
Sbjct: 304 SNKDKQDEDGK--TP---IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNH 358
Query: 86 TEVVSLLLERGADVD 100
+V + + +
Sbjct: 359 HNIVDIFDRCRPERE 373
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 6/72 (8%), Positives = 18/72 (25%), Gaps = 9/72 (12%)
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ + ++ +L A+ G+ + + + P N
Sbjct: 25 EKNRKNHQSITSSQHSLLEASYDGYIKRQ---------RNELQHYSLYPNPQGYGNGNDF 75
Query: 121 VIKLLEKHGAKP 132
+ + P
Sbjct: 76 LGDFNHTNLQIP 87
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 40/204 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S+ RA+R EL LL+ +RH NV+ L T + +V
Sbjct: 50 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
++ DL +K + L + +G+ Y+H IIHRDL+P
Sbjct: 109 MPFMGT-DLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPG------ 157
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEE 341
N+ ++ LK+ DFG+++ + D +T YV APEV
Sbjct: 158 -----NLAVNEDCELKILDFGLAR----QADSEMT------GYVVTRWYRAPEVILNWMR 202
Query: 342 YDTKVDVFSFALILQEMIEGCPPF 365
Y VD++S I+ EMI G F
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLF 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 69/257 (26%), Positives = 107/257 (41%), Gaps = 52/257 (20%)
Query: 134 MAPMHVKHAREVPEY---EIDPHELDFTNSVEITK-------GTFILAFWR--GIQVAVK 181
MA H H++E P + E++ + + G+ AF G++VAVK
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 182 KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPKG 235
KL S R +R EL LL+ ++H NV+ L T + + +VT +
Sbjct: 61 KLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA- 118
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295
DL +K + L I RG+ Y+H IIHRDL+PS N+
Sbjct: 119 DLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS-----------NL 163
Query: 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDV 348
++ LK+ DFG++ R + T YV APE+ Y+ VD+
Sbjct: 164 AVNEDCELKILDFGLA--------RHTADEMTG--YVATRWYRAPEIMLNWMHYNQTVDI 213
Query: 349 FSFALILQEMIEGCPPF 365
+S I+ E++ G F
Sbjct: 214 WSVGCIMAELLTGRTLF 230
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 47/227 (20%), Positives = 84/227 (37%), Gaps = 43/227 (18%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
VA+KK+ D R R E+ +L +++ +++ + + IV
Sbjct: 51 EKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
E DL+ K L ++ G N++HE+ IIHRDL+P+
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPA------- 158
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------------YV-- 332
N L + ++KV DFG+++ + ++D + +V
Sbjct: 159 ----NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214
Query: 333 ----APEV-FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374
APE+ E Y +D++S I E++ N P
Sbjct: 215 RWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 35/207 (16%)
Query: 175 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IV 228
G VA+KK+ E +R R E+ +L+ +H N++ S I+
Sbjct: 36 GEIVAIKKI--EPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288
E + DL + + L F R + LH + +IHRDL+PS
Sbjct: 93 QELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPS------ 141
Query: 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YV------APEV-FK 338
N+L + + +LKV DFG+++++ +V APEV
Sbjct: 142 -----NLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196
Query: 339 NEEYDTKVDVFSFALILQEMIEGCPPF 365
+ +Y +DV+S IL E+ P F
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 49/232 (21%), Positives = 83/232 (35%), Gaps = 48/232 (20%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
VA+KK+ D R R E+A+L ++ H +VV+ L V +V
Sbjct: 78 KRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
E D + + L ++ G+ Y+H I+HRDL+P+
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPA------- 185
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR------------------- 330
N L + ++KV DFG+++ + E+ +
Sbjct: 186 ----NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241
Query: 331 -YV------APEV-FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374
+V APE+ E Y +DV+S I E++ H + P
Sbjct: 242 GHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 42/202 (20%), Positives = 83/202 (41%), Gaps = 30/202 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI--VTEY 231
+V VK + + + R E+ +L+ +R PN++ V V E+
Sbjct: 61 NEKVVVKI-----LKPVKKKKIKR-EIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
+ D + + L + +I + ++Y H I+HRD++P
Sbjct: 115 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPH--------- 159
Query: 292 DRNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVF 349
N++ D + L++ D+G+++ + + S + PE+ + + YD +D++
Sbjct: 160 --NVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMW 215
Query: 350 SFALILQEMIEGCPPFTMKHDN 371
S +L MI PF HDN
Sbjct: 216 SLGCMLASMIFRKEPFFHGHDN 237
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 47/235 (20%), Positives = 86/235 (36%), Gaps = 68/235 (28%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-------- 226
G + A+KK + D R R EL +++ + H N+++ + +
Sbjct: 32 GKRFALKK-----VLQDPR-YKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84
Query: 227 ------------------------------IVTEYLPKGDL----RAFLKRKGALKPSTA 252
++ EY+P L ++F++ ++ +
Sbjct: 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLI 143
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD-DSGNLKVADFGVS 311
+ + R + ++H I HRD++P N+L + LK+ DFG +
Sbjct: 144 SIYIYQLFRAVGFIHSLG---ICHRDIKPQ-----------NLLVNSKDNTLKLCDFGSA 189
Query: 312 KLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 365
K L P S Y APE+ EY +D++S + E+I G P F
Sbjct: 190 KKLI--PSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 42/207 (20%)
Query: 175 GIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----I 227
++VA+KK+ E R R E+ +L + RH N++ + + I
Sbjct: 52 KVRVAIKKISPFEHQT---YCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVA 287
V + + DL L + L F I RG+ Y+H ++HRDL+PS
Sbjct: 108 VQDLMET-DLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPS----- 157
Query: 288 YWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEV-FK 338
N+L + + +LK+ DFG++++ D LT YV APE+
Sbjct: 158 ------NLLLNTTCDLKICDFGLARVADPDHDHTGFLT------EYVATRWYRAPEIMLN 205
Query: 339 NEEYDTKVDVFSFALILQEMIEGCPPF 365
++ Y +D++S IL EM+ P F
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 54/241 (22%), Positives = 105/241 (43%), Gaps = 26/241 (10%)
Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGD 236
A+K L ++ R E +L+ IR P +V A + + ++ +Y+ G+
Sbjct: 86 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
L L ++ + +I + +LH+ II+RD++ NIL
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE-----------NIL 191
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE--YDTKVDVFSF 351
D +G++ + DFG+SK V ++ C Y+AP++ + + +D VD +S
Sbjct: 192 LDSNGHVVLTDFGLSK-EFVADETERA--YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248
Query: 352 ALILQEMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 410
+++ E++ G PFT+ N + + P ++ + K+LI+ + P K
Sbjct: 249 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM-SALAKDLIQRLLMKDPKK 307
Query: 411 R 411
R
Sbjct: 308 R 308
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 51/216 (23%)
Query: 175 GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----- 226
+VA+KK I D A R E+ +++++ H N+V+ + S +
Sbjct: 36 DKRVAIKK-----IVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89
Query: 227 ---------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
IV EY+ DL L +G L A F + RG+ Y+H ++HR
Sbjct: 90 SLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHR 144
Query: 278 DLEPSDLYVAYWQNDRNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQDTSCRYV---- 332
DL+P+ N+ + LK+ DFG+++ + + +
Sbjct: 145 DLKPA-----------NLFINTEDLVLKIGDFGLAR--IMDPHYSHKGHLSE--GLVTKW 189
Query: 333 --APEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 365
+P + Y +D+++ I EM+ G F
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 62/309 (20%), Positives = 102/309 (33%), Gaps = 95/309 (30%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
+ A+K ++ D + R E+ L + + P++V+ + ++IV
Sbjct: 43 QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94
Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVA 287
E L G+L R + A A I + YLH I HRD++P
Sbjct: 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE----- 146
Query: 288 YWQNDRNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 344
N+L + + LK+ DFG A E E+YD
Sbjct: 147 ------NLLYTSKRPNAILKLTDFGF----------------------AKETTG-EKYDK 177
Query: 345 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QRPPFKAP--------AKLYA 393
D++S +I+ ++ G PPF H + R + F P
Sbjct: 178 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV---- 233
Query: 394 RGLKELIEECWNEKPAKRPTFRQII-------------TRLESINNSINHKRRWK----- 435
K LI +P +R T + + T L + K RW+
Sbjct: 234 ---KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 290
Query: 436 ----IRTMK 440
+ TM+
Sbjct: 291 MTSALATMR 299
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 45/217 (20%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM----IVT 229
G VAVKK+ + + D R FR E+ +L ++ H N+V L + + +V
Sbjct: 34 GEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLR--ADNDRDVYLVF 90
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
+Y+ DL A + R L+P + + + YLH ++HRD++PS
Sbjct: 91 DYMET-DLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPS------- 138
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------YV--- 332
NIL + ++KVADFG+S+ + YV
Sbjct: 139 ----NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATR 194
Query: 333 ---APEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 365
APE+ + +Y +D++S IL E++ G P F
Sbjct: 195 WYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 21/127 (16%), Positives = 35/127 (27%), Gaps = 2/127 (1%)
Query: 11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
LL +R K+ + + F ++ + LL S V
Sbjct: 66 LLCLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQ 125
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGDAIYYKNHEVIKLLEKH 128
+N A +AA G V++ L E A + V+ L +
Sbjct: 126 AENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCEL 185
Query: 129 GAKPLMA 135
A
Sbjct: 186 APTEATA 192
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 17/87 (19%), Positives = 24/87 (27%), Gaps = 5/87 (5%)
Query: 57 KELLDSGIDVNFRDI--DNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGD 112
L + I +N A +AA G V++ L E
Sbjct: 145 NRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRW 204
Query: 113 AIYYKNH-EVIKLLEKHGAKPLMAPMH 138
A + H VI L A +H
Sbjct: 205 AAVGRGHHNVINFLLDCPVMLAYAEIH 231
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 15/118 (12%), Positives = 33/118 (27%), Gaps = 14/118 (11%)
Query: 24 KEAELNGLDD--DGEEIKPEFRLMFLANERDVEGIKELL---------DSGIDVNFRDID 72
K + +G+ D E F ++ R+ E + + + + D
Sbjct: 259 KLSNPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGD 318
Query: 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
L +A G +LLL + + ++ + +H
Sbjct: 319 ANELLRLALRLGNQGACALLLSIPSVLALTKA---NNYYINETGGRLDLRAVALEHHH 373
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 12/91 (13%)
Query: 56 IKELLDSGIDVNFRDI--DNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRWGSTPLGD 112
+ L + I +N A AA G V++ LL+ + +
Sbjct: 179 LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFE---- 234
Query: 113 AIYYKNHEVIKLLEKHGA--KPLMAPMHVKH 141
Y V + +H K + + +
Sbjct: 235 ---YGEKYVNPFIARHVNRLKEMHDAFKLSN 262
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 21/125 (16%), Positives = 48/125 (38%), Gaps = 8/125 (6%)
Query: 14 QSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNF-R 69
Q L P+ + L + + + E + ++ + ++ + + ++ +++N
Sbjct: 68 QRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPV 127
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLL 125
D T LH E+V L++ G++ D G + L A+ N+ LL
Sbjct: 128 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALL 187
Query: 126 EKHGA 130
+
Sbjct: 188 DYLYP 192
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 18/87 (20%), Positives = 33/87 (37%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K+ E+ + +E + +N +D + T L++AA
Sbjct: 234 KKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARL 293
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPL 110
G +V LL+ GAD ++ G P+
Sbjct: 294 GNISIVDALLDYGADPFIANKSGLRPV 320
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 19/145 (13%), Positives = 46/145 (31%), Gaps = 22/145 (15%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-------FTEVVSLLLERG 96
L +L + ++E +K L+ G + + D + L A F ++ L
Sbjct: 135 LHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYL---Y 191
Query: 97 ADVDPKDRWGSTPL------------GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144
+ +D T L A Y ++ + K +P+ + + K ++
Sbjct: 192 PCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKP 251
Query: 145 VPEYEIDPHELDFTNSVEITKGTFI 169
+ + ++ +
Sbjct: 252 NDKNGERKDSILENLDLKWIIANML 276
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 12/83 (14%), Positives = 25/83 (30%), Gaps = 4/83 (4%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAA----CQGFTEVVSLLLERGADVDPKDRWGSTP 109
+ ++ + + + E + L ++ +D G T
Sbjct: 227 ILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTC 286
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A N ++ L +GA P
Sbjct: 287 LNIAARLGNISIVDALLDYGADP 309
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 16/121 (13%), Positives = 30/121 (24%), Gaps = 21/121 (17%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLA---NERDVEGIKELLDSGI-DVNFRDIDNRTALHVAA 81
+ D+ GE L+ N D + LLD + D NRT LH
Sbjct: 155 SNRLYGDNMGE--SC---LVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHII 209
Query: 82 CQGFTE------------VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
++ ++++ + + + I
Sbjct: 210 ITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLK 269
Query: 130 A 130
Sbjct: 270 W 270
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 68/330 (20%), Positives = 115/330 (34%), Gaps = 68/330 (20%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIR---------- 208
G F LA VA+K ++ D A DE+ LLQ++
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 209 -HPNVVQFLGAVTQSSPMM----IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIAR 261
++++ L P +V E L +L A +K+ P V+ + +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 262 GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS------GNLKVADFGVSKLLT 315
G++Y+H IIH D++P N+L + +K+AD G +
Sbjct: 143 GLDYMHRR--CGIIHTDIKPE-----------NVLMEIVDSPENLIQIKIADLGNA---- 185
Query: 316 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375
D T + Y +PEV + D++S A ++ E+I G F + K
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 376 -----AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430
A P+ L G + +N + R + LE + +
Sbjct: 246 DDDHIAQIIELLGEL--PSYLLRNG--KYTRTFFNSRGLLRNISKLKFWPLEDV---LTE 298
Query: 431 KRRWKIRTMKCFHN-LEAMLKKDHSSPSSR 459
K ++ K + L ML+ D P R
Sbjct: 299 KYKFSKDEAKEISDFLSPMLQLD---PRKR 325
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 8e-15
Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 21/121 (17%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A LN + + I + L R + +K+ + +TALH+A +
Sbjct: 61 AMLNLHNGQNDTIA-----LLLDVARKTDSLKQFV--NASYTDSYYKGQTALHIAIERRN 113
Query: 86 TEVVSLLLERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+V+LL+E GADV +G PL A ++K L ++ +
Sbjct: 114 MTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQ 173
Query: 132 P 132
P
Sbjct: 174 P 174
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 25/112 (22%), Positives = 38/112 (33%), Gaps = 22/112 (19%)
Query: 44 LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
L A + +K LL + D++ RD T LH T + +
Sbjct: 152 LSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNE 211
Query: 92 LLERGADVDP-------KDRWGSTPLGDAIYYKNHEVIKLL---EKHGAKPL 133
+L GA + P +R G TPL A V+ + E H +
Sbjct: 212 ILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECR 263
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 11/64 (17%), Positives = 22/64 (34%), Gaps = 8/64 (12%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
+L + + T L +AA G V++ +L+R A ++
Sbjct: 217 AKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH-------EPECRHAAAHH 269
Query: 117 KNHE 120
+H
Sbjct: 270 -HHH 272
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 11/88 (12%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-------RGADVDPKDR-WGSTPLGDA- 113
+ +R ++ A Q + + LL R D + KD G T L A
Sbjct: 3 SAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAM 62
Query: 114 --IYYKNHEVIKLLEKHGAKPLMAPMHV 139
++ ++ I LL K V
Sbjct: 63 LNLHNGQNDTIALLLDVARKTDSLKQFV 90
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 27/93 (29%), Positives = 44/93 (47%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
AN+ + + ++ +G ++ + D TALH AA + + LLL+ A V + G
Sbjct: 201 ANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGE 260
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
T L A + E +LLE+ A P+HV
Sbjct: 261 TALDIARKKHHKECEELLEQAQAGTFAFPLHVD 293
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 49 NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQGF---TEVVSLLLERGADV 99
RD+ + E +G D LH+A +V +++ G +
Sbjct: 160 CNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHL 219
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D K G+T L A Y + +KLL K A
Sbjct: 220 DAKAADGNTALHYAALYNQPDCLKLLLKGRALV 252
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 27/142 (19%), Positives = 46/142 (32%), Gaps = 37/142 (26%)
Query: 21 RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN------- 73
+ A+ G L +R ++ +K L+++G DV+ R
Sbjct: 76 KPLVNAQCTDEFYQGH--SA---LHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQG 130
Query: 74 ------RTALHVAACQGFTEVVSLLLERG---ADVDPKDRWGSTPL------GD------ 112
L +AAC +VV+ LLE A ++ D G+T L D
Sbjct: 131 TCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENS 190
Query: 113 ----AIYYKNHEVIKLLEKHGA 130
+Y ++ L
Sbjct: 191 ALVIHMYDGLLQMGARLCPTVQ 212
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 21/91 (23%), Positives = 34/91 (37%), Gaps = 15/91 (16%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-------------WGSTP 109
+ALH+A + + V LL+E GADV + +G P
Sbjct: 80 NAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELP 139
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
L A K +V+ L ++ +P A +
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQP--ASLEAT 168
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 13/76 (17%), Positives = 26/76 (34%), Gaps = 1/76 (1%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ + +AL + G ++ + L + + G TPL A E+ + +
Sbjct: 181 MIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHI 240
Query: 126 EKHGAKPLMAPMHVKH 141
+ A H H
Sbjct: 241 LQREFSG-AAAHHHHH 255
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 22/110 (20%)
Query: 43 RLMFLANERDVEGIKELLDS--------GIDVNFRDIDNRTALHVAAC---QGFTEVVSL 91
RL + + E + LL+ +T L A G +
Sbjct: 5 RLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMP 64
Query: 92 LLERG-----------ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
LL+ A + G + L AI ++ + +KLL ++GA
Sbjct: 65 LLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGA 114
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 9/48 (18%), Positives = 18/48 (37%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
++ L + + T L +AA +G E+ +L+R
Sbjct: 201 LQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGA 248
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 13/71 (18%), Positives = 20/71 (28%), Gaps = 11/71 (15%)
Query: 73 NRTALHVAACQGFTEVVSLLLE--------RGADVDPKDRWGSTPLGDAIY--YKNH-EV 121
+R L +G E ++ LLE + G T L A+
Sbjct: 2 DRDRLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNAC 61
Query: 122 IKLLEKHGAKP 132
I L +
Sbjct: 62 IMPLLQIDKDS 72
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 26/114 (22%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN--------------RTALHVAACQGFTEVV 89
L R ++ L++ G DV+ + L +AAC +V
Sbjct: 97 LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156
Query: 90 SLLLERG---ADVDPKDRWGSTPLGDAIYYKNH---------EVIKLLEKHGAK 131
L E G AD+ +D G+T L + ++ ++ LL AK
Sbjct: 157 HYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAK 210
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 25/113 (22%)
Query: 45 MFLANERDVEGIKELLDSG---------IDVNFRDIDNR--TALHVAACQGFTEVVSLLL 93
+ + + I LLD I+ FRD+ R TALH+A + V LL+
Sbjct: 54 LLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLV 113
Query: 94 ERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E+GADV + R +G PL A ++ L ++G K
Sbjct: 114 EKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQ 166
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 22/105 (20%)
Query: 48 ANERDVEGIKE----LLDSGIDVNFRDIDN----RTALHVAA---CQGFTEVVSLLLERG 96
+ +G++ LL + + +T L A G + + +LL+
Sbjct: 13 VSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTIPILLDIA 72
Query: 97 ADVDP-----------KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G T L AI + ++LL + GA
Sbjct: 73 EKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGA 117
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 19/107 (17%), Positives = 34/107 (31%), Gaps = 19/107 (17%)
Query: 44 LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
L A + L ++G D+ +D T LH T++ L
Sbjct: 144 LSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDL 203
Query: 92 LLERGADVDPK-------DRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
LL + A + P + G +PL A + + + +
Sbjct: 204 LLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIA 250
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 14/70 (20%), Positives = 23/70 (32%), Gaps = 11/70 (15%)
Query: 73 NRTALHVAA----CQGFTEVVSLLLERGADVDPKDRW----GSTPLGDA---IYYKNHEV 121
NR L G ++S LL + ++ G T L A + ++
Sbjct: 5 NRPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDT 64
Query: 122 IKLLEKHGAK 131
I +L K
Sbjct: 65 IPILLDIAEK 74
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 8/59 (13%), Positives = 17/59 (28%), Gaps = 7/59 (11%)
Query: 49 NERDVEGIKELLDSGIDVN-------FRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
+ + LL + + D + L +AA G + ++ R
Sbjct: 194 TKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADA 252
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 42/225 (18%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH------PNV 212
KG+F + A+ VA+K ++ ++ R R +E+ +L+ +R NV
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP--STAVR-FALDIARGMNYLHEN 269
+ L T + + + E L +L +K K + VR FA I + ++ LH+N
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIK-KNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 327
+ IIH DL+P NIL + +KV DFG S E + +
Sbjct: 220 R---IIHCDLKPE-----------NILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQ 261
Query: 328 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372
S Y APEV Y +D++S IL E++ G P + + +
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 20/93 (21%), Positives = 40/93 (43%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
+ + + L+ + +++ + TALH E + LLL A ++ + G
Sbjct: 180 VDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGE 239
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
TPL A K+ +LL + + + +HV+
Sbjct: 240 TPLDIAKRLKHEHCEELLTQALSGRFNSHVHVE 272
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 49 NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQG---FTEVVSLLLERGADV 99
RD+ G+ + G+D+ + TALH+A +V L++ ++
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D + GST L N E +KLL + A
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASI 231
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 47/210 (22%), Positives = 79/210 (37%), Gaps = 33/210 (15%)
Query: 174 RGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMM 226
VA+K +I + + E+ LL+ + +V + +
Sbjct: 78 EQEWVAIK-----IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132
Query: 227 IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSDL 284
+V E L +L L+ R FA + + +L + + IIH DL+P
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPE-- 188
Query: 285 YVAYWQNDRNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 342
NIL +K+ DFG S + + + S Y +PEV Y
Sbjct: 189 ---------NILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRFYRSPEVLLGMPY 235
Query: 343 DTKVDVFSFALILQEMIEGCPPFTMKHDNE 372
D +D++S IL EM G P F+ ++ +
Sbjct: 236 DLAIDMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 66/323 (20%), Positives = 121/323 (37%), Gaps = 48/323 (14%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRH-----PNVV 213
GTF +L AVK V+ + + + + E +L+KI++ N+V
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKP 271
++ G M ++ E L L + R ++ + ++I + +NYL +
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS- 157
Query: 272 VPIIHRDLEP--------------SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
+ H DL+P + I R S +K+ DFG +
Sbjct: 158 --LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----TF 211
Query: 318 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377
+ + +Y APEV N +D D++SF +L E+ G F H++ A
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR-THEHMEHLAM 270
Query: 378 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIR 437
P P + K + N K + + + + + SI + +KI
Sbjct: 271 MESIIQPI--PKNMLYEATKTNGSKYVN-KDELKLAWPENASSINSIKHVKKCLPLYKII 327
Query: 438 TMKCFHN-LEAMLKKDHSSPSSR 459
+ F + L ++L+ D P+ R
Sbjct: 328 KHELFCDFLYSILQID---PTLR 347
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 26/99 (26%), Positives = 38/99 (38%), Gaps = 9/99 (9%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVN------FRDIDNRTALHVA---ACQGFTEVVSLLL 93
RL RD+ + E +G D LH+A A Q +V ++
Sbjct: 135 RLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFII 194
Query: 94 ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ G +D K G+T L A Y + +KLL K A
Sbjct: 195 QNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALV 233
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 52/213 (24%), Positives = 78/213 (36%), Gaps = 30/213 (14%)
Query: 177 QVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVT 229
QVA+K +I + + R A R E+ +L+KI+ V M I
Sbjct: 47 QVALK-----IIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101
Query: 230 EYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEP------ 281
E L K + FLK P VR A + + +LHEN+ + H DL+P
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFV 157
Query: 282 --SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 339
+ + +++VADFG + + T + Y PEV
Sbjct: 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTTIVATRHYRPPEVILE 213
Query: 340 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372
+ DV+S IL E G F + E
Sbjct: 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 50/256 (19%), Positives = 85/256 (33%), Gaps = 65/256 (25%)
Query: 164 TKGTFILA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPN---VV 213
T L+ VA+K V S + DE+ LL+ +R PN VV
Sbjct: 49 HFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 214 QFLGAVTQSSP----MMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLH 267
Q L S + +V E L L ++ + L + + +G++YLH
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163
Query: 268 ENKPVPIIHRDLEP-------SDLYVAYWQNDRNI------------------------- 295
IIH D++P ++ Y+ +
Sbjct: 164 TK--CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 296 ------LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 349
+ +K+AD G + + T + +Y + EV Y+T D++
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277
Query: 350 SFALILQEMIEGCPPF 365
S A + E+ G F
Sbjct: 278 STACMAFELATGDYLF 293
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 31/211 (14%)
Query: 178 VAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVTE 230
VAVK ++ + DR A R E+ +L+ + VQ L + IV E
Sbjct: 43 VAVK-----IVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97
Query: 231 YLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDL--------E 280
L F+K G L +R A I + +N+LH NK + H DL +
Sbjct: 98 LLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQ 153
Query: 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 340
+ R+ + ++KV DFG + +D + ++ Y APEV
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSA----TYDDEHHSTLVSTRHYRAPEVILAL 209
Query: 341 EYDTKVDVFSFALILQEMIEGCPPFTMKHDN 371
+ DV+S IL E G F HD+
Sbjct: 210 GWSQPCDVWSIGCILIEYYLGFTVFP-THDS 239
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 7e-10
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 3/101 (2%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N ++ + P L+ + + LL +G +VN D R LH A G
Sbjct: 224 ADVNWVNGGQDNATP---LIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGH 280
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
T + L L+RGAD+ +D G PL A+ N +++ LL
Sbjct: 281 TGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLR 321
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 58.3 bits (140), Expect = 2e-09
Identities = 24/87 (27%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 48 ANERDVEGIKELLDSGIDVNFR--DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105
+ + + + L G DVN+ DN T L A LL+ GA+V+ D
Sbjct: 208 GHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSA 267
Query: 106 GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G PL A + + L K GA
Sbjct: 268 GRGPLHHATILGHTGLACLFLKRGADL 294
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 52/472 (11%), Positives = 131/472 (27%), Gaps = 164/472 (34%)
Query: 19 PDRER---KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT 75
D + + E++ + + + RL + + E +++ ++ + +N+
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY------- 91
Query: 76 ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
F L+ + + T + Y + + + + + A
Sbjct: 92 --------KF------LMSPIKT-EQRQPSMMTRM----YIEQRDRL-----YNDNQVFA 127
Query: 136 PMHVKHAREVPE-----YEIDPHELDFTNSVEIT----KGTFILAFWRGIQVAVKKLGEE 186
+V + + E+ P + + G+ G + +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKN-------VLIDGVLGS-------GKTW----VALD 169
Query: 187 VISDDDRVRAF---------------RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
V L +LQK+ + + SS + +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH- 228
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
++A L+R L ++KP L L
Sbjct: 229 ----SIQAELRR----------------------LLKSKPYE---NCL----L------- 248
Query: 292 DRNILRD--DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 349
+L + ++ + LLT + + +T +++ + D
Sbjct: 249 ---VLLNVQNAKAWNAFNLSCKILLTTR-FKQVT------DFLSAATTTHISLDHHSMTL 298
Query: 350 S-------FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 402
+ L C P ++P+ P + + A +++ +
Sbjct: 299 TPDEVKSLLLKYL-----DCRPQ------DLPR--EVLTTNPRR--LSIIAESIRDGLAT 343
Query: 403 CWNEKPAKRPTFRQI-ITRLES-INNSINHKRRWKIRTMKCFHNLEAMLKKD 452
W+ ++ + +L + I +S+N + R K F L ++
Sbjct: 344 -WD-------NWKHVNCDKLTTIIESSLNVLEPAEYR--KMFDRL-SVFPPS 384
|
| >3agd_A Salt-tolerant glutaminase; glutaminase super family, hydrolase; 2.20A {Micrococcus luteus} PDB: 3age_A* 3if5_A 3ih8_A 3ih9_A 3iha_A* 3ihb_A 2dfw_A Length = 456 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 6e-04
Identities = 6/85 (7%), Positives = 17/85 (20%), Gaps = 2/85 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ F E ++ + +L A + +
Sbjct: 335 IRFGGAEAVLDALTDLRTGAEKPGTGWDAAVYPRWQEAAADRAALSAATGGGAVHEAAAA 394
Query: 104 RWGSTPLGD--AIYYKNHEVIKLLE 126
G + V ++ +
Sbjct: 395 AARDENDGPIRTVVLNLARVDRIDD 419
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 469 | |||
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.91 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.89 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.88 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.86 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.86 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.85 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.85 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.84 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.84 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.84 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.84 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.84 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.83 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.83 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.83 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.83 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.83 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.83 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.83 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.83 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.83 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.83 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.83 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.82 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.82 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.82 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.82 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.82 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.82 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.82 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.81 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.81 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.81 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.81 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.8 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.8 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.8 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.8 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.8 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.8 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.8 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.8 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.79 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.79 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.79 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.79 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.79 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.79 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.79 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.79 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.78 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.78 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.78 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.78 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.78 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.78 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.78 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.78 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.78 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.78 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.78 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.78 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.78 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.77 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.77 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.77 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.77 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.77 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.77 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.77 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.77 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.76 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.76 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.76 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.76 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.76 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.76 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.76 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.76 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.76 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.76 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.76 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.75 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.75 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.75 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.75 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.74 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.74 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.74 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.74 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.73 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.73 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.73 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.73 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.72 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.72 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.72 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.72 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.71 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.71 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.69 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.68 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.68 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.67 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.67 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.65 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.6 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.59 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.58 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.55 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.51 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.45 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.45 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.78 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.92 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.91 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.61 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.57 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.11 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.89 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.79 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.91 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.58 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.04 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 93.84 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.6 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 81.12 |
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=428.29 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=217.8
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
..|+..+.||+|+||.||. +|+.||||++..+.. ..+|+.+++.++|||||++++++.+.+.+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3577888999999999985 588999999976543 246999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC-CeEEeec
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG-NLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~-~vkl~Df 308 (469)
|||+||+|.+++++.+.+++.++..++.||+.||+|||+++ ||||||||+ |||++.+| .+||+||
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~-----------NILl~~~g~~vKl~DF 195 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKAD-----------NVLLSSDGSRAALCDF 195 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGG-----------GEEECTTSCCEEECCC
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHH-----------HEEEeCCCCEEEEeeC
Confidence 99999999999999889999999999999999999999999 999999999 88888887 6999999
Q ss_pred CCccccccCCCC----CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 309 GVSKLLTVKEDR----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 309 gla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
|+|+........ ......||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++...+.... ++
T Consensus 196 Gla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~ 274 (336)
T 4g3f_A 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP-PP 274 (336)
T ss_dssp TTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC-CG
T ss_pred CCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC-CC
Confidence 999876533211 1233579999999999999999999999999999999999999999888777777665433 33
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
....++.+++.+.+||.+||+.||++|||+.|++++|.........
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 3334567899999999999999999999999999999998877553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-56 Score=425.28 Aligned_cols=252 Identities=28% Similarity=0.487 Sum_probs=217.3
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|...++||+|+||.||. +|..||||++... +....+.|.+|++++++++|||||+++++|.+.+.+
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 577788999999999874 3678999998743 455668899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccC
Q 012164 226 MIVTEYLPKGDLRAFLKRK-------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~ 292 (469)
++|||||++|+|.+++.+. ..+++.++..++.||+.||.|||+++ ||||||||+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~---------- 157 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR---------- 157 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG----------
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHh----------
Confidence 9999999999999999764 25999999999999999999999998 999999999
Q ss_pred cceeeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012164 293 RNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 370 (469)
Q Consensus 293 ~nil~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~ 370 (469)
|||++.++.+||+|||+|+......... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+.
T Consensus 158 -NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 158 -NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp -GEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred -hEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 8888899999999999998654332221 223458999999999999999999999999999999998 9999998887
Q ss_pred CcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 371 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.++...+....+++. +..+|+++.+||.+||+.||++|||++++.+.|+.+.+.
T Consensus 237 ~~~~~~i~~~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 237 NEVIECITQGRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 777777765555443 456889999999999999999999999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=426.30 Aligned_cols=252 Identities=27% Similarity=0.491 Sum_probs=212.7
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
++...++||+|+||.||. +++.||||++... +....+.|.+|++++++++|||||+++++|.+.+.+
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 566778999999999985 3678999999743 456668899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccc
Q 012164 226 MIVTEYLPKGDLRAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~ 290 (469)
++|||||++|+|.+++.+. +++++.++..++.||+.||.|||+.+ ||||||||+
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~-------- 187 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATR-------- 187 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG--------
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHh--------
Confidence 9999999999999999753 35899999999999999999999998 999999999
Q ss_pred cCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 012164 291 NDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMK 368 (469)
Q Consensus 291 ~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~ 368 (469)
|||++.++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 188 ---NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 188 ---NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp ---GEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred ---hEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence 88889999999999999986543322 22234578999999999999999999999999999999999 99999988
Q ss_pred CCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 369 HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+..++...+....+++. +..+++++.+||.+||+.||++|||+++++++|+.+.+.
T Consensus 265 ~~~~~~~~i~~g~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 265 SNTEAIDCITQGRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CHHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHcCCCCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 77777766655555443 456889999999999999999999999999999998775
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-55 Score=418.50 Aligned_cols=264 Identities=28% Similarity=0.481 Sum_probs=215.9
Q ss_pred ccccCCCCcccccceeeecCeEEEEEEe--ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~~--g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
.||++..++ +..++||+|+||.||.. ...||||+++... .+....+.|.+|+.++++++|||||++++++.+ +.
T Consensus 30 ~Wei~~~~l--~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 30 YWEIEASEV--MLSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CCBCCTTSC--CEEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcEEcHHHe--EEeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 578877655 45679999999999852 3469999987543 345667889999999999999999999998854 57
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
++||||||++|+|.+++... +.+++.++..++.||+.||+|||+++ ||||||||+ |||++.++.+
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~-----------NILl~~~~~~ 171 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSN-----------NIFLHEGLTV 171 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSS-----------SEEEETTEEE
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHH-----------HEEECCCCcE
Confidence 89999999999999999754 56999999999999999999999998 999999999 8888899999
Q ss_pred EEeecCCccccccCC-CCCcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 304 KVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 304 kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
||+|||+|+...... ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+..........
T Consensus 172 Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~ 251 (307)
T 3omv_A 172 KIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG 251 (307)
T ss_dssp EECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred EEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 999999998754322 223345679999999999854 3689999999999999999999999988766544444433
Q ss_pred cC--CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 380 RQ--RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 380 ~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.+ .+.....+..+++++.+||.+||+.||++|||+.+++++|+.++.++
T Consensus 252 ~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 252 RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 33 33334455678999999999999999999999999999999987764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=429.92 Aligned_cols=246 Identities=22% Similarity=0.450 Sum_probs=209.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||++..... .....+.+.+|+.++++++|||||++++++.+++.+|||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 799999999999999985 589999999986654 34556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+||+|.+++..++ .+++.++..++.||+.||+|||+++ ||||||||+ |||++.+|.+||+||
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~-----------NILl~~~g~vKl~DF 169 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQ-----------NIFLTKDGTVQLGDF 169 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGG-----------GEEECTTCCEEECST
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHH-----------HEEECCCCCEEEccc
Confidence 999999999997543 4789999999999999999999999 999999999 888899999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|+|+...... .......||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.....++.
T Consensus 170 Gla~~~~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~--- 245 (350)
T 4b9d_A 170 GIARVLNSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV--- 245 (350)
T ss_dssp TEESCCCHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---
T ss_pred ccceeecCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---
Confidence 9998754321 112345699999999999999999999999999999999999999998777666666655544433
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..+++++.+||.+||+.||++|||++|+++|
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 45688999999999999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=423.22 Aligned_cols=249 Identities=30% Similarity=0.524 Sum_probs=214.3
Q ss_pred cccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 157 FTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
++..++||+|+||.||. +++.||||++.... .....+.|.+|+.++++++|||||+++|+|.+.+.++
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 44567899999999984 35789999997543 2334578999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccc
Q 012164 227 IVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~ 290 (469)
+|||||++|+|.++|..+ ..+++..+..++.||+.||+|||+++ ||||||||+
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~-------- 174 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATR-------- 174 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG--------
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCcccc--------
Confidence 999999999999999642 35899999999999999999999999 999999999
Q ss_pred cCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 012164 291 NDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMK 368 (469)
Q Consensus 291 ~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~ 368 (469)
|||++.++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.
T Consensus 175 ---NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 175 ---NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp ---GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred ---ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 88889999999999999987644322 22344678999999999999999999999999999999998 89999988
Q ss_pred CCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 369 HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
+..++...+....+++. +..+|+.+.+||.+||+.||++|||+++|+++|+++
T Consensus 252 ~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 252 SNQDVVEMIRNRQVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CHHHHHHHHHcCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 87777777765555443 456889999999999999999999999999999865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-55 Score=424.36 Aligned_cols=245 Identities=22% Similarity=0.376 Sum_probs=213.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..++||+|+||.||. +|+.||||++....... .+.+.+|+.+|++++|||||+++++|.+.+.+|||||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 588889999999999985 58999999997554322 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||+||+|.+++.+ +.+++.++..++.||+.||+|||+++ ||||||||+ |||++.+|.+||+|||+
T Consensus 152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~-----------NILl~~~g~vKl~DFGl 216 (346)
T 4fih_A 152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSD-----------SILLTHDGRVKLSDFGF 216 (346)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTCCEEECCCTT
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHH-----------HEEECCCCCEEEecCcC
Confidence 9999999999976 56999999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+...... .......||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.....+ ....+.
T Consensus 217 a~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~ 294 (346)
T 4fih_A 217 CAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLH 294 (346)
T ss_dssp CEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCSCGG
T ss_pred ceecCCCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccc
Confidence 98765332 2334578999999999999999999999999999999999999999887666665555443333 333456
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+++++++||.+||+.||++|||+.|+++|
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 789999999999999999999999999887
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=424.06 Aligned_cols=247 Identities=21% Similarity=0.404 Sum_probs=216.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||||++.+.........+.+.+|++++++++||||++++++|.+++.+|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 699999999999999985 689999999976543333345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||+||+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||+
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPe-----------NILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPE-----------NILLNEDMHIQITDFGT 178 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTSCEEECCCTT
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHH-----------HeEEcCCCCEEEEEcCC
Confidence 9999999999999889999999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
|+...... .......+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+.... ..+ +
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~---p 254 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-YDF---P 254 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCC---C
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCC---C
Confidence 98765332 233455789999999999999999999999999999999999999998877666666664433 222 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+++++++||.+||+.||++|||++|++.+
T Consensus 255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 255 EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred cccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 4678899999999999999999999998765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=411.30 Aligned_cols=244 Identities=27% Similarity=0.452 Sum_probs=198.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||||++.+...........+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 689999999999999985 589999999987665555556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|| +|+|.+++.+++.+++.++..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||+
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~-----------NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPE-----------NLLLDEHLNVKIADFGL 158 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTT-----------TEEECTTCCEEECCSSC
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChH-----------HeEECCCCCEEEeecCC
Confidence 99 6899999999899999999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
|+..... .......||+.|||||++.+..+ +.++|||||||++|+|+||+.||.+.+..++...+... ..++ +
T Consensus 159 a~~~~~~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~-~~~~---p 232 (275)
T 3hyh_A 159 SNIMTDG--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG-VYTL---P 232 (275)
T ss_dssp C-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCC---C
T ss_pred CeecCCC--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-CCCC---C
Confidence 9865432 22344679999999999998876 57999999999999999999999876655555555333 3222 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+++++++||.+||+.||++|||++|+++|
T Consensus 233 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 233 KFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 5678999999999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=407.46 Aligned_cols=246 Identities=26% Similarity=0.497 Sum_probs=204.3
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe----CCceEE
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMI 227 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 227 (469)
|+..++||+|+||.||. +|..||+|.+..... .....+.|.+|++++++++|||||+++++|.+ ...+|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 35567899999999985 578999999976544 34556789999999999999999999999875 245899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC-CCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD-DSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~-~~~~vkl~ 306 (469)
|||||++|+|.+++.+.+.+++..+..++.||+.||+|||++++ +||||||||+ |||++ .++.+||+
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~-----------NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCD-----------NIFITGPTGSVKIG 174 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGG-----------GEEESSTTSCEEEC
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChh-----------heeEECCCCCEEEE
Confidence 99999999999999998899999999999999999999999863 4999999999 88886 47899999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|||+|+... ........||+.|||||++.+ .|+.++|||||||++|||+||+.||.+................+ .
T Consensus 175 DFGla~~~~---~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~-~ 249 (290)
T 3fpq_A 175 DLGLATLKR---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-A 249 (290)
T ss_dssp CTTGGGGCC---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-G
T ss_pred eCcCCEeCC---CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-C
Confidence 999997543 223345689999999999876 69999999999999999999999998655433322222222222 1
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+..+++++++||.+||+.||++|||++++++|
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2344567899999999999999999999999876
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=425.47 Aligned_cols=245 Identities=22% Similarity=0.379 Sum_probs=213.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..++||+|+||.||. +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 588999999999999985 58999999997553322 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||+||+|.+++.. +.+++.++..++.||+.||+|||+++ ||||||||+ |||++.+|.+||+|||+
T Consensus 229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~-----------NILl~~~g~vKl~DFGl 293 (423)
T 4fie_A 229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSD-----------SILLTHDGRVKLSDFGF 293 (423)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTT-----------TEEECTTCCEEECCCTT
T ss_pred CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHH-----------HEEEcCCCCEEEecCcc
Confidence 9999999999975 46999999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.....+. ...+.
T Consensus 294 a~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~~~~~ 371 (423)
T 4fie_A 294 CAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-LKNLH 371 (423)
T ss_dssp CEECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSCTT
T ss_pred ceECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-Ccccc
Confidence 98765332 23345679999999999999999999999999999999999999998877666666554443332 23345
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+++++++||.+||..||++|||+.|+++|
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 788999999999999999999999999887
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=413.26 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=204.2
Q ss_pred ccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|++.+.||+|+||.||. +++.||||++.+...... ....+.+|++++++++||||+++++++.+++.+|+
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 699999999999999984 357899999875433221 12357889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||||+||+|.+++.+.+.+++.++..++.||+.||+|||+++ |+||||||+ |||++.+|.+||+|
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~-----------NILl~~~g~vKl~D 169 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPE-----------NILLDEEGHIKLTD 169 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGG-----------GEEECTTSCEEEES
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH-----------HeEEcCCCCEEecc
Confidence 9999999999999999889999999999999999999999999 999999999 88889999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||+|+...... .......||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++...+.... .++
T Consensus 170 FGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~-- 245 (304)
T 3ubd_A 170 FGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGM-- 245 (304)
T ss_dssp SEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC--
T ss_pred cccceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCC--
Confidence 99998654322 23345689999999999999999999999999999999999999999877666666664432 222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCH-----HHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTF-----RQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~ 420 (469)
+..+++++++||.+||+.||++|||+ +|+++|
T Consensus 246 -p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 246 -PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 35688999999999999999999984 666655
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=411.64 Aligned_cols=260 Identities=27% Similarity=0.481 Sum_probs=216.7
Q ss_pred ccccCCCCcccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCC-CceeeE
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 215 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~ 215 (469)
.||+... +|+..+.||+|+||.||. .++.||||++.... .....+.|.+|+++++++.| ||||++
T Consensus 58 ~wEi~~~--~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCGG--GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecHH--HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4666543 577788999999999985 23679999987542 34556789999999999965 999999
Q ss_pred EeEEEeC-CceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012164 216 LGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278 (469)
Q Consensus 216 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 278 (469)
+++|.+. ..+++|||||++|+|.++|+.. ..+++..+..++.||+.||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 5689999999999999999752 24889999999999999999999999 99999
Q ss_pred CCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHH
Q 012164 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357 (469)
Q Consensus 279 lkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~e 357 (469)
|||+ |||++.++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++||
T Consensus 211 LK~~-----------NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~E 279 (353)
T 4ase_A 211 LAAR-----------NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 279 (353)
T ss_dssp CSGG-----------GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cCcc-----------ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHH
Confidence 9999 888889999999999999876543222 2233568999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCcHHH-HHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 358 MIE-GCPPFTMKHDNEVPK-AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 358 l~t-g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
|+| |+.||.+.+..+... .+....+++. +..+++++.+||.+||+.||++|||+.+|+++|+.+.++
T Consensus 280 l~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 280 IFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HTTTSCCSSTTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 998 999999876555443 3333334443 456788999999999999999999999999999998765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=390.33 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=189.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC-------
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------- 223 (469)
+|+..+.||+|+||.||. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 578889999999999985 58899999987542 4555678999999999999999999999987544
Q ss_pred -----ceEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 224 -----PMMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 224 -----~~~lv~E~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
.+|+|||||++|+|.+++...+. .++..++.++.||+.||+|||+++ |+||||||+ ||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~-----------NI 149 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPS-----------NI 149 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHH-----------He
Confidence 37999999999999999987654 345668899999999999999999 999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCCC-----------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKEDR-----------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 364 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p 364 (469)
|++.++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||++ |
T Consensus 150 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---P 226 (299)
T 4g31_A 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P 226 (299)
T ss_dssp EECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---C
T ss_pred EECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---C
Confidence 8899999999999999876533211 1133569999999999999999999999999999999996 7
Q ss_pred CCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 365 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
|.... +....+........+......++.+.+||.+||+.||++|||+.++++|
T Consensus 227 f~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 227 FSTQM--ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp CSSHH--HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCcc--HHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 75422 1111111111222222344556778999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=390.76 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=196.5
Q ss_pred ccccceeeecCeEEEEE---EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC----ceEEE
Q 012164 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 228 (469)
+|...+.||+|+||.|| ++|+.||||++.... ........|+..+.+++||||+++++++.+.+ .+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 56778899999999887 479999999986432 22223345666677889999999999998654 57999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-----PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
||||++|+|.++++.. .+++..+.+++.|++.||+|||++. ..+||||||||+ |||++.++.+
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~-----------NILl~~~~~~ 147 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK-----------NILVKKNGTC 147 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGG-----------GEEECTTSCE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcc-----------cEEECCCCCE
Confidence 9999999999999864 5999999999999999999999861 112999999999 8899999999
Q ss_pred EEeecCCccccccCCCC---CcccCCCCCcccCCcccCCC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc--
Q 012164 304 KVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-- 372 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-- 372 (469)
||+|||+|+........ ......||+.|||||++.+. .++.++|||||||++|||+||+.||......+
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 99999999876543221 22335799999999998764 36679999999999999999987764322211
Q ss_pred -------------HHHHHhhcC-CCCCCCCh--hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 373 -------------VPKAYAARQ-RPPFKAPA--KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 373 -------------~~~~~~~~~-~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+...+.... +++.+... ...++.+.+|+.+||+.||++|||+.++++.|+.+.++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 112222222 33332211 23557899999999999999999999999999998765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=395.85 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=206.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------Cc
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~ 224 (469)
+|++.+.||+|+||.||. +|+.||||++..... .....+.+.+|+++|++++||||+++++++... +.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 699999999999999985 589999999975543 344557788999999999999999999997643 57
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
+|+|||||+ |+|.+++.+++.+++..+..++.||+.||.|||+++ ||||||||+ |||++.++.+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~-----------NIl~~~~~~~K 198 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPS-----------NLLVNENCELK 198 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG-----------GEEECTTCCEE
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCcc-----------ccccCCCCCEE
Confidence 899999995 789999998889999999999999999999999999 999999999 88889999999
Q ss_pred EeecCCccccccCC---CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc
Q 012164 305 VADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 305 l~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 380 (469)
|+|||+|+.+.... ........||+.|||||++.+. .++.++||||+||++|||++|++||.+.+..+....+...
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 99999998764321 2233457899999999998875 5689999999999999999999999887665554444221
Q ss_pred -CCCC---------------------C-CC----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 -QRPP---------------------F-KA----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 -~~~~---------------------~-~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.++ . .. ..+.+++++.+||.+||..||++|||+.|+++|
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1111 0 00 012457889999999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=406.04 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=205.4
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCC---CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
.+|++.+.||+|+||.||. +|+.||||++.+..+. ..........++.+++.++||||++++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 3799999999999999985 6899999998754321 1222223344567778889999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
+|||||+||+|.+++.+.+.+++..+..++.||+.||+|||+++ ||||||||+ |||++.+|.+||+
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPe-----------NILld~~G~vKL~ 334 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPA-----------NILLDEHGHVRIS 334 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGG-----------GEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchH-----------HeEEeCCCCEEec
Confidence 99999999999999999999999999999999999999999999 999999999 8999999999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH--hhcCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRP 383 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~--~~~~~~ 383 (469)
|||+|+..... .....+||+.|||||++.+ ..|+.++|+|||||++|||++|++||.+.+........ ......
T Consensus 335 DFGlA~~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~ 411 (689)
T 3v5w_A 335 DLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411 (689)
T ss_dssp CCTTCEECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC
T ss_pred ccceeeecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Confidence 99999876432 2344689999999999974 57999999999999999999999999865544432222 122222
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
.+ +..+++++++||.+||..||++|++ ++++++|
T Consensus 412 ~~---p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 EL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CC---CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CC---CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 22 4568899999999999999999998 7888887
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=405.01 Aligned_cols=246 Identities=22% Similarity=0.380 Sum_probs=213.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.|+. +|+.||+|.+... .....+.+.+|+.+|+.++||||++++++|.+...+|+|||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 689999999999999985 6899999998654 23445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC--CCCeEEee
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD--SGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~--~~~vkl~D 307 (469)
||+||+|.+++.. .+.+++.++..++.||+.||.|||+++ |+||||||+ |||++. .+.+||+|
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~-----------Nill~~~~~~~vKl~D 300 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPE-----------NIMFTTKRSNELKLID 300 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEESSSSCCCEEECC
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChh-----------hccccCCCCCCEEEee
Confidence 9999999999964 467999999999999999999999999 999999999 666664 48999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||+|+..... .......||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+..........
T Consensus 301 FG~a~~~~~~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 378 (573)
T 3uto_A 301 FGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 378 (573)
T ss_dssp CSSCEECCTT--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG
T ss_pred ccceeEccCC--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc
Confidence 9999876532 23344679999999999999999999999999999999999999999877766666664443332233
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..+++++++||.+||..||.+|||+.|+++|
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 345788999999999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=377.04 Aligned_cols=244 Identities=20% Similarity=0.283 Sum_probs=193.6
Q ss_pred cccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCce
Q 012164 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 225 (469)
.+|++.+.||+|+||.||. +++.||+|.+.... . ...+.+|+++++.+ +||||++++++|.+.+.+
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3689999999999999984 36789999886542 1 24578899999998 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC-CCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS-GNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~-~~vk 304 (469)
|+|||||++|+|.+++. .+++.++..++.||+.||+|||++| |+||||||+ |||++.+ +.+|
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPe-----------NiLl~~~~~~~k 158 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPS-----------NFLYNRRLKKYA 158 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEEETTTTEEE
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHH-----------HeEEeCCCCeEE
Confidence 99999999999999984 4899999999999999999999999 999999999 7777765 7899
Q ss_pred EeecCCccccccCCC---------------------------CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHH
Q 012164 305 VADFGVSKLLTVKED---------------------------RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQ 356 (469)
Q Consensus 305 l~Dfgla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~ 356 (469)
|+|||+|+....... .......||+.|+|||++.+. .|+.++||||+||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 999999975432211 112345799999999999875 5899999999999999
Q ss_pred HHHhCCCCCCCCCCCc-HHHHHhh-----------------------------------cC-----CC----------CC
Q 012164 357 EMIEGCPPFTMKHDNE-VPKAYAA-----------------------------------RQ-----RP----------PF 385 (469)
Q Consensus 357 el~tg~~p~~~~~~~~-~~~~~~~-----------------------------------~~-----~~----------~~ 385 (469)
+|++|+.||...++.. ....+.. .. .+ ..
T Consensus 239 ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 318 (361)
T 4f9c_A 239 SLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN 318 (361)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccc
Confidence 9999999996544321 1111100 00 00 00
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
......+++++.+||.+||+.||++|||++|+++|
T Consensus 319 ~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 319 LEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp ---CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 01123567889999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=358.43 Aligned_cols=245 Identities=27% Similarity=0.460 Sum_probs=213.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.|+. +|+.||||++..... +....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 3789999999999999884 688999999876543 4455677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~-----------NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAE-----------NLLLDADMNIKIADFG 159 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTSCEEECSTT
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHH-----------HEEEcCCCCEEEeecc
Confidence 99999999999998888999999999999999999999999 999999999 8888999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++...... .......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+..... ..
T Consensus 160 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~--- 233 (328)
T 3fe3_A 160 FSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RI--- 233 (328)
T ss_dssp CCGGGSSS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CC---
T ss_pred CceecCCC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC---
Confidence 99765432 233456799999999999887765 789999999999999999999988776666555544322 22
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..+++++.+||.+||..||.+|||++++++|
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 23567899999999999999999999999987
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=354.09 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=215.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. ++..||+|.+...........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 789999999999999984 578999999876655666777889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~-----------Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQ-----------NILIDSNKTLKIFDFGI 157 (294)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTSCEEECCCSS
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEECCCCCEEEEeCCC
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC-CCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF-KAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 389 (469)
++..............||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+....+..........+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSC
T ss_pred ccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcc
Confidence 987654333333445689999999999998999999999999999999999999987655444333323222221 1123
Q ss_pred hhhHHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHHHhhh
Q 012164 390 KLYARGLKELIEECWNEKPAKRP-TFRQIITRLESINNSI 428 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~L~~~~~~~ 428 (469)
..+++.+.++|.+||+.||.+|| ++.++.+.|+.+....
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 45788999999999999999998 9999999998876553
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=359.93 Aligned_cols=255 Identities=28% Similarity=0.529 Sum_probs=218.3
Q ss_pred cccccceeeecCeEEEEEE------------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEe
Q 012164 155 LDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~------------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 221 (469)
.+|+..+.||+|+||.||. ++..||||++... ......+.+.+|+.+++++ +||||+++++++.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4788899999999999984 2457999999754 3455667899999999999 89999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccc
Q 012164 222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285 (469)
Q Consensus 222 ~~~~~lv~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil 285 (469)
.+.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~--- 232 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR--- 232 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG---
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchh---
Confidence 999999999999999999998643 3789999999999999999999999 999999999
Q ss_pred ccccccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 012164 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 363 (469)
Q Consensus 286 ~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~ 363 (469)
||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 233 --------NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~ 304 (370)
T 2psq_A 233 --------NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304 (370)
T ss_dssp --------GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred --------hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 88888999999999999986543322 22233456789999999999899999999999999999999 999
Q ss_pred CCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 364 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 364 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
||.+....++...+....+++. +..+++.+.+||.+||+.||++|||+.+++++|+.+.+..
T Consensus 305 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 305 PYPGIPVEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 9998777676666544444333 3567889999999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.29 Aligned_cols=258 Identities=36% Similarity=0.592 Sum_probs=209.4
Q ss_pred cccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
.+|++.+.||+|+||.||. +|..||||.+..... .....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 3788899999999998874 689999999876543 455567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 232 LPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
+++|+|.+++...+. +++..++.++.|++.||.|||+.++ +|+||||||+ ||+++.++.+||+||
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~-----------NIll~~~~~~kL~Df 183 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSP-----------NLLVDKKYTVKVCDF 183 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGG-----------GEEECTTCCEEECCC
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChh-----------hEEEeCCCcEEECCC
Confidence 999999999987553 9999999999999999999999862 4999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|+++..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+...... ...
T Consensus 184 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~ 260 (309)
T 3p86_A 184 GLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--LEI 260 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC--CCC
T ss_pred CCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCC
Confidence 999754432 12223456899999999999999999999999999999999999999877655554444322211 122
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
+..+++.+.+||.+||+.||++|||+.++++.|+.+.++.
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 4568889999999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=359.16 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=212.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 688999999999999985 578999999976544 34556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC---CCeEEee
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS---GNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~---~~vkl~D 307 (469)
||++|+|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.+ +.+||+|
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~-----------NIll~~~~~~~~~kl~D 174 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPE-----------NLLLASKAKGAAVKLAD 174 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGG-----------GEEESCSSTTCCEEECC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchH-----------HEEEecCCCCCCEEEee
Confidence 9999999999988888999999999999999999999999 999999999 6666543 4699999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..........
T Consensus 175 fG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 252 (362)
T 2bdw_A 175 FGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 252 (362)
T ss_dssp CTTCBCCTTC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cCcceEecCC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 9999875532 22334678999999999999899999999999999999999999998776655555554443332233
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+++++.+||.+||..||++|||+.++++|
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 346788999999999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=360.07 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=211.6
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCH---HHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
...|+..+.||+|+||.||. +|+.||+|.+........ ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 34688999999999999985 588999999876543211 1246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC----
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG---- 301 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~---- 301 (469)
++||||+++|+|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~-----------NIll~~~~~~~~ 156 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPE-----------NIMLLDKNIPIP 156 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEESCTTSSSC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEEeCCCCCcc
Confidence 999999999999999998888999999999999999999999999 999999999 77766665
Q ss_pred CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC
Q 012164 302 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 381 (469)
.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 157 ~vkl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 234 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234 (361)
T ss_dssp CEEECCCSSCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred CEEEEecCCceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 7999999999876532 22344679999999999999899999999999999999999999998876655555554332
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.......+..+++.+.+||.+||..||++|||+.++++|
T Consensus 235 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 221112234678899999999999999999999999976
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=347.99 Aligned_cols=247 Identities=22% Similarity=0.432 Sum_probs=211.6
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.||. +|+.||+|.+....... .+.+.+|+.++++++||||+++++++...+..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 34788999999999999985 57899999987554333 35688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||||++|+|.+++.+. .+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+||
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~-----------Nil~~~~~~~kl~Df 160 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSD-----------NILLGMDGSVKLTDF 160 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTCCEEECCC
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHH-----------HEEECCCCCEEEeeC
Confidence 9999999999999865 5999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....+.. ..
T Consensus 161 g~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~ 238 (297)
T 3fxz_A 161 GFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QN 238 (297)
T ss_dssp TTCEECCSTT-CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SC
T ss_pred CCceecCCcc-cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CC
Confidence 9998765332 223446789999999999999999999999999999999999999987665444444444443333 23
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..+++.+.+||.+||+.||++|||+.++++|
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 56788999999999999999999999999876
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=356.83 Aligned_cols=246 Identities=25% Similarity=0.405 Sum_probs=211.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.|+. +|+.||+|.+.+...........+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 688899999999999985 588999999875432222334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+ ||+++.+|.+||+|||+
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~-----------NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLE-----------NLMLDKDGHIKITDFGL 151 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG-----------GEEECTTSCEEECCCTT
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHH-----------HEEECCCCCEEEeeccc
Confidence 9999999999998888999999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..+ +.
T Consensus 152 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~---p~ 226 (337)
T 1o6l_A 152 CKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRF---PR 226 (337)
T ss_dssp CBCSCCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CT
T ss_pred hhhcccC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC---CC
Confidence 9764322 222344678999999999999999999999999999999999999998766555555554332 222 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
.+++++.+||.+||+.||++|| +++++++|
T Consensus 227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 6788999999999999999999 99999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=365.58 Aligned_cols=249 Identities=19% Similarity=0.328 Sum_probs=213.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 688899999999999984 589999999876543 33445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC---CCCCeEEee
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD---DSGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~---~~~~vkl~D 307 (469)
||++|+|.+.+...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++ .++.+||+|
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~-----------NIll~~~~~~~~vkL~D 156 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPE-----------NLLLASKLKGAAVKLAD 156 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSST-----------TEEESBSSTTCCEEECC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHH-----------HEEEeccCCCCcEEEcc
Confidence 9999999999998888999999999999999999999999 999999999 66665 467899999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..........
T Consensus 157 FG~a~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 235 (444)
T 3soa_A 157 FGLAIEVEGE-QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP 235 (444)
T ss_dssp CSSCBCCCTT-CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT
T ss_pred CceeEEecCC-CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc
Confidence 9999765532 222344679999999999999899999999999999999999999998877666666665444333333
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+++++.+||.+||+.||++|||+.++++|
T Consensus 236 ~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 345788999999999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=352.95 Aligned_cols=259 Identities=29% Similarity=0.482 Sum_probs=216.6
Q ss_pred CcccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
..+|++.+.||+|+||.||. .+..||||.+... ......+.+.+|+.++++++||||+++++++.+.+..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34788899999999999974 2345999998754 2455667899999999999999999999999998899
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++||||+++++|.+++... +.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+|
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~k 191 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAAR-----------NVLVDSNLVCK 191 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTCCEE
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcc-----------eEEECCCCCEE
Confidence 9999999999999999754 56999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 305 VADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
|+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....
T Consensus 192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 271 (325)
T 3kul_A 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271 (325)
T ss_dssp ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC
Confidence 99999998765432221 122345778999999998889999999999999999999 999998877666666654443
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 431 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 431 (469)
..+. +..+++.+.+||.+||..||++|||+.++++.|+.+.+.....
T Consensus 272 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 272 RLPA---PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred CCCC---CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 3332 3567889999999999999999999999999999998875543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=351.56 Aligned_cols=246 Identities=16% Similarity=0.295 Sum_probs=209.5
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|+.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 3788899999999999985 5789999998643 234467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC--CCCeEEe
Q 012164 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD--SGNLKVA 306 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~--~~~vkl~ 306 (469)
|||++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+ ||+++. ++.+||+
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~-----------NIl~~~~~~~~~kl~ 146 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPE-----------NIIYQTRRSSTIKII 146 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEESSSSCCCEEEC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHH-----------HEEEccCCCCCEEEE
Confidence 9999999999998654 6999999999999999999999999 999999999 666665 7899999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.........
T Consensus 147 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 224 (321)
T 1tki_A 147 EFGQARQLKPG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224 (321)
T ss_dssp CCTTCEECCTT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH
T ss_pred ECCCCeECCCC--CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh
Confidence 99999875432 2223456899999999999988899999999999999999999999887666665555444332222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....+++++.+||.+||..||++|||+.++++|
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2234678899999999999999999999999997
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=342.61 Aligned_cols=252 Identities=29% Similarity=0.563 Sum_probs=214.4
Q ss_pred cccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.+|+..+.||+|+||.||. +++.||+|.+...... .+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3688889999999999875 5788999999765432 2568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++++|.+++... +.+++..++.++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~-----------Nil~~~~~~~kl~Dfg 151 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAAR-----------NCLVGENQVIKVSDFG 151 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECGGGCEEECCTT
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchh-----------eEEEcCCCCEEecccc
Confidence 99999999999754 45899999999999999999999999 999999999 8888888999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++...............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+....... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 228 (269)
T 4hcu_A 152 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---K 228 (269)
T ss_dssp GGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---C
T ss_pred ccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC---C
Confidence 998654332222334456788999999998899999999999999999999 999998876666555554433322 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+..+++.+.+|+.+||+.||++|||+.+++++|+.+.++
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 345688999999999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=351.15 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=209.8
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCH---HHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
..|+..+.||+|+||.||. +|+.||+|.+........ ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3688999999999999985 478999999875432211 12467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC----C
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG----N 302 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~----~ 302 (469)
+||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++ .
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~-----------NIll~~~~~~~~~ 156 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPE-----------NIMLLDRNVPKPR 156 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEESCSSSSSCC
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHH-----------HEEEecCCCCCCC
Confidence 99999999999999998888999999999999999999999999 999999999 77776666 8
Q ss_pred eEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC
Q 012164 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 157 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234 (326)
T ss_dssp EEECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred EEEEECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence 9999999998764322 22345689999999999988999999999999999999999999987665555444433322
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.........+++.+.+||.+||..||++|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22111234678899999999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=342.06 Aligned_cols=253 Identities=30% Similarity=0.547 Sum_probs=213.4
Q ss_pred CcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
..+|+..+.||+|+||.||. ++..||+|.+...... .+.+.+|+.++++++||||+++++++.+....++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 44788999999999999874 4568999998765332 256889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~-----------Nil~~~~~~~~l~Df 148 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAAR-----------NCLVDRDLCVKVSDF 148 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGG-----------GEEECTTCCEEECCT
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcc-----------eEEECCCCCEEEccC
Confidence 9999999999998754 4999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
|++...............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.......
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--- 225 (268)
T 3sxs_A 149 GMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY--- 225 (268)
T ss_dssp TCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---
T ss_pred ccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC---
Confidence 9998655433222233456778999999988889999999999999999999 999998766655555443333222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.+..+++.+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 2345678999999999999999999999999999988655
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=346.99 Aligned_cols=252 Identities=31% Similarity=0.495 Sum_probs=211.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|+.||+|.+... +....+.+.+|++++++++||||+++++++.+....++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 3688899999999999885 4789999987542 4566788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+++++|.+++.. .+.+++.++..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+||
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~-----------Nil~~~~~~~kl~Df 152 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSH-----------NCLVRENKNVVVADF 152 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTT-----------SEEECTTSCEEECCC
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcC-----------eEEECCCCCEEEeec
Confidence 99999999999987 456999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCC-------------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH--
Q 012164 309 GVSKLLTVKEDRP-------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-- 373 (469)
Q Consensus 309 gla~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~-- 373 (469)
|+++......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~ 232 (310)
T 3s95_A 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232 (310)
T ss_dssp TTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence 9998654322111 1145689999999999999999999999999999999999999875433221
Q ss_pred ---HHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 374 ---PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 374 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
........ .+..+++.+.+|+.+||+.||++|||+.++++.|+.+...+.
T Consensus 233 ~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 233 GLNVRGFLDRY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp SBCHHHHHHHT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhhhhcccccc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11111111 123466789999999999999999999999999999987754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=341.27 Aligned_cols=254 Identities=24% Similarity=0.467 Sum_probs=204.7
Q ss_pred CcccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
..+|+..+.||+|+||.||. .+..||+|.+... ......+.+.+|+.++++++||||+++++++. .+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34788899999999999874 2456999988743 34556678999999999999999999999984 5678
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-----------Nil~~~~~~~k 156 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAAR-----------NVLVSSNDCVK 156 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEEEETTEEE
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHH-----------HEEECCCCCEE
Confidence 99999999999999998654 5999999999999999999999999 999999999 88888889999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCC
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
|+|||+++..............+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~ 236 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred ECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC
Confidence 99999998765433323333456789999999988889999999999999999996 99999987776666666544433
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+. +..+++.+.++|.+||+.||++|||+.+++++|+.+...
T Consensus 237 ~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 PM---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 33 456789999999999999999999999999999999776
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=359.15 Aligned_cols=246 Identities=25% Similarity=0.399 Sum_probs=208.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.|+. +|+.||||++.+.........+.+..|..+++.+ +||||+++++++.+.+.+|+||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 788899999999999985 4789999998765332333456788899999988 6999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|||++|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||
T Consensus 104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~-----------NILl~~~g~ikL~DFG 169 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLD-----------NVLLDHEGHCKLADFG 169 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG-----------GEEECTTSCEEECCCT
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHH-----------HEEECCCCCEEEcccc
Confidence 99999999999998888999999999999999999999999 999999999 8888999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+.... ..+ +
T Consensus 170 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~---p 244 (353)
T 3txo_A 170 MCKEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVY---P 244 (353)
T ss_dssp TCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---C
T ss_pred ceeecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCC---C
Confidence 99754322 223344679999999999998889999999999999999999999999877666666664433 222 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCH------HHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTF------RQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~ 420 (469)
..+++.+.+||.+||..||++||++ .++++|
T Consensus 245 ~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 245 TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 4578899999999999999999998 888876
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=357.12 Aligned_cols=246 Identities=24% Similarity=0.420 Sum_probs=205.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.|+. +++.||+|++.+.........+.+..|..+++++ +||||+++++++.+...+++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 788999999999999985 5789999999876655555566788999999887 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|||++|+|.+++.+.+.+++..+..++.||+.||+|||+.+ |+||||||+ |||++.++.+||+|||
T Consensus 133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~-----------NILl~~~g~ikL~DFG 198 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD-----------NVLLDSEGHIKLTDYG 198 (396)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG-----------GEEECTTSCEEECCCT
T ss_pred EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHH-----------HEEECCCCCEEEeecc
Confidence 99999999999998888999999999999999999999999 999999999 8888999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc---------HHHHHhhc
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---------VPKAYAAR 380 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~---------~~~~~~~~ 380 (469)
+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ +...+ ..
T Consensus 199 la~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-~~ 276 (396)
T 4dc2_A 199 MCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LE 276 (396)
T ss_dssp TCBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH-HH
T ss_pred eeeecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH-hc
Confidence 99753322 223345679999999999999999999999999999999999999996432211 12222 22
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCH------HHHHHH
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF------RQIITR 420 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~ 420 (469)
....+ +..+++++.+||.+||+.||++||++ .++++|
T Consensus 277 ~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 277 KQIRI---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCCCC---CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred cccCC---CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 22222 34578899999999999999999995 677766
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=360.64 Aligned_cols=260 Identities=30% Similarity=0.517 Sum_probs=217.7
Q ss_pred ccccCCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 221 (469)
.|++.. .+|+..+.||+|+||.||. +|+.||||.+... ......+.+.+|+.++++++||||+++++++..
T Consensus 108 ~~~~~~--~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 108 KWVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp TTBCCG--GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccEEch--HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 444443 3678889999999999874 5789999998744 234555678999999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 222 SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 222 ~~~~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
.+..++||||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ ++||||||+ |||++.+
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~-----------Nil~~~~ 249 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAAR-----------NCLVTEK 249 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTT
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHH-----------HEEEcCC
Confidence 899999999999999999998654 5999999999999999999999999 999999999 8888899
Q ss_pred CCeEEeecCCccccccCCCCCc-ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHh
Q 012164 301 GNLKVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~ 378 (469)
+.+||+|||+++.......... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.
T Consensus 250 ~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~ 329 (377)
T 3cbl_A 250 NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329 (377)
T ss_dssp CCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH
T ss_pred CcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999976432211111 11224678999999988889999999999999999998 999999877666665554
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
...+.+. +..+++.+.+||.+||+.||++|||+.++++.|+++.+.
T Consensus 330 ~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 330 KGGRLPC---PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 4444433 355788999999999999999999999999999998765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=349.14 Aligned_cols=243 Identities=24% Similarity=0.458 Sum_probs=209.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.|+. +|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 688899999999999985 588999999875432112234668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+ ||+++.+|.+||+|||+
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~-----------NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPE-----------NILLDKNGHIKITDFGF 152 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGG-----------GEEECTTSCEEECCCSS
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChh-----------eEEEcCCCCEEEeecCc
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..+ +.
T Consensus 153 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~---p~ 224 (318)
T 1fot_A 153 AKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRF---PP 224 (318)
T ss_dssp CEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCC---CT
T ss_pred ceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC---CC
Confidence 9865422 234578999999999999999999999999999999999999998766555555554332 222 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
.+++++.+||.+||..||++|| +++++++|
T Consensus 225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 5788999999999999999999 89999877
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=341.82 Aligned_cols=252 Identities=26% Similarity=0.503 Sum_probs=211.6
Q ss_pred cccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.+|+..+.||+|+||.||. ++..||+|++...... .+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4788899999999999875 4568999999765332 2568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~-----------Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAAR-----------NCLVNDQGVVKVSDFG 165 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGG-----------GEEECTTSCEEECSTT
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccc-----------eEEEcCCCCEEEcccc
Confidence 9999999999986 456999999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~--- 242 (283)
T 3gen_A 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR--- 242 (283)
T ss_dssp GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---
T ss_pred ccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---
Confidence 998654332222233456788999999998889999999999999999998 9999987766555555544333222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+..+++.+.+||.+||+.||++|||+.+++++|+.+.+.
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 345678999999999999999999999999999998765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=348.38 Aligned_cols=246 Identities=24% Similarity=0.413 Sum_probs=209.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.|+. +|+.||+|++...........+.+.+|..+++++ +||||+++++++.+...+++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 688899999999999985 5889999999877666677778899999999988 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++|+|.+++.+.+.+++..+..++.||+.||+|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~-----------NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD-----------NVLLDSEGHIKLTDYG 155 (345)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG-----------GEEECTTSCEEECCGG
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHH-----------HEEECCCCCEEEEecc
Confidence 99999999999998888999999999999999999999999 999999999 8888999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC---------cHHHHHhhc
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------EVPKAYAAR 380 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~---------~~~~~~~~~ 380 (469)
+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .+...+ ..
T Consensus 156 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i-~~ 233 (345)
T 3a8x_A 156 MCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LE 233 (345)
T ss_dssp GCBCSCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH-HH
T ss_pred ccccccCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH-Hc
Confidence 99754322 22334467999999999999999999999999999999999999999753211 112222 22
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCH------HHHHHH
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF------RQIITR 420 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~------~~ll~~ 420 (469)
....+ +..++.++.+||.+||+.||++||++ .++++|
T Consensus 234 ~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 234 KQIRI---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCC---CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 22222 34678899999999999999999995 677765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=359.86 Aligned_cols=246 Identities=30% Similarity=0.549 Sum_probs=212.7
Q ss_pred ccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC-ceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-PMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. .|+.||||.+.... ..+.+.+|+.++++++||||+++++++.... ..++||||
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred HeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 677889999999998874 68899999987543 2367899999999999999999999987665 79999999
Q ss_pred cCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|++|+|.+++...+. +++..+..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~-----------Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAAR-----------NVLVSEDNVAKVSDFG 334 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEECTTSCEEECCCT
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHh-----------hEEECCCCCEEEeeCC
Confidence 999999999987654 799999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
+++..... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...+..++...+....+.+.
T Consensus 335 ~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~--- 407 (450)
T 1k9a_A 335 LTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA--- 407 (450)
T ss_dssp TCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC---
T ss_pred Cccccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 99854322 122356889999999999999999999999999999998 9999998888777776655444433
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+..+++.+.+||.+||+.||++|||+.++++.|+.+.+.
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 456789999999999999999999999999999998765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.57 Aligned_cols=257 Identities=28% Similarity=0.521 Sum_probs=219.3
Q ss_pred cccccceeeecCeEEEEEEe------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEe
Q 012164 155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~~------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 221 (469)
.+|+..+.||+|+||.||.. +..||+|++... ......+.+.+|+++++++ +||||+++++++.+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 47888999999999999852 257999998755 3456667899999999999 89999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccc
Q 012164 222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285 (469)
Q Consensus 222 ~~~~~lv~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil 285 (469)
.+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~--- 220 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR--- 220 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG---
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc---
Confidence 999999999999999999998653 4899999999999999999999999 999999999
Q ss_pred ccccccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 012164 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 363 (469)
Q Consensus 286 ~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~ 363 (469)
||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.
T Consensus 221 --------NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~ 292 (382)
T 3tt0_A 221 --------NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 292 (382)
T ss_dssp --------GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred --------eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 88888999999999999986653322 22233457889999999999899999999999999999999 999
Q ss_pred CCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 364 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 364 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
||......++...+........ +..+++++.+||.+||+.||++|||+.+++++|+.+......
T Consensus 293 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 293 PYPGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred CCCCCCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 9988776666555544433332 346788999999999999999999999999999999877543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=343.44 Aligned_cols=255 Identities=28% Similarity=0.504 Sum_probs=217.5
Q ss_pred CcccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 012164 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 223 (469)
..+|+..+.||+|+||.||. ++..||+|.+... ......+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 34788899999999999875 2378999998754 34566688999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGA------------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 279 (469)
..++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999986543 889999999999999999999999 999999
Q ss_pred CCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHH
Q 012164 280 EPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 358 (469)
Q Consensus 280 kp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el 358 (469)
||+ ||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|
T Consensus 177 kp~-----------NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 245 (314)
T 2ivs_A 177 AAR-----------NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245 (314)
T ss_dssp SGG-----------GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred chh-----------eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHH
Confidence 999 888888999999999999865433221 12334567889999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 359 IE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 359 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
++ |+.||......+....+........ +..+++.+.+||.+||+.||++|||+.+++++|+.+...
T Consensus 246 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 246 VTLGGNPYPGIPPERLFNLLKTGHRMER---PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HhCCCCCCCCCCHHHHHHHhhcCCcCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99 9999998777666665544433332 356788999999999999999999999999999998765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=356.03 Aligned_cols=246 Identities=24% Similarity=0.430 Sum_probs=206.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 788999999999999875 578899999875432222334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||.+|+|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~-----------NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPD-----------NILLDEHGHVHITDFNI 161 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTSCEEECCCTT
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHH-----------HeEECCCCCEEEeccce
Confidence 9999999999998888999999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh--cCCCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA--RQRPPF 385 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~ 385 (469)
++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.. .....
T Consensus 162 a~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~- 238 (384)
T 4fr4_A 162 AAMLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT- 238 (384)
T ss_dssp CEECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC-
T ss_pred eeeccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC-
Confidence 9875432 23345679999999999964 4688999999999999999999999986655444332221 22222
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCC-HHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPT-FRQIITR 420 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~ll~~ 420 (469)
.+..+++.+.+||.+||+.||.+||+ ++++++|
T Consensus 239 --~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 239 --YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred --CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 23467889999999999999999998 7777664
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=350.08 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=207.8
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc----e
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----M 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~ 225 (469)
.+|+..+.||+|+||.||. +|+.||||++.............+.+|+.++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 4789999999999999984 678999999987766666777889999999999999999999999876644 4
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
|+||||+++++|.+++...+.+++.+++.++.|++.||.|||+.+ |+||||||+ ||+++.++.+||
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~-----------Nil~~~~~~~kl 157 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA-----------NIMISATNAVKV 157 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEEETTSCEEE
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHH-----------HEEEcCCCCEEE
Confidence 999999999999999998888999999999999999999999999 999999999 888888999999
Q ss_pred eecCCccccccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 306 ADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 306 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+...........
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence 99999986543322 1223346899999999999989999999999999999999999999876655544444333332
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH-HHHHHHhh
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT-RLESINNS 427 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~-~L~~~~~~ 427 (469)
+.......+++++.+||.+||+.||++||++.+++. .|..+...
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 222223457889999999999999999997666654 45554443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=352.62 Aligned_cols=243 Identities=24% Similarity=0.408 Sum_probs=210.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 788999999999999885 588999999865432222234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+ ||+++.++.+||+|||+
T Consensus 122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~-----------NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE-----------NLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTSCEEECCCTT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccc-----------eEEECCCCCEEEccccc
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..+ +.
T Consensus 188 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~---p~ 259 (350)
T 1rdq_E 188 AKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRF---PS 259 (350)
T ss_dssp CEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CT
T ss_pred ceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCC---CC
Confidence 9865432 233568999999999999999999999999999999999999998776655555554432 222 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
.+++++.+||.+||+.||++||+ ++++++|
T Consensus 260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 67889999999999999999998 8888876
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=351.78 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=210.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.||. +|+.||+|++...........+.+..|..+++.+ +||||+++++++.+.+.+|+||
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 788899999999999985 5789999998754322223346688899999988 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+ |||++.+|.+||+|||
T Consensus 101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~-----------NIll~~~g~vkL~DFG 166 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLD-----------NVMLDSEGHIKIADFG 166 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG-----------GEEECTTSCEEECCCT
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHH-----------HEEEcCCCcEEEEeCC
Confidence 99999999999998888999999999999999999999999 999999999 8888999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.... ..+ +
T Consensus 167 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~---p 241 (353)
T 2i0e_A 167 MCKENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAY---P 241 (353)
T ss_dssp TCBCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---C
T ss_pred cccccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCC---C
Confidence 99864322 223345679999999999999999999999999999999999999998876666665554432 222 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
..+++++.+||.+||..||++||+ +.++++|
T Consensus 242 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 467889999999999999999995 6888876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=354.61 Aligned_cols=248 Identities=29% Similarity=0.446 Sum_probs=210.1
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 227 (469)
..+|+..+.||+|+||.||. +|+.||||.+...........+.+..|..+++.+ +||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 34788999999999999885 5889999998754321122345677899999877 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||||++|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+ ||+++.+|.+||+|
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~-----------NIll~~~g~vkL~D 161 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLD-----------NILLDKDGHIKIAD 161 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG-----------GEEECTTSCEEECC
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChh-----------hEEECCCCCEEEeE
Confidence 9999999999999998888999999999999999999999999 999999999 88889999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+.... +.+
T Consensus 162 FG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~-- 237 (345)
T 1xjd_A 162 FGMCKENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFY-- 237 (345)
T ss_dssp CTTCBCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC--
T ss_pred ChhhhhcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCC--
Confidence 9999764322 222345679999999999999999999999999999999999999998776655555554332 222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHH-HHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFR-QIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~-~ll~~ 420 (469)
+..+++++.+||.+||..||++||++. ++++|
T Consensus 238 -p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 238 -PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 345788999999999999999999997 77665
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=354.30 Aligned_cols=244 Identities=27% Similarity=0.449 Sum_probs=205.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||+|.+.............+.+|+.+++.++||||+++++++.+....++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 688999999999999874 678999998864322111223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+ +|+|.+++...+.+++.++..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~-----------NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPE-----------NLLLDDNLNVKIADFGL 154 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTT-----------TEEECTTCCEEECCSSC
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchh-----------hEEEcCCCCEEEEEecc
Confidence 99 7899999988888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+.. .....+
T Consensus 155 s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~----~~~~~p 228 (336)
T 3h4j_B 155 SNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS----CVYVMP 228 (336)
T ss_dssp TBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS----SCCCCC
T ss_pred ceeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----CCCCCc
Confidence 98654332 2344578999999999988766 6799999999999999999999987655443322211 111224
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+++++.+||.+||+.||.+|||+.++++|
T Consensus 229 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 5678899999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=345.08 Aligned_cols=266 Identities=27% Similarity=0.528 Sum_probs=219.5
Q ss_pred CCccccCCCCcccccceeeecCeEEEEEE------------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCc
Q 012164 145 VPEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN 211 (469)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~ig~G~~~~~~~------------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 211 (469)
.+.|++. ..+|+..+.||+|+||.||. ++..||+|.+.... .....+.+.+|+.+++++ +|||
T Consensus 27 ~~~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 27 DPKWEFP--RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp CTTTBCC--GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CccccCC--HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCC
Confidence 3444443 34788899999999999874 35679999987542 455667899999999999 8999
Q ss_pred eeeEEeEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012164 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPII 275 (469)
Q Consensus 212 i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 275 (469)
|+++++++.+.+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 179 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CI 179 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999999999999998643 3889999999999999999999999 99
Q ss_pred ecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHH
Q 012164 276 HRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354 (469)
Q Consensus 276 H~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvi 354 (469)
||||||+ ||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||++
T Consensus 180 H~Dlkp~-----------NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 248 (334)
T 2pvf_A 180 HRDLAAR-----------NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248 (334)
T ss_dssp CSCCSGG-----------GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHH
T ss_pred CCCCccc-----------eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHH
Confidence 9999999 88888999999999999986543321 11223456788999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012164 355 LQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 431 (469)
Q Consensus 355 l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 431 (469)
+|+|++ |+.||.+....++...+........ +..++..+.+||.+||+.||.+|||+.+++++|+.+.......
T Consensus 249 l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 249 MWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp HHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 999999 9999987766555555544433332 3467889999999999999999999999999999998875543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=335.44 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=213.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4788999999999999985 478999999876543 4455678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC---CeEEe
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG---NLKVA 306 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~---~vkl~ 306 (469)
||+++++|.+.+...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++ .+||+
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~-----------Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPE-----------NLLLASKAKGAAVKLA 150 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEESSSSTTCCEEEC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHH-----------HEEEecCCCCCcEEEe
Confidence 99999999999988888999999999999999999999999 999999999 66665544 49999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|||++...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.........
T Consensus 151 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 151 DFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228 (284)
T ss_dssp CCTTCEECCSS--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred eceeeEEcccC--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc
Confidence 99999765432 2223467899999999999999999999999999999999999999877666665555444433323
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....+++++.+||.+||+.||++|||+.++++|
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 3345678999999999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=342.73 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=207.6
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|+.||+|.+...........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 3789999999999998874 57899999998665555666688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~-----------NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPE-----------NILVSADDFAYLVDFG 179 (309)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTSCEEECSCC
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChH-----------HEEEcCCCCEEEecCc
Confidence 99999999999998888999999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++...............+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ....+.....+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~ 258 (309)
T 2h34_A 180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVR 258 (309)
T ss_dssp C----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTS
T ss_pred cCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccC
Confidence 99765543333334456899999999999989999999999999999999999999865443222222 22222222234
Q ss_pred hhhHHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHHHhhhh
Q 012164 390 KLYARGLKELIEECWNEKPAKRP-TFRQIITRLESINNSIN 429 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~L~~~~~~~~ 429 (469)
..+++.+.+||.+||+.||++|| +++++++.|+.......
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 56788999999999999999999 99999999998866643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=353.96 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=214.3
Q ss_pred cccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
.+|+..+.||+|+||.||. ++..||||++... ........+.+|+.++++++||||+++++++.+...
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3688899999999998874 3468999998643 345555678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
.++|||||++|+|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+ |||+
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~-----------NIll 214 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR-----------NCLL 214 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChh-----------hEEE
Confidence 999999999999999998643 4899999999999999999999999 999999999 7777
Q ss_pred CCCC---CeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012164 298 DDSG---NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE 372 (469)
Q Consensus 298 ~~~~---~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~ 372 (469)
+.++ .+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 215 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~ 294 (367)
T 3l9p_A 215 TCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294 (367)
T ss_dssp SCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 7444 599999999976533221 22233457889999999988899999999999999999998 999999877666
Q ss_pred HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 373 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
....+........ +..+++.+.+||.+||+.||++|||+.+++++|+.+....
T Consensus 295 ~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 295 VLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 6666654443332 4567889999999999999999999999999999987764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=351.43 Aligned_cols=256 Identities=29% Similarity=0.500 Sum_probs=206.2
Q ss_pred cccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
.+|+..+.||+|+||.||. ++..||||.+... ......+.+.+|+.++++++||||+++++++.+....+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 4788899999999999985 3667999998754 24556678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
+||||+++|+|.+++...+ .+++.++..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~kl 188 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAAR-----------NILINSNLVCKV 188 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTCCEEE
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcc-----------eEEEcCCCCEEE
Confidence 9999999999999998754 5999999999999999999999999 999999999 888889999999
Q ss_pred eecCCccccccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCC
Q 012164 306 ADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+....+
T Consensus 189 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~ 268 (373)
T 2qol_A 189 SDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR 268 (373)
T ss_dssp CCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred CcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999998765332211 122235678999999998899999999999999999998 9999987766555555543333
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
.+. +..++..+.+||.+||+.||++||++.++++.|+.+.+...
T Consensus 269 ~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 269 LPP---PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp CCC---CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred CCC---CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 222 34578899999999999999999999999999999987643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=349.82 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=212.6
Q ss_pred CcccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 012164 154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 222 (469)
..+|+..+.||+|+||.||.. ++.||||.+... ......+.+.+|+.+++++ +||||+++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 347888999999999999852 478999999754 3455567899999999999 799999999999876
Q ss_pred C-ceEEEEeccCCCCHHHHHHhcCC-------------------------------------------------------
Q 012164 223 S-PMMIVTEYLPKGDLRAFLKRKGA------------------------------------------------------- 246 (469)
Q Consensus 223 ~-~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 246 (469)
+ ..++|||||++|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4 48999999999999999986432
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccc
Q 012164 247 -----------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLT 315 (469)
Q Consensus 247 -----------l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~ 315 (469)
+++..++.++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||+++...
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~-----------NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR-----------NILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEECGGGCEEECCCGGGSCTT
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChh-----------hEEEcCCCcEEEEeccceeeec
Confidence 889999999999999999999999 999999999 8888889999999999998654
Q ss_pred cCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC-CCCCCCChhhh
Q 012164 316 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLY 392 (469)
Q Consensus 316 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 392 (469)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+....+......... .... +..+
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 321 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYT 321 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC---CTTC
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC---CCCC
Confidence 32221 2233457889999999998899999999999999999998 999998876555444333333 2222 3457
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 393 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 393 ~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
++++.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 88999999999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=363.82 Aligned_cols=253 Identities=28% Similarity=0.502 Sum_probs=214.5
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. ++..||||.+..... ..+.+.+|+.++++++||||+++++++. ....++||||
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 677888999999999885 367899999875432 2467899999999999999999999986 5678999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+ |||++.++.+||+|||
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~-----------Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAA-----------NILVSASLVCKIADFG 329 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGG-----------GEEECTTCCEEECSTT
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH-----------HEEECCCCcEEEeeCC
Confidence 9999999999753 35899999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
+++..............+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+....+.+.
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~--- 406 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR--- 406 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 998754322222233446788999999988899999999999999999999 9999998777666666654444433
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
+..+++++.+||.+||+.||++|||++++++.|+.+.+....
T Consensus 407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 456789999999999999999999999999999998776443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=350.49 Aligned_cols=272 Identities=27% Similarity=0.484 Sum_probs=216.8
Q ss_pred CccccCCCCcccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEe
Q 012164 146 PEYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (469)
Q Consensus 146 ~~~~~~~~~~~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 217 (469)
..+.+......|+..+.||+|+||.||.. +..||+|.+... ......+.+.+|+.++++++||||+++++
T Consensus 80 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 157 (373)
T 3c1x_A 80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 157 (373)
T ss_dssp TTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCE
T ss_pred cccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 34556666778888999999999998841 246899988643 34456678999999999999999999999
Q ss_pred EEEe-CCceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 218 AVTQ-SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 218 ~~~~-~~~~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
++.. .+..++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+ ||
T Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~-----------NI 223 (373)
T 3c1x_A 158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAAR-----------NC 223 (373)
T ss_dssp EECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GE
T ss_pred EEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchh-----------eE
Confidence 8754 457899999999999999998654 4889999999999999999999999 999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCCC---CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 371 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~ 371 (469)
+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......
T Consensus 224 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 224 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp EECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred EECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 8889999999999999865432211 1123456788999999998899999999999999999999 78899888777
Q ss_pred cHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccchhh
Q 012164 372 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKI 436 (469)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~~ 436 (469)
+....+....+... +..+++.+.++|.+||+.||++|||+.+++++|+.+...+....+..+
T Consensus 304 ~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~~~ 365 (373)
T 3c1x_A 304 DITVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV 365 (373)
T ss_dssp CHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCC
T ss_pred HHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccceeec
Confidence 77666644443322 346788999999999999999999999999999999998776655443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=347.09 Aligned_cols=257 Identities=29% Similarity=0.456 Sum_probs=215.6
Q ss_pred CCcccccceeeecCeEEEEEE---e-------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 012164 153 HELDFTNSVEITKGTFILAFW---R-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~---~-------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 222 (469)
...+|+..+.||+|+||.||. . ++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344788899999999999874 2 3789999987542 455667899999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 278 (469)
+..++||||+++|+|.+++... ..+++.+++.++.||+.||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999999999999999999863 46899999999999999999999999 99999
Q ss_pred CCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHH
Q 012164 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357 (469)
Q Consensus 279 lkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~e 357 (469)
|||+ ||+++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|+
T Consensus 200 lkp~-----------NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 268 (343)
T 1luf_A 200 LATR-----------NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268 (343)
T ss_dssp CSGG-----------GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCcc-----------eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHH
Confidence 9999 88888899999999999976543221 22233457889999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 358 MIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 358 l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
|++ |+.||......+....+....... .+..+++.+.+||.+||+.||++|||+.+++++|+++....
T Consensus 269 l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 269 IFSYGLQPYYGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHhcCCCcCCCCChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 999 999998776656555554433332 24567889999999999999999999999999999987653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=344.06 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=205.6
Q ss_pred CCCcccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc----
Q 012164 152 PHELDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (469)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 224 (469)
....+|+..+.||+|+||.||. .++.||||++... .........|+.++++++||||+++++++.....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cchhhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3345889999999999998874 6899999998644 2333456679999999999999999999987543
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCcccccccccCcc
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN----------KPVPIIHRDLEPSDLYVAYWQNDRN 294 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------~~~~ivH~Dlkp~Nil~~~~~~~~n 294 (469)
+++|||||++|+|.+++... .+++..+..++.|++.||.|||+. + |+||||||+ |
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~-----------N 161 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSK-----------N 161 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGG-----------G
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChH-----------h
Confidence 69999999999999999864 599999999999999999999998 8 999999999 8
Q ss_pred eeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 012164 295 ILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMK 368 (469)
Q Consensus 295 il~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDi~SlGvil~el~tg~~p~~~~ 368 (469)
|+++.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 162 ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp EEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred EEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 88889999999999999776543222 22335689999999999873 4556889999999999999999999765
Q ss_pred CCCcH----------------HHHHhhcC-CCCCCC--ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 369 HDNEV----------------PKAYAARQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 369 ~~~~~----------------~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
..... ........ ++.... .....++++.+||.+||+.||++|||+.++++.|+.+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 43221 11111111 222211 1123467799999999999999999999999999999765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=347.54 Aligned_cols=256 Identities=18% Similarity=0.354 Sum_probs=208.6
Q ss_pred cCCCCcccccceeeecC--eEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 012164 150 IDPHELDFTNSVEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (469)
Q Consensus 150 ~~~~~~~~~~~~~ig~G--~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 222 (469)
+.+...+|++.+.||+| +||.||. +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 34455589999999999 9998875 588999999986543 345667889999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
+.+++|||||++|+|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+ |||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~-----------NIll~~~ 164 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKAS-----------HILISVD 164 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTT
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEEcCC
Confidence 9999999999999999999875 66999999999999999999999999 999999999 8888899
Q ss_pred CCeEEeecCCccccccCC------CCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012164 301 GNLKVADFGVSKLLTVKE------DRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~ 372 (469)
+.+||+|||++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 165 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp CCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred CCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999999986543211 111123468899999999987 578999999999999999999999998766655
Q ss_pred HHHHHhhcCCC------------------------------------------CCCCChhhhHHHHHHHHHHHcccCCCC
Q 012164 373 VPKAYAARQRP------------------------------------------PFKAPAKLYARGLKELIEECWNEKPAK 410 (469)
Q Consensus 373 ~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~ 410 (469)
..........+ +....+..+++.+.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 324 (389)
T 3gni_B 245 MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324 (389)
T ss_dssp HHHHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTT
T ss_pred HHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCccc
Confidence 44332211110 001123456788999999999999999
Q ss_pred CCCHHHHHHH
Q 012164 411 RPTFRQIITR 420 (469)
Q Consensus 411 Rps~~~ll~~ 420 (469)
|||+.++++|
T Consensus 325 Rpta~ell~h 334 (389)
T 3gni_B 325 RPSASTLLNH 334 (389)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=364.59 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=210.8
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.||. +|+.||+|++.+...........+.+|..+++.++||||+++++++.+.+.+++|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 34788999999999999985 4789999998653221111223478899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
||||++|+|.+++.+ .+.+++..+..++.||+.||.|||+.+ |+||||||+ |||++.++.+||+|
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~-----------NILl~~~g~vkL~D 218 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPD-----------NILMDMNGHIRLAD 218 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTSCEEECC
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHH-----------HeeEcCCCCEEEcc
Confidence 999999999999987 467999999999999999999999999 999999999 88889999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ- 381 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~- 381 (469)
||+|+..............||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 9999766543333334467999999999986 4578999999999999999999999998876666555554322
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAK--RPTFRQIITR 420 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 420 (469)
...++.....+++++++||.+||..+|++ ||+++++++|
T Consensus 299 ~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 22333333457899999999999988888 9999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=362.92 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=208.3
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.||. +|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 34788999999999999985 5789999998643211111123478899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||||++|+|.+++.+ ..+++..+..++.||+.||+|||+.+ |+||||||+ |||++.++.+||+||
T Consensus 148 ~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~-----------NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPD-----------NMLLDKSGHLKLADF 212 (410)
T ss_dssp ECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTSCEEECCC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHH-----------HeeECCCCCEEEecc
Confidence 999999999999976 46999999999999999999999999 999999999 888899999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP 383 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~ 383 (469)
|+++..............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+.... ..
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence 999876543222234567999999999997655 7889999999999999999999998776666655554332 11
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAK--RPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~~ll~~ 420 (469)
.+ +....+++++++||.+||..+|.+ ||+++++++|
T Consensus 293 ~~-p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CC-CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cC-CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11 123457889999999999999998 9999999988
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=340.67 Aligned_cols=255 Identities=26% Similarity=0.520 Sum_probs=205.5
Q ss_pred CcccccceeeecCeEEEEEE---------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--
Q 012164 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-- 222 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 222 (469)
..+|+..+.||+|+||.||. +|+.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34788999999999999863 5789999998743 455667899999999999999999999998653
Q ss_pred CceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
..+++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~-----------Nil~~~~~ 151 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATR-----------NILVENEN 151 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEEEETT
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHh-----------hEEEcCCC
Confidence 56899999999999999998754 4999999999999999999999999 999999999 88888899
Q ss_pred CeEEeecCCccccccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--------
Q 012164 302 NLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------- 371 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-------- 371 (469)
.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 231 (295)
T 3ugc_A 152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231 (295)
T ss_dssp EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT
T ss_pred eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc
Confidence 999999999987643322 1223345677899999999889999999999999999999999998643210
Q ss_pred --------cHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 372 --------EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 372 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.....+....+.+ .+..+++++.+||.+||+.||++|||+.++++.|+.+.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 232 KQGQMIVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp CCTHHHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccchhHHHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0111111222222 24567899999999999999999999999999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=334.29 Aligned_cols=254 Identities=26% Similarity=0.492 Sum_probs=211.1
Q ss_pred CcccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 154 ELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
..+|+..+.||+|+||.||.. +..||+|.+.... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 347888999999999998741 3459999987542 44566789999999999999999999999865 457
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+|
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~-----------Nil~~~~~~~k 153 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVR-----------NILVASPECVK 153 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGG-----------GEEEEETTEEE
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccc-----------eEEECCCCcEE
Confidence 89999999999999997654 5999999999999999999999999 999999999 88888889999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCC
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
|+|||++...............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+......
T Consensus 154 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~ 233 (281)
T 3cc6_A 154 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL 233 (281)
T ss_dssp ECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC
T ss_pred eCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC
Confidence 99999998765433323334557889999999988889999999999999999998 99999877766666555444433
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+. +..+++.+.++|.+||..||++|||+.+++++|+.+...
T Consensus 234 ~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 234 PK---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 32 345788999999999999999999999999999998765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=337.23 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=213.4
Q ss_pred Ccccccce-eeecCeEEEEEEe-------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 154 ELDFTNSV-EITKGTFILAFWR-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 154 ~~~~~~~~-~ig~G~~~~~~~~-------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
..+|+..+ .||+|+||.||.. ++.||||.+..... .....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 34677777 9999999998753 68899999875532 334457899999999999999999999999 56778
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~-----------Nil~~~~~~~kl 158 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR-----------NVLLVTQHYAKI 158 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEEEETTEEEE
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcc-----------eEEEeCCCcEEE
Confidence 999999999999999998888999999999999999999999999 999999999 888888899999
Q ss_pred eecCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCC
Q 012164 306 ADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.....
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 238 (291)
T 1xbb_A 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 238 (291)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred ccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999865433221 1122346788999999988888999999999999999999 9999988766555555544433
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
+.. +..+++.+.++|.+||+.||++|||+.++++.|+.+..+..
T Consensus 239 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 239 MGC---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 332 35678899999999999999999999999999999988754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=342.58 Aligned_cols=266 Identities=25% Similarity=0.408 Sum_probs=217.0
Q ss_pred CCccccCCCCcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 012164 145 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (469)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 220 (469)
.+..++.....+|+..+.||+|+||.||. +|+.||||.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 44455666667899999999999999885 47899999887542 234567899999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 221 QSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 221 ~~~~~~lv~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
+.+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+ ||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~-----------Nil 171 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSI-----------NIL 171 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCST-----------TEE
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHH-----------HEE
Confidence 9999999999999999999997543 4899999999999999999999999 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHH
Q 012164 297 RDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~ 375 (469)
++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+...
T Consensus 172 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~ 251 (321)
T 2qkw_B 172 LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251 (321)
T ss_dssp ECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred ECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence 889999999999999865432221 2233457899999999988889999999999999999999999998655443221
Q ss_pred HH------hhcCC------C-CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 376 AY------AARQR------P-PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 376 ~~------~~~~~------~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.. ..... + ........++..+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 252 LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 11 01110 1 11123456788999999999999999999999999999988764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.44 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=206.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3788999999999999985 588999999865432 223366889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|||++++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~-----------NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPE-----------NLLLDERDNLKISDFG 150 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTCCEEECCCT
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchH-----------HEEEeCCCCEEEEEee
Confidence 99999999999988878999999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCC-CCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 310 VSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 310 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
+++...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||................. ....
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~ 229 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLN 229 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC-TTST
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc-ccCC
Confidence 997654322 122334678999999999987665 6789999999999999999999987665433322222222 2222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+++.+.+||.+||..||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 346788999999999999999999999999887
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.73 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=202.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC--CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
+|+..+.||+|+||.||. +|+.||||.+...... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 688999999999999985 5789999988643211 111246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC---
Q 012164 229 TEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG--- 301 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~--- 301 (469)
||||++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+ ||+++.++
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~-----------NIl~~~~~~~~ 170 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPH-----------CVLLASKENSA 170 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECSSSTTC
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChH-----------HeEEecCCCCC
Confidence 9999999998888642 24899999999999999999999999 999999999 66665544
Q ss_pred CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC
Q 012164 302 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 381 (469)
.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. .+....+....
T Consensus 171 ~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~ 248 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGK 248 (351)
T ss_dssp CEEECCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTC
T ss_pred cEEEecCcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCC
Confidence 49999999998765322 22334578999999999999899999999999999999999999998643 22333332322
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..........+++++.+||.+||..||++|||+.++++|
T Consensus 249 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 221111224678899999999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.04 Aligned_cols=245 Identities=22% Similarity=0.385 Sum_probs=207.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|...+.||+|+||.||. +|+.||||++...... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 356677999999999884 5889999998754322 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~kl~Dfg~ 187 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD-----------SILLTLDGRVKLSDFGF 187 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTCCEEECCCTT
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEECCCCcEEEeeeee
Confidence 9999999999875 46999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
+....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.....+. .....
T Consensus 188 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 265 (321)
T 2c30_A 188 CAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSH 265 (321)
T ss_dssp CEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGG
T ss_pred eeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccc
Confidence 98655332 22234578999999999999899999999999999999999999998765544444443333322 23345
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+++.+.+||.+||+.||++|||+.+++++
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 678899999999999999999999999886
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=362.39 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=202.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||||++.............+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 688999999999999984 578999999876544444555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||++|+|.+++...+.+++..+..++.||+.||+|||+ .+ |+||||||+ |||++.++.+||+|||
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~-----------NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLE-----------NLMLDKDGHIKITDFG 294 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGG-----------GEEECSSSCEEECCCC
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHH-----------HEEECCCCCEEEccCC
Confidence 99999999999988889999999999999999999998 88 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .+ +
T Consensus 295 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~---p 369 (446)
T 4ejn_A 295 LCKEGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RF---P 369 (446)
T ss_dssp CCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CC---C
T ss_pred CceeccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC---C
Confidence 99764322 2223446799999999999999999999999999999999999999987766555555543322 22 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
..+++++.+||.+||+.||.+|| +++++++|
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 45788999999999999999999 99999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=333.69 Aligned_cols=252 Identities=30% Similarity=0.569 Sum_probs=213.4
Q ss_pred cccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.+|+..+.||+|+||.||. +++.||+|.+...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3678889999999999875 5778999998765432 2568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++++|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~-----------Nili~~~~~~kl~dfg 149 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAAR-----------NCLVGENQVIKVSDFG 149 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGG-----------GEEECGGGCEEECCTT
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchh-----------eEEECCCCCEEEcccc
Confidence 99999999999865 45899999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
++...............+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~---~ 226 (267)
T 3t9t_A 150 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---K 226 (267)
T ss_dssp GGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---C
T ss_pred cccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC---C
Confidence 998654322222233456788999999988889999999999999999999 999998776655555554433322 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+..+++.+.+++.+||+.||++|||+.+++++|+.+.++
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 345688999999999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=334.77 Aligned_cols=256 Identities=25% Similarity=0.475 Sum_probs=204.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+.............+.+|+.++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 789999999999999884 588999999986555566777889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 231 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~-----------NIl~~~~~~~kl~ 178 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPA-----------NVFITATGVVKLG 178 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTSCEEEC
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHH-----------HEEEcCCCCEEEE
Confidence 9999999999974 455899999999999999999999999 999999999 8888899999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc--HHHHHhhcCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--VPKAYAARQRPP 384 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~ 384 (469)
|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+..... ....+.....++
T Consensus 179 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 257 (310)
T 2wqm_A 179 DLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 257 (310)
T ss_dssp CC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC
T ss_pred eccceeeecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC
Confidence 999997654322 22233568899999999999899999999999999999999999997654332 222222222222
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
. ....+++++.+||.+||..||++|||+.++++.|+.+....
T Consensus 258 ~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 258 L--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp C--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 2 23567889999999999999999999999999999997763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.10 Aligned_cols=250 Identities=26% Similarity=0.449 Sum_probs=202.2
Q ss_pred CcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
..+|+..+.||+|+||.||. +|+.||+|++..... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34799999999999999875 578999999875432 2233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||++ ++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+||
T Consensus 99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~-----------NIl~~~~~~~kl~Df 163 (311)
T 3niz_A 99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQ-----------NLLINSDGALKLADF 163 (311)
T ss_dssp ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTCCEEECCC
T ss_pred cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchH-----------hEEECCCCCEEEccC
Confidence 9996 5888888764 44999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFK 386 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~ 386 (469)
|+++..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+... +.+...
T Consensus 164 g~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 242 (311)
T 3niz_A 164 GLARAFGIP-VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242 (311)
T ss_dssp TTCEETTSC-CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred cCceecCCC-cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence 999875432 222334568999999999876 56899999999999999999999999887776655444221 111100
Q ss_pred -------------------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 -------------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 -------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+.+++++.+||.+||+.||++|||++++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0012456789999999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=350.90 Aligned_cols=247 Identities=18% Similarity=0.350 Sum_probs=208.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 3689999999999999985 57899999986542 334467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC--CCCCeEEe
Q 012164 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD--DSGNLKVA 306 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~--~~~~vkl~ 306 (469)
|||++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+ ||+++ ..+.+||+
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~-----------NIll~~~~~~~vkL~ 193 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPE-----------NIMCETKKASSVKII 193 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEESSTTCCCEEEC
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchH-----------HeEEecCCCCceEEE
Confidence 9999999999997654 6999999999999999999999999 999999999 66665 35789999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.........
T Consensus 194 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 271 (387)
T 1kob_A 194 DFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 271 (387)
T ss_dssp CCTTCEECCTT--SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred ecccceecCCC--cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 99999875432 2223456899999999999989999999999999999999999999876655555555433322222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....+++++.+||.+||..||++|||+.++++|
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 2345678999999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.34 Aligned_cols=268 Identities=29% Similarity=0.518 Sum_probs=220.1
Q ss_pred CccccCCCCcccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEe
Q 012164 146 PEYEIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (469)
Q Consensus 146 ~~~~~~~~~~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 217 (469)
..+.+......|...+.||+|+||.||. ++..||+|.+... ......+.+.+|+.+++.++||||+++++
T Consensus 12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 89 (298)
T 3pls_A 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIG 89 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 3455566667788889999999999984 2237999998743 34566688999999999999999999999
Q ss_pred EEEeCCce-EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 218 AVTQSSPM-MIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 218 ~~~~~~~~-~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
++.+.+.. ++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+ ||
T Consensus 90 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~-----------Ni 155 (298)
T 3pls_A 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAAR-----------NC 155 (298)
T ss_dssp EECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GE
T ss_pred EEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcc-----------eE
Confidence 99876655 999999999999999986 345899999999999999999999999 999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCC---CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 371 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~ 371 (469)
+++.++.+||+|||+++...... ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......
T Consensus 156 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~ 235 (298)
T 3pls_A 156 MLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235 (298)
T ss_dssp EECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG
T ss_pred EEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH
Confidence 88899999999999997654321 122234567889999999999999999999999999999999 55556655555
Q ss_pred cHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccc
Q 012164 372 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 432 (469)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 432 (469)
+....+......+. +..+++.+.+|+.+||+.||.+|||++++++.|+.+.+.+....
T Consensus 236 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 236 DLTHFLAQGRRLPQ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp GHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HHHHHhhcCCCCCC---CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 55555544333322 45578899999999999999999999999999999998876544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.32 Aligned_cols=266 Identities=28% Similarity=0.500 Sum_probs=219.6
Q ss_pred ccccCCCCcccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeE
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 218 (469)
.+.+.+....|+..+.||+|+||.||.. +..||+|.+... ......+.+.+|+.++++++||||++++++
T Consensus 17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 4556677788999999999999999841 235899988743 355667889999999999999999999998
Q ss_pred EE-eCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 219 VT-QSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 219 ~~-~~~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
+. ..+..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+ ||+
T Consensus 95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~-----------Nil 160 (298)
T 3f66_A 95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAAR-----------NCM 160 (298)
T ss_dssp ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEE
T ss_pred EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchh-----------eEE
Confidence 65 456789999999999999999764 45899999999999999999999999 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCCC---CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012164 297 RDDSGNLKVADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE 372 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~ 372 (469)
++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+
T Consensus 161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 240 (298)
T 3f66_A 161 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240 (298)
T ss_dssp ECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT
T ss_pred ECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 88999999999999986543221 11233456788999999998899999999999999999999 777888777766
Q ss_pred HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012164 373 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 431 (469)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 431 (469)
....+........ +..+++.+.+++.+||+.||++|||+.++++.|+.+...+..+
T Consensus 241 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 241 ITVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred HHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 6665544433322 3457889999999999999999999999999999998876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=342.42 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=209.9
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCH---HHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
..+|+..+.||+|+||.||. +|+.||+|.+........ ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34688999999999999875 578999999875432211 1246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC----
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG---- 301 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~---- 301 (469)
++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~-----------NIl~~~~~~~~~ 156 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPE-----------NIMLLDKNIPIP 156 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEESCTTSSSC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChH-----------HEEEecCCCCcC
Confidence 999999999999999998888999999999999999999999999 999999999 77777776
Q ss_pred CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC
Q 012164 302 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 381 (469)
.+||+|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+....
T Consensus 157 ~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 234 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234 (321)
T ss_dssp CEEECCCTTCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred CEEEccCccceecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 7999999999875532 22234568999999999999899999999999999999999999998766555544443322
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..........+++.+.+||.+||..||++|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 211111224578899999999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=360.18 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=207.7
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.|+. +|+.||+|++.+.........+.+.+|..++..++||||+++++++.+.+.+|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 34788899999999999875 5889999998753222222234578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
||||++|+|.+++.+.+ .+++..+..++.||+.||+|||+.+ |+||||||+ |||++.++.+||+|
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~-----------NILld~~g~vkL~D 205 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPD-----------NILLDRCGHIRLAD 205 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTSCEEECC
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHH-----------HeeecCCCCEEEee
Confidence 99999999999998754 6999999999999999999999999 999999999 88889999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 380 (469)
||+++..............||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+...
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 9999876543322233457999999999987 357899999999999999999999999887666655555432
Q ss_pred C-CCCCCCChhhhHHHHHHHHHHHcccCCCCC---CCHHHHHHH
Q 012164 381 Q-RPPFKAPAKLYARGLKELIEECWNEKPAKR---PTFRQIITR 420 (469)
Q Consensus 381 ~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~ll~~ 420 (469)
. ...++.....+++++++||.+||. +|.+| |+++++++|
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 2 222222245688999999999999 99998 599999887
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=343.53 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=200.0
Q ss_pred cccccceeeecCeEEEEEE--------eceeehhhhcccccCC-CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
.+|+..+.||+|+||.||. +|+.||+|++...... .......+.+|+.+++.++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 3788999999999999873 5789999998765322 223345678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~-----------Nill~~~~~~kl 162 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPE-----------NIMLNHQGHVKL 162 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTT-----------TEEECTTSCEEE
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHH-----------HeEECCCCcEEE
Confidence 999999999999999998888999999999999999999999999 999999999 888889999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
+|||+++..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+... ...+
T Consensus 163 ~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~ 240 (327)
T 3a62_A 163 TDFGLCKESIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-KLNL 240 (327)
T ss_dssp CCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCC
T ss_pred EeCCcccccccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-CCCC
Confidence 999999754322 12223456899999999999989999999999999999999999999876655555544332 2222
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+..+++++.+||.+||..||++|| ++.++++|
T Consensus 241 ---p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 241 ---PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 345788999999999999999999 88898887
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=346.75 Aligned_cols=245 Identities=25% Similarity=0.370 Sum_probs=192.6
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +++.||||.+.... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3688999999999999985 46789999987542 2356888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC---CCCeEEe
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD---SGNLKVA 306 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~---~~~vkl~ 306 (469)
||+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++. ++.+||+
T Consensus 128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~-----------NIll~~~~~~~~~kl~ 193 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPE-----------NLLYATPAPDAPLKIA 193 (349)
T ss_dssp CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEESSSSTTCCEEEC
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcc-----------cEEEecCCCCCCEEEc
Confidence 99999999999998888999999999999999999999999 999999999 666654 7899999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-HHHHHhhcCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPF 385 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~ 385 (469)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ ....+........
T Consensus 194 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~ 271 (349)
T 2w4o_A 194 DFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI 271 (349)
T ss_dssp CCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC
T ss_pred cCccccccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC
Confidence 99999865432 22234568999999999999899999999999999999999999998765544 3333333322222
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
......++.++.+||.+||..||++|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 23345678899999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=333.49 Aligned_cols=261 Identities=28% Similarity=0.495 Sum_probs=197.6
Q ss_pred cccccceeeecCeEEEEEE---eceeehhhhcccccCCC-HHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISD-DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.+|+..+.||+|+||.||. +|+.||||.+....... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 3688889999999998874 68999999987543222 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++.. +.+++..++.++.|++.||.|||+.+..+++||||||+||++.......+ ..++.+||+|||+
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~---~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 87 FARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD---LSNKILKITDFGL 162 (271)
T ss_dssp CCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC---CSSCCEEECCCCC
T ss_pred cCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc---ccCcceEEccCCc
Confidence 9999999999864 56999999999999999999999998555889999999444431100000 0267899999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
+....... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.................. ...+.
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 237 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--LPIPS 237 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC--CCCCT
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC--CCCCc
Confidence 97654322 22356899999999999888999999999999999999999999876654444444333221 12245
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
.+++.+.++|.+||+.||++|||+.+++++|+++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 6788999999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=340.76 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=214.7
Q ss_pred CcccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 012164 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 223 (469)
..+|+..+.||+|+||.||. ++..||+|.+... ........+.+|+.+++.++||||+++++++.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34788999999999998874 3678999998754 23455567899999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCc
Q 012164 224 PMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ 293 (469)
..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~----------- 167 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAAR----------- 167 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGG-----------
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccc-----------
Confidence 999999999999999999752 34689999999999999999999999 999999999
Q ss_pred ceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 012164 294 NILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 371 (469)
Q Consensus 294 nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~ 371 (469)
||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 888888999999999999865433221 1123346788999999988889999999999999999999 89999877665
Q ss_pred cHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 372 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
+....+......+ .+..+++.+.+||.+||+.||++|||+.+++++|+.+....
T Consensus 248 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 248 QVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 5555554433322 24567889999999999999999999999999998876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=361.22 Aligned_cols=245 Identities=29% Similarity=0.451 Sum_probs=210.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|...+.||+|+||.|+. +|+.||||.+........+....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 688899999999998874 588999999875432222234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++.+++.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~-----------NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPE-----------NVLLDAHMNAKIADFGL 162 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGG-----------GEEECTTCCEEECCCSS
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHH-----------HEEEecCCCeEEEeccc
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+..... . .+
T Consensus 163 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~---~p 236 (476)
T 2y94_A 163 SNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-Y---TP 236 (476)
T ss_dssp CEECCTT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-C---CC
T ss_pred hhhcccc--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-C---CC
Confidence 9875432 22344678999999999988765 6799999999999999999999987766555555533322 1 23
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+++++.+||.+||..||++|||+.++++|
T Consensus 237 ~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 237 QYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 4577899999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=340.87 Aligned_cols=258 Identities=28% Similarity=0.475 Sum_probs=202.5
Q ss_pred CcccccceeeecCeEEEEEE-----ec---eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
..+|+..+.||+|+||.||. ++ ..||||.+....... ...+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34788999999999999984 22 279999987654333 4457899999999999999999999999876554
Q ss_pred ------EEEEeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCc
Q 012164 226 ------MIVTEYLPKGDLRAFLKRKG------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293 (469)
Q Consensus 226 ------~lv~E~~~~gsL~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ 293 (469)
++||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~----------- 166 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAAR----------- 166 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcc-----------
Confidence 99999999999999996532 5899999999999999999999999 999999999
Q ss_pred ceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 012164 294 NILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 371 (469)
Q Consensus 294 nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~ 371 (469)
||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+....
T Consensus 167 NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 167 NCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp GEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred eEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 888889999999999999865433221 1223456788999999998899999999999999999999 99999988777
Q ss_pred cHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 372 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
+....+........ +..+++.+.+|+.+||+.||++|||+.++++.|+.+.....
T Consensus 247 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 247 EIYNYLIGGNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp GHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHhcCCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 77666654443332 34678899999999999999999999999999999988744
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=332.70 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=215.5
Q ss_pred ccccce-eeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~-~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|.+.. .||+|+||.||. ++..||+|.+... ......+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 455555 899999999874 4678999999754 3456678899999999999999999999999 5567899
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-----------Nili~~~~~~kl~ 152 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAAR-----------NVLLVNRHYAKIS 152 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEEEETTEEEEC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchh-----------eEEEcCCCCEEEC
Confidence 99999999999999754 45999999999999999999999999 999999999 8888888999999
Q ss_pred ecCCccccccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCC
Q 012164 307 DFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 307 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....++
T Consensus 153 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~ 232 (287)
T 1u59_A 153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 232 (287)
T ss_dssp CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC
T ss_pred cccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC
Confidence 9999987643322 11223456889999999988889999999999999999998 99999887766666555444333
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 431 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 431 (469)
+. +..+++.+.++|.+||..||++|||+.+++++|+.+..+....
T Consensus 233 ~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 233 EC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp CC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CC---CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 33 3567899999999999999999999999999999998886544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=348.28 Aligned_cols=245 Identities=21% Similarity=0.336 Sum_probs=201.3
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+...+.||+|+||.||. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 34467899999999885 57899999987542 34557799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee--CCCCCeEEeec
Q 012164 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR--DDSGNLKVADF 308 (469)
Q Consensus 232 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~--~~~~~vkl~Df 308 (469)
|++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+ |||+ +.++.+||+||
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~~~kl~DF 233 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPE-----------NILCVNRDAKQIKIIDF 233 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEEEETTTTEEEECCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHH-----------HEEEecCCCCcEEEEeC
Confidence 9999999988754 45999999999999999999999999 999999999 6666 56678999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...........
T Consensus 234 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 311 (373)
T 2x4f_A 234 GLARRYKPRE--KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311 (373)
T ss_dssp SSCEECCTTC--BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred CCceecCCcc--ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh
Confidence 9998764322 22345689999999999988899999999999999999999999987766555555544332222223
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+++++.+||.+||+.||.+|||+.++++|
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 45678999999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.72 Aligned_cols=246 Identities=23% Similarity=0.370 Sum_probs=208.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. ++..||+|.+....... .+.+.+|++++++++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 3688899999999999985 46789999987654332 367889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee---CCCCCeEEe
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR---DDSGNLKVA 306 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~---~~~~~vkl~ 306 (469)
||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||++ +.++.+||+
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~-----------Nil~~~~~~~~~~~l~ 151 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPE-----------NFLFLTDSPDSPLKLI 151 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEESSSSTTCCEEEC
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHH-----------HEEEecCCCCCcEEEE
Confidence 99999999999998888999999999999999999999999 999999999 6676 678899999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|||++...... .......+|+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+.........
T Consensus 152 Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T 3f3z_A 152 DFGLAARFKPG--KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE 228 (277)
T ss_dssp CCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred ecccceeccCc--cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 99999765432 22334568999999999876 4899999999999999999999999877665555555443332221
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....+++.+.+||.+||+.||++|||+.++++|
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223678899999999999999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=333.20 Aligned_cols=256 Identities=16% Similarity=0.247 Sum_probs=210.9
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 228 (469)
.+|+..+.||+|+||.||. +|+.||||.+..... .+.+.+|+.+++.+ +|+|++++++++.+....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3688999999999998874 589999998864422 13578899999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC-----
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN----- 302 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~----- 302 (469)
|||+ +++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~-----------NIl~~~~~~~~~~~ 149 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPD-----------NFLIGRPNSKNANM 149 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGG-----------GEEECCSSSTTTTC
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH-----------HEEeccCCCCCCCe
Confidence 9999 999999998754 5999999999999999999999999 999999999 666665554
Q ss_pred eEEeecCCccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 303 LKVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 229 (298)
T 1csn_A 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 229 (298)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence 99999999987654322 122445689999999999999999999999999999999999999987655443322
Q ss_pred Hh---hcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 377 YA---ARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 377 ~~---~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
+. ... ..+.......+++++.+|+.+||+.||++|||++++++.|+.+.+..+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 230 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 21 111 1221112235788999999999999999999999999999999888654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=336.55 Aligned_cols=255 Identities=29% Similarity=0.493 Sum_probs=217.5
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.||. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 44788899999999998875 37889999987542 3456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 229 TEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~-----------Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAAR-----------NCLVGENHLVKVA 153 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGG-----------GEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcc-----------eEEEcCCCCEEEc
Confidence 9999999999999864 34899999999999999999999999 999999999 8888889999999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
|||++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+........
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 3kfa_A 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233 (288)
T ss_dssp CCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred cCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC
Confidence 999998765433222233446778999999998899999999999999999999 9999998777666666544433332
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
+..+++.+.+|+.+||..||.+|||+.++++.|+.+.....
T Consensus 234 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 234 ---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 35678899999999999999999999999999999987643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=335.09 Aligned_cols=245 Identities=25% Similarity=0.478 Sum_probs=205.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|++.+.||+|+||.||. ++..||+|++.............+.+|+.++++++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 3788999999999999985 46789999886543222222466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~-----------Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPE-----------NLLLGSAGELKIADFG 154 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGG-----------GEEECTTSCEEECSCC
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChH-----------hEEEcCCCCEEEEecc
Confidence 99999999999998888999999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++...... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.... ... +
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~---~ 227 (279)
T 3fdn_A 155 WSVHAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTF---P 227 (279)
T ss_dssp EESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCC---C
T ss_pred ccccCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCC---C
Confidence 98654322 2234568999999999999899999999999999999999999998766555444443322 221 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+++.+.+||.+||+.||++|||++++++|
T Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 4577899999999999999999999999988
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=359.05 Aligned_cols=253 Identities=31% Similarity=0.506 Sum_probs=208.6
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. .+..||||.+..... . .+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-C---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 677888999999999875 346799999876532 2 3568999999999999999999999876 678999999
Q ss_pred cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~-----------Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAA-----------NILVGENLVCKVADFG 325 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEECGGGCEEECCCC
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChh-----------hEEECCCCCEEECCCc
Confidence 999999999974 345999999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
+++..............+++.|+|||++.+..++.++||||||+++|||++ |+.||.+....++...+....+.+.
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~--- 402 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--- 402 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---
T ss_pred cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 998765333222333456789999999988899999999999999999999 9999998776666666654444433
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
+..+++.+.+||.+||+.||++|||++++++.|+.+..+...
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 356788999999999999999999999999999998776443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.31 Aligned_cols=256 Identities=27% Similarity=0.485 Sum_probs=201.4
Q ss_pred cccccceeeecCeEEEEEE--eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 155 LDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~--~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
.+|+..+.||+|+||.||. ....||+|++.... ......+.+.+|+.++++++||||+++++++ .....++||||+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 101 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 101 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred cceeeeeEecCCCCeEEEEEEEcCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence 3688899999999999985 34579999987653 3455668899999999999999999999965 456789999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 233 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||++
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~-----------Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSN-----------NIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp CEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEEETTTEEEECCCC--
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccc-----------eEEECCCCCEEEccceec
Confidence 999999999653 45999999999999999999999999 999999999 888888999999999999
Q ss_pred cccccCC-CCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC--CCCC
Q 012164 312 KLLTVKE-DRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPF 385 (469)
Q Consensus 312 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~ 385 (469)
....... ........||+.|+|||++. +..++.++||||||+++|+|++|+.||......+......... .+..
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 7654321 22223456899999999986 5578889999999999999999999998766544433333222 2333
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
......+++.+.+||.+||+.||++|||+.++++.|+.+.+
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 33445788999999999999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=349.77 Aligned_cols=242 Identities=26% Similarity=0.413 Sum_probs=198.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHH-HhcCCCCceeeEEeEEEeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
.+|+..+.||+|+||.||. +++.||+|++.+...........+..|..+ ++.++||||+++++++.+.+.+|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 3789999999999999885 578899999987665555555667778777 5778999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|||+++|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+ |||++.+|.+||+||
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~-----------NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPE-----------NILLDSQGHIVLTDF 183 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTSCEEECCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHH-----------HEEECCCCCEEEeeC
Confidence 999999999999998888999999999999999999999999 999999999 888899999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|+++..... ........||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..++...+.... ..+
T Consensus 184 G~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~--- 258 (373)
T 2r5t_A 184 GLCKENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQL--- 258 (373)
T ss_dssp CBCGGGBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCC---
T ss_pred ccccccccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCC---
Confidence 999864322 223345679999999999999999999999999999999999999998776666655554432 222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFR 415 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~ 415 (469)
+..++..+.+||.+||+.||.+||++.
T Consensus 259 ~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 259 KPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 245788999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.72 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=217.0
Q ss_pred CCccccCC-CCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeE
Q 012164 145 VPEYEIDP-HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (469)
Q Consensus 145 ~~~~~~~~-~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 218 (469)
.|+..+++ ...+|+..+.||+|+||.||. +++.||+|.+...........+.+.+|+.+++.++||||++++++
T Consensus 4 ~p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (294)
T 2rku_A 4 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83 (294)
T ss_dssp CCSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcceeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence 34443432 334799999999999999885 478899999887665566777889999999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 219 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
+.+.+..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~-----------Nil~~ 149 (294)
T 2rku_A 84 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLG-----------NLFLN 149 (294)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEEC
T ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChH-----------hEEEc
Confidence 9999999999999999999999998888999999999999999999999999 999999999 88888
Q ss_pred CCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh
Q 012164 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 299 ~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 378 (469)
.++.+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 228 (294)
T 2rku_A 150 EDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 228 (294)
T ss_dssp TTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCCCEEEEeccCceecccCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 99999999999998654322 22334568999999999999889999999999999999999999998765444443332
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. ... .+..+++.+.+||.+||+.||++|||+.+++++
T Consensus 229 ~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 229 KN-EYS---IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TT-CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hc-cCC---CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 22 212 234677899999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=363.65 Aligned_cols=248 Identities=25% Similarity=0.456 Sum_probs=213.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||||++...........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 688999999999999984 678999999876544333445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee---CCCCCeEEee
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR---DDSGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~---~~~~~vkl~D 307 (469)
||.+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+ ||++ +.++.+||+|
T Consensus 107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~-----------Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPE-----------NLLLESKSKDANIRIID 172 (484)
T ss_dssp CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEESSSSTTCCEEECC
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHH-----------HEEEecCCCCCcEEEEe
Confidence 9999999999998888999999999999999999999999 999999999 6666 4678999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+....+.........+
T Consensus 173 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 249 (484)
T 3nyv_A 173 FGLSTHFEAS--KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP 249 (484)
T ss_dssp TTHHHHBCCC--CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred eeeeEEcccc--cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 9999865432 22334568999999999876 68999999999999999999999999877666666665544333333
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..+++.+.+||.+||+.||++|||+.++++|
T Consensus 250 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 250 QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 456789999999999999999999999999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=346.23 Aligned_cols=249 Identities=27% Similarity=0.362 Sum_probs=195.0
Q ss_pred CCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
.....+|+..+.||+|+||.||. +|+.||||.+....... +.+.+|+.+++.++||||+++++++.+....
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 33445899999999999998874 67899999987543322 4578899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC--e
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN--L 303 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~--v 303 (469)
++||||+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+ ||+++.++. +
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~-----------Nill~~~~~~~~ 157 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLE-----------NTLLDGSPAPRL 157 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGG-----------GEEECSSSSCCE
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEEcCCCCceE
Confidence 999999999999999988888999999999999999999999999 999999999 777766554 9
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh---
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA--- 379 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~--- 379 (469)
||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..............
T Consensus 158 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 235 (361)
T 3uc3_A 158 KICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235 (361)
T ss_dssp EECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH
T ss_pred EEeecCcccccccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 99999999753322 22234568999999999988777655 9999999999999999999987655433222211
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...... .....+++.+.+||.+||+.||++|||+.++++|
T Consensus 236 ~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 236 SVKYSI-PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TTCCCC-CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCC-CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111111 1223568899999999999999999999999988
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=361.87 Aligned_cols=252 Identities=29% Similarity=0.504 Sum_probs=214.9
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. ++..||||.+..... ..+.+.+|+.++++++||||+++++++.....+++||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 3678889999999998874 378999999875432 2467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 230 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+ |||++.++.+||+|
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~-----------NIll~~~~~~kl~D 361 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAAR-----------NCLVGENHLVKVAD 361 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECGGGCEEECC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChh-----------hEEECCCCcEEEee
Confidence 999999999999864 34899999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
||+++..............+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+....+.+.
T Consensus 362 FG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~- 440 (495)
T 1opk_A 362 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER- 440 (495)
T ss_dssp TTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC-
T ss_pred cccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence 99998764332222233456788999999988889999999999999999999 9999998877776666544433332
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+..+++.+.+||.+||+.||++|||+.++++.|+.+...
T Consensus 441 --~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 441 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred --CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 456788999999999999999999999999999987544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=341.70 Aligned_cols=255 Identities=24% Similarity=0.490 Sum_probs=206.9
Q ss_pred CcccccceeeecCeEEEEEE-----ecee----ehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~----vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
..+|+..+.||+|+||.||. +|+. ||+|.+.... .....+.+.+|+.++++++||||+++++++.+. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-S
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-C
Confidence 34789999999999999985 3444 5777765332 233446789999999999999999999999875 4
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~-----------NIll~~~~~~ 156 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR-----------NVLVKTPQHV 156 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEEEETTEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChh-----------eEEECCCCCE
Confidence 78999999999999999874 56999999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 304 KVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......++...+....
T Consensus 157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 236 (327)
T 3poz_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236 (327)
T ss_dssp EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC
Confidence 99999999876533222 1233456889999999999999999999999999999999 999999877777666654444
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
..+. +..++..+.+|+.+||+.||++|||+.+++++|+.+....
T Consensus 237 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 237 RLPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CCCC---CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCCC---CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 3332 3457889999999999999999999999999999997753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=335.12 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=215.4
Q ss_pred CcccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 012164 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 222 (469)
..+|+..+.||+|+||.||. +++.||+|.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 34788899999999999874 35789999987542 345567899999999999 899999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcc
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDL 284 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Ni 284 (469)
+..++||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-- 174 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR-- 174 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG--
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc--
Confidence 99999999999999999998653 3899999999999999999999999 999999999
Q ss_pred cccccccCcceeeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CC
Q 012164 285 YVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GC 362 (469)
Q Consensus 285 l~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~ 362 (469)
||+++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+
T Consensus 175 ---------Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 245 (313)
T 1t46_A 175 ---------NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (313)
T ss_dssp ---------GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ---------eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 8888889999999999998765432211 123346778999999988899999999999999999999 99
Q ss_pred CCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 363 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 363 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.||.................... .+..+++.+.+||.+||+.||.+|||+.+++++|+++..+.
T Consensus 246 ~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 246 SPYPGMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp CSSTTCCSSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCcccchhHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 99987766554444333332221 23467889999999999999999999999999999988763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=343.43 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=209.1
Q ss_pred cccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCC
Q 012164 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 223 (469)
.+|+..+.||+|+||.||. ++..||+|.+.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4788899999999999874 34679999987542 233456789999999999 8999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 280 (469)
..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 9999999999999999998643 2789999999999999999999999 9999999
Q ss_pred CCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHH
Q 012164 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 359 (469)
Q Consensus 281 p~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~ 359 (469)
|+ ||+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|+
T Consensus 200 p~-----------NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 268 (344)
T 1rjb_A 200 AR-----------NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268 (344)
T ss_dssp GG-----------GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred hh-----------hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence 99 8888889999999999998664332211 12334678899999998889999999999999999999
Q ss_pred h-CCCCCCCCCCCcHHHHHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 360 E-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 360 t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
+ |+.||................ ..+ .+..+++.+.+||.+||..||.+|||+.+++++|+.+.....
T Consensus 269 t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 269 SLGVNPYPGIPVDANFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cCCCCCcccCCcHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 8 999998876655444443333 222 234578899999999999999999999999999999877643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=335.45 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=206.5
Q ss_pred CcccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC--
Q 012164 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-- 223 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 223 (469)
..+|+..+.||+|+||.||. ++..||+|.+..... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34788999999999998873 345899999875533 3455678999999999999999999999997654
Q ss_pred ---ceEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcc
Q 012164 224 ---PMMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRN 294 (469)
Q Consensus 224 ---~~~lv~E~~~~gsL~~~l~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~n 294 (469)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+ |
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~-----------N 177 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAAR-----------N 177 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGG-----------G
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcc-----------e
Confidence 35999999999999999942 345999999999999999999999999 999999999 8
Q ss_pred eeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012164 295 ILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE 372 (469)
Q Consensus 295 il~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~ 372 (469)
|+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 8888999999999999976543321 12233457889999999999899999999999999999999 999998877766
Q ss_pred HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 373 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
....+........ +..+++.+.+||.+||..||++|||+.+++++|+.+.+.+.
T Consensus 258 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 258 MYDYLLHGHRLKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHHTTCCCCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHcCCCCCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 6666544433332 45678899999999999999999999999999999988753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=335.04 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=204.1
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC--ceE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 226 (469)
..+|+..+.||+|+||.||. +|+.||||++...... ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 34789999999999999985 4789999998754322 22466789999999999999999999998765 789
Q ss_pred EEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee----CC
Q 012164 227 IVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR----DD 299 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~----~~ 299 (469)
+||||+++++|.+++..... +++..++.++.||+.||.|||+.+ |+||||||+ ||++ +.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~ 151 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPG-----------NIMRVIGEDG 151 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEEEECTTS
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHH-----------HEEEeccCCC
Confidence 99999999999999986433 999999999999999999999999 999999999 6665 66
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 371 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~ 371 (469)
++.+||+|||+++...... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||......
T Consensus 152 ~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 152 QSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp CEEEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred CceEEEccCCCceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 7789999999998765332 223456899999999985 467889999999999999999999999754432
Q ss_pred c----HHHHHhhcCC---------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 372 E----VPKAYAARQR---------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 372 ~----~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
. ....+..... +........++..+.+||.+||+.||++|||+++++++..+.
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2 2222222111 111123356788999999999999999999999999997754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=341.41 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=210.4
Q ss_pred ccccCCCCcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 222 (469)
..++.....+|+..+.||+|+||.||. +|+.||||.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 344455566899999999999999985 578999999875432 11223688999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCCeEecCCCCCcccccccccCcce
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHEN---KPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
...++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+ ||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~-----------Ni 165 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAA-----------NI 165 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGG-----------GE
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchh-----------hE
Confidence 99999999999999999998643 389999999999999999999999 8 999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-----CCC
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-----KHD 370 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~-----~~~ 370 (469)
+++.++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|+|++|+.||.. ...
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 245 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred EECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence 888999999999999987654443334445689999999999888899999999999999999999999951 111
Q ss_pred CcHHHHHhhcCCC----------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 371 NEVPKAYAARQRP----------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 371 ~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
............. .........+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 1121111110000 00112345678899999999999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=339.05 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=214.0
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|...+.||+|+||.||. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 34799999999999999985 4788999998876666667778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|||+++++|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+ ||+++.++.+||+||
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~-----------NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLG-----------NLFLNEDLEVKIGDF 185 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCch-----------hEEEcCCCCEEEeec
Confidence 999999999999998888999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|++....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.... .. .
T Consensus 186 g~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~---~ 260 (335)
T 2owb_A 186 GLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YS---I 260 (335)
T ss_dssp TTCEECCSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CC---C
T ss_pred cCceecccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CC---C
Confidence 9998654322 22334568999999999998889999999999999999999999998765444444333222 22 1
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..+++.+.+||.+||+.||++|||+.+++++
T Consensus 261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 34577889999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=337.35 Aligned_cols=257 Identities=28% Similarity=0.494 Sum_probs=210.3
Q ss_pred cccccceeeecCeEEEEEEe---------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 155 LDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~~---------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
.+|+..+.||+|+||.||.. +..||+|.+.... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 46778899999999998751 2459999987542 345566789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++||||+++++|.+++... +.+++..++.++.||+.||.|||+.+ |+||||||+ ||+++.++.+|
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~-----------NIl~~~~~~~k 187 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAAR-----------NILVNSNLVCK 187 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTCCEE
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChh-----------eEEECCCCcEE
Confidence 9999999999999999864 56999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 305 VADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
|+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 267 (333)
T 1mqb_A 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF 267 (333)
T ss_dssp ECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred ECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC
Confidence 9999999875433211 1122345778999999998899999999999999999999 999998776655555554443
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
+.+. +..+++.+.++|.+||+.||++||++.+++++|+.+......
T Consensus 268 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 268 RLPT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp CCCC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred cCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 3332 346788999999999999999999999999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.06 Aligned_cols=248 Identities=21% Similarity=0.414 Sum_probs=199.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|++..... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 688899999999999875 578999999876543 33445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+++ +|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~-----------Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQ-----------NLLINRNGELKLANFG 146 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTSCEEECCCT
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEEcCCCCEEEeecc
Confidence 9965 66665554 667999999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCC-CCCCCcHHHHHhh-cCCCC--
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAA-RQRPP-- 384 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~SlGvil~el~tg~~p~~-~~~~~~~~~~~~~-~~~~~-- 384 (469)
+++..... ........+|+.|+|||++.+.. ++.++|||||||++|+|++|..||. ..+..+....+.. .+.+.
T Consensus 147 ~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 147 LARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp TCEECCSC-CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cceecCCc-cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 99865432 22234456899999999997765 7999999999999999999887754 3332222222211 11100
Q ss_pred ----------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 ----------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ----------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....+.+++.+.+||.+||+.||++|||++++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 011123567899999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=358.77 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=207.1
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCH----------HHHHHHHHHHHHHhcCCCCceeeEEeEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD----------DRVRAFRDELALLQKIRHPNVVQFLGAV 219 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 219 (469)
.+|++.+.||+|+||.||. +++.||+|++........ ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4799999999999999985 578999999876533211 2246788999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 220 ~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
.+....++|||||++|+|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~-----------Nil~~~ 181 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPE-----------NILLEN 181 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEESS
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHH-----------HEEEec
Confidence 999999999999999999999988888999999999999999999999999 999999999 666665
Q ss_pred CC---CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 300 SG---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 300 ~~---~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
++ .+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..++...
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 258 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCCccEEEEECCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 54 6999999999876532 22344678999999999875 689999999999999999999999998777666666
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+...........+..+++++.+||.+||..||.+|||+.++++|
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 64443222222235678999999999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.89 Aligned_cols=247 Identities=23% Similarity=0.423 Sum_probs=206.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. ++..||+|++....... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999984 57899999987543221 224678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC---CCCeEEee
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD---SGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~---~~~vkl~D 307 (469)
||++|+|.+++.....+++..+..++.||+.||.|||+.+ |+||||||+ ||+++. ++.+||+|
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~-----------Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPE-----------NLLLESKEKDALIKIVD 182 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEESCSSTTCCEEECC
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChh-----------hEEEeCCCCCCcEEEEE
Confidence 9999999999988888999999999999999999999999 999999999 666654 45699999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..++...+..........
T Consensus 183 fG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 259 (494)
T 3lij_A 183 FGLSAVFENQ--KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP 259 (494)
T ss_dssp CTTCEECBTT--BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG
T ss_pred CCCCeECCCC--ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch
Confidence 9999876532 22344578999999999875 68999999999999999999999999877766666665544333333
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 445788999999999999999999999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=340.03 Aligned_cols=255 Identities=15% Similarity=0.226 Sum_probs=209.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 228 (469)
.+|+..+.||+|+||.||. +|+.||||.+...... +.+.+|+.+++++ +||||+++++++......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 3688899999999998874 6889999988654321 3578899999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC-----
Q 012164 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN----- 302 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~----- 302 (469)
|||+ +++|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+ ||+++.++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~-----------Nill~~~~~~~~~~ 148 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPE-----------NFLIGRPGNKTQQV 148 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECCGGGTCTTS
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH-----------HeeeccCCCCCCce
Confidence 9999 9999999986 367999999999999999999999999 999999999 777766665
Q ss_pred eEEeecCCccccccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 303 LKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........
T Consensus 149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~ 228 (330)
T 2izr_A 149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER 228 (330)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH
T ss_pred EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH
Confidence 999999999875433221 12346789999999999999999999999999999999999999998766655433
Q ss_pred Hhhc---C-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 377 YAAR---Q-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 377 ~~~~---~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
+... . ..+.......+| ++.+|+..||+.||.+||+++++++.|+.+......
T Consensus 229 ~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 229 YQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 3211 1 111111112355 899999999999999999999999999999877543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=330.46 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=212.3
Q ss_pred cccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.+|+..+.||+|+||.||. ++..||+|.+..... ..+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 3788899999999999885 467899999875432 1356889999999999999999999986 456899999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+||
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~-----------Nil~~~~~~~kl~Df 153 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA-----------NILVSDTLSCKIADF 153 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTSCEEECCC
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHh-----------hEEEcCCCCEEECCC
Confidence 999999999997543 6999999999999999999999999 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.......
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--- 230 (279)
T 1qpc_A 154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV--- 230 (279)
T ss_dssp TTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---
T ss_pred cccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---
Confidence 9998765433222233456788999999988888999999999999999999 999998776655555553332322
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
.+..+++.+.+|+.+||..||++|||++++++.|+.+......
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 2356788999999999999999999999999999999877543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.31 Aligned_cols=248 Identities=26% Similarity=0.432 Sum_probs=209.5
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|++.+.||+|+||.||. +|+.||||++....... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 3789999999999999885 57899999986432211 12367889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC---CCCCeEEe
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD---DSGNLKVA 306 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~---~~~~vkl~ 306 (469)
|||.+++|.+.+...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++ .++.+||+
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~-----------Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPE-----------NILLESKEKDCDIKII 166 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEESSSSTTCCEEEC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchH-----------HEEEecCCCCCCEEEE
Confidence 99999999999988888999999999999999999999999 999999999 66663 45689999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|||+++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..++...+.........
T Consensus 167 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 167 DFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243 (486)
T ss_dssp SCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS
T ss_pred ECCcCeECCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 99999865432 22334578999999999976 5899999999999999999999999887766666666544433333
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.+..+++++.+||.+||+.||++|||+.++++|
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 3456788999999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=329.85 Aligned_cols=251 Identities=30% Similarity=0.501 Sum_probs=202.6
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHH----HHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRV----RAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
..+|+..+.||+|+||.||. +++.||+|.+........... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 34788899999999998874 578999999875443322221 67889999999999999999999986554
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC-
Q 012164 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN- 302 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~- 302 (469)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ .+++||||||+ ||+++.++.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~-----------Nil~~~~~~~ 163 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSP-----------NIFLQSLDEN 163 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGG-----------GEEESCCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcc-----------eEEEeccCCC
Confidence 7999999999999888654 46999999999999999999999986 24999999999 666666665
Q ss_pred ----eEEeecCCccccccCCCCCcccCCCCCcccCCcccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH--
Q 012164 303 ----LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-- 374 (469)
Q Consensus 303 ----vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~-- 374 (469)
+||+|||+++.... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||.........
T Consensus 164 ~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 239 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239 (287)
T ss_dssp CSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH
T ss_pred CceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH
Confidence 99999999975332 233456899999999984 446788999999999999999999999877665542
Q ss_pred HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
..+...... ...+..+++.+.+||.+||+.||++|||++++++.|+++
T Consensus 240 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 NMIREEGLR--PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHSCCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHhccCCC--CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 222222211 123456789999999999999999999999999999763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=344.91 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=203.3
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccC--CCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
.+|+..+.||+|+||.||. ++..||+|++..... ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 4799999999999999884 567899998865421 123445779999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 012164 228 VTEYLPKGDLRAFLKRK----------------------------------------GALKPSTAVRFALDIARGMNYLH 267 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~qi~~~L~~LH 267 (469)
|||||++|+|.+++... ..+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998520 11356778889999999999999
Q ss_pred hCCCCCeEecCCCCCcccccccccCcceeeCCCC--CeEEeecCCccccccCCC---CCcccCCCCCcccCCcccCC--C
Q 012164 268 ENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG--NLKVADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKN--E 340 (469)
Q Consensus 268 ~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~--~vkl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~ 340 (469)
+.+ |+||||||+ ||+++.++ .+||+|||++........ .......||+.|+|||++.+ .
T Consensus 186 ~~~---ivH~Dlkp~-----------NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 186 NQG---ICHRDIKPE-----------NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HTT---EECCCCCGG-----------GEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HCC---ccccCCChh-----------hEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 999 999999999 77776665 899999999986543221 12244568999999999875 6
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 341 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 341 ~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.++.++||||||+++|+|++|+.||......+....+..............+++.+.+||.+||+.||.+|||+.++++|
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 78899999999999999999999998777666555554444333333344678999999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=337.11 Aligned_cols=255 Identities=25% Similarity=0.486 Sum_probs=210.2
Q ss_pred ccccceeeecCeEEEEEE---------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--Cc
Q 012164 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 224 (469)
.|+..+.||+|+||.||. +|+.||||++... ......+.+.+|++++++++||||+++++++.+. ..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 348899999999999952 6789999999755 3455667899999999999999999999999874 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
+++||||+++++|.+++...+ +++..++.++.|++.||.|||+.+ |+||||||+ ||+++.++.+|
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~-----------Nil~~~~~~~k 174 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAAR-----------NVLLDNDRLVK 174 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTCCEE
T ss_pred EEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchh-----------eEEEcCCCCEE
Confidence 899999999999999998654 999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----------
Q 012164 305 VADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---------- 372 (469)
Q Consensus 305 l~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~---------- 372 (469)
|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 254 (318)
T 3lxp_A 175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ 254 (318)
T ss_dssp ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH
T ss_pred ECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc
Confidence 999999987653321 11233457888999999998888999999999999999999999997532110
Q ss_pred -----HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 373 -----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 373 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
....+...... ..+..+++.+.+||.+||+.||++|||+.++++.|+.+.+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 255 MTVLRLTELLERGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHhcccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 11111111122 22456788999999999999999999999999999999887654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=334.79 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=197.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCC-----------------------HHHHHHHHHHHHHHhcC
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----------------------DDRVRAFRDELALLQKI 207 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l 207 (469)
+|+..+.||+|+||.||. +|+.||||.+....... ....+.+.+|+.+++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 788899999999999985 47899999987543211 12235688999999999
Q ss_pred CCCceeeEEeEEEe--CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccc
Q 012164 208 RHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285 (469)
Q Consensus 208 ~h~~i~~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil 285 (469)
+||||+++++++.+ ....++||||+++++|.+++. .+.+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~--- 166 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS--- 166 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG---
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH---
Confidence 99999999999986 567899999999999988654 356999999999999999999999999 999999999
Q ss_pred ccccccCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCC---CCCchhHHHHHHHHHHHHhCC
Q 012164 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGC 362 (469)
Q Consensus 286 ~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDi~SlGvil~el~tg~ 362 (469)
||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+
T Consensus 167 --------Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 167 --------NLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp --------GEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred --------HEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 8888899999999999998754322 2223457899999999998764 367899999999999999999
Q ss_pred CCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 363 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 363 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.||...........+.... ...+ ....+++.+.+||.+||+.||++|||+.++++|
T Consensus 238 ~pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 238 CPFMDERIMCLHSKIKSQA-LEFP-DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CSSCCSSHHHHHHHHHHCC-CCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCCccHHHHHHHHhccc-CCCC-CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 9998765444433333222 2221 234678899999999999999999999999876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=333.84 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=206.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|...+.||+|+||.||. +|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 688899999999999884 58899999987542 2233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee---CCCCCeEEee
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR---DDSGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~---~~~~~vkl~D 307 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||++ +.++.+||+|
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~-----------NIl~~~~~~~~~~kl~D 152 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPE-----------NLLYLTPEENSKIMITD 152 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGG-----------GCEESSSSTTCCEEBCS
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHH-----------HEEEecCCCCCCEEEcc
Confidence 9999999999988888999999999999999999999999 999999999 6666 6788999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+..........
T Consensus 153 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (304)
T 2jam_A 153 FGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESP 229 (304)
T ss_dssp CSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTT
T ss_pred CCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 9998754321 2223458899999999999899999999999999999999999998766555555554443322223
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+++.+.+||.+||..||++|||+.++++|
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 345678999999999999999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=342.06 Aligned_cols=240 Identities=24% Similarity=0.389 Sum_probs=179.6
Q ss_pred ceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEeccC
Q 012164 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 160 ~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
.+.||+|+||.||. +|+.||||.+... ....+.+|+.+++.+. ||||+++++++.+....++|||||+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 36899999999985 5789999998643 2356778999999997 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC---CeEEeecCC
Q 012164 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG---NLKVADFGV 310 (469)
Q Consensus 234 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~---~vkl~Dfgl 310 (469)
+|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++ .+||+|||+
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPE-----------NLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEEEC----CEEEECCCTT
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHH-----------HEEEecCCCcccEEEecccc
Confidence 9999999999888999999999999999999999999 999999999 66665544 799999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-------cHHHHHhhcCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------EVPKAYAARQRP 383 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-------~~~~~~~~~~~~ 383 (469)
++..... ........+|+.|+|||++.+..++.++||||||+++|+|++|+.||...... +....+......
T Consensus 156 a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 156 ARLKPPD-NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp CEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred ceecCCC-CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 9865432 22233456799999999999999999999999999999999999999865432 122223222221
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
........+++++.+||.+||..||++|||+.++++|
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1112234678999999999999999999999999866
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=341.28 Aligned_cols=244 Identities=26% Similarity=0.468 Sum_probs=207.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..+.||+|+||.||. +|+.||||.+...........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 588889999999999984 588999999876544455566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|+. |+|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAG-----------NILLSEPGLVKLGDFG 199 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGG-----------GEEEETTTEEEECCCT
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHH-----------HEEECCCCCEEEeecc
Confidence 996 688888864 566999999999999999999999999 999999999 8888889999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
++...... ....||+.|+|||++. +..++.++|||||||++|+|++|+.||...+.......+.....+..
T Consensus 200 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~- 273 (348)
T 1u5q_A 200 SASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL- 273 (348)
T ss_dssp TCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-
T ss_pred CceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-
Confidence 99765422 2356899999999984 56789999999999999999999999987655444444434333322
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
....+++.+.+||.+||+.||++|||+.+++++.
T Consensus 274 -~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 274 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 2346788999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.63 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=207.7
Q ss_pred ccceeeecCeEEEEEE---eceeehhhhccccc-CCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccC
Q 012164 158 TNSVEITKGTFILAFW---RGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 158 ~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
...+.||+|+||.||. +++.||+|.+.... .......+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113 (307)
T ss_dssp TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred ccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence 3457999999999875 78899999987532 2234456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 234 KGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 234 ~gsL~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
+++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||+
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~-----------Nili~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSA-----------NILLDEAFTAKISDFGL 179 (307)
T ss_dssp TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEECTTCCEEECCCTT
T ss_pred CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHH-----------HEEEcCCCcEEEeeccc
Confidence 9999999974 345999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh----c-----
Q 012164 311 SKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA----R----- 380 (469)
Q Consensus 311 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~----~----- 380 (469)
+......... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...........+.. .
T Consensus 180 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (307)
T 2nru_A 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIE 258 (307)
T ss_dssp CEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHH
T ss_pred ccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhh
Confidence 9865432221 1233568999999999876 578999999999999999999999987655443222211 0
Q ss_pred --CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 381 --QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 381 --~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
........+..++..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 259 DYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 0112223345678899999999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=363.56 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=207.3
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|+.||+|.+.............+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 4688899999999999985 58899999987543222223456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 230 EYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||+||+|.+++...+. +++..+..++.||+.||+|||+++ |+||||||+ |||++.+|.+||+|
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPe-----------NILld~~g~vKL~D 329 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPE-----------NILLDDHGHIRISD 329 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTSCEEECC
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchh-----------eEEEeCCCCeEEEe
Confidence 99999999999987544 999999999999999999999999 999999999 88889999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH---hhcCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQRPP 384 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~---~~~~~~~ 384 (469)
||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ .......
T Consensus 330 FGla~~~~~~--~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~ 407 (576)
T 2acx_A 330 LGLAVHVPEG--QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407 (576)
T ss_dssp CTTCEECCTT--CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC
T ss_pred cccceecccC--ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc
Confidence 9999875432 2233457999999999999989999999999999999999999999876543222111 1222222
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
+ +..+++++.+||.+||..||++|| +++++++|
T Consensus 408 ~---p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 408 Y---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp C---CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred C---CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 2 356789999999999999999999 78999887
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=343.79 Aligned_cols=243 Identities=24% Similarity=0.420 Sum_probs=201.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.|+. +|+.||||.+...... ..+|++++.++ +||||+++++++.+....|+||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 688899999999999885 5889999998765322 34688888887 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC-C---CCeEE
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD-S---GNLKV 305 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~-~---~~vkl 305 (469)
|||++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+ ||++.. + +.+||
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~-----------NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPS-----------NILYVDESGNPESIRI 161 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEESSSSCSGGGEEE
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHH-----------HEEEecCCCCcCeEEE
Confidence 99999999999998888999999999999999999999999 999999999 555432 2 35999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc---HHHHHhhcCC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAYAARQR 382 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~---~~~~~~~~~~ 382 (469)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... +...+.....
T Consensus 162 ~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 162 CDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF 240 (342)
T ss_dssp CCCTTCEECBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC
T ss_pred EECCCcccCcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc
Confidence 9999998755332 22344678999999999988788999999999999999999999998643332 3333333332
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
......+..+++++.+||.+||..||++|||+.++++|
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22222345688999999999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=331.18 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=204.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCH---HHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|+..+.||+|+||.||. +|+.||+|.+........ ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 688899999999999885 488999998875433211 124678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC----Ce
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG----NL 303 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~----~v 303 (469)
||||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++ .+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPE-----------NIMLLDKNVPNPRI 151 (283)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEESCSSSSSCCE
T ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChH-----------HEEEecCCCCCCce
Confidence 9999999999999988888999999999999999999999999 999999999 66666665 89
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+......
T Consensus 152 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229 (283)
T ss_dssp EECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred EEEecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence 999999998654322 223356899999999999889999999999999999999999999876654444444332222
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
........+++.+.+|+.+||..||++|||+.++++|
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1111234567889999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=332.66 Aligned_cols=252 Identities=25% Similarity=0.515 Sum_probs=203.6
Q ss_pred ccccceeeecCeEEEEEE---------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--Cc
Q 012164 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 224 (469)
.|+..+.||+|+||.||. +|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 588899999999999873 57899999987543 223346789999999999999999999999876 66
Q ss_pred eEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~-----------Nil~~~~~~~ 165 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAAR-----------NVLVESEHQV 165 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEEEETTEE
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchh-----------eEEEcCCCCE
Confidence 8999999999999999954 456999999999999999999999999 999999999 8888889999
Q ss_pred EEeecCCccccccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----------C-
Q 012164 304 KVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH----------D- 370 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~----------~- 370 (469)
||+|||++........ .......+|..|+|||.+.+..++.++||||||+++|+|++|+.|+.... .
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc
Confidence 9999999987654322 12234567888999999988888999999999999999999999864221 0
Q ss_pred Cc----HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 371 NE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 371 ~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
.. ....+......+ .+..+++.+.+||.+||+.||.+|||+.++++.|+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp GGHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ccCHHHHHHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 00 111111122222 245678999999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.89 Aligned_cols=254 Identities=24% Similarity=0.498 Sum_probs=205.4
Q ss_pred CcccccceeeecCeEEEEEE-----eceee----hhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQV----AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~v----aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
..+|+..+.||+|+||.||. +|+.| |+|.+.... .....+.+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-C
Confidence 34789999999999999985 34544 666654332 223346788999999999999999999999865 4
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.++|+||+.+|+|.+++... +.+++..++.++.|++.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~-----------NIl~~~~~~~ 156 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR-----------NVLVKTPQHV 156 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEEEETTEE
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHH-----------HEEEcCCCCE
Confidence 78999999999999999864 56999999999999999999999999 999999999 8888888999
Q ss_pred EEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 304 KVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+....
T Consensus 157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 236 (327)
T 3lzb_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236 (327)
T ss_dssp EECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999876433221 2233456788999999999899999999999999999999 999999887777766665444
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
..+. +..++.++.+||.+||..||.+|||+.++++.|+.+...
T Consensus 237 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 RLPQ---PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 3333 345788999999999999999999999999999999876
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=331.89 Aligned_cols=244 Identities=25% Similarity=0.470 Sum_probs=207.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. ++..||+|.+...........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 788899999999999885 467899998864322111223578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+|||+
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPE-----------NLLMGYKGELKIADFGW 160 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGG-----------GEEECTTCCEEECCCTT
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHH-----------HEEEcCCCCEEEecccc
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
+...... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+... .... +.
T Consensus 161 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---~~ 233 (284)
T 2vgo_A 161 SVHAPSL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKF---PP 233 (284)
T ss_dssp CEECSSS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCC---CT
T ss_pred cccCccc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-ccCC---CC
Confidence 8764422 223456899999999999989999999999999999999999999876554444444322 2222 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.++..+.+||.+||+.||.+|||++++++|
T Consensus 234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 578899999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=327.91 Aligned_cols=250 Identities=27% Similarity=0.420 Sum_probs=209.3
Q ss_pred ccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC--CceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|..||+|.+..... .....+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 688889999999998874 689999999886543 345567899999999999999999999999877 77899999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+++|+|.+++.... .+++..++.++.|++.||.|||+.++ +++||||||+ ||+++.++.++|+||
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~-----------Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSR-----------SVMIDEDMTARISMA 157 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGG-----------GEEECTTSCEEEEGG
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccc-----------eEEEcCCcceeEEec
Confidence 999999999998765 48999999999999999999999763 4999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCC---chhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 385 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 385 (469)
|++..... ....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||......+...........+
T Consensus 158 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 230 (271)
T 3kmu_A 158 DVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP- 230 (271)
T ss_dssp GSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC-
T ss_pred cceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC-
Confidence 88754221 2245789999999998765544 7999999999999999999998776655544443333222
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 386 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 386 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
..+..+++.+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 -TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1245678899999999999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=344.89 Aligned_cols=242 Identities=26% Similarity=0.376 Sum_probs=192.1
Q ss_pred ccccc-eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHh-cCCCCceeeEEeEEEe----CCc
Q 012164 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQ----SSP 224 (469)
Q Consensus 156 ~~~~~-~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~----~~~ 224 (469)
+|... +.||+|+||.||. +|+.||||++... ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 56555 6899999999985 5788999998632 34677888874 4579999999999875 467
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC---
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD--- 299 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~--- 299 (469)
+|+|||||++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+ |||++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~-----------Nill~~~~~ 199 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE-----------NLLYTSKRP 199 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEESSSST
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcc-----------eEEEecCCC
Confidence 899999999999999998754 4999999999999999999999999 999999999 777766
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----HHH
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPK 375 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~----~~~ 375 (469)
++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 200 ~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 277 (400)
T 1nxk_A 200 NAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277 (400)
T ss_dssp TCCEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH
T ss_pred CccEEEEecccccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH
Confidence 788999999999865432 22234578999999999999999999999999999999999999998665433 333
Q ss_pred HHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 376 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
.+..............+++++.+||.+||..||++|||+.++++|-
T Consensus 278 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 3333322222223356889999999999999999999999999983
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=336.52 Aligned_cols=247 Identities=25% Similarity=0.482 Sum_probs=189.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 688889999999999985 488999999875432 2223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 231 YLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 231 ~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
|++ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+|
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~-----------NIl~~~~~~~k 148 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQ-----------NLLINKRGQLK 148 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTCCEE
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChH-----------HeEEcCCCCEE
Confidence 996 6999999753 34899999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CC
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR 382 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~ 382 (469)
|+|||+++...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+... +.
T Consensus 149 l~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 227 (317)
T 2pmi_A 149 LGDFGLARAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227 (317)
T ss_dssp ECCCSSCEETTSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred ECcCccceecCCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999998754322 222345689999999999764 6899999999999999999999999876654443333211 10
Q ss_pred CC----------------CC-------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PP----------------FK-------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~----------------~~-------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
++ .. .....+++++.+||.+||+.||++|||+.++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 00 0012467889999999999999999999999876
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=340.59 Aligned_cols=248 Identities=22% Similarity=0.366 Sum_probs=203.2
Q ss_pred ccccc-eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEE
Q 012164 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 156 ~~~~~-~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 228 (469)
.|.+. +.||+|+||.||. +|+.||+|.+...... ......+.+|+.+++.+. ||||+++++++.+....++|
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 45555 7899999999985 4889999998765432 223467889999999995 79999999999999999999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC---CCCe
Q 012164 229 TEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD---SGNL 303 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~---~~~v 303 (469)
|||+++|+|.+++... +.+++..++.++.|++.||.|||+.+ |+||||||+ ||+++. ++.+
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~-----------NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQ-----------NILLSSIYPLGDI 173 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEESCBTTBCCE
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChH-----------HEEEecCCCCCcE
Confidence 9999999999998653 56999999999999999999999999 999999999 666665 7899
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+......
T Consensus 174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 251 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc
Confidence 999999998764322 223456899999999999999999999999999999999999999877665555444433333
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
........+++.+.+||.+||+.||++|||++++++|
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 3333345688999999999999999999999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=339.97 Aligned_cols=251 Identities=21% Similarity=0.346 Sum_probs=198.3
Q ss_pred CCcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCC--CceeeEEeEEEeCCceE
Q 012164 153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~ 226 (469)
...+|++.+.||+|+||.||. +++.||||++..... .....+.+.+|+.++++++| |||+++++++.+....+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 445799999999999999985 578899999875543 45556789999999999976 99999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
+|||+. +++|.+++...+.+++.++..++.||+.||.|||+.+ |+||||||+ |||++ ++.+||+
T Consensus 86 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~-----------NIll~-~~~~kl~ 149 (343)
T 3dbq_A 86 MVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPA-----------NFLIV-DGMLKLI 149 (343)
T ss_dssp EEECCC-SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEEE-TTEEEEC
T ss_pred EEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcc-----------eEEEE-CCcEEEe
Confidence 999955 8899999999888999999999999999999999999 999999999 66665 5789999
Q ss_pred ecCCccccccCCCC-CcccCCCCCcccCCcccCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH
Q 012164 307 DFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374 (469)
Q Consensus 307 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~ 374 (469)
|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 229 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence 99999876433221 2234578999999999854 57888999999999999999999999764432111
Q ss_pred HHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012164 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 421 (469)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L 421 (469)
......... ....+...+..+.+||.+||+.||.+|||+.++++|-
T Consensus 230 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 230 LHAIIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHHHCTTS-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHhcCCc-ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111111111 1112334567899999999999999999999999873
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=331.05 Aligned_cols=247 Identities=23% Similarity=0.429 Sum_probs=184.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|++.+.||+|+||.||. +|+.||+|.+...........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 3788899999999999874 57899999986432211122467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+++++|.+++... +.+++..++.++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+||
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~-----------Nili~~~~~~kl~df 156 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLS-----------NLLLTRNMNIKIADF 156 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGG-----------GEEECTTCCEEECCC
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEEcCCCCEEEEee
Confidence 999999999999875 56999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|++........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+.... . ..
T Consensus 157 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~---~~ 231 (278)
T 3cok_A 157 GLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-Y---EM 231 (278)
T ss_dssp TTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC-C---CC
T ss_pred cceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc-c---CC
Confidence 99986543221 2223568999999999998889999999999999999999999998766544433322111 1 12
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..++.++.+||.+||+.||++|||++++++|
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 34578899999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=341.38 Aligned_cols=255 Identities=25% Similarity=0.493 Sum_probs=209.1
Q ss_pred CcccccceeeecCeEEEEEE-----ecee----ehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~----vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
..+|+..+.||+|+||.||. +|+. ||+|.+.... .....+.+.+|+.++++++||||+++++++. ...
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 34788899999999999985 3444 6777664332 1122245678999999999999999999986 467
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.++||||+.+|+|.+++... +.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~-----------Nil~~~~~~~ 154 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAAR-----------NVLLKSPSQV 154 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSST-----------TEEESSSSCE
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchh-----------eEEECCCCeE
Confidence 89999999999999999864 56999999999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 304 KVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
||+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 234 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 234 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence 99999999876543322 2234567889999999998899999999999999999999 999999887777766665443
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.... +..++.++.+||.+||..||.+|||+.+++++|+.+....
T Consensus 235 ~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 235 RLAQ---PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp BCCC---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CCCC---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 3332 3346778999999999999999999999999999987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=329.42 Aligned_cols=247 Identities=30% Similarity=0.550 Sum_probs=204.4
Q ss_pred cccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-CceEEEEe
Q 012164 155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTE 230 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~E 230 (469)
.+|+..+.||+|+||.||. +|+.||+|.+.... ..+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 4788899999999998874 78999999987542 346788999999999999999999997654 47899999
Q ss_pred ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
|+++++|.+++...+. +++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+||
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~-----------Nil~~~~~~~~l~Df 161 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAAR-----------NVLVSEDNVAKVSDF 161 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEECTTSCEEECCC
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcc-----------eEEEeCCCcEEEeec
Confidence 9999999999986543 899999999999999999999999 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
|++....... ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.......
T Consensus 162 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--- 234 (278)
T 1byg_A 162 GLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD--- 234 (278)
T ss_dssp CC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---
T ss_pred cccccccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---
Confidence 9987644221 22356889999999988889999999999999999998 999998877666655554333322
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.+..+++.+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 2456788999999999999999999999999999999775
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=335.81 Aligned_cols=244 Identities=23% Similarity=0.378 Sum_probs=195.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC-------
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------- 223 (469)
+|+..+.||+|+||.||. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 688889999999999884 58899999987543 2334577999999999999999999999986543
Q ss_pred --------------------------------------------------ceEEEEeccCCCCHHHHHHhcCC---CCHH
Q 012164 224 --------------------------------------------------PMMIVTEYLPKGDLRAFLKRKGA---LKPS 250 (469)
Q Consensus 224 --------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~---l~~~ 250 (469)
..++|||||++++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27999999999999999987544 4556
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCC-----------
Q 012164 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED----------- 319 (469)
Q Consensus 251 ~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~----------- 319 (469)
.++.++.||+.||.|||+++ |+||||||+ ||+++.++.+||+|||+++.......
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~ 230 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPS-----------NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTCCEEECCCTTCEECSCC-------------
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcc-----------cEEEeCCCCEEEeecCcccccccchhhcccccccccc
Confidence 68999999999999999999 999999999 88888999999999999987654321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHH
Q 012164 320 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 399 (469)
Q Consensus 320 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 399 (469)
.......||+.|+|||++.+..++.++||||||+++|+|++|..|+.. .............+......++.+.+|
T Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLLFTQKYPQEHMM 305 (332)
T ss_dssp -CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCHHHHHHCHHHHHH
T ss_pred ccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCcccccCChhHHHH
Confidence 122335689999999999998999999999999999999998776531 111111111222222345667889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 012164 400 IEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 400 i~~cl~~dp~~Rps~~~ll~~ 420 (469)
|.+||+.||++|||+.++++|
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCCCcCCCHHHHhhc
Confidence 999999999999999999976
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=329.18 Aligned_cols=246 Identities=23% Similarity=0.435 Sum_probs=199.5
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|..||+|.+...... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3789999999999999984 5789999998765422 22467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee---CCCCC
Q 012164 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR---DDSGN 302 (469)
Q Consensus 230 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~---~~~~~ 302 (469)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+ ||++ +.++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~-----------NIl~~~~~~~~~ 165 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPE-----------NILFQDTSPHSP 165 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGG-----------GEEESSSSTTCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHH-----------HEEEecCCCCCC
Confidence 99999999999864 366999999999999999999999999 999999999 6666 45678
Q ss_pred eEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC
Q 012164 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+||+|||++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+....+........ .
T Consensus 166 ~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~ 241 (285)
T 3is5_A 166 IKIIDFGLAELFKSD--EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-E 241 (285)
T ss_dssp EEECCCCCCCC------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-C
T ss_pred EEEEeeecceecCCc--ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-C
Confidence 999999999765432 22234568999999999864 6889999999999999999999999876655544443222 2
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+........+++.+.+||.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22222334467899999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.91 Aligned_cols=248 Identities=24% Similarity=0.404 Sum_probs=192.8
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCC--ceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS--PMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~--~~~l 227 (469)
+|+..+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++...+ .+|+
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 688899999999999875 58899999987543 34555677889999999997 999999999997554 6899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||||+ ++|.+++.. +.+++..+..++.||+.||+|||+.+ |+||||||+ |||++.++.+||+|
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~-----------NIll~~~~~~kl~D 152 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPS-----------NILLNAECHVKVAD 152 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTCCEEECC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHH-----------HeEEcCCCCEEecC
Confidence 999996 699999986 46999999999999999999999999 999999999 88889999999999
Q ss_pred cCCccccccCC--------------------CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 012164 308 FGVSKLLTVKE--------------------DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFT 366 (469)
Q Consensus 308 fgla~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~ 366 (469)
||+|+...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus 153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 99998653211 111234579999999999976 578999999999999999999999998
Q ss_pred CCCCCcHHHHHhhcC-CCC-----------------------------CCC-------------ChhhhHHHHHHHHHHH
Q 012164 367 MKHDNEVPKAYAARQ-RPP-----------------------------FKA-------------PAKLYARGLKELIEEC 403 (469)
Q Consensus 367 ~~~~~~~~~~~~~~~-~~~-----------------------------~~~-------------~~~~~~~~l~~li~~c 403 (469)
+.+.......+.... .+. ... +...+++++.+||.+|
T Consensus 233 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 766544433332111 110 000 0114577899999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 012164 404 WNEKPAKRPTFRQIITR 420 (469)
Q Consensus 404 l~~dp~~Rps~~~ll~~ 420 (469)
|..||++|||++++++|
T Consensus 313 L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 313 LQFNPNKRISANDALKH 329 (388)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hccCcccCCCHHHHhCC
Confidence 99999999999999988
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=332.59 Aligned_cols=248 Identities=27% Similarity=0.470 Sum_probs=198.0
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 688899999999999985 478999999865432 122235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
++ ++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+ ||+++.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-----------Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 82 LD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQ-----------NLLINREGELKIADFGL 146 (288)
T ss_dssp CS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTSCEEECCTTH
T ss_pred cC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HEEEcCCCCEEEeECcc
Confidence 96 5999999864 56999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CCCC----
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPP---- 384 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~---- 384 (469)
++...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+... +.+.
T Consensus 147 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 147 ARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence 97654221 222335689999999998764 5899999999999999999999999876544433332211 1000
Q ss_pred ------------C--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 ------------F--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ------------~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
. ......+++++.+||.+||+.||++|||+.++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00113467899999999999999999999999876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=334.06 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=200.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+.... ......+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 688899999999999885 48899999887553 334556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~-----------Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPE-----------NILITKHSVIKLCDFGF 148 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTSCEEECCCTT
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChh-----------hEEEcCCCCEEEeeCCC
Confidence 9999999999988888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc---------
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------- 380 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~--------- 380 (469)
+....... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+...
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 149 ARLLTGPS-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp CEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred chhccCcc-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 98654322 22234568999999999876 57899999999999999999999999876554433222110
Q ss_pred -----------CCCCCCC-------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 -----------QRPPFKA-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 -----------~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+... ..+.+++.+.+||.+||+.||++|||++++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 013567889999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.21 Aligned_cols=264 Identities=15% Similarity=0.224 Sum_probs=205.2
Q ss_pred CcccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHH--------HHHHHHHHHHhcCCCCceeeE
Q 012164 154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQF 215 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~h~~i~~~ 215 (469)
..+|++.+.||+|+||.||.. ++.||||.+........... ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 347999999999999999853 57899998865421101111 123456667788899999999
Q ss_pred EeEEEeC----CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccc
Q 012164 216 LGAVTQS----SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290 (469)
Q Consensus 216 ~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~ 290 (469)
++++... ...++||||| +++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~-------- 181 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKAS-------- 181 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG--------
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHH--------
Confidence 9998765 4489999999 99999999875 56999999999999999999999999 999999999
Q ss_pred cCcceeeC--CCCCeEEeecCCccccccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCC
Q 012164 291 NDRNILRD--DSGNLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 362 (469)
Q Consensus 291 ~~~nil~~--~~~~vkl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~ 362 (469)
|||++ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 182 ---Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 182 ---NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp ---GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred ---HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 77777 7899999999999765433211 113345999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcHHHHHhh-cCCCCCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccc
Q 012164 363 PPFTMKHDNEVPKAYAA-RQRPPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 432 (469)
Q Consensus 363 ~p~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 432 (469)
.||.+............ ........ ....+++++.+|+..||..||++||++.++++.|+.+.+......
T Consensus 259 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 259 LPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 99986544332221111 10111000 113457899999999999999999999999999999998865543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=337.11 Aligned_cols=252 Identities=32% Similarity=0.542 Sum_probs=207.5
Q ss_pred ccccceeeecCeEEEEEE-----ecee--ehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~--vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 227 (469)
+|+..+.||+|+||.||. +|.. ||+|.+... ......+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 788899999999998874 3444 599988643 2334456789999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc
Q 012164 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~ 291 (469)
||||+++++|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~--------- 171 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR--------- 171 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG---------
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccc---------
Confidence 999999999999998654 6999999999999999999999999 999999999
Q ss_pred CcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012164 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 370 (469)
Q Consensus 292 ~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~ 370 (469)
||+++.++.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 172 --NIl~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 172 --NILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp --GEEECGGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred --eEEEcCCCeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 888888999999999999753322 12223456788999999988888999999999999999998 9999987765
Q ss_pred CcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 371 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.+....+....... .+..+++.+.+||.+||..||++|||+.+++++|+.+....
T Consensus 248 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 248 AELYEKLPQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHHHHGGGTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHhhcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 55555443332222 23467889999999999999999999999999999998774
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=341.18 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=207.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC-C----HHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCc
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-D----DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~-~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 224 (469)
+|+..+.||+|+||.||. +|+.||||++...... . ....+.+.+|+.+++++ +||||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 688889999999999885 5889999988654311 1 12245688999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
.++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ |+|+||||+ ||+++.++.+|
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~-----------NIl~~~~~~ik 240 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPE-----------NILLDDNMQIR 240 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTCCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEECCCCCEE
Confidence 9999999999999999998888999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 378 (469)
|+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus 241 l~DfG~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 241 LSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp ECCCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEecCcccccCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999999875532 22344678999999999853 367889999999999999999999998765544444443
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..........+..+++.+.+||.+||+.||++|||+.++++|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 319 EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 333222212234567889999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=333.51 Aligned_cols=256 Identities=27% Similarity=0.471 Sum_probs=212.1
Q ss_pred CcccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 012164 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 222 (469)
..+|+..+.||+|+||.||. +++.||||.+... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 44788999999999999874 3478999998754 2345567899999999999 699999999998775
Q ss_pred C-ceEEEEeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccc
Q 012164 223 S-PMMIVTEYLPKGDLRAFLKRKGA----------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLY 285 (469)
Q Consensus 223 ~-~~~lv~E~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil 285 (469)
+ ..++||||+++++|.+++..... +++..++.++.|++.||.|||+.+ |+||||||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~--- 177 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR--- 177 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG---
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccc---
Confidence 4 58999999999999999987543 789999999999999999999999 999999999
Q ss_pred ccccccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 012164 286 VAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 363 (469)
Q Consensus 286 ~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~ 363 (469)
||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.
T Consensus 178 --------Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 178 --------NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp --------GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred --------eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 888888899999999999865432221 1123346788999999998899999999999999999998 999
Q ss_pred CCCCCCCCcHHHHH-hhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 364 PFTMKHDNEVPKAY-AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 364 p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
||......+..... ........ +..+++.+.++|.+||+.||.+|||+.+++++|+.+....
T Consensus 250 p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 250 PYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp SSTTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCcccchhHHHHHHhccCccCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 99876655443333 22222222 3457889999999999999999999999999999998763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=328.54 Aligned_cols=249 Identities=29% Similarity=0.465 Sum_probs=196.4
Q ss_pred cccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhc--CCCCceeeEEeEEEeC----Cce
Q 012164 155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQS----SPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~----~~~ 225 (469)
.+|+..+.||+|+||.||. +|+.||||++.... ...+..|.+++.. ++||||+++++++... ...
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 3788999999999998874 68999999986431 2445556666665 7899999999987543 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCcccccccccCcceee
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
++||||+++|+|.++++. ..+++..++.++.|++.||.||| +.+ |+||||||+ ||++
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~-----------Nill 146 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSK-----------NILV 146 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGG-----------GEEE
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChH-----------hEEE
Confidence 999999999999999964 46999999999999999999999 888 999999999 8888
Q ss_pred CCCCCeEEeecCCccccccCCCC---CcccCCCCCcccCCcccCCC------CCCCchhHHHHHHHHHHHHhC-------
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEG------- 361 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDi~SlGvil~el~tg------- 361 (469)
+.++.+||+|||+++........ ......||+.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 89999999999999765433221 12334789999999999876 345699999999999999999
Q ss_pred ---CCCCCCCCCCcH-----HHHHhhcC-CCCCCC--ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 362 ---CPPFTMKHDNEV-----PKAYAARQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 362 ---~~p~~~~~~~~~-----~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
+.||........ ........ .+..+. ....+++.+.+|+.+||+.||++|||+.++++.|+++
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 888865433221 11111111 222211 1234678899999999999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=331.07 Aligned_cols=246 Identities=31% Similarity=0.569 Sum_probs=199.2
Q ss_pred ccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
+|+..+.||+|+||.||. .++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 678889999999998864 6889999998643 33467899999999999999999999876 4579999999
Q ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCCeEecCCCCCcccccccccCcceeeCCCCC-eEE
Q 012164 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHE---NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN-LKV 305 (469)
Q Consensus 233 ~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~-vkl 305 (469)
++++|.+++.... .++...++.++.|+++||.|||+ ++ |+||||||+ ||+++.++. +||
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~-----------NIll~~~~~~~kl 147 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPP-----------NLLLVAGGTVLKI 147 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGG-----------GEEEETTTTEEEE
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChh-----------HEEEeCCCCEEEE
Confidence 9999999998654 37889999999999999999999 66 999999999 777777776 799
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHH--HHhhcCCC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK--AYAARQRP 383 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~--~~~~~~~~ 383 (469)
+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... .......+
T Consensus 148 ~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 223 (307)
T 2eva_A 148 CDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223 (307)
T ss_dssp CCCCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC
T ss_pred cccccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC
Confidence 999999754322 123458999999999999899999999999999999999999998655443222 22222222
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
+ ....+++.+.+||.+||+.||++|||+.++++.|+.+.....
T Consensus 224 ~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 224 P---LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp C---CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred C---cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 2 245678899999999999999999999999999999877643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=364.58 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=209.2
Q ss_pred eeeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccC
Q 012164 161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 161 ~~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
+.||+|+||.||. .++.||||++..... +....+.+.+|+.++++++||||+++++++.. +..++|||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999974 357899999876532 33445779999999999999999999999964 56899999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 234 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+ |||++.++.+||+|||+++.
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~-----------NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR-----------NVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEEEETTEEEECCTTHHHH
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChH-----------hEEEeCCCCEEEEEcCCccc
Confidence 9999999998888999999999999999999999999 999999999 88888899999999999987
Q ss_pred cccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 314 LTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 314 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+....+.+. +.
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~ 595 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PA 595 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CT
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 643322 11233446788999999998899999999999999999998 9999998877666666655544443 35
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.+++++.+||..||+.||++|||+.++++.|+.+...+
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 67899999999999999999999999999999987764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=361.01 Aligned_cols=249 Identities=24% Similarity=0.419 Sum_probs=207.8
Q ss_pred eeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccCC
Q 012164 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (469)
Q Consensus 162 ~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~~ 234 (469)
.||+|+||.||. ++..||||++.... .....+.+.+|++++++++||||+++++++.. +.+++|||||++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 799999999874 35679999997542 22345779999999999999999999999976 569999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 235 gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+ |||++.++.+||+|||+++.
T Consensus 420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~-----------NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAAR-----------NVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEEEETTEEEECCCSTTTT
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHH-----------HEEEcCCCcEEEeeccCccc
Confidence 9999999754 45999999999999999999999999 999999999 88888899999999999987
Q ss_pred cccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 314 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 314 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+....+.+. +.
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~ 562 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PP 562 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC---CT
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 64332211 122345688999999998899999999999999999998 9999998887777766655544443 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
.+++++.+||.+||..||++||++.++++.|+.+..+...
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 6789999999999999999999999999999999877554
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=352.70 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=194.9
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 223 (469)
.+|+..+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 3788999999999999975 58899999987553 34555678889999999999999999999996543
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.+|+|||||+ ++|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+ |||++.++.+
T Consensus 141 ~~~lv~E~~~-~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~-----------NIll~~~~~~ 203 (464)
T 3ttj_A 141 DVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS-----------NIVVKSDCTL 203 (464)
T ss_dssp EEEEEEECCS-EEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTSCE
T ss_pred eEEEEEeCCC-CCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChH-----------hEEEeCCCCE
Confidence 4699999996 467777753 4899999999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CC
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR 382 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~ 382 (469)
||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... +.
T Consensus 204 kl~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 204 KILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp EECCCCCC-------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEEeeeecCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999999986543 22334567899999999999999999999999999999999999999876543332222111 00
Q ss_pred --------------------CCCC-C----------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 --------------------PPFK-A----------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 --------------------~~~~-~----------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+... . .....++++.+||.+||..||++|||++++++|
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0 011226789999999999999999999999988
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=357.94 Aligned_cols=247 Identities=25% Similarity=0.394 Sum_probs=205.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|...+.||+|+||.||. +|+.||+|++...........+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 4788899999999999885 58999999987543322223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 230 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 230 E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
||++||+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+ ||+++.+|.+||
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~-----------NILl~~~g~vkL 330 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPE-----------NVLLDDDGNVRI 330 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTSCEEE
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChH-----------HEEEeCCCCEEE
Confidence 999999999999763 35999999999999999999999999 999999999 888899999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----HHHHHhhcC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQ 381 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~----~~~~~~~~~ 381 (469)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+. ..
T Consensus 331 ~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~-~~ 408 (543)
T 3c4z_A 331 SDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL-EQ 408 (543)
T ss_dssp CCCTTCEECCTTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH-HC
T ss_pred eecceeeeccCCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh-hc
Confidence 9999998755332 22234579999999999999999999999999999999999999998764322 222222 22
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCH-----HHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTF-----RQIITR 420 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~ 420 (469)
...+ +..+++.+.+||.+||+.||++||++ +++++|
T Consensus 409 ~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 409 AVTY---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CCCC---CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ccCC---CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 2222 35678999999999999999999964 677765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.48 Aligned_cols=253 Identities=32% Similarity=0.511 Sum_probs=213.2
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. .+..||||++...... .+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 268 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 577888999999999885 3467999999765322 3568999999999999999999999876 678999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 232 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+ |||++.++.+||+|||
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~-----------NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAA-----------NILVGENLVCKVADFG 408 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEECGGGCEEECCTT
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHh-----------hEEEcCCCcEEEcccc
Confidence 9999999999753 45999999999999999999999999 999999999 8888888999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
+++..............++..|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+....+.+.
T Consensus 409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~--- 485 (535)
T 2h8h_A 409 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--- 485 (535)
T ss_dssp STTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC---
T ss_pred cceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 998654322112233456788999999988899999999999999999999 9999998776666666654444433
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
+..+++.+.+||.+||+.||++|||+++|++.|+.+......
T Consensus 486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 346788999999999999999999999999999998776543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=334.81 Aligned_cols=258 Identities=26% Similarity=0.456 Sum_probs=213.2
Q ss_pred CcccccceeeecCeEEEEEEe-----c-----eeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 012164 154 ELDFTNSVEITKGTFILAFWR-----G-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~~-----g-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 222 (469)
..+|+..+.||+|+||.||.. + ..||+|.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 346888899999999999852 2 379999987542 345567899999999999 899999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccc
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAY 288 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~ 288 (469)
+..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~------ 193 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAAR------ 193 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG------
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccc------
Confidence 9999999999999999999753 35799999999999999999999999 999999999
Q ss_pred cccCcceeeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 012164 289 WQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 366 (469)
Q Consensus 289 ~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~ 366 (469)
||+++.++.+||+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 194 -----NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 194 -----NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp -----GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred -----eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 7777888999999999998654332211 123346778999999988889999999999999999998 999998
Q ss_pred CCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 367 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
................... .+..+++.+.+||.+||+.||.+|||+.+++++|+.+.....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 269 GILVNSKFYKLVKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp TCCSSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 7766554444433332211 234567899999999999999999999999999999877643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.34 Aligned_cols=247 Identities=22% Similarity=0.383 Sum_probs=198.5
Q ss_pred CcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC--CCceeeEEeEEEeCCceEE
Q 012164 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~l 227 (469)
...|++.+.||+|+||.||. +|+.||||.+..... .....+.+.+|+.++++++ ||||+++++++.....+++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34699999999999999985 478899999876543 4556678999999999996 5999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||+ .+++|.+++...+.+++.++..++.||+.||.|||+.+ |+||||||+ |||++ ++.+||+|
T Consensus 134 v~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~-----------NIll~-~~~~kl~D 197 (390)
T 2zmd_A 134 VMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPA-----------NFLIV-DGMLKLID 197 (390)
T ss_dssp EEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGG-----------GEEES-SSCEEECC
T ss_pred EEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHH-----------HEEEE-CCeEEEEe
Confidence 9995 58899999998888999999999999999999999999 999999999 66664 57899999
Q ss_pred cCCccccccCCCC-CcccCCCCCcccCCcccCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-HH
Q 012164 308 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VP 374 (469)
Q Consensus 308 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-~~ 374 (469)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..
T Consensus 198 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 277 (390)
T 2zmd_A 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 277 (390)
T ss_dssp CSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH
T ss_pred cCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH
Confidence 9999876433221 2234579999999999865 368889999999999999999999997654321 12
Q ss_pred HHHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 375 KAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 375 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+.... ..+. +...+.++.+||.+||+.||++|||+.++++|
T Consensus 278 ~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 HAIIDPNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHCTTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhCccccCCC---CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 2221111 1111 23346789999999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=331.97 Aligned_cols=247 Identities=21% Similarity=0.352 Sum_probs=195.5
Q ss_pred ccccc-eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEE
Q 012164 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 156 ~~~~~-~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 228 (469)
.|++. +.||+|+||.||. +|+.||||.+..... ...+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 56663 6799999999985 588999999875432 2235688999999885 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC---eEE
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN---LKV 305 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~---vkl 305 (469)
|||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++. +||
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~-----------Nil~~~~~~~~~~kl 155 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPE-----------NILCEHPNQVSPVKI 155 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEESCSSSSCSEEE
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHH-----------HEEEccCCCcCceEE
Confidence 999999999999998888999999999999999999999999 999999999 777766655 999
Q ss_pred eecCCccccccCCC------CCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc--
Q 012164 306 ADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-- 372 (469)
Q Consensus 306 ~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-- 372 (469)
+|||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 99999876532211 11123458999999999875 467889999999999999999999998765432
Q ss_pred -------------HHHHHhhcCCCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 373 -------------VPKAYAARQRPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 373 -------------~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+... ...++ .....+++.+.+||.+||+.||++|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 236 WDRGEACPACQNMLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp C----CCHHHHHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccccchhHHHHHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 12222222 22221 1123578899999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.28 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=210.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCC--C----HHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeC
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--D----DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS 222 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~--~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 222 (469)
.+|+..+.||+|+||.||. +|+.||||.+...... . ....+.+.+|+.+++++. ||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 4788999999999999885 5789999998654311 1 233466889999999996 99999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~ 302 (469)
...++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~~~ 162 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPE-----------NILLDDDMN 162 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcc-----------eEEEcCCCc
Confidence 999999999999999999998888999999999999999999999999 999999999 888889999
Q ss_pred eEEeecCCccccccCCCCCcccCCCCCcccCCcccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
+||+|||++...... .......+++.|+|||++. ...++.++||||||+++|+|++|+.||......+....
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 240 (298)
T 1phk_A 163 IKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240 (298)
T ss_dssp EEECCCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEecccchhhcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence 999999999865432 2233456899999999984 45688899999999999999999999987665555554
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..............++..+.+||.+||+.||++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 44433332223345788999999999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=327.62 Aligned_cols=245 Identities=28% Similarity=0.445 Sum_probs=199.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||.+...........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 788899999999999884 578999999865422122234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||+
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~~~~~l~dfg~ 157 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPE-----------NVLLDAHMNAKIADFGL 157 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGG-----------GEEECTTSCEEECCCCG
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChh-----------hEEECCCCCEEEeeccc
Confidence 9999999999998888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+....... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+... ... .+
T Consensus 158 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~---~~ 231 (276)
T 2h6d_A 158 SNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG-VFY---IP 231 (276)
T ss_dssp GGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCC---CC
T ss_pred ccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-ccc---Cc
Confidence 97654321 2233568899999999988765 57999999999999999999999876554444444332 222 23
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..++..+.++|.+||+.||++|||+.++++|
T Consensus 232 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 4567889999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=345.58 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=203.5
Q ss_pred cccccceeeecCeEEEEEE--------eceeehhhhcccccCC-CHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCc
Q 012164 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 224 (469)
.+|+..+.||+|+||.||. +|+.||||++...... .....+.+.+|+.+++++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 3789999999999999883 5789999998753211 111224567799999999 69999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
.++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ |||++.++.+|
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~k 199 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE-----------NILLDSNGHVV 199 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTSCEE
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEECCCCcEE
Confidence 9999999999999999998888999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh---h
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---A 379 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~---~ 379 (469)
|+|||+++..............||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+. .
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 999999986543322233345689999999999863 57889999999999999999999998654433222221 1
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 380 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
...++ .+..++..+.+||.+||..||++|| +++++++|
T Consensus 280 ~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 280 KSEPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCCC---CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 22222 2356788999999999999999999 99999887
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=325.11 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=206.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 688899999999999875 588999999875433 2344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||+
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPE-----------NLLLDERDNLKISDFGL 151 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTCCEEECCCTT
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChH-----------HEEEccCCCEEEeeCCC
Confidence 9999999999987778999999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCC-CCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 311 SKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 311 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
+....... ........|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.................. ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~ 230 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNP 230 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-TSTT
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-ccCc
Confidence 97654322 122234568999999999987665 67899999999999999999999876554332222122221 2223
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+++.+.+||.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 45788999999999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=338.77 Aligned_cols=239 Identities=23% Similarity=0.398 Sum_probs=201.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCH-----HHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|+..+.||+|+||.||. +|+.||||.+........ .....+.+|+.++++++||||+++++++.+.+..
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 789999999999998875 578999999876543221 1234577899999999999999999999999999
Q ss_pred EEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++||||+.+| +|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+|
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~k 170 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDE-----------NIVIAEDFTIK 170 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTSCEE
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHH-----------HEEEcCCCcEE
Confidence 9999999766 99999998888999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
|+|||++...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... .. ..
T Consensus 171 L~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~-~~--- 239 (335)
T 3dls_A 171 LIDFGSAAYLERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----TV-EA--- 239 (335)
T ss_dssp ECCCTTCEECCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----GT-TT---
T ss_pred EeecccceECCCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----HH-hh---
Confidence 9999999875432 22234568999999999988776 7899999999999999999999975221 11 11
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+..+++++.+||.+||+.||++|||+.+++++
T Consensus 240 -~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 -AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233478899999999999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=327.58 Aligned_cols=242 Identities=21% Similarity=0.259 Sum_probs=192.1
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 228 (469)
.+|+..+.||+|+||.||. +|+.||||++........ .......|+..+..+ +||||+++++++.+.+..++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 3689999999999999985 588999998875543333 334444555555444 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||+ +++|.+++...+ .+++..++.++.|++.||.|||+.+ |+||||||+ |||++.++.+||+|
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~-----------NIll~~~~~~kl~D 200 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPA-----------NIFLGPRGRCKLGD 200 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECGGGCEEECC
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHH-----------HEEECCCCCEEEcc
Confidence 9999 779999987644 5999999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..|+.... ....+.....+ ..
T Consensus 201 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~--~~ 272 (311)
T 3p1a_A 201 FGLLVELGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLP--PE 272 (311)
T ss_dssp CTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCC--HH
T ss_pred ceeeeecccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCC--cc
Confidence 9999765432 22234568999999999886 78999999999999999999976654321 12222111111 11
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..+++++.+||.+||+.||++|||+.+++++
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 234578899999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=337.14 Aligned_cols=248 Identities=21% Similarity=0.387 Sum_probs=193.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||.+..... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 799999999999999875 588999999875532 23334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee-----CCCCCeEE
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR-----DDSGNLKV 305 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~-----~~~~~vkl 305 (469)
|++ |+|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||++ +..+.+||
T Consensus 114 ~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 114 YAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQ-----------NLLLSVSDASETPVLKI 178 (329)
T ss_dssp CCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEEEC-----CCEEEE
T ss_pred cCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHH-----------HEEEecCCCCccceEEE
Confidence 996 699999998888999999999999999999999999 999999999 5555 34556999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CCC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP 383 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~ 383 (469)
+|||+++..... ........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+... +.+
T Consensus 179 ~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 179 GDFGLARAFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp CCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CcCCCccccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 999999865432 1222345679999999999874 5899999999999999999999999876554443333221 111
Q ss_pred CCCC-------------------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKA-------------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~-------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+... ....+++++.+||.+||+.||++|||+.++++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 1000 011267889999999999999999999999876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=350.23 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=187.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-----Cc
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 224 (469)
.+|+..+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3799999999999999874 58899999987542 3455567899999999999999999999998543 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
+|+||||+ +++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ |||++.++.+|
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~-----------NILl~~~~~~k 196 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPA-----------NCLVNQDCSVK 196 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG-----------GEEECTTCCEE
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChh-----------hEEECCCCCEe
Confidence 89999999 6799999998888999999999999999999999999 999999999 88889999999
Q ss_pred EeecCCccccccCCC--------------------------CCcccCCCCCcccCCccc-CCCCCCCchhHHHHHHHHHH
Q 012164 305 VADFGVSKLLTVKED--------------------------RPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQE 357 (469)
Q Consensus 305 l~Dfgla~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDi~SlGvil~e 357 (469)
|+|||+++....... .......||+.|+|||++ .+..++.++|||||||++||
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 999999987542211 112345689999999986 45679999999999999999
Q ss_pred HHh-----------CCCCCCCCCCCc--------------------HHHHH-hhcC------------------------
Q 012164 358 MIE-----------GCPPFTMKHDNE--------------------VPKAY-AARQ------------------------ 381 (469)
Q Consensus 358 l~t-----------g~~p~~~~~~~~--------------------~~~~~-~~~~------------------------ 381 (469)
|++ |+++|.+..... ....+ ...+
T Consensus 277 lltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 356 (458)
T 3rp9_A 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPK 356 (458)
T ss_dssp HHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCC
T ss_pred HHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCC
Confidence 998 677776543110 00000 0000
Q ss_pred --CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 --RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 --~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+....+.+++++.+||.+||..||++|||++++++|
T Consensus 357 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 357 REGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001111123457889999999999999999999999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=335.75 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=200.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-----CCceeeEEeEEEeCCc
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPNVVQFLGAVTQSSP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~ 224 (469)
.+|++.+.||+|+||.||. +|+.||||++... ......+..|+.+++.++ ||||+++++++...+.
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 4799999999999999985 5789999998632 344567788999999996 9999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc-----------
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN----------- 291 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~----------- 291 (469)
.++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+.....
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccc
Confidence 99999999 899999998754 4999999999999999999999999 999999999666642100
Q ss_pred -C--cceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 012164 292 -D--RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 368 (469)
Q Consensus 292 -~--~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~ 368 (469)
+ ..+....++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 0 0011134789999999999864322 23456899999999999999999999999999999999999999876
Q ss_pred CCCcHHHHHhhcCCCCC-------------------------CC-----------------ChhhhHHHHHHHHHHHccc
Q 012164 369 HDNEVPKAYAARQRPPF-------------------------KA-----------------PAKLYARGLKELIEECWNE 406 (469)
Q Consensus 369 ~~~~~~~~~~~~~~~~~-------------------------~~-----------------~~~~~~~~l~~li~~cl~~ 406 (469)
...+....+.....+.. +. .....++.+.+||.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 54443333322111000 00 0011236788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 012164 407 KPAKRPTFRQIITR 420 (469)
Q Consensus 407 dp~~Rps~~~ll~~ 420 (469)
||++|||++++++|
T Consensus 343 dP~~Rpta~elL~h 356 (360)
T 3llt_A 343 DPTLRPSPAELLKH 356 (360)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=334.63 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=209.0
Q ss_pred cccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
.+|+..+.||+|+||.||. ++..||||.+... ........+.+|+.++++++||||+++++++.+...
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4788999999999998874 3457999998643 345556788999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+ ||++
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~-----------NIli 173 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR-----------NCLL 173 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHh-----------HEEE
Confidence 999999999999999998653 4889999999999999999999999 999999999 6666
Q ss_pred C---CCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 012164 298 D---DSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE 372 (469)
Q Consensus 298 ~---~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~ 372 (469)
+ .+..+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+
T Consensus 174 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 253 (327)
T 2yfx_A 174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253 (327)
T ss_dssp SCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH
Confidence 6 345699999999975433221 12233457889999999988889999999999999999998 999998776655
Q ss_pred HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 373 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
....+........ +..+++.+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 254 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 254 VLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHhcCCCCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 5555544433332 4567889999999999999999999999999999887653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=332.61 Aligned_cols=249 Identities=28% Similarity=0.401 Sum_probs=198.8
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCC--HHHHHHHHHHHHHHhcC---CCCceeeEEeEEEeCC-
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSS- 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~- 223 (469)
.+|+..+.||+|+||.||. +|+.||||.+....... ......+.+|+.+++++ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 3789999999999999884 57899999987432211 11113456677777666 4999999999998765
Q ss_pred ----ceEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 224 ----PMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 224 ----~~~lv~E~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
..++||||++ ++|.+++..... +++..+..++.|++.||.|||+.+ |+||||||+ ||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~-----------Nil~ 153 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPE-----------NILV 153 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTT-----------TEEE
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEEE
Confidence 4899999995 699999987654 999999999999999999999999 999999999 8888
Q ss_pred CCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~ 377 (469)
+.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 231 (308)
T 3g33_A 154 TSGGTVKLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231 (308)
T ss_dssp CTTSCEEECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred cCCCCEEEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 89999999999999865432 2234457899999999999889999999999999999999999999876655544443
Q ss_pred hhc-CCCCCC----------------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AAR-QRPPFK----------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~-~~~~~~----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... +.++.. ...+.+++.+.+||.+||+.||++|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 221 111100 0112467889999999999999999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=346.82 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=195.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC-----CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|...+.||+|+||.||. +++.||||.+...... .......+.+|+.++++++||||+++++++. .+..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence 688999999999999985 5789999998754322 1222335789999999999999999999985 4568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC---CCC
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD---SGN 302 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~---~~~ 302 (469)
++|||||++|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ |||++. ++.
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~-----------NIll~~~~~~~~ 280 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPE-----------NVLLSSQEEDCL 280 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEESSSSSSCC
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChH-----------hEEEecCCCcce
Confidence 999999999999999988888999999999999999999999999 999999999 666643 446
Q ss_pred eEEeecCCccccccCCCCCcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-HHHHHh
Q 012164 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYA 378 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-~~~~~~ 378 (469)
+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+.
T Consensus 281 ~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~ 358 (419)
T 3i6u_A 281 IKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358 (419)
T ss_dssp EEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH
T ss_pred EEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh
Confidence 999999999875432 22234678999999999864 577889999999999999999999998755443 334443
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.............+++.+.+||.+||+.||++|||+.++++|
T Consensus 359 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 333322222234678899999999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=321.88 Aligned_cols=251 Identities=25% Similarity=0.477 Sum_probs=205.0
Q ss_pred CCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe----C
Q 012164 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S 222 (469)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~ 222 (469)
.....|+..+.||+|+||.||. ++..||+|.+..... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 3444678888999999999985 567899999876543 34556789999999999999999999999875 3
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC-CCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD-DSG 301 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~-~~~ 301 (469)
..+++||||+++++|.+++...+.+++..+..++.|++.||.|||+.++ +++||||||+ ||+++ .++
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~-----------Nil~~~~~~ 169 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCD-----------NIFITGPTG 169 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGG-----------GEEESSTTS
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHH-----------HEEEECCCC
Confidence 4589999999999999999988889999999999999999999999862 4999999999 77776 788
Q ss_pred CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC
Q 012164 302 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 381 (469)
.+||+|||++..... .......|++.|+|||++.+ .++.++||||||+++|+|++|+.||................
T Consensus 170 ~~kl~Dfg~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (290)
T 1t4h_A 170 SVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245 (290)
T ss_dssp CEEECCTTGGGGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred CEEEeeCCCcccccc---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc
Confidence 999999999975432 22334568999999998875 68999999999999999999999998754433322222222
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+ ...+...++++.+||.+||+.||.+|||+.++++|
T Consensus 246 ~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 VKP-ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCc-cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 221 12234566889999999999999999999999976
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=336.46 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=197.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 223 (469)
.+|+..+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3789999999999999875 58899999986543 34555677899999999999999999999997653
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.+++||||+ +++|.+++.. +.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~ 167 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPG-----------NLAVNEDCEL 167 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTCCE
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHH-----------HEEEcCCCCE
Confidence 469999999 8899999986 56999999999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-cC
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQ 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~~ 381 (469)
||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.. .+
T Consensus 168 kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 168 KILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp EECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEEeeeccccccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999986542 2234578999999999877 6889999999999999999999999987654333322211 11
Q ss_pred C--------------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 R--------------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~--------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
. ..+......+++.+.+||.+||..||++|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 1 11111223567899999999999999999999999997
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=339.37 Aligned_cols=246 Identities=28% Similarity=0.488 Sum_probs=205.8
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|..||+|.+... ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3788999999999999985 4789999998754 24556678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+++++|.+++...+.+++..+..++.|++.||.|||+. + |+||||||+ ||+++.++.+||+||
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~-----------Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPS-----------NILVNSRGEIKLCDF 176 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGG-----------GEEECTTCCEEECCC
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHH-----------HEEECCCCCEEEEEC
Confidence 9999999999999888899999999999999999999995 7 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh----------
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---------- 378 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~---------- 378 (469)
|++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.
T Consensus 177 g~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 177 GVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp CCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred CCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 999755322 1233568999999999999999999999999999999999999997654332211110
Q ss_pred -------------------------------hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 -------------------------------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 -------------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... .....+...++.++.+||.+||+.||++|||++++++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE-PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------------------CCCHHHHHHHHHHS-CCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhcc-CCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 011 11112234578899999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=334.86 Aligned_cols=255 Identities=29% Similarity=0.515 Sum_probs=207.2
Q ss_pred CcccccceeeecCeEEEEEE---------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEE--eC
Q 012164 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QS 222 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~ 222 (469)
..+|+..+.||+|+||.||. +++.||||.+... .....+.+.+|++++++++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 34788999999999999873 5688999998754 3455677999999999999999999999986 34
Q ss_pred CceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
...++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+ ||+++.++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~-----------NIl~~~~~ 164 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAAR-----------NILVESEA 164 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEEEETT
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChh-----------hEEECCCC
Confidence 568999999999999999986 445999999999999999999999999 999999999 88888899
Q ss_pred CeEEeecCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--------
Q 012164 302 NLKVADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------- 371 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-------- 371 (469)
.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 165 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 244 (327)
T 3lxl_A 165 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244 (327)
T ss_dssp EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence 9999999999876433211 223345788899999998888899999999999999999999998643221
Q ss_pred -------cHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 372 -------EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 372 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.....+......+ .+..+++.+.+||.+||+.||++|||+.+++++|+.+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 245 RDVPALSRLLELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp --CCHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred cccccHHHHHHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0111111121222 24567899999999999999999999999999999987663
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=331.19 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=197.4
Q ss_pred cccccceeeecCeEEEEEE-----ec-------eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 012164 155 LDFTNSVEITKGTFILAFW-----RG-------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g-------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 222 (469)
.+|+..+.||+|+||.||. ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3788899999999999874 22 569999986542 23346789999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
+..++||||+++++|.+++...+. +++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~-----------NIll~~~~ 150 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAK-----------NILLIREE 150 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEEEECC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcc-----------eEEEecCC
Confidence 999999999999999999987654 999999999999999999999999 999999999 55555555
Q ss_pred C--------eEEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCC
Q 012164 302 N--------LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG-CPPFTMKHDN 371 (469)
Q Consensus 302 ~--------vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg-~~p~~~~~~~ 371 (469)
. +||+|||++...... ....+++.|+|||++.+ ..++.++||||||+++|+|++| .+||......
T Consensus 151 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~ 225 (289)
T 4fvq_A 151 DRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225 (289)
T ss_dssp BGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred cccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence 4 999999998654321 22346788999999987 6789999999999999999995 5555443332
Q ss_pred cHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 372 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
........ .... +...++++.+||.+||+.||++|||+.+++++|+++.++.
T Consensus 226 ~~~~~~~~--~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 226 RKLQFYED--RHQL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHHHHHHT--TCCC---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred HHHHHhhc--cCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 22222222 1111 2234667999999999999999999999999999987763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=366.33 Aligned_cols=246 Identities=27% Similarity=0.416 Sum_probs=211.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.||. +|+.||||++.+.........+.+..|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 688899999999999885 5778999998754322223346678899999988 6999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++|+|.+++...+.+++..+..++.||+.||+|||+.+ |+||||||+ |||++.++.+||+|||
T Consensus 422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~-----------NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLD-----------NVMLDSEGHIKIADFG 487 (674)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCST-----------TEEECSSSCEEECCCT
T ss_pred eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChh-----------hEEEcCCCcEEEeecc
Confidence 99999999999998888999999999999999999999999 999999999 8888999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.... ..+ +
T Consensus 488 la~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~---p 562 (674)
T 3pfq_A 488 MCKENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAY---P 562 (674)
T ss_dssp TCEECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCC---C
T ss_pred eeeccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCC---C
Confidence 99864322 223345679999999999999999999999999999999999999999877666666664432 222 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCH-----HHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTF-----RQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~-----~~ll~~ 420 (469)
..+++++.+||.+||+.||++||++ ++|++|
T Consensus 563 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 4678999999999999999999997 777765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=336.21 Aligned_cols=247 Identities=23% Similarity=0.405 Sum_probs=194.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+..... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 688899999999999985 578899999864421 1112245579999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|++ |+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~-----------NIl~~~~~~~kl~Dfg 145 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQ-----------NLLINERGELKLADFG 145 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGG-----------GEEECTTCCEEECSSS
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHH-----------HEEECCCCCEEEccCc
Confidence 996 69999988754 4899999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFKA 387 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~ 387 (469)
+++..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+... +.+....
T Consensus 146 ~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 146 LARAKSIP-TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224 (324)
T ss_dssp EEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccCC-ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHh
Confidence 99765432 222234567999999999876 57899999999999999999999999876655444333221 1111000
Q ss_pred -------------------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 -------------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 -------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+++++.+||.+||+.||++|||++++++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 012457889999999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=348.16 Aligned_cols=246 Identities=13% Similarity=0.147 Sum_probs=195.3
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHH---HHhcCCCCceeeEE-------eE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA---LLQKIRHPNVVQFL-------GA 218 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~~i~~~~-------~~ 218 (469)
..+|+..+.||+|+||.||. +|+.||||++...........+.+.+|+. .+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788999999999999884 58899999997654444556678999994 55555799999998 66
Q ss_pred EEeCC-----------------ceEEEEeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCCe
Q 012164 219 VTQSS-----------------PMMIVTEYLPKGDLRAFLKRKGALKP-------STAVRFALDIARGMNYLHENKPVPI 274 (469)
Q Consensus 219 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~l~~-------~~~~~i~~qi~~~L~~LH~~~~~~i 274 (469)
+.+.+ ..++||||+ +|+|.+++...+.+++ ..++.++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 288999999 6899999987555555 788889999999999999999 9
Q ss_pred EecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-----------CCC
Q 012164 275 IHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----------EYD 343 (469)
Q Consensus 275 vH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~ 343 (469)
+||||||+ |||++.++.+||+|||+++.... ......| +.|+|||++.+. .++
T Consensus 228 vHrDikp~-----------NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~ 291 (377)
T 3byv_A 228 VHTYLRPV-----------DIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMT 291 (377)
T ss_dssp ECSCCCGG-----------GEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC
T ss_pred ecCCCCHH-----------HEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCC
Confidence 99999999 88888999999999999986332 2234556 899999999887 899
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--H
Q 012164 344 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--L 421 (469)
Q Consensus 344 ~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L 421 (469)
.++|||||||++|+|++|+.||...........+.. ....+++++.+||.+||+.||++|||+.++++| +
T Consensus 292 ~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 292 FSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred hhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 999999999999999999999986654443322211 123567889999999999999999999999975 4
Q ss_pred HHHHhh
Q 012164 422 ESINNS 427 (469)
Q Consensus 422 ~~~~~~ 427 (469)
+.+.+.
T Consensus 364 ~~~~~~ 369 (377)
T 3byv_A 364 EQLRTE 369 (377)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 444433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.89 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=200.0
Q ss_pred cccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC--CCCceeeEEeEEEeC----Cce
Q 012164 155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQS----SPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~ 225 (469)
.+|+..+.||+|+||.||. +|+.||||++.... ...+..|.+++..+ +||||+++++++... ...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3789999999999998874 78999999985431 13344566666555 899999999999877 678
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEecCCCCCcccccccccCcceee
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN--------KPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
++||||+++|+|.++++.. .+++..++.++.|++.||.|||+. + |+||||||+ ||++
T Consensus 111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~-----------Nill 175 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSK-----------NILV 175 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGG-----------GEEE
T ss_pred EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchH-----------HEEE
Confidence 9999999999999999764 699999999999999999999998 7 999999999 8888
Q ss_pred CCCCCeEEeecCCccccccCCCCC---cccCCCCCcccCCcccCCCCCCCc------hhHHHHHHHHHHHHhC-------
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDRP---LTCQDTSCRYVAPEVFKNEEYDTK------VDVFSFALILQEMIEG------- 361 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDi~SlGvil~el~tg------- 361 (469)
+.++.+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|+|++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 899999999999997654332211 124578999999999988766655 9999999999999999
Q ss_pred ---CCCCCCCCCCc-----HHHHHhhcC-CCCCCC--ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 362 ---CPPFTMKHDNE-----VPKAYAARQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 362 ---~~p~~~~~~~~-----~~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
+.||....... ......... .+.... ....+++.+.+||.+||+.||++|||+.+++++|+.+.++.+
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 67776543222 111111111 222211 123678899999999999999999999999999999988754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=339.59 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=196.1
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-----Cc
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 224 (469)
.+|+..+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 3799999999999999985 57899999997542 3455567889999999999999999999999766 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.+ |+||||||+ |||++.++.+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~-----------NILl~~~~~~k 169 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPA-----------NCLLNQDCSVK 169 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTCCEE
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHH-----------HeEECCCCCEE
Confidence 899999995 699999998888999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCC---------------------CCcccCCCCCcccCCccc-CCCCCCCchhHHHHHHHHHHHHhCC
Q 012164 305 VADFGVSKLLTVKED---------------------RPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGC 362 (469)
Q Consensus 305 l~Dfgla~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDi~SlGvil~el~tg~ 362 (469)
|+|||+++....... .......||+.|+|||++ .+..++.++|||||||++|||++|.
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 999999987643221 112456789999999986 5567999999999999999999854
Q ss_pred CC-----------CCCCCCCc------------------H----------------------HHHHhhcCCCCCCC----
Q 012164 363 PP-----------FTMKHDNE------------------V----------------------PKAYAARQRPPFKA---- 387 (469)
Q Consensus 363 ~p-----------~~~~~~~~------------------~----------------------~~~~~~~~~~~~~~---- 387 (469)
.| |.+.+... + ...+..........
T Consensus 250 ~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (432)
T 3n9x_A 250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ 329 (432)
T ss_dssp TTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred cccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHH
Confidence 44 43322100 0 00000000000000
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+.+++++.+||.+||..||++|||++++++|
T Consensus 330 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 330 KYPSISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 113568899999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=325.22 Aligned_cols=256 Identities=16% Similarity=0.228 Sum_probs=203.8
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEE-EeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 228 (469)
.+|+..+.||+|+||.||. +|+.||||.+..... ...+.+|+.+++.++|++++..+..+ ......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3688999999999999874 578999998654322 23578899999999987777665555 666788999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee---CCCCCeE
Q 012164 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR---DDSGNLK 304 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~---~~~~~vk 304 (469)
|||+ +++|.+++.. .+.+++..+..++.|++.||.|||+++ |+||||||+ ||++ +.++.+|
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~-----------NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPD-----------NFLMGLGKKGNLVY 148 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECCGGGTTCEE
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HeeeeccCCCCeEE
Confidence 9999 8999999985 456999999999999999999999999 999999999 7777 6788999
Q ss_pred EeecCCccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH---HH
Q 012164 305 VADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---PK 375 (469)
Q Consensus 305 l~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~---~~ 375 (469)
|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ ..
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence 999999987654322 122345789999999999999999999999999999999999999987554332 22
Q ss_pred HHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 376 AYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 376 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
.+.... ..+.......+++.+.+||.+||+.||++|||++++++.|+.+......
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 229 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 221111 1111111245678999999999999999999999999999999888654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=328.07 Aligned_cols=257 Identities=26% Similarity=0.461 Sum_probs=201.4
Q ss_pred CcccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 154 ELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
..+|+..+.||+|+||.||.. +..||+|.+...........+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 347899999999999987741 2369999988665445566788999999999999999999999998654 8
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++|+||+++++|.+++... +.+++..+..++.|++.||.|||+++ ++|+||||+ ||+++.++.+|
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~-----------Nili~~~~~~k 161 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAAR-----------NLLLATRDLVK 161 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEEEETTEEE
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchh-----------eEEEcCCCCEE
Confidence 9999999999999999764 56999999999999999999999999 999999999 88888889999
Q ss_pred EeecCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 305 VADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
|+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 9999999876433221 1223457788999999988888999999999999999999 999998776655555543332
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
... ..+..+++.+.++|.+||..||++|||+.+++++|+.+...
T Consensus 242 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 ERL--PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCC--CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 211 22456789999999999999999999999999999988654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=323.02 Aligned_cols=256 Identities=16% Similarity=0.227 Sum_probs=206.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEE-EeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 228 (469)
.+|+..+.||+|+||.||. +|+.||||.+...... +.+.+|+.+++.++|++++..+..+ ......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 3788999999999999874 5889999988654322 3588899999999988766655554 566778999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee---CCCCCeE
Q 012164 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR---DDSGNLK 304 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~---~~~~~vk 304 (469)
|||+ +++|.+++.. .+.+++..+..++.|++.||.|||+++ |+||||||+ ||++ +.++.+|
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~-----------NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPD-----------NFLMGLGKKGNLVY 148 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEECCGGGTTCEE
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHH-----------HeEEecCCCCCeEE
Confidence 9999 8999999984 456999999999999999999999999 999999999 6666 4778999
Q ss_pred EeecCCccccccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC---cHHH
Q 012164 305 VADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---EVPK 375 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~---~~~~ 375 (469)
|+|||++......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... +...
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence 9999999876543221 123457899999999999999999999999999999999999999875433 2222
Q ss_pred HHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 376 AYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 376 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
.+.... ..+.......+++.+.+|+.+||+.||++|||+.++++.|+.+......
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 229 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 222211 1111111245678999999999999999999999999999999888654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=324.75 Aligned_cols=246 Identities=25% Similarity=0.442 Sum_probs=202.7
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.||. +|+.||+|.+.... ..+.+.+|+.++++++||||+++++++......++|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34788999999999999875 48899999987542 125688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~~~~kl~d 168 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAG-----------NILLNTEGHAKLAD 168 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTCCEEECC
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHH-----------HEEECCCCCEEEee
Confidence 999999999999974 567999999999999999999999999 999999999 88888899999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+... ..+...
T Consensus 169 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 246 (314)
T 3com_A 169 FGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFR 246 (314)
T ss_dssp CTTCEECBTTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCS
T ss_pred cccchhhhhhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-CCcccC
Confidence 99997654322 1223456899999999999989999999999999999999999999865543333333222 222223
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 456678999999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=327.09 Aligned_cols=247 Identities=30% Similarity=0.501 Sum_probs=209.6
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
..|+..+.||+|+||.||. +|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3588899999999999885 478999999875532 233577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++++|.+++.. +.+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++.++.+||+|||
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAA-----------NVLLSEHGEVKLADFG 164 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTSCEEECCCT
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChh-----------eEEECCCCCEEEeecc
Confidence 99999999999975 56999999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++....... .......+++.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....+. ..
T Consensus 165 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 240 (303)
T 3a7i_A 165 VAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LE 240 (303)
T ss_dssp TCEECBTTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CC
T ss_pred cceecCccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---Cc
Confidence 997755332 22234568999999999999899999999999999999999999998765544444443333322 23
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
..++..+.+||.+||..||++|||+.+++++..
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 467889999999999999999999999998844
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=329.24 Aligned_cols=260 Identities=26% Similarity=0.447 Sum_probs=191.2
Q ss_pred ccCCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEe-
Q 012164 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ- 221 (469)
Q Consensus 149 ~~~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~- 221 (469)
.+.....+|+..+.||+|+||.||. +|+.||+|.+... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 3444456899999999999999875 6789999988543 3455677899999999996 9999999999942
Q ss_pred -------CCceEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc
Q 012164 222 -------SSPMMIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291 (469)
Q Consensus 222 -------~~~~~lv~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~ 291 (469)
....+++|||++ |+|.+++.. .+.+++..++.++.||+.||.|||+.++ +|+||||||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~--------- 167 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVE--------- 167 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGG---------
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcc---------
Confidence 344899999994 799998865 4569999999999999999999999852 4999999999
Q ss_pred CcceeeCCCCCeEEeecCCccccccCCCCC-----------cccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHH
Q 012164 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRP-----------LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQE 357 (469)
Q Consensus 292 ~~nil~~~~~~vkl~Dfgla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDi~SlGvil~e 357 (469)
||+++.++.+||+|||+++......... .....+|+.|+|||++ .+..++.++||||||+++|+
T Consensus 168 --NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~e 245 (337)
T 3ll6_A 168 --NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245 (337)
T ss_dssp --GCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHH
T ss_pred --cEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHH
Confidence 8888889999999999998765332111 1134589999999998 56678899999999999999
Q ss_pred HHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 358 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 358 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
|++|+.||............ ... ......+..+.+||.+||+.||++|||+.+++++|+.+......
T Consensus 246 l~~g~~p~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 246 LCFRQHPFEDGAKLRIVNGK---YSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp HHHSSCCC---------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred HHhCCCCCcchhHHHhhcCc---ccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 99999999765443322211 111 11234556789999999999999999999999999999877443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=329.35 Aligned_cols=256 Identities=21% Similarity=0.376 Sum_probs=204.3
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe----CCc
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSP 224 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~ 224 (469)
..+|+..+.||+|+||.||. +|+.||||.+... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34799999999999999874 5789999988643 34566789999999999999999999999863 346
Q ss_pred eEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 225 MMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
.++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+ ||+++.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~-----------NIl~~~~ 170 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPT-----------NILLGDE 170 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTT
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH-----------HEEEcCC
Confidence 8999999999999999975 456999999999999999999999999 999999999 8888899
Q ss_pred CCeEEeecCCccccccCCCCC--------cccCCCCCcccCCcccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCC-
Q 012164 301 GNLKVADFGVSKLLTVKEDRP--------LTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMK- 368 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~sDi~SlGvil~el~tg~~p~~~~- 368 (469)
+.+||+|||++.......... .....|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 171 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 250 (317)
T 2buj_A 171 GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250 (317)
T ss_dssp SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHH
T ss_pred CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhh
Confidence 999999999987543211100 01234688999999987653 688999999999999999999999642
Q ss_pred -CCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 369 -HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
...............+ ....+++.+.+||.+||+.||.+|||+.+++++|+.+.....
T Consensus 251 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 251 QKGDSVALAVQNQLSIP---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HTTSCHHHHHHCC--CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred cccchhhHHhhccCCCC---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 1222333332221211 234678899999999999999999999999999998865543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=330.74 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=197.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC-----CHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|+..+.||+|+||.||. +|+.||||.+...... .......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 688899999999999985 4789999998754321 1222345889999999999999999999987654 8
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC---C
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG---N 302 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~---~ 302 (469)
++||||+++++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+ ||+++.++ .
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~-----------NIl~~~~~~~~~ 155 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPE-----------NVLLSSQEEDCL 155 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEESSSSSSCC
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH-----------HEEEecCCCCCe
Confidence 999999999999999988888999999999999999999999999 999999999 66666544 4
Q ss_pred eEEeecCCccccccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-cHHHHHh
Q 012164 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYA 378 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-~~~~~~~ 378 (469)
+||+|||++...... .......|++.|+|||++. +..++.++||||||+++|+|++|+.||...... .....+.
T Consensus 156 ~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 233 (322)
T 2ycf_A 156 IKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233 (322)
T ss_dssp EEECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH
T ss_pred EEEccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH
Confidence 999999999865422 1112345889999999973 557889999999999999999999999876554 3333343
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.............+++.+.+||.+||..||++|||+.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 332222222234578899999999999999999999999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=336.27 Aligned_cols=258 Identities=16% Similarity=0.219 Sum_probs=198.1
Q ss_pred CcccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHH--------HHHHHHHHHHHhcCCCCceeeEEe
Q 012164 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDR--------VRAFRDELALLQKIRHPNVVQFLG 217 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~ 217 (469)
..+|+..+.||+|+||.||. ++..||+|.+.......... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 34799999999999998874 56789999887542111111 123567889999999999999999
Q ss_pred EEEe----CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCc
Q 012164 218 AVTQ----SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR 293 (469)
Q Consensus 218 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ 293 (469)
++.. ....++||||+ +++|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~----------- 180 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAA----------- 180 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHH-----------
Confidence 9987 67899999999 9999999988778999999999999999999999999 999999999
Q ss_pred ceeeCCCC--CeEEeecCCccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 012164 294 NILRDDSG--NLKVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 365 (469)
Q Consensus 294 nil~~~~~--~vkl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~ 365 (469)
||+++.++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 77777666 999999999986643221 1113457899999999999988999999999999999999999999
Q ss_pred CCCCCCcHHHH-HhhcCCCCCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 366 TMKHDNEVPKA-YAARQRPPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 366 ~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
........... ........... ....+++++.+||..||..||++|||+.++++.|+.+.-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 261 EQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp GGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 65433322111 11111111110 011577899999999999999999999999999987644
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.54 Aligned_cols=254 Identities=15% Similarity=0.215 Sum_probs=205.9
Q ss_pred CcccccceeeecCeEEEEEE-------------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceee------
Q 012164 154 ELDFTNSVEITKGTFILAFW-------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ------ 214 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-------------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~------ 214 (469)
..+|+..+.||+|+||.||. .++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 45899999999999999884 2789999998644 35788999999999999887
Q ss_pred ---------EEeEEEe-CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012164 215 ---------FLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (469)
Q Consensus 215 ---------~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 282 (469)
+++++.. ....++||||+ +++|.+++... +.+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 6777776 67889999999 99999999875 67999999999999999999999999 999999999
Q ss_pred cccccccccCcceeeCCCC--CeEEeecCCccccccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHH
Q 012164 283 DLYVAYWQNDRNILRDDSG--NLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 354 (469)
Q Consensus 283 Nil~~~~~~~~nil~~~~~--~vkl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvi 354 (469)
||+++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||++
T Consensus 189 -----------NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 257 (352)
T 2jii_A 189 -----------NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYC 257 (352)
T ss_dssp -----------GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred -----------HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHH
Confidence 77778887 8999999999866533211 1133478999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCCCc--HHHHHh--hcCCCCCC---CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 355 LQEMIEGCPPFTMKHDNE--VPKAYA--ARQRPPFK---APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 355 l~el~tg~~p~~~~~~~~--~~~~~~--~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+|+|++|+.||....... +..... ......+. .....+++.+.+||.+||+.||++|||++++++.|+.+.+.
T Consensus 258 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 258 MLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 999999999998764222 111111 11111111 11235688999999999999999999999999999999888
Q ss_pred hhc
Q 012164 428 INH 430 (469)
Q Consensus 428 ~~~ 430 (469)
...
T Consensus 338 ~~~ 340 (352)
T 2jii_A 338 LRV 340 (352)
T ss_dssp TTC
T ss_pred cCC
Confidence 653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=334.55 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=192.6
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 223 (469)
.+|+..+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3789999999999999875 47899999987543 34555677889999999999999999999997654
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~-----------NIl~~~~~~~ 166 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS-----------NIVVKSDCTL 166 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTSCE
T ss_pred ceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHH-----------HEEEcCCCCE
Confidence 6899999995 58988886 35899999999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC-
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR- 382 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~- 382 (469)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 167 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 167 KILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp EECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEEeecccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999865422 222345789999999999998999999999999999999999999987654333322221110
Q ss_pred --------------------CCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 --------------------PPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 --------------------~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+... ......++.+.+||.+||..||++|||++++++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 0012236789999999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=333.50 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=198.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------- 222 (469)
.+|+..+.||+|+||.||. +|+.||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4799999999999998874 5789999988654332 22234677899999999999999999999773
Q ss_pred -CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 223 -SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 223 -~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
+..++||||++ ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~-----------NIl~~~~ 160 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAA-----------NVLITRD 160 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTT
T ss_pred CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHH-----------HEEEcCC
Confidence 46899999996 5887777653 56999999999999999999999999 999999999 8888899
Q ss_pred CCeEEeecCCccccccCC---CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 301 GNLKVADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
+.+||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 240 (351)
T 3mi9_A 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240 (351)
T ss_dssp SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 999999999998654322 122234568999999999876 4679999999999999999999999987665444433
Q ss_pred Hhhc-CCCCCC--CCh-------------------------hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 377 YAAR-QRPPFK--APA-------------------------KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 377 ~~~~-~~~~~~--~~~-------------------------~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+... +..+.. ... ...++.+.+||.+||+.||++|||++++++|
T Consensus 241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 3221 111100 000 0125679999999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=332.97 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=197.7
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCC--HHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
..+|+..+.||+|+||.||. +|+.||||.+....... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 34788999999999999985 47899999987543211 111246788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
+||||++ ++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||
T Consensus 89 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~-----------Nil~~~~~~~kl 153 (346)
T 1ua2_A 89 LVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPN-----------NLLLDENGVLKL 153 (346)
T ss_dssp EEEECCS-EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTCCEEE
T ss_pred EEEEcCC-CCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHH-----------HEEEcCCCCEEE
Confidence 9999996 49999987653 5899999999999999999999999 999999999 888889999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CCC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP 383 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~ 383 (469)
+|||+++..... ........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+... +.+
T Consensus 154 ~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 154 ADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp CCCGGGSTTTSC-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EecccceeccCC-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999999875432 2223445789999999998764 5888999999999999999999999876654444333221 111
Q ss_pred CCC------------------C-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFK------------------A-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~------------------~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... . ....+++++.+||.+||..||++|||+.++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0 013456889999999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=334.05 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=201.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||+|.+.... ......+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 789999999999998874 47899999986543 344555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~-----------Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPE-----------NILVSQSGVVKLCDFGF 170 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTSCEEECCCTT
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChh-----------eEEEcCCCcEEEEeCCC
Confidence 9999999998887778999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-C-------
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-Q------- 381 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~------- 381 (469)
+....... .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+... +
T Consensus 171 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 171 ARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp C-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceeecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 97654322 222345689999999999875 7889999999999999999999999876544333222110 0
Q ss_pred -------------CCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 -------------RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 -------------~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+... ...+.+++.+.+||.+||+.||++|||+.++++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0112567899999999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.82 Aligned_cols=250 Identities=19% Similarity=0.337 Sum_probs=197.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|+..+.||+|+||.||. +|+.||+|.+....... .....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 688899999999999885 58999999987654433 3446778899999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccC--------cceee
Q 012164 230 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND--------RNILR 297 (469)
Q Consensus 230 E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~--------~nil~ 297 (469)
||+++++|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+||++...... .....
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999864 66999999999999999999999999 9999999995555321100 00000
Q ss_pred CCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
+....+||+|||++...... ....+++.|+|||++.+. .++.++||||||+++|+|++|.+|+... .....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~ 239 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHE 239 (289)
T ss_dssp --CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHHH
T ss_pred CCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHHH
Confidence 14457999999999875432 224589999999999875 5667999999999999999998877533 22333
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.....+. .+..+++.+.+||.+||+.||++|||+.++++|
T Consensus 240 ~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 240 IRQGRLPR---IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHTTCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHcCCCCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 32332322 245678899999999999999999999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=356.65 Aligned_cols=253 Identities=24% Similarity=0.468 Sum_probs=210.7
Q ss_pred cccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
.+|+..+.||+|+||.||.. +..||+|.+... ......+.+.+|+.++++++||||+++++++. .+..+
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 46888899999999998741 457999988643 34555678999999999999999999999985 46789
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
+||||+++|+|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+ |||++.++.+||
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~-----------NILl~~~~~vkL 532 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAAR-----------NVLVSSNDCVKL 532 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEEEETTEEEE
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchH-----------hEEEeCCCCEEE
Confidence 9999999999999998654 5899999999999999999999999 999999999 888888999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
+|||+++..............+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+....+.+
T Consensus 533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~ 612 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612 (656)
T ss_dssp CCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC
T ss_pred EecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999998765433323333456789999999988899999999999999999997 999998877666666555544443
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
. +..+++.+.+||.+||..||++|||+.++++.|+.+...
T Consensus 613 ~---~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 613 M---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C---CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 3 356788999999999999999999999999999999765
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=327.01 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=205.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe--CCceEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMI 227 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 227 (469)
.+|+..+.||+|+||.||. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4788999999999998875 578999999876543 34556789999999999999999999998854 567899
Q ss_pred EEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 228 VTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENK--PVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ..+++||||||+ ||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~-----------NIl~~~~~ 153 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA-----------NVFLDGKQ 153 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGG-----------GEEECSSS
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchh-----------hEEEcCCC
Confidence 99999999999999753 34999999999999999999999975 123999999999 88888999
Q ss_pred CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC
Q 012164 302 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 381 (469)
.+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+....
T Consensus 154 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~ 232 (279)
T 2w5a_A 154 NVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232 (279)
T ss_dssp CEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CEEEecCchheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence 99999999997654221 11123457889999999998889999999999999999999999998776555555554443
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~ 422 (469)
.+.. +..+++++.++|.+||+.||++|||+.++++++.
T Consensus 233 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 FRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cccC---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 3332 3467889999999999999999999999998753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=322.85 Aligned_cols=247 Identities=26% Similarity=0.437 Sum_probs=205.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||+|.+....... ...+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 788999999999999885 57899999986543322 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC---CCCeEEee
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD---SGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~---~~~vkl~D 307 (469)
|+++++|.+++...+.+++..++.++.||+.||.|||+.+ ++|+||||+ ||+++. ++.+||+|
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~-----------NIlv~~~~~~~~~kL~D 167 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPE-----------NILLESKEKDCDIKIID 167 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEESCSSTTCCEEECS
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChh-----------hEEEecCCCcccEEEec
Confidence 9999999999988788999999999999999999999999 999999999 666644 45799999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||++....... ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+....+..........
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 168 FGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (287)
T ss_dssp TTGGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred cCcceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch
Confidence 99997654322 1222347889999999876 58899999999999999999999998776655555554433322222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+++++.+||.+||..||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 335678999999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.67 Aligned_cols=255 Identities=26% Similarity=0.517 Sum_probs=207.8
Q ss_pred CcccccceeeecCeEEEEEE---------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC-
Q 012164 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 223 (469)
..+|+..+.||+|+||.|+. +|+.||+|.+... .....+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 44788899999999999873 4789999998753 3455678999999999999999999999986643
Q ss_pred -ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 224 -PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 224 -~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+ ||+++.++
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~-----------NIli~~~~ 182 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATR-----------NILVENEN 182 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEEEETT
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcc-----------eEEEcCCC
Confidence 789999999999999999875 45999999999999999999999999 999999999 88888889
Q ss_pred CeEEeecCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----------
Q 012164 302 NLKVADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH---------- 369 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~---------- 369 (469)
.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 183 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~ 262 (326)
T 2w1i_A 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262 (326)
T ss_dssp EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT
T ss_pred cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc
Confidence 9999999999876533211 1223456778999999988888999999999999999999999986321
Q ss_pred CC-c-----HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 370 DN-E-----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 370 ~~-~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.. . +...+....+.+ .+..+++++.+||.+||+.||++|||+.++++.|+.+...+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 263 KQGQMIVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp CCTHHHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhhhHHHHHHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11 1 111111222222 24567889999999999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=339.36 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=205.8
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC--ceE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 226 (469)
..+|+..+.||+|+||.||. +|+.||||++...... ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 34789999999999999985 4889999998754321 22466788999999999999999999998765 689
Q ss_pred EEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee----CC
Q 012164 227 IVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR----DD 299 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~----~~ 299 (469)
+|||||++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+ ||++ +.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~-----------NIll~~~~~~ 151 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPG-----------NIMRVIGEDG 151 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEEEECTTS
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHH-----------HEEEeecCCC
Confidence 9999999999999997643 3999999999999999999999999 999999999 6665 56
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 371 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~ 371 (469)
++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 152 ~~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 152 QSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp CEEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred ceeEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 6779999999998754332 2234568999999999864 46678999999999999999999999754332
Q ss_pred c----HHHHHhhcCCC---------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012164 372 E----VPKAYAARQRP---------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 372 ~----~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~ 426 (469)
. ....+...... ........++..+.+++.+||+.||++|||++++++.++.++.
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 2 22222222111 1111235678899999999999999999999999999999977
Q ss_pred h
Q 012164 427 S 427 (469)
Q Consensus 427 ~ 427 (469)
.
T Consensus 310 ~ 310 (396)
T 4eut_A 310 R 310 (396)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=335.73 Aligned_cols=247 Identities=12% Similarity=0.104 Sum_probs=184.6
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC--CCCceeeEE-------eEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFL-------GAVT 220 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~-------~~~~ 220 (469)
.+|+..+.||+|+||.||. +|+.||||++...........+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4588999999999999875 5789999999876554556667788885544444 699988755 5554
Q ss_pred eCC-----------------ceEEEEeccCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeEe
Q 012164 221 QSS-----------------PMMIVTEYLPKGDLRAFLKRK-GALKPSTA------VRFALDIARGMNYLHENKPVPIIH 276 (469)
Q Consensus 221 ~~~-----------------~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~------~~i~~qi~~~L~~LH~~~~~~ivH 276 (469)
..+ .+++|||||+ |+|.+++... ..++...+ ..++.||+.||+|||+++ |+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 332 3799999997 8999999864 33555555 678899999999999999 999
Q ss_pred cCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHH
Q 012164 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALI 354 (469)
Q Consensus 277 ~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~SlGvi 354 (469)
|||||+ |||++.++.+||+|||+++..... .....+++.|+|||++.+ ..++.++|||||||+
T Consensus 218 rDikp~-----------NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 218 GHFTPD-----------NLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp TTCSGG-----------GEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred CcCCHH-----------HEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 999999 888889999999999999865422 113446699999999987 689999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcHHHH-----HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 355 LQEMIEGCPPFTMKHDNEVPKA-----YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 355 l~el~tg~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+|+|++|+.||........... ...............+++.+.+||.+||+.||++|||+.++++|
T Consensus 283 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999987643321100 00001111111234678999999999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.98 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=203.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-----Cc
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 224 (469)
.+|+..+.||+|+||.||. +++.||||++... ......+.+.+|+.++++++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4799999999999999975 5789999998743 3455567889999999999999999999999654 36
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
.++||||++ ++|.+++.. +.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+|
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~-----------NIl~~~~~~~k 168 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPS-----------NLLLNTTCDLK 168 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTCCEE
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChH-----------hEEECCCCCEE
Confidence 899999995 699999976 45999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCC--CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC
Q 012164 305 VADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 305 l~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 381 (469)
|+|||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+....
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 248 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHH
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHh
Confidence 999999986653322 11244578999999998654 458999999999999999999999998876655544432110
Q ss_pred -CC----------------------CCCC----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 -RP----------------------PFKA----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 -~~----------------------~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+ .... ....+++++.+||.+||+.||++|||+.++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 10 0000 113467889999999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=331.59 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=194.5
Q ss_pred cccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHH--HhcCCCCceeeEEeEEEe-----CCc
Q 012164 155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELAL--LQKIRHPNVVQFLGAVTQ-----SSP 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~i~~~~~~~~~-----~~~ 224 (469)
.+|+..+.||+|+||.||. +|+.||||++.... ...+..|.++ +..++||||+++++.+.. ...
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred HHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 3788899999999999874 68999999986432 1334444444 445899999999986643 235
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCcccccccccCcce
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN---------KPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
+++|||||++|+|.+++.... .++..+..++.||+.||.|||+. + |+||||||+ ||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~-----------Ni 151 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSR-----------NV 151 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGG-----------GE
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccc-----------eE
Confidence 789999999999999997654 58899999999999999999999 8 999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCC-------CCcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHhC
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKED-------RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIEG 361 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDi~SlGvil~el~tg 361 (469)
|++.++.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 152 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 888899999999999986543211 11224568999999999987 3556789999999999999999
Q ss_pred CCCCCCCCC-CcH-----------------HHHHhh-cCCCCCCC---ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 012164 362 CPPFTMKHD-NEV-----------------PKAYAA-RQRPPFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIIT 419 (469)
Q Consensus 362 ~~p~~~~~~-~~~-----------------~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~ 419 (469)
+.||..... .+. ...... ..++.++. ....+++.+.+||.+||+.||++|||++++++
T Consensus 232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 776643222 110 001111 11222221 22346778999999999999999999999999
Q ss_pred HHHHHHhhhh
Q 012164 420 RLESINNSIN 429 (469)
Q Consensus 420 ~L~~~~~~~~ 429 (469)
.|+.+.....
T Consensus 312 ~L~~ll~~~~ 321 (336)
T 3g2f_A 312 RMAELMMIWE 321 (336)
T ss_dssp HHHHHHHCCC
T ss_pred HHHHHHHHHH
Confidence 9999987744
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=328.01 Aligned_cols=253 Identities=16% Similarity=0.211 Sum_probs=205.6
Q ss_pred ccCCCCcccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC---CCceeeE
Q 012164 149 EIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQF 215 (469)
Q Consensus 149 ~~~~~~~~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~ 215 (469)
++.....+|++.+.||+|+||.||.. ++.||+|++.... ...+..|++++++++ |+||+++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 44445568999999999999998853 6789999987542 245777888888886 9999999
Q ss_pred EeEEEeCCceEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccc
Q 012164 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQ 290 (469)
Q Consensus 216 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~ 290 (469)
++++...+..++|||||++|+|.+++.. .+.+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~-------- 201 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPD-------- 201 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGG--------
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHH--------
Confidence 9999999999999999999999999974 456999999999999999999999999 999999999
Q ss_pred cCcceeeCC-----------CCCeEEeecCCccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHH
Q 012164 291 NDRNILRDD-----------SGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 358 (469)
Q Consensus 291 ~~~nil~~~-----------~~~vkl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el 358 (469)
|||++. ++.+||+|||+|+...... ........||+.|+|||++.+..++.++|||||||++|+|
T Consensus 202 ---NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 278 (365)
T 3e7e_A 202 ---NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278 (365)
T ss_dssp ---GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHH
T ss_pred ---HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHH
Confidence 555555 7899999999997654222 2223446799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCC-CCHHHHHHHHHHHHhhhh
Q 012164 359 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR-PTFRQIITRLESINNSIN 429 (469)
Q Consensus 359 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-ps~~~ll~~L~~~~~~~~ 429 (469)
++|+.||......... . ...+.. ...++.+.+++..|++.+|.+| |++.++.+.|+.+.....
T Consensus 279 ltg~~pf~~~~~~~~~----~--~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 279 LFGTYMKVKNEGGECK----P--EGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp HHSSCCCEEEETTEEE----E--CSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HhCCCccccCCCCcee----e--chhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 9999999654332211 0 011111 1236778999999999999999 688999999999887743
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=320.45 Aligned_cols=246 Identities=23% Similarity=0.404 Sum_probs=188.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|+.||+|.+..... .....+.+.++...++.++||||+++++++.+.+..++||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 4788999999999999875 688999999875432 2333444556666688889999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 230 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
||++ |+|.+++.. .+.+++..+..++.|++.||.|||++ + ++||||||+ ||+++.++.+|
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~-----------Nil~~~~~~~k 150 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPS-----------NVLINALGQVK 150 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGG-----------GCEECTTCCEE
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHH-----------HEEECCCCCEE
Confidence 9996 598887754 45799999999999999999999998 8 999999999 88888899999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-HHHHHhh
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAA 379 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-~~~~~~~ 379 (469)
|+|||++...... .......|++.|+|||++ .+..++.++||||||+++|+|++|+.||....... .......
T Consensus 151 l~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 228 (290)
T 3fme_A 151 MCDFGISGYLVDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228 (290)
T ss_dssp BCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH
T ss_pred EeecCCccccccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc
Confidence 9999999765432 222334689999999996 55678899999999999999999999997643322 2222222
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+. .....+++++.+||.+||+.||++|||+.++++|
T Consensus 229 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 229 EPSPQ--LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp SCCCC--CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCC--cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 22222 2235678899999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=326.49 Aligned_cols=251 Identities=26% Similarity=0.469 Sum_probs=188.6
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.||. +|+.||||.+..... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34788899999999998874 578999999875432 23446788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 229 TEYLPKGDLRAFLKR--------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
|||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ ++||||||+ ||+++.+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~ 157 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAG-----------NILLGED 157 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGG-----------GEEECTT
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChh-----------hEEEcCC
Confidence 999999999999974 345899999999999999999999999 999999999 8888899
Q ss_pred CCeEEeecCCccccccCCC----CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHH
Q 012164 301 GNLKVADFGVSKLLTVKED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~ 375 (469)
+.+||+|||++........ .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 158 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 237 (303)
T 2vwi_A 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237 (303)
T ss_dssp CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH
Confidence 9999999999876543211 11233568999999999875 468999999999999999999999998766555443
Q ss_pred HHhhcCCCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 376 AYAARQRPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 376 ~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.......+... .....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 238 LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 33222222211 1124567899999999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=338.26 Aligned_cols=243 Identities=26% Similarity=0.358 Sum_probs=198.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC------CCCceeeEEeEEEeCC
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI------RHPNVVQFLGAVTQSS 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~ 223 (469)
.+|++.+.||+|+||.||. +|+.||||++... ......+.+|+.+++.+ +|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 3699999999999999985 4789999998743 34456677888888877 5779999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
..++||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+ |||++.++
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~-----------NILl~~~~ 237 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPE-----------NILLKQQG 237 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGG-----------GEEESSTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HeEEccCC
Confidence 9999999995 79999998654 4899999999999999999999999 999999999 88888887
Q ss_pred C--eEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 302 N--LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 302 ~--vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
. +||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 238 ~~~vkL~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~ 313 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313 (429)
T ss_dssp SCCEEECCCTTCEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcceEEeecccceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 6 99999999976432 22345789999999999999999999999999999999999999987655443322211
Q ss_pred c-CCC-------------------------------------------------CCCCC-----hhhhHHHHHHHHHHHc
Q 012164 380 R-QRP-------------------------------------------------PFKAP-----AKLYARGLKELIEECW 404 (469)
Q Consensus 380 ~-~~~-------------------------------------------------~~~~~-----~~~~~~~l~~li~~cl 404 (469)
. +.+ +.... ....++.+.+||.+||
T Consensus 314 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L 393 (429)
T 3kvw_A 314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL 393 (429)
T ss_dssp HHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHT
T ss_pred HcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHC
Confidence 1 000 00000 0123678999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 012164 405 NEKPAKRPTFRQIITR 420 (469)
Q Consensus 405 ~~dp~~Rps~~~ll~~ 420 (469)
+.||++|||+.++++|
T Consensus 394 ~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 394 EWDPAVRMTPGQALRH 409 (429)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred CCChhhCCCHHHHhCC
Confidence 9999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=326.10 Aligned_cols=247 Identities=24% Similarity=0.405 Sum_probs=201.4
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|++.+.||+|+||.||. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3688999999999998875 47899999986542 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+ ||+++.++.+||+||
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~-----------Nil~~~~~~~kl~Df 161 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAG-----------NVLMTLEGDIRLADF 161 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGG-----------GEEECTTSCEEECCC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHH-----------HEEECCCCCEEEEEC
Confidence 99999999999876 456999999999999999999999999 999999999 888888999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
|++....... .......|++.|+|||++ .+..++.++||||||+++|+|++|+.||...........+.....
T Consensus 162 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~- 239 (302)
T 2j7t_A 162 GVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP- 239 (302)
T ss_dssp HHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-
T ss_pred CCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-
Confidence 9875432111 111234689999999998 466788999999999999999999999987665444444433332
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+....+..++..+.+||.+||..||++|||+.++++|
T Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 2233456788999999999999999999999999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.29 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=203.6
Q ss_pred ccccceeeecCeEEEEEE---eceeehhhhcccccCCCHHHHHHHHHHHHHHhc--CCCCceeeEEeEEEeCC----ceE
Q 012164 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQSS----PMM 226 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~~ 226 (469)
+|+..+.||+|+||.||. +|+.||||.+... ....+.+|.++++. ++||||+++++++.... ..+
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 788999999999998874 6899999998643 12557778888887 68999999999998775 789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
+||||+++|+|.+++.+. .+++..++.++.|++.||.||| +.+ |+||||||+ ||+++
T Consensus 117 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~-----------NIll~ 181 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSK-----------NILVK 181 (342)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGG-----------GEEEC
T ss_pred EEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHH-----------HEEEC
Confidence 999999999999999764 5999999999999999999999 777 999999999 88888
Q ss_pred CCCCeEEeecCCccccccCCCC---CcccCCCCCcccCCcccCCCC------CCCchhHHHHHHHHHHHHhC--------
Q 012164 299 DSGNLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEG-------- 361 (469)
Q Consensus 299 ~~~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDi~SlGvil~el~tg-------- 361 (469)
.++.+||+|||++......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999765533221 123456899999999998752 33689999999999999999
Q ss_pred --CCCCCCCCCCc-----HHHHHhhcC-CCCCCC--ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 362 --CPPFTMKHDNE-----VPKAYAARQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 362 --~~p~~~~~~~~-----~~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
+.||....... +...+.... ++.... ....+++.+.+||.+||+.||++|||+.+++++|+.+.++..
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred ccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 78887653322 122222222 222211 123566789999999999999999999999999999987743
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=319.95 Aligned_cols=243 Identities=26% Similarity=0.458 Sum_probs=200.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe---------
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------- 221 (469)
+|+..+.||+|+||.||. +|+.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 688899999999998874 48899999987542 346789999999999999999998854
Q ss_pred -------CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccC
Q 012164 222 -------SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND 292 (469)
Q Consensus 222 -------~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~ 292 (469)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~---------- 151 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPS---------- 151 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG----------
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHH----------
Confidence 34589999999999999999754 56999999999999999999999999 999999999
Q ss_pred cceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012164 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372 (469)
Q Consensus 293 ~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~ 372 (469)
||+++.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.... .
T Consensus 152 -Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~ 226 (284)
T 2a19_B 152 -NIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--K 226 (284)
T ss_dssp -GEEEEETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--H
T ss_pred -HEEEcCCCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--H
Confidence 8888888999999999998765332 2234568999999999999899999999999999999999999875321 1
Q ss_pred HHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 373 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
....+.. .. .+..+++.+.+||.+||..||.+|||+.+++++|+.+.++..
T Consensus 227 ~~~~~~~-~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 227 FFTDLRD-GI-----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHHHHT-TC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHHHhhc-cc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1111111 11 124567889999999999999999999999999999877644
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.32 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=197.0
Q ss_pred CCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-----
Q 012164 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS----- 222 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 222 (469)
...+|+..+.||+|+||.||. +|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345799999999999999985 578999998864421 234699999999999999999998543
Q ss_pred ---------------------------------CceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 012164 223 ---------------------------------SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNY 265 (469)
Q Consensus 223 ---------------------------------~~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~ 265 (469)
..+++||||++ ++|.+.+.. .+.+++..+..++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 34889999996 588777753 5679999999999999999999
Q ss_pred HHhCCCCCeEecCCCCCcccccccccCcceeeC-CCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCC
Q 012164 266 LHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYD 343 (469)
Q Consensus 266 LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~-~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 343 (469)
||+.+ |+||||||+ ||+++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++
T Consensus 157 LH~~g---i~H~Dikp~-----------Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ 220 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQ-----------NLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYT 220 (383)
T ss_dssp HHTTT---EECSCCCGG-----------GEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCC
T ss_pred HHHCc---CccCccCHH-----------HEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCC
Confidence 99999 999999999 77776 57899999999998654322 23345689999999998775 589
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CCC------------------CCCC------ChhhhHHHHHH
Q 012164 344 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP------------------PFKA------PAKLYARGLKE 398 (469)
Q Consensus 344 ~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~------------------~~~~------~~~~~~~~l~~ 398 (469)
.++|||||||++|+|++|+.||.+.+..+....+... +.+ .... .+..+++++.+
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence 9999999999999999999999876654443333211 110 0000 12346788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH--HHHHHh
Q 012164 399 LIEECWNEKPAKRPTFRQIITR--LESINN 426 (469)
Q Consensus 399 li~~cl~~dp~~Rps~~~ll~~--L~~~~~ 426 (469)
||.+||..||++|||+.++++| ++.+..
T Consensus 301 li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 9999999999999999999987 555443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=334.08 Aligned_cols=245 Identities=27% Similarity=0.381 Sum_probs=184.3
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------C
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~ 223 (469)
.+|+..+.||+|+||.||. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3789999999999999875 48899999987543 3445567788999999999999999999998654 5
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++|+|++ +++|.+++.. +.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~-----------NIll~~~~~~ 171 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS-----------NLAVNEDCEL 171 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTCCE
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHh-----------hEEECCCCCE
Confidence 679999999 7899999876 56999999999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-C
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-Q 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~ 381 (469)
||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+... +
T Consensus 172 kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 172 KILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp EECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999999764321 234578999999999877 67899999999999999999999999876543333222111 0
Q ss_pred CC-----------------------CCC---CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 RP-----------------------PFK---APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~~-----------------------~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+ +.. ......++.+.+||.+||..||++|||+.++++|
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 000 0112456889999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=337.79 Aligned_cols=257 Identities=15% Similarity=0.233 Sum_probs=208.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCC-CceeeEEeEEEeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 228 (469)
.+|++.+.||+|+||.||. +|+.||||++...... ..+..|+++++.++| ++|..+..++......++|
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 3688899999999999985 4889999987644322 347889999999986 5666677777788889999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee---CCCCCeE
Q 012164 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR---DDSGNLK 304 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~---~~~~~vk 304 (469)
|||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+ |||+ +.++.+|
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~-----------NILl~~~~~~~~vk 146 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPD-----------NFLMGLGRRANQVY 146 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECCGGGTTCEE
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcc-----------eEEEecCCCCCeEE
Confidence 9999 8999999985 456999999999999999999999999 999999999 6666 5788999
Q ss_pred EeecCCccccccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh
Q 012164 305 VADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 378 (469)
|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 226 (483)
T 3sv0_A 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (483)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH
T ss_pred EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH
Confidence 9999999876543221 1224678999999999999999999999999999999999999999876654433321
Q ss_pred h---cC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012164 379 A---RQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 431 (469)
Q Consensus 379 ~---~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 431 (469)
. .. ..........+++++.+||..||+.||++||++.+|++.|+.+.......
T Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 227 KISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 1 11 11111122456789999999999999999999999999999998876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=322.89 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=198.1
Q ss_pred CCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEe---
Q 012164 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ--- 221 (469)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--- 221 (469)
.....+|+..+.||+|+||.||. +|+.||||.+..... ....+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33445799999999999999875 578999999865432 225688899999999 79999999999976
Q ss_pred ---CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 222 ---SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 222 ---~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
....++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+ ||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~-----------NIl 161 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQ-----------NVL 161 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGG-----------GEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHH-----------HEE
Confidence 45789999999999999999864 46999999999999999999999999 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 012164 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 371 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~ 371 (469)
++.++.+||+|||++....... .......|++.|+|||++. +..++.++||||||+++|+|++|+.||......
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 162 LTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp ECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred EcCCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 8889999999999997654321 1223356899999999987 457889999999999999999999999866544
Q ss_pred cHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 372 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.....+.....+.. ....+++.+.+||.+||..||.+|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 RALFLIPRNPAPRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHHHSCCCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhcCccccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 43333323222222 234678899999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=319.69 Aligned_cols=246 Identities=23% Similarity=0.355 Sum_probs=198.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCC-CHHHHHHHHHHHHHHhcCCCCceeeEEeEEE--eCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~l 227 (469)
+|++.+.||+|+||.||. +++.||+|.+...... .......+.+|+.++++++||||+++++++. +....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 688899999999999874 5789999998754211 1233467899999999999999999999984 4467899
Q ss_pred EEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
||||++++ |.+++.. .+.+++..+..++.||+.||.|||+++ ++||||||+ ||+++.++.+||
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~-----------NIl~~~~~~~kl 150 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPG-----------NLLLTTGGTLKI 150 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTCCEEE
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcc-----------cEEEcCCCcEEe
Confidence 99999765 8888875 346999999999999999999999999 999999999 888888999999
Q ss_pred eecCCccccccCC-CCCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC
Q 012164 306 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 306 ~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+|||++....... ........+++.|+|||++.+.. ++.++||||||+++|+|++|+.||......+....+....
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~- 229 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS- 229 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-
Confidence 9999998654322 12223456899999999997643 3679999999999999999999998765544444443322
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... +..+++.+.+||.+||..||++|||+.++++|
T Consensus 230 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 YAI---PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCC---CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCC---CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222 34577899999999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=331.25 Aligned_cols=247 Identities=23% Similarity=0.425 Sum_probs=204.0
Q ss_pred ccccceeeecCeEEEEEE---eceeehhhhcccccCCCH--------------HHHHHHHHHHHHHhcCCCCceeeEEeE
Q 012164 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDD--------------DRVRAFRDELALLQKIRHPNVVQFLGA 218 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 218 (469)
+|+..+.||+|+||.||. +|+.||+|.+........ ...+.+.+|+.++++++||||++++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred ceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 789999999999998764 689999999875432211 112678999999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCccccccc
Q 012164 219 VTQSSPMMIVTEYLPKGDLRAF------LKR--KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYW 289 (469)
Q Consensus 219 ~~~~~~~~lv~E~~~~gsL~~~------l~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~ 289 (469)
+.+.+..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .+ ++||||||+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~------- 181 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS------- 181 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG-------
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH-------
Confidence 9999999999999999999998 665 5669999999999999999999999 88 999999999
Q ss_pred ccCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCC-chhHHHHHHHHHHHHhCCCCCCC
Q 012164 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDT-KVDVFSFALILQEMIEGCPPFTM 367 (469)
Q Consensus 290 ~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDi~SlGvil~el~tg~~p~~~ 367 (469)
||+++.++.+||+|||++...... ......+++.|+|||++.+. .++. ++||||||+++|+|++|+.||..
T Consensus 182 ----Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 182 ----NILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp ----GEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ----hEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 888889999999999999865432 23345689999999999887 6666 99999999999999999999987
Q ss_pred CCC-CcHHHHHhhcCCCCCCC----------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 368 KHD-NEVPKAYAARQRPPFKA----------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 368 ~~~-~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... .+....+.. .....+. ....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 255 ~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 255 KISLVELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SSCSHHHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCcHHHHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 665 333333322 2222211 014678899999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=323.72 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=199.0
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-----C
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----S 223 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 223 (469)
..+|+..+.||+|+||.||. +|+.||||.+... ........+.+|+.++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 34789999999999999875 4889999998643 3455567788999999999999999999988654 6
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
..++||||+. ++|.+++.. +.+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~-----------Nil~~~~~~~ 151 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPS-----------NLLINSNCDL 151 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEECTTCCE
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH-----------HeEEcCCCcE
Confidence 7899999995 699999986 46999999999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCC---------CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH
Q 012164 304 KVADFGVSKLLTVKEDR---------PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~ 373 (469)
||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 152 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 231 (353)
T 2b9h_A 152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231 (353)
T ss_dssp EECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 99999999865432111 1123468999999998754 6788999999999999999999999987653332
Q ss_pred HHHHhh-cCCCC----------------------CC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 374 PKAYAA-RQRPP----------------------FK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 374 ~~~~~~-~~~~~----------------------~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+.. .+.+. .. .....+++++.+||.+||..||++|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 222111 00000 00 0113567899999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.39 Aligned_cols=244 Identities=27% Similarity=0.485 Sum_probs=195.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
++.....||+|+||.||. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 344455899999999875 57899999987542 2344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC-CCCeEEe
Q 012164 231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD-SGNLKVA 306 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~-~~~vkl~ 306 (469)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+ ||+++. ++.+||+
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~-----------Nil~~~~~~~~kl~ 165 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGD-----------NVLINTYSGVLKIS 165 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEEETTTCCEEEC
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChh-----------hEEEECCCCCEEEe
Confidence 999999999998642 3668889999999999999999999 999999999 777776 8899999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH--hhcCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQR 382 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~--~~~~~ 382 (469)
|||++....... .......|++.|+|||++.+. .++.++||||||+++|+|++|+.||............ .....
T Consensus 166 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (295)
T 2clq_A 166 DFGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH 244 (295)
T ss_dssp CTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC
T ss_pred ecccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc
Confidence 999998654321 122345689999999998764 3788999999999999999999999754432221111 11112
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+. .+..+++++.+||.+||+.||++|||+.+++++
T Consensus 245 ~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 245 PE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CC---CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cc---ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22 245678899999999999999999999999876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=317.69 Aligned_cols=247 Identities=26% Similarity=0.456 Sum_probs=184.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|+.||||.+..... .....+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 3788899999999998875 588999999875432 2333344555666788889999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
||+ ++.+..+... .+.+++..+..++.|++.||.|||+. + ++|+||||+ ||+++.++.+||+|
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~-----------Nil~~~~~~~kl~d 168 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPS-----------NILLDERGQIKLCD 168 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGG-----------GEEECTTSCEEECC
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHH-----------HEEECCCCCEEEEE
Confidence 999 6677776654 46799999999999999999999995 8 999999999 88888999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-cHHHHHhhcC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQ 381 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~ 381 (469)
||++....... ......+++.|+|||++. +..++.++||||||+++|+|++|+.||...... +....+...
T Consensus 169 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~- 245 (318)
T 2dyl_A 169 FGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE- 245 (318)
T ss_dssp CTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-
T ss_pred CCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-
Confidence 99997654322 223356899999999984 457889999999999999999999999864332 223333222
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+.......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 222222334578899999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=327.77 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=197.3
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce----
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM---- 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~---- 225 (469)
.+|...+.||+|+||.||. +|+.||||.+.... ......+.+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3788899999999999985 48999999987643 3455567889999999999999999999999877654
Q ss_pred --EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 226 --MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 226 --~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.++.+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~-----------NIll~~~~~~ 183 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPG-----------NLAVNEDCEL 183 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTCCE
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHH-----------HeEECCCCCE
Confidence 99999995 69988875 34999999999999999999999999 999999999 8888899999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ- 381 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~- 381 (469)
||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 184 kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 184 KILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp EECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999999764322 234568999999999887 688999999999999999999999998765444333321110
Q ss_pred CC-----------------------CCC---CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 RP-----------------------PFK---APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~~-----------------------~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+ +.. .....+++.+.+||.+||+.||++|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 000 0113457899999999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=319.57 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=198.0
Q ss_pred cccccceeeecCeEEEEEE------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCC------ceeeEEeEEEeC
Q 012164 155 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP------NVVQFLGAVTQS 222 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~ 222 (469)
.+|++.+.||+|+||.||. +|+.||+|++... ....+.+.+|+.+++.++|+ +|+++++++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3799999999999999874 4789999998643 34457788999999988665 499999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCc-------
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDR------- 293 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~------- 293 (469)
+..++||||+ +++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||+.......
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999 889999998765 5889999999999999999999999 99999999955543211000
Q ss_pred -ceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012164 294 -NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372 (469)
Q Consensus 294 -nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~ 372 (469)
..-...++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 000001678999999999764322 234568999999999999899999999999999999999999998765443
Q ss_pred HHHHHhhcC-CC---------------------------------------CCCCChhhhHHHHHHHHHHHcccCCCCCC
Q 012164 373 VPKAYAARQ-RP---------------------------------------PFKAPAKLYARGLKELIEECWNEKPAKRP 412 (469)
Q Consensus 373 ~~~~~~~~~-~~---------------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 412 (469)
....+.... .. .........++.+.+||.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 322221110 00 00011234578899999999999999999
Q ss_pred CHHHHHHH
Q 012164 413 TFRQIITR 420 (469)
Q Consensus 413 s~~~ll~~ 420 (469)
|+.++++|
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.76 Aligned_cols=244 Identities=25% Similarity=0.346 Sum_probs=192.3
Q ss_pred CCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-----
Q 012164 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS----- 222 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 222 (469)
...+|+..+.||+|+||.||. +|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 445799999999999999985 588999998864421 234699999999999999999998542
Q ss_pred -CceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 223 -SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 223 -~~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
..+++||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+ |||+
T Consensus 125 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~-----------NILl 189 (420)
T 1j1b_A 125 EVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQ-----------NLLL 189 (420)
T ss_dssp EEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGG-----------GEEE
T ss_pred ceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChh-----------hEEE
Confidence 23679999996 477776653 456999999999999999999999999 999999999 7777
Q ss_pred CCC-CCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHH
Q 012164 298 DDS-GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375 (469)
Q Consensus 298 ~~~-~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~ 375 (469)
+.+ +.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...
T Consensus 190 ~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~ 267 (420)
T 1j1b_A 190 DPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267 (420)
T ss_dssp ETTTTEEEECCCTTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eCCCCeEEeccchhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 755 568999999998654322 22345789999999998765 78999999999999999999999998765433332
Q ss_pred HHhhc-CC-------------CC--CC---C------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 376 AYAAR-QR-------------PP--FK---A------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 376 ~~~~~-~~-------------~~--~~---~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+... +. .. +. . ....+++++.+||.+||..||.+|||+.++++|
T Consensus 268 ~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 22110 00 00 00 0 113457899999999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=331.85 Aligned_cols=244 Identities=24% Similarity=0.387 Sum_probs=177.7
Q ss_pred ccc-ceeeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe--CCceE
Q 012164 157 FTN-SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMM 226 (469)
Q Consensus 157 ~~~-~~~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 226 (469)
|.. .+.||+|+||.||. +++.||||.+...... ..+.+|+.++++++||||+++++++.. ...++
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 443 45799999999874 3678999998754322 357789999999999999999999965 56799
Q ss_pred EEEeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 227 IVTEYLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+ |||+
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~-----------NIll 161 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPA-----------NILV 161 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHH-----------HeEE
Confidence 9999995 6898888632 24899999999999999999999999 999999999 6666
Q ss_pred ----CCCCCeEEeecCCccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q 012164 298 ----DDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 370 (469)
Q Consensus 298 ----~~~~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~ 370 (469)
+.++.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 162 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 162 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 5678999999999987643211 222445789999999999874 589999999999999999999999976543
Q ss_pred C---------cHHHHH-hhcCCCCCCCCh---------------------------------hhhHHHHHHHHHHHcccC
Q 012164 371 N---------EVPKAY-AARQRPPFKAPA---------------------------------KLYARGLKELIEECWNEK 407 (469)
Q Consensus 371 ~---------~~~~~~-~~~~~~~~~~~~---------------------------------~~~~~~l~~li~~cl~~d 407 (469)
. +....+ ...+.++..... ...++.+.+||.+||..|
T Consensus 242 ~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~d 321 (405)
T 3rgf_A 242 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321 (405)
T ss_dssp -----CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSS
T ss_pred cccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCC
Confidence 2 111111 111111110000 011567899999999999
Q ss_pred CCCCCCHHHHHHH
Q 012164 408 PAKRPTFRQIITR 420 (469)
Q Consensus 408 p~~Rps~~~ll~~ 420 (469)
|.+|||++++++|
T Consensus 322 P~~R~ta~e~L~h 334 (405)
T 3rgf_A 322 PIKRITSEQAMQD 334 (405)
T ss_dssp GGGSCCHHHHHTS
T ss_pred cccCCCHHHHhcC
Confidence 9999999999988
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=326.26 Aligned_cols=255 Identities=24% Similarity=0.433 Sum_probs=203.1
Q ss_pred cccccceeeecCeEEEEEE--eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEecc
Q 012164 155 LDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~--~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
.+|+..+.||+|+||.||. .+..||+|.+...... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 3688889999999999874 3457999988754321 222345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 233 PKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 233 ~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+ ||+++ ++.+||+|||++
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~-----------NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSK-----------NVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCST-----------TEEEC---CCEECCCSCC
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChh-----------hEEEe-CCCEEEeecCCc
Confidence 9999999998754 6999999999999999999999999 999999999 77776 679999999998
Q ss_pred cccccCC----CCCcccCCCCCcccCCcccCC---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh
Q 012164 312 KLLTVKE----DRPLTCQDTSCRYVAPEVFKN---------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 312 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 378 (469)
....... ........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 7543211 122233458899999999874 357889999999999999999999998776655555554
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
....+... ...++.++.+|+.+||..||++|||+.++++.|+.+.+.
T Consensus 257 ~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 257 TGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TTCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred cCCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 43333322 235678899999999999999999999999999998766
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.95 Aligned_cols=240 Identities=21% Similarity=0.365 Sum_probs=194.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEe--CCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~l 227 (469)
+|+..+.||+|+||.||. +|+.||||.+.... .+.+.+|+.++++++ ||||+++++++.+ ....++
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 689999999999999985 57899999986432 256889999999997 9999999999987 567899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC-CeEEe
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG-NLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~-~vkl~ 306 (469)
||||+++++|.+++.. +++..+..++.||+.||.|||+.+ |+||||||+ ||+++.++ .+||+
T Consensus 111 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~-----------Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPH-----------NVMIDHEHRKLRLI 173 (330)
T ss_dssp EEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEEETTTTEEEEC
T ss_pred EEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHH-----------HEEEcCCCCEEEEE
Confidence 9999999999998853 899999999999999999999999 999999999 77777666 89999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-HHHHH-------
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAY------- 377 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-~~~~~------- 377 (469)
|||+++...... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+
T Consensus 174 Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~ 251 (330)
T 3nsz_A 174 DWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251 (330)
T ss_dssp CCTTCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred eCCCceEcCCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence 999998654332 2334568999999999877 678999999999999999999999996443221 11000
Q ss_pred -----hhcCCCC---------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 -----AARQRPP---------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 -----~~~~~~~---------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....... .......+++++.+||.+||+.||++|||++++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 011123478899999999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=319.80 Aligned_cols=250 Identities=26% Similarity=0.453 Sum_probs=179.9
Q ss_pred CCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHH-HHhcCCCCceeeEEeEEEeCCce
Q 012164 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
....+|+..+.||+|+||.||. +|+.||||.+.... .......+..|+. +++.++||||+++++++...+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 3345788899999999999874 48899999987542 3344455555665 77788999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 226 MIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
++||||++ ++|.+++.. ...+++..+..++.|++.||.|||+. + ++||||||+ ||+++.
T Consensus 97 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~-----------NIll~~ 161 (327)
T 3aln_A 97 WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPS-----------NILLDR 161 (327)
T ss_dssp EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGG-----------GEEEET
T ss_pred EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHH-----------HEEEcC
Confidence 99999996 588888863 56699999999999999999999998 8 999999999 888888
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-cHH
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVP 374 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~-~~~ 374 (469)
++.+||+|||+++...... ......|++.|+|||++ .+..++.++||||||+++|+|++|+.||...... +..
T Consensus 162 ~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 239 (327)
T 3aln_A 162 SGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239 (327)
T ss_dssp TTEEEECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------
T ss_pred CCCEEEccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH
Confidence 9999999999997654321 22234689999999998 4567899999999999999999999999864321 111
Q ss_pred HHHhhcCCCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 375 KAYAARQRPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 375 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+.....+.+. .....+++.+.+||.+||+.||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111122221 1224578899999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=315.72 Aligned_cols=244 Identities=27% Similarity=0.421 Sum_probs=190.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe---------
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------- 221 (469)
+|+..+.||+|+||.||. +|+.||||.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 688889999999999875 5789999998642 3556788999999999999999999998865
Q ss_pred ----CCceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 222 ----SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 222 ----~~~~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
....++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ ++||||||+ ||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~-----------Nil 148 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPM-----------NIF 148 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHH-----------hEE
Confidence 346899999999999999998644 4788999999999999999999999 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCC-------------CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCC
Q 012164 297 RDDSGNLKVADFGVSKLLTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGC 362 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~ 362 (469)
++.++.+||+|||++....... ........|++.|+|||++.+. .++.++||||||+++|+|++
T Consensus 149 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp ECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred EcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 8899999999999997654221 1112334688999999999864 78999999999999999998
Q ss_pred CCCCCCC-CCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 363 PPFTMKH-DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 363 ~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
||.... ..+....+...............++.+.+||.+||+.||.+|||+.++++|
T Consensus 227 -p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 227 -PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 554221 112222222221111112234567789999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.30 Aligned_cols=243 Identities=24% Similarity=0.389 Sum_probs=197.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc------
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP------ 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------ 224 (469)
+|...+.||+|+||.||. +|+.||||.+.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 688899999999999885 48899999987543 345556788999999999999999999999987654
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
.++||||++ ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+ ||+++.++.+|
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~-----------NIl~~~~~~~k 166 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPG-----------NLAVNEDCELK 166 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGG-----------GEEECTTCCEE
T ss_pred EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH-----------HEeECCCCcEE
Confidence 499999995 688887753 4999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc---
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--- 380 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~--- 380 (469)
|+|||++...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 167 l~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 167 ILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242 (353)
T ss_dssp ECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred EeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999764322 233568999999999877 67899999999999999999999999876543322222110
Q ss_pred ------------------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 ------------------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+......+++.+.+||.+||..||++|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112222234678899999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=328.45 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=191.4
Q ss_pred CcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc-----
Q 012164 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----- 224 (469)
..+|+..+.||+|+||.||. .+..||+|++..... ...+|+++++.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 34799999999999999985 345589998764322 12369999999999999999999965433
Q ss_pred -eEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC-
Q 012164 225 -MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD- 298 (469)
Q Consensus 225 -~~lv~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~- 298 (469)
+++||||+++ ++.+.+. ....+++..+..++.||+.||.|||+.+ |+||||||+ ||+++
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~-----------Nill~~ 176 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQ-----------NLLLDP 176 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEEET
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHH-----------HEEEcC
Confidence 8899999965 5544443 2567999999999999999999999999 999999999 88887
Q ss_pred CCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH
Q 012164 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377 (469)
Q Consensus 299 ~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~ 377 (469)
.++.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 177 ~~~~~kL~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i 254 (394)
T 4e7w_A 177 PSGVLKLIDFGSAKILIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254 (394)
T ss_dssp TTTEEEECCCTTCEECCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcEEEeeCCCcccccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7899999999999875432 223346789999999998765 5899999999999999999999999876654433332
Q ss_pred hhc-CC------------------CCCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AAR-QR------------------PPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~-~~------------------~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... +. +.... .+..+++++.+||.+||+.||++|||+.++++|
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 211 00 00000 112367899999999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=319.71 Aligned_cols=250 Identities=28% Similarity=0.450 Sum_probs=198.3
Q ss_pred CCcccccceeeecCeEEEEEE------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC---CCCceeeEEeEEE---
Q 012164 153 HELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT--- 220 (469)
Q Consensus 153 ~~~~~~~~~~ig~G~~~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~--- 220 (469)
...+|+..+.||+|+||.||. +|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 345799999999999999874 36789999987543211 1112455677777666 8999999999987
Q ss_pred --eCCceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 221 --QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 221 --~~~~~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
.....++||||++ |+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+ ||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~-----------Nil 152 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQ-----------NIL 152 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHH-----------HeE
Confidence 4567899999996 69999998753 4999999999999999999999999 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
++.++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+....
T Consensus 153 i~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 230 (326)
T 1blx_A 153 VTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230 (326)
T ss_dssp ECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 8899999999999997654321 22345689999999999998999999999999999999999999987655443333
Q ss_pred Hhhc-CCC----------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 377 YAAR-QRP----------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 377 ~~~~-~~~----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+... +.+ +.......+++.+.+||.+||..||++|||+.++++|
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 3211 000 0011123578899999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=319.05 Aligned_cols=247 Identities=23% Similarity=0.395 Sum_probs=191.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEE---------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--------- 220 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--------- 220 (469)
.+|+..+.||+|+||.||. +|+.||+|.+... +....+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 3788999999999999885 4889999988643 4556678999999999999999999999873
Q ss_pred -----eCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 221 -----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 221 -----~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
+....++||||++ |+|.+++.. +.+++..+..++.|++.||.|||+.+ |+||||||+ ||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-----------Ni 151 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA-----------NL 151 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGG-----------GE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH-----------HE
Confidence 3367899999996 699999975 56999999999999999999999999 999999999 77
Q ss_pred eeC-CCCCeEEeecCCccccccCCC--CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 012164 296 LRD-DSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 371 (469)
Q Consensus 296 l~~-~~~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~ 371 (469)
+++ .++.+||+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......
T Consensus 152 l~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 231 (320)
T 2i6l_A 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231 (320)
T ss_dssp EEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 776 567899999999986543211 11233456889999998865 67889999999999999999999999876544
Q ss_pred cHHHHHhhcCCC-----------------------CC---CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 372 EVPKAYAARQRP-----------------------PF---KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 372 ~~~~~~~~~~~~-----------------------~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+....+...... +. ......+++++.+||.+||+.||++|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 333322211100 00 00113468899999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=315.05 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=197.4
Q ss_pred CCCCcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC--CCceeeEEeEEEeCCc
Q 012164 151 DPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSP 224 (469)
Q Consensus 151 ~~~~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~ 224 (469)
.....+|+..+.||+|+||.||. +|+.||+|.+..... .....+.+.+|+.++++++ ||||+++++++.+...
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 33445799999999999999985 478899999875433 4556678999999999997 5999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
.++|||+. +++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+ ||+++ ++.+|
T Consensus 103 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~-----------NIl~~-~~~~k 166 (313)
T 3cek_A 103 IYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPA-----------NFLIV-DGMLK 166 (313)
T ss_dssp EEEEECCC-SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEEE-TTEEE
T ss_pred EEEEEecC-CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcc-----------cEEEE-CCeEE
Confidence 99999954 8899999998888999999999999999999999999 999999999 66664 47899
Q ss_pred EeecCCccccccCCCC-CcccCCCCCcccCCcccCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012164 305 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~ 372 (469)
|+|||++......... ......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence 9999999865433211 1234568999999999875 467889999999999999999999997654322
Q ss_pred HH-HHHhhc-CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 373 VP-KAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 373 ~~-~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. ..+... .... .+...++.+.+||.+||+.||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 SKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhcccccC---CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11 111111 1111 223457789999999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.86 Aligned_cols=242 Identities=25% Similarity=0.358 Sum_probs=168.9
Q ss_pred cccccce-eeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe----CCc
Q 012164 155 LDFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSP 224 (469)
Q Consensus 155 ~~~~~~~-~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~ 224 (469)
.+|++.+ .||+|+||.||. +|+.||||++... ... ..+....++.++||||+++++++.. ...
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 3677754 699999999985 4889999998643 221 2222334566789999999999976 345
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC---
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD--- 299 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~--- 299 (469)
.++|||||++|+|.+++...+ .+++.+++.++.||+.||.|||+.+ |+||||||+ ||+++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~-----------NIll~~~~~ 166 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPE-----------NLLYTSKEK 166 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEESCSST
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH-----------HEEEEecCC
Confidence 899999999999999998754 5999999999999999999999999 999999999 666654
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH---
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA--- 376 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~--- 376 (469)
++.+||+|||++...... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...........
T Consensus 167 ~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (336)
T 3fhr_A 167 DAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243 (336)
T ss_dssp TCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred CceEEEeccccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence 456999999999765422 22345679999999999888889999999999999999999999976655443211
Q ss_pred -HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 377 -YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 377 -~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+..............+++.+.+||.+||..||++|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 244 RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111111112234678999999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=328.01 Aligned_cols=254 Identities=21% Similarity=0.301 Sum_probs=194.1
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC--------CCceeeEEeEEE-
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--------HPNVVQFLGAVT- 220 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~- 220 (469)
.+|++.+.||+|+||.||. +|+.||||++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4799999999999999985 4789999998643 345577889999999995 788999999987
Q ss_pred ---eCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCccccccccc---
Q 012164 221 ---QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSDLYVAYWQN--- 291 (469)
Q Consensus 221 ---~~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~Nil~~~~~~--- 291 (469)
.....++||||+ +++|.+.+... +.+++..+..++.||+.||.|||++ + |+||||||+|||+.....
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 446799999999 66777766543 4599999999999999999999998 8 999999999555542110
Q ss_pred ----------------------------Ccceee-------CCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcc
Q 012164 292 ----------------------------DRNILR-------DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 336 (469)
Q Consensus 292 ----------------------------~~nil~-------~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~ 336 (469)
..+..+ .....+||+|||++...... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 000000 01137999999999865432 233568999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH------HHH-hhcCCCC-------------------------
Q 012164 337 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP------KAY-AARQRPP------------------------- 384 (469)
Q Consensus 337 ~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~------~~~-~~~~~~~------------------------- 384 (469)
+.+..++.++|||||||++|+|++|+.||...+..+.. ..+ ...+..+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99989999999999999999999999999866543321 001 0001000
Q ss_pred ------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 ------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+...++.+.+||.+||+.||++|||+.++++|
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 001134567789999999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=331.29 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=189.5
Q ss_pred CcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 228 (469)
..+|+..+.||+|+||.|++ +|+.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 34788899999999997543 688999999865432 2356799999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
||||+ |+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+...+. +....+||+|
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~------~~~~~~kL~D 166 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNA------HGKIKAMISD 166 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBT------TTBCCEEECC
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCC------CCceeEEEec
Confidence 99995 69999998654 3666678899999999999999999 999999999444421100 2234688999
Q ss_pred cCCccccccCCC--CCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 308 FGVSKLLTVKED--RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 308 fgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
||+++....... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||.......... .....
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~ 245 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGAC 245 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCC
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccC
Confidence 999987653321 2223456899999999997 4567889999999999999999 999997544333222 22222
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...........+..+.+||.+||+.||++|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 222223344567789999999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=322.39 Aligned_cols=244 Identities=27% Similarity=0.374 Sum_probs=182.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc------
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP------ 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------ 224 (469)
+|++.+.||+|+||.||. +|+.||||++....... ....+|+..++.++||||+++++++.....
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 788999999999999884 57899999886443221 345667888888999999999999976433
Q ss_pred -eEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCcccccccccCcceee
Q 012164 225 -MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLH--ENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 225 -~~lv~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
.++||||+++ +|.+.+. ....+++..+..++.|++.||.||| +.+ |+||||||+ ||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~-----------NIll 164 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPH-----------NVLV 164 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGG-----------GEEE
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHH-----------HEEE
Confidence 8899999965 6655443 4556899999999999999999999 888 999999999 7777
Q ss_pred CC-CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHH
Q 012164 298 DD-SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375 (469)
Q Consensus 298 ~~-~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~ 375 (469)
+. ++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+......
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eCCCCcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 76 8899999999998765332 22345689999999998664 48999999999999999999999998766544433
Q ss_pred HHhhcC-CCC---------------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 376 AYAARQ-RPP---------------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 376 ~~~~~~-~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+.... .++ +.......++++.+||.+||+.||.+|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 332110 000 000112257889999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=325.14 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=193.2
Q ss_pred CcccccceeeecCeEEEEEE----eceeehhhhcccccC--------CCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 012164 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVI--------SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 221 (469)
..+|+..+.||+|+||.||. +|..||||++..... .+....+.+.+|+.++++++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 34788999999999999985 478999998865322 233445789999999999999999999999854
Q ss_pred C-----CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcce
Q 012164 222 S-----SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNI 295 (469)
Q Consensus 222 ~-----~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~ni 295 (469)
. ...++||||++ |+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+ ||
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~-----------NI 165 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPG-----------NI 165 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GE
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChH-----------HE
Confidence 3 35899999996 6888888754 36999999999999999999999999 999999999 88
Q ss_pred eeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH
Q 012164 296 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 374 (469)
Q Consensus 296 l~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~ 374 (469)
+++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+..
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 8889999999999999754322 22234568899999999877 67899999999999999999999999876544333
Q ss_pred HHHhhc-CCC----------------------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 375 KAYAAR-QRP----------------------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 375 ~~~~~~-~~~----------------------~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+... +.+ ... .....+++.+.+||.+||+.||++|||+.++++|
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 322111 000 000 0112457789999999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.97 Aligned_cols=243 Identities=24% Similarity=0.306 Sum_probs=194.9
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CC-----ceeeEEeEEEeCC
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HP-----NVVQFLGAVTQSS 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~ 223 (469)
.+|+..+.||+|+||.||. +|+.||||++... ......+..|+.+++.++ |+ +|+++++++....
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3789999999999999985 4789999998743 344567788999988885 55 4999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEecCCCCCcccccccccCcceee--
Q 012164 224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHE--NKPVPIIHRDLEPSDLYVAYWQNDRNILR-- 297 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~--~~~~~ivH~Dlkp~Nil~~~~~~~~nil~-- 297 (469)
..++||||++ ++|.+++... +.+++..+..++.|++.||.|||+ .+ |+||||||+ |||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~-----------NIll~~ 194 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPE-----------NILLCN 194 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGG-----------GEEESS
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcc-----------cEEEec
Confidence 9999999995 6999999865 459999999999999999999995 56 999999999 6666
Q ss_pred CCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~ 377 (469)
+.++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i 270 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270 (382)
T ss_dssp TTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 34778999999999875422 23457899999999999999999999999999999999999999876554433333
Q ss_pred hhcC-CCC---------------------------------CCC--------------------------ChhhhHHHHH
Q 012164 378 AARQ-RPP---------------------------------FKA--------------------------PAKLYARGLK 397 (469)
Q Consensus 378 ~~~~-~~~---------------------------------~~~--------------------------~~~~~~~~l~ 397 (469)
.... .++ ... ......+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (382)
T 2vx3_A 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350 (382)
T ss_dssp HHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHH
T ss_pred HHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHH
Confidence 2110 000 000 0001124789
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 012164 398 ELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 398 ~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+||.+||+.||++|||+.++++|
T Consensus 351 dli~~mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 351 DLILRMLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHhcCCChhhCCCHHHHhcC
Confidence 99999999999999999999886
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=317.45 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=196.9
Q ss_pred cccccceeeecCeEEEEEE-----e-ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCc------eeeEEeEEEeC
Q 012164 155 LDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN------VVQFLGAVTQS 222 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~-g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~ 222 (469)
.+|++.+.||+|+||.||. + ++.||+|++... ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 4799999999999999984 2 378999998643 344577888999999997665 89999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccC--------
Q 012164 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQND-------- 292 (469)
Q Consensus 223 ~~~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~-------- 292 (469)
...++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+......
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 678877776543 6999999999999999999999999 9999999995555311000
Q ss_pred cceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 012164 293 RNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 372 (469)
Q Consensus 293 ~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~ 372 (469)
..-.-+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0000146789999999999764322 234578999999999999999999999999999999999999998765443
Q ss_pred HHHHHhhc-CCCC---------------------------------------CCCChhhhHHHHHHHHHHHcccCCCCCC
Q 012164 373 VPKAYAAR-QRPP---------------------------------------FKAPAKLYARGLKELIEECWNEKPAKRP 412 (469)
Q Consensus 373 ~~~~~~~~-~~~~---------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rp 412 (469)
....+... +..+ ........+.++.+||.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 32222111 0000 0011123466899999999999999999
Q ss_pred CHHHHHHH
Q 012164 413 TFRQIITR 420 (469)
Q Consensus 413 s~~~ll~~ 420 (469)
|+.++++|
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.93 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=184.5
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|...+.||+|+||.|+. +|+.||||++.... .+.+.+|+.+++++ +||||+++++++.+....++|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 355568899999998753 68899999886432 24577899999876 89999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc--CcceeeCCCC
Q 012164 231 YLPKGDLRAFLKRKGAL-------KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN--DRNILRDDSG 301 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l-------~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~--~~nil~~~~~ 301 (469)
||+ |+|.+++...+.. ++..++.++.||+.||+|||+.+ |+||||||+|||+..... ..+..-+.++
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence 995 6999999865432 23345789999999999999999 999999999555532100 0000002345
Q ss_pred CeEEeecCCccccccCCCC---CcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012164 302 NLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 370 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~ 370 (469)
.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 7999999999876543221 1234568999999999875 578899999999999999999 9999976543
Q ss_pred CcHHHHHhhcC--CCCC-CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 371 NEVPKAYAARQ--RPPF-KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 371 ~~~~~~~~~~~--~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+ ..+.... .+.. ......+++++.+||.+||+.||++|||+.++++|
T Consensus 246 ~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 32 2221211 1111 11234678899999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=317.75 Aligned_cols=244 Identities=26% Similarity=0.404 Sum_probs=199.7
Q ss_pred cCCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCH---HHHHHHHHHHHHHhcCC--CCceeeEEeEE
Q 012164 150 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIR--HPNVVQFLGAV 219 (469)
Q Consensus 150 ~~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~i~~~~~~~ 219 (469)
......+|+..+.||+|+||.||. +|+.||||.+........ ...+.+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344456899999999999999885 578999999876533221 11234677999999996 59999999999
Q ss_pred EeCCceEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 220 TQSSPMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 220 ~~~~~~~lv~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
...+..++|+|++.+ ++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+ ||+++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~-----------NIll~ 183 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDE-----------NILID 183 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHH-----------HEEEe
Confidence 999999999999976 899999998888999999999999999999999999 999999999 77777
Q ss_pred -CCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHH
Q 012164 299 -DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 376 (469)
Q Consensus 299 -~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~ 376 (469)
.++.+||+|||++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.... .
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~ 254 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E 254 (320)
T ss_dssp TTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H
T ss_pred CCCCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------h
Confidence 6789999999999875432 2234568999999999877665 678999999999999999999996431 1
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.. .... .+..+++++.+||.+||+.||++|||+.+++++
T Consensus 255 ~~~-~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 IIR-GQVF---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHH-CCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhc-cccc---ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1111 134577899999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=312.64 Aligned_cols=240 Identities=28% Similarity=0.416 Sum_probs=192.0
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCH---HHHHHHHHHHHHHhcC----CCCceeeEEeEEEe
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKI----RHPNVVQFLGAVTQ 221 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~i~~~~~~~~~ 221 (469)
..+|+..+.||+|+||.||. +|+.||||.+........ .....+.+|+.+++++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 44799999999999999985 578999999875543221 1223456799999988 89999999999998
Q ss_pred CCceEEEEec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC-C
Q 012164 222 SSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD-D 299 (469)
Q Consensus 222 ~~~~~lv~E~-~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~-~ 299 (469)
.+..++|+|+ +.+++|.+++.+.+.+++..++.++.||+.||.|||+.+ |+||||||+ ||+++ .
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~-----------Nil~~~~ 175 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDE-----------NILIDLR 175 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGG-----------GEEEETT
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChh-----------hEEEeCC
Confidence 8899999999 789999999998888999999999999999999999999 999999999 77777 7
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 378 (469)
++.+||+|||++...... ......++..|+|||++.+..+. .++||||||+++|+|++|+.||.... .+.
T Consensus 176 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~ 246 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EIL 246 (312)
T ss_dssp TTEEEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH
T ss_pred CCeEEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHh
Confidence 889999999999875432 22345689999999998776654 48999999999999999999996421 111
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
. .... .+..++..+.+||.+||+.||++|||+.+++++
T Consensus 247 ~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 E-AELH---FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp H-TCCC---CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred h-hccC---CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1111 134578899999999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=319.08 Aligned_cols=250 Identities=19% Similarity=0.306 Sum_probs=192.9
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-----------CCceeeEEe
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLG 217 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~ 217 (469)
..+|+..+.||+|+||.||. +|+.||||.+... ......+.+|+.++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 34799999999999999985 5789999998643 344567888999999886 899999999
Q ss_pred EEEeCC----ceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcccccccc
Q 012164 218 AVTQSS----PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSDLYVAYWQ 290 (469)
Q Consensus 218 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~Nil~~~~~ 290 (469)
++...+ ..++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ + |+||||||+|||+....
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence 997654 689999999 89999999863 4599999999999999999999998 8 99999999955443111
Q ss_pred cCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q 012164 291 NDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 370 (469)
Q Consensus 291 ~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~ 370 (469)
.. +..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 170 ~~-----~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 170 SP-----ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp TT-----TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred CC-----cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 00 23447999999999865432 2335689999999999998999999999999999999999999986543
Q ss_pred CcH------H-HHHhhcCCCC-------------------------------------CCCChhhhHHHHHHHHHHHccc
Q 012164 371 NEV------P-KAYAARQRPP-------------------------------------FKAPAKLYARGLKELIEECWNE 406 (469)
Q Consensus 371 ~~~------~-~~~~~~~~~~-------------------------------------~~~~~~~~~~~l~~li~~cl~~ 406 (469)
... . ..+...+..+ ....+..+++++.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 211 0 1110000000 0012346788999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 012164 407 KPAKRPTFRQIITR 420 (469)
Q Consensus 407 dp~~Rps~~~ll~~ 420 (469)
||++|||+.++++|
T Consensus 321 dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 321 DPRKRADAGGLVNH 334 (373)
T ss_dssp STTTCBCHHHHHTC
T ss_pred CccccCCHHHHhhC
Confidence 99999999999886
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=303.53 Aligned_cols=229 Identities=13% Similarity=0.097 Sum_probs=188.8
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
-+|++.+.||+|+||.||. +|+.||||.+......+....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 3699999999999999885 48999999998776666677788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||+++++|.+++.+. ....++..++.|++.||.|||+++ |+||||||+ ||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~-----------NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPS-----------RVRVSIDGDVVLAYPA 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGG-----------GEEEETTSCEEECSCC
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcc-----------cEEEcCCCCEEEEecc
Confidence 999999999999643 466678999999999999999999 999999999 8888889999998543
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH---hhcCCCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQRPPFK 386 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~ 386 (469)
|++ .++.++|||||||++|+|++|+.||.+.+..+..... .........
T Consensus 175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226 (286)
T ss_dssp ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH
T ss_pred ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh
Confidence 222 3688999999999999999999999876554321110 011111111
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.....+++++.+||.+||+.||++| |+.++++.|+.+....
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 1124578899999999999999999 9999999999987663
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=328.62 Aligned_cols=253 Identities=27% Similarity=0.370 Sum_probs=197.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe------CCc
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SSP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~ 224 (469)
+|++.+.||+|+||.||. +|+.||||.+... ......+.+.+|+.++++++||||+++++++.. .+.
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 688899999999999874 5889999998754 245566789999999999999999999998755 567
Q ss_pred eEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
.++|||||++|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+ ||+++.++
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~-----------NILl~~~g 158 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPE-----------NIVLQPGP 158 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCST-----------TEEEECCS
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHH-----------HeEeecCC
Confidence 899999999999999998644 5899999999999999999999999 999999999 66666555
Q ss_pred C---eEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc------
Q 012164 302 N---LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE------ 372 (469)
Q Consensus 302 ~---vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~------ 372 (469)
. +||+|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 159 ~~~~vKL~DFG~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i 236 (676)
T 3qa8_A 159 QRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236 (676)
T ss_dssp SSCEEEECSCCCCCBTTSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC
T ss_pred CceeEEEcccccccccccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh
Confidence 4 899999999876533 22344678999999999999999999999999999999999999996431100
Q ss_pred ---HHHHHh----hcC-------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHH-----HHHHHHHh
Q 012164 373 ---VPKAYA----ARQ-------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII-----TRLESINN 426 (469)
Q Consensus 373 ---~~~~~~----~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll-----~~L~~~~~ 426 (469)
...... ..+ .+........+++.+.+||.+||..||++|||+.+++ +.++.+..
T Consensus 237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000000 000 0111122346889999999999999999999999854 44555544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=298.89 Aligned_cols=220 Identities=26% Similarity=0.430 Sum_probs=175.0
Q ss_pred ccccc-eeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHH-hcCCCCceeeEEeEEEe----CCc
Q 012164 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQ----SSP 224 (469)
Q Consensus 156 ~~~~~-~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~----~~~ 224 (469)
+|... +.||+|+||.||. +|+.||+|.+... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 56665 6799999999884 5789999998632 3567788887 55689999999999976 567
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC---
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD--- 299 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~--- 299 (469)
.++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+ ||+++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~-----------Nil~~~~~~ 155 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE-----------NLLYTSKRP 155 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEESSSST
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH-----------HEEEecCCC
Confidence 899999999999999998754 5999999999999999999999999 999999999 667666
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
++.+||+|||++.... +..++.++|||||||++|+|++|+.||..............
T Consensus 156 ~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 212 (299)
T 3m2w_A 156 NAILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212 (299)
T ss_dssp TCCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC
T ss_pred CCcEEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH
Confidence 7889999999986432 13467899999999999999999999976554332211111
Q ss_pred cCC-CCCCCC---hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 RQR-PPFKAP---AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ~~~-~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... .....+ ...+++++.+||.+||+.||++|||+.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 111111 14578899999999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=318.83 Aligned_cols=247 Identities=13% Similarity=0.132 Sum_probs=186.6
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCC-Cce---------e-----
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNV---------V----- 213 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i---------~----- 213 (469)
...|...+.||+|+||.||. +|+.||||++...........+.+.+|+.+++.++| ++. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577889999999999985 488999999875443333445779999999999987 211 1
Q ss_pred -------eEEeEEEe-----CCceEEEEeccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012164 214 -------QFLGAVTQ-----SSPMMIVTEYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARGMNYLHENKPVPI 274 (469)
Q Consensus 214 -------~~~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 274 (469)
.++.++.. ....+++|+++ +++|.+++.. .+.+++..+..++.||+.||.|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111111 23467888877 7899999952 223778889999999999999999999 9
Q ss_pred EecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCccc----------CCCCCCC
Q 012164 275 IHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----------KNEEYDT 344 (469)
Q Consensus 275 vH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ 344 (469)
+||||||+ |||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.
T Consensus 233 iHrDiKp~-----------NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~ 296 (413)
T 3dzo_A 233 VHTYLRPV-----------DIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF 296 (413)
T ss_dssp ECSCCCGG-----------GEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred ccCCcccc-----------eEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence 99999999 888899999999999999865432 233456 899999999 5557888
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HH
Q 012164 345 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LE 422 (469)
Q Consensus 345 ~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~--L~ 422 (469)
++|||||||++|+|++|+.||......+....+.. ....+++.+.+||.+||+.||++|||+.+++++ ++
T Consensus 297 ~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 297 AFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp HHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 99999999999999999999987654333222211 112457889999999999999999999999876 55
Q ss_pred HHHhhh
Q 012164 423 SINNSI 428 (469)
Q Consensus 423 ~~~~~~ 428 (469)
.+.+.+
T Consensus 369 ~~~~~~ 374 (413)
T 3dzo_A 369 QLRTEL 374 (413)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 555543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=328.77 Aligned_cols=238 Identities=20% Similarity=0.305 Sum_probs=193.0
Q ss_pred cccccceeeecCeEEEEEE------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc----
Q 012164 155 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 224 (469)
-+|++.+.||+|+||.||. +|+.||||.+... ........+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3799999999999999884 4789999988643 345566788999999999999999999999987665
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 -~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.|+||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+ ||+++.+ .+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~-----------NIll~~~-~~ 220 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPE-----------NIMLTEE-QL 220 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECSS-CE
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChH-----------HeEEeCC-cE
Confidence 7999999999999998765 6999999999999999999999999 999999999 6666654 89
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
||+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......
T Consensus 221 kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------- 284 (681)
T 2pzi_A 221 KLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------- 284 (681)
T ss_dssp EECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------
T ss_pred EEEecccchhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------
Confidence 99999999865432 345689999999998764 48899999999999999999999875322111
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCC-HHHHHHHHHHHHhh
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPT-FRQIITRLESINNS 427 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~ll~~L~~~~~~ 427 (469)
+........++.+.+||.+||+.||++||+ ++++...|..+...
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 111122345678999999999999999994 66666777777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=307.13 Aligned_cols=239 Identities=13% Similarity=0.148 Sum_probs=180.3
Q ss_pred cccccceeeecCeEEEEEE---eceeehhhhcccccCC-----CHHHHHHHHHHHHHHhcCC---------CCceeeEEe
Q 012164 155 LDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIR---------HPNVVQFLG 217 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~i~~~~~ 217 (469)
.+|+..+.||+|+||.||. +|+.||||++...... .....+.+.+|+.+++.++ ||||+++.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 3788899999999998874 6899999999765321 1222366888999988885 777777666
Q ss_pred EEE-----------------e-------------CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 012164 218 AVT-----------------Q-------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267 (469)
Q Consensus 218 ~~~-----------------~-------------~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH 267 (469)
++. + ...+|+|||||++|++.+.+.+ +.+++..+..++.||+.||.|||
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 542 2 6789999999999976666643 56899999999999999999999
Q ss_pred -hCCCCCeEecCCCCCcccccccccCcceeeCCCC--------------------CeEEeecCCccccccCCCCCcccCC
Q 012164 268 -ENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG--------------------NLKVADFGVSKLLTVKEDRPLTCQD 326 (469)
Q Consensus 268 -~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~--------------------~vkl~Dfgla~~~~~~~~~~~~~~~ 326 (469)
+.+ |+||||||+ |||++.++ .+||+|||+|+..... ...
T Consensus 179 ~~~~---ivHrDlKp~-----------NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~ 238 (336)
T 2vuw_A 179 ASLR---FEHRDLHWG-----------NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVV 238 (336)
T ss_dssp HHHC---CBCSCCCGG-----------GEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEE
T ss_pred HhCC---EeECCCCHH-----------HEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEE
Confidence 898 999999999 55555554 8999999999875422 246
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCC-CcHHHHHhhc-C--CCCCCCChhhhHHHHHHHHH
Q 012164 327 TSCRYVAPEVFKNEEYDTKVDVFSFALI-LQEMIEGCPPFTMKHD-NEVPKAYAAR-Q--RPPFKAPAKLYARGLKELIE 401 (469)
Q Consensus 327 gt~~y~aPE~~~~~~~~~~sDi~SlGvi-l~el~tg~~p~~~~~~-~~~~~~~~~~-~--~~~~~~~~~~~~~~l~~li~ 401 (469)
||+.|+|||++.+.. +.++||||||++ .+++++|..||..... ......+... . .......+..+++++.+||.
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence 899999999998765 889999998777 6678889999853210 0011122111 1 11222234578999999999
Q ss_pred HHcccCCCCCCCHHHHH-HH
Q 012164 402 ECWNEKPAKRPTFRQII-TR 420 (469)
Q Consensus 402 ~cl~~dp~~Rps~~~ll-~~ 420 (469)
+||+.| |+.+++ +|
T Consensus 318 ~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 318 TMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HGGGSS-----SHHHHHHHC
T ss_pred HHhccC-----CHHHHHhcC
Confidence 999977 999998 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=275.62 Aligned_cols=172 Identities=15% Similarity=0.115 Sum_probs=129.6
Q ss_pred EEeceeehhhhcccccCC---C----HHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEEEEeccCCCCHHHHHHh
Q 012164 172 FWRGIQVAVKKLGEEVIS---D----DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243 (469)
Q Consensus 172 ~~~g~~vaiK~~~~~~~~---~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 243 (469)
++.|+.||+|.+...... . ....+.|.+|+++|+++ +|+||++++++++++...|||||||+|++|.+++.+
T Consensus 256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~ 335 (569)
T 4azs_A 256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA 335 (569)
T ss_dssp EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence 568999999998754321 1 23346799999999999 699999999999999999999999999999999998
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCCcc
Q 012164 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLT 323 (469)
Q Consensus 244 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~ 323 (469)
.++++.. +|+.||+.||+|+|++| ||||||||+ |||++.+|.+||+|||+|+...... ....
T Consensus 336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPe-----------NILL~~dg~vKL~DFGlAr~~~~~~-~~~~ 397 (569)
T 4azs_A 336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPW-----------NVMVDARQHARLIDFGSIVTTPQDC-SWPT 397 (569)
T ss_dssp TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGG-----------GEEECTTSCEEECCCTTEESCC----CCSH
T ss_pred CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchH-----------hEEECCCCCEEEeecccCeeCCCCC-cccc
Confidence 8888764 47899999999999999 999999999 8888999999999999998765432 2233
Q ss_pred cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCC
Q 012164 324 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 362 (469)
Q Consensus 324 ~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~ 362 (469)
...||+.|+|||++.+ .+..++|+||+|++++++.++.
T Consensus 398 t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 398 NLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 4568999999999987 4667899999999888765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-26 Score=239.12 Aligned_cols=184 Identities=20% Similarity=0.234 Sum_probs=142.3
Q ss_pred cceeeecCeEEEEEE---eceeehhhhcccccCCCH-----HHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 159 NSVEITKGTFILAFW---RGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 159 ~~~~ig~G~~~~~~~---~g~~vaiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
..+.||+|+||.||. .+..+++|.......... ...+.+.+|++++++++||||+++..++...+..|+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 356899999999983 678899997654433222 224568999999999999999966555667778899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++++|.+++.. +..++.|++.||+|||+++ |+||||||+ |||++. .+||+|||+
T Consensus 420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~-----------NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTS-----------NFIFDK--DLYIIDFGL 475 (540)
T ss_dssp CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTT-----------SEEESS--SEEECCCTT
T ss_pred CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHH-----------HEEECC--eEEEEECcc
Confidence 9999999999875 5689999999999999999 999999999 777776 999999999
Q ss_pred ccccccCCCCC------cccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 012164 311 SKLLTVKEDRP------LTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFT 366 (469)
Q Consensus 311 a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDi~SlGvil~el~tg~~p~~ 366 (469)
++......... .....||+.|+|||++.+ ..|+..+|+||..+-..+-+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 98765322111 124568999999999987 567888999999998888888877774
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.5e-25 Score=192.58 Aligned_cols=126 Identities=38% Similarity=0.420 Sum_probs=73.4
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
.+||++.....+......-.--.|+|++.++.+|.||||+||..|+.+++++|+++|+|+|.+|.+|+||||+||..|+.
T Consensus 37 g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~ 116 (169)
T 4gpm_A 37 GRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHK 116 (169)
T ss_dssp SCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCH
T ss_pred CCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCH
Confidence 34455544444444443334445555556666666666666666666666666666666666666666666666666666
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCC
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
+++++|+++|+|++.+|..|+||||+|+..|+.+++++|+++|+++
T Consensus 117 ~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GA~i 162 (169)
T 4gpm_A 117 EVVKLLISKGADVNTSDSDGRTPLDLAREHGNEEVVKLLEKQGGWL 162 (169)
T ss_dssp HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTC----
T ss_pred HHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCc
Confidence 6666666666666666666666666666666666666666666554
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-23 Score=182.09 Aligned_cols=127 Identities=36% Similarity=0.440 Sum_probs=115.5
Q ss_pred cccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHH
Q 012164 10 TLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89 (469)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v 89 (469)
.|+.+...|.+...+..--+|+|+|.++.+|+||||+|+..++.+++++|++.|+|+|.+|..|+||||+||..|+.+++
T Consensus 7 ~L~~Aa~~G~~~~v~~Ll~~Gadvn~~d~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v 86 (169)
T 4gpm_A 7 RLIEAAENGNKDRVKDLIENGADVNASDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVV 86 (169)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHH
T ss_pred HHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHH
Confidence 34555566666655566668899999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 90 ~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
++|+++|+|+|.+|..|+||||+|+..|+.+++++|++.|+++....
T Consensus 87 ~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d 133 (169)
T 4gpm_A 87 KLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSD 133 (169)
T ss_dssp HHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccC
Confidence 99999999999999999999999999999999999999999876543
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=7.7e-23 Score=160.92 Aligned_cols=93 Identities=46% Similarity=0.578 Sum_probs=89.2
Q ss_pred CCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccch
Q 012164 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118 (469)
Q Consensus 39 ~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~ 118 (469)
+|+||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~ 80 (93)
T 1n0q_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (93)
T ss_dssp --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhcCC
Q 012164 119 HEVIKLLEKHGAK 131 (469)
Q Consensus 119 ~~~~~~L~~~~~~ 131 (469)
.+++++|++.|++
T Consensus 81 ~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 81 LEVVKLLLEAGAY 93 (93)
T ss_dssp HHHHHHHHHTTCC
T ss_pred HHHHHHHHHcCCC
Confidence 9999999998864
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=8.1e-23 Score=172.80 Aligned_cols=127 Identities=18% Similarity=0.194 Sum_probs=100.7
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCC-CCcHHHHHHH
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAAC 82 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~-g~t~Lh~A~~ 82 (469)
+....||++.+...+.....+-.--+|+|++..+..|.||||+|+. |+.+++++|+++|+++|.+|.. |+||||+|+.
T Consensus 9 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~ 87 (136)
T 1d9s_A 9 GGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAR 87 (136)
T ss_dssp CCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHH
T ss_pred CCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHH
Confidence 3456677777777777666555555677777777888888888888 8888888888888888888887 8888888888
Q ss_pred cCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCC
Q 012164 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (469)
Q Consensus 83 ~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~ 131 (469)
.|+.+++++|+++|++++.+|..|.||||+|+..++.+++++|+++|++
T Consensus 88 ~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~Gad 136 (136)
T 1d9s_A 88 EGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGHRDIARYLHAATGD 136 (136)
T ss_dssp HTCHHHHHHHHHTCCCCCCCSSSSSCHHHHHHHHTCHHHHHHHHHHHCC
T ss_pred cCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 8888888888888888888888888888888888888888888887764
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-22 Score=170.24 Aligned_cols=125 Identities=29% Similarity=0.379 Sum_probs=111.5
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
....||++.+...+.....+-.--+|+|.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 12 ~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~ 91 (136)
T 2jab_A 12 SDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIG 91 (136)
T ss_dssp CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHT
T ss_pred ccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcC
Confidence 34567888888888877766666678888889999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhc
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~ 129 (469)
+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|++.|
T Consensus 92 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~Ll~~G 136 (136)
T 2jab_A 92 HLEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQKLN 136 (136)
T ss_dssp CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHC-
T ss_pred CHHHHHHHHHcCCCCcCcCCCCCCHHHHHHHCCCHHHHHHHHHcC
Confidence 999999999999999999999999999999999999999998765
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=163.53 Aligned_cols=108 Identities=30% Similarity=0.362 Sum_probs=98.5
Q ss_pred CCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccc
Q 012164 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (469)
Q Consensus 30 ~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tp 109 (469)
|+|+ .++..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 1 G~d~-~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~ 79 (137)
T 3c5r_A 1 GIDP-FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSP 79 (137)
T ss_dssp ---C-CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCH
T ss_pred CCCC-CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCH
Confidence 5677 678899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhcCCCCCCccc
Q 012164 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (469)
Q Consensus 110 l~~A~~~~~~~~~~~L~~~~~~~~~~~~~ 138 (469)
||+|+..|+.+++++|++.|+++......
T Consensus 80 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 108 (137)
T 3c5r_A 80 LHDAAKNGHVDIVKLLLSYGASRNAVNIF 108 (137)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999999987655443
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-22 Score=174.20 Aligned_cols=135 Identities=19% Similarity=0.205 Sum_probs=116.2
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCc-HHHHHHH
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT-ALHVAAC 82 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t-~Lh~A~~ 82 (469)
..+..||++.+...+.....+-.--+|+|++..+..|.||||+|+ .|+.+++++|+++|+++|.+|..|+| |||+|+.
T Consensus 9 ~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~ 87 (156)
T 1bi7_B 9 MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAR 87 (156)
T ss_dssp -CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHH
T ss_pred CccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHH
Confidence 456678888888888887777666788999999999999999985 99999999999999999999999999 9999999
Q ss_pred cCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCcccc
Q 012164 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (469)
Q Consensus 83 ~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 139 (469)
.|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++.......
T Consensus 88 ~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 144 (156)
T 1bi7_B 88 EGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHAR 144 (156)
T ss_dssp HTCHHHHHHHHHHTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHSSCC----------
T ss_pred CCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHhCHHHHHHHHHHcCCCCCccCcCc
Confidence 999999999999999999999999999999999999999999999999886654433
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-21 Score=170.43 Aligned_cols=131 Identities=32% Similarity=0.376 Sum_probs=120.3
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
.+..++++.+...+.....+-.--+|+|.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 12 ~~~~~~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 91 (169)
T 2y1l_E 12 SDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFG 91 (169)
T ss_dssp -CHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred CcccchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcC
Confidence 45567788888888877766677788999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++...
T Consensus 92 ~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 142 (169)
T 2y1l_E 92 HLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQ 142 (169)
T ss_dssp CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCc
Confidence 999999999999999999999999999999999999999999999887544
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=2e-21 Score=161.06 Aligned_cols=124 Identities=40% Similarity=0.439 Sum_probs=111.2
Q ss_pred cccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHH
Q 012164 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~ 87 (469)
+||++.+...+.....+-.--+|.+.+..+..|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+.+
T Consensus 3 ~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~ 82 (126)
T 1n0r_A 3 RTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLE 82 (126)
T ss_dssp CCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred ccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHH
Confidence 46666666666655555555578888888999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCC
Q 012164 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (469)
Q Consensus 88 ~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~ 131 (469)
++++|+++|++++.+|..|.|||++|+..|+.+++++|+++|++
T Consensus 83 ~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~Gad 126 (126)
T 1n0r_A 83 VVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY 126 (126)
T ss_dssp HHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCC
T ss_pred HHHHHHHcCCCCcccCCCCCCHHHHHHHcCcHHHHHHHHHcCCC
Confidence 99999999999999999999999999999999999999999875
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.5e-21 Score=168.48 Aligned_cols=129 Identities=22% Similarity=0.267 Sum_probs=119.2
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
..||++.+...+.....+-.--.+.+.+..+..|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+.
T Consensus 3 ~~t~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~ 82 (167)
T 3v31_A 3 NSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYT 82 (167)
T ss_dssp TCCCHHHHHHTTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCH
T ss_pred CcchHHHHHHCCCHHHHHHHHHcCCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCH
Confidence 46788888888887776666667888999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++...
T Consensus 83 ~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 131 (167)
T 3v31_A 83 DIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIE 131 (167)
T ss_dssp HHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred HHHHHHHHCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCc
Confidence 9999999999999999999999999999999999999999999887544
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-21 Score=167.22 Aligned_cols=125 Identities=23% Similarity=0.220 Sum_probs=91.3
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
..+|++.+...+.....+-.--+|.+.+..+..|.||||+|+. |+.+++++|++.|+++|.+|..|+||||+|+..|+.
T Consensus 5 ~~~~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~ 83 (162)
T 1ihb_A 5 WGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFL 83 (162)
T ss_dssp CHHHHHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCH
T ss_pred HhhHHHHHHHcCCHHHHHHHHhCCCCccccCccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCH
Confidence 4455666666665555444445667777777777777777777 777777777777777777777777777777777777
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCC
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
+++++|+++|++++.+|..|.||||+|+..|+.+++++|++.++++
T Consensus 84 ~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~ 129 (162)
T 1ihb_A 84 DTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASN 129 (162)
T ss_dssp HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCC
T ss_pred HHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCC
Confidence 7777777777777777777777777777777777777777777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.2e-22 Score=188.27 Aligned_cols=143 Identities=17% Similarity=0.098 Sum_probs=111.2
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCH---------------HHHHHHHHHHHHHhcCCCCceeeEE
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD---------------DRVRAFRDELALLQKIRHPNVVQFL 216 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~i~~~~ 216 (469)
.|+..+.||+|+||.||. +|+.||+|.+........ .....+.+|+.++++++ | ++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 455668999999999875 588999999864321110 23467889999999999 4 5555
Q ss_pred eEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCccee
Q 012164 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296 (469)
Q Consensus 217 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil 296 (469)
+++.. +..++|||||+|++|.+ +. ......++.|++.||.|||+.+ |+||||||+ |||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~-----------NIL 225 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQY-----------NVL 225 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT-----------SEE
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHH-----------HEE
Confidence 55543 55699999999999987 42 2345579999999999999999 999999999 888
Q ss_pred eCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccC
Q 012164 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 338 (469)
Q Consensus 297 ~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 338 (469)
++ ++.+||+|||+|+.. ..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~~--------------~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEV--------------GEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEET--------------TSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeEC--------------CCCCHHHHHH
Confidence 88 899999999998642 2467888874
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.3e-21 Score=172.74 Aligned_cols=132 Identities=26% Similarity=0.308 Sum_probs=120.5
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
+.-.+||++.+...+.....+-.--++.|.+..+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..
T Consensus 32 d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 111 (192)
T 2rfm_A 32 DSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIF 111 (192)
T ss_dssp CTTCCCHHHHHHHHTCGGGHHHHHHHHCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHhccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHc
Confidence 44567888888888877766666667888899999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 84 g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++...
T Consensus 112 ~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~ 163 (192)
T 2rfm_A 112 GYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISAR 163 (192)
T ss_dssp TCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCB
T ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999999999999999999999999999999887544
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=3.2e-21 Score=166.25 Aligned_cols=127 Identities=30% Similarity=0.332 Sum_probs=109.1
Q ss_pred ccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHH
Q 012164 9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88 (469)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~ 88 (469)
++++.+...+.....+-.--+|.+.+ .+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.++
T Consensus 4 ~~L~~A~~~g~~~~v~~Ll~~g~~~~-~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~ 82 (153)
T 1awc_B 4 KKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANI 82 (153)
T ss_dssp HHHHHHHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHH
T ss_pred HHHHHHHHcCCHHHHHHHHHcCCCCC-cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHH
Confidence 44555555555544444444566655 57789999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 89 v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
+++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++....
T Consensus 83 v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 130 (153)
T 1awc_B 83 VEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQS 130 (153)
T ss_dssp HHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccC
Confidence 999999999999999999999999999999999999999998875443
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=167.18 Aligned_cols=128 Identities=20% Similarity=0.233 Sum_probs=83.7
Q ss_pred ccccccccCCCccccccccc-cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHH
Q 012164 9 TTLLKQSSLAPDRERKEAEL-NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87 (469)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~-~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~ 87 (469)
++++.+...+.+...+..-. .+.+.+..+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+
T Consensus 7 ~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~ 86 (179)
T 3f6q_A 7 DDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRD 86 (179)
T ss_dssp CCHHHHHHHTCHHHHHHHHHCTTSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred HHHHHHHHcCCHHHHHHHHhcCcccccccCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHH
Confidence 34444444444443332222 24556666666777777777777777777777777777777777777777777777777
Q ss_pred HHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 88 ~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++....
T Consensus 87 ~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 135 (179)
T 3f6q_A 87 IVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICN 135 (179)
T ss_dssp HHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCC
T ss_pred HHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhc
Confidence 7777777777777777777777777777777777777777776665443
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.83 E-value=8.6e-21 Score=168.09 Aligned_cols=132 Identities=18% Similarity=0.118 Sum_probs=120.6
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
.-..||++.+...+.....+-.--+|+|++..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 37 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~ 116 (179)
T 3f6q_A 37 DHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWG 116 (179)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcC
Confidence 34567888888777776666566678999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
+.+++++|+++|++++.+|..|.||+++|+..++.+++++|++.|+++...+
T Consensus 117 ~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~g~~~~~~~ 168 (179)
T 3f6q_A 117 QDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNRIP 168 (179)
T ss_dssp CHHHHHHHHHTTCCSSBCCTTSCCGGGGSCHHHHHHHHHHHHHTTCCCSCBC
T ss_pred CHHHHHHHHHCCCCcchhccCCCCcHHHHHHHHHHHHHHHHHHhhcCcccCC
Confidence 9999999999999999999999999999999999999999999999885543
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.5e-21 Score=169.30 Aligned_cols=127 Identities=24% Similarity=0.297 Sum_probs=79.5
Q ss_pred ccccccccCCCccccccccccCCC-CCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHH
Q 012164 9 TTLLKQSSLAPDRERKEAELNGLD-DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87 (469)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~ 87 (469)
+|++.+...+.+...+..-..+.+ .+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+
T Consensus 4 ~~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~ 83 (172)
T 3v30_A 4 LSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTD 83 (172)
T ss_dssp CCHHHHHHTTCHHHHHHHHTTCSGGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred hhHHHHHHcCCHHHHHHHHHcCcccccCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHH
Confidence 444555555554443333333333 4555666666666666666666666666666666666666666666666666666
Q ss_pred HHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 88 ~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
++++|+++|++++.+|..|.||||+|+..|+.+++++|++.|+++...
T Consensus 84 ~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~ 131 (172)
T 3v30_A 84 IVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTE 131 (172)
T ss_dssp HHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred HHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccc
Confidence 666666666666666666666666666666666666666666665443
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-21 Score=158.00 Aligned_cols=102 Identities=37% Similarity=0.473 Sum_probs=96.9
Q ss_pred CCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccccc
Q 012164 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (469)
Q Consensus 35 ~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~ 114 (469)
-+|.+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 4 ~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~ 83 (115)
T 2l6b_A 4 WGSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAK 83 (115)
T ss_dssp CCSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHH
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Confidence 35778999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHhhcCCCCCCc
Q 012164 115 YYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 115 ~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
..++.+++++|+++|+++....
T Consensus 84 ~~~~~~~~~~Ll~~ga~~n~~~ 105 (115)
T 2l6b_A 84 KNGHHEIVKLLDAKGADVNARS 105 (115)
T ss_dssp TTTCHHHHHHHHTTSSSHHHHS
T ss_pred HCCCHHHHHHHHHcCCCCCcCC
Confidence 9999999999999999875443
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6.1e-21 Score=167.77 Aligned_cols=132 Identities=23% Similarity=0.193 Sum_probs=120.5
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
.-..||++.+...+.....+-.--+|+|++..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 34 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 113 (172)
T 3v30_A 34 ERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGN 113 (172)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC
Confidence 34678888888888776666666678999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++++++....
T Consensus 114 ~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~ 165 (172)
T 3v30_A 114 HVKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKLFQSN 165 (172)
T ss_dssp CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHHSCC-
T ss_pred CHHHHHHHHHcCCCccccCCCCCCHHHHHHHhCcHHHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999999999999999999998765543
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=164.91 Aligned_cols=136 Identities=29% Similarity=0.340 Sum_probs=114.5
Q ss_pred ccccccccccCCCccccccc-cccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCC
Q 012164 7 VRTTLLKQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~ 85 (469)
..++++.+...+.+...+.. +..+.+.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus 8 ~~~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~ 87 (165)
T 3twr_A 8 ADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGH 87 (165)
T ss_dssp HHHHHHHHHHHTCHHHHHHHCCTTTTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred hhHHHHHHHHhCCHHHHHHHHHcCCCCccccccCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCc
Confidence 34556666655555543322 22556777788889999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCccccccc
Q 012164 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (469)
Q Consensus 86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (469)
.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++........++
T Consensus 88 ~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 144 (165)
T 3twr_A 88 YEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTP 144 (165)
T ss_dssp HHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred HHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCh
Confidence 999999999999999999999999999999999999999999999887665444333
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=4.6e-21 Score=161.93 Aligned_cols=106 Identities=24% Similarity=0.228 Sum_probs=100.7
Q ss_pred CCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCC-Ccc
Q 012164 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-GST 108 (469)
Q Consensus 30 ~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~-g~t 108 (469)
+.|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+. |+.+++++|+++|++++.+|.. |.|
T Consensus 2 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t 80 (136)
T 1d9s_A 2 SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTR 80 (136)
T ss_dssp CCCCSCCCCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBC
T ss_pred CCCccCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCC
Confidence 56788889999999999999999999999999999999999999999999999 9999999999999999999999 999
Q ss_pred ccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 109 pl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
|||+|+..|+.+++++|+++|+++....
T Consensus 81 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~d 108 (136)
T 1d9s_A 81 PVHDAAREGFLDTLVVLHRAGARLDVCD 108 (136)
T ss_dssp HHHHHHHHTCHHHHHHHHHTCCCCCCCS
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCccC
Confidence 9999999999999999999998875543
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.83 E-value=8.3e-21 Score=165.71 Aligned_cols=123 Identities=27% Similarity=0.231 Sum_probs=112.1
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
..||++.+...+.....+-.--+|+|++..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus 42 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~ 121 (165)
T 3twr_A 42 QSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKY 121 (165)
T ss_dssp CCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCH
T ss_pred CCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCH
Confidence 45888888888777666666667899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcC
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~ 130 (469)
+++++|+++|++++.+|..|.||+|+|+. ++.+++++|++.|+
T Consensus 122 ~~v~~Ll~~ga~~~~~~~~g~t~l~~a~~-~~~~i~~~L~~~gA 164 (165)
T 3twr_A 122 EICKLLLQHGADPTKKNRDGNTPLDLVKD-GDTDIQDLLRGDAA 164 (165)
T ss_dssp HHHHHHHHTTCCTTCCCTTSCCTGGGSCT-TCHHHHHHHHTC--
T ss_pred HHHHHHHHcCCCCcccCCCCCChhHhHhc-CChHHHHHHhhccc
Confidence 99999999999999999999999999887 88899999998775
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=8.2e-21 Score=179.81 Aligned_cols=130 Identities=27% Similarity=0.300 Sum_probs=71.4
Q ss_pred ccccccccccCCCcc-ccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHH------------------------
Q 012164 7 VRTTLLKQSSLAPDR-ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD------------------------ 61 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~-~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~------------------------ 61 (469)
..+|++.....+... .....--+|+|+|..+.+|+||||+||..|+.++|++|++
T Consensus 52 ~~t~L~~a~~~~~~~~~v~~Ll~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~ 131 (269)
T 4b93_B 52 FCHPLCQCPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGH 131 (269)
T ss_dssp -----------------------CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTC
T ss_pred CCCHHHHHHHhCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccCh
Confidence 455666555544432 1222333455566666666666666666666665555555
Q ss_pred ---------CCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCC
Q 012164 62 ---------SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 62 ---------~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
.|+++|.+|..|+||||+||..|+.++|++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|+++
T Consensus 132 ~~~~~~Ll~~g~~~n~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~Gad~ 211 (269)
T 4b93_B 132 FQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASV 211 (269)
T ss_dssp HHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHCCCCC
Confidence 45556666666677777777777777777777777777777777777777777777777777777777666
Q ss_pred CCCc
Q 012164 133 LMAP 136 (469)
Q Consensus 133 ~~~~ 136 (469)
....
T Consensus 212 ~~~d 215 (269)
T 4b93_B 212 QVLN 215 (269)
T ss_dssp CCCC
T ss_pred CCcC
Confidence 5443
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=3.8e-21 Score=162.57 Aligned_cols=126 Identities=23% Similarity=0.161 Sum_probs=111.9
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
+.-..||++.+...+.....+-.--+|+|++..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus 7 ~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 86 (137)
T 3c5r_A 7 NHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKN 86 (137)
T ss_dssp CTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHT
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHc
Confidence 44567888888888776666656667889999999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhc
Q 012164 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (469)
Q Consensus 84 g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~ 129 (469)
|+.+++++|+++|++++.+|..|.||+|+|+..+..+++.++.+.+
T Consensus 87 ~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~l~~l~~~~ 132 (137)
T 3c5r_A 87 GHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNE 132 (137)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTSCCGGGGCCCHHHHHHHSCC----
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHhhccHHHHHhhccccc
Confidence 9999999999999999999999999999999999999987776554
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2e-20 Score=155.05 Aligned_cols=100 Identities=30% Similarity=0.405 Sum_probs=86.5
Q ss_pred CCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccccccc
Q 012164 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (469)
Q Consensus 37 ~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~ 116 (469)
+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++.+|..|+||||+|+..
T Consensus 4 ~~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~ 83 (123)
T 3aaa_C 4 GSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83 (123)
T ss_dssp ---CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHH
T ss_pred ccccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence 34678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHhhcCCCCCCc
Q 012164 117 KNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 117 ~~~~~~~~L~~~~~~~~~~~ 136 (469)
|+.+++++|+++|+++....
T Consensus 84 ~~~~~v~~Ll~~ga~~~~~~ 103 (123)
T 3aaa_C 84 GHVSCVKLLLSKGADKTVKG 103 (123)
T ss_dssp TCHHHHHHHHHTTCCTTCCC
T ss_pred CCHHHHHHHHHcCCCCCCcC
Confidence 99999999999888765443
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-20 Score=163.05 Aligned_cols=121 Identities=26% Similarity=0.279 Sum_probs=110.9
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
....||++.+...+.....+-.--+|+|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 32 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 111 (153)
T 1awc_B 32 WLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHN 111 (153)
T ss_dssp TTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC
Confidence 34567888887777766555555678899999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHH
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L 125 (469)
+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|
T Consensus 112 ~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~i~~~L 152 (153)
T 1awc_B 112 HQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152 (153)
T ss_dssp CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred CHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHh
Confidence 99999999999999999999999999999999999999887
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.82 E-value=6.8e-21 Score=165.59 Aligned_cols=126 Identities=25% Similarity=0.271 Sum_probs=113.4
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
.-.+||++.+.. +.....+-.--+|+|++..+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|
T Consensus 36 ~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 114 (162)
T 1ihb_A 36 GFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEG 114 (162)
T ss_dssp TTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred ccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcC
Confidence 345677777766 6666555555678999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCC-CCCCcCCCccccccccccchHHHHHHHHhhcCC
Q 012164 85 FTEVVSLLLERGAD-VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~-~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~ 131 (469)
+.+++++|+++|++ ++.+|..|.||||+|+..|+.+++++|+++|++
T Consensus 115 ~~~~v~~Ll~~g~~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~GAd 162 (162)
T 1ihb_A 115 HLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGAG 162 (162)
T ss_dssp CHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC--
T ss_pred CHHHHHHHHHccCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHhCCC
Confidence 99999999999998 699999999999999999999999999999975
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.82 E-value=7e-21 Score=157.80 Aligned_cols=117 Identities=23% Similarity=0.172 Sum_probs=103.6
Q ss_pred cccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCC
Q 012164 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~ 85 (469)
...+|++.+...+.....+..--+|.|.+..+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+
T Consensus 6 ~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~ 85 (123)
T 3aaa_C 6 MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGH 85 (123)
T ss_dssp -CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTC
T ss_pred ccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCC
Confidence 34567777777777666666666788999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHCCCCCCCCcCCCccccccccccchHHHH
Q 012164 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122 (469)
Q Consensus 86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~ 122 (469)
.+++++|+++|++++.+|..|.||+|+|...+..+++
T Consensus 86 ~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~ll 122 (123)
T 3aaa_C 86 VSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALL 122 (123)
T ss_dssp HHHHHHHHHTTCCTTCCCTTSCCHHHHCCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcCCCCCCHHHHhCCHHHHHHh
Confidence 9999999999999999999999999999766655543
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-20 Score=161.96 Aligned_cols=102 Identities=25% Similarity=0.286 Sum_probs=67.2
Q ss_pred CCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccc
Q 012164 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (469)
Q Consensus 31 ~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl 110 (469)
.+.+..+..|.||||+ |..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 27 ~~~~~~~~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L 105 (156)
T 1bd8_A 27 VHPDALNRFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPI 105 (156)
T ss_dssp CCTTCCCTTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHH
T ss_pred cCccccCCCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHH
Confidence 3555566666666666 666666666666666666666666666666666666666666666666666666666666666
Q ss_pred ccccccchHHHHHHHHhhcCCCCC
Q 012164 111 GDAIYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 111 ~~A~~~~~~~~~~~L~~~~~~~~~ 134 (469)
|+|+..|+.+++++|++. +++..
T Consensus 106 ~~A~~~~~~~~v~~Ll~~-~~~~~ 128 (156)
T 1bd8_A 106 HLAVQEGHTAVVSFLAAE-SDLHR 128 (156)
T ss_dssp HHHHHHTCHHHHHHHHTT-SCTTC
T ss_pred HHHHHhChHHHHHHHHhc-cCCCC
Confidence 666666666666666665 54433
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-20 Score=174.53 Aligned_cols=130 Identities=17% Similarity=0.058 Sum_probs=117.5
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
..||++.+...+.....+-.--+|+|++..+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+||..|+.
T Consensus 21 ~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~ 100 (229)
T 2vge_A 21 PLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDT 100 (229)
T ss_dssp HHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCH
T ss_pred hhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCH
Confidence 34667777777776666666667889999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHCCCCCCCCc-CCCccccccc--cccchHHHHHHHHhhcCCCCCCc
Q 012164 87 EVVSLLLERGADVDPKD-RWGSTPLGDA--IYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~-~~g~tpl~~A--~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
+++++|+++|++++..+ ..|.||||+| +..|+.+++++|++.|+++....
T Consensus 101 ~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~ 153 (229)
T 2vge_A 101 VICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMN 153 (229)
T ss_dssp HHHHHHHTTTCCTTCCCSSTTCCTGGGCCTTSTTHHHHHHHHHHHHHHTTTSG
T ss_pred HHHHHHHHcCCCcccccCCCCCCHHHHHHHHhcChHHHHHHHHHcCCCccccc
Confidence 99999999999999997 6999999999 99999999999999999876654
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-20 Score=164.38 Aligned_cols=125 Identities=29% Similarity=0.326 Sum_probs=113.7
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
.-..||++.+...+.....+-.--+|+|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 45 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 124 (169)
T 2y1l_E 45 ASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFG 124 (169)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC
Confidence 34567788877777766555555678899999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhc
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~ 129 (469)
+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|++.|
T Consensus 125 ~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~G 169 (169)
T 2y1l_E 125 HLEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKLN 169 (169)
T ss_dssp CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTC-
T ss_pred CHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcC
Confidence 999999999999999999999999999999999999999998765
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.82 E-value=3e-20 Score=172.75 Aligned_cols=127 Identities=21% Similarity=0.071 Sum_probs=74.9
Q ss_pred cccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHH
Q 012164 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~ 87 (469)
.||++.+...+.+...+-.--.|+|++..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+||..|+.+
T Consensus 38 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~ 117 (239)
T 1ycs_B 38 LALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQ 117 (239)
T ss_dssp HHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred hHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHH
Confidence 34444444444444444444455555666666666666666666666666666666666666666666666666666666
Q ss_pred HHHHHHHCCCCCCCCcCCCc-cccccc--cccchHHHHHHHHhhcCCCCC
Q 012164 88 VVSLLLERGADVDPKDRWGS-TPLGDA--IYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 88 ~v~~Ll~~g~~~~~~~~~g~-tpl~~A--~~~~~~~~~~~L~~~~~~~~~ 134 (469)
++++|+++|++++.++..|. ||||+| +..|+.+++++|+..++++..
T Consensus 118 ~v~~Ll~~ga~~~~~~~~~~~t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~ 167 (239)
T 1ycs_B 118 VCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKMGI 167 (239)
T ss_dssp HHHHHHHTTCCTTCCCSSSCCCHHHHCCSSSTTCCCHHHHHHHHHHHTTT
T ss_pred HHHHHHHcCCCcceecCCCCcchHHHHHHhhhccHHHHHHHHHhhhcccc
Confidence 66666666666666665555 666666 455566666666666655443
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.81 E-value=2e-20 Score=173.96 Aligned_cols=130 Identities=25% Similarity=0.265 Sum_probs=93.8
Q ss_pred cccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCC
Q 012164 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~ 85 (469)
..+||++.+...+.....+..--+|+|.+. +..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+||..|+
T Consensus 4 ~g~t~L~~a~~~~~~~~~~~ll~~g~~~~~-~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~ 82 (239)
T 1ycs_B 4 TGQVSLPPGKRTNLRKTGSERIAHGMRVKF-NPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGH 82 (239)
T ss_dssp ----------------------------------CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTC
T ss_pred cccccCchhhhhhhHHHHHHHhccCCCccc-CchhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCC
Confidence 467888888888777766666667777775 4789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|+++....
T Consensus 83 ~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~ 133 (239)
T 1ycs_B 83 TEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMT 133 (239)
T ss_dssp HHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceec
Confidence 999999999999999999999999999999999999999999999875443
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.4e-20 Score=167.12 Aligned_cols=125 Identities=26% Similarity=0.257 Sum_probs=114.8
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
....||++.+...+.....+-.--+|+|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 66 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 145 (192)
T 2rfm_A 66 IEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYG 145 (192)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHT
T ss_pred ccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcC
Confidence 34678888888777766555555578899999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhc
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~ 129 (469)
+.+++++|+++|++++.+|..|.||+|+|+..|+.+++++|++.+
T Consensus 146 ~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~v~~Ll~~~ 190 (192)
T 2rfm_A 146 RSEIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVR 190 (192)
T ss_dssp CHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHHH
T ss_pred CHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCcHHHHHHHHhcc
Confidence 999999999999999999999999999999999999999999875
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=163.71 Aligned_cols=130 Identities=25% Similarity=0.192 Sum_probs=118.3
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
+.-..||++.+...+.....+-.--+|+|++..+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..
T Consensus 33 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 112 (167)
T 3v31_A 33 DEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHG 112 (167)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHHHc
Confidence 34467888888888776665555567889999999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCC
Q 012164 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (469)
Q Consensus 84 g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~ 133 (469)
|+.+++++|+++|++++.+|..|.||+|+|+..|+.+++++|++++++..
T Consensus 113 ~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~ 162 (167)
T 3v31_A 113 NHVKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLKLL 162 (167)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999887653
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-20 Score=176.59 Aligned_cols=101 Identities=20% Similarity=0.183 Sum_probs=96.4
Q ss_pred CCCCCCCCChHHHHHHHc---CCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccc
Q 012164 33 DDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (469)
Q Consensus 33 ~~~~~~~g~t~l~~Aa~~---~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tp 109 (469)
.+..+..|.||||+||.. |+.+++++|+++|+++|.+|..|+||||+||..|+.+++++|+++|+|++.+|..|.||
T Consensus 162 l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tp 241 (278)
T 1dcq_A 162 LANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETP 241 (278)
T ss_dssp CSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred ccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCCH
Confidence 555678899999999999 89999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhcCCCC
Q 012164 110 LGDAIYYKNHEVIKLLEKHGAKPL 133 (469)
Q Consensus 110 l~~A~~~~~~~~~~~L~~~~~~~~ 133 (469)
||+|+..|+.+++++|+++|++..
T Consensus 242 L~~A~~~~~~~~v~~Ll~~ga~~~ 265 (278)
T 1dcq_A 242 LDIAKRLKHEHCEELLTQALSGRF 265 (278)
T ss_dssp HHHHHHTTCHHHHHHHHHHHTTCC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCC
Confidence 999999999999999999998653
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-20 Score=172.38 Aligned_cols=127 Identities=20% Similarity=0.207 Sum_probs=89.4
Q ss_pred cccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHC-CCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~-g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
.||++.+...+.+...+-.--+|+|++..+..|.||||+||..|+.+++++|++. |+++|.+|..|+||||+|+..|+.
T Consensus 74 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~ 153 (222)
T 3ehr_A 74 DNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYA 153 (222)
T ss_dssp SCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCH
T ss_pred ccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCH
Confidence 5666666666666555555556777777777788888888888888888888877 788888888888888888888888
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCC
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~ 134 (469)
+++++|+++|++++.+|..|.||||+|+..+..++++.+...++....
T Consensus 154 ~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~l~~l~~~~~~~~~ 201 (222)
T 3ehr_A 154 DIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTL 201 (222)
T ss_dssp HHHHHHHHHTCCSCCCCTTSCCHHHHCCSHHHHHHHC-----------
T ss_pred HHHHHHHHcCCCCccccCCCCCHHHHhcchhHHHHHHHHhccchhhhc
Confidence 888888888888888888888888888888888888777777766543
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.80 E-value=6.4e-20 Score=149.00 Aligned_cols=94 Identities=32% Similarity=0.449 Sum_probs=86.1
Q ss_pred CCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccc
Q 012164 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (469)
Q Consensus 32 d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~ 111 (469)
.....+.+|.|+||+||..|+.+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++.+|..|.||||
T Consensus 16 ~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~ 95 (110)
T 2zgd_A 16 RGSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFD 95 (110)
T ss_dssp ------CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred cccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHH
Confidence 34556778999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHH
Q 012164 112 DAIYYKNHEVIKLL 125 (469)
Q Consensus 112 ~A~~~~~~~~~~~L 125 (469)
+|+..|+.+++++|
T Consensus 96 ~A~~~~~~~~~~~L 109 (110)
T 2zgd_A 96 ISIDNGNEDLAEIL 109 (110)
T ss_dssp HHHHHTCHHHHHHH
T ss_pred HHHHcCCHHHHHHh
Confidence 99999999999876
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.80 E-value=8e-20 Score=154.28 Aligned_cols=101 Identities=32% Similarity=0.399 Sum_probs=94.2
Q ss_pred CCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccccc
Q 012164 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (469)
Q Consensus 35 ~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~ 114 (469)
.....|.||||+||..|+.+++++|+++|+++|.+|..|+||||+||..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 9 ~~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~ 88 (136)
T 2jab_A 9 HHGSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAA 88 (136)
T ss_dssp ---CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred cccccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHH
Confidence 34557899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHhhcCCCCCC
Q 012164 115 YYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 115 ~~~~~~~~~~L~~~~~~~~~~ 135 (469)
..|+.+++++|+++|+++...
T Consensus 89 ~~~~~~~v~~Ll~~g~~~~~~ 109 (136)
T 2jab_A 89 FIGHLEIAEVLLKHGADVNAQ 109 (136)
T ss_dssp HHTCHHHHHHHHHTTCCTTCC
T ss_pred HcCCHHHHHHHHHcCCCCcCc
Confidence 999999999999999887544
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.3e-20 Score=172.56 Aligned_cols=105 Identities=25% Similarity=0.296 Sum_probs=68.6
Q ss_pred CCCCCCCCCChHHHHHHHcCCH-HHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccc
Q 012164 32 DDDGEEIKPEFRLMFLANERDV-EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (469)
Q Consensus 32 d~~~~~~~g~t~l~~Aa~~~~~-~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl 110 (469)
..+..+..|.||||+|+..+.. .++++|++.|+|+|.+|.+|+||||+||..|+.++|++|++.|++++..+..|.||+
T Consensus 44 ~~~~~~~~~~t~L~~a~~~~~~~~~v~~Ll~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l 123 (269)
T 4b93_B 44 TVSAADPEFCHPLCQCPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPL 123 (269)
T ss_dssp -------------------------------CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHH
T ss_pred cccccCccCCCHHHHHHHhCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCcc
Confidence 3566777889999999988775 588999999999999999999999999999999999999999999999998999999
Q ss_pred ccccccchHHHHHHHHhhcCCCCCCc
Q 012164 111 GDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 111 ~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
++|+..++.+++++|++.|+++....
T Consensus 124 ~~a~~~~~~~~~~~Ll~~g~~~n~~d 149 (269)
T 4b93_B 124 HLACQQGHFQVVKCLLDSNAKPNKKD 149 (269)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCSCCCC
T ss_pred ccccccChHHHHHHHHHCCCCCCCCC
Confidence 99988888888888888888876543
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.4e-20 Score=178.39 Aligned_cols=132 Identities=25% Similarity=0.219 Sum_probs=114.1
Q ss_pred cccccccccCCCccccccccccCCCCCC------CCCCCChHHHHHHHc---CCHHHHHHHHHCCCCCCCcCCCCCcHHH
Q 012164 8 RTTLLKQSSLAPDRERKEAELNGLDDDG------EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALH 78 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~------~~~~g~t~l~~Aa~~---~~~~~v~~Ll~~g~~in~~d~~g~t~Lh 78 (469)
.++++.+...+.+......-.+|.|++. .+..|.||||+||.. |+.+++++|+++|+++|.+|..|+||||
T Consensus 152 ~~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh 231 (301)
T 2b0o_E 152 PQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALH 231 (301)
T ss_dssp HHHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHH
T ss_pred HHHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHH
Confidence 3445555555555554445557778777 688999999999997 8999999999999999999999999999
Q ss_pred HHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCcccc
Q 012164 79 VAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (469)
Q Consensus 79 ~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 139 (469)
+|+..|+.+++++|+++|+|++.+|..|.||||+|+..|+.+++++|++.+++...++.+.
T Consensus 232 ~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~iv~~Ll~~ga~~g~tpLh~ 292 (301)
T 2b0o_E 232 YAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLEQAQAGTFAFPLHV 292 (301)
T ss_dssp HHHHTTCHHHHHHHHHTTCCCSCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHTTSSCCC-
T ss_pred HHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCChhHH
Confidence 9999999999999999999999999999999999999999999999999998865555443
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=171.93 Aligned_cols=113 Identities=30% Similarity=0.335 Sum_probs=101.2
Q ss_pred CCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCC-CCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcc
Q 012164 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (469)
Q Consensus 30 ~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~-~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t 108 (469)
+.+.+..+..|.||||+||..|+.+++++|+++|+++|.++. .|+||||+||..|+.+++++|+++|++++.+|..|.|
T Consensus 148 ~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t 227 (282)
T 1oy3_D 148 RLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRT 227 (282)
T ss_dssp GGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred hhcCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccCCCC
Confidence 456778888999999999999999999999999999999985 5999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhcCCCCCCccccccc
Q 012164 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (469)
Q Consensus 109 pl~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (469)
|||+|+..|+.+++++|+++|+++........++
T Consensus 228 pL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 261 (282)
T 1oy3_D 228 PLGSALLRPNPILARLLRAHGAPEPEDGGDKLSP 261 (282)
T ss_dssp HHHHHHTSSCHHHHHHHHHTTCCCCCCC------
T ss_pred HHHHHHHcCCcHHHHHHHHcCCCcCcCCCccccc
Confidence 9999999999999999999999987665544444
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=166.44 Aligned_cols=132 Identities=23% Similarity=0.153 Sum_probs=106.1
Q ss_pred cccccccccccCCCccccccccccC--CCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 6 PVRTTLLKQSSLAPDRERKEAELNG--LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~--~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
-..||++.+...+.....+-.--.| .|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus 71 ~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 150 (228)
T 2dzn_A 71 SGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASV 150 (228)
T ss_dssp TSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHT
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHc
Confidence 4556666666666554444444455 67777888888889999999999999999988999988888899999999999
Q ss_pred CCHHHHHHHHHCC-CCCCCCcCCCccccccccccchHHHHHHHH-hhcCCCCCCcc
Q 012164 84 GFTEVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLLE-KHGAKPLMAPM 137 (469)
Q Consensus 84 g~~~~v~~Ll~~g-~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~-~~~~~~~~~~~ 137 (469)
|+.+++++|++.| ++++.+|..|+||||+|+..|+.+++++|+ +.|+++.....
T Consensus 151 ~~~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~ 206 (228)
T 2dzn_A 151 GSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDN 206 (228)
T ss_dssp TCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCBCT
T ss_pred CCHHHHHHHHhcCcccccCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCccCC
Confidence 9999999999888 888888888999999999888889988888 88887755443
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=154.57 Aligned_cols=122 Identities=24% Similarity=0.277 Sum_probs=111.7
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
....||++. ...+.....+-.--+|+|++..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 34 ~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 112 (156)
T 1bd8_A 34 RFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEG 112 (156)
T ss_dssp TTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHT
T ss_pred CCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhC
Confidence 346788888 7777766666666678999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhh
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~ 128 (469)
+.+++++|+++ ++++.+|..|.||||+|+..|+.+++++|+++
T Consensus 113 ~~~~v~~Ll~~-~~~~~~~~~g~t~l~~A~~~~~~~~v~~Ll~~ 155 (156)
T 1bd8_A 113 HTAVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp CHHHHHHHHTT-SCTTCCCTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred hHHHHHHHHhc-cCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhh
Confidence 99999999999 99999999999999999999999999999864
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=167.70 Aligned_cols=129 Identities=23% Similarity=0.266 Sum_probs=110.1
Q ss_pred ccccccccccCCCcccccccccc-CCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCC-----CCcCCCCCcHHHHH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELN-GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVA 80 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~-~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~i-----n~~d~~g~t~Lh~A 80 (469)
.+||++.+...+.....+..-.. |.|.+..+..|+||||+||..|+.+++++|++.|+++ +.+|..|+||||+|
T Consensus 3 g~t~L~~A~~~g~~~~v~~Ll~~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A 82 (232)
T 2rfa_A 3 WESPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIA 82 (232)
T ss_dssp TTCHHHHHHHTTCHHHHHHHHTTTCSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHH
T ss_pred CCCHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHH
Confidence 46777777777776655444444 8888888999999999999999999999999999887 67788999999999
Q ss_pred HHcCCHHHHHHHHHCCCCCCCCcC-------------CCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 81 ACQGFTEVVSLLLERGADVDPKDR-------------WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 81 ~~~g~~~~v~~Ll~~g~~~~~~~~-------------~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
+..|+.+++++|+++|++++..+. .|.||||+|+..|+.+++++|+++|+++...
T Consensus 83 ~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~ 150 (232)
T 2rfa_A 83 VINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQ 150 (232)
T ss_dssp HHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred HHcCCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence 999999999999999999988866 7999999999999999999999998886544
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.79 E-value=8.7e-20 Score=170.97 Aligned_cols=131 Identities=21% Similarity=0.140 Sum_probs=81.4
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCC-CCCCcCCCCCcHHHHHHHc
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~-~in~~d~~g~t~Lh~A~~~ 83 (469)
.-..||++.+...+.....+-.--.|+|++..+..|.||||+|+..|+.+++++|++.|+ +++.+|..|+||||+|+..
T Consensus 55 ~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~ 134 (253)
T 1yyh_A 55 RTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARL 134 (253)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTTSCTTCCCTTCCCHHHHHHHH
T ss_pred CCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCCCcHHHHHHHc
Confidence 345566666666665554444444556666666666666666666666666666666655 6666666666666666666
Q ss_pred CCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 84 g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|++.|+++...
T Consensus 135 ~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~ 186 (253)
T 1yyh_A 135 AVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQ 186 (253)
T ss_dssp TCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred ChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCc
Confidence 6666666666666666666666666666666666666666666666655443
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=165.96 Aligned_cols=132 Identities=25% Similarity=0.200 Sum_probs=97.6
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
+.-..||++.+...+.....+-.--.|+|.+..+..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..
T Consensus 37 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 116 (231)
T 3aji_A 37 DQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASK 116 (231)
T ss_dssp CTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc
Confidence 34456677777666666555555556677777777777778777777777777777777777777777777777777777
Q ss_pred CCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 84 g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|++.++++...
T Consensus 117 ~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 168 (231)
T 3aji_A 117 NRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQ 168 (231)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCC
T ss_pred CCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccc
Confidence 7777777777777777777777777777777777777777777777766544
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=160.93 Aligned_cols=105 Identities=19% Similarity=0.196 Sum_probs=89.9
Q ss_pred CCCCC-CCCChHHHHHHHcCCH----HHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCC------HHHHHHHHHCCCCCCC
Q 012164 33 DDGEE-IKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGF------TEVVSLLLERGADVDP 101 (469)
Q Consensus 33 ~~~~~-~~g~t~l~~Aa~~~~~----~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~------~~~v~~Ll~~g~~~~~ 101 (469)
++..+ ..|+||||+|+.+|+. +++++||++|+|+|.+|..|+||||+|+..|+ .+++++|+++|+|+|.
T Consensus 30 ~~~~~~~~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~ 109 (186)
T 3t8k_A 30 YEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITA 109 (186)
T ss_dssp SSCHHHHHTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSS
T ss_pred cccccccCCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCc
Confidence 34444 6799999999999975 58999999999999999999999999999887 6789999999999999
Q ss_pred CcCCCc-ccccccccc-----chHHHHHHHHh-hcCCCCCCcc
Q 012164 102 KDRWGS-TPLGDAIYY-----KNHEVIKLLEK-HGAKPLMAPM 137 (469)
Q Consensus 102 ~~~~g~-tpl~~A~~~-----~~~~~~~~L~~-~~~~~~~~~~ 137 (469)
+|..|. ||||+|+.. +..+++++|+. +|+++.....
T Consensus 110 ~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~ 152 (186)
T 3t8k_A 110 LYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDK 152 (186)
T ss_dssp CBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCT
T ss_pred cCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCC
Confidence 999999 999999984 44578999998 8988766543
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.79 E-value=2.5e-19 Score=165.80 Aligned_cols=99 Identities=24% Similarity=0.234 Sum_probs=63.6
Q ss_pred CCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCC-CCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccc
Q 012164 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (469)
Q Consensus 34 ~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~-~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~ 112 (469)
+..+..|.||||+|+..|+.+++++|+++|+++|.+|. .|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 111 ~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~ 190 (236)
T 1ikn_D 111 KATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQL 190 (236)
T ss_dssp GCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGG
T ss_pred hccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCHHHH
Confidence 34444566666666666666666666666666666665 66666666666666666666666666666666666666666
Q ss_pred ccccchHHHHHHHHhhcCCC
Q 012164 113 AIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 113 A~~~~~~~~~~~L~~~~~~~ 132 (469)
|+..|+.+++++|+++|+++
T Consensus 191 A~~~~~~~~~~~Ll~~ga~~ 210 (236)
T 1ikn_D 191 TWGRPSTRIQQQLGQLTLEN 210 (236)
T ss_dssp CTTSSCHHHHHHHHTTSCGG
T ss_pred HHccCchHHHHHHHHcchhh
Confidence 66666666666666666654
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.1e-19 Score=164.67 Aligned_cols=132 Identities=26% Similarity=0.150 Sum_probs=103.6
Q ss_pred ccccccccccccCCCccccccccccCC-CCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGL-DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
...+||++.+...+.....+-.--++. +.+..+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..
T Consensus 56 ~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 135 (223)
T 2f8y_A 56 NMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAV 135 (223)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHc
Confidence 345677777776666554333333443 6777778888888888888888888888888888888888888888888888
Q ss_pred CCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 84 g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++....
T Consensus 136 ~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 188 (223)
T 2f8y_A 136 NNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITD 188 (223)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred CCHHHHHHHHHcCCCCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccc
Confidence 88888888888888888888888888888888888888888888888775543
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=165.77 Aligned_cols=126 Identities=23% Similarity=0.285 Sum_probs=64.4
Q ss_pred cccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCC------CCCcCCCCCcHHHHHH
Q 012164 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHVAA 81 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~------in~~d~~g~t~Lh~A~ 81 (469)
+||++.+...+.....+-.--+|+|++..+..|.||||+|+..|+.+++++|++.|++ ++..|..|+||||+|+
T Consensus 46 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~ 125 (236)
T 1ikn_D 46 QTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLAS 125 (236)
T ss_dssp CCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHH
T ss_pred CCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHH
Confidence 3444444444433333333334445555555555555555555555555555555543 3444455555555555
Q ss_pred HcCCHHHHHHHHHCCCCCCCCcC-CCccccccccccchHHHHHHHHhhcCCCC
Q 012164 82 CQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (469)
Q Consensus 82 ~~g~~~~v~~Ll~~g~~~~~~~~-~g~tpl~~A~~~~~~~~~~~L~~~~~~~~ 133 (469)
..|+.+++++|+++|++++.++. .|.||||+|+..|+.+++++|+++|+++.
T Consensus 126 ~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~ 178 (236)
T 1ikn_D 126 IHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVN 178 (236)
T ss_dssp HTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSC
T ss_pred HcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCC
Confidence 55555555555555555555554 55555555555555555555555555443
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-20 Score=174.05 Aligned_cols=129 Identities=22% Similarity=0.134 Sum_probs=103.4
Q ss_pred cccccccccccCCCccccccccccCCCCCCCCC--------------CCChHHHHHHHcCCHHHHHHHHH---CCCCCCC
Q 012164 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEI--------------KPEFRLMFLANERDVEGIKELLD---SGIDVNF 68 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~--------------~g~t~l~~Aa~~~~~~~v~~Ll~---~g~~in~ 68 (469)
-..||++.+...+.....+-.--+|+|++..+. .|.||||+||..|+.+++++|++ .|+++|.
T Consensus 100 ~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~ 179 (273)
T 2pnn_A 100 KGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISA 179 (273)
T ss_dssp TTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTC
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCCcee
Confidence 567888888777776554444445666666665 78899999999999999999998 8899999
Q ss_pred cCCCCCcHHHHHHHcCC---------HHHHHHHHHCCCCCC-------CCcCCCccccccccccchHHHHHHHHhhcC-C
Q 012164 69 RDIDNRTALHVAACQGF---------TEVVSLLLERGADVD-------PKDRWGSTPLGDAIYYKNHEVIKLLEKHGA-K 131 (469)
Q Consensus 69 ~d~~g~t~Lh~A~~~g~---------~~~v~~Ll~~g~~~~-------~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~-~ 131 (469)
+|..|+||||+||..|+ .+++++|+++|++++ .+|..|.||||+|+..|+.+++++|+++|+ +
T Consensus 180 ~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~d 259 (273)
T 2pnn_A 180 RDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHE 259 (273)
T ss_dssp CCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTC-
T ss_pred eCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcccccccccccCCCCCCHHHHHHHhChHHHHHHHHHCCCCC
Confidence 99899999999998888 788889999888886 488889999999999999999999998888 5
Q ss_pred CCC
Q 012164 132 PLM 134 (469)
Q Consensus 132 ~~~ 134 (469)
+..
T Consensus 260 p~~ 262 (273)
T 2pnn_A 260 PEC 262 (273)
T ss_dssp ---
T ss_pred chh
Confidence 543
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-19 Score=161.53 Aligned_cols=97 Identities=35% Similarity=0.367 Sum_probs=61.4
Q ss_pred CCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCc-CCCcccccccccc
Q 012164 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYY 116 (469)
Q Consensus 38 ~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~-~~g~tpl~~A~~~ 116 (469)
..|.||||+||..|+.++++.|++ |+++|.+|..|+||||+||..|+.+++++|+++|++++.+| ..|+||||+|+..
T Consensus 42 ~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~ 120 (183)
T 3deo_A 42 SEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGY 120 (183)
T ss_dssp HHHHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhc
Confidence 355666666666666666666666 66666666666666666666666666666666666666665 5666666666666
Q ss_pred chHHHHHHHHhhcCCCCCC
Q 012164 117 KNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 117 ~~~~~~~~L~~~~~~~~~~ 135 (469)
|+.+++++|+++|+++...
T Consensus 121 ~~~~~v~~Ll~~ga~~~~~ 139 (183)
T 3deo_A 121 VRPEVVEALVELGADIEVE 139 (183)
T ss_dssp TCHHHHHHHHHHTCCTTCC
T ss_pred CcHHHHHHHHHcCCCCcCC
Confidence 6666666666666655433
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.8e-20 Score=166.03 Aligned_cols=126 Identities=17% Similarity=0.092 Sum_probs=107.1
Q ss_pred cccccccccccCCCcc----ccccccccCCCCCCCCCCCChHHHHHHHcCC------HHHHHHHHHCCCCCCCcCCCCC-
Q 012164 6 PVRTTLLKQSSLAPDR----ERKEAELNGLDDDGEEIKPEFRLMFLANERD------VEGIKELLDSGIDVNFRDIDNR- 74 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~----~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~------~~~v~~Ll~~g~~in~~d~~g~- 74 (469)
-.+||++.+..-+... -.+-.--+|+|+|.++..|+||||+|+..|+ .+++++|+++|+|+|.+|..|+
T Consensus 37 ~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~t 116 (186)
T 3t8k_A 37 LKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKI 116 (186)
T ss_dssp HTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTB
T ss_pred CCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCc
Confidence 3578888887766421 1222233788889999999999999999987 6889999999999999999999
Q ss_pred cHHHHHHHcC-----CHHHHHHHHH-CCCCCCCCcCCCccccccccccchHHHHHHHHhhcCC
Q 012164 75 TALHVAACQG-----FTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (469)
Q Consensus 75 t~Lh~A~~~g-----~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~ 131 (469)
||||+|+..| +.+++++|++ +|+|++.+|..|.||||+|+..|+.+++++|.....+
T Consensus 117 tpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~~ 179 (186)
T 3t8k_A 117 VVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKK 179 (186)
T ss_dssp CTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHHH
T ss_pred hHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHHH
Confidence 9999999954 4679999999 9999999999999999999999999999999876543
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=4.7e-19 Score=146.64 Aligned_cols=97 Identities=44% Similarity=0.543 Sum_probs=93.3
Q ss_pred CCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccch
Q 012164 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118 (469)
Q Consensus 39 ~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~ 118 (469)
+|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~ 80 (126)
T 1n0r_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (126)
T ss_dssp CCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCh
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhcCCCCCC
Q 012164 119 HEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 119 ~~~~~~L~~~~~~~~~~ 135 (469)
.+++++|++.|+++...
T Consensus 81 ~~~~~~Ll~~g~~~~~~ 97 (126)
T 1n0r_A 81 LEVVKLLLEAGADVNAK 97 (126)
T ss_dssp HHHHHHHHHTTCCTTCC
T ss_pred HHHHHHHHHcCCCCccc
Confidence 99999999999887544
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=172.08 Aligned_cols=101 Identities=31% Similarity=0.323 Sum_probs=79.4
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCcCCCc
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGS 107 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~-~g~~~~~~~~~g~ 107 (469)
.|.+.+..+..|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+||..|+.+++++|++ .|+|++.+|..|.
T Consensus 172 ~g~~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~ 251 (276)
T 4hbd_A 172 LGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGS 251 (276)
T ss_dssp HSCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSC
T ss_pred cCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCC
Confidence 445556666677888888888888888888888888888888888888888888888888888887 6888888888888
Q ss_pred cccccccccchHHHHHHHHhhc
Q 012164 108 TPLGDAIYYKNHEVIKLLEKHG 129 (469)
Q Consensus 108 tpl~~A~~~~~~~~~~~L~~~~ 129 (469)
||||+|+..|+.+++++|+++.
T Consensus 252 TpL~~A~~~g~~~iv~~Ll~~~ 273 (276)
T 4hbd_A 252 TALMVALDAGQSEIASMLYSRM 273 (276)
T ss_dssp CHHHHHHHHTCHHHHHHHHHHC
T ss_pred CHHHHHHHcCCHHHHHHHHhcc
Confidence 8888888888888888777654
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-19 Score=168.67 Aligned_cols=123 Identities=28% Similarity=0.279 Sum_probs=99.1
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcC-CCCCcHHHHHHHcCC
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGF 85 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d-~~g~t~Lh~A~~~g~ 85 (469)
..||++.+...+.....+..-- +.|++..+..|.||||+||..|+.++|++|+++|+++|.+| ..|+||||+||..|+
T Consensus 45 g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~ 123 (244)
T 3ui2_A 45 YETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVR 123 (244)
T ss_dssp HHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTC
T ss_pred CCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCC
Confidence 3577777777776655444333 77888888888888999998888999998888888888887 778899999998888
Q ss_pred HHHHHHHHHCCCCCCCCcCCCcccccccc----------------ccchHHHHHHHHhhcC
Q 012164 86 TEVVSLLLERGADVDPKDRWGSTPLGDAI----------------YYKNHEVIKLLEKHGA 130 (469)
Q Consensus 86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~----------------~~~~~~~~~~L~~~~~ 130 (469)
.+++++|+++|++++.+|..|.||||+|+ ..|+.+++++|.....
T Consensus 124 ~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~ 184 (244)
T 3ui2_A 124 PEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVF 184 (244)
T ss_dssp HHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHE
T ss_pred HHHHHHHHHCCCCCCCCCCCCCcHHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhcc
Confidence 99999998888888888888888888887 5577788888877654
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.4e-19 Score=163.22 Aligned_cols=134 Identities=20% Similarity=0.131 Sum_probs=121.5
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCC-CCCCcCCCCCcHHHHHHH
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAAC 82 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~-~in~~d~~g~t~Lh~A~~ 82 (469)
+.-..||++.+...+.....+-.--+|+|.+..+..|.||||+|+..|+.+++++|++.|+ +++.+|..|+||||+|+.
T Consensus 22 d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~ 101 (223)
T 2f8y_A 22 DRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAAR 101 (223)
T ss_dssp TTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHH
T ss_pred CCCCCchHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHH
Confidence 4456788999888888776666666788999999999999999999999999999999987 899999999999999999
Q ss_pred cCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCcc
Q 012164 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 83 ~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~ 137 (469)
.|+.+++++|+++|++++..|..|.||||+|+..|+.+++++|++.|+++.....
T Consensus 102 ~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~ 156 (223)
T 2f8y_A 102 LAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNN 156 (223)
T ss_dssp HTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred hCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence 9999999999999999999999999999999999999999999999998865543
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.8e-19 Score=159.45 Aligned_cols=129 Identities=22% Similarity=0.279 Sum_probs=114.2
Q ss_pred ccccccccccccCCCccccccccccCC-CCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGL-DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
+...+|++.+...+........-..+. |.+..+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus 3 ~~~~~~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~ 82 (201)
T 3hra_A 3 TYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQ 82 (201)
T ss_dssp CCCTTHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred cccccHHHHHHHhccHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc
Confidence 445677777777777766555444444 8899999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHH-HCCCCCCCCcCCCccccccccccchHHHHHHHHhhc-CCCC
Q 012164 84 GFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG-AKPL 133 (469)
Q Consensus 84 g~~~~v~~Ll-~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~-~~~~ 133 (469)
|+.+++++|+ ..+++++..|..|.||||+|+..|+.+++++|++.+ +++.
T Consensus 83 ~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~ 134 (201)
T 3hra_A 83 GRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDID 134 (201)
T ss_dssp TCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTT
T ss_pred CCHHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcC
Confidence 9999999999 578899999999999999999999999999999998 5543
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-19 Score=163.82 Aligned_cols=129 Identities=27% Similarity=0.309 Sum_probs=104.9
Q ss_pred cccccccccCCCccccccccc-cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 8 RTTLLKQSSLAPDRERKEAEL-NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~-~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
.+|++.+...|.+...+..-. .+.+.+..+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.
T Consensus 7 ~~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~ 86 (231)
T 3aji_A 7 NIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXD 86 (231)
T ss_dssp SSHHHHHHHHTCHHHHHHHHHHCGGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCH
T ss_pred cchHHHHHHhCCHHHHHHHHHhchhhhhcCCCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHH
Confidence 455566666665544332222 2233566778889999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
+++++|+++|++++..|..|.||||+|+..++.+++++|++.++++....
T Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~ 136 (231)
T 3aji_A 87 EIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD 136 (231)
T ss_dssp HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 99999999999999999999999999999999999999999988876543
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.1e-20 Score=173.05 Aligned_cols=127 Identities=17% Similarity=0.085 Sum_probs=77.7
Q ss_pred cccccccccccCCCccccccccccCCCCCCCC--------------CCCChHHHHHHHcCCHHHHHHHHH---CCCCCCC
Q 012164 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEE--------------IKPEFRLMFLANERDVEGIKELLD---SGIDVNF 68 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--------------~~g~t~l~~Aa~~~~~~~v~~Ll~---~g~~in~ 68 (469)
-.+||++.+...+.....+-.--+|+|++..+ ..|.||||+||..|+.+++++|++ .|+++|.
T Consensus 92 ~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~ 171 (260)
T 3jxi_A 92 RGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRR 171 (260)
T ss_dssp ESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTC
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcc
Confidence 34555665555555443333333444555444 456666666666666666666666 6666666
Q ss_pred cCCCCCcHHHHHHHcCC---------HHHHHHHHHCCCCC-------CCCcCCCccccccccccchHHHHHHHHhhcCCC
Q 012164 69 RDIDNRTALHVAACQGF---------TEVVSLLLERGADV-------DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 69 ~d~~g~t~Lh~A~~~g~---------~~~v~~Ll~~g~~~-------~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
+|..|+||||+||..|+ .+++++|+++|+++ +.+|..|.||||+|+..|+.+++++|+++|+++
T Consensus 172 ~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~ 251 (260)
T 3jxi_A 172 QDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIAD 251 (260)
T ss_dssp CCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred cCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccccccchhhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCc
Confidence 66666666666666655 56666666666666 456666666666666666666666666666543
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.4e-19 Score=164.35 Aligned_cols=130 Identities=25% Similarity=0.240 Sum_probs=113.8
Q ss_pred cccccccccccccCCCccc-----cccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCC-------
Q 012164 4 KVPVRTTLLKQSSLAPDRE-----RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI------- 71 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~------- 71 (469)
+.-.+||++.+...+.... ..++++...+.+..+..|.||||+||..|+.+++++|+++|++++.++.
T Consensus 34 ~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~ 113 (232)
T 2rfa_A 34 GAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYR 113 (232)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCC
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccCCcceeec
Confidence 3456788888877776543 4455555555588888999999999999999999999999999999876
Q ss_pred ------CCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHH----HHHHhhcCCCC
Q 012164 72 ------DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI----KLLEKHGAKPL 133 (469)
Q Consensus 72 ------~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~----~~L~~~~~~~~ 133 (469)
.|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++.+++ ++|++.|+++.
T Consensus 114 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~~ 185 (232)
T 2rfa_A 114 PHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH 185 (232)
T ss_dssp TTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSCS
T ss_pred ccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCchh
Confidence 799999999999999999999999999999999999999999999999988 99999998764
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.8e-20 Score=171.07 Aligned_cols=91 Identities=22% Similarity=0.223 Sum_probs=48.1
Q ss_pred CChHHHHHHHcCCHHHHHHHHH---CCCCCCCcCCCCCcHHHHHHH--cCCHH-------HHHHHHHCCCCC-------C
Q 012164 40 PEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALHVAAC--QGFTE-------VVSLLLERGADV-------D 100 (469)
Q Consensus 40 g~t~l~~Aa~~~~~~~v~~Ll~---~g~~in~~d~~g~t~Lh~A~~--~g~~~-------~v~~Ll~~g~~~-------~ 100 (469)
|.||||+||..|+.+++++|++ .|+++|.+|..|+||||+||. .++.+ ++++|+++|+++ +
T Consensus 136 g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~~~~~~~~~ 215 (256)
T 2etb_A 136 GELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARLCPTVQLEE 215 (256)
T ss_dssp CSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHSTTCCGGG
T ss_pred CCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCccccccccc
Confidence 5555555555555555555555 555555555555555555555 44444 555555555555 4
Q ss_pred CCcCCCccccccccccchHHHHHHHHhhcC
Q 012164 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130 (469)
Q Consensus 101 ~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~ 130 (469)
.+|..|.||||+|+..|+.+++++|+++|+
T Consensus 216 ~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~ 245 (256)
T 2etb_A 216 ISNHQGLTPLKLAAKEGKIEIFRHILQREF 245 (256)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHHHH
T ss_pred ccCCCCCCHHHHHHHhCCHHHHHHHHhCCC
Confidence 555555555555555555555555555543
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.77 E-value=5.9e-19 Score=163.43 Aligned_cols=131 Identities=21% Similarity=0.170 Sum_probs=101.5
Q ss_pred ccccccccccCCCccccccccccCC----CCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcC-CCCCcHHHHHH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGL----DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAA 81 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~----d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d-~~g~t~Lh~A~ 81 (469)
..||++.+...+.....+-.--.+. +.+..+..|.||||+|+..|+.+++++|++.|++++.+| ..|+||||+|+
T Consensus 79 g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~ 158 (241)
T 1k1a_A 79 GQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAV 158 (241)
T ss_dssp SCCHHHHHHHTTCHHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHH
T ss_pred CCCHHHHHHHcCCHHHHHHHHHcCCCccccccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHH
Confidence 4556665555554443322222333 677777888888888888888888888888888888888 77888888888
Q ss_pred HcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCcc
Q 012164 82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 82 ~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~ 137 (469)
..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++.....
T Consensus 159 ~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~ 214 (241)
T 1k1a_A 159 ENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNC 214 (241)
T ss_dssp HTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred HcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCcCC
Confidence 88888888888888888888888888888888888888888888888888755443
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=6.8e-19 Score=168.69 Aligned_cols=130 Identities=26% Similarity=0.202 Sum_probs=82.7
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCC---------------
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI--------------- 71 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~--------------- 71 (469)
..||++.+...+.....+-.--+|+|++..+..|.||||+|+..|+.+++++|+++|++++.+|.
T Consensus 73 g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~ 152 (299)
T 1s70_B 73 GLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAME 152 (299)
T ss_dssp CCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHH
T ss_pred CCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHhcchH
Confidence 45566665555554444444445666666666666667777666666677766666666665442
Q ss_pred ---------------------------------------------CCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCC
Q 012164 72 ---------------------------------------------DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (469)
Q Consensus 72 ---------------------------------------------~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g 106 (469)
.|.||||+||..|+.+++++|+++|++++.+|..|
T Consensus 153 ~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~g 232 (299)
T 1s70_B 153 ELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDG 232 (299)
T ss_dssp HHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTC
T ss_pred HHHHHHHhhcCCCchhhhhhhhhHHHHHHHHHHhccCcchhhhcCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCCC
Confidence 34566666666666677777776677777777777
Q ss_pred ccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 107 ~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
.||||+|+..|+.+++++|+++|+++....
T Consensus 233 ~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d 262 (299)
T 1s70_B 233 WTPLHAAAHWGKEEACRILVENLCDMEAVN 262 (299)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred CcHHHHHHhcCCHHHHHHHHHcCCCCCCcC
Confidence 777777777777777777777666654443
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.2e-19 Score=168.41 Aligned_cols=129 Identities=23% Similarity=0.282 Sum_probs=108.5
Q ss_pred cccccccccccccC---CCccc-----cccccccCCC------CCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCc
Q 012164 4 KVPVRTTLLKQSSL---APDRE-----RKEAELNGLD------DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFR 69 (469)
Q Consensus 4 ~~~~~~~~~~~~~~---~~~~~-----~~~~~~~~~d------~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~ 69 (469)
+.-.+||++.+... +.... ..+++++..+ ....+..|.||||+||..|+.+++++|+++|+++|.+
T Consensus 40 d~~g~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~ 119 (256)
T 2etb_A 40 GSTGKTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLR 119 (256)
T ss_dssp TTTTBCHHHHHHHTCBTTBCTTHHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred CCCCCCHHHHHHHccccchHHHHHHHHhcCCcccchhhhcccccccccccCCCHHHHHHHcCCHHHHHHHHHcCCCCCcc
Confidence 44567888877665 54332 4455554333 2234467999999999999999999999999999999
Q ss_pred CCC-------------CCcHHHHHHHcCCHHHHHHHHH---CCCCCCCCcCCCccccccccc--cchHH-------HHHH
Q 012164 70 DID-------------NRTALHVAACQGFTEVVSLLLE---RGADVDPKDRWGSTPLGDAIY--YKNHE-------VIKL 124 (469)
Q Consensus 70 d~~-------------g~t~Lh~A~~~g~~~~v~~Ll~---~g~~~~~~~~~g~tpl~~A~~--~~~~~-------~~~~ 124 (469)
|.. |+||||+||..|+.+++++|++ +|++++.+|..|+||||+|+. .++.+ ++++
T Consensus 120 ~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~ 199 (256)
T 2etb_A 120 ACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDG 199 (256)
T ss_dssp CCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHH
Confidence 886 9999999999999999999999 999999999999999999998 77888 9999
Q ss_pred HHhhcCCC
Q 012164 125 LEKHGAKP 132 (469)
Q Consensus 125 L~~~~~~~ 132 (469)
|+++|+++
T Consensus 200 Ll~~ga~~ 207 (256)
T 2etb_A 200 LLQMGARL 207 (256)
T ss_dssp HHHHHHHH
T ss_pred HHHcCCCc
Confidence 99999887
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.77 E-value=3.9e-19 Score=166.56 Aligned_cols=108 Identities=25% Similarity=0.252 Sum_probs=83.0
Q ss_pred cCCCCCC-CCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCC-CCCCCcCCC
Q 012164 29 NGLDDDG-EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPKDRWG 106 (469)
Q Consensus 29 ~~~d~~~-~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~-~~~~~~~~g 106 (469)
+|.+.+. .+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|+ +++..+..|
T Consensus 45 ~g~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g 124 (253)
T 1yyh_A 45 QGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDG 124 (253)
T ss_dssp -------CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTTSCTTCCCTTC
T ss_pred ccCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCC
Confidence 3445433 46778888888888888888888888888888888888888888888888888888888876 888888888
Q ss_pred ccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 107 ~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
.||||+|+..|+.+++++|++.|+++....
T Consensus 125 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d 154 (253)
T 1yyh_A 125 TTPLILAARLAVEGMLEDLINSHADVNAVD 154 (253)
T ss_dssp CCHHHHHHHHTCSSHHHHHHHTTCCTTCBC
T ss_pred CcHHHHHHHcChHHHHHHHHHcCCCCCCcC
Confidence 888888888888888888888887765443
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.2e-19 Score=174.97 Aligned_cols=122 Identities=26% Similarity=0.317 Sum_probs=108.4
Q ss_pred cccccccC-CCccccccccccCCCCCCCC--CCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 10 TLLKQSSL-APDRERKEAELNGLDDDGEE--IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 10 ~~~~~~~~-~~~~~~~~~~~~~~d~~~~~--~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
+++.+... +.+......--+|+|++..+ ..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus 202 ~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~ 281 (368)
T 3jue_A 202 LLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHT 281 (368)
T ss_dssp HHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCH
T ss_pred HHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcH
Confidence 55555555 55555555556788888887 8899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCC
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~ 131 (469)
+++++|+++|++++.+|..|.||||+|+..++.+++++|+..+..
T Consensus 282 ~~v~~LL~~Gad~~~~d~~G~TpL~~A~~~g~~~iv~lLl~~~~~ 326 (368)
T 3jue_A 282 GLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLRLAKMR 326 (368)
T ss_dssp HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHC-
T ss_pred HHHHHHHHCcCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCC
Confidence 999999999999999999999999999999999999999988744
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=8.3e-19 Score=161.92 Aligned_cols=110 Identities=25% Similarity=0.294 Sum_probs=98.5
Q ss_pred ccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCc
Q 012164 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (469)
Q Consensus 24 ~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~ 103 (469)
++++.+..+ ..+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++.+|
T Consensus 7 ~~~~~~~~~--~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d 84 (229)
T 2vge_A 7 KAGSPRKAR--RARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPD 84 (229)
T ss_dssp ---CCCCCC--CTTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred cCCCCcccc--ccccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Confidence 344443333 456678999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 104 ~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
..|.||||+|+..|+.+++++|++.|+++...
T Consensus 85 ~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~ 116 (229)
T 2vge_A 85 SHGWTPLHCAASCNDTVICMALVQHGAAIFAT 116 (229)
T ss_dssp TTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCC
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCcccc
Confidence 99999999999999999999999999887554
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.8e-19 Score=162.35 Aligned_cols=127 Identities=22% Similarity=0.202 Sum_probs=68.1
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCC-CCCCCcCCCCCcHHHHHHHcCC
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGF 85 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g-~~in~~d~~g~t~Lh~A~~~g~ 85 (469)
..||++.+...+.....+-.--+|++.+..+..|.||||+|+..|+.+++++|++.| ++++.+|..|+||||+|+..|+
T Consensus 44 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~ 123 (237)
T 3b7b_A 44 QRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKH 123 (237)
T ss_dssp CCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcccCCCCCCCHHHHHHHcCC
Confidence 344555554444443333333344555555555555555555555555555555555 5555555555555555555555
Q ss_pred HHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCC
Q 012164 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (469)
Q Consensus 86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~ 133 (469)
.+++++|+++|++++.+|..|.||||+|+..|+.+++++|++.|+++.
T Consensus 124 ~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~ 171 (237)
T 3b7b_A 124 VDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLH 171 (237)
T ss_dssp HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTT
T ss_pred HHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCC
Confidence 555555555555555555555555555555555555555555555543
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.3e-19 Score=164.37 Aligned_cols=125 Identities=22% Similarity=0.196 Sum_probs=107.2
Q ss_pred cccccccccccCCCccccccccccCCCCCCCC-CCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
-..||++.+...+.....+-.--.|+|.+..+ ..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 115 ~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 194 (241)
T 1k1a_A 115 DGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRG 194 (241)
T ss_dssp TSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHT
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcC
Confidence 45567777766666555555555788888888 78999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcC
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~ 130 (469)
+.+++++|+++|++++.+|..|.||+|+|+..|+.++++.|...++
T Consensus 195 ~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~i~~~l~~~~a 240 (241)
T 1k1a_A 195 LLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILRGKATRPA 240 (241)
T ss_dssp CHHHHHHHHHTTCCTTCCCTTSCCTTTTCSSHHHHHHHTC------
T ss_pred CHHHHHHHHhcCCCCCCcCCCCCCHHHHHHhcCcHHHHhhhccCCC
Confidence 9999999999999999999999999999999999999998887654
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.5e-19 Score=154.04 Aligned_cols=102 Identities=25% Similarity=0.253 Sum_probs=93.4
Q ss_pred CCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcc-cccc
Q 012164 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST-PLGD 112 (469)
Q Consensus 34 ~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t-pl~~ 112 (469)
+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+ .|+.+++++|+++|++++.+|..|.| |||+
T Consensus 6 ~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~ 84 (156)
T 1bi7_B 6 GSSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHD 84 (156)
T ss_dssp ----CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHH
T ss_pred cCCCccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHH
Confidence 455667899999999999999999999999999999999999999986 99999999999999999999999999 9999
Q ss_pred ccccchHHHHHHHHhhcCCCCCCc
Q 012164 113 AIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 113 A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
|+..|+.+++++|+++|+++....
T Consensus 85 A~~~~~~~~v~~Ll~~ga~~~~~d 108 (156)
T 1bi7_B 85 AAREGFLDTLVVLHRAGARLDVRD 108 (156)
T ss_dssp HHHHTCHHHHHHHHHHTCCSSCCC
T ss_pred HHHCCCHHHHHHHHHcCCCCcccC
Confidence 999999999999999998876543
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.76 E-value=8.8e-19 Score=155.80 Aligned_cols=120 Identities=26% Similarity=0.222 Sum_probs=104.6
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcC-CCCCcHHHHHHHcCC
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGF 85 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d-~~g~t~Lh~A~~~g~ 85 (469)
.+||++.+...+.....+..-- +.|++..+..|.||||+||..|+.+++++|+++|+++|.+| ..|+||||+|+..|+
T Consensus 44 g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~ 122 (183)
T 3deo_A 44 YETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVR 122 (183)
T ss_dssp HHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTC
T ss_pred CCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCc
Confidence 4677888877777665444433 88999999999999999999999999999999999999998 899999999999999
Q ss_pred HHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHh
Q 012164 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127 (469)
Q Consensus 86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~ 127 (469)
.+++++|+++|++++.+|..|.||||+|+..++.+....++.
T Consensus 123 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~~l~ 164 (183)
T 3deo_A 123 PEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQ 164 (183)
T ss_dssp HHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHHHTCCCCSHHH
T ss_pred HHHHHHHHHcCCCCcCCCCCCCCHHHHHHHhccCcccccHHH
Confidence 999999999999999999999999999998776654443333
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=8.2e-19 Score=171.59 Aligned_cols=129 Identities=29% Similarity=0.360 Sum_probs=113.0
Q ss_pred cccccccccCCCccccccc-cccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 8 RTTLLKQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
.++++.+...|........ .-.+.+.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+||..|+.
T Consensus 25 ~~~L~~A~~~g~~~~v~~ll~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~ 104 (351)
T 3utm_A 25 KDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHY 104 (351)
T ss_dssp HHHHHHHHHHTCHHHHHHHCCTTTTTCCCSSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCH
T ss_pred chhHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCH
Confidence 4555666655555533222 235788888899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
+++++|+++|++++..|..|.||||+|+..|+.+++++|+++|+++....
T Consensus 105 ~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~ 154 (351)
T 3utm_A 105 EVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVN 154 (351)
T ss_dssp HHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccc
Confidence 99999999999999999999999999999999999999999998875543
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.76 E-value=8.5e-19 Score=160.79 Aligned_cols=101 Identities=23% Similarity=0.326 Sum_probs=95.4
Q ss_pred CCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHC-CCCCCCCcCCCccccccccc
Q 012164 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIY 115 (469)
Q Consensus 37 ~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~-g~~~~~~~~~g~tpl~~A~~ 115 (469)
+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++ |++++.+|..|.||||+|+.
T Consensus 70 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~ 149 (222)
T 3ehr_A 70 AESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAW 149 (222)
T ss_dssp EEEESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHH
T ss_pred ccccccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHH
Confidence 44678999999999999999999999999999999999999999999999999999998 99999999999999999999
Q ss_pred cchHHHHHHHHhhcCCCCCCcc
Q 012164 116 YKNHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 116 ~~~~~~~~~L~~~~~~~~~~~~ 137 (469)
.|+.+++++|++.|+++.....
T Consensus 150 ~~~~~~v~~Ll~~ga~~~~~~~ 171 (222)
T 3ehr_A 150 KGYADIVQLLLAKGARTDLRNI 171 (222)
T ss_dssp HTCHHHHHHHHHHTCCSCCCCT
T ss_pred cCCHHHHHHHHHcCCCCccccC
Confidence 9999999999999998765443
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.4e-19 Score=157.54 Aligned_cols=132 Identities=23% Similarity=0.247 Sum_probs=117.7
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHH-HCCCCCCCcCCCCCcHHHHHHHc
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll-~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
.-..||++.+...+.....+-.--+|+|++..+..|.||||+|+..|+.+++++|+ ..+++++.+|..|+||||+|+..
T Consensus 37 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~ 116 (201)
T 3hra_A 37 TEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEK 116 (201)
T ss_dssp TTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHc
Confidence 34567888887777766665566678999999999999999999999999999999 67889999999999999999999
Q ss_pred CCHHHHHHHHHCC-CCCCCCcCCCccccccccccch-----HHHHHHHHhhcCCCCCCc
Q 012164 84 GFTEVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKN-----HEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 84 g~~~~v~~Ll~~g-~~~~~~~~~g~tpl~~A~~~~~-----~~~~~~L~~~~~~~~~~~ 136 (469)
|+.+++++|+++| ++++.+|..|.||||+|+..++ .+++++|+++|+++....
T Consensus 117 ~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~~ 175 (201)
T 3hra_A 117 GHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGADQSIKD 175 (201)
T ss_dssp TCHHHHHHHHHHCCCCTTCCCTTSCCHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCCC
T ss_pred CCHHHHHHHHHcCCCCcCCCCCCCCCHHHHHHHhccchhhHHHHHHHHHHCCCCCCccC
Confidence 9999999999998 9999999999999999998887 899999999999876543
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.8e-19 Score=166.39 Aligned_cols=129 Identities=21% Similarity=0.199 Sum_probs=108.2
Q ss_pred ccccccccccc---cCCCccc-----cccccccC------CCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcC
Q 012164 5 VPVRTTLLKQS---SLAPDRE-----RKEAELNG------LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70 (469)
Q Consensus 5 ~~~~~~~~~~~---~~~~~~~-----~~~~~~~~------~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d 70 (469)
...+||++.+. ..+.... ..+++.+. .+.+..+..|.||||+||..|+.++|++|+++|+++|.+|
T Consensus 44 ~~g~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~ 123 (260)
T 3jxi_A 44 STGKTCLPKALLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQA 123 (260)
T ss_dssp TTCCCHHHHHHTSCBTTBCTHHHHHHHHHHHTTCHHHHHTCCBCCSSEESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred CCCCcHHHHHHHHhhcCCHHHHHHHHHhcccccchHhhhcccccccccCCCCHHHHHHHcCCHHHHHHHHhCCCCcCccc
Confidence 44678887655 3444332 34444322 4456666789999999999999999999999999999999
Q ss_pred --------------CCCCcHHHHHHHcCCHHHHHHHHH---CCCCCCCCcCCCccccccccccch---------HHHHHH
Q 012164 71 --------------IDNRTALHVAACQGFTEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKN---------HEVIKL 124 (469)
Q Consensus 71 --------------~~g~t~Lh~A~~~g~~~~v~~Ll~---~g~~~~~~~~~g~tpl~~A~~~~~---------~~~~~~ 124 (469)
..|+||||+||..|+.+++++|++ +|++++.+|..|+||||+|+..++ .+++++
T Consensus 124 ~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~ 203 (260)
T 3jxi_A 124 RGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDL 203 (260)
T ss_dssp EECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHH
T ss_pred cccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHH
Confidence 689999999999999999999999 999999999999999999998776 689999
Q ss_pred HHhhcCCCC
Q 012164 125 LEKHGAKPL 133 (469)
Q Consensus 125 L~~~~~~~~ 133 (469)
|+++|+++.
T Consensus 204 Ll~~ga~~~ 212 (260)
T 3jxi_A 204 LLIKCAKLF 212 (260)
T ss_dssp HHHHHHHHC
T ss_pred HHHhCcccc
Confidence 999998863
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-19 Score=176.23 Aligned_cols=127 Identities=19% Similarity=0.118 Sum_probs=113.4
Q ss_pred cccccccccccCC--CccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCC-----CCCcCCCCCcHHH
Q 012164 6 PVRTTLLKQSSLA--PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID-----VNFRDIDNRTALH 78 (469)
Q Consensus 6 ~~~~~~~~~~~~~--~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~-----in~~d~~g~t~Lh 78 (469)
-..||++.+...+ .....+-.--+|+|++..+..|.||||+||..|+.+++++|++.|++ +|.+|..|+||||
T Consensus 137 ~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~ 216 (364)
T 3ljn_A 137 KGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLH 216 (364)
T ss_dssp SCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTH
T ss_pred CCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHH
Confidence 3578888888777 55555555556888889999999999999999999999999999998 9999999999999
Q ss_pred HHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCC
Q 012164 79 VAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 79 ~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
+||..|+.++|++|+++|+|++.+|..|.||||+|+..|+.+++++|+++++++
T Consensus 217 ~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~ 270 (364)
T 3ljn_A 217 WAILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVF 270 (364)
T ss_dssp HHHTTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTCCHHHHHHHHHHSCHH
T ss_pred HHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhChHHHHHHHHHcCCch
Confidence 999999999999999999999999999999999999999999999999998765
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.76 E-value=5.7e-19 Score=167.48 Aligned_cols=132 Identities=20% Similarity=0.127 Sum_probs=88.0
Q ss_pred cccccccccccccCCCccccccccccCCC---CCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHH
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLD---DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA 80 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A 80 (469)
+.-.+||++.+...+.....+-.--.|.+ .+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|
T Consensus 6 d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A 85 (282)
T 1oy3_D 6 TEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLA 85 (282)
T ss_dssp CTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHHH
T ss_pred CCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHH
Confidence 34456677776666665544444434444 556666777777777777777777777777777777777777777777
Q ss_pred HHcCCHHHHHHHHHCCCC-----------------------------------------------CCCCcCCCccccccc
Q 012164 81 ACQGFTEVVSLLLERGAD-----------------------------------------------VDPKDRWGSTPLGDA 113 (469)
Q Consensus 81 ~~~g~~~~v~~Ll~~g~~-----------------------------------------------~~~~~~~g~tpl~~A 113 (469)
+..|+.+++++|+++|++ ++.+|..|.||||+|
T Consensus 86 ~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A 165 (282)
T 1oy3_D 86 CRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVA 165 (282)
T ss_dssp TTTTCHHHHHHHSSSCCSSCCCC-----------------------------------CCCGGGGTTCCCTTSCCHHHHH
T ss_pred HHcCCcchhHhhhccCCCCchhhHHHHhhcccccCcchhcchhhhccccccchhhhhhhhhhhhcCCCcCCCCcCHHHHH
Confidence 777777777777766544 556666777777777
Q ss_pred cccchHHHHHHHHhhcCCCCCC
Q 012164 114 IYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 114 ~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
+..|+.+++++|+++|+++...
T Consensus 166 ~~~g~~~~v~~Ll~~g~~~~~~ 187 (282)
T 1oy3_D 166 VIHKDAEMVRLLRDAGADLNKP 187 (282)
T ss_dssp HHTTCHHHHHHHHHHTCCTTCC
T ss_pred HHcCCHHHHHHHHHcCCCCCCC
Confidence 7777777777777776665443
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=166.45 Aligned_cols=102 Identities=25% Similarity=0.266 Sum_probs=84.9
Q ss_pred CCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccc
Q 012164 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (469)
Q Consensus 33 ~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~ 112 (469)
.+.++..|+||||+||..|+.+++++|++.|+++|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|.||||+
T Consensus 52 ~~~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~ 131 (285)
T 3d9h_A 52 LMGDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFN 131 (285)
T ss_dssp TCSSSCCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHH
T ss_pred ccCCCccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHH
Confidence 45677778888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred ccccchHHHHHHHHhhcCCCCC
Q 012164 113 AIYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 113 A~~~~~~~~~~~L~~~~~~~~~ 134 (469)
|+..|+.+++++|++.++++..
T Consensus 132 A~~~~~~~~v~~Ll~~g~~~~~ 153 (285)
T 3d9h_A 132 ACVSGSWDCVNLLLQHGASVQP 153 (285)
T ss_dssp HHHHTCHHHHHHHHHTTCCSSC
T ss_pred HHHcCHHHHHHHHHHCCCCCCC
Confidence 8888888888888888877643
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.76 E-value=3e-19 Score=170.53 Aligned_cols=102 Identities=25% Similarity=0.260 Sum_probs=79.3
Q ss_pred CCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccc
Q 012164 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (469)
Q Consensus 32 d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~ 111 (469)
+++.+|.+|.||||+||..|+.+++++|++.|+++|.+| |+||||+||..|+.+++++|+++|++++.+|..|.||||
T Consensus 23 ~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~ 100 (285)
T 3kea_A 23 DTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALY 100 (285)
T ss_dssp TTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred CCCccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHH
Confidence 566777777788888888888888888888887777774 778888888888888888888888888888888888888
Q ss_pred cccccchHHHHHHHHhhcCCCCCC
Q 012164 112 DAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 112 ~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
+|+..|+.+++++|+++|+++...
T Consensus 101 ~A~~~g~~~~v~~Ll~~ga~~~~~ 124 (285)
T 3kea_A 101 YAVDSGNMQTVKLFVKKNWRLMFY 124 (285)
T ss_dssp HHHHTTCHHHHHHHHHHCGGGGGC
T ss_pred HHHHcCCHHHHHHHHhcCCCCCcc
Confidence 888888888888888777776543
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=9.6e-19 Score=177.14 Aligned_cols=129 Identities=25% Similarity=0.241 Sum_probs=89.1
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
..||++.+...+.....+-.--+++|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus 245 g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~ 324 (437)
T 1n11_A 245 GVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNI 324 (437)
T ss_dssp CCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCS
T ss_pred CCCHHHHHHHCCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcH
Confidence 44555555555544433333345666666677777777777777777777777777777777777777777777777777
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
++|++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++...
T Consensus 325 ~~v~~Ll~~gad~n~~~~~g~t~L~~A~~~g~~~iv~~Ll~~ga~~~~~ 373 (437)
T 1n11_A 325 KLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEV 373 (437)
T ss_dssp HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCC
T ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHCChHHHHHHHHHCcCCCCCC
Confidence 7777777777777777777777777777777777777777777766443
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=159.08 Aligned_cols=123 Identities=24% Similarity=0.222 Sum_probs=66.9
Q ss_pred ccccccccccCCCccccccccccC--CCCCC-CCCCCChHHHHHHHcCCHHHHHHHHHCC--CCCCCcCCCCCcHHHHHH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNG--LDDDG-EEIKPEFRLMFLANERDVEGIKELLDSG--IDVNFRDIDNRTALHVAA 81 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~--~d~~~-~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g--~~in~~d~~g~t~Lh~A~ 81 (469)
..||++.+...+.....+-.--.| .+.+. .+..|.||||+|+..|+.+++++|++.| ++++.+|..|+||||+|+
T Consensus 36 g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~ 115 (228)
T 2dzn_A 36 GRIPLHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAV 115 (228)
T ss_dssp SCCHHHHHHHTTCHHHHHHHHHTCTTCCGGGCCCTTSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHH
T ss_pred CCCHHHHHHHcCCHHHHHHHHhccccccccccCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHH
Confidence 344455444444433333333333 33333 4455555566666666666666666555 555555555666666666
Q ss_pred HcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhc
Q 012164 82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (469)
Q Consensus 82 ~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~ 129 (469)
..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|++.+
T Consensus 116 ~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g 163 (228)
T 2dzn_A 116 GKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLG 163 (228)
T ss_dssp HTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTT
T ss_pred HcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcC
Confidence 666666666666666666555555666666666555556666555555
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.2e-18 Score=163.39 Aligned_cols=130 Identities=21% Similarity=0.144 Sum_probs=117.3
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
+.-..||++.+...+.....+-.--+|+|.+..+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus 56 ~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~ 135 (285)
T 3d9h_A 56 AVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVS 135 (285)
T ss_dssp SCCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHH
T ss_pred CccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHc
Confidence 34567888888888877766666667899999999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCC
Q 012164 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 84 g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~ 134 (469)
|+.+++++|+++|++++..+ .|.||||+|+..|+.+++++|++.++++..
T Consensus 136 ~~~~~v~~Ll~~g~~~~~~~-~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~ 185 (285)
T 3d9h_A 136 GSWDCVNLLLQHGASVQPES-DLASPIHEAARRGHVECVNSLIAYGGNIDH 185 (285)
T ss_dssp TCHHHHHHHHHTTCCSSCSC-TTSCHHHHHHHHTCHHHHHHHHHTTCCTTC
T ss_pred CHHHHHHHHHHCCCCCCCCC-CCCCHHHHHHHcCCHHHHHHHHHCCCCCCC
Confidence 99999999999999998655 499999999999999999999999887643
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.7e-19 Score=166.87 Aligned_cols=132 Identities=25% Similarity=0.167 Sum_probs=105.0
Q ss_pred ccccccccccccCCCccccccccccCC-CCCCCCCCCChHHHHHH-----HcCCHHHHHHHHHCCCCCCCcCCCCCcHHH
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGL-DDDGEEIKPEFRLMFLA-----NERDVEGIKELLDSGIDVNFRDIDNRTALH 78 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~~~~~~g~t~l~~Aa-----~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh 78 (469)
.-..||++.+...+.....+-.--.|+ +.+..+..|.||||+|+ ..++.++++.|++.|++++..|..|+||||
T Consensus 109 ~~g~T~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpLh 188 (276)
T 4hbd_A 109 SNGNTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTALM 188 (276)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCCHHH
T ss_pred CCCCCHHHHHHHCCCHHHHHHHHHCCCCcCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCCHHH
Confidence 345666666666666555444444555 67777777777777777 556777777777777777777888999999
Q ss_pred HHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHh-hcCCCCCCc
Q 012164 79 VAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAP 136 (469)
Q Consensus 79 ~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~-~~~~~~~~~ 136 (469)
+||..|+.+++++|+++|+|++.+|..|+||||+|+..|+.+++++|++ .|+++....
T Consensus 189 ~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d 247 (276)
T 4hbd_A 189 LAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTD 247 (276)
T ss_dssp HHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCC
T ss_pred HHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcC
Confidence 9999999999999999999999999999999999999999999999998 788775443
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.3e-18 Score=159.14 Aligned_cols=131 Identities=29% Similarity=0.313 Sum_probs=105.7
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
+...+||++.+...+.....+-.--+|+|.+..+..|.||||+|+..|+.+++++|++.|++++.+|..|.||||+|+..
T Consensus 8 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 87 (237)
T 3b7b_A 8 HQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKK 87 (237)
T ss_dssp SCCSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHT
T ss_pred cCCCCCHHHHHHHcCcHHHHHHHHHcCCCcCccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHc
Confidence 34566777777777776655555556778888888888888888888888888888888888888888888888888888
Q ss_pred CCHHHHHHHHHCC-CCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCC
Q 012164 84 GFTEVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 84 g~~~~v~~Ll~~g-~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~ 134 (469)
|+.+++++|++.| ++++..+..|.||||+|+..++.+++++|++.|+++..
T Consensus 88 ~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~ 139 (237)
T 3b7b_A 88 GHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINI 139 (237)
T ss_dssp TCHHHHHHHHTTTCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred CCHHHHHHHHhCCCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCc
Confidence 8888888888887 78888888888888888888888888888888776543
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.74 E-value=3.3e-18 Score=162.04 Aligned_cols=129 Identities=26% Similarity=0.195 Sum_probs=114.1
Q ss_pred ccccccccccCCCcccccccccc-CCCCCCCCCCCChHHHHHHHcCC----HHHHHHHHHCCCCCCCcCCCCCcHHHHHH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELN-GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAA 81 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~-~~d~~~~~~~g~t~l~~Aa~~~~----~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~ 81 (469)
..+|++.+...+.....+-.--+ |.+.+..+..|.||||+|+..++ .+++++|++.|+++|.+|..|+||||+|+
T Consensus 148 g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~ 227 (285)
T 1wdy_A 148 GATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227 (285)
T ss_dssp CCCHHHHHHHHTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHH
T ss_pred CCcHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCCHHHHHHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHH
Confidence 45677776666655443333333 88888999999999999999999 99999999999999999999999999999
Q ss_pred HcCCHHHHHHHHH-CCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 82 CQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 82 ~~g~~~~v~~Ll~-~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
..|+.+++++|++ .|++++.+|..|.||||+|+..|+.+++++|+++|+++...
T Consensus 228 ~~~~~~~v~~Ll~~~g~~~~~~~~~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~ 282 (285)
T 1wdy_A 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG 282 (285)
T ss_dssp HTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCS
T ss_pred HcCCHHHHHHHHhccCCCccccCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCCcc
Confidence 9999999999999 89999999999999999999999999999999999998654
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2e-18 Score=160.95 Aligned_cols=98 Identities=35% Similarity=0.361 Sum_probs=93.4
Q ss_pred CCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCc-CCCcccccccccc
Q 012164 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYY 116 (469)
Q Consensus 38 ~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~-~~g~tpl~~A~~~ 116 (469)
..|.||||+||..|+.++++.|++ |+++|.+|..|+||||+||..|+.+++++|+++|++++.++ ..|.||||+|+..
T Consensus 43 ~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~ 121 (244)
T 3ui2_A 43 SEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGY 121 (244)
T ss_dssp HHHHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHT
T ss_pred cCCCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHc
Confidence 478999999999999999999999 99999999999999999999999999999999999999998 8899999999999
Q ss_pred chHHHHHHHHhhcCCCCCCc
Q 012164 117 KNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 117 ~~~~~~~~L~~~~~~~~~~~ 136 (469)
|+.+++++|+++|+++....
T Consensus 122 g~~~~v~~Ll~~ga~~~~~d 141 (244)
T 3ui2_A 122 VRPEVVEALVELGADIEVED 141 (244)
T ss_dssp TCHHHHHHHHHTTCCTTCCC
T ss_pred CCHHHHHHHHHCCCCCCCCC
Confidence 99999999999999876544
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-18 Score=165.45 Aligned_cols=130 Identities=21% Similarity=0.214 Sum_probs=106.3
Q ss_pred cccccccccccccC---CCcc-----ccccccccC------CCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCc
Q 012164 4 KVPVRTTLLKQSSL---APDR-----ERKEAELNG------LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFR 69 (469)
Q Consensus 4 ~~~~~~~~~~~~~~---~~~~-----~~~~~~~~~------~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~ 69 (469)
+.-.+||++.+... +... ...+++.+. .+....+..|.||||+||..|+.+++++|+++|+++|.+
T Consensus 51 ~~~g~tpL~~A~~~~~~g~~~~v~~Ll~~ga~~~~~~~~i~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~ 130 (273)
T 2pnn_A 51 PETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAA 130 (273)
T ss_dssp TTTCCCHHHHHHHSCBTTBCHHHHHHHHHHHHTTCHHHHHTCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred CcCCCCHHHHHHHHHhcCChHHHHHHHHhhccccchhHHhhcccccccCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCcc
Confidence 34567777777643 4332 233443211 122335668999999999999999999999999999999
Q ss_pred CC--------------CCCcHHHHHHHcCCHHHHHHHHH---CCCCCCCCcCCCccccccccccch---------HHHHH
Q 012164 70 DI--------------DNRTALHVAACQGFTEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKN---------HEVIK 123 (469)
Q Consensus 70 d~--------------~g~t~Lh~A~~~g~~~~v~~Ll~---~g~~~~~~~~~g~tpl~~A~~~~~---------~~~~~ 123 (469)
|. .|+||||+||..|+.+++++|++ +|++++.+|..|+||||+|+..|+ .++++
T Consensus 131 ~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~ 210 (273)
T 2pnn_A 131 ANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYN 210 (273)
T ss_dssp BCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHH
Confidence 87 79999999999999999999999 999999999999999999999887 78999
Q ss_pred HHHhhcCCCC
Q 012164 124 LLEKHGAKPL 133 (469)
Q Consensus 124 ~L~~~~~~~~ 133 (469)
+|++.|+++.
T Consensus 211 ~Ll~~ga~~n 220 (273)
T 2pnn_A 211 EILILGAKLH 220 (273)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHhhhhcc
Confidence 9999998764
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.73 E-value=5e-18 Score=160.83 Aligned_cols=128 Identities=23% Similarity=0.235 Sum_probs=114.2
Q ss_pred cccccccccCCCccccccccccCCCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 8 RTTLLKQSSLAPDRERKEAELNGLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
.++++.+...+.+...+-.--+|.+.+.. +..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.
T Consensus 6 ~~~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~ 85 (285)
T 1wdy_A 6 NHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSV 85 (285)
T ss_dssp HHHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCH
T ss_pred chHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCH
Confidence 45666666666666555555567787777 77899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
+++++|+++|++++..|..|.||||+|+..|+.+++++|++.++++...
T Consensus 86 ~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~ 134 (285)
T 1wdy_A 86 KLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLR 134 (285)
T ss_dssp HHHHHHHHTTCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred HHHHHHHHcCCCCCccCcccCCHHHHHHHhCCHHHHHHHHHhCCCcccc
Confidence 9999999999999999999999999999999999999999999876543
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.73 E-value=3e-18 Score=173.47 Aligned_cols=127 Identities=29% Similarity=0.232 Sum_probs=88.8
Q ss_pred cccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCC
Q 012164 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~ 85 (469)
-.+||++.+...|.+...+-.--+|+|++..+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+||..|+
T Consensus 13 ~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~ 92 (437)
T 1n11_A 13 SGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGH 92 (437)
T ss_dssp --CCHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTC
T ss_pred CCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCC
Confidence 35666666666666665555555666666677777777777777777777777777777777777777777777777777
Q ss_pred HHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCC
Q 012164 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
.+++++|+++|++++..+..|.||||+|+..|+.++++.|++.+++.
T Consensus 93 ~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~ 139 (437)
T 1n11_A 93 TNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQ 139 (437)
T ss_dssp HHHHHHHHHHTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCS
T ss_pred HHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCC
Confidence 77777777777777777777777777777777777777777766554
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-18 Score=164.25 Aligned_cols=127 Identities=20% Similarity=0.092 Sum_probs=102.1
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
+.-.+||++.+...+.....+-.--+|+|++.. +|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus 28 d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~--~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~ 105 (285)
T 3kea_A 28 DVHGHSASYYAIADNNVRLVCTLLNAGALKNLL--ENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDS 105 (285)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCC--TTCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCC--CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Confidence 445677888887777766554444456666655 478888888888888888888888888888888888888888888
Q ss_pred CCHHHHHHHHHCCCCCCCCcCCC-ccccccccccchHHHHHHHHhhcCCC
Q 012164 84 GFTEVVSLLLERGADVDPKDRWG-STPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 84 g~~~~v~~Ll~~g~~~~~~~~~g-~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
|+.+++++|+++|++++.+|..| .||||+|+..|+.+++++|++++++.
T Consensus 106 g~~~~v~~Ll~~ga~~~~~~~~g~~t~L~~A~~~~~~~~v~~Ll~~g~~~ 155 (285)
T 3kea_A 106 GNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST 155 (285)
T ss_dssp TCHHHHHHHHHHCGGGGGCSSSGGGSHHHHHHHTTCHHHHHHHHTTSCTT
T ss_pred CCHHHHHHHHhcCCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHhCCCcc
Confidence 88888888888888888888888 68888888888888888888888766
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-18 Score=170.93 Aligned_cols=102 Identities=21% Similarity=0.166 Sum_probs=96.9
Q ss_pred CCCCCCCChHHHHHHHcC--CHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCC-----CCCCcCCC
Q 012164 34 DGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-----VDPKDRWG 106 (469)
Q Consensus 34 ~~~~~~g~t~l~~Aa~~~--~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~-----~~~~~~~g 106 (469)
+..+..|.||||+||..| +.+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++ ++..|..|
T Consensus 132 ~~~~~~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g 211 (364)
T 3ljn_A 132 HVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQG 211 (364)
T ss_dssp EEEEESCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTC
T ss_pred ccCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCC
Confidence 338889999999999999 99999999999999999999999999999999999999999999999 99999999
Q ss_pred ccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 107 STPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 107 ~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
.||||+|+..|+.+++++|+++|+++...
T Consensus 212 ~t~L~~A~~~g~~~~v~~Ll~~gad~~~~ 240 (364)
T 3ljn_A 212 NSHLHWAILINWEDVAMRFVEMGIDVNME 240 (364)
T ss_dssp CCTTHHHHTTTCHHHHHHHHTTTCCTTCC
T ss_pred CcHHHHHHHcCCHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999887544
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=4.1e-18 Score=163.24 Aligned_cols=101 Identities=26% Similarity=0.376 Sum_probs=82.8
Q ss_pred CCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccc
Q 012164 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (469)
Q Consensus 36 ~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~ 115 (469)
.+.+|.||||+||..|+.++|++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++..|..|.||||+|+.
T Consensus 36 ~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~ 115 (299)
T 1s70_B 36 VKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAAS 115 (299)
T ss_dssp CEECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred cccCCccHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHH
Confidence 44567788888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cchHHHHHHHHhhcCCCCCCc
Q 012164 116 YKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 116 ~~~~~~~~~L~~~~~~~~~~~ 136 (469)
.|+.+++++|+++|+++....
T Consensus 116 ~g~~~~v~~Ll~~g~~~~~~~ 136 (299)
T 1s70_B 116 CGYLDIAEYLISQGAHVGAVN 136 (299)
T ss_dssp HTCHHHHHHHHHTTCCTTCCC
T ss_pred cCCHHHHHHHHhCCCCCCCcC
Confidence 888888888888887765443
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=9e-18 Score=163.99 Aligned_cols=100 Identities=27% Similarity=0.353 Sum_probs=56.0
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHC-CCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCc
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~-g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~ 107 (469)
+|+|++.++..|.||||+||..|+.++++.|++. |+++|.+|.+|+||||+||..|+.++|++|+++|||+|.+
T Consensus 228 ~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~----- 302 (337)
T 4g8k_A 228 HGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG----- 302 (337)
T ss_dssp TTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC-----
T ss_pred CCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC-----
Confidence 3445555555555555555555555555555543 5555555555555555555555555555555555555432
Q ss_pred cccccccccchHHHHHHHHhhcCCCC
Q 012164 108 TPLGDAIYYKNHEVIKLLEKHGAKPL 133 (469)
Q Consensus 108 tpl~~A~~~~~~~~~~~L~~~~~~~~ 133 (469)
||||+|+..|+.+++++|+++|+++.
T Consensus 303 ~~L~~A~~~~~~~iv~~Ll~~GA~~d 328 (337)
T 4g8k_A 303 DLVMTARRNYDHSLVKVLLSHGAKED 328 (337)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCC-
T ss_pred CHHHHHHHcCCHHHHHHHHHCcCCCC
Confidence 35555555555555555555555543
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-17 Score=163.64 Aligned_cols=88 Identities=27% Similarity=0.150 Sum_probs=48.1
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
..||++.+...+.....+-.--+|+|++..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus 58 g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~ 137 (351)
T 3utm_A 58 KSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRV 137 (351)
T ss_dssp CCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCH
T ss_pred CCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCH
Confidence 45555555555555444444444555555555555555555555555555555555555555555555555555555555
Q ss_pred HHHHHHHH
Q 012164 87 EVVSLLLE 94 (469)
Q Consensus 87 ~~v~~Ll~ 94 (469)
+++++|++
T Consensus 138 ~~v~~Ll~ 145 (351)
T 3utm_A 138 EVCSLLLS 145 (351)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 44444443
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=3.9e-18 Score=169.23 Aligned_cols=95 Identities=24% Similarity=0.318 Sum_probs=62.0
Q ss_pred CCCCCChHHHHHHHcCCHHHHHHHHHCC-CCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccccc
Q 012164 36 EEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (469)
Q Consensus 36 ~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g-~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~ 114 (469)
.+..|.||||+||..|+.++|++|++.| +++|.+|..|+||||+|+..|+.++|++|+++|++++.+|..|.||||+|+
T Consensus 275 ~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g~t~l~~A~ 354 (373)
T 2fo1_E 275 EKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQ 354 (373)
T ss_dssp SSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHHH
T ss_pred ccccCCCHHHHHHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCCCCCCHHHHHH
Confidence 4456666666666666666666666553 666666666666666666666666666666666666666666666666666
Q ss_pred ccchHHHHHHHHhhcC
Q 012164 115 YYKNHEVIKLLEKHGA 130 (469)
Q Consensus 115 ~~~~~~~~~~L~~~~~ 130 (469)
..|+.+++++|+++++
T Consensus 355 ~~g~~~iv~~Ll~~~a 370 (373)
T 2fo1_E 355 ANNHHNIVDIFDRCRP 370 (373)
T ss_dssp HTTCHHHHHHHHTTC-
T ss_pred HcCCHHHHHHHHhcCc
Confidence 6666666666666554
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.71 E-value=9.7e-18 Score=166.35 Aligned_cols=130 Identities=24% Similarity=0.216 Sum_probs=115.8
Q ss_pred ccccccccccccCCCcccccccc--------ccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcH
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAE--------LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTA 76 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~ 76 (469)
.-.+||++.+...+.....+-.- -+|+|++..+.+|.||||+||..|+.++|++|+++|+++|.+|..|+||
T Consensus 123 ~~g~t~Lh~Aa~~g~~~~v~~Ll~~~~~~ll~~ga~vn~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~ 202 (373)
T 2fo1_E 123 RHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSA 202 (373)
T ss_dssp SSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCH
T ss_pred cCCCCHHHHHHHCCCHHHHHHHHHHHHHHHHhcCCCCcCCCCCCCCHHHHHHHcChHHHHHHHHHCCCCCcccCCCCCCH
Confidence 45778888888877765444332 4788899999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCHHHHHHHHHCC---CCCCCCcCCCccccccccccc---hHHHHHHHHhhcCCCCC
Q 012164 77 LHVAACQGFTEVVSLLLERG---ADVDPKDRWGSTPLGDAIYYK---NHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 77 Lh~A~~~g~~~~v~~Ll~~g---~~~~~~~~~g~tpl~~A~~~~---~~~~~~~L~~~~~~~~~ 134 (469)
||+|+..|+.+++++|+++| ++++..|..|.||||+|+..+ +.+++++|++.|+++..
T Consensus 203 L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~d~~g~t~L~~A~~~~~~~~~~~v~~Ll~~g~~~~~ 266 (373)
T 2fo1_E 203 LHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDY 266 (373)
T ss_dssp HHHHHHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSC
T ss_pred HHHHHHCCCHHHHHHHHhcCccccChhhcCCCCCCHHHHHHHhCCcchHHHHHHHHHCCCCccc
Confidence 99999999999999999998 899999999999999999988 89999999999988754
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-18 Score=168.56 Aligned_cols=110 Identities=20% Similarity=0.188 Sum_probs=76.2
Q ss_pred cCCCCCC-CCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC-----------------------
Q 012164 29 NGLDDDG-EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG----------------------- 84 (469)
Q Consensus 29 ~~~d~~~-~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g----------------------- 84 (469)
.|+|+|. .+..|.||||+||..|+.++|++|+++|+++|.+|..|+||||+||..|
T Consensus 119 ~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~~~d 198 (327)
T 1sw6_A 119 TQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILED 198 (327)
T ss_dssp SCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEEC
T ss_pred cCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhccccCCC
Confidence 4566666 5666677777777777777777777777777766666666666666654
Q ss_pred ------------------CHHHHHHHHHCCC---------------------------------------------CCCC
Q 012164 85 ------------------FTEVVSLLLERGA---------------------------------------------DVDP 101 (469)
Q Consensus 85 ------------------~~~~v~~Ll~~g~---------------------------------------------~~~~ 101 (469)
+.+++++|++.++ +++.
T Consensus 199 ~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~~n~ 278 (327)
T 1sw6_A 199 SMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNA 278 (327)
T ss_dssp TTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTC
T ss_pred CCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhCCCC
Confidence 4455566655432 5777
Q ss_pred CcCCCccccccccccchHHHHHHHHhhcCCCCCCccc
Q 012164 102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (469)
Q Consensus 102 ~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~ 138 (469)
+|..|+||||+|+..|+.+++++|+++|+++......
T Consensus 279 ~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~ 315 (327)
T 1sw6_A 279 QDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKS 315 (327)
T ss_dssp CCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTT
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCC
Confidence 7788888888888888888888888888887655433
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.4e-17 Score=156.62 Aligned_cols=135 Identities=21% Similarity=0.215 Sum_probs=101.4
Q ss_pred cccceeeecCeEEEEEE-----ecee--ehhhhcccccCCC---------------------HHHHHHHHHHHHHHhcCC
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQ--VAVKKLGEEVISD---------------------DDRVRAFRDELALLQKIR 208 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~--vaiK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 208 (469)
|+..+.||+|+||.||. +|+. ||||++....... ......+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678999999999874 5788 9999865432110 111236788999999998
Q ss_pred CCce--eeEEeEEEeCCceEEEEeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCC
Q 012164 209 HPNV--VQFLGAVTQSSPMMIVTEYLPK-G----DLRAFLKRKGALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLE 280 (469)
Q Consensus 209 h~~i--~~~~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH~Dlk 280 (469)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 8754 444443 356899999942 3 77776543 345678899999999999999 888 9999999
Q ss_pred CCcccccccccCcceeeCCCCCeEEeecCCcccc
Q 012164 281 PSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLL 314 (469)
Q Consensus 281 p~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~ 314 (469)
|+ |||++. .++|+|||+|...
T Consensus 199 p~-----------NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EY-----------NIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TT-----------SEEESS--SEEECCCTTCEET
T ss_pred HH-----------HEEEcC--cEEEEECcccccC
Confidence 99 777766 8999999999753
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=3e-17 Score=151.40 Aligned_cols=132 Identities=20% Similarity=0.157 Sum_probs=119.2
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcC-CCCCcHHHHHHH
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAAC 82 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d-~~g~t~Lh~A~~ 82 (469)
+....++++.+...+.+...+-.--.|+|.+..+..|.||||+|+..|+.+++++|++.|++++..+ ..|+||||+|+.
T Consensus 6 d~~~~~~l~~A~~~g~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~ 85 (240)
T 3eu9_A 6 DDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATR 85 (240)
T ss_dssp SCGGGCCHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHH
T ss_pred ccccchHHHHHHHcCChHHHHHHHHcCCCcCCCCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHH
Confidence 4456778888888888877777777889999999999999999999999999999999999998765 559999999999
Q ss_pred cCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 83 ~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
.|+.+++++|++.|++++..|..|.||||+|+..|+.+++++|++.++++...
T Consensus 86 ~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~ 138 (240)
T 3eu9_A 86 QGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMM 138 (240)
T ss_dssp HTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred cCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCHHHHHHHHHhcCCCcccc
Confidence 99999999999999999999999999999999999999999999998876543
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.69 E-value=2.7e-17 Score=128.95 Aligned_cols=91 Identities=36% Similarity=0.386 Sum_probs=81.9
Q ss_pred cccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHH
Q 012164 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~ 87 (469)
+||++.+...+.....+-.--+|+|++.++..|+||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+
T Consensus 3 ~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~ 82 (93)
T 1n0q_A 3 RTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLE 82 (93)
T ss_dssp CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred CcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHH
Confidence 56777777777666555555678899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHCCCC
Q 012164 88 VVSLLLERGAD 98 (469)
Q Consensus 88 ~v~~Ll~~g~~ 98 (469)
++++|+++|++
T Consensus 83 ~~~~Ll~~ga~ 93 (93)
T 1n0q_A 83 VVKLLLEAGAY 93 (93)
T ss_dssp HHHHHHHTTCC
T ss_pred HHHHHHHcCCC
Confidence 99999999986
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3.7e-17 Score=159.62 Aligned_cols=128 Identities=26% Similarity=0.193 Sum_probs=108.5
Q ss_pred ccccccccccCCCcccccccc-ccCCCCCCCCCCCChHHHHHHHcCC----HHHHHHHHHCCCCCCCcCCCCCcHHHHHH
Q 012164 7 VRTTLLKQSSLAPDRERKEAE-LNGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAA 81 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~-~~~~d~~~~~~~g~t~l~~Aa~~~~----~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~ 81 (469)
..||++.+...+...-.+-.- -.|+|++..+..|.|++|+++..+. ..++++|+++|+++|.+|..|+||||+||
T Consensus 168 g~T~L~~A~~~g~~~~v~~LL~~~gad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~ 247 (337)
T 4g8k_A 168 GATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 247 (337)
T ss_dssp SCCHHHHHHHHTCHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHH
T ss_pred CCcHHHHHHHCCCHHHHHHHHhccCCCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence 567777776666554332221 2578888889999999998877554 46889999999999999999999999999
Q ss_pred HcCCHHHHHHHHHC-CCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCC
Q 012164 82 CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (469)
Q Consensus 82 ~~g~~~~v~~Ll~~-g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~ 134 (469)
..|+.+++++|++. |++++.+|..|+||||+|+..|+.+++++|+++|+++..
T Consensus 248 ~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~ 301 (337)
T 4g8k_A 248 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDC 301 (337)
T ss_dssp HTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTT
T ss_pred HhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCC
Confidence 99999999999985 899999999999999999999999999999999998754
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-17 Score=136.81 Aligned_cols=108 Identities=29% Similarity=0.283 Sum_probs=96.1
Q ss_pred ccccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHH
Q 012164 3 TKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82 (469)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~ 82 (469)
++.-.+||++.+...+.....+-.--+|+|.+..+..|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+.
T Consensus 5 ~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~ 84 (115)
T 2l6b_A 5 GSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKK 84 (115)
T ss_dssp CSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHT
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Confidence 35567788888888877776666666788999999999999999999999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHCCCCCCCCcCCCcccc
Q 012164 83 QGFTEVVSLLLERGADVDPKDRWGSTPL 110 (469)
Q Consensus 83 ~g~~~~v~~Ll~~g~~~~~~~~~g~tpl 110 (469)
.|+.+++++|+++|++++.++..|.||-
T Consensus 85 ~~~~~~~~~Ll~~ga~~n~~~~~~~~~~ 112 (115)
T 2l6b_A 85 NGHHEIVKLLDAKGADVNARSWGSSHHH 112 (115)
T ss_dssp TTCHHHHHHHHTTSSSHHHHSCCCC---
T ss_pred CCCHHHHHHHHHcCCCCCcCCccccccc
Confidence 9999999999999999999999999874
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.67 E-value=2.3e-17 Score=160.70 Aligned_cols=90 Identities=18% Similarity=0.104 Sum_probs=78.4
Q ss_pred CChHHHHHHHcCCHHHHHHHHHCCCCCCC-cCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccch
Q 012164 40 PEFRLMFLANERDVEGIKELLDSGIDVNF-RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118 (469)
Q Consensus 40 g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~-~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~ 118 (469)
..+.+|+|+..+..++++.|++.|+|+|. +|..|+||||+||..|+.++|++|+++|++++.+|..|+||||+|+..|+
T Consensus 97 ~~~~~~~a~~~~~~~~~~~l~~~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~ 176 (327)
T 1sw6_A 97 NQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVN 176 (327)
T ss_dssp -------CHHHHHHHHHHHCTTSCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSH
T ss_pred ccchhHHHHHhhHHHHHHHHHhcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcc
Confidence 34557999999999999999999999999 89999999999999999999999999999999999999999999999998
Q ss_pred ---HHHHHHHHhhc
Q 012164 119 ---HEVIKLLEKHG 129 (469)
Q Consensus 119 ---~~~~~~L~~~~ 129 (469)
.++++.|++.+
T Consensus 177 ~~~~~~~~~ll~~~ 190 (327)
T 1sw6_A 177 NYDSGTFEALLDYL 190 (327)
T ss_dssp HHHTTCHHHHHHHH
T ss_pred cccHHHHHHHHHhh
Confidence 67777777665
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=6.3e-17 Score=149.26 Aligned_cols=128 Identities=23% Similarity=0.183 Sum_probs=76.4
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCC-CCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCC
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEI-KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~ 85 (469)
..||++.+...+.....+-.--++.+.+.... .|.||||+|+..|+.+++++|++.|++++.+|..|.||||+|+..|+
T Consensus 42 g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~ 121 (240)
T 3eu9_A 42 NVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGH 121 (240)
T ss_dssp SCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCH
Confidence 44555555555554444444444555444332 36666666666666666666666666666666666666666666666
Q ss_pred HHHHHHHHHCCCCCCCCcCCCccccccccccch-HHHHHHHHhhcCCCCC
Q 012164 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN-HEVIKLLEKHGAKPLM 134 (469)
Q Consensus 86 ~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~-~~~~~~L~~~~~~~~~ 134 (469)
.+++++|+++|++++..+..|.||||+|+..++ .+++++|...++++..
T Consensus 122 ~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~ 171 (240)
T 3eu9_A 122 TSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNL 171 (240)
T ss_dssp HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTC
T ss_pred HHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcch
Confidence 666666666666666666666666666664443 5566666666655543
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-16 Score=156.17 Aligned_cols=103 Identities=26% Similarity=0.306 Sum_probs=94.1
Q ss_pred CCCCCCCChHHHHHHHc-CCHHHHHHHHHCCCCCCCcC--CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccc
Q 012164 34 DGEEIKPEFRLMFLANE-RDVEGIKELLDSGIDVNFRD--IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (469)
Q Consensus 34 ~~~~~~g~t~l~~Aa~~-~~~~~v~~Ll~~g~~in~~d--~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl 110 (469)
+.....+.|+||+||.. |+.++++.|+++|+|+|..| ..|+||||+||..|+.+++++|+++|++++.+|..|.|||
T Consensus 193 ~l~~~~~~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpL 272 (368)
T 3jue_A 193 DLGSLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPL 272 (368)
T ss_dssp ----CCHHHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred ccccCCCCcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHH
Confidence 33445678999999999 99999999999999999998 8999999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHhhcCCCCCCc
Q 012164 111 GDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 111 ~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
|+|+..|+.+++++|+++|+++....
T Consensus 273 h~A~~~g~~~~v~~LL~~Gad~~~~d 298 (368)
T 3jue_A 273 HHATILGHTGLACLFLKRGADLGARD 298 (368)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHcCcHHHHHHHHHCcCCCCCcC
Confidence 99999999999999999999875543
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.9e-15 Score=155.64 Aligned_cols=98 Identities=26% Similarity=0.280 Sum_probs=92.0
Q ss_pred CChHHHHHHHcCCHHHHHHHHHCCCCCCCc------CCCCCcHHHHHHH---cCCHHHHHHHHHCCCCCCCCcCCCcccc
Q 012164 40 PEFRLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAAC---QGFTEVVSLLLERGADVDPKDRWGSTPL 110 (469)
Q Consensus 40 g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~------d~~g~t~Lh~A~~---~g~~~~v~~Ll~~g~~~~~~~~~g~tpl 110 (469)
..+.||.|+..|+.++++.|++.|+|+|.+ |..|+||||+||. .|+.+++++|+++|+|+|.+|..|+|||
T Consensus 132 ~~~~L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpL 211 (497)
T 3lvq_E 132 EPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTAL 211 (497)
T ss_dssp CHHHHHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHH
T ss_pred cHHHHHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHH
Confidence 347899999999999999999999999988 8899999999976 9999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHhhcCCCCCCcc
Q 012164 111 GDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 111 ~~A~~~~~~~~~~~L~~~~~~~~~~~~ 137 (469)
|+|+..|+.+++++|+++|+++.....
T Consensus 212 h~A~~~g~~~~v~~Ll~~ga~~~~~d~ 238 (497)
T 3lvq_E 212 HYAALYNQPDCLKLLLKGRALVGTVNE 238 (497)
T ss_dssp HHHTTTTCHHHHHHHHHTCCCCSCCCT
T ss_pred HHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence 999999999999999999999876544
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.7e-15 Score=145.43 Aligned_cols=98 Identities=24% Similarity=0.271 Sum_probs=91.4
Q ss_pred CCChHHHHHHHcCCHHHHHHHHHCCCCCCC------cCCCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCcCCCccc
Q 012164 39 KPEFRLMFLANERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTP 109 (469)
Q Consensus 39 ~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~------~d~~g~t~Lh~A~~~---g~~~~v~~Ll~~g~~~~~~~~~g~tp 109 (469)
.+.++||.|+..|+.+.++.|++.|+++|. .|..|+||||+||.. |+.+++++|+++|++++.+|..|.||
T Consensus 150 ~~~~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~Tp 229 (301)
T 2b0o_E 150 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTA 229 (301)
T ss_dssp -CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCH
T ss_pred chHHHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 356789999999999999999999999998 689999999999997 89999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhcCCCCCCc
Q 012164 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 110 l~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
||+|+..|+.+++++|+++|+++....
T Consensus 230 Lh~A~~~g~~~~v~~Ll~~gad~~~~d 256 (301)
T 2b0o_E 230 LHYAALYNQPDCLKLLLKGRALVGTVN 256 (301)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 999999999999999999999875543
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.58 E-value=3.9e-15 Score=141.35 Aligned_cols=98 Identities=26% Similarity=0.298 Sum_probs=90.5
Q ss_pred CCChHHHHHHHcCCHHHHHHHHHCCCCCC------CcCCCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCcCCCccc
Q 012164 39 KPEFRLMFLANERDVEGIKELLDSGIDVN------FRDIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTP 109 (469)
Q Consensus 39 ~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in------~~d~~g~t~Lh~A~~~---g~~~~v~~Ll~~g~~~~~~~~~g~tp 109 (469)
...++|+.|+..|+.+.++.+++.|++++ ..|..|+||||+||.. |+.+++++|+++|+++|.+|..|.||
T Consensus 129 ~~l~~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~Tp 208 (278)
T 1dcq_A 129 AKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTA 208 (278)
T ss_dssp HHHHHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCH
T ss_pred hhhhhhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCH
Confidence 34578999999999999999999999954 4588999999999999 99999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhcCCCCCCc
Q 012164 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 110 l~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
||+|+..|+.+++++|+++|+++....
T Consensus 209 Lh~A~~~g~~~~v~~Ll~~gad~~~~d 235 (278)
T 1dcq_A 209 LHYCCLTDNAECLKLLLRGKASIEIAN 235 (278)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999999876554
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.55 E-value=1e-16 Score=158.52 Aligned_cols=123 Identities=12% Similarity=-0.014 Sum_probs=93.4
Q ss_pred ccccccccccCCCccccccccccCCC---CCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCC---CCcCCCCCcHHHHH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLD---DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV---NFRDIDNRTALHVA 80 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d---~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~i---n~~d~~g~t~Lh~A 80 (469)
.+||++.++..|.+...+-.--+|.+ .+..+..|.||||+||..|+.++|++|+++|+|+ +..+.+ +||||+|
T Consensus 92 ~~T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~A 170 (376)
T 2aja_A 92 SEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLA 170 (376)
T ss_dssp HHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHH
T ss_pred cCCHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHH
Confidence 35777777777776654444444442 1233446788999999999999999999999762 222223 8999999
Q ss_pred HHcCCHHHHHHHHHCCCCCCC--CcCCCcccccccc-ccchHHHHHHHHhhcC
Q 012164 81 ACQGFTEVVSLLLERGADVDP--KDRWGSTPLGDAI-YYKNHEVIKLLEKHGA 130 (469)
Q Consensus 81 ~~~g~~~~v~~Ll~~g~~~~~--~~~~g~tpl~~A~-~~~~~~~~~~L~~~~~ 130 (469)
|..|+.++|++|+++|++++. .|..|.||||+|+ ..|+.+++++|+++|+
T Consensus 171 a~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~Aa~~~G~~eiv~~Ll~~ga 223 (376)
T 2aja_A 171 AENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPV 223 (376)
T ss_dssp HHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHH
T ss_pred HHCCCHHHHHHHHHcCCccchhccCCCCCCHHHHHHHHCCCHHHHHHHHhCCC
Confidence 999999999999999999887 8888999999999 9999999999988663
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.51 E-value=9e-15 Score=143.38 Aligned_cols=133 Identities=17% Similarity=0.134 Sum_probs=93.9
Q ss_pred cccceeeecCeEEEEEE----eceeehhhhcccccCC---------------CHHHH----HHHHHHHHHHhcCCCCcee
Q 012164 157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---------------DDDRV----RAFRDELALLQKIRHPNVV 213 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~---------------~~~~~----~~~~~E~~~l~~l~h~~i~ 213 (469)
|++...||.|+||.||. +|+.||||+++..... ..... -....|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 77888999999999985 5889999986532111 00111 1124577888888655443
Q ss_pred --eEEeEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc
Q 012164 214 --QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291 (469)
Q Consensus 214 --~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~ 291 (469)
..++. . ..+|||||++|++|.++.. ......++.|++.+|.+||+.| ||||||||.
T Consensus 177 vp~p~~~--~--~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~--------- 234 (397)
T 4gyi_A 177 VPEPIAQ--S--RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG---LIHGDFNEF--------- 234 (397)
T ss_dssp CCCEEEE--E--TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT---------
T ss_pred CCeeeec--c--CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH---------
Confidence 33332 2 2379999999888865432 2345678899999999999999 999999999
Q ss_pred CcceeeCCCC----------CeEEeecCCccc
Q 012164 292 DRNILRDDSG----------NLKVADFGVSKL 313 (469)
Q Consensus 292 ~~nil~~~~~----------~vkl~Dfgla~~ 313 (469)
|||++.++ .+.|+||+-+..
T Consensus 235 --NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 --NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp --SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred --HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 55555444 388999997754
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.45 E-value=5e-14 Score=113.86 Aligned_cols=88 Identities=24% Similarity=0.306 Sum_probs=77.8
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
.-..++++.+...+.....+-.--+|+|.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|
T Consensus 22 ~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~ 101 (110)
T 2zgd_A 22 SDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISIDNG 101 (110)
T ss_dssp CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred CccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHHHHHcC
Confidence 34567777777777766655555678899999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHH
Q 012164 85 FTEVVSLL 92 (469)
Q Consensus 85 ~~~~v~~L 92 (469)
+.+++++|
T Consensus 102 ~~~~~~~L 109 (110)
T 2zgd_A 102 NEDLAEIL 109 (110)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHh
Confidence 99999987
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.45 E-value=6.9e-16 Score=152.52 Aligned_cols=116 Identities=12% Similarity=0.021 Sum_probs=98.3
Q ss_pred ccccccccccCCCccccccccccCCC-----CCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCC--cCCCCCcHHHH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLD-----DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF--RDIDNRTALHV 79 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d-----~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~--~d~~g~t~Lh~ 79 (469)
..||++.++..|+.--.+-.--+|+| .+..+ .||||+||..|+.++|++|+++|++++. .|..|+||||+
T Consensus 128 ~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~---~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~ 204 (376)
T 2aja_A 128 NYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN---YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRW 204 (376)
T ss_dssp HHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH---HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC---CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCCHHHH
Confidence 35678888887776654444445543 33333 8999999999999999999999999998 89999999999
Q ss_pred HH-HcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCC
Q 012164 80 AA-CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 80 A~-~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
|| ..|+.++|++|+++|++ |.|||++|+..|+.+++++|+++++++
T Consensus 205 Aa~~~G~~eiv~~Ll~~ga~-------~~taL~~Aa~~g~~evv~lL~~~ga~~ 251 (376)
T 2aja_A 205 AAVGRGHHNVINFLLDCPVM-------LAYAEIHEFEYGEKYVNPFIARHVNRL 251 (376)
T ss_dssp HHSTTCCHHHHHHHTTSHHH-------HHHHHHCTTTTTTTTHHHHHHHHHHHH
T ss_pred HHHHCCCHHHHHHHHhCCCc-------cchHHHHHHHCCCHHHHHHHHhcCccc
Confidence 99 99999999999998853 899999999999999999999998765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=2.7e-10 Score=106.66 Aligned_cols=137 Identities=12% Similarity=0.030 Sum_probs=99.3
Q ss_pred cccceeeecCeEEEEE---EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEecc
Q 012164 157 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYL 232 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~ 232 (469)
|+....++.|+...|| ..|..+++|......... ...+.+|+.+++.+. +..++++++++...+..|+||||+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 4444555555554444 346899999886432111 135888999999985 677889999998888899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 012164 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK------------------------------------------ 270 (469)
Q Consensus 233 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------------ 270 (469)
+|.+|.+.+. +......++.+++++|..||+..
T Consensus 93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9999987631 22334578889999999999811
Q ss_pred --------------CCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcc
Q 012164 271 --------------PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312 (469)
Q Consensus 271 --------------~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~ 312 (469)
+..++|+|++|. ||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~-----------Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDS-----------NIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTT-----------SEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcC-----------cEEEECCcEEEEEEchhcc
Confidence 123899999999 7777655556799998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.82 E-value=6e-09 Score=102.25 Aligned_cols=138 Identities=14% Similarity=0.204 Sum_probs=96.9
Q ss_pred eeeecCeEEEEE---Eeceeehhhhcc--cccCCCHHHHHHHHHHHHHHhcCC--CCceeeEEeEEEeC---CceEEEEe
Q 012164 161 VEITKGTFILAF---WRGIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQS---SPMMIVTE 230 (469)
Q Consensus 161 ~~ig~G~~~~~~---~~g~~vaiK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~E 230 (469)
+.|+.|.+..+| ..+..+++|+.. .... ......+.+|..+++.+. +..+++++.++.+. +..|+|||
T Consensus 44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEcCCcccceEEEEEECCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 456777665444 346778888775 3211 112346788999999997 45678899888766 34799999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK---------------------------------------- 270 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------- 270 (469)
|++|..+.+.. ...++......++.++++.|..||+..
T Consensus 122 ~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 122 FVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred ecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 99987774311 223678888899999999999999731
Q ss_pred ---------------CCCeEecCCCCCcccccccccCcceeeCCCCC--eEEeecCCccc
Q 012164 271 ---------------PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN--LKVADFGVSKL 313 (469)
Q Consensus 271 ---------------~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~--vkl~Dfgla~~ 313 (469)
+..++|+|++|. ||+++.++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~-----------Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLD-----------NLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGG-----------GEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCC-----------cEEEeCCCCcEEEEECcccccc
Confidence 234899999999 777776643 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=3.3e-09 Score=101.57 Aligned_cols=185 Identities=17% Similarity=0.134 Sum_probs=120.2
Q ss_pred eeeecCeEEEEEEeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCc--eeeEEeEEEeCC---ceEEEEeccCC
Q 012164 161 VEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPN--VVQFLGAVTQSS---PMMIVTEYLPK 234 (469)
Q Consensus 161 ~~ig~G~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~E~~~~ 234 (469)
+.++.|....+|.-+..+++|.... ......+.+|.++++.+. +.. +++++....... ..|+|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEINRDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEESTTSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEECCEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 3588888888887777888987542 234567899999998883 433 445555443332 34889999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 012164 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-------------------------------------------- 270 (469)
Q Consensus 235 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------------- 270 (469)
.+|.+... ..++..+...++.++++.|..||+..
T Consensus 101 ~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 101 VPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp EECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred eECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 88875433 23777888888889999888888621
Q ss_pred -----------CCCeEecCCCCCcccccccccCcceeeCC--CCCeEEeecCCccccccCCCCCcccCCCCCcccCCccc
Q 012164 271 -----------PVPIIHRDLEPSDLYVAYWQNDRNILRDD--SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 337 (469)
Q Consensus 271 -----------~~~ivH~Dlkp~Nil~~~~~~~~nil~~~--~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~ 337 (469)
+..++|+|++|. ||+++. .+.+.|+||+.+........ .........-..|+..
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~-----------N~l~~~~~~~~~~~iD~~~~~~~~~~~D--l~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSD-----------HILFDTEKNTICGIIDFGDAAISDPDND--FISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGG-----------GEEEETTTTEEEEECCCTTCEEECTTHH--HHTTCCTTTSCCHHHH
T ss_pred HHHhccccccCCceeEeCCCCcc-----------cEEEeCCCCCEEEEEeCCCCccCChHHH--HHHHHhhccccCHHHH
Confidence 124799999999 777776 45678999999865322100 0000000000122211
Q ss_pred C----C-CCC---------CCchhHHHHHHHHHHHHhCCCCC
Q 012164 338 K----N-EEY---------DTKVDVFSFALILQEMIEGCPPF 365 (469)
Q Consensus 338 ~----~-~~~---------~~~sDi~SlGvil~el~tg~~p~ 365 (469)
. . +.. ..-.+.|++|.++|.+.+|..+|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 0 011 11268999999999999998776
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.78 E-value=3.7e-09 Score=98.45 Aligned_cols=124 Identities=19% Similarity=0.144 Sum_probs=86.6
Q ss_pred cCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCc--eeeEEeEEEeCCceEEEEeccCCCCHH
Q 012164 165 KGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYLPKGDLR 238 (469)
Q Consensus 165 ~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~E~~~~gsL~ 238 (469)
.|..+.++. +|..+++|...... ...+..|+.+++.+.+.+ +++++++....+..++||||++|.+|.
T Consensus 30 gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 30 GCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp TTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 444355543 35679999875431 134778999999886434 567888888777889999999998884
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 012164 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENK------------------------------------------------ 270 (469)
Q Consensus 239 ~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------------------ 270 (469)
.. ... ...++.++++.|..||+..
T Consensus 104 --~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 --SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp --TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred --cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 21 111 2356777888888888643
Q ss_pred -------CCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 271 -------PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 271 -------~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
+..++|+|++|. ||+++.++.+.|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~-----------Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLP-----------NIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGG-----------GEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCC-----------cEEEECCcEEEEEcchhccc
Confidence 112999999999 77776665667999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=4.6e-06 Score=79.70 Aligned_cols=101 Identities=16% Similarity=0.062 Sum_probs=68.0
Q ss_pred eeeecCeEEEEEEeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCC---ceeeEEeEEE-eCCceEEEEeccCCCC
Q 012164 161 VEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP---NVVQFLGAVT-QSSPMMIVTEYLPKGD 236 (469)
Q Consensus 161 ~~ig~G~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~E~~~~gs 236 (469)
..++.|....+|.-|..+++|... .......+..|..+++.+.+. .|.+.+.++. ..+..++|||+++|.+
T Consensus 25 ~~l~~G~~n~v~~vg~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILVNGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEETTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEECCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 457777777777668888888743 234456789999999999642 3567777764 3456789999999988
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 012164 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268 (469)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~ 268 (469)
|.+..- ..++......++.++.+.|..||+
T Consensus 100 l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 100 LGEDGM--AVLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp CHHHHH--TTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred Cchhhh--hhCCHHHHHHHHHHHHHHHHHHhc
Confidence 876322 124455555555566555555554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=2.7e-05 Score=72.66 Aligned_cols=118 Identities=14% Similarity=0.161 Sum_probs=85.9
Q ss_pred ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHH
Q 012164 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253 (469)
Q Consensus 175 g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~ 253 (469)
+..+.+|.-.. .....+..|...++.+. +--|.++++++.+.+..++|||+++|.++.+..... .....
T Consensus 50 ~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~ 119 (272)
T 4gkh_A 50 APELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGE 119 (272)
T ss_dssp CCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHH
T ss_pred CeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHH
Confidence 46788887542 23456888999998885 334778899998888999999999998888776532 23344
Q ss_pred HHHHHHHHHHHHHHhCC-------------------------------------------------------CCCeEecC
Q 012164 254 RFALDIARGMNYLHENK-------------------------------------------------------PVPIIHRD 278 (469)
Q Consensus 254 ~i~~qi~~~L~~LH~~~-------------------------------------------------------~~~ivH~D 278 (469)
.+..+++..|..||... +..++|+|
T Consensus 120 ~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGD 199 (272)
T 4gkh_A 120 NIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGD 199 (272)
T ss_dssp HHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSC
T ss_pred HHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCC
Confidence 56677777777777521 01268999
Q ss_pred CCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 279 lkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
+.+. ||+++.++.+-|+||+.+..
T Consensus 200 l~~~-----------Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 200 FSLD-----------NLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCTT-----------SEEEETTEEEEECCCTTCEE
T ss_pred CCCC-----------eEEEECCeEEEEEECccccc
Confidence 9999 77777666677999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=4.2e-05 Score=74.44 Aligned_cols=76 Identities=7% Similarity=0.037 Sum_probs=48.2
Q ss_pred ceee-ecCeEEEEEE---e--------ceeehhhhccccc---CCCHHHHHHHHHHHHHHhcCC-C--CceeeEEeEEEe
Q 012164 160 SVEI-TKGTFILAFW---R--------GIQVAVKKLGEEV---ISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQ 221 (469)
Q Consensus 160 ~~~i-g~G~~~~~~~---~--------g~~vaiK~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~ 221 (469)
.+.| +.|....+|. . |..+++|...... ... ...+..|+.+++.+. + -.+.+++.++.+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3456 6666554442 2 6778888765432 100 134677888888884 3 356788887765
Q ss_pred C---CceEEEEeccCCCCHH
Q 012164 222 S---SPMMIVTEYLPKGDLR 238 (469)
Q Consensus 222 ~---~~~~lv~E~~~~gsL~ 238 (469)
. +..++||||++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3468999999886643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0027 Score=56.32 Aligned_cols=140 Identities=11% Similarity=0.103 Sum_probs=90.2
Q ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCC-CCCcccccccccCcceeeCCCCCeEEeecCCcc
Q 012164 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDL-EPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312 (469)
Q Consensus 236 sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dl-kp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~ 312 (469)
||.++|.. ..+++++++|.++.|.+.+|.-+-. .. -|..| -|. .|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~----~~~~i~~~~-----------~i~l~~dG~V~f~~-~~s~ 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ----PRHRVRSAA-----------QIRVWRDGAVTLAP-AADD 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC----CCCCCCSGG-----------GEEEETTSCEEECC-C---
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc----CCceecCCc-----------ceEEecCCceeccc-cccc
Confidence 79999986 4579999999999999999877622 11 01122 233 88888999988763 1111
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChhhh
Q 012164 313 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 392 (469)
Q Consensus 313 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (469)
.....+.|||... ...+.+.=|||||+++|.-+--..| ...+..+
T Consensus 98 -------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eL 142 (229)
T 2yle_A 98 -------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------------ENEEREL 142 (229)
T ss_dssp ----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECC
T ss_pred -------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhh
Confidence 1122467888764 2456788999999999987732111 0113456
Q ss_pred HHHHHHHHHHHccc-------------------------CCCCCCCHHHHHHHHHHHHh
Q 012164 393 ARGLKELIEECWNE-------------------------KPAKRPTFRQIITRLESINN 426 (469)
Q Consensus 393 ~~~l~~li~~cl~~-------------------------dp~~Rps~~~ll~~L~~~~~ 426 (469)
++.|.+||..|.+. .+..|++++++++.=..-..
T Consensus 143 S~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~ 201 (229)
T 2yle_A 143 SPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP 201 (229)
T ss_dssp CHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred CHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence 78899999999766 24688999998876544443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00043 Score=68.33 Aligned_cols=73 Identities=18% Similarity=0.135 Sum_probs=43.6
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccC-CCH---HHHHHHHHHHHHHhcCCC--C-ceeeEEeEEEeCCceEEE
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVI-SDD---DRVRAFRDELALLQKIRH--P-NVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-~i~~~~~~~~~~~~~~lv 228 (469)
+.+|.|..+.+|. +++.+++|....... ... .....+..|.++++.+.. | .+++++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 4688888877653 357899997653211 000 012346778888887742 3 44566654 34456899
Q ss_pred EeccCCC
Q 012164 229 TEYLPKG 235 (469)
Q Consensus 229 ~E~~~~g 235 (469)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0037 Score=59.90 Aligned_cols=29 Identities=21% Similarity=0.336 Sum_probs=24.8
Q ss_pred CeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcc
Q 012164 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312 (469)
Q Consensus 273 ~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~ 312 (469)
.++|+|+++. ||+++.++.+.|+||+.+.
T Consensus 223 ~l~HgD~~~~-----------Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 223 NLCHQDYGTG-----------NTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CEECSSCSTT-----------SEEECGGGCEEECCCTTCE
T ss_pred ceecCCCCcc-----------cEEEeCCCcEEEEehhhcc
Confidence 4999999999 7777767889999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.002 Score=61.27 Aligned_cols=72 Identities=19% Similarity=0.105 Sum_probs=52.1
Q ss_pred ceeeecCeEEEEE---EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC---CCceeeEEeEEEeCCceEEEEeccC
Q 012164 160 SVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 160 ~~~ig~G~~~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
.+.|+.|....+| .++..+++|..... ....+..|...|+.+. ...+++++.++...+..++||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3467777654443 35677888876532 1356888999998884 3568889988887788999999999
Q ss_pred CCCH
Q 012164 234 KGDL 237 (469)
Q Consensus 234 ~gsL 237 (469)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0039 Score=61.92 Aligned_cols=77 Identities=14% Similarity=0.090 Sum_probs=43.2
Q ss_pred CeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCC---CCchhHH
Q 012164 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY---DTKVDVF 349 (469)
Q Consensus 273 ~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDi~ 349 (469)
.++|+|++|. ||+++.++ +.|+||+.+...............-...|.+|+......- ....++.
T Consensus 233 ~liHGDl~~~-----------Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (420)
T 2pyw_A 233 ALIHGDLHTG-----------SVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWIL 300 (420)
T ss_dssp EEECSCCSGG-----------GEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHH
T ss_pred eEEecCCCCC-----------cEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHH
Confidence 4999999999 77776666 9999999887533111000000000123566655432111 1234555
Q ss_pred HHHHHHHHHHhC
Q 012164 350 SFALILQEMIEG 361 (469)
Q Consensus 350 SlGvil~el~tg 361 (469)
+....+|+.+++
T Consensus 301 ~~~~~~~~~y~~ 312 (420)
T 2pyw_A 301 RTIEQTWNLFNK 312 (420)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 777777777654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.013 Score=56.05 Aligned_cols=32 Identities=31% Similarity=0.444 Sum_probs=25.1
Q ss_pred CCeEecCCCCCcccccccccCcceeeCCC----CCeEEeecCCcccc
Q 012164 272 VPIIHRDLEPSDLYVAYWQNDRNILRDDS----GNLKVADFGVSKLL 314 (469)
Q Consensus 272 ~~ivH~Dlkp~Nil~~~~~~~~nil~~~~----~~vkl~Dfgla~~~ 314 (469)
..++|+|+.+. ||+++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~-----------Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQ-----------NLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGG-----------GEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcc-----------cEEeccCcCCCCCeEEEeCCCcCcC
Confidence 34999999999 6666553 67899999988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.013 Score=55.09 Aligned_cols=71 Identities=14% Similarity=0.134 Sum_probs=40.0
Q ss_pred ceeeecCeEEEEEEeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEecc-CCCCH
Q 012164 160 SVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYL-PKGDL 237 (469)
Q Consensus 160 ~~~ig~G~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~-~~gsL 237 (469)
.+.|+.|....+|.- ..+++|...... ........|+.+++.+. +.-..+++.+. .+.-++++||+ +|.+|
T Consensus 23 i~~l~gG~tN~~~~~-~~~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-GDLCLRIPGKGT----EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-eeEEEECCCCCc----cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 456777766655544 667777765321 00011245777777774 22225666553 33347899999 66444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.58 E-value=0.062 Score=50.09 Aligned_cols=72 Identities=18% Similarity=0.121 Sum_probs=47.1
Q ss_pred ccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-C--CceeeEEeEEEeCCceEEEEe
Q 012164 158 TNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 158 ~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~~~~~lv~E 230 (469)
...+.+|.|....+|. +|+.|.+|+........ ...+..|...|+.+. . --+++++++. .-++|||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 3456778887776653 68999999865432211 135788999998884 2 2345566542 2378999
Q ss_pred ccCCCC
Q 012164 231 YLPKGD 236 (469)
Q Consensus 231 ~~~~gs 236 (469)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.04 E-value=0.068 Score=53.09 Aligned_cols=53 Identities=11% Similarity=0.118 Sum_probs=32.8
Q ss_pred ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEeccCCCC
Q 012164 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (469)
Q Consensus 175 g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~~~gs 236 (469)
+..+.+|+.... .. ...+..|..+++.+. +.-.+++++.+.+ .+|+||++|.+
T Consensus 105 ~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 105 PNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp CSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred CceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence 367888876432 11 133457889888885 3333577776542 38999997633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=93.84 E-value=0.053 Score=52.88 Aligned_cols=54 Identities=17% Similarity=0.252 Sum_probs=33.3
Q ss_pred eeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 176 ~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
..+.+|+.... .. ....+.+|..+++.+. +.-..++++.+.+ .+|+||++|.+|
T Consensus 83 ~~~vlR~~g~~-~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l 137 (379)
T 3feg_A 83 REVLLRLYGAI-LQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPL 137 (379)
T ss_dssp SEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEEC
T ss_pred CeEEEEECCCc-cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccC
Confidence 56777765321 11 1244568999998885 4334677776643 289999987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=81.12 E-value=1.5 Score=41.24 Aligned_cols=29 Identities=24% Similarity=0.264 Sum_probs=23.5
Q ss_pred CCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 272 VPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 272 ~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
..++|+|+++. ||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~-----------Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAG-----------NILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGG-----------GEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcc-----------cEeEc-C-CCEEEECCCCCc
Confidence 34889999999 77777 4 789999987754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 469 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-24 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 7e-22 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 6e-16 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-14 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-13 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-12 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 6e-12 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-11 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 1e-19 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 1e-13 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 3e-09 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 4e-08 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 3e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-17 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 3e-16 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 9e-11 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 4e-09 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 9e-06 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 2e-14 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 3e-11 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 2e-09 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 3e-06 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 3e-05 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 1e-13 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 4e-10 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 3e-09 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 1e-06 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 5e-13 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 1e-11 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 7e-10 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 6e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 9e-13 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 1e-10 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 5e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 8e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 2e-04 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 3e-12 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 1e-06 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 2e-06 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 4e-06 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 4e-12 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 6e-12 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 8e-11 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-07 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 0.001 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 1e-11 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 2e-05 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 2e-11 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 2e-08 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 6e-05 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 7e-10 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 3e-08 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 1e-07 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 5e-09 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-08 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-07 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 9e-06 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 9e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-08 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 2e-07 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 6e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 3e-04 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 5e-07 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 7e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 2e-04 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 8e-07 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 4e-04 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 2e-04 | |
| d1bi7b_ | 125 | d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 9e-60
Identities = 75/292 (25%), Positives = 134/292 (45%), Gaps = 29/292 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++EI ++ I G+F W G VAVK L + +AF++E+ +
Sbjct: 2 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQL-QAFKNEVGV 57
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L+K RH N++ F+G T + IVT++ L L + + + A A+G
Sbjct: 58 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
M+YLH IIHRDL+ + NI + +K+ DFG++ + +
Sbjct: 117 MDYLHAK---SIIHRDLKSN-----------NIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 323 TCQDT-SCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378
Q + S ++APEV + ++ Y + DV++F ++L E++ G P++ ++ +
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222
Query: 379 ARQ--RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428
R P + +K L+ EC +K +RP F QI+ +E + S+
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 8e-59
Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 35/286 (12%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+ ++ EL I KG F +L +RG +VAVK I +D +AF E +++
Sbjct: 2 WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVM 54
Query: 205 QKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIAR 261
++RH N+VQ LG + + + IVTEY+ KG L +L+ +G L ++F+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 262 GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP 321
M YL N +HRDL N+L + KV+DFG++K + +
Sbjct: 115 AMEYLEGN---NFVHRDLAAR-----------NVLVSEDNVAKVSDFGLTKEASSTQ--- 157
Query: 322 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 380
++ APE + +++ TK DV+SF ++L E+ G P+ +V
Sbjct: 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 216
Query: 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 426
+ + E+++ CW+ A RP+F Q+ +LE I
Sbjct: 217 YKMDA---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-55
Identities = 66/277 (23%), Positives = 119/277 (42%), Gaps = 30/277 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDEL 201
++ ++ DF + KG F LA + +A+K L + + R E+
Sbjct: 2 QWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
+ +RHPN+++ G ++ + ++ EY P G + L++ + ++A
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117
Query: 262 GMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP 321
++Y H + +IHRD++P N+L +G LK+ADFG S
Sbjct: 118 ALSYCHSKR---VIHRDIKPE-----------NLLLGSAGELKIADFGWSVHA---PSSR 160
Query: 322 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 381
T + Y+ PE+ + +D KVD++S ++ E + G PPF E Y
Sbjct: 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRIS 217
Query: 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
R F P G ++LI P++RP R+++
Sbjct: 218 RVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-55
Identities = 72/281 (25%), Positives = 128/281 (45%), Gaps = 29/281 (10%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP +L F E+ G F WR VA+K + E +S+D+ F +E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
+ H +VQ G T+ P+ I+TEY+ G L +L+ + + + D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YL +HRDL N L +D G +KV+DFG+S+ + E
Sbjct: 115 YLESK---QFLHRDLAAR-----------NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160
Query: 325 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRP 383
R+ PEV ++ +K D+++F +++ E+ G P+ ++E + A R
Sbjct: 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 220
Query: 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
L + + ++ CW+EK +RPTF+ +++ + +
Sbjct: 221 YRP---HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 4e-55
Identities = 83/284 (29%), Positives = 142/284 (50%), Gaps = 29/284 (10%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP EL F EI G F L +W +VA+K + E +S++D F +E ++
Sbjct: 2 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 55
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIARGMN 264
K+ HP +VQ G + +P+ +V E++ G L +L+ + L T + LD+ GM
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 265 YLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 324
YL E +IHRDL RN L ++ +KV+DFG+++ + + T
Sbjct: 116 YLEEA---CVIHRDLAA-----------RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161
Query: 325 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRP 383
++ +PEVF Y +K DV+SF +++ E+ EG P+ + ++EV + + R
Sbjct: 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 221
Query: 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427
+L + + +++ CW E+P RP F +++ +L I S
Sbjct: 222 YKP---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-55
Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 31/289 (10%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDEL 201
E+E+ L + G F + ++ +VAVK L + +S D F E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS--TAVRFALDI 259
L+++++H +V+ VTQ P+ I+TEY+ G L FLK +K + + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
A GM ++ E IHRDL + NIL D+ + K+ADFG+++L+ E
Sbjct: 119 AEGMAFIEER---NYIHRDLRAA-----------NILVSDTLSCKIADFGLARLIEDNEY 164
Query: 320 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYA 378
++ APE + K DV+SF ++L E++ G P+ + EV +
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
Query: 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427
R L +L+ CW E+P RPTF + + LE +
Sbjct: 225 RGYRMVRP---DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 3e-54
Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 35/301 (11%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
++ DP +L F++ EI G+F A VA+KK+ +++ + E+
Sbjct: 9 FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQK+RHPN +Q+ G + +V EY K L+ +G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
+ YLH + +IHRD++ NIL + G +K+ DFG + ++ P
Sbjct: 128 LAYLHSHN---MIHRDVKAG-----------NILLSEPGLVKLGDFGSASIMA-----PA 168
Query: 323 TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379
+ ++APEV +YD KVDV+S + E+ E PP + A
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI-----ITRLESINNSINHKRRW 434
+ P + ++ + ++ C + P RPT + + R ++ +R
Sbjct: 229 NESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRT 286
Query: 435 K 435
K
Sbjct: 287 K 287
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-54
Identities = 60/276 (21%), Positives = 116/276 (42%), Gaps = 29/276 (10%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
D+ I G++ + G + K+L +++ ++ + E+ LL++++HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63
Query: 211 NVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMN 264
N+V++ + ++ + IV EY GDL + + + + L +R + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 265 YLHENKPV--PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
H ++HRDL+P+ N+ D N+K+ DFG++++L
Sbjct: 124 ECHRRSDGGHTVLHRDLKPA-----------NVFLDGKQNVKLGDFGLARILNHDTSFAK 172
Query: 323 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 382
T Y++PE Y+ K D++S +L E+ PPFT E+ +
Sbjct: 173 AFVGT-PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 231
Query: 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
Y+ L E+I N K RP+ +I+
Sbjct: 232 RRIPYR---YSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-53
Identities = 71/281 (25%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+++P + + E+ G F A + + A K + + ++ + + E+ +
Sbjct: 7 DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDI 62
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L HPN+V+ L A + + I+ E+ G + A + + + L S
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
+NYLH+NK IIHRDL+ NIL G++K+ADFGVS T + +
Sbjct: 123 LNYLHDNK---IIHRDLKAG-----------NILFTLDGDIKLADFGVSAKNT-RTIQRR 167
Query: 323 TCQDTSCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377
+ ++APEV K+ YD K DV+S + L EM E PP + V
Sbjct: 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 227
Query: 378 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
A + P P++ ++ K+ +++C + R T Q++
Sbjct: 228 AKSEPPTLAQPSR-WSSNFKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 8e-53
Identities = 67/267 (25%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
EI +G+F ++VA +L + ++ +R R F++E +L+ ++HPN+V+F
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIVRFY 74
Query: 217 GA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
+ V +++VTE + G L+ +LKR +K + I +G+ +LH P
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 273 PIIHRDLEPSDLYVAYWQNDRNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 331
PIIHRDL+ NI +G++K+ D G++ L K + +
Sbjct: 134 PIIHRDLKCD-----------NIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEF 179
Query: 332 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 391
+APE+++ +YD VDV++F + + EM P++ + P K+
Sbjct: 180 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-KV 237
Query: 392 YARGLKELIEECWNEKPAKRPTFRQII 418
+KE+IE C + +R + + ++
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-52
Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 30/289 (10%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+D L + E+ G F +++ VAVK L E +D E
Sbjct: 3 LDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEAN 60
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
++Q++ +P +V+ +G + ++ M+V E G L +L++ +K + ++ G
Sbjct: 61 VMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 263 MNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPL 322
M YL E+ +HRDL N+L K++DFG+SK L E+
Sbjct: 120 MKYLEESN---FVHRDLAAR-----------NVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 323 TCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA 379
++ APE ++ +K DV+SF +++ E G P+ +EV
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
Query: 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428
+R A R + +L+ CW RP F + RL + +
Sbjct: 226 GERMGCPAG---CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-52
Identities = 64/293 (21%), Positives = 117/293 (39%), Gaps = 32/293 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRD 199
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 2 KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 58
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E ++ ++ +P +V+ +G V Q+ +M+V E G L FL ++ + S
Sbjct: 59 EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
++ GM YL E +HRDL N+L + K++DFG+SK L +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAAR-----------NVLLVNRHYAKISDFGLSKALGADD 163
Query: 319 D--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK 375
+ ++ APE ++ ++ DV+S+ + + E + G P+ EV
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 223
Query: 376 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428
+R L L+ +CW K RP F + R+ + S+
Sbjct: 224 FIEQGKRMEC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-51
Identities = 67/307 (21%), Positives = 114/307 (37%), Gaps = 63/307 (20%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF E+ G + G+ +A K + E EL +L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+V F GA + I E++ G L LK+ G + + ++ + +G+ YL E
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 271 PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 330
I+HRD++PS NIL + G +K+ DFGVS L D +
Sbjct: 125 --KIMHRDVKPS-----------NILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRS 168
Query: 331 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-------- 382
Y++PE + Y + D++S L L EM G P E+ + +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 383 --------------------------------PPFKAPAKLYARGLKELIEECWNEKPAK 410
PP K P+ +++ ++ + +C + PA+
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 411 RPTFRQI 417
R +Q+
Sbjct: 289 RADLKQL 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 3e-51
Identities = 82/294 (27%), Positives = 130/294 (44%), Gaps = 31/294 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+EI L ++ +G F + W +VA+K L +S + F E
Sbjct: 11 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 64
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIA 260
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 65 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123
Query: 261 RGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR 320
GM Y+ +HRDL + NIL ++ KVADFG+++L+ E
Sbjct: 124 SGMAYVERMN---YVHRDLRAA-----------NILVGENLVCKVADFGLARLIEDNEYT 169
Query: 321 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA 379
++ APE + K DV+SF ++L E+ +G P+ + EV
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229
Query: 380 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 433
R P L +L+ +CW ++P +RPTF + LE S + +
Sbjct: 230 GYRMPCPPE---CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 5e-51
Identities = 57/262 (21%), Positives = 118/262 (45%), Gaps = 25/262 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +G A G +VA++++ + + +E+ ++++ ++PN+V +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V EYL G L + + + + +LH N+ +IH
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 336
RD++ NIL G++K+ DFG +T ++ + + + ++APEV
Sbjct: 140 RDIKSD-----------NILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEV 187
Query: 337 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 396
+ Y KVD++S ++ EMIEG PP+ ++ A P + P KL +
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL-SAIF 246
Query: 397 KELIEECWNEKPAKRPTFRQII 418
++ + C + KR + ++++
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELL 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-51
Identities = 70/309 (22%), Positives = 116/309 (37%), Gaps = 55/309 (17%)
Query: 162 EITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
I KG F WRG +VAVK S ++R E+ +RH N++ F+ A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV-- 272
+ + + +V++Y G L +L R + ++ AL A G+ +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 273 ---PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 329
I HRDL+ NIL +G +AD G++ D +
Sbjct: 125 GKPAIAHRDLKSK-----------NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 330 ---RYVAPEVF------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP------ 374
RY+APEV K+ E + D+++ L+ E+ C + D ++P
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 375 ------------KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 422
R P + + R + +++ ECW A R T +I L
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
Query: 423 SINNSINHK 431
++ K
Sbjct: 294 QLSQQEGIK 302
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 3e-50
Identities = 74/289 (25%), Positives = 130/289 (44%), Gaps = 31/289 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
++E++ ++ + ++ G + W+ + VAVK L E D V F
Sbjct: 8 NYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFL 61
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFA 256
E A++++I+HPN+VQ LG T+ P I+TE++ G+L +L + + + A
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV 316
I+ M YL + IHRDL N L ++ +KVADFG+S+L+T
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAAR-----------NCLVGENHLVKVADFGLSRLMTG 167
Query: 317 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK 375
++ APE ++ K DV++F ++L E+ G P+ ++V +
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227
Query: 376 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
R + + EL+ CW P+ RP+F +I E++
Sbjct: 228 LLEKDYRMERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 5e-50
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 24/273 (8%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
P D+ + +G + LA R VAVK + + D + E+ + +
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKM 59
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
+ H NVV+F G + + + EY G+L ++ + A RF + G+ YL
Sbjct: 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 267 HENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTV-KEDRPLTCQ 325
H I HRD++P N+L D+ NLK++DFG++ + +R L
Sbjct: 120 HGIG---ITHRDIKPE-----------NLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
Query: 326 DTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384
+ YVAPE+ K E+ VDV+S ++L M+ G P+ D+ + +++
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKT 224
Query: 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 417
+ P K L+ + E P+ R T I
Sbjct: 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 7e-50
Identities = 65/288 (22%), Positives = 128/288 (44%), Gaps = 32/288 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFR 198
+YEI ++ I +G F + + VA+K + + D F
Sbjct: 1 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFL 56
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF-LKRKGALKPSTAVRFAL 257
E +++ HP++V+ +G +T+ +P+ I+ E G+LR+F RK +L ++ + +A
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
++ + YL + +HRD+ RN+L + +K+ DFG+S+ +
Sbjct: 116 QLSTALAYLESKR---FVHRDIAA-----------RNVLVSSNDCVKLGDFGLSRYMEDS 161
Query: 318 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKA 376
+ +++APE + + DV+ F + + E++ G PF +N+V
Sbjct: 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221
Query: 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+R P L L+ +CW P++RP F ++ +L +I
Sbjct: 222 IENGERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 9e-50
Identities = 63/262 (24%), Positives = 114/262 (43%), Gaps = 20/262 (7%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G F ILA + VA+K + ++ + + + + +E+A+L KI+HPN+V
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ ++ + + G+L + KG A R + + YLH+ I+H
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVH 130
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 336
RDL+P +N D+ + ++DFG+SK+ L+ + YVAPEV
Sbjct: 131 RDLKP--------ENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEV 180
Query: 337 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 396
+ Y VD +S +I ++ G PPF ++D ++ + + +
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 397 KELIEECWNEKPAKRPTFRQII 418
K+ I + P KR T Q +
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQAL 262
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-49
Identities = 73/315 (23%), Positives = 122/315 (38%), Gaps = 58/315 (18%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-------IQVAVKKLGEEVISDDDRVR 195
++E L+F + G F + A G IQVAVK L E+ +D
Sbjct: 30 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 85
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL ++ ++ H N+V LGA T S P+ ++ EY GDL +L+ K
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291
L + FA +A+GM +L +HRDL
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR--------- 193
Query: 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFS 350
N+L +K+ DFG+++ + + + +++APE Y K DV+S
Sbjct: 194 --NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251
Query: 351 FALILQEMI-EGCPPFT-MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 408
+ ++L E+ G P+ + D K + + +++ CW
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDS 308
Query: 409 AKRPTFRQIITRLES 423
KRP+F + + L
Sbjct: 309 RKRPSFPNLTSFLGC 323
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (425), Expect = 4e-49
Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 35/290 (12%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDE 200
EID + I G F + I VA+K L + + R F E
Sbjct: 22 EIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSE 77
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDI 259
+++ + HPNV+ G VT+S+P+MI+TE++ G L +FL++ G V I
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137
Query: 260 ARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED 319
A GM YL + +HRDL NIL + + KV+DFG+S+ L
Sbjct: 138 AAGMKYLADMN---YVHRDLAAR-----------NILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 320 RPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVP 374
P R+ APE + ++ + DV+S+ +++ E++ G P+ + +V
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 375 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
A R P P L +L+ +CW + RP F QI+ L+ +
Sbjct: 244 NAIEQDYRLP---PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (429), Expect = 4e-49
Identities = 61/289 (21%), Positives = 115/289 (39%), Gaps = 32/289 (11%)
Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISD 190
P+ +KH + Y+I E+ G F R G A K + SD
Sbjct: 16 PVEIKHDHVLDHYDIHE---------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKP 249
+ R E+ + +RHP +V A + M+++ E++ G+L + +
Sbjct: 67 KET---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309
AV + + +G+ ++HEN +H DL+P ++ S LK+ DFG
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIM---------FTTKRSNELKLIDFG 171
Query: 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 369
++ L K+ +T + APEV + + D++S ++ ++ G PF ++
Sbjct: 172 LTAHLDPKQSVKVTTGT--AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229
Query: 370 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
D+E + + + + K+ I + P R T Q +
Sbjct: 230 DDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 7e-49
Identities = 66/264 (25%), Positives = 111/264 (42%), Gaps = 21/264 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
+G + + + VAVK L +V+S + + F E+ + + H N+++ G V + P
Sbjct: 26 RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPP 84
Query: 225 MMIVTEYLPKGDLRAF-LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSD 283
M +VTE P G L K +G T R+A+ +A GM YL IHRDL
Sbjct: 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAAR- 140
Query: 284 LYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEE 341
N+L +K+ DFG+ + L +D + + + APE K
Sbjct: 141 ----------NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 342 YDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 400
+ D + F + L EM G P+ + +++ ++ P + + ++
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-DKEGERLPRPEDC-PQDIYNVM 248
Query: 401 EECWNEKPAKRPTFRQIITRLESI 424
+CW KP RPTF + L
Sbjct: 249 VQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-48
Identities = 54/315 (17%), Positives = 121/315 (38%), Gaps = 29/315 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
++ +G F K + + D+V + E+++L RH N++
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVL-VKKEISILNIARHRNILHLH 67
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ ++++ E++ D+ + L V + + + +LH + I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124
Query: 276 HRDLEPSDLYVAYWQNDRNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 333
H D+ P NI+ S +K+ +FG ++ L K T+ Y A
Sbjct: 125 HFDIRPE-----------NIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYA 171
Query: 334 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 393
PEV +++ T D++S ++ ++ G PF + + ++ + + + K +
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 394 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDH 453
+ ++ ++ R T + + + + I IRT+K ++KKD
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEAL-QHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDL 290
Query: 454 SSPSSRSKSSCSTSS 468
+ S ++ SC +
Sbjct: 291 NMVVSAARISCGGAI 305
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-48
Identities = 54/268 (20%), Positives = 116/268 (43%), Gaps = 24/268 (8%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + +G+F +LA + A+K L + I +++V E ++ ++ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
V+ + Y G+L ++++ G+ + + +I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK- 127
Query: 271 PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 330
IIHRDL+P NIL ++ ++++ DFG +K+L+ + +
Sbjct: 128 --GIIHRDLKPE-----------NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 331 -YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389
YV+PE+ + D+++ I+ +++ G PPF ++ + + + + P
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKIIKLEYDFPE 231
Query: 390 KLYARGLKELIEECWNEKPAKRPTFRQI 417
K + + ++L+E+ KR ++
Sbjct: 232 KFFPK-ARDLVEKLLVLDATKRLGCEEM 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 9e-48
Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 50/315 (15%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A + VAVK L +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
A EL +L + H N+V LGA T P +++TEY GDL FL+RK
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
AL + F+ +A+GM +L IHRDL NIL
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR-----------NIL 177
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 355
K+ DFG+++ + + + +++APE N Y + DV+S+ + L
Sbjct: 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
Query: 356 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 415
E+ + ++ +P + ++++ CW+ P KRPTF+
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHA-PAEMYDIMKTCWDADPLKRPTFK 296
Query: 416 QIITRLES-INNSIN 429
QI+ +E I+ S N
Sbjct: 297 QIVQLIEKQISESTN 311
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (420), Expect = 9e-48
Identities = 43/263 (16%), Positives = 100/263 (38%), Gaps = 23/263 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ G F + G K + D ++E++++ ++ HP ++
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLH 92
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
A M+++ E+L G+L + + + + + + G+ ++HE+ I+
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IV 149
Query: 276 HRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 335
H D+ + + ++K+ DFG++ L D + + + APE
Sbjct: 150 HLDI---------KPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPE 198
Query: 336 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 395
+ E D+++ ++ ++ G PF + D E + + +
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 396 LKELIEECWNEKPAKRPTFRQII 418
K+ I+ ++P KR T +
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDAL 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-47
Identities = 78/318 (24%), Positives = 144/318 (45%), Gaps = 35/318 (11%)
Query: 143 REVPEYEIDPHELDFTNSVEITKGTF---ILAFW-----RGIQVAVKKLGEEVISDDDRV 194
+ V I P L + I +G F + I AVK L I+D V
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEV 72
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLK-RKGALKPSTA 252
F E +++ HPNV+ LG +S ++V Y+ GDLR F++
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312
+ F L +A+GM +L K +HRDL RN + D+ +KVADFG+++
Sbjct: 133 IGFGLQVAKGMKFLASKK---FVHRDL-----------AARNCMLDEKFTVKVADFGLAR 178
Query: 313 LLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMK 368
+ KE + + + +++A E + +++ TK DV+SF ++L E++ G PP+
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 369 HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428
+ ++ +R + L E++ +CW+ K RP+F ++++R+ +I ++
Sbjct: 239 NTFDITVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
Query: 429 NHKRRWKIRTMKCFHNLE 446
+ + + N++
Sbjct: 296 IGEH--YVHVNATYVNVK 311
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 6e-47
Identities = 78/317 (24%), Positives = 128/317 (40%), Gaps = 57/317 (17%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF----------ILAFWRGIQVAVKKLGEEVISDDDR 193
++ E + +++ +I +G F +L + VAVK L EE + D
Sbjct: 4 KLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADM 59
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------- 245
F+ E AL+ + +PN+V+ LG PM ++ EY+ GDL FL+
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYW 289
L + + A +A GM YL E K +HRDL
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT-------- 168
Query: 290 QNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDV 348
RN L ++ +K+ADFG+S+ + + D R++ PE Y T+ DV
Sbjct: 169 ---RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
Query: 349 FSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 407
+++ ++L E+ G P+ EV + L L+ CW++
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKL 282
Query: 408 PAKRPTFRQIITRLESI 424
PA RP+F I L+ +
Sbjct: 283 PADRPSFCSIHRILQRM 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-45
Identities = 60/280 (21%), Positives = 114/280 (40%), Gaps = 30/280 (10%)
Query: 156 DFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
+F + G F W I VA+K+L E + + DE ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 67
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
+ +P+V + LG S+ +I L + K + + + + IA+GMNYL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 267 HENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 326
+ + ++HRDL N+L ++K+ DFG++KLL +E
Sbjct: 128 EDRR---LVHRDLAAR-----------NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 327 T-SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPP 384
+++A E + Y + DV+S+ + + E++ G P+ +E+ +R P
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233
Query: 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+ + ++ +CW RP FR++I +
Sbjct: 234 QP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-45
Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 34/289 (11%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
EI P + I G F + + VA+K L + + F
Sbjct: 3 EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLG 58
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD-LRAFLKRKGALKPSTAVRFALD 258
E ++ + H N+++ G +++ PMMI+TEY+ G + ++ G V
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
IA GM YL +HRDL NIL + + KV+DFG+S++L
Sbjct: 119 IAAGMKYLANMN---YVHRDLAAR-----------NILVNSNLVCKVSDFGLSRVLEDDP 164
Query: 319 DRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK 375
+ T R+ APE ++ + DV+SF +++ E++ G P+ ++EV K
Sbjct: 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 224
Query: 376 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
A R P + +L+ +CW ++ A+RP F I++ L+ +
Sbjct: 225 AINDGFRLPTPMD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (397), Expect = 2e-45
Identities = 60/275 (21%), Positives = 111/275 (40%), Gaps = 22/275 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G LA VAVK L ++ D FR E + HP +V
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 217 GAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
+P IV EY+ LR + +G + P A+ D + +N+ H+N
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG-- 131
Query: 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 332
IIHRD++P+++ ++ + + + + + V++ V + +Y+
Sbjct: 132 -IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI---------GTAQYL 181
Query: 333 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 392
+PE + + D + DV+S +L E++ G PPFT V + P A +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 393 ARGLKELIEECWNEKPAKRP-TFRQIITRLESINN 426
+ L ++ + + P R T ++ L ++N
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-45
Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 25/269 (9%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRH 209
DF + KG+F LA ++ A+K L ++V+ DD V E +L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
P + + V EYL GDL ++ S A +A +I G+ +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 329
I++RDL+ NIL D G++K+ADFG+ K + + + T T
Sbjct: 123 G---IVYRDLKLD-----------NILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT-P 167
Query: 330 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389
Y+APE+ ++Y+ VD +SF ++L EM+ G PF + + E+ + + + P
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSIRMDNPFYPR 224
Query: 390 KLYARGLKELIEECWNEKPAKRPTFRQII 418
L + K+L+ + + +P KR R I
Sbjct: 225 WL-EKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 8e-45
Identities = 78/310 (25%), Positives = 131/310 (42%), Gaps = 52/310 (16%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR---------GIQVAVKKLGEEVISDDDR 193
P +E+ L + +G F +LA +VAVK L + D
Sbjct: 6 PRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 61
Query: 194 VRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------- 245
+ E+ +++ I +H N++ LGA TQ P+ ++ EY KG+LR +L+ +
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
L V A +ARGM YL IHRDL N+L
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR-----------NVL 167
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 355
+ +K+ADFG+++ + + T +++APE + Y + DV+SF ++L
Sbjct: 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 227
Query: 356 QEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 414
E+ G P+ E+ K R L ++ +CW+ P++RPTF
Sbjct: 228 WEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTF 284
Query: 415 RQIITRLESI 424
+Q++ L+ I
Sbjct: 285 KQLVEDLDRI 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (392), Expect = 1e-44
Identities = 60/275 (21%), Positives = 109/275 (39%), Gaps = 34/275 (12%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-H 209
+ +G + + AVK + + A E+ +L+K+ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN++Q ++ +V + + KG+L +L K L + + + LH+
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 329
I+HRDL+P NIL DD N+K+ DFG S L L +
Sbjct: 130 N---IVHRDLKPE-----------NILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTP 173
Query: 330 RYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383
Y+APE+ + Y +VD++S +I+ ++ G PPF + + + +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
Y+ +K+L+ +P KR T + +
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-44
Identities = 79/301 (26%), Positives = 131/301 (43%), Gaps = 48/301 (15%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRDEL 201
+D +++ F + I +G F + A + + A+K++ + + D R F EL
Sbjct: 6 VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGEL 61
Query: 202 ALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------------- 244
+L K+ HPN++ LGA + + EY P G+L FL++
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 245 GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304
L + FA D+ARGM+YL + IHRDL NIL ++ K
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAAR-----------NILVGENYVAK 167
Query: 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 363
+ADFG+S+ + T R++A E Y T DV+S+ ++L E++ G
Sbjct: 168 IADFGLSRG--QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 364 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423
P+ E+ + R + +L+ +CW EKP +RP+F QI+ L
Sbjct: 226 PYCGMTCAELYEKLPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 424 I 424
+
Sbjct: 283 M 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-43
Identities = 67/300 (22%), Positives = 132/300 (44%), Gaps = 43/300 (14%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
E+E+ ++ + E+ +G+F +G+ +VA+K + E +
Sbjct: 14 EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIE 69
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------A 246
F +E +++++ +VV+ LG V+Q P +++ E + +GDL+++L+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306
S ++ A +IA GM YL+ N +HRDL N + + +K+
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAAR-----------NCMVAEDFTVKIG 175
Query: 307 DFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PP 364
DFG+++ + + R R+++PE K+ + T DV+SF ++L E+ P
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235
Query: 365 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424
+ + +V + L EL+ CW P RP+F +II+ ++
Sbjct: 236 YQGLSNEQVLRFVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-42
Identities = 60/269 (22%), Positives = 103/269 (38%), Gaps = 28/269 (10%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDR---VRAFRDELALLQKIRHPNVV 213
E+ G F + G+Q A K + + R E+++L++I+HPNV+
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
+ ++++ E + G+L FL K +L A F I G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---Q 133
Query: 274 IIHRDLEPSDLYVAYWQNDRNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQDTSC 329
I H DL+P NI+ D +K+ DFG++ + +
Sbjct: 134 IAHFDLKP-----------ENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTP 180
Query: 330 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389
+VAPE+ E + D++S +I ++ G PF E +A
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 390 KLYARGLKELIEECWNEKPAKRPTFRQII 418
+ K+ I + P KR T + +
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (374), Expect = 4e-41
Identities = 56/270 (20%), Positives = 105/270 (38%), Gaps = 27/270 (10%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF+ I +G F G A+K L ++ I +E L+L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P +V A + + + + GDL L + G + +A +I G+ ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 268 ENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 327
+++RDL+P+ NIL D+ G+++++D G++ +
Sbjct: 125 NRF---VVYRDLKPA-----------NILLDEHGHVRISDLGLACDF---SKKKPHASVG 167
Query: 328 SCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386
+ Y+APEV K YD+ D FS +L +++ G PF + + +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
Query: 387 APAKLYARGLKELIEECWNEKPAKRPTFRQ 416
P ++ L+ L+E +R
Sbjct: 228 LPDS-FSPELRSLLEGLLQRDVNRRLGCLG 256
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-40
Identities = 63/271 (23%), Positives = 110/271 (40%), Gaps = 35/271 (12%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+ G + F + + A+K L D +A R+ + + P++V+ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72
Query: 218 A----VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKP 271
++IV E L G+L + ++ +G A A I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 272 VPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 331
I HRD++P +L + + LK+ DFG +K T LT + Y
Sbjct: 132 --IAHRDVKPENLLYTSKRPN--------AILKLTDFGFAKETT--SHNSLTTPCYTPYY 179
Query: 332 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAK 390
VAPEV E+YD D++S +I+ ++ G PPF H + P + ++ P
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 391 LYAR---GLKELIEECWNEKPAKRPTFRQII 418
++ +K LI +P +R T + +
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (365), Expect = 3e-40
Identities = 61/260 (23%), Positives = 113/260 (43%), Gaps = 27/260 (10%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G+F L R G A+K L +E++ +V DE +L + HP +++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
G + + ++ +Y+ G+L + L++ A +A ++ + YLH II+
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIY 127
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 336
RDL+P NIL D +G++K+ DFG +K + + Y+APEV
Sbjct: 128 RDLKPE-----------NILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEV 172
Query: 337 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 396
+ Y+ +D +SF +++ EM+ G PF + + Y + P +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKILNAELRFPPFF-NEDV 228
Query: 397 KELIEECWNEKPAKRPTFRQ 416
K+L+ ++R Q
Sbjct: 229 KDLLSRLITRDLSQRLGNLQ 248
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 4e-40
Identities = 38/280 (13%), Positives = 84/280 (30%), Gaps = 20/280 (7%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I G+F L G +VA+K + + E + + ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 217 GAV-TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ ++V E L F T + A + + Y+H I
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FI 125
Query: 276 HRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 335
HRD++P + + + + D G K + + + RY +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT--GTARYASIN 183
Query: 336 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 395
E + D+ S +L G P+ + Y P ++ +G
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 396 ----LKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 431
+ C + + +P + + ++ +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-40
Identities = 71/309 (22%), Positives = 126/309 (40%), Gaps = 46/309 (14%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDR 193
+ ++E L + +G F I A GI VAVK L E + R
Sbjct: 4 DASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 61
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRKG------- 245
+ L+ H NVV LGA T+ P+M++ E+ G+L +L+ K
Sbjct: 62 -ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNIL 296
L + ++ +A+GM +L K IHRDL RNIL
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA-----------RNIL 166
Query: 297 RDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALIL 355
+ +K+ DFG+++ + D +++APE + Y + DV+SF ++L
Sbjct: 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226
Query: 356 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 415
E+ + ++ +AP + + + +CW+ +P++RPTF
Sbjct: 227 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY-TTPEMYQTMLDCWHGEPSQRPTFS 285
Query: 416 QIITRLESI 424
+++ L ++
Sbjct: 286 ELVEHLGNL 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-38
Identities = 68/270 (25%), Positives = 114/270 (42%), Gaps = 40/270 (14%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIR--HPN 211
+ G F + VA+K + ++ ISD + E+ LL+K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 212 VVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
V++ L + +++ E P DL F+ +GAL+ A F + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 271 PVPIIHRDLEPSDLYVAYWQNDRNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 329
++HRD++ NIL D + G LK+ DFG LL +D T D +
Sbjct: 131 ---VLHRDIKDE-----------NILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTR 173
Query: 330 RYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388
Y PE + Y + V+S ++L +M+ G PF +HD E+ R + F+
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-----IRGQVFFRQR 226
Query: 389 AKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ + LI C +P+ RPTF +I
Sbjct: 227 ---VSSECQHLIRWCLALRPSDRPTFEEIQ 253
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-37
Identities = 64/287 (22%), Positives = 107/287 (37%), Gaps = 45/287 (15%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215
+ +G F A + VA+KK+ G + D R E+ LLQ++ HPN++
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
L A S + +V +++ L PS + L +G+ YLH++ I+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WIL 122
Query: 276 HRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 335
HRDL+P+ N+L D++G LK+ADFG++K T
Sbjct: 123 HRDLKPN-----------NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 171
Query: 336 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA------------------- 376
+F Y VD+++ IL E++ P D +
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 377 -----YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ + P L +LI+ + P R T Q +
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 4e-37
Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 24/266 (9%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + KGTF IL + G A+K L +EVI D V E +LQ RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+ A + V EY G+L L R+ A + +I + YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 271 PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 330
+++RD++ N++ D G++K+ DFG+ K + + +
Sbjct: 125 --DVVYRDIKLE-----------NLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPE 170
Query: 331 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390
Y+APEV ++ +Y VD + +++ EM+ G PF + + + + P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILMEEIRFPRT 227
Query: 391 LYARGLKELIEECWNEKPAKRPTFRQ 416
L + K L+ + P +R
Sbjct: 228 L-SPEAKSLLAGLLKKDPKQRLGGGP 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 134 bits (337), Expect = 1e-36
Identities = 40/285 (14%), Positives = 84/285 (29%), Gaps = 28/285 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
I +G+F QVA+K SD ++R LL V +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
G + ++V + L T A + + +HE +++
Sbjct: 70 G--QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 124
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT------SCR 330
RD++P + + ++ + V DFG+ K + + R
Sbjct: 125 RDIKPDNFLI------GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 331 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA----ARQRPPFK 386
Y++ E + D+ + + + G P+ + Y +Q P +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 431
+ + + N P + + + +N
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 130 bits (328), Expect = 3e-35
Identities = 58/286 (20%), Positives = 119/286 (41%), Gaps = 44/286 (15%)
Query: 162 EITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+I +GT+ A G A+KK+ E + R E+++L++++H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYD 67
Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
+ +++V E+L + + +G L+ TA F L + G+ Y H+ + ++HR
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124
Query: 278 DLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 337
DL+P +L + + G LK+ADFG+++ + + T +
Sbjct: 125 DLKPQNLLI-----------NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 338 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV------------------------ 373
+++Y T +D++S I EM+ G P F + +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 374 -PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+ + P+++ K +L+ + P +R T +Q +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 9e-35
Identities = 59/260 (22%), Positives = 112/260 (43%), Gaps = 27/260 (10%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G+F +L + G A+K L ++ + ++ +E +LQ + P +V+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ +S + +V EY+ G++ + L+R G A +A I YLH +I+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 336
RDL+P N+L D G ++V DFG +K + + +APE+
Sbjct: 165 RDLKPE-----------NLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEI 209
Query: 337 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 396
++ Y+ VD ++ +++ EM G PPF ++ Y + P+ ++ L
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEKIVSGKVRFPSH-FSSDL 265
Query: 397 KELIEECWNEKPAKRPTFRQ 416
K+L+ KR +
Sbjct: 266 KDLLRNLLQVDLTKRFGNLK 285
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-34
Identities = 55/256 (21%), Positives = 104/256 (40%), Gaps = 18/256 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH-PNVVQFLGAVTQS 222
I G A+K L + I + R E +L+ IR P +V A
Sbjct: 42 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ + ++ +Y+ G+L L ++ + +I + +LH+ II+RD++
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE 158
Query: 283 DLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE- 341
NIL D +G++ + DFG+SK E + Y+AP++ + +
Sbjct: 159 -----------NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 207
Query: 342 -YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 400
+D VD +S +++ E++ G PFT+ + + R + + K+LI
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 267
Query: 401 EECWNEKPAKRPTFRQ 416
+ + P KR
Sbjct: 268 QRLLMKDPKKRLGCGP 283
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-34
Identities = 65/306 (21%), Positives = 112/306 (36%), Gaps = 60/306 (19%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
P E+ +T++ I G+F A G VA+KK+ R EL +++K
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFAL 257
+ H N+V+ S + +V +Y+P+ R + + K L +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVK 317
+ R + Y+H I HRD++P +L L D+ LK+ DFG +K L V+
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLL----------LDPDTAVLKLCDFGSAKQL-VR 175
Query: 318 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF------------ 365
+ ++ + +F +Y + +DV+S +L E++ G P F
Sbjct: 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 366 -------TMKHDNEVPKAYAARQRPPFKAPAKLYARG------LKELIEECWNEKPAKRP 412
T + E+ Y + P KA L P R
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 413 TFRQII 418
T +
Sbjct: 296 TPLEAC 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-34
Identities = 58/301 (19%), Positives = 109/301 (36%), Gaps = 60/301 (19%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +GTF A R G +VA+KK+ E + + A R E+ +LQ ++H NVV +
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 75
Query: 217 GAVTQSSP--------MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
+ + +V ++ S R + G+ Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 269 NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 328
NK I+HRD++ + N+L G LK+ADFG+++ ++ ++
Sbjct: 136 NK---ILHRDMKAA-----------NVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 329 C---RYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFT------------------ 366
Y PE+ E +Y +D++ I+ EM P
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 367 ----------MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 416
+ ++ +++ + A + +LI++ PA+R
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 417 I 417
Sbjct: 302 A 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-33
Identities = 61/311 (19%), Positives = 124/311 (39%), Gaps = 50/311 (16%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
+F +I +GT+ A + G VA+KK+ + ++ A R E++LL+++ HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN 269
N+V+ L + + + +V E+L + + + + + +G+ + H +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 270 KPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 329
++HRDL+P +N+L + G +K+ADFG+++ R T + +
Sbjct: 122 ---RVLHRDLKP-----------QNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 166
Query: 330 RYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEV--------------- 373
Y APE+ +Y T VD++S I EM+ F + +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 374 ----------PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--L 421
++ R F + L+ + + P KR + + +
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
Query: 422 ESINNSINHKR 432
+ + + H R
Sbjct: 287 QDVTKPVPHLR 297
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-32
Identities = 63/310 (20%), Positives = 118/310 (38%), Gaps = 59/310 (19%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+++ P +TN I +G + A+ ++VA+KK+ + E+
Sbjct: 4 FDVGPR---YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIK 58
Query: 203 LLQKIRHPNVVQFLGAV----TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
+L + RH N++ + + + + +L DL LK + L F
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117
Query: 259 IARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKE 318
I RG+ Y+H ++HRDL+PS N+L + + +LK+ DFG++++
Sbjct: 118 ILRGLKYIHSAN---VLHRDLKPS-----------NLLLNTTCDLKICDFGLARVADPDH 163
Query: 319 DRPLTCQD--TSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV-- 373
D + + Y APE+ N + T +D++S IL EM+ P F KH +
Sbjct: 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 223
Query: 374 -------------------------PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 408
+ + + P+ +L+++ P
Sbjct: 224 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 283
Query: 409 AKRPTFRQII 418
KR Q +
Sbjct: 284 HKRIEVEQAL 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-32
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 53/294 (18%)
Query: 162 EITKGTF---ILAFWR---GIQVAVKKLGEEVISDDDRVRAFR--DELALLQKIRHPNVV 213
EI +G + A G VA+K++ + + + R L L+ HPNVV
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 214 QFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLH 267
+ T S + +V E++ + K + T + RG+++LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 268 ENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 327
++ ++HRDL+P NIL SG +K+ADFG++++ + +
Sbjct: 134 SHR---VVHRDLKPQ-----------NILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 177
Query: 328 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-------------- 373
+ Y APEV Y T VD++S I EM P F D +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 374 ---------PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 418
+A+ ++ P + K+L+ +C PAKR + +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 4e-31
Identities = 55/287 (19%), Positives = 110/287 (38%), Gaps = 46/287 (16%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +GT+ A R VA+K++ + + A R E+ LL++++H N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLH 67
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V E+ + + F G L P F + +G+ + H ++H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124
Query: 277 RDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 336
RDL+P N+L + +G LK+A+FG+++ + T +
Sbjct: 125 RDLKPQ-----------NLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 337 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--------------------VPKA 376
F + Y T +D++S I E+ P +D + + K
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 377 YAARQRPPFKAPAKLYARG------LKELIEECWNEKPAKRPTFRQI 417
+ P + A L ++L++ P +R + +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-28
Identities = 66/313 (21%), Positives = 109/313 (34%), Gaps = 64/313 (20%)
Query: 148 YEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
E+ + + G + A G +VA+KKL S+ RA+R
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEYLPKGDLRAFLKRKGALKPSTA 252
EL LL+ +RH NV+ L T + +V ++ G L + L
Sbjct: 67 -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI 123
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312
+ +G+ Y+H IHRDL+P N+ ++ LK+ DFG+++
Sbjct: 124 QFLVYQMLKGLRYIHAAGI---IHRDLKPG-----------NLAVNEDCELKILDFGLAR 169
Query: 313 LLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDN 371
+ D +T + Y APEV N Y VD++S I+ EMI G F
Sbjct: 170 ----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
Query: 372 EVP---------------------------KAYAARQRPPFKAPAKLYARGLKELIEECW 404
+ K ++ F + + L+E+
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285
Query: 405 NEKPAKRPTFRQI 417
+R T +
Sbjct: 286 VLDAEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 109 bits (272), Expect = 3e-27
Identities = 51/329 (15%), Positives = 112/329 (34%), Gaps = 71/329 (21%)
Query: 137 MHVKHAREVPEYEIDPHELDFTNS------VEITKGTF---ILAFWR--GIQVAVKKLGE 185
V R ++ + H +++ N ++ +G + A +V VK L
Sbjct: 11 TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-- 68
Query: 186 EVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLK 242
+ + + E+ +L+ +R PN++ V S +V E++ D + +
Sbjct: 69 ----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302
L + +I + ++Y H I+HRD++P + ++ +
Sbjct: 125 T---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHN----------VMIDHEHRK 168
Query: 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 362
L++ D+G+++ ++ + + + + YD +D++S +L MI
Sbjct: 169 LRLIDWGLAEFYHPGQEYNVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
Query: 363 PPFTMKHDN-----------------EVPKAYAARQRPPFKAPAKLYARG---------- 395
PF HDN + Y P F ++R
Sbjct: 228 EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 287
Query: 396 -------LKELIEECWNEKPAKRPTFRQI 417
+ +++ R T R+
Sbjct: 288 QHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 8e-25
Identities = 65/309 (21%), Positives = 105/309 (33%), Gaps = 41/309 (13%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
I G A+ VA+KKL + RA+R EL L++ + H N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLL 82
Query: 217 GAVTQSSPMM------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
T + +V E + + + G+ +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSA- 138
Query: 271 PVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 330
IIHRDL+PS NI+ LK+ DFG+++ T +T +
Sbjct: 139 --GIIHRDLKPS-----------NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 183
Query: 331 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390
Y APEV Y VD++S I+ EM+ F + + + P K
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLK 450
++ +E P +L + K++ + L ML
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFP-------KLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 451 KDHSSPSSR 459
D P+ R
Sbjct: 297 ID---PAKR 302
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 9e-24
Identities = 62/292 (21%), Positives = 99/292 (33%), Gaps = 54/292 (18%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G + AF G++VAVKKL S R +R EL LL+ ++H NV+ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 217 GAVTQSSPMMIVTEYL----PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
T + + + G + + L I RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 141
Query: 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 332
IIHRDL+PS N+ ++ LK+ DFG+++ +D T
Sbjct: 142 -IIHRDLKPS-----------NLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 186
Query: 333 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 392
+ Y+ VD++S I+ E++ G F + K P K
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 393 ARG---------------------------LKELIEECWNEKPAKRPTFRQI 417
+ +L+E+ KR T Q
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.0 bits (235), Expect = 7e-22
Identities = 36/145 (24%), Positives = 57/145 (39%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + +K LL G N ++ T LH+AA G TEV LL+ A V+ K
Sbjct: 4 LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 63
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEI 163
+ TPL A + ++KLL ++ A P +A + E + E
Sbjct: 64 KDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEA 123
Query: 164 TKGTFILAFWRGIQVAVKKLGEEVI 188
++ + + VA K V
Sbjct: 124 SQACMTKKGFTPLHVAAKYGKVRVA 148
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.3 bits (189), Expect = 6e-16
Identities = 33/119 (27%), Positives = 53/119 (44%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+G+ D L ++ +++ +K LL DVN + + LH AA QG T++
Sbjct: 286 HGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDI 345
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPE 147
V+LLL+ GA + G+TPL A V +L+ + + KH PE
Sbjct: 346 VTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSFPE 404
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.9 bits (175), Expect = 3e-14
Identities = 35/152 (23%), Positives = 56/152 (36%), Gaps = 12/152 (7%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK--- 131
T LHVA+ G +V LL+RGA + + TPL A + EV K L ++ AK
Sbjct: 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNA 61
Query: 132 -------PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
PL + H + + ++ + + + +A G V L
Sbjct: 62 KAKDDQTPLHCAARIGH-TNMVKLLLE-NNANPNLATTAGHTPLHIAAREGHVETVLALL 119
Query: 185 EEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ S + L + K V + L
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELL 151
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.2 bits (168), Expect = 2e-13
Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 17/217 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ + +G L A + VE + LL G N + T LH+AA +
Sbjct: 187 RGGSPHSPAWNGY-----TPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQE 241
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PL 133
G E+V+LLL + A+ + ++ G TPL + V +L KHG PL
Sbjct: 242 GHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPL 301
Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 193
H + + V +++ + + A +G V L + S ++
Sbjct: 302 HVASHYGNIKLVKFLLQHQADVNAKTKLGYS--PLHQAAQQGHTDIVTLLLKNGASPNEV 359
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
LA+ +++ + +V L VT + ++V++
Sbjct: 360 SSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 396
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.8 bits (159), Expect = 3e-12
Identities = 41/182 (22%), Positives = 55/182 (30%), Gaps = 12/182 (6%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V + LL+ N + T LHVA ++V LLL RG
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 195
Query: 104 RWGSTPLGDAIYYKNHEVIKLL----------EKHGAKPLMAPMHVKHAREVPEYEIDPH 153
G TPL A EV + L G PL HA V
Sbjct: 196 WNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQA 255
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
+ N +T L G L + + D R L + + +V
Sbjct: 256 NGNLGNKSGLT--PLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLV 313
Query: 214 QF 215
+F
Sbjct: 314 KF 315
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.6 bits (156), Expect = 6e-12
Identities = 36/143 (25%), Positives = 47/143 (32%), Gaps = 38/143 (26%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
++ A N + E L A E K LL + VN + D++T LH AA
Sbjct: 21 QRGASPNVSNVKVETP-----LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAAR 75
Query: 83 QGFTEVVSLLLER---------------------------------GADVDPKDRWGSTP 109
G T +V LLLE A + G TP
Sbjct: 76 IGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTP 135
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A Y V +LL + A P
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHP 158
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.7 bits (151), Expect = 3e-11
Identities = 40/164 (24%), Positives = 63/164 (38%), Gaps = 8/164 (4%)
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ T LHVAA G V LLLER A + + G TPL A+++ N +
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLD 179
Query: 121 VIKLLEKHGAKPL------MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGT--FILAF 172
++KLL G P P+H+ + E + + + E +G LA
Sbjct: 180 IVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAA 239
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
G V L + + + ++ L L+ + H V L
Sbjct: 240 QEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVL 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.6 bits (213), Expect = 1e-19
Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 2/112 (1%)
Query: 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
+ A++N D+ G + + LLD G DVN R +T L +A
Sbjct: 169 DEMGADVNACDNMGRNALIHAL-LSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227
Query: 82 CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +V LLE+ +++ D G T L A+ K ++ +LL K GA
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.8 bits (167), Expect = 1e-13
Identities = 21/79 (26%), Positives = 39/79 (49%), Gaps = 6/79 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A++N + G+ L+ ++ + ++ LL+ I++N D D +TAL +A
Sbjct: 210 ADVNVRGERGKTP-----LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264
Query: 85 FTEVVSLLLERGADVDPKD 103
++ LL +RGA D D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.7 bits (133), Expect = 3e-09
Identities = 20/72 (27%), Positives = 39/72 (54%), Gaps = 1/72 (1%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYYKNHEVIKLLEKHG 129
+++ L A ++V LLE GA+V+ ++ G TPL +A+ ++++LL +HG
Sbjct: 3 VEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHG 62
Query: 130 AKPLMAPMHVKH 141
A P++ +
Sbjct: 63 ADPVLRKKNGAT 74
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (124), Expect = 4e-08
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 1/96 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ DV+ +++LL+ G +VNF++ + T LH A ++V LLL GAD +
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
+ G+TP A + +++KL GA +
Sbjct: 69 KKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFY 104
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (116), Expect = 3e-07
Identities = 24/72 (33%), Positives = 31/72 (43%), Gaps = 5/72 (6%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----E 120
TAL AA +G EV+ +LL E GADV+ D G L A+ +
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200
Query: 121 VIKLLEKHGAKP 132
+ LL HGA
Sbjct: 201 ITHLLLDHGADV 212
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.7 bits (195), Expect = 7e-17
Identities = 61/322 (18%), Positives = 112/322 (34%), Gaps = 46/322 (14%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
++ G F LA VA+K + D A DE+ LLQ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 217 GAVTQ---------------SSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIA 260
+++V E L + L K + P + + +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 261 RGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR 320
G++Y+H IIH D++P ++ + + ++ +K+AD G + D
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLM-----EIVDSPENLIQIKIADLGNAC----WYDE 184
Query: 321 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--- 377
T + Y +PEV + D++S A ++ E+I G F + K
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244
Query: 378 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIR 437
A + P+ L G +N + R + LE + + + +
Sbjct: 245 AQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302
Query: 438 TMKCFHNLEAMLKKDHSSPSSR 459
+ F L ML+ D P R
Sbjct: 303 EISDF--LSPMLQLD---PRKR 319
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 76.3 bits (186), Expect = 3e-16
Identities = 18/65 (27%), Positives = 35/65 (53%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G + + +D D +T + +AA +G EVV L+++GA V+ D T A +H ++
Sbjct: 211 GSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIV 270
Query: 123 KLLEK 127
+ ++
Sbjct: 271 DIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 60.1 bits (144), Expect = 9e-11
Identities = 28/110 (25%), Positives = 39/110 (35%), Gaps = 10/110 (9%)
Query: 41 EFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLL------ 93
E + I E + VN D NRT LH A E L+
Sbjct: 1 ESPIKLHTEAAGSYAITEPITR-ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKE 59
Query: 94 --ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
GADV+ D +TPL A+ + ++ L K GA P + +
Sbjct: 60 CIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERS 109
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 55.1 bits (131), Expect = 4e-09
Identities = 12/51 (23%), Positives = 20/51 (39%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
+M A E +E + L+ G V D + TA +A +V +
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 45.1 bits (105), Expect = 9e-06
Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 1/71 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+ RTALH AA V L+ E+G++ D +D G TP+ A EV
Sbjct: 177 AARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEV 236
Query: 122 IKLLEKHGAKP 132
+ L + GA
Sbjct: 237 VMYLIQQGASV 247
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 71.8 bits (175), Expect = 2e-14
Identities = 15/82 (18%), Positives = 25/82 (30%), Gaps = 2/82 (2%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR--WGSTPL 110
++ + LL S V +N A +AA G V++ L E
Sbjct: 106 LDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAF 165
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
A + V+ L +
Sbjct: 166 RLAAENGHLHVLNRLCELAPTE 187
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 62.2 bits (150), Expect = 3e-11
Identities = 13/83 (15%), Positives = 22/83 (26%), Gaps = 3/83 (3%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVDPKDRWGS 107
+ D + + I + VAA G + + LLL V
Sbjct: 68 YYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENY 127
Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
A + V+ L +
Sbjct: 128 QAFRLAAENGHLHVLNRLCELAP 150
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 56.8 bits (136), Expect = 2e-09
Identities = 27/166 (16%), Positives = 48/166 (28%), Gaps = 13/166 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID--NRTALHVAA 81
+ + + + + A + + L + I N A +AA
Sbjct: 115 SDEIVKVIQAENYQA-----FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAA 169
Query: 82 CQGFTEVVSLLLERGADVD---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
G V++ L E + A+ +H VI L A +
Sbjct: 170 ENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEI- 228
Query: 139 VKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
H E E ++P N ++ F L+ G+ V K
Sbjct: 229 --HEFEYGEKYVNPFIARHVNRLKEMHDAFKLSNPDGVFDLVTKSE 272
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 46.4 bits (109), Expect = 3e-06
Identities = 10/77 (12%), Positives = 20/77 (25%), Gaps = 7/77 (9%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-----GST 108
+G+ +L+ + L + + + LL +
Sbjct: 262 DGVFDLVTK--SECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 319
Query: 109 PLGDAIYYKNHEVIKLL 125
L A+ N LL
Sbjct: 320 LLRLALRLGNQGACALL 336
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 43.7 bits (102), Expect = 3e-05
Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 5/56 (8%)
Query: 44 LMFLANERDVEGIKELLDSG-----IDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
L+ +E ++ I+ LL D L +A G +LLL
Sbjct: 283 LIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACALLLS 338
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 69.0 bits (167), Expect = 1e-13
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + E +K L+ + DVN +D D T LH AA G E +L+E D++ +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ G T + +++ LE+ K
Sbjct: 263 KVGQTAF----DVADEDILGYLEELQKK 286
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 58.6 bits (140), Expect = 4e-10
Identities = 27/115 (23%), Positives = 41/115 (35%), Gaps = 9/115 (7%)
Query: 48 ANERDVEGIKELLDSGIDVNFR---------DIDNRTALHVAACQGFTEVVSLLLERGAD 98
A ++ E +K + S D+ D+ A G TE V LLERGAD
Sbjct: 6 AKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD 65
Query: 99 VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPH 153
++ + G T L A N +++K L ++GA
Sbjct: 66 INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLD 120
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 55.9 bits (133), Expect = 3e-09
Identities = 26/74 (35%), Positives = 39/74 (52%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
L I+ TALHVAA +G+TEV+ LL++ DV+ KD G TPL A ++
Sbjct: 185 LNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGK 244
Query: 119 HEVIKLLEKHGAKP 132
E ++L ++
Sbjct: 245 EEACRILVENLCDM 258
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 47.4 bits (111), Expect = 1e-06
Identities = 34/175 (19%), Positives = 65/175 (37%), Gaps = 2/175 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + D E + LL+ G D+N+ ++D TALH A ++V L+E GA+++ D
Sbjct: 44 FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPD 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHAREVPEYEIDPHELDFTNSV 161
G PL A ++ + L GA E + + +
Sbjct: 104 NEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQG 163
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ ++ A + L I+D ++ L + + V++ L
Sbjct: 164 VDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLL 218
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 66.7 bits (161), Expect = 5e-13
Identities = 24/65 (36%), Positives = 31/65 (47%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
RT LH+A V+ LLL+ GAD + G TPLG A+ N + +LL
Sbjct: 186 KPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLR 245
Query: 127 KHGAK 131
HGA
Sbjct: 246 AHGAP 250
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.4 bits (150), Expect = 1e-11
Identities = 15/59 (25%), Positives = 23/59 (38%), Gaps = 1/59 (1%)
Query: 45 MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ ++ LL +G D R RT L A + + LL GA +P+D
Sbjct: 197 HLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 57.4 bits (137), Expect = 7e-10
Identities = 19/78 (24%), Positives = 28/78 (35%), Gaps = 3/78 (3%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGAD---VDPKDRWGSTPLGDAIYYKNHEVIK 123
+ D TALH+A + LL A +D ++ G T L A ++
Sbjct: 3 GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVE 62
Query: 124 LLEKHGAKPLMAPMHVKH 141
L GA L+A
Sbjct: 63 KLYAAGAGVLVAERGGHT 80
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 51.2 bits (121), Expect = 6e-08
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)
Query: 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
+ +DG+ L + + LL ++ ++ +TALH+AA G
Sbjct: 2 FGYVTEDGDTA-----LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V L GA V +R G T L A + H +L +
Sbjct: 57 EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 66.6 bits (161), Expect = 9e-13
Identities = 16/58 (27%), Positives = 28/58 (48%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+E + +N +D + T L++AA G +V LL+ GAD ++ G P+
Sbjct: 239 LENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 296
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.1 bits (144), Expect = 1e-10
Identities = 19/129 (14%), Positives = 45/129 (34%), Gaps = 2/129 (1%)
Query: 2 ETKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD 61
E K+ + L + + + + E + ++ + ++ + +
Sbjct: 34 EQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFP 93
Query: 62 -SGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
+ +++N D T LH E+V L++ G++ D G + L A+ N+
Sbjct: 94 NTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNN 153
Query: 120 EVIKLLEKH 128
E
Sbjct: 154 YDSGTFEAL 162
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 52.0 bits (123), Expect = 5e-08
Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 3/77 (3%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER---GADVDPKDRWGSTPLGDAIY 115
+ + + + + + ++ L + ++ +D G T L A
Sbjct: 209 VKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR 268
Query: 116 YKNHEVIKLLEKHGAKP 132
N ++ L +GA P
Sbjct: 269 LGNISIVDALLDYGADP 285
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.6 bits (122), Expect = 8e-08
Identities = 28/132 (21%), Positives = 48/132 (36%), Gaps = 5/132 (3%)
Query: 6 PVRTT---LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
P+ T L +P + K ++D+ +++K E L L E L +
Sbjct: 2 PIITFTHDLTSDFLSSPLKIMKALPSPVVNDNEQKMKLEAFLQRLLFPEIQEMPTSLNND 61
Query: 63 GIDVNFRDIDNRTALHVAACQGFT-EVVSLLLERGADVD-PKDRWGSTPLGDAIYYKNHE 120
+ N + + EV +++ P D G+TPL N E
Sbjct: 62 SSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLE 121
Query: 121 VIKLLEKHGAKP 132
++K L KHG+
Sbjct: 122 LVKHLVKHGSNR 133
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.4 bits (93), Expect = 2e-04
Identities = 12/57 (21%), Positives = 19/57 (33%), Gaps = 5/57 (8%)
Query: 25 EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
LN D +G+ L A ++ + LLD G D + + A
Sbjct: 249 ANMLNAQDSNGDTC-----LNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 63.3 bits (152), Expect = 3e-12
Identities = 25/104 (24%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
+A++N D+ G+ L + A + E + LL + + +D + T L +AA
Sbjct: 111 TADADINAADNSGKTA-----LHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAR 165
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+G E LL+ A+ + D P A +H++++LL+
Sbjct: 166 EGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLLD 209
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.1 bits (110), Expect = 1e-06
Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 1/56 (1%)
Query: 87 EVVSLLLERGADVDPK-DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
+V+S LL +GA+++ D+ G T L A + + K L GA +
Sbjct: 3 QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRT 58
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.3 bits (108), Expect = 2e-06
Identities = 26/76 (34%), Positives = 39/76 (51%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
++L+ + D+N D +TALH AA TE V++LL A+ D +D TPL A
Sbjct: 107 EDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAARE 166
Query: 117 KNHEVIKLLEKHGAKP 132
++E K L + A
Sbjct: 167 GSYEASKALLDNFANR 182
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.6 bits (106), Expect = 4e-06
Identities = 12/40 (30%), Positives = 19/40 (47%), Gaps = 1/40 (2%)
Query: 54 EGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLL 92
+ I +LL G ++N D T+LH+AA + L
Sbjct: 3 QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.4 bits (153), Expect = 4e-12
Identities = 32/123 (26%), Positives = 46/123 (37%), Gaps = 34/123 (27%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG------------------ 84
+ LA +E +KE + + D D+RTALH A G
Sbjct: 7 VCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 66
Query: 85 ---------------FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
E+V LL +GA V+ ++ G TPL A HE+ +L + G
Sbjct: 67 DDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGG 126
Query: 130 AKP 132
A P
Sbjct: 127 ANP 129
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.1 bits (152), Expect = 6e-12
Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N ++ +G L + A++ E LL+ G + + +D TA+H AA +G
Sbjct: 94 AQVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+++ +LL A + +D G+TPL A + E KLL GA
Sbjct: 149 LKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASI 195
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (143), Expect = 8e-11
Identities = 24/70 (34%), Positives = 37/70 (52%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
LL G VN + + T LH AA + E+ +LLE GA+ D KD + +T + A N
Sbjct: 89 LLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148
Query: 119 HEVIKLLEKH 128
++I +L +
Sbjct: 149 LKMIHILLYY 158
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (118), Expect = 1e-07
Identities = 13/52 (25%), Positives = 23/52 (44%), Gaps = 1/52 (1%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
L +E VE K L+ G + + + +T L VA G ++ ++E
Sbjct: 172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE 222
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.001
Identities = 8/48 (16%), Positives = 15/48 (31%), Gaps = 1/48 (2%)
Query: 73 NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
+ + A G E+ +L + D+ T L A +
Sbjct: 3 SNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHT 50
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 60.4 bits (145), Expect = 1e-11
Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 42/140 (30%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAA---CQGFTEVVSLLL 93
L RD+ G+ + G+D+ + + TALH+A + +V L+
Sbjct: 9 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLV 68
Query: 94 ERGADVDPK---------------------------------DRWGSTPLGDAIYYKNHE 120
+ ++D + + G TPL A K+
Sbjct: 69 QNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEH 128
Query: 121 VIKLLEKHGAKPLMAPMHVK 140
+LL + + + +HV+
Sbjct: 129 CEELLTQALSGRFNSHVHVE 148
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.7 bits (99), Expect = 2e-05
Identities = 15/129 (11%), Positives = 30/129 (23%), Gaps = 12/129 (9%)
Query: 72 DNRTALHV---AACQGFTEVVSLLLERGADVDPK------DRWGSTPLGDAIYYKNH--- 119
D LH A + G D+ K T L A+ +
Sbjct: 2 DTAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSL 61
Query: 120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVA 179
++ L ++ A + L + + + + +A
Sbjct: 62 HIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 121
Query: 180 VKKLGEEVI 188
+ E
Sbjct: 122 KRLKHEHCE 130
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (147), Expect = 2e-11
Identities = 21/82 (25%), Positives = 38/82 (46%)
Query: 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP 101
L+ + ++ LL G +VN + +ALH A+ +G +V L+ GAD
Sbjct: 146 SPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSL 205
Query: 102 KDRWGSTPLGDAIYYKNHEVIK 123
K+ TPL A + ++++
Sbjct: 206 KNCHNDTPLMVARSRRVIDILR 227
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 2e-08
Identities = 15/52 (28%), Positives = 22/52 (42%), Gaps = 4/52 (7%)
Query: 72 DNRTALHVAACQGFTEVVSLLL----ERGADVDPKDRWGSTPLGDAIYYKNH 119
D T LH+A QG V L+ + G ++D + TPL A+
Sbjct: 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLP 53
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 6e-05
Identities = 20/102 (19%), Positives = 40/102 (39%), Gaps = 4/102 (3%)
Query: 44 LMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
L + ++ + L++ G +++ + +T LH+A VV LL+ GA
Sbjct: 7 LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 66
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
DR G T A +++ ++ L A + +
Sbjct: 67 MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNY 108
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.8 bits (135), Expect = 7e-10
Identities = 19/67 (28%), Positives = 31/67 (46%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+ RTALH+A ++VSLLL+ GADV+ G +P + + + L
Sbjct: 139 AQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLG 198
Query: 127 KHGAKPL 133
+ + L
Sbjct: 199 QLTLENL 205
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.8 bits (122), Expect = 3e-08
Identities = 9/55 (16%), Positives = 20/55 (36%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
L + ++ + + LL G DVN + + + T + L + +
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (118), Expect = 1e-07
Identities = 11/52 (21%), Positives = 20/52 (38%), Gaps = 4/52 (7%)
Query: 72 DNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
D + LH+A EV+ + A ++ ++ TPL A+
Sbjct: 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQP 52
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 54.4 bits (129), Expect = 5e-09
Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKL 124
VN++D T L A +G + LL+E+ GA+ D D G+ A+ N +V K
Sbjct: 165 VNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKF 221
Query: 125 LEKHGA 130
+
Sbjct: 222 FLNNVV 227
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 53.3 bits (126), Expect = 1e-08
Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 1/68 (1%)
Query: 75 TALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
LH A + V LL + + + KD+ G PL ++ ++ HE+ L
Sbjct: 2 YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61
Query: 134 MAPMHVKH 141
+
Sbjct: 62 LDDYPDDS 69
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 49.4 bits (116), Expect = 2e-07
Identities = 10/55 (18%), Positives = 17/55 (30%), Gaps = 4/55 (7%)
Query: 45 MFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
E + L++ G + + D A VA + +V L D
Sbjct: 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNE---QVKKFFLNNVVD 228
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 44.4 bits (103), Expect = 9e-06
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 45 MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-VDPKD 103
++ E + L+++G V +D N+ LH AA G +++ LL G V+ +D
Sbjct: 110 HLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQD 169
Query: 104 RWGSTPLGDAIYYKNHEVIK-LLEKHGAKP 132
+ G TPL A+ + + L+EK+GA+
Sbjct: 170 KQGWTPLFHALAEGHGDAAVLLVEKYGAEY 199
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 44.4 bits (103), Expect = 9e-06
Identities = 19/99 (19%), Positives = 39/99 (39%), Gaps = 1/99 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L E + ++ELL S + +D D R LH + E+ S LL + +V+
Sbjct: 4 LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 63
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
D + + +++++ +PL ++
Sbjct: 64 DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKIT 102
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 52.1 bits (124), Expect = 2e-08
Identities = 27/202 (13%), Positives = 60/202 (29%), Gaps = 48/202 (23%)
Query: 174 RGIQVAVKKLGEEVISDDD---------------RVRAFRDELALLQKIRHPNVVQFLGA 218
+ + VK S +R+ R+E LQK++ V +
Sbjct: 23 KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
++ E + +L + I + + I+H D
Sbjct: 83 ----EGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHR---GIVHGD 128
Query: 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 338
L ++ V+ + + DF S + + R + +D +
Sbjct: 129 LSQYNVLVSEE------------GIWIIDFPQSVEVGEEGWREILERDVRN----IITYF 172
Query: 339 NEEYDTKVDVFSFALILQEMIE 360
+ Y T+ D+ S + +++
Sbjct: 173 SRTYRTEKDINS---AIDRILQ 191
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (113), Expect = 2e-07
Identities = 9/32 (28%), Positives = 18/32 (56%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
L AA +G E ++ LL+ +V+ ++ +G
Sbjct: 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFG 34
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 6e-06
Identities = 12/31 (38%), Positives = 15/31 (48%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERG 96
V R+ TA +A G EVVSL+ G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 3e-04
Identities = 9/31 (29%), Positives = 16/31 (51%)
Query: 99 VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
V ++ G T A Y +EV+ L++ +G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 47.2 bits (110), Expect = 5e-07
Identities = 23/64 (35%), Positives = 36/64 (56%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVN +D+ TALH A EVV LL++ GADV + ++ T +I N ++
Sbjct: 90 GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149
Query: 123 KLLE 126
++L+
Sbjct: 150 EILQ 153
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.0 bits (94), Expect = 7e-05
Identities = 12/64 (18%), Positives = 29/64 (45%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+G D + +++ L + E ++ L+ G DV+ + +TA ++ G ++
Sbjct: 89 HGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDL 148
Query: 89 VSLL 92
+L
Sbjct: 149 AEIL 152
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.5 bits (90), Expect = 2e-04
Identities = 15/48 (31%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
D L AA G + V +L+ GA D G++PL A Y +
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHF 47
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 8e-07
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 1/66 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVN D +H+A +G T VVS L +D+ +D G TPL A+ +++
Sbjct: 91 GADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLV 149
Query: 123 KLLEKH 128
+L+ H
Sbjct: 150 DILQGH 155
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 4e-04
Identities = 13/46 (28%), Positives = 19/46 (41%), Gaps = 1/46 (2%)
Query: 75 TALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNH 119
L AA +G + V LL R D +R+G T L ++
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTA 49
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 2e-04
Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)
Query: 56 IKELLDSGIDVNFRDI-DNRTA--LHVAACQGFTEVVSLLLERGADV 99
K L++SG V D +TA +G+T+ L +
Sbjct: 83 CKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 129
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.1 bits (81), Expect = 0.002
Identities = 20/114 (17%), Positives = 33/114 (28%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
L AA +G E V LLE GA+ + + +G P+ + LL
Sbjct: 5 DWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCA 64
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVI 188
P + E L + + +A + +V
Sbjct: 65 DPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVA 118
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 469 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.86 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.85 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.83 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.83 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.82 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.77 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.75 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.75 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.74 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.74 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.72 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.72 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.71 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.71 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.7 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.69 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.69 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.69 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.68 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.67 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.67 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.66 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.65 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.65 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.65 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.62 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.62 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.61 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.6 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.6 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.58 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.58 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.58 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.58 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.57 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.5 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.5 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.69 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.88 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 92.99 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 85.15 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=405.12 Aligned_cols=244 Identities=25% Similarity=0.486 Sum_probs=212.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 688899999999999985 578999999875433222334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||+
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~-----------Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPE-----------NLLLGSAGELKIADFGW 152 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTSCEEECCCCS
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccc-----------cceecCCCCEeecccce
Confidence 9999999999998888999999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ...+ +.
T Consensus 153 a~~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~~~~---p~ 225 (263)
T d2j4za1 153 SVHAPSS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTF---PD 225 (263)
T ss_dssp CSCCCCC---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCC---CT
T ss_pred eeecCCC---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC---Cc
Confidence 9865432 234467999999999999999999999999999999999999999877665555554332 2222 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+++++.+||.+||+.||++|||++|+++|
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 226 FVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 678999999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=401.64 Aligned_cols=264 Identities=28% Similarity=0.473 Sum_probs=213.6
Q ss_pred ccccCCCCcccccceeeecCeEEEEEE--eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~--~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 224 (469)
+||+... +|+..+.||+|+||.||. .+..||||++..... +....+.|.+|+.++++++||||+++++++.+ ..
T Consensus 2 dwei~~~--~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 77 (276)
T d1uwha_ 2 DWEIPDG--QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ 77 (276)
T ss_dssp CCBCCTT--CCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred Ccccccc--cEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence 4566544 466778999999999985 345699999876543 33456789999999999999999999998754 56
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
+++|||||++|+|.+++... +.+++..+..++.||+.||+|||+++ ||||||||+ |||++.++.+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~-----------NiLl~~~~~~ 143 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSN-----------NIFLHEDLTV 143 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEEETTSSE
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHH-----------HEEEcCCCCE
Confidence 89999999999999999754 56999999999999999999999998 999999999 8888999999
Q ss_pred EEeecCCccccccCCC-CCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 304 KVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
||+|||+|+....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.+..........
T Consensus 144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~ 223 (276)
T d1uwha_ 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223 (276)
T ss_dssp EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 9999999987653322 233456789999999998643 578999999999999999999999988766544433333
Q ss_pred cC--CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 380 RQ--RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 380 ~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
.+ .+.....+..+++++.+||.+||+.||++|||+++++++|+.+.+++
T Consensus 224 ~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 224 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 33 22333345678899999999999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=402.06 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=208.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|+..+.||+|+||.||. +|+.||||++..... .+..+.+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 688999999999999985 588999999875532 2334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++.+++.+++.++..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||+
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~-----------NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPE-----------NLLLDERDNLKISDFGL 149 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEECTTCCEEECCCTT
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHH-----------HEEECCCCCEEEccchh
Confidence 9999999999988888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCC-CCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCC
Q 012164 311 SKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 388 (469)
Q Consensus 311 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 388 (469)
|+...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............... .......
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~-~~~~~~~ 228 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNP 228 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT-TCTTSTT
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCc
Confidence 98765332 223345679999999999988776 56899999999999999999999876554443333222 2223334
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 389 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 389 ~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+++++.+||.+||+.||++|||++|+++|
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 56788999999999999999999999999765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=400.10 Aligned_cols=246 Identities=22% Similarity=0.432 Sum_probs=213.2
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
.+|+..+.||+|+||.||. +|+.||||++....... .+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 3688899999999999985 58999999987554332 356899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|||++|+|.+++.+ +.+++.++..++.||+.||+|||++| |+||||||+ |||++.++.+||+|||
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~-----------NILl~~~~~vkl~DFG 161 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSD-----------NILLGMDGSVKLTDFG 161 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTCCEEECCCT
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHH-----------HeEECCCCcEeeccch
Confidence 99999999998875 46999999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+|+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....+.. ..+
T Consensus 162 ~a~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~ 239 (293)
T d1yhwa1 162 FCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNP 239 (293)
T ss_dssp TCEECCSTT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSG
T ss_pred hheeecccc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCc
Confidence 998765332 233456799999999999999999999999999999999999999987665555555544444433 335
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+++++++||.+||+.||++|||++|+++|
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 6789999999999999999999999999876
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=398.33 Aligned_cols=251 Identities=29% Similarity=0.565 Sum_probs=204.4
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. +++.||||++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 567788999999999875 5778999998754322 25689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+ |||++.++.+||+|||+
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~-----------Nill~~~~~~Kl~DFGl 147 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAAR-----------NCLVGENQVIKVSDFGM 147 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGG-----------GEEECGGGCEEECSCC-
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchh-----------heeecCCCCeEecccch
Confidence 9999999998754 55899999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
|+..............||+.|+|||++.+..++.++|||||||++|||+| |++||...+..++...+....++.. +
T Consensus 148 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p 224 (263)
T d1sm2a_ 148 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---P 224 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---C
T ss_pred heeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---c
Confidence 98765444333344678999999999999999999999999999999999 5777776665556665554444333 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
..+++++.+||.+||+.||++|||+++++++|+++.++
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 56788999999999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-52 Score=400.83 Aligned_cols=256 Identities=30% Similarity=0.519 Sum_probs=208.7
Q ss_pred ccccceeeecCeEEEEEE-----ec---eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|+..+.||+|+||.||. +| ..||||.+... ......+.|.+|++++++++||||+++++++.+.+.+++
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 577788999999999974 22 25889988644 345566789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|||||++|+|.+++... +.+++.++..++.||+.||.|||+++ |+||||||+ |||++.++.+||+
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~-----------NILl~~~~~~Kl~ 170 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAAR-----------NILVNSNLVCKVS 170 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTCCEEEC
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccc-----------eEEECCCCcEEEC
Confidence 99999999999988864 56999999999999999999999999 999999999 8888999999999
Q ss_pred ecCCccccccCCCCC----cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC
Q 012164 307 DFGVSKLLTVKEDRP----LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 381 (469)
Q Consensus 307 Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 381 (469)
|||+|+......... .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++...+....
T Consensus 171 DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~ 250 (299)
T d1jpaa_ 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250 (299)
T ss_dssp CC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred CcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999998765332211 122457899999999999999999999999999999998 899999887777766665554
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012164 382 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 430 (469)
Q Consensus 382 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~ 430 (469)
+++. +..+++++.+||.+||+.||++|||+.++++.|+.+.++.+.
T Consensus 251 ~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~s 296 (299)
T d1jpaa_ 251 RLPP---PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296 (299)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred CCCC---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhh
Confidence 4443 456789999999999999999999999999999999877543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=395.26 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=201.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe--CCceEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 228 (469)
+|++.+.||+|+||.||. +|+.||+|.+..... +....+.+.+|++++++++||||+++++++.+ ...+|+|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 688899999999999985 578999999986644 45566789999999999999999999999865 4568999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEecCCCCCcccccccccCcceeeCCCCC
Q 012164 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP--VPIIHRDLEPSDLYVAYWQNDRNILRDDSGN 302 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~--~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~ 302 (469)
||||++|+|.+++.+ ++.+++..++.++.||+.||+|||+.++ .+|+||||||+ |||++.++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~-----------NIll~~~~~ 152 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA-----------NVFLDGKQN 152 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG-----------GEEECTTSC
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh-----------hcCcCCCCc
Confidence 999999999999864 4569999999999999999999998541 23999999999 888899999
Q ss_pred eEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC
Q 012164 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+..++...+.....
T Consensus 153 vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~ 231 (269)
T d2java1 153 VKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 231 (269)
T ss_dssp EEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred EEEeeccceeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999998765332 223446789999999999999999999999999999999999999988776666665544443
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
++ .+..+++++.+||.+||+.||++|||++|+++|
T Consensus 232 ~~---~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 RR---IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC---CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 33 245688999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-52 Score=403.18 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=197.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..+.||+|+||.||. +|+.||||++...... .....+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 488899999999998875 5889999999765432 233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||+||+|.+++.+.+.+++.++..++.||+.||+|||+++ |+||||||+|||+.. .+.++.+||+|||+
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~--------~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYS--------LDEDSKIMISDFGL 156 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESS--------SSTTCCEEECCC--
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecc--------cCCCceEEEeccce
Confidence 9999999999998889999999999999999999999999 999999999444421 14578999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.............
T Consensus 157 a~~~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (307)
T d1a06a_ 157 SKMEDPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred eEEccCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc
Confidence 9865432 22344679999999999999999999999999999999999999998876666666655444333333456
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+++++.+||.+||+.||++|||++|+++|
T Consensus 235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 788999999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=394.90 Aligned_cols=260 Identities=30% Similarity=0.481 Sum_probs=216.4
Q ss_pred CCCccccCCCCcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEE
Q 012164 144 EVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (469)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 219 (469)
....||+... +|+..+.||+|+||.||. +++.||||++...... .+.|.+|+.++++++||||+++++++
T Consensus 4 ~~~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~ 77 (272)
T d1qpca_ 4 WEDEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVV 77 (272)
T ss_dssp TTCTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeee
Confidence 4456777654 677888999999999984 4678999998754321 35689999999999999999999987
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 220 TQSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 220 ~~~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
.+ +..++|||||++|+|.+++... ..+++..+..++.||++||.|||+++ |+||||||+ |||+
T Consensus 78 ~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~-----------NIll 142 (272)
T d1qpca_ 78 TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA-----------NILV 142 (272)
T ss_dssp CS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEE
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchh-----------heee
Confidence 54 5679999999999999987643 35999999999999999999999999 999999999 8888
Q ss_pred CCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCcHHHH
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKA 376 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg-~~p~~~~~~~~~~~~ 376 (469)
+.++.+||+|||+|+..............||+.|+|||++.+..++.++|||||||++|||+|| .+||...+..++...
T Consensus 143 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~ 222 (272)
T d1qpca_ 143 SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222 (272)
T ss_dssp CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999987654433333456789999999999988999999999999999999995 555665555555555
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+....+++. +..+++++.+||.+||+.||++|||++++++.|+.+.++
T Consensus 223 i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 223 LERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCCC---cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 544434433 456888999999999999999999999999999998765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-52 Score=401.64 Aligned_cols=244 Identities=25% Similarity=0.446 Sum_probs=213.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|+..+.||+|+||.||. +|+.||||++......+....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 588899999999999985 588999999987665566667789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|..++..++.+++..+..++.||+.||.|||+++ |+||||||+ |||++.++.+||+|||+
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~-----------NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAG-----------NILLSEPGLVKLGDFGS 161 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGG-----------GEEEETTTEEEECCCTT
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcc-----------eEEECCCCCEEEeeccc
Confidence 9999999888888888999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
|+..... ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....+.....+..
T Consensus 162 a~~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 234 (309)
T d1u5ra_ 162 ASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-- 234 (309)
T ss_dssp CBSSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--
T ss_pred ccccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--
Confidence 9864422 34579999999999864 3688999999999999999999999987765555555544444333
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+++++.+||.+||+.||++|||++++++|
T Consensus 235 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 235678999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=394.65 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=208.7
Q ss_pred eeeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEeccC
Q 012164 161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (469)
Q Consensus 161 ~~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~~~ 233 (469)
++||+|+||.||. .++.||||++..... +....+.+.+|+.++++++||||+++++++.. +..++|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 5799999999975 246899999875543 34455789999999999999999999999864 56799999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 234 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
+|+|.+++.+...+++..+..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||+|+.
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~-----------Nill~~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR-----------NVLLVTQHYAKISDFGLSKA 156 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEEEETTEEEECCCTTCEE
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcch-----------hhcccccCcccccchhhhhh
Confidence 9999999999888999999999999999999999999 999999999 88888999999999999987
Q ss_pred cccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 314 LTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 314 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
....... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++...+....+++. +.
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~ 233 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PA 233 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CT
T ss_pred ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC---Cc
Confidence 5433221 1233568999999999998899999999999999999998 8999998877666666655545444 45
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 391 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.+|+++.+||.+||+.||++|||+.++++.|+.+...
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 6889999999999999999999999999988877544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=398.79 Aligned_cols=246 Identities=28% Similarity=0.406 Sum_probs=211.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
.|++.+.||+|+||.||. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+.+++|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 478889999999999985 57899999987542 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 231 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
||++|+|.+++.+ .+.+++..+..++.||+.||.|||+++ |+||||||+ |||++.++.+||+|||
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~-----------NIll~~~~~~Kl~DFG 155 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAG-----------NILFTLDGDIKLADFG 155 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTSCEEECCCT
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChh-----------heeECCCCCEEEEech
Confidence 9999999999865 456999999999999999999999999 999999999 8888899999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
+|+...... .......||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.+..+....+.....+.
T Consensus 156 ~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~ 234 (288)
T d2jfla1 156 VSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234 (288)
T ss_dssp TCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC
T ss_pred hhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 997654321 1223467999999999984 4568899999999999999999999999887777766665444333
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
...+..+++++.+||.+||+.||++|||++|+++|
T Consensus 235 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 -LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 33456789999999999999999999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=393.12 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=215.5
Q ss_pred ccccce-eeecCeEEEEEE-------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~-~ig~G~~~~~~~-------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
++...+ +||+|+||.||. ++..||||++... ......+.|.+|++++++++||||+++++++.+ +.+++
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 344555 599999999875 2457999998754 345667889999999999999999999999865 56899
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
|||||++|+|.+++.. ++.+++..+..++.||+.||+|||+++ |+||||||+ ||+++.++.+||+
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~-----------Nill~~~~~~Kl~ 151 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAAR-----------NVLLVNRHYAKIS 151 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEEEETTEEEEC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchh-----------heeeccCCceeec
Confidence 9999999999999865 456999999999999999999999999 999999999 8888889999999
Q ss_pred ecCCccccccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCC
Q 012164 307 DFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 307 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+....++
T Consensus 152 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~ 231 (285)
T d1u59a_ 152 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231 (285)
T ss_dssp CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC
T ss_pred cchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999987654322 22234568899999999998899999999999999999998 99999988877777766555555
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
+. +..+|+++.+||.+||+.||++|||+.++++.|+.+..++.
T Consensus 232 ~~---p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 232 EC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp CC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CC---CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 44 45688999999999999999999999999999998876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=402.20 Aligned_cols=247 Identities=21% Similarity=0.402 Sum_probs=210.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||++.+.........+.+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 688999999999999984 588999999875433223334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++...+.+++..+..++.|++.||+|||+.+ |+||||||+ ||+++.++.+||+|||+
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~-----------NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPE-----------NILLNEDMHIQITDFGT 154 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTSCEEECCCTT
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCcc-----------ccccCCCceEEeccccc
Confidence 9999999999998889999999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
|+...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+... ...+ +
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~~~---p 230 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDF---P 230 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-CCCC---C
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-CCCC---C
Confidence 98765332 22234467999999999999999999999999999999999999999887665555555333 2222 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+++++++||.+||+.||++|||++|++++
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 4678899999999999999999999998776
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-52 Score=397.47 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=215.5
Q ss_pred CCccccCCCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEE
Q 012164 145 VPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (469)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 219 (469)
...||++.. +|+..+.||+|+||.||. +|+.||||++..... ..+.+.+|++++++++||||+++++++
T Consensus 9 ~~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (287)
T d1opja_ 9 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVC 82 (287)
T ss_dssp CCTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccE
Confidence 345777654 577788999999998875 478999999875432 235689999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 220 TQSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 220 ~~~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
.+.+.+++|||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+ |||+
T Consensus 83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~-----------NILl 148 (287)
T d1opja_ 83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAAR-----------NCLV 148 (287)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEE
T ss_pred eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccC-----------eEEE
Confidence 9999999999999999999999764 45899999999999999999999999 999999999 8888
Q ss_pred CCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCC-CCCCCcHHHH
Q 012164 298 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKA 376 (469)
Q Consensus 298 ~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~-~~~~~~~~~~ 376 (469)
+.++.+||+|||+|+..............|++.|+|||++.+..++.++|||||||++|||++|..||. ..+..++...
T Consensus 149 ~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~ 228 (287)
T d1opja_ 149 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 228 (287)
T ss_dssp CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH
Confidence 899999999999998765433333333457889999999999999999999999999999999666554 4443334444
Q ss_pred HhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 377 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
+....+++. +..+++++.+||.+||+.||++|||++++++.|+.+.+.
T Consensus 229 i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 229 LEKDYRMER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HhcCCCCCC---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 433333333 456889999999999999999999999999999887544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=386.63 Aligned_cols=246 Identities=25% Similarity=0.485 Sum_probs=203.1
Q ss_pred cccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe----CCceEE
Q 012164 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMI 227 (469)
Q Consensus 157 ~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 227 (469)
|+..++||+|+||.||. +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+ ...+++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 35566899999999985 578999999876544 44556789999999999999999999999865 345899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC-CCCCeEEe
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD-DSGNLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~-~~~~vkl~ 306 (469)
|||||++|+|.+++.+.+.+++..+..++.||+.||+|||+++ .+|+||||||+ |||++ .++.+||+
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~-----------NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCD-----------NIFITGPTGSVKIG 157 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGG-----------GEEESSTTSCEEEC
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChh-----------hceeeCCCCCEEEe
Confidence 9999999999999998888999999999999999999999986 24999999999 77775 57899999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
|||+|+.... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.............+..+ .
T Consensus 158 DFGla~~~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~-~ 232 (270)
T d1t4ha_ 158 DLGLATLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-A 232 (270)
T ss_dssp CTTGGGGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-G
T ss_pred ecCcceeccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-c
Confidence 9999976432 23345679999999999876 69999999999999999999999998655433322222222222 1
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..+..+++++.+||.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 2244577889999999999999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-52 Score=388.09 Aligned_cols=248 Identities=27% Similarity=0.514 Sum_probs=216.2
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..++||+|+||.||. +++.||||++...... .+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 567778999999999985 5679999998865432 25689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 232 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
+++|+|.+++.. ...+++..+..++.|+++||+|||+++ |+||||||+ ||+++.++.+||+|||+
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~-----------Nill~~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAAR-----------NCLVNDQGVVKVSDFGL 146 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGG-----------GEEECTTCCEEECCCSS
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccce-----------eEEEcCCCcEEECcchh
Confidence 999999999764 456899999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
++..............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++...+....+++. +
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p 223 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---P 223 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---C
T ss_pred heeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---c
Confidence 98766544444445678999999999999999999999999999999998 8999998887777776655444433 4
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
..+++++.+||.+||+.||++|||+++++++|.+|
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 56788999999999999999999999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=401.86 Aligned_cols=248 Identities=27% Similarity=0.492 Sum_probs=206.8
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEE
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 228 (469)
+.+|++.+.||+|+||.||. +|+.||+|++.... .....+.+.+|+.++++++||||++++++|.+...+|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34788999999999999885 58999999987543 234456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
||||++|+|.+++.+.+.+++..+..++.|++.||.|||+ ++ |+||||||+ |||++.++.+||+|
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~-----------NILl~~~~~vkl~D 148 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPS-----------NILVNSRGEIKLCD 148 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGG-----------GEEECTTCCEEECC
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHH-----------HeeECCCCCEEEee
Confidence 9999999999999988889999999999999999999997 47 999999999 88888999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh--------
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-------- 379 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-------- 379 (469)
||+|+...... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+.......
T Consensus 149 FGla~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 149 FGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp CCCCHHHHHHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred CCCccccCCCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence 99998654322 2346799999999999999999999999999999999999999987654332111000
Q ss_pred --------------------------------cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 --------------------------------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 --------------------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+...+...++.++.+||.+||..||++|||++|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00001111223467899999999999999999999999997
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=389.41 Aligned_cols=259 Identities=25% Similarity=0.475 Sum_probs=210.2
Q ss_pred cccCCCCcccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEE
Q 012164 148 YEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (469)
Q Consensus 148 ~~~~~~~~~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 219 (469)
||++.. +|+..+.||+|+||.||.. +..||||.+... ......+.+.+|+.++++++||||+++++++
T Consensus 2 ~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 566544 6888899999999998741 346889988643 3456667899999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 220 TQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 220 ~~~~~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
. ++.+++|||||++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+ ||+++
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~-----------NIll~ 142 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAAR-----------NVLVS 142 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEEE
T ss_pred e-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchh-----------heeec
Confidence 5 4678999999999999998765 456999999999999999999999999 999999999 88888
Q ss_pred CCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHH
Q 012164 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY 377 (469)
Q Consensus 299 ~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~ 377 (469)
.++.+||+|||+|+..............||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+
T Consensus 143 ~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i 222 (273)
T d1mp8a_ 143 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222 (273)
T ss_dssp ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 89999999999998765444444445668999999999999999999999999999999998 89999988888887777
Q ss_pred hhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 378 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
....+++. +..+|+++.+||.+||+.||++|||+++|+++|+++.+..
T Consensus 223 ~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 223 ENGERLPM---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HcCCCCCC---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 66555543 4578899999999999999999999999999999987763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-51 Score=401.20 Aligned_cols=246 Identities=22% Similarity=0.381 Sum_probs=212.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 799999999999999985 5899999998754 23455778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC--CCCCeEEee
Q 012164 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD--DSGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~--~~~~vkl~D 307 (469)
||++|+|.+++. ..+.+++..+..++.||+.||.|||+++ ||||||||+ |||++ .++.+||+|
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~-----------NIll~~~~~~~vkL~D 169 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPE-----------NIMFTTKRSNELKLID 169 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEESSTTSCCEEECC
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---Ceeeeechh-----------HeeeccCCCCeEEEee
Confidence 999999999995 4567999999999999999999999999 999999999 66664 467899999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||+|+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..........
T Consensus 170 FG~a~~~~~~--~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 247 (350)
T d1koaa2 170 FGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 247 (350)
T ss_dssp CTTCEECCTT--SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG
T ss_pred cchheecccc--cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 9999876532 23344678999999999999999999999999999999999999998877666666665444333333
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+++++++||.+||+.||++|||++|+++|
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 446788999999999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=392.96 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=212.1
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCC---HHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
.+|+..+.||+|+||.||. +|+.||||++.+..... ....+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3689999999999999985 58899999987543322 123467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC----C
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG----N 302 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~----~ 302 (469)
+|||||++|+|.+++.+.+.+++..+..++.|++.||+|||+.+ |+||||||+ ||+++.++ .
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~-----------Nill~~~~~~~~~ 155 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPE-----------NIMLLDRNVPKPR 155 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEESCSSSSSCC
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccc-----------eEEEecCCCcccc
Confidence 99999999999999998888999999999999999999999999 999999999 66666555 5
Q ss_pred eEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCC
Q 012164 303 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 303 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+||+|||+|+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 156 vkl~DfG~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233 (293)
T ss_dssp EEECCCTTCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred eEecchhhhhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence 999999999876533 223446789999999999999999999999999999999999999998776666555544333
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
......+..+++.+++||.+||+.||++|||++++++|
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22222335678899999999999999999999999876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6e-51 Score=387.17 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=214.6
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCc----eE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----MM 226 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~ 226 (469)
+|++.+.||+|+||.||. +|+.||||++......+....+.+.+|+++++.++||||+++++++...+. .|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 588999999999999985 589999999987776677777889999999999999999999999976543 78
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
+|||||+|++|.+++...+.+++.++..++.||+.||+|||+++ |+||||||+ ||+++.++.++++
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~-----------NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA-----------NIMISATNAVKVM 153 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEEETTSCEEEC
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCc-----------ccccCccccceee
Confidence 99999999999999998889999999999999999999999999 999999999 8888899999999
Q ss_pred ecCCccccccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCC
Q 012164 307 DFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 384 (469)
Q Consensus 307 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 384 (469)
|||.+........ .......||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+..+...........+
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC
Confidence 9999876543222 22344579999999999999999999999999999999999999998776656555554444333
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHHH
Q 012164 385 FKAPAKLYARGLKELIEECWNEKPAKRP-TFRQIITRLESIN 425 (469)
Q Consensus 385 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~ll~~L~~~~ 425 (469)
.......+|+++.+||.+||+.||++|| |++++++.|.++.
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 3333456889999999999999999999 8999999988875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=397.58 Aligned_cols=246 Identities=25% Similarity=0.402 Sum_probs=214.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.|+. +|+.||||++.+.........+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 688899999999999985 689999999876533233345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||++|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+ |||++.+|.+||+|||+
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~-----------NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLE-----------NLMLDKDGHIKITDFGL 151 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG-----------GEEECTTSCEEECCCTT
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHH-----------HeEecCCCCEEEeeccc
Confidence 9999999999999889999999999999999999999999 999999999 88999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+..... ........||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++...+... ...+ +.
T Consensus 152 a~~~~~~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-~~~~---p~ 226 (337)
T d1o6la_ 152 CKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRF---PR 226 (337)
T ss_dssp CBCSCCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CT
T ss_pred ccccccC-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-CCCC---Cc
Confidence 9865432 22334467999999999999999999999999999999999999999987766666555433 2332 45
Q ss_pred hhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
.+++++++||.+||++||++||+ +.++++|
T Consensus 227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred cCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 68899999999999999999995 8899886
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.1e-51 Score=397.53 Aligned_cols=246 Identities=18% Similarity=0.357 Sum_probs=212.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||++.... ......+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 589999999999999985 58999999987542 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC--CCCCeEEee
Q 012164 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD--DSGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~--~~~~vkl~D 307 (469)
||++|+|.+++...+ .+++.++..++.||+.||.|||++| |+||||||+ |||++ .++.+||+|
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~-----------NILl~~~~~~~vkL~D 172 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPE-----------NIMCETKKASSVKIID 172 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEESSTTCCCEEECC
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccc-----------cccccccCCCeEEEee
Confidence 999999999886544 6999999999999999999999999 999999999 77766 568999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||+|+..... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+..........
T Consensus 173 FGla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 250 (352)
T d1koba_ 173 FGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED 250 (352)
T ss_dssp CTTCEECCTT--SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS
T ss_pred cccceecCCC--CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 9999876532 23344678999999999999999999999999999999999999998877666666654444333233
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+++++.+||.+||+.||++|||+.|+++|
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 446789999999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=383.58 Aligned_cols=260 Identities=29% Similarity=0.499 Sum_probs=209.0
Q ss_pred ccCCCCcccccceeeecCeEEEEEEe-----c----eeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEE
Q 012164 149 EIDPHELDFTNSVEITKGTFILAFWR-----G----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (469)
Q Consensus 149 ~~~~~~~~~~~~~~ig~G~~~~~~~~-----g----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 219 (469)
|+.+. .|+..+.||+|+||.||.. + ..||||.+.... .......|.+|++++++++||||++++|++
T Consensus 3 ei~~~--~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 3 EIHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp BCCTT--TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHH--HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence 34444 4677889999999998741 1 469999987542 345556799999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 220 TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 220 ~~~~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
.+.+..++|||||.+++|.+++... +.+++.++..++.||+.||+|||+.+ |+||||||+ |||++
T Consensus 79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~-----------NILl~ 144 (283)
T d1mqba_ 79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAAR-----------NILVN 144 (283)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEEC
T ss_pred ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccc-----------eEEEC
Confidence 9999999999999999999988754 56999999999999999999999999 999999999 88889
Q ss_pred CCCCeEEeecCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCcHHH
Q 012164 299 DSGNLKVADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPK 375 (469)
Q Consensus 299 ~~~~vkl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg-~~p~~~~~~~~~~~ 375 (469)
.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++| .+||...+..++..
T Consensus 145 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~ 224 (283)
T d1mqba_ 145 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 224 (283)
T ss_dssp TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH
Confidence 9999999999999876433221 22334689999999999999999999999999999999995 45555555555555
Q ss_pred HHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012164 376 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 429 (469)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~ 429 (469)
.+....+++. +..+++.+.+||.+||+.||++|||+.++++.|+.+.+..+
T Consensus 225 ~i~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 225 AINDGFRLPT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp HHHTTCCCCC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHhccCCCCC---chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 5544444443 35678899999999999999999999999999999887644
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=394.53 Aligned_cols=256 Identities=26% Similarity=0.441 Sum_probs=210.2
Q ss_pred ccccCCCCcccccceeeecCeEEEEEEe----------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeE
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 215 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~~----------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~ 215 (469)
.||++.. +|+..+.||+|+||.||.. ...||+|.+.... .......+.+|+.+++++ +||||+++
T Consensus 31 kwei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 31 KWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGBCCGG--GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHH--HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 3555443 5777899999999999752 2369999886542 233446789999999998 89999999
Q ss_pred EeEEEeCCceEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012164 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPV 272 (469)
Q Consensus 216 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~ 272 (469)
++++.+.+.+++|||||++|+|.+++.++. .+++..++.++.||+.||+|||+++
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-- 184 (325)
T d1rjba_ 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184 (325)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 999999999999999999999999997542 4889999999999999999999999
Q ss_pred CeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHH
Q 012164 273 PIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 351 (469)
Q Consensus 273 ~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~Sl 351 (469)
||||||||+ ||+++.++.+||+|||+|+......... .....||+.|+|||++.+..++.++|||||
T Consensus 185 -IiHRDlKp~-----------Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~ 252 (325)
T d1rjba_ 185 -CVHRDLAAR-----------NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252 (325)
T ss_dssp -EEETTCSGG-----------GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred -eeeccCchh-----------ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccch
Confidence 999999999 8888899999999999998765433221 223457999999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCCCcHHHHHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012164 352 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 423 (469)
Q Consensus 352 Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~ 423 (469)
||++|||+| |+.||.+.+..+....+...+ +++. +..+++++.+||.+||+.||++|||+++|+++|..
T Consensus 253 Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 999999998 899999877666555444433 3332 45678999999999999999999999999999863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-50 Score=380.37 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=214.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCC------HHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCC
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS 223 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 223 (469)
+|+..+.||+|+||.||. +|+.||||++....... ....+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 688899999999999985 68899999987654322 223456889999999997 999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.+|+|||||++|+|.+++..++.+++.++..++.||+.||+|||+++ |+||||||+ ||+++.++.+
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~-----------Nill~~~~~~ 149 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPE-----------NILLDDDMNI 149 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEECTTCCE
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccc-----------eEEEcCCCCe
Confidence 99999999999999999998889999999999999999999999999 999999999 8888999999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~ 377 (469)
||+|||+++..... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+....+
T Consensus 150 kl~DFG~a~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i 227 (277)
T d1phka_ 150 KLTDFGFSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227 (277)
T ss_dssp EECCCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEccchheeEccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH
Confidence 99999999876542 23344679999999999853 35788999999999999999999999987766665555
Q ss_pred hhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..............+|+++++|+.+||+.||++|||++|+++|
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 5444333334456899999999999999999999999999876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-50 Score=390.16 Aligned_cols=243 Identities=24% Similarity=0.458 Sum_probs=212.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||++.+.........+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 688899999999999875 588999999875433222335678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
||+||+|..++.....+++..+..++.||+.||+|||+++ |+||||||+ |||++.+|.+||+|||+
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~-----------NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPE-----------NILLDKNGHIKITDFGF 150 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGG-----------GEEECTTSCEEECCCSS
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCch-----------heeEcCCCCEEEecCcc
Confidence 9999999999999888999999999999999999999999 999999999 88889999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... ... +.
T Consensus 151 a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~---p~ 222 (316)
T d1fota_ 151 AKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRF---PP 222 (316)
T ss_dssp CEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCC---CT
T ss_pred ceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCC---CC
Confidence 9875432 234679999999999999999999999999999999999999998877666665554332 222 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
.+++++.++|.+||..||.+|| |++++++|
T Consensus 223 ~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 6788999999999999999996 89999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=379.06 Aligned_cols=252 Identities=30% Similarity=0.552 Sum_probs=209.9
Q ss_pred cccCCCCcccccceeeecCeEEEEE---EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe-CC
Q 012164 148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS 223 (469)
Q Consensus 148 ~~~~~~~~~~~~~~~ig~G~~~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 223 (469)
|+++..+ |+..+.||+|+||.|| ++|..||||+++.+. ..+.+.+|++++++++||||+++++++.+ .+
T Consensus 2 w~i~~~~--~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKE--LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGG--EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHH--eEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 6666664 5567899999999887 578999999997542 23678999999999999999999999865 46
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
.+++||||+++|+|.+++..++ .+++..++.++.||+.||.|||+.+ |+||||||+ ||+++.++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~-----------Nil~~~~~ 140 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAAR-----------NVLVSEDN 140 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEECTTS
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchH-----------hheecCCC
Confidence 6899999999999999997543 4899999999999999999999998 999999999 88889999
Q ss_pred CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhc
Q 012164 302 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 380 (469)
.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|||+| |++||...+..++...+...
T Consensus 141 ~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~ 216 (262)
T d1byga_ 141 VAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 216 (262)
T ss_dssp CEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred CEeecccccceecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999865432 223457889999999998899999999999999999998 79999988877777777655
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.+++. +..+++++.+||.+||..||++|||+.+++++|+.+.+.
T Consensus 217 ~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 217 YKMDA---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC---CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 56554 345788999999999999999999999999999998765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=383.44 Aligned_cols=259 Identities=31% Similarity=0.497 Sum_probs=209.0
Q ss_pred CccccCCCCcccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 012164 146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (469)
Q Consensus 146 ~~~~~~~~~~~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 221 (469)
..|+++.. +|++.+.||+|+||.||. ++..||||++..... . .+.|.+|+.++++++||||+++++++.+
T Consensus 10 ~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 10 DAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-C---HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 35777654 688899999999999885 456899999875532 2 2568999999999999999999999854
Q ss_pred CCceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC
Q 012164 222 SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD 299 (469)
Q Consensus 222 ~~~~~lv~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~ 299 (469)
+..++|||||++|+|..++.. .+.+++.++..++.||+.||+|||+++ |+||||||+ |||++.
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~-----------NIll~~ 148 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAA-----------NILVGE 148 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEECG
T ss_pred -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccce-----------EEEECC
Confidence 568999999999999999864 356999999999999999999999999 999999999 888889
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCcHHHHHh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg-~~p~~~~~~~~~~~~~~ 378 (469)
++.+||+|||+|+..............||+.|+|||++.++.++.++|||||||++|||++| ++||......++...+.
T Consensus 149 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~ 228 (285)
T d1fmka3 149 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228 (285)
T ss_dssp GGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred CCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999999987654443444446789999999999999999999999999999999995 45555555555555554
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 379 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 379 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
...+.+. +..+++++.+||.+||+.||++|||++++++.|+.+.++.
T Consensus 229 ~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 229 RGYRMPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred hcCCCCC---CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 4444443 4567899999999999999999999999999988877664
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=387.61 Aligned_cols=245 Identities=16% Similarity=0.296 Sum_probs=209.1
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||.+.... .....+.+|+++|++++||||+++++++.+.+.+|+|||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 688999999999999985 58899999997542 233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC--CCCeEEee
Q 012164 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD--SGNLKVAD 307 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~--~~~vkl~D 307 (469)
||+||+|.+++.+.+ .+++.++..++.||+.||+|||+++ |+||||||+ |||++. .+.+||+|
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~-----------NIll~~~~~~~ikl~D 147 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPE-----------NIIYQTRRSSTIKIIE 147 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEESSSSCCCEEECC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCccccccc-----------ceeecCCCceEEEEcc
Confidence 999999999998765 6999999999999999999999999 999999999 666653 45899999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 387 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 387 (469)
||+++..... .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+..........
T Consensus 148 FG~~~~~~~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 148 FGQARQLKPG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE 225 (321)
T ss_dssp CTTCEECCTT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH
T ss_pred cchhhccccC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh
Confidence 9999875432 22334568999999999999999999999999999999999999999877666666664443322222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 388 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 388 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+++++++||.+||..||++|||++|+++|
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 234678899999999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-50 Score=391.97 Aligned_cols=243 Identities=24% Similarity=0.408 Sum_probs=211.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 789999999999999985 589999999875433223334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
|+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ ||||||||+ |||++.+|.+||+|||+
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~-----------NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE-----------NLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTSCEEECCCTT
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHH-----------HcccCCCCCEEeeecee
Confidence 9999999999998889999999999999999999999999 999999999 88888999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCChh
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 390 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (469)
|+..... .....||+.|||||++.+..++.++|||||||++|+|+||+.||.+.+.......+.... ... +.
T Consensus 188 a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~---p~ 259 (350)
T d1rdqe_ 188 AKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRF---PS 259 (350)
T ss_dssp CEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CT
T ss_pred eeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-CCC---Cc
Confidence 9876432 234568999999999999999999999999999999999999998776555555554332 222 35
Q ss_pred hhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 391 LYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 391 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
.+++++.+||.+||..||.+|+ |++++++|
T Consensus 260 ~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 6788999999999999999994 89999886
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-49 Score=390.79 Aligned_cols=247 Identities=22% Similarity=0.348 Sum_probs=205.4
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCC---HHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 227 (469)
+|++.+.||+|+||.||. +|+.||||++.+..... .........|+.+++.++||||+++++++.+.+.+|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 688899999999999984 58999999986443211 1112223345777888899999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||||++|+|.+++.+++.+++..+..++.||+.||.|||+++ ||||||||+ |||++.+|.+||+|
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~-----------NILl~~~g~iKl~D 150 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPA-----------NILLDEHGHVRISD 150 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECSSSCEEECC
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccc-----------eeEEcCCCcEEEee
Confidence 9999999999999998888999999999999999999999999 999999999 88889999999999
Q ss_pred cCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCC
Q 012164 308 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 386 (469)
Q Consensus 308 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 386 (469)
||+|+..... ......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||..................+ .
T Consensus 151 FGla~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-~ 226 (364)
T d1omwa3 151 LGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-V 226 (364)
T ss_dssp CTTCEECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC-C
T ss_pred eceeeecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-C
Confidence 9999876533 2234579999999999875 578999999999999999999999998776655544332222222 2
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012164 387 APAKLYARGLKELIEECWNEKPAKRPT-----FRQIITR 420 (469)
Q Consensus 387 ~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~~ll~~ 420 (469)
..+..+++++++||.+||+.||++||| ++++++|
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 234568899999999999999999999 7999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=377.15 Aligned_cols=263 Identities=29% Similarity=0.528 Sum_probs=217.1
Q ss_pred CCCccccCCCCcccccceeeecCeEEEEEEe------------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCC
Q 012164 144 EVPEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHP 210 (469)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~ig~G~~~~~~~~------------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 210 (469)
..|.|+++.. +|...+.||+|+||.||.. +..||||++.... .......+.+|...+.++ +||
T Consensus 4 ~~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 4 EDPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp CCTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCT
T ss_pred cCCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCC
Confidence 3456777655 6777889999999998751 2479999997653 345567788899998888 799
Q ss_pred ceeeEEeEEEeCCceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012164 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPI 274 (469)
Q Consensus 211 ~i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 274 (469)
||+++++++.+++..++|||||++|+|.+++... ..+++.+++.++.||+.||+|||+++ |
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---i 156 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---C 156 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---E
Confidence 9999999999999999999999999999999754 24899999999999999999999999 9
Q ss_pred EecCCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHH
Q 012164 275 IHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 353 (469)
Q Consensus 275 vH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGv 353 (469)
|||||||+ |||++.++.+||+|||+++........ ......+++.|+|||.+.++.|+.++|||||||
T Consensus 157 vHrDiKp~-----------NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gv 225 (299)
T d1fgka_ 157 IHRDLAAR-----------NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225 (299)
T ss_dssp CCSCCSGG-----------GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred Eeeeeccc-----------ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHH
Confidence 99999999 888899999999999999876543322 234456899999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 354 ILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 354 il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
++|||++ |.+||.+.+..++...+....+++. +..+++++.+||.+||+.||++|||+.++++.|+++...
T Consensus 226 vl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 9999998 7999988777666666554444443 456789999999999999999999999999999988643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=379.32 Aligned_cols=260 Identities=27% Similarity=0.465 Sum_probs=204.9
Q ss_pred ccccCCCCcccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeE
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 215 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~ 215 (469)
.||+... +|+..+.||+|+||.||. +++.||||++.... .....+.+.+|..++.++ +|+||+.+
T Consensus 7 ~wei~~~--~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGG--GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHH--HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 4555543 578889999999999974 34689999987542 345556778888888777 68999999
Q ss_pred EeEEEeC-CceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012164 216 LGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278 (469)
Q Consensus 216 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 278 (469)
++++.+. ..+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9998765 4689999999999999999753 23889999999999999999999999 99999
Q ss_pred CCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHH
Q 012164 279 LEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 357 (469)
Q Consensus 279 lkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~e 357 (469)
|||+ |||++.++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++||
T Consensus 160 lKp~-----------NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~e 228 (299)
T d1ywna1 160 LAAR-----------NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 228 (299)
T ss_dssp CCGG-----------GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCcc-----------ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHH
Confidence 9999 88888899999999999986554332 22344679999999999999999999999999999999
Q ss_pred HHhC-CCCCCCCCCCcHHHHHhhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 358 MIEG-CPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 358 l~tg-~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
|+|| .+||......+........+ +++. +..+++++.+||.+||+.||++|||+++++++|+.+.++
T Consensus 229 llt~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 229 IFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHTTSCCSSTTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 9986 67888766555444333333 3332 456788999999999999999999999999999998765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-49 Score=380.00 Aligned_cols=251 Identities=29% Similarity=0.465 Sum_probs=214.0
Q ss_pred ccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
+|+..+.||+|+||.||. +++.||||++... ...+..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 578889999999999984 2468999998754 3455667899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 012164 226 MIVTEYLPKGDLRAFLKRKG------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 281 (469)
+++|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ +|||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999996432 3788999999999999999999999 99999999
Q ss_pred CcccccccccCcceeeCCCCCeEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh
Q 012164 282 SDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 360 (469)
Q Consensus 282 ~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t 360 (469)
+ |||++.++.+||+|||+|+....... .......+++.|+|||.+.+..++.++|||||||++|||++
T Consensus 169 ~-----------NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 169 R-----------NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp G-----------GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred c-----------ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 9 88888999999999999986543322 22334568899999999999999999999999999999999
Q ss_pred C-CCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012164 361 G-CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 425 (469)
Q Consensus 361 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~ 425 (469)
| .+||.+.+..++...+....+++. +..+++++.+||.+||+.||++|||+.+|++.|+++.
T Consensus 238 ~~~~p~~~~~~~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 238 YGLQPYYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 8 468888777777776655544433 4567889999999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=381.47 Aligned_cols=253 Identities=24% Similarity=0.487 Sum_probs=209.5
Q ss_pred cccccceeeecCeEEEEEE-----ece----eehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCce
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 225 (469)
.+|+..+.||+|+||.||. +|+ .||+|.+.... +....+.+.+|+.++++++||||+++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 3689999999999999984 333 58888776432 233456799999999999999999999999864 56
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++++||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+ |||++.++.+|
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~-----------NIll~~~~~~k 151 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR-----------NVLVKTPQHVK 151 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEEEETTEEE
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhh-----------cceeCCCCCeE
Confidence 8889999999999988764 56999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCC
Q 012164 305 VADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 382 (469)
|+|||+|+......... .....||+.|+|||++.++.++.++|||||||++|||+| |++||.+.+..++...+....+
T Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~ 231 (317)
T d1xkka_ 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 231 (317)
T ss_dssp ECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC
T ss_pred eeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999998765433222 233468999999999999999999999999999999998 8999998887777776655555
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
++. +..+++.+.+||.+||+.||++|||+.+++++|+.+.+.
T Consensus 232 ~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 232 LPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp CCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCC---CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 544 356789999999999999999999999999999988654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=376.98 Aligned_cols=253 Identities=26% Similarity=0.472 Sum_probs=202.0
Q ss_pred cccccceeeecCeEEEEEEe--------ceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceE
Q 012164 155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 226 (469)
.+|+..+.||+|+||.||.. +..||||++........+..+.|.+|+.++++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 36888999999999988742 24799999987665556667889999999999999999999999965 5678
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 227 IVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
+|||||++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+ ||+++.++.+||
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~-----------NIll~~~~~vkl 152 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAAR-----------NLLLATRDLVKI 152 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG-----------GEEEEETTEEEE
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHH-----------Hhccccccceee
Confidence 99999999999988765 456999999999999999999999999 999999999 888888999999
Q ss_pred eecCCccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCcHHHHHhhcCC
Q 012164 306 ADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 382 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 382 (469)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+...+.
T Consensus 153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232 (273)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred ccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence 999999876443221 1233457889999999999999999999999999999998 8999998877776666644432
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012164 383 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 424 (469)
Q Consensus 383 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~ 424 (469)
.+ ..+..+|+++.+||.+||+.||++|||+.+|++.|++.
T Consensus 233 ~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RL--PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC--CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 21 22456789999999999999999999999999888764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=386.28 Aligned_cols=246 Identities=29% Similarity=0.458 Sum_probs=209.5
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHh-cCCCCceeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~ 229 (469)
+|...+.||+|+||.||. +|+.||||++.+.........+.+..|..++. .++||||+++++++.+++.+|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 588889999999999985 68999999987543222223355666777655 689999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecC
Q 012164 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFG 309 (469)
Q Consensus 230 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfg 309 (469)
|||++|+|.+++...+.+++.++..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~-----------NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLD-----------NILLDKDGHIKIADFG 148 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG-----------GEEECTTSCEEECCCT
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCccc-----------ceeecCCCceeccccc
Confidence 99999999999999889999999999999999999999999 999999999 8888999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCCCCCCCh
Q 012164 310 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 389 (469)
Q Consensus 310 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (469)
+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+... .+.+ +
T Consensus 149 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~---p 223 (320)
T d1xjda_ 149 MCKENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFY---P 223 (320)
T ss_dssp TCBCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---C
T ss_pred hhhhcccc-cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCC---C
Confidence 99865433 23334467999999999999999999999999999999999999999987766666555433 3332 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHH-HHHHH
Q 012164 390 KLYARGLKELIEECWNEKPAKRPTFR-QIITR 420 (469)
Q Consensus 390 ~~~~~~l~~li~~cl~~dp~~Rps~~-~ll~~ 420 (469)
..+++++.+||.+||..||++|||+. ++++|
T Consensus 224 ~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 224 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 56789999999999999999999995 78765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=374.74 Aligned_cols=261 Identities=27% Similarity=0.460 Sum_probs=211.4
Q ss_pred cccccceeeecCeEEEEEE--------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-Cce
Q 012164 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPM 225 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 225 (469)
+.+...+.||+|+||.||. +...||||.+... .+....+.|.+|++++++++||||++++|++.+. ...
T Consensus 27 ~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 27 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred ceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence 3333357899999999984 1236899998643 4566678899999999999999999999998764 578
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
++|||||++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+ |||++.++.+|
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~-----------NILl~~~~~~k 170 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAAR-----------NCMLDEKFTVK 170 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG-----------GEEECTTCCEE
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHH-----------hEeECCCCCEE
Confidence 99999999999999998543 4788899999999999999999999 999999999 88889999999
Q ss_pred EeecCCccccccCCCC---CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCCCcHHHHHhhc
Q 012164 305 VADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAAR 380 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~-~~~~~~~~~~~~~ 380 (469)
|+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+||..||.. .+..++...+...
T Consensus 171 L~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g 250 (311)
T d1r0pa_ 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250 (311)
T ss_dssp ECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT
T ss_pred EecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999876543221 12335689999999999999999999999999999999997666654 3444455555444
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccch
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRW 434 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~ 434 (469)
.++.. +..+++++.+||.+||+.||++|||+.|++++|+++.++.......
T Consensus 251 ~~~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~ 301 (311)
T d1r0pa_ 251 RRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 301 (311)
T ss_dssp CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred CCCCC---cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhch
Confidence 44433 3567889999999999999999999999999999999886655443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=377.65 Aligned_cols=251 Identities=31% Similarity=0.530 Sum_probs=207.4
Q ss_pred ccccceeeecCeEEEEEE-----ece--eehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEeCCceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~--~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 227 (469)
+|+..+.||+|+||.||. +|. .||||.+... ...+..+.+.+|+++++++ +||||+++++++.+++.+++
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 566678999999999874 233 5788887533 2334456799999999999 69999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCccccccccc
Q 012164 228 VTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQN 291 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~ 291 (469)
|||||++|+|.+++..+ ..+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~--------- 156 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR--------- 156 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG---------
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccc---------
Confidence 99999999999999753 46899999999999999999999998 999999999
Q ss_pred CcceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCC
Q 012164 292 DRNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHD 370 (469)
Q Consensus 292 ~~nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg-~~p~~~~~~ 370 (469)
|||++.++.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++| .+||.+.+.
T Consensus 157 --NIL~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 157 --NILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp --GEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred --eEEEcCCCceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 8888889999999999997654332 22335689999999999999999999999999999999996 567887776
Q ss_pred CcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 371 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
.++...+....+++. +..+++++.+||.+||+.||++|||+++++++|+++.+.
T Consensus 233 ~~~~~~i~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 233 AELYEKLPQGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHHGGGTCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHhcCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 666666654444433 456889999999999999999999999999999998765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=377.99 Aligned_cols=241 Identities=27% Similarity=0.415 Sum_probs=195.8
Q ss_pred ccccce-eeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeEEeEEEe----CCc
Q 012164 156 DFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----SSP 224 (469)
Q Consensus 156 ~~~~~~-~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~ 224 (469)
+|.+.. .||+|+||.||. +|+.||||++... ..+.+|+.++.++ +||||++++++|.+ ...
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 677764 599999999985 5789999998643 4577899987655 79999999999875 356
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC---
Q 012164 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD--- 299 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~--- 299 (469)
+|+|||||+||+|.+++.+.+ .+++.++..++.||+.||+|||+.+ |+||||||+ |||++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~-----------NIll~~~~~ 149 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE-----------NLLYTSKRP 149 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEESCSST
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccc-----------ccccccccc
Confidence 899999999999999998743 5999999999999999999999999 999999999 666653
Q ss_pred CCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh
Q 012164 300 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 379 (469)
Q Consensus 300 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~ 379 (469)
.+.+||+|||+|+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+..+....+..
T Consensus 150 ~~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~ 227 (335)
T d2ozaa1 150 NAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227 (335)
T ss_dssp TCCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred cccccccccceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH
Confidence 5679999999998765432 33456799999999999999999999999999999999999999987766554443322
Q ss_pred cC---CCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 RQ---RPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ~~---~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. ...++ .....+++++.+||.+||+.||++|||+.++++|
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 21 11222 2235688999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=372.09 Aligned_cols=261 Identities=28% Similarity=0.454 Sum_probs=218.1
Q ss_pred ccccCCCCcccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC-CCCceeeE
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 215 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~ 215 (469)
.|+++.. +|+..+.||+|+||.||. +++.||||++.... .......+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 17 KWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 4666654 666688999999999974 34689999997543 345567899999999999 69999999
Q ss_pred EeEEEeCCceEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012164 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (469)
Q Consensus 216 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 277 (469)
++++.+....++|||||++|+|.+++.+.. .+++..+..++.||+.||+|||+++ +|||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr 169 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR 169 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 999999999999999999999999997543 4889999999999999999999999 9999
Q ss_pred CCCCCcccccccccCcceeeCCCCCeEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHH
Q 012164 278 DLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 356 (469)
Q Consensus 278 Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~ 356 (469)
||||+ ||+++.++.+|++|||+++........ ......||+.|+|||++.+..++.++|||||||++|
T Consensus 170 DLKp~-----------NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 170 DLAAR-----------NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (311)
T ss_dssp CCSGG-----------GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ccccc-----------cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHH
Confidence 99999 888889999999999999876543322 223456899999999999989999999999999999
Q ss_pred HHHh-CCCCCCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 357 EMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 357 el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
||+| |.+||...+..+....+...+..+. .+..+++.+.+||.+||+.||++|||+++|++.|+++...
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 9998 6777777666665555544443222 2356788999999999999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=374.92 Aligned_cols=247 Identities=28% Similarity=0.387 Sum_probs=197.5
Q ss_pred cceeeecCeEEEEEE-----eceeehhhhcccccCCCH--HHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 159 ~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
..+.||+|+||.||. +|+.||||++........ ...+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 356899999999985 588999999875432211 1234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
|.++++..+...++.+++..+..++.||+.||+|||+++ |+||||||+ |||++.++.+||+|||+|
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~-----------NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPN-----------NLLLDENGVLKLADFGLA 147 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTCCEEECCCGGG
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcc-----------eEEecCCCccccccCccc
Confidence 988777777666677999999999999999999999999 999999999 888899999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc-CCCC-----
Q 012164 312 KLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPP----- 384 (469)
Q Consensus 312 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~----- 384 (469)
+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+... +.+.
T Consensus 148 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 148 KSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp STTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred cccCCCc-ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 8755432 223346789999999998654 6789999999999999999999999876655544433211 1000
Q ss_pred -------------CCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 -------------FKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 -------------~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... ....+++++.+||.+||+.||++|||++|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 012457889999999999999999999999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=370.49 Aligned_cols=260 Identities=26% Similarity=0.445 Sum_probs=220.0
Q ss_pred ccccCCCCcccccceeeecCeEEEEEE----------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEE
Q 012164 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (469)
Q Consensus 147 ~~~~~~~~~~~~~~~~ig~G~~~~~~~----------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 216 (469)
.||+++. +|+..+.||+|+||.||. ++..||||++... ........+.+|+.++++++||||++++
T Consensus 14 ~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 4777764 667788999999999873 3578999998754 3445567799999999999999999999
Q ss_pred eEEEeCCceEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccc
Q 012164 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYV 286 (469)
Q Consensus 217 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~ 286 (469)
+++......++|||||++|+|.+++... ..+++..+..++.|+++||.|||+++ |+||||||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~---- 162 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAAR---- 162 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGG----
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCC----
Confidence 9999999999999999999999998642 23688899999999999999999998 999999999
Q ss_pred cccccCcceeeCCCCCeEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC-CCC
Q 012164 287 AYWQNDRNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPP 364 (469)
Q Consensus 287 ~~~~~~~nil~~~~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg-~~p 364 (469)
|||++.++.+||+|||+|+......... .....+|+.|+|||.+.+..++.++||||||+++|||+|| ++|
T Consensus 163 -------NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p 235 (308)
T d1p4oa_ 163 -------NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235 (308)
T ss_dssp -------GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred -------ceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCC
Confidence 8899999999999999998665432222 2334589999999999999999999999999999999997 588
Q ss_pred CCCCCCCcHHHHHhhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 365 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
|.+.+..++...+....+++. +..+++.+.+||.+||+.||++|||+++++++|++....
T Consensus 236 ~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 236 YQGLSNEQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp TTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCCCCHHHHHHHHHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 988877777776655554443 456788999999999999999999999999998777554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=364.55 Aligned_cols=240 Identities=26% Similarity=0.410 Sum_probs=198.8
Q ss_pred CcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHH---HHHHHHHHHHHHhcCC--CCceeeEEeEEEeCC
Q 012164 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD---RVRAFRDELALLQKIR--HPNVVQFLGAVTQSS 223 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~ 223 (469)
+.+|++.+.||+|+||.||. +|+.||||++......... ....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 45799999999999999984 5899999998765432211 1133668999999996 899999999999999
Q ss_pred ceEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCC-CC
Q 012164 224 PMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDD-SG 301 (469)
Q Consensus 224 ~~~lv~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~-~~ 301 (469)
..++||||+.+ +++.+++.+++.+++.++..++.||+.||+|||+.+ |+||||||+ |||++. ++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~-----------NIll~~~~~ 148 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDE-----------NILIDLNRG 148 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG-----------GEEEETTTT
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCccc-----------ceEEecCCC
Confidence 99999999975 688899988888999999999999999999999999 999999999 777774 47
Q ss_pred CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc
Q 012164 302 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 380 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~ 380 (469)
.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+ .+..
T Consensus 149 ~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~- 218 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR- 218 (273)
T ss_dssp EEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH-
T ss_pred eEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh-
Confidence 8999999999865422 2344679999999999987665 567999999999999999999997531 2212
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+ +..+|+++++||.+||+.||++|||++|+++|
T Consensus 219 ~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 GQVFF---RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCC---CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 22222 34578899999999999999999999999876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=364.27 Aligned_cols=248 Identities=24% Similarity=0.448 Sum_probs=196.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||++..... .....+.+.+|++++++++||||+++++++.+...+|+|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 688899999999999985 588999999975432 22334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 231 YLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 231 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||.+ ++.+++.. .+.+++..+..++.||+.||+|||+++ ||||||||+ |||++.++.+||+||
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpe-----------NIl~~~~~~~kl~DF 146 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQ-----------NLLINTEGAIKLADF 146 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTSCEEECST
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCch-----------heeecccCcceeccC
Confidence 9965 55555543 456999999999999999999999999 999999999 888889999999999
Q ss_pred CCccccccCCCCCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-cCCCC--
Q 012164 309 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP-- 384 (469)
Q Consensus 309 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~~-- 384 (469)
|+|+..... ........||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+..+....+.. .+.+.
T Consensus 147 G~a~~~~~~-~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 225 (298)
T d1gz8a_ 147 GLARAFGVP-VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225 (298)
T ss_dssp THHHHHCCC-SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CcceeccCC-cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 999876433 22334457899999999877654 57899999999999999999999986654333222211 00000
Q ss_pred --------------C----C----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 385 --------------F----K----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 385 --------------~----~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
. . .....+++++.+||.+||..||++|||++|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0 0112456889999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6e-47 Score=361.26 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=200.8
Q ss_pred ccccceeeecCeEEEEEE----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEec
Q 012164 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E~ 231 (469)
+|+..+.||+|+||.||. +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++++||
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 688899999999999985 578999999976533 223346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCc
Q 012164 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVS 311 (469)
Q Consensus 232 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla 311 (469)
+.++.+..+....+.+++..+..++.||+.||+|||+.+ ||||||||+ |||++.++.+||+|||+|
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~-----------NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQ-----------NLLINREGELKIADFGLA 147 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTSCEEECCTTHH
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCc-----------eeeEcCCCCEEecccccc
Confidence 987777777777788999999999999999999999999 999999999 888899999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-cCCC------
Q 012164 312 KLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRP------ 383 (469)
Q Consensus 312 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~------ 383 (469)
....... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+.. .+.+
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 148 RAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226 (286)
T ss_dssp HHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred eecccCc-cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhcc
Confidence 8754332 222345688999999998764 568999999999999999999999987654433332211 0000
Q ss_pred ------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 ------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 ------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.......+++.+.+||.+||+.||++|||++|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011123567899999999999999999999999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=357.81 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=195.8
Q ss_pred ccccceeeecCeEEEEE---EeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC----ceEEE
Q 012164 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV 228 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 228 (469)
+|...+.||+|+||.|| ++|+.||||++.... ........|+..+++++||||+++++++.+.+ .+|+|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 56677899999999886 478999999986432 22222334555667789999999999997654 57999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCCCeEecCCCCCcccccccccCcceeeCCC
Q 012164 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE--------NKPVPIIHRDLEPSDLYVAYWQNDRNILRDDS 300 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~--------~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~ 300 (469)
||||++|+|.+++++. .+++..++.++.|++.||.|||+ ++ |+||||||+ |||++.+
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~-----------NILl~~~ 144 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSK-----------NILVKKN 144 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGG-----------GEEECTT
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCcc-----------ceEEcCC
Confidence 9999999999999875 59999999999999999999997 35 999999999 8889999
Q ss_pred CCeEEeecCCccccccCCC---CCcccCCCCCcccCCcccCCCC------CCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 012164 301 GNLKVADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDN 371 (469)
Q Consensus 301 ~~vkl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~~~~sDi~SlGvil~el~tg~~p~~~~~~~ 371 (469)
+.+||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|||+||+.||......
T Consensus 145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence 9999999999987654322 1223467999999999987642 567899999999999999999887543221
Q ss_pred c---------------HHHHHhhcC-CCCCCCC--hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012164 372 E---------------VPKAYAARQ-RPPFKAP--AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 427 (469)
Q Consensus 372 ~---------------~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~ 427 (469)
. ......... +++.+.. ....+..+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1 111111112 2332221 223456799999999999999999999999999998765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=361.81 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=196.6
Q ss_pred CcccccceeeecCeEEEEEE------eceeehhhhcccccCCCHHHHHHHHHHHHHHhcC---CCCceeeEEeEEEe---
Q 012164 154 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ--- 221 (469)
Q Consensus 154 ~~~~~~~~~ig~G~~~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~--- 221 (469)
+.+|++.+.||+|+||.||. +++.||||++....... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 45899999999999999985 25679999987543221 1123355677776665 79999999999853
Q ss_pred --CCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 222 --SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 222 --~~~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
...++++||||+++.+...... ...+++..+..++.|++.||+|||+++ |+||||||+ |||++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~-----------NILi~ 150 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQ-----------NILVT 150 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEEC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCcc-----------EEEEc
Confidence 2468999999987766555443 345899999999999999999999999 999999999 88889
Q ss_pred CCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHh
Q 012164 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 378 (469)
Q Consensus 299 ~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~ 378 (469)
.++.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.
T Consensus 151 ~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 228 (305)
T d1blxa_ 151 SSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228 (305)
T ss_dssp TTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999999999999765432 23345679999999999999999999999999999999999999998776544433332
Q ss_pred hc-CC----------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 AR-QR----------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ~~-~~----------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.. +. .+.......+++.+.+||.+||+.||++|||++|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11 00 01111123567889999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=365.80 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=209.0
Q ss_pred ccccceeeecCeEEEEEE--------eceeehhhhcccccCC-CHHHHHHHHHHHHHHhcCCC-CceeeEEeEEEeCCce
Q 012164 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~--------~g~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 225 (469)
+|+..+.||+|+||.||. +|+.||||.+.+.... +....+.+.+|++++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 599999999999999985 3788999998754321 12223567889999999965 8999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
+++|||+.+|+|.+++...+.+++..+..++.||+.||+|||+.+ |+||||||+ ||+++.++.+||
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~-----------Nill~~~~~vkL 170 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE-----------NILLDSNGHVVL 170 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTSCEEE
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCcc-----------ceeecCCCCEEE
Confidence 999999999999999999888999999999999999999999999 999999999 888899999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcCCC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 383 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 383 (469)
+|||+++..............|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+......
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 99999987654444444456789999999999764 5678999999999999999999999887766655544332211
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012164 384 PFKAPAKLYARGLKELIEECWNEKPAKRP-----TFRQIITR 420 (469)
Q Consensus 384 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~ll~~ 420 (469)
.....+..+++++.+||.+||.+||++|| |++|+++|
T Consensus 251 ~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11122456889999999999999999999 58888875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-45 Score=352.02 Aligned_cols=256 Identities=16% Similarity=0.236 Sum_probs=198.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCc-eeeEEeEEEeCCceEEEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSSPMMIVT 229 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 229 (469)
+|++.+.||+|+||.||. +|+.||||++...... ..+..|+++++.++|++ |+.+.+++.+....++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 588999999999999985 4789999987654321 34778999999998665 555566667778899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeec
Q 012164 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADF 308 (469)
Q Consensus 230 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Df 308 (469)
||+ +++|.+.+.. .+.+++..+..++.|++.||+|||+++ |+||||||+|||+. +.+.+..+||+||
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~--------~~~~~~~vkl~DF 150 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMG--------LGKKGNLVYIIDF 150 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC--------CGGGTTCEEECCC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhcccc--------ccCCCceeeeecc
Confidence 999 5677776654 456999999999999999999999999 99999999955553 1234567999999
Q ss_pred CCccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc--
Q 012164 309 GVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-- 380 (469)
Q Consensus 309 gla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-- 380 (469)
|+|+....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+...
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 99987654321 1223457999999999999999999999999999999999999999876554433222111
Q ss_pred --CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012164 381 --QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 428 (469)
Q Consensus 381 --~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~ 428 (469)
...+.......+|+++.+||..||+.||++||+++++.+.|+.+....
T Consensus 231 ~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 112221223467899999999999999999999999999998886543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=356.42 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=196.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 223 (469)
.+|++.+.||+|+||.||. +|+.||||++.... .+....+.+.+|+.+|++++||||++++++|...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3799999999999999985 58999999997654 34556678899999999999999999999997654
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCe
Q 012164 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNL 303 (469)
Q Consensus 224 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~v 303 (469)
.+|+||||| +++|..+++. +.+++..+..++.||+.||.|||+++ |+||||||+ |||++.++.+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~-----------NIL~~~~~~~ 160 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPG-----------NLAVNEDCEL 160 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTCCE
T ss_pred eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcc-----------hhhccccccc
Confidence 479999999 6788887764 56999999999999999999999999 999999999 8888999999
Q ss_pred EEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc--
Q 012164 304 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-- 380 (469)
Q Consensus 304 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-- 380 (469)
|++|||+|+.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 161 kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 161 KILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp EECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccccccceeccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 9999999987543 22446789999999998764 6689999999999999999999999876543322211110
Q ss_pred -------------------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 -------------------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 -------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
....+.......++++.+||.+||..||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0111111224567889999999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=354.26 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=195.7
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEe--------
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-------- 221 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------- 221 (469)
-+|++.+.||+|+||.||. +|+.||||++..+... ......+.+|++++++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4899999999999999985 5789999998755432 2334668899999999999999999999854
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC
Q 012164 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG 301 (469)
Q Consensus 222 ~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~ 301 (469)
...+++|||||.++.+..+......+++..++.++.||+.||.|||+.+ |+||||||+ |||++.++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~-----------NILl~~~~ 154 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAA-----------NVLITRDG 154 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTS
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCch-----------heeecCCC
Confidence 3468999999977666655555667999999999999999999999999 999999999 88889999
Q ss_pred CeEEeecCCccccccCCC---CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH
Q 012164 302 NLKVADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 377 (469)
Q Consensus 302 ~vkl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~ 377 (469)
.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i 234 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH
Confidence 999999999976653221 222335689999999998765 6899999999999999999999999876554443333
Q ss_pred hhcC-CCCCC----------------------CC-----hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 378 AARQ-RPPFK----------------------AP-----AKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 378 ~~~~-~~~~~----------------------~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.... ..+.. .. ....++.+.+||.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 2111 00000 00 01235678899999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=359.89 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=193.7
Q ss_pred CCCcccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC----
Q 012164 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS---- 222 (469)
Q Consensus 152 ~~~~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 222 (469)
+.+.+|+..+.||+|+||.||. +|+.||||++..... .+.+|++++++++||||++++++|...
T Consensus 17 ~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp CEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred cccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence 4456899999999999999985 688999999875432 234699999999999999999998543
Q ss_pred --CceEEEEeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceee
Q 012164 223 --SPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILR 297 (469)
Q Consensus 223 --~~~~lv~E~~~~gsL~~~l---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~ 297 (469)
.++++|||||+++.+..+. .....+++.++..++.||+.||+|||+++ |+||||||+ |||+
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~-----------NILl 155 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQ-----------NLLL 155 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGG-----------GEEE
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcc-----------eEEE
Confidence 3478999999755333332 23556999999999999999999999999 999999999 8888
Q ss_pred CCCC-CeEEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHH
Q 012164 298 DDSG-NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 375 (469)
Q Consensus 298 ~~~~-~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~ 375 (469)
+.++ .+||+|||+++..... .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+...
T Consensus 156 ~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~ 233 (350)
T d1q5ka_ 156 DPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233 (350)
T ss_dssp CTTTCCEEECCCTTCEECCTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH
T ss_pred ecCCCceeEecccchhhccCC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHH
Confidence 8765 8999999999876433 22344678999999998765 478999999999999999999999998765443332
Q ss_pred HHhhc-C------------------CCCC------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 376 AYAAR-Q------------------RPPF------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 376 ~~~~~-~------------------~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
.+... + .+.. .......++++.+||.+||..||++|||+.|+++|
T Consensus 234 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22110 0 0000 01123567899999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-44 Score=343.23 Aligned_cols=262 Identities=15% Similarity=0.237 Sum_probs=209.0
Q ss_pred cccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCC-CceeeEEeEEEeCCceEEE
Q 012164 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 155 ~~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 228 (469)
.+|++.+.||+|+||.||. +|+.||||++..... ...+.+|++.++.++| +|++.+++++.+....++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 3688999999999999985 588999998764422 1347789999999974 8999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEee
Q 012164 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVAD 307 (469)
Q Consensus 229 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~D 307 (469)
|||+ +++|.+++...+ .++..++..++.|++.||+|||+.| |+||||||+|||++... -..++.+||+|
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~------~~~~~~vkl~D 149 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPN------SKNANMIYVVD 149 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSS------STTTTCEEECC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcc------cccCCceEEcc
Confidence 9999 789999997654 5999999999999999999999999 99999999955443110 01357899999
Q ss_pred cCCccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHH---h
Q 012164 308 FGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---A 378 (469)
Q Consensus 308 fgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~---~ 378 (469)
||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+ .
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 999987643221 1223457999999999999999999999999999999999999999876655443222 1
Q ss_pred hcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012164 379 ARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 431 (469)
Q Consensus 379 ~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~L~~~~~~~~~~ 431 (469)
... ..+.......+|+++.+|+..|+..+|++||+++.+.+.|+++.+..+..
T Consensus 230 ~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 111 11111122457889999999999999999999999999999987765443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=353.97 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=194.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCC----ceE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMM 226 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~ 226 (469)
+|++.+.||+|+||.||. +|+.||||++.... .....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 599999999999999885 58999999987542 4555678899999999999999999999997643 234
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEe
Q 012164 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVA 306 (469)
Q Consensus 227 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~ 306 (469)
++++|+.+|+|.+++..+ .+++..+..++.|++.||+|||+++ ||||||||+ |||++.++.+||+
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~-----------NILl~~~~~~kl~ 151 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPS-----------NLLLNTTCDLKIC 151 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG-----------GEEECTTCCEEEC
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcc-----------eEEECCCCCEEEc
Confidence 445556689999999764 6999999999999999999999999 999999999 8888899999999
Q ss_pred ecCCccccccCCC--CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhc---
Q 012164 307 DFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--- 380 (469)
Q Consensus 307 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~--- 380 (469)
|||+|+....... .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||...+...........
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~ 231 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence 9999986543322 22344678999999999855 46788999999999999999999999765543222211100
Q ss_pred --------------------C-C---CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 381 --------------------Q-R---PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 381 --------------------~-~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
. . .+.......+++++.+|+.+||+.||++|||++++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0 00001123456789999999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=343.46 Aligned_cols=249 Identities=21% Similarity=0.371 Sum_probs=205.2
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeCCceEEEEe
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~E 230 (469)
+|++.+.||+|+||.||. +|+.||||+++.... .......+.+|+.+++.++||||+++++++.+....++++|
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 689999999999999985 678899999976543 34456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCC
Q 012164 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGV 310 (469)
Q Consensus 231 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgl 310 (469)
++.+++|..++...+.+++..+..++.|++.||+|||+++ |+||||||+ |||++.++.+||+|||.
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~-----------NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQ-----------NLLINRNGELKLANFGL 147 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEECTTCCEEECCCTT
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCc-----------ccccccCCceeeeecch
Confidence 9999999999888888999999999999999999999999 999999999 88888899999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-HHHHHhh-cC------
Q 012164 311 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAA-RQ------ 381 (469)
Q Consensus 311 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~-~~~~~~~-~~------ 381 (469)
|+..... ........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||....... ....+.. ..
T Consensus 148 a~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 148 ARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CEECCSC-CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred hhcccCC-CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhh
Confidence 9876543 2233345678889999998765 46899999999999999999999975443322 2221111 00
Q ss_pred ------------------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 382 ------------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 382 ------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..........+++.+.+||.+||+.||++|||++|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111234567889999999999999999999999886
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-43 Score=342.92 Aligned_cols=240 Identities=21% Similarity=0.352 Sum_probs=193.3
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeC--CceEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMI 227 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~l 227 (469)
+|++.+.||+|+||.||. +|+.||||++.... .+.+.+|+.+|+.++ ||||+++++++... ..+++
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 699999999999999985 58999999986432 256889999999996 99999999999754 56899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCC-CeEEe
Q 012164 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSG-NLKVA 306 (469)
Q Consensus 228 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~-~vkl~ 306 (469)
|||||++++|.++. +.+++..+..++.||+.||+|||++| |+||||||+ |||++.++ .+||+
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~-----------NILi~~~~~~vkl~ 172 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPH-----------NVMIDHEHRKLRLI 172 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG-----------GEEEETTTTEEEEC
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---ccccccccc-----------ceEEcCCCCeeeec
Confidence 99999999997663 45999999999999999999999999 999999999 77777655 58999
Q ss_pred ecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHH-HHHh------
Q 012164 307 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYA------ 378 (469)
Q Consensus 307 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~-~~~~------ 378 (469)
|||+|+..... .......+|+.|+|||.+.+. .++.++||||+||++++|++|+.||......... ..+.
T Consensus 173 DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 173 DWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp CGGGCEECCTT--CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred ccccceeccCC--CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence 99999875532 233446789999999998765 5789999999999999999999999765432210 0000
Q ss_pred ------hcC-C--------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 379 ------ARQ-R--------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 379 ------~~~-~--------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
... . .........+++++.+||.+||..||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 00111234567899999999999999999999999886
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=346.73 Aligned_cols=245 Identities=25% Similarity=0.341 Sum_probs=189.7
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC------Cc
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~ 224 (469)
+|++.+.||+|+||.|+. +|+.||||++..... +......+.+|+.++++++||||++++++|... ..
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 699999999999999985 589999999976543 455567789999999999999999999999643 57
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeE
Q 012164 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLK 304 (469)
Q Consensus 225 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vk 304 (469)
+|+|||||.+ ++.+.+. ..+++..+..++.||+.||.|||+.| |+||||||+ |||++.++.+|
T Consensus 97 ~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~-----------Nil~~~~~~~k 159 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS-----------NIVVKSDCTLK 159 (355)
T ss_dssp EEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG-----------GEEECTTCCEE
T ss_pred eEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcc-----------cccccccccee
Confidence 8999999965 5555553 45999999999999999999999999 999999999 88888999999
Q ss_pred EeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhh-----
Q 012164 305 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA----- 379 (469)
Q Consensus 305 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~----- 379 (469)
++|||+++..... .......+|+.|+|||++.+..++.++||||+||++++|++|+.||.+.+.......+..
T Consensus 160 l~df~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 160 ILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp ECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eechhhhhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence 9999998765432 233445789999999999999999999999999999999999999976553332222110
Q ss_pred ----------------cCCCC-----------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 380 ----------------RQRPP-----------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 380 ----------------~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
..... ........++++.+||.+||..||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000123457889999999999999999999999988
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=346.72 Aligned_cols=245 Identities=27% Similarity=0.354 Sum_probs=195.0
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCCCCceeeEEeEEEeC-----Cce
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 225 (469)
+|++.+.||+|+||.||. +|+.||||++.... .+....+.+.+|++++++++||||+++++++... ...
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 699999999999999875 58999999998654 3445557788999999999999999999998643 334
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeCCCCCeEE
Q 012164 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKV 305 (469)
Q Consensus 226 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl 305 (469)
+++++|+.+|+|.+++.. +.+++.++..++.||+.||+|||+++ |+||||||+ |||++.++.+|+
T Consensus 98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~-----------NILi~~~~~~kl 162 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS-----------NLAVNEDCELKI 162 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG-----------GEEECTTCCEEE
T ss_pred EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCc-----------cccccccccccc
Confidence 666777779999999965 46999999999999999999999999 999999999 888899999999
Q ss_pred eecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcHHHHHhhcC-CC
Q 012164 306 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP 383 (469)
Q Consensus 306 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~ 383 (469)
+|||++..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+.... .+
T Consensus 163 ~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 163 LDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp CCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999976432 22345688999999987665 56889999999999999999999998765443333221110 00
Q ss_pred -----------------------CCC---CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012164 384 -----------------------PFK---APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 420 (469)
Q Consensus 384 -----------------------~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ll~~ 420 (469)
+.. .....+++++++||.+||..||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000 0113467889999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-37 Score=304.49 Aligned_cols=249 Identities=18% Similarity=0.297 Sum_probs=179.9
Q ss_pred ccccceeeecCeEEEEEE-----eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-----------CCceeeEEeEE
Q 012164 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLGAV 219 (469)
Q Consensus 156 ~~~~~~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~ 219 (469)
+|++.++||+|+||.||. +|+.||||++..+ ....+.+.+|+.+++.++ |+||+++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 599999999999999985 5899999998754 233466788999888875 57899999988
Q ss_pred EeC--CceEEEEeccCCCC-HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcccccccccCc
Q 012164 220 TQS--SPMMIVTEYLPKGD-LRAFLK--RKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSDLYVAYWQNDR 293 (469)
Q Consensus 220 ~~~--~~~~lv~E~~~~gs-L~~~l~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~~ 293 (469)
... ...+++++++..+. ...... ....+++..+..++.||+.||+|||+ .+ |+||||||+|||+......
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~- 165 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP- 165 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT-
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcc-
Confidence 643 45566666654443 333332 34568999999999999999999998 77 9999999995555321110
Q ss_pred ceeeCCCCCeEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCcH
Q 012164 294 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 373 (469)
Q Consensus 294 nil~~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~SlGvil~el~tg~~p~~~~~~~~~ 373 (469)
.....++++|||.|...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||........
T Consensus 166 ----~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 166 ----ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp ----TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ----cccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 00124899999999764422 2345789999999999999999999999999999999999999975432210
Q ss_pred -------HHHHhhcCC-------------------------CC------------CCCChhhhHHHHHHHHHHHcccCCC
Q 012164 374 -------PKAYAARQR-------------------------PP------------FKAPAKLYARGLKELIEECWNEKPA 409 (469)
Q Consensus 374 -------~~~~~~~~~-------------------------~~------------~~~~~~~~~~~l~~li~~cl~~dp~ 409 (469)
...+...+. .. ........++++.+||.+||..||+
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 000000000 00 0011245678899999999999999
Q ss_pred CCCCHHHHHHH
Q 012164 410 KRPTFRQIITR 420 (469)
Q Consensus 410 ~Rps~~~ll~~ 420 (469)
+|||++|+++|
T Consensus 318 ~Rpta~e~L~H 328 (362)
T d1q8ya_ 318 KRADAGGLVNH 328 (362)
T ss_dssp TCBCHHHHHTC
T ss_pred HCcCHHHHhcC
Confidence 99999999876
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.86 E-value=3.4e-22 Score=162.73 Aligned_cols=102 Identities=30% Similarity=0.403 Sum_probs=92.7
Q ss_pred ChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHH
Q 012164 41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120 (469)
Q Consensus 41 ~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~ 120 (469)
+|||++||.+|+.++|++|+++|+|+|.+|..|+||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.+
T Consensus 3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~ 82 (118)
T d1myoa_ 3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS 82 (118)
T ss_dssp HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence 48999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCccccccc
Q 012164 121 VIKLLEKHGAKPLMAPMHVKHA 142 (469)
Q Consensus 121 ~~~~L~~~~~~~~~~~~~~~~~ 142 (469)
++++|+++|+++........++
T Consensus 83 ~v~~Ll~~Gad~~~~d~~G~t~ 104 (118)
T d1myoa_ 83 CVKLLLSKGADKTVKGPDGLTA 104 (118)
T ss_dssp HHHHHHTTCCCSSSSSSSTCCC
T ss_pred hhhhhhcccccceeeCCCCCCH
Confidence 9999999999887665444443
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.85 E-value=1e-21 Score=167.39 Aligned_cols=100 Identities=20% Similarity=0.194 Sum_probs=93.0
Q ss_pred CCCCCChHHHHHHHc---CCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccc
Q 012164 36 EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (469)
Q Consensus 36 ~~~~g~t~l~~Aa~~---~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~ 112 (469)
.+..|+||||+|+.. |+.+++++|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|+|++.+|..|.||||+
T Consensus 41 ~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~ 120 (154)
T d1dcqa1 41 GHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDI 120 (154)
T ss_dssp CSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred CCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccccccCCCCCCHHHH
Confidence 366799999999974 67899999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHhhcCCCCCC
Q 012164 113 AIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 113 A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
|+..|+.+++++|++.++.....
T Consensus 121 A~~~~~~~i~~~L~~~~~~~~~~ 143 (154)
T d1dcqa1 121 AKRLKHEHCEELLTQALSGRFNS 143 (154)
T ss_dssp HHHTTCHHHHHHHHHHHTTCCCS
T ss_pred HHHcCCHHHHHHHHHhCCCCCCc
Confidence 99999999999999988765433
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.85 E-value=2.6e-22 Score=163.44 Aligned_cols=107 Identities=26% Similarity=0.202 Sum_probs=98.5
Q ss_pred ccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHH
Q 012164 9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88 (469)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~ 88 (469)
|||+.+...|.+...+-.--+|+|++..+.+|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+.+|+.++
T Consensus 4 tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~ 83 (118)
T d1myoa_ 4 KEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSC 83 (118)
T ss_dssp HHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHH
T ss_pred hHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchhh
Confidence 56777777777776666666889999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHCCCCCCCCcCCCccccccccc
Q 012164 89 VSLLLERGADVDPKDRWGSTPLGDAIY 115 (469)
Q Consensus 89 v~~Ll~~g~~~~~~~~~g~tpl~~A~~ 115 (469)
+++|+++|+|++.+|..|.||||+|..
T Consensus 84 v~~Ll~~Gad~~~~d~~G~t~l~~a~~ 110 (118)
T d1myoa_ 84 VKLLLSKGADKTVKGPDGLTALEATDN 110 (118)
T ss_dssp HHHHHTTCCCSSSSSSSTCCCCCTCSS
T ss_pred hhhhhcccccceeeCCCCCCHHHHHhH
Confidence 999999999999999999999999954
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.4e-21 Score=173.29 Aligned_cols=162 Identities=18% Similarity=0.128 Sum_probs=115.5
Q ss_pred ccceeeecCeEEEEEE----eceeehhhhcccccCC---------------CHHHHHHHHHHHHHHhcCCCCceeeEEeE
Q 012164 158 TNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---------------DDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (469)
Q Consensus 158 ~~~~~ig~G~~~~~~~----~g~~vaiK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 218 (469)
.+.+.||+|+||.||. +|+.||||.++..... ..........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999985 6889999986532111 01112345678999999999999998866
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcccccccccCcceeeC
Q 012164 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSDLYVAYWQNDRNILRD 298 (469)
Q Consensus 219 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~~nil~~ 298 (469)
. ..+++|||+++..+. .++......++.|++.+|.|||+++ |+||||||+ |||++
T Consensus 83 ~----~~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~-----------NILv~ 137 (191)
T d1zara2 83 E----GNAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQY-----------NVLVS 137 (191)
T ss_dssp E----TTEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT-----------SEEEE
T ss_pred c----CCEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChh-----------heeee
Confidence 3 237999999875543 2566777889999999999999999 999999999 66766
Q ss_pred CCCCeEEeecCCccccccCCCCCcccCCCCCcccCC------cccCCCCCCCchhHHHHHHHH
Q 012164 299 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP------EVFKNEEYDTKVDVFSFALIL 355 (469)
Q Consensus 299 ~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDi~SlGvil 355 (469)
++ .++|+|||+|........ ..|... +.+ ...|+.++|+||+.--+
T Consensus 138 ~~-~~~liDFG~a~~~~~~~~---------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 138 EE-GIWIIDFPQSVEVGEEGW---------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TT-EEEECCCTTCEETTSTTH---------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CC-CEEEEECCCcccCCCCCc---------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 54 489999999976432110 011111 111 24678899999976443
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=5e-21 Score=158.52 Aligned_cols=93 Identities=30% Similarity=0.371 Sum_probs=73.1
Q ss_pred hHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHH
Q 012164 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (469)
Q Consensus 42 t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~ 121 (469)
++||.||..|+.++|++|+++|+|+|.+|.+|+||||+||..|+.+++++|++.|++++.+|..|+||||+|+.+|+.++
T Consensus 3 ~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~ 82 (130)
T d1ycsb1 3 ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQV 82 (130)
T ss_dssp HHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHH
Confidence 56777888888888888888888888777778888888888888888888887788888778888888888888888888
Q ss_pred HHHHHhhcCCCCC
Q 012164 122 IKLLEKHGAKPLM 134 (469)
Q Consensus 122 ~~~L~~~~~~~~~ 134 (469)
+++|+++|+++..
T Consensus 83 v~~Ll~~ga~v~~ 95 (130)
T d1ycsb1 83 CKFLVESGAAVFA 95 (130)
T ss_dssp HHHHHHTTCCTTC
T ss_pred HHHHHHcCCCccc
Confidence 8888777777643
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=2.8e-21 Score=160.04 Aligned_cols=120 Identities=22% Similarity=0.080 Sum_probs=102.6
Q ss_pred ccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHH
Q 012164 11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS 90 (469)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~ 90 (469)
++.++..|.+...+-.--+|+|++.++.+|+||||+||..|+.+++++|++.|+++|.+|.+|+||||+||.+|+.++++
T Consensus 5 L~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~ 84 (130)
T d1ycsb1 5 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCK 84 (130)
T ss_dssp HHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHH
T ss_pred HHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHHHH
Confidence 44445555555555555678999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHCCCCCCCCcC-CCccccc--cccccchHHHHHHHHhhcC
Q 012164 91 LLLERGADVDPKDR-WGSTPLG--DAIYYKNHEVIKLLEKHGA 130 (469)
Q Consensus 91 ~Ll~~g~~~~~~~~-~g~tpl~--~A~~~~~~~~~~~L~~~~~ 130 (469)
+|+++|++++..+. .|.||++ .|...|+.+++++|+..+.
T Consensus 85 ~Ll~~ga~v~~~~~~~~~~~~~~~~a~~~g~~eiv~~L~~~~~ 127 (130)
T d1ycsb1 85 FLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQE 127 (130)
T ss_dssp HHHHTTCCTTCCCSSSCCCHHHHCCSSSTTCCCHHHHHHHHHH
T ss_pred HHHHcCCCcccccCCCCCCHHHHHHHHHcChHHHHHHHHhHHH
Confidence 99999999998775 5788755 5567788999999987543
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=1.1e-21 Score=161.44 Aligned_cols=121 Identities=21% Similarity=0.258 Sum_probs=107.1
Q ss_pred cccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCC-cHHHHHHHcC
Q 012164 6 PVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQG 84 (469)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~-t~Lh~A~~~g 84 (469)
|..++|+.+...|.+-..+-.--+|+|++..+.+|.||||+|+ .|+.+++++|+++|+++|.+|..|. ||||+||..|
T Consensus 2 p~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g 80 (125)
T d1bi7b_ 2 PSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREG 80 (125)
T ss_dssp CSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHT
T ss_pred CChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence 4556677777777777666666688889999999999999765 7999999999999999999998765 6999999999
Q ss_pred CHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHh
Q 012164 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127 (469)
Q Consensus 85 ~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~ 127 (469)
+.+++++|+++|+|++.+|..|+||||+|+..|+.+++++|+.
T Consensus 81 ~~~~v~~Ll~~ga~~~~~d~~G~T~l~~A~~~g~~~~v~~Lls 123 (125)
T d1bi7b_ 81 FLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRA 123 (125)
T ss_dssp CHHHHHHHHHHTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHSS
T ss_pred cccccccccccccccccccCCCCCHHHHHHHcCCHHHHHHHHh
Confidence 9999999999999999999999999999999999999999864
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.77 E-value=4.2e-19 Score=163.83 Aligned_cols=102 Identities=33% Similarity=0.410 Sum_probs=96.3
Q ss_pred CCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCc-CCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcc
Q 012164 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (469)
Q Consensus 30 ~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~-d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t 108 (469)
+.+.+.++..|.||||+||..|+.+++++|++.|++++.. +..|+||||+||..|+.+++++|+++|+|++.+|..|.|
T Consensus 148 ~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d~~g~t 227 (255)
T d1oy3d_ 148 RLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRT 227 (255)
T ss_dssp GGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CcccccccccCcccccccccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCCCCCCC
Confidence 4556778889999999999999999999999999999875 578999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhcCC
Q 012164 109 PLGDAIYYKNHEVIKLLEKHGAK 131 (469)
Q Consensus 109 pl~~A~~~~~~~~~~~L~~~~~~ 131 (469)
|||+|+..++.+++++|+++||+
T Consensus 228 ~L~~A~~~~~~~i~~~Ll~~Ga~ 250 (255)
T d1oy3d_ 228 PLGSALLRPNPILARLLRAHGAP 250 (255)
T ss_dssp HHHHHHTSSCHHHHHHHHHTTCC
T ss_pred HHHHHHHCCCHHHHHHHHHcCCC
Confidence 99999999999999999999985
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2e-18 Score=156.38 Aligned_cols=109 Identities=27% Similarity=0.265 Sum_probs=102.9
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcc
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t 108 (469)
++.|.+..+.+|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|++.|++++.+|..|+|
T Consensus 92 ~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~T 171 (223)
T d1uoha_ 92 KGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNT 171 (223)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCC
T ss_pred cCceeEeeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCc
Confidence 66788889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhcCCCCCCcc
Q 012164 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 109 pl~~A~~~~~~~~~~~L~~~~~~~~~~~~ 137 (469)
|||+|+..|+.+++++|++.|+++.....
T Consensus 172 pL~~Aa~~g~~~~v~~LL~~Gad~~~~d~ 200 (223)
T d1uoha_ 172 PLHLACDEERVEEAKLLVSQGASIYIENK 200 (223)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCSCCCCT
T ss_pred eeccccccCcHHHHHHHHHCCCCCCCCCC
Confidence 99999999999999999999999865543
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.2e-18 Score=148.56 Aligned_cols=120 Identities=24% Similarity=0.293 Sum_probs=83.8
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
..||++.+. .+........-.++.|.+..+..|.+||++|+..++.++++.+++.|+++|.+|.+|+||||+||..|+.
T Consensus 36 g~t~L~~A~-~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~ 114 (156)
T d1bd8a_ 36 GKTALQVMM-FGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHT 114 (156)
T ss_dssp SCCHHHHSC-TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCH
T ss_pred CCccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCeeeccccccccc
Confidence 455555443 2343333333346666777777777777777777777777777777777777777777777777777777
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhh
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~ 128 (469)
+++++|+ .|++++.+|..|+||||+|+..|+.+++++|++|
T Consensus 115 ~i~~~L~-~~~~~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~h 155 (156)
T d1bd8a_ 115 AVVSFLA-AESDLHRRDARGLTPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp HHHHHHH-TTSCTTCCCTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred ccccccc-ccccccccCCCCCCHHHHHHHcCCHHHHHHHHhh
Confidence 7777766 5777777777777777777777777777777654
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=5.3e-19 Score=145.04 Aligned_cols=96 Identities=25% Similarity=0.275 Sum_probs=89.0
Q ss_pred CChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCc-cccccccccch
Q 012164 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS-TPLGDAIYYKN 118 (469)
Q Consensus 40 g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~-tpl~~A~~~~~ 118 (469)
+.++||+||..|+.++|++|+++|+|+|.+|..|+||||+|+ .|+.+++++|+++|++++.++..|. ||||+|+..|+
T Consensus 3 ~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~ 81 (125)
T d1bi7b_ 3 SADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF 81 (125)
T ss_dssp STTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred ChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence 457899999999999999999999999999999999999775 7999999999999999999999876 59999999999
Q ss_pred HHHHHHHHhhcCCCCCCc
Q 012164 119 HEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 119 ~~~~~~L~~~~~~~~~~~ 136 (469)
.+++++|++.|+++....
T Consensus 82 ~~~v~~Ll~~ga~~~~~d 99 (125)
T d1bi7b_ 82 LDTLVVLHRAGARLDVRD 99 (125)
T ss_dssp HHHHHHHHHHTCCSSCCC
T ss_pred cccccccccccccccccc
Confidence 999999999999876544
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.6e-18 Score=156.97 Aligned_cols=120 Identities=21% Similarity=0.147 Sum_probs=105.0
Q ss_pred ccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH
Q 012164 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (469)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~ 86 (469)
..||++.+...+...-.+-.--+|+|++..+.+|.||||+|+..++.+++++|++.|+++|.+|.+|+||||+||..|+.
T Consensus 103 g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~ 182 (223)
T d1uoha_ 103 GCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERV 182 (223)
T ss_dssp CCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCH
T ss_pred CCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCceeccccccCcH
Confidence 45666666555554333333347888999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHh
Q 012164 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127 (469)
Q Consensus 87 ~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~ 127 (469)
++|++|+++|+|++.+|..|+||||+|. .|+.++++.|++
T Consensus 183 ~~v~~LL~~Gad~~~~d~~g~tpl~~A~-~~~~~i~~~Ll~ 222 (223)
T d1uoha_ 183 EEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE 222 (223)
T ss_dssp HHHHHHHHTTCCSCCCCTTSCCHHHHCC-TTHHHHHHHHHC
T ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHHHH-CCCHHHHhcccC
Confidence 9999999999999999999999999985 689999998874
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=6.4e-18 Score=150.83 Aligned_cols=99 Identities=22% Similarity=0.229 Sum_probs=94.7
Q ss_pred cccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCC
Q 012164 27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (469)
Q Consensus 27 ~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g 106 (469)
...+.+.+..+..|.|||++|+..+..++++.|++.++++|.+|..|.||||+||..|+.++|++|+++|+|++.+|..|
T Consensus 110 ~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g 189 (209)
T d1ot8a_ 110 ITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMD 189 (209)
T ss_dssp HHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred hhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcCCCC
Confidence 34677788889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccchHHHHHHH
Q 012164 107 STPLGDAIYYKNHEVIKLL 125 (469)
Q Consensus 107 ~tpl~~A~~~~~~~~~~~L 125 (469)
+||||+|+..|+.+++++|
T Consensus 190 ~Tpl~~A~~~~~~~iv~lL 208 (209)
T d1ot8a_ 190 RLPRDVASERLHHDIVRLL 208 (209)
T ss_dssp CCHHHHHHHTTCHHHHHHH
T ss_pred CCHHHHHHHcCCHHHHhhc
Confidence 9999999999999999986
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.72 E-value=4.3e-18 Score=156.90 Aligned_cols=96 Identities=23% Similarity=0.156 Sum_probs=89.7
Q ss_pred CCCCCCChHHHHHHHcCCHHHHHHHHHCCCC---CCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccc
Q 012164 35 GEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (469)
Q Consensus 35 ~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~---in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~ 111 (469)
..+.+|+||||+||..|+.+++++|++.|++ +|.+|..|.||||+||..|+.+++++|+++|++++.+|..|.||||
T Consensus 4 ~i~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~ 83 (255)
T d1oy3d_ 4 YVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALH 83 (255)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHH
T ss_pred cCCcCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhh
Confidence 3467899999999999999999999999988 6778899999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHhhcC
Q 012164 112 DAIYYKNHEVIKLLEKHGA 130 (469)
Q Consensus 112 ~A~~~~~~~~~~~L~~~~~ 130 (469)
+|+..++.++++.|++...
T Consensus 84 ~A~~~~~~~~~~~Ll~~~~ 102 (255)
T d1oy3d_ 84 LACRVRAHTCACVLLQPRP 102 (255)
T ss_dssp HHTTTTCHHHHHHHSSSCC
T ss_pred hhhccCchHHHHHHHhhcc
Confidence 9999999999999987654
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.71 E-value=7.2e-18 Score=142.90 Aligned_cols=86 Identities=33% Similarity=0.424 Sum_probs=69.4
Q ss_pred CChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchH
Q 012164 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119 (469)
Q Consensus 40 g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~ 119 (469)
+.++++.++...+.+++++|++.|++++.+|.+|+||||+||..|+.+++++|++.|+|++.+|..|.||||+|+..|+.
T Consensus 67 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~ 146 (153)
T d1awcb_ 67 DRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNE 146 (153)
T ss_dssp CCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCH
T ss_pred cccccccccccccceeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHHHcCCH
Confidence 33333333344444556666677788888999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHH
Q 012164 120 EVIKLL 125 (469)
Q Consensus 120 ~~~~~L 125 (469)
+++++|
T Consensus 147 eiv~lL 152 (153)
T d1awcb_ 147 DLAEIL 152 (153)
T ss_dssp HHHHHH
T ss_pred HHHHhC
Confidence 998876
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.71 E-value=9.2e-18 Score=152.04 Aligned_cols=101 Identities=25% Similarity=0.238 Sum_probs=91.8
Q ss_pred ccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCC-CCCCCcCCCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCcCC
Q 012164 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRW 105 (469)
Q Consensus 28 ~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g-~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~-~g~~~~~~~~~ 105 (469)
-.+.+.+..+..|+||||+|+..|+.+++++|++.| .++|.+|.+|+||||+|+..|+.++|++|++ .|+|++.+|..
T Consensus 126 ~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~ 205 (229)
T d1ixva_ 126 ENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNK 205 (229)
T ss_dssp HTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTT
T ss_pred hhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCC
Confidence 467778888899999999999999999999999987 6889999999999999999999999999997 59999999999
Q ss_pred CccccccccccchHHHHHHHHhhcCC
Q 012164 106 GSTPLGDAIYYKNHEVIKLLEKHGAK 131 (469)
Q Consensus 106 g~tpl~~A~~~~~~~~~~~L~~~~~~ 131 (469)
|+||||+|+. .+++++|++.|++
T Consensus 206 g~t~l~~A~~---~~~~~~Ll~~g~d 228 (229)
T d1ixva_ 206 GAKAEDVALN---EQVKKFFLNNVVD 228 (229)
T ss_dssp SCCTGGGCSC---HHHHHHHHHHCCC
T ss_pred CCCHHHHHhh---HHHHHHHHHcCCC
Confidence 9999999984 4789999999886
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.70 E-value=2.4e-18 Score=160.43 Aligned_cols=92 Identities=22% Similarity=0.282 Sum_probs=85.1
Q ss_pred CCCChHHHHHHHcCCHHHHHHH--------HHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccc
Q 012164 38 IKPEFRLMFLANERDVEGIKEL--------LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (469)
Q Consensus 38 ~~g~t~l~~Aa~~~~~~~v~~L--------l~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tp 109 (469)
.+|+||||+||..|+.++|+.| ++.|||||.+|.+|+||||+|+..|+.+++++|+++|+|++.+|..|.||
T Consensus 31 ~~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~~~~g~t~ 110 (277)
T d2fo1e1 31 RHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSA 110 (277)
T ss_dssp SSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCH
T ss_pred CCCccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeecccccccccccccccccccccccccccccccc
Confidence 3699999999999999988776 56799999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhc
Q 012164 110 LGDAIYYKNHEVIKLLEKHG 129 (469)
Q Consensus 110 l~~A~~~~~~~~~~~L~~~~ 129 (469)
+++|...++.+++..+....
T Consensus 111 l~~a~~~~~~~~~~~l~~~~ 130 (277)
T d2fo1e1 111 LHQAAANRDFGMMVYMLNST 130 (277)
T ss_dssp HHHHHHTTCHHHHHHHTTSH
T ss_pred ccchhhhcchhhhhhhhhcc
Confidence 99999999999988876543
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.5e-17 Score=163.82 Aligned_cols=95 Identities=32% Similarity=0.372 Sum_probs=90.3
Q ss_pred ChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHH
Q 012164 41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120 (469)
Q Consensus 41 ~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~ 120 (469)
.||||+||..|+.++|++|+++|+++|.+|..|+||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+
T Consensus 1 ~TpL~~Aa~~g~~~~v~~Ll~~g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~~~~g~t~L~~A~~~g~~~ 80 (408)
T d1n11a_ 1 LTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTN 80 (408)
T ss_dssp CCHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCHH
T ss_pred CChHHHHHHCcCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHH
Confidence 49999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCC
Q 012164 121 VIKLLEKHGAKPLMA 135 (469)
Q Consensus 121 ~~~~L~~~~~~~~~~ 135 (469)
++++|+....++...
T Consensus 81 ~~~~Ll~~~~~~~~~ 95 (408)
T d1n11a_ 81 MVKLLLENNANPNLA 95 (408)
T ss_dssp HHHHHHHHTCCTTCC
T ss_pred HHHHHHHhhhccccc
Confidence 999999887765433
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.69 E-value=3.2e-17 Score=155.42 Aligned_cols=112 Identities=20% Similarity=0.197 Sum_probs=92.5
Q ss_pred cCCCCCCC-CCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCH-------HHHHHHH-------
Q 012164 29 NGLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT-------EVVSLLL------- 93 (469)
Q Consensus 29 ~~~d~~~~-~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~-------~~v~~Ll------- 93 (469)
.++|+|.. |.+|+||||+||..|+.++|++||++|||++.+|..|+||||+||..++. +++++|.
T Consensus 95 ~~~dvn~~~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d 174 (301)
T d1sw6a_ 95 TQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILED 174 (301)
T ss_dssp SCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEEC
T ss_pred cCCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcc
Confidence 46677755 88999999999999999999999999999999999999999999986642 3333322
Q ss_pred -----------------------------------HCCC-------------------------------------CCCC
Q 012164 94 -----------------------------------ERGA-------------------------------------DVDP 101 (469)
Q Consensus 94 -----------------------------------~~g~-------------------------------------~~~~ 101 (469)
..+. .+|.
T Consensus 175 ~~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~ 254 (301)
T d1sw6a_ 175 SMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNA 254 (301)
T ss_dssp TTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTC
T ss_pred cccCCHHHHHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccC
Confidence 2111 1688
Q ss_pred CcCCCccccccccccchHHHHHHHHhhcCCCCCCccccc
Q 012164 102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (469)
Q Consensus 102 ~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 140 (469)
+|..|+||||+|+..|+.+++++|+++|+++........
T Consensus 255 ~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~ 293 (301)
T d1sw6a_ 255 QDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGL 293 (301)
T ss_dssp CCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Confidence 899999999999999999999999999999877654433
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=4.2e-17 Score=160.54 Aligned_cols=98 Identities=30% Similarity=0.303 Sum_probs=92.1
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcc
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t 108 (469)
+|+|++..+..+.||||.|+..++.++++.+++.|+++|.+|.+|.||||+||.+|+.++|++|+++|||++.+|..|+|
T Consensus 286 ~g~~~~~~~~~~~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~t 365 (408)
T d1n11a_ 286 HGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTT 365 (408)
T ss_dssp HTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCC
T ss_pred CCCccccccccccccchhhcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Confidence 57888888888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHH
Q 012164 109 PLGDAIYYKNHEVIKLLE 126 (469)
Q Consensus 109 pl~~A~~~~~~~~~~~L~ 126 (469)
|||+|+..|+.+++++|.
T Consensus 366 ~L~~A~~~~~~~iv~~L~ 383 (408)
T d1n11a_ 366 PLAIAKRLGYISVTDVLK 383 (408)
T ss_dssp HHHHHHHTTCHHHHHHHH
T ss_pred HHHHHHHcCCHHHHHHHH
Confidence 999999999999988664
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.68 E-value=3.5e-17 Score=153.82 Aligned_cols=135 Identities=27% Similarity=0.275 Sum_probs=112.3
Q ss_pred cccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCC-------------------
Q 012164 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF------------------- 68 (469)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~------------------- 68 (469)
.|+|+.+..-|.+...+..--+|+|+|..|.+|.||||+|+..|+.++|++|+++|++.+.
T Consensus 41 ~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~~~~ 120 (291)
T d1s70b_ 41 GAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLD 120 (291)
T ss_dssp HHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHH
T ss_pred chHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeecccccccccccccccccccccccccccc
Confidence 3667777777777776666678999999999999999999999999999999988765332
Q ss_pred --------------------------------------------------------------------------cCCCCC
Q 012164 69 --------------------------------------------------------------------------RDIDNR 74 (469)
Q Consensus 69 --------------------------------------------------------------------------~d~~g~ 74 (469)
.+..|.
T Consensus 121 ~~~~l~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 200 (291)
T d1s70b_ 121 IAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGG 200 (291)
T ss_dssp HHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTCC
T ss_pred hhhcccccCcccccccccCccccccccccccchhccccccccccccccccccccccccccchhhhcccccccccccCCCC
Confidence 234567
Q ss_pred cHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCccccccc
Q 012164 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (469)
Q Consensus 75 t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 142 (469)
||||+|+..|+.+++++|++.|+|++.++..|+||||+|+..|+.+++++|+++|+++........++
T Consensus 201 t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~Ta 268 (291)
T d1s70b_ 201 TALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTA 268 (291)
T ss_dssp CHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred ChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 88888888899999999999999999999999999999999999999999999999886654433333
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=4.9e-17 Score=146.71 Aligned_cols=129 Identities=24% Similarity=0.216 Sum_probs=93.2
Q ss_pred cccccccccCCCcc----ccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Q 012164 8 RTTLLKQSSLAPDR----ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (469)
Q Consensus 8 ~~~~~~~~~~~~~~----~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~ 83 (469)
.||+|.+...+... ..+....++.++|.++.+|+||||+||..|+.+++++|++.|+|++.+|..|+||||+|+..
T Consensus 3 ~t~Lh~A~~~g~~~~~~~li~~~~~~~~~in~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~ 82 (221)
T d1iknd_ 3 DSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQ 82 (221)
T ss_dssp CCTTHHHHHTTCSSSSSCCCC-----CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHH
T ss_pred ChHHHHHHHcCCHHHHHHHHHHHHhCCCCcccCCCCCCcccccccccccccccccccccccccccccccccccccccccc
Confidence 46666555444321 12334446788888899999999999999999999999999999999988888888888877
Q ss_pred CCHHHHHHHHHC---------------------------------------CCCCCCCc-CCCccccccccccchHHHHH
Q 012164 84 GFTEVVSLLLER---------------------------------------GADVDPKD-RWGSTPLGDAIYYKNHEVIK 123 (469)
Q Consensus 84 g~~~~v~~Ll~~---------------------------------------g~~~~~~~-~~g~tpl~~A~~~~~~~~~~ 123 (469)
|+.++++.|++. |++++..+ ..|.||||+|+..|+.++++
T Consensus 83 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~ 162 (221)
T d1iknd_ 83 GCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVS 162 (221)
T ss_dssp TCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHH
T ss_pred ccccccchhhhhcccccccccccccccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHH
Confidence 777776666543 44444443 46788888888888888888
Q ss_pred HHHhhcCCCCCCc
Q 012164 124 LLEKHGAKPLMAP 136 (469)
Q Consensus 124 ~L~~~~~~~~~~~ 136 (469)
+|+++|+++....
T Consensus 163 ~Ll~~gad~~~~~ 175 (221)
T d1iknd_ 163 LLLKCGADVNRVT 175 (221)
T ss_dssp HHHTTTCCSCCCC
T ss_pred HHHhcCCcccccC
Confidence 8888887765443
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=9.8e-17 Score=136.54 Aligned_cols=121 Identities=21% Similarity=0.236 Sum_probs=103.4
Q ss_pred ccccCCCccccccc-cccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHH
Q 012164 13 KQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSL 91 (469)
Q Consensus 13 ~~~~~~~~~~~~~~-~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~ 91 (469)
.+...|.+...+.. +-++.|++..|..|+||||+|+ .|+.+++++|++.|+++|.++..|.+||++|+..++.+++++
T Consensus 8 ~Aa~~g~~~~vk~lL~~~~~~~n~~d~~g~t~L~~A~-~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 86 (156)
T d1bd8a_ 8 GAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKV 86 (156)
T ss_dssp HHHHHTCHHHHHHHHHTTCCCTTCCCTTSCCHHHHSC-TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHH
T ss_pred HHHHcCCHHHHHHHHHhCCCCCCccCCCCCccccccc-cccccccccccccccccccccccccccccccccccccccccc
Confidence 33334444443332 2357899999999999999987 488999999999999999999999999999999999999999
Q ss_pred HHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCC
Q 012164 92 LLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (469)
Q Consensus 92 Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~ 135 (469)
++++|++++.+|..|.||||+|+..|+.+++++|. .++++...
T Consensus 87 ~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~ 129 (156)
T d1bd8a_ 87 LVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRR 129 (156)
T ss_dssp HHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCC
T ss_pred ccccccccccccCCCCeeecccccccccccccccc-cccccccc
Confidence 99999999999999999999999999999999887 56665443
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.66 E-value=1e-16 Score=150.50 Aligned_cols=95 Identities=27% Similarity=0.319 Sum_probs=86.0
Q ss_pred CCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccc
Q 012164 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (469)
Q Consensus 30 ~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tp 109 (469)
..+....+..|.||||+|+..|+.++++.|++.|+|+|.+|..|+||||+||..|+.++|++|+++|+|++.+|..|+||
T Consensus 189 ~~~~~~~~~~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~Ta 268 (291)
T d1s70b_ 189 HINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTA 268 (291)
T ss_dssp CCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred ccccccccCCCCChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 44556677889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhh
Q 012164 110 LGDAIYYKNHEVIKLLEKH 128 (469)
Q Consensus 110 l~~A~~~~~~~~~~~L~~~ 128 (469)
||+|+. +++++|.+.
T Consensus 269 L~~A~e----~~~~~L~~~ 283 (291)
T d1s70b_ 269 FDVADE----DILGYLEEL 283 (291)
T ss_dssp TTSCCS----GGGHHHHHH
T ss_pred HHHHHH----HHHHHHHHH
Confidence 999986 455555543
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=2.3e-16 Score=142.26 Aligned_cols=94 Identities=26% Similarity=0.248 Sum_probs=79.4
Q ss_pred CCChHHHHHHHcCCHHHHHHHHHCCCCCCCcC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccc
Q 012164 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (469)
Q Consensus 39 ~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~ 117 (469)
.|.||||.|+..++.+.+++|+..|++++..+ .+|+||||+|+..|+.+++++|+++|+|++.+|..|.||||+|+..+
T Consensus 110 ~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~~~~ 189 (221)
T d1iknd_ 110 NGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRP 189 (221)
T ss_dssp TCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCTTSS
T ss_pred ccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHHHHCC
Confidence 34555555555566666666667777887765 67999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhhcCCC
Q 012164 118 NHEVIKLLEKHGAKP 132 (469)
Q Consensus 118 ~~~~~~~L~~~~~~~ 132 (469)
+.+++++|.+...+.
T Consensus 190 ~~~~~~~l~~~~~~~ 204 (221)
T d1iknd_ 190 STRIQQQLGQLTLEN 204 (221)
T ss_dssp CHHHHHHHHTTSCGG
T ss_pred CHHHHHHHHHcCCcc
Confidence 999999999887653
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.65 E-value=6.2e-18 Score=163.60 Aligned_cols=99 Identities=19% Similarity=0.071 Sum_probs=82.5
Q ss_pred CCCCCCCChHHHHHHHcCCHHHHHH---HHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCc--CCCcc
Q 012164 34 DGEEIKPEFRLMFLANERDVEGIKE---LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGST 108 (469)
Q Consensus 34 ~~~~~~g~t~l~~Aa~~~~~~~v~~---Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~--~~g~t 108 (469)
+.++..|.||||+||.+|+.+++++ |++.|+++|.+|.+|+||||+||.+|+.++|++|+++|++++..+ ..|+|
T Consensus 84 ~~~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t 163 (346)
T d2ajaa1 84 HKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYH 163 (346)
T ss_dssp HHHTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHH
T ss_pred HhccCCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCC
Confidence 3556678899999999999877665 788999999999999999999999999999999999999998876 45899
Q ss_pred ccccccccchHHHHHHHHhhcCCC
Q 012164 109 PLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 109 pl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
|||+|+..|+.+++++|++.++..
T Consensus 164 ~L~~Aa~~g~~~iv~~Ll~~~~~~ 187 (346)
T d2ajaa1 164 AFRLAAENGHLHVLNRLCELAPTE 187 (346)
T ss_dssp HHHHHHHTTCHHHHHHHHHSCGGG
T ss_pred hhHHHHHHhhHHHHHHHHHcCCcc
Confidence 999999999999999999887653
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.65 E-value=1.1e-18 Score=168.93 Aligned_cols=128 Identities=12% Similarity=-0.043 Sum_probs=104.5
Q ss_pred ccccccccccccCCCccc---cccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcC--CCCCcHHHH
Q 012164 5 VPVRTTLLKQSSLAPDRE---RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD--IDNRTALHV 79 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d--~~g~t~Lh~ 79 (469)
....||++.++.-|+... .....-.|++++..+.+|.||||+||.+|+.++|++|++.|++++..| .+|+||||+
T Consensus 88 ~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~ 167 (346)
T d2ajaa1 88 IKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRL 167 (346)
T ss_dssp CCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHH
T ss_pred CCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhHH
Confidence 345677777777776432 223444788889999999999999999999999999999999999876 469999999
Q ss_pred HHHcCCHHHHHHHHHCCCCCC---CCcCCCccccccccccchHHHHHHHHhhcCCC
Q 012164 80 AACQGFTEVVSLLLERGADVD---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (469)
Q Consensus 80 A~~~g~~~~v~~Ll~~g~~~~---~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~ 132 (469)
||.+|+.++|++|++.|++.. ..+..|.||++.|+.+|+.+++++|++.|+++
T Consensus 168 Aa~~g~~~iv~~Ll~~~~~~~~~~~~~~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~ 223 (346)
T d2ajaa1 168 AAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVML 223 (346)
T ss_dssp HHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHHHH
T ss_pred HHHHhhHHHHHHHHHcCCcccccccccCCCcchhhHHhhcCHHHHHHHHHhCCCCc
Confidence 999999999999999998753 44566788999999999999999999988764
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=8.9e-16 Score=143.26 Aligned_cols=108 Identities=27% Similarity=0.226 Sum_probs=93.8
Q ss_pred cCCCCCCCCCCCChHHHHHHHcC----CHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCc
Q 012164 29 NGLDDDGEEIKPEFRLMFLANER----DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKD 103 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~----~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~-~g~~~~~~~ 103 (469)
.|+|++..+..|.++++.+...+ ..+++++|+++|+++|.+|..|.||||+|+..|+.+++++|++ .|++++.+|
T Consensus 171 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d 250 (285)
T d1wdya_ 171 MGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 250 (285)
T ss_dssp SCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCC
T ss_pred cCCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCC
Confidence 46677777777777776654433 3568889999999999999999999999999999999999998 499999999
Q ss_pred CCCccccccccccchHHHHHHHHhhcCCCCCCc
Q 012164 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 104 ~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
..|.||||+|+..|+.+++++|+++||++....
T Consensus 251 ~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d 283 (285)
T d1wdya_ 251 SDGKTALLLAVELKLKKIAELLCKRGASTDCGD 283 (285)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccc
Confidence 999999999999999999999999999986553
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.6e-16 Score=133.57 Aligned_cols=119 Identities=24% Similarity=0.243 Sum_probs=85.5
Q ss_pred ccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHH
Q 012164 11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS 90 (469)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~ 90 (469)
++.+...|.+-..+..--+|+|++.+|.+|.||||+|+ .|+.+++++|+++|++++.++..|.|+|+.|+..++.++++
T Consensus 5 Lh~Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~ 83 (156)
T d1ihba_ 5 LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQ 83 (156)
T ss_dssp HHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHH
T ss_pred HHHHHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccccc
Confidence 34444444444444444467777777777777777665 57777777777777777777777777777777777777777
Q ss_pred HHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcC
Q 012164 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130 (469)
Q Consensus 91 ~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~ 130 (469)
+|++.+.+++..|..|.+|+++|+..++.+++++|+++++
T Consensus 84 ~l~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~Ll~~~~ 123 (156)
T d1ihba_ 84 TLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTA 123 (156)
T ss_dssp HHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccccccccccccccccccc
Confidence 7777777777777777777777777777777777777765
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=6.4e-16 Score=131.07 Aligned_cols=124 Identities=26% Similarity=0.293 Sum_probs=108.8
Q ss_pred ccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcC
Q 012164 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (469)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g 84 (469)
.-..||++-+. .+.....+-.-..|+|++..+..|.++|+.++..+..+.++.|++.+.+++..|..|.+|||+|+..|
T Consensus 32 ~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~a~~~~ 110 (156)
T d1ihba_ 32 GFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEG 110 (156)
T ss_dssp TTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred Ccccccccccc-cccccccccccccccccccccccCcccccccccccccccccccccccccccccccccccccccccccc
Confidence 34577877554 45443333344478889999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHCCC-CCCCCcCCCccccccccccchHHHHHHHHhhc
Q 012164 85 FTEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (469)
Q Consensus 85 ~~~~v~~Ll~~g~-~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~ 129 (469)
+.+++++|+++|+ +++.+|..|.||||+|+..++.+++++|+++|
T Consensus 111 ~~~~~~~Ll~~~~~~~~~~d~~g~TpL~~A~~~~~~~iv~~Ll~~G 156 (156)
T d1ihba_ 111 HLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG 156 (156)
T ss_dssp CHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC
T ss_pred cccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHhcC
Confidence 9999999999876 89999999999999999999999999999876
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.60 E-value=1.2e-15 Score=129.23 Aligned_cols=94 Identities=27% Similarity=0.335 Sum_probs=85.1
Q ss_pred HHHHHHHcCCHHHHHHHHHCCCCCCCc------CCCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCcCCCccccccc
Q 012164 43 RLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (469)
Q Consensus 43 ~l~~Aa~~~~~~~v~~Ll~~g~~in~~------d~~g~t~Lh~A~~~---g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A 113 (469)
.|+.|++.+++..+..++..|+|++.+ +..|+||||+|+.. |+.+++++|+++|+|++.+|..|+||||+|
T Consensus 9 ~L~~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A 88 (154)
T d1dcqa1 9 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYC 88 (154)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHH
T ss_pred HHHHHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccc
Confidence 355788999999999999999998765 67799999999974 688999999999999999999999999999
Q ss_pred cccchHHHHHHHHhhcCCCCCCc
Q 012164 114 IYYKNHEVIKLLEKHGAKPLMAP 136 (469)
Q Consensus 114 ~~~~~~~~~~~L~~~~~~~~~~~ 136 (469)
+..|+.+++++|+++|+++....
T Consensus 89 ~~~~~~~~v~~Ll~~gad~~~~d 111 (154)
T d1dcqa1 89 CLTDNAECLKLLLRGKASIEIAN 111 (154)
T ss_dssp HHTTCHHHHHHHHHTTCCTTCCC
T ss_pred cccccccccccccccCccccccC
Confidence 99999999999999999876553
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.60 E-value=7.7e-16 Score=143.07 Aligned_cols=98 Identities=26% Similarity=0.359 Sum_probs=90.7
Q ss_pred CCCCCCCCCCChHHHHHHHcCCHHHHHHHH-HCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccc
Q 012164 31 LDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (469)
Q Consensus 31 ~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll-~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tp 109 (469)
...+..+..|.||||+|+..++.+++++++ ..|.+++.+|..|+||||+||..|+.++|++|+++|+|++.+|..|.||
T Consensus 178 ~~~~~~~~~g~t~L~~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~ 257 (277)
T d2fo1e1 178 ARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTA 257 (277)
T ss_dssp GGTSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCH
T ss_pred ccccccccCCCCccccccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCCH
Confidence 445667788999999999999999999766 6789999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhh
Q 012164 110 LGDAIYYKNHEVIKLLEKH 128 (469)
Q Consensus 110 l~~A~~~~~~~~~~~L~~~ 128 (469)
||+|+..|+.+++++|.+.
T Consensus 258 L~~A~~~~~~~iv~lL~~c 276 (277)
T d2fo1e1 258 RQLAQANNHHNIVDIFDRC 276 (277)
T ss_dssp HHHHHHTTCHHHHHHHHTT
T ss_pred HHHHHHcCCHHHHHHHHHh
Confidence 9999999999999999853
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.58 E-value=4.1e-16 Score=138.84 Aligned_cols=108 Identities=31% Similarity=0.287 Sum_probs=90.2
Q ss_pred cCCCCCC-CCCCCChHHHHHHHcCCHHHHHHHHHCCCC------------------------------------------
Q 012164 29 NGLDDDG-EEIKPEFRLMFLANERDVEGIKELLDSGID------------------------------------------ 65 (469)
Q Consensus 29 ~~~d~~~-~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~------------------------------------------ 65 (469)
+|+|++. .|.+|+||||+||..|+.+++++|++.|++
T Consensus 11 ~g~din~~~d~~G~t~L~~A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (209)
T d1ot8a_ 11 QGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNLNARMHDG 90 (209)
T ss_dssp HHHHHHHHHHHHCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTC
T ss_pred CCCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHhhccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3444444 356777888888888888888888876643
Q ss_pred -------------------------CCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCccccccccccchHH
Q 012164 66 -------------------------VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120 (469)
Q Consensus 66 -------------------------in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~ 120 (469)
++.+|..|+||||+|+..|..++++.|++.+++++..|..|.||||+|+..|+.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~ 170 (209)
T d1ot8a_ 91 TTPLILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYE 170 (209)
T ss_dssp CCHHHHHHHTTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred cccccccccccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHH
Confidence 4566777889999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCc
Q 012164 121 VIKLLEKHGAKPLMAP 136 (469)
Q Consensus 121 ~~~~L~~~~~~~~~~~ 136 (469)
+++.|+++|+++....
T Consensus 171 ~v~~Ll~~gad~n~~d 186 (209)
T d1ot8a_ 171 ASKALLDNFANREITD 186 (209)
T ss_dssp HHHHHHHTTCCTTCCC
T ss_pred HHHHHHHCCCCCCCcC
Confidence 9999999999876543
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.58 E-value=1.2e-15 Score=128.92 Aligned_cols=128 Identities=30% Similarity=0.326 Sum_probs=100.9
Q ss_pred ccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHH
Q 012164 9 TTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88 (469)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~ 88 (469)
|||+.+...|.....+-.--+|+|.+ .+..|+||||+|+..++.++++.++......+..+..+.++++.++...+.++
T Consensus 4 t~L~~Aa~~g~~~~v~~LL~~ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (153)
T d1awcb_ 4 KKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANI 82 (153)
T ss_dssp HHHHHHHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHH
T ss_pred HHHHHHHHCCCHHHHHHHHHcCCCcc-cccCCCcccccccccccccccccccccccccccccccccccccccccccccee
Confidence 45555555555554444444566555 46778888888888888888888887777777777777788888888888889
Q ss_pred HHHHHHCCCCCCCCcCCCccccccccccchHHHHHHHHhhcCCCCCCcc
Q 012164 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (469)
Q Consensus 89 v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~~~~~~~~~~ 137 (469)
+++|+.+|++++.+|..|+||||+|+..|+.+++++|++.|+++.....
T Consensus 83 ~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~ 131 (153)
T d1awcb_ 83 VEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSK 131 (153)
T ss_dssp HHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred eecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCC
Confidence 9999999999999999999999999999999999999999998865443
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=2.2e-15 Score=134.29 Aligned_cols=91 Identities=21% Similarity=0.280 Sum_probs=85.8
Q ss_pred CCChHHHHHHHcCCHHHHHHHHH----CCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccccc
Q 012164 39 KPEFRLMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (469)
Q Consensus 39 ~g~t~l~~Aa~~~~~~~v~~Ll~----~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~ 114 (469)
+|+||||+||..|+.+++++|++ .|+++|.+|..|+||||+||..|+.+++++|+++|++++..+..|.++++.|.
T Consensus 2 dG~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a~ 81 (228)
T d1k1aa_ 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLAC 81 (228)
T ss_dssp TTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred CCccHHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhccccccccccccccccccccccccccccccccc
Confidence 69999999999999999999884 89999999999999999999999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHhhc
Q 012164 115 YYKNHEVIKLLEKHG 129 (469)
Q Consensus 115 ~~~~~~~~~~L~~~~ 129 (469)
..++.++++.+....
T Consensus 82 ~~~~~~~~~~~~~~~ 96 (228)
T d1k1aa_ 82 EHRSPTCLRALLDSA 96 (228)
T ss_dssp HTTCHHHHHHHHHHS
T ss_pred ccccccchhhhhhcc
Confidence 999999888776654
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=3e-15 Score=133.31 Aligned_cols=91 Identities=24% Similarity=0.304 Sum_probs=86.0
Q ss_pred CCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccc
Q 012164 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (469)
Q Consensus 33 ~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~ 112 (469)
.......|.++|+.|+..+...+++.+++.|.+++.+|..|.||||+||..|+.+++++|+++|+|++.+|..|+||||+
T Consensus 137 ~~~~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~ 216 (228)
T d1k1aa_ 137 DAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMV 216 (228)
T ss_dssp TCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTT
T ss_pred ccccccchhhHHHHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHH
Confidence 44556678999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHH
Q 012164 113 AIYYKNHEVIK 123 (469)
Q Consensus 113 A~~~~~~~~~~ 123 (469)
|+..|+.++++
T Consensus 217 A~~~~~~divk 227 (228)
T d1k1aa_ 217 ARSRRVIDILR 227 (228)
T ss_dssp CSSHHHHHHHT
T ss_pred HHhCCCccccC
Confidence 99999998874
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.57 E-value=9.8e-16 Score=144.96 Aligned_cols=111 Identities=21% Similarity=0.111 Sum_probs=92.3
Q ss_pred cccccccccccccCCCccccccccccCCCCCCCCCCCChHHHHHHHcCCH-------HHHHH------------------
Q 012164 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDV-------EGIKE------------------ 58 (469)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~g~t~l~~Aa~~~~~-------~~v~~------------------ 58 (469)
+.-.+||+|.++..+.+.-.+-.--+|+|++.+|..|+||||.||..++. +++++
T Consensus 104 D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d~~g~t~lh~ 183 (301)
T d1sw6a_ 104 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHH 183 (301)
T ss_dssp STTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHHH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcccccCCHHHH
Confidence 45578999999999988777766678999999999999999999986541 23222
Q ss_pred ------------------------HHHCCC-------------------------------------CCCCcCCCCCcHH
Q 012164 59 ------------------------LLDSGI-------------------------------------DVNFRDIDNRTAL 77 (469)
Q Consensus 59 ------------------------Ll~~g~-------------------------------------~in~~d~~g~t~L 77 (469)
+++.+. .+|.+|.+|+|||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~D~~G~TpL 263 (301)
T d1sw6a_ 184 IIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCL 263 (301)
T ss_dssp HHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCHH
T ss_pred HHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccCCCCCCCCHH
Confidence 222221 1788999999999
Q ss_pred HHHHHcCCHHHHHHHHHCCCCCCCCcCCCcccccccc
Q 012164 78 HVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (469)
Q Consensus 78 h~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~ 114 (469)
|+||+.|+.++|++|+++|||++.+|..|.|||++|+
T Consensus 264 h~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~ 300 (301)
T d1sw6a_ 264 NIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300 (301)
T ss_dssp HHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred HHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence 9999999999999999999999999999999999997
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.50 E-value=4.8e-14 Score=127.04 Aligned_cols=106 Identities=25% Similarity=0.234 Sum_probs=95.9
Q ss_pred CCCCCCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCC-CCCCCCcCCCcccc
Q 012164 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPL 110 (469)
Q Consensus 32 d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g-~~~~~~~~~g~tpl 110 (469)
+....+..+.|+++.++..++.++++.|++.|.+++.+|..|+||||+|+..|+.+++++|++.| .+++.+|..|+|||
T Consensus 97 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpL 176 (229)
T d1ixva_ 97 DLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPL 176 (229)
T ss_dssp CTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHH
T ss_pred cccccccccccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCch
Confidence 34556667889999999999999999999999999999999999999999999999999999986 78999999999999
Q ss_pred ccccccchHHHHHHHHh-hcCCCCCCcc
Q 012164 111 GDAIYYKNHEVIKLLEK-HGAKPLMAPM 137 (469)
Q Consensus 111 ~~A~~~~~~~~~~~L~~-~~~~~~~~~~ 137 (469)
|+|+..|+.+++++|+. .|+++.....
T Consensus 177 h~A~~~~~~~~v~~Ll~~~gad~~~~d~ 204 (229)
T d1ixva_ 177 FHALAEGHGDAAVLLVEKYGAEYDLVDN 204 (229)
T ss_dssp HHHHHTTCHHHHHHHHHHHCCCSCCCCT
T ss_pred hhhcccccHHHHHHHHHhcCCCCCCcCC
Confidence 99999999999999996 5888765543
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.8e-14 Score=134.26 Aligned_cols=76 Identities=26% Similarity=0.369 Sum_probs=71.9
Q ss_pred cCCCCCCCCCCCChHHHHHHHcCCHHHHHHHHHC-CCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCcC
Q 012164 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (469)
Q Consensus 29 ~~~d~~~~~~~g~t~l~~Aa~~~~~~~v~~Ll~~-g~~in~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~ 104 (469)
.|+|.+.++..|.||||+||..|+.+++++|++. |+|+|.+|.+|.||||+|+.+|+.++|++|+++|||+|.+|.
T Consensus 208 ~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~ 284 (285)
T d1wdya_ 208 HGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL 284 (285)
T ss_dssp TTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred CCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence 5778888899999999999999999999999985 999999999999999999999999999999999999999873
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.69 E-value=4.9e-05 Score=68.21 Aligned_cols=126 Identities=13% Similarity=0.020 Sum_probs=82.2
Q ss_pred EEEEEeceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEeccCCCCHHHHHHhcCCC
Q 012164 169 ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247 (469)
Q Consensus 169 ~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l 247 (469)
..+..++..+.+|......... ...+.+|...++.+. +--+.+++.++...+..++||++++|.++.+....
T Consensus 31 ~rv~~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~---- 103 (263)
T d1j7la_ 31 YKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---- 103 (263)
T ss_dssp EEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT----
T ss_pred EEEEeCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc----
Confidence 3444566778888765432211 124667888887774 43467888888888889999999998887654321
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------------------C
Q 012164 248 KPSTAVRFALDIARGMNYLHENK--------------------------------------------------------P 271 (469)
Q Consensus 248 ~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------------------------~ 271 (469)
......++.++++.+..||+.. +
T Consensus 104 -~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 182 (263)
T d1j7la_ 104 -EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEE 182 (263)
T ss_dssp -CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCC
T ss_pred -cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCC
Confidence 1223334555556666666421 0
Q ss_pred CCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCccc
Q 012164 272 VPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSKL 313 (469)
Q Consensus 272 ~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~~ 313 (469)
..++|+|+.|. |+++++++.+-|+||+.+..
T Consensus 183 ~~l~HgD~~~~-----------Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 183 LVFSHGDLGDS-----------NIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEEECSCCCTT-----------SEEEETTEEEEECCCTTCEE
T ss_pred cEEEEeeccCc-----------ceeecCCceEEEeechhccc
Confidence 12689999999 77777666667999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.10 E-value=0.00017 Score=64.18 Aligned_cols=58 Identities=21% Similarity=0.164 Sum_probs=40.5
Q ss_pred eceeehhhhcccccCCCHHHHHHHHHHHHHHhcCC--CCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 174 ~g~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
.|..+.+|....... ..+..|...++.+. .-.+.+++.+..+.+..++||++++|.++
T Consensus 34 ~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 34 GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 355677787654322 23667888887774 23366788888888889999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.88 E-value=0.001 Score=63.30 Aligned_cols=74 Identities=18% Similarity=0.082 Sum_probs=40.6
Q ss_pred eeeecCeEEEEEE-----eceeehhhhcccccCC----CHHHHHHHHHHHHHHhcCC-C--CceeeEEeEEEeCCceEEE
Q 012164 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVIS----DDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQSSPMMIV 228 (469)
Q Consensus 161 ~~ig~G~~~~~~~-----~g~~vaiK~~~~~~~~----~~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~~~~~lv 228 (469)
+.||.|..-.+|. +|+.|+||.-.+.... ......+...|.+.++.+. + ..+++++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 4677776655542 3567787743321000 0011233456787777663 2 356677655 44556899
Q ss_pred EeccCCCC
Q 012164 229 TEYLPKGD 236 (469)
Q Consensus 229 ~E~~~~gs 236 (469)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=92.99 E-value=0.041 Score=51.65 Aligned_cols=38 Identities=16% Similarity=0.239 Sum_probs=26.8
Q ss_pred HHHHHHHHHhcCC-CCceeeEEeEEEeCCceEEEEeccCCCCH
Q 012164 196 AFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (469)
Q Consensus 196 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~E~~~~gsL 237 (469)
...+|..+++.+. +.-.+++++++.+ .+|+||++|.+|
T Consensus 90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3457888888885 5445578887743 689999986443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=85.15 E-value=0.11 Score=46.65 Aligned_cols=30 Identities=23% Similarity=0.207 Sum_probs=24.8
Q ss_pred CCeEecCCCCCcccccccccCcceeeCCCCCeEEeecCCcc
Q 012164 272 VPIIHRDLEPSDLYVAYWQNDRNILRDDSGNLKVADFGVSK 312 (469)
Q Consensus 272 ~~ivH~Dlkp~Nil~~~~~~~~nil~~~~~~vkl~Dfgla~ 312 (469)
.++||+|+.++ |++++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~d-----------Nvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQD-----------NVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGG-----------GEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchh-----------hhhcccccceeEecccccc
Confidence 34999999999 7777777767899999875
|